{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions_in_experiment": 1000
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "\nBetween 2023 and 2024 the gross benefit obligation of LMT’s non‑qualified defined‑benefit pension plans stayed essentially unchanged at about **$1.0 billion** (the filing notes the same $1.0 billion figure for both 31 Dec 2023 and 31 Dec 2024).  At the same time, the actuarial‑loss balance recorded in accumulated other comprehensive loss fell from **$347 million** as of 31 Dec 2023 to **$303 million** as of 31 Dec 2024, indicating a modest reduction in unrecognized actuarial losses over the year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error regarding the gross benefit obligation. The ground truth clearly states the obligation was $1.0 billion in 2023 and DECREASED to $905 million in 2024. However, the LLM claims it 'stayed essentially unchanged at about $1.0 billion' for both years, explicitly stating 'the filing notes the same $1.0 billion figure for both 31 Dec 2023 and 31 Dec 2024.' This is factually incorrect. The LLM failed to capture the $95 million decrease ($1.0B to $905M), which is a material change and a key part of the answer. The actuarial losses figures are correct ($347M in 2023, $303M in 2024, representing a $44M decline), and the characterization of this as a 'modest reduction' is appropriate. The LLM correctly identified the metrics, company (LMT), years, and time periods. However, the fundamental misstatement about the gross benefit obligation being unchanged when it actually decreased significantly undermines the entire answer. The question specifically asks how these metrics 'evolved,' and the LLM missed half of the evolution story. The reasoning about actuarial losses is sound, but the core quantitative error on the primary metric (gross benefit obligation) is a critical failure that cannot be overlooked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 356,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "\nGM lifted its long‑term expected return on U.S. pension‑plan assets from roughly 6 % (the 2022‑2023 level) to **6.5 % at the end of 2024** (up from 6.3 % in 2023).  This upward adjustment is tied to a modest but intentional shift in the plan’s strategic mix: the allocation stays about **11 % equity**, **≈60 % debt**, but the “other” bucket (private‑equity, real‑estate, hedge‑fund and absolute‑return strategies) expands from roughly **15 % of non‑U.S. assets to 29 % of the U.S. portfolio**, while the overall debt weight is held steady.  The change signals that GM is tilting the portfolio toward higher‑return alternative assets to improve funded status while still using a liability‑driven, risk‑mitigated asset mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 2024 endpoint (6.5% from 6.3% in 2023) and provides relevant strategic asset mix details. However, there are significant issues with the 2022 baseline comparison. The original answer clearly states that in 2022, GM reported rates of 5.4% (2021) and 5.6% (2020), not '~6%' as the LLM claims. This is a critical factual error that undermines the core comparison requested in the question about evolution between 2022 and 2024. The LLM appears to have conflated 2022-2023 data with a '~6%' level, which is inaccurate. The LLM does provide valuable additional detail about the strategic asset mix adjustments (equity ~11%, debt ~60%, alternatives expanding to 29%), which goes beyond the original answer and demonstrates good synthesis. However, this additional detail cannot compensate for the fundamental error in the 2022 baseline figure. The reasoning about moving from conservative to optimistic assumptions is sound, but the quantitative foundation is flawed. The LLM correctly captures the 2024 figures and the directional shift, but fails to accurately represent the 2022 starting point, which is essential for answering a question specifically about evolution 'between 2022 and 2024.' The multi-hop synthesis is partially successful (combining asset allocation data with return assumptions), but the missing/incorrect 2022 baseline is a material omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 389,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "\nChevron moved from acquiring PDC Energy in 2023 to fully integrating it as a wholly‑owned subsidiary by 2024, so that PDC’s upstream assets and production are now reported within Chevron’s own segments.  The integration added roughly **$3.5 billion to U.S. upstream earnings** and **boosted net oil‑equivalent production by about 250 k bbl/d**, contributing to higher segment earnings and revenue; it also caused the company to exclude PDC from its internal‑control assessment because the acquisition occurred during 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) EARNINGS IMPACT - INCORRECT: The LLM states '$3.5 billion' increase in U.S. upstream earnings, but the ground truth specifies '$2.2 billion'. This is a $1.3 billion overstatement (59% error). This is a material misrepresentation of financial impact. (2) PRODUCTION IMPACT - INCORRECT METRIC: The LLM provides '250 k bbl/d' (barrels per day), but the ground truth states '19% increase in net oil-equivalent production'. These are fundamentally different metrics - one is an absolute production rate, the other is a percentage increase. The LLM appears to have invented a specific production number not supported by the ground truth. (3) CORRECT ELEMENTS: The LLM correctly identifies that Chevron acquired PDC Energy in 2023, that integration progressed through 2024, that PDC was excluded from internal control assessment due to the acquisition timing, and that PDC became a wholly-owned subsidiary contributing to segment earnings. (4) MULTI-HOP REASONING: The LLM demonstrates understanding of the acquisition-to-integration progression and correctly synthesizes the relationship evolution between 2023-2024. However, this qualitative accuracy is severely undermined by the quantitative errors. (5) SEMANTIC ISSUES: While the LLM's narrative structure is coherent and addresses the question's components, the specific financial figures are materially wrong, which is unacceptable for financial analysis. The 19% production increase is a key metric that should not be replaced with an invented absolute figure. SUMMARY: The answer demonstrates partial understanding of the business relationship evolution but fails critically on financial accuracy - the two most important quantitative metrics are either wrong or misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 504,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "\nSouthern Company continues to value its energy‑related derivatives at fair value, but the 2024 filing presents them with a far more detailed balance‑sheet breakdown—separate current and non‑current asset and liability lines, gross amounts, an offset‑collateral column, and a net‑amount line—whereas the 2022 filing aggregated the balances as a single regulatory‑hedge asset or liability. Consequently, the unrealized position moved from a modest net regulatory‑hedge asset of roughly $21 million in 2022 to a net liability of about $84 million in 2024, and the gains/losses are now shown net of $7 million of offsetting collateral.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific numerical claims that cannot be verified against the ground truth and appear to introduce unsupported details. Critical issues: (1) QUANTITATIVE PROBLEMS: The LLM cites specific dollar amounts ($21 million net regulatory-hedge asset in 2022, $84 million net liability in 2024, $7 million offsetting collateral) that are not mentioned in the ground truth. These precise figures are presented as factual but lack verification. The ground truth does not provide these specific numbers, making it impossible to confirm accuracy. (2) PRESENTATION DETAILS: While the LLM correctly identifies that there was a shift from aggregated to more detailed balance-sheet presentation (current/non-current breakdown, gross amounts, collateral offsets), the ground truth only mentions a general shift to 'fair value' presentation under 'Other' or 'Risk Management Activities' categories. The LLM adds granular details about presentation format that go beyond what the ground truth confirms. (3) MULTI-HOP REASONING: The LLM does attempt to synthesize the change between 2022 and 2024, which is appropriate for the question. However, the synthesis relies on unverified numerical claims. (4) SEMANTIC ALIGNMENT: The LLM correctly identifies the core concept of a shift from regulatory hedge treatment to fair value presentation, which aligns with the ground truth's statement about 'change in both the valuation approach and the presentation.' However, the specific quantitative claims undermine confidence in the overall answer. (5) MISSING ELEMENTS: The LLM does not mention the specific reference to 'designated as regulatory hedging instruments and deferred' or the historical comparison to December 31, 2021 and 2020 data mentioned in the ground truth. The answer is partially correct in concept but fails on quantitative precision and introduces unverified specific numbers that are critical to the answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 524,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "\nChevron’s investment in Tengizchevroil expanded – the carrying value rose from roughly **$23–$24 billion at the end of 2022** to **about $27.4 billion at the end of 2024** (CVX 10‑K 2024, Note 15, p. 83).  At the same time, Chevron’s equity earnings from the affiliate fell from **≈ $4.4 billion in 2022** to **≈ $3.6 billion in 2024** (CVX 10‑K 2024, Segmented Income Statement, Upstream – Equity‑affiliate income, p. 84).  The higher carrying value reflects additional capital contributions and loan accruals, while the earnings decline is due to lower net income generated by TCO in those years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the overall trend of Chevron's investment in Tengizchevroil growing from ~$23-24 billion in 2022 to ~$27.4 billion in 2024, which aligns with the ground truth showing $26,954M (2023) and $27,368M (2024). The answer appropriately addresses both investment carrying value and equity earnings components. The reasoning about capital contributions and loan accruals is sound and contextually relevant.\n\nCRITICAL ERRORS: (1) EQUITY EARNINGS FIGURE FOR 2024 IS INCORRECT: The LLM states equity earnings declined to '≈ $3.6 billion in 2024' but the ground truth clearly states $3,033 million ($3.033 billion) in 2024. This is a material error of ~$567 million or ~18.7% overstatement. (2) MISSING KEY DETAIL: The ground truth specifically mentions the $4,500 million loan to fund FGP/WPMP development in 2022, which the LLM omits entirely. This was a significant structural element of the investment relationship. (3) INCOMPLETE 2022 BASELINE: While the LLM provides a range ($23-24B), the ground truth indicates the carrying value was about $100 million higher than underlying equity in net assets, with the $4.5B loan being a major component - this nuance is lost.\n\nQUANTITATIVE VERIFICATION: 2024 investment value of $27.4B is approximately correct (ground truth: $27,368M). 2022 equity earnings of $4.4B is correct. However, 2024 equity earnings of $3.6B is WRONG - should be $3.033B. The error magnitude is significant enough to affect the accuracy of the earnings decline narrative.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across multiple data points (investment values across years, earnings across years, and provides reasonable explanation for the trends). However, the incorrect 2024 earnings figure undermines the credibility of the earnings decline analysis.\n\nSEMANTIC EQUIVALENCE: The general narrative about investment growth and earnings decline is semantically equivalent to the ground truth, but the specific quantitative error on 2024 earnings prevents full equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 553,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart’s ownership of Alert Innovation stayed at 100 % – the stake was already fully consolidated after the prior year’s purchase. The change in relationship was triggered by the **fiscal 2023 $0.4 billion acquisition of Alert Innovation**, which moved the entity from being a variable‑interest entity to a 100 % owned subsidiary, after which no further ownership transactions occurred through fiscal 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that fundamentally misrepresents the evolution of Walmart's ownership stake in Alert Innovation. (1) MAJOR ERROR - INCOMPLETE ANSWER: The ground truth clearly states that by fiscal 2024, Walmart had 'subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity.' The LLM answer completely omits this crucial transaction and incorrectly claims 'no further ownership transactions occurred through fiscal 2024.' This is a fundamental misunderstanding of the question's core requirement to describe how the ownership stake 'evolved' between the two years. (2) QUANTITATIVE ACCURACY: The $0.4 billion acquisition amount is correct, and the 100% ownership percentage is accurate for fiscal 2023. However, the answer fails to address the fiscal 2024 deconsolidation/sale, which would represent a 100% to 0% change. (3) MULTI-HOP REASONING FAILURE: The question explicitly asks about evolution 'between fiscal 2023 and fiscal 2024' and what 'specific transaction occurred to change its relationship.' The LLM only addresses the fiscal 2023 transaction and misses the critical fiscal 2024 sale/deconsolidation transaction. This is a failure to synthesize the complete multi-year narrative. (4) SEMANTIC MISMATCH: The LLM's statement that 'no further ownership transactions occurred through fiscal 2024' directly contradicts the ground truth that a sale and deconsolidation occurred in fiscal 2024. The answer describes a static situation (100% ownership maintained) when the ground truth describes a dynamic transformation (100% ownership to complete exit). This is not a wording difference but a factual contradiction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 463,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 Starbucks cut the fair‑value of its foreign‑currency‑other derivatives.  The combined asset position fell from about **$115 million** (≈ $73 million of designated assets plus $42 million of non‑designated assets) in 2022 to roughly **$64 million** in 2023, while total liabilities dropped from roughly **$6.2 million** to **$4.3 million**.  The reduction in both the notional size and net fair‑value of these contracts shows that the company is scaling back its explicit currency‑hedge program and is managing foreign‑exchange exposure more conservatively—likely by relying more on natural hedges and operational adjustments rather than maintaining a large derivative book.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims 2022 combined assets were ~$115 million ($73M designated + $42M non-designated), but the ground truth shows only $55.3 million in AOCI for 2022. The LLM's 2023 figure of ~$64 million ($1.9M current + $1.7M long-term = $3.6M total assets) is also incorrect - the ground truth shows only $3.6 million in total assets for 2023, not $64 million. The LLM appears to have fabricated or misread the 2023 asset position entirely. For liabilities, the LLM claims $6.2 million in 2022 (no ground truth provided for 2022 liabilities to verify), but states $4.3 million in 2023 when ground truth shows $8.8 million ($4.7M current + $4.1M long-term). This is a critical error - the LLM understated 2023 liabilities by approximately 50%. (2) STRUCTURAL MISUNDERSTANDING: The LLM conflates different balance sheet line items and appears to have invented the $73M/$42M breakdown for 2022 with no basis in the ground truth. The ground truth clearly distinguishes between AOCI positions in 2022 versus current/long-term asset/liability positions in 2023, which are different accounting presentations. (3) MULTI-HOP REASONING: While the LLM correctly identifies the general trend (reduction in exposure and shift toward more conservative management), the numerical foundation supporting this conclusion is entirely wrong. The conclusion about 'scaling back' and 'natural hedges' may be directionally reasonable but is built on false numbers. (4) MISSING KEY DETAILS: The LLM fails to mention the specific $55.3 million AOCI position in 2022 or the $32.5 million reclassification expectation, which are material details from the ground truth. The answer demonstrates poor data synthesis and significant calculation/transcription errors that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 517,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Medtronic eliminated any outstanding A Preferred Shares. In the third quarter of FY 2022 the company redeemed the 1,872 A Preferred Shares that had been outstanding (for a nominal $0.075 million), and by the end of FY 2022 — and consequently throughout FY 2023 and FY 2024 — no A Preferred Shares remained issued or outstanding. No further actions regarding these shares were taken in later years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative details are correct: 1,872 A Preferred Shares redeemed in Q3 FY2022 for $0.075 million. The temporal sequence is accurate - no shares outstanding by end of FY2022 and continuing through FY2024. The answer correctly addresses both parts of the multi-part question: (1) the specific action taken in 2022 (redemption of 1,872 shares for $0.075M in Q3), and (2) the evolution between FY2022 and FY2024 (discontinuation with no reissuance). The multi-hop reasoning is sound, synthesizing information about the redemption event and subsequent status across multiple fiscal years. The semantic meaning matches the ground truth perfectly - the LLM conveys that the company eliminated these shares through redemption and did not reintroduce them. Minor note: The LLM uses slightly different phrasing (\"eliminated any outstanding A Preferred Shares\" vs. the ground truth's \"redeemed\") but this is semantically equivalent and actually adds clarity. The answer is well-structured and provides appropriate context about the discontinuation. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 328,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "\nBetween 2022 and 2023 the equity income (loss) that Comcast records from its investment in Atairos flipped sign.  In 2022 the investment generated a **$434 million loss**, driven by fair‑value adjustments to Atairos’ underlying holdings, while in 2023 it produced a **$1.1 billion gain** from those same fair‑value adjustments.  This swing helped turn Comcast’s consolidated “Investment and other income (loss), net” from a negative $(861) million in 2022 to a positive $1.252 billion in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: the 2022 loss of $434 million and the 2023 gain of $1.1 billion are accurately stated. The characterization of these as fair-value adjustments on underlying investments is correct. The multi-hop reasoning is sound - the answer correctly synthesizes Comcast's equity income from Atairos across two years and identifies the significant turnaround. The LLM goes beyond the ground truth by providing additional context about how this swing affected Comcast's consolidated 'Investment and other income (loss), net' (from $(861) million in 2022 to $1.252 billion in 2023), which demonstrates deeper understanding of the financial relationships. The wording 'flipped sign' and 'swing' effectively conveys the dramatic reversal. All entities are correctly identified (Comcast, Atairos, years 2022-2023). The only minor consideration is that the additional context about consolidated investment income, while accurate and helpful, goes slightly beyond what was explicitly asked, though this is a strength rather than a weakness. No calculation errors detected. The answer is semantically equivalent to and more comprehensive than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 349,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the company’s **consolidated** natural‑gas reserves in the Asia‑Pacific/Middle‑East region slipped from about **312 billion cubic feet to 296 billion cubic feet** (≈ 5 % lower).  When the **equity‑affiliate** reserves are added, total regional reserves actually rose from roughly **5.6 trillion to 6.2 trillion cubic feet**, showing that ConocoPhillips is compensating for modest declines in its direct holdings with growth through partnerships, underscoring a continued strategic emphasis on the Asia‑Pacific/Middle‑East.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers: consolidated reserves declined from 312 BCF (2023) to 296 BCF (2024), matching the ground truth exactly. The calculated percentage decline of approximately 5% is accurate (16 BCF / 312 BCF ≈ 5.1%). The LLM correctly identifies this as a 'consolidated' figure and distinguishes it from equity-affiliate reserves. The answer goes beyond the ground truth by introducing additional context about equity-affiliate reserves (5.6 trillion to 6.2 trillion cubic feet) and providing a more nuanced strategic interpretation—that ConocoPhillips is compensating for direct holdings declines through partnership growth. This additional information, while not contradicted by the ground truth, cannot be verified against it. The LLM's interpretation that this indicates 'continued strategic emphasis' on the region is a reasonable inference from the data presented, though slightly more optimistic than the ground truth's characterization of 'limited growth or strategic reallocation.' The answer is well-structured, clearly distinguishes between consolidated and equity-affiliate reserves, and provides sound multi-hop reasoning. Minor deduction due to the introduction of unverified equity-affiliate data and a slightly different strategic interpretation than the ground truth, though the core facts about consolidated reserves are entirely correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 393,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "\nENBREL’s Canadian sales fell sharply—from $73 million in 2022 to $47 million in 2023 (a 36 % drop) and then to $28 million in 2024 (another 40 % decline). This consecutive year‑over‑year reduction indicates a weakening market position for ENBREL in Canada, likely driven by biosimilar competition and pricing pressure, pointing to a continued downward trajectory.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN PRIMARY METRIC: The LLM provided an incorrect 2022 baseline figure. Ground truth shows ENBREL Canada revenue was $113 million in 2022, but the LLM states $73 million. This is a $40 million discrepancy (35% understatement) on the starting value, which is a fundamental factual error. The 2023 ($47M) and 2024 ($28M) figures are correct. CALCULATION VERIFICATION: The LLM's percentage calculations are mathematically correct given their stated numbers ($73M to $47M = 36% decline; $47M to $28M = 40% decline), but these percentages are based on the wrong 2022 baseline. The correct 2022-2023 decline from $113M to $47M represents a 58% drop, not 36%. MULTI-HOP REASONING: The LLM correctly synthesized the downward trend across three years and appropriately identified the market trajectory as declining. The qualitative assessment about biosimilar competition and pricing pressure is reasonable contextual interpretation, though not explicitly stated in the ground truth. COMPLETENESS: The answer addresses both parts of the question (revenue evolution and market trajectory implications). ENTITY ACCURACY: ENBREL and Canada are correctly identified. The core issue is the factual error in the 2022 starting point, which undermines the entire quantitative foundation of the answer despite correct subsequent years and sound reasoning about the trend direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 383,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 Qualcomm tightened the way human‑capital progress influences executive bonuses – the 2023 bonus modifier was applied over a wider band (roughly 0.8 to 1.2), whereas for fiscal 2024 the HR & Compensation Committee limits the non‑financial performance modifier to a narrower 0.9 to 1.1 range. This tighter band reflects a more direct and stringent linkage of measurable human‑capital advancements to the final bonus payout.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual inaccuracy regarding the fiscal 2023 modifier range. The LLM claims the 2023 bonus modifier was applied over a 0.8 to 1.2 range, but the ground truth does not support this claim. The ground truth explicitly states that in fiscal 2023, human capital advancements would be 'considered' in determining fiscal 2024 bonuses - it does not specify a 0.8 to 1.2 modifier range for fiscal 2023. The LLM appears to have fabricated this comparison point. The fiscal 2024 modifier range of 0.9 to 1.1 is correctly stated and matches the ground truth. However, the core comparison between fiscal 2023 and 2024 is fundamentally flawed because the LLM mischaracterizes what happened in fiscal 2023. The ground truth indicates an evolution from 'general consideration' to a 'quantified performance modifier,' not a narrowing from 0.8-1.2 to 0.9-1.1. The LLM's interpretation that this represents a 'tightening' or 'narrowing' is unsupported by the evidence provided. The answer does correctly identify Qualcomm and the fiscal years, and it does address the question's request for the specific performance modifier range (0.9 to 1.1), but the comparative analysis and the claimed fiscal 2023 range are inaccurate. This represents a failure in multi-hop reasoning and factual accuracy on a key claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 378,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "\nBetween 2022 and 2024 Breyanzi’s approved disease portfolio widened markedly. The 2022 filing shows that the CAR‑T was initially approved only for relapsed/refractory large‑B‑cell lymphoma; by 2024 the FDA had granted accelerated approvals for three additional B‑cell malignancies—relapsed/refractory CLL/SLL, relapsed/refractory follicular lymphoma and relapsed/refractory mantle‑cell lymphoma (with further Japanese approvals for FL)—thereby expanding the therapeutic scope from a single lymphoma indication to a broader set of refractory/relapsed B‑cell cancers【BMY_10k_2022.pdf pp. 18‑22】【BMY_10k_2024.pdf pp. 43‑46】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) INCORRECT BASELINE: The LLM states Breyanzi was 'initially approved only for relapsed/refractory large-B-cell lymphoma' in 2022, but the ground truth makes no mention of this indication. The ground truth explicitly states that in 2022, Breyanzi was associated with TRIALS (not approvals) for 3L+ CLL and 3L+ FL. (2) INCORRECT EXPANSION COUNT: The LLM claims three additional indications were added by 2024 (CLL/SLL, FL, and mantle-cell lymphoma), but the ground truth documents only TWO FDA accelerated approvals in 2024: FL (May 2024) and CLL/SLL (March 2024). Mantle-cell lymphoma is NOT mentioned in the ground truth. (3) MISSING APPROVAL DATES: The ground truth provides specific approval dates (March 2024 for CLL/SLL, May 2024 for FL) which the LLM omits. (4) MISSING SPECIFICITY ON PRIOR THERAPY REQUIREMENTS: The ground truth specifies detailed prior therapy requirements (e.g., for CLL/SLL: 'including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor'), which the LLM does not include. (5) INCORRECT CHARACTERIZATION: The LLM describes a shift from 'single lymphoma indication' to multiple, but the ground truth shows a shift from TRIALS to APPROVALS in specific populations, not from one approved indication to multiple. The mention of Japanese approvals for FL is not substantiated in the ground truth provided. CORRECT ELEMENTS: The LLM correctly identifies that Breyanzi's scope expanded between 2022-2024, correctly names CLL/SLL and FL as approved indications, and correctly identifies these as B-cell malignancies. However, the foundational premise about 2022 status is wrong, the count of new indications is inflated, and critical approval dates and specificity are missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 474,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "\nIn fiscal 2024 the Resorts‑and‑Vacations business generated about **$8.38 billion in revenue**, up **5 %** from $7.95 billion in 2023.  That growth is essentially in step with the **overall Parks & Experiences segment**, whose revenue rose **5 %** to $34.15 billion, so the vacation‑club and resort operations contributed proportionally to the segment’s total top‑line expansion (the segment’s operating income also edged up 4 % to $9.27 billion).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - Resorts and Vacations revenue of $8.38B (2024) vs $7.95B (2023) matches ground truth ($8,375M and $7,949M respectively); the 5% growth calculation is accurate; Parks & Experiences overall revenue of $34.15B matches ground truth ($34,151M); the 5% growth rate for the segment is correct. The additional detail about operating income ($9.27B, up 4%) is accurate and adds value. COMPLETENESS: The answer addresses all parts of the multi-part question - it covers the Resorts and Vacations segment evolution (2023-2024), the growth rate, and the comparison to overall Parks & Experiences segment growth. ENTITY ACCURACY: All entities are correctly identified (Disney, Resorts and Vacations segment, Parks & Experiences segment, fiscal years 2023-2024). MULTI-HOP REASONING: The synthesis is sound - the model correctly identifies that both segments grew at 5%, making them essentially in step, and appropriately notes that the Resorts and Vacations segment maintained proportional contribution to the overall segment. SEMANTIC EQUIVALENCE: The wording differs slightly from ground truth but conveys identical information. The phrase 'essentially in step' effectively communicates the comparison. Minor note: The LLM includes additional context about operating income that wasn't in the ground truth, but this is supplementary and accurate, not contradictory. The answer is well-structured, clear, and provides appropriate context about the vacation-club and resort operations' contribution to segment growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 448,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "\nThe company’s forward contracts tied to accelerated share‑repurchase (ASR) transactions continued to be treated as equity instruments recorded in capital surplus, using the same two‑step structure: an initial treasury‑stock purchase for roughly 80 % of the ASR notional and a forward contract for the remaining portion. In 2023 the company entered a $2.0 bn ASR with Citibank, with a $0.4 bn forward contract that was settled in February 2023, and in 2024 it executed a larger $3.0 bn ASR with Morgan Stanley, again with a $0.4 bn forward that was settled in March 2024; the forward amount stayed close to 20 % of the notional (≈ $0.4 bn) even as the notional size grew, and the forward was re‑classified to treasury stock once the final shares were received. Thus, the contract’s structure was unchanged, but the absolute forward exposure increased in line with the larger 2024 ASR.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information. CORRECT ELEMENTS: (1) Both ASR transactions correctly identified ($2.0B in 2023 with Citibank, $3.0B in 2024 with Morgan Stanley); (2) Forward contract values correctly stated at $0.4B for both years; (3) Settlement dates correct (February 2023, March 2024); (4) Classification as equity instruments in capital surplus is correct; (5) The observation that forward contract value remained constant despite ASR size increase is accurate and insightful. CRITICAL ERRORS: (1) The LLM states the forward contract represented 'roughly 80%' of the ASR notional and 'remaining portion,' which is backwards - the forward was actually ~20% of the notional, with the initial treasury stock purchase being ~80%. The ground truth explicitly states '80% of the ASR notional' for treasury stock and the remaining portion for forward contracts. (2) The LLM claims 'the absolute forward exposure increased in line with the larger 2024 ASR,' which directly contradicts the ground truth stating the forward contract value 'remained constant at $0.4 billion.' This is a significant logical error - if the forward stayed at $0.4B while the ASR grew from $2.0B to $3.0B, the absolute forward exposure did NOT increase. (3) The LLM mentions the forward was 're-classified to treasury stock once final shares were received,' which is not mentioned in the ground truth and may be inaccurate. MULTI-HOP REASONING: The LLM successfully synthesized information across two years and two different counterparties, but made a fundamental error in interpreting the proportional relationship and the evolution of absolute forward exposure. The statement about 'absolute forward exposure increased' contradicts the core finding that the forward contract value remained constant. QUANTITATIVE ISSUES: While individual numbers are correct, the percentage allocation is inverted (80% vs 20%), and the conclusion about increasing absolute exposure is mathematically incorrect given the constant $0.4B forward value.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 549,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "\nFrom 2023 to 2024 Duke Energy made the fair‑value hierarchy disclosure for the Master Retirement Trust more explicit and granular.  The 2024 tables separate Level 1, Level 2 and Level 3 amounts (with Level 3 now limited to partnership interests of $68 million) and show a reduced “Not Categorized (b)” balance of $14 million, while also providing a reconciliation of the Level 3 beginning‑ and ending‑balances.  This tighter segmentation and the accompanying reconciliation improve transparency about how each asset class is valued and where it falls in the fair‑value hierarchy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution in Duke Energy's disclosure approach from 2023 to 2024, specifically the addition of Level 3 reconciliation and improved fair value hierarchy segmentation. The qualitative assessment of increased transparency is accurate and well-reasoned. However, there are significant quantitative accuracy issues: (1) The LLM provides specific dollar amounts ($68 million for Level 3 partnership interests and $14 million for 'Not Categorized') that are not present in the ground truth answer. These numbers cannot be verified against the original answer and may be fabricated or from a different source. (2) The ground truth emphasizes that allocation percentages were 'maintained the same' between years, but the LLM does not mention this continuity. (3) The ground truth specifically notes that certain investments using the 'net asset value per share practical expedient were not categorized in the fair value hierarchy' in 2023, which the LLM does not explicitly address. The LLM's characterization of the evolution is directionally correct—moving toward more explicit and granular disclosure with Level 3 reconciliation—but the introduction of unverified specific numbers and the omission of the allocation percentage continuity detail represent material gaps. The multi-hop reasoning is sound in connecting the 2023 and 2024 disclosures, but the factual grounding is weakened by the unsubstantiated quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 406,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "\nIn 2023 Pfizer recorded a $3.5 bn non‑cash revenue reversal tied to the expected return of roughly 6.5 million EUA‑labeled Paxlovid courses bought by the U.S. government, which was reflected in a large deferred‑revenue balance of about $5.1 bn at year‑end 2023. In 2024 the company reversed $771 m of that estimate after 5.1 million courses were actually returned, recognized $442 m of revenue for the creation of a U.S. Strategic National Stockpile of 1 million courses (with no cash consideration), and reduced the deferred Paxlovid balance to $2.2 bn, leaving only about $1 bn of contracted revenue remaining for future Paxlovid deliveries under long‑term agreements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the multi-hop financial question. STRENGTHS: (1) All core numbers are correct: $3.5 billion revenue reversal in 2023, 6.5 million EUA-labeled courses expected return, $771 million favorable adjustment in 2024, 5.1 million actual returns, $442 million SNS revenue recognition, and 1.0 million SNS courses. (2) The answer correctly synthesizes information across 2023 and 2024, showing the shift from revenue reversal to revenue recognition. (3) Additional context provided (deferred revenue balances of $5.1 billion at end-2023, reduction to $2.2 billion, ~$1 billion remaining contracted revenue) adds valuable detail and demonstrates deeper understanding of the financial impact. (4) The multi-hop reasoning is sound: connecting the expected return estimate in 2023 to actual returns in 2024, then to the SNS creation and its revenue impact. (5) Entity identification is accurate (Pfizer, U.S. government, EUA-labeled Paxlovid, Strategic National Stockpile). MINOR CONSIDERATIONS: The LLM answer goes beyond the ground truth by including deferred revenue balances and future contracted revenue information. While this additional detail is accurate and contextually relevant, it slightly expands the scope. However, this represents enhanced completeness rather than error. The answer maintains semantic equivalence with the ground truth while providing more comprehensive financial context. All calculations are accurate, and the narrative flow clearly explains the transition from 2023 to 2024 dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 433,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "\nERLEADA sales jumped from $1.88 billion in 2022 to $2.39 billion in 2023—a 26.9 % increase (≈27 % on an operational basis). This strong growth helped lift the overall Oncology segment up 10.5 % and underscores ERLEADA’s rising importance as a key growth driver within J&J’s oncology portfolio, particularly in the metastatic castration‑resistant prostate‑cancer market.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on core financial metrics and growth calculations. Quantitative verification: ERLEADA sales of $1.88B (2022) and $2.39B (2023) are correct (ground truth: $1,881M and $2,387M - minor rounding acceptable), and the 26.9% growth calculation is accurate. The oncology segment growth of 10.5% is correctly cited. The LLM appropriately emphasizes ERLEADA's rising importance and growth trajectory relative to the overall segment. However, the answer has notable omissions: (1) It fails to mention the decline in other key oncology products (IMBRUVICA and ZYTIGA) that the ground truth highlights as important context for understanding ERLEADA's relative importance, and (2) It adds specific market context (metastatic castration-resistant prostate cancer) that, while accurate and relevant, goes slightly beyond the ground truth synthesis. The multi-hop reasoning is sound - correctly synthesizing ERLEADA's growth rate, segment growth rate, and drawing conclusions about portfolio role. The answer is well-structured and semantically equivalent to the ground truth on the main points, but the omission of comparative product performance (IMBRUVICA/ZYTIGA decline) represents a meaningful gap in completeness that prevents a higher score. The quantitative accuracy is strong with only minor formatting differences from ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 381,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "\nERLEADA’s worldwide sales jumped from **$1.88 billion in 2022 to $2.39 billion in 2023**, a **26.9 % increase** (see J&J 2023 10‑K, page 31).  This growth outpaces the overall oncology segment’s 10.5 % rise, indicating that ERLEADA is gaining strong market traction and is on a clear upward trajectory.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the primary financial figures. Ground truth shows ERLEADA 2022 sales of $1,291 million ($1.291 billion), but LLM states $1.88 billion - an error of approximately $589 million or 45.6% overstatement. For 2023, ground truth shows $2,387 million ($2.387 billion), while LLM states $2.39 billion - this is approximately correct in rounded form. The growth rate of 26.9% is correctly stated and matches ground truth. MULTI-HOP REASONING ISSUES: The LLM answer introduces a comparison to the oncology segment's 10.5% growth rate, which is not present in the ground truth answer and cannot be verified from the provided information. This represents unsupported synthesis. MISSING CONTEXT: The LLM answer omits the critical 2022 growth rate of 70.0% year-over-year, which is essential context for understanding the market trajectory evolution and the deceleration from 2022 to 2023. The ground truth explicitly notes this represents a 'maturing growth phase,' which the LLM answer does not capture. ENTITY ACCURACY: The product name ERLEADA is correct, and the reference to J&J 2023 10-K is appropriate, though the specific page number cannot be verified. SEMANTIC ISSUES: While the LLM correctly identifies the 26.9% growth and general upward trajectory, the 2022 baseline figure is fundamentally wrong, undermining the entire analysis. The conclusion about 'clear upward trajectory' is reasonable but misses the important nuance about growth deceleration that indicates market maturation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 432,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 NVIDIA kept the 0.584 % Notes Due 2024 on its balance sheet at roughly $1.25 billion (the same $1.25 billion carrying amount reported for both years).  The company did not refinance or retire the issue during that period; instead it continued to carry the notes as a short‑term obligation while beginning to plan their repayment, which was ultimately executed in fiscal 2025.  Thus, the evolution was a shift from simply maintaining the notes in FY 2023‑24 to actively preparing for and completing their payoff in the following year.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct but has some notable gaps and minor inaccuracies. STRENGTHS: (1) Correctly identifies the note amount as $1.25 billion for both FY2023 and FY2024, matching the ground truth of $1,250 million. (2) Accurately captures that the notes were not refinanced or retired during FY2023-2024. (3) Correctly identifies that repayment occurred in fiscal 2025. (4) The characterization of the evolution (from maintaining to preparing for payoff) is reasonable and semantically aligned with the ground truth. WEAKNESSES: (1) The LLM answer omits the effective interest rate of 0.66% mentioned in the ground truth, which is a specific detail about NVDA's debt management strategy. (2) The ground truth explicitly states the notes were 'repaid in fiscal year 2025, resulting in no remaining balance as of January 26, 2025,' while the LLM answer says 'completing their payoff in the following year' - this is correct but less precise about the timing and final status. (3) The LLM answer characterizes the strategy evolution as 'shift from simply maintaining the notes in FY 2023-24 to actively preparing for and completing their payoff' - while this is a reasonable interpretation, the ground truth more directly states it was 'a shift...where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.' The LLM's framing is slightly different in emphasis. QUANTITATIVE VERIFICATION: The $1.25 billion figure is correct (equivalent to $1,250 million). No calculation errors detected. MULTI-HOP REASONING: The answer correctly synthesizes information across fiscal years 2023, 2024, and 2025, showing understanding of the multi-year evolution. The logic is sound. OVERALL: The answer is largely accurate with good understanding of the debt management evolution, but lacks some specific details (interest rate) and could be more precise about the characterization of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 530,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the company’s mortgage‑/asset‑backed‑security holdings in its non‑U.S. pension portfolio fell from **$31 million to $10 million**.  That is a **$21 million decline**—roughly a two‑thirds reduction—over the one‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM reports 2022 holdings of $31 million in non-U.S. plans, but the ground truth shows $982 million in U.S. Plans for 2022. The LLM reports a $21 million decline, but the ground truth shows a $972 million reduction. The LLM's calculation of 'roughly two-thirds reduction' is mathematically inconsistent with the stated $21M decline from $31M (which would be ~68%, but the actual magnitude is wrong). (2) ENTITY/CLASSIFICATION ERRORS: The LLM incorrectly identifies the 2022 holdings as being in 'non-U.S. pension portfolio' when the ground truth clearly states they were in 'U.S. Plans.' This is a critical misidentification of which pension plan category held the securities. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the major strategic shift described in the ground truth - the movement from $982M in U.S. Plans to only $10M in Non-U.S. Plans represents a 98% reduction, not the 68% reduction the LLM describes. (4) MISSING CONTEXT: The LLM completely misses the magnitude of the change (over $972M vs. $21M) and the strategic significance of this shift. The answer appears to reference different data points entirely, possibly from a different section of the filing or a different company. The core numbers are wrong by orders of magnitude, making this answer fundamentally incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 395,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "\nBetween 2022 and 2023 Capital One’s securitized‑debt balance rose from roughly **$16.97 billion** (carrying value on 12/31/22) to **$18.04 billion** (carrying value on 12/31/23), underscoring a modest expansion of securitization as a funding source to support loan‑portfolio growth and diversify the company’s wholesale funding mix. In both years the obligations are reported at carrying value with their **estimated fair values classified as Level 2** in the fair‑value hierarchy—i.e., they are measured using observable market inputs rather than unobservable inputs. The increase is reflected in both the reported carrying amounts and the corresponding fair‑value figures, indicating that securitized debt remained a Level 2‑valued component of Capital One’s funding structure from 2022 through 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Capital One's securitized debt evolution. STRENGTHS: (1) Quantitative accuracy is excellent - the 2023 carrying value of $18.04 billion matches the ground truth's $18,043 million (minor rounding difference acceptable), and the 2022 figure of $16.97 billion is correctly identified as the prior year baseline. (2) Fair value classification is correctly stated as Level 2 for both years, with accurate explanation that Level 2 uses observable market inputs. (3) The multi-hop synthesis is sound - the answer correctly connects the carrying value increase to fair value figures and maintains the Level 2 classification across both years. (4) The answer addresses all key aspects of the question: evolution of securitized debt, role in funding mix, and fair value classification. (5) The contextual framing about diversifying wholesale funding and supporting loan portfolio growth is appropriate and aligns with the ground truth's characterization. MINOR CONSIDERATIONS: (1) The ground truth mentions 2023 fair value of $18,067 million, which the LLM answer does not explicitly state, though it correctly notes that fair values correspond to carrying amounts. (2) The ground truth emphasizes a 'shift toward more detailed disclosure' in 2023, which the LLM answer doesn't explicitly highlight, though it does note the provision of 'more specific transparency.' (3) The LLM answer could have been slightly more explicit about the specific fair value figure ($18,067M) for 2023, though the general characterization of the relationship between carrying value and fair value is correct. Overall, the answer successfully synthesizes multi-hop information across years and correctly identifies the key financial metrics and classifications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 491,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "\nFrom 2023 to 2024 the firm’s CECL‑related capital transition relief was phased down: the CET1 capital benefit that stemmed from the U.S. CECL transition provisions fell from **$1.4 billion at the end of 2023 to $0.72 billion at the end of 2024**, a net reduction of roughly **$0.68 billion**. This decline reflects the scheduled wind‑down of the transition provision, which was fully phased out as of January 1 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: the 2023 CECL benefit of $1.4 billion, the 2024 benefit of $720 million (correctly formatted as $0.72 billion), and the calculated reduction of approximately $680 million ($0.68 billion). The calculation is accurate: $1.4B - $0.72B = $0.68B. The answer correctly identifies the entity (JPMorgan), the metric (CECL-related capital transition provisions/CET1 capital benefit), and the time period (2023 to 2024). The multi-hop reasoning is sound: the answer synthesizes the evolution of the provision across two years and explains the underlying cause (phased reduction under U.S. capital rules). The answer also correctly notes the full phase-out date of January 1, 2025. The only minor distinction from the ground truth is that the LLM uses slightly different phrasing ('phased down' vs 'phased reduction') and 'phased out' vs 'phased in,' but these are semantically equivalent and accurately convey the same meaning. The answer is well-structured, directly addresses all parts of the multi-part question, and provides appropriate context about the scheduled nature of the transition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 335,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Salesforce replaced its prior $3 billion unsecured revolving credit facility—originally set to mature on December 23 2025—with a new $5 billion revolving loan credit agreement that now matures in October 2029. The amendment increased borrowing capacity by $2 billion and extended the maturity date, while still providing an unsecured facility that had no outstanding borrowings as of the fiscal‑year‑end filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) Fiscal 2023 facility: $3.0 billion unsecured revolving credit - CORRECT; (2) Fiscal 2023 maturity: December 2025 (LLM specifies December 23, 2025 - acceptable level of detail) - CORRECT; (3) Fiscal 2024 facility: $5.0 billion unsecured revolving credit - CORRECT; (4) Fiscal 2024 maturity: October 2029 - CORRECT; (5) Capacity increase calculation: $5B - $3B = $2B - CORRECT. The LLM answer goes beyond the ground truth by adding the detail that there were no outstanding borrowings as of fiscal year-end, which is accurate contextual information that enhances the answer without contradicting the ground truth. The multi-hop synthesis is sound: the answer correctly identifies the evolution across two fiscal years, compares the old and new agreements, and explains the strategic implications (increased capacity and extended maturity). The answer maintains semantic equivalence with the ground truth while providing slightly more specific detail (exact date of December 23 vs. just December). All entities are correctly identified (Salesforce, Revolving Loan Credit Agreement, unsecured facility status). The reasoning is logical and the answer directly addresses all aspects of the question about how the terms and capacity evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 369,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "\nBetween 2022 and 2024 UPS moved from operating Coyote as an owned truck‑load brokerage business within its Supply Chain Solutions segment (see page 7 of the 2022 filing) to completing the sale of the unit in the third quarter of 2024 (see page 30 of the 2024 filing).  The divestiture generated a pre‑tax gain of **$156 million** (approximately **$152 million after tax**) that was recorded in “Other expenses” and excluded from GAAP operating profit but boosted the company’s reported net‑income adjustments for 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All financial figures are correct - the pre-tax gain of $156 million and after-tax gain of $152 million match the ground truth exactly. The timing (Q3 2024) is accurate. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the relationship evolved (from owned subsidiary in 2022 to divested in 2024), and (2) the financial impact ($156M pre-tax gain). ENTITY ACCURACY: UPS, Coyote, Supply Chain Solutions segment, and 2024 are all correctly identified. The reference to page numbers in filings adds credibility. MULTI-HOP REASONING: The answer correctly synthesizes information across two different years/filings, showing the transition from 2022 operational status to 2024 divestiture outcome. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth, with slightly different wording but equivalent meaning. The description of Coyote as a 'truckload brokerage business' in the LLM answer matches the ground truth's 'truckload brokerage services.' The mention of 'Supply Chain Solutions segment' adds helpful context. MINOR NOTES: The LLM answer provides slightly more operational detail (mentioning it was in 'Other expenses' and excluded from GAAP operating profit) which is accurate and helpful context not contradicting the ground truth. The phrasing about 'boosted the company's reported net-income adjustments' is slightly less precise than the ground truth's direct statement of the after-tax gain, but is not incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 432,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "\nBetween 2023 and 2024 Union Pacific cut its chassis fleet dramatically – total chassis units fell from roughly 48,300 (30,600 owned + 17,700 leased) to about 5,550 (4,350 owned + 1,200 leased), a decline of roughly 88 percent.  At the same time the proportion of owned chassis rose from roughly 63 percent of the fleet to about 78 percent, while leased chassis fell from ≈37 percent to ≈22 percent, reflecting a shift toward greater ownership and far less reliance on leased units.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. Quantitative verification: (1) 2023 totals: 48,340 vs 'roughly 48,300' - acceptable rounding; 30,635 owned vs '30,600' - acceptable rounding; 17,705 leased vs '17,700' - acceptable rounding. (2) 2024 totals: 5,553 vs 'about 5,550' - acceptable rounding; 4,356 owned vs '4,350' - acceptable rounding; 1,197 leased vs '1,200' - acceptable rounding. (3) Decline calculation: (48,340-5,553)/48,340 = 88.5%, correctly stated as 'roughly 88 percent'. (4) Ownership percentage 2023: 30,635/48,340 = 63.4%, correctly stated as 'roughly 63 percent'. (5) Ownership percentage 2024: 4,356/5,553 = 78.4%, correctly stated as 'about 78 percent'. (6) Leased percentage 2023: 17,705/48,340 = 36.6%, correctly stated as '≈37 percent'. (7) Leased percentage 2024: 1,197/5,553 = 21.6%, correctly stated as '≈22 percent'. All calculations are accurate. Multi-hop reasoning: The answer correctly synthesizes the comparison across two years, identifies the strategic shift from mixed ownership to greater owned proportion, and provides both absolute and relative metrics. The answer fully addresses the question about evolution in total units and ownership structure. Minor deduction only for rounding presentation (using approximations rather than exact figures), though this is appropriate given the context and improves readability. The semantic meaning and factual content align perfectly with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 404,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "\nBetween 2022 and 2024 Boeing shifted from a largely implicit treatment of its aluminum supply contracts—where they were simply bundled with other commodity purchases and not singled out as distinct derivatives—to an explicit disclosure that these agreements are derivative instruments that **do not qualify for hedge accounting** and are therefore recorded at fair value with changes in fair value recognized immediately in earnings.  The 2024 filing also reveals that the aluminum‑related commodity contracts have notional amounts of roughly 129 million pounds (2024) and are intended to hedge forecasted aluminum needs **through 2028** (with certain contracts carrying original maturities of at least five years), a time horizon and detailed derivative‑accounting description that were not separately presented in the 2022 filing.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Boeing's aluminum agreement disclosures between 2022 and 2024, capturing the key shift from implicit/bundled treatment to explicit derivative classification with a defined hedging horizon through 2028. The qualitative reasoning about the transition from strategic sourcing to structured hedging is sound and well-articulated.\n\nHowever, there are quantitative accuracy concerns:\n\n1. SPECIFIC NUMBER ISSUE: The LLM introduces a specific figure of \"roughly 129 million pounds (2024)\" for notional amounts. The ground truth does not mention this specific quantity. While the LLM may have sourced this from the actual 2024 filing, it represents additional detail not present in the ground truth answer, which could indicate either: (a) the LLM is adding unsourced specificity, or (b) the LLM is correctly citing filing data not captured in the ground truth summary. This creates uncertainty about quantitative accuracy.\n\n2. CHARACTERIZATION OF 2022 TREATMENT: The LLM describes 2022 treatment as \"implicit\" and \"bundled with other commodity purchases and not singled out as distinct derivatives.\" The ground truth states they were \"disclosed\" as derivatives but not designated for hedge accounting. The LLM's characterization of 2022 as lacking explicit disclosure may overstate the change, though the ground truth does confirm they were disclosed in 2022.\n\n3. HEDGE ACCOUNTING CONSISTENCY: Both answers correctly identify that the agreements do not qualify for hedge accounting and changes are recorded immediately in earnings. This is accurate.\n\n4. TIME HORIZON: Both correctly identify 2028 as the time horizon for hedging forecasted transactions. The LLM adds detail about \"original maturities of at least five years\" which is not in the ground truth but appears reasonable.\n\nSTRENGTHS: The answer demonstrates strong multi-hop reasoning, correctly synthesizing the evolution across years, and provides clear explanation of the shift in disclosure and classification. The semantic understanding of the question is excellent.\n\nWEAKNESSES: Introduction of specific quantitative details (129 million pounds) not verified against ground truth creates quantitative accuracy concerns. The characterization of 2022 as having implicit vs. explicit treatment may slightly misrepresent the ground truth's statement that they were disclosed in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 643,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 P&G’s currency‑risk exposure and hedging program showed essentially no material change.  The company continues to manage foreign‑exchange risk primarily through short‑term forward contracts and currency swaps (typically with maturities under 18 months) as part of a diversified, natural‑hedge approach, and its internal risk‑measurement models (a one‑year, 95 % confidence‑level VaR analysis) indicate that even significant near‑term exchange‑rate movements would not have a material effect on the financial statements.  Consequently, management remains confident that its existing hedging instruments can effectively mitigate short‑term currency fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: All factual claims are accurate - P&G's currency risk exposure remained materially unchanged between FY2023 and FY2024, the company uses forward contracts and currency swaps with maturities under 18 months, and the 95% confidence level VaR analysis is correctly cited. The answer properly conveys that management remains confident in its hedging instruments' effectiveness. (2) QUANTITATIVE ACCURACY: All numeric values are correct - the 95% confidence level is accurately stated, the 'less than 18 months' maturity timeframe is correctly referenced, and the one-year VaR analysis period is appropriately mentioned. No calculation errors present. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information about both the hedging instruments AND the risk assessment metrics across the two fiscal years, demonstrating proper understanding that both remained essentially unchanged. The characterization of the hedging approach as part of a 'diversified, natural-hedge approach' adds appropriate context. (4) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'one-year, 95% confidence-level VaR analysis' vs. 'at a 95% confidence level based on historical currency rate movements') but conveys the same essential information. The addition of 'VaR analysis' terminology is technically accurate and appropriate. (5) MINOR OBSERVATION: The LLM answer includes the phrase 'one-year' when describing the VaR analysis, which is not explicitly stated in the ground truth, though this is a reasonable technical detail that doesn't contradict the source material. The answer fully addresses all parts of the multi-part question regarding exposure evolution, hedging instruments, and confidence in mitigation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 515,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe broadened Frame.io’s functional scope and deepened its integration with the rest of its portfolio.  The 2022 filing described Frame.io mainly as a cloud‑native collaboration hub for video review that linked to Premiere Pro, After Effects, Photoshop and Lightroom, but the 2024 filing adds capabilities such as Camera‑to‑Cloud ingest, AI‑enhanced frame‑accurate commenting, and native connectivity to Adobe Express and Firefly‑powered services, positioning Frame.io as a central, end‑to‑end workflow layer within Adobe’s Creative Cloud and GenStudio offerings.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) FACTUAL INACCURACY - The LLM claims the 2022 filing described Frame.io as 'a cloud-native collaboration hub for video review that linked to Premiere Pro, After Effects, Photoshop and Lightroom.' The ground truth explicitly states that in 2022, Frame.io was ONLY 'listed among Adobe's trademarks' with 'no detailed description of its functionality or integration.' This is a major factual error - the LLM fabricated specific 2022 capabilities and integrations that did not exist in the 2022 filing. (2) PARTIALLY CORRECT 2024 DESCRIPTION - The LLM correctly identifies several 2024 capabilities (Camera-to-Cloud, frame-accurate commenting, integration with Premiere Pro, After Effects, Photoshop, Lightroom, and GenStudio positioning). However, it adds 'Adobe Express and Firefly-powered services' which are not mentioned in the ground truth. (3) MISSING KEY CONTEXT - The ground truth emphasizes the evolution from 'a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow,' highlighting the significance of the transformation. The LLM's answer misses this crucial narrative by incorrectly suggesting Frame.io had substantial functionality in 2022. (4) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the 2022 vs 2024 comparison. It should have noted the dramatic shift from minimal description to detailed functional integration, but instead created a false continuity by attributing 2024 features to 2022. (5) WORKFRONT OMISSION - The ground truth mentions Workfront integration in 2024, which the LLM does not include. The core error is the fabrication of 2022 capabilities, which fundamentally undermines the answer's credibility and accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 473,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "\nBetween the 2022 and 2023 fiscal years AMD’s equity‑method investment in the ATMP joint venture grew from roughly **$83 million (as of Dec 31 2022)** to **about $99 million (as of Dec 30 2023)** – an increase of roughly **$16 million**.  This rise is disclosed in the “Investment in ATMP JV” line of other non‑current assets and is accompanied by detailed related‑party tables that show purchases, sales, payables, receivables and the **$14 million gain in 2022 and $16 million gain in 2023 recorded in “Equity income in investee.”**  AMD continues to account for the ATMP JV under the equity method (no consolidation, no funding obligation) and reports the investment, related‑party balances and resulting gains in its financial statements.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL NUMERIC ERRORS: The LLM claims the carrying value grew from $83 million (Dec 31 2022) to $99 million (Dec 30 2023), but the ground truth explicitly states the 2022 filing showed carrying values of $69 million (Dec 25, 2021) and $63 million (Dec 26, 2020). The LLM appears to have fabricated entirely different numbers and dates that do not match the actual SEC filing data. (2) MISSING KEY INFORMATION: The ground truth emphasizes that the 2023 filing OMITS disclosure of carrying value and specific transaction figures, representing a reduction in financial disclosure. The LLM instead claims detailed disclosure continued with specific dollar amounts ($14M and $16M gains), which contradicts the ground truth's core finding about reduced disclosure. (3) TRANSACTION FIGURES: The ground truth mentions purchases of $1.1 billion in 2021 and $831 million in 2020, which the LLM completely omits. The LLM's mention of $14M and $16M gains appears to be unverified and inconsistent with the ground truth's narrative. (4) MULTI-HOP REASONING: The LLM failed to synthesize the key insight from the ground truth - that there was a REDUCTION in disclosure between 2022 and 2023 filings. Instead, it presents a narrative of continued detailed disclosure with growing investment values. (5) DATES: The LLM uses different date references (Dec 31 2022, Dec 30 2023) that don't match the ground truth's specific dates (Dec 25, 2021; Dec 26, 2020). The fundamental premise of the LLM answer is factually incorrect and contradicts the ground truth on nearly every quantitative claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 455,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "\nHoneywell’s Commercial Aviation Original Equipment sales slipped from **$2.397 billion in 2023 to $2.223 billion in 2024** (a decline of roughly 7 %). This dip reflects the softer demand and slower aircraft‑production environment that have weighed on the commercial aerospace market, yet the company remains a leading OEM supplier, underscoring its strong overall position in the sector despite the recent contraction.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and calculations. Quantitative verification: (1) 2023 revenue of $2.397 billion ($2,397 million) - CORRECT, (2) 2024 revenue of $2.223 billion ($2,223 million) - CORRECT, (3) Decline calculation: ($2,397M - $2,223M) / $2,397M = $174M / $2,397M = 7.26%, rounded to 'roughly 7%' - CORRECT. The number format variation (billions vs millions) is acceptable and consistent with standard financial reporting conventions. The LLM correctly identified the multi-hop synthesis: comparing two years of Commercial Aviation Original Equipment revenue and drawing conclusions about Honeywell's market position. The reasoning is sound - the answer acknowledges the segment decline while contextualizing it within the broader aerospace market dynamics (softer demand, slower aircraft production). Minor deduction: The original answer emphasizes 'potential weakening in original equipment demand or supply constraints,' while the LLM provides broader market context ('softer demand and slower aircraft-production environment'). The LLM's interpretation is reasonable and adds relevant context, though it slightly shifts emphasis from the original's more cautious framing. The LLM appropriately addresses both parts of the question: (1) the revenue evolution with accurate numbers and percentage change, and (2) what this indicates about Honeywell's position (acknowledging contraction while noting strong overall position as leading OEM supplier). All entities are correctly identified (Honeywell, Commercial Aviation Original Equipment, fiscal years 2023-2024).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 446,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "\nHeart‑Failure device sales rose from **$1.161 billion in 2023 to $1.279 billion in 2024**.  This reflects a **10.2 % increase in total revenue** (or **≈10.3 % when the foreign‑exchange effect is excluded**) between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: (1) 2023 revenue of $1.161 billion ($1,161 million) - CORRECT; (2) 2024 revenue of $1.279 billion ($1,279 million) - CORRECT; (3) Percentage change calculation: ($1,279 - $1,161) / $1,161 = $118 / $1,161 = 10.16% ≈ 10.2% - CORRECT; (4) The mention of ~10.3% when excluding foreign-exchange effects is a reasonable additional detail that aligns with the ground truth's note about 'minimal impact from exchange rate fluctuations.' COMPLETENESS: The answer addresses both parts of the multi-part question: (1) evolution between 2023 and 2024 (both years' figures provided), and (2) percentage change (10.2% stated). ENTITY ACCURACY: Correctly identifies 'Heart Failure Devices' segment and the correct fiscal years (2023, 2024). REASONING: The multi-hop synthesis is sound - the model correctly combined revenue figures from two different years and accurately calculated the percentage change. SEMANTIC EQUIVALENCE: The use of '$1.161 billion' and '$1.279 billion' is semantically equivalent to the ground truth's '$1,161 million' and '$1,279 million' (same values, different formatting). MINOR CONSIDERATIONS: The LLM answer includes an additional detail about foreign-exchange effects (10.3% excluding FX) which, while not explicitly stated in the ground truth, is consistent with the ground truth's mention of 'minimal impact from exchange rate fluctuations.' This adds value without contradicting the source. The only minor deviation is the slightly different presentation style (using hyphens in 'Heart‑Failure' and spacing in '10.2 %'), but these are purely stylistic and do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 462,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings IBM did not change the accounting classification or the substantive terms of the 0.300 % Notes due 2028.  In both filings the securities are listed under “Notes payable” (2022) and later under the same series identifier “IBM 28B” in the 2023 filing, continuing to be presented as long‑term debt (non‑current) with no re‑classification, amendment or change in measurement treatment.",
      "correctness_score": 2,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The original answer clearly states that there WAS a significant evolution in treatment between 2022 and 2023: (1) In 2022, the notes were referenced via incorporation by reference to an external exhibit (Form 8-K filed February 10, 2020), and (2) In 2023, they were formally listed in a table of registered securities with explicit trading symbol (IBM 28B) and called out as a distinct class on the NYSE. This represents a shift from indirect/incorporated reference to explicit disclosure and formal registration. The LLM answer incorrectly claims 'IBM did not change the accounting classification or the substantive terms' and states the notes were listed under 'Notes payable' in both years with the same series identifier 'IBM 28B' in both filings. This is factually wrong - the ground truth indicates the 2023 filing introduced explicit listing and formal registration that was not present in 2022. The LLM failed to identify the key evolution: the shift from incorporation by reference to explicit disclosure and formal NYSE registration. The answer also misses the critical detail about the Form 8-K reference from February 10, 2020 in the 2022 filing. While the LLM correctly identifies the security name (0.300% Notes due 2028) and the ticker symbol (IBM 28B), it fundamentally misunderstands the nature of the change between filings. The answer focuses on accounting classification and measurement treatment (which may not have changed) but completely misses the disclosure and registration evolution that is the actual substance of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 446,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "\nApple’s Rest of Asia Pacific net sales rose modestly, climbing from **$29.38 billion in 2022 to $29.62 billion in 2023** (≈ 0.8 % growth), and operating income increased more notably from **$11.57 billion to $12.07 billion** (≈ 4.3 % growth) over the same period, reflecting a small sales uptick but a stronger improvement in profitability for that region.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key metrics: (1) Net sales 2022: Ground truth $29,375M vs LLM $29.38B - correct (format variation, $29.375B rounded to $29.38B is acceptable); (2) Net sales 2023: Ground truth $29,615M vs LLM $29.62B - correct (format variation, $29.615B rounded to $29.62B is acceptable); (3) Operating income 2022: Ground truth $11,569M vs LLM $11.57B - correct (format variation); (4) Operating income 2023: Ground truth $12,066M vs LLM $12.07B - correct (format variation); (5) Net sales growth: Ground truth $240M (0.8%) vs LLM 0.8% - correct; (6) Operating income growth: Ground truth $497M (4.3%) vs LLM 4.3% - correct. The LLM correctly synthesized multi-hop information by comparing 2022 and 2023 figures across both metrics, accurately calculated percentage changes, and provided appropriate contextual interpretation (modest sales growth vs. stronger profitability improvement). The answer is complete, addresses all aspects of the question, uses proper entity identification (Apple, Rest of Asia Pacific region), and presents the information in a clear, accessible format with appropriate rounding conventions. Minor note: The LLM used approximate symbols (≈) which is reasonable given the rounding of billions, though the ground truth provides exact percentages. This is a negligible difference that does not affect correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 388,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "\nThe 2022 10‑K notes that “stock options granted **prior to 2022** under the 2007 Omnibus Incentive Plan generally vest pro‑rata over a **five‑year** period,” whereas the 2024 10‑K states that “stock options granted **subsequent to December 31, 2021** … generally vest pro‑rata over a **four‑year** period.” Thus, the vesting schedule was shortened from a five‑year graded schedule for pre‑2022 grants to a four‑year graded schedule for grants made after that date (both still terminating after ten years).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question. Verification of key facts: (1) Quantitative accuracy - All numeric values are correct: five-year vesting for pre-2022 grants, four-year vesting for post-December 31, 2021 grants. The dates are correctly identified (2022 10-K, 2024 10-K, December 31, 2021 cutoff). (2) Entity accuracy - Correctly identifies the 2007 Omnibus Incentive Plan, the two filing years (2022 and 2024), and the two grant periods. (3) Multi-hop synthesis - The answer successfully synthesizes information across two different 10-K filings (2022 and 2024) and correctly identifies the evolution/change in vesting periods between the two grant cohorts. (4) Completeness - The answer addresses all parts of the question: how vesting evolved, the specific periods involved, and the comparison between pre-2022 and post-2021 grants. The parenthetical note about the ten-year termination period adds helpful context not explicitly required but consistent with typical option grant structures. Minor observation: The LLM uses 'subsequent to December 31, 2021' which is semantically equivalent to 'after December 31, 2021' and 'post-2021 grants' used in the ground truth. The phrase 'graded schedule' is a standard financial term for pro-rata vesting and is appropriate. The answer is clear, precise, and demonstrates sound reasoning across multiple data sources.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 392,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "\nFrom 2022 to 2023 CVS continued to validate each Level 2 debt‑security fair‑value estimate by obtaining a single quoted price from a primary source, then selecting a sample of those prices for cross‑check against a secondary source and reviewing any variance that exceeds a preset threshold; importantly, the company **did not adjust any Level 2 fair‑value amounts in either 2022 or 2023**.  The same quarterly sampling and internal‑team comparison process that was used in 2022 was retained in 2023, indicating a consistent approach with no material changes to price adjustments.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: No response from LLM",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "No response from LLM"
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "\nCVS continued to classify its privately‑placed equity securities as Level 3 in both 2022 and 2023.  Fair value is still derived from internal valuation models that use unobservable inputs—mainly earnings and revenue multiples, a discount for lack of marketability, and comparability adjustments—with the company explicitly stating that any change in those inputs would affect the measured fair value.  No material change in hierarchy or methodology was disclosed; the 2023 filing simply reiterated the same Level 3 approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies Level 3 classification in both 2022 and 2023 with no change in hierarchy; (2) Accurately lists the specific unobservable inputs (earnings and revenue multiples, discount for lack of marketability, comparability adjustments); (3) Properly synthesizes the multi-hop information across two years; (4) Correctly notes that the company uses internal valuation models; (5) Accurately conveys that changes in inputs would affect fair value. MINOR WEAKNESSES: (1) The LLM answer states 'No material change in hierarchy or methodology was disclosed' which is accurate but slightly understates the ground truth's emphasis on 'added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.' The ground truth indicates there was an evolution in emphasis/scrutiny even if not a fundamental methodology change; (2) The phrase 'simply reiterated the same Level 3 approach' could be interpreted as dismissing the nuanced evolution in emphasis that the ground truth highlights. VERIFICATION: All factual claims are accurate - no incorrect numbers, dates, or entities. The multi-hop reasoning correctly synthesizes information across 2022 and 2023. The answer captures the essential finding that methodology remained consistent while emphasis on sensitivity analysis increased. The semantic meaning aligns well with ground truth despite slightly different framing of the 'evolution' aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 448,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "\nThe total net revenue for Alphagan/Combigan fell from **$272 million in 2023 to $248 million in 2024**, a decline of roughly **8‑9 %**.  During the same period its **international sales rose modestly**, increasing from **$151 million to $153 million** (about a **1‑2 % increase**).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-part question. Verification of key facts: (1) Total revenue 2023: $272M ✓, 2024: $248M ✓ - both correct. (2) Revenue decline calculation: Ground truth states 8.8%, LLM states 'roughly 8-9%' - this is accurate rounding and appropriately qualified with 'roughly'. The actual decline is ($272M-$248M)/$272M = 8.82%, so 8-9% is a reasonable approximation. (3) International revenue 2023: $151M ✓, 2024: $153M ✓ - both correct. (4) International revenue growth: Ground truth states 1.5%, LLM states 'about a 1-2% increase' - this is accurate rounding. The actual growth is ($153M-$151M)/$151M = 1.32%, so 1-2% is a reasonable approximation. The LLM appropriately qualified percentage ranges with 'roughly' and 'about', which is good practice when rounding. All entities are correctly identified (Alphagan/Combigan product, years 2023-2024, revenue metrics). The multi-hop synthesis is sound: the answer correctly combines total revenue trends with international revenue trends to show the contrasting patterns (total declining while international growing). The answer is well-structured, complete, and semantically equivalent to the ground truth. Minor: The LLM uses slightly broader percentage ranges (8-9% vs 8.8%, 1-2% vs 1.5%) but these are reasonable approximations and appropriately qualified, not errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 384,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "\nChevron’s relationship with PDC Energy shifted from an independent producer to a fully‑owned subsidiary after the 2023 acquisition, so that by the 2024 filing PDC’s assets and production are fully integrated into Chevron’s operations.  This integration added the “full‑year of legacy PDC Energy production” to Chevron’s output, contributing to a roughly 7 percent year‑over‑year increase in worldwide oil‑equivalent production in 2024, especially through growth in the Permian Basin and other U.S. fields.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the key elements of Chevron's evolving relationship with PDC Energy. STRENGTHS: (1) Correctly identifies the 2023 acquisition and transition to fully-owned subsidiary status; (2) Accurately cites the 7% year-over-year increase in worldwide oil-equivalent production in 2024; (3) Properly attributes this growth to the full-year contribution from legacy PDC operations; (4) Adds relevant contextual detail about Permian Basin and U.S. fields growth; (5) Demonstrates sound multi-hop reasoning by synthesizing acquisition timing, integration status, and production impact. MINOR WEAKNESSES: (1) The original answer specifically mentions that PDC was excluded from Chevron's internal control assessment in 2023 due to acquisition timing - the LLM answer omits this detail, though it's not critical to answering the core question about operational impact; (2) The LLM answer adds information about Permian Basin growth that, while contextually relevant, is not explicitly confirmed in the ground truth provided. QUANTITATIVE VERIFICATION: The 7% production increase figure is correctly stated and matches the ground truth exactly. The characterization of the relationship evolution (independent → fully-owned subsidiary → integrated operations) is accurate. The answer successfully addresses both parts of the multi-part question: (1) how the relationship evolved, and (2) what specific operational impact occurred. The semantic meaning aligns well with the ground truth despite different wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 425,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "\nFrom 2023 to 2024 UPS deepened its cold‑chain platform by acquiring **Bomi Group** (2022) and **MNX Global Logistics** (2023), then in 2024 it completed the purchase‑accounting for those deals, integrated the businesses and divested its non‑cold‑chain Coyote brokerage unit, laying the groundwork for further expansion—highlighted by the announced 2025 purchase of **Frigo‑Trans** and **Biotech & Pharma Logistics** to boost its international cold‑chain capabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) TIMELINE ERRORS: The LLM incorrectly dates Bomi Group acquisition to 2022 (ground truth: 2023) and MNX Global Logistics to 2023 (ground truth: also 2023, but presented as if separate years). More critically, the LLM states Frigo-Trans and Biotech & Pharma Logistics were 'announced 2025 purchase' when ground truth clearly indicates these were 2024 acquisitions completed for approximately $440 million. This is a fundamental factual error about the timing of major acquisitions. (2) MISSING CRITICAL INFORMATION: The LLM completely omits the $440 million acquisition price for Frigo-Trans and Biotech & Pharma Logistics, which is a key quantitative detail demonstrating the 'significant increase in international investment' mentioned in ground truth. (3) IRRELEVANT INFORMATION: The LLM introduces the Coyote brokerage divestment, which is not mentioned in the ground truth and appears to be extraneous information that doesn't address the cold-chain logistics evolution question. (4) MISCHARACTERIZATION OF EVOLUTION: Ground truth emphasizes a shift from 'general expansion to targeted, high-value international acquisitions' - the LLM fails to capture this strategic evolution clearly. (5) QUANTITATIVE ACCURACY: The $440 million figure is completely absent from the LLM response, representing a significant omission of financial data. The LLM's characterization of 2024 acquisitions as 'announced 2025 purchase' is factually incorrect and suggests the acquisitions hadn't occurred yet, contradicting the ground truth that they were completed in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 435,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "\nBetween 2022 and 2024 Linde plc replaced the legacy non‑employee‑director RSU awards that had been issued under the 2009 Praxair Long‑Term Incentive Plan with a dedicated award under the 2021 Linde plc Long‑Term Incentive Plan (first filed as Exhibit 10.0e in the 2021 Form 10‑K and later amended in early 2024).  The Board formalized a **Non‑Employee Director Deferral Program** (adopted July 30 2024) that requires directors to defer receipt of vested RSUs and subjects a greater portion of the award to performance‑based clawback and equity‑holding rules, thereby tightening governance oversight and aligning director compensation with long‑term shareholder value.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct dates (July 30, 2024 adoption), proper identification of the 2021 Linde plc Long-Term Incentive Plan, and accurate characterization of the evolution from legacy 2009 Praxair plan awards. The quantitative elements are accurate: the timeline (2022-2024), the specific adoption date, and the plan references are all correct. The answer correctly identifies the key governance enhancement through the Non-Employee Director Deferral Program and its mechanisms (deferral of vested RSUs, performance-based clawback, equity-holding rules). However, there are some qualitative differences from the ground truth: (1) The LLM introduces additional detail about 'replacing legacy non-employee-director RSU awards' and references to the 2009 Praxair plan, which adds specificity but goes slightly beyond the ground truth's framing; (2) The LLM emphasizes 'performance-based clawback and equity-holding rules' as specific mechanisms, while the ground truth more broadly describes the deferral program as 'enhancing governance' and 'reinforcing long-term alignment'; (3) The LLM's characterization of the evolution as 'tightening governance oversight' is slightly more specific than the ground truth's 'strengthening board accountability.' The multi-hop reasoning is sound—the answer correctly synthesizes the 2022 introduction of RSU awards under the 2021 plan with the 2024 deferral program adoption. The answer is contextually relevant and addresses the question's focus on governance structure and shareholder alignment mechanisms. Minor deductions reflect that while the answer is substantively correct, some details appear to exceed what can be verified from the stated ground truth, though they are not contradictory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 482,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "\nBetween 2022 and 2024 the only lingering financial link to Stellantis is the indemnification provision built into the 2017 sale of Opel/Vauxhall; the 2024 filing notes that GM must cover certain post‑sale losses (e.g., emissions, product‑liability and recall claims) subject to time‑limited caps, and that it cannot quantify any reasonably possible material loss—effectively rendering the exposure immaterial.  At the same time, any equity stakes or other investments tied to that transaction generated only modest, non‑material gains that are recorded in other income and do not affect GM’s core automotive results, so the relationship has evolved into a largely passive indemnity arrangement with no significant investment upside.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that undermine its credibility. CRITICAL ISSUES: (1) MISSING KEY FACT: The ground truth explicitly states GM reported a $0.2 billion gain related to Stellantis warrants in 2022. The LLM completely omits this specific, quantified financial benefit, which is a core element of how the relationship 'evolved.' (2) INCORRECT CHARACTERIZATION: The LLM claims 'any equity stakes or other investments tied to that transaction generated only modest, non‑material gains' - this directly contradicts the ground truth's $0.2 billion warrant gain in 2022, which is material by any standard. (3) INCOMPLETE TEMPORAL ANALYSIS: The question asks about evolution 'between 2022 and 2024.' The ground truth shows a clear progression: 2022 = positive gains ($0.2B), 2024 = contingent liabilities and legal risks. The LLM fails to establish this temporal contrast and instead presents a one-dimensional view focused only on 2024 indemnification. (4) QUANTITATIVE ACCURACY FAILURE: The LLM provides no specific numbers for the 2022 warrant gains or 2024 indemnification amounts, while the ground truth includes the $0.2 billion figure. The LLM's statement that GM 'cannot quantify any reasonably possible material loss' may be accurate for 2024, but this doesn't negate the $0.2B gain from 2022. (5) REASONING FLAW: The LLM's conclusion that the relationship is 'largely passive indemnity arrangement with no significant investment upside' misses the key evolution: from investment gains to legal liabilities. The answer reads as if only 2024 matters, ignoring the comparative analysis required by the question. WHAT WAS CORRECT: The LLM correctly identifies the indemnification obligations related to the 2017 Opel/Vauxhall sale, emissions claims, product liabilities, recalls, and the time-limited caps. The characterization of 2024 as involving contingent liabilities is accurate. However, these correct elements cannot compensate for the omission of the $0.2 billion warrant gain and the failure to show the evolution from gains to liabilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 562,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "\nFrom the 2022 filing Southern Company presented its energy‑related derivatives in a single, relatively coarse‑grained table that combined regulatory, cash‑flow and non‑designated contracts and gave only total asset/liability figures with minimal offset disclosure. In the 2024 filing the company separates those contracts into clearly labeled categories (regulatory hedges, cash‑flow/ fair‑value hedges, and non‑designated contracts), shows current versus non‑current balances, discloses gross amounts, offsetting (including cash collateral), and provides detailed breakdowns of interest‑rate and foreign‑currency derivatives—resulting in a far more granular and transparent presentation of how the derivatives are categorized and reported on the balance sheet.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides detailed information about the evolution of Southern Company's derivatives disclosure from 2022 to 2024, but diverges significantly from the ground truth in key respects. CORRECT ELEMENTS: (1) The answer correctly identifies that there was an evolution in disclosure practices between 2022 and 2024; (2) The answer correctly notes a shift toward more granular presentation with better categorization; (3) The answer correctly identifies that 2024 shows more detailed breakdowns including current vs. non-current balances and offsetting information. INCORRECT/DIVERGENT ELEMENTS: (1) The ground truth emphasizes a shift FROM income statement focus (pre-tax effects on statements of income) TO balance sheet focus (fair value as assets/liabilities). The LLM answer focuses entirely on balance sheet presentation details without mentioning the income statement vs. balance sheet shift that is central to the ground truth; (2) The ground truth specifically mentions 'Other' or 'Risk Management Activities' categorization on balance sheets, which the LLM answer does not reference; (3) The ground truth references specific prior years (2021, 2020, 2019) in the 2022 filing context, which the LLM answer omits; (4) The LLM answer introduces details about 'interest-rate and foreign-currency derivatives' that are not mentioned in the ground truth, suggesting possible hallucination or over-specification. MULTI-HOP REASONING: The LLM answer demonstrates sound reasoning about the evolution of disclosure granularity but fails to capture the fundamental shift in reporting philosophy (income-focused to balance sheet-oriented) that is the core insight of the ground truth. The answer addresses 'how' the presentation changed but misses the 'why' or the nature of the fundamental shift. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. SEMANTIC EQUIVALENCE: While both answers discuss evolution and improved transparency, they emphasize different aspects of that evolution, suggesting the LLM may have focused on presentation mechanics rather than the substantive reporting shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 576,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "\nBetween the end of 2023 and early 2024 Gilead lifted its ownership in Arcus from roughly 19.9 % (≈14.8 million shares) to about 33 % after a $320 million equity investment in January 2024, and it added a third designee to Arcus’s board (expanding from two seats).  The earlier three‑year standstill that had limited Gilead’s share purchases expired in Q2 2023, and the amended agreement now lets Gilead buy up to 35 % of Arcus’s outstanding voting shares over the next five years, giving it both a larger equity stake and stronger governance influence.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2023 ownership of 19.9% - CORRECT; (2) January 2024 $320 million investment - CORRECT; (3) Ownership increase to 33% - CORRECT; (4) Board representation expansion from 2 to 3 designees - CORRECT. The LLM answer goes beyond the ground truth by providing additional context about the standstill agreement expiration in Q2 2023 and the new 5-year purchase option allowing up to 35% ownership, which adds valuable context without contradicting the original answer. The share count reference (≈14.8 million shares) is a reasonable approximation for the 19.9% stake. Multi-hop reasoning is sound: the answer correctly synthesizes the timeline of events (standstill expiration → investment → ownership increase → governance expansion) and explains the causal relationship between the investment and increased influence. All entities are correctly identified (GILD/Gilead, Arcus). The answer directly addresses both components of the question (equity ownership evolution and governance influence evolution). Minor note: The ground truth doesn't explicitly mention the standstill agreement details or the 35% future purchase option, but the LLM's inclusion of this information appears to be accurate supplementary context that enhances rather than contradicts the answer. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 383,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "\nBetween the end of 2022 and the 2023 amendment, the 2021 Multicurrency Credit Facility’s maturity was extended—from July 1, 2026 (the date in force at the close of 2022) to July 1, 2028 (after the June 29 2023 amendment).  The total commitment remained unchanged at $6.0 billion (including the $3.5 billion multicurrency sub‑limit), with the amendment only replacing the LIBOR benchmark with SOFR.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains critical factual errors that directly contradict the ground truth. Key issues: (1) MATURITY DATE ERROR - The LLM states the maturity date evolved from July 1, 2026 to July 1, 2028, but the ground truth clearly indicates it went from June 30, 2025 (in 2022) to July 1, 2026 (in 2023). The LLM's 2026 starting point is incorrect - this was the 2023 end state, not the 2022 state. The LLM also incorrectly claims a 2028 maturity date after the June 29, 2023 amendment, which is not supported by the ground truth. (2) BORROWING CAPACITY - The LLM correctly identifies the $6.0 billion commitment and the $3.5 billion multicurrency sub-limit, which aligns with ground truth. (3) MULTI-HOP REASONING - The LLM failed to properly synthesize the evolution between 2022 and 2023. It reversed the chronology or misidentified which dates applied to which years. (4) ADDITIONAL INFORMATION - The LLM adds information about LIBOR-to-SOFR benchmark replacement, which while potentially accurate, was not part of the ground truth answer and suggests the LLM may be conflating different amendments or time periods. (5) CORE FINDING - The ground truth's key insight (one-year extension from June 30, 2025 to July 1, 2026 without capacity increase) is completely missed or contradicted. The answer demonstrates fundamental misunderstanding of the temporal evolution requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 388,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "\nChevron’s mix of crude in its U.S. refineries was essentially unchanged – imported crude still made up roughly 60 percent of refinery inputs in both 2023 and 2024.  What did shift was the overall plant utilization: average crude‑unit distillation capacity utilisation fell from about **89.8 % in 2023 to 87.9 % in 2024**, indicating that the refineries were running slightly less full even though the share of imported versus domestic crude stayed steady.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative: Chevron's imported crude oil percentage remained stable at approximately 60% in both 2023 and 2024, and refinery utilization declined between the two years. The qualitative reasoning and entity identification are sound. However, there is a CRITICAL QUANTITATIVE ERROR in the refinery capacity utilization percentages. Ground truth states: 2023 = 90.8%, 2024 = 86.6%. LLM states: 2023 = 89.8%, 2024 = 87.9%. These are material discrepancies of approximately 1.0 percentage point for 2023 and 1.3 percentage points for 2024. While the directional trend (decline from 2023 to 2024) is correct, the specific numeric values are incorrect. The difference between 90.8% and 89.8% may seem small, but in financial/operational reporting, such precision matters significantly. The LLM also correctly conveys that imported crude remained at ~60% in both years (semantic match with 'approximately 60%'). The multi-hop synthesis is appropriate - connecting the stable import ratio with the declining utilization rate. The answer is well-structured and contextually relevant to the question. The primary failure is quantitative accuracy on the specific utilization percentages, which are factual claims that must be precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 355,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "\nBetween 2023 and 2024 UPS trimmed its British‑Pound‑Sterling hedge book: the notional amount of GBP‑denominated contracts fell from **$663 million (2023)** to **$536 million (2024)**, and the AOCI balance on foreign‑currency debt designated as a net‑investment hedge swung from a **$119 million loss** to a **$127 million gain**.  This reduction in hedged notional and the reversal of the AOCI result reflect a deliberate scaling back of explicit GBP hedges—UPS is relying more on natural offsets and cash‑flow hedges for its GBP exposure, signaling a more measured approach to currency‑risk management.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core hedging position change from 663 million to 536 million units between 2023 and 2024, and accurately calculates the reduction of 127 million units. The qualitative interpretation about strategic repositioning and more measured currency risk management is sound and well-reasoned. The answer appropriately addresses the multi-hop question about how the position evolved and what it indicates about strategy.\n\nCRITICAL ISSUES: (1) UNIT CONFUSION: The LLM states the figures as '$663 million' and '$536 million' when the ground truth specifies these are '663 million units' and '536 million units' of GBP. This is a significant distinction—the original answer clearly refers to notional units of currency, not dollar amounts. The LLM's dollar sign notation is misleading and technically incorrect. (2) EXTRANEOUS INFORMATION: The LLM introduces AOCI (Accumulated Other Comprehensive Income) balance information ($119 million loss to $127 million gain) that is NOT present in the ground truth answer. While this information may be from the actual 10-K filing, it goes beyond what was provided in the original answer and introduces unverified data points that cannot be validated against the ground truth. (3) CALCULATION VERIFICATION: The reduction of 127 million units (663-536=127) is correct, and the percentage reduction of approximately 19.15% is accurate, though the LLM doesn't explicitly state this percentage.\n\nMULTI-HOP REASONING: The synthesis is generally sound—the LLM correctly connects the numerical change to strategic implications about currency risk management. However, the introduction of AOCI data suggests the model may be conflating different pieces of information or adding details not in the ground truth.\n\nSEMANTIC EQUIVALENCE: The core message about reducing GBP hedges and adopting a more conservative approach is preserved, but the unit/currency notation error undermines precision. The mention of 'natural offsets and cash-flow hedges' is a reasonable inference but not explicitly stated in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 561,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "\nThe fair‑value of Bank of America’s money‑market investments edged up from **$1.2 billion at the end of 2023 to $1.3 billion at the end of 2024** (as disclosed in Note 4 – Securities, page 113).  This modest rise indicates that the company is modestly increasing its allocation to short‑term, highly liquid cash‑equivalents—likely to take advantage of higher yields in a rising‑rate environment while maintaining ample liquidity for funding and risk‑management purposes.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $1.2 billion (Dec 31, 2023) and $1.3 billion (Dec 31, 2024). The quantitative comparison is accurate, showing the $0.1 billion increase. The answer correctly identifies Bank of America as the company and the appropriate time period. The LLM goes beyond the ground truth by providing additional context about the strategic rationale (higher yields in rising-rate environment, liquidity management, risk management), which is reasonable inference but not explicitly stated in the ground truth. The citation to 'Note 4 – Securities, page 113' adds credibility and specificity. The semantic meaning aligns well with the ground truth's characterization of 'modest growth' and 'expansion in liquidity management.' Minor deduction: the ground truth uses simpler language ('modest growth' and 'slight expansion'), while the LLM adds interpretive analysis about yield-seeking behavior and rate environment considerations. While this additional analysis is logical and contextually appropriate, it slightly exceeds what the ground truth explicitly states. The answer fully addresses both parts of the multi-part question: (1) the evolution of fair value (correctly stated), and (2) what it indicates about strategy (appropriately interpreted with reasonable inferences). No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 388,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "\nThe maximum expected volume of natural gas subject to physical‑supply contracts with sell‑back options fell sharply – from roughly **26 million mmBtu** (the level disclosed for the 2021/2022 reporting period) to about **15 million mmBtu** in 2024, a reduction of roughly **11 million mmBtu**.  At the subsidiary level this translates to a drop from **6 → 4 mmBtu** for Alabama Power, **8 → 6 mmBtu** for Georgia Power, **4 → 2 mmBtu** for Mississippi Power, and **8 → 3 mmBtu** for Southern Power.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - the 2022 total of 26 million mmBtu and 2024 total of 15 million mmBtu match ground truth exactly. The subsidiary-level breakdowns are accurate: Alabama Power (6→4), Georgia Power (8→6), Mississippi Power (4→2), and Southern Power (8→3). The calculated difference of 11 million mmBtu is arithmetically correct (26-15=11). COMPLETENESS: The answer addresses all required elements - the time period (2022 to 2024), the metric (maximum expected volume of natural gas subject to physical supply contracts with sell-back options), and all four subsidiaries. ENTITY ACCURACY: All company names and subsidiaries are correctly identified. The metric terminology is precise and matches the question. REASONING: The multi-hop synthesis is sound - the answer correctly aggregates subsidiary data to show company-wide trends and then breaks down the changes at the subsidiary level, demonstrating understanding of the hierarchical relationship. MINOR NOTES: The LLM parenthetically references '2021/2022 reporting period' which is slightly imprecise wording (should be 2022 specifically), but this is a minor contextual note that doesn't affect the core factual accuracy. The characterization of the change as 'sharp' and 'consistent reduction across all entities' is appropriate and supported by the data. Overall, this is a high-quality answer with accurate numbers, proper synthesis, and clear presentation of the multi-hop information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 427,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Adobe expanded the Firefly Vector Model from a newly‑launched feature limited to Illustrator and Adobe Express into a cross‑portfolio capability.  The model is now natively embedded in Photoshop, Illustrator, Express, Acrobat, Experience Cloud and other products, with a tiered‑access model that provides free monthly Generative Credits and a paid Firefly subscription for additional usage.  In addition, Adobe introduced enterprise‑focused Firefly Services and Custom‑Model APIs, allowing organizations to apply the vector‑generation technology at scale and with brand‑specific training while maintaining commercial‑use safety.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT TIMELINE: The LLM claims Firefly Vector Model was 'newly-launched' and 'limited to Illustrator and Adobe Express' in 2023, but ground truth states it was integrated into Adobe Express in 2023 with no mention of Illustrator in 2023. (2) INCORRECT PRODUCT EXPANSION: The LLM lists Photoshop, Acrobat, and Experience Cloud as having Firefly Vector Model integration by 2024, but ground truth only confirms expansion to Adobe Illustrator by 2024. The mention of Photoshop, Acrobat, and Experience Cloud appears to be fabricated or confused with general Firefly AI features rather than the specific Vector Model. (3) MISSING KEY FEATURE: The LLM fails to mention the 'Generative Recolor' feature that is explicitly highlighted in the ground truth as a key 2024 application in Illustrator. (4) ADDED UNVERIFIED DETAILS: The LLM introduces information about 'tiered-access model,' 'Generative Credits,' 'Firefly subscription,' 'Firefly Services,' and 'Custom-Model APIs' that are not present in the ground truth and cannot be verified as accurate for the Firefly Vector Model specifically. (5) MULTI-HOP REASONING FAILURE: The answer fails to correctly synthesize the evolution from single-app (Express) to dual-app (Express + Illustrator) integration. Instead, it presents an inflated expansion narrative that goes beyond what the ground truth supports. The core narrative of expansion is correct in concept, but the specific products and features are largely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 433,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "\nBetween 2022 and 2023 Biktarvy’s sales jumped ≈ 14 % to **$11.85 bn**, representing roughly **65 % of GILD’s $18.2 bn HIV franchise** and about **44 % of total company revenue**, underscoring its central commercial role.  The 2024 filing, however, flags intensified pricing pressure from Medicare‑Part D rebate reforms, Medicaid‑rebate caps and growing generic competition, meaning that future growth for Biktarvy will have to come from **label‑expansion, earlier‑line adoption and complementary pipeline assets rather than volume alone**, shaping a strategy that leans on lifecycle management and next‑generation HIV innovations to protect the franchise.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Biktarvy's 2023 sales at $11.85 billion (matching ground truth's $11,850 million), accurately calculates the ~14% growth from 2022 ($10,390M), and properly contextualizes Biktarvy's commercial significance within GILD's portfolio. The answer appropriately addresses the evolution from 2023 to 2024 by noting increased competitive and regulatory pressures (generic competition, Medicare Part D rebates, Medicaid caps). The strategic implications are well-articulated: the shift toward label expansion, earlier-line adoption, and pipeline innovation rather than volume growth alone aligns with the ground truth's emphasis on diversification and innovation needs.\n\nWEAKNESSES: (1) The LLM introduces specific percentages (65% of HIV franchise, 44% of total company revenue) and a total HIV franchise figure ($18.2bn) that are NOT present in the ground truth answer. While these may be factually accurate from the filings, they represent additional detail beyond what was provided in the original answer, making verification against ground truth difficult. (2) The LLM mentions specific regulatory mechanisms (Medicare Part D rebate reforms, Medicaid rebate caps) that are more detailed than the ground truth's general reference to 'generic competition' and 'potential shifts in treatment paradigms.' While not incorrect, this adds specificity not confirmed in the ground truth. (3) The answer focuses heavily on 2022-2023 comparison but could have more explicitly addressed the 2023-2024 evolution as the question specifically asks.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across years (2022, 2023, 2024) and connects financial performance to strategic implications. The logic linking revenue pressure to diversification strategy is sound and well-reasoned.\n\nNUMERIC VERIFICATION: $11.85bn = $11,850 million ✓; ~14% growth calculation: ($11,850-$10,390)/$10,390 = 13.9% ✓. The percentages provided (65%, 44%) cannot be verified against ground truth but appear reasonable.\n\nSCORE JUSTIFICATION: The answer is substantially correct on core facts and demonstrates solid multi-hop reasoning. The main deduction is for introducing unverified percentages and specific regulatory details beyond the ground truth scope, though these don't contradict the original answer. The answer adequately addresses both the evolution question and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 647,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "\nBetween 2022 and 2023 the Series 2018‑1A Securities remained part of the same securitization trust, with their outstanding carrying principal modestly rising from **$496.1 million (2022)** to **$496.8 million (2023)**.  The securities kept the **fixed coupon of 3.652 %** and the **anticipated repayment date of March 15 2028** (final legal maturity March 15 2048) unchanged; the slight increase in principal reflects routine accruals/adjustments within the trust rather than a new issuance or refinancing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) PRINCIPAL AMOUNT DISCREPANCY - The LLM states 2022 principal was $496.1 million, but ground truth shows $500.0 million. This is a $3.9 million error (0.78% variance). The LLM also claims principal 'modestly rose' from $496.1M to $496.8M, but ground truth shows it DECREASED from $500.0M to $496.8M. This is a fundamental directional error in the trend analysis. (2) INTEREST RATE - Correctly identified as 3.652% (fixed coupon) - this matches ground truth. (3) COMPLETENESS - The LLM provides additional context about repayment dates (March 15, 2028 anticipated; March 15, 2048 final maturity) and explains the change as 'routine accruals/adjustments,' which adds interpretive value but doesn't address the core factual error. (4) MULTI-HOP REASONING - The LLM correctly synthesizes that this is the same securitization trust across years, but fails on the primary quantitative comparison. The claim that principal 'modestly rose' contradicts the ground truth showing a decrease of $3.2 million. (5) SEMANTIC EQUIVALENCE - While the LLM's explanation of routine adjustments is reasonable interpretation, it cannot overcome the factual error in the baseline numbers. The 2022 principal figure is materially incorrect, making the entire trend analysis unreliable. Ground truth clearly states $500.0M (2022) → $496.8M (2023), representing a decrease, not an increase.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 388,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 UPS moved from treating Coyote as a core, indefinite‑lived trade name in its Supply‑Chain Solutions unit—where it recorded an $111 million goodwill/intangible‑asset impairment in late 2023 after testing for impairment and began exploring strategic alternatives—to completing a full divestiture in September 2024, which generated a $156 million gain on sale and eliminated Coyote’s revenue (down $976 million) and related expenses from the business.  The transaction reflects a strategic shift away from the Coyote brokerage platform and a focus on growing the remaining Logistics and Forwarding operations, while the 2023 impairment highlighted the unit’s weakening financial performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the UPS-Coyote relationship evolution. STRENGTHS: (1) All key numbers are correct: $111 million impairment in 2023, September 2024 divestiture timing, $156 million gain on sale, and $976 million revenue impact are all accurate. (2) Multi-hop synthesis is sound: the answer correctly traces the progression from impairment/strategic review in 2023 to full divestiture in 2024, showing clear cause-and-effect reasoning. (3) Entity identification is precise: correctly identifies Coyote as part of Supply Chain Solutions unit, accurately characterizes it as a trade name/intangible asset, and properly contextualizes the business as a brokerage platform. (4) Strategic context is well-articulated: explains the shift from core asset to divestiture and the focus on remaining Logistics and Forwarding operations. MINOR CONSIDERATIONS: (1) The LLM provides additional details beyond the ground truth (gain on sale of $156 million, revenue decline of $976 million, characterization as brokerage platform) that are accurate but represent elaboration rather than the core ground truth answer. (2) The ground truth emphasizes 'declining market conditions' as a driver, while the LLM focuses more on 'weakening financial performance'—semantically equivalent but slightly different framing. (3) The LLM's description of Coyote as 'indefinite-lived trade name' is technically precise but the ground truth simply calls it 'Coyote trade name.' These are not contradictions but rather the LLM providing more technical detail. The answer fully addresses the question's two-part structure (financial impact and strategic direction) with accurate numbers and sound reasoning across the 2023-2024 timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 481,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "\nBetween 2019 and 2024 Linde’s Performance Share Unit (PSU) awards were governed first by the Amended & Restated 2009 Praxair Long‑Term Incentive Plan, which for grants beginning in 2019 introduced two distinct performance‑share designs—one tied to **Return on Capital** and another tied to **Total Shareholder Return**. When the 2021 Linde plc Long‑Term Incentive Plan replaced the older plan, it retained those same two metrics for its PSU grants, but the **January 2024 amendment** (effective January 29 2024) updated the award language and clarified the performance‑metric definitions, though the underlying metrics remained Return on Capital and Total Shareholder Return. Thus, the evolution reflects a continuity of the same performance metrics with only refinements to the award documentation and thresholds in the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS ON TIMELINE: The LLM answer introduces information about a '2021 Linde plc Long-Term Incentive Plan' and a 'January 2024 amendment (effective January 29, 2024)' that are NOT mentioned in the ground truth. The ground truth specifically states the awards were under the 'Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan' in both 2022 and 2024, with no mention of plan changes or amendments. (2) UNSUPPORTED CLAIMS: The LLM claims there was a plan replacement and a January 2024 amendment with updated award language and clarified definitions. These specific details cannot be verified against the ground truth and appear to be fabricated or hallucinated. (3) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM correctly identifies the two performance metrics (Return on Capital and Total Shareholder Return) and their continuity, it adds unverified information about plan transitions and amendments that muddy the core finding. (4) CORRECT ELEMENTS: The LLM does correctly identify that the two performance metrics (ROC and TSR) remained consistent from 2019 through 2024, which aligns with the ground truth's conclusion about 'maintaining the same dual structure.' (5) QUANTITATIVE ACCURACY ISSUE: The specific date 'January 29, 2024' is provided without ground truth support. The ground truth references 2024 exhibits but does not specify amendment dates. (6) REASONING QUALITY: The multi-hop reasoning about metric continuity is sound, but the introduction of unsupported plan changes and amendments represents a significant deviation from the ground truth narrative. The answer conflates what may be true about plan administration with what the ground truth actually documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 472,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "\nBetween 2023 and 2024 Trodelvy shifted from a newly‑approved therapy in metastatic HR⁺/HER2⁻ breast cancer—where the FDA granted full approval and the European Commission followed suit—to receiving a Breakthrough Therapy designation from the FDA for a completely different indication, extensive‑stage small‑cell lung cancer, in 2024. This progression—from a first‑in‑class approval in breast cancer to a designated expedited‑review pathway in lung cancer—signals that Trodelvy’s development is expanding into additional oncology indications and that the company is leveraging regulatory incentives to accelerate its pipeline growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key regulatory developments for Trodelvy between 2023 and 2024, including the Breakthrough Therapy designation for extensive-stage small cell lung cancer in 2024. The answer accurately captures the shift from approved indications to new designation pathways and correctly interprets this as strategic expansion into new oncology indications. However, there are some issues with completeness and accuracy: (1) The LLM mentions 'newly-approved therapy in metastatic HR+/HER2- breast cancer' with FDA approval and European Commission approval in 2023, but the ground truth only specifies that Trodelvy was 'indicated for' these conditions in 2023, without explicitly confirming new approvals in that year. The LLM adds details about European Commission approval that are not mentioned in the ground truth. (2) The ground truth lists three 2023 indications (triple-negative breast cancer, HR+/HER2- breast cancer, and urothelial cancer), but the LLM only explicitly mentions HR+/HER2- breast cancer when discussing 2023 status. (3) The LLM characterizes Trodelvy as 'first-in-class' which is not stated in the ground truth. (4) The reasoning about regulatory incentives and pipeline acceleration is sound and represents appropriate interpretation of the data. The core facts about the 2024 Breakthrough Therapy designation for small cell lung cancer are accurate. The multi-hop synthesis connecting 2023 status to 2024 developments is logically sound, though the answer adds some details not present in the ground truth while omitting some of the 2023 indications. The answer demonstrates good understanding of the regulatory trajectory but lacks complete fidelity to all specified indications from 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 474,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "\nFrom 2023 to 2024, Vertex AI grew from a generic generative‑AI development platform into the primary engine for Google’s Gemini family within Google Cloud. In 2024 Gemini 2.0—Google’s most capable multimodal model—is now natively available through Vertex AI, and the platform adds pre‑packaged AI agents for coding, testing, documentation and cybersecurity, while integrating tightly with Cloud infrastructure, data‑analytics and security services to enable end‑to‑end training, fine‑tuning, deployment and operation of Gemini‑powered applications.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and inaccurate elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. Correctly identifies the evolution from 2023 to 2024\n2. Accurately notes Gemini integration as a key development\n3. Correctly mentions additional capabilities like fine-tuning and deployment\n4. Appropriately emphasizes the shift toward more advanced generative AI integration\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. FACTUAL ERROR: The LLM claims \"Gemini 2.0\" is \"Google's most capable multimodal model\" available through Vertex AI in 2024. The ground truth does not mention Gemini 2.0 specifically, only \"Gemini and other leading generative AI models.\" This appears to be an unsupported claim not in the source material.\n2. MISSING CAPABILITIES: The ground truth specifically mentions \"Enterprise Search and Conversations\" (2023) and \"vector search, grounding, and distillation\" (2024). The LLM answer omits these specific services entirely, instead substituting \"pre-packaged AI agents for coding, testing, documentation and cybersecurity\" which are not mentioned in the ground truth.\n3. INCOMPLETE SYNTHESIS: The LLM adds details about \"Cloud infrastructure, data-analytics and security services\" integration that are not present in the ground truth, potentially introducing unsupported information.\n4. SCOPE CREEP: The LLM frames Vertex AI as \"the primary engine for Google's Gemini family\" which goes beyond what the ground truth states about the platform's role.\n\nMULTI-HOP REASONING: The LLM demonstrates understanding of the evolution concept but fails to accurately synthesize the specific capabilities mentioned in the ground truth. It substitutes different capabilities rather than building on the documented ones.\n\nQUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is neutral. Both answers correctly reference 2023 and 2024.\n\nSEMANTIC EQUIVALENCE: While the LLM captures the general theme of evolution and Gemini integration, it diverges significantly from the specific technical capabilities documented in the ground truth, making it partially but not substantially equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 589,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "\nSouthern Company has continued the same accounting treatment for weather‑related contracts from 2022 through 2024—these instruments are carried at fair value as energy‑related derivatives and are presented in the balance‑sheet line items for “Energy‑related derivatives not designated as hedging instruments.”  The key change is that the 2024 filing makes the exclusion explicit: the reconciliation of gross to net derivative amounts (note (b)) states that “net amounts recognized in the Balance Sheets … exclude immaterial premium and intrinsic value associated with weather derivatives for all periods presented.”  Consequently, while weather derivatives are still valued at fair value, the amounts reported as assets or liabilities no longer include any premium or intrinsic value that the company deems immaterial, a clarification that was not separately highlighted in the 2022 disclosure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant omissions and fails to address key quantitative information from the ground truth. Specific issues: (1) MISSING CRITICAL NUMBERS: The ground truth explicitly states that cash collateral held in broker margin accounts was $17 million (2024) and $62 million (2023)—these specific dollar amounts are completely absent from the LLM response, representing a major factual omission. (2) INCOMPLETE COMPARISON: The question asks how treatment 'changed from 2022 to 2024,' but the LLM states the treatment remained 'the same' and focuses primarily on clarification/disclosure improvements rather than substantive changes. The ground truth indicates a shift from non-specific disclosure ('did not specify exact amounts') to more specific context (the $17M/$62M collateral figures), which represents a meaningful change in disclosure detail. (3) QUANTITATIVE ACCURACY: The LLM provides zero specific dollar amounts while the ground truth provides two key figures ($17M and $62M). This is a critical failure for a question explicitly asking about 'amounts considered immaterial.' (4) REASONING QUALITY: While the LLM correctly identifies that weather derivatives remain excluded as immaterial and notes improved disclosure clarity in 2024, it fails to synthesize the multi-hop information about the specific collateral amounts that demonstrate the evolution of SO's derivative disclosures. (5) SEMANTIC ISSUE: The LLM characterizes the change as merely a 'clarification' of existing treatment, when the ground truth suggests a more substantive shift toward providing specific quantitative context (the collateral amounts) that was absent in 2022. The answer is partially correct on the accounting treatment but fundamentally incomplete on the quantitative changes that are central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 494,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "\nBetween 2023 and 2024, Gilead’s disclosures show that Biktarvy remained under strong IP protection—its core U.S. and EU compound patents (and related extensions) are projected to expire in 2033, with U.S. regulatory exclusivity set to run through 2032 and pediatric exclusivity adding further protection.  In early 2024 the FDA granted an expanded indication for Biktarvy to treat HIV‑infected patients who have M184V/I resistance and to use the drug in pregnancy, thereby adding a new clinical claim that bolsters its premium market positioning and delays the onset of generic competition.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) Correctly identifies the 2033 U.S. patent expiration date matching the ground truth; (2) Accurately captures the 2024 FDA expanded indication for M184V/I resistance treatment; (3) Correctly notes the pregnancy indication approval in 2024; (4) Properly synthesizes the evolution from patent protection focus (2023) to expanded therapeutic applications (2024); (5) Adds relevant context about EU patents, regulatory exclusivity through 2032, and pediatric exclusivity that reinforces the core narrative. MINOR ISSUES: (1) The LLM introduces additional details (EU compound patents, 2032 regulatory exclusivity, pediatric exclusivity, generic competition delay) that are not explicitly mentioned in the ground truth answer. While these details appear plausible and contextually relevant to Gilead's disclosures, they represent information beyond what was provided in the original answer. This is not necessarily incorrect but represents expansion beyond the ground truth scope. (2) The phrasing 'early 2024' for the FDA indication is slightly more specific than the ground truth's simple '2024,' though this is a minor distinction. QUANTITATIVE VERIFICATION: All dates (2023, 2024, 2033, 2032) are correctly stated. The core patent expiration year of 2033 matches exactly. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods and correctly identifies the shift in positioning from IP protection to expanded clinical applications. The logic connecting patent protection to market positioning is sound. SEMANTIC EQUIVALENCE: The answer conveys the same fundamental information as the ground truth while adding contextual depth about regulatory exclusivity mechanisms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 483,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "\nBetween 2022 and 2023 AMT moved from a modest net draw of roughly **$850 million** under the 2021 Multicurrency Credit Facility in 2022 (used for general corporate purposes and to repay existing debt) to a far larger gross borrowing of **$3.0 billion** in 2023, which was subsequently offset by **$6.1 billion of repayments**, leaving an outstanding balance of **$723.4 million** at year‑end 2023 (page 44 – 2022 borrowing; page 52 – 2023 borrowings/repayments and balance).  In June 2023 the facility was amended to extend its maturity to **July 1 2026**, increase the commitment levels and replace LIBOR with SOFR (page 52).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key quantitative changes between 2022 and 2023: $850.0 million net borrowing in 2022, $3.0 billion gross borrowing in 2023, and $6.1 billion in repayments. The amendment details are accurate (July 1, 2026 maturity date, LIBOR to SOFR replacement). The multi-hop synthesis across years and facility amendments is sound. The answer appropriately addresses both borrowing amounts and facility amendments as requested.\n\nWEAKNESSES: (1) The LLM introduces a calculated figure of $723.4 million outstanding balance at year-end 2023 that is not mentioned in the ground truth. While this calculation ($3.0B borrowed - $6.1B repaid = -$3.1B net, suggesting a net repayment position) appears mathematically reasonable, it represents information not explicitly confirmed in the original answer and adds a detail not requested. (2) The ground truth specifically mentions a significant EUR repayment of 842.6 million EUR ($919.1 million) in 2023, which the LLM answer completely omits. This is a material detail that demonstrates the multicurrency nature of the facility and represents a significant transaction. (3) The LLM states the amendment \"increase[d] the commitment levels\" but the ground truth specifies the commitment was \"maintained\" at $6.0 billion, not increased. This is a factual error regarding the amendment terms.\n\nCALCULATION VERIFICATION: The net position calculation ($3.0B - $6.1B = -$3.1B net repayment) is mathematically sound, but the specific $723.4 million figure cannot be verified against the ground truth provided.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 activities and correctly identifies the facility amendments as a separate but related development. The comparison structure effectively highlights the transformation in usage patterns.\n\nOVERALL: The answer captures the main narrative and most key facts but contains one material factual error (commitment increase vs. maintenance) and omits a significant transaction detail (EUR repayment). The introduction of an unverified calculated balance is a minor concern.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 576,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "\nBetween 2023 and 2024 Alphabet moved from a generic “Google Network” label to a more explicit treatment of Google Ad Manager as a distinct platform in its revenue‑recognition framework.  The 2024 filing clarifies that Ad Manager inventory is evaluated for principal‑versus‑agent status, and revenue is recorded gross when Alphabet controls the advertising inventory—consistent with the earlier gross‑basis rule—but now the gross amount is allocated to separate performance obligations (e.g., brand vs. performance ads) and variable‑consideration estimates are applied.  Consequently, Ad Manager’s proceeds are integrated more tightly into the revenue‑reporting model, with clearer segregation of gross revenue, cost‑of‑revenues to network partners, and allocations tied to the specific performance obligations delivered through Ad Manager.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces problematic inaccuracies and unsupported claims. CORRECT ELEMENTS: (1) The identification of a shift from generic 'Google Network' labeling to more explicit Google Ad Manager treatment is reasonable; (2) The mention of principal-versus-agent evaluation and control-based assessment aligns with the ground truth's emphasis on control-driven justification; (3) The 2023-2024 timeframe is correct. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific operational details NOT present in the ground truth—specifically the claim about 'separate performance obligations (e.g., brand vs. performance ads)' and 'variable-consideration estimates.' The ground truth makes no mention of these specific revenue recognition mechanics or performance obligation segregation; (2) The LLM's description of 'clearer segregation of gross revenue, cost-of-revenues to network partners, and allocations tied to specific performance obligations' goes beyond what the ground truth states and appears to be fabricated detail; (3) The ground truth emphasizes a shift from 'transactional reporting model to control-driven justification,' but the LLM frames this as adding complexity through performance obligation allocation, which is a different narrative. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution but does so by adding unsupported operational details rather than accurately reflecting the ground truth's focus on the justification framework shift. The core insight about control-based evaluation is present but diluted by incorrect elaboration. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension scores well (8/10) due to no false numbers, though the lack of specificity is notable. QUALITATIVE ACCURACY: The reasoning quality suffers from the introduction of unsubstantiated claims about performance obligations and variable consideration, reducing this to 5/10. The answer reads plausibly but diverges from the ground truth's actual emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 550,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "\nBetween 2023 and 2024 UPS moved from an outright goodwill write‑down of **$56 million** for Roadie in 2023 to **no impairment in 2024**, but the unit remains “high‑risk”: the 2024 annual test showed only a **limited excess of fair value** for Roadie (and two other units), representing about **$1.1 billion of the $4.3 billion consolidated goodwill** and flagged as especially sensitive to cost‑of‑capital and cash‑flow assumptions. Consequently, while UPS’s financial exposure to Roadie has been reduced (no new impairment charge), the company continues to monitor the reporting unit closely, noting that a further miss on forecasts could trigger future impairment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of key financial metrics and the evolution of UPS's Roadie exposure. STRENGTHS: (1) Correctly identifies the $56 million goodwill impairment in 2023; (2) Accurately notes no impairment in 2024; (3) Properly characterizes the shift from active impairment to cautious monitoring; (4) Correctly identifies Roadie as having 'limited excess of fair value'; (5) Provides additional context about sensitivity to cost-of-capital and cash-flow assumptions; (6) Appropriately notes the risk of future impairment if forecasts miss. QUANTITATIVE VERIFICATION: The $56 million figure is correct. The mention of $1.1 billion and $4.3 billion goodwill figures adds specificity beyond the ground truth but appears reasonable as supporting detail. The percentages implied are internally consistent. MINOR CONSIDERATIONS: (1) The ground truth emphasizes a 'shift from active impairment to cautious monitoring stance,' which the LLM captures well with 'moved from an outright goodwill write-down...to no impairment in 2024, but the unit remains high-risk'; (2) The LLM provides slightly more granular detail about the consolidated goodwill breakdown ($1.1B of $4.3B) which, while not explicitly in the ground truth, represents reasonable elaboration rather than error; (3) The characterization of Roadie as 'high-risk' and the forward-looking statement about potential future impairment align well with the ground truth's emphasis on 'ongoing financial risk' and 'continued sensitivity.' MULTI-HOP REASONING: The answer correctly synthesizes the 2023-2024 comparison and identifies the causal relationship between the impairment charge and the subsequent monitoring stance. The logic flow is sound and addresses all aspects of the question regarding financial exposure and strategic positioning. The only minor gap is that the ground truth could have been slightly more explicit about the specific goodwill amounts, but the LLM's additional detail does not contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 548,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "\nOver the 2022‑2024 period Linde’s helium business moved from a modest growth contributor to a cost‑pressured unit: helium‑related sales fell 2% in 2024, a decline of about $32 million, while the “Other” segment’s operating profit rose $19 million (44%), an increase driven largely by an insurance recovery that more than offset higher helium costs, leaving the net effect on consolidated sales essentially negligible (≈0.1% of total sales) and producing only a modest uplift in operating profit (well under 0.2% of total operating profit).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces specific dollar amounts ($32 million sales decline, $19 million operating profit increase, 44% increase, 0.1% of total sales, 0.2% of operating profit) that are NOT present in the ground truth. The ground truth only states '2% underlying sales decrease' in the Other segment and mentions 'increased costs related to helium, partially offset by an insurance recovery' - it provides NO specific dollar figures for these impacts. The LLM appears to have fabricated precise numbers without source justification. (2) INCOMPLETE SYNTHESIS - The ground truth clearly identifies that the 2% decline was 'primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT)' - the LLM mentions LAMT but doesn't emphasize this dual driver. (3) CHARACTERIZATION ISSUES - The LLM describes helium as moving from 'modest growth contributor' to 'cost-pressured unit,' but the ground truth only states it was 'a supply component' in 2022 (not necessarily a growth contributor) and became a source of 'cost pressure' by 2024. The 'modest growth' characterization is unsupported. (4) CORRECT ELEMENTS - The LLM correctly identifies: the 2% sales decrease, the shift from neutral/positive to negative impact, the insurance recovery offsetting costs, and the focus on the 'Other' segment. (5) CALCULATION VERIFICATION - Without access to actual filing data, the specific dollar amounts ($32M, $19M, percentages) cannot be verified and appear to be extrapolations or fabrications. The ground truth provides no basis for these calculations. The core narrative about helium's deteriorating role is directionally correct, but the quantitative specificity is problematic and unsupported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 478,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "\nThe long‑term credit‑protection agreements with FNMA and FHLMC covered **$8.7 billion of loans at the end of 2023**, but that balance fell to **$8.0 billion at the end of 2024** – a reduction of about $0.7 billion (≈8 %). Because these residential‑mortgage loans are fully insured, the Corporation does **not record any allowance for credit losses** on them, so the decline signals a modest reduction in the protected loan portfolio while still leaving a sizable, but largely mitigated, credit‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $8.7 billion in 2023, $8.0 billion in 2024, and the calculated reduction of $0.7 billion (approximately 8%) is accurate. The calculation is properly verified: ($8.7B - $8.0B) / $8.7B = 0.0805 or ~8.05%, which rounds correctly to 'about 8%'. ENTITY ACCURACY: Correctly identifies FNMA and FHLMC, the Corporation's residential mortgage loans, and the time periods (2023 to 2024). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points - the loan values, the credit protection mechanism, the accounting treatment (no allowance for credit losses), and the implications for credit risk exposure. SEMANTIC EQUIVALENCE: The LLM's phrasing 'fully insured' is semantically equivalent to the ground truth's 'full credit protection,' and both convey the same meaning about the accounting treatment and risk mitigation. COMPLETENESS: The answer addresses both parts of the multi-part question - how the value evolved (with specific numbers and percentage change) and what this indicates about credit risk exposure (reduction in reliance on protection, decrease in high-risk loans). MINOR OBSERVATION: The LLM uses slightly different language ('modest reduction' vs. the ground truth's more neutral 'reduction') and adds the phrase 'largely mitigated' which is a reasonable inference but not explicitly stated in the ground truth. However, this represents appropriate contextual interpretation rather than an error. The answer is comprehensive, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 444,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Adobe deepened Firefly’s integration—moving it from a stand‑alone generative‑AI app into a native layer across Photoshop, Illustrator, Express and the broader Experience Cloud suite—and began coupling that technical breadth with enterprise‑level IP indemnification to stress “safe‑for‑commercial‑use” as its key competitive differentiator.  At the same time, the company highlighted the growing regulatory exposure of AI, noting that new AI‑specific rules such as the EU AI Act could impose stricter compliance, governance and liability requirements that may slow adoption or force costly redesigns.  Consequently, Firefly’s competitive edge now hinges on both its expanded AI‑enabled workflows and its ability to meet evolving regulatory standards, while the associated risk is that regulatory constraints could limit its rollout or increase compliance costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core strategic evolution of Adobe Firefly between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from 2023 positioning emphasizing generative AI capabilities and commercial safety to 2024 positioning that adds regulatory risk awareness. (2) Accurately references the EU AI Act as the key regulatory concern introduced in 2024. (3) Properly synthesizes the multi-hop concept that Firefly's competitive differentiation now encompasses both technical capabilities (native integration across products) AND regulatory compliance ability. (4) Correctly captures the risk dimension—that regulatory constraints could limit rollout or increase costs. (5) Adds valuable specificity about IP indemnification and enterprise-level positioning that enhances the answer without contradicting ground truth. MINOR GAPS: (1) The LLM answer provides more granular detail about specific product integrations (Photoshop, Illustrator, Express, Experience Cloud) than the ground truth explicitly states, though this appears to be reasonable elaboration rather than error. (2) The phrase 'fiscal 2023 and 2024' is appropriate but the ground truth uses calendar years '2023 and 2024'—this is a minor semantic variation that doesn't affect accuracy. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The dates (2023, 2024, EU AI Act adoption in 2024) are all correct. QUALITATIVE ACCURACY: The reasoning correctly synthesizes the evolution from competitive emphasis to risk-aware positioning, properly identifies the regulatory shift as a key change, and logically connects technical differentiation with compliance requirements. CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses both parts of the multi-part question (competitive differentiation evolution AND regulatory risks evolution). The answer is well-structured and appropriately detailed for the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 552,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "\nBetween 2023 and 2024 Trodelvy’s top‑line performance accelerated sharply – its product sales jumped 56 % year‑over‑year to **$1.06 billion in 2023** and continued to rise in 2024 as the company added new indications and a Breakthrough‑Therapy designation for extensive‑stage small‑cell lung cancer, while its U.S. patent life (expiring **2028**) and EU exclusivity (until **2029**) remain protected by regulatory exclusivity that extends to **2032**.  This combination of expanding clinical approvals and a still‑protected IP position drove a **37 % increase in oncology sales** and helped lift overall product revenue, offsetting declines in Veklury and contributing to a modest rise in total revenues despite pricing pressures.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Trodelvy's 56% sales increase to $1.06 billion in 2023 and the FDA's Breakthrough Therapy designation for extensive-stage small cell lung cancer in 2024. The numeric values and percentages are accurate. However, there are several issues: (1) The answer introduces additional information about patent expiration (2028), EU exclusivity (2029), and regulatory exclusivity (2032) that is not in the ground truth and cannot be verified as correct or incorrect from the provided context. (2) The answer mentions a '37% increase in oncology sales' and discusses Veklury declines and overall revenue changes, which are not addressed in the ground truth answer. While this additional context may be factually accurate from the filing, it goes beyond what was asked and what the ground truth covers. (3) The answer structure is somewhat convoluted, mixing 2023 and 2024 information in a way that could be clearer. The ground truth provides a cleaner chronological comparison: 2023 sales performance ($1,063M, 56% increase) followed by 2024 regulatory advancement (Breakthrough designation). The LLM answer does address both the financial performance and regulatory trajectory as requested, but adds substantial information not in the ground truth. The core facts are correct, but the answer is less focused and introduces unverified claims about patent/exclusivity dates that weren't part of the original question or ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 408,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "\nChevron’s 36.4 % equity stake in Angola LNG Limited grew sharply – the investment’s carrying value rose from about **$405 million in 2022 to $1.66 billion in 2024**, and equity‑method earnings from the project surged from **$1.86 billion in 2022 to $3.38 billion in 2024** (as disclosed in the 2024 10‑K notes on investments and earnings).  This increase reflects both the higher market value of the LNG assets and Chevron’s deeper financial commitment, including financing arrangements that support the plant’s expansion, positioning Angola LNG as a key pillar of Chevron’s upstream growth strategy through 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains specific financial figures that cannot be verified against the ground truth and appear to be fabricated or hallucinated. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims carrying value rose from $405M (2022) to $1.66B (2024) and equity-method earnings surged from $1.86B (2022) to $3.38B (2024). These specific numbers are NOT present in the ground truth answer. The ground truth only mentions: (a) 2022: improved income from equity affiliates including Angola LNG contributing to $5,657M total equity affiliate income (not $1.86B specifically for Angola LNG), and (b) 2024: 36.4% ownership stake disclosed. The LLM fabricated precise carrying values and earnings figures without source verification. (2) MULTI-HOP REASONING: While the LLM correctly identifies the 36.4% ownership stake (matching ground truth), it invents supporting financial metrics that are not corroborated. The ground truth does not provide the specific carrying value progression or the $1.86B→$3.38B earnings trajectory claimed by the LLM. (3) ENTITY ACCURACY: The company name (Angola LNG Limited) and ownership percentage (36.4%) are correct, but the financial metrics are unsupported. (4) SEMANTIC ISSUES: The LLM's narrative about 'sharp growth' and 'deeper financial commitment' goes beyond what the ground truth supports. The ground truth emphasizes 'continued strategic emphasis' and 'more defined positioning' in 2024 compared to 2022, not dramatic financial growth. (5) HALLUCINATION RISK: The specific dollar amounts ($405M, $1.66B, $1.86B, $3.38B) appear to be invented details not present in the source material, representing a fundamental failure in factual accuracy. The answer reads plausibly but contains unverified quantitative claims that significantly exceed the ground truth's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 494,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "\nFrom the end of 2023 to the end of 2024 the balance of Meta’s fixed‑rate senior unsecured notes surged from **$18.5 billion to $29.0 billion**, an increase of roughly **$10.5 billion** that came from a new issuance in August 2024 (the August 2024 series, maturing 2029‑2064 at 4.30‑5.55% interest).  The 2024 portfolio therefore includes the older 2022‑2023 series (maturing 2027‑2063 at 3.5‑5.75% interest) plus the August 2024 notes, and interest expense on the notes rose to **$683 million in 2024** (up from $420 million in 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) Balance progression: $18.5B (end 2023) to $29.0B (end 2024) - CORRECT; (2) Increase amount: $10.5B - CORRECT (calculated as $29.0B - $18.5B); (3) August 2024 issuance: $10.5B - CORRECT and properly identified as the source of the increase; (4) Interest rate ranges: 4.30-5.55% for August 2024 series and 3.5-5.75% for older series - CORRECT; (5) Maturity ranges: 2029-2064 for August 2024 and 2027-2063 for older series - CORRECT; (6) Interest expense: $683M in 2024 vs $420M in 2023 - CORRECT. The LLM answer goes beyond the ground truth by providing additional context including specific interest rates, maturity dates, and interest expense figures, which adds valuable detail without contradicting the original answer. The multi-hop reasoning is sound: the model correctly synthesized the 2023 baseline, 2024 ending balance, identified the specific August 2024 issuance as the driver of change, and provided supporting details about the composition of the portfolio. The answer directly addresses how the value and issuance activity evolved across the two-year period. Minor deduction (1 point) only because the ground truth mentions a 2023 May issuance of $8.46B in net proceeds, which the LLM answer does not explicitly reference, though this is a minor omission that doesn't affect the core answer about 2023-2024 evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 392,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "\nThe only quantitative reference to helium in the excerpts is the “Raw materials and supplies” line, which was $614 million at the end of 2023 and fell to $529 million at the end of 2024 (page 62). Neither the 2023 nor the 2024 filing includes a separate disclosure that re‑classifies helium from a generic supply to a “dependency,” nor does either period contain specific cost‑or‑sourcing language beyond this aggregate inventory figure. Thus, based on the provided pages, there is no explicit evidence of a change in financial exposure or a new dependency classification for helium.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM cites aggregate 'Raw materials and supplies' inventory figures ($614M in 2023, $529M in 2024) which are irrelevant to the question. The ground truth provides specific helium cost percentages (4.2% of raw material expenses in 2023, 6.8% in 2024), which the LLM completely fails to identify or reference. These percentages represent the actual financial exposure metrics requested in the question. (2) ENTITY/CLASSIFICATION ERRORS: The LLM explicitly denies that helium was reclassified from 'supply' to 'dependency' status, stating 'there is no explicit evidence of a change in financial exposure or a new dependency classification.' However, the ground truth clearly documents this exact reclassification occurred between 2023 and 2024. (3) MULTI-HOP REASONING FAILURE: The question requires synthesizing information about helium's categorization change AND corresponding cost exposure changes. The LLM failed to identify either piece of information, instead focusing on unrelated balance sheet inventory data. (4) SEMANTIC MISALIGNMENT: The LLM's conclusion that 'there is no explicit evidence' directly contradicts the ground truth's documented findings of specific cost percentages and dependency classification changes. The LLM appears to have searched for information in the wrong sections of the filings or failed to locate the relevant disclosures entirely. The answer demonstrates a fundamental failure to address the core question about helium's changing financial importance and strategic role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 450,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the pool of European customer balances that PayPal could designate for credit activities was reduced from **$3.8 billion** (approved as of 31 Dec 2022) to **$3.0 billion** (approved as of 31 Dec 2023).  This is a **decline of about 21 %** (≈$0.8 billion) in the amount approved for such credit activities.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key financial figures ($3.8B in 2022, $3.0B in 2023) and accurately calculated the absolute decline of approximately $0.8 billion and the percentage change of about 21%. The dates are correct (31 Dec 2022 and 31 Dec 2023). The numerical calculations are sound and properly formatted.\n\nWEAKNESSES: The LLM answer is incomplete in addressing the full scope of the original question. The ground truth explicitly mentions that these amounts represented approximately 37% of European customer balances in 2022 and approximately 39% in 2023. The LLM omitted these percentage-of-total figures entirely, which are important context for understanding how PayPal's utilization evolved. The ground truth also provides interpretive insight that despite the percentage increasing slightly, the absolute amount decreased, signaling a more conservative approach. The LLM mentions the decline but doesn't synthesize the full picture of what the percentages reveal about the evolution of utilization strategy.\n\nMULTI-HOP REASONING: The LLM successfully synthesized the comparison between two years and calculated the percentage change correctly. However, it failed to complete the full multi-hop synthesis by not incorporating the percentage-of-total metrics that provide crucial context about the evolution of utilization patterns.\n\nCALCULATION VERIFICATION: $3.8B - $3.0B = $0.8B ✓; ($0.8B / $3.8B) × 100 = 21.05% ≈ 21% ✓\n\nThe answer is factually accurate on the numbers provided but incomplete in addressing all dimensions of the question about how utilization evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 440,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "\nBetween fiscal 2023 (ended Oct 1 2023) and fiscal 2024 (ended Sep 29 2024) the fair‑value of Starbucks’ foreign‑currency “other” derivatives contracted markedly – derivative assets fell from $32 million (current) and $22.9 million (long‑term) in 2023 to $1.9 million (current) and $1.7 million (long‑term) in 2024, while related liabilities rose from $2 million to $4.7 million (accrued) and from $0 to $4.1 million (long‑term).  Consequently, the amount of gains remaining in AOCI that is expected to be re‑classified into earnings over the next 12 months dropped sharply from $39.6 million in 2023 to $9.5 million in 2024, and the realized re‑classification impact on earnings moved from a $3.6 million loss in 2023 to a modest $0.1 million gain in 2024.  (See SBUX_10K_2023 pp. 69‑73 and SBUX_10K_2024 pp. 68‑73.)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. Critical issues: (1) FAIR VALUE DISCREPANCY: The ground truth states fair values of $1,164M (2023) and $920M (2024) for foreign currency-other instruments overall. The LLM instead reports derivative asset/liability components ($32M current + $22.9M long-term = $54.9M in 2023; $1.9M + $1.7M = $3.6M in 2024) which are clearly different metrics and much smaller values. The LLM appears to be discussing only derivative asset/liability line items rather than the total fair value of the foreign currency-other instruments category. (2) AOCI GAIN ERRORS: The ground truth specifies net gains in AOCI of $39.6M (2023) and $11.5M (2024). The LLM incorrectly states the 2023 AOCI reclassification expectation as $39.6M, confusing the AOCI gain amount with the expected reclassification amount. The ground truth clearly shows expected reclassification of $55.3M (2023) declining to $9.5M (2024). The LLM only mentions $39.6M→$9.5M, missing the correct 2023 reclassification figure of $55.3M. (3) REALIZED RECLASSIFICATION: The LLM introduces information about realized reclassification impact ($3.6M loss in 2023 to $0.1M gain in 2024) that is not mentioned in the ground truth answer, suggesting potential confusion with different metrics. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three key metrics: (a) fair value of instruments, (b) net gains in AOCI, and (c) expected reclassification amounts. Instead, it appears to have mixed derivative asset/liability positions with AOCI metrics. The answer demonstrates partial understanding of the question but fundamental errors in identifying and reporting the correct financial metrics from the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 479,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "\nThe fair‑value of Alabama Power’s energy‑related derivatives grew from roughly $15 million (recorded as an asset) in 2022 to about $55 million (also an asset) in 2023, with no liability recorded in either year – a clear strengthening of its asset position.  \nFor Georgia Power, the same line item rose from a $13 million asset and a $124 million liability in 2022 to a $358 million asset and a $358 million liability in 2023, so both its asset and liability exposures expanded, with the liability growing much more sharply.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and pervasive factual errors across all key metrics for both companies. ALABAMA POWER: The LLM reversed the 2022 and 2023 values entirely. Ground truth shows 2022: $55M assets/$11M liabilities; 2023: $15M assets/$110M liabilities. The LLM incorrectly states 2022 had $15M assets and 2023 had $55M assets, and falsely claims no liabilities in either year when 2023 had $110M in liabilities. This is a complete inversion of the actual trend. GEORGIA POWER: The LLM provides entirely fabricated numbers. Ground truth shows 2022: $75M assets/$8M liabilities; 2023: $13M assets/$124M liabilities. The LLM claims 2022 had $13M assets/$124M liabilities (which are actually 2023 figures) and invents 2023 values of $358M assets/$358M liabilities that do not appear in the source data. The directional analysis is also fundamentally wrong: the LLM claims Alabama Power strengthened its asset position when it actually weakened significantly (from $55M to $15M assets) while liabilities exploded (from $11M to $110M). For Georgia Power, the LLM's invented $358M figures create a false narrative of balanced expansion when the actual story is a dramatic shift from net asset position ($75M-$8M=$67M net) to net liability position ($13M-$124M=-$111M net). The multi-hop synthesis completely fails—the model did not correctly extract or compare data across the two years for either entity. This answer would mislead any user relying on it for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 409,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "\nFrom the 2022 disclosures the U.S. Retiree Health Care Plan was invested roughly 65 % in fixed‑income securities (cash and cash equivalents) and 35 % in equity securities. By the end of 2023 the allocation had shifted to about 80 % fixed‑income and 20 % equity, moving the portfolio toward the upper end of the plan’s target fixed‑income range (65‑80 %) and away from the higher‑equity weighting it held in 2022. This re‑balancing reflects the company’s strategy to better match the plan’s asset duration with its liability profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth: 2022 allocation of 65% fixed income/35% equity, and 2023 allocation of 80% fixed income/20% equity. The answer correctly identifies the shift toward a more conservative strategy. The LLM provides additional valuable context not in the ground truth answer, including: (1) the target range of 65-80% for fixed income, (2) the specific characterization of moving toward the 'upper end' of the target range, and (3) the strategic rationale about matching asset duration with liability profile. These additions enhance understanding without contradicting the ground truth. The multi-hop synthesis is sound - correctly comparing allocations across two years and drawing appropriate conclusions about the strategic shift. All entities are correctly identified (U.S. Retiree Health Care Plan, fixed income securities, equity securities, years 2022-2023). The only minor consideration is that the additional context about duration matching and target ranges, while accurate and helpful, goes slightly beyond what was explicitly stated in the ground truth answer, but this represents value-added information rather than error. The answer demonstrates excellent understanding of the question's multi-part nature and provides clear, well-reasoned analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 375,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy moved from being an investigational oncology product (still only being evaluated for HR⁺/HER2⁻ breast cancer and NSCLC in 2022) to receiving regulatory approval for a new indication. In 2023 the FDA granted full approval and the European Commission granted conditional marketing authorization for **monotherapy treatment of adults with unresectable or metastatic HR⁺/HER2⁻ breast cancer who have received endocrine‑based therapy and at least two additional systemic therapies**—a new breast‑cancer label that expands Trodelvy’s approved uses beyond its earlier metastatic triple‑negative breast‑cancer indication.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that substantially undermine its accuracy. CRITICAL ERRORS: (1) The LLM claims Trodelvy was 'still only being evaluated for HR+/HER2- breast cancer and NSCLC in 2022' - this is INCORRECT. According to the ground truth, in 2022 Trodelvy was ALREADY APPROVED for two indications: unresectable locally advanced or metastatic TNBC (after 2+ prior systemic therapies) AND metastatic urothelial cancer (after platinum-based chemotherapy and PD-1/PD-L1 inhibitor). The LLM incorrectly characterizes the 2022 status as investigational. (2) The LLM completely OMITS the urothelial cancer indication that existed in 2022, failing to provide a complete picture of the drug's regulatory evolution. (3) The LLM correctly identifies the HR+/HER2- breast cancer approval in 2023 with accurate details (endocrine-based therapy and at least two additional systemic therapies), but this is presented as if it were the only or primary evolution, when in fact the ground truth shows this was an EXPANSION of existing approvals. WHAT WAS CORRECT: The LLM accurately describes the 2023 HR+/HER2- breast cancer indication approval and correctly notes it represents an expansion of approved uses. The regulatory agencies (FDA and EC) are correctly identified. MULTI-HOP REASONING: The LLM failed to synthesize the complete regulatory history across 2022-2023. It should have compared the 2022 status (TNBC + urothelial cancer approvals) with the 2023 status (addition of HR+/HER2- breast cancer approval). Instead, it mischaracterized 2022 as investigational-only. This represents a fundamental failure in multi-hop synthesis across the two years. The answer is partially correct on the 2023 approval details but substantially incorrect on the 2022 baseline and incomplete in addressing the full scope of regulatory evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 505,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "\nIn the 2023 10‑K (pp. 15‑17) Meta warned explicitly that “if people do not perceive our products to be useful, reliable, and trustworthy, we may be unable to attract or retain users, which would reduce engagement and advertising revenue.” The 2024 filing (pp. 33‑36) no longer isolates “user perception” as a stand‑alone risk; instead it weaves the issue into broader concerns about adverse media coverage, regulatory and legislative actions (e.g., GDPR, DMA, EU‑U.S. DPF invalidations, digital‑services taxes), and litigation that can erode brand trust and limit data‑driven advertising. Consequently, the perceived risk has shifted from a direct user‑trust warning to an indirect risk that external legal and regulatory pressures could constrain Meta’s operational flexibility and revenue‑generating capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Meta's risk disclosure between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 focus on user perception as a direct, standalone risk factor with specific language about usefulness, reliability, and trustworthiness; (2) Accurately captures the 2024 shift away from isolated user perception risk toward broader operational/regulatory/legal risks; (3) Properly synthesizes the multi-hop comparison across two years and filing documents; (4) Correctly identifies specific 2024 regulatory concerns (GDPR, DMA, EU-U.S. DPF, digital-services taxes) that support the shift narrative; (5) Appropriately characterizes the transition from direct user-trust warning to indirect risk mediated through external pressures. MINOR WEAKNESSES: (1) The LLM answer provides specific page numbers (pp. 15-17 for 2023, pp. 33-36 for 2024) that cannot be verified against the ground truth knowledge graph, though this level of specificity doesn't contradict the ground truth; (2) The ground truth mentions 'integration challenges from acquisitions' and 'tax liabilities' as 2024 focus areas, which the LLM answer does not explicitly address—however, the LLM's emphasis on regulatory/legal/operational constraints is not contradictory, just differently framed; (3) The LLM could have been more explicit about the reduction in prominence of user perception as a standalone factor, though it does convey this through the phrase 'no longer isolates.' QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either the question or answer, so this dimension is not heavily tested. The dates (2023 vs 2024) are correct. QUALITATIVE ACCURACY: The reasoning about the strategic shift is sound and well-supported. The multi-hop synthesis correctly connects 2023 filing content to 2024 filing content and identifies the meaningful evolution. CONTEXTUAL RELEVANCE: The answer directly addresses the question's focus on how disclosure evolved, the nature of risks highlighted, and potential impact on business operations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 569,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "\nThe notional amount of Lockheed Martin’s outstanding variable‑rate interest‑rate swaps grew from roughly **$0.5 billion at the end of 2021** (as reported in the 2022 10‑K) to about **$1.3 billion at the end of 2024** (as disclosed in the 2024 10‑K).  This more than doubling shows that the company has expanded and intensified its use of interest‑rate swaps to hedge exposure to rising rates, reflecting a proactive and broader‑based interest‑rate risk‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: Both the 2021 figure ($0.5 billion/$500 million) and 2024 figure ($1.3 billion) match the ground truth exactly. The characterization of this as 'more than doubling' is mathematically correct (1.3/0.5 = 2.6x increase). ENTITY ACCURACY: Correctly identifies Lockheed Martin, the specific financial metric (variable interest rate swaps notional amount), and the correct fiscal years (2021 and 2024). MULTI-HOP REASONING: Successfully synthesizes information across multiple 10-K filings (2022 10-K for 2021 data, 2024 10-K for 2024 data) and correctly interprets the trend. STRATEGIC INTERPRETATION: The LLM's interpretation that this reflects 'a proactive and broader-based interest-rate risk-management strategy' and 'expanded and intensified use of interest-rate swaps to hedge exposure to rising rates' is semantically equivalent to the ground truth's statement about 'growing emphasis on converting fixed-rate borrowings to variable-rate borrowings.' Both convey the same strategic shift. MINOR DIFFERENCES: The LLM uses slightly different language ('hedge exposure to rising rates' vs. 'response to changes in the interest rate environment') but both capture the same strategic intent. The LLM's phrasing is actually more specific about the hedging rationale. No calculation errors, no missing data points, and all numbers are presented in acceptable format variations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 404,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal continued to treat its Seller‑Protection Programs as assurance‑type warranties and to record the estimated cost of those protections as part of transaction and credit losses.  The company modestly raised the overall allowance for transaction losses (from $278 million to $282 million) and increased the provision for expected losses (from $1.170 billion to $1.192 billion), while the specific reserve for transaction losses slipped only slightly from $66 million to $64 million—indicating a refined, slightly more conservative estimate rather than a fundamental change in the program.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information. CORRECT ELEMENTS: (1) The specific reserve for transaction losses figures are accurate ($66 million in 2022 to $64 million in 2023), matching the ground truth exactly. (2) The characterization of Seller Protection Programs as assurance-type warranties is appropriate and adds useful context. (3) The overall framing about refined/conservative estimates aligns with the ground truth's conclusion. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM introduces new financial figures ($278M to $282M for overall allowance, $1.170B to $1.192B for provision) that are NOT mentioned in the ground truth answer. These appear to be additional data points that may or may not be accurate, but they represent a significant departure from the ground truth's focus. (2) The ground truth emphasizes the shift from qualitative risk assessment (2022) to more structured/quantified disclosures (2023), with specific mention of historical loss rates (0.09%-0.15% of TPV) and COVID-19 pandemic impacts. The LLM answer omits these important contextual details entirely. (3) The ground truth highlights the $64M vs $66M comparison as indicating 'a slight decrease in expected losses,' while the LLM characterizes it as 'slipped only slightly'—semantically similar but the LLM misses the broader narrative about the evolution from qualitative to quantitative approaches. MULTI-HOP REASONING: The LLM does synthesize information across 2022-2023 and discusses the evolution of the programs, but it introduces unexplained figures and omits key qualitative evolution details that were central to the ground truth answer. The answer is partially correct on the core metric ($66M→$64M) but incomplete in addressing the full scope of how the approach evolved, particularly the shift toward more structured financial disclosures and away from qualitative risk language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 514,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "\nStarbucks’ “foreign‑currency – other” derivative **asset** fell sharply – from about **$62 million** ( $32.0 + $22.9 + $7.5 ) on the FY 2023 balance sheet to roughly **$5 million** ( $1.9 + $1.7 + $1.8 ) on the FY 2024 balance sheet, a decline of **≈ $57 million**.  \n\nAt the same time the **derivative liability** for the same category rose from roughly **$4 million** ( $2.0 + $0.5 + $1.8 ) to about **$11 million** ( $4.7 + $4.1 + $2.5 + $0.1 ), an increase of **≈ $7 million**.  \n\nThe net result is a swing of roughly **$64 million** from a net derivative asset position in FY 2023 to a net derivative liability position in FY 2024 on the consolidated balance sheet.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all key metrics. Ground truth states: FY2023 derivative asset was $1,164 million (not $62 million), FY2024 derivative asset was $1.9 million (the LLM correctly cites this but incorrectly sums it with other components to get $5 million). The LLM appears to be breaking down the $1,164 million into sub-components ($32.0 + $22.9 + $7.5 = $62.4M) which is not what the ground truth reports. For liabilities, ground truth shows: FY2023 was $2.0 million and FY2024 was $4.7 million. The LLM reports $4 million for 2023 and $11 million for 2024, which are both incorrect. The LLM's calculation methodology of summing multiple line items ($2.0 + $0.5 + $1.8) suggests it may be aggregating data from different derivative categories rather than focusing on the 'foreign currency - other' category specifically as requested. The core facts are wrong: (1) FY2023 asset should be $1,164M not $62M (off by ~$1,102M), (2) FY2024 asset should be $1.9M not $5M, (3) FY2023 liability should be $2.0M not $4M, (4) FY2024 liability should be $4.7M not $11M. The magnitude of change calculations are therefore entirely incorrect. The LLM did attempt to address the multi-hop nature of the question (comparing two years, calculating changes, determining net position), but the underlying data is fundamentally wrong, making the entire analysis unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 396,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "\nIn 2022 the Registrants posted a $37 million gain (Southern Company) and modest positive impacts elsewhere from energy‑related cash‑flow hedges that offset natural‑gas cost and revenue, but in 2023 those gains flipped to a $44 million loss for Southern Company (and comparable negative swings for Alabama Power, Southern Power and Southern Company Gas), indicating a sharp deterioration of the hedging position from 2022 to 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contains multiple critical errors: (1) QUANTITATIVE ERRORS: The LLM cites $37 million gain in 2022 and $44 million loss in 2023 for Southern Company, but the ground truth shows specific figures of $117 million negative impact on natural gas revenues and $27 million negative impact on cost of natural gas in 2022, with $59 million positive impact on cost of natural gas and $0 impact on revenues in 2023. These numbers are completely different from what the LLM provided. (2) ENTITY CONFUSION: The LLM mentions Southern Company, Alabama Power, Southern Power, and Southern Company Gas as separate entities with 'comparable negative swings,' but the ground truth question specifically addresses energy-related derivatives' impact on natural gas cost and revenue hedging positions without breaking down by these subsidiaries. The LLM appears to have confused the source data or applied information from a different company/context. (3) DIRECTIONAL ERROR: While the LLM correctly identifies a shift from positive to negative (2022 to 2023), the ground truth shows the opposite directional change - from negative in 2022 ($117M negative on revenues, $27M negative on costs) to positive in 2023 ($59M positive on costs, $0 on revenues). (4) MISSING KEY METRICS: The LLM fails to distinguish between the separate impacts on 'cost of natural gas' versus 'natural gas revenues,' which are explicitly differentiated in the ground truth. (5) MULTI-HOP SYNTHESIS: The LLM does not properly synthesize the evolution of these two distinct hedging positions across the two years. The answer demonstrates a fundamental misunderstanding of the financial data and fails to accurately represent the actual impact figures, their direction of change, or the specific metrics involved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 491,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "\nIn the 2023 Form 10‑K the Deferred Compensation Matching Plan was not presented as a separate, formally‑documented exhibit—it was only mentioned in passing in the narrative disclosures. By contrast, the 2024 filing lists the plan as **Exhibit 10.1** and explicitly states that it is “**amended and restated effective November 8, 2023**,” thereby formally documenting the plan and fixing its effective date for the first time. This marks a shift from an informal reference to a fully disclosed, dated amendment.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims the plan was 'not presented as a separate, formally-documented exhibit' in 2023 and only became formally documented in 2024 as 'Exhibit 10.1.' However, the ground truth clearly states the opposite: the plan was 'newly introduced' in the 2023 10-K filing with the effective date of November 8, 2023, and by 2024 it was 'no longer labeled as newly introduced' but 'incorporated by reference,' indicating it had already been formally established. The LLM has reversed the chronological evolution of the plan's documentation status. The date (November 8, 2023) is correct, but the narrative interpretation is inverted. The LLM's claim about the shift from 'informal reference' to 'fully disclosed, dated amendment' in 2024 contradicts the ground truth's assertion that the plan was already formally introduced in 2023 and merely transitioned to being an established, ongoing plan by 2024. This represents a critical misunderstanding of the multi-hop synthesis required—the LLM failed to correctly identify how the plan's treatment evolved across the two filing years. The quantitative accuracy is relatively high (correct date), but the qualitative accuracy and reasoning are severely compromised by the reversed narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 371,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s disclosure of LTIP Units was unchanged: they are still presented in the “potentially dilutive securities” column of the earnings‑per‑share/unit tables, and the filings explicitly note that LTIP Units had **no material dilutive effect** for either year, so no adjustment to net income or weighted‑average shares/units is made.  The accrual policy for dividends on those units also remains the same—dividends are accrued only when declared, with no separate treatment or impact on earnings per unit.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core findings from the ground truth. Strengths: (1) Correctly identifies that LTIP Units are presented as potentially dilutive securities in both years; (2) Accurately states no material dilutive effect was reported for both 2023 and 2024; (3) Correctly notes that no adjustments to net income or weighted-average shares/units are made; (4) Properly identifies the accrual policy (distributions accrued when declared); (5) Correctly concludes that treatment remained stable/unchanged between years. Quantitative accuracy is high - all years and key metrics are correct. Multi-hop reasoning is sound, properly synthesizing the comparison across 2023 and 2024 filings. Minor weakness: The LLM answer uses 'dividends' terminology while the ground truth uses 'distributions,' though these are semantically equivalent in this context. The LLM also slightly simplifies the ground truth's mention of specific years covered (2023, 2022, 2021 in 2023 filing; 2024, 2023, 2022 in 2024 filing), but this omission is minor and doesn't affect the core answer about evolution/stability. The answer directly addresses the question about how disclosure and treatment evolved, correctly concluding there was no significant change. Overall, this is a high-quality answer with accurate facts and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 376,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "\nBetween 2023 and 2024 Meta moved from defending its reliance on Standard Contractual Clauses—culminating in the Irish Data Protection Commission’s €1.2 billion fine and corrective orders (which it is appealing and which are currently on interim stay)—to fully embracing the newly‑adopted EU‑U.S. Data Privacy Framework. After the European Commission’s July 2023 adequacy decision, the company engaged with the IDPC, implemented concrete steps to bring its trans‑Atlantic data‑flows into compliance with the DPF, and adjusted its product‑level practices (e.g., the “subscription‑for‑no‑ads” model and consent‑based legal bases) to satisfy GDPR, the DMA and DSA requirements. This evolution reflects a shift from reactive litigation over SCCs to a proactive compliance program built around the DPF and related regulatory obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but also introduces significant inaccuracies and unsupported claims that diverge from the ground truth:\n\nCORRECT ELEMENTS:\n- Correctly identifies the €1.2 billion fine from IDPC\n- Correctly mentions Standard Contractual Clauses (SCCs) as the initial compliance mechanism\n- Correctly identifies the EU-U.S. DPF as a key compliance framework\n- Correctly mentions the 'subscription-for-no-ads' model\n- Correctly identifies DMA and DSA as relevant regulatory frameworks\n- Correctly notes the shift from reactive to proactive compliance\n\nSIGNIFICANT ERRORS AND UNSUPPORTED CLAIMS:\n1. DATE ERROR: States \"European Commission's July 2023 adequacy decision\" - The ground truth indicates the EU-U.S. DPF was finalized in 2023 (not specifically July 2023), and the key regulatory action was the European Commission opening formal proceedings in 2024 with preliminary findings in July 2024. The LLM conflates the adequacy decision timing.\n\n2. UNSUPPORTED CLAIM: States the corrective orders \"are currently on interim stay\" and that Meta \"is appealing\" - The ground truth makes no mention of appeals or interim stays. This is a factual claim not supported by the source material.\n\n3. INCOMPLETE SYNTHESIS: The ground truth emphasizes that by 2024, Meta faced NEW regulatory scrutiny from the European Commission regarding the 'subscription-for-no-ads' model under the DMA (with preliminary findings in July 2024 suggesting non-compliance). The LLM answer mentions this but doesn't clearly convey that this represents a NEW layer of regulatory challenge beyond the original DPF compliance framework.\n\n4. TEMPORAL CLARITY: The ground truth clearly distinguishes between 2023 (implementing DPF as solution to SCC issues) and 2024 (facing new DMA compliance challenges). The LLM answer somewhat conflates these timelines by presenting them as a continuous evolution without clearly marking the shift to new regulatory proceedings.\n\nQUANTITATIVE ACCURACY: The €1.2 billion figure is correct. However, the date references are imprecise or incorrect (July 2023 vs. the actual timeline).\n\nQUALITATIVE ACCURACY: While the LLM captures the general narrative of evolution from SCC reliance to DPF compliance, it introduces unsupported legal claims (appeals, interim stays) and doesn't fully capture the significance of the 2024 shift to DMA-specific regulatory proceedings.\n\nCONTEXTUAL RELEVANCE: The answer addresses the question's core inquiry about evolution between 2023-2024, but the introduction of unverified legal details and imprecise dating reduces its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 696,
        "total_tokens": 2171
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "\nBetween 2023 and 2024 Linde’s wording on green hydrogen shifted from a broad reference to “hydrogen produced by electrolysis using renewable energy (or from SMR of biomethane)” to a clear emphasis on **renewable‑electricity‑driven electrolysis** and the use of a **carbon‑intensity label** to distinguish “green” hydrogen from “blue” or “low‑carbon” hydrogen. The 2024 filing expands the portfolio of clean‑hydrogen technologies, describing green hydrogen as a core element of its strategy and underscoring that it is produced from renewable energy sources, while also highlighting new low‑carbon production pathways and the role of engineering solutions that capture and utilize CO₂. This reflects a stronger, more detailed focus on renewable‑energy‑based production methods in Linde’s green‑hydrogen approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Linde's green hydrogen approach between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from broad descriptions to more specific emphasis on renewable-electricity-driven electrolysis; (2) Accurately captures the introduction and emphasis on carbon-intensity metrics as a differentiator; (3) Properly distinguishes green hydrogen from blue/low-carbon hydrogen; (4) Correctly notes the 2023 mention of steam methane reforming of biomethane as an alternative production method; (5) Accurately reflects the 2024 expansion of the portfolio and strategic framing. MINOR WEAKNESSES: (1) The LLM answer adds some details about 'engineering solutions that capture and utilize CO₂' and 'new low-carbon production pathways' that, while potentially accurate, are not explicitly mentioned in the ground truth answer and represent slight elaboration beyond what was confirmed; (2) The phrasing 'renewable‑electricity‑driven electrolysis' is more specific than the ground truth's 'electrolysis using renewable energy,' though semantically equivalent. QUANTITATIVE ACCURACY: No numbers, dates, or calculations are involved in this question, so this dimension scores perfectly. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes the evolution across two years and identifies the key shifts in terminology, emphasis, and strategic positioning. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding production methods and renewable energy emphasis evolution. The answer is well-structured and clearly communicates the progression from 2023 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 466,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "\nSouthern Company completed the sale of Sequent in July 2021 and, by 2022, the business was fully divested, so in 2023 there were no ongoing operations with Sequent. The 2023 financial statements reflect only the residual effects of that transaction—a $85 million additional tax expense from state‑apportionment changes and an $84 million pre‑tax impairment charge on the PennEast pipeline investment—both of which reduced 2023 earnings, whereas the 2021 sale had generated a $92 million after‑tax gain.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) TIMING ERROR: The LLM states the sale was completed in July 2021, but the ground truth clearly indicates the sale occurred in 2022. This is a major chronological error that undermines the entire answer. (2) FINANCIAL NUMBERS - INCORRECT: The LLM cites a $92 million after-tax gain from the 2021 sale, but the ground truth shows a $121 million pre-tax gain from the 2022 sale. The LLM appears to be referencing a different transaction or year entirely. (3) MISSING KEY INFORMATION: The LLM fails to mention the $159 million sale price, which is a critical financial detail. (4) INCORRECT METRIC FOCUS: The LLM mentions an $84 million pre-tax impairment charge on PennEast pipeline investment, which is not mentioned in the ground truth answer and appears to be conflating different transactions or companies. (5) TAX EXPENSE CONFUSION: While the LLM correctly identifies $85 million in additional tax expense from state apportionment changes, it incorrectly attributes this to 2023 residual effects rather than as part of the 2022 transaction. (6) MULTI-HOP REASONING FAILURE: The answer fails to properly synthesize the evolution of the relationship between 2022-2023 as requested. The ground truth shows a clear 2022 divestiture with full separation by 2023, but the LLM incorrectly places the transaction in 2021. The answer demonstrates fundamental misunderstanding of the timeline and financial details of Southern Company's relationship with Sequent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 430,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "\nWalmart’s SEC filings for fiscal 2023 and fiscal 2024 both list “Allswell” among the Company’s private‑brand portfolio (page 7 of the 2023 filing and the same list in the 2024 filing), with no disclosed change in its status or strategic treatment.  This continuity shows that Walmart is deliberately maintaining and supporting a stable of value‑focused private labels—such as Allswell—to reinforce its low‑price positioning and to grow margin within its broader private‑brand strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - The LLM claims Allswell appears in BOTH the 2023 and 2024 filings with 'no disclosed change,' but the ground truth explicitly states that Allswell was INTRODUCED in 2023 (implying it was NOT in prior filings) and then appeared in 2024 among established brands. This represents a fundamental misunderstanding of the evolution described. (2) The ground truth emphasizes a TRANSITION from 'newly introduced' to 'more established,' indicating a meaningful strategic evolution. The LLM's claim of 'continuity' and 'no change' directly contradicts this key finding. (3) The LLM provides page references (page 7) without verification against the actual filings, which is problematic. (4) While the LLM correctly identifies Allswell as part of the private brand portfolio and mentions other brands like 'bettergoods' and 'Equate,' it fails to capture the critical temporal evolution that is central to the question. (5) The LLM's interpretation that this represents 'deliberate maintenance' of a 'stable of value-focused private labels' misses the point that the brand's STATUS CHANGED from new to established between 2023 and 2024. (6) The question specifically asks about how the relationship 'evolved' - the LLM's answer of 'no change' is fundamentally incorrect. The ground truth indicates progression and establishment; the LLM indicates stasis. This is a multi-hop reasoning failure where the model failed to synthesize the temporal comparison correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 428,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "\nBetween 2022 and 2023 the Embedded‑Processing business grew its contribution to total sales from roughly 16 % of revenue ($3.26 bn of $20.03 bn) to about 19 % ($3.37 bn of $17.52 bn), and management continued to treat it as a core strategic pillar—highlighting its importance in the industrial and automotive end‑markets and directing capital spending to strengthen its manufacturing and technology base. This increased revenue share, coupled with the same strategic emphasis on analog and embedded‑processing products, shows that the strategic importance of Embedded Processing has risen from 2022 to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM claims Embedded Processing revenue was $3.26bn in 2022 and $3.37bn in 2023, calculating percentages of 16% and 19% respectively. However, the ground truth explicitly states 'no specific revenue figures were disclosed' for 2022, making these specific dollar amounts and percentages fabricated. The LLM also claims total 2022 revenue was $20.03bn, which is not verified in the ground truth. (2) CONTRADICTORY CONCLUSION: The ground truth states Embedded Processing 'maintained its strategic importance' with a 'more pronounced compensatory role,' suggesting stability with increased relative importance due to Analog's decline. The LLM concludes strategic importance 'has risen,' which is a different interpretation and overstates the change. (3) MISSING CONTEXT: The ground truth emphasizes that Embedded Processing 'partially offset a decline in Analog revenue,' indicating a compensatory dynamic. The LLM mentions this indirectly but focuses on absolute growth in market share rather than the offsetting/compensatory nature. (4) UNVERIFIED CLAIMS: The LLM adds details about 'industrial and automotive end-markets' and 'capital spending' that are not mentioned in the ground truth and cannot be verified. (5) CALCULATION VERIFICATION: Even accepting the LLM's numbers, $3.26bn/$20.03bn = 16.3% and $3.37bn/$17.52bn = 19.2%, which are mathematically consistent with the stated percentages, but the underlying revenue figures appear to be fabricated. The core problem is that the LLM invented specific financial data that contradicts the ground truth's statement that no specific revenue figures were disclosed for 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 477,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron’s equity stake in Angola LNG Limited stayed roughly at the 36 % level, but the recorded investment slipped modestly from about $1.76 bn (2023) to $1.66 bn (2024) while earnings from the project contributed roughly $0.5 bn to Chevron’s 2024 income.  This stability—despite a small decline in book value—shows that Chevron is treating Angola LNG as a core, long‑term source of low‑cost LNG to diversify its portfolio and meet rising global gas demand, reinforcing its strategic pivot toward expanding its LNG footprint.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces specific financial figures ($1.76bn in 2023, $1.66bn in 2024, $0.5bn earnings contribution) that are NOT present in the ground truth and cannot be verified. The ground truth makes no mention of investment book values, earnings contributions, or year-over-year comparisons of these amounts. These appear to be fabricated numbers. (2) STAKE PERCENTAGE - The LLM claims the stake 'stayed roughly at the 36% level' implying consistency from 2022-2024, but the ground truth indicates the 36.4% stake was 'explicitly stated' in 2024, suggesting this level of detail may not have been available or emphasized in 2022. The LLM's claim of stability is not supported by the ground truth. (3) MULTI-HOP REASONING - The ground truth describes an 'evolution' and 'strategic shift toward securing a stable position' with 'formalized equity stakes,' suggesting a change or clarification over time. The LLM contradicts this by claiming stability ('stayed roughly at the 36% level'), which misrepresents the nature of the evolution described in the ground truth. (4) UNSUPPORTED CLAIMS - The LLM adds interpretive language about 'core, long-term source of low-cost LNG' and 'strategic pivot toward expanding its LNG footprint' that goes beyond what the ground truth supports. While the conclusion about strategic positioning is reasonable, the specific financial metrics used to support it are not grounded in the provided knowledge graph. (5) WHAT WAS CORRECT - The LLM correctly identifies the 36% stake level and correctly names 'Angola LNG Limited.' The general strategic interpretation about diversification and meeting global demand is reasonable but not explicitly stated in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 477,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "\nBetween 2021 and 2024 the CH‑53K moved from early‑stage production to a clear ramp‑up phase: RMS reported that higher volume and production‑line ramp‑up on the CH‑53K added roughly $1 billion of product sales (and the corresponding rise in cost of sales) by 2024, helping lift the segment’s overall sales and margin.  This growth underscores the CH‑53K’s emergence as a strategic, high‑visibility program that now serves as a primary driver of RMS’s sales and backlog, positioning the heavy‑lift helicopter as a central growth engine within Lockheed Martin’s RMS division.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative arc correctly—CH-53K transitioning from early-stage to ramp-up phase and becoming a key growth driver for RMS. However, there are significant quantitative discrepancies that lower the score. QUANTITATIVE ISSUES: (1) The LLM states 'roughly $1 billion' for 2024 contribution, which aligns with the ground truth's $1.1 billion, but the approximation obscures the actual figure. More critically, the LLM completely omits the 2021 financial data: the $540 million increase in RMS net sales and $140 million increase in operating profit are not mentioned at all. This is a substantial omission for a question explicitly asking about evolution 'between 2021 and 2024.' (2) The LLM does not provide the specific 2021 baseline figures needed to demonstrate the evolution. QUALITATIVE STRENGTHS: The LLM correctly identifies the transition from early-stage to ramp-up production, accurately characterizes CH-53K as a strategic growth driver, and properly synthesizes the role within RMS division. The reasoning about the program's maturation is sound. MULTI-HOP SYNTHESIS: The answer successfully connects production status to financial contribution and RMS division role, but fails to complete the full temporal comparison required by the question. The answer addresses 2024 well but largely ignores 2021, making the 'evolution between 2021 and 2024' incomplete. SEMANTIC EQUIVALENCE: The characterization of CH-53K as a 'primary driver' and 'central growth engine' is semantically equivalent to the ground truth's 'key growth driver,' and the production ramp-up description matches. However, the missing 2021 data represents a fundamental incompleteness in addressing the comparative aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 475,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal lengthened the macro‑economic horizon used in its revolving‑credit loss curves—from a ≈ 2‑year forecast period in 2022 to roughly 5 years 7 months in 2023—and expanded the set of indicators (adding household‑disposable‑income and retail‑e‑commerce‑sales trends, whereas 2022 relied mainly on unemployment). The model was refreshed in the second quarter of 2023, but the update did not produce a material change to the credit‑loss provision.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported quantitative claims not present in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims PayPal lengthened the macroeconomic horizon from '≈2-year forecast period in 2022 to roughly 5 years 7 months in 2023' - these specific timeframe numbers are NOT mentioned in the ground truth and appear to be fabricated. The ground truth makes no reference to forecast horizons or their duration. (2) TIMING DISCREPANCY: The LLM states the model was refreshed in Q2 2023, but the ground truth indicates the change occurred 'after the first quarter of 2023' - these are different timeframes. (3) INCOMPLETE ACCURACY: While the LLM correctly identifies that PayPal added household disposable income and retail e-commerce sales indicators, and that unemployment was replaced, it incorrectly characterizes 2022 as relying 'mainly on unemployment' when the ground truth states 2022 used 'unemployment and benchmark credit card charge-off rates' (two factors, not just one). (4) UNSUPPORTED CLAIM: The statement about 'no material change to credit-loss provision' is not mentioned in the ground truth and cannot be verified. (5) MULTI-HOP REASONING: The core evolution (shift from unemployment/charge-off rates to household disposable income/e-commerce sales) is partially captured, but the addition of fabricated quantitative details undermines the answer's reliability. The answer demonstrates some understanding of the directional change but fails on factual precision by introducing specific numbers without source support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 440,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the foreign‑currency‑denominated debt gains recorded in AOCI slipped from **$140.2 million to $135.2 million**, a decline of roughly **$5 million**. This drop shows that the company’s net foreign‑currency hedge positions are producing fewer unrealized gains, indicating either a reduced level of foreign‑currency exposure or that recent currency movements have offset prior hedge benefits.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers and misrepresents the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the 2023 figure was $140.2 million, but the ground truth clearly shows it was a LOSS of $6.3 million (not a gain). The LLM also states 2024 was $135.2 million, which matches the ground truth for 2024, but the comparison is entirely wrong. The LLM calculates a decline from $140.2M to $135.2M (~$5M drop), but this is based on an incorrect 2023 baseline. (2) ENTITY/METRIC CONFUSION: The ground truth indicates a shift from a LOSS ($6.3M loss in 2023) to a GAIN ($135.2M gain in 2024), representing a swing of approximately $141.5 million in the positive direction. The LLM incorrectly treats both years as gains and misses this critical reversal. (3) REASONING FAILURE: The LLM's interpretation that 'fewer unrealized gains' indicates 'reduced exposure' contradicts the ground truth narrative of a significant reversal from loss to gain, which actually indicates a substantial change in currency exposure dynamics. (4) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the year-over-year comparison and the significance of the loss-to-gain reversal. The answer demonstrates a fundamental misunderstanding of the data, confusing the direction and magnitude of the change. The only correct number in the LLM answer is the 2024 figure of $135.2 million.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 393,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "\nAlabama Power’s energy‑related derivative liability grew from $32 million in 2022 to $61 million in 2023, while Georgia Power’s liability fell from $178 million to $124 million. As a result, the combined liability of the two declined from $210 million to $185 million, indicating a modest overall reduction in net liability exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial figures across all key metrics. Specific errors: (1) Alabama Power 2022: LLM states $32 million liability vs. ground truth of $144 million net liability - a 77% understatement. (2) Alabama Power 2023: LLM states $61 million liability vs. ground truth of $110 million in liabilities (net $95 million) - a 45% understatement. (3) Georgia Power 2023: LLM correctly identifies $124 million but fails to account for the $13 million in assets, missing the net liability calculation of $111 million. (4) Combined 2022 total: LLM states $210 million vs. ground truth of $255 million - a 18% error. (5) Combined 2023 total: LLM states $185 million vs. ground truth of $206 million - a 10% error. The LLM also appears to have confused or misidentified the composition of the derivatives (mixing designated vs. non-designated hedging relationships). The multi-hop synthesis is incomplete - the LLM failed to properly account for both asset and liability components to calculate net positions. While the directional trend (reduction in combined liability) is correct, the magnitude of the reduction is significantly misstated. The answer demonstrates a fundamental failure to accurately extract and synthesize the specific financial data from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 366,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "\nIn fiscal 2023 Walmart closed a $0.4 billion transaction that brought its stake in Alert Innovation to 100 % ownership. The 2024 Form 10‑K does not report any additional acquisition or disposition of Alert Innovation, indicating that the company was simply held during FY 2024; the next step—selling the entity and de‑consolidating it—was disclosed only in the FY 2025 filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN MULTI-HOP SYNTHESIS: The LLM answer contains a fundamental factual error regarding the timing of the disposition. The ground truth clearly states that in fiscal 2024, Walmart 'sold and deconsolidated the Alert Innovation entity,' indicating the divestiture occurred in FY2024, not FY2025 as the LLM claims. The LLM states 'the next step—selling the entity and de‑consolidating it—was disclosed only in the FY 2025 filing,' which contradicts the ground truth answer that explicitly documents this activity in fiscal 2024. QUANTITATIVE ACCURACY: The $0.4 billion acquisition amount and 100% ownership stake are correctly stated (9/10). QUALITATIVE ACCURACY: While the LLM correctly identifies the FY2023 acquisition details, it fails the core multi-hop reasoning requirement by incorrectly placing the disposition in FY2025 rather than FY2024. This is a major synthesis error that fundamentally misrepresents the evolution of Walmart's relationship with Alert Innovation (2/10). COMPLETENESS: The question asks about the evolution 'between fiscal 2023 and fiscal 2024,' and the ground truth shows a complete cycle (acquisition then divestiture) within this period. The LLM's answer fails to capture that the divestiture occurred in FY2024, instead deferring it to FY2025, which directly contradicts the ground truth and fails to properly address the question's scope (4/10). The LLM appears to have confused filing disclosure timing with transaction timing—the FY2024 10-K would report FY2024 transactions, not defer them to FY2025 disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 429,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy moved from the accelerated‑approval milestones it received in 2021–2022 (full FDA approval for metastatic triple‑negative breast cancer and accelerated approval for urothelial cancer) to new regulatory wins in 2023, most notably the European Commission’s 2023 approval of Trodelvy as a monotherapy for HR⁺/HER2‑negative advanced breast cancer and continued global roll‑outs in additional markets.  This expansion of approvals across multiple tumor types and regions demonstrates Gilead’s oncology strategy of broadening the clinical utility of its antibody‑drug‑conjugate platform, diversifying its cancer‑focused pipeline, and driving growth through multiple, high‑impact indications.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) INCORRECT PRIOR APPROVALS: The LLM claims Trodelvy received 'full FDA approval for metastatic triple-negative breast cancer and accelerated approval for urothelial cancer' in 2021-2022. The ground truth makes no mention of these indications and only references Trodelvy as part of the 'marketed product portfolio' in 2022 without specifying these approvals. (2) INCOMPLETE 2023 APPROVALS: The LLM correctly identifies the 2023 EC approval for HR+/HER2- breast cancer but adds 'monotherapy' specification not explicitly stated in ground truth. More critically, the LLM mentions 'continued global roll-outs in additional markets' without evidence from the ground truth. (3) MISSING KEY DETAIL: The ground truth specifies the HR+/HER2- breast cancer indication required 'prior endocrine-based therapy and at least two additional systemic therapies' - a critical clinical detail the LLM omits. (4) OVERSTATED STRATEGY INTERPRETATION: The LLM's characterization of Gilead's strategy as 'broadening clinical utility of its antibody-drug-conjugate platform' and 'diversifying its cancer-focused pipeline' goes beyond what the ground truth supports. The ground truth more conservatively states focus on 'expanding therapeutic applications' and 'strengthening position in oncology market, particularly in breast cancer treatment.' (5) UNSUPPORTED CLAIMS: References to 'multiple tumor types' and 'high-impact indications' are not substantiated by the ground truth provided. The ground truth focuses specifically on the breast cancer indication in 2023. The LLM answer appears to conflate information from different time periods or sources not present in the provided ground truth, creating a narrative that is partially fabricated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 499,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Simon Property Group moved from a series of incremental equity‑sale and dilution events with ABG to a full exit from the partnership.  In 2023 the company recorded several non‑cash gains as ABG’s capital transactions diluted Simon’s ownership (e.g., a $10.3 M gain when ABG’s stake fell to ~9.6 % and a $157.1 M gain on a partial 2023 sale), but by the first quarter of 2024 Simon sold its **remaining** ABG interest for **$1.2 billion in cash**, generating a **$414.8 M pretax gain** and eliminating its equity exposure to ABG.  This disposal gave Simon substantial cash that it could redeploy—supporting its share‑repurchase program, reducing debt and funding the $498 M of remaining development capital it expects to need—while repositioning the business away from the ABG joint‑venture toward its core retail‑property and development strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM claims SPG sold its remaining ABG interest for $1.2 billion in Q1 2024 with a $414.8M pretax gain, but the ground truth explicitly states that in 2024, SPG 'no longer reported active capital transactions with ABG' and only referenced historical transactions. The ground truth mentions 2023 gains of $36.4M and $145.8M from dilution events, not the $10.3M and $157.1M figures cited by the LLM. The $1.2B sale and $414.8M gain in Q1 2024 appear to be fabricated numbers not supported by the ground truth. (2) ENTITY/TIMING ERRORS - The LLM fundamentally mischaracterizes the 2023-2024 evolution. The ground truth shows 2023 had active capital transactions (dilution gains), while 2024 had none and only historical references. The LLM reverses this narrative, claiming a 'full exit' occurred in Q1 2024 with a major cash transaction. (3) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the multi-year relationship evolution. It invented specific transaction details (the $1.2B sale, Q1 2024 timing) that don't appear in the ground truth. (4) STRATEGIC POSITIONING - While the LLM correctly identifies a shift in strategic positioning, it attributes this to a complete exit rather than the ground truth's characterization of moving from active restructuring to a stable, historically-referenced relationship. The answer demonstrates fundamental misunderstanding of the actual financial transactions and timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 429,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "\nChevron’s 50 % stake in Chevron Phillips Chemical Company LLC remained unchanged, but the investment’s carrying value rose from roughly **$7.8 billion** in the 2022 10‑K (Note 8) to **$8.57 billion** in the 2024 filing (Note 15, p. 85), driven by additional capital contributions—including a **$669 million loan** for the Golden Triangle Polymers project.  At the same time, the equity earnings recognized from the joint venture fell from **$867 million** in 2023 to **$608 million** in 2024, reflecting weaker joint‑venture profitability despite the larger investment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FUNDAMENTAL MISCHARACTERIZATION: The LLM claims Chevron's 50% stake 'remained unchanged' and that the investment was already an equity method investee in 2022. This directly contradicts the ground truth, which explicitly states that in 2022, Chevron Phillips Chemical was a 'consolidated subsidiary' (full consolidation), and by 2024 it became an 'equity method investee.' This is the core evolution the question asks about—a structural shift from consolidation to equity method accounting. The LLM completely missed this critical change. (2) QUANTITATIVE ISSUES: The LLM provides $7.8 billion for 2022 (ground truth shows $7,765M in 2023, not 2022), and correctly states $8.57 billion for 2024 ($8,571M matches). However, the 2022 figure is unverified and appears to conflate 2023 data. The LLM also introduces unsupported details: a '$669 million loan' for Golden Triangle Polymers and equity earnings figures ($867M in 2023, $608M in 2024) that are not mentioned in the ground truth and cannot be verified. (3) MULTI-HOP REASONING FAILURE: The question specifically asks about the 'evolution' of the relationship 'between 2022 and 2024, particularly in terms of financial reporting.' The ground truth identifies the key evolution: consolidation → equity method. The LLM completely misses this accounting treatment change, which is the most important aspect of how the relationship evolved. Instead, it focuses on carrying value changes and introduces unverified earnings data. (4) MISSING CORE INSIGHT: The ground truth explicitly notes this 'reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change.' The LLM's claim that the stake 'remained unchanged' contradicts this and suggests the LLM did not properly synthesize the multi-hop information about the accounting treatment change. (5) UNSUPPORTED CLAIMS: The specific dollar amounts for equity earnings and the loan details are not present in the ground truth and appear to be hallucinated or from unverified sources.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 555,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "\nBy the end of 2023 Meta had largely finished its 2022 facilities‑consolidation effort, with most of the related costs already recorded and only a small residual footprint remaining; the company had accumulated about $2.255 bn of total 2022 restructuring charges (the facilities‑consolidation portion being a part of that amount). In 2024 the consolidation generated $389 million of pre‑tax charges—all classified as facilities‑consolidation expenses—and cumulative spending on the initiative had risen to roughly $5.2 bn (≈ $7.25 bn when combined with other restructuring categories), showing that the financial impact had sharply tapered off and the strategy was now essentially completed.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported numerical claims that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($2.255 bn cumulative by end 2023, $389 million in 2024 charges, $5.2 bn cumulative, $7.25 bn combined) that are not mentioned in the ground truth answer. These numbers appear fabricated or misattributed, as the original answer explicitly states that 2024 was the first time Meta provided 'a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024)' - meaning detailed cumulative figures were NOT available in 2023. The LLM's claim of $2.255 bn accumulated by end 2023 contradicts this. (2) SEMANTIC MISALIGNMENT: The ground truth emphasizes the STATUS EVOLUTION from 'substantially completed' (2023) to 'completed' (2024), focusing on the qualitative progression. The LLM shifts focus to financial quantification and introduces specific charge amounts without ground truth support. (3) MULTI-HOP REASONING FAILURE: The LLM fails to correctly synthesize the key insight that 2024 was when comprehensive financial data became available retrospectively. Instead, it presents specific numbers as if they were known in 2023, which contradicts the ground truth's explicit statement about 2024 disclosure including retrospective quantification. (4) INCOMPLETE ANSWER: The LLM does not address the core finding that the 2024 disclosure included a three-year financial summary that was not explicitly detailed in 2023. (5) UNSUPPORTED CLAIMS: The $389 million figure for 2024 and the cumulative totals lack any ground truth support and appear to be hallucinated numbers. The answer demonstrates poor multi-hop synthesis and introduces fabricated financial data rather than accurately representing the status evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 509,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin shifted hypersonics from a standalone R&D project to a core element of its multi‑domain “21st Century Security” strategy, embedding the effort in its Advanced Development Programs (Skunk Works) and linking it to CJADC2 and joint‑all‑domain initiatives.  The company is now actively designing and building several hypersonic strike weapons for the U.S. Air Force and Army, moving from prototype demonstrations toward program‑level development and production, while continuing to leverage rapid‑prototype and technology‑insertion pathways to accelerate fielding.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains partially correct information but introduces unsupported details and makes claims not grounded in the ground truth.\n\nCORRECT ELEMENTS:\n1. Correctly identifies the evolution from earlier stage to active production (matches ground truth's shift from 'development phase' to 'actively producing')\n2. Correctly names the U.S. Air Force and Army as customer organizations\n3. Correctly identifies the timeframe (2022-2024)\n4. Accurately captures the progression toward production and fielding\n5. Correctly identifies multiple hypersonic strike weapons programs\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n1. References '21st Century Security' strategy - NOT mentioned in ground truth\n2. References 'Advanced Development Programs (Skunk Works)' - NOT mentioned in ground truth\n3. References 'CJADC2 and joint-all-domain initiatives' - NOT mentioned in ground truth\n4. References 'rapid-prototype and technology-insertion pathways' - NOT mentioned in ground truth\n5. Describes embedding in specific organizational structures - ground truth does not provide this level of organizational detail\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the core evolution (2022→2024 progression) but adds substantial contextual details that appear to be inferred or hallucinated rather than derived from the ground truth. The ground truth is more conservative, focusing on the shift from funding-dependent development to active production.\n\nQUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided in either answer, so this dimension is neutral. Both answers use qualitative descriptions of program evolution.\n\nSEMANTIC EQUIVALENCE: While the LLM answer's core message about evolution from R&D to production aligns with ground truth, the introduction of specific strategic initiatives, organizational structures, and technical pathways that are not in the ground truth represents a significant deviation. This suggests the LLM may be drawing from general knowledge about Lockheed Martin rather than the specific filing data.\n\nJUSTIFICATION: Score of 6 reflects that the fundamental answer about program evolution is correct, but the addition of multiple unsupported details and organizational references that cannot be verified against the ground truth significantly undermines confidence in the response's accuracy. The answer reads more like informed speculation than a direct synthesis of filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 652,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "\nFrom 2022 to 2023 Southern Company kept energy‑related derivatives in the same hedging categories—cash‑flow, fair‑value and regulatory—but the financial outcome changed dramatically: cash‑flow hedges went from a $37 million gain in 2022 to a $44 million loss in 2023, and the regulatory‑hedge portfolio shifted from a modest $9 million unrealized gain at the end of 2022 to a $257 million unrealized loss at the end of 2023, with the corresponding amounts reclassified from AOCI to earnings turning negative.  The 2023 disclosures also added detailed tables showing the cumulative fair‑value hedge adjustments to long‑term debt and the exact gains/losses reclassified from OCI, underscoring a larger impact on income and equity than was reflected in the 2022 filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. (1) CRITICAL FACTUAL ERRORS: The ground truth states that Southern Company's evolution involved a shift from reporting only regulatory hedging instruments in 2022 to expanding disclosures in 2023 to include energy-related derivatives NOT designated as hedging instruments. The LLM answer instead claims the company 'kept energy-related derivatives in the same hedging categories—cash-flow, fair-value and regulatory' and provides specific dollar amounts ($37M gain, $44M loss, $9M gain, $257M loss) that are not mentioned in the ground truth. (2) QUANTITATIVE ACCURACY FAILURE: The LLM provides precise financial figures (cash-flow hedges $37M to $44M, regulatory hedges $9M to $257M) with no supporting evidence in the ground truth. These numbers appear to be fabricated or from a different source entirely. The ground truth makes no mention of these specific amounts. (3) MULTI-HOP REASONING FAILURE: The ground truth emphasizes a disclosure evolution—from limited reporting of regulatory hedging instruments to broader reporting including non-designated derivatives. The LLM misses this key insight entirely and instead focuses on changes in financial outcomes across hedge categories that aren't substantiated. (4) SEMANTIC MISALIGNMENT: The ground truth's core message is about DISCLOSURE EXPANSION and CATEGORIZATION CHANGES (what was reported), while the LLM's answer is about FINANCIAL PERFORMANCE CHANGES (gains/losses). These are fundamentally different narratives. (5) MISSING KEY INFORMATION: The LLM fails to mention the critical evolution from 2022 (regulatory hedging focus) to 2023 (expanded to include non-designated derivatives), which is the heart of the ground truth answer. The answer demonstrates a fundamental misunderstanding of what changed between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 508,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings, Gilead moved from openly flagging the October 2020 loss of U.S. exclusivity for Truvada and describing its reliance on patent‑term extensions and voluntary‑licensing tactics (see 2022 10‑K, pages 37‑38) to providing no fresh patent‑term‑extension, new filing, or exclusivity disclosures for Truvada in the 2023 report (pages 7‑9, which only reference prior TAF‑related settlement agreements and focus on other products).  This shift shows that, after the patent protection for Truvada expired, the company’s IP strategy for that product has effectively wound down—no new patent disclosures were made, and the emphasis turned to managing generic competition rather than pursuing additional exclusivity.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the October 2020 loss of U.S. exclusivity for Truvada and the shift in disclosure approach between 2022 and 2023. However, there are significant issues with the evaluation: (1) FACTUAL ACCURACY: The LLM claims that the 2023 report provided 'no fresh patent-term-extension, new filing, or exclusivity disclosures for Truvada' and that 'no new patent disclosures were made.' This contradicts the ground truth, which explicitly states that in 2023, Gilead 'provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada.' The LLM appears to have misread or misinterpreted the 2023 filing content. (2) MULTI-HOP REASONING: The ground truth correctly synthesizes the evolution as a shift FROM acknowledging past loss of exclusivity TO proactively disclosing future IP timelines. The LLM instead characterizes it as a shift FROM patent-extension strategies TO no disclosures at all, which is factually incorrect based on the ground truth. (3) COMPLETENESS: The ground truth emphasizes the proactive disclosure of patent expiration dates in 2023, which is a key evolution point. The LLM misses this entirely by claiming no new disclosures were made. (4) DATES/NUMBERS: Both answers correctly cite October 2020 as the loss of exclusivity date. Page references in the LLM answer (pages 37-38 for 2022, pages 7-9 for 2023) cannot be verified against ground truth but appear to be specific claims that may be inaccurate given the factual errors about disclosure content. The core error is the LLM's assertion that 2023 contained no patent disclosures for Truvada, when the ground truth explicitly states structured disclosures were provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 468,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "\nBetween 2022 and 2024 SPG’s use of the Supplemental Facility shifted from a single $1.05 bn draw in December 2021 – which it fully repaid with note proceeds on January 12 2022 – to a complete retirement of the borrowing.  In November 2023 the company used the proceeds of a €750 m euro‑denominated bond issuance to extinguish the remaining €750 m (≈ $815 m) outstanding under the Supplemental Facility, leaving the facility with no balance on its books; the 2024 filing therefore reports only the facility’s available capacity, not any outstanding borrowings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. CRITICAL DATE ERROR: The LLM states the initial $1.05 billion draw occurred in 'December 2021' and was repaid 'January 12 2022', but the ground truth clearly states it was 'borrowed $1.05 billion under the Supplemental Facility in January 2022.' This is a fundamental chronological error.\n\n2. INCORRECT CHARACTERIZATION OF 2023 TRANSACTION: The LLM claims the €750 million was used to 'extinguish the remaining €750 m outstanding under the Supplemental Facility' and that this left 'the facility with no balance on its books.' However, the ground truth states the €750 million was 'borrowed' in November 2023 and then 'repaid on November 17, 2023' - meaning it was a short-term borrowing and repayment, not an extinguishment of existing debt. The LLM mischaracterizes the nature of this transaction.\n\n3. MISSING KEY INFORMATION: The ground truth mentions that the 2022 borrowing was 'used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion.' The LLM completely omits this important detail about the purpose of the borrowing.\n\n4. INCOMPLETE 2024 INFORMATION: The ground truth notes that 'in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy.' The LLM does not address this 2024 activity.\n\n5. MISREPRESENTATION OF EVOLUTION: The LLM's characterization of the evolution as showing 'complete retirement' and 'no balance on its books' is misleading. The ground truth shows continued reliance on the facility for short-term financing needs, not a permanent retirement.\n\nThe LLM answer demonstrates poor multi-hop synthesis, incorrect date attribution, and fundamental misunderstanding of the transaction nature (borrowing/repayment vs. debt extinguishment). While some numbers are correct (€750 million, $815.4 million equivalent), the context and timing are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 535,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "\nFrom 2022 to 2024 MetLife shifted the cash‑buffer from a vague “capacity‑to‑pay‑dividends” constraint to a concrete, forward‑looking liquidity framework.  The 2024 disclosures tie the buffer size to daily cash‑flow forecasts, rolling‑12‑month stress tests and collateral‑call scenarios, so any rise in required buffer—driven by market volatility, rating‑agency expectations or securities‑lending collateral demands—directly limits capital‑allocation decisions such as dividend payouts, share‑repurchases and the scale of external financing.  In short, the buffer now explicitly governs how much capital can be deployed, rather than merely flagging a potential restriction.",
      "correctness_score": 3,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer provides NO specific numbers from the ground truth. The original answer cites concrete figures: $12.4 billion short-term liquidity (2022), $223.0 billion total liquid assets (2022). The LLM completely omits these critical quantitative data points, which are essential for evaluating how cash buffer needs evolved. (2) FACTUAL DIVERGENCE: The LLM introduces concepts NOT in the ground truth (daily cash-flow forecasts, rolling-12-month stress tests, collateral-call scenarios, securities-lending collateral demands, rating-agency expectations). While these may be reasonable inferences about liquidity management, they are NOT supported by the provided ground truth and represent speculation rather than evidence-based synthesis. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks specifically about evolution from 2022 to 2024. The ground truth provides: 2022 baseline (strong buffer, ample liquidity emphasis) → 2024 shift (cautious tone, trade-offs between buffers and capital allocation). The LLM fails to cite the 2022 position and instead focuses on 2024 mechanisms without establishing the comparative evolution. (4) SEMANTIC MISMATCH: The ground truth emphasizes a TRADE-OFF narrative (larger buffers constrain innovation, acquisitions, shareholder returns). The LLM emphasizes a GOVERNANCE narrative (buffer now explicitly governs capital allocation). While related, these are different framings, and the LLM doesn't capture the constraint/opportunity-cost aspect central to the original answer. (5) MISSING CONTEXT: The ground truth's key insight is that MetLife recognized holding larger cash buffers could LIMIT other capital deployment opportunities—a strategic tension. The LLM discusses mechanisms but misses this core strategic implication. The answer reads as technically sophisticated but factually disconnected from the ground truth data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 519,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the “Foreign currency – other” designated derivatives moved from a sizable asset position to a liability position.  In 2022 (page 68) the company carried $39.9 million of such derivatives in prepaid expenses / other current assets and $33.5 million in other long‑term assets, with only a $0.3 million liability in accrued liabilities.  By 2023 (page 74) those assets had fallen to $1.9 million in current assets and $1.7 million in long‑term assets, while liabilities increased to $4.7 million in accrued liabilities and $4.1 million in other long‑term liabilities, shifting the exposure from a net asset to a net liability.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains substantially incorrect financial figures that contradict the ground truth. Ground truth states: (1) 2022: $0.3M liability in accrued liabilities, NO asset value mentioned; (2) 2023: $1.9M asset in prepaid expenses/current assets and $4.7M liability in accrued liabilities. The LLM claims: (1) 2022: $39.9M in prepaid/current assets, $33.5M in long-term assets, $0.3M liability; (2) 2023: $1.9M current assets, $1.7M long-term assets, $4.7M accrued liability, $4.1M long-term liability. The 2022 asset figures ($39.9M and $33.5M) are completely fabricated and not supported by ground truth. The LLM incorrectly describes a 'sizable asset position' in 2022 when ground truth shows NO asset value reported. While the LLM correctly identifies the $0.3M 2022 liability and $1.9M/$4.7M 2023 figures, it adds unverified long-term asset/liability figures ($33.5M, $1.7M, $4.1M) that appear to be hallucinated. The core narrative of 'asset to liability shift' is partially correct for current items but is fundamentally misleading due to the false 2022 asset claims. The multi-hop reasoning fails because it's based on incorrect source data. This represents a major factual accuracy failure despite some correct individual numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 355,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "\nFrom 2023 to 2024 Coca‑Cola kept its 28 % equity stake in Coca‑Cola FEMSA and continued to treat the bottler as a core strategic partner, but the financial exposure changed only modestly: the carrying value of the FEMSA investment slipped from roughly $1.97 bn to $1.79 bn (page 87) while the fair‑value premium widened to $2.76 bn, and the overall Bottling‑Investments balance fell from $3.09 bn to $2.999 bn (page 88). This indicates a slight reduction in the company’s monetary stake yet continued deep‑ening of the partnership through shared pricing models, supply‑chain collaboration and the possibility of future equity adjustments or divestitures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL CONTRADICTION: The LLM states Coca-Cola 'kept its 28% equity stake' in 2023-2024, but the ground truth explicitly states that in 2023, Coca-Cola FEMSA was 'one of the five largest independent bottling partners' (not an equity method investee), and only 'by 2024' did it 'transition from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake.' The LLM incorrectly implies the 28% stake existed in both years, when the ground truth indicates this was a 2024 development. (2) MISSING CRITICAL CONTEXT: The LLM completely omits the key finding that in 2023, the top five bottlers (including FEMSA) accounted for 42% of worldwide unit case volume - a crucial metric for understanding the strategic importance. (3) UNVERIFIABLE NUMBERS: The LLM provides specific carrying values ($1.97bn to $1.79bn), fair-value premiums ($2.76bn), and balance sheet figures ($3.09bn to $2.999bn) with page references (87, 88) that cannot be verified against the ground truth knowledge graph. These numbers may be fabricated or from different contexts. (4) INCOMPLETE SYNTHESIS: The LLM fails to properly synthesize the evolution described in the ground truth - the transition from traditional bottler relationship to equity method investee status represents a fundamental shift in the relationship structure, not merely a 'modest' financial exposure change. (5) SPECULATIVE LANGUAGE: Phrases like 'possibility of future equity adjustments or divestitures' introduce speculation not present in the ground truth. The core answer should focus on the documented transition that occurred, not possibilities. The LLM answer demonstrates poor multi-hop reasoning by conflating the 2023 and 2024 positions rather than clearly delineating the evolution between them.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 497,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "\nBetween 2022 and 2024 Intel moved FPGAs from a discrete “Programmable Solutions” offering into the core of its **xPU** architecture, using them as the programmable networking and acceleration engine inside the **Infrastructure Processing Unit (IPU)** and other adjacent product families (e.g., modem, Ethernet, silicon‑photonic and AI‑accelerator blocks).  This integration lets FPGAs bind together platform CPUs, AI accelerators and Mobileye/NSG components into end‑to‑end platform solutions, while Intel’s “Smart Capital” and production‑capacity investments now target scalable fab capacity for these programmable devices to support its broader CCG‑DCG‑IOTG focus.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces concepts not supported by the ground truth. Key issues: (1) The ground truth explicitly states FPGAs moved from 'adjacent products' in 2022 to 'direct product definitions' in 2024, but the LLM answer claims they moved into 'xPU architecture' and 'Infrastructure Processing Unit (IPU)' - these specific product architectures are not mentioned in the ground truth and appear to be fabricated or confused with other Intel initiatives. (2) The LLM introduces unsupported details about 'Programmable Solutions,' 'programmable networking,' 'modem,' 'Ethernet,' 'silicon-photonic,' 'Mobileye/NSG components,' and 'Smart Capital' investments - none of which appear in the ground truth answer. (3) The core finding is inverted: the ground truth emphasizes FPGAs moving from a 'supplementary role' to 'core product offering' with explicit listing in product definitions, while the LLM focuses on integration into larger xPU/IPU architectures, which doesn't align with the stated shift toward 'direct product definitions.' (4) The LLM answer demonstrates poor multi-hop synthesis by introducing architectural details that weren't part of the original knowledge graph data. (5) While the LLM correctly identifies the 2022-2024 timeframe and mentions CCG-DCG-IOTG groups, the overall narrative diverges substantially from the ground truth's simpler but more accurate positioning shift. The answer reads as speculative rather than grounded in actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 419,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "\nBetween 2022 and 2023 ConocoPhillips grew its Lower 48 position by spending more on capital projects—capital expenditures jumped from **$5.6 bn to $6.5 bn** (page 135)—and its depreciation, depletion and amortization expense rose from **$4.85 bn to $5.73 bn** (page 134).  This increase in DDA reflects the added acreage from the Concho acquisition and subsequent extensions and discoveries that expanded proved undeveloped reserves in the Lower 48 (pages 163, 165).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key metrics: (1) DDA expenses: Ground truth states $4,854M (2022) to $5,729M (2023), LLM reports $4.85bn to $5.73bn - these are equivalent and correct (difference of $875M confirmed). (2) Capital expenditures: LLM provides $5.6bn to $6.5bn for Lower 48, which represents a $900M increase - this additional detail goes beyond ground truth but is not contradicted. (3) The LLM correctly identifies the Concho acquisition as the driver of increased activity, matching the ground truth narrative. (4) Multi-hop synthesis is sound: the answer connects asset acquisition (capex increase), depreciation/depletion/amortization expense increase, and the underlying cause (Concho acquisition) across multiple pages (135, 134, 163, 165). (5) The reasoning that increased DDA reflects added acreage and proved undeveloped reserves is logical and supported by the ground truth context. Minor note: The LLM provides additional context about capital expenditures that wasn't explicitly in the ground truth answer, but this enhances rather than contradicts the response. All numeric values are accurate, calculations are correct, and the semantic meaning aligns perfectly with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 351,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s stake in AspenTech grew from the ~55 % ownership it obtained after the May 2022 acquisition of Heritage AspenTech to about 57 % by late‑2024, and in November 2024 it announced a proposal to acquire the remaining shares—moving the relationship from a joint‑venture stake toward full control.  The added software and analytics businesses from AspenTech helped lift Emerson’s consolidated gross margin to **50.8 % in 2024** (up from 49.0 % in 2023), although a $231 million acquisition‑related inventory‑step‑up amortization in 2024 offset roughly **1.3 percentage‑points** of that improvement.  Thus, while the strategic partnership deepened and contributed to higher margins, the net margin effect was a modest increase tempered by the step‑up amortization.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ERRORS IN OWNERSHIP STRUCTURE: The LLM states Emerson's stake grew from ~55% to ~57% by late 2024, but the ground truth clearly states Emerson owned 55% of AspenTech on a fully diluted basis in 2024 (not 57%). The LLM also incorrectly characterizes the relationship as evolving from a 'joint-venture stake' when the ground truth indicates Emerson completed a full acquisition in 2022, retaining 55% ownership while AspenTech continued operating under its own name and ticker. The November 2024 proposal to acquire remaining shares is mentioned but not in the ground truth provided, suggesting potential hallucination or external knowledge injection.\n\nCORRECT NUMBERS: The LLM correctly identifies: (1) gross margin of 50.8% in 2024, (2) prior year margin of 49.0% in 2023, (3) $231 million inventory step-up amortization, (4) 1.3 percentage points margin reduction from step-up amortization. These are accurate.\n\nMISSING CRITICAL DETAILS: The LLM omits several key facts from the ground truth: (1) the $6.0 billion cash payment, (2) the $87.69 per share price to Heritage AspenTech stockholders, (3) the $168 million retained in AspenTech's balance sheet, (4) the 0.6 percentage point margin impact in 2023, (5) the 1.8 percentage point gross margin increase to 50.8% in 2024 (the LLM only mentions the net effect after step-up amortization).\n\nCALCULATION/REASONING ISSUES: The LLM's characterization of margin impact is incomplete. The ground truth indicates the acquisition contributed 1.8 percentage points to the 2024 margin increase, but the $231 million step-up amortization reduced margins by 1.3 percentage points, resulting in a net positive contribution of 0.5 percentage points. The LLM describes this as 'modest increase tempered by step-up amortization' which is directionally correct but lacks the quantitative precision of the ground truth.\n\nMULTI-HOP SYNTHESIS: The LLM attempts to synthesize ownership evolution and margin impact but fails on the ownership structure accuracy. The relationship characterization as moving from 'joint-venture stake toward full control' is misleading—the 2022 acquisition was already a controlling transaction, not a joint venture.\n\nSCORING JUSTIFICATION: Correctness score of 5 reflects significant errors in ownership structure (55% vs 57%, joint-venture characterization) despite correct margin numbers. Quantitative accuracy of 4 due to ownership percentage error and missing key financial details ($6.0B, $87.69/share, $168M retained). Qualitative accuracy of 6 because the reasoning about margin impact is partially sound but the ownership evolution narrative is fundamentally flawed. Contextual relevance of 7 because the answer addresses the question's main themes but with material inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 731,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "\nBetween 2022 and 2024 the 2015 Director Stock Plan continued to treat forfeited, expired or cash‑settled awards—and the shares tendered for tax withholding—as newly available on a one‑for‑one basis, but the net pool of shares that can still be issued fell.  The 2022 filing showed about 31.5 million shares had been recovered since 2015, leaving roughly 34 million shares available for future grants; by the 2024 filing cumulative recoveries had risen to 37.6 million shares, yet after deducting shares used for new awards and imputed dividend credits the remaining authorized shares had dropped to 30.66 million.  Thus, while the recovery mechanism kept adding back shares, the volume of new grants outpaced those recoveries, tightening overall availability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of key metrics and sound multi-hop reasoning. STRENGTHS: (1) All major numbers are accurate: 37.6 million shares recovered (matches ground truth 37,608,213), 30.66 million shares available (matches 30,660,961), and the directional claim about declining availability despite increased recoveries is correct. (2) The answer correctly synthesizes the evolution between 2022 and 2024, noting that while recovery mechanisms added shares, new awards outpaced recoveries. (3) The explanation of the one-for-one recovery mechanism is accurate and relevant. (4) The reasoning about the net reduction in available shares despite ongoing recovery is sound and matches the ground truth narrative. MINOR WEAKNESSES: (1) The 2022 comparison figures (~31.5 million recovered, ~34 million available) are approximations not explicitly verified against ground truth, though they appear directionally reasonable. (2) The answer doesn't explicitly mention the 35,395,894 shares authorized as of January 1, 2015, or the 42,343,146 shares covered by new awards and reinvested dividends—these specific figures from the ground truth are omitted. (3) The phrase 'imputed dividend credits' is used instead of 'reinvested dividends,' which is a minor semantic variation. CALCULATION VERIFICATION: The ground truth shows 35,395,894 authorized + 37,608,213 recovered = 73,004,107 total potential shares; minus 42,343,146 used = 30,660,961 available. The LLM's conclusion about the net reduction is mathematically sound. The answer captures the essential evolution and mechanics accurately, though it lacks some specific baseline figures from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 464,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 Starbucks deepened the strategic role of the Global Coffee Alliance, moving it from a modest royalty‑ and product‑sales line (which generated about $216 million of “other” revenue in 2022) to a primary growth engine for the Channel Development segment; the partnership was highlighted as a key driver of the segment’s 16 % revenue increase and a larger share of total net revenue. This shift reflects a stronger strategic emphasis on co‑developed products, expanded licensing and joint marketing, and a higher overall contribution of the Alliance to Starbucks’ top‑line performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims the Global Coffee Alliance generated 'about $216 million of other revenue in 2022' - this number does not appear in the ground truth and contradicts the stated $250 million increase in Channel Development segment revenue. The LLM also cites a '16% revenue increase' for the Channel Development segment with no supporting evidence in the ground truth. These specific numbers are unverified and appear fabricated. (2) INCOMPLETE SYNTHESIS: The ground truth explicitly states the $250 million increase was 'driven by product sales and royalty income from the alliance' in FY2022, but the LLM mischaracterizes this as a 'modest' contribution and provides an unsupported alternative figure. (3) CONCEPTUAL MISALIGNMENT: The ground truth describes an evolution from 'revenue driver' to 'strategic enabler of global product reach' - a qualitative shift in emphasis. The LLM reverses this narrative, claiming the alliance moved FROM 'modest royalty and product sales' TO 'primary growth engine,' which contradicts the ground truth's characterization of the evolution. (4) MISSING KEY CONTEXT: The ground truth emphasizes the Nestlé licensing relationship as explicitly highlighted in FY2023 filings. The LLM mentions 'co-developed products' and 'joint marketing' without grounding these in the actual filing language about the Nestlé licensing relationship. (5) UNSUBSTANTIATED CLAIMS: References to '16% revenue increase' and specific revenue figures lack citation to the ground truth source material. The answer reads as plausible but contains invented specifics that contradict or diverge from the actual knowledge graph data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 462,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "\nBetween 2022 and 2023 NEE’s exposure to the Mountain Valley Pipeline was sharply reduced – the carrying amount of its equity‑method investment in the pipeline fell by roughly $1 billion and a $1.2 billion impairment charge was recorded in 2023, reflecting a write‑down of the asset. This decline signals that NEE is pulling back from long‑haul gas‑pipeline investments and reallocating capital toward renewable‑energy and clean‑energy projects.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims a ~$1 billion reduction in carrying amount and a $1.2 billion impairment charge in 2023. However, the ground truth shows total equity method investments were $6,159 million in 2022 and $6,156 million in 2023 - a decrease of only $3 million, not $1 billion. No impairment charge of $1.2 billion is mentioned in the ground truth. These numbers appear to be fabricated or confused with other entities. (2) ENTITY/METRIC CONFUSION: The LLM conflates equity method investment carrying amounts with ownership percentages and impairment charges. The ground truth discusses ownership interest percentages (32%-55% in 2022, 32.8%-52.6% in 2023) and total equity method investments, not individual asset write-downs. (3) MISSING CONTEXT: The LLM completely ignores the actual data points from the ground truth: the total equity method investment amounts ($6,159M vs $6,156M), the ownership percentage ranges, and the mention of Nonrecurring Fair Value Measurements in 2023. (4) UNSUPPORTED CONCLUSIONS: The claim about 'pulling back from long-haul gas-pipeline investments' is not supported by the ground truth, which shows relatively stable total equity method investments and a narrowing (not elimination) of ownership stakes. The ground truth suggests a 'refined or strategic investment posture,' not a sharp reduction. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the available data across years and correctly identify the nature of changes in NEE's Mountain Valley Pipeline involvement. The answer appears to be based on incorrect assumptions rather than actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 472,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 Medtronic expanded the InterStim portfolio with new recharge‑free (InterStim X and InterStim II) and rechargeable (InterStim Micro) neurostimulators, and broadened its approved therapeutic indications to include overactive bladder, non‑obstructive urinary retention and chronic fecal incontinence, while continuing to support pelvic‑health applications.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) PRODUCT LINEUP CONTRADICTION: The LLM answer states InterStim Micro is a 'rechargeable' neurostimulator in the 2022-2024 period, but the ground truth indicates InterStim Micro was present in 2022 and notably ABSENT from the 2024 product line description. The LLM conflates the product evolution by suggesting Micro continued as a rechargeable option, when the ground truth shows it was discontinued or de-emphasized. (2) INCOMPLETE PRODUCT EVOLUTION: The ground truth explicitly states that by 2024, the product line 'continued to include InterStim II and InterStim X' - notably omitting InterStim Micro from the 2024 lineup. The LLM fails to capture this key evolution/discontinuation. (3) THERAPEUTIC INDICATIONS - PARTIALLY CORRECT: The LLM correctly identifies the expansion to 'chronic fecal incontinence' and maintains overactive bladder and urinary retention. However, the ground truth uses the specific term 'non-obstructive urinary retention' while the LLM uses 'non-obstructive urinary retention' - this is actually aligned. The phrase 'pelvic-health applications' in the LLM answer is vague and not explicitly stated in the ground truth. (4) RECHARGE-FREE LABELING: The LLM correctly identifies InterStim X and InterStim II as 'recharge-free' in the 2024 period, matching the ground truth's 'recharge-free' designation. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the product line evolution across the two years - it presents a confused picture where Micro appears to remain as a rechargeable option when it should have been identified as discontinued or removed from the primary product line by 2024. This is a fundamental error in tracking product portfolio changes over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 474,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "\nFrom 2022 through 2024 Simon Property Group steadily pared down its ownership in Authentic Brands Group (ABG).  In 2022 it sold a portion of its licensing‑venture interest to ABG and acquired additional ABG equity, generating a $159 million pre‑tax gain while its non‑controlling stake fell to roughly 10 %.  By the end of 2023 a further capital transaction diluted the holding to about 9.6 % and SPG recorded a $10.3 million non‑cash gain on the deemed disposal.  In the first quarter of 2024 SPG sold the remaining ABG interest for $1.2 billion, recognizing a $414.8 million pre‑tax gain and effectively ending the strategic relationship.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every material fact. Specific errors: (1) OWNERSHIP TRAJECTORY: Ground truth shows SPG held 1.37% in 2022 and increased to 50% stake in SPARC Group merger, then later sold a portion. LLM claims SPG 'steadily pared down' ownership from 2022-2024, which is backwards - SPG actually increased its stake initially. (2) FINANCIAL GAINS: Ground truth cites $18.8 million pre-tax gain from selling a portion of ABG stake in 2024. LLM claims $159 million gain in 2022, $10.3 million non-cash gain in 2023, and $414.8 million gain in Q1 2024 - none of these figures appear in ground truth and the $414.8M figure is particularly implausible given the $18.8M stated in ground truth. (3) STAKE PERCENTAGES: Ground truth does not mention 10% or 9.6% stakes. LLM's claim of these percentages is unsupported. (4) FINAL TRANSACTION: Ground truth mentions $100 million cash acquisition of additional ABG interests in 2024. LLM claims SPG sold remaining ABG interest for $1.2 billion in Q1 2024 - this is a completely different transaction and contradicts the ground truth narrative of acquiring additional interests. (5) STRATEGIC RELATIONSHIP: Ground truth indicates an ongoing dynamic relationship with acquisitions continuing through 2024. LLM claims the relationship 'effectively ended' with a complete exit in Q1 2024, which contradicts ground truth. (6) SPARC GROUP: Ground truth mentions the Forever 21 merger into SPARC Group with 50% stake increase. LLM makes no mention of SPARC Group at all. The LLM answer appears to describe a completely different transaction history than what is documented in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 462,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "\nFrom 2021 through 2023 the depreciation, depletion and amortization (DD&A) charge linked to ConocoPhillips’ Lower 48 operations rose sharply—from **$4.07 bn in 2021 to $4.85 bn in 2022 and $5.73 bn in 2023**.  This increase mirrors the jump in capital spending for that region (CapEx grew from **$3.13 bn in 2021 to $5.63 bn in 2022 and $6.49 bn in 2023**) and the 2021 acquisitions of Concho and Shell Permian that expanded the asset base.  Consequently, Lower 48 DD&A grew by roughly **41 % over the three‑year period** and remained the single largest contributor to the company’s consolidated DD&A of **$8.28 bn in 2023**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All key DD&A figures are correct: $4.07bn (2021), $4.85bn (2022), and $5.73bn (2023) match the ground truth values ($4,067M = $4.07bn, $5,729M = $5.73bn). The 41% growth calculation is accurate: ($5.73bn - $4.07bn) / $4.07bn = 40.8%, correctly rounded to 41%. The CapEx figures ($3.13bn, $5.63bn, $6.49bn) and consolidated DD&A figure ($8.28bn in 2023) are presented with appropriate precision. COMPLETENESS: The answer exceeds the ground truth by providing: (1) intermediate year data (2022), (2) supporting CapEx context, (3) historical context about 2021 acquisitions (Concho and Shell Permian), and (4) Lower 48's contribution to consolidated DD&A. These additions enhance understanding without contradicting the core answer. ENTITY ACCURACY: All entities correctly identified (ConocoPhillips, Lower 48 region, DD&A metric, relevant years 2021-2023). REASONING QUALITY: The multi-hop synthesis is sound—the answer connects DD&A growth to capital spending growth and acquisition activity, demonstrating understanding of how acquisitions expand the asset base and drive depreciation. The logical flow from acquisitions → expanded assets → higher DD&A is well-reasoned. SEMANTIC EQUIVALENCE: The core message matches ground truth: DD&A increased significantly from 2021 to 2023, reflecting growing investment activity. Minor note: The answer uses billion notation (bn) instead of million notation (M), but this is a standard format variation and fully acceptable. The answer is well-structured, provides appropriate context, and maintains factual accuracy throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 464,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "\nVerizon’s international‑bond holdings in its pension and post‑retirement plans fell sharply from a $341 million fair‑value base in 2023—essentially all classified as Level 2 (with only a $3 million Level 1 component) and no Level 3 exposure—to $113 million in 2024, still reported solely as Level 2 (no Level 3 items).  The valuation methodology stayed the same (matrix‑price quotes and third‑party inputs), but the reduced allocation reflects a strategic shift toward more liability‑hedging assets and cash rather than a change in how the bonds are measured.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to reference completely different data than what is stated in the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites $341 million in 2023 and $113 million in 2024 for international bonds in pension/post-retirement plans, while the ground truth specifies $12 million total in 2024 ($10M Level 1, $2M Level 2). These are entirely different figures with no reconciliation possible. (2) ENTITY CONFUSION: The ground truth discusses international bonds in the context of fixed income securities valuation disclosures in the 10-K, while the LLM appears to be discussing pension and post-retirement plan holdings - potentially a different asset category or misidentification. (3) LEVEL CLASSIFICATION ERRORS: Ground truth shows $10M Level 1 and $2M Level 2 in 2024, while LLM claims all $113M was Level 2 with no Level 3. This is a fundamental mischaracterization of the valuation hierarchy. (4) MISSING KEY EVOLUTION: The ground truth's core finding - that 2023 used general matrix price descriptions while 2024 provided specific itemized tables with transparent segmentation - is completely absent from the LLM answer. (5) INCORRECT NARRATIVE: The LLM's explanation about strategic shifts toward liability-hedging and cash allocation is not supported by the ground truth and appears to be fabricated reasoning. The LLM has either accessed incorrect source data or fundamentally misunderstood the question about disclosure evolution in valuation approaches.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 420,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s ownership of AspenTech grew from the 55 % stake it acquired in 2022 (when the Heritage AspenTech purchase added $7.3 bn of goodwill and $8.3 bn of intangibles) to roughly 57 % by the end of 2023, and in May 2024 Emerson announced a proposal to buy the remaining ≈ 43 % of AspenTech for $240 per share—effectively taking the company private.  The integration has been operational as well as financial: AspenTech’s software portfolio (including the Micromine acquisition and related hedging activities) is now embedded in Emerson’s Automation Solutions segment, driving cross‑segment revenue synergies and contributing to the higher‑margin, higher‑growth industrial‑technology portfolio Emerson describes in its 2024 outlook.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) OWNERSHIP STAKE PROGRESSION: The LLM claims Emerson acquired a 55% stake in 2022 and grew it to ~57% by end of 2023, then proposed buying remaining 43% in May 2024. This is fundamentally incorrect. The ground truth states Emerson had a financial stake valued at $8,326 million in 2022, then in 2024 contributed the AspenTech Industrial Software Business plus $6.0 billion in cash to form 'New AspenTech' while retaining 55% ownership. The LLM's narrative of progressive ownership increases (55%→57%→full acquisition) does not match the ground truth's description of a strategic restructuring event. (2) FINANCIAL NUMBERS: The LLM mentions $7.3 billion goodwill and $8.3 billion intangibles from Heritage AspenTech purchase, but the ground truth specifically states the 2022 stake was valued at $8,326 million total. The LLM's breakdown of components is not verified against ground truth and appears to conflate different transactions. The $6.0 billion cash contribution mentioned in ground truth is not mentioned in LLM answer. (3) TRANSACTION STRUCTURE: The LLM describes a traditional acquisition proposal ($240/share to take company private), but the ground truth describes a different structure: contributing the AspenTech Industrial Software Business plus cash to form 'New AspenTech' with 55% retained ownership. These are fundamentally different transaction types. (4) OPERATIONAL INTEGRATION: While the LLM correctly identifies operational integration (Micromine acquisition, embedding in Automation Solutions segment), the ground truth emphasizes the 2024 restructuring as the key evolution point, not a gradual ownership increase. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the relationship evolution between 2022-2024, presenting an incorrect narrative of ownership progression rather than the strategic restructuring described in ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 533,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Starbucks kept its interest‑rate swaps classified as **designated fair‑value hedges of fixed‑rate long‑term debt**, with the swap itself recorded as a **derivative liability in other long‑term liabilities**.  In 2022 the liability stood at **$34 million** (and the hedged debt carried a $1.05 billion balance, with a $(52.3 million) fair‑value adjustment), and the hedge generated a **$65 million loss** in earnings.  By the end of 2023 the same liability had fallen to roughly **$19 million** (down from $41 million the prior year), the hedging adjustment to the debt was reduced to about **$(18 million)**, and the swap now produced a **$10 million gain** in earnings—showing that the size of the liability and the associated earnings impact improved markedly, even though the hedge remained in the same classification.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about Starbucks' interest rate swaps but contains significant quantitative discrepancies that undermine its accuracy. CORRECT ELEMENTS: (1) The 2022 liability of $34 million is accurate; (2) The general characterization of swaps as designated fair-value hedges is appropriate; (3) The directional trend (decrease from 2022 to 2023) is correct; (4) The answer appropriately addresses the classification evolution question. CRITICAL ERRORS: (1) The 2023 liability figure is stated as 'roughly $19 million' in one place but then contradicts itself by saying it 'had fallen to roughly $19 million (down from $41 million the prior year)' - this is internally inconsistent and the $41 million figure appears to be fabricated; (2) The ground truth shows 2023 liabilities split as $0.4 million (current) + $19.2 million (long-term) = $19.6 million total, not $19 million; (3) The LLM introduces unsupported details about earnings impacts ($65 million loss in 2022, $10 million gain in 2023), hedged debt balance ($1.05 billion), and fair-value adjustments ($(52.3 million) and $(18 million)) that are not present in the ground truth and cannot be verified; (4) The statement about the liability being '$41 million the prior year' is unexplained and contradicts the established $34 million 2022 figure. MULTI-HOP REASONING: The LLM attempts to synthesize classification information with liability values and earnings impacts, but the introduction of unverified financial metrics (earnings impacts, debt balances, fair-value adjustments) suggests either hallucination or reliance on information not in the ground truth. The core answer about the evolution from $34M to ~$19.6M is directionally correct, but the additional details create confusion and reduce credibility. The answer would have been stronger by sticking to the verifiable classification and liability changes without introducing unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 528,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "\nIn 2022 NextEra Energy Resources recorded a $0.8 billion impairment and fully wrote off its $0.6 billion equity investment in the Mountain Valley Pipeline, while also establishing a $0.2 billion liability for its share of future abandonment costs because regulatory and legal hurdles made completion highly unlikely. By 2023 the company’s involvement had shifted to a modest, future equity contribution—approximately $1 billion of planned 2024 capital outlays listed under “Other (i)” for the pipeline in NEER’s capital‑expenditure table—so it remained a 32.8 % joint‑venture partner with no additional impairments or major financial commitments reported.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported information that contradicts the ground truth. CRITICAL ERRORS: (1) The breakdown of the $0.8B impairment into $0.6B equity investment write-off and $0.2B abandonment liability is NOT supported by the ground truth, which only mentions the $0.8B impairment charge without this specific decomposition. (2) The claim about '$1 billion of planned 2024 capital outlays' for the pipeline is not mentioned in the ground truth and appears to be fabricated or misinterpreted. (3) The statement 'no additional impairments or major financial commitments reported' contradicts the ground truth, which explicitly states NEER 'committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million.' This is a major financial commitment that the LLM incorrectly claims was not reported. CORRECT ELEMENTS: (1) The $0.8B impairment charge in 2022 is correct. (2) The 32.8% equity investment stake in 2023 is correct. (3) The general characterization of regulatory/legal hurdles is appropriate. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution from 2022 to 2023. The ground truth shows a shift from impairment (2022) to maintaining investment with a new 20-year transportation agreement (2023). The LLM instead suggests the involvement became 'modest' with only future capital outlays, missing the significant $70M annual obligation commitment. The answer demonstrates incomplete understanding of the financial commitment evolution and introduces unsupported details while omitting the critical 20-year transportation agreement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 453,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "\nBetween 2023 and 2024 the captive insurance company that reinsures the group‑annuity contracts raised its solvency‑capital investments from **$1.643 billion of equity and $1.378 billion of debt** (as of 31 Dec 2023) to **$1.883 billion of equity and $1.643 billion of debt** (as of 31 Dec 2024).  That represents an increase of roughly **$240 million (≈15 %) in equity holdings** and **$265 million (≈19 %) in debt holdings**, expanding the captive’s marketable‑security portfolio to support the annuity reinsurance liabilities.  These securities remain classified as “other non‑current assets” because they cannot be used to meet current obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer provides a fundamentally different breakdown than the ground truth. Ground truth states: 2023 total = $1,643 million; 2024 total = $1,883 million. The LLM breaks this into equity and debt components ($1.643B equity + $1.378B debt = $3.021B for 2023, and $1.883B equity + $1.643B debt = $3.526B for 2024), which contradicts the ground truth totals. The ground truth does not specify separate equity vs. debt breakdowns - it only provides combined totals of $1,643M (2023) and $1,883M (2024). The LLM appears to have fabricated the equity/debt split and the corresponding calculations ($240M equity increase, $265M debt increase). The total increase should be $240M ($1,883M - $1,643M), not split into separate equity and debt increases. The LLM's calculations are internally consistent with its stated numbers but are based on incorrect source data. The classification as 'other non-current assets' may be accurate contextual information, but it does not compensate for the fundamental factual errors in the primary numbers. The answer demonstrates multi-hop reasoning capability but applies it to incorrect data, resulting in a misleading response that contradicts the ground truth by a significant margin.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 351,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "\nFrom 2022 to 2024 Intel 4 moved from a planned EUV‑based node to a fully ramped, high‑volume process, with production commencing in Ireland in 2023 and expanding throughout 2024 to power the Core Ultra “AI‑PC” family and other client CPUs.  This evolution places Intel 4 at the core of Intel’s IDM 2.0 strategy, serving both internal product lines and external foundry customers and positioning the node as a key growth driver for the company’s AI‑PC and foundry revenue roadmap.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The general evolution from planned/early-stage to high-volume manufacturing is accurate; (2) Ireland production location is correct; (3) Core Ultra processor association is correct; (4) The 2024 timeframe for high-volume manufacturing is accurate; (5) The mention of AI-PC positioning is relevant and appropriate. PROBLEMATIC ELEMENTS: (1) DATE INACCURACY - The LLM states 'production commencing in Ireland in 2023' but the ground truth indicates higher period charges in 2022 related to ramp-up, with transition to high-volume manufacturing by 2024. The specific claim about 2023 commencement is not supported by the ground truth and appears to be an unsupported interpolation; (2) SCOPE EXPANSION - The LLM introduces information about 'external foundry customers' and 'foundry revenue roadmap' that is not mentioned in the ground truth. While this may be factually accurate from other sources, it goes beyond what the ground truth establishes and represents potential hallucination or synthesis from external knowledge; (3) IDM 2.0 STRATEGY - Similarly, the explicit mention of 'IDM 2.0 strategy' is not in the ground truth, though it may be contextually relevant; (4) INCOMPLETE GROUND TRUTH SYNTHESIS - The LLM does not clearly articulate the 2022 'higher period charges' and 'production challenges' that the ground truth emphasizes as a key distinction from 2024. MULTI-HOP REASONING: The answer demonstrates reasonable synthesis of Intel 4's evolution across the time period, but introduces details not grounded in the provided ground truth. The core narrative of progression from early-stage to high-volume is sound, but the specific dating and scope additions create factual uncertainty. The answer would score higher if it stuck more closely to the ground truth's documented progression without adding unverified details about foundry customers and specific 2023 commencement dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 533,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s stake in AspenTech grew modestly—from roughly 55 % of the fully‑diluted share count after the 2022 “New AspenTech” transaction to about 57 % by 2023, and in early 2024 Emerson announced a proposal to acquire the remaining shares for $240 per share, effectively seeking to take AspenTech private.  Financially, AspenTech’s results are woven into Emerson’s adjusted EBITA (e.g., the $231 million acquisition‑related inventory step‑up and the $1.9 billion note‑receivable gain/loss in 2024), Emerson earned interest income on the Copeland note, and the 2024 sale of its 40 % equity interest and associated note to Blackstone generated a $539 million gain in discontinued operations while providing $1.5 billion cash and a $1.9 billion note receivable, illustrating the deepening financial integration and the move toward full ownership.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth:\n\n1. CRITICAL OWNERSHIP STRUCTURE ERROR: The LLM states Emerson's stake grew from 55% to 57% by 2023, then describes a 2024 proposal to acquire remaining shares. However, the ground truth clearly states that by 2024, Emerson retained a 55% ownership stake in 'New AspenTech' after the merger. The LLM's narrative about increasing ownership percentages (55% → 57%) is not supported by the ground truth.\n\n2. CONTRADICTORY NARRATIVE: The LLM describes a 2024 sale of a 40% equity interest to Blackstone, which is completely absent from the ground truth. The ground truth makes no mention of Blackstone, a 40% stake sale, or any transaction involving Blackstone. This appears to be fabricated information.\n\n3. TIMELINE CONFUSION: The LLM references the 'New AspenTech' transaction as occurring in 2022, but the ground truth indicates this was the state by 2024. The LLM's chronology is muddled.\n\n4. UNVERIFIED FINANCIAL FIGURES: The LLM cites specific numbers ($231 million inventory step-up, $1.9 billion note receivable, $539 million gain, $1.5 billion cash) that are not present in the ground truth. While some financial integration is mentioned in the ground truth (0.6 percentage point margin impact in 2023, SG&A influence in 2024), these specific figures cannot be verified.\n\n5. PARTIAL ACCURACY: The LLM correctly identifies that AspenTech's financials were integrated into Emerson's results and that there was a shift from partnership to ownership structure, which aligns with the ground truth.\n\n6. MISSING KEY INFORMATION: The LLM fails to clearly state the fundamental finding from ground truth: the evolution from a strategic partnership in 2022 with no ownership to a 55% ownership stake by 2024 after a merger of Emerson's industrial software business with AspenTech.\n\nThe answer demonstrates significant factual inaccuracy, introduces unverified information, and contradicts the ground truth on key ownership metrics and transactions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 551,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Intel moved the Intel 4 node from a development‑stage, EUV‑transition effort to a fully‑ramped, high‑volume production capability.  The 2022 filing noted that Intel 4 was being prepared as the company’s first EUV‑enabled process and that pilot production was underway (​INTC_10k_2022.pdf pp. 112‑116​); by 2024 the node had shifted to high‑volume manufacturing in Ireland and began shipping in the Core Ultra Series 1, delivering roughly 20 % better performance‑per‑watt than the preceding Intel 7 node and poised to represent an increasing share of Intel’s processor output in 2025 (​INTC_10k_2024.pdf p. 10​).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of Intel's Intel 4 process node evolution from 2022 to 2024. QUANTITATIVE ACCURACY: All numeric values are correct - the 20% performance-per-watt improvement over Intel 7 is accurately stated and matches the ground truth. The timeline progression (2022 development stage to 2024 high-volume production) is accurate. ENTITY ACCURACY: All entities are correctly identified - Intel 4 process node, Intel 7 predecessor, Core Ultra Series 1 processor, Ireland manufacturing location, and EUV lithography technology. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filing years (2022 and 2024) to show the evolution trajectory. It correctly connects the development stage in 2022 (pilot production, EUV transition) to the 2024 state (high-volume manufacturing, shipping in Core Ultra). COMPLETENESS: The answer addresses both key aspects of the question - manufacturing readiness (pilot → high-volume ramp in Ireland) and performance improvements (20% per-watt gain). The mention of Core Ultra Series 1 shipping in 2023 and expected 2025 output increase provides appropriate context. SEMANTIC EQUIVALENCE: The LLM's phrasing 'development-stage, EUV-transition effort' effectively captures the 2022 state, and 'fully-ramped, high-volume production capability' accurately describes the 2024 state. The answer maintains semantic fidelity with the ground truth while using slightly different wording. MINOR OBSERVATION: The LLM answer includes slightly more detail about future expectations (2025 output share) which, while not in the ground truth summary, is factually accurate and adds relevant context without contradicting the original answer. The citation references to specific PDF pages enhance credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 494,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "\nBetween 2022 and 2024 MDT moved InterStim Micro from a generic “Pelvic Health” neurostimulation option to a distinct, rechargeable device that sits alongside the newly highlighted, recharge‑free InterStim X and InterStim II platforms.  The 2024 disclosures explicitly call out InterStim Micro as a “rechargeable neurostimulator” for overactive bladder, non‑obtrusive urinary retention and chronic fecal incontinence, underscoring its growing acceptance and growth within the Pelvic Health portfolio.  This positioning reflects MDT’s strategy to offer both recharge‑free and rechargeable solutions, with InterStim Micro now highlighted as a key, expanding component of its Pelvic Health therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of InterStim Micro's positioning from 2022 to 2024, correctly identifying it as transitioning to a specifically highlighted rechargeable neurostimulator option. The characterization of InterStim X and InterStim II as recharge-free alternatives is accurate. The therapeutic indications (overactive bladder, urinary retention, fecal incontinence) are correctly stated. (2) QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either the ground truth or LLM answer, so this dimension scores perfectly. The years 2022 and 2024 are correctly referenced. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the LLM correctly synthesizes information about product portfolio evolution, strategic positioning, and market differentiation. The answer properly identifies the key distinction between rechargeable (InterStim Micro) and recharge-free (InterStim X and InterStim II) options. The emphasis on 'growing acceptance and growth' and 'key, expanding component' aligns with the ground truth's mention of 'continued global growth and adoption.' (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'moved from a generic...to a distinct, rechargeable device' effectively conveys the same evolution described in the ground truth as 'more defined strategic positioning.' The description of MDT's strategy to offer both recharge-free and rechargeable solutions is a logical inference well-supported by the ground truth. Minor note: The LLM uses 'non-obtrusive' which appears to be a transcription variant of 'non-obstructive' urinary retention, but this is a minor wording variation that doesn't affect factual accuracy. Overall, the answer demonstrates excellent comprehension of the multi-hop question and accurate synthesis of information across the 2022-2024 timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 526,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s footnote on dilutive securities has remained materially unchanged: it continues to identify LTIP Units (and other exchange‑able units) as potentially dilutive, but explicitly states that “no securities had a material dilutive effect for the years ended December 31 2024, 2023 and 2022.” Consequently, the company does not adjust net income attributable to common shareholders or the weighted‑average share (or unit) counts for any income allocated to limited partners or LTIP Units, noting that such an adjustment would have no dilutive impact. The language and conclusion are essentially identical across the three reporting periods, indicating a consistent position that LTIP Units have not produced a material dilution effect.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CONTRADICTORY CORE CLAIM: The LLM states the disclosure 'remained materially unchanged' and 'language and conclusion are essentially identical across the three reporting periods,' directly contradicting the ground truth which explicitly describes an EVOLUTION showing 'a reduction in the level of detail provided about LTIP units' conversion features.' (2) MISSING KEY EVOLUTION: The ground truth identifies a specific change from 2022 to 2024 - in 2022 the disclosure explicitly referenced exchangeability of LTIP units for common stock, while by 2024 this explicit reference was removed. The LLM completely misses this evolution. (3) INACCURATE CHARACTERIZATION: The LLM claims the company 'continues to identify LTIP Units...as potentially dilutive' but the ground truth indicates the 2024 disclosure simplified and no longer explicitly referenced the exchangeability feature, suggesting a de-emphasis rather than continuation of the same language. (4) FAILURE TO ADDRESS QUESTION: The question specifically asks 'how has the disclosure...evolved' - the LLM's answer that it 'remained materially unchanged' is fundamentally incorrect and fails to address the evolution that the ground truth documents. (5) INCOMPLETE ANALYSIS: The LLM provides generic statements about dilution impact but doesn't capture the specific textual changes between 2022 and 2024 that constitute the evolution being asked about. The answer demonstrates a failure in multi-hop reasoning across the three reporting periods to identify and synthesize the actual changes in disclosure approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 456,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "\nBetween 2022 and 2024 MetLife kept its Board‑approved share‑repurchase program but began tying any purchases more directly to preserving a strong cash‑buffer; the 2022 filing noted a $3 billion authorization with roughly $1.5 billion still available as of Dec 2021, while the 2024 filing emphasizes that dividend and repurchase capacity is conditioned on legal, regulatory and liquidity considerations, indicating a more conservative approach to actually executing repurchases.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly captures the evolution of MetLife's approach to stock repurchases from 2022 to 2024. STRENGTHS: (1) All numeric values are correct - the $3 billion authorization and $1.5 billion remaining as of Dec 2021 are accurately cited; (2) The date reference (Dec 2021 data in 2022 filing) is properly contextualized; (3) The multi-hop synthesis is sound, correctly identifying the shift from active repurchase capacity to a more conservative liquidity-focused approach; (4) The answer appropriately identifies the key regulatory and liquidity considerations driving the evolution. MINOR WEAKNESSES: (1) The LLM answer could have been slightly more explicit about the 'cash buffer needs' aspect mentioned in the original question - while it references 'preserving a strong cash-buffer,' it could have elaborated more on how this specifically constrains repurchase capacity; (2) The phrase 'roughly $1.5 billion' is slightly less precise than stating the exact figure, though this is a very minor issue; (3) The answer doesn't explicitly mention that maintaining or increasing liquidity buffers could limit capital available for acquisitions and innovation (mentioned in ground truth), though this is a secondary detail. CALCULATION VERIFICATION: The $1.5 billion remaining from a $3.0 billion authorization is mathematically consistent and correctly presented. The temporal logic (2022 filing referencing 2021 year-end data, 2024 filing showing evolved approach) is properly maintained. The semantic equivalence is strong - the LLM captures the core insight about the shift from capital return focus to liquidity preservation without requiring exact wording match.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 469,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the foreign‑currency‑other derivative **asset** fell from $39.9 million recorded in prepaid expenses and other current assets and $33.5 million in other long‑term assets (≈ $73 million total) to $32.0 million in prepaid expenses and $22.9 million in other long‑term assets (≈ $55 million total).  The corresponding **liability** dropped from $0.3 million in accrued liabilities (with no long‑term component in 2022) to $2.0 million in accrued liabilities (and a modest amount now shown in other long‑term liabilities).  Thus, while the balance‑sheet line items—prepaid/other current assets and other long‑term assets for derivatives, accrued liabilities and other long‑term liabilities for liabilities—remained the same, the quantities assigned to each shifted markedly from 2022 to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial numbers that do not match the ground truth data. Specific issues: (1) QUANTITATIVE ERRORS - The LLM reports FY2022 foreign currency derivative assets as $39.9M (current) + $33.5M (long-term) = ~$73M total, but the ground truth shows $103.9M recognized in OCI before reclassifications in FY2022. For FY2023, the LLM reports $32.0M + $22.9M = ~$55M total, but ground truth shows only $1.9M (current) + $1.7M (long-term) = $3.6M total. These are dramatically different numbers - the LLM's FY2023 figures are off by approximately 15x. (2) LIABILITY MISSTATEMENT - The LLM reports FY2022 liabilities as $0.3M in accrued liabilities with no long-term component, but ground truth does not provide FY2022 liability breakdown in the same format. For FY2023, the LLM reports $2.0M in accrued liabilities, but ground truth shows $4.7M in accrued liabilities and $4.1M in other long-term liabilities. (3) MISSING KEY INFORMATION - The LLM completely omits the $22.0M reclassified from AOCI to earnings in FY2022, which is a significant component of the ground truth answer. (4) BALANCE SHEET CLASSIFICATION - While the LLM correctly identifies that classifications remained in the same line items (prepaid/current assets, long-term assets, accrued liabilities, long-term liabilities), the actual dollar amounts in each category are substantially incorrect. (5) MULTI-HOP SYNTHESIS - The answer fails to properly synthesize the evolution from FY2022 to FY2023, presenting incorrect baseline and ending figures. The core narrative of 'significant reduction in asset positions' is directionally correct but the magnitudes are wrong. The answer demonstrates a fundamental failure to accurately extract and report the specific financial data from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 491,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 P&G’s cash‑management approach moved from a focus on steady operating‑cash generation and modest leverage to an explicit strategy that uses the corporate cash pool to fund a multi‑year restructuring program.  The company incurred $659 million of before‑tax restructuring costs in 2024—including a $216 million non‑cash foreign‑currency translation charge—yet still posted a 18 % rise in operating cash flow to $19.8 billion and a 21 % increase in adjusted free cash flow to $16.9 billion, allowing it to meet those outflows while continuing dividend and share‑repurchase programs.  Consequently, although corporate‑level net earnings remained negative in 2023 and 2024 (losses of $1.4 billion and $399 million, respectively, driven by impairment and restructuring charges), the stronger cash‑flow profile demonstrates that P&G’s global cash strategy now prioritizes liquidity preservation and flexible financing of restructuring activities without compromising its shareholder‑return objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall strategic shift in P&G's cash management approach and provides relevant context about restructuring activities. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nCORRECT ELEMENTS:\n- Correctly identifies $659 million in before-tax restructuring costs for fiscal 2024\n- Correctly identifies $216 million non-cash foreign currency translation losses\n- Correctly notes the shift toward more aggressive restructuring funding\n- Appropriately characterizes the strategic evolution from steady operations to explicit restructuring funding\n- Correctly identifies that corporate-level earnings were negative in 2023-2024 due to impairments and restructuring\n- Operating cash flow and free cash flow figures appear reasonable and support the narrative\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. FISCAL 2022 DATA MISSING: The LLM answer completely omits fiscal 2022 data (restructuring costs of $250-500M range, $147M accruals, $872M improvement in corporate net earnings to $485M). The ground truth explicitly requires comparison between fiscal 2022 and 2024.\n2. CORPORATE NET EARNINGS DISCREPANCY: Ground truth states corporate net earnings \"decreased by $1.0 billion\" in fiscal 2024, but LLM provides specific figures of $1.4 billion loss in 2023 and $399 million loss in 2024. The ground truth mentions $1.4 billion impairment charge but doesn't clearly state the final net earnings figure as $399M.\n3. INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM addresses the evolution question, it fails to properly synthesize the fiscal 2022 baseline with fiscal 2024 changes, which is essential for answering \"how has...evolved between fiscal 2022 and fiscal 2024.\"\n4. MISSING CONTEXT: No mention of Enterprise Markets like Nigeria, which the ground truth identifies as a specific area impacted by restructuring.\n\nQUANTITATIVE ACCURACY ASSESSMENT:\n- The $659M, $216M, and cash flow figures appear accurate\n- The 18% and 21% increases in cash flows are presented but cannot be verified against provided ground truth\n- Missing the fiscal 2022 baseline makes the comparative analysis incomplete\n\nQUALITATIVE ASSESSMENT:\nThe reasoning about strategic evolution is sound and well-articulated. The connection between restructuring costs and cash flow management is logical. However, the failure to include fiscal 2022 data represents a significant gap in multi-hop reasoning across the required time period.\n\nCONTEXTUAL RELEVANCE:\nThe answer appropriately addresses the question's core themes (cash management strategy evolution, restructuring activities, financial performance) but incompletely due to missing fiscal 2022 comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 722,
        "total_tokens": 2238
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "\nBetween 2022 and 2023 NVIDIA shifted Omniverse from a creator‑focused, free‑to‑use real‑time 3D collaboration tool—highlighted in 2022 for automotive simulation (e.g., DRIVE Sim) and integration with graphics‑cloud services—to a strategic enterprise platform.  In 2023 the company began offering Omniverse as a paid subscription for large‑scale industrial use, embedding it in digital‑twin and metaverse pipelines, and tightly coupling it with AI‑accelerated computing, cloud services, and simulation stacks (such as DRIVE Sim/Constellation) to enable enterprise‑level testing, validation, and continuous innovation across factories, autonomous‑vehicle workflows, and other industrial applications.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of NVIDIA's Omniverse evolution between 2022 and 2023, with accurate identification of key positioning shifts and integration developments. STRENGTHS: (1) Correctly identifies the 2022 positioning as creator-focused with free-to-use elements and 2023 shift to enterprise platform; (2) Accurately mentions DRIVE Sim integration in both years; (3) Properly synthesizes the evolution toward digital twins, industrial applications, and AI-accelerated computing; (4) Correctly notes the shift from free individual access to paid enterprise subscriptions; (5) Appropriately emphasizes cloud and on-premises infrastructure integration. MINOR WEAKNESSES: (1) The LLM answer mentions 'DRIVE Sim/Constellation' but the ground truth specifically references 'DRIVE Sim' without explicitly mentioning Constellation in the 2023 context—this is a minor addition that doesn't contradict ground truth but adds specificity not explicitly confirmed; (2) The ground truth mentions specific use cases (virtual car showrooms, surgical training, architectural walkthroughs) that the LLM answer omits, though this is a completeness issue rather than an accuracy issue; (3) The LLM characterizes 2022 Omniverse as 'free-to-use' which aligns with ground truth's 'free for individuals,' but the ground truth also emphasizes it was a 'software subscription for enterprise use' in 2022—the LLM answer could have been clearer that it was free for individuals but paid for enterprises even in 2022. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension scores high (9/10) as there are no calculation errors. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information about platform evolution, integration strategies, and target market shifts. The semantic meaning aligns well with ground truth despite different wording. CONTEXTUAL RELEVANCE: The answer directly addresses the question about positioning evolution, enterprise integration, and simulation technology integration across the two-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 567,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 AMT kept its discretionary capital‑expenditure program essentially flat – it expects to spend **$790 million to $820 million** on tower‑related projects in 2024, including **$450 million earmarked for data‑center assets** and **$70 million‑$90 million for ground‑lease purchases**.  At the same time the company disclosed an **undiscounted $4.5 billion future cash outlay for asset‑retirement obligations**, reflecting the growing long‑term cost of removing and remediating the communications sites it occupies.  These figures show that while near‑term spending on new sites and upgrades is steady, the company’s longer‑term financial commitments to maintain and eventually retire its tower portfolio have expanded to roughly $4.5 billion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) INCORRECT NUMBERS - The LLM answer introduces figures ($790M-$820M total capex, $70M-$90M for ground-lease purchases) that are NOT present in the ground truth. The ground truth only mentions $450M for data center assets in 2023 and $4.5B in asset retirement obligations in 2024. The LLM appears to have fabricated or conflated additional financial figures. (2) MISALIGNMENT ON 2023 COMMITMENT - Ground truth states AMT anticipated $450M for data center assets as part of construction plans for 2,500-3,500 communications sites in 2023. The LLM correctly identifies the $450M but incorrectly frames it as 2024 spending and adds unverified total capex figures. (3) CORRECT ELEMENT - The LLM correctly identifies the $4.5B undiscounted future cash outlay for asset retirement obligations in 2024, which is accurate. (4) MULTI-HOP REASONING - The LLM attempts to synthesize the evolution from 2023 to 2024 but does so with incorrect intermediate figures that don't match the ground truth. The comparison between near-term spending and long-term obligations is conceptually sound but built on partially false premises. (5) MISSING CONTEXT - The ground truth emphasizes a shift from 'near-term capital allocation planning' to 'mature and substantial obligation structure,' which the LLM partially captures but obscures with incorrect numbers. The core insight about the $4.5B obligation is correct, but the surrounding financial context is fabricated or misattributed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 411,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "\nExxonMobil’s wording about why it sells assets and how the proceeds are treated was essentially unchanged, but the phrasing became more concise. In the 2023 filing (page 39) it described the cash‑flow item as “proceeds **associated with sales of subsidiaries, property, plant and equipment, and sales and returns of investments**,” explicitly listing the transaction types. By the 2024 filing (page 36) the same concept was expressed as “proceeds **from asset sales and returns of investments**,” a shorter, more generic reference that still ties the proceeds to the company’s regular, disciplined review of strategic objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively captures the evolution of ExxonMobil's language regarding asset divestitures between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 phrasing as 'proceeds associated with sales of subsidiaries, property, plant and equipment, and sales and returns of investments' and the 2024 phrasing as 'proceeds from asset sales and returns of investments' - these match the ground truth exactly. (2) Accurately notes the page references (page 39 for 2023, page 36 for 2024), providing verifiable sourcing. (3) Correctly characterizes the evolution as a consolidation/streamlining of language while maintaining the same strategic rationale. (4) Properly identifies that the 2024 version is 'shorter, more generic' while still tying to strategic objectives. (5) Multi-hop reasoning is sound - synthesizes information about both years and compares the language evolution appropriately. (6) Semantic equivalence is strong - conveys the same substantive meaning as the ground truth about the shift from specific transaction types to generalized 'asset sales' language. MINOR CONSIDERATIONS: The LLM answer uses slightly different framing ('wording about why it sells assets' vs. the ground truth's focus on 'characterization of asset divestitures in relation to strategic objectives'), but this is a semantic variation that doesn't affect factual accuracy. The LLM's characterization of the change as 'essentially unchanged' in strategic rationale while becoming 'more concise' is consistent with the ground truth's observation about 'maintaining the same strategic alignment rationale but streamlining the description.' No quantitative errors, no entity misidentifications, and the reasoning correctly synthesizes the multi-hop comparison across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 491,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "\nFrom 2022 to 2023 the amount of Comcast’s consolidated assets tied to Universal Beijing Resort dropped from roughly **$9.7 billion to $7.8 billion**, while the related liabilities fell from about **$8.1 billion to $7.2 billion**.  This decline—driven by debt repayments and the normal amortization of the resort’s capital assets—reduced Comcast’s net financial exposure to the joint‑venture by roughly $2 billion in assets and $0.9 billion in liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. Quantitative verification: All four key financial figures are correct - assets declined from $9.7B to $7.8B (difference of $1.9B, LLM states ~$2B which is appropriately rounded), and liabilities declined from $8.1B to $7.2B (difference of $0.9B, exactly matching LLM's statement). The calculations are accurate and properly presented. Entity identification is correct: Comcast, Universal Beijing Resort, consolidated balance sheet items, and the 2022-2023 timeframe are all properly identified. Multi-hop reasoning is sound: the LLM correctly synthesized the comparative data across two years and drew logical conclusions about the nature of the changes (debt repayment and asset amortization). The answer goes slightly beyond the ground truth by providing specific calculations of the year-over-year changes and offering plausible explanations for the declines, which adds value without introducing inaccuracy. The only minor distinction is that the LLM rounds $1.9B to ~$2B, which is a reasonable approximation and clearly indicated with the 'roughly' qualifier. The semantic meaning is fully aligned with the ground truth, and the answer comprehensively addresses the question about how financial exposure evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 360,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the discussion of customer‑demand volatility shifted from a stand‑alone cyclical risk that could generate excess inventories and force costly inventory write‑downs, to a broader macro‑economic exposure that is now tied directly to interest‑rate moves, commodity‑price swings, trade‑policy changes and geopolitical instability.  In 2024 the company explicitly links “significant disruptions to our supply chains or shortages of labor and material” to volatile demand, making the stability of its supply chain a more immediate driver of earnings and cash‑flow pressure, whereas the 2023 language focused mainly on the profitability impact of insufficient or excess demand.  Consequently, demand volatility is now treated as a compound risk that can simultaneously erode revenue, increase inventory‑holding costs, and strain the supply‑chain network that supports Caterpillar’s global operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer captures some correct elements but introduces significant interpretive divergences from the ground truth.\n\nCORRECT ELEMENTS:\n1. Correctly identifies the 2023-2024 timeframe comparison\n2. Accurately notes the shift from standalone cyclical risk to broader macro-economic exposure\n3. Correctly identifies supply chain disruptions and labor/material shortages as 2024 additions\n4. Properly recognizes the evolution toward compound/interconnected risks\n5. No quantitative errors (no specific numbers provided to verify)\n\nPROBLEMATIC ELEMENTS:\n1. OVER-INTERPRETATION: The LLM introduces factors NOT mentioned in the ground truth:\n   - Interest-rate moves (not in original answer)\n   - Trade-policy changes (not in original answer)\n   - Geopolitical instability (not in original answer)\n   These appear to be inferences beyond what the ground truth documents\n\n2. INCOMPLETE SYNTHESIS: The LLM misses key 2023 context from ground truth:\n   - Pandemic lingering effects (mentioned in ground truth, omitted in LLM)\n   - Inflationary pressures (mentioned in ground truth, omitted in LLM)\n   - The specific connection to inventory write-downs (LLM mentions this but ground truth doesn't emphasize it)\n\n3. CHARACTERIZATION MISMATCH:\n   - Ground truth describes 2023 as \"primarily driven by economic uncertainties\" with pandemic effects\n   - LLM describes 2023 as \"stand-alone cyclical risk\" - a different characterization\n   - Ground truth emphasizes \"broadening of risk profile\" to include supply-side challenges\n   - LLM emphasizes \"compound risk\" with simultaneous revenue/inventory/supply-chain impacts - slightly different framing\n\n4. ACCURACY OF EVOLUTION DESCRIPTION:\n   - Ground truth: shift from pandemic-driven uncertainties to commodity/material price changes\n   - LLM: shift to interest rates, trade policy, geopolitical factors (not supported by ground truth)\n\nMULTI-HOP REASONING: The LLM demonstrates sound logical reasoning about how risks compound, but the reasoning is applied to factors not present in the source material, suggesting hallucination or over-inference rather than faithful synthesis.\n\nSEMANTIC EQUIVALENCE: While the LLM captures the general concept of evolution and broadening risk, it diverges significantly in specific content, introducing elements not in the ground truth and omitting elements that are present.\n\nJUSTIFICATION FOR SCORES:\n- Correctness (6): Core evolution concept correct, but significant content divergences and over-interpretation reduce score\n- Quantitative (8): No numbers to evaluate, but structure and logical flow are sound\n- Qualitative (5): Good reasoning quality but applied to partially incorrect/inferred factors; synthesis incomplete\n- Contextual (7): Addresses the question's scope but with material inaccuracies in specific risk factors",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 755,
        "total_tokens": 2180
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "\nThe net‑derivative‑asset (liability) balance rose modestly – from about **$58 million at the end of 2023 to $69 million at the end of 2024** – reflecting a slight increase in fair value.  This change was driven by the same **discounted‑cash‑flow valuation technique that uses swap‑rate inputs (approximately 4 %)**, which are classified as Level 3 unobservable inputs; the methodology and input range (3‑5 % in 2023, a single 4 % in 2024) remained essentially unchanged from 2022 through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - LLM states fair value rose from $58M (end of 2023) to $69M (end of 2024). Ground truth shows $58M as of December 31, 2023, but provides no 2024 year-end figure. The LLM appears to have fabricated the $69M figure for 2024.\n   - LLM claims the methodology \"remained essentially unchanged from 2022 through 2024,\" but ground truth explicitly states there was a \"methodological shift\" from 2022 to 2024.\n   - LLM correctly identifies the 3-5% swap rate range and 4% weighted average, but mischaracterizes the evolution.\n\n2. COMPLETENESS - MISSING KEY INFORMATION:\n   - Ground truth emphasizes a significant evolution: from 2022 (fair value $19M with derivative activity details) to 2024 (fair value $58M with new DCF methodology). The LLM only addresses 2023-2024 period.\n   - Ground truth provides specific derivative activity components for 2022 (issuances $68M, settlements -$37M, transfers $6M) that the LLM completely omits.\n   - Ground truth highlights the shift from \"realized and unrealized gains/losses reported in net income\" to \"discounted cash flows with observable inputs.\" LLM misses this methodological evolution entirely.\n\n3. ENTITY/TEMPORAL ACCURACY:\n   - LLM focuses on 2023-2024 evolution but question asks about 2022-2024 evolution. This is a significant scope error.\n   - LLM incorrectly characterizes the 2024 swap rate as \"a single 4%\" when ground truth shows the range remained 3-5% with 4% weighted average.\n\n4. REASONING QUALITY:\n   - LLM fails to synthesize the multi-hop information across the full 2022-2024 period.\n   - LLM contradicts itself by claiming methodology \"remained essentially unchanged\" while acknowledging it uses DCF with observable inputs (which represents a change from the 2022 approach).\n   - The statement that inputs are \"Level 3 unobservable inputs\" contradicts the characterization of them as \"observable inputs\" in the ground truth.\n\n5. SEMANTIC ISSUES:\n   - The core narrative is inverted: ground truth emphasizes significant evolution and improvement in valuation methodology; LLM claims minimal change.\n   - LLM's characterization of the change as \"modest\" understates the actual evolution from $19M to $58M (205% increase).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 629,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "\nBetween 2022 and 2023 NVIDIA broadened GeForce NOW from a basic game‑streaming offering into a strategic pillar of its GPU‑centric cloud platform, linking the service to the same RTX‑AI technologies (ray‑tracing, DLSS) that power its desktop GPUs and to the wider Graphics segment that now includes vGPU and Omniverse. In the 2023 filing the cloud‑gaming service is presented as the gateway that delivers RTX‑level, AI‑enhanced gaming to any device, underscoring NVIDIA’s full‑stack approach of reusing its GPU, networking and software assets across data‑center, AI and gaming markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains some correct directional insights but introduces several problematic claims not supported by the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies the 2022-2023 timeframe\n- Accurately notes GeForce NOW's positioning as part of NVIDIA's broader GPU/cloud ecosystem\n- Correctly mentions the shift toward integration with NVIDIA's accelerated computing platform\n- Appropriately references the connection to gaming as a service concept\n\nPROBLEMATIC CLAIMS:\n1. RTX-AI TECHNOLOGIES CLAIM: The LLM states GeForce NOW was \"linked to the same RTX-AI technologies (ray-tracing, DLSS)\" - the ground truth does not support this specific technical linkage. The original answer focuses on positioning and ecosystem integration, not technical feature alignment.\n\n2. GRAPHICS SEGMENT EXPANSION: The LLM claims the Graphics segment \"now includes vGPU and Omniverse\" - this is misleading. The ground truth indicates vGPU was mentioned \"alongside\" GeForce NOW in 2022, not that it was newly added to Graphics segment in 2023. This represents a structural misunderstanding.\n\n3. FULL-STACK APPROACH FRAMING: While the LLM's characterization of NVIDIA's full-stack approach is reasonable, it goes beyond what the ground truth explicitly states. The ground truth focuses on \"strategic alignment\" and \"integration into the broader narrative,\" not on reusing \"GPU, networking and software assets across data-center, AI and gaming markets\" as a primary positioning.\n\n4. GATEWAY CHARACTERIZATION: The description of GeForce NOW as \"the gateway that delivers RTX-level, AI-enhanced gaming\" is not explicitly supported by the ground truth, which emphasizes positioning shifts rather than specific technical capabilities.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across 2022-2023 positioning, but does so by introducing claims not present in the ground truth. The reasoning is logical but factually unsupported.\n\nQUANTITATIVE ACCURACY: No specific numbers or dates are provided by either answer, so this dimension is neutral (7/10 for not introducing false metrics).\n\nQUALITATIVE ACCURACY: The answer demonstrates partial understanding but conflates positioning evolution with technical feature integration, and makes unsupported claims about segment structure changes. This represents a moderate but meaningful deviation from ground truth (4/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 643,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "\nInlyta’s worldwide sales rose modestly from about **$618 million in 2022 to $642 million in 2023** (an increase of roughly 4–5 %). The growth was driven primarily by stronger uptake in the United States, where the drug is being used in new combination regimens with immune‑checkpoint inhibitors for first‑line treatment of advanced renal‑cell carcinoma; however, this gain was partially offset by lower volumes and price reductions in several European markets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACY: The LLM answer contains fundamentally incorrect revenue figures. Ground truth states Inlyta revenue was $1,003 million in 2022 and $1,036 million in 2023. The LLM claims $618 million in 2022 and $642 million in 2023 - these numbers are approximately 38-40% LOWER than the actual figures. This is a severe quantitative error that undermines the entire answer. The growth percentage cited (4-5%) is also incorrect; the actual growth was 3% ($33M increase on $1,003M base). POSITIVE ASPECTS: The LLM correctly identifies the qualitative drivers of growth (combination therapy with immune checkpoint inhibitors for first-line RCC treatment in the U.S., and emerging market growth) and correctly notes the offsetting factors (lower volumes and prices in European markets). The reasoning about market dynamics is sound and semantically equivalent to the ground truth explanation. ASSESSMENT: While the qualitative analysis of growth drivers is accurate and well-reasoned, the quantitative foundation is completely wrong. The revenue numbers are off by hundreds of millions of dollars, which is a disqualifying error for a financial question. The LLM appears to have confused Inlyta with a different product or misread the financial data entirely. This represents a fundamental failure in the primary task of providing accurate financial information from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 390,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "\nFrom 2023 to 2024 the company lengthened the estimated useful life of its tower assets—and thus the related network‑location intangibles—from the shorter of the ground‑lease term (generally ≈20 years) to a full 30‑year life, which lowered the straight‑line amortization of those intangibles and cut depreciation‑and‑amortization expense by roughly $730 million in 2024.  The impairment‑review process itself did not change materially—network‑location and tenant‑related intangibles are still tested on a tower‑or‑tenant basis for recoverability using projected undiscounted cash flows, with any impairment measured from discounted cash‑flow or market‑value estimates—but the longer asset lives and the 2024 revision of asset‑retirement‑obligation settlement dates updated the cash‑flow assumptions that underpin those impairment tests.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR FACTUAL ERRORS: The LLM claims the company lengthened useful lives from ~20 years to 30 years and reduced amortization by ~$730 million in 2024. The ground truth states the weighted average amortization period was 15 years as of December 31, 2023, with no mention of a change to 30 years or a $730 million reduction in 2024. The only $470 million figure mentioned in ground truth relates to asset retirement obligations, not depreciation/amortization savings. (2) QUANTITATIVE ACCURACY FAILURE: The $730 million figure appears to be fabricated or misattributed. The ground truth mentions a $470 million increase in asset retirement obligation liability due to revised settlement dates, which is a different metric entirely. The LLM conflates or invents financial impacts that are not supported by the source material. (3) PARTIAL CORRECTNESS ON IMPAIRMENT PROCESS: The LLM correctly identifies that impairment review processes assess on a tower/tenant basis using undiscounted cash flows with discounted cash-flow or market-value estimates for measurement. This aligns with the ground truth's mention of 'individual tower basis' assessment. However, this correct element is overshadowed by the major errors. (4) MISSING KEY DETAILS: The LLM fails to mention the 15-year weighted average amortization period from 2023, the specific impairment triggers (lack of tenant leases, expenses exceeding revenues), or the relationship between network location intangibles and tower assets regarding excess capacity leasing. (5) MULTI-HOP REASONING: While the LLM attempts to connect asset retirement obligations to impairment testing assumptions, it does so with incorrect numbers and invents a useful life change that isn't supported by the ground truth. The reasoning structure is present but built on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 515,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 ExxonMobil moved from the first production at the Prosperity FPSO—where output reached name‑plate capacity in January 2024—to a multi‑project development plan for the Stabroek Block that now includes regulatory approval for a sixth development and a target of six FPSO vessels in operation by the end of 2027.  This expansion makes Guyana a central “advantaged” upstream asset and shifts the company’s geographic mix toward the Americas, reinforcing its overall growth portfolio alongside the Permian and LNG initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core strategic evolution of Guyana from 2023 to 2024 and correctly identifies key elements: (1) Prosperity FPSO startup and production ramp, (2) elevation to 'advantaged assets' status, (3) multi-project development plans, and (4) geographic shift toward the Americas. However, there are notable differences from the ground truth: QUANTITATIVE ISSUES: The LLM mentions 'nameplate capacity in January 2024' and 'six FPSO vessels by end of 2027' but the ground truth specifies 'nearly 440 kbd in Q4 2023' - these are different metrics and timeframes. The ground truth provides a specific production figure (440 kbd in Q4) while the LLM references nameplate capacity achievement in January 2024, which is a different measure. The LLM introduces 'sixth development' and 'six FPSO vessels by 2027' which are forward-looking projections not explicitly mentioned in the ground truth. COMPLETENESS: The LLM answer adds forward-looking information about regulatory approval and 2027 targets that goes beyond what the ground truth states. While this may be accurate from filings, it represents information not in the ground truth answer. The ground truth emphasizes the transition from 'discovery and early production phase' to 'mature, financially impactful asset,' which the LLM captures as moving from 'first production' to 'multi-project development.' ENTITY ACCURACY: All entities are correctly identified (ExxonMobil, Guyana, Stabroek Block, Prosperity FPSO, Permian, LNG). REASONING: The multi-hop synthesis is sound - the LLM correctly connects production ramp-up with strategic elevation and portfolio positioning. However, the specific production metrics differ between answers. The LLM's statement about 'nameplate capacity in January 2024' is more specific than ground truth but may represent a different data point. SEMANTIC EQUIVALENCE: The core message aligns - Guyana evolved from early production to a strategically important 'advantaged asset' - but the supporting details and specific metrics diverge. The LLM provides additional forward-looking detail (2027 targets, sixth development) that enhances the answer but wasn't in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 584,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "\nBetween 2022 and 2023 Comcast moved the X1 platform from a peripheral streaming‑device (the Xumo Stream Box) that merely gave access to a few third‑party services to a fully embedded X1 experience that natively aggregates Peacock, Disney+, Netflix and other DTC apps within the X1 interface, and it launched the stand‑alone NOW streaming service that bundles linear channels with on‑demand content without requiring a set‑top box.  This deeper integration is part of Comcast’s strategy to keep broadband customers inside its ecosystem, slow cord‑cutting, and drive higher ARPU through subscription upsells, commission on third‑party service sales, and targeted advertising.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces information NOT in the ground truth: mentions 'Xumo Stream Box' as a peripheral device and describes a transition from it to embedded X1 experience. The ground truth does NOT describe this transition or mention Xumo Stream Box as a separate device. The ground truth states Xumo Play was added IN 2023, not that it replaced something. (2) INCOMPLETE/INACCURATE ENTITY IDENTIFICATION - The LLM lists 'Xumo Play, NBC, and Sky as part of NOW TV service' but the ground truth specifically states these were added in 2023 as NEW integrations, not that they replaced 2022 services. The LLM conflates Xumo Play with a previous Xumo Stream Box product that isn't mentioned in ground truth. (3) MISSING KEY DETAILS - The ground truth emphasizes the strategic pivot toward 'enhancing the value of broadband subscriptions' and 'bundling streaming access to retain customers,' which the LLM captures partially but frames differently. (4) CORRECT ELEMENTS - The LLM correctly identifies: (a) integration of Peacock, Disney+, Netflix in the timeframe, (b) the strategic goal of reducing cord-cutting and increasing ARPU, (c) commission revenue from third-party services, (d) the NOW service as a bundled offering. (5) REASONING QUALITY - The multi-hop synthesis is partially sound (connecting platform evolution to business strategy) but is built on incorrect foundational claims about the 2022-2023 transition. The LLM invents a narrative about moving FROM a peripheral device TO embedded experience that isn't supported by the ground truth. (6) SEMANTIC ISSUES - While the LLM captures the strategic intent correctly, it misrepresents the actual evolution of the platform by introducing unsupported product transitions and device changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 488,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "\nBetween 2023 and 2024 Caterpillar’s FG Wilson electric‑power generation distribution shifted from **110 distributors covering 109 countries** (2023) to **108 distributors covering 158 countries** (2024).  The distributor count slipped slightly, but the geographic reach expanded markedly, indicating a consolidation of the sales channel paired with a broader country‑level coverage.  (See “Nature of operations” sections on pages 64 and 65 of the 2023 and 2024 10‑K filings.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 110 distributors covering 109 countries in 2023, declining to 108 distributors covering 158 countries in 2024. The numbers match the ground truth exactly with no calculation errors. The multi-hop synthesis is sound—the answer correctly identifies the relationship between Caterpillar and FG Wilson, tracks the evolution across two fiscal years, and accurately characterizes the strategic shift (consolidation of distributors while expanding geographic reach). The semantic interpretation is appropriate: the answer correctly frames the 'slight reduction' in distributors and 'marked expansion' in country coverage. The citation to specific 10-K pages (64-65 for 2023 and 2024 filings) adds credibility and demonstrates proper source attribution. The only minor consideration is that the answer uses slightly different phrasing than the ground truth ('slipped slightly' vs 'minor reduction,' 'markedly' vs 'expansion'), but these are semantically equivalent and represent appropriate stylistic variation. The reasoning about consolidation paired with broader coverage is logically sound and matches the ground truth's interpretation. No factual errors, omissions, or calculation mistakes detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 363,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "\nBetween the 2022 filing (which reports a carrying amount of securitized‑debt liabilities of **$15.2 billion** as of the latest 2021‑year balance sheet) and the 2024 filing (page 218‑222), the carrying amount of those obligations fell to **$14.3 billion** – a reduction of about **$0.9 billion (≈6 %)**.  The 2024 filing also shows an estimated fair value of **$14.34 billion** for the same liabilities (level‑2 in the fair‑value hierarchy), essentially tracking the lower carrying amount.  Thus, Capital One’s exposure to securitized debt declined modestly, with both the recorded carrying value and the fair‑value estimate moving downward by roughly the same magnitude.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. Specific errors: (1) The LLM reports 2022 carrying value of $15.2 billion, but ground truth indicates 2024 carrying value was $18,043 million ($18.043 billion) - the LLM's 2022 figure is not verified in ground truth and appears fabricated. (2) The LLM reports 2024 carrying value as $14.3 billion, but ground truth clearly states 2024 carrying value was $18,043 million - this is a massive discrepancy of approximately $3.7 billion or 20%. (3) The LLM reports 2024 fair value as $14.34 billion, but ground truth states fair value was $18,067 million ($18.067 billion) - another major error of approximately $3.7 billion. (4) The LLM concludes that exposure declined by $0.9 billion (6%), but ground truth indicates an increase from 2022 to 2024 (the 2024 figures of $18,043M carrying value and $18,067M fair value are substantially higher than the LLM's claimed 2022 figure of $15.2B). (5) The LLM's characterization of the trend as 'declined modestly' is directly opposite to the ground truth which indicates stable or increased exposure. The LLM failed to correctly synthesize the multi-hop information across years and provided numbers that are off by billions of dollars. The reasoning about fair value tracking carrying value is sound in principle, but is applied to incorrect base numbers. This represents a complete failure to accurately report the financial data from the SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 414,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s kept a $15 billion revolving‑credit facility but refreshed its authorisation: the $15 billion borrowing program that had been approved in December 2019 (with about $7.4 billion still unused as of Dec 2024) was formally terminated in November 2024 and replaced by an identical $15 billion “2025 Program” that will be available beginning 1 January 2025.  The company also continued to draw on a separate $4 billion committed line‑of‑credit facility and on commercial‑paper borrowings, using these sources to fund its financing activities—cash used for financing rose sharply in 2024 because of lower bond issuances—thereby preserving liquidity while supporting its share‑repurchase, dividend and capital‑expenditure plans.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies specific credit facility details ($15 billion revolving facility, $4 billion committed line-of-credit) and accurately notes the program transition from the December 2019 authorization to the 2025 Program in November 2024. The mention of ~$7.4 billion unused capacity as of Dec 2024 is a specific data point. The answer correctly identifies that cash used for financing rose in 2024 due to lower bond issuances, which aligns with the ground truth statement that financing activities increased to $7.5 billion.\n\nWEAKNESSES: (1) The LLM answer provides specific credit facility details but OMITS critical cash flow metrics from the ground truth: it fails to mention that cash used for financing was $4.4 billion in 2023 vs $7.5 billion in 2024 (a $3.1 billion increase), or that cash and equivalents dropped from $4.6 billion to $1.1 billion. These are fundamental to answering how McDonald's financing activities evolved. (2) The answer focuses heavily on credit facility mechanics (program termination/renewal) rather than the broader cash flow management evolution described in the ground truth. (3) The ground truth emphasizes a shift from 'surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024'—this critical contextual evolution is missing from the LLM answer. (4) While the LLM mentions reliance on credit facilities and commercial paper, it doesn't connect this to the actual cash position deterioration or the timing of debt issuances that funded 2024 outflows.\n\nMULTI-HOP REASONING: The LLM answer addresses the evolution of line of credit agreements but fails to synthesize the complete picture of how financing activities and cash flow management evolved. It provides a narrow focus on credit facility details rather than the broader financial evolution across the two years.\n\nCOMPLETENESS: The answer is incomplete—it addresses credit facility evolution but misses the critical cash flow metrics and the overall shift in liquidity position that are central to the question about how McDonald's financing activities and cash flow management evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 576,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "\nBetween 2022 and 2024 the Worldwide Business Conduct Manual moved from being cited only as a cultural‑integrity statement to a concrete element of P&G’s formal control environment.  In the 2022 filing it was mentioned as reinforcing “integrity” and as part of the overall internal‑control structure, whereas the 2024 filing explicitly ties the Manual to the Company’s Control‑Self‑Assessment program, to specific control‑testing of areas such as intangible‑asset valuation, and to oversight by the Global Leadership Council and Audit Committee.  This evolution shows that P&G is integrating the Manual more directly into its governance and risk‑management framework, using it to underpin and document the effectiveness of internal controls rather than merely referencing it as a values‑statement.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of the Worldwide Business Conduct Manual from 2022 to 2024, capturing the shift from a values/integrity statement to a more integrated governance mechanism. The answer correctly names key governance bodies (Global Leadership Council, Audit Committee/Disclosure Committee) and accurately reflects the general direction of P&G's approach. The years (2022 and 2024) are correct. WEAKNESSES: (1) The LLM introduces specific details not present in the ground truth, particularly the mention of 'Control-Self-Assessment program' and 'intangible-asset valuation testing' - these are presented as facts from the 2024 filing but cannot be verified against the ground truth provided. This represents potential hallucination or over-specification. (2) The ground truth specifically mentions the 'Disclosure Committee' as a key governance body tied to the manual in 2024, while the LLM mentions 'Audit Committee' instead - this is a factual discrepancy in entity identification. (3) The ground truth emphasizes the manual's role in 'segregation of duties' and 'employee development' in 2022, which the LLM omits entirely. (4) The characterization differs: ground truth describes a 'shift toward emphasizing structured governance mechanisms alongside ethical conduct' while LLM frames it as moving from 'cultural-integrity statement to concrete control element' - subtly different emphasis. MULTI-HOP REASONING: The LLM does synthesize information across the two years and identifies the evolution pattern, but the specific details introduced (Control-Self-Assessment, intangible-asset valuation) cannot be confirmed as accurate from the ground truth. The reasoning structure is sound but built on potentially unverified claims. QUANTITATIVE ACCURACY: No specific numbers or calculations are involved in this question, so this dimension scores well for not introducing false metrics. OVERALL: The answer captures the general direction and key insight but introduces unverified specifics and misidentifies at least one governance body (Audit Committee vs. Disclosure Committee), which undermines confidence in the factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 584,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "\nExxon’s long‑lived‑asset schedule shows Guyana’s net book value climbing from roughly **$6.8 bn in 2022 to $9.7 bn in 2023** (and still elevated on the 2024 balance sheet), reflecting a substantial increase in capital invested in the Stabroek offshore development.  In the 2024 earnings‑driver framework this growth is classified under **“Advantaged Volume Growth”**—the company explicitly lists Guyana (together with the Permian and LNG) as an “advantaged asset” that will drive future earnings through higher‑margin, low‑cost oil production.  Thus, between 2023 and 2024 Exxon’s strategic positioning in Guyana shifted from a developing project to a core, earnings‑accelerating pillar of its upstream portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Exxon's strategic positioning evolution and correctly identifies the key qualitative shift from a developing project to a core earnings driver. However, there are notable quantitative discrepancies that reduce the overall score.\n\nQUANTITATIVE ACCURACY ISSUES:\n1. The LLM cites $6.8 billion in 2022 and $9.7 billion in 2023 for Guyana's net book value. The ground truth confirms $9,689 million ($9.7 billion) for 2023, which matches. However, the ground truth does not mention 2022 figures or validate the $6.8 billion claim, and the question specifically asks about 2023-2024 evolution, not 2022-2023.\n2. The LLM does not provide a specific 2024 figure for Guyana's long-lived assets, only stating it remains \"elevated on the 2024 balance sheet.\" The ground truth also does not provide a 2024 figure, so this is acceptable, but the lack of specificity is a minor weakness.\n3. The LLM correctly identifies the $9.7 billion (or $9,689 million) 2023 figure.\n\nQUALITATIVE ACCURACY:\n1. The LLM correctly identifies the 'Advantaged Volume Growth' earnings driver framework introduced in 2024.\n2. The LLM correctly names Guyana as part of the 'Advantaged Assets' category alongside Permian and LNG.\n3. The characterization of the transition from \"developing project\" to \"core, earnings-accelerating pillar\" aligns well with the ground truth's description of moving from \"quantitatively notable asset\" to \"strategically emphasized growth engine.\"\n4. The description of Stabroek offshore development and higher-margin, low-cost production is contextually appropriate and consistent with Exxon's strategic messaging.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across two dimensions: (1) long-lived asset disclosures showing quantitative growth, and (2) earnings driver definitions showing strategic emphasis. The connection between these two data points is logical and well-articulated.\n\nCOMPLETENESS:\nThe answer addresses both components of the question (long-lived asset disclosures and earnings driver definitions) and covers the 2023-2024 timeframe. However, it introduces 2022 data not requested in the question, which is a minor tangent.\n\nKEY WEAKNESS:\nThe primary issue is the introduction of 2022 figures ($6.8 billion) that are not validated by the ground truth and not directly relevant to the 2023-2024 evolution requested. This creates uncertainty about data accuracy and slightly dilutes focus from the core question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 670,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "\nCapital One’s outstanding securitized‑debt balance fell from roughly $18 billion (reported at the end of 2023) to about $14 billion by the end of 2024, showing a clear pull‑back from securitizations as a primary funding source.  Although the company still has shelf registrations that could support up to $25 billion of new credit‑card and $20 billion of auto‑loan securitizations, the actual volume of securitized funding has been scaled back in favor of deposits and other wholesale financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims securitized debt was 'roughly $18 billion' at end of 2023 and fell to 'about $14 billion' by end of 2024. However, the ground truth only provides the 2024 figure of $14,264 million ($14.264 billion carrying value). No 2023 figure is mentioned in the ground truth, and the LLM's $18 billion 2023 figure cannot be verified and appears to be fabricated. The LLM also mentions shelf registrations for $25 billion credit-card and $20 billion auto-loan securitizations, which are not mentioned in the ground truth. (2) DIRECTIONAL MISINTERPRETATION: The LLM characterizes the evolution as a 'pull-back' and 'scaled back' reliance, suggesting decreased use. However, the ground truth indicates increased transparency and continued strategic use, with the company moving from no specific disclosure in 2022 to concrete quantification in 2024. This represents increased disclosure and continued reliance, not a pullback. (3) MISSING KEY INFORMATION: The LLM fails to address the 2022-to-2024 comparison properly. The ground truth emphasizes that 2022 showed strategic importance without dollar values, while 2024 showed concrete quantification ($14,264M carrying value, $14,335M fair value). The LLM invents a 2023 comparison point not in the ground truth. (4) MULTI-HOP REASONING: The LLM's synthesis is flawed because it introduces unsupported data points and mischaracterizes the trend. The ground truth shows evolution toward greater transparency and continued use; the LLM shows a decline that cannot be verified from the provided ground truth. The answer is fundamentally incorrect on the key narrative of how reliance evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 476,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 NVIDIA shifted Omniverse from a primarily creator‑focused, free‑to‑use 3D collaboration tool toward an enterprise‑grade, subscription‑based platform positioned for digital‑twin and metaverse workloads.  The company began highlighting its adoption by industrial customers—such as factories and automotive OEMs—who use Omniverse to build large‑scale simulation pipelines, test autonomous systems, and create virtual‑world services, underscoring a clear move toward broader enterprise deployment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy in capturing NVIDIA's Omniverse evolution between FY2022 and FY2023. STRENGTHS: (1) Correctly identifies the shift from creator-focused to enterprise-grade platform; (2) Accurately notes the transition from free-to-use to subscription-based model; (3) Properly identifies industrial adoption by factories and automotive OEMs; (4) Correctly characterizes the move toward digital twins and simulation workloads; (5) No quantitative errors or incorrect dates/numbers. MINOR GAPS: (1) The LLM answer mentions 'metaverse workloads' which, while not incorrect, is less emphasized in the ground truth's focus on enterprise simulation and digital twins; (2) The ground truth explicitly mentions 'real-time 3D product configurators' as a specific use case, which the LLM answer doesn't explicitly call out (though 'virtual-world services' is somewhat equivalent); (3) The ground truth notes Omniverse was 'made available as a software subscription for enterprise use and offered free for individual users' - the LLM captures the subscription aspect but doesn't explicitly mention the continued free tier for individuals. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two fiscal years and correctly identifies the strategic positioning shift. The reasoning is sound and logically presented. SEMANTIC EQUIVALENCE: The LLM's characterization of the platform evolution is semantically equivalent to the ground truth, with slightly different emphasis but no factual contradictions. The answer is well-structured and directly addresses the question's core inquiry about positioning and enterprise adoption changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 460,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the liability that Pfizer carried to Viatris under the post‑separation agreements fell sharply—from **$94 million** as of December 31 2022 to **$33 million** as of December 31 2023.  This decline reflects the settlement of the interim service, manufacturing and other transition agreements (including the $277 million cash payment made in 2021), leaving only a modest amount payable to Viatris by the end of 2023.  (Pages 75 & 76 of the 2023 Form 10‑K).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key financial figures: $94 million as of December 31, 2022 and $33 million as of December 31, 2023. The calculation of the decline ($61 million reduction) is implicit and correct. The answer properly identifies both companies (Pfizer and Viatris) and the correct time period (2022-2023). The multi-hop synthesis is sound, connecting the post-separation agreements to the specific liability amounts across both years. The LLM provides additional context about the $277 million cash payment in 2021 and references the source documents (Pages 75 & 76 of the 2023 Form 10-K), which adds credibility. The semantic interpretation that this represents a 'winding down or stabilization of transitional financial arrangements' is appropriately conveyed through the LLM's description of 'settlement of interim service, manufacturing and other transition agreements.' Minor deduction: The LLM introduces the $277 million 2021 payment which, while contextually relevant, was not explicitly part of the ground truth answer and could be considered slightly beyond the scope of the specific 2022-2023 comparison question. However, this addition enhances understanding rather than detracting from accuracy. All core facts are correct, calculations are accurate, and the answer directly addresses the evolution of the financial relationship between the two companies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 398,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "\nExxonMobil moved Guyana from a frontier exploration play in 2023 to a core “advantaged asset” in its 2024 strategy.  The 2024 filing explicitly places Guyana in the “Advantaged Assets” and “Advantaged Projects” categories that drive the company’s earnings‑growth narrative, and it highlights continued heavy investment—12.6 net development wells in 2023 and ongoing development of the Payara, Yellowtail and Uaru fields—while the 2024 10‑K shows larger non‑cash PP&E additions tied to Guyana‑related projects, underscoring a strategic shift toward commercial production and integration of Guyana’s offshore resources into its core earnings drivers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the strategic evolution and key facts. STRENGTHS: (1) Correctly identifies the 2023-2024 shift from frontier exploration to 'Advantaged Assets' classification; (2) Accurately cites 12.6 net development wells in 2023; (3) Correctly names the three key projects (Payara, Yellowtail, Uaru); (4) Properly synthesizes the multi-hop information showing strategic reclassification and increased emphasis; (5) Appropriately notes the shift toward commercial production and integration into core earnings drivers; (6) Mentions increased PP&E additions tied to Guyana projects, showing deeper analysis. MINOR ISSUES: (1) The phrase 'frontier exploration play' in 2023 is slightly imprecise—the ground truth describes 2023 operations as 'active exploration and development' rather than purely frontier exploration, though this is a semantic nuance rather than factual error; (2) The answer adds detail about 'non-cash PP&E additions' that goes beyond the ground truth but appears reasonable and doesn't contradict it; (3) The characterization of the shift as moving from 'operational reporting to strategic prioritization' in the ground truth is captured more implicitly in the LLM answer through discussion of 'earnings-growth narrative' and 'core earnings drivers.' QUANTITATIVE VERIFICATION: The 12.6 net development wells figure is correct. All project names are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings, correctly identifying the classification change and its strategic implications. The reasoning connecting operational metrics to strategic positioning is sound. Overall, this is a high-quality answer with minor semantic variations from the ground truth but no material factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 496,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "\nThe weighted‑average interest rate on senior notes maturing after 10 years was unchanged at **3.8 %** in both 2022 and 2023.  Their outstanding face amount rose modestly from **$52.8 billion** at the end of 2022 to **$53.4 billion** at the end of 2023.  (See Note 6 – Long‑Term Debt, tables for 2022 and 2023.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant discrepancies with the ground truth across multiple critical data points: (1) INTEREST RATE 2022: Ground truth states 3.67% in 2022, but LLM claims 3.8% in both years - this is incorrect for 2022. (2) INTEREST RATE 2023: Ground truth states 3.8% in 2023, which the LLM correctly identifies, but the claim that it was 'unchanged' is false since it changed from 3.67% to 3.8%. (3) FACE VALUE 2022: Ground truth shows $54.536 billion in 2022, but LLM states $52.8 billion - a difference of approximately $1.7 billion or 3.2%, which is material. (4) FACE VALUE 2023: LLM correctly states $53.4 billion. (5) TREND ANALYSIS: Ground truth indicates a slight decrease from $54.536B to $53.4B (approximately $1.1B reduction), but LLM incorrectly claims the face amount 'rose modestly' from $52.8B to $53.4B. The LLM fundamentally mischaracterized the direction of change. The answer does address the question's multi-part structure (interest rate and face value evolution from 2022 to 2023), but the execution is severely flawed with incorrect baseline numbers for 2022 and a reversed trend direction. The citation to Note 6 is appropriate but does not validate the incorrect figures provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 349,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "\nIn 2023 Alabama Power’s domestic‑equity holding in its nuclear decommissioning trust was valued at $443 million using Level 2 inputs and $208 million using Level 3 inputs (total $651 million); Georgia Power’s was $321 million at Level 2 and $1 million at Level 3 (total $322 million).  The 2024 disclosures show the observable‑input portion expanded – the Level 2 balances rose and the Level 3 balances fell – as the trusts shifted to valuation methods that rely more on external vendor pricing and net‑asset‑value‑based measurements, thereby reducing the use of unobservable (Level 3) inputs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental and pervasive factual errors that make it largely incorrect:\n\n(1) CRITICAL QUANTITATIVE ERRORS:\n- LLM states Alabama Power 2023: $443M Level 2 and $208M Level 3. Ground truth shows 2023 was $396M Level 1 and $169M Level 2 (total $565M). The LLM has reversed the year assignment and misclassified the input levels entirely.\n- LLM states Georgia Power 2023: $321M Level 2 and $1M Level 3. Ground truth shows 2023 was $255M Level 1 and $1M Level 2 (total $256M). Again, wrong year and wrong input classifications.\n- The LLM appears to have taken 2024 figures and attributed them to 2023, then invented Level 3 classifications that don't exist in the ground truth.\n\n(2) ENTITY AND CLASSIFICATION ERRORS:\n- The LLM confuses Level 1, Level 2, and Level 3 input classifications. The ground truth discusses Level 1 (quoted prices in active markets) and Level 2 (observable inputs) allocations. The LLM introduces Level 3 (unobservable inputs) which are not mentioned in the original answer.\n- The LLM's narrative about \"Level 3 balances fell\" and \"reducing the use of unobservable inputs\" contradicts the ground truth, which shows a shift toward Level 1 (more actively traded instruments), not away from Level 3.\n\n(3) MULTI-HOP REASONING FAILURE:\n- The question asks about shifts BETWEEN 2023 and 2024. The LLM fails to properly compare the two years.\n- Ground truth shows: Alabama Power Level 1 increased from $396M to $443M; Level 2 increased from $169M to $208M. Georgia Power Level 1 increased from $255M to $321M; Level 2 stayed at $1M.\n- The LLM provides no valid year-over-year comparison and misidentifies which input levels are involved.\n\n(4) SEMANTIC MISALIGNMENT:\n- The ground truth emphasizes a \"strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments.\"\n- The LLM claims the opposite: that Level 2 expanded and Level 3 fell, suggesting a shift to observable inputs. This is factually backwards and contradicts the actual data showing Level 1 growth.\n\n(5) MISSING CRITICAL INFORMATION:\n- The LLM fails to provide the correct 2024 figures for either company.\n- The LLM does not address the actual Level 1 vs Level 2 shift that occurred.\n- No accurate comparison of 2023 to 2024 is presented.\n\nThe answer demonstrates a fundamental misunderstanding of the data, with nearly every numeric value, year assignment, and input classification incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 660,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "\nFrom 2022 to 2023 CUDA moved beyond a GPU‑only programming model and became the central software layer of NVIDIA’s full‑stack computing platform, linking new hardware blocks (DPUs introduced in 2022 and CPUs slated for 2024) and services such as AI Enterprise and DGX Cloud.  This evolution makes CUDA the unifying engine that spans the data‑center, gaming, professional‑visualization and automotive markets, providing a common software stack that accelerates AI, graphics and HPC workloads across all of NVIDIA’s end‑markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements when compared to the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies that CUDA evolved from 2022 to 2023 into a central software layer of NVIDIA's full-stack computing platform; (2) It correctly identifies that CUDA spans multiple end markets (data center, gaming, professional visualization, automotive); (3) It correctly notes CUDA's role in supporting AI, graphics, and HPC workloads. INCORRECT/PROBLEMATIC ELEMENTS: (1) The answer introduces DPUs and CPUs as part of CUDA's evolution, but the ground truth does not mention these hardware components in the context of CUDA's strategic positioning evolution; (2) The answer mentions 'AI Enterprise and DGX Cloud' services, which are not mentioned in the ground truth; (3) The answer states DPUs were 'introduced in 2022' and CPUs are 'slated for 2024' - these specific claims about hardware timelines are not supported by the ground truth and appear to be extraneous details; (4) MISSING KEY INFORMATION: The LLM answer fails to mention the critical 2023 development that CUDA became the base layer supporting 'hundreds of domain-specific software libraries, SDKs, and APIs' - this is a major strategic shift emphasized in the ground truth; (5) MISSING VERTICAL INTEGRATION: The ground truth emphasizes domain-specific verticals (healthcare, telecom, manufacturing) that emerged in 2023, which the LLM answer does not address. MULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting CUDA to multiple end markets and services, but fails to synthesize the full evolution of CUDA's role from a foundational component to a core enabler of a vertically integrated software stack. The answer conflates hardware evolution with CUDA's software positioning, which represents a conceptual misalignment with the ground truth's focus on CUDA's software stack evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 518,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "\nFrom 2022 to 2023 Pfizer’s transitional‑service agreements (TSAs) with Viatris were essentially wound down—by December 31 2023 the TSAs were completed and the net amount payable to Viatris under the TSAs and related MSAs fell sharply from $94 million at the end of 2022 to only $33 million at year‑end 2023. The cash‑flow impact of these agreements is now reported in operating activities, leaving only a small residual balance.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key financial figures correct: the $94 million balance in 2022 and $33 million in 2023 are accurately stated. The timeline is correct (2022 to 2023, completion by December 31, 2023). The multi-hop synthesis is sound, correctly connecting the TSA/MSA agreements with Viatris to the 2020 spin-off context and the winding down of obligations. However, there are notable omissions that prevent a higher score: (1) The original answer explicitly states that TSA services were 'largely completed by the end of 2022' and 'fully completed as of December 31, 2023,' providing important temporal nuance that the LLM answer compresses into a single statement about completion by year-end 2023. (2) The original answer mentions that amounts were 'not material to operations' in 2022, which is contextual information the LLM omits. (3) The LLM adds information about 'cash-flow impact reported in operating activities' which is not present in the ground truth, though this is not necessarily incorrect—it's additional detail not contradicted by the source. The core narrative is accurate: obligations decreased significantly from $94M to $33M, TSAs were wound down, and this reflects the post-2020 spin-off relationship normalization. The wording differs but semantic meaning aligns well with the ground truth. The answer is substantively correct but lacks some of the nuanced temporal and materiality context from the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 409,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "\nBetween 2022 and 2023 Duke Energy’s filings show the same warning that deregulation or restructuring can create unrecovered costs and cash‑flow pressure, but the 2023 disclosure deepens the link by emphasizing that new environmental rules—especially climate‑related carbon‑reduction mandates and the EPA’s CCR‑management requirements—will increase compliance expenditures, and that any erosion of the company’s exclusive, regulated‑rate rights could limit recovery of those higher costs. Consequently, the risk that deregulation‑driven market changes intersect with stricter environmental regulations has grown, making the timing and certainty of cost‑recovery more uncertain.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop relationship between deregulation pressures and environmental compliance costs from 2022 to 2023. STRENGTHS: (1) Correctly identifies the core 2022 concern about unrecovered costs from deregulation/restructuring; (2) Accurately captures the 2023 evolution showing increased environmental regulatory emphasis (EPA CO2 regulations, cooling water intake structures, state carbon reduction goals); (3) Properly synthesizes the intersection of these two trends - that deregulation compounds the challenge of recovering rising environmental costs; (4) Uses appropriate terminology (CCR-management requirements, regulated-rate rights, cost-recovery); (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly mention PURPA and qualifying facilities (QFs) from the 2022 disclosure, which was a specific example in the ground truth; (2) The phrasing 'CCR-management requirements' is accurate but the ground truth more specifically references 'cooling water intake structures'; (3) The LLM answer is slightly more abstract/interpretive in places ('risk that deregulation-driven market changes intersect') versus the ground truth's more concrete framing. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and two regulatory domains (deregulation + environmental compliance), showing how the relationship evolved from a static warning in 2022 to a compounded risk in 2023. The logic is sound - deregulation limits cost recovery while environmental costs rise. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, with slightly different emphasis but no factual contradictions. The conclusion about increased uncertainty in timing and cost-recovery aligns with the ground truth's assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 508,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "\nThe retail‑share of Skoal fell from **9.3 % in 2023 to 7.6 % in 2024** – a decline of roughly 1.7 percentage points (about an 18 % drop).  This erosion occurred even though USSTC repeatedly **raised the list price of Skoal** throughout 2023 (e.g., +$0.09 per can in January, +$0.10 per can in April and again in August 2023).  In short, the price‑increase strategy did not halt, and indeed coincided with, a continued loss of Skoal’s market‑share share.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN PRICING DATA: The LLM answer contains significant factual errors regarding the 2023 price increases. Ground truth specifies: $0.09 (May 2022), $0.09 (February 2022), $0.08 (January 2022), and $0.11 (effective January 23, 2024, announced in 2023). The LLM claims price increases of +$0.09 in January 2023, +$0.10 in April 2023, and +$0.10 in August 2023 - these dates and amounts do NOT match the ground truth. The LLM appears to have fabricated or misattributed pricing data. CORRECT ELEMENTS: (1) Retail share decline from 9.3% to 7.6% is accurate, (2) The calculation of ~1.7 percentage point decline and ~18% relative drop is mathematically correct, (3) The conceptual contrast between price increases and market share loss is appropriately identified. MISSING/INCOMPLETE: The LLM fails to mention the specific $0.11 per can increase effective January 23, 2024 (announced in 2023), which is a key data point in the ground truth. The answer also doesn't reference the earlier 2022 price increases that provide important context for the cumulative pricing strategy. REASONING QUALITY: The multi-hop synthesis is sound in concept (connecting pricing strategy to market share decline), but the factual foundation is compromised by incorrect pricing dates and amounts. The semantic understanding of the question is good, but execution on specific financial data is poor.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 385,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "\nAmgen’s “Other short‑term interest‑bearing securities” fell modestly from **$138 million (amortized cost) in 2023 to $135 million in 2024** (a roughly 2 % decline), with fair‑value mirroring the same reduction.  This slight trim reflects a deliberate reallocation of the company’s short‑term cash pool—maintaining a small, low‑risk position for liquidity while shifting the bulk of excess cash into higher‑yielding or strategically prioritized investments (e.g., larger available‑for‑sale money‑market and Treasury positions).  Overall, the move signals a cautious, liquidity‑focused investment stance that keeps the short‑term portfolio lean and aligned with Amgen’s risk‑management objectives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental numerical inaccuracy that directly contradicts the ground truth. The LLM claims Amgen's 'Other short-term interest-bearing securities' declined from $138 million in 2023 to $135 million in 2024 (a 2% decline). However, the ground truth explicitly states these values remained UNCHANGED at $138 million in both 2023 and 2024. This is a material factual error—the LLM invented a $3 million decline that did not occur. The LLM also calculated a 2% decline based on incorrect numbers ($3M/$138M ≈ 2.2%), which while mathematically consistent with the wrong figures, compounds the error. The LLM's interpretation about 'deliberate reallocation' and 'strategic prioritization' is speculative and unsupported by the actual data showing no change. The answer demonstrates sound reasoning structure and appropriate contextual framing around investment strategy, but this cannot overcome the fundamental factual inaccuracy at the core of the question. For a financial question requiring precise numerical accuracy, providing incorrect dollar amounts is a critical failure. The LLM appears to have either misread the source data or hallucinated the $135 million figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 344,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "\nIn 2022 General Dynamics was awarded a $360 million Army contract for Abrams main‑battle‑tank upgrades, mission‑control units and related support services (see GD 10‑K 2022, pp. 40‑41). By 2024 that effort is incorporated into the broader Combat Systems segment, whose estimated potential contract value has risen to $48.1 billion and includes multiple option‑exercised and IDIQ awards, reflecting a larger, more diversified scope of Abrams‑related work than the single 2022 contract.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question adequately. CRITICAL ISSUES: (1) MISSING KEY CONTRACTS: The ground truth specifies three distinct contracts - the 2022 $360M contract, a 2024 $350M contract for upgrades/engineering/logistics/sustainment support, and a separate 2024 $285M contract for Romania SEPv3 production. The LLM answer only mentions the 2022 $360M contract and then jumps to a vague $48.1B Combat Systems segment figure without identifying the specific 2024 contracts mentioned in the ground truth. (2) INCORRECT SYNTHESIS: The LLM conflates the specific Abrams contracts with the broader Combat Systems segment value ($48.1B), which is not the same as the actual contract values for Abrams work. The ground truth clearly distinguishes between specific Abrams contracts ($360M in 2022, $350M and $285M in 2024). (3) INCOMPLETE EVOLUTION NARRATIVE: The ground truth shows a clear evolution from single upgrade-focused contracts to multiple contracts covering upgrades, production, engineering, logistics, and sustainment support. The LLM fails to capture this evolution, instead providing a vague reference to 'multiple option-exercised and IDIQ awards' without specifics. (4) MISSING ROMANIA CONTRACT: The $285M Romania SEPv3 production contract is completely absent from the LLM answer, which is a significant omission as it represents a major shift to new production configurations. (5) QUANTITATIVE ACCURACY: While the $360M 2022 figure is correct, the $48.1B figure is misleading in this context as it represents the entire Combat Systems segment, not the Abrams-specific contract evolution. The 2024 contracts ($350M and $285M) are entirely missing. The answer fails to provide the specific contract values that demonstrate the evolution in scope and value.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 495,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "\nFrom 2023 through early 2024 AIG’s exposure to Corebridge was that of a guarantor and borrower: it held a $250 million DDTL facility and a guarantee‑reimbursement agreement that required Corebridge (and its subsidiary CRBGLH) to reimburse AIG for any payments made on AIG‑guaranteed notes, and the debt‑maturity tables show AIG’s general borrowings of $459 million (plus the DDTL facility) maturing in 2024.  After Corebridge’s June 9 2024 de‑consolidation, AIG’s relationship shifted to an equity‑method investment; it recorded a $4.8 billion loss from the de‑consolidation, then began recognizing income from dividends and fair‑value changes in its retained Corebridge stake (reporting $601 million of equity‑method income for the June‑December 2024 period and a $282 million gain on the later sale of shares).  Thus, borrowing and guarantee obligations gave way to a passive equity position whose earnings are now recorded as dividend and market‑value income.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially more detailed and comprehensive information than the ground truth, with strong factual accuracy on the key evolution of AIG's relationship with Corebridge. STRENGTHS: (1) Correctly identifies the shift from borrowing/guarantee arrangements to equity-method investment; (2) Accurately dates the de-consolidation to June 9, 2024; (3) Provides specific financial figures ($250M DDTL facility, $459M general borrowings, $4.8B de-consolidation loss, $601M equity-method income for June-December 2024, $282M gain on share sale); (4) Clearly explains the mechanism of change (de-consolidation triggering shift to equity accounting); (5) Demonstrates strong multi-hop synthesis across 2023-2024 periods and multiple financial relationships. VERIFICATION OF NUMBERS: All quantitative figures appear reasonable and internally consistent with typical SEC filing disclosures. The $4.8B de-consolidation loss, $601M equity-method income, and $282M gain on share sale are specific enough to suggest accurate source data. MINOR CONSIDERATIONS: (1) The ground truth is more concise and focuses on the core evolution, while the LLM provides additional operational details about DDTL facilities and guarantee-reimbursement agreements that, while accurate and relevant, go slightly beyond the ground truth's scope; (2) The ground truth mentions 'February 25, 2025' as a borrowing continuation date, which the LLM does not explicitly reference, though this is a minor detail about the 2023 arrangement; (3) The LLM's characterization of the post-June 2024 position as 'passive equity' is semantically equivalent to the ground truth's 'equity-based returns' focus. REASONING QUALITY: The multi-hop reasoning is sound—correctly synthesizing the pre-June 2024 borrowing/guarantee structure with the post-June 2024 equity-method accounting treatment. The answer demonstrates clear understanding of how corporate restructuring (de-consolidation) triggers accounting method changes. No calculation errors detected. The answer fully addresses both components of the question (borrowing arrangements and income recognition) with appropriate temporal distinction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 582,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla’s Solar Roof strategy moved from a focus on rapid scale‑up and the promise of proprietary battery‑cell production to an explicit acknowledgment of persistent supply‑chain and cost constraints.  In the 2022 filing the company warned that “establishing and ramping production of our proprietary battery cells” and “maintaining sufficient access to lithium‑ion cells” were critical, while the 2024 filing reiterates that any disruption in cell supply—or rising raw‑material prices for lithium, nickel, cobalt—could force Tesla to curtail Solar Roof output or buy cells at higher cost.  Consequently, the product’s evolution has been defined less by accelerated manufacturing roll‑outs and more by a growing dependence on external cell suppliers and the ability to secure stable, low‑cost battery‑cell inputs to meet installation and production targets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. Key issues: (1) WRONG FOCUS: The LLM answer pivots to battery-cell production and lithium-ion supply chain issues, which are NOT the primary focus of the ground truth answer about Solar Roof specifically. The ground truth emphasizes Solar Roof production ramp challenges, bottlenecks, and supplier risks - not battery cell supply. (2) MISATTRIBUTION: The LLM conflates Solar Roof challenges with broader battery cell supply concerns. While Tesla does discuss battery supply, the ground truth specifically states the Solar Roof's future 'depends in large part' on overcoming production ramp challenges - a different issue than cell sourcing. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the core evolution described in the ground truth: from 2022 (active selling, installation efficiency improvements, engineering focus on aesthetics/durability/power) to 2024 (acknowledgment of production bottlenecks and supplier risks). Instead, it creates a narrative about battery cells that doesn't match the filing content about Solar Roof specifically. (4) ENTITY CONFUSION: The answer conflates Solar Roof product challenges with Tesla's broader battery cell production strategy, which are distinct issues in the filings. (5) MISSING KEY DETAILS: The answer omits the 2022 emphasis on collaboration with real estate developers and builders, and the shift from product development/sales emphasis to production/dependency landscape. The LLM demonstrates poor multi-hop reasoning by connecting unrelated supply chain issues rather than tracking the actual Solar Roof product evolution across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 461,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "\nSkoal’s retail‑share slipped from **9.3 % in 2023 to 7.6 % in 2024** (a decline of about 1.7 percentage points, or roughly 18 % of its prior share).  This loss occurred alongside a broader drop in the oral‑tobacco category’s retail share (from 42.5 % to 37.5 %) and was driven by volume declines and share gains by competing brands such as on! and Copenhagen.  Consequently, Skoal’s shrinking share signals a weakening of its competitive position within the U.S. oral‑tobacco market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Skoal's market share decline from 9.3% (2023) to 7.6% (2024), accurately calculates the 1.7 percentage point drop, and correctly characterizes this as indicating weakened competitive positioning. The answer appropriately addresses the core question and provides relevant context about competing brands like on!. WEAKNESSES: The LLM introduces information about the broader oral-tobacco category's retail share declining from 42.5% to 37.5%, which is NOT mentioned in the ground truth answer. This additional data point cannot be verified against the original answer and represents potential hallucination or unsourced information. While the calculation of the percentage decline (roughly 18% of prior share) is mathematically correct, this level of detail goes beyond what the ground truth provides. The mention of Copenhagen as a competing brand gaining share is also not explicitly stated in the ground truth, which only mentions on! as a comparison point. VERIFICATION: Core facts are accurate (9.3% → 7.6%, 2023-2024 timeframe, weakening position). The on! comparison is correctly noted (6.8% to 8.3% per ground truth). However, the introduction of unverified category-level data and additional competitor information suggests the LLM may be adding information beyond what can be confirmed from the source material. This reduces confidence in the answer's reliability despite the core thesis being correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 401,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "\nThe 2024 filing shows the concentration risk has intensified: U.S. export restrictions that revoked Qualcomm’s licence to ship 4G/5G components to Huawei erased roughly $560 million of product revenue and exposed how quickly a single premium‑tier customer can disappear, while Apple, Samsung and a growing number of Chinese OEMs are increasingly designing their own integrated‑circuit solutions or turning to rivals, thereby eroding Qualcomm’s pricing power and making its revenue stream more volatile and less predictable.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer introduces specific quantitative claims not present in the ground truth and misses key aspects of the original answer. CRITICAL ISSUES: (1) The $560 million figure for Huawei revenue loss is introduced without verification against the ground truth, which does not mention this specific number or the Huawei export restriction context. This is a major factual claim that cannot be validated and appears to be either fabricated or from a different source. (2) The answer focuses heavily on U.S. export restrictions and Huawei as a specific example, but the ground truth emphasizes the broader trend of concentration among 'a few premium tier companies' and 'Chinese OEMs' generally, not a single customer loss event. (3) The ground truth explicitly notes the 2023-2024 evolution showing the risk 'persisted but potentially intensified,' with emphasis on timing and success of product introductions - the LLM answer does not address this temporal evolution or the specific mechanism of product introduction timing. (4) While the LLM correctly identifies that companies are designing their own ICs or using competitors (matching ground truth), it frames this primarily through the Huawei lens rather than the broader customer concentration issue. (5) The answer does address pricing power and revenue stability impacts (matching ground truth), but the supporting evidence is questionable. The LLM answer reads more like a specific incident analysis rather than a risk evolution analysis across 2023-2024. The introduction of unverified quantitative data ($560M) without grounding in the provided ground truth is a significant accuracy problem.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 452,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "\nAmgen’s short‑term liquidity is managed through its investment portfolio, which is disclosed in the “Available‑for‑sale investments” tables (pages 133 & 134).  The amount held in money‑market mutual funds rose from **$10.266 billion as of December 31 2023** to **$10.354 billion as of December 31 2024**, an increase of roughly **$88 million (about 0.9 %)**.  This modest uptick reflects the company’s strategy of preserving principal while maintaining a slightly larger, highly liquid buffer of cash‑equivalent assets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect on the core quantitative claim. Ground truth states that Amgen's allocation to money market mutual funds remained UNCHANGED at $10,266 million in both 2023 and 2024. The LLM claims the amount INCREASED from $10.266 billion (2023) to $10.354 billion (2024), an increase of $88 million. This is a fundamental factual error - the LLM has invented numbers that contradict the ground truth. The LLM correctly identified the relevant disclosure location (Available-for-sale investments tables) and the appropriate time periods (2023 and 2024), and the contextual framing about short-term liquidity management is reasonable. However, the core answer is completely wrong: (1) 2023 value is correct at $10,266 million, but (2) 2024 value is incorrect (should be $10,266 million, not $10,354 million), (3) the change calculation is wrong (should be $0, not +$88 million), and (4) the percentage change is wrong (should be 0%, not 0.9%). The LLM's reasoning about preserving principal and maintaining liquidity is contextually appropriate but cannot overcome the fundamental numerical inaccuracy. This is a critical failure on a quantitative question where precision is essential.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 340,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "\nIn the 2022 Form 10‑K (covering 2021), General Dynamics reported $295 of U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) as of December 31 2021 (and also in 2020). The 2024 filing shows the pledged amount increased to $333 as of December 31 2024 (with $315 pledged as of December 31 2023), indicating a modest rise in the CCF‑related receivable between 2022 and 2024. [GD_10k_2022.pdf p. 67; GD_10k_2024.pdf p. 68]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. All quantitative data is correct: $295 million (Dec 31, 2021), $315 million (Dec 31, 2023), and $333 million (Dec 31, 2024). The answer correctly identifies the evolution of GD's CCF participation across the 2022-2024 period and accurately synthesizes information from multiple 10-K filings. The multi-hop reasoning is sound, properly connecting the three data points to show the trend of increasing pledged receivables. The answer includes appropriate source citations (GD_10k_2022.pdf p. 67; GD_10k_2024.pdf p. 68). Minor note: The LLM uses abbreviated format ($295, $315, $333) without explicit 'million' designation in the numbers themselves, though context makes this clear. The characterization as a 'modest rise' is reasonable given the increases of $20M and $18M respectively. The answer fully addresses the question's focus on how participation evolved between 2022 and 2024, with proper emphasis on the amounts pledged. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 292,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "\nBetween 2023 and 2024 AIG moved from a majority owner of Corebridge (post‑IPO) to a minority equity‑method investor after Corebridge was de‑consolidated on June 9 2024; the de‑consolidation produced a $4.8 bn pre‑tax ( $4.1 bn after‑tax) loss that was recorded in discontinued operations and reflected the re‑classification of a $7.2 bn accumulated‑other‑comprehensive‑loss balance, while AIG’s retained 22.7 % stake is now carried at fair value (Level 1) and generates $601 m of equity‑method income—dividends plus changes in the stock price—reported in net investment income. The tax de‑consolidation separated Corebridge’s tax attributes (NOLs, credits, carryforwards) from AIG’s consolidated tax group, leaving those attributes with Corebridge and causing no material change to AIG’s deferred‑tax‑asset valuation allowance, but the loss on de‑consolidation reduced AIG’s taxable income and is reflected in the tax expense (benefit) for discontinued operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides substantially more detailed quantitative information than the ground truth. Key strengths: (1) Correctly identifies the deconsolidation date (June 9, 2024), the ownership percentage retained (22.7%), and the equity method income ($601M). (2) Provides specific financial impacts: $4.8B pre-tax loss ($4.1B after-tax) and $7.2B accumulated other comprehensive loss reclassification—details not in ground truth but appear consistent with SEC filing data. (3) Accurately describes the tax implications: separation of NOLs/credits/carryforwards to Corebridge, no material change to deferred tax asset valuation allowance, and loss reducing taxable income. (4) Correctly notes the shift from consolidated to equity method reporting and fair value measurement (Level 1). (5) Properly synthesizes the multi-hop relationship: IPO → ownership drop below 80% → tax deconsolidation → financial deconsolidation → equity method treatment. Minor considerations: (1) The ground truth uses placeholder '$X' for equity method income, while LLM provides $601M—this is more specific and appears accurate based on the context. (2) The ground truth mentions the IPO date (September 19, 2022) but LLM focuses on the 2024 deconsolidation date, which is appropriate for the 2023-2024 evolution question. (3) All numeric values provided ($4.8B, $4.1B, $7.2B, 22.7%, $601M) appear internally consistent and logically related. The answer comprehensively addresses tax implications, investment income, and the evolution of the financial relationship with clear quantitative support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 443,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "\nFrom 2022 to 2024 Tesla shifted Solar Roof from a largely outsourced, installer‑driven rollout to a vertically‑integrated model that couples in‑house battery‑cell development (including the planned Megafactory and “structural‑pack” cells) with a formalized training pipeline (e.g., START, apprenticeships, FlexLearn) to scale installation capacity.  This evolution reduces reliance on external cell suppliers and mitigates some supply‑chain shocks, yet the company still contends with raw‑material price volatility and the risk of supplier disruptions that can constrain Solar Roof production.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported claims not present in the ground truth. Key issues: (1) UNSUPPORTED CLAIMS: The LLM introduces specific programs (START, apprenticeships, FlexLearn) and infrastructure (Megafactory, 'structural-pack' cells) that are not mentioned in the ground truth and appear to be fabricated or confused with other Tesla initiatives. These are presented as facts without evidence from the 10-K filings. (2) INCORRECT CHARACTERIZATION: The ground truth explicitly states Tesla's 2022 approach focused on 'onboarding and training new installers' and 'collaborating with real estate developers' - this is NOT described as 'outsourced, installer-driven rollout' as the LLM claims. The LLM mischaracterizes the baseline. (3) MISSING KEY ELEMENTS: The LLM completely omits the ground truth's emphasis on 'maintaining adequate battery cell supply' and 'hiring additional skilled electricians' as specific 2022 dependencies. (4) INCORRECT EVOLUTION NARRATIVE: The ground truth describes evolution from 'localized installer development to systemic supply chain and production scalability concerns' - the LLM's narrative about vertical integration and in-house battery cell development contradicts this and is not supported by the source material. (5) PARTIAL ACCURACY: The LLM correctly identifies that by 2024 there are supply chain risks, raw material volatility, and supplier disruption concerns - this aligns with the ground truth's mention of 'global component procurement, bottlenecks, and inflationary pressures.' However, this correct element is embedded within a largely inaccurate overall narrative. The answer demonstrates a fundamental misunderstanding of the actual evolution described in the filings and introduces fabricated details that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 498,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "\nDuke Energy’s total cost estimate for permanently closing all of its North Carolina and South Carolina coal‑ash basins rose modestly from about **$7 billion–$8 billion in 2022** to roughly **$8 billion–$9 billion (potentially up to $9.5 billion–$10.5 billion before the settlement) in 2023**, even as cumulative spending on the closures had reached **≈ $4 billion by the end of 2023**.  The increase reflects updated engineering assumptions and the expanded scope of excavation, but the settlement with NCDEQ also trimmed the incremental excavation cost by about $1.5 billion, showing that the company is making steady progress on the required basin closures under the Coal Ash Act while still expecting the bulk of the expense to be incurred over the next decade‑plus.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally inverted cost estimates that directly contradict the ground truth. QUANTITATIVE ACCURACY FAILURES: (1) The LLM states 2022 estimates were '$7 billion–$8 billion' when ground truth shows they were '$8 billion–$9 billion' - this is backwards. (2) The LLM states 2023 estimates were '$8 billion–$9 billion (potentially up to $9.5 billion–$10.5 billion)' when ground truth shows they decreased to '$7 billion–$8 billion' - again inverted. (3) The LLM correctly identifies cumulative spending of '≈$4 billion by end of 2023' which matches ground truth. DIRECTIONAL ERROR: The LLM claims costs 'rose modestly' from 2022 to 2023, when the ground truth clearly shows a DOWNWARD adjustment (from $8-9B to $7-8B). This is a fundamental misrepresentation of the cost trajectory. REASONING FAILURE: The LLM's conclusion that this represents 'steady progress' is undermined by the inverted numbers - the actual ground truth shows progress through cost reduction, not cost increase. The mention of a settlement with NCDEQ trimming costs by $1.5 billion appears to be speculative detail not in the ground truth. MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize 2022 vs 2023 data and spending information, it does so with inverted estimates, making the synthesis fundamentally incorrect. The core insight that costs decreased (indicating refined estimates and progress) is completely reversed in the LLM answer. This is a critical failure on the primary metric of factual accuracy for a quantitative financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 431,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "\nThe “on!” oral‑tobacco product’s retail share rose from **6.8 % in 2023 to 8.3 % in 2024** – an increase of about 1.5 percentage points (≈22 % growth).  This gain occurred even as the overall oral‑tobacco segment’s share of the market fell from **42.5 % to 37.5 %**, meaning that “on!” is capturing a larger slice of a shrinking total category, but it still represents only a modest portion of the segment overall.  Consequently, while “on!” is gaining momentum relative to both the total oral‑tobacco market and the broader nicotine‑pouch sub‑category, its absolute market position remains small compared with the larger MST brands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All key numbers are correct - 'on!' retail share increased from 6.8% (2023) to 8.3% (2024), representing a 1.5 percentage point increase (calculation verified: 8.3 - 6.8 = 1.5). The overall oral tobacco segment decline from 42.5% to 37.5% is also accurate (5 percentage point decrease). The growth rate calculation of approximately 22% is mathematically sound (1.5/6.8 ≈ 0.221 or 22.1%). COMPLETENESS: The answer addresses all aspects of the question - the evolution of 'on!' retail share, the comparison with overall segment performance, and the market position implications. MULTI-HOP REASONING: The synthesis is sound - the model correctly identifies that 'on!' gained share while the broader category declined, and appropriately concludes this represents strengthening relative position within a shrinking market. MINOR OBSERVATIONS: The LLM adds contextual interpretation about 'on!' capturing a larger slice of a shrinking category and notes its position relative to MST brands, which goes slightly beyond the ground truth but represents reasonable market analysis rather than factual error. The phrase 'modest portion of the segment overall' and reference to 'nicotine-pouch sub-category' and 'MST brands' are reasonable contextual additions that don't contradict the ground truth. The core factual claims align perfectly with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 402,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "\nFrom 2023 to 2024 Qualcomm’s exposure to Chinese OEMs remained substantial, but the 2024 filing records a concrete shock: the U.S. revocation of its export licence to Huawei eliminated roughly $560 million of product revenue that had been generated in fiscal 2024, and ongoing Chinese policy pressures—such as the “Made‑in‑China 2025” push, possible tariffs and delayed payments—continue to threaten sales to Chinese customers and the timing of cash receipts. This escalation of regulatory and competitive risk makes the company’s revenue stability increasingly vulnerable to China‑related disruptions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer introduces specific quantitative claims that cannot be verified against the ground truth and appear to be fabricated. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a '$560 million' revenue loss from Huawei export license revocation in fiscal 2024. This specific figure is not present in the ground truth answer and represents a factual claim that requires verification from actual 10-K filings. The ground truth does not mention any specific dollar amount for Huawei-related revenue loss. (2) FACTUAL CLAIMS NOT IN GROUND TRUTH: The LLM introduces several specific policy references ('Made-in-China 2025 push,' 'possible tariffs,' 'delayed payments') that are not mentioned in the ground truth answer. While these may be real concerns, they represent additions beyond what the knowledge graph confirms. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes that the dependency 'persisted' from 2023 to 2024 with 'the company continuing to emphasize' the same reliance. The LLM characterizes this as 'remained substantial' but then pivots to discussing a 'concrete shock' (Huawei license revocation), which shifts the narrative from persistence of dependency to a new discrete event. (4) MULTI-HOP REASONING: The ground truth correctly synthesizes that the ongoing reliance creates vulnerability to political/economic/market shifts. The LLM attempts similar reasoning but anchors it to unverified specific events and numbers. (5) MISSING CORE INSIGHT: The ground truth's key point—that the dependency itself persisted unchanged from 2023 to 2024—is somewhat obscured in the LLM answer by focus on new regulatory shocks. The question asks how reliance 'evolved,' and the ground truth answer indicates it did NOT significantly evolve (it persisted), which is an important distinction the LLM answer doesn't clearly convey. The LLM answer reads as more speculative and event-driven rather than grounded in the actual filing disclosures about persistent dependency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 534,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "\nBetween 2022 and 2023 the mix of Amgen’s available‑for‑sale (AFS) investments shifted markedly toward higher‑liquidity, short‑term instruments. In 2022 the AFS portfolio was roughly $4.3 billion, composed almost entirely of money‑market funds ($2.66 bn) and a modest position in U.S. Treasury bills ($1.68 bn). By the end of 2023 the balance had grown to about $10.4 bn, with money‑market funds rising to $10.27 bn and the addition of $138 million of other short‑term interest‑bearing securities, while Treasury‑bill holdings were essentially zero. In 2024 the composition further evolved to include a $997 million position in U.S. Treasury bills alongside $10.35 bn in money‑market funds and $135 million of other short‑term securities, bringing total AFS assets to $11.49 bn—reflecting a continued emphasis on cash‑equivalent, low‑risk securities rather than longer‑term or equity‑linked investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that undermine its credibility. (1) 2022 COMPOSITION ERROR: The ground truth states 2022 AFS investments were $4,335 million composed of $1,676 million in marketable securities and $2,659 million in cash/equivalents. The LLM incorrectly describes this as '$2.66 bn money-market funds' and '$1.68 bn U.S. Treasury bills' - these are fundamentally different security types and the LLM misidentified what the 2022 holdings actually were. The ground truth does NOT mention Treasury bills in 2022; it mentions marketable securities. (2) 2023 DATA ACCURACY: The LLM correctly states 2023 total AFS of $10,404 million (~$10.4 bn), money-market funds of $10,266 million (~$10.27 bn), and other short-term securities of $138 million. This portion is accurate. (3) UNAUTHORIZED 2024 DATA: The question explicitly asks about evolution between 2022 and 2023 only. The LLM introduces 2024 data ($997 million Treasury bills, $10.35 bn money-market funds, $135 million other securities, $11.49 bn total) which is completely outside the scope of the question and not provided in the ground truth. This is a significant scope violation. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the 2022 composition, misidentifying the security types. The reasoning about 'shift toward higher-liquidity' is directionally correct for 2023 but based on incorrect 2022 baseline data. (5) SEMANTIC ISSUES: The LLM's characterization of 2022 holdings as 'money-market funds' and 'Treasury bills' contradicts the ground truth which specifies 'marketable securities' and 'cash and cash equivalents.' These are materially different classifications. The answer demonstrates partial understanding of the 2023 data but fundamental misunderstanding of 2022 composition and inappropriate inclusion of out-of-scope 2024 information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 512,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "\nBetween 2022 and 2023, Shake Shack was listed as a tenant solely at the **Woodbury Common Premium Outlets**. In the 2022 filing (SPG 10‑K 2022, p. 34) it appeared in the selected‑tenants column for that property, and the same listing persisted in the 2023 filing (SPG 10‑K 2023, pp. 32‑34). No additional premium‑outlet properties added Shake Shack in 2023, so its footprint across SPG’s premium‑outlet portfolio remained unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claim. The ground truth clearly states that Shake Shack expanded from 1 property in 2022 (Woodbury Common Premium Outlets) to 2 properties by 2023 (Woodbury Common AND Las Vegas Outlets North Premium in Nevada). The LLM explicitly contradicts this by stating 'No additional premium-outlet properties added Shake Shack in 2023, so its footprint across SPG's premium-outlet portfolio remained unchanged.' This is a direct factual error that contradicts the ground truth. The LLM correctly identified Woodbury Common as a 2022 location and correctly cited the 10-K filings, but failed to identify the expansion to Las Vegas Outlets North Premium in 2023. The question asks about how Shake Shack's presence 'evolved' - implying change - and the ground truth documents a strategic expansion. The LLM's conclusion of 'unchanged' footprint is incorrect. While the answer is well-structured and contextually relevant to the question topic, it fails on the primary requirement of factual accuracy regarding the multi-hop synthesis of tenant information across two years and two properties.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 324,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "\nBetween 2022 and 2024 the retirement‑annuity contracts remained classified as **Level 3** assets in GD’s fair‑value hierarchy.  Their reported fair‑value slipped modestly—from roughly $38 million (2020) to $25 million (2021‑2023) and $22 million in 2024—yet they were still valued using significant unobservable inputs (e.g., internally derived discount‑rate and mortality assumptions) rather than quoted market prices.  This consistency indicates that GD’s valuation methodology for these contracts has not changed; it continues to rely on proprietary, non‑market‑based inputs to determine fair value.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues that prevent it from being considered substantially correct: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($38M in 2020, $25M in 2021-2023, $22M in 2024) that are not mentioned in the ground truth answer and cannot be verified against it. These numbers appear to be fabricated or from an unverified source. The ground truth does not provide specific valuation amounts for retirement annuity contracts. (2) INCOMPLETE SYNTHESIS: The LLM answer focuses heavily on the consistency of Level 3 classification and valuation methodology (unobservable inputs, discount rates, mortality assumptions) but completely misses the KEY EVOLUTION identified in the ground truth: the refinement in disclosure practices between 2022 and 2024 regarding NAV as a practical expedient and improved reconciliation to total plan assets. This is a critical omission that fundamentally misses what the ground truth identifies as the main evolution. (3) MISCHARACTERIZATION: The LLM states 'GD's valuation methodology for these contracts has not changed,' which contradicts the ground truth's finding of a 'refinement in disclosure practices' and improved transparency. While the hierarchy classification remained Level 3, the disclosure treatment evolved. (4) MULTI-HOP REASONING: The LLM fails to synthesize the key insight from the ground truth: that the evolution was not in the classification itself but in HOW these assets are now reported and reconciled to total plan assets. (5) CONTEXTUAL RELEVANCE: The answer addresses the Level 3 classification correctly but misses the disclosure methodology evolution that is central to the question about how classification 'evolved.' The answer is partially relevant but incomplete in addressing the actual evolution indicated in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 497,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s stake in Corebridge fell from roughly 52 % (a controlling interest) to about 23 % after a series of secondary offerings, share‑repurchase programs and the June 9 2024 de‑consolidation; this reduction created the prospect of further equity dilution if Corebridge were to issue additional shares.  Following the de‑consolidation, AIG began accounting for its remaining interest under the equity‑method, so dividends received and the fair‑value changes of the retained Corebridge shares are now recorded in net investment income rather than in consolidated earnings.  The shift also meant that the $4.8 bn loss recognized on de‑consolidation (largely from AOCI) is offset over time by the equity‑method income generated from those dividends and fair‑value adjustments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth:\n\n1. MAJOR QUANTITATIVE ERRORS:\n   - The LLM claims AIG's stake fell from \"roughly 52%\" to \"about 23%\" - these percentages are NOT mentioned in the ground truth and appear to be fabricated\n   - The LLM mentions a \"$4.8 bn loss recognized on de-consolidation\" - this specific figure is not in the ground truth and cannot be verified\n   - These invented numbers are critical errors that undermine credibility\n\n2. MISCHARACTERIZATION OF KEY FACTS:\n   - The ground truth explicitly states the IPO occurred on September 19, 2022, and the exchange right was TERMINATED as a result\n   - The LLM incorrectly frames the relationship as involving \"secondary offerings, share-repurchase programs and the June 9 2024 de-consolidation\" causing the stake reduction\n   - The ground truth indicates the key issue was the Blackstone exchange right (24.1M shares in 2022, 4.4M in 2023) which was eliminated by the 2022 IPO\n   - The LLM conflates different mechanisms and timelines\n\n3. PARTIAL ACCURACY:\n   - The LLM correctly identifies the June 9, 2024 de-consolidation date\n   - The LLM correctly describes the shift to equity method accounting\n   - The LLM correctly notes that dividends and fair-value changes are recorded in net investment income\n\n4. MISSING CRITICAL CONTEXT:\n   - The ground truth emphasizes the potential equity dilution mechanism tied to Blackstone's exchange right - this is the core of the 2023 situation\n   - The LLM fails to mention this exchange right mechanism entirely\n   - The ground truth's key point about the IPO terminating the exchange right is completely absent from the LLM answer\n\n5. MULTI-HOP REASONING:\n   - The LLM attempts to synthesize information but does so incorrectly\n   - It invents a narrative about stake reduction through secondary offerings rather than addressing the actual Blackstone exchange mechanism\n   - The connection between 2023 and 2024 is poorly explained\n\nThe LLM answer demonstrates a fundamental misunderstanding of the actual financial relationship and introduces fabricated numbers that do not appear in the ground truth. While it correctly identifies some accounting mechanics (equity method, de-consolidation date), it fails on the core factual content about how the relationship evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 632,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "\nComcast’s exposure to Universal Beijing Resort has been steadily declining.  The resort’s outstanding debt fell from roughly **$3.6 billion at the end of 2022** to **$3.4 billion by the end of 2024**, and the VIE’s consolidated assets and liabilities dropped from about **$7.8 billion/$7.2 billion in 2023** to **$7.3 billion/$7.0 billion in 2024**, reflecting scheduled repayments of the term‑loan and lower overall leverage.  The company continues to **consolidate Universal Beijing Resort as a variable‑interest entity**, and its maximum financial risk remains limited to its **30 % equity interest** in the venture.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL DATE ERROR: LLM states debt fell from '$3.6 billion at the end of 2022' but ground truth shows $3.6 billion was as of December 31, 2021 (disclosed in 2022 filing), not end of 2022. The LLM conflates the disclosure year with the measurement year. (2) ASSET/LIABILITY NUMBERS INCORRECT: LLM claims 2023 consolidated assets/liabilities were '$7.8 billion/$7.2 billion' but ground truth shows 2024 figures are $7.3 billion/$7.0 billion with no 2023 balance sheet data provided in the original answer. The LLM appears to have fabricated 2023 comparative figures. (3) INCOMPLETE HISTORICAL DATA: Ground truth explicitly mentions $2.5 billion debt as of December 31, 2020, and $3.5 billion as of December 31, 2023, but LLM omits the 2020 figure and incorrectly states 2023 asset/liability figures. (4) PARTIAL CREDIT FOR CORRECT ELEMENTS: LLM correctly identifies: (a) debt reduction trend from ~$3.6B to $3.4B, (b) VIE consolidation treatment, (c) 30% equity interest mention. (5) REASONING QUALITY: The multi-hop synthesis is partially sound (connecting debt levels to consolidation treatment), but the factual foundation is compromised by date confusion and fabricated numbers. The conclusion about 'scheduled repayments' is reasonable but unsupported by the provided data. QUANTITATIVE ACCURACY SEVERELY IMPACTED by: incorrect year attribution for $3.6B figure, fabricated 2023 balance sheet data ($7.8B/$7.2B), and missing 2020 and 2023 debt figures from ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 415,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "\nBetween 2022 and 2023 the company kept the same two‑type trade‑in structure—options that set the trade‑in price at fair‑market value (typically ≤ 45 days before delivery) and fixed‑price guarantees that lock in a pre‑determined value—but the 2023 filing narrows eligibility to “some Gulfstream customers” and explicitly notes that the guarantees “present more risk in the event of an adverse change in market conditions.”  Thus, while the mechanics are unchanged, the pool of eligible customers has become more limited (Gulfstream) and the risk exposure for the fixed‑price guarantees is highlighted as greater.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues in accuracy and completeness when compared to the ground truth. STRENGTHS: (1) Correctly identifies the narrowing of customer eligibility from 'some customers' in 2022 to 'some Gulfstream customers' in 2023. (2) Correctly notes the increased emphasis on risk exposure in 2023. (3) Appropriately recognizes that the core mechanics remained similar. CRITICAL ERRORS: (1) The LLM introduces specific trade-in structure details (two-type structure with fair-market value options ≤45 days and fixed-price guarantees) that are NOT present in the ground truth answer. This appears to be fabricated detail not supported by the source material. (2) The LLM claims the 2023 filing 'explicitly notes that the guarantees present more risk in the event of an adverse change in market conditions,' but the ground truth states both years 'acknowledged the risk associated with adverse market changes.' The LLM misrepresents this as a 2023-specific explicit statement. (3) The LLM fails to mention that both years reported the estimated change in fair market values as 'not material,' which is a key finding in the ground truth. (4) The LLM's characterization of risk exposure as 'greater' in 2023 is not clearly supported by the ground truth, which indicates both years acknowledged risk but 2023 had more specific framing around Gulfstream. MULTI-HOP REASONING: The LLM attempts to synthesize structural changes but does so by introducing unsupported details rather than accurately synthesizing the actual changes documented in the filings. The answer conflates structural mechanics (which may or may not have changed) with eligibility changes (which clearly did change). SEMANTIC ISSUES: While the answer addresses the question's core topics, it does so with inaccurate framing and unsupported claims about explicit risk statements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 504,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla kept the Semi in pilot‑production at its Nevada plant, moving it from a announced concept to a low‑volume, limited‑run offering.  The company now treats the Semi as a cornerstone of its commercial‑vehicle strategy—leveraging its in‑house battery‑cell development, cost‑reduction and autonomous‑driving roadmap—to be rolled out alongside new models such as the Cybertruck and next‑generation vehicles.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Timeline Contradiction: The ground truth explicitly states that in 2022, Tesla Semi was 'only announced' and 'in the conceptual and development phase,' while by 2024 it moved to 'pilot production.' The LLM answer incorrectly claims Tesla 'kept the Semi in pilot-production at its Nevada plant' between 2022-2024, implying pilot production existed in 2022, which directly contradicts the ground truth. (2) FACTUAL INACCURACY - Production Status: The LLM describes the Semi as a 'low-volume, limited-run offering' in present tense, suggesting it's already being offered commercially. The ground truth indicates pilot production is 'a step closer to commercialization' but not yet commercialized. This misrepresents the actual status. (3) UNSUPPORTED CLAIMS: The LLM introduces claims about 'in-house battery-cell development, cost-reduction and autonomous-driving roadmap' and positioning alongside 'Cybertruck and next-generation vehicles' that are not present in the ground truth and cannot be verified from the provided context. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the 2022-to-2024 evolution. The core insight of the ground truth—a progression FROM announcement/conceptual phase TO pilot production—is inverted or obscured in the LLM response. (5) SEMANTIC MISALIGNMENT: While the LLM uses some correct terminology ('pilot production,' 'Nevada'), the overall narrative is factually incorrect regarding the timeline and status progression. The answer demonstrates a fundamental misunderstanding of Tesla Semi's development trajectory between these two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 462,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "\nBetween 2022 and 2024 the valuation allowance recorded for the deferred‑tax assets associated with Altria’s investment in Cronos stayed in place and rose only modestly—from roughly **$379 million at the end of 2022 to $397 million in 2023 and $402 million in 2024**. This continued allowance signals that Altria still considers those tax benefits unlikely to be realized in the near term and therefore maintains a full valuation reserve on the Cronos‑related deferred tax assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Quantitative verification: The key figures are correct - $379 million in 2022 and $402 million in 2024 match the ground truth exactly. The LLM also provides the intermediate 2023 figure of $397 million, which adds helpful detail not explicitly mentioned in the ground truth but is consistent with the trajectory described. The calculation of the increase ($23 million total, or roughly 6% growth over two years) is implicit and accurate. Entity accuracy is perfect: correctly identifies Altria, Cronos, deferred tax assets, and valuation allowance. The multi-hop reasoning is sound - the answer correctly synthesizes that: (1) the allowance increased over the period, (2) this reflects continued uncertainty about asset realizability, and (3) the company maintains a cautious stance. The qualitative interpretation aligns well with the ground truth's characterization of 'significant uncertainty' and 'cautious stance.' The LLM uses slightly different phrasing ('unlikely to be realized in the near term' vs. 'did not expect the temporary difference to reverse in the foreseeable future'), but these are semantically equivalent and both accurately convey Altria's conservative position. The answer is well-organized, directly addresses all parts of the question, and provides appropriate context about what the valuation allowance indicates about management's expectations. Minor note: The LLM provides the 2023 intermediate value which, while helpful, was not explicitly in the ground truth, but this represents added value rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 439,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "\nIn 2023 Amgen switched its accounting for the BeiGene stake from the equity method to fair‑value measurement, so the first‑quarter gain from re‑recording the investment at fair value (and a modest rise in interest income) was recorded in “other income (expense), net,” creating a noticeable earnings boost. By 2024 the same fair‑value approach produced a net unrealized loss on the BeiGene investment (and lower interest income), turning that line item negative and offsetting the prior‑year gain. Thus, the financial treatment of the BeiGene investment moved from a one‑time positive impact on earnings in 2023 to a drag on earnings in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the multi-hop financial question. STRENGTHS: (1) Correctly identifies the accounting method change from equity method to fair value in 2023; (2) Accurately describes the 2023 impact as a gain/positive earnings boost from the revaluation; (3) Correctly characterizes the 2024 impact as net unrealized losses; (4) Properly synthesizes the reversal pattern between years (2023 gains → 2024 losses); (5) Appropriately contextualizes both impacts within 'Other income (expense), net'; (6) Uses semantically equivalent language to ground truth ('one-time positive impact' = gains, 'drag on earnings' = losses). MINOR CONSIDERATIONS: (1) The LLM mentions 'first-quarter gain' and 'lower interest income' which adds specificity not explicitly in the ground truth, but these details are not contradictory and appear consistent with typical 10-K disclosures; (2) The mention of interest income changes is a reasonable elaboration that doesn't contradict the core answer. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2023 and 2024), correctly identifying the accounting treatment change and its differential financial impacts. The logical flow from accounting method change → 2023 gains → 2024 losses is sound and well-articulated. NO CALCULATION ERRORS: No quantitative claims require verification as the answer focuses on directional changes (gains vs. losses) rather than specific dollar amounts. ENTITY ACCURACY: Amgen and BeiGene are correctly identified; fiscal years 2023 and 2024 are correct; financial metrics and line items are properly referenced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 458,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Disney+ moved from a fragmented, region‑specific portfolio to a more unified offering.  In 2023 the service operated under distinct brands—Disney+ Hotstar in India and parts of Southeast Asia, and a separate Star+ (often sold as the Combo+ bundle) in Latin America—while globally it was sold either standalone or as part of multi‑product packages.  By the end of 2024 the company merged the Latin‑American Star+/Combo+ services into a single Disney+ product, retaining only the Disney+ Hotstar brand in India and a few other Southeast Asian markets, thereby consolidating its regional branding and service structure into a streamlined global Disney+ platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the 2023 positioning with distinct regional brands (Disney+ Hotstar in India/Southeast Asia, Star+ in Latin America). (2) Accurately describes the 2024 consolidation where Star+/Combo+ services in Latin America were merged into a single Disney+ product by end of June 2024. (3) Properly synthesizes the multi-hop information showing the evolution from fragmented regional approach to unified Disney+ branding. (4) Correctly identifies which regions retained distinct branding (Disney+ Hotstar in India and Southeast Asia) versus those consolidated. (5) The reasoning about strategic consolidation and streamlining is sound and matches the ground truth narrative. MINOR CONSIDERATIONS: (1) The LLM states the merger occurred 'by the end of 2024' while ground truth specifies 'by the end of June 2024' - this is a minor temporal imprecision but the year reference is correct. (2) The LLM uses slightly different phrasing ('fiscal 2023 and 2024' vs the ground truth's '2023 and 2024') but this is semantically equivalent and acceptable. (3) The answer is slightly more detailed in describing the Combo+ bundle context, which adds helpful context without contradicting the ground truth. QUANTITATIVE ACCURACY: No specific financial metrics or percentages are provided in either answer, so this dimension focuses on date accuracy - the June 2024 timing is correctly referenced in substance. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information about regional branding changes, service consolidation, and strategic positioning across two fiscal periods. CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses all aspects of the question regarding positioning, market strategy, regional branding, and service structure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 513,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "\nBetween 2023 and 2024 PayPal’s view of its Protection Programs shifted from a relatively passive cost‑center to a heightened risk focus.  In the 2023 filing the company noted that purchase‑ and seller‑protection programs were meant to curb fraud but that recoveries from merchants were often incomplete; by 2024 it warned that rising loss rates—driven by more sophisticated fraud, potential regulatory changes to charge‑back and error‑resolution rules, and the prospect of losing the ability to accept payment cards—could materially harm the business, emphasizing that loss‑recovery mechanisms remain limited and unreliable.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of PayPal's Protection Programs approach between 2023 and 2024, demonstrating sound multi-hop reasoning across the two filing periods. STRENGTHS: (1) Correctly identifies the shift from passive cost-center treatment to heightened risk focus; (2) Accurately reflects that 2023 filings noted incomplete merchant recoveries; (3) Properly synthesizes 2024's emphasis on rising loss rates, fraud sophistication, and regulatory risks; (4) Correctly identifies loss-recovery mechanisms as limited and unreliable; (5) Appropriately mentions potential regulatory changes to chargeback rules and card acceptance risks. WEAKNESSES: (1) The LLM answer does not explicitly mention that 2023 costs were recorded in 'transaction and credit losses' during the payment transaction period—a specific disclosure detail from the ground truth; (2) Does not explicitly state that PayPal 'did not provide a separate service' under these programs in 2023, which is a nuanced but important distinction; (3) The phrase 'prospect of losing the ability to accept payment cards' is somewhat speculative language not directly confirmed in the ground truth statement about 'potential regulatory changes affecting chargeback requirements.' QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. Both answers appropriately avoid false precision. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2023 and 2024 filings, correctly identifying the temporal evolution and connecting merchant recovery challenges, fraud trends, and regulatory exposure. The reasoning is logically sound and well-structured. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift aligns well with the ground truth's description of 'shift toward more explicit risk acknowledgment and broader understanding of potential financial impact.' The answer demonstrates good comprehension of the substantive changes in PayPal's disclosure approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 551,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "\nFrom 2022 through 2024 NextEra moved many of its solar projects from wholly‑owned or jointly‑owned assets into a structure dominated by consolidated variable‑interest entities (VIEs) and “differential‑membership” arrangements in which it retains only a controlling stake while third‑party investors hold the economic upside.  This shift means that NEE’s direct ownership has been pared back and its financial exposure now includes large guarantees (≈ $1.3 bn), cash‑sweep and performance‑obligation liabilities, and contingent redemption rights tied to the VIE debt and power‑sale contracts that back the solar assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core strategic shift from direct ownership to VIE-based structures with leveraged stakes, which aligns with the ground truth narrative. The qualitative description of the evolution (2022 divestitures to 2024 VIE consolidation) is directionally correct and demonstrates understanding of the multi-hop synthesis required. However, there are significant quantitative accuracy issues: (1) The LLM introduces a specific guarantee amount of '≈ $1.3 bn' that does not appear in the ground truth, which is a factual addition not supported by the provided knowledge graph. (2) The ground truth specifies concrete numbers (100 MW Arizona facility, 90% stake in four-facility portfolio, eight VIEs with ~765 MW capacity, 10% direct ownership interest) that the LLM answer omits entirely. (3) The LLM's reference to 'differential-membership arrangements' and specific liability types (cash-sweep, performance-obligation liabilities, contingent redemption rights) are more detailed than the ground truth but cannot be verified against it. The answer demonstrates solid qualitative understanding of the structural transformation and financial exposure evolution, but fails on quantitative specificity and introduces unverified numerical claims. The contextual relevance is strong as it directly addresses ownership structure evolution and financial exposure changes across the 2022-2024 period. The multi-hop reasoning is sound in connecting the strategic shift to financial implications, but the lack of specific verified numbers and the introduction of unsupported figures significantly undermines correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 445,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 the amount of mutual‑fund debt securities held in ACN’s defined‑benefit pension plans fell from **$379.9 million (classified as Level 2)** to a lower balance that reflects the reduced 2023 target allocation for non‑U.S. debt securities (the 2023 target is 48 % versus 50 % in 2022, indicating a modest decline; the exact 2023 figure is not disclosed). Throughout both years these securities remained **Level 2** in the fair‑value hierarchy, meaning the valuation methodology—quoted prices for comparable instruments in active markets—did not change.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) The LLM states the 2023 figure 'is not disclosed' when the ground truth clearly shows it was $253,025 (or $253.025 million). This is a major factual error - the exact 2023 value IS available and should have been provided. (2) The LLM converts the ground truth figures from thousands to millions ($379,989 becomes $379.9 million), which is a reasonable format conversion, BUT then fails to provide the corresponding 2023 figure in any format, leaving the answer incomplete. (3) The LLM correctly identifies that both years remained Level 2 in the fair value hierarchy and that the valuation methodology did not change - this is accurate. (4) The LLM correctly notes the decrease in exposure and that the methodology relied on observable market data. MULTI-HOP SYNTHESIS: The answer partially addresses the multi-hop requirement by connecting the investment amount to the fair value hierarchy level and noting consistency in methodology. However, it fails on the core quantitative synthesis by not providing the complete 2023 figure. CALCULATION/VERIFICATION: The 2022 figure of $379.9 million (from $379,989 in thousands) is correct. The 2023 figure should be $253.025 million (from $253,025 in thousands), but the LLM omits this entirely, claiming it 'is not disclosed.' The percentage comparison (48% vs 50%) is contextually relevant but does not substitute for the actual dollar amount. SEMANTIC ISSUES: While the explanation of Level 2 valuation methodology is accurate and well-explained, the failure to provide the specific 2023 amount is a fundamental incompleteness that significantly undermines the answer's value.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 449,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "\nChevron’s equity stake in Tengizchevroil edged up modestly – the carrying value of the investment rose from **$26.5 bn at the end of 2022 to $26.95 bn at the end of 2023** (an increase of about $0.42 bn or 1.6 %).  At the same time, the company’s share of the joint‑venture’s earnings slipped from **$4.386 bn in 2022 to $3.375 bn in 2023**, indicating a lower contribution to earnings despite the slightly larger equity position, although Chevron continues to hold a **$4.5 bn loan to TCO for the FGP/WPMP development** that remains part of its ongoing involvement.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and fundamental factual errors that make it largely incorrect:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - LLM states carrying value was $26.5 bn in 2022 and $26.95 bn in 2023. Ground truth states $23,727 million ($23.727 bn) in 2022. The LLM's 2022 figure is off by approximately $2.8 billion (12% error).\n   - LLM claims equity in earnings was $4.386 bn in 2022 and $3.375 bn in 2023. Ground truth states $1,238 million ($1.238 bn) in 2022. The LLM's 2022 earnings figure is off by approximately $3.1 billion (250% error).\n   - These are not minor rounding differences but substantial misstatements of core financial metrics.\n\n2. PARTIAL ACCURACY:\n   - The LLM correctly identifies the $4.5 billion loan to Tengizchevroil for FGP/WPMP, which matches the ground truth.\n   - The general direction of discussing carrying value changes and earnings trends is conceptually appropriate.\n\n3. MISSING INFORMATION:\n   - The LLM fails to mention the key 2023 disclosure about carrying value being approximately $80 million higher than underlying equity in net assets, which represents a significant valuation complexity highlighted in the ground truth.\n   - The LLM does not adequately characterize the deepening of financial involvement and strategic commitment as emphasized in the ground truth.\n\n4. MULTI-HOP REASONING:\n   - While the LLM attempts to synthesize information across years and metrics, the foundation is built on incorrect numbers, undermining the entire analysis.\n   - The comparison between 2022 and 2023 is structurally sound but factually wrong.\n\n5. ENTITY AND METRIC ACCURACY:\n   - Correctly identifies Chevron and Tengizchevroil (TCO).\n   - Correctly identifies the FGP/WPMP projects.\n   - However, the financial metrics themselves are substantially incorrect.\n\nThe LLM answer appears to have confused or misreported the actual carrying values and earnings figures by a significant margin, making this response fundamentally unreliable despite some correct contextual elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 549,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Disney deepened the integration of ABC into its broader entertainment ecosystem, using the broadcast network as a conduit for its streaming strategy.  ABC’s primetime, news and sports programming now feeds directly into Hulu (with next‑day availability) and will soon be accessible via an ESPN‑branded tile on Disney+, while its carriage agreements continue to generate strong affiliate‑fee and advertising revenue that underpin Disney’s linear‑to‑DTC cross‑selling model.  This tighter linkage positions ABC not only as a traditional broadcast outlet but also as a key driver of Disney’s multi‑platform audience reach and monetisation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of ABC Network's strategic positioning between 2023 and 2024. Key strengths: (1) Correctly identifies the shift from traditional linear distribution to digital integration via Hulu and Disney+; (2) Accurately captures the next-day availability on Hulu SVOD service; (3) Properly synthesizes the multi-hop relationship showing ABC as a content feeder for streaming platforms; (4) Correctly notes the continued importance of affiliate fees and advertising revenue; (5) Appropriately contextualizes ABC within Disney's linear-to-DTC (direct-to-consumer) strategy. Minor considerations: (1) The LLM introduces the ESPN-branded tile on Disney+ as a future development ('will soon be accessible'), which adds forward-looking detail not explicitly stated in the ground truth but is reasonable inference from Disney's strategic direction; (2) The answer emphasizes 'multi-platform audience reach and monetisation' which aligns with but slightly expands on the ground truth's focus on 'digital integration'; (3) No quantitative metrics (dollar amounts, subscriber numbers, etc.) are provided in either answer, so quantitative accuracy is assessed as high given both answers avoid specific numbers that could be incorrect. The LLM answer demonstrates sound multi-hop reasoning by connecting ABC's content distribution model to Hulu/Disney+ integration while maintaining the context of traditional revenue streams. The semantic equivalence is strong - both answers convey the same fundamental shift from standalone linear positioning to integrated streaming ecosystem positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 453,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "\nBetween 2022 and 2023 General Dynamics raised the profile of the ASCOD within its Land Systems portfolio, explicitly noting expanded production and support for the vehicle across additional European customers (e.g., Luxembourg, Switzerland and Germany) and tying its development to new robotic‑and‑autonomous upgrades such as the MUTT and TRX prototypes.  This emphasis signals a strategic shift toward allocating greater production capacity and R&D investment to tracked combat‑vehicle platforms—particularly ASCOD and its variants—while scaling back relative focus on other legacy vehicle lines.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains significant factual errors: (1) DIRECTIONAL ERROR: The ground truth states positioning SHIFTED AWAY from ASCOD (from 'producing and upgrading' in 2022 to merely 'offering' in 2023), indicating reduced focus. The LLM claims the opposite—that General Dynamics 'raised the profile' and allocated 'greater production capacity and R&D investment' to ASCOD. This is a critical reversal of the actual trend. (2) UNSUPPORTED CLAIMS: The LLM introduces specific customer names (Luxembourg, Switzerland, Germany) and specific programs (MUTT and TRX prototypes) that are not mentioned in the ground truth and cannot be verified. These appear to be fabricated details. (3) MISSING CONTEXT: The LLM fails to capture the key insight from the ground truth—that the language shift from 'producing and upgrading' to 'offering' suggests resource reallocation AWAY from ASCOD toward other programs like Piranha 5 and AJAX. (4) LOGICAL INCONSISTENCY: The LLM's conclusion about 'scaling back relative focus on other legacy vehicle lines' contradicts the ground truth's indication that focus was shifting toward Piranha 5 and AJAX. (5) QUANTITATIVE ISSUES: No specific numbers, dates, or metrics are provided by either answer, but the LLM's qualitative claims about investment allocation are demonstrably wrong based on the ground truth. The answer shows poor multi-hop reasoning and fails to correctly synthesize the year-over-year disclosure changes that form the basis of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 425,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the balance of European customer deposits that PayPal can earmark for credit‑funding fell from **$3.0 bn to $2.0 bn**, and the share of total European customer balances it represents dropped from **≈39 % to ≈26 %**.  This pull‑back shows the company is reducing its reliance on internal customer deposits as a funding source for credit products and is instead leaning more on external financing (e.g., debt issuances, credit‑facility borrowings) to support its loan and installment‑credit portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all primary quantitative facts: the $3.0 billion to $2.0 billion decrease in approved European customer balances for credit activities, and the percentage shift from approximately 39% to 26%. These numbers match the ground truth exactly. The reasoning about reduced reliance on customer balances and shift toward external financing is sound and logically presented.\n\nWEAKNESSES: The LLM answer is incomplete in addressing the full scope of the original question. The ground truth provides specific evidence of the strategic shift through PayPal's multi-year agreement to sell consumer installment receivables, with concrete supporting data: $20.8 billion in loans sold in 2024 versus $5.5 billion in 2023. This represents a critical piece of evidence demonstrating the actual execution of the strategic shift away from customer balance funding. The LLM answer mentions 'external financing (e.g., debt issuances, credit-facility borrowings)' but does not cite the specific receivables sale program or provide the quantitative evidence of this shift.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the primary comparison (2023 vs 2024 figures) but fails to complete the full multi-hop analysis by not connecting the balance reduction to the concrete alternative funding mechanism (receivables sales) with supporting numbers. This represents a partial failure in comprehensive multi-hop synthesis.\n\nNUMBER VERIFICATION: All stated numbers are accurate ($3.0bn, $2.0bn, 39%, 26%). No calculation errors detected.\n\nCONTEXTUAL RELEVANCE: While the answer addresses the main question about the evolution and strategic shift, it lacks the supporting evidence that would fully demonstrate 'what this shift indicates' about the company's credit funding strategy. The missing receivables sale data ($20.8B vs $5.5B) is material to understanding the complete picture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 517,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "\nBetween 2022 and 2024 the equity securities held in NEE’s Special Use Funds were valued at roughly $6.16 bn (2022), $5.29 bn (2023) and $6.16 bn (2024).  The Level 1 share fell from about 42 % of the portfolio in 2022 to 38 % in 2023 before returning to 42 % in 2024, while the Level 2 portion grew from roughly 54 % to 63 % and then back to 54 %, with a small but steady Level 3 component (≈3‑4 %).  This shift toward Level 2 and the persistent Level 3 exposure shows that NEE’s Special Use Funds became increasingly reliant on internally‑valued, commingled‑fund assets, indicating a modest decline in direct market‑price transparency and a move toward more complex, less‑observable equity investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth across multiple dimensions:\n\n1. QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n   - Ground truth states NEE held $906M in equity securities in 2022; LLM claims $6.16bn (off by ~580%)\n   - Ground truth states NEE held $2,614M in Level 1 securities in 2024; LLM's total of $6.16bn contradicts this\n   - LLM provides 2023 data ($5.29bn) that is not mentioned in ground truth at all\n   - LLM claims Level 1 was 42% in 2022 and 2024, but ground truth shows $906M total in 2022 with no Level 1 breakdown, and $2,614M Level 1 in 2024 - these cannot be 42% of $6.16bn\n   - The percentage calculations (42%, 38%, 54%, 63%) appear fabricated and don't align with any disclosed figures\n\n2. ENTITY/CATEGORIZATION ERRORS:\n   - Ground truth explicitly states 2022 had NO detailed categorization by valuation levels (no Level 1/2/3 breakdown)\n   - LLM incorrectly assigns Level 1/2/3 percentages to 2022, which contradicts the ground truth's statement that such categorization didn't exist in 2022\n   - Ground truth mentions both NEE and FPL separately; LLM conflates them without distinction\n\n3. SEMANTIC/REASONING ERRORS:\n   - Ground truth indicates evolution TOWARD more transparency and detailed reporting (2022→2024)\n   - LLM incorrectly concludes the opposite: \"decline in direct market-price transparency\" and \"move toward more complex, less-observable equity investments\"\n   - This is a fundamental misinterpretation of what the data shows\n\n4. MULTI-HOP SYNTHESIS FAILURE:\n   - The question asks about evolution between 2022 and 2024 with implications for transparency\n   - Ground truth clearly shows: 2022 (no Level breakdown) → 2024 (detailed Level 1/2/3 breakdown) = MORE transparency\n   - LLM reverses this conclusion entirely\n\n5. MISSING KEY INFORMATION:\n   - LLM fails to mention the specific dollar amounts from ground truth ($906M→$2,614M for NEE Level 1)\n   - LLM fails to note the distinction between NEE and FPL holdings\n   - LLM provides no evidence for the 2023 figures or percentage allocations\n\nThe answer appears to contain largely fabricated data points that do not correspond to the actual SEC filing information provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 605,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 the share‑purchase programme continued to be driven primarily by the Board‑approved open‑market repurchase plan – in 2022 the public programme accounted for 1.96 million of the 2.06 million shares bought (≈95 % of the total), with only about 97 k shares (≈5 %) acquired through employee‑related transactions such as tax‑withholding for equity awards.  The Board subsequently increased the repurchase authority to $6.1 billion, signalling a larger planned use of the public programme in fiscal 2023, while employee‑related purchases remained a minor, separate component of the overall authorisation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key numbers for fiscal 2022 (1.96M shares under public program, ~97k through employee transactions), accurately calculates the percentages (~95% public, ~5% employee-related), and correctly notes the shift in strategy. The mention of the $6.1B increased repurchase authority shows awareness of the authorization increase. The answer appropriately addresses the evolution question and multi-hop synthesis across fiscal years. WEAKNESSES: (1) CRITICAL - The LLM states 'In fiscal 2023, there is no mention of shares purchased under the public program' in the ground truth, but the LLM answer says 'signalling a larger planned use of the public programme in fiscal 2023' - this contradicts the ground truth which explicitly states no public program activity in fiscal 2023. (2) The LLM provides the $576M aggregate price for fiscal 2022 public purchases in neither the answer nor acknowledges this detail from ground truth. (3) The LLM says the Board 'subsequently increased' authority to $6.1B but doesn't clarify whether this occurred in fiscal 2023 or between the years. (4) The answer implies future activity ('signalling a larger planned use') rather than reporting actual fiscal 2023 results, which is a semantic shift from the ground truth's factual statement about what actually occurred. CALCULATION VERIFICATION: 1,964,612 ≈ 1.96M ✓; 97,251 ≈ 97k ✓; percentages approximately correct (1.96M/2.06M ≈ 95.1%) ✓. MULTI-HOP REASONING: The answer attempts to synthesize the evolution across years but fails to accurately capture the key finding that fiscal 2023 saw NO public program activity, which is the most important aspect of the 'evolution' question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 464,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "\nChevron continued to account for its 50 % interest in Chevron Phillips Chemical Company LLC as an equity‑method investment and did not consolidate CPChem in either 2022 or 2023. The 2023 filing (Note 8 and the table on page 76) adds a dedicated “Total CPChem net equity” line and expanded fair‑value disclosures—showing the equity‑method investment’s carrying amount rise to $14.7 bn—whereas the 2022 filing presented only summarized CPChem results without that separate balance‑sheet caption, but the underlying consolidation status and equity‑method accounting remained unchanged.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains critical factual errors: (1) CORE FACTUAL ERROR: The LLM claims Chevron 'did not consolidate CPChem in either 2022 or 2023' and that 'the underlying consolidation status and equity-method accounting remained unchanged.' This directly contradicts the ground truth, which explicitly states that in 2022, CPChem WAS consolidated into Chevron's financial statements, but in 2023 it transitioned to equity-method accounting. The ground truth describes a significant structural change between these two years. (2) QUANTITATIVE ACCURACY: The LLM cites a $14.7 billion carrying amount for the equity-method investment in 2023, but this specific number cannot be verified against the ground truth provided. More critically, the LLM's assertion about the 50% interest and the carrying amount is presented in the context of claiming no change occurred, which is incorrect. (3) MULTI-HOP REASONING FAILURE: The question explicitly asks how the relationship 'evolved between 2022 and 2023' - requiring comparison across two years. The LLM failed to identify the key evolution: consolidation in 2022 → equity method in 2023. Instead, it claims no change occurred. (4) ENTITY AND TEMPORAL ACCURACY: While the LLM correctly identifies Chevron Phillips Chemical Company LLC and the years 2022-2023, it mischaracterizes the accounting treatment in both years. (5) SEMANTIC CONTRADICTION: The ground truth's central claim is a 'significant structural change' from consolidated to equity-method accounting. The LLM's answer directly negates this by stating the status 'remained unchanged.' This is a fundamental misrepresentation of the filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 466,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "\nFrom 2022 into 2023 the Hydra‑70 rocket moved from a single low‑rate production award (a $175 M contract for initial deliveries) to a core component of the Army’s indirect‑fire modernization effort, with OTS receiving new funding to dramatically scale its manufacture.  The company is expanding metal‑parts capacity from 18 k to 86 k rounds per month by 2025 and propellant capacity from 4 M to 16 M lb per year by 2028, underscoring a deeper contract involvement and a strategic push to boost production capacity for Hydra‑70 rockets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the evolution of Hydra-70 rockets in General Dynamics' Combat Systems segment and correctly identifies key facts, but introduces unverified information that creates accuracy concerns. CORRECT ELEMENTS: (1) The $175 million 2022 contract is accurately cited; (2) OTS's market-leading position is correctly identified; (3) The metal parts production capacity expansion from 18,000 to 86,000 rounds per month by 2025 is accurate; (4) The characterization of the evolution from single contract to core Army modernization component is reasonable and well-reasoned. PROBLEMATIC ELEMENTS: (1) The LLM introduces propellant capacity expansion figures (4M to 16M lb per year by 2028) that are NOT present in the ground truth answer. While these numbers may exist in source documents, they cannot be verified against the provided ground truth, creating a factual accuracy concern; (2) The specific framing of 'low-rate production award' for the 2022 contract is interpretive language not explicitly in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022-2023 timeframes and connects contract awards to production capacity expansion, demonstrating sound multi-hop reasoning. The logical flow from initial contract to expanded capacity is clear and well-articulated. QUANTITATIVE ACCURACY PENALTY: The introduction of unverified propellant capacity numbers (4M to 16M lb per year by 2028) without ground truth confirmation reduces quantitative accuracy from what would otherwise be 8-9 to 5, as this represents factual claims beyond the verified knowledge graph. OVERALL ASSESSMENT: The answer is substantially correct on core facts but introduces additional claims not in the ground truth, which violates strict evaluation standards for financial/technical data from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 505,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings, PayPal moved the **Global Restricted Stock Unit Award Grant Notice** from an exhibit that was directly attached to the filing (Exhibit 10.07⁺ in the 2023 10‑K) to a document that is now only **incorporated by reference** from the earlier 2015 filing (shown as “Form of Global Restricted Stock Unit Award Grant Notice… under the 2015 Equity Incentive Award Plan” in the 2024 exhibit list).  Consequently, the notice is no longer separately filed in the 2024 filing, and the related award agreements are likewise referenced rather than attached, indicating a shift from explicit inclusion to reliance on prior incorporation.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. Key issues: (1) INCORRECT CLAIM ABOUT INCORPORATION STATUS: The LLM states the Global RSU Award Grant Notice moved from 'directly attached' in 2023 to 'incorporated by reference' in 2024. However, the ground truth explicitly states that in BOTH 2023 and 2024, the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) was 'incorporated by reference from 10-12B/A filed on May 14, 2015.' The LLM mischaracterizes the 2023 status as direct attachment when it was already incorporated by reference. (2) MISSING KEY INFORMATION: The LLM completely fails to address the critical evolution mentioned in the ground truth - the introduction of an UPDATED Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+) in 2024 that was linked to a more recent 10-Q filing on April 30, 2024. This is a significant development that the LLM entirely omits. (3) INCORRECT CHARACTERIZATION OF CHANGE: The LLM frames the evolution as a shift from 'explicit inclusion to reliance on prior incorporation,' but the ground truth shows the base RSU notice remained unchanged in its incorporation status, while the actual evolution was the addition of a performance-based variant with updated documentation. (4) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the multi-hop information correctly - it should have identified that while the standard RSU notice remained stable, the performance-based variant represented the actual documentary evolution in 2024. The answer demonstrates a fundamental misunderstanding of the filing structure and misrepresents the factual basis for comparison between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 464,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "\nOpdivo has stayed at the core of BMS’s oncology franchise, delivering roughly $7–8 billion in annual sales through 2022‑2024 and expanding its label with several new approvals—including first‑line NSCLC (Oct 2024), EC‑approved Opdivo + Yervoy for colorectal cancer (Dec 2024), and the subcutaneous formulation Opdivo Qvantig (Dec 2024) – while also being used in combination regimens for urothelial carcinoma and other indications (see BMY 10‑K 2024 pp. 44‑45). These regulatory wins broadened the drug’s market reach and reinforced its role as BMS’s primary revenue driver and a key engine of the company’s overall growth from 2022 into 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims Opdivo generated '$7–8 billion in annual sales through 2022‑2024' but the ground truth specifies 2022 revenue was $7,523 million ($7.523 billion). The LLM's range of $7-8B is imprecise and doesn't provide the specific 2022 figure from ground truth. More critically, the LLM provides NO 2024 revenue figure, which is essential for answering 'how has the role evolved from 2022 to 2024' - this is a major omission. (2) FACTUAL ERRORS - The LLM lists several approvals NOT mentioned in ground truth: 'first-line NSCLC (Oct 2024)', 'EC-approved Opdivo + Yervoy for colorectal cancer (Dec 2024)', and 'subcutaneous formulation Opdivo Qvantig (Dec 2024)'. The ground truth only mentions ONE specific 2024 approval: March 2024 FDA approval for urothelial carcinoma in combination with cisplatin and gemcitabine. The LLM appears to have hallucinated additional approvals not in the source material. (3) MULTI-HOP REASONING - The ground truth explicitly states Opdivo showed 'not showing a significant revenue increase from earlier years,' but the LLM claims it was 'a key engine of the company's overall growth from 2022 into 2024' - this contradicts the ground truth's assessment. (4) MISSING CRITICAL INFORMATION - The LLM fails to address the key insight from ground truth that despite regulatory expansion, there was NO significant revenue increase, which is central to understanding the evolution of Opdivo's role. (5) CITATION ISSUES - The LLM cites 'BMY 10-K 2024 pp. 44-45' but provides information not verifiable against the ground truth knowledge graph. The answer conflates regulatory approvals with revenue performance without proper synthesis. CORRECT ELEMENTS: The LLM correctly identifies Opdivo as core to BMS's oncology franchise and mentions the urothelial carcinoma indication, though with less specificity than ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 515,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "\nChevron’s equity investment in Chevron Phillips Chemical Company LLC grew from **$6.8 billion at the end of 2022 to $7.8 billion at the end of 2023** (Note 15, CVX_10K_2023 p. 82), indicating that the partnership moved from planning to capital deployment.  In 2023 the company also **provided a $387 million loan to fund the Golden Triangle Polymers project** and, after a final investment decision, began financing two new petrochemical expansions—a 1‑hexene unit and a C3 splitter at Cedar Bayou—signaling a more project‑specific investment structure that underpins Chevron’s strategic support.  (See CVX_10K_2022 p. 19 for the 2022 project pipeline and CVX_10K_2023 p. 18 for the 2023 FIDs.)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution in Chevron's financial involvement with CPChem between 2022 and 2023, including the critical $387 million loan to the Golden Triangle Polymers Project and the shift toward project-specific investment structures. The answer appropriately synthesizes multi-hop information across years and documents.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. EQUITY VALUE CLAIMS: The LLM states equity investment grew from \"$6.8 billion at the end of 2022 to $7.8 billion at the end of 2023.\" The ground truth does not mention these specific equity values. While the LLM cites Note 15 of the 2023 10-K, these numbers cannot be verified against the provided ground truth and appear to be unsupported claims. This is a major concern for quantitative accuracy.\n\n2. PROJECT DETAILS: The LLM mentions \"1-hexene unit and a C3 splitter at Cedar Bayou\" as being financed in 2023 after FID. However, the ground truth indicates these were \"planned\" projects with \"targeted start-ups in 2023\" mentioned in 2022 disclosures. The LLM's characterization of these as newly financed in 2023 may conflate the 2022 announcements with 2023 actions.\n\n3. CORRECT ELEMENTS: The $387 million loan to Golden Triangle Polymers Project is correctly identified and matches the ground truth. The 51% ownership stake in that project is also correct. The shift from equity ownership/announcements to direct financial support is accurately captured.\n\n4. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings and correctly identifies the evolution pattern requested. The logic connecting equity growth to capital deployment is sound, though the specific equity figures are unverified.\n\n5. CITATION ISSUES: While the LLM provides specific page references (Note 15, p. 82 for 2023; p. 19 for 2022; p. 18 for 2023), the equity values cited cannot be confirmed against the ground truth provided.\n\nThe answer demonstrates good qualitative understanding of the strategic shift but introduces unverified quantitative claims that significantly undermine confidence in the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 580,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "\nBetween 2023 and 2024 PayPal markedly expanded the financial commitment of its protection programs – the allowance for transaction‑loss reserves rose from **$64 million (2023) to $86 million (2024)**, and the allowance for negative customer balances increased from **$218 million to $256 million**.  The 2024 Form 10‑K now discloses a full reconciliation of these allowances (beginning balance, provision, realized losses, recoveries, ending balance) and explicitly describes the reserves as “assurance‑type warranties” that are estimated and recorded as part of transaction and credit losses, providing far more detailed transparency about the company’s expected loss exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: transaction loss allowance increased from $64M (2023) to $86M (2024), and negative customer balances allowance rose from $218M to $256M. The year-over-year comparison is accurate and properly formatted. The answer correctly identifies PayPal as the company and properly synthesizes the multi-hop information about the evolution of protection programs between the two fiscal years. The LLM goes beyond the ground truth by providing additional context about the 2024 Form 10-K disclosures, including the full reconciliation details and characterization of reserves as 'assurance-type warranties.' This additional detail is accurate and enhances the answer without introducing errors. The reasoning is sound: the answer correctly identifies that the increases represent expanded financial commitments and increased risk exposure. The only minor distinction is that the ground truth notes 2023 lacked specific disclosures while 2024 provided them, and the LLM answer captures this evolution by emphasizing the 'far more detailed transparency' in 2024. The semantic equivalence is strong - both answers convey the same core message about the evolution and increased financial commitments. No calculation errors are present, and all entities are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 378,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s continued to present franchising as the cornerstone of its business, but the way it described the franchise‑franchisor relationship shifted from a purely financial model to a strategic partnership.  \n\n- **2022 (Form 10‑K 2022, pp. 42‑44)** – The filing framed franchising as the “heavily franchised business model” that generates stable cash flow, emphasized that franchisees bear most capital costs, and mentioned co‑investment only as a tactical means to fund restaurant upgrades (“the Company may co‑invest… to accelerate implementation of certain initiatives”).  \n- **2024 (Form 10‑K 2024, pp. 4‑5)** – The narrative still calls franchising “paramount” but now presents co‑investment as a collaborative tool that “accelerates implementation of certain initiatives,” modernizes restaurants, caters to consumer preferences, and “increases the value of the McDonald’s brand” while aligning with the company’s broader purpose‑driven goals (e.g., sustainability, community impact).  \n\nThus, by 2024 the company recast franchisee co‑investment from a peripheral financing mechanism into a strategic, value‑creating partnership that supports both financial and purpose‑related objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the strategic shift in McDonald's framing between 2022 and 2024. STRENGTHS: (1) Correctly identifies the core evolution from neutral/structural framing (2022) to strategic/value-laden framing (2024); (2) Accurately captures the shift in how co-investment is presented - from 'tactical means' to 'strategic partnership'; (3) Properly synthesizes multi-hop information across two filing years; (4) Uses appropriate terminology ('paramount,' 'strategic partnership,' 'value-creating'); (5) Provides specific page references (pp. 42-44 for 2022, pp. 4-5 for 2024) that add credibility; (6) Correctly identifies that franchising remained central to the business model in both years. MINOR WEAKNESSES: (1) The LLM answer adds interpretive framing about 'purpose-driven goals' and 'sustainability, community impact' that, while plausible, are not explicitly mentioned in the ground truth answer - this represents slight over-interpretation beyond what was confirmed in the knowledge graph; (2) The phrase 'purely financial model' in 2022 is slightly stronger than the ground truth's 'neutral, structural terms' - though semantically similar, it adds interpretive weight not in the original; (3) The answer could have more explicitly stated that franchisees are 'co-participants' as mentioned in the ground truth. VERIFICATION: The core factual claims align with the ground truth: (a) 2022 = neutral/structural framing with division of responsibilities ✓; (b) 2024 = 'paramount' framing ✓; (c) Co-investment importance emphasized in 2024 ✓; (d) Shift from descriptive to strategic ✓. No numerical errors detected. The multi-hop reasoning correctly synthesizes information across two years and identifies the strategic evolution. The answer is well-structured and directly addresses all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 502,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "\nBetween March 2022 and January 2023 the FDA moved from granting a Modified‑Risk Tobacco Product (MRTP) designation to the IQOS 3 device (which includes Marlboro HeatSticks) to authorizing three new Marlboro HeatStick flavors through Premarket Tobacco Product Applications (PMTAs) in early 2023. This sequence shows that Altria has secured successive FDA clearances for its heated‑tobacco offerings, but the products remain subject to ongoing post‑market surveillance and potential future rulemaking, indicating that regulatory progress is advancing yet still contingent on continued FDA approval and compliance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces information NOT in the ground truth about an MRTP designation for IQOS 3 in March 2022. The ground truth makes no mention of an MRTP designation being granted in 2022. This is a significant factual error that misrepresents the regulatory timeline. (2) INCOMPLETE SYNTHESIS - The ground truth clearly states that in 2022 'the FDA had not yet authorized Marlboro HeatSticks' and was considering them on a case-by-case basis. The LLM answer conflates this with an MRTP designation that is not mentioned in the ground truth. (3) CORRECT ELEMENTS - The LLM correctly identifies: (a) January 2023 as the timeframe for PMTA authorizations, (b) three new tobacco-flavored varieties being authorized, (c) that this represents regulatory progress for Altria's heated tobacco products. (4) PROBLEMATIC ADDITIONS - The LLM adds context about 'post-market surveillance and potential future rulemaking' which, while potentially accurate in general regulatory terms, goes beyond what the ground truth establishes and may introduce unsupported claims. (5) MULTI-HOP REASONING - The LLM fails to properly synthesize the key contrast between 2022 (no authorization yet) and 2023 (three varieties authorized), instead introducing an intermediate MRTP step that contradicts the ground truth's statement that authorization had not yet occurred in 2022. The core finding that Altria made 'notable progress' is correct, but the pathway described is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 416,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "\nThe fair‑value of ACN’s mutual‑fund equity securities in its defined‑benefit pension plans was $239.3 million as of August 31 2022 (comprised of $4.9 million Level 1 and $234.3 million Level 2). The 2023 filing shows the target equity allocation for non‑U.S. pension assets raised from 21 % to 27 %, and the reported fair‑value of those mutual‑fund equity holdings increased accordingly. This shift signals that ACN is deliberately tilting its pension‑plan portfolio toward equities to pursue higher long‑term returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the 2022 value was $239.3 million, but the ground truth shows $239,293 million (approximately 1,000x larger). The LLM also claims the 2023 value 'increased accordingly,' but the ground truth clearly shows a DECREASE from $239,293 million to $196,226 million (a reduction of $43,067 million). The LLM's directional claim is completely wrong. (2) MISSING CRITICAL DATA: The LLM fails to provide the 2023 valuation figure at all, which is essential to answer the question about how the valuation 'evolved between 2022 and 2023.' (3) INCORRECT INTERPRETATION: The LLM interprets the shift as a deliberate tilt 'toward equities to pursue higher long-term returns,' but the ground truth indicates a reduction/reallocation AWAY from mutual fund equity securities. The LLM's reasoning about pension allocation percentages (21% to 27%) appears to reference different data and does not address the actual decline in mutual fund equity holdings. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the year-over-year comparison that is central to the question. The answer provides context about pension plan structure but misses the core finding: a $43 billion decline in holdings. (5) SEMANTIC CONTRADICTION: The LLM's conclusion that ACN is 'deliberately tilting its pension-plan portfolio toward equities' directly contradicts what the numbers show—a strategic reduction in mutual fund equity securities. The answer demonstrates a fundamental misunderstanding of the data or a calculation error of massive magnitude.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 462,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "\nFrom 2022 to 2023 Chevron trimmed its equity holding in Angola LNG Limited, cutting the book value of the investment from about **$1.96 bn (2022)** to **$1.76 bn (2023)** (see Note 15, page 82).  The company continues to focus on supplying the Angola LNG plant with reliable feedstock—especially through the SLGC gas‑connection project and the development of non‑associated offshore gas—but the modest reduction in its invested balance indicates a strategic pull‑back, with capital being redirected toward other upstream growth areas while still retaining its 36.4 % ownership stake.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The ground truth explicitly states Chevron 'continued to hold the same 36.4% interest' from 2022 to 2023 with no change in ownership stake. The LLM incorrectly claims Chevron 'trimmed its equity holding,' which is factually wrong. (2) The LLM introduces specific book value figures ($1.96bn in 2022 declining to $1.76bn in 2023) that are not mentioned in the ground truth and cannot be verified. These numbers appear to be fabricated or misattributed. (3) The LLM references 'Note 15, page 82' and mentions 'SLGC gas-connection project' which are not corroborated by the ground truth source material. (4) The characterization of a 'strategic pull-back' is contradicted by the ground truth, which indicates the 36.4% stake remained constant. CORRECT ELEMENTS: The LLM correctly identifies the 36.4% ownership percentage and acknowledges Chevron's continued involvement in supplying feedstock to the Angola LNG plant. However, these correct elements are overshadowed by the fundamental misrepresentation of the equity holding change. The core narrative of the answer—that Chevron reduced its investment—is factually incorrect according to the ground truth. The ground truth emphasizes a shift in disclosure emphasis (from operational focus to portfolio integration), not an actual reduction in equity stake, which the LLM fundamentally misses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 400,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "\nMMM’s holdings of certificates of deposit/time deposits rose sharply year‑over‑year.  The 2023 10‑K (page 110) shows $49 million of such securities in 2023 versus $21 million in 2022 – an increase of $28 million, or about a 133 % growth from 2022 to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors in the core numerical data. Ground truth shows: 2022 = $14 million, 2023 = $49 million, change = $35 million (250% increase). LLM answer states: 2022 = $21 million, 2023 = $49 million, change = $28 million (133% increase). The 2022 figure is incorrect ($21M vs $14M), leading to cascading errors: the dollar change is wrong ($28M vs $35M) and the percentage increase is wrong (133% vs 250%). The 2023 figure of $49 million is correct. The LLM correctly identified the company (MMM), the metric (Certificates of Deposit/Time Deposits), the years (2022-2023), and the general direction of change (increase). The reasoning structure is sound - comparing year-over-year values and calculating the magnitude of change. However, the fundamental numerical errors are critical failures for a financial question where precision is essential. The LLM appears to have cited page 110 of the 2023 10-K, suggesting an attempt at source verification, but the 2022 baseline figure is demonstrably incorrect according to the ground truth knowledge graph. This represents a major factual error that undermines the entire answer despite correct methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 336,
        "total_tokens": 1476
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "\nBetween 2021 and 2024 the share of McDonald’s restaurants operated by franchisees rose modestly—from about 93 % of the system at the end of 2021 to roughly 95 % by the end of 2024. This incremental increase reflects the company’s ongoing strategy of expanding its heavily franchised model while maintaining a stable, predictable revenue base driven by franchisee sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. (1) QUANTITATIVE ACCURACY: All key numbers are correct - 93% in 2021 and approximately 95% in 2024 match the ground truth exactly. The characterization of this as a 'modest' or 'slight' increase is appropriate given the 2 percentage point change. (2) COMPLETENESS: The answer fully addresses the question about how McDonald's franchisee relationship evolved between 2021 and 2024, providing both the starting and ending percentages. (3) ENTITY ACCURACY: McDonald's is correctly identified, the time period (2021-2024) is accurate, and the metric (percentage of franchised restaurants) is properly specified. (4) REASONING & SYNTHESIS: The LLM correctly synthesizes the multi-hop information by comparing the two years and drawing a logical conclusion about the strategic shift toward franchising. The additional context about 'maintaining a stable, predictable revenue base driven by franchisee sales' adds relevant business insight that aligns with McDonald's known business model, though this specific detail is not explicitly in the ground truth statement. (5) SEMANTIC EQUIVALENCE: The wording differs slightly from the ground truth ('modestly' vs 'slight but deliberate shift'), but both convey the same essential meaning - a small but intentional increase in franchising. The LLM's phrasing is clear and professional. Minor note: The ground truth emphasizes 'deliberate shift' while the LLM emphasizes 'ongoing strategy' - both are semantically equivalent interpretations of the same trend. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 446,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "\nThe 2015 Stock Compensation Plan for Non‑Employee Directors was most recently amended and restated effective **October 26 2022** (as disclosed in the 2022 Form 10‑Q). No further amendment or restatement was filed in the 2023 Form 10‑K, so the plan’s terms and the October 26 2022 effective date remained unchanged through 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to properly address the question's core requirement. CRITICAL ISSUES: (1) The question asks how the plan 'evolved between 2022 and 2023,' requiring comparison of the plan's status in both years. The ground truth shows the plan had an effective date of March 31, 2021 in 2022, then was amended to October 26, 2022 by 2023. (2) The LLM answer incorrectly states the October 26, 2022 amendment was 'disclosed in the 2022 Form 10-Q,' when the ground truth indicates this was the status by 2023. (3) The LLM answer claims 'no further amendment or restatement was filed in the 2023 Form 10-K,' which contradicts the ground truth showing the plan WAS amended and restated with an October 26, 2022 effective date appearing in 2023 filings. (4) The LLM fails to identify the evolution: the plan went from being 'amended and restated effective March 31, 2021' (2022 status) to 'amended and restated effective October 26, 2022' (2023 status). This represents a clear structural/temporal evolution that the LLM completely missed. (5) The answer provides the correct October 26, 2022 date but misplaces it temporally and mischaracterizes when it became effective. The LLM demonstrates a fundamental misunderstanding of the multi-hop synthesis required—comparing the plan's status across two different filing years to identify how it evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 386,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Accenture continued to account for its stake in Duck Creek Technologies as an equity‑method investment.  In the FY 2022 filing (page 70) the investment’s carrying amount was $138.9 million, with an estimated fair value of $223.2 million; by FY 2023 the company recorded a $253 million pre‑tax investment gain related to Duck Creek (page 40), reflecting a substantial rise in the investment’s fair value and boosting adjusted earnings per share.  Thus, the financial impact evolved from a modest $138 million book value in 2022 to a significant $253 million gain in 2023, markedly improving Accenture’s reported results.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about Accenture's Duck Creek Technologies investment evolution. STRENGTHS: (1) All key numeric values are correct: FY2022 carrying amount of $138.9 million (matches $138,902 in thousands), FY2022 fair value of $223.2 million (matches $223,166 in thousands), and FY2023 gain of $253 million. (2) The accounting method (equity-method investment) is correctly identified and maintained across both years. (3) The multi-hop synthesis is sound: the answer traces the investment from FY2022 valuation through to FY2023 realization event, showing the evolution from a long-term equity stake to a significant gain recognition. (4) The answer correctly identifies this as a shift from book value to gain realization, capturing the essence of the ground truth's observation about 'shift from a long-term equity stake to a more active financial realization event.' (5) Page references (page 70 for FY2022, page 40 for FY2023) add credibility and specificity. (6) The characterization of the impact on adjusted EPS is accurate. MINOR CONSIDERATIONS: (1) The ground truth mentions '16% ownership' which the LLM answer does not include, though this is a minor omission that doesn't affect the core financial relationship analysis. (2) The LLM answer could have been slightly more explicit about the ownership percentage, but this is not critical to answering the main question about financial relationship evolution. (3) Number format variations are handled correctly (thousands converted to millions appropriately). The answer effectively conveys the same information as the ground truth with accurate calculations and sound reasoning across the multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 479,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "\nBetween 2022 and 2024 Breyanzi’s approved scope widened from its initial use in relapsed/refractory large‑B‑cell lymphoma to include other B‑cell cancers, and in 2024 the FDA granted two accelerated approvals that specifically expand its market: May 2024 – accelerated approval for adult patients with relapsed or refractory follicular lymphoma who have received ≥ 2 prior lines of systemic therapy, and March 2024 – accelerated approval for relapsed or refractory chronic lymphocytic leukemia/small‑lymphocytic lymphoma after ≥ 2 prior therapies that include a BTK inhibitor and a BCL‑2 inhibitor. In addition, Japan approved Breyanzi in August 2024 for high‑risk follicular lymphoma after a single prior line, further enlarging the eligible patient population.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Breyanzi's indications between 2022 and 2024, with accurate dates for the two 2024 FDA approvals (March 2024 for CLL/SLL and May 2024 for follicular lymphoma). However, there are significant issues: (1) The LLM adds information about Japan's August 2024 approval for high-risk follicular lymphoma after a single prior line, which is NOT in the ground truth answer and appears to be unsupported by the knowledge graph provided. This is a factual addition beyond the scope of the original answer. (2) The LLM specifies additional details about the CLL/SLL approval requiring 'a BTK inhibitor and a BCL-2 inhibitor' as prior therapies, which is more specific than the ground truth's simpler statement of 'at least two prior lines of therapy.' While this additional specificity may be accurate, it goes beyond what the ground truth confirms. (3) The LLM correctly captures that these are 'accelerated approvals,' though the ground truth doesn't explicitly use this terminology. (4) The 2022 baseline indication is correctly characterized as relapsed/refractory large B-cell lymphoma. The multi-hop reasoning is sound in connecting the evolution from 2022 to 2024, but the introduction of unsupported information (Japan approval) and additional specificity not in the ground truth creates factual discrepancies. The answer is contextually relevant and well-structured, but the addition of information not in the knowledge graph is a significant accuracy concern.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 417,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "\nBetween 2022 and 2023, 3M’s methodology for estimating insurance recoveries under ASC 450 became more detailed and quantitative: it now ties every recorded legal‑proceeding liability to a specific, assessable insurance receivable and records receivables not only when a loss is probable and estimable but also when defense expenses are incurred, provided recovery is deemed probable. The 2023 disclosures show a $57 million increase in the accrual for respirator‑mask/asbestos claims and an associated, still immaterial, insurance receivable, reflecting a more precise estimation of probable losses and the portion of those losses that the company expects to recover. Consequently, while the company acknowledges greater uncertainty about the upper bound of potential liability, it continues to recognize insurance receivables only to the extent recovery is reasonably estimable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported information not present in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a '$57 million increase in the accrual for respirator-mask/asbestos claims' with no supporting evidence in the ground truth. This specific dollar amount is not mentioned in the original answer and appears to be fabricated. (2) MISSING CRITICAL DATA: The ground truth explicitly states that claimant numbers increased from 4,028 in 2022 to 4,042 in 2023 - a key quantitative metric that the LLM completely omits. This is a material factual gap. (3) METHODOLOGY DESCRIPTION: While the LLM attempts to describe a more detailed methodology in 2023, it introduces concepts like 'ties every recorded legal-proceeding liability to a specific, assessable insurance receivable' and 'records receivables...when defense expenses are incurred' that are not substantiated in the ground truth. The ground truth specifically mentions 'loss recovery and/or gain contingency models under ASC 450 and ASC 610-30' which the LLM does not reference. (4) PARTIAL ALIGNMENT: The LLM correctly identifies that 2023 showed more explicit/detailed methodology compared to 2022, which aligns with the ground truth's statement that 2022 'did not specifically mention the methodology' while 2023 'explicitly described' it. (5) UNSUPPORTED CLAIMS: The statement about 'still immaterial' insurance receivable and 'greater uncertainty about the upper bound' are not mentioned in the ground truth and appear to be inferences without filing support. The answer demonstrates weak multi-hop synthesis - it fails to connect the increasing claimant numbers to the evolution in methodology as the ground truth does, and introduces fabricated financial figures that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 494,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "\nBetween 2022 and 2023 PepsiCo no longer owned the Naked juice brand; in Q1 2022 it sold Naked (along with Tropicana and other select juice brands) to PAI Partners but kept a 39 % non‑controlling equity interest in the newly created Tropicana Brands Group (TBG).  Consequently, PepsiCo’s relationship shifted from full‑scale brand ownership to a minority stake coupled with an exclusive distribution role—PepsiCo now distributes TBG’s portfolio (including Naked) to small‑format and food‑service customers in the United States via its direct‑store‑delivery network.  This arrangement gives PepsiCo an ongoing operational involvement through distribution while its financial exposure is limited to the 39 % equity interest in TBG.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 39% noncontrolling interest in the joint venture and accurately dates the transaction to Q1 2022. The core narrative about the shift from ownership to minority stake is sound. The mention of exclusive distribution to small-format and foodservice customers via direct-store-delivery is accurate.\n\nCRITICAL ERRORS: (1) Entity name error: The LLM calls the joint venture 'Tropicana Brands Group (TBG)' when the ground truth specifies it as 'The Beachbody Company (TBG)'. This is a significant factual error in entity identification. (2) Geographic scope error: The LLM states distribution occurs 'in the United States' when the ground truth indicates the joint venture operates 'across North America and Europe'. This is a material omission of geographic scope. (3) Incomplete evolution narrative: The LLM fails to capture the key evolution point - that by 2023, PepsiCo 'no longer directly distributed Naked products' and the relationship became 'purely financial.' The LLM's answer suggests ongoing distribution involvement ('now distributes TBG's portfolio'), which contradicts the ground truth's explicit statement that by 2023 there was 'no further operational involvement in the distribution of Naked products.'\n\nMULTI-HOP REASONING: The answer demonstrates partial synthesis but misses the critical temporal evolution. The question specifically asks how the relationship 'evolved between 2022 and 2023,' and the ground truth emphasizes a shift FROM operational involvement (2022) TO purely financial stake (2023). The LLM presents a static view of the 2022 arrangement without clearly articulating the 2023 change.\n\nQUANTITATIVE: The 39% figure is correct and properly formatted. The Q1 2022 date is accurate.\n\nQUALITATIVE: The entity name error and geographic scope omission are significant weaknesses. The failure to clearly distinguish the 2022 vs 2023 operational status represents incomplete multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 532,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s disclosure of the ExtraBucks Rewards program remained anchored in the same core model—recognizing a distinct performance obligation at the point of the initial transaction and allocating revenue based on the relative standalone selling price, with revenue recorded only as the rewards are redeemed and unredeemed amounts held as a contract‑liability—but the 2024 filing added clearer, more detailed quantitative disclosures.  The 2024 10‑K explicitly ties the ExtraBucks liability to “rewards earnings and gift‑card issuances,” breaks out the impact of recent acquisitions on that liability, and emphasizes breakage estimates derived from historical redemption patterns, thereby sharpening the explanation of how the performance obligation is satisfied over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the consistent core accounting model across 2023-2024 (performance obligation at initial transaction, revenue recognition upon redemption, contract liability treatment). (2) Accurately captures the key evolution: 2024 added more refined and detailed disclosures without changing the fundamental approach. (3) Properly synthesizes multi-hop information about how the program's accounting treatment evolved. (4) Correctly identifies specific 2024 enhancements (quantitative disclosures, ties to rewards earnings and gift-card issuances, acquisition impacts, breakage estimates). (5) No quantitative errors or incorrect numbers/dates. MINOR WEAKNESSES: (1) The LLM answer emphasizes 'quantitative disclosures' and specific line items (rewards earnings, gift-card issuances, acquisition impacts) that are more granular than the ground truth explicitly states. While these details appear reasonable and consistent with typical 10-K evolution, the ground truth uses more general language about 'more refined language' and 'more structured language' around performance obligations and standalone selling prices. (2) The ground truth emphasizes that 2024 language became 'more refined' regarding the determination of performance obligations being 'specifically tied to customers who accumulate ExtraBucks based on historical spending levels,' whereas the LLM answer focuses more on quantitative breakouts rather than this specific refinement about customer-level determination. (3) The LLM answer could have more explicitly mentioned the emphasis on historical spending levels as a factor in determining performance obligations. OVERALL ASSESSMENT: The answer is substantially correct in its core claims about consistency and evolution, accurately captures the multi-hop synthesis required, and contains no factual errors. The minor gap relates to emphasis and specificity of certain disclosure refinements rather than fundamental inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 554,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "\nThe 2024 cost‑of‑revenues schedule shows total cost of revenues falling from **58 % of revenue in 2023 to 54 % in 2024**, indicating a modest improvement in overall expense efficiency, but the filing does not break out the amount paid to **integrated payment partners** as a separate line item. Consequently, while the aggregate cost‑of‑revenues share is lower, the documents provide **no quantitative evidence of a change in the volume or importance of payments to integrated payment partners** between 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core of the ground truth answer. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific percentages (58% in 2023, 54% in 2024) without verification against the actual filings. These numbers are presented as fact but cannot be confirmed from the provided context. The ground truth does not mention these specific percentages. (2) FUNDAMENTAL MISALIGNMENT: The ground truth explicitly states that Netflix DID mention payment processing fees to integrated payment partners in BOTH 2023 and 2024, but with reduced granular detail in 2024. The LLM incorrectly concludes that 'the filing does not break out the amount paid to integrated payment partners as a separate line item' and claims there is 'no quantitative evidence.' This directly contradicts the ground truth, which confirms these fees were referenced in both years. (3) MISSED CORE INSIGHT: The ground truth's key finding is about a SHIFT IN DISCLOSURE STRATEGY - the relationship persisted but with less explicit detail. The LLM focuses instead on cost-of-revenues percentages and the absence of separate line items, missing the actual evolution described in the ground truth. (4) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the multi-hop information correctly: it should have identified that payment processing fees were mentioned in both years' cost of revenues sections, but with different levels of detail/granularity. Instead, it claims no quantitative evidence exists. (5) REASONING FLAW: The LLM's conclusion that 'documents provide no quantitative evidence of a change' contradicts the ground truth's finding that there WAS a documented change (in disclosure detail, if not in the relationship itself). The answer demonstrates a fundamental misunderstanding of what the filings actually disclosed about integrated payment partners.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 507,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "\nFrom 2022 to 2023 3M moved beyond the baseline remediation required by the 2007 Minnesota Settlement Agreement and began treating PFAS management as a financial‑risk issue as well as a compliance one.  The company substantially increased its PFAS‑related liability reserve ($10.6 billion accrual in 2023) and entered new settlement talks (e.g., the proposed PWS Settlement) while intensifying its dialogue with the Minnesota Pollution Control Agency in response to regulatory moves such as the MPCA’s March 2023 notice of violation, the draft Clean‑Water Act permit that proposes stricter PFAS limits, and the Minnesota Department of Health’s January 2024 update to health‑based values for PFOA and PFOS.  These health‑based standard changes forced 3M to re‑evaluate its remedial obligations and to plan for additional treatment or alternative water supplies to meet the tighter thresholds.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key regulatory developments and timeline. STRENGTHS: (1) Correctly identifies all major regulatory actions: MPCA March 2023 Notice of Violation at Hutchinson facility, December 2022 MPCA order on Cottage Grove stormwater, January 2024 MDH updated HBVs for PFOA/PFOS, and proposed Clean Water Act permit with stricter PFAS limits. (2) Accurately captures the evolution from 2022 to 2023 showing increased regulatory pressure and 3M's response. (3) The $10.6 billion accrual figure for 2023 is a specific quantitative detail that appears reasonable for PFAS-related liabilities. (4) Correctly synthesizes multi-hop information about how regulatory changes prompted re-evaluation of remedial obligations. (5) Appropriately characterizes the shift from baseline compliance to financial risk management. MINOR WEAKNESSES: (1) The original answer provides more specific site-level details (Cottage Grove substantially completed in 2022, ongoing operations at Oakdale and Woodbury, Decatur Alabama facility under 2020 interim Consent Order with ADEM) that the LLM answer omits. These details provide important context about the scope of 3M's PFAS management across multiple facilities. (2) The LLM answer mentions 'proposed PWS Settlement' which is not explicitly mentioned in the ground truth, though this may represent additional accurate information not contradicted by the source. (3) The answer could have been more explicit about the May 2007 Settlement Agreement and Consent Order (SACO) as the baseline framework. QUANTITATIVE VERIFICATION: The $10.6 billion figure cannot be directly verified against the ground truth provided, but it is presented as a specific 2023 accrual and appears contextually appropriate. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple regulatory bodies (MPCA, MDH), multiple time periods (2022-2024), and multiple facility locations, showing sound understanding of how regulatory changes cascade into financial and operational impacts. The logical flow from regulatory action → re-evaluation → financial reserve increase is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 591,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the notional amount of PepsiCo’s foreign‑currency derivatives grew from roughly **$3.0 billion to $3.8 billion** (the company reports $3.0 bn outstanding as of Dec 31 2022 and $3.8 bn as of Dec 30 2023).  This increase reflects a deliberate expansion of its hedging program—adding more forward and swap contracts and extending coverage to protect a larger share of its overseas cash flows, investments and purchase‑price exposures.  The move signals that PepsiCo is strengthening its proactive foreign‑exchange risk management, seeking to lock in favorable rates and reduce earnings volatility from currency fluctuations across its global operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $3.0 billion for 2022 and $3.8 billion for 2023 match the ground truth exactly. The dates are also accurate (Dec 31, 2022 and Dec 30, 2023). The calculation of the increase ($800 million or ~26.7% growth) is implicit and correct. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the derivatives evolved (quantitative change from $3.0B to $3.8B), and (2) what this indicates about risk management strategy (expansion of hedging program). ENTITY ACCURACY: PepsiCo is correctly identified, the metric (notional value of foreign currency derivatives) is correct, and the time periods are accurate. REASONING QUALITY: The LLM provides sound multi-hop synthesis by connecting the numerical increase to strategic implications - explaining that the expansion reflects deliberate hedging program growth, forward/swap contracts, and broader coverage of overseas exposures. The reasoning about locking in favorable rates and reducing earnings volatility is logical and consistent with standard FX risk management practices. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while adding helpful context about the types of instruments (forward and swap contracts) and specific exposures being hedged (cash flows, investments, purchase-price exposures). The ground truth mentions 'no material net impact on earnings in 2023' which the LLM does not explicitly state, but the LLM's reference to 'reduce earnings volatility' is semantically related and contextually appropriate. This is a minor omission but does not significantly detract from the answer's quality. Overall, the answer is factually accurate, well-reasoned, and appropriately detailed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 495,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "\nBetween 2022 and 2023 ExxonMobil shifted from mainly expanding Gulf‑Coast petrochemical capacity—such as the Corpus Christi ethane cracker, Baytown and Baton Rouge projects and advanced‑recycling facilities—to a dual‑track growth strategy that adds high‑value specialty capacity in the United States (e.g., new performance‑polymer and linear‑alpha‑olefin lines) while simultaneously deepening its geographic reach with a multi‑billion‑dollar, 100 % foreign‑owned petrochemical complex in China’s Dayawan Industrial Park, designed to deliver more than 2.5 million metric tons per year of polyethylene and polypropylene for China’s rising middle‑class demand. This evolution reflects a move toward higher‑margin, specialty products and a broader global footprint to capture the improving living‑standard‑driven demand for chemicals.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core strategic evolution correctly and includes most key facts from the ground truth. Strengths: (1) Correctly identifies the shift from 2022 to 2023; (2) Accurately mentions Corpus Christi ethane cracker completion in 2022; (3) Correctly states the 500,000 metric tons advanced recycling capacity target by 2026 in Baytown (implied through context); (4) Accurately describes the Dayawan, China complex as 100% foreign-owned with 2.5+ million metric tons per year of polyethylene and polypropylene; (5) Properly synthesizes the geographic and product focus evolution. Weaknesses: (1) The LLM mentions 'Baton Rouge projects' which are not explicitly mentioned in the ground truth answer, introducing potentially extraneous information; (2) The answer adds interpretive language about 'multi-billion-dollar' investment and 'higher-margin specialty products' that, while reasonable inferences, go beyond what the ground truth explicitly states; (3) Minor: The phrasing 'Baytown and Baton Rouge projects' in the 2022 context is not clearly supported by the ground truth, which focuses on Corpus Christi and Baytown specifically. Quantitative verification: All numeric values are correct (500,000 metric tons, 2.5 million metric tons, 100% ownership, 2026 timeline). The multi-hop reasoning is sound—the answer correctly synthesizes information about the company's strategic shift across two years and geographic locations. The semantic meaning aligns well with the ground truth despite some additional interpretive elements. The answer appropriately addresses both the chemical production capacity additions and geographic focus evolution requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 461,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "\nFrom 2022 to 2023 the amount of 3M’s certificates‑of‑deposit/time‑deposits recorded as marketable securities rose sharply from **$21 million to $49 million** (an increase of more than 130 %).  At the same time the company’s total marketable‑security balance fell dramatically—from $261 million to $73 million—driven largely by a cut in commercial‑paper holdings.  \n\nThis shift signals that 3M is deliberately moving its short‑term cash into **safer, higher‑yielding fixed‑income instruments** (CDs/time deposits) while trimming exposure to more volatile short‑term assets such as commercial paper.  The move reflects a strategy focused on **preserving liquidity and capital amid rising interest rates**, locking in modest returns with low credit risk rather than maintaining a broader, higher‑risk short‑term investment portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and goes beyond the ground truth in providing comprehensive context. QUANTITATIVE VERIFICATION: All numbers are correct - $21 million (2022), $49 million (2023), and the calculation of 'more than 130%' increase is accurate (($49-$21)/$21 = 133.3%). The additional context about total marketable securities declining from $261 million to $73 million is factually sound and adds valuable perspective. ENTITY ACCURACY: Correctly identifies 3M, the specific investment category (Certificates of Deposit/Time Deposits), and the correct fiscal years (2022 to 2023). MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple dimensions - not just the CD/time deposit evolution, but also contextualizes it within the broader marketable securities portfolio, noting the shift away from commercial paper. This multi-hop analysis is logically sound and demonstrates understanding of portfolio reallocation strategy. SEMANTIC EQUIVALENCE: The core message matches the ground truth - the shift indicates strategic movement toward safer, higher-yielding instruments and liquidity preservation. The LLM's explanation about 'rising interest rates' and 'locking in modest returns' provides additional strategic context that is reasonable and consistent with the data pattern shown. MINOR CONSIDERATIONS: The LLM provides more detailed analysis than the ground truth (mentioning commercial paper decline, interest rate environment), which enhances rather than detracts from the answer. The percentage calculation (130%+) is slightly more precise than the ground truth's 'more than doubling' but both are correct characterizations. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 467,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "\nMastercard’s language about proprietary insights stayed essentially unchanged from 2022 to 2023, continuing to describe those insights as coming from a “principled use of consumer and merchant data” and delivering them through its “well‑known and trusted brands.”  The 2023 text does not add new responsibility or trust‑building qualifiers—it simply reiterates the same commitment to responsible data use—indicating a steady, rather than evolving, emphasis on data responsibility and trust.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim and directly contradicts the ground truth. (1) FACTUAL ERRORS: The LLM states that Mastercard's language 'stayed essentially unchanged from 2022 to 2023' and that '2023 text does not add new responsibility or trust-building qualifiers.' This is directly contradicted by the ground truth, which explicitly documents an evolution in language from 'principled use' (2022) to 'principled and responsible use of secure consumer and merchant data' (2023). The addition of 'responsible' and 'secure' are material changes that the LLM failed to identify. (2) MULTI-HOP REASONING: The question asks specifically about how the approach 'evolved' from 2022 to 2023. The LLM's conclusion that there was no evolution is the opposite of what the ground truth establishes. The ground truth clearly identifies a shift that 'indicates a stronger emphasis on data security and trust as a core component.' (3) SEMANTIC ACCURACY: While the LLM correctly identifies that both years reference 'principled use of consumer and merchant data,' it fails to recognize the critical additions in 2023 ('responsible' and 'secure'). These are not minor wording variations—they represent substantive changes in how Mastercard positioned its data strategy. (4) CONTEXTUAL UNDERSTANDING: The LLM misses the broader narrative context that the ground truth identifies: the evolution reflects 'a broader narrative around cybersecurity and stakeholder confidence.' The LLM's characterization of this as 'steady, rather than evolving' demonstrates a fundamental misreading of the evidence. The only element the LLM gets correct is the reference to 'well-known and trusted brands,' but this does not compensate for the incorrect core conclusion about evolution versus stasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 488,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "\nBetween 2022 and 2023 the drivers of the pension‑ and retiree‑medical estimate shifted from mainly demographic‑mortality assumptions toward greater sensitivity to macro‑economic shocks—particularly higher interest‑rate volatility, rising health‑care cost inflation and geopolitical uncertainty (as noted in the “Impact of” line on page 57 and the critical‑accounting‑policy discussion on page 60).  This evolution reflects a more unpredictable external environment, forcing the company to adopt more conservative and frequently reassessed inputs for those liabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains some correct elements but makes significant errors in identifying the key factors and misses critical information from the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies the shift between 2022 and 2023\n- Mentions higher interest rates and inflation as factors in 2023\n- References geopolitical uncertainty\n- Acknowledges the evolution toward a more unpredictable environment\n\nCRITICAL ERRORS:\n1. MISIDENTIFICATION OF 2022 FACTORS: The LLM claims 2022 was influenced by \"demographic-mortality assumptions\" and \"macro-economic shocks.\" The ground truth explicitly states 2022 was influenced by \"uncertainties related to the ongoing impacts of the COVID-19 pandemic.\" This is a fundamental factual error about what drove 2022 estimates.\n\n2. INCOMPLETE 2023 FACTORS: While the LLM mentions interest rates, inflation, and geopolitical uncertainty, it omits the specific geopolitical conflicts mentioned in the ground truth: \"ongoing conflicts in Ukraine and the Middle East.\" The ground truth is more specific about which geopolitical events were relevant.\n\n3. MISCHARACTERIZATION OF SHIFT: The LLM describes the shift as \"from mainly demographic-mortality assumptions toward greater sensitivity to macro-economic shocks.\" This is incorrect. The ground truth describes the shift as \"from health-related disruptions [COVID-19] to broader macroeconomic and geopolitical concerns.\" These are fundamentally different characterizations.\n\n4. MISSING CORE INSIGHT: The ground truth emphasizes the shift FROM COVID-19 pandemic impacts TO geopolitical/macroeconomic factors. The LLM misses this central narrative by incorrectly identifying 2022 drivers.\n\nQUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is less critical. Both answers avoid numerical claims.\n\nQUALITATIVE ACCURACY: The LLM's reasoning about the evolution is partially sound, but it's built on an incorrect foundation regarding 2022 factors. The multi-hop synthesis fails because it doesn't correctly identify what changed between the two years.\n\nCONTEXTUAL RELEVANCE: The answer addresses the question's structure but provides incorrect content about the external environment factors, particularly for 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 609,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "\nBetween year‑end 2022 and year‑end 2023 ExxonMobil’s undeveloped acreage in the **Other Americas** region contracted modestly – gross undeveloped acres fell from **≈25,096 (thousand) to ≈24,221 (thousand)**, and net undeveloped acres from **≈11,977 to ≈11,548 (thousand)** (roughly a 3–4 % decline in each).  This reduction reflects the company’s practice of releasing non‑core or fully‑evaluated parcels while still retaining a large, strategically held undeveloped base.  Because most of these lands are held under leases and licenses that can be extended, the shrinkage does **not** diminish the region’s exploration upside; rather, it signals that ExxonMobil is focusing its resources on the most prospective acreage while preserving ample room for future discoveries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - gross undeveloped acres decreased from 25,096 to 24,221 thousand acres (875 thousand acre reduction, approximately 3.5%), and net undeveloped acres decreased from 11,977 to 11,548 thousand acres (429 thousand acre reduction, approximately 3.6%). The percentage calculations cited (3-4% decline) are accurate. ENTITY ACCURACY: Correctly identifies ExxonMobil, the Other Americas region, and the 2022-2023 timeframe. COMPLETENESS: The answer addresses both parts of the multi-part question - it describes how the acreage position evolved (with specific numbers) and interprets what this indicates about exploration potential. REASONING QUALITY: The LLM provides sound multi-hop synthesis by: (1) presenting the quantitative changes, (2) explaining the mechanism (relinquishment/transition to developed status), and (3) contextualizing the implications (focus on prospective acreage while maintaining exploration upside). The interpretation that the reduction reflects strategic portfolio management rather than diminished exploration potential is reasonable and aligns with the ground truth's suggestion of focusing on higher-potential properties. SEMANTIC EQUIVALENCE: The LLM's explanation that the company is 'focusing its resources on the most prospective acreage' semantically matches the ground truth's statement about 'focus on properties with higher exploration potential.' The additional context about lease extensions and preservation of exploration upside adds valuable nuance without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM uses approximate symbols (≈) which is appropriate given the context, and the phrasing 'contracted modestly' effectively conveys the modest nature of the decline. No factual errors or calculation mistakes detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 513,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "\nFrom 2022 to 2023 the company continued to employ foreign‑currency forward and option contracts that are **not designated as hedging instruments** to offset the effects of non‑functional‑currency items (e.g., intercompany financing balances).  The notional amount and fair‑value of these derivatives fell sharply—gross notional dropped from $2.8 bn to $1.0 bn and the related fair‑value exposure fell from $73 m to $5 m—while the earnings impact improved from a $76 million loss in 2022 to a $9 million loss in 2023, with the gains/losses recorded directly in income rather than through OCI.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant quantitative inaccuracies that fundamentally contradict the ground truth. (1) GROSS NOTIONAL AMOUNT DISCREPANCY: The LLM states the gross notional amount dropped from $2.8 billion to $1.0 billion, but the ground truth clearly indicates it was $3.7 billion in 2022. This is a major factual error ($900 million discrepancy). The LLM provides specific numbers ($2.8bn, $1.0bn) that do not match the source data. (2) FAIR VALUE AND EARNINGS IMPACT: The LLM introduces specific fair value figures ($73m to $5m) and earnings impact figures ($76 million loss to $9 million loss) that are NOT present in the ground truth answer. These appear to be fabricated or sourced from incorrect data. The ground truth does not provide these specific quantitative metrics. (3) MULTI-HOP REASONING: While the LLM correctly identifies that the company used foreign currency contracts not designated as hedging instruments for both years and correctly notes that gains/losses were recorded directly in income, the foundational numbers are wrong. (4) WHAT WAS CORRECT: The LLM correctly identifies (a) the use of forward and option contracts not designated as hedging instruments, (b) the purpose of offsetting non-functional currency items including intercompany financing balances, (c) that fair value gains/losses impact earnings directly rather than through OCI, and (d) the general trend of continued use across both years. (5) SEMANTIC ALIGNMENT: The answer does address the evolution question and attempts to show a comparison between years, which is appropriate to the question structure. However, the specific numbers provided are factually incorrect, making this a severely flawed response despite addressing the right conceptual framework. The confidence in providing specific quantitative data that contradicts the ground truth is particularly problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 516,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard moved cyber‑and‑intelligence solutions from a peripheral add‑on to a core component of its value‑added services portfolio.  In the 2023 Form 10‑K (pages 80 and 82) these solutions are listed under “Other revenues” and management explicitly cites growth in “value‑added services and solutions”—including cyber and intelligence offerings—as a primary driver of the 13 % increase in net revenue and the improvement in operating margin, underscoring a stronger strategic emphasis on security‑focused products than in the prior year.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Cyber and Intelligence Solutions from a peripheral to core component of Mastercard's value proposition, which aligns with the ground truth. The qualitative assessment of the strategic shift is sound and well-reasoned. However, there are significant quantitative accuracy issues: (1) The LLM cites a '13% increase in net revenue' as being driven by cyber and intelligence solutions growth, but this specific percentage and its attribution to these solutions is not verified in the ground truth and appears to be an unsupported claim. (2) The LLM references specific page numbers (80 and 82) from the 2023 Form 10-K, but these cannot be verified against the ground truth provided. (3) The ground truth does not mention a specific percentage increase in net revenue or operating margin improvement tied to cyber solutions. The LLM appears to have added quantitative details that go beyond what the ground truth supports. The multi-hop reasoning is sound—comparing 2022 positioning (supporting role) to 2023 positioning (core component)—but the introduction of unverified financial metrics weakens the answer. The semantic equivalence is good regarding the evolution narrative, but the addition of specific percentages and page references without ground truth support is problematic for a financial evaluation context where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 389,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "\nIn both the 2022 and 2023 Form 10‑K filings, “Income Tax Expense and Accruals” continues to be listed as a critical accounting policy, with essentially the same substance—reliance on statutory rates, transfer‑pricing considerations and judgment in establishing tax reserves. The 2023 filing moves the detailed description into the consolidated “Critical Accounting Policies and Estimates” section, whereas the 2022 filing presented it as a separate subsection, but the core language and disclosure have not changed materially.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth clearly states that in 2022, 'income tax expense and accruals' was explicitly listed as a critical accounting policy, and by 2023 it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with more structured presentation. The LLM answer reverses this relationship, claiming that in 2022 it was presented as a separate subsection and in 2023 it was moved into the consolidated section—the opposite of what actually occurred. This is a critical error in understanding the evolution of disclosure structure between the two years. The LLM correctly identifies that both years include income tax expense and accruals as a critical accounting policy and mentions relevant concepts like statutory rates and transfer pricing, but the core claim about the directional change in presentation structure is inverted. The LLM also states 'the core language and disclosure have not changed materially,' which contradicts the ground truth's assertion that there was a meaningful evolution toward 'more detailed and organized reporting' in 2023. While the LLM demonstrates some understanding of the topic (quantitative accuracy is reasonable as no specific numbers are involved), the qualitative reasoning about the structural evolution is fundamentally flawed, making this answer misleading despite some correct contextual elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 401,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "\nIn 2023 Intel first demonstrated the Universal Chiplet Interconnect Express (UCXE) in silicon, using the proof‑of‑concept to illustrate how chiplets can be linked together for AI‑focused, system‑of‑chips designs. By 2024 the company has elevated UCXE from a technical showcase to a core strategic standard within its Open‑System Foundry model, embedding it in foundry services, expanding design‑win momentum and partner ecosystems, and coupling it with advanced packaging to accelerate customer adoption of chiplet‑based systems.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) ENTITY NAME ERROR - The LLM consistently refers to the standard as 'UCXE' (Universal Chiplet Interconnect Express) when the correct acronym is 'UCIe' (Universal Chiplet Interconnect Express). This is a fundamental factual error that appears throughout the answer. The ground truth clearly states 'UCIe' multiple times. (2) INCOMPLETE SYNTHESIS - While the LLM captures the general progression from 2023 demonstration to 2024 production/integration, it introduces unsupported claims about 'Open-System Foundry model,' 'design-win momentum,' and 'partner ecosystems' that are not present in the ground truth. The ground truth specifically mentions 'advanced semiconductor assembly and test offerings' which the LLM does not reference. (3) MISSING KEY CONTEXT - The ground truth emphasizes Intel's 'systems of chips strategy' as the broader strategic context, which the LLM mentions only tangentially. The ground truth's specific mention of 'advanced packaging technologies and system-level standards' is not adequately captured. (4) ACCURACY ASSESSMENT - The core timeline (2023 demonstration, 2024 production/integration) is correct, but the specific details about what Intel was doing in 2024 differ from ground truth. The LLM adds speculative elements about foundry services and partner ecosystems without grounding in the provided knowledge graph. The systematic misspelling of the standard name (UCXE vs UCIe) is a critical factual error that undermines credibility throughout the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 420,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "\nIn the 2023 10‑K CVS disclosed two prior ASRs (the $2 bn Citibank transaction in January 2023 and the $1.5 bn Barclays transaction in January 2022) in which the company initially recorded the received shares as treasury stock and the forward component as an equity‑classified forward contract in capital surplus; the remaining shares were delivered in February 2023 (and February 2022 for the earlier deal), at which point the forward contract was re‑classified from capital surplus to treasury stock.  \nThe 2024 10‑K shows a new $3 bn ASR entered in January 2024 with Morgan Stanley, again using an 85 % immediate share receipt and recording the forward contract in capital surplus, but the balance of the shares was received in March 2024, completing the transaction and triggering the same re‑classification of the forward contract to treasury stock.  \nThus, the accounting model (initial treasury‑stock entry, forward‑contract recorded in capital surplus, later re‑classification upon final receipt) has remained consistent, while the scale and completion timeline have progressed to a larger, more recent ASR.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates understanding of the accounting treatment consistency and provides relevant context, but contains significant quantitative errors that undermine accuracy. CORRECT ELEMENTS: (1) The accounting treatment remained consistent across years - initial treasury stock recording, forward contract in capital surplus, reclassification upon completion. (2) The 2024 ASR was $3.0 billion with Morgan Stanley. (3) The 85% initial receipt percentage for 2024 is correct. (4) The completion timeline evolved from one month (2023) to two months (2024). (5) The multi-hop synthesis across 2023 and 2024 filings is logically sound. CRITICAL ERRORS: (1) The LLM incorrectly states the 2023 Citibank ASR received shares in 'February 2023' when the ground truth specifies initial receipt of 17.4 million shares (80% of $2.0B) with an additional 5.4 million in February 2023 - the LLM conflates the timing. (2) The LLM introduces a $1.5 billion Barclays transaction from January 2022 that is not mentioned in the ground truth answer, which focuses specifically on 2023 and 2024 comparisons. This is extraneous information that wasn't requested. (3) The LLM does not provide the specific share counts (17.4M + 5.4M for 2023; 31.4M + 8.3M for 2024) that are central to understanding the transaction details. (4) The LLM states the 2023 transaction was 'in January 2023' but doesn't clearly distinguish the initial receipt from the final receipt timing. QUANTITATIVE ACCURACY ISSUES: Missing specific share quantities and percentages (80% for 2023 vs 85% for 2024) that demonstrate the evolution. The answer lacks the granular numerical detail needed for a complete evaluation of how the transactions evolved. MULTI-HOP REASONING: The synthesis across years is sound in concept, but the execution lacks precision in the specific metrics that define the evolution. The answer correctly identifies the pattern but misses quantitative details that would strengthen the comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 534,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "\nIn 2022 UPS reported a $2.3 billion pre‑tax actuarial loss from coordinating benefits under the Central States Pension Fund (shown in the footnote disclosures) but did not quantify that exposure with a separate sensitivity analysis. By 2023 the 10‑K includes a dedicated sensitivity table that quantifies the effect of a 25‑basis‑point discount‑rate shift on the projected benefit obligation (≈ $1.55 billion) and on ongoing expense (≈ $15–$16 million), explicitly linking those impacts to the Central States Pension Fund coordinating‑benefit estimate.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM introduces specific numbers NOT in the ground truth - it claims a 25 basis point shift affects the PBO by '≈ $1.55 billion' and ongoing expense by '≈ $15-$16 million'. The ground truth only mentions '25 basis point change in expected and actual returns on assets' without specifying these dollar impact figures. The LLM appears to have fabricated or hallucinated these sensitivity analysis results. (2) PARTIAL CORRECTNESS: The LLM correctly identifies the $2.3 billion pre-tax actuarial loss from 2022 and the shift to sensitivity analysis in 2023, which aligns with ground truth. The mention of 25 basis points is correct. (3) PROBLEMATIC SPECIFICITY: The ground truth states the 2023 reporting 'references a 25 basis point change' as a 'key assumption' but does NOT provide the specific dollar impacts on PBO or expense that the LLM claims. The LLM's addition of '≈ $1.55 billion' and '≈ $15-$16 million' cannot be verified against the ground truth and appear to be unsupported fabrications. (4) REASONING QUALITY: The overall narrative structure is sound - describing a shift from quantifying a specific obligation to sensitivity analysis - but the introduction of unverified numbers undermines credibility. (5) MULTI-HOP SYNTHESIS: The LLM correctly synthesizes the 2022-to-2023 evolution and links it to the Central States Pension Fund, but the added quantitative details break the chain of verifiable reasoning. The answer conflates what the ground truth says with additional specificity that cannot be confirmed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 433,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard shifted from merely describing cyber‑and‑intelligence capabilities as part of its “value‑added services” to presenting them as a core growth engine.  In the 2023 filing (Item 7 Business Overview, p. 49) the company explicitly linked these solutions to “secure, easy and confident” transactions and to “proprietary insights” that drive revenue, noting that growth in payment‑network and value‑added services—including cyber‑intelligence—accounted for the 13 % rise in net revenue and helped lift adjusted operating margin.  Thus, the stakeholder narrative moved from a generic service mention to a strategic emphasis on cyber‑intelligence as a differentiator that delivers secure payments, data‑driven insights and measurable financial upside.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Mastercard's messaging around Cyber and Intelligence Solutions from 2022 to 2023, correctly identifying a shift from describing these as value-added services to positioning them as strategic growth drivers. The qualitative reasoning about the evolution is sound and aligns with the ground truth's core narrative.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. QUANTITATIVE PROBLEMS: The LLM cites a \"13% rise in net revenue\" attributed to growth in payment-network and value-added services including cyber-intelligence. This specific percentage claim is not verified in the ground truth and appears to be either fabricated or misattributed. The ground truth does not mention this specific 13% figure in relation to cyber-intelligence solutions. This is a critical error as it presents a specific metric as fact without verification.\n\n2. CITATION ACCURACY: The LLM references \"Item 7 Business Overview, p. 49\" as the source. While this may be accurate, the ground truth does not provide these specific page citations, making it impossible to verify whether this reference is correct or if the quoted language actually appears there.\n\n3. SEMANTIC ALIGNMENT: The ground truth emphasizes that 2023 messaging linked cyber solutions to \"open banking and digital identity\" as new strategic networks. The LLM answer does not mention these specific new network initiatives, which represents an omission of important contextual details about the evolution.\n\n4. CORRECT ELEMENTS: The LLM correctly identifies the shift from generic service description to strategic emphasis, correctly notes the connection to \"secure, easy and confident\" transactions, and appropriately characterizes the evolution as moving toward positioning cyber-intelligence as a differentiator.\n\n5. MULTI-HOP REASONING: The answer demonstrates sound multi-hop reasoning by synthesizing information about how the company's positioning evolved and connecting it to financial performance, though the specific financial claim lacks verification.\n\nThe answer is partially correct in its qualitative assessment but undermined by unverified quantitative claims that reduce overall reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 598,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "\nIn the 2022 filing the 4.450 % Senior Note due 2046 is listed under **Exhibit 4.11** and the filing cites the original 8‑K that announced the notes – “Form of 4.450 % Senior Note due 2046, incorporated herein by reference to Exhibit 4.4 to PepsiCo’s Current Report on Form 8‑K filed October 14, 2015.”  \nIn the 2023 filing the same instrument appears under **Exhibit 4.13** and is now tied to a later 8‑K filing – “Form of 4.450 % Senior Note due 2046, incorporated herein by reference to Exhibit 4.4 to PepsiCo’s Current Report on Form 8‑K filed February 24, 2016.”  \n\nThus, between the 2022 and 2023 SEC filings the company moved the note from Exhibit 4.11 (referencing the 2015 filing) to Exhibit 4.13 (referencing the 2016 filing), updating both the exhibit number and the documentation date used to describe the note’s terms.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN EXHIBIT NUMBERING: The LLM answer contains significant factual errors that directly contradict the ground truth. (1) 2022 FILING EXHIBIT NUMBER: Ground truth states Exhibit 4.12, but LLM claims Exhibit 4.11 - this is a direct factual error. (2) 2023 FILING EXHIBIT NUMBER: Both sources agree on Exhibit 4.13, so this is correct. (3) DOCUMENTATION DATES: The LLM correctly identifies October 14, 2015 for the 2022 filing and February 24, 2016 for the 2023 filing, matching the ground truth. (4) FORM 8-K EXHIBIT REFERENCES: The LLM states both references point to 'Exhibit 4.4' of the respective 8-K filings, which appears consistent with the ground truth's description of incorporation by reference. (5) MULTI-HOP REASONING: The LLM correctly synthesizes the evolution between years and identifies the shift in exhibit numbering and documentation dates. However, the fundamental error in the 2022 exhibit number (4.11 vs. 4.12) is a critical factual mistake that undermines the entire answer. The LLM does provide good contextual explanation of what the changes represent, but this cannot overcome the quantitative error. The answer demonstrates understanding of the question's intent and provides relevant analysis, but the incorrect exhibit number in the 2022 filing is a material factual error that significantly reduces the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 381,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "\nBetween 2023 and 2024 Intel continued to interact with Positive Technologies only under the authority of the U.S. OFAC license (General License 1B) that permits limited communications for vulnerability‑research and coordinated disclosure.  The 2023 filing notes that, after the 2021 sanctions, Intel resumed those communications on the basis of the OFAC license and “plans to continue these communications in accordance with the terms and conditions of the OFAC license,” and the 2024 filing repeats the same language, confirming that the relationship remained confined to sanctioned‑party activities with no gross revenue or net profit generated.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains accurate factual information but has significant issues with how it characterizes the evolution of the relationship. STRENGTHS: (1) Correctly identifies OFAC General License 1B as the authorization mechanism; (2) Accurately notes that both 2023 and 2024 filings confirm no gross revenues or net profits; (3) Correctly references the 2021 sanctions as the triggering event; (4) Accurately states that communications resumed under OFAC license authority. WEAKNESSES: (1) The core claim that the relationship 'remained confined' and that 2024 'repeats the same language' contradicts the ground truth, which explicitly states the relationship 'evolved' from 'disclosure of past communication' in 2023 to 'explicit statement of intent to continue' in 2024 - this is a material difference in how the filings characterize the relationship; (2) The LLM answer suggests stasis ('remained confined,' 'repeats the same language') when the ground truth emphasizes evolution and a 'more forward-looking and sustained partnership posture'; (3) The LLM fails to capture the qualitative shift from retrospective disclosure to prospective commitment that distinguishes the two years; (4) The answer misses the key insight that 2024 reflects a more explicit and forward-looking stance compared to 2023's more cautious disclosure approach. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and identifies the OFAC licensing framework, but fails to properly characterize the directional change in the relationship's nature and Intel's stated intentions. The factual elements are present but the interpretive framework is incorrect - this is a case where accurate facts are assembled into an inaccurate narrative about evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 480,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "\nThe carrying amount of CVS’s 4.78 % Senior Notes due March 2038 was $5.0 billion in both the 2023 and 2024 filings – it showed no net increase or decrease between the two years.  This stability indicates that, while the company has been actively issuing new senior notes and retiring shorter‑dated debt to reshape its maturity profile, it has kept this large, long‑dated tranche of fixed‑rate debt on the books as a core component of its long‑term capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: the 4.78% Senior Notes due March 2038 remained stable at $5.0 billion in both 2023 and 2024. The numeric values are accurate and properly formatted ($5.0 billion is equivalent to $5,000 million). The answer correctly addresses the first part of the question about how the balance evolved (no change). However, the answer has a notable weakness in addressing the second part of the question about what this indicates about the company's long-term debt structure. The original answer provides a more complete analysis by including a comparative example (the 2.7% senior notes due August 2040 that decreased from $1,250 million to $367 million), which demonstrates selective debt management and refinancing activity. The LLM answer mentions that CVS has been 'actively issuing new senior notes and retiring shorter-dated debt' but does not provide specific supporting evidence from the filings. The LLM's statement about reshaping maturity profile and keeping this as a 'core component' is reasonable inference but lacks the concrete comparative data that would strengthen the analysis. The reasoning is sound but incomplete - it makes a general claim about debt management strategy without the specific examples that would substantiate it. The answer is semantically coherent and contextually relevant, but falls short of the comprehensive analysis provided in the ground truth by omitting the comparative debt instrument example that illustrates the selective nature of CVS's debt management.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 427,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "\nThe 0.835 % Notes due 2032 continue to be listed as outstanding registered securities in both the 2022 and the 2024 Form 10‑K filings (they appear in the “Securities Registered” tables with the ticker XOM32 on the NYSE). No redemption, conversion or amendment of the notes is disclosed, so their legal status and terms remain unchanged between the two filings.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that the 0.835% Notes due 2032 remained outstanding in both 2022 and 2024 filings with ticker XOM32, and accurately notes no redemption/conversion/amendment was disclosed. The numeric values (0.835%, 2032, XOM32) are correct. However, the answer is significantly incomplete in addressing the core question about how the status 'evolved.' The ground truth emphasizes a critical comparative insight: while the 0.835% Notes remained consistent, the 0.142% Notes due 2024 (XOM24B) disappeared from the 2024 filing, indicating a meaningful change in debt composition. The LLM answer fails to provide this comparative analysis across the two years, which is essential for answering a question about 'evolution' between filings. The LLM focuses narrowly on the 0.835% Notes in isolation rather than synthesizing the broader debt structure changes. While the LLM's statement about the 0.835% Notes is factually accurate, it misses the multi-hop reasoning required: comparing what was present in 2022 vs. 2024 to identify compositional changes. The answer is partially correct but incomplete in scope and lacks the comparative synthesis needed to fully address how the status 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 342,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "\nBetween 2022 and the end of 2024 American Express pared back its U.S. Government‑treasury book dramatically – the fair‑value allocation fell from roughly $1.7 billion (cost ≈ $1.68 billion) in 2021 to just $0.29 billion (cost ≈ $0.29 billion) in 2024 – and it reshaped the maturity profile from a sizable long‑dated slice (about $1 billion of securities maturing after 5 years in 2021) to a near‑entirely short‑term ladder of $0.19 billion due within one year and $0.098 billion due in 1‑5 years by 2024.  Consequently, the portfolio moved from a modest unrealized gain of $25 million in 2021 to a small unrealized loss of roughly $2 million in 2024, reflecting both the size reduction and the shift toward shorter‑maturity Treasuries.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. CRITICAL ISSUES: (1) WRONG NUMBERS: The LLM cites 2021 data ($1.7 billion fair value, $1 billion long-dated) which is not part of the question scope (2022-2024). The ground truth specifies 2022 as the starting point with $477 million in short-term treasuries and zero long-term exposure. (2) INCORRECT 2024 FIGURES: LLM states $0.29 billion total fair value in 2024, but ground truth shows $287 million ($189M short-term + $98M intermediate-term = $287M total), which is approximately $0.287 billion - close in magnitude but the LLM's breakdown is wrong. The LLM correctly identifies $0.19 billion (~$189M) short-term and $0.098 billion (~$98M) intermediate-term for 2024, but the total stated ($0.29B) doesn't match the sum of these components. (3) SCOPE CREEP: The LLM introduces 2021 data and unrealized gains/losses information that, while potentially accurate, are not requested in the question and distract from the 2022-2024 comparison. (4) MATURITY CLASSIFICATION ERROR: The ground truth clearly states 2022 had 'short-term instruments' (less than 12 months) with no long-term exposure. The LLM's characterization of the shift is directionally correct (short-term to diversified maturity) but the baseline year is wrong. (5) MISSING KEY COMPARISON: The ground truth emphasizes the transformation from exclusively short-term ($477M) to a diversified portfolio including intermediate-term holdings. The LLM does capture this shift but with incorrect baseline numbers. The answer demonstrates some understanding of maturity diversification but fails on quantitative accuracy and introduces irrelevant 2021 data that contradicts the question's 2022-2024 timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 479,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "\nAmazon first issued the 2.500 % Note due 2050 in a June 3 2020 officers’ certificate (referenced in the 2020 Form 8‑K and reproduced in the 2022 10‑K as Exhibit 4.6).  The company did not retire, refinance, or amend that tranche in the subsequent 2022 or 2024 filings; it continued to be treated as a long‑term, fixed‑rate debt obligation with the same 2.5 % coupon and 2050 maturity, appearing only in the standard “Description of Securities” and indenture exhibits without any new issuance or modification disclosed through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCY: The LLM states the note appeared in 'Exhibit 4.6' in the 2022 10-K, but the ground truth explicitly states it was in 'Exhibit 4.5' in 2022 and then 'Exhibit 4.6' in 2024. This is a significant factual error in exhibit citation. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth clearly traces the evolution across three time points (2020 Officers' Certificate → 2022 Exhibit 4.5 → 2024 Exhibit 4.6), showing the progression and replication. The LLM conflates the exhibit numbers and doesn't clearly distinguish the 2022 vs 2024 treatment. (3) MISSING KEY DETAIL: The ground truth emphasizes that the 2024 Exhibit 4.6 was 'an exact replication of Exhibit 4.5 from 2020,' which is a crucial detail about how the note was treated. The LLM mentions no modification but doesn't capture this specific replication detail. (4) CORRECT ELEMENTS: The LLM correctly identifies the June 3, 2020 date, the 2.500% coupon, the 2050 maturity, and that the note was not retired, refinanced, or amended. The characterization as a long-term fixed-rate debt obligation is accurate. (5) REASONING QUALITY: While the LLM's reasoning about non-modification is sound, it fails to properly track the exhibit evolution across years, which is central to answering how the treatment 'evolved.' The answer reads more like a static description rather than a temporal evolution narrative. The core factual error regarding exhibit numbers in 2022 significantly undermines the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 421,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "\nBetween the 2022 and 2023 fiscal years Costco filed five separate amendments to its Citibank, N.A. Co‑Branded Credit Card Agreement: the eighth, ninth and tenth amendments were filed in 2022 (February 13 2022, November 20 2022 and November 20 2022, respectively), and the eleventh and twelfth amendments were filed in 2023 (February 12 2023 and October 11 2023). This progression shows a steady series of updates—three amendments in 2022 followed by two more in 2023—reflecting ongoing revisions to the credit‑card agreement over that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides more comprehensive detail than the ground truth. Verification of key facts: (1) Eighth Amendment filed March 10, 2022 - LLM states February 13, 2022 for the eighth amendment, which is a DATE DISCREPANCY. However, the LLM correctly identifies that the eighth amendment was in 2022. (2) Ninth and Tenth Amendments in 2022 (November 20, 2022 for both) - correctly identified and dated. (3) Eleventh Amendment in 2023 (February 12, 2023) - correctly identified and dated. (4) Twelfth Amendment on October 11, 2023 - correctly identified and dated, matching ground truth exactly. (5) Total count: Ground truth states 'four additional amendments' from 2022 to 2023 (Eighth to Twelfth = 4 new amendments). LLM states 'five separate amendments' total across both years (8th, 9th, 10th, 11th, 12th = 5 amendments), which is accurate for the full period. The LLM correctly synthesizes the multi-hop information: identifying Costco as the filer, the specific agreement type, the amendment numbers, filing dates, and the progression pattern. The reasoning is sound - showing three amendments in 2022 and two in 2023. The main issue is the discrepancy on the Eighth Amendment date (February 13 vs March 10, 2022), though both place it in 2022. The LLM provides superior detail with specific filing dates for all amendments, making it more useful than the ground truth answer. The semantic meaning and overall narrative match well.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 406,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA broadened CUDA from a GPU‑only model into a unified, full‑stack programming environment that runs on its new data‑center CPUs (Grace), DPUs, and the Blackwell GPU architecture.  The CUDA‑X library suite and AI‑focused extensions (e.g., NIM, NeMo, AI Blueprints) are now packaged inside the AI Enterprise software stack, allowing the same CUDA code to target GPUs, DPUs and CPUs and to be tightly coupled with networking, storage and cloud services across the company’s accelerated‑computing platforms.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of NVIDIA's CUDA evolution between 2022 and 2024, with mostly accurate information and good multi-hop synthesis. STRENGTHS: (1) Correctly identifies the shift from GPU-only to full-stack computing platform; (2) Accurately mentions new architectures (Grace CPUs, DPUs, Blackwell GPUs) introduced in fiscal 2024; (3) Properly describes CUDA-X library suite expansion; (4) Correctly notes integration with AI Enterprise software stack; (5) Good synthesis of how CUDA now targets heterogeneous architectures (GPUs, DPUs, CPUs). WEAKNESSES: (1) Introduces specific product names (NIM, NeMo, AI Blueprints) that are not mentioned in the ground truth, which adds specificity but goes beyond what can be verified from the provided knowledge graph; (2) The phrase 'tightly coupled with networking, storage and cloud services' is somewhat speculative and not explicitly stated in the ground truth; (3) Minor: The answer could have been clearer about CUDA's role in 2022 as a foundational building block across Gaming, Data Center, Professional Visualization, and Automotive markets. MULTI-HOP REASONING: The answer successfully synthesizes information about CUDA's evolution across the 2022-2024 period and correctly identifies the integration with new computing architectures (CPUs, DPUs) and software ecosystems (AI Enterprise). The core narrative of evolution from GPU-focused to heterogeneous computing platform is sound and matches the ground truth. ENTITY ACCURACY: All major entities are correct (NVIDIA, CUDA, Grace, Blackwell, DPUs, CPUs). The fiscal 2024 timing for CPU introduction is accurate. Overall, this is a strong answer with minor additions beyond the ground truth that don't contradict it but add interpretive detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 482,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer moved Paxlovid from a peak‑year government‑contract business to a largely commercial, deferred‑revenue model. In 2023 the company recorded only $1.28 bn of Paxlovid product revenue, but in Q4 2023 it booked a $3.5 bn non‑cash revenue reversal for expected returns of EUA‑labeled courses, and in Q1 2024 it reversed $771 m of that estimate and recognized $442 m from a U.S. SNS supply of 1 m courses. As of 31 Dec 2024 Pfizer had about $1 bn of remaining performance obligations for future Paxlovid deliveries (expected through 2025‑2028), reflecting the shift from large‑scale government purchases to commercial sales and the recognition of revenue only as product is shipped.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative of Pfizer's Paxlovid financial evolution correctly but contains a significant factual error that undermines quantitative accuracy. CORRECT ELEMENTS: (1) 2023 revenue of $1.28-1.279 billion is accurate; (2) $3.5 billion non-cash revenue reversal in Q4 2023 is correct; (3) $771 million favorable adjustment in 2024 is correct; (4) $442 million revenue from SNS supply is correct; (5) ~$1 billion remaining performance obligations as of Dec 31, 2024 is correct; (6) The narrative about shift from government-driven to more stable contracted model is accurate; (7) Timeline references (Q4 2023, Q1 2024, through 2025-2028) are appropriate. CRITICAL ERROR: The LLM states the SNS supply involved '1 m courses' when the ground truth specifies this was in connection with the creation of the SNS, not a specific quantity of 1 million courses. The ground truth mentions 6.5 million treatment courses expected to be returned initially and 5.1 million actually returned, but the LLM conflates this with the SNS transaction. This is a material factual error regarding the nature and scope of the SNS transaction. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023-2024 periods and connects revenue recognition, contractual obligations, and business model shifts. The logic flow is sound and the comparative analysis is well-structured. COMPLETENESS: The answer addresses all major components of the question including revenue recognition evolution, contractual obligations, and the business model transition. The inclusion of future delivery timeline (2025-2028) adds helpful context. The error regarding the SNS transaction specifics prevents a higher score despite otherwise strong performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 479,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 the pool of shares reserved for the 2003 Incentive Program shrank from roughly **66 million shares** that were available for future grants (as disclosed in the 2022 filing) to about **47 million shares** remaining at the end of 2024.  This reduction reflects the issuance of new awards—including the conversion of Pioneer restricted‑stock units—plus vested and forfeited awards, causing the number of outstanding restricted‑stock/RSU awards to rise from **37.8 million at the start of 2024 to 39.6 million by year‑end**.  The program continues to allow grants of options, SARs, restricted stock and RSUs under its 220‑million‑share ceiling, with the same graded‑vesting structure (50 % after three years, the remainder after seven years), while a separate Pioneer LTIP still had about **9.4 million shares** available for future issuance at the end of 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about share availability evolution but contains significant quantitative discrepancies and introduces information not in the ground truth. CORRECT ELEMENTS: (1) Correctly identifies the shrinkage from ~66 million to ~47 million shares available; (2) Correctly notes the 220 million share ceiling; (3) Correctly identifies RSU grants increased from 9,392 thousand (2022) to 10,393 thousand (2024); (4) Appropriately discusses the program structure and vesting terms. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific numbers about outstanding RSU/restricted stock awards (37.8 million at start of 2024 rising to 39.6 million by year-end) that are NOT in the ground truth and cannot be verified; (2) The LLM mentions a separate Pioneer LTIP with 9.4 million shares available, which is not mentioned in the ground truth answer and appears to conflate or add information beyond what was provided; (3) The ground truth explicitly states RSU grants were 9,392 thousand in 2022 and 10,393 thousand in 2024, but the LLM conflates this with outstanding awards (37.8M to 39.6M), which are different metrics. MULTI-HOP REASONING: The LLM attempts to explain the mechanism of share reduction (new awards, vesting, forfeitures) which shows good reasoning, but this explanation goes beyond the ground truth without clear sourcing. The answer demonstrates understanding of how share pools work but introduces unverified details. QUANTITATIVE ACCURACY ISSUE: The introduction of the 37.8M to 39.6M figures and the 9.4M Pioneer LTIP shares represents a significant departure from the ground truth, reducing confidence in the quantitative accuracy despite getting the main 66M→47M and 220M figures correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 472,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "\nBetween 2022 and 2024 AdSense remained part of Google’s “Google Network” but its relative importance faded as Google consolidated its advertising technology into a broader, AI‑driven suite.  The 2024 filing emphasizes a unified portfolio of performance‑ and brand‑focused products—such as Performance Max, Demand Gen and Product Studio—that deliver ads across Search, YouTube and partner properties, with AdSense now functioning only as one component of that larger ecosystem rather than a primary growth driver.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively captures the core evolution of AdSense's role between 2022 and 2024. STRENGTHS: (1) Correctly identifies the shift from AdSense as an explicitly cited growth driver in 2022 to a more foundational component by 2024; (2) Accurately names the newer AI-powered products (Performance Max, Demand Gen, Product Studio) that replaced AdSense as strategic priorities; (3) Properly synthesizes the multi-hop concept that AdSense remained part of Google Network but lost prominence; (4) Correctly characterizes the strategic shift toward a unified, AI-driven advertising portfolio. QUANTITATIVE ACCURACY: The LLM answer does not cite the specific $8.6 billion figure mentioned in the ground truth for 2022, which represents a minor omission. However, the question does not explicitly ask for specific revenue figures, and the absence of this number does not fundamentally undermine the answer's accuracy regarding the evolution narrative. QUALITATIVE ASSESSMENT: The reasoning is sound and demonstrates proper multi-hop synthesis across years and product portfolios. The characterization of AdSense transitioning from 'primary growth driver' to 'one component of a larger ecosystem' accurately reflects the ground truth's core message. MINOR GAPS: The answer could have been strengthened by including the specific $8.6 billion figure to provide quantitative context for AdSense's 2022 importance, though this is not essential to answering the question about evolution and strategic positioning. The answer appropriately emphasizes the shift toward AI-powered solutions and the consolidation of advertising technology, which aligns with the ground truth's narrative about strategic repositioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 477,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "\nBetween 2022 and 2023 the UPS Retirement Plan moved from a traditional defined‑benefit accrual that continued to build future benefits for non‑union participants to a “frozen” structure: effective January 1 2023 the plan stopped accruing any additional benefit credits for future service and compensation for those participants. Instead, beginning in 2023 non‑union employees (including those who had been accruing benefits under the UPS Retirement Plan) began receiving a defined‑contribution contribution of 5 %–8 % of eligible pay into the UPS 401(k) Savings Plan, replacing the prior benefit‑accrual mechanism.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core structural change: the UPS Retirement Plan transitioned from an active benefit-accruing defined-benefit plan to a frozen structure effective January 1, 2023, for non-union participants. The date (January 1, 2023) is accurate, and the characterization of the shift from DB accruals to a frozen plan is correct. The answer also accurately adds important context about the replacement mechanism: non-union employees began receiving 5%-8% defined-contribution contributions to the 401(k) Savings Plan. This additional detail about the replacement benefit structure is not explicitly mentioned in the ground truth but represents a logical and accurate extension of the accrual freeze policy. Quantitatively, all numbers are correct (5%-8% contribution range, January 1, 2023 effective date). The multi-hop reasoning is sound: the answer synthesizes the change across years and explains both what was eliminated (DB accruals) and what replaced it (DC contributions). The only minor gap is that the LLM answer goes slightly beyond the ground truth by introducing the 401(k) replacement details, which while accurate and relevant, weren't explicitly confirmed in the provided ground truth statement. This represents appropriate contextual expansion rather than an error. The semantic equivalence is strong: 'frozen structure' and 'ceased accruals' convey the same meaning, and 'stopped accruing any additional benefit credits for future service and compensation' matches the ground truth language precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 425,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon replaced its old $7 bn revolving line (maturing June 2023, LIBOR + 0.50 % with a 0.04 % commitment fee and no drawn balance) with a larger $15 bn unsecured revolving facility (maturing Nov 2028, benchmark + 0.45 % and a 0.03 % fee) and added a $5 bn 364‑day revolving facility (SOFR + 0.45 %, 0.03 % fee, maturing Oct 2025).  The company has kept borrowings under these short‑term facilities essentially zero in 2023‑24, relying instead on modest commercial‑paper draws and the repayment of a $8 bn term loan, indicating a shift toward greater credit capacity, slightly lower‑cost terms and a minimal use of drawn credit.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the main evolution of Amazon's credit facilities between 2022 and 2024 with generally accurate information, but has some notable omissions and one potential inaccuracy:\n\nCORRECT ELEMENTS:\n- $7.0 billion facility in 2022 with LIBOR + 0.50% and 0.04% commitment fee (correctly identified as maturing June 2023)\n- $15.0 billion replacement facility with benchmark + 0.45% and 0.03% fee (correctly identified as maturing Nov 2028)\n- $5.0 billion 364-day facility with SOFR + 0.45% and 0.03% fee (correctly identified as maturing Oct 2025)\n- No borrowings outstanding under main Credit Agreement or Short-Term Credit Agreement as of Dec 31, 2024\n- Overall characterization of shift toward greater capacity and lower-cost terms\n\nOMISSIONS/GAPS:\n- Failed to mention the $147 million and $151 million in borrowings under OTHER short-term credit facilities as of Dec 31, 2023 and 2024 respectively. This is a material omission since the question specifically asks about \"outstanding borrowings\" and the ground truth explicitly notes these amounts were included in 'Accrued expenses and other'\n- Did not mention the $8.3 billion in unused letters of credit by end of 2024 (ground truth mentions $7.2 billion in 2021 and $8.3 billion in 2024)\n- The reference to \"repayment of a $8 bn term loan\" is not mentioned in the ground truth and appears to be extraneous information not directly relevant to the short-term credit facilities question\n- Did not explicitly mention the $7.2 billion in unused letters of credit as of December 31, 2021 for 2022 baseline\n\nQUANTITATIVE ACCURACY:\nAll stated numbers are correct, but the answer is incomplete by omitting the $147M-$151M borrowings under other facilities. This represents a significant gap in answering the \"outstanding borrowings\" component of the question.\n\nQUALITATIVE ACCURACY:\nThe multi-hop reasoning is sound in synthesizing the evolution across years and identifying the key changes. However, the answer fails to fully address all dimensions of the question (particularly outstanding borrowings under other facilities).\n\nCONTEXTUAL RELEVANCE:\nThe answer is highly relevant and well-structured, addressing credit capacity, interest rate terms, and the evolution between 2022-2024. The characterization of the shift is appropriate and insightful.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 624,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "\nCostco’s filing for both 2022 and 2023 states that it continues to supplement a base of fixed‑price power‑ and gas‑supply contracts with variable‑priced, index‑based agreements for electricity, natural‑gas and fuel, and that these variable contracts are treated as “normal purchases and normal sales” and therefore are not marked‑to‑market.  The wording in the 2023 document mirrors the 2022 description, indicating that the company’s commodity‑price risk management has not changed materially—it still relies on a mixed strategy of fixed‑price contracts for key locations while using variable‑price, index‑based contracts to capture market movements and limit exposure without formal hedging.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates strong understanding of Costco's commodity price risk management strategy. STRENGTHS: (1) Correctly identifies the use of variable-priced, index-based contracts for electricity, natural gas, and fuel; (2) Accurately notes the 'normal purchases and normal sales' exception treatment with no mark-to-market adjustment; (3) Properly synthesizes the multi-hop comparison between 2022 and 2023, correctly concluding that the strategy remained consistent with no material change; (4) Accurately characterizes the mixed strategy of fixed-price contracts supplemented by variable-price contracts; (5) No quantitative errors or incorrect dates/numbers. MINOR WEAKNESSES: (1) The LLM adds interpretive language about 'capturing market movements and limit exposure without formal hedging' that goes slightly beyond what the ground truth explicitly states—while this interpretation is reasonable and not contradicted by the source material, it represents a modest inference beyond the stated facts; (2) The phrase 'supplement a base of fixed-price power- and gas-supply contracts' is slightly more specific than the ground truth, which doesn't explicitly detail the 'base' structure, though this is a reasonable characterization of the mixed strategy described; (3) Could have been more explicit about the specific commodities (electricity, natural gas, fuel for gas stations) being called out in both years, though this is adequately covered. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2023 filings to identify the evolution (or lack thereof) in strategy, properly comparing the two years and drawing the correct conclusion about consistency. The reasoning is sound and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 483,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "\nBetween 2022 and 2024, NVIDIA AI Enterprise shifted from a peripheral, license‑only add‑on for enterprise‑grade AI software to a central, revenue‑generating subscription suite that is tightly coupled with the company’s newest data‑center hardware (e.g., the Blackwell GPUs, CPUs and DPUs).  In the 2022 filing (pages 78‑82) AI Enterprise was described only as a paid software layer sold alongside the data‑center platform, but by the 2024 filing (pages 4‑8) it is presented as a strategic, end‑to‑end AI software stack—including NIM, NeMo and AI Blueprints—marketed directly to enterprises and cloud partners as a core component of NVIDIA’s data‑center offering.  This evolution reflects a broader commercial model that emphasizes subscription licensing, deeper integration with the full computing stack, and a dedicated go‑to‑market push to drive data‑center revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of NVIDIA AI Enterprise's evolution between 2022 and 2024, with mostly accurate characterization of the strategic shift. STRENGTHS: (1) Correctly identifies the core evolution from a peripheral offering to a central revenue-generating component; (2) Accurately names specific product components (NIM, NeMo, AI Blueprints) that represent the expanded suite; (3) Properly synthesizes the multi-hop concept of integration with newer hardware (Blackwell GPUs, CPUs, DPUs); (4) Correctly captures the shift toward subscription licensing and go-to-market emphasis; (5) Appropriately references 2022 and 2024 filings as sources. MINOR ISSUES: (1) The characterization of 2022 positioning as 'peripheral' and 'license-only add-on' is slightly more negative than the ground truth's 'foundational role' - the ground truth suggests it was strategically important from inception, not peripheral; (2) Page number citations (pages 78-82 for 2022, pages 4-8 for 2024) cannot be verified against the ground truth and may be inaccurate, though this doesn't affect the core factual claims; (3) The answer adds specific product details (NIM, NeMo, AI Blueprints) not explicitly mentioned in the ground truth, which is appropriate elaboration but goes slightly beyond what was confirmed. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The temporal references (2022, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions - product evolution, commercial positioning, hardware integration, and business model changes - demonstrating sound multi-hop reasoning. The connection between AI Enterprise and the broader data center platform is properly established. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth: AI Enterprise evolved from a strategic initiative to a key monetization vehicle. The emphasis on 'subscription licensing' and 'full-stack integration' matches the ground truth's concept of 'key monetization vehicle within its full-stack data center platform.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 584,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer’s Paxlovid contracts moved from large‑scale government stock‑piling under EUA‑labelled supply (which generated $5.1 bn of deferred revenue and a $3.5 bn non‑cash reversal in Q4 2023) to commercial‑market agreements; by year‑end 2024 the company had reduced deferred Paxlovid revenue to $2.2 bn, recognized a $771 m favorable adjustment in Q1 2024 and $442 m of revenue from a U.S. SNS shipment in Q3 2024, and disclosed only about $1 bn of remaining contracted revenue to be recognized through 2025‑2028. This shrinkage of deferred obligations and the shift to commercial sales indicate that Pfizer now expects only modest, limited future revenue from Paxlovid rather than the blockbuster sales seen in 2022‑23.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides additional detail and context beyond the ground truth, but introduces several quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) The $3.5 billion non-cash reversal in Q4 2023 is accurate; (2) The ~$1 billion remaining performance obligations as of December 31, 2024 matches ground truth; (3) The overall narrative about shift from government stockpiling to commercial markets is reasonable; (4) The conclusion about modest future revenue expectations aligns with ground truth. PROBLEMATIC ELEMENTS: (1) The LLM cites $5.1 billion in deferred revenue in 2023, which is not mentioned in the ground truth and cannot be verified; (2) The claim of $2.2 billion deferred revenue by year-end 2024 contradicts the ground truth's statement of ~$1 billion remaining performance obligations; (3) The $771 million favorable adjustment in Q1 2024 and $442 million U.S. SNS shipment in Q3 2024 are not mentioned in ground truth and appear to be unsupported details; (4) The specific revenue recognition figures ($771M, $442M) lack verification against the original answer. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution from 2023 to 2024 and draws appropriate conclusions about demand stabilization, but the additional quantitative claims introduce uncertainty. The reasoning about the shift from blockbuster to modest revenue is sound and supported by the core facts. SEMANTIC EQUIVALENCE: The core message about contractual obligation evolution is preserved, but the introduction of unverified numbers ($5.1B, $2.2B, $771M, $442M) creates factual accuracy concerns. The answer is more detailed but less reliable than ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 459,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "\nBetween 2022 and 2024 the scope of Google’s exposure to international regulatory costs shifted from a focus on structural trade and economic barriers—such as foreign‑ownership limits, currency controls, import‑export tariffs, longer payment cycles, and evolving foreign‑policy‑driven data‑transfer rules—to a broader, geopolitically‑driven set of compliance risks.  In 2024 the filing explicitly cites sanctions, export‑control restrictions, armed conflicts (e.g., Middle East, Ukraine) and new customer‑requirement regulations as sources of additional regulatory costs, expanding the nature of challenges from primarily economic‑trade hurdles to include security‑related and policy‑driven compliance obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer fundamentally mischaracterizes Google's regulatory exposure evolution. The ground truth clearly states that in 2022, Google's concerns were primarily about 'data transfers between the EU and the UK' and 'new customer requirements,' while in 2024 the scope expanded to include 'uncertainty regarding regulatory outcomes' and 'other liabilities under local laws that may not offer due process or clear legal precedent.' The LLM answer instead describes a shift from 'foreign-ownership limits, currency controls, import-export tariffs, longer payment cycles' (which are NOT mentioned in the ground truth for 2022) to 'sanctions, export-control restrictions, armed conflicts' (which are NOT mentioned in the ground truth for 2024). The LLM appears to have fabricated or confused regulatory concerns that are not supported by the ground truth. The answer does correctly identify the years (2022 and 2024) and the general concept of evolving regulatory challenges, but the SPECIFIC NATURE of those challenges is entirely incorrect. The LLM's characterization of 2022 concerns as 'structural trade and economic barriers' contradicts the ground truth's focus on data-transfer rules. Similarly, the 2024 description of 'sanctions, export-control restrictions, armed conflicts' does not match the ground truth's emphasis on 'uncertainty regarding regulatory outcomes' and 'lack of due process.' This represents a fundamental failure in multi-hop synthesis and factual accuracy. The answer demonstrates no quantitative errors (no numbers were provided to verify), but the qualitative accuracy is severely compromised by the misrepresentation of core facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 459,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "\nBetween 2022 and 2023 UPS kept the same funding mix for post‑retirement medical benefits—payments are drawn from plan trusts and corporate assets—but the projected cash‑flow amounts were trimmed sharply.  The 2022 filing projected ≈ $1.9 billion of employer contributions for 2022 and $229 million of benefit payments, whereas the 2023 filing shows only $74 million of contributions to the trust (and $92 million to participants) and $216 million of expected benefit payments for 2024.  Thus, while the source of funds remained unchanged, the scale of funding was reduced, reflecting a more conservative approach to covering post‑retirement medical obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The ground truth explicitly states there was NO CHANGE in funding sources between 2022 and 2023 - both years used plan trusts and corporate assets. The LLM correctly identifies this continuity but then undermines it by claiming 'the scale of funding was reduced,' which introduces unsupported claims about changes not mentioned in the ground truth. (2) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($1.9 billion contributions in 2022, $229 million benefit payments, $74 million contributions in 2023, $92 million to participants, $216 million expected benefit payments for 2024) that are NOT VERIFIED in the ground truth. The ground truth provides NO numerical data about contribution or payment amounts, making these figures unsubstantiated and potentially fabricated. (3) The LLM introduces a narrative about 'more conservative approach' and 'sharply trimmed' funding that goes beyond what the ground truth supports. The ground truth is explicit: 'there was no change in the sources used for expected benefit payments.' (4) The LLM conflates different concepts - the question asks about SOURCES of funding (plan trusts vs. corporate assets), not the AMOUNTS of funding. While the LLM correctly identifies the sources, it inappropriately adds unsupported claims about amount changes. CORRECT ELEMENTS: The LLM correctly identifies that both years used plan trusts and corporate assets as funding sources, which aligns with the ground truth's core finding. However, the addition of unverified financial figures and claims about funding scale changes represents a fundamental departure from the factual ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 473,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "\nFrom its 2022 launch, NVIDIA AI Enterprise was positioned as a paid, enterprise‑grade software suite that bundled tools such as NIM, Nemot and AI Blueprints to streamline the development and deployment of production‑grade generative‑AI workloads on NVIDIA‑accelerated infrastructure. By 2024 the scope had broadened dramatically: the suite was now integrated into the full‑stack data‑center platform (GPUs, DPUs and CPUs), offered through DGX Cloud and sold as a license‑based service, and was being adopted across a wider range of industries and partner ecosystems, with tighter coupling to the Blackwell architecture and expanded capabilities for scaling, security and multi‑cloud deployment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERROR - LLM claims NIM, 'Nemot' (misspelled as 'Nemot' instead of 'NeMo'), and AI Blueprints were bundled in 2022 at launch, but ground truth states these components were added BY 2024, not present in 2022. The 2022 introduction was described as a 'software suite aimed at simplifying deployment' without specifying these particular components. (2) MISSING KEY METRIC - LLM completely omits the specific 2.5x token throughput improvement mentioned in ground truth as a notable 2024 performance enhancement. (3) UNSUPPORTED CLAIMS - LLM introduces details not in ground truth: DGX Cloud integration, Blackwell architecture coupling, multi-cloud deployment, security enhancements, and broader industry adoption. While these may be plausible, they are not verified in the source material and represent speculation beyond the knowledge graph. (4) SEMANTIC ISSUE - LLM describes 2022 as having 'bundled tools' when ground truth indicates 2022 was the foundational introduction, with the full-stack evolution occurring by 2024. (5) PARTIAL CREDIT - LLM correctly identifies the evolution from foundational to comprehensive solution and mentions the shift to production-grade generative AI platform, which aligns with ground truth's core narrative. The answer demonstrates understanding of the general trajectory but introduces unverified details and misrepresents the 2022 baseline. The quantitative accuracy is particularly weak due to the missing 2.5x metric and the temporal misplacement of component introductions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 424,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "\nBetween 2022 and 2024 ExxonMobil’s proved reserves that are reported through equity‑company joint ventures grew from roughly **1.2 billion oil‑equivalent barrels to 1.48 billion boe** (an increase of about 23 %).  The bulk of this growth came from **Asia‑Pacific joint ventures and U.S. on‑shore/off‑shore plays**, while reserves in Europe and Africa stayed flat, indicating that the company is deliberately concentrating its equity‑based resource base in higher‑return, growth‑oriented basins (North America and Asia) and scaling back exposure to more mature or politically sensitive regions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. QUANTITATIVE ERRORS: (1) The LLM reports 2022 reserves as '1.2 billion boe' when ground truth shows only 14 million barrels gross (1 million net) - this is off by a factor of ~1,200x. (2) The LLM reports 2024 reserves as '1.48 billion boe' when ground truth specifies 467 million barrels crude oil + 120 million barrels NGL + 5,367 billion cubic feet natural gas - the LLM's aggregate figure is dramatically inflated and doesn't match the component breakdown. (3) The LLM calculates a 23% increase, but the actual growth from 1 million net barrels (2022) to the 2024 figures represents exponential growth, not 23%. ENTITY/METRIC ERRORS: (1) The LLM conflates 'equity companies' reserves with broader 'equity-company joint ventures' and includes U.S. onshore/offshore plays, which contradicts the ground truth's specific focus on equity company reserves. (2) The ground truth clearly states the 2024 growth was 'concentrated in Asia' while the LLM claims 'bulk of growth came from Asia-Pacific joint ventures AND U.S. onshore/offshore plays' - this misrepresents the regional concentration. REASONING ISSUES: The LLM's conclusion about 'scaling back exposure to Europe and Africa' may be directionally correct but is based on entirely wrong baseline numbers, making the strategic analysis unreliable. The multi-hop synthesis failed because the LLM appears to have used incorrect source data or misinterpreted the reserve figures. The answer demonstrates a fundamental misunderstanding of the magnitude of reserves being discussed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 442,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "\nBetween 2022 and 2024, Google Network Partners continued to be a core conduit for Alphabet’s ad‑driven revenue, with “TAC includes amounts paid to Google Network partners primarily for ads displayed on their properties” (p. 53, 56).  The company’s operating‑income commentary notes that the rise in operating income was “partially offset by increases in … TAC,” indicating that payments to these partners grew in absolute dollars as ad revenue expanded (p. 41).  Consequently, while the cost structure shifted slightly toward higher variable outlays for network‑partner payouts, the underlying revenue generated through those partners increased faster, leaving overall profitability still on an upward trajectory.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and misses the core evolution described in the ground truth. CORRECT ELEMENTS: (1) Correctly identifies Google Network Partners as a revenue/cost component; (2) Accurately notes TAC (Traffic Acquisition Costs) includes payments to Google Network partners; (3) Correctly references page numbers (p. 53, 56, 41); (4) Appropriately notes the cost structure relationship. CRITICAL GAPS AND ERRORS: (1) The ground truth emphasizes a SHIFT in financial reporting framing between 2022 and 2024 - from 'gross basis revenue reporting' to 'net cash flow impact' - but the LLM answer does not capture this fundamental evolution in how the relationship is presented; (2) The ground truth explicitly states that in 2022, Google acted as 'principal' with revenues reported 'on a gross basis' - the LLM answer omits this principal/agent distinction entirely; (3) The ground truth notes the 2024 shift to emphasizing 'net cash flow impact' and 'primary use of cash from operating activities' - the LLM answer does not address this reporting evolution; (4) The LLM answer focuses on absolute dollar growth and profitability trajectory, which is not the core point of the ground truth's evolution narrative. MULTI-HOP REASONING: The LLM attempts to synthesize information across years but fails to identify the key structural change in how the relationship is reported/framed. The answer treats the relationship as relatively static (continuing as 'core conduit') rather than highlighting the shift from revenue-centric to cash-flow-centric framing. QUANTITATIVE ISSUES: No specific numbers are provided in either answer, so this is not a differentiator, but the LLM's focus on 'absolute dollars' and 'upward trajectory' is not grounded in specific metrics from the filings. The answer reads more like general commentary than precise financial analysis of the evolution. The answer is partially relevant but misses the essential narrative of how the financial relationship's presentation evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 556,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s exposure to non‑designated foreign‑currency forwards fell sharply, cutting the earnings hit from these contracts from a $69 million loss in 2022 to only about a $7 million loss in 2023.  The reduction is reflected in the lower notional amounts of outstanding non‑designated currency derivatives (e.g., Hong‑Kong‑dollar exposure dropped from $4.3 bn to $1.8 bn) and a corresponding decline in the amount of gains/(losses) recorded in income under “Investment income and other,” indicating that UPS’s foreign‑exchange risk‑management strategy became less volatile and more reliant on designated or natural hedges.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains specific quantitative claims that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($69 million loss in 2022, $7 million loss in 2023) and notional amounts (Hong Kong dollar exposure from $4.3 billion to $1.8 billion) that are not mentioned in the ground truth answer. These numbers appear to be hallucinated rather than derived from actual SEC filings. The ground truth explicitly states that 2023 filings reported amounts 'side-by-side in millions' but does not provide these specific loss figures. (2) INCOMPLETE SYNTHESIS: While the ground truth emphasizes the evolution in disclosure practices and transparency (from 2022 to 2023 showing more structured presentation), the LLM answer focuses entirely on quantitative changes in exposure and earnings impact without addressing the disclosure evolution that is central to the original answer. (3) UNSUPPORTED CLAIMS: The LLM makes assertions about 'designated or natural hedges' becoming more relied upon, which is not supported by the ground truth. The ground truth does not discuss a shift in hedging strategy types. (4) PARTIAL RELEVANCE: The LLM does address the 2022-2023 comparison and earnings volatility impact, which are relevant to the question, but the specific numbers provided lack verification and the answer misses the key disclosure methodology evolution that the ground truth emphasizes. The answer reads as plausible but contains fabricated specificity that undermines its credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 435,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "\nBetween 2022 and 2023 the membership format remained the cornerstone of Costco’s profitability, but the way it generated fee revenue shifted.  In 2022 fee revenue rose 9 % to $4.224 billion, driven by new sign‑ups, Executive‑membership upgrades and an improving renewal rate, while in 2023 the same levers produced a more modest 5 % increase to $4.828 billion, with the company noting that growth in paid memberships may be dampened as more warehouses open in existing markets.  Thus, the strategy moved from aggressive base‑expansion toward extracting higher loyalty‑linked revenue from the existing member base, especially through Executive upgrades and sustained renewal rates.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. While it attempts to address the evolution of membership strategy between 2022 and 2023, it introduces specific financial figures that cannot be verified against the ground truth and appear to be fabricated. Specifically: (1) The fee revenue figures ($4.224 billion in 2022 and $4.828 billion in 2023) and growth percentages (9% and 5%) are presented as facts but are not mentioned in the original answer and cannot be verified. These specific numbers appear to be hallucinated. (2) The LLM answer focuses heavily on quantitative fee revenue analysis, which is not the primary focus of the ground truth answer. The ground truth emphasizes the qualitative evolution of language describing the membership model's role ('integral part' language) and the emergence of new concerns about renewal rates in newer markets. (3) The LLM answer does capture some correct conceptual elements: it acknowledges the membership format remained central to profitability, mentions Executive membership upgrades, and discusses renewal rates. However, it misses the key insight from the ground truth about the new concern regarding lower renewal rates in newer markets that emerged in 2023. (4) The reasoning about shifting from 'aggressive base-expansion toward extracting higher loyalty-linked revenue' is plausible but is not explicitly supported by the ground truth, which focuses on the company's emerging challenges with renewal rates in newer markets rather than a strategic pivot. (5) The answer fails to address the specific language evolution noted in the ground truth ('significant effect on' vs. 'integral part of') and the explicit mention of new market challenges. The quantitative inaccuracy is particularly problematic because financial figures must be precisely correct in SEC filing analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 508,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA expanded CUDA from a GPU‑only parallel programming model into the heart of a full‑stack data‑center platform, embedding it with new DPUs and CPUs (e.g., Grace), high‑speed networking, and the AI‑Enterprise software suite.  This integration lets CUDA‑accelerated AI workloads be delivered end‑to‑end—through Blackwell‑based appliances, DGX Cloud, and managed services—rather than as isolated GPU compute.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the directional evolution of CUDA from 2022 to 2024 and correctly identifies key themes: integration into a full-stack platform, expansion beyond GPUs to include CPUs and DPUs, and positioning as infrastructure for enterprise-scale computing. The mention of specific products (Grace, Blackwell, DGX Cloud) and the AI-Enterprise suite demonstrates relevant knowledge.\n\nHowever, there are significant gaps and inaccuracies:\n\n1. QUANTITATIVE ACCURACY (4/10): The ground truth provides a specific quantitative anchor—'nearly 3 million developers using CUDA' in 2022—which the LLM answer completely omits. This is a concrete, verifiable metric that should have been included to demonstrate the scale of CUDA's adoption. The LLM provides no comparable metrics for 2024, making it impossible to assess the magnitude of growth or change.\n\n2. MISSING KEY ELEMENTS: The ground truth emphasizes CUDA-X as 'a collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks.' While the LLM mentions 'high-speed networking' and 'AI-Enterprise software suite,' it doesn't explicitly reference CUDA-X or the specific architectural components (libraries, APIs, SDKs, frameworks) that define the 2024 positioning.\n\n3. PARTNERSHIP/ECOSYSTEM CONTEXT: The ground truth highlights NVIDIA's developer programs (Deep Learning Institute, Inception program) as part of the 2022 positioning. The LLM answer doesn't address the evolution of these partnership and developer ecosystem elements, focusing instead on infrastructure and delivery mechanisms.\n\n4. SEMANTIC ALIGNMENT: The LLM correctly captures the shift from 'developer-focused tool' to 'core infrastructure layer,' but frames it differently (GPU-only to full-stack platform). While semantically similar, the LLM's framing emphasizes hardware integration (DPUs, CPUs, networking) rather than the software ecosystem evolution emphasized in the ground truth.\n\n5. DELIVERY MECHANISMS: The LLM introduces delivery mechanisms (Blackwell appliances, DGX Cloud, managed services) that aren't mentioned in the ground truth. While these may be accurate, they represent a different analytical angle than the ground truth's focus on CUDA's role within the software/platform architecture.\n\nThe answer demonstrates good contextual understanding and relevance but lacks the quantitative specificity and complete coverage of the software ecosystem evolution that the ground truth provides.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 654,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "\nBy the end of 2024 Pfizer had generated about $5.7 billion of Paxlovid revenue—down sharply from the $18.9 billion earned in 2022—and the company now expects only roughly $1 billion of remaining contracted revenue from future Paxlovid sales, to be recognized gradually from 2025 through 2028 under renegotiable long‑term supply agreements. This marks a transition from the large, near‑term government‑procurement (EUA) purchases of 2022‑23 to a commercial‑market model where deliveries are spread over the next few years rather than concentrated in bulk shipments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the evolution of Pfizer's Paxlovid financial commitments from 2023 to 2024 and correctly identifies the $1 billion remaining performance obligations with 2025-2028 delivery timeline. However, there are significant issues with quantitative accuracy and completeness relative to the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies ~$1 billion in remaining performance obligations for 2025-2028 delivery\n- Accurately captures the shift from EUA-driven government procurement to commercial market model\n- Properly contextualizes the transition from bulk shipments to spread-out deliveries\n- Correctly notes the decline from 2022 peak levels\n\nINCORRECT/MISSING ELEMENTS:\n1. CRITICAL OMISSION: The ground truth specifically mentions the 2023 Q4 non-cash revenue reversal of $3.5 billion related to 6.5 million treatment courses expected to be returned from U.S. government inventory. This is a key evolution point showing the contractual obligation changes from 2023 to 2024, but the LLM answer completely omits this.\n\n2. QUANTITATIVE ISSUES: While the LLM provides 2022 ($18.9B) and 2024 (~$5.7B) revenue figures, these are not part of the ground truth answer and appear to be supplementary context. The ground truth focuses on the 2023 reversal and 2024 remaining obligations.\n\n3. INCOMPLETE SYNTHESIS: The question specifically asks about evolution \"from 2023 to 2024.\" The ground truth directly addresses this by contrasting the 2023 Q4 reversal situation with the 2024 remaining obligations outlook. The LLM answer provides broader context but misses the specific 2023-2024 evolution point.\n\n4. CHARACTERIZATION: The LLM describes agreements as \"renegotiable long-term supply agreements,\" but the ground truth simply states \"firm contracts.\" This characterization difference could be material.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable multi-hop synthesis by connecting historical context (2022 peak), current status (2024 obligations), and future outlook (2025-2028). However, it fails to synthesize the critical 2023 reversal event that represents the key evolution point between 2023 and 2024.\n\nOVERALL: The answer is partially correct and contextually relevant but fails to address the most important evolution point (the $3.5B reversal) that directly answers the question about how commitments evolved from 2023 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 637,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "\nBetween 2022 and 2024 ExxonMobil moved Guyana from a peripheral offshore prospect to a core “advantaged asset” in its strategic portfolio.  The 2024 filing explicitly places Guyana in the same “advantaged assets” group as the Permian and LNG projects, and it is cited in the company’s earnings‑driver definitions as a source of future volume growth, indicating that capital and investment focus have been deliberately shifted toward developing its proved reserves and producing the offshore discoveries.  This emphasis is reinforced by ongoing reserve‑development activities that continue to add proved undeveloped barrels and aim to transition them to producing status, underscoring Guyana’s elevated strategic importance.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the strategic evolution of Guyana from 2022 to 2024, accurately identifying the shift from reserves growth region to 'advantaged assets' status. The qualitative reasoning is sound and well-articulated, with appropriate synthesis of the multi-hop information about reserves development and strategic positioning.\n\nSTRENGTHS:\n- Correctly identifies the 2022-2024 timeframe and evolution\n- Accurately characterizes Guyana's transition to 'advantaged assets' status\n- Properly synthesizes the connection between reserves development and strategic emphasis\n- Correctly notes the grouping with Permian and LNG projects\n- Sound multi-hop reasoning connecting reserves, earnings drivers, and strategic importance\n- Appropriate contextual framing of the shift from peripheral to core asset\n\nWEAKNESSES:\n- The LLM answer does not include the specific quantitative figure from the ground truth: the ~1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves added in 2022. This is a material omission for a question focused on 'disclosures around reserves development.'\n- While the answer mentions 'ongoing reserve-development activities that continue to add proved undeveloped barrels,' it lacks the concrete 2022 baseline figure that would strengthen the quantitative support\n- The answer is somewhat more general/interpretive than the ground truth, which provides specific reserve metrics\n\nQUANTITATIVE ACCURACY ASSESSMENT:\nThe ground truth provides a specific metric (1.3 billion GOEB) that the LLM answer does not reference. This represents a gap in quantitative precision, though the answer does not contain any incorrect numbers. The omission of this key metric reduces quantitative accuracy from what would be a 9-10 to a 6.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across multiple dimensions: (1) reserves development in 2022, (2) advantaged assets classification in 2024, (3) earnings driver positioning, and (4) strategic implications. The reasoning chain is logical and complete.\n\nSEMANTIC EQUIVALENCE:\nThe core message aligns well with the ground truth: Guyana evolved from a reserves growth contributor to a recognized advantaged asset driving earnings. The LLM's characterization of moving from 'peripheral offshore prospect' to 'core advantaged asset' is semantically equivalent to the ground truth's 'reserves growth region' to 'recognized source of advantaged production and earnings visibility.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 664,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "\nFrom the 2022 filing the company had scheduled 6 ATR 72‑600F deliveries for 2024 (with a total of 24 such aircraft committed through 2026), but by the 2024 filing the plan had been trimmed to 3 aircraft for delivery in 2026 (and 7 for 2025), sharply reducing the overall ATR 72‑600F commitment. This pull‑back signals that FedEx is shifting its fleet strategy toward larger, more fuel‑efficient freighters—principally the B767F and B777F—while deprioritizing the smaller ATR 72‑600F for its regional package network.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM states '6 ATR 72-600F deliveries for 2024' and 'total of 24 such aircraft committed through 2026' from the 2022 filing, but the ground truth indicates 11 units in 2023 declining to 1 by 2026 (not 24 total). The LLM also claims the 2024 filing showed '3 aircraft for delivery in 2026 (and 7 for 2025)' which partially aligns with ground truth (7 for 2025, 3 for 2026), but the overall narrative is inverted. (2) DIRECTIONAL ERROR: The ground truth indicates a STABILIZATION/IMPROVEMENT in ATR projections (from rapid phase-out to sustained role), while the LLM characterizes it as a 'sharp reduction' and 'pull-back.' This is a fundamental misinterpretation of the trend. The ground truth shows 2022 projections of 11→1 (steep decline) versus 2024 projections of 7→3 (much more gradual), indicating the aircraft's role was PRESERVED more than initially expected. (3) INCOMPLETE SYNTHESIS: The LLM adds context about FedEx shifting to B767F and B777F, which may be accurate but is not part of the ground truth answer and represents speculation beyond what the data shows. (4) MISSING CORE INSIGHT: The LLM fails to capture that the evolution actually shows the company maintaining a stronger ATR presence than previously planned, contradicting its 'deprioritizing' conclusion. The answer demonstrates poor multi-hop reasoning by misinterpreting the directional change in fleet planning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 417,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA broadened Omniverse from a specialized industrial‑digital‑twin/simulation tool into a central hub of its AI‑accelerated platform.  The 2024 releases tied Omniverse directly to the AI Enterprise stack (NIM, NeMo, AI Blueprints) and to the Blackwell GPU architecture, added generative‑AI avatar services (ACE), and opened the environment to both enterprise subscriptions and a free‑tier, enabling synthetic‑data generation, digital‑twin creation and AI‑driven content across automotive, gaming, professional visualization and other domains.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Omniverse from 2022 to 2024, capturing the shift toward enterprise-focused simulation and digital twin applications. It accurately mentions key 2024 developments including integration with AI Enterprise stack (NIM, NeMo), Blackwell GPU architecture, and generative AI avatar services (ACE). The mention of synthetic data generation, digital twin creation, and application domains (automotive, gaming, professional visualization) aligns with the ground truth. The subscription model evolution (enterprise subscriptions + free-tier) is correctly noted.\n\nWEAKNESSES: (1) The LLM answer reverses the chronological direction of evolution - it states Omniverse was 'broadened from a specialized industrial-digital-twin/simulation tool' in 2022, when the ground truth indicates it was a general 3D collaboration platform in 2022 that EVOLVED INTO a specialized digital twin platform by 2024. This is a significant directional error in the narrative arc. (2) The answer omits specific 2022 use cases mentioned in ground truth (VR/AR integration, virtual car showrooms, surgical training). (3) The answer introduces specific product names (NIM, NeMo, ACE, Blackwell) that are not mentioned in the ground truth, which while potentially accurate, goes beyond what can be verified against the provided knowledge graph. (4) The phrasing 'central hub of its AI-accelerated platform' is somewhat vague and doesn't clearly convey the shift from general 3D collaboration to specialized enterprise simulation focus.\n\nMULTI-HOP REASONING: The answer attempts to synthesize evolution across years but gets the direction wrong. It should show: 2022 (general 3D collaboration) → 2024 (specialized digital twin/simulation). Instead it implies: 2022 (specialized) → 2024 (broader hub). This is a fundamental reasoning error despite capturing some correct elements.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or dates are provided in either answer, so quantitative accuracy is not directly testable. However, the product names and architectural references in the LLM answer cannot be verified against the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 585,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "\nBetween 2022 and 2023 the share of Google Play in Alphabet’s non‑advertising revenue expanded noticeably.  The company’s overall Google Services revenue rose 8 % (an additional $19 billion), and the filing repeatedly notes that “non‑advertising revenues—including sales of apps and in‑app purchases from Google Play—are growing and now represent a larger portion of total revenue.”  While exact dollar figures for Google Play are not disclosed, the upward trend in Google Services and the emphasis on expanding “platforms” such as Google Play show that its contribution to non‑advertising revenue increased materially from 2022 to 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general directional trend (Google Play's role expanded between 2022-2023) and correctly identifies that non-advertising revenues grew, but has significant issues with quantitative accuracy and specificity. STRENGTHS: (1) Correctly identifies the time period (2022-2023), (2) Appropriately notes Google Play's role in non-advertising revenue, (3) Mentions the strategic shift toward 'platforms' which aligns with ground truth, (4) Acknowledges that exact dollar figures aren't disclosed. WEAKNESSES: (1) The claim about '8% rise' and '$19 billion additional' in Google Services revenue cannot be verified against the ground truth and appears to be unsupported specificity - the LLM provides precise numbers without clear sourcing, (2) The ground truth emphasizes a categorical/structural evolution (from introduction in 2022 to 'more defined revenue stream under platforms' in 2023), while the LLM focuses primarily on quantitative growth without adequately addressing this strategic repositioning, (3) The LLM states 'exact dollar figures for Google Play are not disclosed' which is accurate, but then provides specific Google Services figures that may or may not be correct, creating internal inconsistency, (4) Missing the key insight from ground truth about the transition from 'component of diversification' to 'key monetization platform' with 'more structured categorization.' MULTI-HOP REASONING: The LLM attempts to synthesize information about Google Play's evolution but relies heavily on inferred growth rather than the documented categorical shift emphasized in the ground truth. The reasoning is logical but incomplete - it addresses 'how much' rather than adequately addressing 'how' the role evolved structurally. QUANTITATIVE ISSUES: The specific percentages and dollar amounts cited (8%, $19 billion) lack clear verification against the provided ground truth, which focuses on structural evolution rather than precise financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 534,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 AIG shifted more of the workers‑compensation reserve weight toward the Expected‑Loss‑Ratio (ELR) technique for the excess‑of‑deductible segment—reflecting the growing share of large‑deductible policies and the slower claim‑development pattern—while still limiting ELR to the most recent accident year for guaranteed‑cost business.  In the 2023 filing the company explicitly noted that ELR inputs for excess‑of‑deductible lines were given “significant weight in the most recent five accident years” and that the selected loss‑ratio estimates were now adjusted for recent inflation, rate changes and market‑condition trends, whereas for guaranteed‑cost business the method remained confined to the latest year but was refined with the same trend‑adjusted inputs.  This evolution reflects a deliberate increase in the weighting and sophistication of ELR estimates for excess‑of‑deductible business, with a consistent but refined approach for guaranteed‑cost business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual inaccuracy that contradicts the ground truth. The LLM claims that in 2023, ELR was given 'significant weight in the most recent five accident years' for excess-of-deductible business, but the ground truth explicitly states this was the case in 2022, not 2023. The ground truth indicates the methodology 'remained broadly consistent' between 2022 and 2023, meaning the five-year application for excess-of-deductible business was already in place in 2022 and continued in 2023—not a shift that occurred between these years. The LLM misrepresents the evolution by suggesting a deliberate increase in weighting occurred in 2023 when the ground truth indicates continuity. Additionally, the LLM introduces claims about 'trend-adjusted inputs' and 'adjusted for recent inflation, rate changes and market-condition trends' that are not supported by the ground truth provided. The ground truth mentions changes in claims strategy and loss mitigation efforts accelerating settlements, which the LLM completely omits. The LLM also fails to mention the important 2023 refinement regarding incurred and paid losses being presented net of reinsurance and undiscounted. While the LLM correctly identifies the general structure (ELR limited to most recent year for guaranteed-cost, broader application for excess-of-deductible), it fundamentally mischaracterizes the temporal evolution and introduces unsupported details about trend adjustments. The answer demonstrates partial understanding of the topic but fails on the core question of how the methodology 'evolved' between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 451,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Cisco reshaped its product‑category structure: the 2022 reporting used six groups (“Secure Agile Networks,” “Internet for the Future,” “Collaboration,” “End‑to‑End Security,” “Optimized Application Experiences,” and “Other Products”), while beginning in fiscal 2024 it consolidated the portfolio into four broader categories—Networking, Security, Collaboration, and Observability—aligning the taxonomy with its strategic priorities. The Collaboration category remains a distinct segment, but its revenue trajectory shifted: it fell 9 % in fiscal 2023 (driven by weakness in Collaboration Devices and Meetings) before modestly rebounding with a 2 % increase in fiscal 2024, reflecting growth in Calling, Contact‑Center and other Collaboration‑suite offerings despite ongoing softness in Meetings.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the structural evolution from six categories in fiscal 2022 to four categories in fiscal 2024. The category names are accurately listed for both periods, and the retention of Collaboration as a distinct segment is correctly noted. The introduction of Observability and the consolidation into Networking, Security, Collaboration, and Observability are all accurate. The answer goes beyond the ground truth by providing specific revenue performance metrics for Collaboration (9% decline in fiscal 2023, 2% increase in fiscal 2024) with contextual drivers (weakness in Collaboration Devices and Meetings, growth in Calling and Contact-Center). These additional details are relevant and appear factually grounded, though they were not explicitly mentioned in the ground truth. The multi-hop reasoning is sound—the answer correctly synthesizes the structural changes across fiscal years and connects them to business performance. Minor consideration: the ground truth mentions 'Secure, Agile Networks' while the LLM lists 'Secure Agile Networks' (minor formatting variation, semantically equivalent). The answer is well-structured, addresses all aspects of the question, and provides appropriate context about strategic realignment. The quantitative data provided (percentages) cannot be verified against the ground truth but appears reasonable and adds value without contradicting the provided information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 410,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "\nFrom 2022 to 2023 Amgen stopped presenting the 3.125% 2025 Notes as a stand‑alone line in the debt‑maturity schedule; the series is now rolled into the aggregate long‑term‑debt balance, with its carrying amount shown only as part of the total $63‑$64 bn debt figure.  At the same time the interest‑rate framework was updated: the 2022 filing disclosed an effective LIBOR + 1.8% rate (after swaps) and a $19 million AOCI reclassification expense, whereas the 2023 filing reports an effective SOFR + 2.1% rate (with a $1 bn notional swap) and a reduced AOCI reclassification expense of $6 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) PRESENTATION CHANGE: The LLM claims the notes were 'rolled into aggregate long-term-debt balance' and no longer presented as a stand-alone line, but the ground truth indicates the notes remained disclosed, just in a different table format with more detailed interest rate information. This is a fundamental mischaracterization of the disclosure evolution. (2) INTEREST RATE FRAMEWORK ERRORS: The LLM states the 2022 filing disclosed 'LIBOR + 1.8%' but the ground truth explicitly states 'no specific interest rate framework was disclosed' in 2022. This is a direct contradiction. The LLM also introduces details about AOCI reclassification expenses ($19M in 2022, $6M in 2023) and swap notionals ($1bn) that are not mentioned in the ground truth and appear to be fabricated or confused with other disclosures. (3) SOFR + 2.1% RATE: The LLM correctly identifies the 2023 rate as SOFR + 2.1%, which matches the ground truth. (4) CARRYING VALUE: The ground truth specifies a $1,000 million carrying value in 2022, which the LLM does not mention. Instead, it vaguely references '$63-$64 bn debt figure' without clarifying the specific carrying value of the 3.125% notes. (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution from 2022 to 2023. The ground truth describes a shift from quantitative-only disclosure to qualitative+quantitative disclosure with explicit interest rate mechanism details. The LLM instead describes a consolidation/hiding of the notes, which is incorrect. The answer demonstrates poor understanding of the actual disclosure changes and introduces unsupported numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 473,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2024 ConocoPhillips’ reported natural‑gas reserves in the Asia Pacific/Middle East fell from **≈326 billion cubic feet (BCF)** to **≈312 BCF** in 2023 and further to **≈296 BCF** in 2024—a decline of roughly **30 BCF (≈9 %)**.  The drop reflects downward price‑related revisions and cost assumptions in that region, even though modest reserve additions came from extensions and discoveries in the Middle East via equity affiliates; the net result is a clear scaling‑back of the company’s focus on the Asia Pacific/Middle East and a re‑allocation of capital toward higher‑return basins such as the Lower 48 and Canada.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers and sound multi-hop reasoning. STRENGTHS: (1) All key figures are accurate - 2022: 326 BCF, 2024: 296 BCF, with intermediate 2023 value of 312 BCF provided; (2) Calculation is correct - 30 BCF decline represents approximately 9.2% decrease (30/326 = 0.092 or ~9%), properly rounded; (3) Multi-hop synthesis is excellent - the answer goes beyond the ground truth by explaining the drivers (price-related revisions, cost assumptions, modest reserve additions from extensions/discoveries via equity affiliates) and strategic implications (capital reallocation to higher-return basins like Lower 48 and Canada); (4) Entity identification is correct (ConocoPhillips/COP, Asia Pacific/Middle East region, natural gas reserves); (5) Temporal accuracy is precise with year-by-year progression shown. MINOR CONSIDERATIONS: (1) The ground truth provides only 2022 and 2024 endpoints, while the LLM adds the 2023 intermediate value (312 BCF) - this is additional detail not contradicted by ground truth but not explicitly confirmed; (2) The LLM provides more strategic context and explanation than the ground truth (price revisions, equity affiliates, capital reallocation), which enhances understanding but goes slightly beyond what was explicitly stated in the original answer. The additional context appears reasonable and consistent with typical industry dynamics but represents inference beyond the stated ground truth. VERIFICATION: 2022 (326 BCF) → 2024 (296 BCF) = 30 BCF decline = 9.2% ≈ 9% ✓. The answer correctly addresses both parts of the question: the evolution of reserves and strategic positioning implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 462,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "\nBetween 2022 and 2023 Alphabet’s share‑repurchase program expanded: it bought back a total of **$62.2 billion** of Class A and Class C shares in 2023 versus **$59.3 billion** in 2022 – an increase of roughly **$2.9 billion**.  The Class C component rose slightly from about **$52.58 billion** to **$52.87 billion** (shares repurchased fell a bit, but the dollar amount grew), and the company added a fresh $70 billion authorization in April 2023, leaving $36.3 billion of that authority unused at year‑end 2023.  This uptick signals that Alphabet is accelerating its capital‑return strategy, using a larger share of its cash flow to retire stock and support the share price, reflecting confidence in its cash generation and a preference for equity‑based capital allocation over other investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: $59.3 billion repurchased in 2022, $62.2 billion in 2023, the $2.9 billion increase, the $70 billion April 2023 authorization, and $36.3 billion remaining. The qualitative interpretation about capital allocation strategy is sound and well-reasoned. However, there is a significant quantitative error: the LLM claims Class C repurchases rose from $52.58 billion to $52.87 billion, but the ground truth does not provide these specific Class C breakdowns. The original answer states repurchases were of 'Class A and Class C shares' combined without separating them. The LLM appears to have invented or misremembered specific Class C figures that cannot be verified against the ground truth. Additionally, the statement that 'shares repurchased fell a bit, but the dollar amount grew' is unsupported by the provided ground truth data. The LLM correctly synthesizes the multi-hop information (comparing years, noting the new authorization, and interpreting strategic implications), but the introduction of unverified Class C-specific numbers is a material factual error. The answer is mostly correct on the main points but contains a problematic quantitative claim that reduces overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 349,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "\nBetween the 2022 and 2023 10‑K filings AIG retained frequency/severity reserving for its short‑tail lines—principally U.S. Property, Special‑Risk and program business—to estimate reserves for low‑frequency, high‑severity losses and to adjust for inflation, rate changes and emerging claim trends. In the 2023 filing the company narrowed the explicit reference to these methods to workers’‑compensation and certain liability subsets, explaining that they are used when loss emergence is slow and that high‑severity lines such as aviation are now handled with expected‑loss‑ratio and development techniques rather than frequency/severity approaches.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF 2023 CHANGES: The LLM states that in 2023 AIG 'narrowed' the application to workers' compensation and liability subsets, but the ground truth shows AIG EXPANDED frequency/severity methods to include U.S. Workers' Compensation (a long-tail line) in 2023. This is a fundamental reversal of the actual evolution. (2) MISSING KEY INFORMATION: The LLM fails to mention that in 2022, frequency/severity methods were explicitly avoided for aviation due to high severity and varying claim mixes. The ground truth emphasizes this as an important distinction. (3) INCORRECT REASONING: The LLM suggests that in 2023, aviation is 'now handled with expected-loss-ratio and development techniques rather than frequency/severity approaches,' but this doesn't capture the strategic shift described in the ground truth—which is that frequency/severity methods were EXPANDED to long-tail lines like workers' compensation, not that they were abandoned for high-severity lines. (4) INCOMPLETE SYNTHESIS: The LLM mentions 'Special-Risk and program business' in 2022 but the ground truth specifically identifies U.S. Property as the primary short-tail class where these methods were used. (5) MISSING CONTEXT: The ground truth emphasizes the strategic shift toward using frequency/severity in 'more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased'—this important contextual reasoning is absent from the LLM answer. The LLM answer appears to conflate or misinterpret the evolution, suggesting a narrowing rather than an expansion of these methods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 472,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "\nFrom 2022 to 2023 Amgen’s collaboration with BeiGene shifted markedly: cost recoveries fell sharply to **$109 million in 2023** (down from **$199 million in 2022**), while product sales to BeiGene rose to **$125 million** (up from **$64 million**).  Accordingly, the profit‑and‑loss‑sharing expense that Amgen records fell to **$40 million** (versus **$53 million** the prior year), and the net amounts receivable from BeiGene for cost recoveries and P&L sharing grew to **$44–$47 million** by year‑end 2023.  This reflects a move from a period of heavy shared costs and modest sales toward higher sales volumes and lower shared expense outlays, with Amgen now paying royalties to BeiGene on Chinese sales once product rights revert.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core financial metrics. All primary numbers are correct: cost recovery ($199M→$109M), product sales ($64M→$125M), and P&L sharing expenses ($53M→$40M). The year-over-year comparisons and directional changes are accurately characterized. The multi-hop synthesis is sound, correctly identifying the shift from R&D cost-sharing to product sales dominance. The answer goes beyond the ground truth by adding context about net receivables ($44-$47M) and royalty arrangements on Chinese sales reversion, which demonstrates deeper understanding but introduces information not explicitly verified against the ground truth. The qualitative interpretation that this reflects 'maturation of the collaboration' aligns with the ground truth's assessment. Minor deduction: the additional details about royalties and receivables amounts, while plausible and contextually relevant, extend beyond what was explicitly confirmed in the ground truth, creating slight uncertainty about whether these figures are from the same source documents. The core answer structure and all primary metrics are accurate and well-synthesized across the 2022-2023 comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 338,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2024, proved natural‑gas reserves in the Asia Pacific/Middle East region fell from 326 bcf to 312 bcf to 296 bcf. The decline reflects net downward revisions—particularly a 2 bcf downward revision in consolidated reserves in 2024 and a roughly 26 bcf net downward revision in equity‑affiliate reserves due to lower prices—while production stayed essentially flat at about 25 bcf per year and purchases were essentially nil in this region.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant quantitative discrepancies. CORRECT ELEMENTS: (1) Starting point of 326 bcf in 2022 is accurate; (2) Ending point of 296 bcf in 2024 is accurate; (3) General narrative about revisions and production is directionally correct; (4) Correctly identifies that purchases were nil in the region; (5) Properly synthesizes multi-hop information across years. CRITICAL ERRORS: (1) The LLM states reserves fell to '312 bcf' at end of 2023, but the ground truth only provides 2022 (326 bcf) and 2024 (296 bcf) figures - the 312 bcf intermediate value is not verified in the original answer and appears to be an inference not supported by the ground truth; (2) The LLM claims '2 bcf downward revision in consolidated reserves in 2024' and '26 bcf net downward revision in equity-affiliate reserves' - these specific breakdowns are not mentioned in the ground truth, which only states 'revisions in 2023 added 9 billion cubic feet'; (3) The LLM states 'production stayed essentially flat at about 25 bcf per year' but the ground truth specifies 'production subtracted 25 billion cubic feet in 2024' - this is a significant difference in temporal specificity and the LLM's characterization of 'flat' production is misleading; (4) The LLM provides additional detail about 'lower prices' affecting equity-affiliate reserves, which is not mentioned in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across the 2022-2024 period and identifies the key drivers (revisions, production, purchases), but introduces unsupported details that diverge from the ground truth. The answer is more detailed than the original but contains factual inaccuracies that undermine reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 477,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "\nFrom 2022 to 2024 FedEx’s B767F delivery schedule moved from 14 aircraft slated for 2023, 14 for 2024 and 10 for 2025 (total 38 over 2023‑2025) to a revised plan that calls for only 11 B767Fs in 2025 and 3 in 2026, effectively postponing the remaining 14 aircraft that were previously expected by 2025.  This shift shows that FedEx is using the B767F as a transitional, fuel‑more‑efficient type while it prioritizes newer, higher‑capacity B777F deliveries and delays additional capacity until market demand and cash‑flow considerations justify it, reflecting a more disciplined, long‑term fleet‑modernization strategy rather than rapid expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core strategic shift - FedEx moved from planning 14 B767F aircraft for both 2023 and 2024 to a more accelerated reduction plan. The answer correctly notes the 2025 projection of 11 aircraft and 2026 projection of 3 aircraft. The qualitative interpretation about transitional use and fleet modernization strategy is reasonable and well-reasoned. The answer appropriately addresses the multi-hop nature of comparing 2022 projections to 2024 projections.\n\nWEAKNESSES: Critical quantitative error in the opening statement. The LLM states '14 aircraft slated for 2023, 14 for 2024 and 10 for 2025 (total 38 over 2023-2025)' but 14+14+10=38 is correct arithmetic. However, the ground truth specifies that in 2022, FedEx projected 14 B767F for 2023 AND 2024, then 10 for 2025. The LLM's phrasing is slightly ambiguous but appears to correctly capture this. The phrase 'effectively postponing the remaining 14 aircraft that were previously expected by 2025' is somewhat unclear - it's not entirely clear which 14 aircraft are being referenced (the difference between 38 and the new plan would be 38-14=24, not 14). The LLM introduces additional context about B777F deliveries and market demand/cash-flow considerations that, while strategically plausible, are NOT explicitly stated in the ground truth answer and may represent inference beyond what the filings directly support.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across two time periods (2022 projections vs 2024 projections) and correctly identifies the directional change. However, the specific calculation of 'remaining 14 aircraft' is not clearly justified by the numbers provided.\n\nNUMBER VERIFICATION: 2022 plan: 14 (2023), 14 (2024), 10 (2025) ✓; 2024 plan: 11 (2025), 3 (2026) ✓; but the characterization of what was 'postponed' is imprecise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 508,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "\nBetween 2022 and 2023 AIG kept the Expected‑Loss‑Ratio (ELR) approach as its primary tool for the longest‑tail, high‑attachment lines—especially U.S. Excess Casualty, U.S. Workers’ Compensation, U.S. Other Casualty and U.S. Financial Lines—because those businesses show slow, irregular loss development and often lack sufficient historical loss data.  In 2023 the company placed even greater weight on ELR for the most recent accident years, adjusting older loss‑ratio estimates for inflation, rate changes and emerging market conditions, and it increasingly used the ELR‑based Bornhuetter‑Ferguson and Cape‑Cod hybrids to blend premium‑based projections with development‑based factors where data were sparse or reinsurance limited visibility.  This evolution reflects AIG’s need to rely on ELR when loss‑development patterns are inconsistent, when claims emerge very slowly, or when the underlying primary policies are held by other carriers, ensuring a more reliable estimate of ultimate losses for those lines.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Key issues: (1) ENTITY ERRORS: The LLM introduces lines of business (U.S. Excess Casualty, U.S. Financial Lines) that are NOT mentioned in the ground truth answer. The ground truth specifically identifies U.S. Workers' Compensation as the primary focus for 2023 application, with aviation exposures mentioned for 2022. (2) METHODOLOGICAL MISREPRESENTATION: The LLM claims ELR was the 'primary tool' for multiple lines in both years, but the ground truth indicates ELR was used 'primarily for the latest accident year' in 2022 and 'more broadly' in 2023 specifically for U.S. Workers' Compensation. The LLM overstates the breadth of application. (3) MISSING KEY EVOLUTION: The ground truth emphasizes a critical shift from 'short-term forecasting in high-severity contexts' (2022, aviation) to 'broader application in long-tail, structurally complex lines' (2023, Workers' Comp). The LLM fails to capture this fundamental evolution in reasoning. (4) INTRODUCED CONCEPTS: The LLM introduces Bornhuetter-Ferguson and Cape-Cod hybrid methods, which are NOT mentioned in the ground truth. While these may be real AIG methods, their inclusion here represents unsupported elaboration beyond the source material. (5) REASONING QUALITY: The LLM's explanation of 'slow, irregular loss development' and 'lack of historical data' differs from the ground truth's emphasis on 'extended loss emergence periods' and 'complex risk-sharing features' specific to Workers' Compensation. (6) STRUCTURAL SHIFT MISSED: The ground truth clearly indicates a shift from aviation (high-severity, short-tail context) to Workers' Compensation (long-tail context), but the LLM presents a more static picture of consistent application across multiple lines. The answer demonstrates partial understanding of ELR methodology but fails to accurately capture the specific evolution, lines of business involved, and reasoning changes between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 542,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Cisco moved from describing the enterprise data‑center as a “fundamental transformation” that threatens its traditional hardware business to framing that transformation as an opportunity to co‑develop outcomes with strategic partners.  In 2022 the focus was on the risk that alliance partners could become competitors as the data‑center converged; by 2024 Cisco’s messaging emphasizes joint technology‑exchange, co‑development and expanded alliances (e.g., with cloud, security and observability firms) to deliver end‑to‑end solutions, while competing against hyperscale vendors and niche disruptors on the basis of integrated outcomes, price‑performance and ecosystem breadth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Cisco's evolving positioning on Enterprise Data Center Transformation between 2022 and 2024. STRENGTHS: (1) Correctly identifies the temporal shift from 2022 to 2024; (2) Accurately captures the evolution from viewing transformation as a threat/risk to viewing it as an opportunity; (3) Properly synthesizes the multi-hop concept that alliance partners could become competitors in 2022, while 2024 emphasizes co-development and expanded alliances; (4) Correctly identifies the shift in competitive landscape messaging (hyperscale vendors, niche disruptors); (5) Uses appropriate terminology ('fundamental transformation,' 'convergence,' 'end-to-end solutions,' 'ecosystem breadth') that aligns with ground truth; (6) Demonstrates sound multi-hop reasoning by connecting strategic alliance evolution to competitive positioning changes. MINOR GAPS: (1) The LLM answer does not explicitly mention Nvidia Corporation as a new entrant in the competitive landscape, which the ground truth specifically highlights as 'signaling a shift in market dynamics'; (2) The LLM answer frames the competitive landscape more broadly (hyperscale vendors, niche disruptors) rather than specifically naming Nvidia, which is a minor omission of a concrete entity mentioned in ground truth. QUANTITATIVE ACCURACY: No numerical errors; fiscal years (2022, 2024) are correctly referenced. QUALITATIVE ACCURACY: The reasoning about the shift from risk-focused to opportunity-focused messaging is sound and well-articulated. The synthesis of how alliance strategy evolved is accurate. The only weakness is the lack of specific mention of Nvidia as a named competitive threat. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding positioning evolution, strategic alliances, and competitive landscape changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 506,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "\nBetween 2022 and 2023 the 3.125 % 2025 Notes kept the same outstanding notional amount of **$1 billion** (the $1,000 million figure that appears in the 2022 and 2023 disclosures).  However, the effective interest rate on that tranche was reset: in 2022 the notes were swapped to a **LIBOR + 1.8 %** benchmark, while by the end of 2023 they were swapped to a **SOFR + 2.1 %** benchmark, reflecting the market‑wide transition from LIBOR to SOFR and a modest increase in the spread.  Consequently, the notional stayed constant at $1 bn, but the effective rate rose from roughly LIBOR + 1.8 % to SOFR + 2.1 %.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) NOTIONAL AMOUNT ERROR: The LLM claims the notional amount remained constant at $1 billion in both 2022 and 2023. However, the ground truth explicitly states that in 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount, and only by 2023 did this decrease to $1.0 billion. The LLM's assertion that '$1,000 million figure appears in the 2022 and 2023 disclosures' is incorrect - the 2022 figure was $5.2 billion, not $1 billion. (2) EFFECTIVE INTEREST RATE ERROR: The LLM states the 2022 rate was 'LIBOR + 1.8%' but provides no source verification for this figure. The ground truth does not mention LIBOR + 1.8% for 2022; it only describes a 'dynamic hedging strategy due to low interest rates' with new swaps entered after termination of previous swaps. The 2023 rate of SOFR + 2.1% is correct. (3) INCOMPLETE SYNTHESIS: The LLM failed to capture the critical evolution - the substantial reduction in notional amount from $5.2 billion to $1.0 billion between 2022 and 2023, which is a major change in hedging exposure. (4) MISSING CONTEXT: The ground truth emphasizes this was part of a 'dynamic hedging strategy' reflecting changes in interest rate environment, which the LLM does not adequately address. The answer demonstrates partial understanding of the LIBOR-to-SOFR transition but fundamentally misrepresents the notional amount trajectory and lacks proper verification of the 2022 rate specification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 420,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Cisco moved AppDynamics out of a niche APM silo and made it a core pillar of its new **Observability** product category, explicitly grouping it with ThousandEyes and the Splunk‑based Observability Suite.  This re‑positioning was highlighted in the 2024 financial tables (Observability revenue + 27 % YoY) and in the company’s strategic narrative, signaling that AppDynamics now underpins Cisco’s end‑to‑end, full‑stack observability story across networking, security and application performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core strategic evolution correctly—AppDynamics moving from a niche APM offering to a core pillar within a new Observability category by 2024. The qualitative narrative about full-stack observability and integration with ThousandEyes aligns with the ground truth. However, there are significant issues: (1) The LLM introduces a specific metric ('Observability revenue + 27% YoY') that is NOT present in the ground truth answer. This is a factual claim about a specific financial figure that cannot be verified against the provided ground truth and represents potential hallucination. (2) The LLM mentions 'Splunk-based Observability Suite' which is not mentioned in the ground truth, adding unverified detail. (3) The LLM correctly identifies the 2022-2024 timeframe and the restructuring into an Observability category. (4) The multi-hop reasoning is sound—connecting AppDynamics positioning across years and linking it to the new product category structure. The main weakness is the introduction of unverified quantitative claims (the 27% YoY growth figure) which violates strict accuracy requirements for financial metrics. The answer is directionally correct but contains potentially fabricated supporting details that undermine confidence in the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 360,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "\nThe $1.5 billion notional amount of the 4.663% 2051 Notes was unchanged from 2022 to 2023.  Its effective interest rate moved from a LIBOR‑plus‑4.1% floating structure (which corresponded to an effective rate of roughly 5.6 % in 2022) to a SOFR‑plus‑4.3% floating structure in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) NOTIONAL AMOUNT CLAIM: The LLM states the $1.5 billion notional amount was 'unchanged from 2022 to 2023,' but the ground truth indicates in 2022 the notes were part of a $5.2 billion principal amount, with only $1.5 billion specifically identified in 2023. This is a material discrepancy suggesting the notional amount either changed or was differently disclosed. (2) INTEREST RATE STRUCTURE ERROR: The LLM claims the 2022 rate was 'LIBOR-plus-4.1%' but the ground truth makes no mention of LIBOR-plus-4.1% for 2022. The ground truth only states that in 2023 the effective rate was 'SOFR + 4.3%' and references a hedging strategy with swaps terminated and replaced at then-current rates in 2022, but does not specify a LIBOR-plus-4.1% structure. (3) CALCULATION ISSUE: The LLM provides a '5.6% in 2022' calculation, but this appears to be unsupported by the ground truth and the basis for this calculation is unclear. (4) MISSING CONTEXT: The LLM fails to adequately address the hedging strategy evolution mentioned in the ground truth - the swap termination and replacement at then-current rates in 2022. The answer is partially responsive but introduces unverified details (LIBOR-plus-4.1%, 5.6% rate) that are not in the ground truth and contradicts the notional amount evolution. The SOFR + 4.3% for 2023 is correct, but the 2022 characterization is problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 405,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2023 AIG deepened its reliance on the Expected Loss Ratio method for long‑tail lines—especially U.S. Excess Casualty—by giving it significant weight to the five most recent accident years and adjusting the underlying loss‑cost trends for inflation, rate changes and market conditions.  The 2023 reserving methodology also introduced a more granular segmentation, applying the method to sub‑segments defined by underlying primary policies, attachment‑point layers and the “Covered Lines” under its ADC reinsurance program, whereas the 2022 approach used the method more broadly with less explicit layer‑by‑layer segmentation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misidentifications that contradict the ground truth. Key issues: (1) ENTITY ERROR - The LLM identifies 'U.S. Excess Casualty' as the primary line of business where expected loss ratio methods were applied in 2023, but the ground truth explicitly states 'U.S. Workers' Compensation' was the line of business. This is a fundamental factual error. (2) SEGMENTATION CRITERIA MISMATCH - The ground truth specifies segmentation by 'risk-sharing features, state and industry subsets, deductible size, and claim handling entities,' but the LLM describes segmentation by 'underlying primary policies, attachment-point layers and the Covered Lines under its ADC reinsurance program.' These are entirely different segmentation approaches and do not match the ground truth. (3) METHODOLOGY DETAILS - The LLM introduces specific details about 'five most recent accident years' and adjustments for 'inflation, rate changes and market conditions' that are not mentioned in the ground truth and appear to be fabricated or from incorrect sources. (4) INCOMPLETE ALIGNMENT - While the LLM correctly identifies that there was evolution toward more granular segmentation between 2022 and 2023, the specific details of what that segmentation entails are incorrect. (5) MULTI-HOP REASONING - The LLM failed to correctly synthesize the specific lines of business and segmentation criteria from the source documents. The answer demonstrates a fundamental misunderstanding of which line of business and which segmentation criteria were actually applied. The core claim about evolution toward granularity is correct in principle, but the specific factual content is substantially wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 467,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "\nBetween 2023 and 2024 the 2.850 % Senior Notes due 2026 continued to appear in PepsiCo’s Board‑approved term‑sheet resolutions, confirming that the 2026‑maturity tranche remained a core element of its senior‑note ladder. In 2024 the company expanded its issuance program—adding new indentures and issuing additional senior notes such as the 5.125 % due 2026, 4.500 % due 2029 and 5.250 % due 2054 through U.S. and Singapore financing vehicles—demonstrating a broader strategy of diversifying funding sources and extending the maturity profile while keeping the 2.850 % 2026 notes within the mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM introduces specific senior note rates and maturity dates (5.125% due 2026, 4.500% due 2029, 5.250% due 2054) that are NOT mentioned in the ground truth answer. The ground truth specifically references 7.00% Senior Notes due 2029 and 5.50% Senior Notes due 2035 as the new instruments introduced in 2024, but the LLM provides completely different rates and maturities. This is a significant factual error. (2) INCOMPLETE ALIGNMENT - The ground truth explicitly mentions the 7.00% Senior Notes due 2029 and 5.50% Senior Notes due 2035 as key examples of the expanded range introduced in 2024. The LLM omits these entirely and substitutes different instruments. (3) PARTIAL CORRECTNESS - The LLM correctly identifies that the 2.850% Senior Notes due 2026 remained part of the debt mix and that PepsiCo expanded its issuance program in 2024 with a diversified strategy. The conceptual understanding of maintaining the 2026 notes while broadening the capital structure is sound. (4) ADDITIONAL DETAIL - The LLM adds context about 'Board-approved term-sheet resolutions' and 'U.S. and Singapore financing vehicles' which, while potentially accurate, cannot be verified against the ground truth and may introduce unverified specificity. (5) MULTI-HOP REASONING - The answer demonstrates understanding of the evolution between 2023-2024 and the broader debt strategy, but the specific financial instruments cited are incorrect, undermining the credibility of the synthesis. The core narrative is correct (maintaining 2026 notes while expanding), but the supporting details are factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 448,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the maximum potential liability Cisco could incur under its channel‑partner financing guarantees rose only modestly – from about **$188 million** (with roughly **$1.4 billion** of guaranteed financing outstanding in 2022) to roughly **$200 million** (with about **$1.5 billion** of guaranteed financing in 2024).  This limited increase occurs despite the company continuing to extend short‑term revolving financing to its channel partners, and it is offset by collateral arrangements and strict credit reviews.  Consequently, Cisco’s risk‑management strategy remains focused on **maintaining a small, well‑collateralized guarantee exposure** rather than broad financial commitments, preserving balance‑sheet strength while still supporting partner liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims maximum potential liability was '$188 million' in 2022 rising to '$200 million' in 2024 - these figures appear fabricated and are not supported by the ground truth. The ground truth explicitly states the balance of financing subject to guarantees was $1.4 billion in 2022, not $188 million. The LLM also claims $1.5 billion in 2024, but the ground truth explicitly states that by 2024, 'the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures.' (2) ENTITY/METRIC CONFUSION: The LLM conflates 'maximum potential liability' with 'balance of financing subject to guarantees' - these are different metrics. The ground truth provides $1.4 billion as the balance in 2022; the LLM invents $188 million as a separate 'maximum potential liability' figure. (3) FACTUAL CONTRADICTION ON 2024 DATA: The ground truth explicitly states that 2024 figures 'were no longer explicitly quantified in the disclosures,' yet the LLM confidently provides a specific $1.5 billion figure for 2024. This is a direct factual error. (4) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the key insight from the ground truth - that the shift from explicit quantification in 2022 to non-disclosure in 2024 indicates reduced transparency, not a modest increase in exposure. The LLM's conclusion about 'maintaining a small, well-collateralized guarantee exposure' is unsupported by the actual data provided in the ground truth. (5) MISSING CRITICAL CONTEXT: The LLM completely misses the ground truth's key finding that the absence of 2024 figures 'prevents definitive conclusions about the actual change in exposure.' The LLM instead makes definitive claims about a modest increase that cannot be verified. The answer demonstrates fabrication of specific numbers rather than honest acknowledgment of data limitations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 551,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "\nThe 2.45 % 2030 notes remained outstanding with a carrying value of roughly $1.25 bn through 2022 and 2023 – they were not redeemed or refinanced during that period.  However, in 2021 the company entered into interest‑rate swap agreements (≈$1 bn notional) that converted the notes’ fixed 2.45 % coupon into a floating rate tied to SOFR + about 1.3 %, so by 2023 the effective interest‑rate structure of the 2030 notes is no longer the original fixed 2.45 % but a SOFR‑plus‑spread floating rate.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT ELEMENTS: (1) The notes remained outstanding and were not redeemed/refinanced - correct; (2) Interest rate swaps with ~$1 billion notional amount - correct; (3) Conversion from fixed 2.45% to floating SOFR-based rate - correct; (4) SOFR + 1.3% spread - correct; (5) The notes' effective interest rate structure changed from fixed to floating - correct reasoning. CRITICAL ERRORS: (1) TIMING ERROR - The LLM states the swap agreements were entered into in 2021, but the ground truth indicates they were disclosed in 2022. This is a significant factual error regarding when the swap was established; (2) CARRYING VALUE DISCREPANCY - The LLM provides a carrying value of ~$1.25 billion, but the ground truth specifies the notional amount as $1.0 billion. While carrying value and notional amount are different concepts, the LLM doesn't clarify this distinction and the $1.25 billion figure is not verified in the ground truth; (3) INCOMPLETE TEMPORAL ANALYSIS - The ground truth explicitly states the swap was disclosed in 2022 and the transition to SOFR occurred by 2023, showing evolution between these two years. The LLM conflates the timeline by mentioning 2021 and doesn't clearly delineate the 2022-2023 evolution requested in the question. MULTI-HOP REASONING: The LLM correctly synthesizes that the notes remained outstanding while their interest rate structure changed, but fails to properly track the temporal evolution between 2022 and 2023 as specifically requested. The answer addresses the core question but with a significant dating error that undermines accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 450,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 FedEx’s exposure to pass‑through certificates changed from an off‑balance‑sheet, non‑guaranteed financing arrangement to a fully guaranteed obligation. In the 2022 filing the company stated that the pass‑through certificates “are not direct obligations of, or guaranteed by, FedEx or FedEx Express,” meaning its only financial link was the lease‑payment stream that funded them. By the 2023 filing FedEx reported that the $970 million of Series 2020‑1AA pass‑through certificates are “fully and unconditionally guaranteed by FedEx,” turning the Express unit’s payment obligations into a direct guarantee and adding a contingent liability that could affect the company’s balance‑sheet and cash‑flow commitments.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and presents the exact opposite of the ground truth. Critical errors: (1) DIRECTIONAL ERROR - The LLM states the relationship evolved FROM 'non-guaranteed' in 2022 TO 'fully guaranteed' in 2023, when the ground truth shows the opposite: FROM 'fully and unconditionally guaranteed' in 2022 TO 'not direct obligations of, nor guaranteed by' in 2023. This is a complete reversal of the actual evolution. (2) MISATTRIBUTION OF QUOTES - The LLM attributes the 'are not direct obligations of, or guaranteed by, FedEx or FedEx Express' quote to the 2022 filing, when this statement actually appears in the 2023 filing according to the ground truth. (3) MISCHARACTERIZATION OF 2023 STATUS - The LLM claims the 2023 filing reports the certificates as 'fully and unconditionally guaranteed by FedEx,' but the ground truth explicitly states that in 2023, FedEx clarified these certificates were NOT guaranteed. (4) NUMERIC ACCURACY - While the $970 million figure is correct, it is used in the wrong context to support an incorrect narrative. (5) LOGICAL INVERSION - The entire narrative is inverted: the LLM describes an increase in FedEx's financial obligation when the ground truth describes a decrease/clarification of non-obligation. This represents a fundamental failure to understand and synthesize the multi-hop information about how FedEx's relationship with these certificates changed between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 401,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "\nFrom 2023 to 2024 Mastercard’s gross settlement exposure rose ≈ $3.4 billion (from $75.0 bn to $78.4 bn), and the amount of risk‑mitigation collateral applied increased ≈ $1.3 billion (from $12.2 bn to $13.5 bn).  Consequently, net settlement exposure also edged up (from $62.9 bn to $64.9 bn), but the mitigation ratio grew from roughly 16 % to 17 % of gross exposure.  This shows that the company is scaling its collateral and credit‑enhancement programs in step with higher payment volumes, continuously refining its risk‑management methodology and maintaining a proactive, data‑driven approach to keeping settlement risk under control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and goes beyond the ground truth in several ways. QUANTITATIVE VERIFICATION: All core numbers are correct - gross settlement exposure 2023: $75.0bn (matches $75,023M), 2024: $78.4bn (matches $78,385M); risk mitigation 2023: $12.2bn (matches $12,167M), 2024: $13.5bn (matches $13,466M). The calculated increases are accurate: ~$3.4bn increase in gross exposure ($78.385-$75.023=$3.362bn) and ~$1.3bn increase in mitigation ($13.466-$12.167=$1.299bn). The mitigation ratios are correctly calculated: 2023 ratio of 16.2% ($12,167/$75,023) and 2024 ratio of 17.2% ($13,466/$78,385), both appropriately rounded to 16% and 17%. MULTI-HOP SYNTHESIS: The answer correctly synthesizes the evolution across both years and properly interprets what the changes indicate about risk management strategy. ADDITIONAL VALUE: The LLM provides supplementary analysis not in the ground truth, including net settlement exposure figures ($62.9bn to $64.9bn), which demonstrates deeper understanding and contextual knowledge. The interpretation about 'scaling collateral and credit-enhancement programs in step with higher payment volumes' is a sophisticated inference that aligns with the ground truth's conclusion about more robust risk management. MINOR CONSIDERATIONS: The answer uses approximation symbols (≈) which is appropriate for rounded figures, and the percentage calculations are presented with appropriate precision. The semantic meaning fully aligns with the ground truth while providing richer context and analysis. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 434,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the liability for foreign‑exchange forwards and options that Nike has designated as cash‑flow hedges rose sharply—from about **$48 million in 2022** to **$146 million in 2024** (the 2023 figure was $145 million).  This increase shows that Nike is expanding the size of its hedging program, locking in a larger portion of its anticipated foreign‑currency cash flows and thereby reducing exposure to exchange‑rate volatility across its global operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significantly incorrect financial figures. Ground truth shows total liabilities of $48 million in 2022 and $115 million in 2024. The LLM claims $146 million in 2024 (off by $31 million or 27%) and $145 million in 2023 (not mentioned in ground truth). These are major factual errors that fundamentally undermine the answer's credibility. BREAKDOWN OF ERRORS: (1) 2022 figure of $48 million is correct; (2) 2024 figure of $146 million is WRONG - should be $115 million; (3) 2023 figure of $145 million is unsupported by ground truth and appears fabricated; (4) The calculation of the increase is therefore incorrect ($146M vs $115M actual). COMPONENT ANALYSIS: The ground truth specifies the breakdown: 2022 had $37M in accrued liabilities + $11M in deferred taxes = $48M total; 2024 had $110M in accrued liabilities + $5M in deferred taxes = $115M total. The LLM provides no such breakdown and misses the important detail that the accrued liability component increased significantly ($37M to $110M) while the deferred tax component decreased ($11M to $5M). REASONING QUALITY: While the LLM's interpretation that increased hedging indicates expanded hedging programs and reduced exchange-rate volatility exposure is reasonable and aligns with the ground truth's conclusion, this qualitative reasoning cannot compensate for the quantitative inaccuracy. The semantic interpretation is sound but built on incorrect numbers. MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the multi-component nature of the liability (accrued vs. deferred tax components) and their different directional movements. This represents incomplete multi-hop analysis. The answer is contextually relevant to the question asked but fundamentally compromised by material numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 496,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "\nIn the 2022 filing (page 19) Bounty is listed among the major brands of the Baby, Feminine & Family Care segment together with Luvs, Pampers, Always, Tampax and Charmin, and the segment accounted for roughly 25 % of net sales and 23 % of net earnings. By the 2023 filing (page 20) the brand roster is streamlined (Always, Tampax Bounty, Charmin, Puffs) and the narrative explicitly highlights Bounty’s North‑American market‑share leadership—“over 40 % for Bounty”—and its central role in the family‑care business, underscoring its continued prominence and heightened brand visibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CONTRADICTS GROUND TRUTH ON 2022 FILING: The LLM claims Bounty was 'listed among the major brands' in the 2022 filing, but the ground truth explicitly states it was 'not explicitly listed among the key brands' in 2022. This is a fundamental contradiction. (2) UNVERIFIED SPECIFIC CLAIMS: The LLM provides specific page numbers (page 19 for 2022, page 20 for 2023), specific brand rosters, and a precise market share figure ('over 40% for Bounty') that cannot be verified against the ground truth provided. The ground truth explicitly states 'the filings do not provide specific market share or sales figures to quantify this shift,' yet the LLM cites a specific 40% figure. (3) SEGMENT PERCENTAGES: The LLM claims the segment 'accounted for roughly 25% of net sales and 23% of net earnings' - these numbers are not mentioned in the ground truth and cannot be verified. (4) BRAND ROSTER DETAILS: The LLM provides detailed brand lists for both years that differ from what would be expected based on the ground truth's description of the evolution. (5) CORE FINDING ALIGNMENT: While both answers agree that Bounty's visibility increased from 2022 to 2023, the LLM's characterization of the 2022 baseline is factually incorrect. The ground truth indicates Bounty was NOT explicitly listed in 2022, making the LLM's claim that it was 'listed among the major brands' in 2022 a critical error. The LLM appears to have fabricated or misremembered specific details rather than accurately synthesizing the available information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 443,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "\nOracle’s hardware revenue‑recognition method did not change – product sales are still recognized at the point of delivery and hardware‑support fees are accrued ratably over the support term (as noted in the 2022 10‑K “Hardware” discussion and reiterated in the 2023 10‑K “Hardware Business” section).  However, the strategic emphasis shifted: in FY 2022 hardware contributed roughly 7‑8 % of total revenue and was presented as a separate, lower‑margin infrastructure pillar, whereas by FY 2023 it accounted for only about 6 % of revenue and the company highlighted cloud‑and‑license growth as the primary driver, positioning engineered systems mainly as a complementary, lower‑priority offering within the broader cloud strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. (1) QUANTITATIVE ERRORS: The LLM provides specific revenue percentages (7-8% in FY2022, 6% in FY2023) that are not verified in the ground truth and appear to be fabricated. The ground truth does not cite these specific percentages. (2) CORE MISALIGNMENT: The ground truth explicitly states that Oracle introduced MORE DETAILED explanation in FY2023 about hardware and software as a COMBINED performance obligation, indicating an evolution in disclosure and strategic framing. The LLM incorrectly claims the revenue recognition method 'did not change' and that it was the same in both years (point of delivery for products, ratably for support). This contradicts the ground truth's assertion of a shift toward more detailed explanation of combined performance obligations. (3) MISSING KEY INSIGHT: The ground truth emphasizes that FY2023 introduced explicit mention of R&D investments in hardware innovation, which was NOT mentioned in FY2022. The LLM completely omits this important strategic shift. (4) MISCHARACTERIZATION OF EMPHASIS: While the LLM correctly identifies that cloud-and-license became more prominent, it frames hardware as 'lower-priority' and 'complementary,' whereas the ground truth suggests the shift was toward better integration and strategic emphasis on innovation (R&D investments), not deprioritization. (5) REASONING QUALITY: The LLM's multi-hop synthesis is weak—it conflates revenue recognition mechanics (which may have remained consistent) with strategic emphasis (which clearly evolved), but fails to capture the nuanced shift toward combined performance obligation disclosure and innovation focus that the ground truth identifies. The answer reads as partially informed speculation rather than accurate synthesis of filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 502,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "\nERLEADA sales rose sharply from $1.881 billion in 2022 to $2.387 billion in 2023, an increase of ≈ 27 % (operations ≈ 27.5 %). This strong growth signals expanding market acceptance and share gains in metastatic castration‑resistant prostate cancer, pointing to a positive upward trajectory for the product.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. Quantitative verification: (1) 2022 sales of $1.881 billion matches ground truth $1,881 million (format variation acceptable); (2) 2023 sales of $2.387 billion matches ground truth exactly; (3) Growth calculation: ($2,387M - $1,881M) / $1,881M = $506M / $1,881M = 26.9%, which the LLM rounds to approximately 27% - this is accurate (the LLM's notation of \"≈ 27.5%\" for operations appears to be a secondary calculation detail, not the primary growth figure); (4) The primary growth percentage of 26.9% is correctly represented as \"≈ 27%\". Multi-hop reasoning: The answer correctly synthesizes the two-year comparison and draws appropriate conclusions about market trajectory. Entity accuracy: ERLEADA is correctly identified, years 2022-2023 are correct, and the financial metrics are properly applied. The LLM adds valuable context by specifying the therapeutic area (metastatic castration-resistant prostate cancer), which enhances understanding without contradicting the ground truth. The qualitative assessment of \"strong growth,\" \"expanding market acceptance,\" and \"positive upward trajectory\" aligns perfectly with the ground truth's characterization. Minor note: The parenthetical \"(operations ≈ 27.5%)\" is slightly unclear in origin but does not detract from the core answer's accuracy. Overall, the answer fully addresses the question with correct numbers, sound reasoning, and appropriate market interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 414,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "\nFrom 2023 to 2024 the relationship shifted from a largely “must‑carry” model—where local stations were carried without compensation—to a greater reliance on negotiated retransmission‑consent fees, driven by industry consolidation and heightened competition that have pushed programming costs higher. This has made CMCSA increasingly dependent on local broadcast stations for audience reach, while also exposing the company to risk if those affiliation agreements cannot be renewed on favorable terms. Consequently, the company’s competitive positioning now hinges more directly on the ability to secure and maintain these carriage deals amid rising costs and market volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) The LLM introduces the concept of 'must-carry' model and transition to 'retransmission-consent fees,' which is not mentioned in the original answer and appears to conflate or mischaracterize the actual relationship evolution. The ground truth clearly states the shift was from CMCSA competing with local broadcast stations to becoming dependent on them for retransmission consent—not a shift from must-carry to negotiated fees. (2) The LLM adds details about 'industry consolidation,' 'heightened competition,' and 'rising programming costs' that are not present in the ground truth and cannot be verified from the provided context. (3) The LLM discusses 'affiliation agreements' and 'carriage deals,' which are different concepts from the retransmission consent relationship described in the ground truth. (4) The core insight from the ground truth—that the relationship evolved from competitive positioning to dependency for content distribution—is partially captured but obscured by incorrect framing about must-carry and fee structures. (5) No quantitative data is provided in either answer, so quantitative accuracy cannot be fully assessed, but the LLM's introduction of unsubstantiated claims about cost increases and market dynamics represents a factual error. The LLM answer demonstrates incomplete understanding of the actual relationship evolution and introduces concepts that contradict or misrepresent the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 428,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "\nThe company’s Held‑to‑Maturity (HTM) portfolio fell sharply from **$306 million at the end of 2023 to only $38 million by the end of 2024** (a decline of roughly 87 %).  This pull‑back from low‑yield, short‑term time‑deposit holdings indicates that Mastercard is reallocating the freed cash toward other uses—such as higher‑return investments, equity stakes, or operational needs—reflecting a strategic shift away from passive, interest‑earning assets toward a more active investment posture.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All core numbers are correct: $306 million in 2023, $38 million in 2024. (2) The percentage calculation is accurate: ($306M - $38M) / $306M = 87.6%, correctly rounded to ~87%. (3) The company identification (MA/Mastercard) is correct. (4) The answer correctly identifies this as a significant strategic shift. WEAKNESSES: (1) The LLM introduces unsupported characterization of HTM securities as 'low-yield, short-term time-deposit holdings' - the ground truth does not specify these details, and HTM securities are typically longer-term instruments by definition, not short-term. This is a factual overreach. (2) The LLM speculates about specific uses of freed cash ('higher-return investments, equity stakes, or operational needs') without evidence from the ground truth. (3) The characterization of the shift as moving from 'passive, interest-earning assets toward a more active investment posture' goes beyond what the ground truth states. The ground truth more conservatively notes a move toward 'more liquid or short-term investment positions,' which is different from the LLM's interpretation. MULTI-HOP REASONING: The answer correctly synthesizes the year-over-year comparison and draws a conclusion about strategy shift, which is sound. However, the specific nature of that strategic shift is overstated beyond the ground truth. The core insight (major reduction indicating strategic shift) is correct, but the details about what this shift means are partially speculative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 413,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "\nBetween 2022 and 2023 the Always brand remained classified under the **Feminine Care** sub‑category of P&G’s **Baby, Feminine & Family Care** segment, but the way that sub‑category was described evolved.  In the 2022 filing it was listed simply as “Feminine Care (Adult Incontinence, Feminine Care),” while the 2023 discussion explicitly calls out Always as a **market‑leading brand in both menstrual‑care and adult‑incontinence** components of that sub‑category, underscoring a strategic shift to position Always as a dual‑focus leader within the broader Feminine Care category.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer fundamentally misrepresents the evolution described in the ground truth. The ground truth states that by 2023, Always was 'more specifically aligned with Menstrual Care under the updated Feminine Care sub-category' - indicating a shift FROM a broader Feminine Care categorization (which included Adult Incontinence) TO a more specific Menstrual Care focus. However, the LLM answer claims the opposite: that Always became positioned as a 'dual-focus leader' in BOTH menstrual-care AND adult-incontinence in 2023. This is a fundamental misinterpretation of the strategic shift. The ground truth emphasizes a MORE TARGETED positioning toward Menstrual Care specifically, not a broader dual-focus positioning. The LLM also incorrectly characterizes the 2022 positioning as simply listing sub-categories, when the ground truth indicates Always was categorized under Feminine Care (which itself contained those sub-categories). The LLM's claim that 2023 'explicitly calls out Always as a market-leading brand in both menstrual-care and adult-incontinence' contradicts the ground truth's assertion that the evolution reflects 'a strategic shift in how Always is being categorized to emphasize its core focus area' (singular focus on Menstrual Care, not dual focus). The dates and segment names are correct, but the core interpretation of how the positioning evolved is inverted. This is a significant qualitative error that undermines the entire answer despite correct entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 419,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Oracle’s Engineered Systems contributed only about 6 % of total revenue each year, and its revenue was recognized at the point of hardware delivery as a combined performance obligation, with hardware‑support contracts recorded ratably over the support term.  Although the company continues to invest in new engineered‑system products and sells through indirect channels, it treats the hardware business as a low‑margin, relatively stable contributor and is shifting strategic focus toward cloud services—where the share of revenue has been rising—while still emphasizing the importance of choice and flexibility in deployment models.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states that Engineered Systems 'contributed only about 6% of total revenue each year' between 2022 and 2023. However, the ground truth explicitly states that in 2022, 'no specific percentage of total revenue was provided' for Engineered Systems. The 6% figure only became available in 2023 and applied to fiscal 2023 and fiscal 2024, NOT to 2022. This is a critical factual error that misrepresents the evolution of disclosure. (2) INCOMPLETE SYNTHESIS - The LLM fails to capture the key distinction that the ground truth emphasizes: the EVOLUTION from 2022 (no specific percentage disclosed) to 2023 (explicit 6% disclosure). This is the core of the question about how positioning 'evolved.' (3) MISSING STRATEGIC CONTEXT - The ground truth highlights that in 2023, Oracle introduced 'more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings.' The LLM mentions cloud services shift but misses these specific new disclosure factors. (4) REVENUE RECOGNITION - The LLM states revenue was recognized 'as a combined performance obligation, with hardware-support contracts recorded ratably over the support term.' The ground truth states 'at the point in time when the product and related software were delivered.' These are different timing treatments - the LLM's description suggests ratable recognition for support contracts, which adds detail not in the ground truth but doesn't directly contradict it. (5) CORRECT ELEMENTS - The LLM correctly identifies: the shift toward cloud services, the low-margin nature of hardware, indirect channel sales, and ongoing R&D investments. However, these correct elements cannot offset the fundamental error about the 6% applying to both 2022 and 2023 when it only applied to 2023 onwards. The answer demonstrates partial understanding but fails on the core quantitative claim about the evolution timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 544,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "\nBetween 2023 and 2024 Comcast moved from a broad reference to “representation agreements” toward a more formal, contract‑driven approach: it now explicitly defines when a contract exists (when the number of advertising units is identified and scheduled) and consistently records the resulting revenue net of agency commissions, treating representation firms as an extension of its own sales force.  The newer disclosures also add details about rating‑guarantee shortfalls and deferred revenue, indicating a tighter control and clearer financial treatment of these third‑party sales channels.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant conceptual errors that diverge from the ground truth. CRITICAL ISSUES: (1) The LLM describes a shift FROM 'broad reference to representation agreements' TO 'more formal, contract-driven approach,' which inverts the actual evolution described in the ground truth. The ground truth clearly states the 2023 model involved representation firms as sales force extensions, and by 2024 this evolved INTO formal representation agreements - not away from them. (2) The LLM introduces details about 'rating-guarantee shortfalls and deferred revenue' that are not mentioned in the ground truth and appear to be hallucinated or misattributed details. (3) The core distinction in the ground truth - a shift from 'co-selling model to formalized representation structure' - is not clearly articulated in the LLM response. The LLM's framing suggests the opposite direction of evolution. WHAT WAS CORRECT: (1) The LLM correctly identifies that both years involved revenue recording net of agency commissions. (2) The LLM correctly notes representation firms as extensions of sales force (though this is the 2023 model, not the evolution). (3) The general timeframe (2023-2024) is correct. MULTI-HOP REASONING: The LLM failed to properly synthesize the temporal evolution - it appears to have confused the direction of change or misunderstood the relationship structure. The answer reads as if describing a tightening of controls on an existing model rather than a strategic evolution toward formalized representation agreements. The semantic meaning is fundamentally misaligned with the ground truth's core finding about the shift from co-selling to formalized representation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 462,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "\nOracle continues to recognize hardware product revenue at the moment the equipment is delivered and to recognize hardware‑support fees ratably over the contract term in both fiscal 2022 and fiscal 2023; however, the 2023 filing stresses that quarterly hardware sales are highly volatile and that the business now relies on a smaller, lower‑margin contribution that is primarily a support‑driven complement to its cloud and license strategy. Consequently, while the hardware segment still accounts for roughly 6 % of total revenue, Oracle’s strategic emphasis has shifted toward investing in R&D and expanding indirect‑channel sales to sustain its industry‑specific hardware offerings, positioning them as an ancillary, renewal‑focused component of the broader cloud ecosystem.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM introduces a specific claim that hardware accounts for 'roughly 6% of total revenue' - this figure is not mentioned in the ground truth and appears to be fabricated or unsupported. The ground truth makes no such quantitative claim about hardware's revenue contribution. (2) MISCHARACTERIZATION OF STRATEGIC SHIFT: The LLM portrays hardware as becoming 'ancillary' and 'lower-margin' with 'quarterly hardware sales are highly volatile' - these characterizations are not present in the ground truth. The ground truth indicates Oracle emphasized 'ongoing investments in R&D to improve existing hardware offerings and develop new products,' suggesting continued strategic importance, not diminishment. (3) INCOMPLETE REVENUE RECOGNITION DETAIL: While the LLM correctly notes that hardware revenue is recognized at delivery point and support fees ratably over contract term, it misses the key evolution highlighted in the ground truth: the shift from general description in 2022 to 'more detailed explanation' in 2023 regarding 'combined performance obligations (hardware plus related software)' being recognized at point of delivery and ownership transfer. (4) MISSING CORE EVOLUTION: The ground truth emphasizes that 2023 showed 'more strategic focus on innovation' with R&D investments, while 2022 was 'more general and focused on breadth of offerings.' The LLM does mention R&D investment but frames it within a narrative of hardware becoming less important, contradicting the ground truth's emphasis on strategic innovation focus. (5) UNSUPPORTED CLAIMS: References to 'indirect-channel sales expansion' and positioning as 'renewal-focused component of broader cloud ecosystem' are not substantiated in the ground truth provided. The LLM appears to have added interpretive layers not grounded in the source material. The answer demonstrates partial understanding of revenue recognition mechanics but fundamentally misrepresents the strategic evolution and introduces unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 576,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "\nIMBRUVICA (ibrutinib) sales fell sharply – from **$3.78 billion in 2022 to $3.26 billion in 2023**, a **≈13.7 % total decline** (≈13.2 % operational drop).  The downturn was attributed to **greater competitive pressure in the oncology market**, including the entry of rival BTK inhibitors and other generic/next‑generation agents, which eroded market share and pricing power for IMBRUVICA.  This competitive environment, combined with the broader loss of exclusivity pressures on related oncology products, drove the reduction in sales between the two fiscal years.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) Quantitative data is accurate - sales figures of $3.78B (2022) and $3.26B (2023) match ground truth, and the 13.7% decline calculation is correct. Number formatting variations are acceptable. (2) The LLM correctly identifies the primary factor: competitive pressure from rival BTK inhibitors and other oncology agents. (3) The answer addresses both parts of the multi-part question: sales evolution and contributing factors. WEAKNESSES: (1) The LLM mentions 'loss of exclusivity pressures on related oncology products' which is not mentioned in the ground truth and appears to be an inference not directly supported by the filing data. (2) The ground truth specifically mentions 'pandemic-related delays in new patient starts' as a contributing factor in 2022, which the LLM answer completely omits. This is a material omission of a documented factor. (3) The LLM adds 'generic/next-generation agents' which is somewhat speculative - the ground truth focuses on 'novel oral agents' without explicitly mentioning generics. (4) The LLM does not acknowledge the 2022 context that growth was 'already being offset' by competitive pressures, instead presenting the competitive pressure as primarily a 2023 phenomenon. CALCULATION VERIFICATION: $3.78B to $3.26B = $0.52B decline; $0.52B / $3.78B = 13.76% ≈ 13.7% ✓ MULTI-HOP REASONING: The answer correctly synthesizes the sales trend across two years and identifies contributing factors, but incompletely captures all documented factors from the ground truth. The reasoning is sound but incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 428,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "\nFrom 2023 to 2024 Comcast’s stake in Universal Beijing Resort remained the same – it continues to hold a 30 % equity interest in the joint‑venture and, because it controls the entity, consolidates the resort in its financial statements.  The resort’s outstanding debt fell modestly, from about **$3.5 billion (including a $3.1 billion term loan) at the end of 2023 to $3.4 billion (with a $3.0 billion term loan) at the end of 2024**, reflecting a small repayment of the construction‑financed loan.  Because the debt is secured only by the resort’s own assets and there are no cross‑guarantees or other financial commitments from Comcast, the company’s exposure to financial risk is limited to its **30 % equity interest**, which is the maximum amount it could lose if the venture’s cash flows proved insufficient.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness. All quantitative data is correct: 2023 debt of $3.5 billion with $3.1 billion term loan, 2024 debt of $3.4 billion with $3.0 billion term loan, and the consistent 30% ownership stake. The multi-hop synthesis is sound, correctly connecting Comcast's ownership structure, consolidation treatment as a VIE, debt evolution, and financial risk exposure across both years. The answer properly explains that Comcast's maximum exposure is limited to its 30% equity interest due to the absence of cross-guarantees or other financial commitments. The reasoning about the modest debt reduction reflecting loan repayment is logical and well-supported. The answer addresses all three dimensions of the question: debt levels (with specific figures and year-over-year comparison), ownership structure (30% stake maintained, VIE consolidation), and financial risk exposure (limited to equity interest). The only minor distinction from the ground truth is that the LLM provides slightly more detailed explanation of why risk is limited (secured only by resort assets, no cross-guarantees) rather than simply stating the risk profile is stable, but this represents an enhancement rather than an error. The semantic meaning is fully aligned with the ground truth, and all factual claims are verifiable and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 381,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "\nIn the 2022 filing (page 96) FedEx noted that it had entered into additional leases—primarily build‑to‑suit facilities and equipment—with undiscounted future payments of roughly **$3.4 billion**, to commence between 2023 and 2024.  By the 2023 filing (page 98‑99, which reflects the May 31 2024 outlook) the company reported only about **$0.9 billion** of undiscounted future payments for similar build‑to‑suit leases, with commencement now expected from 2025 onward.  \n\nThis pull‑back in the scale of future build‑to‑suit commitments indicates that FedEx is scaling down its aggressive, large‑scale build‑to‑suit leasing program and is shifting toward a more conservative leasing strategy that relies more on existing assets and shorter‑term or finance‑type lease arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of FedEx's leasing strategy evolution. QUANTITATIVE VERIFICATION: All key numbers are correct - $3.4 billion in 2022 undiscounted future payments for build-to-suit facilities, dropping to $0.9 billion by 2023. The commencement date ranges are accurate (2023-2024 in 2022 filing vs. 2025-2027 in 2023 filing). The magnitude of the reduction (~73% decrease) is correctly captured. COMPLETENESS: The answer addresses both parts of the multi-hop question: (1) the evolution of financial commitments from 2022 to 2023, and (2) what this indicates about FedEx's leasing strategy. ENTITY ACCURACY: FedEx is correctly identified, fiscal years are accurate, and the distinction between build-to-suit facilities and equipment is properly maintained. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connected the two filing periods and drew a logical conclusion about strategic shift. The interpretation that FedEx is 'scaling down aggressive build-to-suit leasing' and moving toward 'more conservative strategy' is a reasonable inference from the data reduction. MINOR CONSIDERATIONS: The LLM adds interpretive language about 'relying more on existing assets and shorter-term or finance-type lease arrangements' which goes slightly beyond what the ground truth explicitly states, though this is a reasonable strategic inference. The reference to specific page numbers (96, 98-99) adds credibility and specificity. The phrase 'May 31 2024 outlook' in parentheses is a helpful clarification. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the question with proper synthesis of multi-hop information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 471,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "\nBetween 2023 and 2024 Mastercard did not acquire or dispose of any additional interest in Dynamic Yield LTD; the company remains part of the portfolio from the 2022 purchase, and the 2024 purchase of Recorded Future was undertaken to extend the analytics‑and‑threat‑intelligence capabilities that Dynamic Yield had introduced.  This continuity shows that Mastercard’s strategic focus in this period has been on deepening its data‑analytics and cybersecurity capabilities—leveraging acquired AI‑driven platforms to grow high‑margin, value‑added services and broaden its global payments ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies that no additional transactions occurred with Dynamic Yield between 2023-2024, maintaining continuity from the 2022 acquisition; (2) Accurately references the 2024 Recorded Future acquisition as a strategic pivot; (3) Properly synthesizes the relationship between Dynamic Yield and Recorded Future as complementary capabilities (data analytics/AI and cybersecurity/threat intelligence); (4) Correctly interprets the strategic narrative about deepening data analytics and cybersecurity capabilities. QUANTITATIVE ACCURACY: The answer does not cite specific dollar amounts ($325 million acquisition price, $200 million goodwill) that were mentioned in the ground truth, but this is not a critical omission since the question asks about the evolution of the relationship and strategic focus rather than specific financial details. The absence of these numbers does not constitute an error, merely less comprehensive detail. MINOR GAPS: (1) Does not explicitly mention the April 2022 acquisition date or the $325 million purchase price and $200 million goodwill attribution, though these details provide useful context; (2) The ground truth emphasizes that integration was 'largely completed by 2023,' while the LLM answer focuses more on the forward-looking strategic implications. REASONING QUALITY: The multi-hop synthesis is sound—correctly connecting the 2022 Dynamic Yield acquisition through 2023 stability to the 2024 Recorded Future acquisition, and properly interpreting this sequence as evidence of strategic focus evolution. The characterization of the strategic pivot toward cybersecurity and threat intelligence is accurate and well-reasoned. The answer appropriately addresses both parts of the question (how the relationship evolved AND what it indicates strategically).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 514,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "\nThe Severance Plan for Senior Officers was most recently restated — amended and restated effective May 26 2022 — and that revision is identified as Exhibit 10.28 in the company’s Form 10‑Q.  The filing that includes this updated plan was filed on **November 27 , 2024**, which is the latest amendment date reflected in the provided documents; no subsequent amendment is listed for 2024, so the May 2022 restatement remains the most recent version through the 2024 filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the most recent amendment date (May 26, 2022), the filing date (November 27, 2024), and the exhibit number (10.28). The dates are accurate and properly formatted. The LLM correctly notes this is from a Form 10-Q filing.\n\nWEAKNESSES: The LLM answer is incomplete in addressing the full scope of the question about how the plan 'evolved between 2022 and 2024.' The ground truth provides important context about the 2022 status (showing the plan was previously 'amended and restated May 29, 2020' and filed August 26, 2020 as Exhibit 10.29), which demonstrates the evolution. The LLM fails to mention:\n1) The prior 2020 amendment date (May 29, 2020) and its filing date (August 26, 2020)\n2) The prior exhibit number (10.29) from the 2022 filing\n3) The comparative evolution showing how the plan changed from 2020 to 2022 to 2024\n\nThe LLM answer focuses only on the 2024 filing information and doesn't adequately address the 'evolution between 2022 and 2024' by comparing what was known in 2022 versus what was updated by 2024. The question specifically asks about evolution, which requires showing the progression of amendments. The LLM provides accurate information about the most recent amendment but misses the comparative/evolutionary aspect that would show how the plan changed over the period.\n\nQUANTITATIVE: All dates and exhibit numbers mentioned are correct (7/10 - minor issue that exhibit 10.29 from 2022 filing wasn't mentioned)\n\nQUALITATIVE: The reasoning is partially sound but incomplete. The multi-hop synthesis is weak because it doesn't connect the 2022 status with the 2024 update to show evolution (5/10)\n\nCONTEXTUAL: The answer addresses part of the question but misses the comparative evolution aspect (6/10)",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 484,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "\nThe 6.375 % Senior Notes were valued at **$999 million** on December 31 2021 (fair‑value Level 2 estimate), but by **December 31 2023** that same issue had fallen to **$872 million**, a decline of roughly **$127 million (≈13 %)**.  \n\nThis drop shows that market participants re‑priced the notes downward over the two‑year span—reflecting higher prevailing interest rates, widening credit spreads, or heightened concerns about Netflix’s leverage and cash‑flow outlook—indicating a more cautious or negative perception of the company’s debt during that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - $999 million (Dec 31, 2021), $872 million (Dec 31, 2023), decline of $127 million, and the percentage calculation of approximately 13% ($127M/$999M ≈ 12.7%) is accurate. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the change in fair value between the two dates, and (2) what this indicates about market perceptions. ENTITY ACCURACY: Netflix, 6.375% Senior Notes, and the specific dates are all correctly identified. REASONING QUALITY: The LLM provides sound multi-hop synthesis by correctly identifying that a decline in fair value indicates negative market sentiment, and offers plausible explanations (higher interest rates, widening credit spreads, concerns about leverage and cash flow). This reasoning aligns with the ground truth's conclusion about 'decline in market confidence or increase in required yields.' SEMANTIC EQUIVALENCE: The LLM's interpretation that the decline 'indicates a more cautious or negative perception' is semantically equivalent to the ground truth's statement about 'decline in market confidence.' The LLM actually provides more detailed context by specifying potential drivers of the repricing. MINOR NOTE: The ground truth states the decline 'indicates a decrease in fair value' (somewhat tautological), while the LLM provides more substantive interpretation of what the decline means for market perception, which is more insightful. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 423,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "\nIMBRUVICA sales fell sharply – from **$3.78 billion in 2022 to $3.26 billion in 2023**, a **13.7 % decline** (see the 2023 sales‑by‑product table).  The drop is attributed to “global competitive pressures” and the loss of exclusivity that is eroding its market share, even though overall oncology sales grew 10.5 % driven by newer agents such as DARZALEX, ERLEADA, CARVYKTI and the launches of TECVAYLI and TALVEY.  Consequently, while IMBRUVICA remains a core oncology product, its growth has stalled and it is being overtaken by newer, higher‑growth oncology therapies.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core financial numbers. Ground truth shows IMBRUVICA sales of $4,369 million in 2022 and $3,264 million in 2023. The LLM states $3.78 billion (2022) and $3.26 billion (2023), which are materially incorrect. The 2022 figure is off by approximately $589 million ($4,369M vs $3,780M), representing a 13.5% understatement. The 2023 figure is approximately correct ($3,264M vs $3,260M). CALCULATION ERROR: The LLM calculates a 13.7% decline, but the correct decline is 25.2% based on the ground truth numbers ($4,369M to $3,264M = $1,105M decrease / $4,369M = 25.2%). The LLM's 13.7% calculation would be correct only if the 2022 baseline were $3.78B, but that figure is wrong. QUALITATIVE ASSESSMENT: The LLM correctly identifies the market position weakening and mentions competitive pressures and loss of exclusivity, which aligns with the ground truth interpretation. The mention of DARZALEX and ERLEADA growth is appropriate context. However, the qualitative reasoning cannot overcome the fundamental quantitative failures. MULTI-HOP REASONING: The answer does synthesize information about IMBRUVICA's decline relative to other oncology products, which is appropriate for the question. However, this synthesis is built on incorrect baseline numbers. CONCLUSION: While the LLM demonstrates understanding of the market dynamics and provides relevant contextual information, the core financial data is materially incorrect, making this answer fundamentally unreliable for decision-making purposes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 436,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the inventory‑shrink reserve edged up from roughly **$425 million to $427 million** (an increase of about $2 million), while the lower‑of‑cost‑or‑net‑realizable‑value (LCNRV) reserve fell from about **$245 million to $222 million** (a decline of roughly $23 million).  The modest rise in the shrink reserve would shave roughly **$6–$7 million off net earnings** (≈ 10 % of the reserve changes equates to a $30‑$35 million earnings impact), whereas the reduction in the LCNRV reserve would add back about **$10–$15 million of earnings**, leaving overall net earnings essentially unchanged but with a slight net drag from the higher shrink reserve.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains multiple major factual errors that fundamentally misrepresent the ground truth: (1) SHRINK RESERVE: LLM states it increased from ~$425M to $427M (a $2M increase), but ground truth shows it increased from $414M to $427M (a $13M increase). The starting value is wrong by $11M. (2) LCNRV RESERVE: LLM states it fell from ~$245M to $222M (a $23M decline), but ground truth shows it increased from $168M to $222M (a $54M increase). This is a directional error - the reserve grew, not declined. The starting value is wrong by $77M. (3) EARNINGS IMPACT CALCULATIONS: LLM provides vague ranges ($6-7M for shrink, $10-15M for LCNRV) without clear methodology. Ground truth provides specific, quantifiable impacts: 10% change in shrinkage rate = ~$32M impact on net earnings; 10% change in LCNRV assumptions = ~$17M impact. The LLM's calculations don't match these figures and appear to be rough estimates rather than precise figures from the filing. (4) OVERALL NARRATIVE: LLM concludes net earnings were 'essentially unchanged' with 'slight net drag,' but ground truth emphasizes 'growing need for reserves, particularly for shrinkage' and 'increasing sensitivity of net earnings to inventory valuation assumptions.' The LLM misses the key implication about growing reserve needs. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the reserve evolution data across the 2022-2024 period and failed to properly connect the reserve changes to the specific earnings sensitivity metrics provided in the filing. The answer demonstrates fundamental misunderstanding of the underlying data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 446,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "\nFrom 2022 to 2023 Qulipta moved from a near‑zero revenue base to a rapidly growing product: its U.S. net sales rose from $158 million to $405 million and international sales from $158 million to $408 million—a greater‑than‑100 % increase year‑over‑year. This surge was driven by the FDA’s April 2023 approval of Qulipta for the preventive treatment of chronic migraine (followed by EU approval in August 2023 and a January 2024 EU launch), which generated strong market‑share uptake and expanded its commercial footprint, making Qulipta an increasingly meaningful contributor to AbbVie’s net revenues.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims 2022 U.S. sales were $158 million and international sales were $158 million, but the ground truth indicates Qulipta was in development in 2022 with near-zero revenue (it only transitioned to commercialization in 2023). The LLM's 2023 figures are also incorrect: it states U.S. sales of $405 million (correct) but international sales of $408 million (ground truth shows $3 million internationally). This is a massive discrepancy of $405 million in international sales. (2) CALCULATION ERROR - The LLM claims 'greater-than-100% increase year-over-year' from $158M to $405M U.S. sales, which would be approximately 156% increase. However, this entire comparison is invalid since 2022 had near-zero revenue. (3) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the key transition: Qulipta moved from being an indefinite-lived R&D asset (reclassified in 2022 upon regulatory approval) to a commercialized product generating revenue in 2023. The LLM incorrectly suggests Qulipta had $158M in both U.S. and international sales in 2022, which contradicts the ground truth's statement of near-zero revenue in 2022. (4) ENTITY/CONTEXT ISSUES - While the LLM correctly identifies FDA approval timing and regulatory milestones, it fundamentally misrepresents the financial trajectory. The ground truth's core message is the transition from development to commercialization; the LLM's answer suggests Qulipta was already generating substantial revenue in 2022, which is factually incorrect. The only correct number in the LLM answer is the $405 million U.S. revenue for 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 473,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "\nBetween 2022 and 2023 the receivable that Honeywell records for 90 % of its environmental remediation costs rose from **$157 million to $187 million**, and the total outstanding amount due from Resideo (short‑ and long‑term) increased from roughly **$614 million to $661 million**.  This shows that Honeywell’s recovery of environmental spending from the Resideo subsidiary has grown markedly, making the company more dependent on those cash inflows, while the $140 million annual cap and the eventual termination of the obligation leave it exposed to any shortfall or disruption in Resideo’s payments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the ground truth. Key issues: (1) CONTRADICTS GROUND TRUTH: The ground truth explicitly states that Honeywell's financial dependency 'remained consistent between 2022 and 2023' with the same 90% obligation and $140 million annual cap. The LLM claims the receivable 'rose from $157 million to $187 million' and total outstanding increased from '$614 million to $661 million' - these specific numbers are not verified in the ground truth and contradict the stated consistency. (2) MISINTERPRETS THE RELATIONSHIP: The ground truth indicates Honeywell's risk mitigation strategy 'has not changed,' but the LLM claims Honeywell is 'more dependent on those cash inflows' and 'markedly' increased recovery - this is a fundamental mischaracterization of the stable arrangement. (3) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($157M, $187M, $614M, $661M) that are not mentioned in the ground truth and appear to be fabricated or from unreliable sources. These numbers cannot be verified against the provided ground truth. (4) REASONING FLAW: The LLM concludes increased dependency based on rising receivables, but the ground truth indicates the arrangement remained unchanged - the LLM failed to recognize that the obligation structure (90%, $140M cap) did not evolve. (5) PARTIAL ACCURACY: The LLM correctly identifies the 90% obligation and $140 million annual cap, and correctly notes exposure to payment disruption, but these correct elements are overshadowed by the fundamental misrepresentation of the trend and the unverified financial figures. The answer demonstrates poor multi-hop synthesis and contradicts the core finding that the arrangement remained consistent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 477,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "\nTarget’s 2022 and 2024 filings both describe cash equivalents as “highly liquid investments with an original maturity of three months or less,” but the 2024 language tightens the phrasing to “original maturity of three months or less from the date of purchase” and explicitly adds that receivables from third‑party credit/debit‑card processors (which settle in five days) are also treated as cash equivalents.  \n\nThis modest evolution shows Target is refining—rather than overhauling—its definition to emphasize ultra‑short‑term, readily convertible assets, especially fast‑settling card‑transaction balances, indicating a strategic focus on tightening working‑capital liquidity and maximizing the speed of cash turnover.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) The LLM claims the 2024 language adds 'from the date of purchase' specification - this detail is not mentioned in the ground truth and appears to be fabricated. (2) The LLM introduces entirely new information about 'receivables from third-party credit/debit-card processors (which settle in five days)' being treated as cash equivalents - this specific claim is not present in the ground truth answer and represents a major factual addition without source verification. (3) The ground truth explicitly states that by 2024, Target 'added a broader discussion around fair value measurements for other short-term assets and liabilities' - the LLM completely omits this key evolution point. (4) The LLM's interpretation about 'tightening working-capital liquidity and maximizing the speed of cash turnover' is speculative and goes beyond what the ground truth supports. The ground truth describes the evolution more conservatively as 'a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.' (5) The core finding that the three-month threshold remained constant is correct, but the LLM adds unverified details about card processor receivables and 'from the date of purchase' language that contradict or extend beyond the ground truth. The answer demonstrates poor multi-hop synthesis by introducing unsupported claims rather than accurately synthesizing the documented evolution between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 438,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "\nBetween the 2023 and 2024 fiscal years the 3.50 % Notes Due 2040 remained classified in the Level 2 tier of NVIDIA’s fair‑value hierarchy (i.e., they are valued using observable market inputs for comparable debt securities rather than quoted prices for identical instruments).  Their reported fair‑value slipped modestly from **$870 million (Jan 29 2023)** to **$851 million (Jan 28 2024)**, while the carrying amount stayed essentially flat at **$1.0 billion** (reflecting amortized cost and the effect of the debt‑discount amortization).  \n\nThis stability in classification and the modest fair‑value decline indicate that NVIDIA continues to treat the 2040 notes as a core component of its long‑term, low‑coupon financing mix—issuing long‑dated senior unsecured debt that is regularly rolled or refinanced as needed, while relying on market‑based (Level 2) valuation rather than mark‑to‑market volatility to support its capital‑structure strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) FAIR VALUE NUMBERS INCORRECT: The LLM states fair value was $870M (Jan 29, 2023) declining to $851M (Jan 28, 2024). However, the ground truth indicates the carrying value was $851M as of Jan 28, 2024, and the valuation increased to $1,000M by Jan 26, 2025. The LLM appears to have confused fair value with carrying value and provided incorrect baseline figures. (2) CARRYING AMOUNT ERROR: The LLM claims carrying amount 'stayed essentially flat at $1.0 billion,' but the ground truth shows the carrying value was $851M in 2023 and increased to $1,000M in 2024—this is a $149M increase, not 'flat.' (3) DATE CONFUSION: The LLM references Jan 29, 2023 as a comparison point, but the ground truth uses Jan 28, 2024 as the 2023 endpoint and Jan 26, 2025 as the 2024 endpoint. (4) MISSING KEY INFORMATION: The LLM fails to mention the effective interest rate of 3.54% and remaining term of 15.2 years that the ground truth includes for 2024. QUALITATIVE ASSESSMENT: The LLM correctly identifies Level 2 classification and provides reasonable interpretation about long-term financing strategy, but this qualitative reasoning cannot compensate for the fundamental quantitative errors. The multi-hop synthesis is partially sound (connecting valuation changes to strategy), but is built on incorrect numbers. The answer demonstrates understanding of debt classification concepts but fails on factual accuracy of the specific financial metrics that are central to answering the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 441,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "\nBetween 2022 and 2023 AbbVie’s Venclexta net revenue rose from **$2,009 million to $2,288 million**—an **≈13.9 % increase at actual currency rates** (about **15 % at constant currency**). The growth was driven by an **8 % rise in U.S. sales** and a **22 % jump in international sales**, translating into an overall **~15 % global revenue expansion** for the product in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the core revenue figures ($2,009M in 2022 and $2,288M in 2023) and properly attributed them to Venclexta. The answer appropriately contextualizes the product within AbbVie. The response addresses the multi-part question about revenue evolution and growth rates.\n\nCRITICAL ERRORS: (1) Growth rate calculation is incorrect. The LLM states '≈13.9% increase at actual currency rates' but this is the 2023 growth rate from the ground truth, not the year-over-year change from 2022 to 2023. The actual YoY growth from $2,009M to $2,288M is ($2,288-$2,009)/$2,009 = 13.9%, which happens to match but the LLM's phrasing is ambiguous. (2) The LLM provides additional metrics (8% U.S. sales rise, 22% international jump, ~15% global expansion) that are NOT in the ground truth answer. While these details may be accurate from the source filing, they were not part of the original answer and represent information beyond what was requested or verified.\n\nMISSING INFORMATION: The ground truth explicitly states the 2022 growth rate was 10.4% and 2023 growth rate was 13.9%, showing the evolution of growth rates themselves. The LLM focuses on the year-over-year change between the two years rather than clearly presenting both individual growth rates, which was part of the original answer's structure.\n\nCALCULATION VERIFICATION: $2,288M - $2,009M = $279M increase. $279M / $2,009M = 13.88% ≈ 13.9%. The percentage is mathematically correct for YoY change, but the ground truth presents this differently (as 2023's growth rate of 13.9%, not as the YoY change).\n\nSEMANTIC ISSUES: The LLM's statement about '~15% global revenue expansion' contradicts its earlier '≈13.9%' figure, creating internal inconsistency. The constant currency adjustment (15%) is additional context not in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 497,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "\nBetween the 2022 and 2023 filings Netflix updated its executive‑severance framework. The 2022 10‑K disclosed the Amended and Restated Executive Severance and Retention Incentive Plan (originally adopted September 10 2021), while the 2023 10‑K includes a further amendment and restatement of that plan, which the company filed in an 8‑K on December 8 2023 and set to become effective January 1 2024. This restated plan revises the severance and retention terms and marks the most recent evolution of the company’s executive‑incentive approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Netflix's executive severance plan evolution. QUANTITATIVE ACCURACY: All dates are correct - September 10, 2021 (original adoption date), December 8, 2023 (filing date), and January 1, 2024 (effective date). No calculations are required for this question. ENTITY ACCURACY: Netflix is correctly identified, the plan names are accurate ('Amended and Restated Executive Severance and Retention Incentive Plan' for 2022 and 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024' for 2023), and the fiscal years (2022 and 2023) are properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two SEC filings (2022 and 2023 10-Ks) and correctly identifies the progression: 2022 filing referenced a plan amended in 2021, while 2023 filing introduced a further amendment filed in December 2023 with January 2024 effective date. The reasoning correctly establishes the chronological evolution and forward-looking nature of the 2024 amendment. SEMANTIC EQUIVALENCE: The LLM answer conveys all essential information from the ground truth with appropriate wording variations (e.g., 'originally adopted September 10 2021' vs 'filing date of September 10, 2021' - both convey the same temporal reference). The answer appropriately characterizes this as 'ongoing adjustments' and 'evolution' consistent with the ground truth's framing. MINOR OBSERVATION: The LLM mentions the plan was 'filed in an 8-K on December 8, 2023' while the ground truth states 'filing date of December 8, 2023' - both are semantically equivalent and accurate. The answer fully addresses the question's focus on how the approach evolved between 2022 and 2023 filings, including plan amendments and effective dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 504,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "\nFrom 2022 to 2024 Lowe’s moved the Benefit Restoration Plan from a brief narrative description in the 2022 10‑K (Note 12 – “The Company maintains a Benefit Restoration Plan to supplement benefits provided under the 401(k) Plan…”) to a formally codified, exhibit‑level amendment that is “amended and restated as of January 1 2025” (Exhibit 10.3 in the 2024 filing).  The 2024 filing also bundles the plan with related retirement‑plan documents (the 401(k) Plan, the Cash Deferral Plan, and various amendment notices), indicating a more structured, consolidated approach to retirement‑benefit governance.  This evolution signals that Lowe’s is tightening the documentation and oversight of its supplemental retirement benefits, treating the Restoration Plan as a formal, stand‑alone component of its broader employee‑benefits framework rather than an after‑thought.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and numeric references are correct - the 2022 10-K reference, the January 1, 2025 effective date, and the Exhibit 10.3 filing designation are all accurate. No calculations are required for this question, and all temporal references are precise. ENTITY ACCURACY: Lowe's is correctly identified, the Benefit Restoration Plan is properly named, and related plans (401(k) Plan, Cash Deferral Plan) are accurately referenced. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how documentation evolved from 2022 to 2024, and (2) what this indicates about the company's approach. The LLM captures the evolution from narrative description to formal exhibit-level documentation with an effective date of January 1, 2025. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the 2022 narrative treatment with the 2024 formal codification and draws appropriate conclusions about strategic intent. The characterization of the evolution as moving from an \"after-thought\" to a \"formal, stand-alone component\" aligns well with the ground truth's description of \"deliberate effort to formalize and likely enhance the structure.\" SEMANTIC EQUIVALENCE: The LLM's language about \"tightening documentation and oversight\" and \"more structured, consolidated approach\" conveys the same meaning as the ground truth's \"more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation.\" MINOR CONSIDERATIONS: The LLM provides slightly more granular detail about the bundling of related documents (401(k) Plan, Cash Deferral Plan, amendment notices), which adds helpful context not explicitly mentioned in the ground truth but is consistent with it. The answer is well-structured and directly addresses the question without extraneous information. No factual errors or calculation mistakes are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 549,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "\nBetween the end of fiscal 2023 and fiscal 2024 the carrying amount of NVIDIA’s 0.584 % Notes Due 2024 grew from about **$1.185 billion** (shown on page 67 for Jan 28 2023) to roughly **$1.250 billion** (shown on page 72 for Jan 28 2024), an increase of roughly **$65 million**.  The notes were then fully retired in fiscal 2025, leaving a zero balance thereafter.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims the carrying amount GREW from $1.185B to $1.250B (an increase of $65M), but the ground truth states the obligation was FULLY REPAID by fiscal 2024, meaning it should have gone to $0, not increased to $1.250B. This is a fundamental factual error. (2) The LLM provides specific page references (page 67 for Jan 28 2023, page 72 for Jan 28 2024) that cannot be verified against the ground truth, and the numbers cited contradict the ground truth. (3) MULTI-HOP REASONING - The LLM correctly identifies the fiscal 2023 amount ($1.185B) matching the ground truth, but then incorrectly states the fiscal 2024 amount and trajectory. The ground truth explicitly states the obligation was 'fully repaid' by fiscal 2024, not increased. (4) ADDITIONAL ISSUE - The LLM adds information about fiscal 2025 retirement, which goes beyond the scope of the question (which asks about fiscal 2023 to 2024 evolution) and may be speculative or from a different source. (5) SEMANTIC MISMATCH - The core finding is inverted: LLM says the debt increased and was retired later; ground truth says it was fully repaid by 2024. This is a critical contradiction that makes the answer fundamentally incorrect despite getting the 2023 starting point right.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 362,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "\nMavyret’s worldwide net revenue slipped 7 % year‑over‑year, falling from **$1.54 billion in 2022 to $1.43 billion in 2023**. The decline was driven primarily by the U.S. market, where sales dropped **13 %** to **$659 million**, while international sales were almost flat, decreasing only **2 %** to **$771 million**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. Quantitative verification: (1) Global revenue 2022: $1.54B matches $1,541M ground truth (format variation acceptable); (2) Global revenue 2023: $1.43B matches $1,430M ground truth; (3) U.S. revenue 2023: $659M matches exactly; (4) International revenue 2023: $771M matches exactly; (5) U.S. decline calculation: 13% stated vs. 12.7% ground truth - minor rounding difference (($755M-$659M)/$755M = 12.7%, LLM rounded to 13%, which is acceptable); (6) International decline: 2% stated vs. 1.9% ground truth - again minor rounding (($786M-$771M)/$786M = 1.9%, LLM rounded to 2%, acceptable); (7) Overall global decline: 7% stated - verification: ($1,541M-$1,430M)/$1,541M = 7.2%, LLM rounded to 7%, which is reasonable. The answer correctly identifies that the U.S. market experienced a more pronounced decline than international markets, which aligns with ground truth. The multi-hop synthesis is sound: comparing 2022 vs 2023 across three metrics (global, U.S., international). The characterization of international sales as 'almost flat' is semantically equivalent to 'marginal decrease.' Minor deduction only for rounding percentages slightly differently than ground truth, though these are within acceptable tolerance for financial reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 367,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "\nBetween 2022 and 2024 Netflix’s senior‑note covenants – which restrict additional indebtedness, mergers, asset sales, liens and other corporate actions – remained materially the same, and the company continued to be in compliance with them (the 2024 filing notes “the Company was in compliance with all related covenants” as of 12/31/24, just as it had been in 2021 and 2020).  However, the **repayment burden grew**: the 5.750 % senior notes maturing in March 2024 were fully repaid ($400 million), and new notes (e.g., the 4.900 % due 2034 and 5.400 % due 2054) were issued, pushing total outstanding senior‑note principal to about $15.6 billion by the end of 2024 (up from roughly $15.4 billion in 2021).  Thus, while the scope of covenantal restrictions did not broaden, the **scale of debt and associated repayment obligations increased**, and Netflix maintained compliance throughout the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Netflix's continued compliance with Senior Note covenants between 2022 and 2024, and accurately notes the $400 million repayment of 5.750% Senior Notes in March 2024. However, there are significant quantitative accuracy issues: (1) The LLM states total outstanding senior-note principal was 'about $15.6 billion by the end of 2024 (up from roughly $15.4 billion in 2021)' - these figures appear inflated compared to the ground truth context, which references €5,170 million in euro-denominated tranches alone, suggesting the total debt figures need verification against actual filings. (2) The LLM introduces new notes (4.900% due 2034 and 5.400% due 2054) not mentioned in the ground truth, which may be accurate but cannot be verified against the provided ground truth. (3) The LLM claims 'the scope of covenantal restrictions did not broaden' and remained 'materially the same,' which contradicts the ground truth's statement that 'certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes.' This is a material factual error - the ground truth explicitly identifies an evolution in scope (narrowing), while the LLM denies any scope change. The LLM correctly emphasizes compliance maintenance and debt management, and the reasoning about increased repayment obligations is sound. However, the failure to recognize the narrowing of covenant scope for certain notes and the unverified debt figures significantly undermine accuracy. The answer addresses the multi-part question but misses a key evolution identified in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 454,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell stopped treating the Safety‑and‑Retail offering as a stand‑alone business unit and instead combined it with its Advanced Sensing Technologies group to create a single “Sensing and Safety Technologies” unit.  In 2023 the company formalized this integration in its segment reporting—re‑classifying the former Safety‑and‑Retail line under the new Sensing and Safety Technologies sub‑segment of the Safety and Productivity Solutions segment—thereby consolidating the safety‑related products and eliminating the separate Retail designation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core structural change: Safety and Retail was merged with Advanced Sensing Technologies to form Sensing and Safety Technologies. The qualitative reasoning about the strategic shift toward integration is sound and well-articulated. However, there are notable quantitative omissions: (1) The original answer specifies that Safety and Retail generated $2,387 million in revenue in 2022—a key metric that the LLM answer completely omits. (2) The original answer provides the specific timing detail that the structural change was 'introduced in July 2022 but reported in the 2023 filing,' which adds important context about when the change occurred versus when it was formally reported. The LLM answer vaguely states it was 'formalized in 2023' without clarifying the July 2022 introduction date. (3) The LLM answer's characterization of 'eliminating the separate Retail designation' is accurate but slightly shifts focus from the core integration narrative. The answer demonstrates strong understanding of the organizational restructuring and its strategic rationale, but lacks the specific financial data and precise timing details that would make it fully comprehensive. The multi-hop synthesis is adequate—connecting the 2022 baseline to the 2023 structural change—but incomplete without the revenue figure and exact implementation date.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 383,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the outstanding balance of class B‑2 common stock fell dramatically – the combined B‑1 + B‑2 shares dropped from 245 million to 125 million – reflecting a conversion/retirement of most B‑2 shares as part of the class B‑1 exchange offer.  Class B‑2 remains convertible into class A common stock, with full conversion scheduled under the Europe‑retrospective responsibility plan no later than 2028; any conversion would increase the number of class A shares and dilute the voting power of existing class A shareholders.  Because holders of B‑2 (together with B‑1 and the preferred series) must approve certain mergers, consolidations and other major transactions, their limited but pivotal voting rights give them a gate‑keeping role that can conflict with class A shareholders and thereby shape Visa’s corporate‑governance dynamics.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ERRORS: The LLM states 'combined B-1 + B-2 shares dropped from 245 million to 125 million' - these specific numbers are not mentioned in the ground truth and appear to be fabricated. The ground truth does not provide these quantitative details about share counts.\n\n2. UNSUPPORTED CLAIMS: The LLM introduces several claims not in the ground truth:\n   - References to a 'Europe-retrospective responsibility plan' with a 2028 conversion deadline - this is not mentioned in the original answer\n   - Specific voting mechanics regarding mergers, consolidations, and 'gate-keeping role' - while the ground truth mentions governance influence, it doesn't provide these specific details\n   - The claim about B-2 holders needing to approve certain transactions alongside B-1 and preferred series - not explicitly stated in ground truth\n\n3. PARTIAL ALIGNMENT: The LLM correctly identifies:\n   - Class B-2 convertibility into Class A stock\n   - Dilutive effects on voting power\n   - A shift in status between 2023 and 2024\n   - The role in corporate governance\n\n4. MISSING KEY GROUND TRUTH ELEMENTS: The LLM fails to clearly emphasize:\n   - The transformation from 'active governance and conversion position' to 'non-outstanding status'\n   - The specific statement that 'no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer' in 2024\n   - The reduction in influence on corporate decisions\n\n5. MULTI-HOP REASONING: While the LLM attempts to synthesize information about convertibility and governance impact, it does so by introducing details not present in the ground truth rather than accurately synthesizing the provided information.\n\nThe answer reads as if the LLM is drawing from external knowledge or hallucinating specific details rather than accurately reflecting the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 535,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Home Depot deepened its “interconnected shopping experience” by coupling continued store‑level upgrades—such as refreshed layouts, way‑finding signage, expanded self‑checkout and curbside‑pickup options, electronic shelf‑labeling, and mobile‑app navigation tools—with a suite of digital enhancements that make online research and in‑store fulfillment seamless.  The company also boosted associate productivity and safety through newer handheld “hdPhone” devices, the Sidekick inventory‑guidance app, and Computer‑Vision vision systems, while expanding same‑day/next‑day delivery, omni‑channel fulfillment centers, and a broader network of BOPIS/BOSS pickup points to meet customers’ expectations for speed, convenience, and personalized service across both digital and physical channels.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies many of the same initiatives mentioned in the ground truth for both 2023 and 2024, including mobile app navigation, electronic shelf labels, self-checkout expansion, and curbside pickup. The answer accurately captures the evolution toward more integrated omnichannel capabilities and mentions the shift toward personalized service. No quantitative errors are present (no specific numbers were claimed that could be wrong). WEAKNESSES: (1) The LLM answer introduces several specific product names and initiatives (hdPhone, Sidekick app, Computer Vision systems, BOPIS/BOSS pickup points) that are NOT mentioned in the ground truth answer. While these may be factually accurate from the 10-K filings, they represent information beyond what the ground truth specifies, creating potential divergence. (2) The ground truth explicitly emphasizes a shift toward 'data-driven insights' and 'personalized digital experiences' with 'customer product review summaries and enhanced product content' - the LLM answer mentions 'personalized service' but does not specifically highlight the data-driven personalization aspect or the product review/content enhancements that were key differentiators in 2024. (3) The LLM answer focuses heavily on operational/associate tools (hdPhone, Sidekick, Computer Vision) which are not mentioned in the ground truth, potentially over-emphasizing backend improvements rather than customer-facing experience enhancements. (4) The ground truth's specific mention of 'customer product review summaries' as a 2024 enhancement is absent from the LLM response. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across 2023-2024 and identifies the progression from basic store improvements to more integrated digital-physical experiences. However, it may have synthesized information from different parts of the 10-K that weren't specifically about the shopping experience evolution. SEMANTIC MATCH: While the overall narrative of evolution is captured, the specific emphasis on data-driven personalization and product content enhancements (key differentiators in ground truth) is missing or underemphasized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 585,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "\nFrom 2022 through 2024 Target’s Long‑Term Incentive Plan moved from a primarily option‑ and performance‑share‑unit‑focused design (see the 2022 10‑K disclosures of SPP I/II and the 2020 LTIP on pages 65‑69) to a broader suite of restricted‑stock‑unit awards.  The 2024 filing (pages 73‑75) lists explicit award forms—performance‑based RSUs, performance‑share units, cliff‑vested RSUs, non‑employee director RSUs, and a dedicated performance‑award performance‑share‑unit agreement—showing that the plan now incorporates multiple, more granular equity‑award types that replace or supplement the earlier stock‑option and basic performance‑share structures.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates substantial accuracy in identifying the evolution of Target's Long-Term Incentive Plan from 2022 to 2024. STRENGTHS: (1) Correctly identifies key award types present in 2022 (stock options, performance share units, RSUs) and 2024 (cliff-vested RSUs, performance-based RSUs, performance award performance share unit agreement). (2) Accurately captures the expansion and diversification of equity compensation vehicles. (3) Properly synthesizes multi-hop information across years and filing documents. (4) Correctly references specific page numbers from 10-K filings (pages 65-69 for 2022, pages 73-75 for 2024), demonstrating document-level accuracy. (5) Semantic equivalence is strong - the characterization of evolution from 'option-and-performance-share-focused' to 'broader suite of RSU awards' matches the ground truth's description of 'expansion in types of equity compensation vehicles.' MINOR WEAKNESSES: (1) The LLM answer mentions 'SPP I/II and the 2020 LTIP' which adds contextual detail not explicitly in the ground truth, though this appears to be accurate supplementary information rather than an error. (2) The phrasing 'replace or supplement' introduces slight interpretive language not explicitly stated in ground truth, though the characterization is reasonable. (3) Does not explicitly list all 2022 award types (Non-Qualified Stock Options, Non-Employee Director Non-Qualified Stock Options are mentioned in ground truth but not explicitly called out in LLM answer), though the core types are covered. QUANTITATIVE ACCURACY: All dates (2022, 2024) and page references are correct. No calculations required. QUALITATIVE ACCURACY: Multi-hop reasoning is sound - correctly synthesizes information across multiple years and filing documents to show structural evolution. Entity identification (Target Corporation, Long-Term Incentive Plan) is correct. The answer demonstrates understanding of the question's requirement to compare plan structures across time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 541,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "\nAfter its September 2021 FDA approval, Qulipta generated about **$1.71 billion** in net sales in 2021.  The following year sales slipped modestly to **$1.54 billion** (‑9.9% YoY), but in 2023 the product’s revenue **more than doubled**—an increase of **>100%** year‑over‑year (≈ $3.5 billion) driven by continued market‑share gains and the 2023 EU launch—while constant‑currency growth was **5.7%** for the year.  Thus, Qulipta’s commercial trajectory was flat in 2022 and then accelerated sharply in 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across all quantitative dimensions. Ground truth shows: (1) Qulipta had $0 revenue in 2021 (approved September 2021, so minimal/no sales that year), $158M in 2022, and $408M total in 2023 ($405M US + $3M international). The LLM claims $1.71B in 2021, $1.54B in 2022, and ~$3.5B in 2023—all numbers are drastically wrong, off by 4-9x the actual figures. (2) The LLM's year-over-year calculations are also incorrect: it claims 2022 was -9.9% decline and 2023 was >100% growth, but the actual trajectory was $0→$158M→$408M, representing massive growth from 2021-2022 and continued strong growth in 2023. (3) The LLM invents details about 'constant-currency growth of 5.7%' and a '2023 EU launch' that are not mentioned in the ground truth and appear fabricated. (4) The multi-hop reasoning fails because the LLM did not correctly synthesize AbbVie's financial disclosures about Qulipta's revenue across the three-year period. (5) The semantic framing of 'flat in 2022 then accelerated in 2023' contradicts the actual data showing strong growth throughout. This is a complete factual failure with invented numbers that bear no resemblance to the actual commercial performance documented in AbbVie's SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 351,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "\nBetween the 2022 and 2024 filings Netflix shifted from a brief, high‑level mention of the 2020 Stock Plan in the 2022 10‑K to a comprehensive, structured disclosure in the 2024 10‑K. The 2024 filing explicitly defines the plan as a stockholder‑approved vehicle that grants incentive and non‑statutory options, RSUs and PSUs, and includes detailed quantitative tables of option grants, exercises, expirations, weighted‑average exercise prices, remaining terms, intrinsic value, as well as RSU/PSU activity, stock‑based compensation expense and unrecognized compensation cost. This evolution reflects a move from a generic reference to a full, transparent presentation of the plan’s structure and the company’s recent equity‑compensation activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the core evolution from 2022 to 2024 - from minimal disclosure to comprehensive disclosure; (2) Accurately characterizes 2022 treatment as 'brief, high-level mention' vs 2024 as 'comprehensive, structured disclosure'; (3) Correctly identifies specific equity instruments: incentive stock options, nonstatutory stock options, RSUs, and PSUs (the ground truth mentions RSUs and performance-based criteria, LLM adds PSUs which is consistent with comprehensive disclosure); (4) Accurately describes the detailed quantitative elements in 2024: option grants, exercises, expirations, weighted-average exercise prices, remaining terms, intrinsic value, RSU/PSU activity, stock-based compensation expense, and unrecognized compensation cost; (5) Properly synthesizes the multi-hop comparison across two filing years; (6) Uses appropriate terminology ('stockholder-approved vehicle,' 'transparent presentation'). MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (mentioning PSUs explicitly, providing more granular detail on tables), but this represents enhancement rather than error - these details are consistent with what would be found in a comprehensive 2024 disclosure. No quantitative errors detected. The semantic meaning and factual content align perfectly with the ground truth. The answer successfully addresses the question's focus on structural description evolution and associated equity compensation activities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 437,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "\nBetween 2022 and 2023 the company kept its aluminum purchase contracts in the “derivatives not receiving hedge‑accounting treatment” category, so they are carried at fair value with gains and losses recorded in other income rather than in OCI.  The quantitative exposure also contracted sharply—commodity‑derivative not‑hedge contracts fell from roughly $412 million of notional amount in 2022 to about $115 million in 2023—reflecting a more selective, strategic use of these agreements for long‑term sourcing and non‑U.S. business needs rather than broad price‑risk hedging.  (Pages 102 and 104).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific quantitative data and accounting treatment details that go beyond the ground truth answer. Strengths: (1) Correctly identifies the accounting classification as 'derivatives not receiving hedge-accounting treatment' with fair value accounting; (2) Provides specific notional amounts ($412 million in 2022 vs $115 million in 2023) showing the contraction in exposure; (3) Correctly notes that gains/losses are recorded in other income rather than OCI; (4) Accurately captures the evolution toward more selective, strategic use for long-term sourcing and non-U.S. business needs. The quantitative data (the $412M to $115M decline) is specific and appears credible, though cannot be independently verified against the ground truth which doesn't provide these exact figures. The LLM answer is more detailed and specific than the ground truth, providing accounting mechanics and precise notional amounts. Minor gap: The ground truth emphasizes 'offsetting positions' and 'market pricing alignment' which the LLM answer doesn't explicitly mention, though the reference to 'priced at prevailing market prices' concept is implicit in the strategic sourcing description. The LLM answer successfully synthesizes the multi-hop information about classification evolution, accounting treatment, and strategic use across the two years. The page references (102 and 104) add credibility. Overall, the answer demonstrates strong understanding of the evolution in approach with concrete supporting data, though it could have more explicitly addressed the offsetting positions concept mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 446,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings the company tightened the way it references the Directors’ Code of Conduct.  In 2023 the code was pointed to a long, unwieldy URL and was described as applying to “directors of BNY Mellon,” with a generic statement that any amendments or waivers would be posted on the website.  By 2024 the reference was shortened to a cleaner URL ( bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf ), the scope was narrowed to “directors of BNY,” and the filing added a separate mention of the employee Code of Conduct and its own URL, explicitly pledging to disclose any future amendments or waivers on the website—making the directors’ code both more easily accessible and its applicability clearer.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors regarding the URLs and scope changes. CRITICAL ERRORS: (1) URL ACCURACY: The LLM claims the 2024 URL was 'shortened to a cleaner URL (bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf)' but the ground truth shows the 2024 URL is 'https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf' - these are NOT the same, and the LLM's version is incomplete/inaccurate. The ground truth shows a domain change from 'bnymellon.com' to 'bny.com', which is a significant structural change the LLM missed. (2) SCOPE CHANGE MISCHARACTERIZATION: The LLM states the scope was 'narrowed to directors of BNY' from 'directors of BNY Mellon,' but the ground truth does not explicitly state this narrowing - it only notes the URL changed. The LLM appears to have inferred or misinterpreted this detail. (3) MISSING KEY INFORMATION: The LLM completely fails to mention the introduction of the new 'INSIDER TRADING POLICIES AND PROCEDURES' section in 2024, which was explicitly highlighted in the ground truth as a significant change reflecting expanded compliance focus. This is a major omission. (4) PARTIAL CREDIT: The LLM correctly identifies that there were changes between 2023 and 2024, and correctly notes that the 2024 filing added references to employee Code of Conduct, which aligns with the ground truth's mention of expanded scope. However, the execution is flawed with inaccurate URL details and missing the insider trading policies section. The answer demonstrates some understanding of the evolution but fails on factual precision regarding URLs and omits a critical new section.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 462,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "\nBetween November 2023 and June 2024 HD added a new $1.75 billion 4.95 % senior‑note tranche that matures on June 25 2034 (issued at a $16.7 million discount) to the $750 million 4.95 % senior notes that had been issued in November 2023 and are due September 30 2026 (issued at a $1.6 million discount).  The addition of a much longer‑dated 4.95 % series expands the company’s 4.95 % exposure from a single 2026 maturity to include a 2034 maturity, signalling a long‑term debt strategy that seeks to lock in low‑cost financing for an extended horizon, diversify the maturity profile of its senior debt, and provide ample funding capacity for strategic acquisitions while preserving flexibility through optional redemption features.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) WRONG DATES: LLM claims the original $750M notes were issued in November 2023, but ground truth states they were issued in 2023 (no November specified in ground truth). More critically, LLM claims a NEW $1.75B tranche was added between November 2023 and June 2024 maturing in 2034, but ground truth makes NO mention of a 2034 maturity or a $1.75B issuance. (2) MISSING KEY INFORMATION: Ground truth explicitly states that by 2024, HD had $980M in 4.95% senior notes due September 2052 - a critical long-term debt component that the LLM completely omits. The 2052 maturity is central to understanding HD's long-term debt strategy. (3) INCORRECT STRUCTURE: LLM describes a 2026-2034 maturity ladder, but ground truth indicates 2026 and 2052 maturities. The 2052 notes represent a much more aggressive extension of debt maturity than the 2034 notes mentioned by LLM. (4) QUANTITATIVE ERRORS: LLM cites $1.75B for a 2034 tranche with $16.7M discount - these figures do not appear in ground truth and appear to be fabricated or confused with other debt issuances. (5) INCOMPLETE SYNTHESIS: While LLM correctly identifies the $750M 2026 notes and the $1.6M discount, it fails to synthesize the critical $980M 2052 notes that represent the most significant evolution in HD's debt strategy between 2023-2024. The ground truth indicates HD's strategy extends to 2052 (26+ year horizon), not 2034 (10-year horizon). The reasoning about locking in rates and extending maturities is directionally correct but based on wrong maturity dates and missing the most important debt component.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 459,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "\nBetween 2021 and 2023 Intel recorded a large $471 million observable‑price adjustment to its non‑marketable equity stake in Beijing Unisoc Technology Ltd. in 2021, then much smaller adjustments of $299 million in 2022 and only $17 million in 2023 (see page 96/97). Consequently, the investment’s net book value remained essentially flat at about $1.1 billion at the end of 2023, matching the $1.1 billion reported at the end of 2022 (page 97).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces significant factual information NOT present in the ground truth. Specifically: (1) The LLM claims observable price adjustments of $299 million in 2022 and $17 million in 2023, with citations to pages 96/97. The ground truth makes NO mention of these 2022 and 2023 adjustments - it only references the $471 million adjustment in 2021. (2) The LLM's statement that the net book value 'remained essentially flat at about $1.1 billion' contradicts the ground truth's explicit statement that the value was 'the same as December 31, 2022' - this is accurate but the LLM's framing of 'remained essentially flat' combined with the invented 2022-2023 adjustments creates a misleading narrative. (3) The LLM correctly identifies the $471 million 2021 adjustment and the $1.1 billion net book value at end of 2023/2022, but fabricates additional adjustment figures without ground truth support. (4) Multi-hop reasoning is compromised because the answer synthesizes information that appears to come from different years but invents data points not in the original knowledge graph. The core facts about 2021 ($471M) and 2023 ($1.1B) are correct, but the addition of unsubstantiated 2022 ($299M) and 2023 ($17M) adjustments represents a major factual error that would mislead readers about the investment's valuation trajectory. The page citations (96/97) cannot be verified against the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 401,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "\nFrom 2022 to 2023 AbbVie moved Qulipta (ABBV‑951) from a pending regulatory filing to full market approval and commercial launch.  In April 2023 the FDA approved Qulipta for the preventive treatment of chronic migraine, and in August 2023 the European Commission approved the product (as “Aquipta”), enabling a launch in the EU in January 2024; the company’s first commercial sales of $158 million in 2022 grew to $405 million by the end of 2023 (see page 42).",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite addressing the general evolution of Qulipta. CRITICAL ERRORS: (1) The LLM claims 'first commercial sales of $158 million in 2022' - this is factually incorrect. According to the ground truth, in 2022 Qulipta was still in regulatory development phase with $1.0 billion of R&D intangible assets being reclassified to developed product rights. Qulipta did not receive FDA approval until April 2023, so it could not have had commercial sales in 2022. (2) The LLM states sales 'grew to $405 million by the end of 2023' - this number cannot be verified against the ground truth and appears to be fabricated or confused with another product. (3) The LLM mentions 'Aquipta' as the European name and a January 2024 EU launch - these details are not present in the ground truth and cannot be verified. CORRECT ELEMENTS: The LLM correctly identifies the April 2023 FDA approval for preventive treatment of chronic migraine and the August 2023 EC approval. The general narrative of progression from regulatory development to approval is correct. However, the inclusion of unverified sales figures and product naming conventions, combined with the false claim of 2022 sales, represents a fundamental misunderstanding of the product's timeline. The multi-hop reasoning fails because the LLM incorrectly synthesized the 2022 status (asset reclassification, not commercial sales) with 2023 approvals. The answer demonstrates partial understanding of the regulatory milestones but severely compromises accuracy through invented financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 443,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "\nIn the 2022 Form 10‑K Boeing merely listed “upgrades and conversions” as one of several services within the Global Services segment, describing them in a generic, portfolio‑wide context. By the 2023 filing the language is far more strategic—positioning upgrades and conversions as a dedicated growth driver that modernizes fleets, leverages digital analytics and underpins the segment’s push to expand market share and customer satisfaction.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains significant inaccuracies in characterizing the evolution of Boeing's framing of 'upgrades and conversions' between 2022 and 2023.\n\nCORRECT ELEMENTS:\n- Correctly identifies 2022 vs 2023 comparison\n- Correctly identifies Boeing and Global Services segment\n- No quantitative errors (no numbers to verify)\n- Correctly notes a shift in positioning\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. OVERSTATED STRATEGIC EMPHASIS: The LLM claims 2023 language positions upgrades and conversions as a \"dedicated growth driver\" with emphasis on \"digital analytics\" and \"market share expansion.\" The ground truth indicates a more subtle shift—the service was \"positioned within a more structured narrative\" but the evolution was described as \"subtle\" rather than dramatic. The LLM significantly overstates the degree of strategic repositioning.\n\n2. UNSUPPORTED CLAIMS: The LLM introduces specific strategic language (\"dedicated growth driver,\" \"modernizes fleets,\" \"leverages digital analytics,\" \"push to expand market share and customer satisfaction\") that is not substantiated in the ground truth. The ground truth describes the shift as positioning within \"a more structured narrative\" and \"a more integrated and strategic role,\" but does not mention these specific strategic elements.\n\n3. INCOMPLETE CONTEXT: The LLM fails to mention that in 2022, upgrades and conversions were grouped alongside other services (supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, digital services). This context is important for understanding the baseline positioning.\n\n4. CHARACTERIZATION ACCURACY: The ground truth describes the 2023 shift as indicating \"a more deliberate positioning...as a core capability rather than a general service offering.\" The LLM's characterization as a \"dedicated growth driver\" goes beyond what the ground truth supports.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the comparison across two years but does so by introducing unsupported interpretations rather than accurately reflecting the ground truth's more measured assessment.\n\nSEMANTIC EQUIVALENCE: While the LLM captures the general idea of increased strategic emphasis, it materially misrepresents the magnitude and specific nature of that emphasis by adding details not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 637,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "\nIntel initially recorded a $471 million observable‑price adjustment to its stake in Beijing Unisoc in 2021, raising the investment’s net book value to $1.1 billion, a balance that remained unchanged through the end of 2023; the holding is accounted as a non‑marketable equity security and is carried at cost adjusted for that 2021 adjustment (with only periodic impairment testing), so no further fair‑value gains or losses were recognized in earnings during 2022‑2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $471 million observable-price adjustment in 2021 matches ground truth exactly, and $1.1 billion net book value as of end of 2023 is accurate. The dates (2021, 2022-2023) are correctly referenced. COMPLETENESS: The answer addresses the core evolution of Intel's financial relationship with Beijing Unisoc by: (1) identifying the 2021 revaluation event ($471M adjustment), (2) noting the stable $1.1 billion valuation through 2023, (3) explaining the accounting treatment (non-marketable equity security at cost), and (4) noting the absence of further fair-value adjustments in 2022-2023. ENTITY ACCURACY: Company names are correct (Intel, Beijing Unisoc), and the investment classification is properly identified. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects the 2021 adjustment event to the stable valuation through 2023, and logically infers that the lack of mentioned adjustments in 2023 reflects stabilization. The explanation of accounting methodology (cost basis with periodic impairment testing) adds appropriate context. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, with slightly more detail about accounting treatment. Minor difference: The LLM states the adjustment 'raised' the investment to $1.1B, while ground truth simply notes it 'stayed at' $1.1B - this is a reasonable inference about causality that doesn't contradict the ground truth. The answer is well-structured and directly responsive to the question about how the relationship 'evolved' between 2021 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 461,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Home Depot transformed its self‑service lockers from a simple convenience feature into a central node of its omnichannel fulfillment network. The lockers are now integrated with the BOSS/BOPIS/BODFS/BORIS programs, placed at store entrances, and tied to mobile‑app navigation and real‑time inventory data, enabling customers to pick up online orders, access curb‑side or same‑day delivery, and complete the seamless “interconnected shopping” journey across digital and physical channels.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Self-Service Lockers from a convenience feature to an omnichannel fulfillment component. It accurately mentions the integration with BOSS/BOPIS/BODFS/BORIS programs and captures the shift toward interconnected retail strategy. The qualitative description of the transformation is sound and semantically aligned with the ground truth. CRITICAL WEAKNESS: The LLM answer completely omits the key quantitative metric from the ground truth - that approximately 50% of U.S. online orders were fulfilled through stores in 2024. This is a significant factual omission that represents a core piece of evidence supporting the evolution narrative. The ground truth explicitly states this statistic as evidence of the 'more integrated and operationally significant role' of Self-Service Lockers. ADDITIONAL ISSUES: The LLM adds specific details not present in the ground truth (e.g., 'placed at store entrances,' 'mobile-app navigation,' 'real-time inventory data,' 'curb-side or same-day delivery') that, while plausible, cannot be verified against the provided ground truth and may represent hallucination or inference beyond the source material. The 2023 reference to 'wayfinding signage and electronic shelf labels' from the ground truth is not mentioned in the LLM answer, though this is a minor omission. QUANTITATIVE ACCURACY: Severely impacted by the missing 50% statistic, which is a concrete, measurable fact that should have been included. The LLM provides no numbers or percentages despite the ground truth containing specific quantitative data. QUALITATIVE ACCURACY: Strong on the conceptual evolution and program integration, but weakened by the omission of supporting quantitative evidence and the addition of unverified details. CONTEXTUAL RELEVANCE: High - the answer directly addresses the question about evolution between 2023 and 2024 and maintains focus on the interconnected shopping experience.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 532,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "\nThe 2024 filing shortens the prior‑year discussion, dropping details about how the captive’s premiums are netted against SG&A, the mechanics of the third‑party reinsurance program, and the disclosed $1.6 billion liability balances, and instead offers a brief statement that the retained‑risk liabilities are “not discounted and are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions.”  Thus, while the core estimation methodology remains the same, the 2024 disclosure is markedly less detailed and specific than the 2023 version.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the fundamental finding. Ground truth states that 2024 disclosure EXPANDED with significantly MORE detail and specificity compared to 2023, including specific estimation factors (historical claims experience, demographic factors, severity factors, actuarial assumptions) and discussion of unpredictability. The LLM answer claims the opposite: that 2024 'shortens the prior-year discussion' and is 'markedly less detailed and specific than the 2023 version.' This is a complete reversal of the correct conclusion. While the LLM correctly identifies some specific estimation factors mentioned (historical claims experience, demographic factors, severity factors, actuarial assumptions), it mischaracterizes the directional change in disclosure detail. The LLM also references specific numbers ($1.6 billion liability balances) and details about captive premiums and reinsurance mechanics that are not mentioned in the ground truth, suggesting potential hallucination or confusion with different source material. The core multi-hop reasoning—comparing disclosure evolution from 2023 to 2024—is fundamentally flawed, reaching the opposite conclusion from the ground truth. This represents a major factual error on the primary question being asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 363,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "\nIn 2021 the Aldevron purchase required a fair‑value uplift to its inventory, which added about **$59 million** to cost of sales. By 2022 those acquisition‑specific inventory adjustments had been fully absorbed and no longer impacted earnings. In 2023, however, the company recorded a **$87 million charge** for excess inventory in the Biotechnology segment—largely reflecting lingering inventory from the Aldevron acquisition—re‑introducing a material inventory‑related drag on gross profit.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IN TIMELINE AND FACTS: The LLM answer contains critical factual errors that fundamentally misrepresent the ground truth. (1) TIMELINE ERROR - The LLM states the $59 million fair-value uplift occurred in 2021 and was absorbed by 2022, but the ground truth clearly indicates this $59 million impact occurred in 2022. This is a one-year shift that changes the entire narrative. (2) INCORRECT CHARACTERIZATION OF 2023 CHARGE - The LLM claims the $87 million 2023 charge was 'largely reflecting lingering inventory from the Aldevron acquisition,' but the ground truth explicitly states it was 'primarily related to excess inventory in the Biotechnology segment due to reduced demand' - a different root cause. The LLM incorrectly attributes the 2023 charge back to Aldevron when the ground truth indicates it represents a shift to operational/demand-driven challenges, not acquisition-related adjustments. (3) QUANTITATIVE ACCURACY - While the dollar amounts ($59M and $87M) are correct, their temporal placement is wrong. The $59M should be associated with 2022, not 2021. (4) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the evolution described in the ground truth: the shift FROM acquisition-driven inventory adjustments (2022) TO operational inventory challenges (2023). Instead, the LLM incorrectly suggests the 2023 charge still relates to Aldevron acquisition inventory. (5) SEMANTIC MEANING - The core insight of the ground truth—that there was a fundamental shift in the nature of inventory costs from acquisition-related to demand-driven—is lost in the LLM answer. The LLM's framing suggests continuity of Aldevron-related issues when the ground truth indicates a transition to different operational problems.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 476,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "\nCostco continues to record shop‑card revenue only when the cards are redeemed and to carry the unredeemed balances as a liability — but now it presents that liability net of a refined estimate of “breakage” (the portion expected never to be used).  The 2024 breakage estimate is slightly higher than in 2023, so the net shop‑card liability is lower, reflecting a more aggressive assessment of how much of the outstanding balances will ultimately remain unclaimed.  This shift shows that Costco is increasingly comfortable quantifying and offsetting unclaimed shop‑card balances, treating them as a measurable liability rather than a potential future earnings source.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Costco's shop card liability accounting between 2023 and 2024, correctly identifying that: (1) revenue is recognized upon redemption, (2) unredeemed balances are carried as liabilities, (3) breakage estimation became more emphasized/refined in 2024, and (4) this reflects improved estimation techniques. The semantic understanding of the shift toward more formalized breakage accounting is sound.\n\nHowever, there are significant quantitative accuracy issues: The LLM states 'The 2024 breakage estimate is slightly higher than in 2023, so the net shop-card liability is lower' - this contains a specific factual claim about comparative breakage estimates between years that is NOT supported by the ground truth. The ground truth does not provide specific numerical comparisons or state that 2024 breakage was 'slightly higher' than 2023. This is an unsupported assertion that goes beyond what the knowledge graph indicates.\n\nAdditionally, the LLM characterizes the shift as treating unclaimed balances 'as a measurable liability rather than a potential future earnings source' - while this interpretation is reasonable, the ground truth does not explicitly make this distinction or characterization. The LLM has inferred a business philosophy shift that exceeds the factual basis provided.\n\nThe answer demonstrates good qualitative reasoning about the evolution of accounting practices and correctly identifies the key elements (redemption-based revenue, liability accounting, breakage estimation refinement). However, the introduction of specific comparative claims about 2024 vs 2023 breakage levels without supporting data, combined with interpretive statements not grounded in the source material, reduces overall correctness. The answer would score higher if it stuck to the documented evolution without adding unsupported quantitative comparisons.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 515,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 Intel’s Foundry Services moved from **building the ecosystem** to **scaling commercial engagement**. In 2022 the company launched IFS and sealed foundational alliances with **ARM and Synopsys**, expanded its **IFS Accelerator ecosystem to >40 partners**, and entered the **U.S. Department of Defense’s RAMP‑C program** with early customers such as Nvidia, IBM, Microsoft, Boeing and Northrop Grumman. By 2023 Intel leveraged that foundation to generate **multiple design wins on the 18A node** (including a high‑performance‑computing win and a sizable prepayment), **doubled the accelerator program**, deepened its **ARM and Synopsys agreements**, and signed a **commercial foundry deal with Tower** for New Mexico analog production—showing a shift from partnership formation to **active, high‑volume customer design and manufacturing engagements**, especially in AI‑focused and advanced‑packaging workloads.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer contains several claims not supported by the ground truth: mentions of 'RAMP-C program' with specific customers (Nvidia, IBM, Microsoft, Boeing, Northrop Grumman), 'doubled the accelerator program' (no doubling mentioned in ground truth), and 'commercial foundry deal with Tower for New Mexico analog production' (not mentioned in ground truth). These are significant fabrications. (2) QUANTITATIVE ACCURACY PROBLEMS - The LLM states ARM and Synopsys agreements were 'sealed' in 2022, but ground truth indicates these were 'multigenerational agreements' entered in 2023, not 2022. The claim about '>40 partners' in 2022 contradicts the ground truth which states the program was 'expanded to over 40 strategic agreements' in 2023. (3) CORRECT ELEMENTS - The LLM correctly identifies: four design wins on Intel 18A in 2023, high-performance computing customer win, five new design wins in advanced packaging, AI-related focus, and the general evolution from strategic intent to concrete engagements. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize a narrative arc from 2022 to 2023, it does so by introducing unsupported details rather than accurately synthesizing the provided ground truth. The core insight about moving from ecosystem building to commercial engagement is sound, but the supporting details are largely inaccurate. (5) MISSING/INCORRECT TIMELINE - The LLM conflates 2022 and 2023 activities, placing ARM/Synopsys agreements and the 40+ partnerships in 2022 when they belong in 2023 according to ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 438,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 the Company did not record any new goodwill or cash‑consideration specifically for Aldevron; the $6.1 billion of goodwill that was initially recognized in the 2021 Aldevron acquisition remained unchanged on the balance sheet during 2022 and 2023.  The only cash outflow related to Aldevron was the $9.56 billion net cash consideration recorded in 2021 (the $582 million and $5.61 billion figures in 2022 and 2023 reflect other acquisitions such as the Abcam purchase), so the financial impact of the Aldevron relationship after the 2021 acquisition was limited to the existing goodwill balance and routine impairment testing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE ERRORS: The LLM claims the $9.56 billion net cash consideration was recorded in 2021, but the ground truth explicitly states it increased to $9.561 billion by 2023. The LLM also incorrectly attributes the $582 million and $5.61 billion figures to other acquisitions (Abcam), when these appear to be related to Aldevron's financial evolution. (2) FACTUAL CONTRADICTION: The ground truth shows an evolution between 2022 and 2023 with the net cash consideration increasing to $9.561 billion, indicating a revised financial assessment. The LLM denies any changes occurred between 2022-2023, stating 'the Company did not record any new goodwill or cash-consideration specifically for Aldevron.' This directly contradicts the ground truth's core finding. (3) INCOMPLETE SYNTHESIS: The question specifically asks about the evolution 'between 2022 and 2023,' and the ground truth shows this evolution clearly. The LLM fails to recognize or explain this temporal evolution, instead claiming the figures remained static. (4) MISINTERPRETATION: The LLM's assertion that the $9.56 billion was a one-time 2021 payment misses the ground truth's point that the net cash consideration figure was revised/clarified by 2023, suggesting a more detailed financial assessment occurred. (5) ENTITY CONFUSION: While the LLM correctly identifies DHR and Aldevron, it incorrectly dismisses the significance of the 2022-2023 period changes. The ground truth clearly indicates material changes in how the acquisition was valued/assessed during this period. The LLM answer demonstrates a fundamental misunderstanding of the question's focus on temporal evolution and provides incorrect information about when key financial figures were recorded.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 498,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "\nThe AT&T Inc. 1.800% Global Notes are scheduled to mature on September 5, 2026 in both the 2022 and 2024 Form 10‑K filings, so the maturity date has not changed. This indicates that AT&T has not refinanced or rolled this specific tranche, suggesting a stable near‑term debt schedule while the company likely continues to extend longer‑dated obligations elsewhere to shape its overall debt structure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claims. According to the ground truth, the AT&T Inc. 1.800% Global Notes maturity date changed from September 5, 2026 (2022 filing) to September 14, 2039 (2024 filing) - a 13-year extension. The LLM claims the maturity date 'has not changed' and remained September 5, 2026 in both filings, which directly contradicts the ground truth. This is a critical factual error on the primary question. The LLM's reasoning about 'stable near-term debt schedule' and 'not refinanced' is based on this incorrect premise. The LLM failed to identify the significant debt structure evolution that occurred - the extension of this note's maturity by over 13 years. The quantitative accuracy is severely compromised because the key date (September 14, 2039) is completely missing from the LLM answer, and the claim that the date remained unchanged is factually wrong. The qualitative reasoning, while internally consistent, is built on false information and therefore invalid. The answer does not address what the question asks about - how the maturity date changed and what this indicates about debt structure evolution. Instead, it incorrectly asserts no change occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 343,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "\nTarget’s debt‑leverage covenant was already being met in 2023 and continued to be satisfied in 2024; the company’s leverage ratio actually improved because long‑term borrowings fell from roughly **$16.0 bn (2023)** to **$14.9 bn (2024)** and the amount of debt maturing within the next year dropped sharply (from $130 m to $1.1 bn).  This reduction kept the covenant‑tested debt‑to‑EBITDA (or comparable) metric comfortably under the covenant threshold in both years.  \n\nThe evolution of the credit‑facility structure helped preserve that compliance: in October 2024 Target replaced its expiring 364‑day revolving credit facility with a new **$1.0 bn 364‑day unsecured facility (now maturing in October 2025)** and retained its **$3.0 bn five‑year revolving facility (maturing in October 2028)**, neither of which had any outstanding balances during 2023‑2024.  The larger, longer‑dated backstop reduced near‑term borrowing pressure and gave the company additional flexibility to manage its leverage while staying well within the covenant limits.  (Pages 33, 35, 52‑53 of the 2023 and 2024 Form 10‑K filings).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies the covenant compliance status in both 2023 and 2024; (2) Accurately states the credit facility structure: $1.0 billion 364-day facility renewed to October 2025 and $3.0 billion five-year facility through October 2028 - matching ground truth exactly; (3) Provides specific debt figures ($16.0 bn in 2023 declining to $14.9 bn in 2024) that demonstrate improved leverage position; (4) Correctly notes the near-term debt maturity changes ($130M to $1.1 bn); (5) Properly synthesizes multi-hop information: connects facility renewal timing (October 2024) to covenant compliance and explains the causal relationship between structure changes and compliance flexibility; (6) Appropriately emphasizes that neither facility had outstanding balances, supporting the compliance narrative. MINOR CONSIDERATIONS: (1) The LLM provides additional quantitative detail (specific debt amounts and maturity figures) beyond the ground truth, which adds value but goes slightly beyond what was explicitly stated in the original answer - however, this is presented as supporting evidence and appears factually sound; (2) The answer includes page references (33, 35, 52-53) which adds credibility but cannot be verified against the ground truth provided. VERIFICATION: The core facts align perfectly with ground truth: covenant compliance in both years, $1.0 bn 364-day facility renewed to October 2025, $3.0 bn five-year facility through October 2028, and the explanation of how facility renewal supported compliance. The multi-hop reasoning correctly synthesizes the relationship between debt reduction, facility structure, and covenant compliance. No calculation errors detected. The answer directly addresses both parts of the question (compliance evolution and credit facility structure changes).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 506,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "\nFrom 2022 to 2023 Intel moved from setting RISE‑linked goals to actively scaling its digital‑readiness agenda through broader external partnerships. In 2022 the company announced its RISE strategy and pledged to expand digital‑readiness programs (e.g., AI‑for‑Youth and AI‑for‑Workforce) in collaboration with governments and institutions, while tying diversity metrics to compensation. By 2023 it deepened those efforts—launching the RISE Technology Initiative, publishing the Alliance for Global Inclusion’s Inclusion Index, expanding multi‑year HBCU partnerships, and funding projects that use technology to boost digital readiness—while continuing to link progress to executive pay and public reporting.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions when compared to the ground truth. CRITICAL ERRORS: (1) The LLM mentions 'RISE Technology Initiative' launching in 2023, but the ground truth does not reference this specific initiative name. (2) The LLM discusses AI-for-Youth and AI-for-Workforce programs, diversity metrics tied to compensation, and HBCU partnerships, but these details are NOT present in the ground truth answer and appear to be hallucinated or from different contexts. (3) QUANTITATIVE ACCURACY FAILURE: The ground truth provides specific metrics - 18 recognized organizations out of 27 respondents in the 2023 Inclusion Index, with a 50% threshold for recognition. The LLM answer completely omits these critical quantitative details. (4) The ground truth emphasizes the 'third global inclusion index survey' and the transition to a structured 'index system' with formal recognition. The LLM mentions 'publishing the Alliance for Global Inclusion's Inclusion Index' but fails to capture the progression from survey to structured system or the specific recognition metrics. (5) MULTI-HOP REASONING: While the LLM attempts to show evolution from 2022 to 2023, it does so by introducing elements not in the ground truth (RISE Technology Initiative, AI programs, HBCU partnerships, compensation linkage) rather than accurately synthesizing the actual evolution described in the ground truth (collaborative framework establishment → structured measurement and recognition). (6) The LLM correctly identifies the Alliance for Global Inclusion and the Inclusion Index, but misses the core narrative of the ground truth: the shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks. The answer demonstrates partial understanding of the general direction but fails on factual accuracy and introduces unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 515,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Emerson’s link to Micromine moved from an active acquisition effort—started when AspenTech (the business Emerson had acquired in 2022) signed an agreement to buy Micromine in July 2022—to a complete termination of that deal in August 2023, after which no further relationship or transaction existed. The termination eliminated the planned purchase price and integration costs and, because the related foreign‑currency forwards were unwound, produced a $24 million mark‑to‑market gain in 2023 (versus a $50 million loss in 2022) with no termination‑fee charge, leaving Emerson with only the residual effect of those hedges and no additional financial impact thereafter.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) TIMELINE CONTRADICTION: The LLM states the acquisition agreement was 'signed in July 2022' and terminated in 'August 2023', but the ground truth clearly indicates the agreement was entered into in 2023 and terminated later in 2023. The LLM's dating of the agreement to 2022 is factually incorrect and contradicts the ground truth's explicit statement that this occurred in 2023. (2) QUANTITATIVE ERRORS: The LLM introduces a '$50 million loss in 2022' that does not appear in the ground truth. The ground truth only mentions a '$24 mark-to-market gain in 2023' related to the foreign currency forward contracts. The introduction of a 2022 loss figure is unsupported and creates confusion about the financial timeline. (3) INCOMPLETE FINANCIAL PICTURE: The LLM mentions 'termination-fee charge' and 'residual effect of those hedges' but the ground truth does not reference these details. The ground truth is clearer: the $24 gain occurred in 2023, and by 2024 all foreign currency forward contracts were terminated with no further exposures. (4) ACQUISITION PRICE DISCREPANCY: The ground truth specifies the acquisition price as 'AU$900 (approximately $623 USD)' but the LLM does not mention any specific acquisition price, making it incomplete. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize the relationship evolution, the fundamental timeline error undermines the entire analysis. The question asks about evolution 'between 2023 and 2024' but the LLM's answer conflates 2022 and 2023 events. (6) WHAT WAS CORRECT: The LLM correctly identifies that AspenTech was involved, that the deal was terminated, that foreign currency forwards were involved, and that there was a mark-to-market gain of $24 million. However, these correct elements are embedded within a fundamentally flawed timeline that significantly reduces the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 510,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "\nThe U.S. ESPP had roughly 17 million shares available at the beginning of fiscal 2022, declining to about 15 million shares at the start of fiscal 2023. During that period the average purchase price fell from $305.14 per share in fiscal 2022 to $277.19 per share in fiscal 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on all key quantitative metrics. All four critical numbers are accurate: 17 million shares available in 2022, 15 million in 2023, $305.14 average purchase price in 2022, and $277.19 in 2023. The numeric values and their comparison across years are correct. However, there is one notable omission: the LLM answer does not mention that associates purchased approximately one million shares in each year, which is a specific detail included in the ground truth. The ground truth explicitly states 'associates purchased approximately one million shares' in both years, providing context about actual share purchases during the fiscal years. The LLM answer focuses only on availability and average price, missing this intermediate data point. The reasoning is sound and the multi-hop synthesis is correct (comparing 2022 to 2023 metrics), but the answer is incomplete. The phrasing 'at the beginning of fiscal 2022' and 'at the start of fiscal 2023' is a reasonable interpretation of the data, though the ground truth presents it more simply as 'in 2022' and 'in 2023.' The conclusion about the reduction in share availability and decrease in average purchase price is logically sound and matches the ground truth's interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 355,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "\nIn the 2022 filing the Company recorded **no impairment charges** for intangible assets, while the 2023 filing disclosed **impairment triggers in the second quarter for the Biotechnology segment and in the fourth quarter for both Diagnostics and Biotechnology**, resulting in **$77 million of impairment charges** recorded in selling, general and administrative expenses.  This shift—from a zero‑charge year to a year with multi‑segment, multi‑quarter triggers—signals that the Company now perceives heightened risk in its finite‑lived intangible assets, especially technology‑ and customer‑related intangibles within biotech and diagnostics, reflecting evolving uncertainties in cash‑flow forecasts or market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM states '2022 filing the Company recorded no impairment charges' but the ground truth explicitly states the 2022 filing reported a $10 million impairment charge in Q1 2021 (Diagnostics segment). This is a fundamental factual error. The LLM incorrectly characterizes 2022 as a 'zero-charge year.' (2) INCOMPLETE SEGMENT ANALYSIS - The LLM correctly identifies the 2023 impairment triggers (Q2 Biotechnology, Q4 Diagnostics and Biotechnology) and the $77 million charge, but fails to mention that the 2022 filing also included the Q1 2021 Diagnostics impairment for comparative purposes. (3) MULTI-HOP REASONING - The LLM's comparison logic is flawed because it's comparing the wrong baseline. It should compare: 2022 filing ($10M, Diagnostics only) vs. 2023 filing ($77M, multiple segments/quarters). Instead, it incorrectly states 2022 had zero charges. (4) CORRECT ELEMENTS - The LLM correctly identifies: the $77 million 2023 charge, the multi-segment/multi-quarter pattern in 2023, the Biotechnology segment emergence as a new impairment focus, and the qualitative interpretation about heightened risk in intangible assets. (5) SEMANTIC ISSUES - While the LLM's qualitative assessment about 'heightened risk' and 'evolving uncertainties' is reasonable, it's based on an incorrect factual foundation (the false claim of zero 2022 charges). The answer demonstrates partial understanding of the risk evolution but fundamentally misrepresents the 2022 baseline data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 418,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "\nThe company’s outstanding letters of credit that are tied to trade contracts grew from **$362 million at the end of fiscal 2022** (as reported in the 2022 10‑K, page 69) to **$598 million at the end of fiscal 2023** (as reported in the 2023 10‑K, page 70).  This $236 million increase—about a 65 % rise—shows that Home Depot expanded its use of trade‑related letters of credit, indicating a larger volume of business transactions that rely on such credit support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $362 million (2022), $598 million (2023), and the calculated increase of $236 million. The percentage calculation of approximately 65% increase is accurate ($236M / $362M = 65.2%). ENTITY ACCURACY: The company is correctly identified as Home Depot, and fiscal years 2022 and 2023 are properly referenced. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the value changed (specific numbers and percentage), and (2) what this indicates about the company's involvement (expansion of trade-related business activities). MULTI-HOP REASONING: The model correctly synthesized information across two fiscal years and drew a logical conclusion about increased business involvement. The reasoning that a $236 million increase in letters of credit indicates expanded trade contract activities is sound and matches the ground truth interpretation. MINOR CONSIDERATIONS: The LLM provides additional context (page numbers from 10-K filings, specific fiscal year references) that goes slightly beyond the ground truth answer but adds credibility and does not contradict any information. The semantic meaning is fully aligned with the original answer - both convey that letters of credit increased significantly and this reflects growing business involvement in trade contracts. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 404,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "\nThe 0.300 % Notes due 2028 were only **incorporated by reference** in the 2023 filing – the 2023 Form 10‑K listed the instrument in the exhibit index (“the instrument defining the rights of the holders of the 0.300 % Notes due 2028… are Exhibits 4.1‑4.3 to a Form 8‑K filed Feb 10 2020”) but it did **not appear in the “Securities Registered Pursuant to Section 12(b)” table**.  \n\nIn the 2024 filing the same series is now **explicitly listed in the securities table** as “0.300 % Notes due 2028 IBM28B”. This change shows that IBM has moved the note from a passive exhibit reference to an active, registered security disclosure, indicating an updated and more transparent presentation of its financial‑instrument obligations in the latest filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and provides a more detailed and nuanced explanation than the ground truth. Strengths: (1) All numeric values are correct - 0.300% interest rate, 2028 maturity date, February 10, 2020 filing date, and trading symbol IBM28B are all accurate. (2) The multi-hop reasoning is sound - the answer correctly synthesizes information across 2023 and 2024 filings to identify the evolution of the instrument's disclosure status. (3) Entity identification is precise - IBM is correctly identified, the specific note series is properly referenced, and the NYSE listing is accurate. (4) The answer goes beyond the ground truth by providing more specific technical detail about the disclosure mechanism (incorporated by reference vs. explicit listing in securities table), which demonstrates deeper understanding of SEC filing conventions. (5) The characterization of the shift from 'passive exhibit reference' to 'active, registered security disclosure' is semantically equivalent to and arguably more precise than the ground truth's description of moving from 'merely disclosing the existence' to 'formally recognizing it as an actively traded financial instrument.' Minor consideration: The LLM answer uses slightly different framing (incorporated by reference vs. exhibit reference) but this is actually more technically accurate to SEC filing terminology. The conclusion about 'updated and more transparent presentation' aligns well with the ground truth's inference about 'increased market engagement or liquidity.' No calculation errors, no factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 438,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings, IBM moved from merely referencing the 1.750% Notes due 2031 in the exhibit list (where the rights were incorporated by reference to a 2019 Form 8‑K) to explicitly registering the series in the “Securities registered pursuant to Section 12(b)” table of the 2024 filing. In the 2024 report the notes appear as a distinct security (ticker IBM31) listed on the New York Stock Exchange, indicating that the company formally disclosed and registered the issue on a public exchange, whereas the 2023 filing did not include such a dedicated listing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of IBM's treatment of the 1.750% Notes due 2031 between 2023 and 2024. STRENGTHS: (1) All key facts are correct - the notes are accurately identified with the correct interest rate and maturity year; (2) The ticker symbol IBM31 is correctly cited; (3) The NYSE listing is accurately mentioned; (4) The temporal evolution is properly captured - moving from exhibit reference in 2023 to formal registration in 2024; (5) The reference to the January 30, 2019 Form 8-K incorporation by reference is accurate; (6) The distinction between 'mere disclosure' in 2023 versus 'formal registration' in 2024 is correctly articulated; (7) The specific mention of 'Securities registered pursuant to Section 12(b)' table demonstrates precise knowledge of SEC filing structure. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth ('exhibit list' vs 'exhibit filed') but this is semantically equivalent and reflects the same underlying fact. The answer effectively synthesizes multi-hop information across two years of filings and correctly identifies the shift in disclosure status. No numerical errors, date errors, or factual inaccuracies are present. The reasoning is sound and the answer directly addresses all aspects of the question regarding how IBM's treatment of these notes evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 393,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "\nIn 2023 Eli Lilly recorded roughly **$1.69 billion** of revenue from the olanzapine portfolio—including Zyprexa—by selling the portfolio rights; this one‑time amount was reported as **collaboration and other revenue** rather than product revenue, reflecting a licensing‑type arrangement in which revenue was recognized when control of the rights transferred (see LLY_10k_2023.pdf p. 48 and the note on “Zyprexa (2) revenue includes sale of the rights for the olanzapine portfolio” on p. 45). By 2024 the company no longer generates product sales of Zyprexa, and the consolidated statements show **no material revenue from that portfolio**, indicating that the rights‑sale was a completed, non‑recurring transaction and the business model shifted away from ongoing Zyprexa sales (consistent with the revenue‑recognition guidance in LLY_10k_2024.pdf pp. 64‑65).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY FAILURE: The LLM states $1.69 billion for 2023 olanzapine portfolio sale, but the ground truth clearly states $1.45 billion. This is a significant $240 million discrepancy (16.6% overstatement). This is a material factual error that cannot be excused as formatting variation. (2) REVENUE CLASSIFICATION REVERSAL: The LLM claims the 2023 sale was reported as 'collaboration and other revenue' in 2023, but the ground truth indicates it was reported as direct product sales revenue in 2023, with the shift to collaboration/licensing revenue occurring in 2024. The LLM has reversed the timeline of the business model change. (3) PARTIAL CREDIT FOR CORRECT ELEMENTS: The LLM correctly identifies that: (a) the transaction involved selling rights to the olanzapine portfolio including Zyprexa, (b) there was a shift from product sales to licensing/collaboration arrangements, (c) by 2024 Zyprexa was no longer generating material product revenue, and (d) the transaction was non-recurring. (4) REASONING QUALITY: While the LLM demonstrates understanding of the conceptual shift from product sales to licensing arrangements, the fundamental misstatement of the 2023 revenue amount and the reversal of when each revenue classification applied undermines the multi-hop synthesis. The answer conflates the 2023 and 2024 revenue recognition approaches. (5) MISSING NUANCE: The ground truth emphasizes that 2023 showed direct product sales revenue ($1.45B), while 2024 showed the same transaction's revenue reclassified as collaboration revenue. The LLM fails to capture this critical temporal distinction in revenue recognition methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 457,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "\nFrom 2023 through early 2024 AT&T’s Mobility Preferred Interests moved from being an outstanding, redeemable class of preferred membership interests (carrying 7 %–6.8 % cash‑distribution rights and, after 2022, recorded as a liability after a equity‑to‑liability reclassification) to being fully repurchased—cash payments of roughly $2.6 bn in 2022 and $5.4 bn in April 2023 settled the remaining 213 million interests—so that no such interests remained on the balance sheet at year‑end 2023. Consequently, in the 2024 EPS calculations there are no dilutive “Mobility preferred interests” to add to the denominator (the diluted‑share count fell from 7,258 million in 2023 to 7,204 million in 2024), eliminating both the redemption obligation and any preferred‑dividend impact on earnings per share.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the evolution of Mobility Preferred Interests from 2023 to 2024 and correctly identifies the key transition from active liability to full retirement. However, there are significant quantitative discrepancies that lower the overall score.\n\nCORRECT ELEMENTS:\n- Correctly identifies the equity-to-liability reclassification in 2023\n- Accurately states the April 2023 repurchase of remaining interests for $5.4 billion (matches ground truth's $5,414 million)\n- Correctly notes that interests were fully retired by year-end 2023\n- Properly explains the shift to retrospective EPS treatment in 2024\n- Correctly identifies that no dilutive Mobility preferred interests remain in 2024 EPS calculations\n- Accurately cites the diluted share count change from 7,258 million (2023) to 7,204 million (2024)\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE ERROR - The LLM states \"cash payments of roughly $2.6 bn in 2022 and $5.4 bn in April 2023.\" The ground truth specifies $2,670 million in current liabilities and $2,670 million in noncurrent liabilities recorded in 2023 (totaling $5,340 million), not separate 2022 and 2023 payments. The $5,414 million repurchase in April 2023 was the actual cash outlay for all remaining interests.\n2. INCOMPLETE BALANCE SHEET DETAIL - The LLM does not mention the specific liability classification ($2,670 current and $2,670 noncurrent) that was recorded in 2023, which is a key detail about the financial impact.\n3. DISTRIBUTION RATES - While the LLM mentions \"7%-6.8% cash-distribution rights,\" the ground truth does not provide these specific percentages, suggesting potential external information mixing.\n4. MISSING CONTEXT - The ground truth emphasizes the shift from \"active financial obligations to retrospective accounting treatment,\" which the LLM addresses but less explicitly.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across 2023-2024, connecting the reclassification, repurchase, and EPS impact. The reasoning is sound and logically structured, though the quantitative details are imprecise.\n\nSEMANTIC EQUIVALENCE:\nThe core message is conveyed correctly - the interests moved from liability to retirement and no longer impact 2024 EPS calculations. However, the specific financial figures and their timing are not accurately represented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 627,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "\nIn the 2023 filing the 0.875 % Notes due 2030 were only mentioned in the “Instruments defining the rights of security holders” section, where the indenture was incorporated by reference from a 2022 8‑K (Exhibit 4.1); there was no separate entry in a registration table. By contrast, the 2024 Form 10‑K includes the notes in the “Securities registered pursuant to Section 12(b)” table, identifying them as “0.875 % Notes due 2030 – IBM30A – New York Stock Exchange,” thereby explicitly registering and listing the issue on the exchange. Thus, IBM’s disclosure evolved from an indirect reference to a full, listed registration of the 0.875 % Notes due 2030.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about IBM's 0.875% Notes due 2030 disclosure evolution. STRENGTHS: (1) All key facts are correct - the 2023 disclosure method (incorporated by reference from Feb 8, 2022 8-K Exhibit 4.1), the 2024 registration in the Section 12(b) table, the trading symbol (IBM30A), and the NYSE listing are all accurately stated. (2) The percentage (0.875%) and maturity year (2030) are correct. (3) The multi-hop synthesis is sound - the answer correctly traces the evolution from indirect reference to explicit registration across two fiscal years. (4) The characterization of the shift from 'indirect reference' to 'full, listed registration' accurately captures the substantive change in disclosure treatment. (5) The specific section references ('Instruments defining the rights of security holders' and 'Securities registered pursuant to Section 12(b)') demonstrate precise knowledge of filing structure. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth ('indirect reference' vs 'referenced disclosure,' 'full, listed registration' vs 'fully listed and registered') but these are semantically equivalent and represent appropriate professional terminology. The answer is more detailed in explaining the specific table location and section references, which adds helpful context without introducing errors. No quantitative errors detected. The answer fully addresses all aspects of the question regarding treatment evolution, disclosure changes, listing status, and registration status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 443,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "\nBetween 2023 and 2024 AT&T layered its Telco LLC preferred equity by adding a new Series A‑4 issuance – $2.25 bn of cumulative preferred interests that pay a 5.94 % initial distribution, reset on Nov 1 2028 (and every four years thereafter) and become callable in 2028 – while retaining the earlier Series A‑1 (4.25 % with a seven‑year reset) and Series A‑2/A‑3 (6.85 % with a 2027 reset).  This staggered, reset‑and‑callable structure lets AT&T fine‑tune the cost of preferred capital, preserve cash‑flow flexibility and fund the redemption of older preferred equity without restricting dividend declarations or share‑repurchase activity.  The evolution reflects a disciplined, multi‑series approach to preferred‑equity financing that balances yield, timing and redemption risk while keeping common‑shareholder returns intact.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer introduces a Series A-4 issuance ($2.25 billion at 5.94% with November 2028 reset) that does NOT appear in the ground truth. The ground truth explicitly states that by 2024, the total Telco Preferred Interests were $7,250 million, consisting only of: (1) Class A-1: $2,000M at 4.25%, and (2) Class A-2/A-3: $5,250M at 6.85%. If a $2.25 billion Series A-4 had been added, the total would be $9,500M, not $7,250M. The LLM fabricated an entire preferred equity issuance with specific terms (5.94% rate, November 2028 reset, four-year reset cycle, 2028 callable date) that are not supported by the ground truth. Additionally, the LLM incorrectly states the A-2/A-3 reset date as 2027, when the ground truth indicates a seven-year reset cycle (consistent with A-1). The ground truth also notes that in 2024, AT&T clarified that failure to pay distributions would NOT restrict cash movements or dividend/repurchase ability - a key point the LLM omits. While the LLM's general narrative about AT&T's preferred equity strategy is reasonable and well-articulated, it is fundamentally undermined by the introduction of false financial data. The quantitative accuracy is severely compromised by the fabricated Series A-4 issuance and incorrect reset dates. The qualitative reasoning about staggered structures and financing strategy is sound in principle but applied to incorrect underlying facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 393,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "\nBetween 2022 and 2023 Capital One’s exposure to multifamily commercial‑real‑estate loss‑sharing arrangements with GSEs more than doubled – the liability recorded for these agreements rose from **$82 million at the end of 2022 to $137 million at the end of 2023**.  This increase reflects the firm’s continued origination of multifamily loans with the intent to sell them to GSEs and the adoption of the fair‑value option for new loss‑sharing agreements, which now records unrealized gains and losses in non‑interest income and drives a higher reserve for expected credit losses.  Consequently, the company’s risk exposure under these loss‑sharing agreements has expanded materially over the one‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $82 million liability in 2022 and $137 million in 2023. The calculation of the increase (approximately 67% or 'more than doubled' characterization) is accurate. The answer correctly identifies Capital One as the company, the correct time period (2022-2023), and the proper financial metrics (loss sharing agreement liabilities). Multi-hop synthesis is sound - the answer connects origination of multifamily loans, GSE sales intent, loss sharing agreements, and the resulting liability increases. The answer goes beyond the ground truth by adding contextual details about the fair-value option adoption and its impact on non-interest income and credit loss reserves. While these additional details are not contradicted by the ground truth and appear reasonable, they represent information not explicitly confirmed in the original answer. The characterization 'more than doubled' is slightly imprecise (actual increase is 67%, not 100%+), though this is a minor semantic issue. The answer is well-structured, addresses all parts of the question about evolution and risk exposure, and provides clear synthesis of the multi-hop information. The only minor weakness is the introduction of additional explanatory details (fair-value option, non-interest income treatment) that, while contextually relevant, go beyond what was explicitly confirmed in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 400,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "\nFrom 2022 to 2023 the co‑branded credit‑card initiatives moved from being a peripheral revenue stream to a higher‑profile business that now carries a heavier regulatory burden. In the 2022 filing the programs were noted only as a risk that “could adversely affect our operating results if renewed on less favorable terms or terminated” (AMZN 10‑K 2022, pp. 13‑14), whereas the 2023 filing expands the exposure to a suite of new compliance obligations—stricter payment‑card association rules, mandatory enhanced authentication, licensing, anti‑money‑laundering and data‑security requirements, and the possibility of fines or loss of card‑processing capabilities (AMZN 10‑K 2023, pp. 14‑16). These added regulatory pressures make the programs more strategically sensitive and increase the risk that any adverse ruling or contract change could materially dent Amazon’s operating results.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core shift in strategic significance from 2022 to 2023, recognizing that co-branded credit card programs moved from a peripheral offering to a higher-profile business with expanded regulatory burden. The answer appropriately captures the general evolution from basic payment card association compliance risks to a broader suite of obligations. The semantic understanding of the question is sound, and the answer demonstrates multi-hop reasoning by comparing across two fiscal years.\n\nWEAKNESSES: (1) QUANTITATIVE ACCURACY: The LLM provides specific page citations (pp. 13-14 for 2022, pp. 14-16 for 2023) that cannot be verified against the ground truth and may be fabricated. This is a significant concern as it suggests potential hallucination of source material. (2) INCOMPLETE SYNTHESIS: The ground truth specifically mentions 'data localization rules' as a NEW compliance obligation in 2023 that was NOT mentioned in 2022. The LLM answer does not explicitly call out data localization rules, instead listing 'enhanced authentication, licensing, anti-money-laundering and data-security requirements.' While data-security is mentioned, the specific emphasis on data localization and cross-border data transfer risks is missing. (3) MISSING CONTEXT: The ground truth emphasizes that data localization rules represent a shift toward international jurisdiction compliance and cross-border data transfer risks. The LLM answer mentions 'fines or loss of card-processing capabilities' which is not explicitly stated in the ground truth and may represent over-specification. (4) REGULATORY DETAIL: The ground truth focuses on payment card association rules and data governance laws, while the LLM introduces additional elements (anti-money-laundering, enhanced authentication, licensing) that, while plausible, are not confirmed in the ground truth.\n\nMULTI-HOP REASONING: The answer demonstrates adequate multi-hop synthesis by comparing 2022 and 2023 filings and identifying the progression of regulatory complexity. However, the synthesis is incomplete because it fails to specifically highlight the data localization rules shift, which is a key distinguishing factor between the two years.\n\nOVERALL ASSESSMENT: The answer captures the general direction and spirit of the shift in strategic significance and regulatory burden, but lacks precision in identifying the specific new compliance obligations (particularly data localization) and includes unverified page citations that raise credibility concerns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 679,
        "total_tokens": 2167
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "\nSince the 2019 de‑consolidation, RBH has remained off‑balance‑sheet for PMI and, by the 2022 filing, was carried only as an equity security “without readily determinable fair value.”  In the 2024 filing PMI recorded a $2.3 bn non‑cash impairment charge, writing the investment down to an estimated $714 m fair value after a discounted‑cash‑flow valuation that required significant judgment over discount rates, sales‑volume and margin assumptions, and the allocation of the global settlement amount.  Thus, between 2022 and 2024 the relationship shifted from a consolidated subsidiary to a minority equity holding whose carrying amount is now subject to periodic impairment testing rather than consolidation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core evolution of PM's relationship with RBH between 2022 and 2024, with mostly accurate financial details and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 2019 de-consolidation and that RBH remained off-balance-sheet through 2022; (2) Accurately cites the $2.3 billion impairment charge and $714 million fair value estimate in 2024; (3) Properly describes the shift from consolidated subsidiary to equity investment requiring impairment testing; (4) Correctly identifies key valuation assumptions (discount rates, sales volumes, margins, global settlement allocation); (5) Appropriately characterizes the investment as 'without readily determinable fair value' in 2022. WEAKNESSES: (1) The original answer mentions the CAD 3.1 billion allocation of compensatory damages against RBH from Canadian tobacco litigation, which is a material contextual detail about the financial relationship that the LLM answer omits entirely; (2) The original answer emphasizes the 'potential material impacts' from unresolved litigation, which provides important context for understanding why impairment analysis became necessary; (3) The LLM answer uses 'PMI' while the question uses 'PM' (though these refer to the same entity, consistency matters). QUANTITATIVE VERIFICATION: The $2.3 billion impairment charge and $714 million fair value are accurate per the ground truth. The timeline (2019 de-consolidation, 2022 status, 2024 impairment) is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and correctly traces the evolution of the accounting treatment. The connection between the valuation methodology and the impairment charge is logically sound. The omission of the litigation context represents incomplete synthesis of the full financial relationship story, though the core accounting evolution is captured correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 523,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "\nBetween 2022 and 2023 Baqsimi’s sales jumped from $139 million to $677.6 million—an increase of roughly 387 %—and in 2023 it represented about 2 % of Eli Lilly’s total $34.1 billion revenue, helping drive the 20 % rise in overall net product revenue. The 2024 filing lists Baqsimi as part of the $40.7 billion net product revenue, confirming that the product continues to contribute to the company’s top‑line growth and remains a strategically important, high‑margin rescue therapy within Lilly’s expanding diabetes‑obesity portfolio. Consequently, Baqsimi’s evolution from a niche launch to a measurable revenue pillar underscores its role in diversifying Lilly’s product mix and supporting long‑term earnings stability.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions:\n\n1. TEMPORAL MISMATCH: The question asks about evolution between 2023 and 2024. The LLM answer discusses 2022-2023 performance instead, which is not what was asked. This is a major scope error.\n\n2. CORE FACTUAL ERROR - 2024 STATUS: The ground truth explicitly states that \"By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales\" and was instead \"disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights.\" The LLM claims Baqsimi \"continues to contribute to the company's top-line growth\" and \"remains a strategically important\" product in 2024, which directly contradicts the ground truth. This is a fundamental misunderstanding of the key finding.\n\n3. QUANTITATIVE ERRORS: While the LLM correctly cites the 2023 figure of $677.6 million, it then claims this product \"continues to contribute\" in 2024 as part of the $40.7 billion net product revenue. The ground truth indicates Baqsimi was divested/sold in 2023, so it should NOT be counted as a direct revenue contributor in 2024.\n\n4. MISSING CRITICAL INFORMATION: The LLM completely misses the strategic pivot that is central to the question - the transition from internal commercialization to a divested asset. This is the most important aspect of how Baqsimi's role \"evolved\" between 2023 and 2024.\n\n5. INCORRECT CHARACTERIZATION: The LLM describes Baqsimi as a \"high-margin rescue therapy within Lilly's expanding diabetes-obesity portfolio\" continuing in 2024, when the ground truth shows it was sold/divested in 2023, fundamentally changing its role.\n\n6. REASONING FAILURE: The multi-hop synthesis is flawed. The LLM failed to identify and synthesize the critical information about the 2023 sale of rights that changed Baqsimi's status in 2024.\n\nThe answer demonstrates a significant misunderstanding of the question's focus (2023-2024 evolution, not 2022-2023) and provides incorrect information about Baqsimi's continued role in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 567,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "\nBetween 2022 and 2024 the owned‑share of Union Pacific’s highway‑revenue equipment increased markedly.  In 2022 the company reported roughly 48,960 owned containers and 1,860 leased containers (≈96 % owned) and about 29,875 owned chassis and 14,150 leased chassis (≈68 % owned) (UNP 10‑K 2022, pp. 22‑24); by 2024 those figures had shifted to roughly 46,375 owned containers and 288 leased containers (≈99.4 % owned) and 4,356 owned chassis and 1,197 leased chassis (≈78 % owned) (UNP 10‑K 2024, p. 19).  Thus, both containers and chassis moved toward a much higher proportion of owned equipment and a correspondingly lower proportion of leased equipment over the two‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical discrepancies compared to the ground truth. Ground truth states: 2022 owned 78,837 total units (containers + chassis combined), 2024 owned 50,731 total units. However, the LLM breaks this down as 48,960 owned containers + 29,875 owned chassis = 78,835 in 2022 (approximately correct sum), but then claims 46,375 owned containers + 4,356 owned chassis = 50,731 in 2024 (correct sum). The critical error is in the leased equipment numbers: Ground truth shows 2022 had 16,004 total leased units, but LLM reports only 1,860 + 14,150 = 16,010 (close but slightly off). More problematically, for 2024, ground truth shows 1,485 total leased units (288 containers + 1,197 chassis = 1,485), which the LLM correctly identifies. However, the LLM's 2022 leased chassis figure of 14,150 appears inconsistent with ground truth's implication of different proportions. The LLM's percentage calculations (96% owned containers, 68% owned chassis in 2022; 99.4% owned containers, 78% owned chassis in 2024) are mathematically consistent with the numbers provided but may be based on incomplete or incorrect underlying data. The LLM correctly identifies the directional trend (shift toward more owned, fewer leased equipment) and the key insight about chassis reduction, but the specific numerical breakdown contains errors that undermine confidence in the analysis. The answer addresses the question's multi-part structure (owned vs. leased, containers vs. chassis, 2022 vs. 2024) but with compromised accuracy on the foundational numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 436,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "\nBetween 2022 and 2023 Capital One’s securitized‑debt balance rose from about **$16.97 bn** (carrying value on 31 Dec 2022, page 211) to **$18.04 bn** (carrying value on 31 Dec 2023, page 210), an increase of roughly **$1.1 bn (≈6 %)**.  Even after the growth, securitized debt represented only **≈4–5 % of total funding** (≈$18 bn of the $354 bn of total funding sources reported for 2023), serving as a modest but strategic source of liquidity to fund its loan portfolios within the broader funding structure that remains dominated by deposits.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific numerical data and calculations that align well with the ground truth. Strengths: (1) Correctly identifies the carrying values of securitized debt obligations at $16.97 billion (2022) and $18.043 billion (2023), with proper citation to page numbers; (2) Accurately calculates the increase of approximately $1.1 billion and the 6% growth rate; (3) Provides contextual information about securitized debt representing 4-5% of total funding sources; (4) Correctly identifies securitized debt as a modest but strategic funding source within a deposit-dominated structure. Weaknesses: (1) The original answer emphasizes a qualitative shift in how securitized debt obligations were categorized (from explicit key funding source description to Level 2 fair value hierarchy classification), suggesting a change in valuation methodology and role characterization. The LLM answer focuses primarily on quantitative growth and percentage of total funding but does not address this important qualitative evolution in how the company characterized or valued these obligations; (2) The original answer's key insight about the shift toward 'more standardized valuation methods' and 'more structured and possibly less volatile role' is not captured in the LLM response; (3) The LLM answer is more quantitatively focused and less analytical about the strategic evolution implied by the reclassification. The numbers are accurate and the synthesis across 2022-2023 is sound, but the answer misses the nuanced shift in how Capital One positioned securitized debt within its funding strategy framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 442,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the way LLY accounted for Zyprexa revenue changed dramatically.  In 2023 the company recorded a one‑time gain of $79.4 million from the **sale of the olanzapine portfolio rights** (shown in the neuroscience line “Zyprexa (5)” on page 68); that gain was recognized as **collaboration and other revenue** when control of the intellectual‑property rights transferred to the buyer.  By 2024 there is no ongoing Zyprexa product sales—any remaining Zyprexa‑related amounts are immaterial and are now reported only within the broader “Other neuroscience” category, with revenue recognized only as part of the **performance‑obligation settlements** (e.g., royalties or milestone payments) rather than as regular product sales.  Consequently, the 2024 revenue from Zyprexa is essentially a residual, non‑product component derived from prior rights‑sale agreements, not a recurring product‑sale revenue stream.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core conceptual shift in how Zyprexa revenue was recognized between 2023 and 2024 (from product sales/rights sale to collaboration/performance obligations), which aligns with the ground truth. However, there are significant issues with quantitative accuracy and some overstatement of details not confirmed in the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the fundamental shift: 2023 involved sale of olanzapine portfolio rights, 2024 involved collaboration/other arrangements\n2. Correctly notes the change in revenue categorization from product sales to collaboration revenue\n3. Appropriately characterizes 2024 revenue as residual/non-product\n4. Correctly identifies that the 2023 transaction involved transfer of IP rights\n\nWEAKNESSES:\n1. QUANTITATIVE ERROR: The LLM cites a specific figure of \"$79.4 million\" gain from the olanzapine portfolio sale. The ground truth does not provide this specific number, and citing a precise figure without verification is problematic. This is a critical error for financial analysis.\n2. OVERSPECIFICATION: The LLM adds details about \"performance-obligation settlements (e.g., royalties or milestone payments)\" that are not explicitly confirmed in the ground truth. While plausible, these specifics go beyond what the ground truth states.\n3. INCOMPLETE SYNTHESIS: The ground truth states 2024 revenue was \"recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights\" - the LLM's characterization of this as \"performance-obligation settlements\" is an interpretation not directly supported.\n4. PAGE REFERENCE: The LLM references \"page 68\" and \"neuroscience line 'Zyprexa (5)'\" - these specific citations cannot be verified against the ground truth and may be hallucinated details.\n\nMULTI-HOP REASONING:\nThe multi-hop synthesis is sound in concept (connecting 2023 transaction to 2024 revenue recognition), but the addition of unverified quantitative details undermines confidence in the analysis.\n\nSEMANTIC EQUIVALENCE:\nThe core semantic meaning aligns with ground truth regarding the shift from product sales to collaboration revenue, but the specific dollar amount and detailed mechanism descriptions create factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 610,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "\nFrom the 2022 filing (pages 70‑74) the pension plan described U.S. Treasury and government‑sponsored‑enterprise securities as being valued by a bid‑evaluation process using independent pricing sources and placed them in **Level 2** of the fair‑value hierarchy. The 2024 filing (pages 57‑58) repeats the identical methodology—bid‑price valuation with independent pricing data—and still reports these securities under **Level 2**; the only evolution is the quantitative disclosure (the amount fell from $1.5 bn in 2023 to $1.45 bn in 2024), while the classification and valuation approach have remained unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM cites $1.5 billion in 2023 and $1.45 billion in 2024, but the ground truth states Federal Government Securities totaled $742 million in 2022. The LLM's figures are approximately 2x the ground truth amount and appear to be fabricated or from a different company/metric. The ground truth does not mention 2023 or 2024 amounts of $1.5bn or $1.45bn. (2) CLASSIFICATION DISCREPANCY - The ground truth explicitly states the 2022 classification was 'Significant Other Observable Inputs (Level 2)' while the LLM claims it was simply 'Level 2' without the full descriptor. While both refer to Level 2, the ground truth provides more specific terminology. (3) METHODOLOGY ACCURACY - The LLM correctly identifies the bid-evaluation process with independent pricing sources, which aligns with the ground truth. However, the LLM's claim that this methodology was described in 2022 cannot be verified against the ground truth provided. (4) EVOLUTION ASSESSMENT - The ground truth emphasizes that 2024 added 'specificity in methodology explanation' as the evolution, while the LLM claims the methodology was already described in 2022 and remained unchanged. This is a fundamental mischaracterization of what evolved. (5) MULTI-HOP REASONING - The LLM failed to correctly synthesize the information across years. The ground truth shows a clear evolution from 2022 to 2024 in how the methodology was explained/disclosed, not just a quantitative change. The LLM's answer contradicts the ground truth's core finding about the nature of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 438,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "\nFrom 2022 to 2023 Capital One moved from merely “occasionally” using borrower credit scores to drive product segmentation toward a more systematic, risk‑based application of those scores.  The 2023 disclosures show updated credit‑score distributions (e.g., a slight increase in the share of auto loans with scores ≤ 660) and explicitly tie score tiers to product design and pricing, indicating that credit‑score data had become a core input for segmenting offerings and refining the firm’s credit‑risk modeling strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to match the ground truth on key points: (1) QUANTITATIVE ERRORS: The LLM claims there was 'a slight increase in the share of auto loans with scores ≤ 660' but provides no specific numbers or data to support this claim. The ground truth references Table 21 with specific credit score distributions from 2020-2021 (2022 baseline) and 2022-2023 (2023 baseline), but the LLM provides no actual data points or percentages. (2) FACTUAL INACCURACY: The LLM's characterization of the evolution as moving from 'occasionally' using credit scores to 'systematic' use is not supported by the ground truth. The ground truth indicates Capital One was already using credit score data for product segmentation in 2022 (based on Table 21), not that they were only 'occasionally' using it. This represents a fundamental mischaracterization of the baseline state. (3) MISSING KEY INFORMATION: The LLM fails to reference Table 21, which is explicitly mentioned in the ground truth as the source of the credit score distribution data. The ground truth specifically notes the shift from 2020-2021 distributions to 2022-2023 distributions, but the LLM provides no such specific temporal reference. (4) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM attempts to connect credit score usage to risk modeling strategy, it does so without the specific data points that ground the analysis. The ground truth's conclusion about 'more current and dynamic' strategy is based on the actual data refresh (from 2020-2021 to 2022-2023), whereas the LLM's conclusion lacks this evidentiary foundation. (5) VAGUE CLAIMS: The LLM mentions 'updated credit-score distributions' and 'explicitly tie score tiers to product design and pricing' but provides no citations, table references, or specific evidence from the filings to support these claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 507,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "\nFrom 2022 to 2023 Amazon re‑cast AWS from a key component of its broader “technology and content” investment portfolio into a distinct, profit‑generating segment that sits at the core of the company’s overall strategy. 2023 disclosures emphasize continued heavy capital spending on AWS data‑center capacity and AI/ML services, and explicitly note that AWS now underpins other Amazon businesses—such as retail, advertising, and seller services—making it the primary engine for long‑term growth and sustainable free‑cash‑flow generation.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core transformation of AWS from 2022 to 2023—from a strategic investment area to a distinct business segment. It accurately captures that AWS evolved into a profit-generating segment and notes the emphasis on data-center capacity and AI/ML services. The answer correctly identifies AWS's role in supporting other Amazon businesses (retail, advertising, seller services). WEAKNESSES: (1) The LLM answer introduces claims not explicitly supported by the ground truth, specifically stating AWS is 'the primary engine for long-term growth and sustainable free-cash-flow generation'—while this may be true, the original answer does not make this claim and the LLM appears to be inferring beyond what the filing explicitly states. (2) The LLM answer emphasizes 'continued heavy capital spending' and 'profit-generating' aspects, but the ground truth focuses more on AWS's positioning as one of three core business segments and its service offerings (compute, storage, database, analytics, ML). (3) The LLM answer lacks the specific detail about AWS's service portfolio (compute, storage, database, analytics, machine learning) that the ground truth explicitly mentions. (4) The characterization of AWS as 'underpinning' other businesses is a reasonable inference but goes beyond what the ground truth explicitly states about AWS's role. MULTI-HOP REASONING: The LLM correctly synthesizes the 2022-to-2023 evolution and identifies the shift in strategic positioning. However, it adds interpretive layers (free-cash-flow generation, primary growth engine) that aren't grounded in the provided ground truth. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are provided in either answer, so this dimension is neutral. The years (2022, 2023) are correctly referenced. SEMANTIC EQUIVALENCE: While the LLM captures the essence of AWS's evolution, it reframes the narrative around profitability and cash flow generation rather than the ground truth's emphasis on structural repositioning and service offerings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 555,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "\nBetween 2022 and 2024 the nature of PMI’s link to Rothmans, Benson & Hedges Inc. shifted from a consolidated subsidiary (pre‑2019) to an equity investment that is now carried under the equity‑method/available‑for‑sale classification and subject to annual impairment testing.  In 2024 PMI recorded a **$2.3 billion non‑cash impairment charge** on that investment—reflecting uncertainty over the allocation of the proposed CAD 32.5 billion settlement in the CCAA proceedings and the lingering exposure to numerous Canadian tobacco class‑action and health‑cost recovery lawsuits.  No liability has been accrued, but the de‑consolidated status and the pending litigation create a contingent financial exposure that could materially affect PMI’s results if settlement amounts or judgments differ from current expectations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of PMI's relationship with RBH and includes the critical $2.3 billion impairment charge figure. STRENGTHS: (1) Correctly identifies the shift from consolidated subsidiary to equity investment model; (2) Accurately states the $2.3 billion impairment charge (formatted as $2.3B vs ground truth's $2,316M - acceptable format variation); (3) Correctly references the CAD 32.5 billion proposed settlement; (4) Properly notes the deconsolidated status and contingent exposure; (5) Appropriately emphasizes the non-cash nature of the impairment. WEAKNESSES: (1) The LLM states the shift occurred 'from a consolidated subsidiary (pre-2019)' but the ground truth specifically indicates deconsolidation occurred in 2022 due to CCAA restructuring - this is a temporal inaccuracy that conflates different periods; (2) Missing the specific detail about the comprehensive stay of Canadian tobacco litigation until March 31, 2022, and the absence of loss accruals in 2022 due to inability to estimate losses; (3) The characterization of the investment as 'equity-method/available-for-sale classification' is somewhat vague compared to ground truth's clearer statement of 'equity investment model'; (4) Does not explicitly state that in 2022 RBH was deconsolidated and financial results were no longer included in consolidated financials - this is an important accounting treatment detail. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022-2024 and connects the CCAA proceedings, litigation exposure, and impairment charge. However, it conflates the pre-2019 consolidation period with the 2022 deconsolidation event. QUANTITATIVE VERIFICATION: The $2.3 billion figure is correct (ground truth states $2,316 million; $2.3B is acceptable rounding). The CAD 32.5 billion settlement figure is correct. No calculation errors detected. The answer is substantially correct on the main financial metrics but has a notable temporal/historical accuracy issue regarding when the deconsolidation occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 551,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Biktarvy’s contribution to GILD’s top line slipped from its position as the single largest HIV driver (≈ $8–9 bn of HIV sales in 2022) to a more modest, plateau‑bound share as generic TAF alternatives and newer long‑acting regimens captured market share; this erosion is reflected in the 10‑K risk disclosures, which now flag heightened pricing pressure from Medicare‑Part D rebate reforms and the Inflation‑Reduction Act, as well as the risk that a shift away from TAF‑based regimens could sharply reduce sales. Consequently, while Biktarvy remains a key product, its revenue weight and growth prospects have declined, and its commercial risk has intensified.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative of Biktarvy's evolution from 2022-2024, capturing the key themes of declining market share, competitive pressures from generics and newer regimens, and heightened commercial risks. The qualitative assessment of risk factors (Medicare Part D rebates, Inflation Reduction Act, TAF-based therapy shifts) demonstrates sound multi-hop reasoning and appropriate synthesis of risk disclosure information. The answer appropriately addresses both revenue contribution and product risks as requested.\n\nWEAKNESSES: (1) QUANTITATIVE INACCURACY: The LLM states Biktarvy generated \"≈ $8–9 bn of HIV sales in 2022\" but the ground truth specifies $8,624 million ($8.624 billion) in total product sales globally for Biktarvy specifically in 2022. The LLM's range is approximately correct but imprecise. More critically, the LLM claims Biktarvy's \"revenue weight and growth prospects have declined\" from 2022 to 2024, but the ground truth explicitly states \"specific revenue figures are not provided\" for 2024. This represents a factual overreach—the LLM is making a claim about 2024 revenue decline that cannot be verified from the provided ground truth. (2) UNSUPPORTED CLAIMS: The LLM introduces specific regulatory pressures (Medicare Part D rebate reforms, Inflation Reduction Act) that are not mentioned in the ground truth answer. While these may be accurate from the actual 10-K filings, they go beyond what the ground truth explicitly confirms. (3) MISSING NUANCE: The ground truth emphasizes that 2024 risk disclosures \"highlight Biktarvy's ongoing importance\" alongside heightened risks, whereas the LLM's framing of \"more modest, plateau-bound share\" and \"declined\" revenue weight suggests a more definitive decline than the ground truth supports given the lack of 2024 revenue data.\n\nMULTI-HOP REASONING: The LLM demonstrates competent synthesis across time periods and across revenue/risk dimensions, correctly linking competitive dynamics to risk factors. However, the reasoning includes inferences not grounded in the provided ground truth.\n\nOVERALL ASSESSMENT: The answer captures the directional narrative correctly but overstates the certainty of 2024 revenue decline and introduces specific regulatory details not confirmed in the ground truth. The quantitative reference to 2022 revenue is approximately correct but imprecise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 642,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "\nUnion Pacific’s equity investment in TTX has risen modestly—​the balance reported under “Investments‑TTX” grew from about **$1.6 billion (as of 2021)** to roughly **$1.9 billion (as of 2024)**, with the ownership share edging up from roughly **36.8 % to 37 %** over the same period.  At the same time, the amount it pays TTX for rail‑car rentals (car‑hire expense) has been increasing, climbing from **≈ $402 million in 2022** to **≈ $432 million in 2024**, reflecting higher utilization or higher rates despite the overall investment level remaining relatively stable.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key metrics (TTX investment and car hire expenses), correctly states the 2024 investment value ($1.9 billion), and provides relevant context about ownership percentage changes. The answer appropriately addresses both components of the question (investment value and car hire expenses) and synthesizes information across multiple years. The reasoning about growing financial involvement is sound.\n\nCRITICAL ERRORS: (1) Car hire expense baseline is WRONG - LLM states \"≈ $402 million in 2022\" but ground truth shows $375 million in 2021 (the baseline year referenced). The LLM appears to have used 2022 as the starting point instead of 2021, which is inconsistent with the ground truth's 2021-2024 comparison framework. (2) The LLM does not explicitly state the 2021 car hire expense ($375 million) which is the baseline in the ground truth answer.\n\nNUMBER VERIFICATION: Investment values are correct ($1.6B to $1.9B). However, the car hire expense trajectory is problematic: Ground truth shows $375M (2021) → $432M (2024), a $57M increase. LLM shows $402M (2022) → $432M (2024), a $30M increase. This represents a different baseline and incomplete period coverage. The ownership percentage addition (36.8% to 37%) is reasonable context but not in the original answer.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across years and connects investment value to operational expenses, showing understanding of the relationship. However, the inconsistent baseline year for car hire expenses undermines the accuracy of the comparative analysis.\n\nSEMANTIC ISSUES: The phrase \"investment level remaining relatively stable\" contradicts the $300M increase in TTX investment value, creating internal inconsistency in the answer's narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 490,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla moved from a broad, ad‑hoc training mention to a concrete installer‑development program—formal onboarding, partnerships with home‑builders and the hiring of additional skilled electricians—to speed Solar Roof deployments.  At the same time, it shifted its supply‑chain strategy, emphasizing localized procurement, diversified sourcing and in‑house battery‑cell production to reduce the component‑shortage risks that had limited Solar Roof scaling in 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces claims NOT supported by the ground truth, specifically mentioning 'localized procurement, diversified sourcing and in-house battery-cell production' - these supply chain strategies are not mentioned in the original answer and appear to be fabricated details. (2) The LLM reverses the temporal direction of the shift: it claims Tesla moved FROM 'broad, ad-hoc training' TO 'concrete installer-development program' in 2023, but the ground truth indicates the opposite - 2022 emphasized installer training/onboarding, while 2023 shifted AWAY from installer-focused growth toward supply chain resilience. (3) The LLM correctly identifies the 2022 focus on installer training, onboarding, partnerships, and hiring skilled electricians, which aligns with ground truth. (4) The LLM correctly identifies a shift toward supply chain risk management in 2023, though it mischaracterizes the specific strategies. (5) QUANTITATIVE ACCURACY is rated 8 because there are no specific numbers to verify, and the dates (2022/2023) are correct. (6) QUALITATIVE ACCURACY is rated 3 because the fundamental reasoning about the direction of change is inverted, and unsupported claims about specific supply chain strategies are introduced. (7) The answer partially addresses the question's two main components (installer training and supply chain risk management) but gets the evolution of these strategies backwards and adds unverified details. The core insight about shifting from installer-focused to supply chain-focused strategy is present but inverted in temporal direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 440,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "\nBetween 2022 and 2023 the way Coca‑Cola supplies fountain syrups to U.S. retailers was unchanged – the company continues to manufacture the syrups and sells them to fountain retailers either directly or through authorized fountain‑wholesalers (and, where permitted, to bottling partners), while U.S. bottlers remain barred from producing the syrups themselves. This long‑standing distribution model is highlighted in both the 2022 and 2023 filings as the channel through which the company’s concentrate operations generate revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The LLM states that 'the way Coca‑Cola supplies fountain syrups to U.S. retailers was unchanged' between 2022 and 2023, claiming the distribution model remained consistent. However, the ground truth explicitly indicates an evolution: in 2022, the Company sold fountain syrups to 'authorized fountain wholesalers (including some bottlers)' but by 2023, it 'explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners.' The key difference is that 2023 shows a more explicit acknowledgment of a tiered distribution model involving bottling partners, suggesting potential expansion or clarification of roles. The LLM's characterization of this as 'unchanged' and 'long‑standing' fundamentally misses the evolution that the question asks about. The LLM correctly identifies that: (1) Coca-Cola manufactures fountain syrups, (2) U.S. bottlers are not authorized to manufacture them, (3) distribution occurs through wholesalers and retailers, and (4) this applies to both 2022 and 2023. However, it fails to capture the nuanced change in how the relationship was characterized or structured between the two years. The answer lacks the critical insight that 2023 represents a clarification or expansion of the distribution network through bottling partners. No numeric errors are present, but the semantic interpretation of 'evolution' versus 'unchanged' is fundamentally incorrect, making this a significant qualitative failure despite accurate identification of the basic facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 445,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "\nFrom 2022 through 2024 IBM has consistently presented the 0.950 % Notes due 2025 as senior unsecured debt securities registered under the Securities Act (ticker IBM25B on the NYSE). The 2024 filing adds a dedicated line for “0.950% Notes due 2025” in the table of registered securities and expands the discussion of these notes in the financing and risk‑factor sections, but the classification and registration details remain unchanged from the 2022 filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in critical ways: (1) MAJOR ERROR - The LLM claims the notes were 'consistently presented...as senior unsecured debt securities registered under the Securities Act' from 2022-2024 with 'unchanged' classification and registration details. However, the ground truth explicitly states an EVOLUTION: in 2022 they were disclosed as exhibits in Form 8-K filings (Exhibit 4.1 from May 22, 2017), but by 2024 they were 'actively listed as a financial instrument with trading symbol IBM25B on the NYSE.' This represents a shift from disclosure to formal registration/listing - the opposite of 'unchanged.' (2) The LLM incorrectly characterizes the 2022 status as already being 'registered under the Securities Act' when the ground truth indicates they were merely disclosed in exhibits. (3) The LLM's claim about a '2024 filing adds a dedicated line' and 'expands discussion' appears to be fabricated detail not supported by the ground truth. (4) The core multi-hop reasoning is flawed - the LLM failed to identify the key evolution from 2022 to 2024 that the question specifically asks about. The ticker symbol IBM25B is correctly mentioned, but the context of its introduction/listing status is misrepresented. (5) The answer demonstrates a fundamental misunderstanding of the distinction between disclosure in exhibits versus formal registration and trading listing. The ground truth clearly indicates evolution/change; the LLM incorrectly asserts consistency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 423,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead has moved Biktarvy from a pure “cash‑cow” single‑tablet HIV regimen to a strategic differentiator that it leans on to preserve market share amid generic encroachment and tightening payer‑price controls; the company now markets it as the preferred, once‑daily, high‑barrier‑to‑resistance option with a renal‑friendly TAF backbone, while simultaneously exposing itself to greater financial risk from Medicare‑price‑negotiation and rebate pressures that could compress the pricing premium it has historically enjoyed.  Consequently, Biktarvy’s competitive edge rests on its superior efficacy and safety profile, but its revenue growth is increasingly vulnerable to the same reimbursement and generic‑competition forces that the 2022‑2024 filings flag as material risks.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and speculative elements that diverge from the ground truth in important ways.\n\nCORRECT ELEMENTS:\n- Correctly identifies Biktarvy as a key HIV product for Gilead across 2022-2024\n- Accurately notes TAF backbone and once-daily dosing as product features\n- Correctly identifies generic competition and payer pressure as material risks\n- Appropriately references Medicare price negotiation concerns\n- Correctly synthesizes the evolution from 2022 to 2024 timeframe\n\nINCORRECT/SPECULATIVE ELEMENTS:\n- Characterizes Biktarvy as moving from \"cash-cow\" to \"strategic differentiator\" - this framing is not supported by the ground truth, which indicates it was already a key marketed product in 2022\n- Introduces specific language about \"high-barrier-to-resistance\" and \"renal-friendly\" positioning that, while potentially accurate product features, are not explicitly confirmed in the ground truth\n- Overstates the shift in positioning - ground truth indicates Biktarvy was already central to HIV portfolio in 2022, not that it transitioned from a different role\n- The phrase \"pure cash-cow single-tablet regimen\" mischaracterizes the 2022 positioning\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across the 2022-2024 period and identifies the key tension between competitive differentiation and financial risk exposure. However, it adds interpretive layers (\"cash-cow\" characterization, specific marketing positioning details) that go beyond what the ground truth supports.\n\nKEY DISCREPANCY:\nGround truth emphasizes GROWING CONCERN about Biktarvy's long-term viability due to paradigm shifts away from TAF-based regimens. The LLM answer focuses more on current competitive positioning and pricing pressures, which are related but represent a different emphasis. The ground truth suggests more fundamental strategic vulnerability, while the LLM suggests tactical market defense.\n\nQUANTITATIVE ACCURACY: No specific numbers provided in either answer, so this dimension is neutral (7/10 for not introducing false metrics).\n\nQUALITATIVE ACCURACY: The reasoning is logical but makes unsupported inferences about positioning strategy that exceed the ground truth's scope (4/10).\n\nCONTEXTUAL RELEVANCE: Addresses the question's core elements but with interpretive additions not grounded in the source material (6/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 641,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Lockheed Martin did not change the structure of its defined‑contribution (DC) savings plan – the DC plan remained frozen for new salaried hires and was still administered as the enhanced retirement vehicle for employees previously moved out of the qualified defined‑benefit (DB) pension. Instead, the company accelerated its “pension‑obligation‑transfer” strategy: in the second quarter of 2022 it bought group‑annuity contracts that transferred about $4.3 bn of DB liabilities, which required a non‑cash settlement charge of roughly $1.5 bn recorded in 2022, and in the fourth quarter of 2023 it offered a voluntary lump‑sum settlement that eliminated about $0.414 bn of obligations and reduced accumulated other‑comprehensive‑loss, but did not generate a new settlement charge. These transfers lowered the net DB liability and AOCL on the balance sheet while leaving the DC plan’s funding and benefits unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: All key financial numbers are accurate - $4.3 billion pension obligation transfer in 2022, $1.5 billion noncash settlement charge in 2022, and $414 million (stated as $0.414 bn) settlement payments in 2023 are all correct. The timing details (Q2 2022 for annuity contracts, Q4 2023 for lump-sum settlement) are accurate. The multi-hop synthesis correctly identifies the strategic shift from large-scale annuity purchases to direct participant settlements. WEAKNESSES: (1) The LLM answer conflates defined-contribution (DC) plan evolution with defined-benefit (DB) pension obligation transfers. The question asks about 'defined contribution retirement savings plans' but the ground truth focuses on DB pension obligations and transfers. The LLM discusses DC plan structure (frozen for new hires, enhanced retirement vehicle) which is not mentioned in the ground truth and may be tangential to the core question. (2) The LLM provides additional context about AOCL (accumulated other comprehensive loss) reduction and balance sheet impacts that, while potentially accurate, are not in the ground truth and represent scope creep beyond what was asked. (3) The LLM states the 2023 settlement 'did not generate a new settlement charge' - the ground truth doesn't explicitly confirm this absence, though it's a reasonable inference. (4) The characterization of the DC plan as 'unchanged' may be misleading since the question specifically asks how the approach 'evolved.' CALCULATION VERIFICATION: All numbers check out ($4.3B = $4.3 billion, $1.5B = $1.5 billion, $414M = $0.414B). The core strategic shift is correctly identified. However, the answer somewhat misinterprets the question's focus on DC plans versus the actual DB pension obligation transfer strategy that evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 484,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "\nBetween 2022 and 2024 the only 2025‑maturing debt that IBM continued to list was the **2.875 % Notes due 2025 (IBM 25A)**; it remained on the company’s balance sheet in both filings.  However, the overall 2025 cohort shifted – IBM added newer 2025 issues (e.g., the 0.950 % and 0.875 % Notes due 2025 and a 7 % Debenture due 2025) and retired or rolled‑over some earlier tranches, so the **relative weight of the 2.875 % Notes within the total 2025 maturity bucket declined slightly**, even though the absolute amount of that specific issue was unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual inversion that contradicts the ground truth. According to the original answer, in 2022 IBM listed the 2.875% Notes due 2025 ALONG WITH the 0.950% and 0.875% Notes due 2025. By 2024, the 0.875% Notes were NO LONGER listed, while the 2.875% Notes remained. The LLM incorrectly states that 'the only 2025-maturing debt that IBM continued to list was the 2.875% Notes due 2025' and that 'IBM added newer 2025 issues (e.g., the 0.950% and 0.875% Notes due 2025)' - this reverses the timeline. The 0.950% and 0.875% Notes were present in 2022, not added later. The LLM also introduces a '7% Debenture due 2025' that is not mentioned in the ground truth, suggesting potential hallucination. While the LLM correctly identifies that the 2.875% Notes remained constant and that relative weight declined, the core narrative about which instruments were added vs. retired is backwards. The claim about 'absolute amount of that specific issue was unchanged' cannot be verified from the ground truth provided. The answer demonstrates partial understanding of debt composition changes but fundamentally misrepresents the chronological evolution of IBM's 2025 debt instruments between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 353,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "\nFrom 2022 through 2024 Biktarvy moved from being the chief growth driver of Gilead’s HIV franchise—benefiting from the post‑exclusivity slump of Truvada/Atripla and delivering higher net prices—to a product whose strategic centrality is now being tested by new treatment paradigms (long‑acting injectables and capsid‑inhibitors) and by aggressive price‑containment measures such as the IRA’s Medicare price‑negotiation and rising generic competition. As a result, its risk profile has shifted from modest revenue‑growth risk to heightened exposure to pricing erosion, reimbursement pressure and the possibility of losing market share to newer HIV regimens.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Biktarvy's strategic positioning from 2022 to 2024, capturing the shift from growth driver to vulnerable asset. It appropriately synthesizes multiple risk factors (new treatment paradigms like long-acting injectables and capsid inhibitors, IRA Medicare price negotiation, generic competition) and demonstrates sound multi-hop reasoning across the time period. The semantic understanding of the paradigm shift and risk profile evolution is accurate and well-articulated.\n\nWEAKNESSES: (1) QUANTITATIVE ERRORS: The LLM cites an '11% revenue increase' attributed to Biktarvy in 2022, but the ground truth states this was Gilead's overall revenue increase, not specifically Biktarvy's growth rate. This is a factual misattribution. (2) UNSUPPORTED CLAIMS: The LLM introduces specific details not present in the ground truth, including 'post-exclusivity slump of Truvada/Atripla,' 'higher net prices,' and 'aggressive price-containment measures' - while these may be contextually reasonable, they exceed what the ground truth explicitly supports. (3) MISSING GROUND TRUTH ELEMENTS: The LLM does not explicitly reference the key 2024 risk disclosure about 'many of our HIV products contain TAF' and the vulnerability to 'shift away from nucleoside-based therapies,' which are central to the ground truth's risk assessment. (4) SPECIFICITY ISSUE: The ground truth emphasizes the 'material impact' risk from paradigm shifts, while the LLM frames this more broadly without the same emphasis on materiality.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022-2024 and connects competitive/regulatory factors to strategic positioning. However, the reasoning relies partly on inferences not explicitly grounded in the provided ground truth.\n\nOVERALL: The answer demonstrates good qualitative understanding of the strategic evolution but contains quantitative inaccuracies and introduces unsupported details that reduce confidence in factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 549,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "\nThe U.S. litigation escrow account balance rose from **$1.449 billion at the end of fiscal 2022** to **$1.764 billion at the end of fiscal 2023**.  During fiscal 2022 the Company deposited **$850 million** into the escrow, and in fiscal 2023 it added **$1.0 billion** (the $1.0 billion deposit is shown in the “Deposits into the U.S. litigation escrow account” line of the table for the year ended September 30 2023).  These deposits, together with subsequent payments to opt‑out merchants, produced the $0.315 billion net increase in the escrow balance over the two years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) BALANCE FIGURES - LLM states the balance rose from $1.449 billion (FY2022) to $1.764 billion (FY2023), but ground truth shows it increased from $1,449 million to $3,089 million. This is a massive discrepancy - the LLM's FY2023 figure of $1.764 billion is less than half the actual $3.089 billion. (2) DEPOSIT CONTRIBUTIONS - LLM claims $850 million was deposited in FY2022 and $1.0 billion in FY2023, but ground truth shows $1,000 million in FY2022 and $1,500 million in FY2023. Both deposit figures are incorrect. (3) CALCULATION ERROR - LLM states a '$0.315 billion net increase over the two years,' which is mathematically inconsistent with its own stated figures ($1.764B - $1.449B = $0.315B), yet this calculation is also wrong relative to the actual data (should be $3.089B - $1.449B = $1.640B). (4) MULTI-HOP SYNTHESIS - While the LLM attempts to synthesize balance changes with deposit contributions, the underlying numbers are all incorrect, making the synthesis fundamentally flawed. The answer does address the question structure (balance evolution and deposit contributions), but with completely inaccurate data. The ground truth shows a much more significant increase in the escrow account balance than the LLM reported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 374,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "\nBetween 2022 and 2023 Coca‑Cola’s handling of fountain syrups in North America did not shift dramatically, but the company’s language clarified the scope of its responsibilities. In both years the company continues to **manufacture fountain syrups in the United States and sell them to fountain retailers (or to authorized fountain wholesalers/bottling partners)**, with those partners then distributing the syrups to the retail outlets that use them. The 2023 disclosures simply reiterated that these syrup sales are reported within the **North America operating segment**, emphasizing that the company’s manufacturing role remains unchanged while the downstream distribution continues to be performed by its bottling partners and wholesalers.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Coca-Cola manufactures fountain syrups in the United States and sells them to fountain retailers, wholesalers, and bottling partners in both 2022 and 2023. The factual statements about manufacturing continuity and distribution through partners are accurate. However, the answer has significant limitations in addressing the full scope of the original question: (1) The LLM answer fails to capture the key evolution mentioned in the ground truth - that by 2023, Coca-Cola's disclosures indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This represents an important shift in the company's approach to manufacturing responsibilities, particularly the authorization-based model outside the U.S. (2) The LLM answer states there is 'no dramatic shift' and emphasizes 'operational continuity,' which misses the nuanced evolution that the ground truth identifies regarding the decentralized, authorization-based model. (3) The answer focuses primarily on U.S. operations and downstream distribution but does not adequately address the geographic distinction (U.S. vs. outside U.S.) that is central to understanding how the role evolved. (4) The LLM answer correctly notes that manufacturing responsibilities within North America itself remained unchanged, which aligns with the ground truth, but this is presented as the main finding rather than as one part of a more complex evolution. The answer demonstrates partial understanding of the question but lacks the depth and nuance required to fully address how the role 'evolved' between the two years, particularly regarding the authorization-based manufacturing model outside the U.S.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 475,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "\nBetween 2022 and 2024 the only debt series that mature in 2025 shown in IBM’s SEC filings are the **2.875 % Notes due 2025 (IBM 25A)** and the **0.950 % Notes due 2025 (IBM 25B)**. The 2024 filing reproduces exactly the same two 2025‑maturing series, indicating that the 0.950 % Notes remained outstanding and unchanged in identity; no new 2025‑maturing issuances were added, so the composition of IBM’s 2025 debt stayed the same, with the 0.950 % tranche coexisting alongside the larger‑coupon 2.875 % tranche.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The original answer clearly states that in 2022, IBM had THREE sets of notes maturing in 2025 (2.875%, 0.950%, and 0.875%), and by 2024, only TWO remained (2.875% and 0.950%), with the 0.875% Notes being removed. This represents a significant compositional change. However, the LLM answer claims that 'Between 2022 and 2024 the only debt series that mature in 2025 shown in IBM's SEC filings are the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B)' and that 'the composition of IBM's 2025 debt stayed the same.' This is factually incorrect. The LLM failed to identify that the 0.875% Notes due 2025 existed in 2022 but were absent by 2024. The LLM also incorrectly concludes that 'no new 2025-maturing issuances were added, so the composition of IBM's 2025 debt stayed the same,' when in fact the composition changed due to the removal of the 0.875% instrument. The question specifically asks about how the composition 'evolved' between 2022 and 2024, and the correct answer is that it evolved by losing one debt instrument. The LLM's statement that the composition 'stayed the same' is the opposite of the correct answer. While the LLM correctly identifies the 2.875% and 0.950% notes, it fundamentally misses the key evolution in the debt composition and provides an incorrect conclusion about the stability of the debt structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 401,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 Disney shifted from a single‑destination focus—announcing the 2024 opening of a private Disney Cruise Line port at Lighthouse Point on Eleuthera—to a broader fleet‑expansion strategy.  In its 2024 filing the company disclosed plans to “expand the fleet of cruise ships” and to treat cruise operations as part of its growing Experiences segment, tying the initiative to overall cost‑realignment, DTC‑related investments and a push for higher‑margin, out‑of‑home entertainment experiences.  Thus, the cruise‑ship strategy evolved from a one‑off destination project to an integrated, growth‑oriented expansion of the cruise fleet and related guest‑experience offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Disney's cruise strategy from 2022 to 2024 and correctly identifies key elements like the shift toward fleet expansion and integration with the Experiences segment. However, there are significant issues with factual accuracy and specificity:\n\n(1) CORRECT ELEMENTS:\n- Correctly identifies the shift from 2022 to 2024\n- Accurately mentions plans to 'expand the fleet of cruise ships' in 2024\n- Correctly ties cruise operations to the Experiences segment\n- Appropriately characterizes the evolution as moving toward growth-oriented expansion\n- Correctly identifies the strategic focus on higher-margin, out-of-home entertainment\n\n(2) PROBLEMATIC ELEMENTS:\n- The LLM introduces specific details about 'Lighthouse Point on Eleuthera' as a 'private Disney Cruise Line port' with a '2024 opening' that are NOT present in the ground truth answer. This appears to be hallucinated or from external knowledge not verified against the 10-K filings\n- The characterization of the 2022 approach as a 'single-destination focus' is not supported by the ground truth, which describes it more generally as dependence on consumer demand\n- The LLM frames the evolution as moving from 'one-off destination project' to fleet expansion, but the ground truth describes it as moving from general dependence on consumer demand to active investment strategy\n\n(3) MULTI-HOP REASONING:\n- The LLM correctly synthesizes information about the 2024 strategy (fleet expansion + Experiences segment integration)\n- However, the comparison to 2022 is less accurate - the ground truth emphasizes a shift from passive dependence to active investment, while the LLM emphasizes a shift from single-destination to multi-destination\n- The connection to cost-realignment and DTC investments is mentioned but not clearly sourced to the ground truth\n\n(4) QUANTITATIVE ACCURACY:\n- No specific numbers, dates, or financial metrics are provided in either answer, so this is less critical\n- However, the specific claim about 'Lighthouse Point on Eleuthera' with '2024 opening' introduces unverified specificity that may be factually incorrect\n\nThe answer demonstrates reasonable understanding of the general strategic shift but introduces unsupported specific details and mischaracterizes the 2022 baseline, reducing overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 627,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 Lockheed Martin kept the same core tactic—periodically moving defined‑benefit obligations into group‑annuity contracts—but it shifted from the one‑off $4.9 bn GAC purchase that generated a $1.7 bn non‑cash settlement charge in 2021 to a more cautious stance that emphasizes future risk‑transfer transactions could again produce material non‑cash charges and that the company will make no additional cash contributions to its pension plans, relying instead on CAS pension‑cost recoveries to offset expense.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and introduces unsupported claims. CORRECT ELEMENTS: (1) The $4.9 billion GAC transaction from 2021 and $1.7 billion noncash settlement charge are accurately cited. (2) The core tactic of using group annuity contracts is correctly identified. (3) The shift toward a more cautious stance between 2022-2023 is directionally correct. SIGNIFICANT OMISSIONS: (1) The answer completely fails to mention the ~$11.6 billion in total pension obligations transferred since December 2018, which is a key metric in the ground truth. (2) The answer omits the 95,000 retirees affected, an important contextual detail. (3) The answer does not address the 2023 introduction of residual liability exposure risk (insurer default scenarios), which represents a critical evolution in how the company framed pension risk. UNSUPPORTED/PROBLEMATIC CLAIMS: (1) The statement about 'no additional cash contributions to its pension plans' and reliance on 'CAS pension-cost recoveries' is not mentioned in the ground truth and appears to be introduced without evidence. (2) The framing about 'one-off' transaction is misleading—the ground truth indicates ongoing strategic intent to continue evaluating transactions, not a shift away from them. MULTI-HOP REASONING: The answer fails to synthesize the full evolution narrative. It captures the 2021 transaction details but doesn't adequately explain how the 2023 filing introduced new risk considerations (insurer default liability) that weren't emphasized in 2022. The answer also misses the strategic continuity—the company continued to pursue these transactions while becoming more transparent about residual risks. QUANTITATIVE ACCURACY: While the $4.9B and $1.7B figures are correct, the omission of $11.6B and 95,000 retirees represents incomplete quantitative reporting. The answer's claim about 'no additional cash contributions' lacks numerical support from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 533,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "\nTesla’s 2022 filing quantified the size of its receivables from financing partners and disclosed allowances for doubtful accounts (e.g., $627 million of long‑term rebates and a $41 million reserve on MyPower notes), whereas the 2023 filing shifts the focus to the risks embedded in those relationships—explicitly warning that partner funding shortfalls or a rise in customer defaults could produce material credit losses and erode the profitability of its direct leasing program. This reflects a move from simply reporting balances to a more proactive, risk‑focused approach to accounts‑receivable management and leasing‑program oversight.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the directional shift in Tesla's disclosure approach from 2022 to 2023—moving from operational cash flow timing concerns to broader risk management. The semantic understanding of the evolution is sound, and the answer appropriately addresses the multi-hop nature of comparing two years. The qualitative characterization of the shift (from 'reporting balances' to 'risk-focused approach') aligns with the ground truth's core insight.\n\nCRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS: The LLM introduces specific dollar amounts ($627 million for long-term rebates and $41 million reserve on MyPower notes) that are NOT present in the ground truth answer. These numbers appear to be fabricated or from unverified sources. The ground truth specifically mentions 'approximately two weeks' for settlement timing in 2022, which the LLM completely omits. (2) MISSING KEY DETAILS: The LLM fails to mention the critical 'two weeks to settle' detail from 2022, which is explicitly highlighted in the ground truth as directly impacting short-term liquidity and balance sheet fluctuations. (3) INCOMPLETE SYNTHESIS: While the LLM mentions 'residual value risks' implicitly through 'erode the profitability of its direct leasing program,' it doesn't explicitly state the residual value risk concern that appears in the ground truth. (4) UNVERIFIED SPECIFICITY: The introduction of specific dollar amounts without ground truth support is problematic—this suggests either hallucination or reliance on unverified data.\n\nMULTI-HOP REASONING: The answer demonstrates adequate multi-hop reasoning by comparing 2022 and 2023 disclosures and synthesizing the evolution. However, the reasoning is undermined by the introduction of unverified numbers.\n\nOVERALL ASSESSMENT: The answer captures the directional shift correctly but fails on factual precision by introducing numbers not in the ground truth and omitting key operational details (two-week settlement timing). The qualitative analysis is sound but incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 550,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "\nBetween 2022 and 2023 Coca‑Cola refined its U.S. fountain‑syrup channel: in 2022 the Company sold syrup to authorized fountain wholesalers (and, where allowed, to bottling partners who then resold to retailers), while bottlers were generally barred from manufacturing the syrup; by 2023 the Company continued to sell directly to those same wholesalers and, where permitted, to fountain retailers, and it further limited bottlers’ involvement to concentrate supply only. Consequently, bottlers’ role in fountain‑syrup distribution receded, and fountain wholesalers assumed the primary responsibility for delivering syrup to restaurants and other end‑users. (See KO_10K‑2022 pp. 6‑7 and KO_10K‑2023 pp. 37‑38.)",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE FACTS: The LLM answer fundamentally contradicts the ground truth on the key strategic shift. Ground truth states that by 2023, bottlers OUTSIDE THE UNITED STATES were authorized to manufacture fountain syrups (representing an EXPANSION of bottler roles internationally). The LLM answer incorrectly claims the opposite - that bottlers' involvement was 'further limited' and their role 'receded' by 2023, with bottlers limited to 'concentrate supply only.' This is a major factual error that inverts the actual strategic evolution. The ground truth emphasizes a shift from centralized to integrated distribution with bottlers playing MORE active roles in international markets. The LLM answer describes a contraction of bottler roles, which is the opposite of what occurred. Additionally, the LLM answer focuses primarily on U.S. strategy and does not adequately address the international dimension that is central to the ground truth answer. The LLM correctly identifies that fountain wholesalers remained key distribution partners and that the 2022-2023 period involved strategic changes, but mischaracterizes the nature and direction of those changes. The answer also lacks clarity on the geographic distinction (U.S. vs. outside U.S.) that is crucial to understanding the actual evolution. While the answer demonstrates some understanding of the fountain syrup distribution channel structure, it fundamentally misrepresents how bottler roles evolved, making this response substantially incorrect despite some accurate contextual elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 430,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "\nBetween 2023 and 2024 AMD deepened its financial ties with the ATMP joint venture.  It added $17 million of equity capital, pushing the investment’s carrying value up from roughly $99 million (end‑2023) to about $149 million (end‑2024), and it entered a one‑year, $100 million term loan to the JV—recorded as a receivable—while payables to the JV rose to $476 million and receivables increased to $12 million.  These moves reflect a substantially larger equity stake, higher transaction volumes and new lending activity compared with the 2023 relationship.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CORRECT ELEMENTS: (1) The $100 million one-year term loan is correctly identified, (2) The $12 million receivables figure for 2024 is correct, (3) The general characterization of deepened financial ties is appropriate. MAJOR ERRORS: (1) The LLM claims AMD added $17 million of equity capital and that the carrying value increased from ~$99M to ~$149M - this information is NOT mentioned in the ground truth and appears to be fabricated or confused with other data, (2) The LLM states payables to the JV rose to $476 million - this figure is not mentioned in the ground truth at all and appears to be introduced without basis, (3) The LLM mentions the $9 million receivables from 2023 implicitly but doesn't explicitly state this comparison. MULTI-HOP REASONING: The LLM attempts to synthesize information across years but introduces unsupported data points that contradict the ground truth's focus on receivables ($9M→$12M) and the new $100M loan. The ground truth explicitly states 'there was no mention of any direct investment or loan made by AMD to the JV' in 2023, yet the LLM adds equity investment details not in the source material. CALCULATION ISSUES: The claimed increase from $99M to $149M carrying value (a $50M increase) doesn't align with the stated $17M equity addition, suggesting either calculation errors or fabricated numbers. The introduction of $476M in payables is completely unsupported and represents a major factual error. The answer demonstrates partial understanding of the relationship evolution but significantly overstates AMD's financial involvement with invented figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 468,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "\nBetween 2022 and 2023 Lockheed Martin moved from a single, large‑scale bulk‑transfer of qualified pension liabilities—​the second‑quarter‑2022 purchase of group‑annuity contracts that shifted about $4.3 billion of gross defined‑benefit obligations and generated a one‑time, non‑cash settlement charge of roughly $1.5 billion in 2022​—to a much smaller, targeted voluntary lump‑sum settlement in 2023.  In the fourth quarter of 2023 the company offered a voluntary exit to former employees who had not yet begun receiving benefits, resulting in $414 million of settlement payments that reduced the plan’s benefit obligation and the accumulated‑other‑comprehensive‑loss balance, but because the payment was accounted for as a simple reduction of the liability it did **not** trigger a new settlement charge or earnings impact.  Thus, the evolution reflects a shift from outsourcing a broad swath of qualified pension obligations in 2022 to a more incremental, cash‑based settlement approach in 2023, with the financial effect being a modest reduction in the unfunded status and AOCL rather than a fresh non‑cash expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness. All key quantitative facts are correct: (1) 2022 group annuity contract purchase of $4.3 billion in gross defined benefit pension obligations - verified; (2) 2022 noncash pension settlement charge of $1.5 billion - verified; (3) 2023 voluntary settlement payments of $414 million to approximately 6,500 former employees - verified. The temporal sequencing is accurate (Q2 2022 for bulk transfer, Q4 2023 for targeted settlement). The LLM correctly synthesizes the multi-hop information by comparing the two years and identifying the strategic evolution from large-scale bulk transfers to targeted, incremental settlements. The answer goes beyond the ground truth by providing additional valuable context: (1) clarifying that the 2023 settlement did NOT trigger a new settlement charge (important accounting distinction), (2) explaining the accounting treatment as a liability reduction affecting AOCL rather than earnings, and (3) noting the targeted nature of the 2023 approach (former employees not yet receiving benefits). The semantic meaning is fully aligned with the ground truth - both convey a shift from large-scale pension obligation transfers to smaller, more targeted settlements. The reasoning is sound and demonstrates proper understanding of pension accounting mechanics. Minor note: The LLM uses slightly more technical language (e.g., 'accumulated-other-comprehensive-loss balance,' 'unfunded status') which adds precision without introducing errors. The answer is well-structured and directly addresses all aspects of the question regarding the evolution of Lockheed Martin's pension management approach between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 468,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 AMD’s stake in the ATMP joint venture grew markedly—its equity‑method investment rose from roughly **$99 million (as of Dec 30 2023)** to **about $149 million (as of Dec 28 2024)**, and the related equity‑income recognized on the consolidated statement of operations jumped from **$16 million in 2023 to $33 million in 2024**.  This increase reflects both the higher carrying value of the 15 % interest and the additional earnings generated by the JV (including the $100 million term‑loan AMD extended to the JV in October 2024), underscoring a deepening financial relationship with the ATMP JV over the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: carrying value of $99 million (Dec 30, 2023), $149 million (Dec 28, 2024), equity income of $16 million (2023) and $33 million (2024). The $17 million contribution is correctly implied through the carrying value increase ($149M - $99M = $50M total increase, which includes the $17M contribution plus retained earnings/other adjustments). The dates are accurate and properly formatted. The LLM correctly identifies the 15% ownership interest and mentions the $100 million term loan extended in October 2024, which provides additional context about the deepening relationship. The multi-hop synthesis is sound—the answer correctly connects investment growth, equity income increases, and contextual factors to explain the evolving relationship. The reasoning is logical and well-structured. Minor note: The LLM doesn't explicitly state the $17 million contribution amount that appears in the ground truth, though this is implied by the carrying value change. The additional detail about the term loan, while not in the ground truth, is factually accurate and enhances the answer's relevance. The semantic equivalence is strong throughout, with appropriate financial terminology and clear presentation of the temporal evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 370,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 Johnson & Johnson’s ownership in Kenvue fell dramatically: after the May 2023 IPO it held about 89.6 % of Kenvue’s common stock, and after the August 23 2023 exchange it retained roughly 9.5 % (valued at $4.3 bn, later $3.9 bn). By May 17 2024 the company completed a debt‑for‑equity swap that cancelled the remaining 182 million shares, leaving J&J with **no equity stake** in Kenvue. The 2023 transaction generated a **$2.8 bn gain** on the equity it kept (part of a $21 bn total gain), while the 2024 swap produced an **≈ $0.4 bn loss** recorded in other income/expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about J&J's evolving relationship with Kenvue. STRENGTHS: (1) All key financial figures are correct: 9.5% retained stake valued at $4.3 billion in 2023, $2.8 billion gain on retained shares, $21.0 billion total gain in 2023, approximately $0.4 billion loss in 2024, and 182,329,550 shares (stated as ~182 million, acceptable rounding). (2) Dates are accurate: May 2023 IPO, August 23, 2023 exchange offer, May 17, 2024 debt-for-equity swap completion. (3) The multi-hop synthesis is sound - correctly traces the evolution from 89.6% post-IPO ownership → 9.5% post-exchange → 0% after 2024 swap. (4) Financial outcomes properly identified: non-cash gain in 2023 vs. loss in 2024. (5) The answer clearly addresses all parts of the question regarding retained equity, ownership percentages, and associated gains/losses across both years. (6) Semantic equivalence is maintained throughout - 'debt-for-equity swap' and 'Debt-for-Equity Exchange' are equivalent terms, and the characterization of the 2024 transaction as producing a loss is accurate. MINOR OBSERVATIONS: The LLM provides additional context (89.6% post-IPO ownership, intermediate valuation of $3.9 billion) that enhances understanding without contradicting the ground truth. The notation of the loss as '≈ $0.4 bn' appropriately reflects the approximate nature of the figure. No calculation errors detected. The answer fully satisfies the multi-hop requirement by synthesizing information across 2023 and 2024 transactions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 436,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "\nAT&T’s guarantee of Southwestern Bell Telephone Co.’s obligations—first filed as Exhibit 4‑c in the 2011 Form 10‑K—was still being referenced in the company’s 2022 (page 103) and 2023 (exhibit list on page 103) SEC filings. No new or amended guarantee agreement involving Southwestern Bell was disclosed for either year, so the relationship remained unchanged between 2022 and 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that AT&T's guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023, which matches the ground truth. The answer appropriately references Exhibit 4-c in both years and correctly notes that no new or amended guarantee agreements were disclosed. However, there are some issues: (1) The LLM introduces a specific detail about the guarantee being 'first filed as Exhibit 4-c in the 2011 Form 10-K' which is not mentioned in the ground truth and cannot be verified from the provided context. This is an unsupported claim that adds information not in the source material. (2) The reference to 'page 103' appears twice and is presented as specific evidence, but the ground truth does not provide page numbers, so this level of specificity cannot be verified. (3) The LLM's phrasing 'was still being referenced' and 'remained unchanged' correctly conveys the consistency message from the ground truth. The multi-hop reasoning is sound—the answer synthesizes that the guarantee appeared in both 2022 and 2023 filings and concludes no change occurred. The core factual claim (consistency of the guarantee across both years, inclusion in Exhibit 4-c, no new amendments) aligns with the ground truth. The main weakness is the introduction of unverified details (2011 origin, specific page numbers) that go beyond what can be confirmed from the provided ground truth, which slightly undermines confidence in the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 417,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "\nFrom 2022 to 2023 Lockheed Martin moved hypersonics from a nascent development effort to a strategically prioritized growth pillar.  In 2022 the company was primarily designing and testing several hypersonic strike weapons for the U.S. Army and Navy, but by 2023 it was explicitly highlighting hypersonics among its four near‑term growth areas and noting that multiple programs had completed testing and were entering early‑production phases through 2026—underscoring a deeper, more central role in program development and a broader strategic positioning for the business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies when compared to the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF 2022 ROLE: The LLM states that in 2022 Lockheed Martin was 'primarily designing and testing several hypersonic strike weapons,' but the ground truth indicates hypersonics was merely listed as a 'growth area' that was 'dependent on U.S. Government authorization and funding' - not an active primary development effort. This is a material misrepresentation of the 2022 status. (2) UNSUPPORTED CLAIMS: The LLM introduces specific details not found in the ground truth, including: (a) 'four near-term growth areas' - no such enumeration appears in ground truth, (b) 'multiple programs had completed testing and were entering early-production phases through 2026' - this specific timeline and production phase information is not mentioned in the ground truth, which only states programs were 'explicitly listed among major programs under the Space segment.' (3) CORRECT ELEMENTS: The LLM correctly identifies the shift from 2022 to 2023 and correctly notes that by 2023 hypersonics became more explicitly positioned and active. The general direction of evolution (from nascent to prioritized) aligns with ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution across years, it does so by introducing unsupported details rather than sticking to what the filings actually state. The ground truth is more conservative and accurate in its characterization. The answer overstates the 2022 involvement and adds specific production timeline details that cannot be verified from the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 455,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "\nThe U.S. litigation escrow account balance rose from **$1.4 billion at September 30 2022** to **$1.764 billion at September 30 2023**.  During fiscal 2022 the company deposited **$850 million** into the escrow, and in fiscal 2023 it added **$1.0 billion** (net of payments of $685 million), producing the higher year‑end balance.  (Page 46 of the 2022 filing and the table on page 73 of the 2023 filing.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS IN CORE NUMBERS: The LLM answer contains a major factual error on the primary metric. The ground truth states the balance increased to $3.089 billion as of September 30, 2023, but the LLM claims it was only $1.764 billion - a difference of $1.325 billion (43% understatement). This is a fundamental error that invalidates the core answer to the question. CORRECT ELEMENTS: The LLM correctly identified the opening balance of $1.4 billion at September 30, 2022, and correctly stated the deposits of $850 million in fiscal 2022 and $1.0 billion in fiscal 2023. The LLM also appropriately noted payments of $685 million in fiscal 2023, showing awareness of the account mechanics. REASONING ISSUE: While the LLM attempted to explain the balance change through deposits and payments, the calculation is fundamentally wrong. If $1.4B + $1.0B - $685M = $1.715B (approximately the $1.764B stated), this suggests the LLM may have missed significant additional deposits or failed to account for all components of the account balance. The ground truth shows the account grew to $3.089B, indicating either additional deposits not mentioned or a misunderstanding of what comprises the account balance. MULTI-HOP SYNTHESIS: The question requires synthesizing information about balance evolution and deposits across two fiscal years. The LLM addressed both years and both components (balance and deposits), but the synthesis is undermined by the incorrect ending balance figure. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's structure and provides citations, but the factual inaccuracy is disqualifying for a financial question where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 460,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Outdoor Garden has stayed within the **Hardlines** product line and has been treated as a core growth category in HD’s merchandising strategy.  Its net sales rose modestly—from **$10.04 B (6.4 % of total sales) in 2022 to $10.28 B (6.7 % in 2023) and $10.31 B (6.5 % in 2024)**—showing a stable contribution to overall revenue despite the 2024 re‑classification of merchandising departments.  Consequently, HD’s positioning of Outdoor Garden has not shifted dramatically; it remains a key, strategically‑prioritized offering within Hardlines, with only incremental growth and a consistently similar share of net sales over the three years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims Outdoor Garden net sales were '$10.04 B (6.4% of total sales) in 2022' but the ground truth states '$10,317 million (6.8% of total net sales)' in 2022. Converting: $10,317M = $10.317B, not $10.04B. The percentage is also wrong: 6.4% vs. 6.8%. For 2024, the LLM states '$10.31 B (6.5%)' which aligns with ground truth's $10,317 million (6.8%), but the percentage is incorrect (6.5% vs. 6.8%). The 2023 figures ($10.28B, 6.7%) cannot be verified against ground truth but appear inconsistent with the trajectory. (2) MULTI-HOP REASONING FAILURE: The LLM fundamentally misunderstands the strategic evolution. The ground truth explicitly states that in 2022, Outdoor Garden was 'disclosed as a distinct product line' and by 2024 it was 'grouped under the broader Hardlines merchandising department,' representing a shift from separate focus to consolidated category. The LLM incorrectly claims Outdoor Garden 'has stayed within the Hardlines product line' throughout 2022-2024, which contradicts the ground truth's core finding that it moved FROM being distinct TO being grouped under Hardlines. (3) ENTITY/CLASSIFICATION ACCURACY: The LLM mischaracterizes the 2022 status. In 2022, Outdoor Garden was NOT part of Hardlines as a distinct classification; it was a separate product line. The LLM's assertion that 'positioning of Outdoor Garden has not shifted dramatically' directly contradicts the ground truth's finding of a strategic integration/reclassification. (4) SEMANTIC MEANING: The LLM's conclusion that the role 'remains a key, strategically-prioritized offering within Hardlines' misses the essential point that the classification itself changed—it was not always within Hardlines. The answer demonstrates a fundamental misunderstanding of the multi-hop synthesis required: comparing 2022 status (distinct line) to 2024 status (grouped under Hardlines) to identify the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 557,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "\nAMD has kept its “engaging and open” culture as it grew from roughly 26,000 employees (2023) to 28,000 (2024) by institutionalising annual workforce surveys, expanding employee‑resource groups, rolling out a company‑wide mentoring and leadership‑development program, and offering flexible, hybrid‑work options together with competitive, equity‑focused rewards.  These practices signal a talent‑retention strategy that leans on strong employee voice, clear career pathways, and inclusive benefits to keep top engineers and managers anchored in a fiercely competitive semiconductor market.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL FABRICATION - The LLM answer introduces specific HR practices (annual workforce surveys, employee-resource groups, mentoring programs, hybrid-work options, equity-focused rewards) that are NOT mentioned in the ground truth or original SEC filing data. These appear to be plausible-sounding but entirely invented details. (2) NUMBERS CORRECT - The employee counts (26,000 in 2023, 28,000 in 2024) and the 7.7% growth calculation are accurate. (3) CORE MESSAGING MISSING - The ground truth emphasizes that AMD used IDENTICAL messaging in both years about 'culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' The LLM answer completely misses this key finding - that AMD deliberately maintained the SAME language, which is the actual evidence of cultural preservation strategy. (4) REASONING FAILURE - The LLM fabricated specific retention mechanisms rather than analyzing what the ground truth actually shows: that AMD's strategy was to preserve and reiterate its cultural values verbatim despite workforce expansion. The LLM's invented practices, while plausible in a real-world context, are not supported by the filing data and represent hallucination. (5) MULTI-HOP SYNTHESIS - Failed to correctly synthesize the comparison between 2023 and 2024 messaging. The ground truth's key insight is the CONSISTENCY of messaging; the LLM answer invents new information instead of analyzing the actual evidence. This is a significant failure in document-based question answering where accuracy to source material is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 445,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "\nBetween 2022 and 2023 AT&T did not add any new guarantee commitments to The Ohio Bell Telephone Company. The only reference to a guarantee for Ohio Bell in the filings is the legacy Exhibit 4‑c that was originally filed in the 2011 Form 10‑K and remains listed in the 2022 and 2023 exhibits index—indicating that the prior guarantee is still part of AT&T’s corporate documentation but has not been expanded, amended, or terminated in the intervening years. Consequently, the company’s guarantee obligations toward Ohio Bell stayed unchanged, with no disclosed modifications or new obligations emerging in the 2022‑2023 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both responses correctly identify that: (1) AT&T maintained a guarantee obligation for The Ohio Bell Telephone Company across 2022-2023, (2) this obligation originated from Exhibit 4-c filed in 2011, (3) the guarantee remained unchanged with no new additions, amendments, or terminations during the 2022-2023 period, and (4) documentation practices were maintained in line with current reporting standards. The LLM answer provides slightly more explicit detail about the legacy nature of the guarantee and the absence of modifications, which adds clarity without contradicting the ground truth. All dates (2011, 2022, 2023) are correct, entity names (AT&T, The Ohio Bell Telephone Company) are accurate, and the multi-hop reasoning correctly synthesizes information about the relationship evolution across the two-year period. The answer appropriately conveys that the relationship was stable rather than evolving in terms of new obligations. Minor point: the LLM uses 'Exhibit 4‑c' formatting while ground truth uses 'Exhibit 4-c', but this is a negligible formatting variation. The semantic meaning is identical to the ground truth, and all factual claims are supported by the filing documentation referenced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 360,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "\nIn 2023 GE recorded a $5.78 billion gain on retained and sold ownership interests—primarily from its AerCap (and GE HealthCare) stakes—fueling a sharp rise in corporate profit (see GE 10‑K 2023, page 13). By 2024 that gain had largely evaporated, falling by roughly $5.2 billion, so the contribution from AerCap‑related sales and retentions was essentially eliminated (GE 10‑K 2024, page 9). This decline reflects the winding‑down of the AerCap relationship and the spin‑offs of GE HealthCare and GE Vernova.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and proper multi-hop synthesis. STRENGTHS: (1) Quantitative accuracy is excellent - the $5.78 billion figure for 2023 is essentially correct (ground truth states $5.7 billion; the minor difference of $0.08B is negligible and within rounding variation), and the $5.2 billion decline in 2024 matches ground truth exactly. (2) Multi-hop reasoning is sound - the answer correctly synthesizes information across 2023 and 2024 filings, identifying AerCap and GE HealthCare as primary drivers, and properly calculates the year-over-year change. (3) Entity identification is accurate - correctly names GE, AerCap, GE HealthCare, and GE Vernova. (4) Temporal accuracy is correct - properly distinguishes 2023 vs 2024 performance. (5) Semantic equivalence is strong - conveys the same core message as ground truth about the significant reduction in gains. MINOR WEAKNESSES: (1) The phrase 'gain had largely evaporated' and 'contribution was essentially eliminated' is slightly more interpretive than the ground truth's more neutral 'decreased by $5.2 billion,' though semantically equivalent. (2) The additional context about 'winding-down of the AerCap relationship' and 'spin-offs' adds interpretive framing not explicitly in the ground truth, though this appears to be reasonable contextual inference. (3) The answer could have been more explicit that the $5.2 billion decrease represents the difference between the two years' gains, though this is clearly implied. Overall, the answer successfully addresses all parts of the multi-part question with accurate numbers, proper synthesis across years, and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 463,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Home Depot transformed HD Supply from a stand‑alone MRO distributor into a central pillar of its professional‑customer strategy.  The company deepened integration by expanding HD Supply’s product breadth, adding dedicated sales and credit capabilities (e.g., Pro X Tra loyalty, Pro House Account), and linking its MRO services to the broader interconnected retail and supply‑chain investments—especially after the SRS acquisition—so that MRO now serves as the primary source of value‑added services for professional remodelers, contractors and facility‑management customers.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERROR - The LLM introduces the 'SRS acquisition' which is NOT mentioned in the ground truth and appears to be fabricated or confused with another transaction. This is a significant factual error that undermines credibility. (2) UNSUPPORTED CLAIMS - The LLM provides specific details about 'Pro X Tra loyalty' and 'Pro House Account' that are NOT present in the ground truth answer. While these may exist in actual filings, they are not verified by the provided ground truth and represent unsubstantiated additions. (3) INCOMPLETE CORE NARRATIVE - The LLM fails to capture the key temporal shift emphasized in the ground truth: the transition FROM 'integration risks and challenges' in 2022 TO a 'mature and strategic role' by 2024. The ground truth explicitly notes this evolution from uncertainty to maturity, which the LLM largely omits. (4) MISSING SPECIFIC CUSTOMER SEGMENTS - The ground truth specifically identifies HD Supply's MRO focus on 'multifamily, hospitality, healthcare, and government housing facilities,' which the LLM generalizes to 'professional remodelers, contractors and facility-management customers' without the same specificity. (5) QUANTITATIVE ACCURACY - No numbers, dates, or percentages are provided by either answer, so this dimension is neutral (score reflects absence of errors but also absence of verification). (6) POSITIVE ASPECTS - The LLM correctly identifies the core transformation from standalone to integrated strategy and correctly names HD Supply as central to professional customer focus. The semantic direction is correct (integration and deepening of role). OVERALL ASSESSMENT: The answer demonstrates partial understanding of the strategic evolution but introduces unverified claims (SRS acquisition) and omits the critical 2022-to-2024 maturation narrative that is central to the ground truth. The fabrication of the SRS acquisition is particularly problematic for a financial analysis context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 531,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "\nBetween the 2023 and 2024 filings AMD’s worldwide patent portfolio grew modestly—issued patents rose from about 12,800 to 13,200 while U.S. patents stayed roughly at 7,500 and pending applications remained steady at ≈5,600.  This slight expansion adds more assets that can be offered in cross‑licensing negotiations, reinforcing AMD’s strategy of exchanging patented technology with rivals rather than pursuing costly litigation.  Consequently, the company’s reliance on cross‑licensing and technology‑exchange agreements has remained strong, using the enlarged patent base to broaden the scope of technology sharing while keeping the overall structure of its licensing relationships essentially unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct patent portfolio numbers and appropriate synthesis of the multi-hop question. STRENGTHS: (1) All key numeric values are accurate - issued patents correctly stated as growing from 12,800 to 13,200, pending applications correctly at 5,600 for both years, and U.S. patents appropriately noted at ~7,500. (2) The multi-hop reasoning is sound, correctly connecting the patent portfolio growth to enhanced leverage in cross-licensing negotiations. (3) The answer properly synthesizes information about both the quantitative patent changes and their strategic implications for technology exchange. (4) The semantic meaning aligns well with the ground truth regarding AMD's continued reliance on cross-licensing agreements and the strategic advantage gained from the expanded patent base. MINOR WEAKNESSES: (1) The LLM mentions U.S. patents at ~7,500, which is additional detail not explicitly stated in the ground truth answer (though not contradicted). (2) The phrase 'keeping the overall structure of its licensing relationships essentially unchanged' is a reasonable inference but goes slightly beyond what the ground truth explicitly states about the strength of reliance remaining 'strong and possibly more strategically advantageous.' (3) The ground truth explicitly states total patent matters grew from 18,500 to 18,800, which the LLM doesn't mention, though this is a minor omission since the issued/pending breakdown is provided. The answer correctly addresses the evolution of reliance on cross-licensing agreements and the implications of portfolio growth, with accurate numbers and sound reasoning throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 459,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "\nFrom the end of 2023 through May 2024, Johnson & Johnson moved from holding a 9.5 % minority stake in Kenvue (the remainder of the ~89.6 % it owned after the August 2023 exchange) to completely exiting that position.  In May 2024 the company swapped its last 182 million Kenvue shares for $3.6 billion of commercial paper, thereby satisfying and retiring the paper and recording a roughly $0.4 billion loss in other (income) expense—leaving J&J with no Kenvue shares and ending its strategic equity relationship with the consumer‑health spin‑off.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline. Verified facts: (1) 9.5% stake in 2023 - CORRECT; (2) $4.3 billion valuation - NOT EXPLICITLY STATED in LLM answer but not contradicted; (3) May 2024 debt-for-equity exchange - CORRECT; (4) 182 million shares (LLM states '182 million' vs ground truth's '182,329,550' - acceptable rounding); (5) $3.6 billion commercial paper satisfaction - CORRECT; (6) $0.4 billion loss - CORRECT; (7) Complete exit from Kenvue - CORRECT. The LLM answer correctly synthesizes the multi-hop evolution from 2023 to 2024, properly identifying the August 2023 exchange offer context and the May 2024 final exit. The reasoning is sound and logically connects the stake retention, valuation changes, and subsequent disposal. Minor weaknesses: (1) The LLM does not explicitly mention the $4.3 billion 2023 valuation or the $0.4 billion expense recorded in 2023 due to subsequent changes - these are ground truth details that add completeness; (2) The phrase 'remainder of the ~89.6% it owned after the August 2023 exchange' is somewhat confusing phrasing (the 9.5% IS the remainder, not a remainder OF 89.6%), though the intent is clear. The answer effectively addresses all parts of the question regarding the evolution of J&J's financial stake and strategic relationship with Kenvue from 2023 to 2024, with accurate numbers, correct dates, and proper multi-hop synthesis across the two-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 413,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "\nBetween the 2022 and 2023 filings AT&T stopped listing Indiana Bell Telephone Co. Inc. as a guarantor in its SEC disclosures. The 2022 filing (page 133) still references a 2011 4‑c guaranty that mentions Indiana Bell, but the 2023 filing (pages 101‑105) no longer includes that exhibit, indicating the guarantee relationship was removed. Consequently, Indiana Bell is no longer part of AT&T’s guarantee disclosures in the most recent SEC reports.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core factual claim. (1) CRITICAL ERROR - OPPOSITE CONCLUSION: The ground truth states that Indiana Bell Telephone Co. Inc. remained listed in guarantee disclosures in both 2022 and 2023 with no change. The LLM claims the opposite - that AT&T 'stopped listing' Indiana Bell and 'no longer includes that exhibit' in 2023. This is a complete reversal of the actual facts. (2) EXHIBIT REFERENCE ERROR: The ground truth specifies Exhibit 4-d for both years. The LLM incorrectly references a '2011 4-c guaranty' in 2022 and claims the exhibit was removed in 2023. The ground truth explicitly states the same guarantee under Exhibit 4-d continued in both years. (3) PAGE NUMBER ISSUES: While the LLM provides specific page numbers (133 for 2022, 101-105 for 2023), these cannot be verified against the ground truth, but the underlying claim about removal is factually wrong according to the knowledge graph. (4) MULTI-HOP REASONING FAILURE: The question asks about evolution/changes between 2022-2023. The correct answer is 'no change' - the guarantee remained in place. The LLM incorrectly synthesized that a change occurred (removal), which is the opposite of what actually happened. (5) SEMANTIC EQUIVALENCE FAILURE: This is not a wording difference - the LLM's answer conveys the opposite meaning from ground truth. The guarantee did NOT change status; it remained consistent. The LLM's claim of removal is factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 415,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "\nIn 2023 GE finished the divestiture of its last AerCap equity position, recording a $5.2 billion gain on the sale that was part of the overall “gains on retained and sold ownership interests” reported in the 2023 results.  By 2024 the tie‑up had become purely commercial: GE now supplies transition services and holds a note receivable for AerCap and, as disclosed in the 2024 filing, paid a net cash amount of **$203 million** to AerCap—meaning cash now flows out of GE rather than in, and no equity‑related investment gains are recognized.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IN FACTUAL ACCURACY AND MULTI-HOP REASONING:\n\n1. CRITICAL FACTUAL ERROR - Timeline Reversal: The LLM states that in 2023 GE 'finished the divestiture of its last AerCap equity position, recording a $5.2 billion gain.' This is BACKWARDS. According to the ground truth, the $5.2 billion decrease in gains occurred in 2024 (not 2023), and this was a DECREASE, not a gain recorded in 2023. The ground truth explicitly states: 'GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion' in 2024.\n\n2. MISCHARACTERIZATION OF $5.2B: The LLM incorrectly frames the $5.2 billion as a gain recorded in 2023. The ground truth indicates this was a decrease in gains in 2024, representing a negative financial impact, not a positive one. This is a fundamental misunderstanding of the financial relationship evolution.\n\n3. INCORRECT CHARACTERIZATION OF 2023 POSITION: The LLM claims GE 'finished the divestiture' in 2023, but the ground truth states that in 2023 GE 'had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services.' This contradicts the LLM's assertion that the equity position was fully divested in 2023.\n\n4. CORRECT ELEMENTS:\n   - The $203 million net cash payment figure is correct\n   - The identification of transition services and note receivable in the later period is correct\n   - The shift from operational involvement to investment-based returns is conceptually correct\n   - The 2024 characterization of purely commercial ties is accurate\n\n5. MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the temporal evolution. It reversed the timeline of when the $5.2 billion impact occurred and mischaracterized whether it was a gain or a decrease in gains. This represents a fundamental failure in multi-hop reasoning across the 2023-2024 comparison.\n\n6. SEMANTIC ISSUES: The phrase 'no equity-related investment gains are recognized' in 2024 is correct, but this should be understood in context of the $5.2 billion decrease that occurred in 2024, not as a clean transition from gains to no gains.\n\nThe answer contains approximately 50% correct information but with critical errors in the core narrative about how the financial relationship evolved and when key financial impacts occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 620,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "\nFrom 2022 to 2024 Home Depot moved beyond isolated store‑refresh projects (e.g., signage, self‑service lockers, electronic shelf‑labels) to treat store appearance as a platform for a fully digital, omnichannel experience; the 2024 filing shows continued investment in mobile‑app‑enabled navigation, AI‑driven inventory visibility (Computer Vision, hdPhone/Sidekick) and curb‑side/BOPIS fulfillment that tie the physical layout directly to online ordering and real‑time product information.  This evolution positions each store not just as a point of sale but as a seamless extension of the customer’s digital journey, using store design and technology to deliver a more personalized, frictionless experience that differentiates Home Depot in a highly competitive market.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from 2022 to 2024, capturing the shift from isolated store improvements to an integrated omnichannel experience. It accurately references specific 2024 technologies (mobile-app navigation, Computer Vision, Sidekick, BOPIS/curbside fulfillment) and correctly emphasizes digital integration as a competitive differentiator. The semantic understanding of the strategic shift is sound. WEAKNESSES: (1) The LLM introduces specific technology names (Computer Vision, hdPhone/Sidekick, BOPIS) that are not explicitly mentioned in the ground truth answer. While these may be accurate details from the 2024 filing, they represent additions beyond what the knowledge graph confirms, creating potential factual risk. (2) The LLM's characterization of 2022 as focused on 'isolated store-refresh projects' (signage, self-service lockers, electronic shelf-labels) is more specific than the ground truth, which simply states the company 'emphasized store appearance as a competitive factor.' This specificity may be accurate but goes beyond verified ground truth. (3) The answer lacks explicit mention of the 2022 baseline factors (price, product availability, location) that the ground truth identifies as context for the evolution. MULTI-HOP REASONING: The LLM correctly synthesizes the temporal evolution across 2022-2024 and links store appearance to digital integration, matching the ground truth's core narrative. However, the introduction of unverified specific technologies creates uncertainty about whether all claims are grounded in actual filings. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this dimension is neutral. The dates (2022, 2024) are correct. OVERALL: The answer demonstrates solid understanding of the strategic evolution but introduces specific details not confirmed by the ground truth, which reduces confidence in complete accuracy despite capturing the essential narrative correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 541,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "\nBetween 2023 and 2024 AMD’s purchases from the ATMP joint venture stayed roughly at $1.7 billion, but resales to the JV surged from only $14 million in 2023 to $121 million in 2024, while payables to the JV rose from $363 million to $476 million.  In addition, AMD’s equity stake in the JV grew to about $149 million (up from $99 million) and, in October 2024, it extended a $100 million one‑year term loan to the JV, underscoring a new, larger financial relationship beyond the earlier equity‑method arrangement.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of AMD's relationship with ATMP JV between 2023 and 2024, including the key metrics requested: resales increasing from $14M to $121M, and the October 2024 $100M term loan. However, there are significant issues with additional information introduced that is not in the ground truth and may be inaccurate or irrelevant:\n\nCORRECT ELEMENTS:\n- Resales 2023: $14 million ✓\n- Resales 2024: $121 million ✓\n- October 2024 term loan: $100 million, one-year ✓\n- Characterization of deepening financial relationship ✓\n\nPROBLEMATIC ELEMENTS:\n- The LLM introduces information about purchases FROM the JV (~$1.7B), payables to JV ($363M to $476M), and equity stake growth ($99M to $149M). While these may be factually accurate from the filings, they were NOT mentioned in the ground truth answer and go beyond what was asked. The question specifically asks about \"resales and new financial arrangements.\"\n- The introduction of these additional metrics, while potentially accurate, represents scope creep beyond the ground truth answer and makes it harder to assess whether the LLM is synthesizing correctly or adding extraneous information.\n- The statement about \"equity-method arrangement\" is vague and not clearly explained in relation to the question.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the relationship evolution across 2023-2024, properly connecting resales data with the new loan arrangement. The reasoning is sound for the core question.\n\nQUANTITATIVE ACCURACY:\nThe numbers provided that match the ground truth are accurate. However, the introduction of unverified additional numbers (purchases, payables, equity stake) without ground truth confirmation creates uncertainty. If these numbers are incorrect, it would significantly impact the score.\n\nCONCLUSION:\nThe answer correctly addresses the primary question about resales and the new loan arrangement, but introduces substantial additional information not in the ground truth, making it difficult to fully validate. The core answer is sound, but the additions create ambiguity about accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 572,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "\nJohnson & Johnson has tightened and expanded its privacy‑compliance framework between 2023 and 2024.  In the 2023 filing the Company noted that it “has established privacy compliance programs and controls” [page 23, 2023 10‑K], but in the 2024 filing it adds detailed governance (CISO‑led program, RCSC board oversight) [page 21, 2024 10‑K], mandatory data‑privacy training for all employees, and a structured third‑party risk‑management process that specifically addresses “controls imposed on cross‑border data flows, unauthorized access, and loss of personal data” [page 21, 2024 10‑K].  The 2024 discussion also emphasizes that new global privacy laws—especially data‑localization and international‑data‑transfer requirements—are driving a more proactive, risk‑based approach to protecting personal data across the Company’s worldwide operations.  Thus, the evolution is marked by deeper governance, broader employee training, and explicit focus on emerging cross‑border data‑flow regulations.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of J&J's privacy compliance programs between 2023 and 2024, capturing the key themes: (1) expansion from established programs to more detailed governance structures, (2) shift from 'other territories' focus to 'global' regulatory scope, (3) emphasis on cross-border data flows and data localization. The answer appropriately cites page numbers from both 10-K filings and correctly identifies specific governance enhancements (CISO-led program, RCSC board oversight, mandatory training, third-party risk management). The semantic content aligns well with the ground truth regarding the broadening compliance focus and more anticipatory posture.\n\nWEAKNESSES: (1) The LLM introduces specific governance details (CISO-led program, RCSC board oversight, mandatory training) that are NOT present in the ground truth answer. While these may be factually accurate from the filings, they represent an expansion beyond what the knowledge graph identified as the key evolution points. (2) The LLM's characterization of the evolution as 'tightened and expanded' with 'deeper governance' and 'broader employee training' adds interpretive layers not explicitly confirmed in the ground truth. (3) The answer emphasizes structural/governance changes more heavily than the ground truth, which focuses on the shift in regulatory scope (from 'other territories' to 'globally') and the company's anticipatory posture. (4) Missing explicit mention of the shift from 'other territories' to 'globally' in regulatory expectations, which is a key distinction in the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2023 and 2024 filings and correctly identifies the evolution trajectory. However, the specific governance details cited may represent over-specification beyond what the knowledge graph captured as the essential evolution.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy is not directly testable. Page citations (page 23 for 2023, page 21 for 2024) cannot be verified against the ground truth but appear plausible.\n\nOVERALL ASSESSMENT: The answer captures the essential evolution but adds details not confirmed in the ground truth, which creates uncertainty about whether these represent accurate filing content or LLM elaboration. The core insight about broadening from territorial to global regulatory focus is present but somewhat de-emphasized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 672,
        "total_tokens": 2162
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "\nBetween 2023 and 2024 the estimated borrower‑litigation loss that GE must absorb for its Polish mortgage‑finance unit (Bank BPH) fell sharply – from about **$2.67 billion** in 2023 to **$2.46 billion** in 2024.  Accordingly, the valuation allowance that offsets the financing‑receivable portfolio (the “loss reserve”) was reduced from roughly **$1.71 billion** (2023) to **$1.52 billion** (2024), a decline of roughly **$195 million**.  This reduction is reflected in the discontinued‑operations results, where the pre‑tax loss attributed to Bank BPH dropped from **$1.252 billion** in 2023 to just **$41 million** in 2024, and the net‑of‑tax loss fell from **$1.242 billion** to **$4 million**, indicating that GE’s financial exposure to Bank BPH has been markedly curtailed.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core financial metrics and their directional changes (decreases from 2023 to 2024). The main figures are accurate: total estimated losses decreased from $2.67B to $2.46B, and valuation allowances decreased from $1.71B to $1.52B. The LLM properly identifies Bank BPH as GE's Polish mortgage-finance unit and correctly characterizes the overall trend as a reduction in financial exposure. The answer appropriately addresses the multi-hop nature of the question by synthesizing information about both estimated losses and valuation allowances.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL OMISSION: The LLM completely fails to mention the $957M and $944M in 'other liabilities' components that are explicitly part of the ground truth answer. The ground truth breaks down the 2023 total as $1,712M (valuation allowances) + $957M (other liabilities) = $2,669M, and 2024 as $1,517M + $944M = $2,461M. This is a significant omission of material information. (2) CALCULATION ERROR: The LLM states the valuation allowance declined by 'roughly $195 million' ($1.71B - $1.52B = $0.19B = $190M), which is approximately correct but the LLM rounds to $195M when the precise figure is $195M ($1,712M - $1,517M = $195M). This is minor. (3) EXTRANEOUS INFORMATION: The LLM introduces discontinued-operations results and pre-tax/net-of-tax loss figures ($1.252B, $41M, $1.242B, $4M) that are NOT mentioned in the ground truth answer and appear to be from a different section of the filing. While these may be factually accurate, they go beyond what the ground truth specifies and could represent information synthesis from different parts of the filing that may not directly address the specific question about 'estimated borrower litigation losses and related valuation allowances.' (4) INCOMPLETE CONTEXT: The ground truth mentions 'a strategic shift in how GE managed its exposure to Bank BPH through a settlement program' and notes that 'the valuation allowance fully offset the financing receivables balance by the end of 2024,' which provides important context about the nature of the reduction. The LLM does not capture these strategic insights.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable multi-hop synthesis by connecting the valuation allowance changes to the overall exposure reduction, but it fails to fully synthesize all components of the estimated losses (missing the other liabilities component entirely).\n\nNUMERIC VERIFICATION: 2023 total: $2,669M ✓ (stated as $2.67B); 2024 total: $2,461M ✓ (stated as $2.46B); 2023 valuation allowance: $1,712M ✓ (stated as $1.71B); 2024 valuation allowance: $1,517M ✓ (stated as $1.52B). However, the missing $957M and $944M components represent incomplete accounting of the total estimated losses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 735,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "\nHD kept the Indoor Garden line in the Hardlines merchandising group both in 2022 and after the 2024 department‑realignment, but its financial footprint expanded modestly—sales rose from about **$10.1 billion (6.4 % of total net sales) in fiscal 2022** to **$10.5 billion (6.6 % of net sales) in fiscal 2024**, underscoring a stable yet slightly growing positioning of the product line within the company’s portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across multiple dimensions: (1) QUANTITATIVE ERRORS - The LLM states 2022 sales were '$10.1 billion (6.4% of total net sales)' and 2024 sales were '$10.5 billion (6.6% of net sales)'. The ground truth clearly states 2022 sales were '$15,546 million' ($15.546 billion) representing '10.3% of total revenue'. This is a massive discrepancy - the LLM understated 2022 sales by approximately $5.4 billion and understated the percentage by 3.9 percentage points. (2) CATEGORICAL POSITIONING ERROR - The LLM claims 'HD kept the Indoor Garden line in the Hardlines merchandising group both in 2022 and after the 2024 department-realignment'. The ground truth explicitly states that in 2022, Indoor Garden was a 'standalone category' and only 'by 2024' was it 'grouped under the Hardlines merchandising department'. This represents a fundamental misunderstanding of the core evolution being asked about - the LLM reversed the actual strategic shift. (3) MULTI-HOP REASONING FAILURE - The question asks about evolution 'from 2022 to 2024' given financial performance in 2022 and categorization in 2024. The LLM failed to synthesize this correctly, missing the key insight that the product line was reclassified from standalone to integrated within Hardlines. (4) SEMANTIC MISALIGNMENT - The LLM's narrative of 'stable yet slightly growing positioning' contradicts the ground truth's characterization of a 'strategic shift' in how the product is organized. The answer demonstrates either fabricated data or severe retrieval errors, making it fundamentally unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 451,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Colgate‑Palmolive kept its core approach of using sourcing‑strategy levers—productivity initiatives, cost‑efficiency programs and only limited commodity‑hedging contracts—to blunt raw‑material price swings. The 2024 filing, however, places greater emphasis on supply‑chain resilience, noting efforts to diversify suppliers, build business‑continuity and contingency plans, and qualify new sources, while still relying on the same limited‑hedging and productivity‑driven cost‑management tactics.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core timeframe (2022-2024) and company (Colgate-Palmolive). (2) It accurately captures that sourcing strategies remained a central approach across both years. (3) The mention of productivity initiatives and cost-efficiency programs aligns with ground truth. (4) The identification of 2024's emphasis on supply-chain resilience and supplier diversification is relevant and supported. (5) No quantitative errors in dates or numbers (none were provided in either answer). WEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM fails to mention specific commodities affected (resins, essential oils, soybeans) that are explicitly highlighted in the ground truth as part of the 2024 disclosure. This is a material omission for a question specifically about commodity price fluctuations. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes a shift toward 'more defensive sourcing and cost management tactics in response to external pressures' and mentions 'increased exposure to geopolitical and climatic disruptions.' The LLM mentions supply-chain resilience and contingency planning but does not explicitly connect these to geopolitical/climatic pressures as the driver of the evolution. (3) CHARACTERIZATION ISSUE: The LLM states 'only limited commodity-hedging contracts' which may be accurate but is not explicitly confirmed in the ground truth, which mentions 'derivative instruments' without specifying they were 'limited.' This introduces an interpretation not clearly supported. (4) MISSING CONTEXT: The ground truth notes the 2022 framework included 'foreign exchange, interest rates, and commodity prices' as part of a broader risk management approach. The LLM focuses narrowly on commodities without this broader context. (5) MULTI-HOP REASONING: While the LLM does synthesize evolution across years, it misses the causal connection between external pressures (geopolitical/climatic) and the shift in strategy that the ground truth emphasizes. The answer is partially correct on the evolution but incomplete on the drivers and specific details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 561,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "\nTREMFYA sales rose sharply from about **$3.1 billion in 2023 to $3.7 billion in 2024** (a **≈16 % increase**). The growth was driven by **overall market expansion and gains in market share**, supported by the launch of **sub‑cutaneous formulations and new indications (e.g., ulcerative colitis and Crohn’s disease)**, which boosted physician and patient adoption. Unlike other immunology products that faced biosimilar pressure, TREMFYA’s newer delivery options and expanding therapeutic portfolio helped sustain its upward sales trajectory.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "QUANTITATIVE ACCURACY: The LLM correctly identified the 2023 sales (~$3.1B/$3,147M) and 2024 sales (~$3.7B/$3,670M), and the approximate 16% increase is accurate (ground truth: 16.6%). The numbers are in the right ballpark with acceptable rounding. HOWEVER, CRITICAL ERRORS IN QUALITATIVE CONTENT: The LLM introduced specific claims NOT present in the ground truth: (1) 'sub-cutaneous formulations' - not mentioned in original answer, (2) 'new indications (e.g., ulcerative colitis and Crohn's disease)' - these are NOT mentioned in the ground truth, (3) 'biosimilar pressure' comparison - not in original answer. These appear to be hallucinated details. MISSING KEY INFORMATION: The LLM failed to include the specific operational drivers mentioned in ground truth: (1) the 18.1% change from operations, (2) the negative 1.5% currency impact, (3) the specific mention of 'PsO/PsA (Psoriasis and Psoriatic Arthritis)' as the therapeutic areas. The ground truth provides precise attribution of growth (18.1% operations offset by -1.5% FX), while the LLM gives vague 'market expansion and market share gains.' MULTI-HOP REASONING: The LLM failed to synthesize the complete picture - it should have mentioned both the operational growth AND the currency headwind that partially offset it. The ground truth shows sophisticated understanding of the growth drivers (operational strength despite FX headwinds), while the LLM oversimplifies. SEMANTIC ISSUES: The LLM's claim about 'newer delivery options' and 'expanding therapeutic portfolio' contradicts the ground truth which specifically attributes growth to strength in existing PsO/PsA areas, not new indications. This represents a fundamental misunderstanding of the actual growth drivers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 473,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "\nThe 2023 filing separates A+E’s audience numbers from the old “equity‑investment” summary and presents them as “domestic subscribers” for each of the three channels (about 58 million each) in the Linear‑Networks table, while still recording Disney’s 50 % stake as “Equity in the income of investees.”  This methodological change—moving from the broader Nielsen estimate that counted both MVPD and OTT subscribers in 2022 to a narrower Nielsen estimate for 2024—lowers the reported subscriber count and makes the partnership’s financial interest explicit as an equity‑method holding rather than an aggregated partnership figure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors and inconsistencies that undermine its credibility:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM states \"about 58 million each\" for three channels, implying ~174 million total, which contradicts the ground truth's 58 million for A+E's channels collectively\n   - The LLM mentions a \"2024\" methodology change, but the question and ground truth focus on 2022-2023 transition; this appears to be an anachronistic error\n   - The LLM incorrectly characterizes the 2022 subscriber count as a \"broader Nielsen estimate that counted both MVPD and OTT subscribers\" without grounding this in the original answer\n\n2. ENTITY AND STRUCTURAL ACCURACY:\n   - The LLM correctly identifies the 50% equity stake in 2023\n   - The LLM correctly notes the shift to \"Equity in the income of investees\" reporting\n   - However, the LLM mischaracterizes the 2022 relationship as not being an equity investment, when the ground truth indicates it was already a partnership with reported subscriber data\n\n3. MULTI-HOP REASONING ISSUES:\n   - The LLM fails to clearly establish the 2022 baseline (69 million domestic subscribers) before discussing the 2023 change\n   - The comparison between 2022 and 2023 is muddled; the LLM doesn't clearly articulate that the subscriber count decreased from 69M to 58M\n   - The explanation of \"why\" the change occurred (structural shift from partnership to 50% equity stake) is present but not clearly connected to the reporting methodology change\n\n4. SEMANTIC AND CONTEXTUAL ISSUES:\n   - The phrase \"about 58 million each\" is ambiguous and potentially misleading\n   - The reference to \"2024\" methodology is confusing and appears to be an error\n   - The LLM correctly identifies the shift from partnership reporting to equity-method accounting, but the explanation lacks clarity about the 2022 baseline\n\n5. WHAT WAS CORRECT:\n   - 50% equity stake identification\n   - 58 million subscriber figure for 2023\n   - Recognition of shift to \"Equity in the income of investees\" reporting\n   - General understanding that the relationship changed from partnership to equity investment\n\n6. CRITICAL OMISSIONS:\n   - Missing the 69 million subscriber figure from 2022\n   - Missing clear explanation of the structural change from partnership to 50% ownership\n   - Unclear about the methodological basis for the subscriber count change\n   - The 2024 reference is unexplained and appears erroneous",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 662,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "\nIn 2023 GE realized a $6.587 billion cash gain by selling its remaining AerCap shares and, separately, recorded a modest $129 million realized/unrealized gain on the AerCap senior note (the only AerCap interest left on its books). By 2024 there were no further disposals, so the AerCap exposure generated only an immaterial, non‑recurring fair‑value adjustment to the senior note that appears in other income (loss); consequently, the relationship no longer produces any material realized or unrealized gains or losses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. (1) MAJOR ERRORS: The LLM claims GE realized a $6.587 billion cash gain from selling AerCap shares in 2023, but the ground truth makes no mention of this transaction. The ground truth explicitly states GE reported an unrealized gain of $129 million in 2023 and a significant $5.2 billion DECREASE in gains on retained and sold ownership interests in 2024 compared to 2023. (2) QUANTITATIVE ACCURACY ISSUES: The $6.587 billion figure appears to be fabricated or misattributed - it's not mentioned in the ground truth at all. The LLM correctly identifies the $129 million figure but mischaracterizes it as 'realized/unrealized' when the ground truth specifically calls it an 'unrealized gain.' The LLM's claim that 2024 shows 'no material realized or unrealized gains or losses' contradicts the ground truth's indication of a significant negative shift (a $5.2 billion decline). (3) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the year-over-year comparison. The ground truth clearly indicates a negative evolution from 2023 to 2024 (from unrealized gains to losses or significantly reduced gains), but the LLM presents a narrative of complete disposition in 2023 followed by immaterial activity in 2024, which is inconsistent with the ground truth's description of a $5.2 billion decline in 2024. (4) ENTITY AND METRIC CONFUSION: While the LLM correctly identifies AerCap and GE, it misidentifies the nature of the financial instruments and transactions. The ground truth discusses 'gains on retained and sold ownership interests' declining by $5.2 billion, suggesting ongoing exposure in 2024, not complete disposition. The LLM's characterization of the 2024 situation as having 'no further disposals' and 'only immaterial' adjustments contradicts the magnitude of the $5.2 billion decline mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 530,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard deepened its multi‑layered security framework by formalizing a dedicated third‑party risk‑management program and by expanding collaboration with external cybersecurity experts, public‑private partnerships and independent assessors to monitor and respond to threats that arise from services supplied by third‑party providers.  At the same time, the company embedded these safeguards into newly launched real‑time, account‑based and disbursement platforms (e.g., Alias‑Based Remittances, VCN and Track BPS), ensuring that the expanded digital‑payment flows are protected by the same layered controls that secure its core network.  This evolution signals a strategic shift toward proactive, ecosystem‑wide cyber resilience, preparing Mastercard for the heightened threat landscape created by broader digital‑payment adoption and increasing reliance on external service partners.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core evolution from 2022 to 2024 regarding third-party risk management integration. (2) Accurately captures the shift toward ecosystem-wide resilience and public-private partnerships. (3) No quantitative errors in dates or metrics. (4) Correctly identifies Mastercard as the subject company. WEAKNESSES: (1) SIGNIFICANT FACTUAL ISSUE - The LLM introduces specific product names (Alias-Based Remittances, VCN, Track BPS) and claims these were 'newly launched' platforms with embedded safeguards. The ground truth makes NO mention of these specific products or their security features. This appears to be hallucinated detail not supported by the source documents. (2) The ground truth explicitly states there was 'no explicit mention of addressing risks related to third-party service providers' in 2022, which the LLM correctly captures, but then adds unsupported product-specific claims. (3) The LLM expands beyond what the ground truth supports by claiming these platforms were 'newly launched' and had 'layered controls' - this level of product-specific detail is not in the original answer. (4) While the overall narrative about ecosystem-wide resilience is correct, the introduction of specific product names and their security features without ground truth support is a material factual error. MULTI-HOP REASONING: The LLM attempts to synthesize information about how security evolved across platforms, but this synthesis appears to be extrapolation rather than synthesis from actual filing data. The core comparison (2022 vs 2024 evolution) is sound, but the product-specific claims undermine credibility. VERDICT: The answer captures the main strategic shift correctly but introduces unsupported specific claims about product launches and their security features, which violates the requirement for factual accuracy from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 511,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "\nTarget has continued to satisfy the debt‑leverage covenant in both 2022 and 2023, reporting that it is “in compliance with these covenants” in each filing.  The company’s credit‑facility structure was updated in 2023—its prior 364‑day revolving facility was terminated and a new $1 billion 364‑day facility was entered into, while its $3 billion five‑year revolving facility was extended to a 2028 maturity—changes that preserve the same leverage limits but provide longer‑term liquidity.  Consequently, the leverage covenant has remained effectively unchanged, and Target has maintained compliance despite the facility modifications.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question well. STRENGTHS: (1) All key financial figures are accurate: $1 billion 364-day facility, $3 billion five-year facility, October 2028 extension date are all correct. (2) The multi-hop synthesis is sound—the answer correctly identifies that Target maintained compliance in both 2022 and 2023 despite credit facility changes. (3) The reasoning about covenant consistency is logical and well-explained. (4) Entity identification is correct (Target Corporation, debt leverage covenant, credit facilities). MINOR WEAKNESSES: (1) The LLM states the prior 364-day facility was 'terminated' but the ground truth doesn't explicitly confirm termination—it only states a new one was 'obtained.' This is a minor semantic issue since obtaining a new facility typically implies the old one expired/was replaced, but the ground truth is less definitive on this point. (2) The LLM could have been more explicit about the original October 2026 expiration date for the $3 billion facility (mentioned in ground truth) to show the evolution more clearly, though this omission is minor. (3) The phrase 'changes that preserve the same leverage limits' is an inference not explicitly stated in the ground truth—the ground truth says Target 'continued to assert compliance' but doesn't explicitly state the leverage limits remained unchanged. This is a reasonable inference but represents slight overreach. QUANTITATIVE VERIFICATION: All numbers check out—$1 billion, $3 billion, 2028 maturity, 364-day facility, 2023 timing all correct. No calculation errors. The answer demonstrates solid multi-hop reasoning by connecting compliance status across years with facility changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 470,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "\nFrom 2023 to 2024 the AI‑related risk narrative shifted from a broad focus on competition, uncertain monetization and the challenges of integrating generative‑AI features such as Agentforce into existing clouds, to a more concrete set of regulatory, privacy and ethical exposures.  The 2024 filing emphasizes newly‑enacted AI‑specific statutes (e.g., Utah and Colorado AI Acts, the EU AI Act), heightened data‑privacy and cross‑border transfer obligations, and the need for extensive governance around accuracy, bias, copyright and liability of generative‑AI outputs, while also noting pricing volatility from consumption‑based models.  In short, the risks have moved from “will AI sell?” to “how do we comply with emerging AI laws and manage the legal‑ and reputation‑risk of generative‑AI behavior?”.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Salesforce's AI risk profile from 2023 to 2024, with accurate identification of key regulatory and compliance concerns. STRENGTHS: (1) Correctly identifies the shift from monetization/integration challenges to regulatory and ethical concerns; (2) Accurately names specific regulations (Utah AI Act, Colorado AI Act, EU AI Act) that appear in 2024 filings; (3) Properly synthesizes the multi-hop concept that risks evolved from 'will AI sell?' to 'how do we comply?'; (4) Mentions key risk categories: accuracy, bias, copyright, liability, data privacy, and governance; (5) Notes pricing volatility from consumption-based models, showing comprehensive understanding. WEAKNESSES: (1) The original answer specifically mentions 'third-party integrations and applications' as the 2023 primary risk focus, which the LLM answer does not capture - instead the LLM focuses on 'competition, uncertain monetization and integration challenges' which is broader but not precisely aligned with the ground truth's emphasis on third-party liability concerns; (2) The LLM answer does not explicitly mention the 2023 focus on 'customer expectations for warranties' on third-party offerings, which was a specific risk articulation in the original; (3) The LLM answer adds details about 'pricing volatility from consumption-based models' which, while potentially accurate, is not mentioned in the original answer and may represent information beyond what was in the knowledge graph. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and identifies the evolution pattern, though it frames the 2023 risks somewhat differently than the ground truth. The core insight about the shift from business model uncertainty to regulatory/compliance concerns is sound and well-articulated. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical. The answer contains no numerical errors. SEMANTIC EQUIVALENCE: While the wording differs significantly from the original, the semantic content largely aligns on the main evolution narrative, though with some framing differences on what the 2023 risks specifically were.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 602,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Lowe’s accelerated parcel‑eligible delivery by expanding its market‑based delivery network and gig‑provider fleet.  In FY 2023 most parcel items could be shipped within two business days, and same‑day delivery was limited to a few products; by FY 2024 the company had rolled out the market‑based model nationwide, added capacity for big‑and‑bulky goods, and extended same‑day delivery across the country, enabling next‑day delivery of major appliances in almost every ZIP code and broader two‑day standard shipping for the majority of parcel‑eligible items.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information when compared to the ground truth. CORRECT ELEMENTS: (1) The core fact that FY 2023 had two-business-day delivery for most parcel-eligible items is accurate. (2) The statement about next-day delivery for major appliances in nearly every/almost every ZIP code in FY 2024 is correct. (3) The mention of two-day standard shipping for majority of parcel-eligible items in FY 2024 aligns with ground truth. PROBLEMATIC ELEMENTS: (1) The LLM introduces claims about 'same-day delivery' being 'limited to a few products' in FY 2023 and then 'extended same-day delivery across the country' by FY 2024. The ground truth makes NO mention of same-day delivery at all - it only discusses two-business-day and next-day delivery. This is a significant factual error/hallucination. (2) The LLM adds details about 'market-based delivery network,' 'gig-provider fleet,' and 'big-and-bulky goods' that are not present in the ground truth. While these details might be accurate from the actual filings, they represent information synthesis beyond what the ground truth specifies. (3) The phrasing 'two business days or less' in ground truth is subtly different from the LLM's 'two-day standard shipping' - though semantically similar, the ground truth emphasizes the improvement to 'or less.' MULTI-HOP REASONING: The LLM does attempt to synthesize the evolution between two fiscal years, but introduces unverified claims about same-day delivery that contradict the ground truth's focus on two-business-day and next-day delivery. The answer conflates different delivery speed tiers. QUANTITATIVE ACCURACY: Geographic coverage claims ('nearly every' vs 'almost every' ZIP code) are semantically equivalent and acceptable. However, the introduction of same-day delivery claims without ground truth support is a quantitative/factual error. OVERALL: The answer captures the main improvement (next-day appliance delivery expansion) but introduces significant inaccuracies regarding same-day delivery that were not part of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 560,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "\nThe Dermstore sale accounted for less than 1 % of Target’s consolidated revenue in both 2022 ($≈ $1 bn of $109.1 bn) and 2023 ($≈ $1 bn of $107.4 bn), and the only gain from the transaction—a $335 million pretax benefit—was recognized in 2021; consequently, the sale’s contribution to revenue is now essentially immaterial, and the increase in operating income from $3.85 bn in 2022 to $5.71 bn in 2023 reflects other operational improvements rather than the sale.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct but contains some issues worth noting: (1) CORRECT ELEMENTS: The answer correctly identifies that Dermstore represented less than 1% of consolidated revenues in both years, correctly cites the $335 million pretax gain recognized in 2021, correctly notes the sale occurred in February 2021, and correctly identifies that the sale's post-2021 financial impact is immaterial. The operating income figures ($3.85B in 2022, $5.71B in 2023) appear accurate. (2) QUANTITATIVE ISSUES: The LLM provides estimated revenue figures ($1 billion for Dermstore in both years) that are not explicitly stated in the ground truth. While the 'less than 1%' characterization is correct (which would support ~$1B estimates given total revenues of $109.1B and $107.4B), these specific estimates are not verified against the original filing data and represent an inference rather than stated fact. (3) MULTI-HOP REASONING: The answer correctly synthesizes information across years (2022-2023) and connects the sale event (2021) to its ongoing impact. The reasoning that the operating income increase reflects 'other operational improvements rather than the sale' is sound and demonstrates proper multi-hop synthesis. (4) COMPLETENESS: The answer addresses both the revenue and operating income aspects of the question, though it could have been more explicit about the 'evolution' or lack thereof between the two years. The ground truth emphasizes that the impact 'remained minimal' and 'no significant post-sale financial contribution or change was observed,' which the LLM captures but could state more directly. (5) MINOR WEAKNESS: The LLM's inclusion of specific revenue estimates ($1 billion) without explicit source attribution is slightly speculative, though mathematically consistent with the 'less than 1%' statement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 499,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "\nBetween 2023 and 2024 Salesforce reframed Data Cloud from a back‑end data‑unification engine that powers its Customer 360 and Einstein AI tools into a stand‑alone, consumption‑based offering that is tightly coupled with the Agentforce AI platform and serves as a primary growth lever across the broader service portfolio.  This shift reflects a strategic pivot toward monetising the data layer amid intensifying competition from other AI‑centric cloud vendors, while also exposing Data Cloud to pricing uncertainty and the need to prove its value to enterprise customers.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and inaccurate elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. The LLM correctly identifies that Data Cloud evolved between 2023 and 2024\n2. Accurately captures the shift toward consumption-based pricing models\n3. Correctly notes increased competition from AI and data platforms\n4. Properly identifies pricing uncertainty and monetization challenges\n5. Appropriately references the connection to AI/Agentforce positioning\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. MAJOR ERROR: The LLM claims Data Cloud became \"tightly coupled with the Agentforce AI platform\" - the ground truth makes no mention of Agentforce coupling. This appears to be an unsupported inference or hallucination.\n2. MAJOR ERROR: The LLM describes Data Cloud as a \"stand-alone, consumption-based offering\" in 2024, but the ground truth emphasizes it remained integrated across Salesforce offerings (Marketing, Analytics) while also being positioned within competitive risk context. The LLM overstates the \"stand-alone\" characterization.\n3. INCOMPLETE: The LLM misses the key 2023 positioning detail about Data Cloud being a \"hyperscale, trusted data engine native to Salesforce\" that unified enterprise data for 360-degree customer view.\n4. INCOMPLETE: The LLM doesn't adequately capture that the 2024 shift was specifically about acknowledging \"limited experience in pricing consumption-based models\" - a more cautious/risk-aware positioning than the LLM's framing suggests.\n5. TONE MISMATCH: The ground truth emphasizes a shift from \"product-centric messaging to one that includes strategic risk and monetization challenges\" - a more nuanced, risk-aware positioning. The LLM frames it more as a confident \"strategic pivot toward monetising the data layer,\" which overstates confidence.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize the evolution across years but introduces unsupported elements (Agentforce coupling) and mischaracterizes the nature of the positioning shift. The reasoning is partially sound but contains logical leaps not supported by the ground truth.\n\nQUANTITATIVE ACCURACY: No specific numbers were required in this qualitative question, so this scores high by default (8/10 - minor deduction for not being more precise about the nature of the positioning).\n\nQUALITATIVE ACCURACY: Moderate-to-low due to the introduction of unsupported claims (Agentforce coupling) and mischaracterization of the strategic positioning as more confident than the ground truth indicates.\n\nCONTEXTUAL RELEVANCE: The answer addresses the question but with significant inaccuracies that undermine its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 710,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Lowe’s changed how it accounts for its forward interest‑rate swaps.  In 2023 the swaps were designated as **cash‑flow hedges** of the interest‑rate risk associated with upcoming debt issuances (a $1.29 bn notional amount) and the after‑tax loss on those hedges was recorded in other‑comprehensive income – $102 m of expense in 2023 (page 59).  In 2024 the same instruments were re‑designated as **fair‑value hedges** of existing fixed‑rate debt and the Company applied the shortcut method, which assumes perfect effectiveness; consequently the fair‑value changes of the swaps now offset the hedged debt’s fair‑value changes directly in earnings, leaving only a modest $5 m after‑tax gain/loss in OCI (page 59) and no net earnings impact from the derivative itself (page 58).  This evolution eliminated the earnings volatility that existed under the cash‑flow‑hedge treatment and resulted in essentially a zero net financial impact from the swaps in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) NOTIONAL AMOUNT ERROR: LLM states $1.29 billion notional amount for 2023 swaps, but ground truth clearly states $2.0 billion notional amount. This is a significant 35% understatement of the actual notional value. (2) SETTLEMENT PROCEEDS MISSING: Ground truth explicitly mentions LOW received $247 million upon settlement of the March 2023 Notes swaps - the LLM completely omits this material financial impact. (3) OCI LOSS AMOUNT DISCREPANCY: LLM cites $102 million after-tax expense in 2023 OCI, but ground truth indicates the loss/gain was recorded in both OCI and earnings without specifying the exact $102M figure as the sole impact. The ground truth is less specific on this number. (4) 2024 OCI IMPACT: LLM mentions $5 million after-tax gain/loss in OCI for 2024, which is not mentioned in the ground truth at all - this appears to be an unsupported detail. (5) CORRECT ELEMENTS: The LLM correctly identifies the shift from cash flow hedges (2023) to fair value hedges (2024), correctly notes the shortcut method application, correctly states no net earnings impact in 2024, and correctly explains the elimination of earnings volatility. The multi-hop reasoning about the evolution of accounting treatment is sound. (6) SYNTHESIS QUALITY: The LLM demonstrates good understanding of the conceptual shift and its implications, but fails on critical quantitative accuracy. The $2.0B vs $1.29B notional amount error and missing $247M settlement proceeds are material omissions that significantly understate the financial magnitude of these instruments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 436,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "\nFrom 2022 to 2023 Target’s owned‑brand strategy shifted from a primary focus on expanding the size and variety of its brand portfolio — “strengthening our owned‑brands portfolio, curating leading national brands, and expanding the breadth and depth of signature partnerships” — to a more curated, partnership‑centric model that leverages exclusive collaborations (e.g., Apple, Disney, Levi’s, Ulta) and the Roundel advertising platform to drive discovery and traffic.  The strategic objective evolved to use these owned and exclusive brands as a differentiator that deepens guest relevance, fuels omnichannel sales (with stores acting as fulfillment hubs), and supports growth in market share while maintaining the value‑price proposition.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH CORE CLAIMS: The LLM answer introduces specific brand partnerships (Apple, Disney, Levi's, Ulta) and mentions the 'Roundel advertising platform' as key strategic elements in the 2023 evolution. However, the ground truth makes NO mention of these specific partnerships or the Roundel platform as part of the owned brands strategy evolution. This represents a significant factual error - the LLM appears to have fabricated or conflated information not present in the source material. WHAT WAS CORRECT: (1) The general direction of evolution from 2022 to 2023 is directionally accurate - moving toward more strategic positioning. (2) The mention of 'strengthening owned brands portfolio' aligns with ground truth language. (3) The connection to traffic, sales, and market share growth is correct. (4) The omnichannel/fulfillment hub concept is reasonable but not explicitly stated in ground truth. WHAT WAS INCORRECT/MISSING: (1) The ground truth emphasizes 'over 40 brands' in 2022 - the LLM completely omits this quantitative detail. (2) The ground truth's specific 2023 positioning around 'delight with newness, style, and value' is not mentioned in the LLM answer. (3) The LLM's characterization of the shift as moving FROM 'expanding breadth and depth' TO 'curated partnership-centric' is not supported by the ground truth, which frames it as moving from descriptive presence to strategic leverage. (4) The specific brand partnerships cited (Apple, Disney, Levi's, Ulta) appear to be hallucinations or from different contexts not supported by the provided ground truth. MULTI-HOP REASONING: The LLM failed to properly synthesize the actual evolution described in the ground truth - it created a narrative around specific partnerships that don't appear in the source material. The reasoning quality is compromised by these factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 503,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "\nFrom 2022 to 2023 GM moved beyond isolated after‑sale services (maintenance, OnStar, extended warranties) that were booked as deferred revenue over a multi‑year period, to a unified, end‑to‑end software platform that is being rolled out across most of its vehicle lineup.  The 2023 disclosures highlight expanded subscription‑based offerings—such as advanced driver‑assist, security, climate‑control and EV‑ownership features—and deeper connectivity (e.g., new charging‑network partnerships and over‑the‑air updates), indicating that GM is deliberately building a scalable, recurring‑revenue digital ecosystem to complement its hardware business.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces significant inaccuracies and unsupported claims. CORRECT ELEMENTS: (1) The evolution from 2022 to 2023 is accurately identified; (2) The mention of end-to-end software platform is correct; (3) Over-the-air updates are correctly mentioned; (4) The shift toward scalable, recurring-revenue digital ecosystem is accurate; (5) The general characterization of moving from isolated services to unified platform is sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific service offerings (advanced driver-assist, security, climate-control) that are NOT mentioned in the ground truth answer. While these may exist in the actual filings, they are not part of the verified ground truth provided; (2) The LLM mentions 'charging-network partnerships' which is not in the ground truth answer and appears to be an inference or addition not verified; (3) The LLM characterizes 2022 services as 'isolated after-sale services (maintenance, OnStar, extended warranties)' with specific deferred revenue language - this level of detail is not in the ground truth, which only states GM 'provides software-enabled services worldwide'; (4) The ground truth specifically mentions Super Cruise, active safety, infotainment, and EV ownership experience as the platform capabilities, while the LLM lists different features (advanced driver-assist, security, climate-control). MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across years and identifies the strategic shift, but adds details not verified in the ground truth. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is neutral. The LLM does not contradict any numeric facts but adds unverified claims. The answer demonstrates understanding of the general trend but introduces specificity that goes beyond what can be verified from the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 515,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the Optimized Application Experiences (now reported as the Observability category) grew from **$581 million to $661 million**—an increase of roughly **14 %**—and management repeatedly cites **ThousandEyes** as a primary driver of that expansion.  The sustained rise in the category’s revenue, together with the explicit reference to ThousandEyes‑related growth in the fiscal‑2022 versus fiscal‑2021 discussion, shows that ThousandEyes’ contribution expanded materially during the 2022‑2023 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about the category name change (Optimized Application Experiences to Observability) and correctly identifies ThousandEyes as a primary driver of growth. However, there are significant quantitative discrepancies that undermine the answer's accuracy. The LLM states the category grew from $581M to $661M (a $80M increase of 14%), which aligns with the ground truth's mention of an $80M increase at 14% for FY2023. However, the ground truth also specifies that FY2022 saw a $75M increase (11%) in the Optimized Application Experiences category. The LLM answer does not clearly distinguish between the FY2022 and FY2023 growth metrics separately—it conflates them by presenting only the FY2023 figures ($581M to $661M, 14% growth) without explicitly addressing the FY2022 growth ($75M, 11%). The answer correctly identifies ThousandEyes as a driver in both years but fails to provide the specific FY2022 growth figures ($75M, 11%) that the ground truth emphasizes. The reasoning about 'material expansion' is sound and the category name transition is correctly noted, but the answer is incomplete in not separately quantifying the FY2022 contribution. The multi-hop synthesis is partially successful—it connects ThousandEyes to category growth across years—but lacks the granular year-by-year breakdown that the question specifically asks for ('evolved between fiscal years 2022 and 2023'). The answer would have been stronger with explicit statement of both years' growth metrics: FY2022 ($75M, 11%) and FY2023 ($80M, 14%).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 429,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "\nIn the 2023 Form 10‑K the amendment was only footnoted—listed as “Exhibit 10.1 to the September 2022 10‑Q” within a table of exhibits and not presented as a separate item in the annual filing. By contrast, the 2024 filing explicitly calls it out as Item 10.34, a stand‑alone exhibit to the 10‑K, thereby giving the amendment a dedicated disclosure spot. This shift indicates that Lockheed Martin has moved the amendment from a peripheral reference to a deliberate, stand‑alone disclosure, reflecting a broader strategy to highlight material changes to its executive‑severance plan in its annual reports.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims Amendment No. 4 was 'only footnoted' and 'not presented as a separate item' in 2023, but the ground truth explicitly states it WAS disclosed as Exhibit 10.34 in the 2023 filing. The LLM then claims it became 'Item 10.34, a stand-alone exhibit' in 2024, which is backwards—the ground truth indicates it moved FROM being a standalone exhibit (10.34) in 2023 TO being part of a sequence of amendments in 2024. (2) EXHIBIT NUMBERING: The LLM incorrectly references 'Exhibit 10.1' and 'Item 10.34' inconsistently and inaccurately. The ground truth specifies Exhibit 10.34 in 2023. (3) DIRECTIONAL REVERSAL: The LLM's conclusion about the shift is inverted—it claims the amendment moved from 'peripheral reference' to 'dedicated disclosure spot,' when the ground truth indicates the opposite: from highlighted/standalone (2023) to integrated/consolidated (2024). (4) MISSING CONTEXT: The LLM fails to mention that in 2024, Amendment No. 4 appears as part of a sequence including Amendments 2, 3, 4, and 5, which is a key detail explaining the shift to a 'more integrated' approach. (5) MISCHARACTERIZATION: The LLM's interpretation that this reflects a strategy to 'highlight material changes' contradicts the ground truth's assessment that it represents a 'more consolidated and retrospective approach.' The answer demonstrates a fundamental misunderstanding of the filing evolution and provides factually incorrect information on the core question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 432,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "\nJPMorgan’s Standardized CET1 capital ratio rose from **15.0 % at the end of 2023 to 15.7 % at the end of 2024**, reflecting a modest strengthening of its core capital position relative to risk‑weighted assets.  By contrast, its Tier 1 leverage ratio stayed essentially flat at **about 7.2 % in both years**, comfortably above the regulatory minimum of 4.0 %.  Thus, while the firm’s leverage compliance was unchanged, its CET1 ratio improved, indicating better adherence to the Basel III capital‑ratio requirements from 2023 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ACCURACY PROBLEMS: The LLM claims the Standardized CET1 capital ratio rose from 15.0% in 2023 to 15.7% in 2024, but the ground truth only provides the 2023 figure of 15.0% with a requirement of 11.4%. The LLM fabricated the 2024 CET1 ratio of 15.7% with no supporting evidence from the ground truth. (2) TIER 1 LEVERAGE RATIO DISCREPANCY: The LLM states the ratio was 'about 7.2% in both years,' but the ground truth only specifies that in 2024 the Tier 1 leverage ratio was 7.2% above the 4.0% requirement. The ground truth does not provide a 2023 Tier 1 leverage ratio figure, so the LLM's claim that it remained 'essentially flat' at 7.2% in both years is unsupported and likely incorrect. (3) MULTI-HOP REASONING FAILURE: The LLM attempted to synthesize year-over-year evolution but did so by introducing data points not present in the ground truth. The question asks about evolution from 2023 to 2024, but the ground truth provides incomplete data (2023 CET1 only, 2024 Tier 1 leverage only), making a complete year-over-year comparison impossible. The LLM should have acknowledged this data limitation rather than filling gaps with invented figures. (4) SEMANTIC ISSUES: While the LLM correctly identifies that JPMorgan maintained compliance and that ratios exceeded minimums, the specific numerical claims are fabricated. The statement about 'modest strengthening' of CET1 from 15.0% to 15.7% cannot be verified and appears to be hallucinated. (5) WHAT WAS CORRECT: The LLM correctly identified the 2024 Tier 1 leverage ratio of 7.2% and the 4.0% regulatory minimum, and correctly noted compliance. The 2023 CET1 ratio of 15.0% is also correct. However, these correct elements are overshadowed by the introduction of unverified data (2024 CET1 of 15.7% and 2023 Tier 1 leverage of 7.2%).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 520,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "\nBetween 2022 and 2023 GM Financial was fully folded into GM’s consolidated reporting: its interest income and expense are now shown as part of operating results (using an EBT‑adjusted metric) and its debt issuance and repayments are reported in the overall financing cash‑flow (e.g., $50.9 bn of new debt and $44.7 bn of repayments in 2023 versus $45.8 bn and $39.6 bn in 2022).  This tighter integration is reflected in the equity section, where the related non‑controlling interest and temporary‑equity balances have been eliminated, giving a more streamlined presentation of GM Financial’s financial position within the consolidated statements.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that diverge substantially from the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM provides specific debt figures ($50.9bn new debt, $44.7bn repayments in 2023; $45.8bn and $39.6bn in 2022) that cannot be verified against the ground truth and appear to be fabricated or incorrectly sourced. These numbers are presented with false confidence as evidence of 'full integration' but are not substantiated in the original answer. (2) FACTUAL MISREPRESENTATION: The ground truth describes an evolution in how GM Financial's financials are presented and adjusted for tax purposes - a descriptive/accounting change. The LLM fundamentally mischaracterizes this as 'full folding into consolidated reporting' with elimination of 'non-controlling interest and temporary-equity balances,' which is not supported by the ground truth. The ground truth makes no mention of eliminating non-controlling interests or temporary equity. (3) MULTI-HOP REASONING FAILURE: The LLM attempts to synthesize information about cash flows, equity sections, and operating results integration, but this synthesis appears to be either fabricated or drawn from incorrect sources. The ground truth focuses on the evolution of descriptive language and tax adjustment methodology, not structural consolidation changes. (4) SEMANTIC DIVERGENCE: While the question asks about 'integration and financial presentation,' the ground truth emphasizes the evolution of disclosure language and tax treatment adjustments. The LLM invents a narrative about structural consolidation that contradicts the actual ground truth. The answer demonstrates hallucination of specific financial metrics and misinterpretation of what constitutes the actual change between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 491,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "\nFrom 2022 through 2024 the Company continued to account for step‑rent provisions and any periodic rent increases tied to price indices or sales volume by recognizing the total lease payments on a straight‑line basis over the lease term (including renewal options that are reasonably certain to be exercised). The 2024 filing adds that such variable‑rent components are excluded from the initial right‑of‑use asset and lease‑liability measurement and are expensed as incurred, with the resulting lease expense presented evenly over the lease term.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth on the core accounting treatment evolution. Ground truth states: (1) 2022: straight-line accounting for step-rent provisions and periodic increases based on price indices/sales volume, and (2) 2024: shift to recognizing these as variable lease payments (NOT straight-lined). The LLM answer claims the opposite: that the company 'continued to account for step-rent provisions...by recognizing the total lease payments on a straight-line basis' through 2024, which directly contradicts the ground truth's assertion of a shift away from straight-line treatment. The LLM does correctly identify that variable-rent components are excluded from initial ROU asset/liability measurement and expensed as incurred, which aligns with variable lease payment treatment, but this contradicts its own statement that they are 'straight-lined.' The LLM appears to conflate two different concepts: (a) the overall lease expense being presented evenly (which could result from straight-lining), and (b) variable components being excluded and expensed as incurred (which is the 2024 treatment per ground truth). The critical error is the failure to identify the evolution/shift in treatment between 2022 and 2024. The LLM states continuity ('continued to account') when the ground truth explicitly indicates a change in accounting approach. No quantitative errors exist (dates and years are correct), but the qualitative understanding of the accounting treatment evolution is severely flawed, making this answer substantially incorrect on the primary question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 442,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "\nThe tables of estimated future benefit payments show that the qualified defined‑benefit pension plan’s expected cash outflow for 2025 fell slightly from **$1.86 billion in the 2023 outlook to $1.80 billion in the 2024 outlook**.  Likewise, the long‑term aggregate projected to be paid from 2029 through 2033 (re‑stated in the 2024 filing as the 2030‑2034 window) declined modestly from **about $10.02 billion to roughly $9.99 billion**.  The company also noted that no additional required contributions are expected to be made to the qualified plans in 2025.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2025 payment projection. The ground truth states that the 2025 payment was $1,860 million in both 2023 and 2024 (no change), but the LLM claims it 'fell slightly from $1.86 billion in the 2023 outlook to $1.80 billion in the 2024 outlook.' This is incorrect - the LLM incorrectly states the 2024 figure as $1.80 billion when it should be $1.86 billion (or $1,860 million). This is a material error that contradicts the ground truth. The long-term projection comparison is correct ($10.02 billion to $9.99 billion, or $10,020 million to $9,990 million), and the characterization of the change as 'modest' is appropriate. The LLM correctly identifies the period shift from 2029-2033 to 2030-2034. However, the fundamental misstatement about the 2025 payment declining when it actually remained flat is a major factual error that undermines the answer's reliability. The additional note about no required contributions in 2025 is contextually relevant but not part of the original ground truth answer. The multi-hop reasoning structure is sound (comparing 2023 to 2024 projections), but the execution contains a critical numerical error that significantly impacts correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 358,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "\nIn the 2023 filing JPMorgan warned that rating downgrades and higher capital‑buffer requirements could strain liquidity and raise the cost of issuing and servicing debt, but it only referenced its resolution‑plan obligations in general terms. By the 2024 filing the discussion is more explicit: the company ties its liquidity‑risk management to the need to pre‑position liquidity in key subsidiaries and to meet resolution‑plan triggers, noting that new Basel III and GSIB‑surcharge proposals—and any breach of capital or liquidity thresholds—could accelerate bankruptcy‑or‑resolution proceedings and further increase funding costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH CORE CONTENT: The LLM answer introduces significant factual errors and misalignments with the ground truth. (1) INCORRECT FRAMING: The LLM discusses rating downgrades and capital-buffer requirements in 2023, which are NOT mentioned in the ground truth as the primary focus. The ground truth specifically emphasizes liquidity coverage ratio (LCR) and net stable funding ratio (NSFR) requirements, regulatory demands for liquidity pre-positioning in subsidiaries, and reliance on alternative funding sources. (2) MISSING KEY 2023 ELEMENTS: The LLM fails to capture the ground truth's emphasis on how resolution plan obligations could lead to higher funding costs and constrained liquidity due to specific regulatory requirements (LCR/NSFR). The ground truth mentions deposits and Federal Home Loan Bank borrowings as traditional funding sources that could be reduced. (3) INCORRECT 2024 CHARACTERIZATION: While the LLM mentions Basel III and GSIB-surcharge proposals, the ground truth emphasizes a different evolution—the 2024 disclosure expanded to include how resolution obligations interact with dynamic regulatory expectations and systemic events, with focus on changes in laws/rules/regulations in response to economic effects of systemic events. The LLM's mention of 'bankruptcy-or-resolution proceedings' is not supported by the ground truth. (4) MISSING CRITICAL SYNTHESIS: The ground truth highlights a shift toward framing resolution-related liquidity risks within broader regulatory evolution and macroeconomic uncertainty. The LLM misses this broader contextual shift. (5) QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. (6) MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution between years—it doesn't capture how the 2024 disclosure represents an expansion of scope (from specific regulatory requirements to systemic event considerations) rather than just becoming 'more explicit' about the same issues. The answer demonstrates a fundamental misunderstanding of what changed between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 564,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "\nBetween 2022 and 2023 Optum Rx continued to recognize product revenue at the moment a prescription is dispensed, while service‑related fees are recorded over the period the services are provided.  The company’s accounts‑receivable balance for products and services rose from **$7.1 billion (2022) to $8.6 billion (2023)**, and “other current receivables” for manufacturer rebates jumped from **$8.2 billion to $11.0 billion**, reflecting higher prescription volumes and longer collection cycles for those rebates.  Thus, while the underlying revenue‑recognition model stayed the same, the scale of receivables—and the timing of rebate recoveries—expanded materially in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and evolution between 2022-2023. STRENGTHS: (1) All primary numbers are accurate: accounts receivable correctly stated as $7.1B (2022) to $8.6B (2023), matching ground truth exactly; (2) Additional detail on 'other current receivables' for manufacturer rebates ($8.2B to $11.0B) provides valuable context not in ground truth but appears factually sound; (3) Revenue recognition model correctly described - product revenue at point of dispensing, service fees over service period; (4) Multi-hop synthesis is sound, connecting revenue recognition practices to accounts receivable growth; (5) Explanation of growth drivers (higher prescription volumes, longer collection cycles) is logical and reasonable. MINOR WEAKNESSES: (1) The ground truth emphasizes the 'gross revenue reporting model' and the company's 'primary obligation to pay network pharmacy providers regardless of payment collection' - the LLM answer doesn't explicitly highlight this structural characteristic, though it's not contradicted; (2) The LLM introduces information about manufacturer rebate receivables that, while accurate and relevant, goes slightly beyond the specific scope of the ground truth answer (which focused on 'accounts receivable related to products and services'); (3) The phrasing differs from ground truth but conveys equivalent meaning. CALCULATION VERIFICATION: The $7.1B to $8.6B increase represents a $1.5B or ~21% growth, which is consistent with the characterization of 'material' expansion. The rebate receivables increase from $8.2B to $11.0B represents a $2.8B or ~34% increase. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between revenue recognition methodology and accounts receivable balances across the two-year period. The answer is more comprehensive than the ground truth while remaining factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 525,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 UPS kept its floating‑to‑fixed interest‑rate swaps on the balance‑sheet as cash‑flow hedges of forecasted fixed‑coupon debt, but the quantitative footprint grew noticeably: the balance of pre‑tax gains deferred in AOCI rose from a modest $(117) million in 2023 to $389 million in 2024, with $146 million of those gains expected to be re‑classified to earnings over the next 12 months.  At the same time, the cumulative fair‑value adjustments recorded on existing long‑term debt remained tiny (≈ $4 million), indicating that the company’s strategic emphasis shifted toward using larger cash‑flow swap positions to lock in lower fixed rates as market rates changed, while still maintaining only limited fair‑value hedge activity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question. CRITICAL ISSUES: (1) The ground truth establishes that in 2022, UPS had a $28 million notional amount for Floating to Fixed Interest Rate Swaps, and by 2024 articulated a broader strategic approach. The LLM answer completely ignores the 2022 baseline ($28 million notional) and the 2024 strategic articulation that form the foundation of the ground truth answer. (2) The LLM introduces numbers NOT in the ground truth ($(117) million in 2023, $389 million in 2024 AOCI gains, $146 million reclassification, $4 million fair-value adjustments) without verification against the original filing data. These appear to be fabricated or from different contexts entirely. (3) The LLM shifts focus from the core evolution question (quantitative exposure growth from $28M notional + strategic shift) to AOCI accounting entries and cash-flow hedge mechanics, which is a different analytical lens. (4) The ground truth emphasizes the EVOLUTION from 'limited use' (2022) to 'comprehensive interest rate risk management approach' (2024), while the LLM discusses balance-sheet treatment and fair-value adjustments without establishing this temporal progression. (5) The LLM answer does not directly compare 2022 vs 2024 positions as required by the question. The answer demonstrates hallucination of specific financial figures and misses the essential narrative of strategic evolution that the ground truth captures. The semantic meaning is fundamentally different - ground truth focuses on notional amounts and strategic intent evolution; LLM focuses on AOCI gains and hedge accounting mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 457,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "\nBetween 2022 and 2023 the GM‑LG Energy Solution (LGES) relationship shifted from an initial, largely unreimbursed recall to a structured cost‑sharing arrangement.  In 2023 GM had accrued $2.6 billion for the Chevrolet Bolt/EUV battery recall, of which $1.6 billion represented expected reimbursements from LGES and a remaining $0.6 billion accrual was still on the books at year‑end; the 2022 filing showed the first $1.1 billion accrual and the start of commercial negotiations for reimbursement.  The expanded recall (covering 2017‑2022 model years) and the settlement of related commercial matters with LGES underscore a deepening financial linkage, especially as the pair’s Ultium Cells LLC joint venture became a central pillar of GM’s EV battery strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about GM's evolving relationship with LG Energy Solution between 2022-2023, correctly identifying the shift from strategic collaboration to cost-sharing arrangements. However, there are significant quantitative accuracy issues:\n\nCORRECT ELEMENTS:\n- Correctly identifies the $2.6 billion total accrual for Chevrolet Bolt EV/EUV battery recall in 2023\n- Correctly identifies $1.6 billion as expected reimbursements from LGES\n- Correctly references Ultium Cells LLC as the joint venture\n- Correctly characterizes the relationship shift from strategic to transactional/cost-driven\n- Appropriately synthesizes multi-hop information across 2022-2023 filings\n\nPROBLEMATIC ELEMENTS:\n- States \"$0.6 billion accrual was still on the books at year-end\" - this calculation is incorrect. If total accrual is $2.6B and $1.6B is receivable from LGES, the remaining accrual should be $1.0B ($2.6B - $1.6B), not $0.6B. This is a material calculation error.\n- References \"$1.1 billion accrual\" in 2022 filing - the ground truth does not explicitly confirm this figure, and the LLM appears to be inferring or adding detail not clearly stated in the original answer\n- The phrase \"remaining $0.6 billion accrual was still on the books\" is confusing and mathematically inconsistent with the stated figures\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across 2022 and 2023 filings, correctly identifying the temporal evolution and the relationship between the joint venture activities and recall costs. The reasoning about the shift from strategic to transactional is sound.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates good understanding of the relationship dynamics and correctly identifies key figures ($2.6B total, $1.6B receivable), but the arithmetic error regarding the remaining accrual ($0.6B vs. correct $1.0B) and unsupported claims about 2022 figures reduce confidence in quantitative accuracy. The qualitative understanding of the relationship evolution is strong, but the mathematical inconsistency is a significant flaw in a financial analysis context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 573,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "\nIn fiscal 2022 the Observability product category (which includes ThousandEyes) generated about **$581 million** in product revenue, and by fiscal 2023 that figure rose to **$661 million**—an increase of roughly **$80 million or 14 %**—with the growth being driven largely by the ThousandEyes offering (as noted in the fiscal 2023 vs. 2022 discussion of the Observability category).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the ground truth information. Key issues: (1) WRONG NUMBERS: The LLM states Observability revenue was $581M in FY2022 and $661M in FY2023, but the ground truth indicates the category increased BY $80M in FY2022 and BY $176M in FY2023—these are incremental increases, not absolute revenue figures. The LLM appears to have confused incremental growth with absolute revenue levels. (2) WRONG PERCENTAGE: The LLM calculates a 14% increase ($80M/$581M), but the ground truth explicitly states FY2023 saw a 27% revenue increase. The 14% figure doesn't match either the ground truth's 27% or the organic growth of 15% excluding Splunk. (3) INCOMPLETE CONTEXT: The LLM fails to mention the critical FY2023 development—the inclusion of Splunk's Observability Suite as a key contributor and the distinction between total growth (27%) versus organic growth excluding Splunk (15%). This is essential context for understanding the evolution. (4) MISSING SYNTHESIS: The ground truth requires synthesizing information about two fiscal years with different dynamics (FY2022 organic growth vs. FY2023 organic + acquisition growth). The LLM only addresses FY2022-to-FY2023 comparison without properly distinguishing the drivers. (5) CALCULATION ERROR: Even if the $581M and $661M figures were correct, the percentage calculation is imprecise ($80M/$581M = 13.8%, not 14%, though this is minor compared to the fundamental number errors). The answer demonstrates a fundamental misunderstanding of the question's multi-hop nature and fails to accurately convey how ThousandEyes' contribution evolved across the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 458,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 the 7.620 % Debentures kept the same redemption framework that was set when the issue was originally launched.  The securities remain callable at UPS’s option at any time, with a redemption price equal to the greater of (i) principal plus accrued interest or (ii) the present value of the remaining scheduled payments discounted at a benchmark Treasury yield plus five basis points, plus accrued interest; they are not subject to any sinking‑fund requirements.  The interest rate stayed fixed at 7.620 % (having been reduced from 8.375 % on April 1 2020) and continues to be paid semi‑annually in April and October, with no amendment to these terms disclosed for 2022‑2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) PRINCIPAL AMOUNT ERROR: The LLM fails to mention the $276 million principal amount or $280 million carrying value from 2022, which are key quantitative facts. (2) INTEREST RATE HISTORY ERROR: The LLM claims the interest rate was 'reduced from 8.375% on April 1 2020' - this is not mentioned in the ground truth and appears to be fabricated information not supported by the source documents. (3) EVOLUTION MISCHARACTERIZATION: The ground truth explicitly states there was an 'evolution' and 'shift from a general description of the debentures in 2022 to a more detailed explanation' in 2024. The LLM incorrectly claims 'the 7.620% Debentures kept the same redemption framework' and that there was 'no amendment to these terms disclosed for 2022-2024,' which contradicts the ground truth's characterization of how the relationship evolved. (4) MISSING KEY DETAILS: The LLM does not acknowledge that 2022 had only a general description while 2024 provided detailed redemption terms and interest payment specifications. (5) CORRECT ELEMENTS: The LLM does correctly identify the 7.620% interest rate, semi-annual payment schedule (April and October), the redemption price formula (greater of principal plus accrued interest or present value calculation), and the lack of sinking-fund requirements. However, these correct elements are overshadowed by the fundamental misunderstanding of how the relationship evolved between the two years and the introduction of unsupported claims about prior interest rate reductions. The answer fails to address the core question about how the relationship 'evolved' between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 472,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "\nFrom 2022 to 2023 the total fair‑value of MET’s Fixed‑Maturity Securities‑AFS slipped modestly, from **$6.802 bn** to **$6.714 bn**.  During the same period the **U.S. government‑bond slice grew** to **$1.575 bn** (up from $1.507 bn) and the **corporate‑security portion rose** to **$3.083 bn** (up from $3.001 bn).  In other words, government and corporate exposures expanded slightly, but the overall AFS portfolio was trimmed a little, reflecting reductions in other asset classes such as foreign bonds and municipals.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the question and provides mostly accurate information with sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 2023 total fair value of $6.714 billion for Fixed Maturity Securities AFS, matching ground truth exactly. (2) Accurately reports U.S. government bonds at $1.575 billion and corporate securities at $3.083 billion for 2023, both matching ground truth. (3) Provides comparative 2022 figures ($6.802 bn total, $1.507 bn government bonds, $3.001 bn corporate securities) that appear reasonable and internally consistent. (4) Correctly synthesizes the multi-hop information showing composition changes across years. (5) Provides logical interpretation that government and corporate exposures expanded while overall portfolio was trimmed. WEAKNESSES: (1) The ground truth mentions a 2021 carrying amount of $2.164 million, which the LLM does not address - however, this appears to be a baseline reference point rather than a 2022 figure, so the omission is minor. (2) The LLM provides 2022 comparative data ($6.802 bn, $1.507 bn, $3.001 bn) that cannot be verified against the ground truth provided, which only gives 2021 and 2023 data. This creates uncertainty about whether the 2022 figures are accurate or inferred. (3) The ground truth mentions Level 1 and Level 2 categorizations ($1.537 million Level 1 for government bonds, $3.029 million Level 2 for corporate securities), which the LLM does not include. QUANTITATIVE VERIFICATION: The 2023 figures match perfectly ($6.714 bn, $1.575 bn, $3.083 bn). The 2022 figures cannot be verified from the provided ground truth but appear internally consistent (government bonds up $68M, corporate securities up $82M, total down $88M). The reasoning about reductions in other asset classes is logical but not explicitly verified. Overall, the answer is substantially correct on the key 2023 metrics and demonstrates proper multi-hop synthesis, though it includes unverified 2022 data and omits fair value level categorizations mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 557,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "\nDuring 2022‑2023 GM deepened its financial commitment to Ultium Cells LLC—continuing to fund the joint venture through additional capital outlays (e.g., the $0.5 bn cash‑outflow recorded in 2021 investing activities and ongoing support via its $10 bn share‑repurchase program and credit facilities)—and in early 2023 the partnership was struck by an EPA TSCA investigation that was settled in November 2023, imposing roughly $5.1 million in civil penalties and joint liability with GM.  Thus, while the alliance expanded financially, it also introduced new regulatory exposure for the venture.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the EPA TSCA investigation and November 2023 settlement with approximately $5.1 million in civil penalties. It accurately captures the shift from investment-based to operationally integrated partnership. The regulatory implications are properly highlighted. The answer demonstrates understanding of the multi-hop synthesis required.\n\nCRITICAL ERRORS: (1) The LLM conflates the $0.5 billion investment with 2021 investing activities when the ground truth specifically states this was reported in 2022. The parenthetical reference '(e.g., the $0.5 bn cash‑outflow recorded in 2021 investing activities)' is factually incorrect—the ground truth clearly states this was a 2022 investment. (2) The LLM introduces the $10 billion share-repurchase program as evidence of deepened financial commitment to Ultium Cells LLC, but this is not mentioned in the ground truth and appears to be a conflation of separate GM financial activities unrelated to Ultium Cells. This is a significant error as it misrepresents the nature of GM's financial involvement with the joint venture.\n\nQUANTITATIVE ACCURACY ISSUES: The $0.5 billion figure is correct in value but incorrectly attributed to 2021 rather than 2022. The $5.1 million settlement figure is accurate. The $10 billion share-repurchase program is not substantiated in the ground truth and appears to be an unsupported claim.\n\nMULTI-HOP REASONING: The answer attempts to synthesize the evolution from 2022 to 2023 but does so with factual errors. The core logic (investment → regulatory exposure) is sound, but the execution is flawed by introducing unverified financial commitments.\n\nSEMANTIC EQUIVALENCE: While the general narrative of deepening commitment and regulatory exposure is conveyed, the specific factual errors undermine the answer's reliability. The ground truth emphasizes a shift from 'primarily investment-based' to 'operationally integrated,' which the LLM captures, but the supporting details are inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 542,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "\nBetween 2022 and 2024 the company did not shift its approach – it continued to purchase a portion of its natural‑gas and fuel (notably for its gas‑station operations) on an index‑based, variable‑price basis.  These contracts were still classified as “normal purchases and normal sales,” so they were recorded without mark‑to‑market adjustments, indicating that the usage and accounting treatment of variable‑priced contracts remained essentially unchanged over the two‑year period.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the evolution of the company's approach to variable-priced contracts. The ground truth explicitly states there was a shift in how these contracts are managed or accounted for between 2022 and 2024 - specifically that by 2024, the company 'explicitly noted that these contracts met the characteristics of derivative instruments' and aligned them with accounting frameworks for derivatives. This represents a more formalized or strategic use by 2024. However, the LLM answer directly contradicts this by stating 'the company did not shift its approach' and that 'usage and accounting treatment remained essentially unchanged.' This is a fundamental misreading of the evolution described in the ground truth. The LLM correctly identifies: (1) the use of index-based, variable-price contracts for natural gas and fuel for gas stations, (2) the 'normal purchases and normal sales' classification, and (3) the lack of mark-to-market adjustments. However, it misses the key insight that by 2024, there was explicit recognition of these contracts as derivative instruments and a more formalized accounting treatment - representing a meaningful evolution from 2022. The answer fails to capture the multi-hop reasoning required to synthesize the change in how the company characterized and managed these contracts across the two-year period. While no specific dollar amounts or percentages were disclosed (so quantitative accuracy is not penalized), the qualitative understanding of the evolution is substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 433,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "\nCisco’s APJC segment continued to exclude the identical set of expenses in fiscal 2023 as it did in fiscal 2022—specifically research‑and‑development, sales‑and‑marketing, general‑and‑administrative costs, amortization and impairment of acquisition‑related intangible assets, share‑based compensation expense, significant litigation settlements and other contingencies, restructuring/impairment charges, and other adjustments to gross margin.  The wording and scope of the exclusions were unchanged, showing no material evolution in the segment‑performance measurement approach between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both answers correctly identify that Cisco's APJC segment maintained consistent exclusions of expense categories between fiscal 2022 and fiscal 2023, with no material evolution in the reporting approach. The LLM answer accurately lists all the excluded expense categories: research and development, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and restructuring/impairment charges. The answer correctly synthesizes the multi-hop information (comparing two fiscal years and identifying consistency in exclusions). The LLM's statement that 'the wording and scope of the exclusions were unchanged' directly supports the ground truth's conclusion about consistency. Minor differences in phrasing (e.g., 'other adjustments to gross margin' in LLM vs. not explicitly mentioned in ground truth) are semantically equivalent and represent reasonable interpretations of the same underlying data. No quantitative errors are present, and the reasoning correctly identifies the lack of evolution in the measurement approach. The answer fully addresses the question's focus on how the approach 'evolved' by correctly noting there was no material evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 381,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 UnitedHealth Group moved from a broadly‑focused cost‑containment toolkit—underwriting standards, product design, provider‑contract negotiations and general care‑management programs—to a more targeted, data‑driven approach that explicitly addresses the surge in senior outpatient utilization.  In 2023 the company began engaging physicians and members with decision‑support information, accelerating value‑based and accountable‑care models, and expanding integrated care‑coordination and analytics to steer seniors toward lower‑cost, high‑quality outpatient services.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the evolution in UNH's approach from 2022 to 2023. STRENGTHS: (1) Correctly identifies the shift from broad cost-containment strategies (underwriting, product design, provider contracts, general care management) in 2022 to targeted, data-driven approaches in 2023; (2) Accurately captures the specific focus on senior outpatient procedure costs as a key concern; (3) Properly synthesizes the multi-hop information showing progression across years; (4) Correctly identifies specific 2023 strategies: physician/member engagement with decision-support information, value-based care models, integrated care coordination, and analytics; (5) No quantitative errors or date inaccuracies; (6) Company name (UnitedHealth Group) correctly identified. MINOR WEAKNESSES: (1) The LLM answer is more detailed and comprehensive than the ground truth, introducing concepts like 'underwriting standards,' 'product design,' and 'accountable-care models' that, while logically consistent with the evolution described, go slightly beyond what the ground truth explicitly states; (2) The ground truth emphasizes the shift from 'general concern' to 'targeted intervention,' while the LLM frames it as moving from 'broadly-focused toolkit' to 'targeted, data-driven approach'—semantically similar but with slightly different framing; (3) The LLM answer doesn't explicitly mention the 2022 concern about deferred care during the pandemic, though this is a minor omission. The answer correctly captures the core narrative of evolution and the specific strategies employed, with accurate synthesis of multi-hop information across the two-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 466,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2024 UPS moved from a largely air‑and‑ground small‑package model to a fully integrated “global smart logistics” network that delivers time‑definite services seven days a week through a single, RFID‑enabled network of pickup points, UPS Access Points and same‑day‑pickup options.  The scope of its time‑definite offering was broadened to include same‑day and returns services, and its digital tools (e.g., the Digital Access Program) were expanded to embed UPS shipping directly into e‑commerce platforms, allowing the company to consolidate all air, ground, domestic and international shipments within one network for greater efficiency and higher‑yield volume.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. CRITICAL ERRORS: (1) The LLM introduces 'RFID-enabled network' and 'Digital Access Program' with no mention in ground truth - these appear to be fabricated details not supported by the source material. (2) The LLM claims 'seven days a week' delivery as a general service evolution, but ground truth specifies only 'same-day pickup seven days a week' - a different service component. (3) The LLM describes a 'global smart logistics' network transformation that is not mentioned in ground truth, which focuses on integrated air/ground network. (4) The LLM omits the critical 2024 development of insourcing final delivery of non-urgent, lightweight residential shipments from USPS through UPS SurePost - a major strategic shift in the ground truth. (5) The LLM mentions 'e-commerce platform integration' and 'Digital Access Program' without any ground truth support. CORRECT ELEMENTS: (1) Same-day pickup expansion is mentioned correctly. (2) Returns services expansion is acknowledged. (3) Network integration concept is present. (4) Service scope broadening is captured. MULTI-HOP REASONING: The LLM failed to properly synthesize the specific evolution from 2022 to 2024, instead creating a narrative that includes unsupported technological details (RFID, Digital Access Program) and mischaracterizes the scope of service changes. The answer reads as plausible but contains hallucinated details that undermine credibility. The ground truth's specific mention of SurePost insourcing and the distinction between same-day pickup (vs. general delivery) are material omissions that significantly alter the accuracy of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 476,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "\nIn both the 2022 and 2023 Form 10‑K filings the 2.50 % Notes due April 2026 continued to be referenced only as part of the original Thirteenth Supplemental Indenture (Exhibit 4.14) and were not the subject of any new supplemental indenture or amendment. The 2023 filing again listed the notes under Exhibit 4.14 (and briefly in the “Description of Securities” table), but no new treatment, recognition, or amendment was provided between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim and directly contradicts the ground truth. CRITICAL ERRORS: (1) The LLM states there was 'no new treatment, recognition, or amendment...between the two years,' but the ground truth explicitly describes an evolution/shift in disclosure treatment from 2022 to 2023 - from 'historical documentation' context to 'explicitly recognized as issued instruments.' This is a direct contradiction of the question's premise about how treatment 'evolved.' (2) The LLM claims the notes were 'referenced only as part of the original Thirteenth Supplemental Indenture' in both years with 'no new treatment,' but the ground truth indicates a procedural/administrative transition showing different recognition levels between the two filings. (3) The LLM's answer suggests static treatment across both years, while the ground truth describes a clear evolution from planning/documentation phase (2022) to active recognition of outstanding debt (2023). QUANTITATIVE ACCURACY: The numeric details provided (2.50%, April 2026, Exhibit 4.14, Thirteenth Supplemental Indenture dated April 20, 2016) are all correct and match the ground truth. However, correct citations cannot compensate for the fundamental misunderstanding of the question's core requirement: identifying HOW the treatment EVOLVED. MULTI-HOP REASONING: The LLM failed to synthesize the comparative analysis across 2022 and 2023 filings that was essential to answer this question. The question explicitly asks about evolution/change, and the LLM's answer denies any evolution occurred, which is the opposite of what the ground truth establishes. This represents a failure in the core multi-hop reasoning required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 467,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "\nFrom 2022 to 2024 the filing shifted from describing sovereign‑debt‑related turmoil as a generic macro‑risk that *could* affect demand and inventory costs to a more concrete, forward‑looking concern.  In 2022 the company warned that sovereign‑debt crises, tariffs and other trade restrictions “could adversely affect demand for our products and services, require a change in product mix, or impact the cost of or ability to purchase inventory.”  By 2024 the same language is expanded to note that such sovereign‑debt and trade pressures—combined with currency fluctuations and heightened international exposure—“adversely affect the financial performance of our Canadian and other international operations” and “may increase merchandise costs and may not be passed on to members,” indicating that the potential impact on Costco’s sourcing decisions and overall cost structure has become a more material, ongoing factor in its cost‑management planning.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of Costco's framing of sovereign debt crises from 2022 to 2024, correctly identifying the shift from conditional language ('could') to more direct impact language ('adversely affect'). However, there are significant issues with accuracy and completeness:\n\n(1) CORRECT ELEMENTS:\n- Accurately identifies the 2022 language about sovereign debt crises potentially affecting demand, product mix, and inventory costs\n- Correctly notes the shift to more concrete language by 2024\n- Properly captures the conditional-to-definitive framing evolution\n- Appropriately identifies the connection to tariffs and trade restrictions\n\n(2) PROBLEMATIC ELEMENTS:\n- The LLM introduces specific language about 'Canadian and other international operations' and 'may increase merchandise costs and may not be passed on to members' that is NOT verified in the ground truth. The ground truth states the 2024 filing emphasized 'supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability' but does NOT specifically mention the Canadian operations language or the 'may not be passed on to members' language attributed to the 2024 filing.\n- The LLM conflates what appears to be language about currency fluctuations and international operations with the sovereign debt crisis discussion, which may be from different sections or contexts in the filing.\n- The ground truth emphasizes 'supply chain risks' and 'cascading effects' as the 2024 focus, while the LLM emphasizes cost-passing and merchandise costs without mentioning supply chain complexity.\n\n(3) MULTI-HOP REASONING:\n- The LLM attempts to synthesize the evolution across years but introduces unsupported specific quotes/paraphrases that don't match the ground truth's characterization of what the 2024 filing emphasized.\n- The reasoning about 'material, ongoing factor in cost-management planning' is logical but goes beyond what the ground truth explicitly states.\n\n(4) MISSING ELEMENTS:\n- Does not mention the 2024 emphasis on 'supplier adherence to standards' and 'geopolitical instability' as key new elements\n- Does not capture the 'cascading effects' concept mentioned in the ground truth\n- Misses the nuance about 'degree of exposure depended on type of goods, tariff rates, and timing' from 2022\n\nThe answer demonstrates reasonable understanding of the general trend but introduces specific claims not supported by the ground truth, which significantly undermines its reliability as a factual response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 679,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "\nThe 2020 Stock Incentive Plan had 64 million shares left for future grants as of December 31 2021 (page 67 of the 2022 10‑K), but that reserve had shrunk to 53 million shares by December 31 2023 (page 73 of the 2023 10‑K)—a reduction of roughly 11 million shares.  This decline reflects the shares already used for prior awards and only modest replenishment of the pool, showing that UnitedHealth still retains a meaningful reserve for new equity awards but with noticeably less capacity than in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key quantitative facts are correct: 64 million shares in 2021, 53 million shares in 2023, and the calculated reduction of 11 million shares. The dates are properly specified (December 31, 2021 and December 31, 2023), and the source citations (page 67 of 2022 10-K and page 73 of 2023 10-K) add credibility. The multi-hop reasoning is sound—the answer correctly synthesizes information across two different annual filings to show the trend. The interpretation that this 'indicates a reduction in the company's available capacity to issue new share-based awards' matches the ground truth. The LLM goes slightly beyond the ground truth by providing additional context ('only modest replenishment of the pool' and 'still retains a meaningful reserve'), which adds valuable insight without contradicting the original answer. The semantic meaning is fully preserved—both answers convey that shares available decreased from 64M to 53M, indicating reduced capacity. The only minor distinction is that the LLM provides more detailed explanation of what caused the decline (shares used for prior awards with modest replenishment), which enhances rather than detracts from the answer. No calculation errors, no factual inaccuracies, and all entities (UnitedHealth Group, 2020 Stock Incentive Plan) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 381,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "\nBetween 2022 and 2024 the collective‑bargaining agreement for the IAM National Pension Fund / National Pension Plan was extended – the expiration moved from **July 31 2024** (shown in the 2022 filing) to **July 31 2029** (disclosed in the 2024 filing).  At the same time UPS’s annual contributions to the plan increased from **≈ $48 million in 2022** to **≈ $53 million in 2024**, reflecting a growing but still non‑surcharge‑subject contribution that continues to satisfy the plan’s funding requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution of the expiration date (July 31, 2024 to July 31, 2029) and properly synthesizes this multi-hop information across the 2022 and 2024 filings. The entity identification (IAM National Pension Fund/National Pension Plan, UPS) is accurate, and the reasoning about the extension is sound. However, there are significant quantitative accuracy issues: (1) The LLM introduces specific dollar amounts ($48 million in 2022, $53 million in 2024) that are NOT present in the ground truth answer. The ground truth only mentions that UPS contributed 'more than 5%' of total plan contributions - it does NOT provide specific dollar amounts. (2) The LLM's characterization of contributions as 'non-surcharge-subject' is not mentioned in the ground truth and appears to be an unsupported inference. (3) The ground truth explicitly states UPS contributed more than 5% for years 2019-2021 (in the 2022 filing) and 2022-2024 (in the 2024 filing), but the LLM omits this percentage-based contribution significance metric entirely, replacing it with invented dollar figures. The core multi-hop synthesis about the date extension is correct, but the introduction of unverified financial specifics and the omission of the actual '5% of total contributions' metric represents a material factual error. The answer partially addresses the question but adds information not in the ground truth while omitting key information that was.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 404,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "\nThe 2020 Credit Agreement was a $2 billion five‑year unsecured revolving facility that, after a December 2021 amendment, matured in March 2025 and had its borrowing capacity reduced only by any commercial‑paper draws.  In FY 2023 the company replaced that facility with the 2023 Credit Agreement, which extended the maturity to September 2028 and added a provision that the combined availability of the new agreement and the third‑amended 2021 agreement could be increased by up to an additional $1 billion, thereby expanding the effective borrowing capacity while preserving the same $2 billion baseline and covenant structure.  No borrowings were outstanding under the agreement as of the FY 2023 filing, and total combined availability under the Credit Agreements was $4 billion.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains mostly correct core facts but includes problematic additions and some inaccuracies that undermine its reliability:\n\nCORRECT ELEMENTS:\n- 2020 Credit Agreement was $2.0 billion facility\n- FY 2022 maturity date was March 2025\n- FY 2023 replacement with 2023 Credit Agreement extending maturity to September 2028\n- Maintained $2.0 billion baseline availability\n- Total combined availability of $4.0 billion in FY 2023\n- No borrowings outstanding as of FY 2023 filing\n\nPROBLEMATIC ELEMENTS:\n1. UNSUPPORTED CLAIMS: The LLM introduces details not in the ground truth about \"December 2021 amendment,\" \"borrowing capacity reduced only by commercial-paper draws,\" and \"provision that combined availability could be increased by up to an additional $1 billion.\" These details appear to be fabricated or inferred beyond what the ground truth supports.\n\n2. INCOMPLETE SYNTHESIS: The ground truth explicitly states the 2020 Credit Agreement \"was amended and restated in September 2023 into the 2023 Credit Agreement.\" The LLM says it was \"replaced\" which is semantically similar but misses the technical precision of \"amended and restated.\"\n\n3. COVENANT STRUCTURE CLAIM: The LLM mentions \"preserving the same...covenant structure\" which is not mentioned in the ground truth and represents unsupported inference.\n\n4. OPTIONAL INCREASE PROVISION: The claim about \"up to an additional $1 billion\" expansion option is not present in the ground truth answer, which only states the combined availability \"remained at $4.0 billion, consistent with the total availability reported in 2022.\"\n\nMULTI-HOP REASONING: The answer does correctly synthesize the evolution across fiscal years 2022-2023 and identifies the relationship between the 2020 and 2023 Credit Agreements, but adds unsupported details that create factual inaccuracy.\n\nQUANTITATIVE ACCURACY: All stated numbers ($2B, $4B, September 2028, March 2025) are correct, but the introduction of the \"additional $1 billion\" provision is problematic as it's not in the ground truth.\n\nThe answer demonstrates understanding of the basic evolution but compromises accuracy by introducing details not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 595,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "\nMDLZ’s net‑investment‑hedge derivative contracts expanded from $3.9 billion in notional amount at the end of 2021 (2022 Form 10‑K, page 113) to $7.5 billion in 2023 (2024 Form 10‑K, page 96) and $8.6 billion as of Dec 31 2024 (2024 Form 10‑K, page 96), more than doubling over the three‑year span. This reflects a steady increase in the hedge program’s scale, with the notional amount rising by about 15% from 2023 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key numbers: (1) 2021 notional amount of $3.9 billion matches ground truth ($3,915 million), (2) 2023 amount of $7.5 billion matches ground truth ($7,456 million), (3) 2024 amount of $8.6 billion matches ground truth ($8,647 million). The calculation of the 15% increase from 2023 to 2024 is correct: ($8,647M - $7,456M) / $7,456M = 16.0%, which rounds to approximately 15% (minor rounding acceptable). The LLM correctly synthesized multi-hop information across three fiscal years (2022, 2023, 2024 10-K filings) and accurately identified the evolution trend. The answer appropriately characterizes the growth as 'more than doubling' over the three-year span (from $3.9B to $8.6B is a 121% increase, which is indeed more than double). The LLM provided proper source citations (page numbers from 10-K filings). Minor note: The ground truth mentions 2020 data ($4,551 million) which the LLM did not include, but this is not required by the question which specifically asks about 2022-2024 evolution. The answer directly addresses the question's focus on how the contracts evolved between 2022 and 2024 in terms of notional amounts, with clear progression and quantitative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 351,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "\nBetween 2022 and 2024 Microsoft 365 progressed from a preview of AI‑enhanced Office tools (the early “Copilot for Microsoft 365” concept) to a fully integrated, AI‑first platform where generative AI is embedded across Word, Excel, PowerPoint, Teams, Windows and security, with role‑specific Copilot extensions (Sales, Service, Finance) and a consumer‑focused Copilot Pro subscription.  \n\nIn 2024 the company added new capabilities such as **Copilot for Security**, **Copilot Studio** (allowing customers to customize Copilot workflows), **AI‑enhanced Windows 11 (Copilot in Windows) and Copilot+ PCs**, AI‑driven features in Teams (meeting recap, Together mode), and expanded Azure AI Studio and role‑based Copilot assistants that draw on Microsoft Graph data to boost productivity and collaboration.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution from 2022 to 2024, accurately mentions role-specific Copilot extensions (Sales, Service, Finance), and correctly identifies that Microsoft 365 became an 'AI-first platform.' The mention of Copilot for Microsoft 365 combining AI with Microsoft Graph and business data aligns with ground truth. The answer appropriately addresses the multi-hop nature of the question by comparing 2022 and 2024 capabilities.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces several capabilities NOT mentioned in the ground truth, including 'Copilot for Security,' 'Copilot Studio,' 'Copilot+ PCs,' 'Together mode,' and 'Azure AI Studio.' While these may be real Microsoft products, they are not part of the ground truth answer derived from the SEC filings, suggesting the LLM may be hallucinating or drawing from external knowledge beyond the filing data. (2) The answer mentions 'Copilot Pro subscription' (consumer-focused), which is not mentioned in the ground truth and appears to be external knowledge. (3) The 2022 description in the LLM answer differs from ground truth - it describes 'preview of AI-enhanced Office tools' rather than the ground truth's description of integration of Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools. (4) The answer lacks the specific 2022 context about 'creativity, collaboration, and innovation' focus mentioned in ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the evolution across years and identifies the shift to AI-first platform, but the addition of unverified capabilities undermines the reliability of the synthesis. The core multi-hop reasoning (comparing 2022 to 2024) is sound, but execution is compromised by apparent hallucinations.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy cannot be penalized on calculations. However, the introduction of unverified product names and features represents a factual accuracy issue.\n\nOVERALL ASSESSMENT: The answer captures the essential evolution and mentions correct core capabilities (role-specific Copilots, Microsoft Graph integration, AI-first platform), but introduces significant unverified information that deviates from the ground truth. This is a partially correct answer with concerning additions that suggest hallucination rather than faithful synthesis of filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 652,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "\nBetween 2022 and 2024 3M moved from a one‑time, corrective disclosure that it had not fully characterized its PFAS discharge in the Decatur Alabama NPDES permit—submitting an amendment request and installing temporary treatment controls— to a formal, multi‑year interim Consent Order (July 2020, still in force in 2024) that obligates the company to conduct ongoing PFAS monitoring, analytical studies, reporting and capital‑improvement projects, and to work with ADEM on any future permit revisions that would incorporate updated health‑based limits. In short, the approach shifted from a reactive, single‑permit amendment to a sustained, consent‑order‑driven program of continuous PFAS discharge characterization and compliance planning.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL DATE ERROR: The LLM references a 'July 2020' Consent Order as the framework for 2024 compliance, but the ground truth makes no mention of any Consent Order from 2020 or any other date. The ground truth specifically states that in 2022, 3M 'submitted an application to ADEM to add additional PFAS to the permit' and by 2024 'had installed and was upgrading wastewater treatment controls' while 'ADEM had not yet acted on the permit modification request.' (2) INCORRECT FRAMEWORK: The LLM characterizes the approach as 'consent-order-driven' when the ground truth indicates it was permit-amendment-driven, with no Consent Order mentioned. (3) MISCHARACTERIZATION OF TIMELINE: The LLM suggests a shift from 'temporary treatment controls' to a 'multi-year interim Consent Order,' but the ground truth shows a progression from non-characterization (2022) to installation and upgrading of controls (2024), with no Consent Order referenced. (4) UNSUPPORTED CLAIMS: The LLM adds details about 'ongoing PFAS monitoring, analytical studies, reporting and capital-improvement projects' that are not present in the ground truth. (5) SEMANTIC MISMATCH: While the LLM correctly identifies that the approach evolved from reactive to more proactive, it does so under a completely incorrect legal/regulatory framework (Consent Order vs. permit amendment). The core narrative of the ground truth—moving from identifying the characterization gap to implementing treatment solutions—is obscured by the introduction of an unsubstantiated Consent Order. The answer demonstrates poor multi-hop synthesis and introduces factual elements not supported by the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 479,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "\nBetween 2022 and 2023 Lowe’s did not issue any new 4.550 % notes; the only reference to that coupon appears in the 2019 Fifteenth Supplemental Indenture (Exhibit 4.16), which created the 4.550 % Notes due April 5, 2049.  The subsequent 2022 Twenty‑First Supplemental Indenture (Exhibit 4.21) and the 2023 Twenty‑Second Supplemental Indenture (Exhibit 4.23) introduced entirely different series—e.g., 4.450 % and 4.800 % notes—indicating that the company moved away from expanding the 4.550 % tranche and instead issued fresh debt with new coupon rates.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides more detailed context than the ground truth. Key strengths: (1) Correctly identifies that no new 4.550% Notes were issued between 2022-2023, matching the ground truth conclusion. (2) Accurately cites the Fifteenth Supplemental Indenture dated April 5, 2019 as the original source. (3) Correctly states the maturity date as April 5, 2049. (4) Accurately references the Twenty-First Supplemental Indenture (2022) and Twenty-Second Supplemental Indenture (2023) as introducing different debt instruments. (5) Correctly identifies the alternative coupon rates (4.450% and 4.800%) issued in those later indentures. All numeric values and dates are accurate. The multi-hop reasoning is sound—the model correctly synthesized information across multiple indentures and years to show the evolution (or lack thereof) of the 4.550% Notes specifically. Minor consideration: The LLM answer goes beyond the ground truth by providing additional context about what Lowe's DID issue instead (different coupon rates), which adds value but wasn't explicitly required by the question. This is a strength rather than a weakness, as it provides more complete understanding of the company's debt issuance strategy. The answer correctly conveys that the 4.550% Notes remained unchanged between 2022-2023, which is the core finding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 379,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 MDLZ’s stake in Keurig Dr Pepper (KDP) moved from an equity‑method investment to a marketable‑security classification after its ownership fell below the 5 % threshold in the first quarter of 2023, and was fully exited later that year.  In 2023 MDLZ recorded a $493 million pre‑tax gain on equity‑method transactions (page 89) and, after re‑measuring the remaining shares at fair value, recognized a total $606 million gain on marketable‑securities sales for the year (page 89); by 2024 the investment was completely divested, so no further gains or equity‑method earnings were recorded.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims a $493 million pre-tax gain was recorded in 2023, but the ground truth states this $493 million gain occurred in 2024. The LLM also introduces a $606 million gain figure for 2023 that does not appear in the ground truth. The ground truth clearly shows: 2022 = $71 million pre-tax gain ($54 million after-tax); 2024 = $493 million pre-tax gain ($368 million after-tax). The LLM has misaligned these gains to the wrong years. (2) TEMPORAL ACCURACY: The LLM correctly identifies that the ownership fell below 5% in Q1 2023 and that the investment was fully exited, but then incorrectly assigns the $493 million gain to 2023 instead of 2024. (3) MISSING INFORMATION: The LLM fails to mention the 2022 $71 million gain entirely, which is a key part of showing the evolution between 2022 and 2024. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize the accounting change narrative (equity-method to marketable securities), it fails at the fundamental task of correctly matching gains to their respective years. The question specifically asks about the evolution 'between 2022 and 2024,' requiring accurate year-by-year comparison. (5) SEMANTIC ISSUES: The LLM's statement that 'by 2024 the investment was completely divested, so no further gains or equity-method earnings were recorded' contradicts the ground truth showing a $493 million gain in 2024. This is a critical factual error. The LLM provides contextual detail about the accounting classification change, which is relevant, but the core numerical facts are wrong, making the answer fundamentally incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 471,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "\nBetween 2022 and 2024 the Xbox Game Pass library swelled from a curated collection of roughly 100 titles to a library of **over 400 first‑ and third‑party games**, a growth spurt fueled by the Activision Blizzard acquisition and ongoing investments in first‑party studios.  This expansion underscores Microsoft’s strategic emphasis on positioning Game Pass as the centerpiece of its gaming ecosystem—leveraging subscription, cloud‑streaming and cross‑platform access to drive sustained growth and deeper engagement across consoles, PC and mobile devices.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on the core factual claims. Quantitative accuracy is excellent: the 2022 figure of 'roughly 100 titles' and 2024 figure of 'over 400 first-and third-party games' match the ground truth precisely. The answer correctly identifies the significant expansion (4x growth) between these years. Entity accuracy is solid - Xbox Game Pass, Microsoft, and the time period (2022-2024) are all correctly identified. The multi-hop reasoning is sound, synthesizing the scale evolution with strategic positioning. The LLM appropriately characterizes Game Pass as the 'centerpiece' of Microsoft's gaming ecosystem, which aligns with the ground truth's description of it as the 'cornerstone.' The answer adds valuable context about the Activision Blizzard acquisition and cross-platform strategy (console, PC, mobile), which provides reasonable explanatory depth for the expansion. Minor areas for improvement: (1) The ground truth emphasizes 'content, community, and cloud services' as the 2022 positioning, while the LLM focuses more on subscription and engagement without explicitly mentioning the community aspect in the 2022 context. (2) The ground truth notes the strategic emphasis shifted to 'subscriptions and community growth' by 2024, but the LLM's phrasing of 'subscription, cloud-streaming and cross-platform access' captures the essence without explicitly calling out community growth as a distinct strategic pillar. These are minor semantic differences rather than factual errors. Overall, the answer successfully addresses both parts of the question (scale evolution and strategic positioning) with accurate numbers and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 458,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "\nFrom 2022 to 2024 the Deferred Stock Unit Award Agreement for non‑employee directors remained a single agreement embedded in the 2016 Long‑Term Incentive Plan.  The 2022 filing cited the agreement only as “incorporated by reference from the 2018 10‑K,” while the 2024 filing updates the plan reference to the amendment adopted May 8 2023 (the most recent plan amendment) and still incorporates the same 2018‑dated agreement form—indicating that any term changes are now reflected in the amended plan rather than a new agreement format.  No separate or substantially restructured DSU agreement was introduced; the evolution is limited to the plan amendment and updated incorporation by reference.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN DATES AND INCORPORATION REFERENCES: The LLM answer contains a significant factual error regarding the incorporation by reference source. The LLM states the 2022 filing cited the agreement 'incorporated by reference from the 2018 10-K,' but the ground truth indicates the agreement was applicable to grants 'on or after January 1, 2019' and was referenced in the 2022 10-K filing. The LLM's claim about a 2018 10-K incorporation appears to be incorrect or unsupported by the ground truth. PARTIAL CORRECTNESS ON PLAN AMENDMENT: The LLM correctly identifies that the 2024 filing references a plan amendment dated May 8, 2023, which matches the ground truth statement about 'amendments as of May 8, 2023.' However, the LLM's characterization of the 2022 filing's incorporation source is problematic. INCOMPLETE SYNTHESIS: The ground truth emphasizes that the effective date remained 'January 1, 2019' in both 2022 and 2024, indicating 'no change in the effective date or structure of the agreement over this period.' The LLM answer does not explicitly confirm this continuity of the January 1, 2019 effective date across both years, which is a key finding. REASONING QUALITY: The LLM's reasoning about plan amendments versus agreement restructuring is sound in principle, but it is built on a potentially incorrect factual foundation regarding the 2018 10-K reference. The conclusion that 'no separate or substantially restructured DSU agreement was introduced' aligns with the ground truth, but the supporting evidence (the 2018 10-K citation) appears to be inaccurate. MISSING DETAILS: The LLM does not explicitly state that the agreement remained the same form across both years, only that it was 'the same 2018-dated agreement form,' which is vague and potentially misleading given the factual error about the 2018 10-K incorporation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 502,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "\nBetween 2023 and 2024 the First‑Mortgage portfolio grew from roughly **$26.15 billion to $27.39 billion**, while HELOCs slipped from **$479 million to $424 million**.  Origination‑cost balances rose modestly from **$100 million to $112 million**, and the geographic concentration in California stayed flat at **about 42‑43 %** of the combined portfolio in both years.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key metrics requested: (1) origination costs increased from $100M to $112M (correct), (2) California concentration at 42-43% in both years (correct directionally), (3) proper multi-hop synthesis across portfolio components. The answer appropriately addresses the evolution of the portfolio composition between 2023 and 2024. WEAKNESSES: The LLM introduced substantial additional information about First Mortgages ($26.15B to $27.39B) and HELOCs ($479M to $424M) that was NOT in the ground truth answer. While this information may be factually accurate from the filings, it represents scope creep beyond what the original answer provided. The ground truth focused specifically on origination costs and California concentration, not on total portfolio sizes. The LLM's characterization of California concentration as 'stayed flat at about 42-43%' is slightly imprecise - the ground truth shows a decrease from 43% to 42%, which is a 1 percentage point shift, not truly 'flat.' CALCULATION VERIFICATION: Origination costs $100M→$112M is correct (+$12M or +12% increase). California concentration 43%→42% is correct but characterized as 'flat' when there was a measurable 1-point decrease. MULTI-HOP REASONING: The synthesis is sound - correctly connecting origination costs and geographic concentration across years. However, the inclusion of unasked-for portfolio size data dilutes focus on the specific question asked. The answer is factually mostly correct but adds extraneous information and slightly mischaracterizes the geographic concentration trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 438,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "\nIn the 2023 filing, Dri‑FIT is mentioned only as one of several headline Nike performance technologies, underscoring its role as a moisture‑wicking fabric within the broader product line. By contrast, the 2024 Form 10‑K places Dri‑FIT inside a list that also includes Air, Zoom, Free, Flyknit, FlyEase, Zoom X and React, framing it as a core component of an integrated performance‑innovation ecosystem and linking it to Nike’s wider sustainability and digital‑experience initiatives. This shift shows that Nike’s strategic emphasis on Dri‑FIT has evolved from a standalone highlight to a central element of a multi‑technology, performance‑and‑sustainability‑driven product strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. The ground truth explicitly states that 'Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024' with 'exact same language used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis.' The LLM answer claims the opposite - that there was a significant evolution from 'a standalone highlight to a central element of a multi-technology, performance-and-sustainability-driven product strategy.' This is a complete factual error. The LLM fabricated details about how Dri-FIT was positioned differently in each year (claiming 2023 showed it as 'only as one of several headline' vs 2024 showing it 'inside a list'), when the ground truth indicates identical language and positioning in both years. The LLM also invented claims about 'sustainability and digital-experience initiatives' that are not supported by the ground truth. While the LLM correctly identified the relevant years (fiscal 2023 and 2024) and the correct technologies mentioned (Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, React), the core conclusion about evolution versus stability is entirely wrong. This represents a fundamental failure to accurately synthesize information from the SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 372,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "\nFrom 2022 through 2024 Mondelez International has steadily expanded the scope and depth of its backup‑and‑disaster‑recovery program—adding capabilities such as enhanced identity‑and‑access management, multi‑factor authentication, risk‑based remote‑connectivity controls and 24/7 security‑operations monitoring to protect critical manufacturing and IT systems.  The company cites the growing frequency and sophistication of cyber threats (and the possible inability to obtain adequate cyber‑insurance) as the primary reason for these additional investments, while acknowledging that no security controls can guarantee absolute protection.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific technical details about backup and disaster recovery investments (enhanced identity-and-access management, multi-factor authentication, risk-based remote connectivity controls, 24/7 monitoring) that are not present in the ground truth. While these details may be accurate from the filings, they represent a different level of specificity than what the ground truth emphasizes. The LLM correctly identifies the time period (2022-2024) and the general trend of expansion in cybersecurity investments. However, there are significant differences in emphasis and framing: (1) The ground truth explicitly mentions state-sponsored actors and artificial intelligence as emerging threats by 2024, which the LLM answer omits entirely. (2) The ground truth emphasizes the pandemic context in 2022 and the evolution toward addressing 'increasingly sophisticated threats,' while the LLM focuses on specific technical controls and insurance concerns. (3) The LLM introduces the concept of cyber-insurance inadequacy, which is not mentioned in the ground truth. (4) The LLM's statement about 'no security controls can guarantee absolute protection' is a reasonable caveat but not explicitly part of the ground truth answer. The multi-hop reasoning is sound in both answers (comparing 2022 to 2024 positions), but they synthesize different aspects of the company's cybersecurity evolution. The LLM answer is not factually incorrect per se, but it diverges from the ground truth's key emphasis on state-sponsored threats and AI as emerging concerns by 2024, which represents incomplete synthesis of the required information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 449,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "\nFrom fiscal year 2022 through fiscal year 2024 Microsoft has steadily expanded the size and scope of its spending on Black‑ and African‑American‑owned suppliers.  In FY 2022 the company announced a $150 million commitment to minority‑depository institutions and small Black‑owned businesses and began building a supplier pipeline for such firms.  By FY 2024 it had more than doubled that effort, pledging to spend $500 million with twice as many Black‑ and African‑American‑owned suppliers and reporting that it had already achieved that goal, while also growing related programs (e.g., the Nonprofit Tech Acceleration for Black communities and the Partner Capital Fund).  This progression reflects a clear escalation from an initial $150 million pledge to a multi‑year, $500 million procurement target with a substantially larger supplier base.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN CHRONOLOGICAL SEQUENCING AND FACT REVERSAL: The LLM answer fundamentally misrepresents the timeline and reverses the progression of Microsoft's commitments. According to the ground truth: (1) FY 2022: Microsoft had reached >90% of its $500M goal with double the number of suppliers (not a $150M commitment at this stage). (2) FY 2024: Microsoft achieved the $500M goal AND allocated $150M to Minority Depository Institutions. The LLM incorrectly states that in FY 2022 Microsoft 'announced a $150 million commitment' and then 'more than doubled that effort' to $500M by FY 2024. This is backwards - the $500M was the primary multi-year goal being pursued in 2022, and the $150M allocation to MDIs was an additional commitment made by 2024, not a predecessor commitment. QUANTITATIVE ERRORS: (1) The LLM claims the $150M was the initial 2022 commitment that was then doubled to $500M - this is factually incorrect. The $500M was the target in 2022, not a doubling of $150M. (2) The LLM fails to accurately represent that by FY 2024, Microsoft had BOTH achieved the $500M goal AND made the additional $150M allocation to MDIs - these are separate, complementary commitments, not sequential ones. MULTI-HOP REASONING FAILURE: The answer fails to correctly synthesize the evolution across the two fiscal years. It inverts the chronological relationship between the $150M and $500M commitments. PARTIAL CREDIT: The answer does correctly identify that Microsoft expanded its supplier diversity efforts and mentions the $500M goal and supplier base expansion, but the fundamental mischaracterization of the timeline and the reversal of which commitment came first/second represents a major factual error that undermines the entire answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 480,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "\nThe reserve of shares authorized for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non‑U.S. Employees was essentially unchanged from 2022 to 2023, holding at 8,565,087 shares as of December 31 2023. This stability indicates that Abbott is maintaining a steady equity‑based compensation pool to support its global workforce while deliberately managing dilution.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains critical factual errors that fundamentally contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the shares were 'essentially unchanged' and 'holding at 8,565,087 shares as of December 31 2023,' but the ground truth shows a significant decline from 10,638,639 shares (as of December 31, 2021) to 8,565,087 shares (as of December 31, 2023). This represents a reduction of 2,073,552 shares, or approximately 19.5% decrease - a material change that is not 'essentially unchanged.' (2) TEMPORAL CONFUSION: The LLM appears to conflate the 2023 figure with the 2022 baseline, suggesting no change when in fact there was a substantial decline over the period. The ground truth explicitly compares 2022 (10,638,639) to 2023 (8,565,087). (3) REASONING ERROR: The LLM's conclusion that 'stability indicates Abbott is maintaining a steady equity-based compensation pool' directly contradicts the actual data showing a declining pool of available shares. This is a fundamental misinterpretation of the multi-hop synthesis required. (4) MISSING CONTEXT: The LLM fails to acknowledge the significant reduction in available shares, which the ground truth correctly identifies as indicating 'a potential tightening or adjustment in Abbott's stock-based incentive strategy.' The LLM's characterization of 'deliberately managing dilution' is somewhat aligned with the tightening concept, but is built on false premises about the data. The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the year-over-year comparison and drawing conclusions opposite to what the data supports.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 448,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Nike moved from treating Air mainly as a marketing‑focused cushioning unit to making it a core, vertically‑controlled component of its product‑development pipeline.  In 2024 the company began producing Air‑Sole units through its Air Manufacturing Innovation subsidiary and expanded the Air family (Air Max, Zoom X, etc.) across a broader range of footwear and apparel, reflecting a more systematic R&D and manufacturing emphasis on Air technology than in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. (1) MAJOR FACTUAL ERRORS: The LLM claims Nike began producing Air-Sole units through an 'Air Manufacturing Innovation subsidiary' in 2024 - this specific claim is not supported by the ground truth and appears to be fabricated. The ground truth makes no mention of any manufacturing subsidiary or vertical control of Air production. (2) INCORRECT STRATEGIC CHARACTERIZATION: The LLM describes a shift from 'marketing-focused cushioning unit' to 'core, vertically-controlled component' - this is fundamentally different from the ground truth, which describes a shift from 'emerging innovation' to 'standard/foundational component.' The LLM's narrative about manufacturing control and vertical integration is not present in the ground truth. (3) UNSUPPORTED PRODUCT EXPANSION CLAIMS: The LLM mentions 'Air Manufacturing Innovation subsidiary' and specific product expansions (Air Max, Zoom X) across footwear and apparel - these details are not corroborated by the ground truth, which simply notes Nike Air was listed among key technologies in both years. (4) MISALIGNMENT WITH CORE FINDING: The ground truth emphasizes that Nike Air became 'a standard component' and 'foundational offering' rather than a 'distinct growth driver' - a maturation narrative. The LLM's answer instead focuses on manufacturing verticalization and systematic R&D emphasis, which represents a different (and unsupported) interpretation. (5) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided in either answer, so this dimension is neutral, but the LLM's specific claims about manufacturing subsidiaries and production processes are unverified and likely incorrect. The answer demonstrates poor multi-hop reasoning by introducing information not present in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 509,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "\nBetween 2022 and 2023 Abbott kept Osmolite in essentially the same place in its Nutritional Products segment – it remains listed among the core enteral‑feeding products (e.g., Jevity, Glucerna 1.2/1.5 Cal, Oxepa, Freego (Enteral Pump), etc.) that the company markets to health‑care institutions (see the Nutritional Products bullet lists on pages 3‑5 of the 2022 filing and pages 2‑4 of the 2023 filing).  The 2022 narrative emphasized competitive pressures, ingredient innovation and the risk of obsolescence, while the 2023 discussion broadened the focus to include direct‑to‑consumer promotion and the overall product‑line strategy, but there was no substantive shift in how Osmolite itself is positioned within the enteral‑feeding portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies that Osmolite remained in a stable, consistent position within Abbott's enteral feeding portfolio between 2022 and 2023; (2) Accurately lists comparable products (Jevity, Glucerna 1.2/1.5 Cal, Oxepa, Freego) that were mentioned alongside Osmolite; (3) Correctly notes the institutional healthcare focus; (4) Properly synthesizes the multi-hop information showing no significant repositioning occurred; (5) Appropriately references specific filing pages (2022 pages 3-5, 2023 pages 2-4) demonstrating document-level verification. MINOR WEAKNESSES: (1) The LLM adds interpretive commentary about narrative shifts between 2022 and 2023 (competitive pressures, ingredient innovation, direct-to-consumer promotion) that goes beyond what the ground truth explicitly states. While this additional context may be accurate from the filings, it represents inference beyond the core factual answer; (2) The ground truth explicitly lists Nepro® and Vital® as part of the 2022 portfolio, which the LLM does not mention (though it uses 'etc.' suggesting awareness of additional products); (3) The LLM's discussion of narrative emphasis changes is not directly addressed in the ground truth, which focuses solely on product positioning consistency. QUANTITATIVE ACCURACY: All year references (2022, 2023) are correct; no calculations required. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and multiple product categories to reach the conclusion of stable positioning. SEMANTIC EQUIVALENCE: The LLM's core message ('essentially the same place,' 'no substantive shift') matches the ground truth's 'largely consistent' and 'stable strategic positioning' language effectively.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 491,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "\nBetween 2022 and 2024, 3M’s PFAS regulatory engagement in **Minnesota** moved from the 2022 MPCA order requiring the company to address PFAS‑laden storm‑water at its Cottage Grove plant to a 2024 draft Clean Water Act permit that imposes markedly stricter effluent limits and incorporates the Minnesota Department of Health’s newly updated health‑based values for PFOA and PFOS; the company is now negotiating the final permit while continuing to meet the obligations of the 2007 Settlement Agreement (providing alternative drinking water and remediating soil and groundwater at Oakdale, Woodbury and Cottage Grove).  \n\nIn **Alabama**, the company remains under the 2020 interim Consent Order with ADEM that obligates ongoing PFAS monitoring, off‑site investigations and capital‑improvement work at its Decatur facility, and it faced heightened scrutiny in 2023‑2024 through a grand‑jury subpoena and EPA information requests concerning historic TSCA violations, but no new binding remediation orders were issued—its obligations stayed focused on complying with the existing consent order and responding to EPA inquiries.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key dates (2007 Settlement Agreement, 2020 Interim Consent Order, 2024 permit developments) and accurately describes the evolution in Minnesota from existing orders to stricter 2024 Clean Water Act permit with revised effluent limits. The mention of MDH's updated health-based values is accurate. The Alabama section correctly notes the 2020 Interim Consent Order remains in effect and mentions ongoing obligations. The answer demonstrates reasonable multi-hop synthesis across the two states and time periods.\n\nWEAKNESSES: (1) The LLM answer omits several important details from the ground truth: it fails to mention the December 2024 revised draft permit from MPCA (only references the August 2024 public comments), which is a significant regulatory development. (2) The answer does not mention that some PFAS effluent limits are below current quantification levels, a key detail about the stringency of the new permit. (3) For Alabama, the answer introduces information about 'grand-jury subpoena and EPA information requests concerning historic TSCA violations' that is NOT in the ground truth, which is a factual error/hallucination. (4) The answer states 'no new binding remediation orders were issued' in Alabama, but the ground truth indicates ongoing investigations and potential future remediation obligations were expected, which is a subtle but important distinction. (5) The answer omits mention of the October 2024 proposed HRLs from the regulatory landscape evolution. (6) The answer does not clearly convey that the December 2024 revised permit 'could have a significant adverse impact on the Cottage Grove facility's operations,' a material regulatory development.\n\nQUANTITATIVE ACCURACY: Dates are generally correct (2007, 2020, 2022, 2024), though the answer misses the December 2024 permit revision and October 2024 HRL proposal. No calculations are required, so this dimension focuses on date/timeline accuracy, which is mostly sound but incomplete.\n\nQUALITATIVE ACCURACY: The multi-hop reasoning is partially sound but contains a significant error (the TSCA violation/grand jury subpoena information appears to be a hallucination not supported by the ground truth). The synthesis across Minnesota and Alabama is reasonable but incomplete, missing key regulatory developments and their potential impacts.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the question's focus on regulatory engagement evolution between 2022 and 2024 in both states, though it misses some material developments that would be relevant to understanding the full scope of regulatory change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1656,
        "completion_tokens": 702,
        "total_tokens": 2358
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "\nBetween 2022 and 2024 Coca‑Cola’s ownership in Coca‑Cola HBC AG stayed around 22 % (22 % in 2022, 22 % in 2023 and 22 % in 2024).  The investment was re‑classified from being aggregated in the “Bottling Investments” line to a distinct equity‑method holding, and the 2024 filing reports a 22 % stake, a $1.147 bn carrying value and $1.770 bn of equity income from the venture.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims Coca-Cola held a 22% stake in Coca-Cola HBC AG in 2022, but the ground truth explicitly states 'the specific ownership percentage was not disclosed in the provided evidence' for 2022. This is a critical factual error. The LLM fabricated a 2022 percentage that contradicts the ground truth. (2) The LLM provides specific financial figures ($1.147 bn carrying value, $1.770 bn equity income) that are not mentioned in the ground truth and cannot be verified against it. These appear to be unsupported claims. (3) MULTI-HOP REASONING - The LLM correctly identifies that the investment remained an equity method investee across both years, which aligns with ground truth. However, the claim about reclassification from 'Bottling Investments' line is not mentioned in the ground truth and cannot be verified. (4) COMPLETENESS - While the LLM addresses the investment classification (equity method) and stake percentage, it does so with incorrect 2022 data. The ground truth emphasizes that 2022 lacked specific percentage disclosure, while 2024 formalized it at 22%. The LLM reverses this narrative by claiming 22% existed in 2022. (5) The core insight from ground truth - that there was a 'formalization and quantification of the relationship' between 2022 and 2024 - is contradicted by the LLM's claim that the percentage remained constant at 22% across all three years. This represents a fundamental misunderstanding of the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 421,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "\nOracle has shifted from a license‑centric model toward making hybrid‑cloud (on‑premise + Oracle Cloud/OCI) the centerpiece of its product strategy.  In fiscal 2022 it highlighted hybrid deployments as a key differentiator and began directing a growing share of its R&D spend—$7.2 billion that year—into cloud‑native services, integration tools (e.g., Cloud@Customer, OCI) and the migration pathways that let customers run workloads across both environments.  By fiscal 2024 the company’s financial disclosures stress that hybrid deployment models are now a core growth engine, with cloud services and license‑support revenue representing roughly 71 % of total sales and continued investment aimed at expanding and unifying those hybrid offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Oracle's strategic evolution toward hybrid deployments between fiscal 2022 and 2024. STRENGTHS: (1) Correctly identifies the $7.2 billion R&D investment in fiscal 2022, matching ground truth exactly. (2) Accurately characterizes the shift from license-centric to hybrid-cloud-focused strategy. (3) Properly names specific offerings (Cloud@Customer, OCI) as part of the hybrid strategy. (4) Correctly notes that by fiscal 2024, hybrid deployments became a core growth engine. (5) The 71% figure for cloud services and license-support revenue as portion of total sales appears reasonable and adds relevant financial context. WEAKNESSES: (1) The LLM answer introduces the 71% metric which is not explicitly mentioned in the ground truth, though it may be accurate from filings—this represents additional information beyond the ground truth rather than an error. (2) The ground truth emphasizes 'interoperability and customer choice' as key themes in the fiscal 2024 positioning, which the LLM answer does not explicitly mention, though it implies this through 'letting customers run workloads across both environments.' (3) The ground truth characterizes the evolution as 'from development-focused to mature, integrated deployment model,' while the LLM frames it as 'license-centric to hybrid-cloud centerpiece'—both are valid characterizations but slightly different framings. MULTI-HOP REASONING: The answer successfully synthesizes information across the two fiscal years and connects R&D investment to strategic positioning. The logic linking product development investment to deployment model integration is sound. NUMERIC VERIFICATION: The $7.2 billion figure is correct. The 71% figure cannot be verified against ground truth but appears plausible and is presented as a supporting metric rather than a core claim. Overall, the answer captures the essential evolution while adding some contextual financial metrics not in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 537,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "\nThe Mandatory Clawback Policy first appeared in the 2023 Form 10‑K as Exhibit 97, listed only as “Incorporated by reference to Exhibit 97 to the Company’s Annual Report on Form 10‑K for the year ended December 31, 2023.” In the 2024 filing the same policy is again presented as Exhibit 97, but the description now reads “Filed herewith,” indicating that the policy is being filed directly in the 2024 filing rather than merely incorporated by reference. Thus, its status evolved from an incorporated exhibit in 2023 to a directly filed exhibit in 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. The ground truth states that in 2023, the policy was filed directly as Exhibit 97, and in 2024 it was incorporated by reference. The LLM answer reverses this evolution entirely, claiming the opposite: that in 2023 it was incorporated by reference and in 2024 it was filed directly. This is a critical factual error that completely inverts the actual filing status evolution. The LLM correctly identifies the entities (Wells Fargo, Mandatory Clawback Policy, Exhibit 97, years 2023 and 2024) and the question is appropriately addressed in terms of scope and relevance. However, the core factual content is backwards. The LLM also correctly identifies the procedural nature of the change (filing method rather than policy substance), but applies this insight to the wrong direction of change. There are no quantitative errors (no numbers to verify), but the qualitative accuracy is severely compromised by the fundamental reversal of the filing status evolution. This represents a failure in multi-hop reasoning or knowledge retrieval regarding the specific SEC filing procedures across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 335,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "\nThermo Fisher acquired CorEvitas, LLC in early 2023 for a net cash outlay of roughly $910 million (cash paid $730 million plus $184 million of assumed debt, net of $4 million cash acquired), which generated $627 million of goodwill and $351 million of definite‑lived intangible assets that are being amortized over an estimated 17‑year life. By 2024 the business was fully integrated into the Laboratory Products and Biopharma Services segment, and the amortization of those intangibles (and the associated goodwill) is reflected in the company’s non‑GAAP adjustments—most notably the $2.3 billion amortization expense that reduced adjusted operating income and was part of the $0.91 billion cash used for acquisitions reported in investing activities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides detailed transaction-level information about the CorEvitas acquisition but contains several significant discrepancies with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - LLM states amortization period as \"17-year life\" while ground truth specifies \"18 years weighted average period\" - this is a factual error\n   - LLM mentions \"$2.3 billion amortization expense\" which is not mentioned in the ground truth and appears to be extraneous information not directly related to CorEvitas\n   - LLM correctly identifies the $0.91 billion net cash outlay and provides detailed breakdown ($730M cash + $184M assumed debt - $4M cash acquired), which aligns with the $0.91B figure\n   - LLM correctly identifies $627M goodwill and $351M definite-lived intangible assets\n\n2. COMPLETENESS:\n   - LLM provides more granular transaction details than ground truth (cash paid, assumed debt, cash acquired breakdown)\n   - LLM addresses the 2023 acquisition and 2024 integration into Laboratory Products and Biopharma Services segment\n   - LLM omits the broader strategic context mentioned in ground truth: the $5.94B senior notes issuance and $3.00B stock repurchase program\n   - LLM does not clearly explain the evolution of the relationship as requested\n\n3. ENTITY AND METRIC ACCURACY:\n   - Correctly identifies CorEvitas, LLC and Thermo Fisher\n   - Correctly identifies Laboratory Products and Biopharma Services segment\n   - Correctly identifies goodwill and intangible assets\n   - Amortization period discrepancy: 17 years vs. 18 years is a factual error\n\n4. REASONING AND SYNTHESIS:\n   - Multi-hop reasoning is sound in connecting 2023 acquisition to 2024 integration\n   - However, the inclusion of \"$2.3 billion amortization expense\" appears to conflate broader company amortization with CorEvitas-specific amortization, which is confusing and potentially incorrect\n   - The answer focuses heavily on transaction mechanics rather than explaining the \"evolution\" of the relationship as the question asks\n\n5. SEMANTIC EQUIVALENCE:\n   - The core narrative of acquisition in 2023 and integration in 2024 is preserved\n   - However, the amortization period error (17 vs. 18 years) is a factual discrepancy, not a wording difference\n   - The $2.3B amortization figure introduces information not in ground truth and potentially misleads about CorEvitas-specific costs\n\nThe answer demonstrates good understanding of the transaction structure but contains a material error in the amortization period and introduces potentially confusing information about broader company amortization that wasn't part of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 708,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "\nBetween 2022 and 2023 the flight‑hour payments that RTX owes under its 2012 Rolls‑Royce acquisition agreement remained tied to V2500‑powered flight hours through June 2027, but the disclosed schedule shifted forward – the 2022 filing (page 110) listed $1.222 bn due in 2022 and $1.051 bn due in 2023, whereas the 2023 filing (page 101) shows $0.836 bn due in 2024, $0.862 bn in 2025, $0.705 bn in 2026 and $0.687 bn in 2027.  The accounting treatment was unchanged: each payment is recorded as a collaboration intangible asset when made and is subsequently amortized over the underlying economic benefit, rather than being expensed immediately.  Thus, while the timing of when the amounts become payable moved into later years, RTX continued to capitalize the flight‑hour payments as collaboration intangibles as they are incurred.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a substantively correct response that addresses the core question about how RTX's flight hour payment obligations evolved between 2022 and 2023. STRENGTHS: (1) Correctly identifies the contingent payment structure tied to V2500-powered flight hours through June 2027; (2) Accurately describes the accounting treatment as capitalization of collaboration intangible assets; (3) Provides specific dollar amounts for payment schedules in both years, showing the temporal shift of obligations; (4) Correctly notes that the accounting treatment remained unchanged between years; (5) Demonstrates proper multi-hop synthesis by connecting the acquisition agreement, payment schedule evolution, and accounting treatment. QUANTITATIVE VERIFICATION: The LLM provides specific numbers ($1.222bn in 2022, $1.051bn in 2023 from 2022 filing; $0.836bn in 2024, $0.862bn in 2025, $0.705bn in 2026, $0.687bn in 2027 from 2023 filing). While these specific figures cannot be independently verified against the ground truth provided, they are internally consistent and logically represent a payment schedule that has shifted forward in time. The pattern makes economic sense - amounts due in 2022-2023 in the 2022 filing become amounts due in 2024-2027 in the 2023 filing. MINOR WEAKNESSES: (1) The ground truth states there was 'no indication of a change in the magnitude or timing of these obligations,' but the LLM answer explicitly describes a shift in timing (amounts moving to later years). However, this is actually a more precise reading of the filings - the timing DID shift forward, which is a factual observation that enhances rather than detracts from the answer; (2) The LLM provides more granular detail than the ground truth, which could be seen as either more informative or potentially introducing unverified specifics. The accounting treatment description is accurate and matches the ground truth. The answer successfully synthesizes information across multiple years and documents to show the evolution of obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 549,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola’s financial tie to fairlife remained a performance‑based milestone payment that is re‑measured each quarter and recorded as a Level‑3 liability; in 2023 the company paid a $275 million milestone after fairlife met a target, reducing the accrued contingent consideration, and the balance that remains is still contingent on achieving further 2024‑2025 financial goals and will be settled in 2025.  The 2024 10‑K (pages 111‑112) shows the liability’s fair‑value hierarchy and notes that any subsequent changes in its fair value are recognized in income, illustrating how the contingent payment evolved from an accrued obligation in 2022 to a partially settled, quarterly‑remeasured liability by 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims a $275 million milestone payment was made in 2023, but the ground truth makes no mention of any payment in 2023 or a $275 million figure. This is a major factual error. The ground truth indicates the milestone payment was scheduled for 2025, not already paid in 2023. (2) TIMELINE DISCREPANCY: The LLM suggests the contingent payment was 'partially settled' by 2024, implying a 2023 payment occurred. The ground truth indicates the payment remained contingent through 2024 with settlement scheduled for 2025. (3) MULTI-HOP REASONING: While the LLM correctly identifies that this involves a performance-based milestone payment and Level-3 liability treatment, it introduces unsupported details about quarterly re-measurement and a specific $275M payment that cannot be verified from the ground truth. (4) PARTIAL ACCURACY: The LLM correctly identifies that: the relationship involves contingent payments tied to financial targets, the payment is scheduled for 2025, and fair value changes are recognized in income. However, these correct elements are undermined by the fabricated $275M payment claim. (5) CITATION ISSUE: The LLM references specific 10-K pages (111-112) but provides information inconsistent with the ground truth, suggesting either misreading or hallucination of source material. The core evolution described in the ground truth (from completed 2020 acquisition to active performance obligation through 2024) is partially captured but distorted by the false payment claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 445,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Oracle moved Oracle Cloud Services from a supplemental offering to the central pillar of its enterprise stack, tightly coupling SaaS applications (Fusion ERP, HCM, SCM, NetSuite, Advertising, etc.) with Oracle Cloud Infrastructure (OCI).  The company now markets a unified, subscription‑based platform that can be run on‑premise, in Oracle‑hosted OCI, or via Oracle Cloud@Customer, delivering end‑to‑end integration of applications and infrastructure, enabling customers to migrate and modernize core business processes on a single, interoperable cloud foundation.  This shift is reflected in the growing share of cloud‑services and license‑support revenue—rising to roughly 71 % of total sales—and in the expanded, cloud‑native portfolio that emphasizes seamless data flow, consistent upgrades, and AI/ML‑enabled services such as the Autonomous Database.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of Oracle's strategic evolution and provides relevant context about the shift toward cloud-centric positioning. However, there are significant quantitative accuracy issues that lower the overall score.\n\nSTRENGTHS:\n1. Correctly identifies the core strategic shift from supplemental to central positioning of Oracle Cloud Services\n2. Accurately names specific SaaS applications (Fusion ERP, HCM, SCM, NetSuite, Advertising)\n3. Properly describes the multi-deployment model (on-premise, OCI, Oracle Cloud@Customer)\n4. Correctly emphasizes integration of applications and infrastructure\n5. Appropriately mentions AI/ML services and Autonomous Database\n6. Good semantic alignment with ground truth's concept of 'holistic, integrated platform'\n7. Contextually relevant discussion of subscription-based model and interoperability\n\nWEAKNESSES:\n1. CRITICAL: States cloud services revenue is \"roughly 71% of total sales\" - this specific percentage is not verified in the ground truth and appears to be an unsupported quantitative claim. The ground truth does not provide this metric.\n2. The answer introduces specific revenue percentages without grounding them in the provided knowledge graph, which violates the principle of strict accuracy on numbers\n3. While the qualitative evolution is well-described, the introduction of unverified quantitative data undermines credibility\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across 2022-2024 timeframe and connects SaaS applications with infrastructure offerings, demonstrating sound multi-hop reasoning. The logical flow from individual innovations to integrated platform is clear and matches the ground truth's narrative.\n\nNUMERIC VERIFICATION:\nThe 71% figure cannot be verified against the ground truth provided. This is a significant issue because the evaluation criteria emphasize strict accuracy on numbers. Without confirmation from the source documents, this percentage claim represents a factual error or hallucination.\n\nOVERALL ASSESSMENT:\nThe answer captures the strategic evolution well qualitatively but introduces an unverified quantitative claim that significantly impacts correctness. The core narrative is sound, but the specific revenue percentage claim is problematic and reduces the score from what would otherwise be 8-9 range to 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 636,
        "total_tokens": 2131
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "\nThe Key/Specified Employee Policy is still disclosed as Exhibit 10(r) in both the 2023 and 2024 Form 10‑K filings, and in each filing it is incorporated by reference to the same 2018 filing (Exhibit 10(v) of the 2018 10‑K).  No new exhibit or separate narrative was added in the 2024 filing; the policy continues to be referenced solely through that historical exhibit designation.  Consequently, the documentation and incorporation method for the policy have remained unchanged between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT DESIGNATION ERROR: The LLM states the policy is disclosed as 'Exhibit 10(r)' in both filings, but the ground truth indicates it should be 'Exhibit 10(v)' - this is a critical factual error in entity identification. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth explicitly states the policy was 'introduced' in 2023 and then became a 'continuing policy' in 2024, indicating a change in status/treatment between the two years. The LLM incorrectly claims the documentation and incorporation method 'remained unchanged,' missing the key distinction that the policy's status evolved from newly introduced to continuing. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the meaningful evolution described in the ground truth - that while the underlying exhibit reference remained the same (Exhibit 10(v) from 2018), the policy's presentation and characterization changed between years. (4) MISSING CONTEXT: The ground truth emphasizes that 'no new amendments or updates' occurred, which is a nuanced point about the policy's stability despite its changing status. The LLM's answer, while noting no new exhibits were added, misses this important distinction about the policy's treatment evolution. The answer demonstrates a fundamental misunderstanding of what changed between the two filings - the status/treatment of the policy itself, not just its documentation method.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 410,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "\nThe $6.700\\%$ notes maturing in 2028 fell from **$400 million** at the end of 2022 to **$285 million** at the end of 2023—a reduction of roughly **$115 million**.  This decline shows that RTX is deliberately shrinking its legacy debt, using new issuances and cash flows to retire older tranches and thereby streamline its long‑term financing and lower overall leverage.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM states the 6.700% notes were $400 million in 2022 and $285 million in 2023, but the ground truth clearly shows $115 million in 2022 and $285 million in 2023. The LLM has the 2022 figure completely wrong ($400M vs $115M - a 247% overstatement). The calculation of the change is also inverted: the LLM claims a $115 million reduction, when the ground truth shows a $170 million INCREASE ($285M - $115M = +$170M). (2) DIRECTIONAL ERROR - CRITICAL: The LLM's interpretation of debt management strategy is backwards. The LLM concludes RTX is 'deliberately shrinking its legacy debt' and 'retiring older tranches,' but the ground truth shows the opposite - RTX INCREASED the outstanding balance of these notes from $115M to $285M, indicating a decision to retain or expand exposure to this fixed-rate debt. This is a fundamental misreading of what the numbers indicate. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison and draw the appropriate conclusion about RTX's debt strategy. The reasoning logic is internally consistent but based on incorrect premises. (4) ENTITY ACCURACY: RTX and the note details (6.700%, due 2028) are correctly identified, but the financial data associated with these entities is wrong. The answer demonstrates a complete reversal of the actual debt evolution and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 412,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "\nThe 1.95 % 12‑Year Senior Notes carried a balance of $773 million at year‑end 2023, which declined to $725 million by year‑end 2024.  During this interval the effective interest rate stayed essentially unchanged, holding near 2.08 % (reported as about 2.07 % for 2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and proper multi-hop synthesis. Verification of key metrics: (1) 2023 carrying value of $773 million - CORRECT; (2) 2024 carrying value of $725 million - CORRECT; (3) 2023 effective interest rate of 2.08% - CORRECT; (4) 2024 effective interest rate of 2.07% - CORRECT. The calculation of the decline ($773M to $725M = $48M reduction) is accurate. The LLM correctly identified the marginal change in effective interest rate (2.08% to 2.07%). However, there is a minor semantic issue: the LLM states the effective interest rate 'stayed essentially unchanged, holding near 2.08%' when the ground truth explicitly notes it 'slightly declined to 2.07%.' While the LLM does mention 2.07% for 2024, the phrasing 'stayed essentially unchanged' and 'holding near 2.08%' could be interpreted as downplaying the decline, whereas the ground truth characterizes it as a 'marginal improvement.' The LLM's characterization is not incorrect (a 1 basis point change is indeed marginal), but it's slightly less precise in emphasizing the directional change. The answer successfully synthesizes information across two fiscal years and correctly addresses both components of the multi-part question (carrying value evolution and effective interest rate evolution). All numeric values are accurate and properly formatted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 382,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "\nThe 2024 filing now lists the Directors’ Code of Conduct as a stand‑alone governance document that is posted on the company’s website alongside the board’s charters and other governance guidelines, whereas the 2022 filing only mentioned it within a broader “Code of Ethics” and pledged to disclose any amendments or waivers on the site. This shift makes the directors’ conduct rules a permanent, easily accessible element of BNY Mellon’s governance framework, signaling greater transparency and formal board oversight.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth states that in 2022, BNY Mellon explicitly detailed the Directors' Code with a direct URL link, and by 2024 it was listed without a direct link or specific mention of updates. The LLM answer reverses this chronology, claiming the 2024 filing now lists it as a 'stand-alone' document with greater transparency, while the 2022 filing only mentioned it within a broader 'Code of Ethics.' This is the opposite of what actually occurred. The LLM also incorrectly characterizes the 2024 change as signaling 'greater transparency and formal board oversight,' when the ground truth indicates the shift may have reduced visibility and transparency by removing the direct link and consolidating it among other materials without specific mention. The LLM's interpretation of the governance implications is therefore inverted from the actual implications described in the ground truth. While the answer addresses the correct companies and years, and contains no mathematical errors, the core factual claims about what changed between 2022 and 2024 are incorrect, making this a substantially flawed response that would mislead stakeholders about the actual governance disclosure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 360,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "\nBetween 2023 and 2024 Amazon refreshed its short‑term revolving facility twice. In November 2023 it entered a new $5 billion, 364‑day unsecured revolving credit agreement that replaced the prior $5 billion facility, and in October 2024 it replaced that agreement with another $5 billion, 364‑day facility whose maturity was extended to October 2025 (with a one‑year extension option). Thus, the facility size remained $5 billion, but the maturity date moved from 2024 to 2025, and the agreement was re‑established in late 2023 and again in October 2024. No borrowings were outstanding under the facility as of December 31 2023 or 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong factual accuracy. STRENGTHS: (1) All key numbers are correct: $5.0 billion facility size in both years, 364-day terms, maturity dates (October 2024 for 2023 agreement, October 2025 for 2024 agreement). (2) Dates are accurate: November 2023 establishment and October 2024 establishment. (3) The core narrative about facility renewal is correct - same size, maturity extended by one year. (4) Additional detail about no borrowings outstanding adds useful context. (5) Multi-hop synthesis is sound, correctly connecting the 2023 and 2024 agreements and their relationship. MINOR ISSUES: (1) The LLM states the 2023 agreement was entered in 'November 2023' but the ground truth says 'November' for the 2023 agreement (which would be November 2023). This is consistent. (2) The LLM mentions 'a one-year extension option' which is not explicitly mentioned in the ground truth - this appears to be additional detail not contradicted by the source but not confirmed either. (3) The ground truth emphasizes that the 2023 agreement replaced a 'prior agreement from November 2022' - the LLM says it 'replaced the prior $5 billion facility' but doesn't specify the November 2022 date. This is a minor omission of historical context. QUANTITATIVE VERIFICATION: All dollar amounts ($5B), dates (November 2023, October 2024, October 2025), and the 364-day term are correct. The one-year maturity extension (2024 to 2025) is accurately captured. REASONING: The multi-hop synthesis correctly identifies the evolution pattern and explains the procedural renewal nature of the changes. The answer properly addresses facility size, maturity date, and timing of establishment as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 469,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "\nFrom 2022 to 2024 AMD shifted its APU roadmap from a pure CPU‑GPU integration aimed at mainstream and commercial PCs toward a **AI‑ready SoC** that adds a dedicated neural‑processing unit and more capable graphics (e.g., Ryzen AI 300 series with an NPU and Ryzen PRO 8000G “integrated AI desktop”).  This tighter hardware‑software integration targets **AI‑centric laptops and desktops for consumers, creators and enterprise users**, expanding the addressable market beyond traditional PC segments.  As a result, AMD can tap a **new, higher‑margin revenue stream in the emerging AI‑PC market**, but the upside will depend on OEM adoption and the growth of on‑device AI software ecosystems.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AMD's APU strategy evolution from 2022 to 2024 and correctly identifies the shift toward AI-integrated solutions. STRENGTHS: (1) Correctly identifies the strategic pivot from traditional CPU-GPU integration to AI-ready SoCs with dedicated NPUs; (2) Accurately names specific products (Ryzen AI 300 series, Ryzen PRO 8000G) showing product knowledge; (3) Properly identifies target markets expanding from mainstream PCs to AI-centric devices for consumers, creators, and enterprise; (4) Correctly emphasizes the revenue potential in the emerging AI PC segment and mentions higher-margin opportunities; (5) Appropriately notes the dependency on OEM adoption and software ecosystems. WEAKNESSES: (1) The LLM answer lacks specific reference to 2022 baseline products (Instinct MI200 series, Radeon PRO V620 GPUs) that the ground truth mentions, which would have provided stronger historical context for the comparison; (2) Does not explicitly state that AMD was 'the first company' to integrate NPU on the same SoC as x86 CPU, which is a key differentiator mentioned in ground truth; (3) The answer focuses more on consumer/creator/enterprise segments rather than explicitly contrasting the 2022 data center/cloud focus with 2024 client device focus; (4) Missing the explicit mention of 'on-device AI processing' as the critical capability shift. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across the time period and connects it to revenue implications, though it could have been more explicit about the data center-to-client transition. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - both identify the NPU integration strategy and AI PC market opportunity. The LLM's mention of 'higher-margin revenue stream' aligns with ground truth's 'revenue growth' positioning. No numerical errors detected. The answer is substantively correct but lacks some specific historical detail and competitive positioning that would elevate it to 8-9 range.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 548,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Medtronic’s disclosures did not introduce any new Irish tax rules – the company continued to state that Irish dividend withholding tax of 25 % applies to dividends on its ordinary shares, but U.S. shareholders can avoid that tax if they provide a valid U.S. certification of residence (Form 6166) or have their broker’s U.S. address on file, and any withheld amount is treated as a full discharge of any Irish income‑tax liability. In short, the treatment of Irish withholding tax for U.S. shareholders remained essentially unchanged, with the 2024 filing merely reaffirming the same exemption conditions and discharge‑of‑liability language.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts and demonstrates sound multi-hop reasoning across 2023-2024 filings. STRENGTHS: (1) Correctly identifies the 25% Irish dividend withholding tax rate in both years; (2) Accurately states that U.S. shareholders can obtain exemptions via Form 6166 or valid U.S. certification of residence; (3) Correctly notes that withheld amounts discharge Irish income tax liability; (4) Properly concludes there was no change between years, indicating stable regulatory framework; (5) All numeric values (25% rate) are accurate. WEAKNESSES: (1) The LLM mentions 'broker's U.S. address on file' as an exemption method, but the ground truth specifically references 'Irish Non-Resident Form V2' as an alternative documentation method - the LLM's mention of broker address is not explicitly confirmed in the ground truth and may represent a slight deviation or incomplete documentation of exemption methods; (2) The ground truth emphasizes the requirement that U.S. residents 'did not hold shares through an Irish branch' as a condition for no Irish income tax liability, which the LLM answer omits entirely - this is a material condition that should have been included; (3) The ground truth explicitly mentions 'Irish Non-Resident Form V2' as a valid exemption document, which the LLM does not reference. MULTI-HOP REASONING: The LLM correctly synthesizes information across both fiscal years and properly identifies the lack of change as the key finding. The comparison between years is logically sound. QUANTITATIVE ACCURACY: The 25% rate is correct; no calculation errors present. SEMANTIC EQUIVALENCE: The core message matches - no evolution/change in treatment between years, with stable exemption conditions. However, the omission of the Irish branch condition and Form V2 documentation method represents incomplete coverage of the exemption framework, reducing the answer's comprehensiveness despite maintaining factual accuracy on the main points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 537,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "\nBetween the 2022 and 2024 filings the discussion of risk moved from a generic warning that “new lines of business, new products and services or transformational or strategic project initiatives subject us to new or additional risks” to a dedicated, explicit risk factor that the company “may not realize some or all of the expected benefits of our transition to a platforms operating model.”  The 2024 filing therefore adds a clear, stand‑alone disclosure that the platforms‑operating‑model initiative itself introduces additional operational, technological and regulatory uncertainties, whereas the 2022 filing only referenced such initiatives in the aggregate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both correctly identify the evolution of risk disclosure from 2022 to 2024 regarding BNY Mellon's platforms operating model initiative. Key strengths: (1) Accurate identification of the 2022 generic language about 'new lines of business, new products and services, or transformational or strategic project initiatives' - exact quote matching; (2) Correct citation of the 2024 specific risk language about 'may not realize some or all of the expected benefits of our transition to a platforms operating model' - semantically equivalent to ground truth; (3) Proper multi-hop synthesis showing the evolution from aggregate/generic risk language to dedicated, explicit platform-specific disclosure; (4) Correct entity identification (BNY Mellon, 2022 vs 2024 filings); (5) Sound reasoning about the shift from general strategic risk to concrete implementation risks. Minor observation: The LLM answer adds interpretive language about 'operational, technological and regulatory uncertainties' which, while reasonable inference, is not explicitly stated in the ground truth provided. However, this represents reasonable elaboration rather than factual error. The answer fully addresses the multi-part question about how risk disclosure evolved and specifically regarding the platforms operating model initiative. No quantitative errors present (no numbers/dates to verify). The semantic meaning and factual content align precisely with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 418,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "\nBetween 2023 and 2024 Amazon did not issue, amend, or retire the 3.600 % Note due 2032; the instrument remained part of the company’s senior unsecured debt under the original April 13 2022 Supplemental Indenture. The note continued to be disclosed in the 10‑K filings, but its reference moved from Exhibit 4.2 in the 2023 filing to the reorganized Exhibit 4.8 (which now bundles the 4.700 % Note due 2032) in the 2024 filing—reflecting only a renumbering of the exhibit list, not a material change in the debt instrument itself.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Key issues: (1) TRUSTEE TRANSITION MISSED: The ground truth explicitly states that the trustee structure evolved from Wells Fargo Bank, National Association (as prior trustee) AND Computershare Trust Company, National Association (as successor trustee) in 2023 to ONLY Computershare Trust Company, National Association in 2024. This is a material procedural change in debt administration. The LLM answer completely fails to identify or mention this trustee transition, which is the primary evolution the question asks about. (2) EXHIBIT RENUMBERING CLAIM: The LLM introduces information about exhibit renumbering (from Exhibit 4.2 to 4.8) that is not present in the ground truth and appears to be fabricated. The ground truth makes no mention of exhibit numbers or reorganization. (3) BUNDLING CLAIM: The LLM states the note moved to an exhibit that 'now bundles the 4.700% Note due 2032,' which is not supported by the ground truth and appears to be an unsupported inference. (4) INDENTURE DATE ACCURACY: Both answers correctly identify the April 13, 2022 Supplemental Indenture date. (5) CORE ANSWER STRUCTURE: The ground truth emphasizes the trustee relationship shift as the key evolution, while the LLM focuses on exhibit reorganization and bundling—neither of which are mentioned in the ground truth. The LLM's characterization of the change as 'only a renumbering of the exhibit list' directly contradicts the ground truth's emphasis on the trustee transition as a 'procedural evolution in the administration of the note.' The answer demonstrates poor multi-hop synthesis and introduces unsupported details while omitting the actual material change documented in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 488,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "\nIn the 2024 filing MDLZ presents net‑investment‑hedge derivatives as a separate line‑item within “derivatives designated as accounting hedges,” showing a gross asset of $305 million and a liability of $50 million (net $255 million), whereas the 2023 disclosure only showed the contracts as part of the aggregate derivative totals with a net liability of $219 million. This shift moves the hedge from a net liability to a net asset and raises the gains excluded from hedge‑effectiveness to $148 million (2024) from $116 million (2023), reflecting a change in the hedge portfolio’s composition and improved hedge performance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. (1) CRITICAL ERRORS: The LLM provides specific numbers ($305M asset, $50M liability, $255M net, $219M net liability in 2023, $148M and $116M excluded gains) that do not appear in or match the ground truth. The ground truth cites $1,347M and $377M in other current assets for 2023, and $250M and $413M in other assets for 2022 - completely different figures. (2) QUANTITATIVE ACCURACY FAILURE: The LLM's numbers cannot be verified against the ground truth and appear to be fabricated or from incorrect sources. The calculation of net positions ($305M - $50M = $255M) is mathematically correct but based on unverified source data. The comparison of $148M vs $116M excluded gains lacks grounding in the provided ground truth. (3) CONCEPTUAL MISALIGNMENT: The ground truth emphasizes a shift FROM balance sheet valuation disclosure TO income statement impact disclosure (from 2023 to 2024). The LLM instead focuses on changes in asset/liability presentation and hedge performance, which is a different analytical framework. The ground truth's key insight about the change in emphasis from balance sheet to income volatility is not captured. (4) MULTI-HOP REASONING: The LLM fails to correctly synthesize the evolution described in the ground truth. It invents a narrative about moving from net liability to net asset and improved hedge performance, rather than explaining the actual shift in disclosure focus and presentation methodology. (5) ENTITY AND METRIC CONFUSION: While MDLZ is correctly identified, the specific metrics and their values are incorrect or unsupported. The ground truth provides clear 2023 and 2022 comparisons; the LLM provides 2023 and 2024 comparisons with different numbers entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 496,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "\nFrom 2023 to 2024 the Abrams modernization moved from incremental enhancements—specifically the delivery of the SEPv3 “system‑enhancement‑package” that adds upgraded communications, power generation, fuel‑efficiency, optics and armor to existing M1A2 tanks and supports upgrades for allied customers—to a more fundamental engineering change: the Army’s announced development of the M1E3 tank, an “engineering‑change” design that adopts a new systems‑architecture standard, promises faster technology refreshes, a smaller sustainment footprint and greater tactical mobility.  Throughout both years NATO and other allies have kept strong demand for Abrams‑type upgrades and new builds, reflected in a growing installed base across Europe, the Middle East, North Africa and the Indo‑Pacific.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: All core facts are correct - SEPv3 details (communications, power generation, fuel efficiency, optics, armor upgrades), M1E3 development announcement, and the shift from incremental to fundamental engineering changes are all accurately represented. The geographic scope of international demand (Europe, Middle East, North Africa, Indo-Pacific) matches perfectly. (2) QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension is not applicable, but the answer correctly avoids introducing false numbers. (3) MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two years - showing the 2023 focus on SEPv3 and M1E3 announcement, then the 2024 emphasis on global strategic relevance and procurement momentum. The logical progression from 'incremental enhancements' to 'fundamental engineering change' is clearly articulated. (4) ENTITY ACCURACY: General Dynamics is correctly implied as the company (though not explicitly named in the LLM answer, the context makes this clear). The tank designations (M1A2, SEPv3, M1E3) are all correct. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly different wording but equivalent meaning. The phrase 'growing installed base' appears in both. The characterization of technological development and international demand evolution is semantically identical. Minor difference: The LLM answer provides slightly more technical detail about the M1E3 (faster technology refreshes, smaller sustainment footprint, greater tactical mobility) which adds value without contradicting the ground truth. The answer is comprehensive, accurate, and appropriately addresses all aspects of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 503,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "\nBetween 2022 and 2024 AMD broadened the APU’s footprint — while it remained the core of the **Client segment** (desktop and notebook CPUs/APUs/chipsets), the company began positioning the APU in **new markets** such as **embedded platforms, semi‑custom SoCs for game consoles and handheld devices, and AI‑oriented compute** (e.g., the Silo AI acquisition and Data‑Center AI accelerators that rely on APU‑style heterogeneous processing).  Consequently, the strategic emphasis shifted from a pure “CPU‑plus‑GPU for mainstream PCs” to a **heterogeneous‑computing narrative** that spans client, embedded and semi‑custom segments and underpins AMD’s AI‑accelerator and AI‑software strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces significant factual inaccuracies and unsupported claims that deviate substantially from the ground truth. (1) INCORRECT CLAIMS: The LLM mentions 'Silo AI acquisition' and 'game consoles and handheld devices' as part of AMD's APU strategy evolution between 2022-2024, but the ground truth makes no mention of these. These appear to be hallucinated details not supported by the filing data. (2) MISSING KEY FACTS: The ground truth explicitly states that by 2024, APUs were included in TWO specific reportable segments: Data Center and Client. The LLM mentions Client segment correctly but fails to clearly articulate the Data Center segment inclusion as a formal reportable segment change. (3) MISCHARACTERIZATION: The ground truth describes APUs in Data Center as 'listed alongside AI accelerators, CPUs, GPUs, and DPUs' - a specific structural change in segment reporting. The LLM vaguely references 'AI‑accelerators that rely on APU‑style heterogeneous processing' which is interpretive rather than factual. (4) REASONING QUALITY: While the LLM correctly identifies the shift toward heterogeneous computing and broader market positioning, it does so by introducing unsupported details rather than accurately synthesizing the actual segment reporting changes documented in the filings. (5) QUANTITATIVE ACCURACY: No specific numbers or dates are provided by either answer, so this dimension is neutral. However, the LLM's introduction of unverified claims (Silo AI, game consoles) represents a failure in factual grounding. The core multi-hop synthesis - comparing 2022 vs 2024 positioning - is partially correct in spirit but fundamentally flawed in execution due to hallucinated details and missing the explicit segment reporting structure that is central to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 496,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "\nIn the 2023 filing Medtronic gave only a brief notice that Ireland’s Minister for Finance could restrict financial transfers under the 1992 Act and that “the list is subject to ongoing change,” without specifying which third‑country transfers might be affected. By the 2024 filing the company expanded the disclosure, explicitly stating that the Minister’s restrictions cover all transfers between Ireland and third countries, that the restricted‑country list is regularly updated, and that any transaction involving a sanctioned jurisdiction or party may be blocked—thereby providing a clearer, more detailed picture of how the Act could affect cross‑border cash movements and shareholder‑related financial flows.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer directly contradicts the ground truth on the fundamental evolution of Medtronic's disclosure. Ground truth states that by 2024, the company 'no longer emphasized the dynamic nature of the list of restricted countries,' suggesting a shift away from highlighting ongoing changes. However, the LLM claims the opposite—that by 2024 the company 'expanded the disclosure' and stated 'the restricted-country list is regularly updated,' which represents an INCREASE in emphasis on the dynamic nature, not a decrease. This is a fundamental factual error that inverts the actual disclosure evolution. The LLM also introduces specific claims not supported by the ground truth: (1) that 2023 disclosure was 'brief' and lacked specificity about affected transfers, (2) that 2024 'explicitly stated' the Minister's restrictions cover 'all transfers between Ireland and third countries,' (3) that 2024 mentioned 'shareholder-related financial flows' and 'sanctioned jurisdiction or party' language. The ground truth makes no such distinctions about the level of detail or these specific phrasings. The LLM appears to have fabricated a narrative of expansion and clarification that contradicts the ground truth's narrative of de-emphasis on the dynamic nature of restrictions. Quantitative accuracy is acceptable (dates and company name correct), but the qualitative reasoning and semantic meaning are fundamentally wrong—the LLM mischaracterized the direction and nature of the disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 421,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "\nIn the 2023 filing Gulfstream said the ultra‑large‑cabin G700 was on track to obtain FAA type‑certification and be ready for service “in early 2024.”  The 2024 filing confirms that the aircraft did receive that certification and began deliveries—specifically, the G700 entered service and started shipments in the second quarter of 2024—showing the model’s evolution from an anticipated future aircraft to an operational, delivered product.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about G700 evolution from 2023 to 2024. (1) CORRECTNESS: All factual information is correct. The 2023 status (on track for FAA certification, expected service in early 2024) matches the ground truth. The 2024 status (received certification, began deliveries in Q2 2024) is accurate. The characterization of the evolution from 'anticipated future aircraft' to 'operational, delivered product' correctly captures the progression. (2) QUANTITATIVE ACCURACY: All dates and timeframes are precise and correct - 'early 2024' for certification expectation in 2023 filing, 'second quarter of 2024' for actual deliveries in 2024 filing. No calculations required, but temporal references are accurate. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer correctly synthesizes information from two different filing years (2023 and 2024) and demonstrates clear understanding of the product lifecycle transition. The logic connecting certification completion to production/delivery is valid. (4) ENTITY ACCURACY: Gulfstream (GD) is correctly identified, G700 aircraft is properly named, and fiscal years are correctly referenced. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with slightly different but equivalent wording ('ultra-large-cabin G700' vs. just 'G700', 'shipments' vs. 'deliveries' - both acceptable synonyms). The answer is comprehensive, addressing both the 2023 expectations and 2024 realization. Minor: The phrase 'ultra-large-cabin' adds descriptive detail not in ground truth but is not incorrect. Overall, this is an excellent response with accurate synthesis across multiple filing periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 478,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "\nFrom the 2023 disclosure, PMI and KT&G formalised a 15‑year, exclusive (outside South Korea) licence that runs through 2038, with three‑year performance‑review cycles tied to volume commitments; the deal gives PMI sole worldwide access to KT&G’s smoke‑free device portfolio and its pipeline of products for low‑ and middle‑income markets, subject to market‑by‑market regulatory clearance. In 2024 the arrangement remains in force and is now reflected in PMI’s heat‑not‑burn (HTU) shipment data, which lists KT&G‑licensed brands such as Fiit and Miix (outside Korea) alongside PMI’s own HTU offerings, indicating that the partnership has moved from a newly‑announced collaboration to an ongoing, strategically important source of licensed smoke‑free products that PMI commercialises globally while still retaining the ability to supplement the portfolio with its own R&D.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the PMI-KT&G relationship evolution. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 15-year agreement duration, the January 29, 2038 end date (correctly referenced as 'through 2038'), the exclusive worldwide scope excluding South Korea, and the three-year performance-review cycles are all accurately stated. ENTITY ACCURACY: All entities correctly identified - PMI, KT&G, specific product brands (Fiit, Miix), and the heat-not-burn (HTU) product category. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings, correctly tracing the evolution from 'newly-announced collaboration' to 'ongoing, strategically important source of licensed smoke-free products.' The answer captures the key shift from exclusive distribution announcement to operational integration within PMI's product portfolio. COMPLETENESS: The answer addresses both parts of the question - the nature of the relationship and its evolution in terms of strategic dependency and product commercialization. The inclusion of specific product names (Fiit, Miix) and the reference to HTU shipment data demonstrates concrete evidence of the integration. MINOR CONSIDERATIONS: The LLM answer adds contextual details about 'three-year performance-review cycles tied to volume commitments' and 'market-by-market regulatory clearance' that enhance understanding, though these weren't explicitly mentioned in the ground truth. The phrase 'retaining the ability to supplement the portfolio with its own R&D' provides additional nuance about PMI's strategic flexibility. The semantic meaning aligns perfectly with the ground truth's characterization of evolution from exclusive distribution to deeper strategic alignment and operational integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 502,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "\nFrom 2022 through 2024 AMD moved its semi‑custom SoC business from a niche, console‑focused revenue stream—where earnings depended on design‑service fees and the success of a few OEM partners (as noted in the 2022 filing’s discussion of semi‑custom revenue reliance)—to a broader, ecosystem‑centric strategy that treats these custom chips as a unifying compute engine across AMD’s AI‑focused product families.  The 2024 disclosures show semi‑custom SoCs now being promoted alongside the Instinct GPU, EPYC CPU and Adaptive SoC portfolios, integrated with the ROCm open‑software stack and paired with strategic acquisitions (e.g., Silo AI, ZT Systems) to embed them in data‑center, embedded and AI‑PC solutions, thereby positioning them as a key component of AMD’s end‑to‑end AI offering.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AMD's strategic evolution in semi-custom SoCs from 2022 to 2024, with accurate characterization of the shift from a niche, dependency-focused model to a broader ecosystem-centric approach. STRENGTHS: (1) Correctly identifies the 2022 positioning as dependent on third-party success and design-service fees; (2) Accurately describes the 2024 evolution toward integrated AI/ecosystem strategy; (3) Properly synthesizes multi-hop information about product integration (Instinct GPU, EPYC CPU, Adaptive SoC, ROCm); (4) Appropriately mentions strategic acquisitions (Silo AI, ZT Systems) as supporting evidence; (5) Correctly identifies application domains (data-center, embedded, AI-PC); (6) Semantic equivalence is strong - 'niche, console-focused' aligns with 'dependent on third-party product success,' and 'ecosystem-centric strategy' matches 'integrated product ecosystem.' MINOR WEAKNESSES: (1) The answer mentions specific product names (Instinct, EPYC, Adaptive SoC, ROCm) and acquisitions that, while likely accurate, are not explicitly verified against the ground truth provided; (2) The ground truth specifically mentions 'dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs' - the LLM answer references AI-PC solutions but doesn't explicitly mention the NPU integration detail; (3) The ground truth emphasizes 'gaming, cloud services, and embedded systems across multiple industries' while the LLM focuses more on data-center and AI applications, though embedded systems are mentioned. QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided in either answer, so this dimension is not directly testable. The temporal framing (2022 to 2024) is correct. MULTI-HOP REASONING: The answer successfully synthesizes information about AMD's strategic positioning across multiple product lines and time periods, demonstrating sound logical progression from dependency model to integrated leadership. The connection between semi-custom SoCs and broader AI strategy is well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 560,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "\nThe 2023 filing said U.S. shareholders could avoid the 25 % Irish dividend withholding only if they held their shares through DTC and the broker’s records showed a U.S. address that was passed to a qualifying intermediary. The 2024 filing keeps that DTC‑based exemption but adds a second, explicit route—providing a U.S. Certification of Residence (Form 6166) or an Irish Non‑Resident Form V2 to the transfer agent—and clarifies that the withholding payment then fully discharges any Irish income‑tax liability, a detail that was not spelled out in the 2023 version.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) The LLM claims the 2023 filing required shares to be held through DTC with broker records showing a U.S. address passed to a qualifying intermediary—this specific mechanism is not mentioned in the ground truth. (2) The LLM introduces Form 6166 (U.S. Certification of Residence) and Irish Non-Resident Form V2 as explicit routes in 2024—these specific forms are not referenced in the ground truth. (3) The ground truth states the 2023 disclosure noted exemptions for those without Irish connections beyond shareholding, but the LLM reframes this as a DTC-based technical requirement. (4) While the LLM correctly identifies the 25% withholding tax rate and that 2024 clarified post-withholding procedures, it mischaracterizes the nature of the exemption conditions. (5) The ground truth emphasizes that exemptions apply to those 'without a connection to Ireland beyond shareholding' and that withholding can 'discharge any further liability'—the LLM's focus on DTC holdings and specific forms represents a fundamental misinterpretation of the actual tax treatment framework. (6) The LLM fails to capture the core evolution: from general statements about exemptions and liability in 2023 to more structured conditions and clarified procedures in 2024. The answer appears to conflate technical share-holding mechanisms with substantive tax treatment rules.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 409,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "\nFrom 2023 to 2024 General Dynamics’ Marine‑Systems segment kept its revenue growth trajectory—up 12.9 % in 2023 and projected to rise to roughly **$12.8‑12.9 billion in 2024**—but it deliberately shifted focus from the margin‑eroding cost pressures that hit the **Virginia‑class submarine** and **DDG‑51 destroyer** programs in 2023 (which shaved >100 bps off operating margin) to a more cost‑controlled outlook.  The 2024 guidance expects the segment’s operating margin to improve to **≈7.6 %**, reflecting tighter cost management on those programs while still capitalising on the **strong Columbia‑class submarine backlog**, which is slated to drive the bulk of the revenue increase.  In short, the company is moving from a period of supply‑chain‑induced cost strain to a strategy that seeks higher‑margin growth by stabilising Virginia‑class/DDG‑51 costs and expanding the Columbia‑class submarine pipeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All key numbers are correct - the 2024 revenue projection of $12.8-12.9 billion matches ground truth exactly, the operating margin of approximately 7.6% is accurate, and the >100 basis point margin decline in 2023 is correctly characterized (ground truth states 110 bps, LLM says >100 bps, which is semantically equivalent and appropriately conservative). The 12.9% revenue growth figure for 2023 is presented but not explicitly verified in ground truth, though it's consistent with the narrative of revenue growth. ENTITY ACCURACY: All entities are correctly identified - General Dynamics, Marine Systems segment, Virginia-class submarine, DDG-51 destroyer, and Columbia-class submarine programs are all properly named and contextualized. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024, correctly identifying the shift from cost-pressure challenges in 2023 (supply chain disruptions, cost overruns) to improved outlook in 2024 (margin recovery, strategic focus on Columbia-class). The causal logic is sound - connecting margin pressure to program-specific issues and projecting improvement through better execution and Columbia-class growth. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) financial performance change, (2) strategic focus shift, (3) cost pressures on specific programs, and (4) Columbia-class revenue outlook. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from 'margin-eroding cost pressures' to 'cost-controlled outlook' and 'higher-margin growth' accurately captures the ground truth's narrative of moving from cost-driven challenges to stabilization and improvement. Minor strengths: The LLM provides slightly more interpretive depth by explicitly framing this as a deliberate strategic shift. No material errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 530,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "\nBooking.com’s accommodation‑reservation services still generate the vast majority of the company’s revenue.  The 2023 10‑K states that ≈ 89 % of total revenue for 2023 (and also 89 % for 2022) comes from online accommodation reservations—up only slightly from 87 % in 2021—so the proportion of revenue derived from Booking.com’s accommodation bookings remained essentially unchanged between 2022 and 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative verification: The answer correctly states 89% for both 2022 and 2023, matching the ground truth exactly. The additional context about 2021 (87%) is accurate and provides helpful historical perspective, though not required by the question. The use of the approximation symbol (≈) before 89% is appropriate given typical rounding in financial reporting. Multi-hop reasoning: The answer correctly synthesizes information across years (2021, 2022, 2023) and properly identifies the metric (accommodation reservations as percentage of total revenue). The conclusion that the proportion 'remained essentially unchanged between 2022 and 2023' is logically sound and matches the ground truth's statement that it 'remained unchanged.' Entity accuracy: BKNG and Booking.com are correctly identified; the fiscal years are accurate. Semantic equivalence: The LLM's phrasing 'remained essentially unchanged' is semantically equivalent to the ground truth's 'remained unchanged'—both convey the same meaning. The answer directly addresses the question about how financial dependency evolved (or didn't evolve) between 2022 and 2023. Minor note: The ground truth says 'slightly increased' in the opening sentence but then clarifies it 'remained unchanged' at 89%—this appears to be an inconsistency in the ground truth itself. The LLM correctly identifies the actual data (89% both years) and appropriately characterizes this as 'essentially unchanged,' which is the factually correct interpretation. The answer is comprehensive, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 442,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "\nIn the 2023 long‑term‑debt table the company listed a Swiss franc note of $299 million, 1.625 % due 2024.  By the 2024 schedule that line is absent, showing the note had been retired (repaid or refinanced) before year‑end 2024.  This removal signals that PMI deliberately reduced its foreign‑currency debt, lowering its exposure to CHF‑related obligations and associated exchange‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE ACCURACY: All numbers are correct - the $299 million Swiss Franc note amount matches the ground truth exactly, and the 1.625% interest rate and 2024 maturity date are accurately cited from the 2023 long-term debt table. The answer correctly identifies that the note is absent from the 2024 schedule. COMPLETENESS: The answer addresses both parts of the multi-hop question: (1) how the position evolved between 2023-2024 (present in 2023, absent in 2024), and (2) what this indicates about foreign currency obligations (deliberate reduction of CHF exposure and exchange-rate risk). ENTITY ACCURACY: The company is correctly identified as PMI (Philip Morris International), the metric is correctly identified as long-term debt/Swiss Franc notes, and the years 2023-2024 are correctly referenced. REASONING: The multi-hop synthesis is sound - the model correctly connected the presence of the note in 2023 to its absence in 2024, and logically inferred that this represents either repayment or refinancing (matching the ground truth's 'repaid or restructured'). The conclusion about strategic reduction of foreign currency exposure is well-reasoned and supported by the data. SEMANTIC EQUIVALENCE: The LLM's phrasing 'retired (repaid or refinanced)' is semantically equivalent to the ground truth's 'repaid or restructured.' The additional detail about 'exchange-rate risk' adds valuable context without contradicting the ground truth. Minor note: The LLM provides slightly more specific detail (interest rate, maturity date) than the ground truth, which enhances rather than detracts from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 455,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "\nThe 2024 10‑K adds several new, explicitly‑named RSU agreements for non‑employee directors—including a cash‑settled RSU award (Exhibit 10.31), a one‑time/year‑end RSU agreement (Exhibit 10.33) and separate fully‑vested and partially‑vested year‑end RSU agreements (Exhibits 10.35‑10.36)—whereas the 2023 filing only referenced a single “Form of Non‑Employee Director RSU Award Agreement” (a pre‑2015 template). This expansion shows that Goldman Sachs refined and diversified the structure of director RSU awards (adding cash‑settlement and performance‑based/vesting variants) between the 2023 and 2024 filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and contradicts the ground truth in multiple critical ways: (1) EXHIBIT NUMBERS ARE WRONG: The LLM cites Exhibits 10.31, 10.33, 10.35-10.36 as new 2024 exhibits for cash-settled RSUs, one-time/year-end RSUs, and vested/partially-vested RSUs. The ground truth identifies Exhibit 10.18 as the new 2024 addition ('Amendments to Certain Non-Employee Director Equity Award Agreements'), which is completely absent from the LLM answer. (2) MISCHARACTERIZATION OF CHANGES: The LLM claims Goldman Sachs 'refined and diversified the structure of director RSU awards' by adding 'cash-settlement and performance-based/vesting variants.' The ground truth indicates the 2024 change was the introduction of amendments to existing agreements (Exhibit 10.18), not the creation of entirely new RSU agreement types. (3) INCOMPLETE SYNTHESIS: The LLM fails to mention that Exhibit 10.8 (the pre-2015 Form) was retained in 2024, which is a key detail in the ground truth showing continuity alongside the new amendments. (4) FACTUAL ACCURACY: The LLM provides specific exhibit numbers (10.31, 10.33, 10.35-10.36) that do not match the ground truth's identified exhibits (10.8 retained, 10.18 new). This represents a fundamental failure in multi-hop reasoning across the two filings. The answer appears to describe a different set of changes than what actually occurred between the 2023 and 2024 filings. The core insight—that Goldman Sachs expanded its disclosures—is present but the specific nature and exhibits cited are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 427,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "\nBetween 2023 and 2024 the debt that was originally taken on to finance the Swedish Match acquisition was markedly reduced and re‑structured.  In 2023 PMI had a €5.5 bn (≈ $5.8 bn) senior unsecured term‑loan facility, with €3 bn of that tranche maturing in 2025 and the remaining €2.5 bn tranche due in 2027; the “Euro credit‑facility borrowings related to the Swedish Match acquisition” shown in the long‑term‑debt table fell from $6,121 m in 2023 to $2,610 m in 2024.  In November 2024 PMI prepaid essentially the entire €3 bn 3‑year tranche (using cash and the proceeds of a November 2024 bond issuance), leaving only the €2.5 bn 5‑year tranche outstanding and thereby substantially lowering its long‑term debt tied to the Swedish Match deal.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: The core numbers match perfectly - long-term debt obligations decreased from $6,121 million in 2023 to $2,610 million in 2024, exactly as stated in the ground truth. The LLM also provides additional accurate details: €5.5 bn senior unsecured term-loan facility with €3 bn maturing in 2025 and €2.5 bn in 2027. The currency conversion (€5.5 bn ≈ $5.8 bn) is reasonable and contextually appropriate. The November 2024 prepayment of the €3 bn tranche is a specific, verifiable detail that adds credibility. COMPLETENESS: The answer addresses the evolution of PM's financial relationship with Swedish Match AB between 2023 and 2024, specifically focusing on long-term debt obligations as requested. It provides both the headline numbers and underlying structural details. ENTITY ACCURACY: All entities are correctly identified (PMI/PM, Swedish Match AB, debt instruments, time periods). REASONING: The multi-hop synthesis is sound - the answer correctly connects the debt reduction figures to specific refinancing actions (November 2024 bond issuance and prepayment), demonstrating understanding of how the debt evolved. The conclusion that PM's financial exposure lessened is well-supported. MINOR CONSIDERATIONS: The LLM provides more granular detail than the ground truth (specific tranche amounts, maturity dates, November 2024 actions), which enhances rather than detracts from accuracy. The semantic meaning is fully aligned with the ground truth - both convey significant debt reduction and improved financial position. No calculation errors detected. The answer demonstrates sophisticated understanding of debt restructuring mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 469,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "\nFrom 2023 through early 2024 BMS moved from a largely internal, early‑stage KRAS‑inhibition program toward a decisive strategic acquisition that gave it a marketed KRAS‑targeted therapy. In January 2024 the company completed a $4.8 bn (net $4.1 bn) all‑cash purchase of Mirati, securing worldwide rights to Krazati—a FDA/EMA‑approved KRAS‑G12C inhibitor for second‑line NSCLC (and colorectal cancer) and a pipeline PRMT5 degrader for AML/MDS. The Mirati deal thus positioned Krazati as the centerpiece of BMS’s KRAS‑focused oncology portfolio and signaled a shift from exploratory R&D to commercializing a KRAS inhibitor, while also adding a contingent‑value right tied to future PRMT5‑inhibitor development.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) Acquisition amount of $4.8 billion is correct; the LLM also provides additional detail about net cost ($4.1 billion) which adds value. (2) Timing is accurate - January 2024 completion date is correct. (3) Krazati's indications are correctly identified: second-line NSCLC and colorectal cancer approvals are both mentioned, matching the ground truth. (4) The characterization of the strategic shift from internal early-stage programs to acquiring a marketed therapy is accurate and well-articulated. (5) Multi-hop reasoning is sound - the answer correctly synthesizes BMY's 2023 position (no Mirati ownership) versus 2024 position (post-acquisition). Minor considerations: The LLM mentions a PRMT5 degrader and contingent-value right, which are additional details not in the ground truth but are factually accurate additions that enhance rather than contradict the answer. The answer also mentions first-line NSCLC development in combination with PD-1 inhibitor, which the ground truth explicitly states but the LLM answer does not explicitly mention (though it references 'pipeline' development). This is a minor omission of a specific clinical development detail. The answer is comprehensive, well-structured, and demonstrates clear understanding of the strategic evolution. All core facts are correct, calculations are accurate, and the multi-hop synthesis across 2023-2024 is properly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 413,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings, Goldman Sachs moved the Restricted Partner Compensation Plan from a stand‑alone, historical reference in the 2023 filing to a centrally positioned element of its newly refreshed compensation‑governance suite.  The 2024 filing explicitly ties the plan to the December 2023‑effective Amended and Restated Clawback Policy and to the 2021 Amended and Restated Stock Incentive Plan, signalling that the partnership‑level compensation framework is now governed by the same recent governance updates (e.g., claw‑back rules and stock‑plan revisions) that were introduced in 2023‑2024.  This repositioning reflects a deliberate evolution toward a more integrated, policy‑driven approach to partner compensation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN EXHIBIT NUMBERING: The LLM answer contains significant factual inaccuracies regarding exhibit numbers. The ground truth states the Restricted Partner Compensation Plan was Exhibit 10.3 in 2023 and Exhibit 10.4 in 2024. The LLM answer references Exhibit 10.4 for 2024 (correct) but fails to mention the 2023 exhibit number and does not clearly establish the shift from 10.3 to 10.4. More problematically, the LLM claims the Clawback Policy is Exhibit 10.1, which contradicts the ground truth that identifies it as a new 2024 introduction without specifying exhibit number, and the LLM's numbering (10.1) suggests it would have appeared BEFORE the Restricted Partner Compensation Plan in the exhibit list, which contradicts the ground truth's statement that the plan's 'relative placement shifted later in the exhibit list.' FACTUAL INACCURACIES: The LLM introduces unsupported claims about a 'December 2023-effective Amended and Restated Clawback Policy' and a '2021 Amended and Restated Stock Incentive Plan' that are not mentioned in the ground truth. While the ground truth confirms a Clawback Policy was introduced in 2024, the specific December 2023 effective date and the reference to a 2021 Stock Incentive Plan appear to be fabrications or hallucinations not supported by the provided ground truth. POSITIONING ANALYSIS: The LLM's characterization of the plan moving to 'centrally positioned' contradicts the ground truth, which explicitly states the plan's placement 'shifted later in the exhibit list' - a move away from prominence, not toward it. This is a fundamental misreading of the disclosure evolution. PARTIAL CREDIT: The LLM correctly identifies that both 2023 and 2024 filings contain the Restricted Partner Compensation Plan, that the plan remained 'substantively unchanged,' and that there was a strategic repositioning related to governance reforms and risk mitigation. The general theme of integration with newer governance policies is directionally correct. However, the specific details about exhibit numbers, effective dates, and the direction of the positioning shift are materially incorrect, which significantly undermines the answer's reliability for someone seeking precise information about Goldman Sachs' disclosure practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 608,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "\nFrom 2022 to 2023 PMI shifted its heat‑not‑burn (HNB) offering from a stand‑alone “Heated Tobacco Units (HTU)” description toward full integration with its broader smoke‑free portfolio.  In the 2023 filing the company reports HTU shipment volume and adjusted in‑market sales as part of the “smoke‑free products excluding Wellness and Healthcare” segment, includes zero‑tobacco consumables (LEVIA) in the HTU definition, and groups the performance of HNB brands (e.g., HEETS, Marlboro HeatSticks, TEREA) together with the newly acquired Swedish Match oral‑nicotine products, reflecting a more unified product‑category and business‑integration approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from 2022 to 2023, capturing the shift toward integration with broader smoke-free portfolio. It accurately mentions specific product names (HEETS, Marlboro HeatSticks, TEREA, LEVIA) and correctly notes the inclusion of Swedish Match oral-nicotine products. The mention of HTU shipment volume and adjusted in-market sales as part of 'smoke-free products excluding Wellness and Healthcare' segment shows understanding of the business integration aspect.\n\nWEAKNESSES: (1) The LLM answer introduces LEVIA (zero-tobacco consumables) as part of the HTU definition in 2023, which is not mentioned in the ground truth and may represent an overstatement or misinterpretation of product categorization. (2) The answer fails to explicitly mention the 2023 inclusion of 'licensed KT&G heat-not-burn products,' which is a specific and important detail in the ground truth about expansion beyond internally developed offerings. (3) The answer does not clearly articulate the 2022 positioning as 'Reduced-Risk Products (RRPs)' or the explicit evolution to 'smoke-free products' categorization alongside e-vapor and oral nicotine products - it implies this but doesn't state it as clearly as the ground truth. (4) The reference to 'newly acquired Swedish Match oral-nicotine products' is contextually relevant but not directly part of the heat-not-burn product evolution narrative in the ground truth.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable synthesis across 2022-2023 filings and connects product categorization changes to business integration. However, it adds details (LEVIA inclusion, Swedish Match acquisition context) that go beyond what the ground truth establishes about heat-not-burn product evolution specifically.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are provided in either answer, so quantitative accuracy is based on factual claims. The product names and segment descriptions appear accurate, but the LEVIA inclusion claim and the emphasis on Swedish Match acquisition represent potential inaccuracies or overstatements relative to the ground truth focus on heat-not-burn product evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 589,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "\nBetween 2023 and 2024 BMS deepened the role of its business‑risk and disclosure group from a newly created oversight function into an integral part of its SEC‑Consent‑Order compliance program.  In the 2023 filing the group was described as part of the remedial measures (formal review, escalation of concerns, bottom‑up budgeting), but the 2024 filing explicitly ties the group to the ongoing inventory‑monitoring and sales‑limit procedures under the DSAs, emphasizes a regular, documented escalation process, and makes the group responsible for ensuring that any deviation from the Consent‑order limits is promptly reported and resolved.  Thus, the company evolved the group from an ad‑hoc governance element to a continuously monitored, operationally embedded compliance function.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Bristol-Myers Squibb and the 2023-2024 timeframe. (2) No quantitative errors detected - no specific numbers, dates, or calculations are present in either answer to verify. (3) The LLM accurately captures that the business risk and disclosure group was established in 2023 for SEC Consent Order compliance. (4) The answer correctly notes the group's continued presence in 2024 filings. (5) The semantic direction of evolution (from newly created to integrated/embedded) aligns with the ground truth. WEAKNESSES: (1) The LLM introduces specific operational details (inventory-monitoring, sales-limit procedures under DSAs, bottom-up budgeting) that are not present in the ground truth answer. While these may be accurate from the actual filings, they represent information beyond what the ground truth synthesized, making it difficult to verify completeness. (2) The characterization differs subtly: ground truth emphasizes 'no indication of modifications or reductions in scope' and 'maintained its enhanced risk governance structure without significant changes,' while LLM emphasizes 'deepened the role' and 'evolved from ad-hoc to continuously monitored.' This suggests a more significant evolution than the ground truth indicates. (3) The ground truth explicitly states 'no indication of modifications or reductions in scope,' implying stability rather than deepening, which the LLM's framing contradicts. (4) The LLM's claim about 'explicitly ties the group to ongoing inventory-monitoring and sales-limit procedures' cannot be verified against the ground truth provided. MULTI-HOP REASONING: The LLM attempts to synthesize 2023 and 2024 filing information, but the specific operational details introduced (DSAs, inventory-monitoring, sales-limits) go beyond the ground truth's more general characterization of integration and maintenance. The core multi-hop synthesis (comparing 2023 to 2024) is present but the specific conclusions drawn differ from ground truth in tone and detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 546,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "\nIn 2023 UNP tied its long‑term expected return of 5.25 % to a glide‑path that was moving the portfolio from a higher‑equity mix toward a de‑risked allocation, targeting roughly 25 % equity and 75 % debt by year‑end 2023. By 2024 the company had reached that target and kept the same 5.25 % return assumption while maintaining a stable allocation of about 24 % equity, 75 % debt and 1 % real estate, showing that the expected‑return assumption is now linked to a more fixed, conservative asset‑allocation mix rather than an evolving glide‑path.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR DISCREPANCIES: The LLM introduces specific numbers (5.25% expected return, 25% equity/75% debt allocation, 24% equity/75% debt/1% real estate) that are not mentioned in the ground truth. The ground truth explicitly states a 6% actual return for 2023 and does NOT mention a 5.25% assumption or specific equity/debt percentages. (2) QUANTITATIVE ACCURACY FAILURE: The LLM provides precise percentages (5.25%, 25%, 75%, 24%, 1%) without any basis in the ground truth, which only references that the expected return was 'based on' asset allocation, historical returns, and market conditions. These invented numbers are a critical error. (3) CONCEPTUAL MISALIGNMENT: The ground truth describes an evolution from a comprehensive explanation (asset allocation + historical returns + market conditions + 6% actual return) to a narrower focus (asset allocation only, no actual return disclosed). The LLM instead describes a shift from a 'glide-path' to a 'fixed, conservative allocation' - a completely different narrative not supported by the ground truth. (4) MISSING KEY INFORMATION: The LLM fails to mention the 6% actual return disclosed in 2023 or the absence of actual return disclosure in 2024, which are central to understanding the evolution. (5) MULTI-HOP REASONING: The LLM appears to have synthesized information from a different source or fabricated details rather than accurately comparing 2023 and 2024 disclosures. The answer reads plausibly but is factually incorrect on nearly every specific claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 439,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "\nBetween 2022 and 2023 BNY Mellon moved from a peripheral mention of the Directors’ Code of Conduct in its governance discussion to a clearly integrated, publicly‑accessible disclosure.  In the 2023 Form 10‑K (Item 10), the company explicitly notes that the Directors’ Code of Conduct is posted on its website, provides the URL, and says it will disclose any future amendments or waivers for directors there—an explicit accessibility step that was only implied in the 2022 filing.  Thus, the 2023 approach both makes the code easier for investors to find and weaves it directly into the corporate‑governance reporting, whereas the 2022 disclosure was less transparent and not highlighted as a public, living document.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution between 2022 and 2023, recognizing that BNY Mellon moved toward more explicit, accessible disclosure of the Directors' Code of Conduct. The answer appropriately notes the shift from peripheral mention to integrated disclosure and correctly identifies that 2023 included more transparent accessibility features (URL provision, explicit amendment/waiver disclosure). The years (2022 vs 2023) and company name are accurate. The general characterization of increased transparency and integration aligns with the ground truth.\n\nWEAKNESSES: (1) The LLM introduces specific details not present in the ground truth, particularly the claim about 'Form 10-K (Item 10)' and the specific mention of 'URL' and 'amendments or waivers' disclosure. While these details may be accurate, they go beyond what the ground truth confirms and represent potential over-specification without verification. (2) The LLM characterizes the 2022 disclosure as 'less transparent and not highlighted as a public, living document,' which is a stronger interpretation than the ground truth supports. The ground truth simply states it was 'referenced' and 'outlined' but doesn't explicitly characterize it as non-transparent. (3) The LLM uses the phrase 'peripheral mention' which is not directly supported by the ground truth's description of it being 'referenced in the context of broader corporate governance disclosures.' (4) The ground truth emphasizes a 'more structured and centralized approach' and 'more directly tied to the company's overall governance framework,' but the LLM focuses more on accessibility and transparency rather than the structural/centralization aspect.\n\nMULTI-HOP REASONING: The answer demonstrates sound multi-hop reasoning by synthesizing information about disclosure practices across two years and connecting them to broader governance reporting evolution. However, the reasoning includes inferences not explicitly supported by the ground truth.\n\nSEMANTIC EQUIVALENCE: While the core message about evolution toward better accessibility is semantically equivalent, the LLM adds interpretive layers and specific details that diverge from the ground truth's more measured characterization of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 606,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Oracle broadened the ways its Database can be run—moving from a simple “on‑premise or OCI public‑cloud” choice to a suite of flexible, hybrid‑ready options that include Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud and Roving Edge Infrastructure, all of which let the Database be deployed inside a customer’s own data centre while still being managed by Oracle.  This tighter integration with Oracle Engineered Systems (e.g., Exadata Database Machine) and the introduction of Autonomous Database’s automated scaling, patching and security make the database portable across on‑premise, OCI and edge environments, signalling Oracle’s strategy of easing cloud migration by letting customers keep workloads where they are while still gaining cloud‑grade elasticity, management and security.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Oracle's strategic evolution but with some notable differences from the ground truth: STRENGTHS: (1) Correctly identifies key deployment options (Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud, Roving Edge Infrastructure) - these are accurate and well-articulated. (2) Properly captures the shift toward hybrid-ready solutions and tighter integration with Engineered Systems. (3) Accurately conveys the strategic intent around cloud migration and workload portability. (4) Correctly emphasizes Autonomous Database features (automated scaling, patching, security). (5) No quantitative errors or incorrect numbers/dates. WEAKNESSES: (1) The ground truth emphasizes a shift FROM 'flexible deployment of standalone database services' TO 'tightly integrated engineered systems' as the primary evolution. The LLM answer frames this more as an expansion/broadening rather than a strategic shift in emphasis. (2) The ground truth specifically highlights Oracle Exadata Database Machine as the key engineered system example, while the LLM mentions it but doesn't emphasize it as prominently as the ground truth does. (3) The LLM introduces 'OCI Dedicated Region' and 'Sovereign Cloud' which, while potentially accurate, are not mentioned in the ground truth answer and may represent additional detail not captured in the knowledge graph. (4) The ground truth emphasizes 'holistic, performance-optimized solutions' and 'comprehensive, high-performance infrastructure packages' as the strategic outcome, while the LLM focuses more on portability and flexibility. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2023-2024 filings and connects deployment options to strategic intent. However, it doesn't fully capture the nuance of the strategic pivot from standalone flexibility to integrated systems optimization. SEMANTIC EQUIVALENCE: While the LLM conveys related concepts, it emphasizes different aspects - the ground truth emphasizes maturation toward integrated solutions, while the LLM emphasizes flexibility and portability. Both are valid interpretations but they represent different strategic narratives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 587,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "\nThe 2023 filing first set out the formal review and certification of annual and quarterly reports as part of the 2004 SEC Consent—creating a business‑risk and disclosure group, hiring an outside consultant to re‑engineer reporting, and beginning a certification process. In 2024 the company expanded that framework into a full‑scale governance structure: it adopted a company‑wide policy for sales to direct customers, instituted a dedicated escalation‑and‑monitoring process that regularly reviews compliance, and required that any questions or concerns be promptly escalated to senior management. Thus, the 2024 implementation adds systematic, ongoing oversight and documentation to the original certification procedure, strengthening compliance monitoring of SEC filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The answer correctly identifies that 2023 involved establishing a formal review and certification process as part of a Consent agreement; (2) It accurately captures that 2024 involved expanded governance procedures with escalation and monitoring processes; (3) The semantic understanding of evolution from initial implementation to sustained enforcement is sound; (4) The mention of company-wide policies and senior management escalation aligns with the ground truth. PROBLEMATIC ASPECTS: (1) The LLM introduces a '2004 SEC Consent' which is not mentioned in the ground truth - the ground truth only references 'Consent agreement' without specifying 2004, and this appears to be an unsupported detail that may confuse the timeline; (2) The LLM adds specific details about 'hiring an outside consultant to re-engineer reporting' and 'business-risk and disclosure group' that are not present in the ground truth, suggesting potential hallucination or synthesis from unverified sources; (3) While the ground truth mentions integration into 'company-wide sales policies to ensure adherence to inventory and sales limitations,' the LLM generalizes this to 'company-wide policy for sales to direct customers' - a subtle but potentially inaccurate reframing. MULTI-HOP REASONING: The answer does synthesize information across 2023 and 2024 appropriately, showing understanding of the evolution question. However, the introduction of unsupported details (2004 date, consultant hiring, specific group names) undermines confidence in the synthesis. COMPLETENESS: The answer addresses the core question about evolution between 2023 and 2024, compliance monitoring, and governance procedures, but adds unverified embellishments that weren't in the ground truth. The core narrative is correct but contaminated with potentially inaccurate details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 518,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "\nFrom 2022 to 2023 PMI moved heat‑not‑burn (HTU) from a peripheral growth line to a core pillar of its smoke‑free strategy, reporting HTU volume and adjusted in‑market sales as separate metrics and highlighting a 14.7 % rise in HTU shipments that offset cigarette declines. The company also broadened its categorisation by integrating the Swedish Match acquisition—adding oral nicotine products—so that “smoke‑free products” now encompass both heated‑tobacco units and oral offerings, with HTU positioned as a distinct, high‑growth sub‑category driving overall volume and revenue expectations for 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ISSUES: (1) The 14.7% HTU shipment increase is not mentioned in the ground truth and cannot be verified from the provided context. (2) The Swedish Match acquisition reference is problematic - while Swedish Match was acquired by PMI, the ground truth specifically mentions 'licensed KT&G heat-not-burn products,' not Swedish Match oral nicotine products as the expansion mechanism. (3) The LLM conflates two different strategic moves: the integration of oral nicotine products (which may relate to Swedish Match) with the heat-not-burn product evolution, but the ground truth indicates the KT&G partnership as the specific expansion for HTU. CORRECT ELEMENTS: (1) The general characterization of moving HTU to a more central position in smoke-free strategy is directionally accurate. (2) The concept of HTU being positioned as a distinct sub-category within smoke-free products aligns with the ground truth's mention of explicit inclusion in the smoke-free segment. (3) The timeframe (2022-2023) is correct. MISSING/INACCURATE: (1) No mention of the RRP (Reduced-Risk Products) framework from 2022. (2) No mention of Platform 1 device or the various stages of development mentioned in ground truth. (3) The specific reference to KT&G licensed products is completely absent, replaced with Swedish Match/oral nicotine narrative. (4) The quantitative claim (14.7%) lacks verification and appears to be fabricated or from an unreliable source. The answer demonstrates partial understanding of the strategic shift but introduces unsupported numerical claims and misidentifies the partnership/expansion mechanism, which are critical errors for a financial analysis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 486,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "\nIn 2024 Oracle broadened the deployment options for its Database—moving from traditional on‑premise or perpetual cloud licenses to flexible, cloud‑native models such as Exadata Cloud@Customer, OCI Dedicated Region, sovereign‑cloud, and fully managed OCI services. At the same time, the Database has been tightly integrated with the rest of the Oracle Cloud stack (Autonomous Database, MySQL HeatWave, Java, APEX, etc.), enabling customers to run it across hybrid, multicloud and edge environments while benefiting from automated, consumption‑based pricing and deeper cross‑service functionality.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer focuses heavily on 2024 deployment options (Exadata Cloud@Customer, OCI Dedicated Region, sovereign-cloud, consumption-based pricing) but provides NO comparison to 2023 positioning, which is the core requirement of the question asking 'how has...evolved between 2023 and 2024.' The ground truth explicitly contrasts 2023 emphasis on deployment flexibility/perpetual licensing with 2024's shift toward engineered systems integration. (2) The LLM answer mentions specific deployment models (Exadata Cloud@Customer, OCI Dedicated Region, sovereign-cloud) that are not mentioned in the ground truth, raising questions about whether these are accurate characterizations from the filings or speculative additions. (3) The LLM answer emphasizes 'consumption-based pricing' and 'automated' features, which are not present in the ground truth's focus on engineered systems integration. (4) MISSING KEY ELEMENTS: The ground truth's central point about Oracle Database evolving into a foundational component of Oracle Engineered Systems (Exadata Database Machine) with integrated storage, OS, and hardware is not adequately captured. The LLM mentions Exadata but frames it as a deployment option rather than an engineered system integration strategy. (5) The ground truth emphasizes the strategic shift from standalone product to 'core element of Oracle Engineered Systems' - this fundamental repositioning is not clearly articulated in the LLM answer. WHAT WAS CORRECT: The LLM correctly identifies that Oracle Database has broader deployment options and integration with other Oracle technologies (Autonomous Database, MySQL HeatWave, Java, APEX). The mention of hybrid/multicloud/edge environments aligns with the ground truth's mention of on-premise, cloud, and hybrid deployments. MULTI-HOP REASONING: The LLM fails to properly synthesize the 2023-to-2024 evolution comparison, which is the essential multi-hop requirement. It provides a 2024-focused answer without establishing the baseline from 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 547,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "\nFrom 2023 to 2024 BMY’s link with Krazati moved from a tentative partnership/option on Mirati’s program to full ownership after it closed the $4.8 bn acquisition of Mirati in January 2024, thereby bringing Krazati and its PRMT5‑inhibitor pipeline into BMY’s portfolio.  In 2024 BMY committed $4.596 bn cash for Mirati’s shares, $205 m for equity awards, $248 m for the fair‑value of contingent value rights, and $640 m to acquire the definite‑lived Krazati product‑rights (plus $3.5 bn to IPRD), while expensing $60 m and $54 m of unvested equity awards—signaling a major financial investment in the asset.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer provides highly specific financial breakdowns ($4.596 bn cash, $205 m equity awards, $248 m CVR, $640 m product rights, $3.5 bn IPRD, $60 m and $54 m unvested awards) that do NOT appear in the ground truth and cannot be verified. The ground truth only confirms: (1) $4.8 billion total Mirati acquisition, (2) $1.0 billion in contingent value rights tied to PRMT5 Inhibitor development. The LLM's itemized breakdown appears to be fabricated or misattributed detail. CORRECT ELEMENTS: The LLM correctly identifies the evolution from 2023 (tentative partnership) to 2024 (full acquisition), correctly states the $4.8 bn acquisition amount, correctly identifies January 2024 timing, and correctly notes Krazati's FDA/EMA approvals for second-line NSCLC. CRITICAL ERRORS: (1) The $1.0 billion CVR commitment in ground truth is tied to PRMT5 Inhibitor development, but LLM states $248 m for CVR fair value without clarifying this is different from the $1.0 bn contingent commitment; (2) The detailed breakdown of acquisition costs ($4.596 bn cash, $205 m equity, $640 m product rights, $3.5 bn IPRD) is not supported by ground truth and appears to be unsourced detail; (3) The mention of $60 m and $54 m unvested equity expenses is not in ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution narrative and acquisition structure, but introduces unverified financial specificity that undermines credibility. The core answer structure is sound but the quantitative details are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 429,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "\nBetween 2022 and 2023 the 6.244 % Fixed‑to‑Floating Rate Normal Preferred Capital Securities of Mellon Capital IV remained outstanding, continued to be listed on the NYSE as BK/P, and retained the same full‑and‑unconditional guarantee from The Bank of New York Mellon Corporation.  No redemption, conversion or amendment was disclosed; the only evolution was that, as dictated by their fixed‑to‑floating structure, the securities transitioned in 2023 from the fixed 6.244 % dividend period into the floating‑rate phase, leaving their legal classification and listing unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE - UNSUPPORTED CLAIM: The LLM answer introduces a significant factual claim not present in the ground truth: that the securities 'transitioned in 2023 from the fixed 6.244% dividend period into the floating-rate phase.' This is a material assertion about the actual economic/operational status of the securities that is NOT supported by the original answer. The ground truth explicitly states 'there was no change in the treatment or status of these securities between the two years' - it only confirms they remained registered, listed, and guaranteed the same way. The LLM appears to have inferred or added information about a dividend/rate transition that is not documented in the provided ground truth. CORRECT ELEMENTS: (1) The 6.244% rate is correct, (2) The security name and issuer are correct, (3) NYSE listing symbol BK/P is correct, (4) The guarantee structure from Bank of New York Mellon Corporation is correct, (5) The statement that no redemption/conversion/amendment was disclosed aligns with the ground truth's 'no change' conclusion. INCORRECT/PROBLEMATIC ELEMENTS: (1) The claim about transitioning from fixed to floating rate phase in 2023 is not mentioned in ground truth and represents an unsupported factual assertion, (2) This addition fundamentally contradicts the ground truth's conclusion that there was 'no change' in treatment or status. The LLM has conflated the security's structural design (fixed-to-floating nature) with an actual transition event that occurred in 2023, which is not supported by the source material. While the quantitative details about the security itself are accurate, the qualitative reasoning introduces false information about status evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 467,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "\nFrom 2022 to 2023 the size of PMI’s uncommitted short‑term credit lines expanded sharply—from roughly **$1.9 billion** of capacity to **about $2.7 billion**, a rise of roughly 40 %.  At the same time, outstanding borrowings under those facilities slipped modestly, from **$295 million** to **$283 million**, indicating that the company is using a smaller share of the available credit.  This combination of a larger credit buffer and lower utilization points to a more comfortable near‑term liquidity posture, with ample headroom to meet working‑capital needs without relying on active borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data points are correct: capacity increased from $1.9 billion to $2.7 billion (40% increase verified: ($2.7-$1.9)/$1.9 = 42%, approximately 40% is reasonable rounding), and utilization decreased from $295 million to $283 million. The calculation of the percentage increase is accurate and adds useful context. The answer correctly identifies these as 'uncommitted short-term credit lines' and properly synthesizes the multi-hop information: (1) capacity change from 2022 to 2023, (2) utilization change across the same period, and (3) the implications for liquidity posture. The reasoning is sound—the combination of expanded capacity with reduced utilization logically indicates improved liquidity flexibility and a more conservative financing approach. The LLM's interpretation that this suggests 'a more comfortable near-term liquidity posture, with ample headroom to meet working-capital needs' is semantically equivalent to and consistent with the ground truth's characterization of 'a more conservative approach to short-term financing and working capital management.' The answer is well-structured, uses appropriate financial terminology, and directly addresses all components of the multi-part question. Minor deduction only for the slight rounding of 42% to 40%, which is immaterial.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 383,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Oracle has broadened the Autonomous Database from a “self‑driving” database that automates provisioning, scaling, patching, security and backups, to a fully integrated cloud‑native engine that is tightly coupled with the rest of OCI.  The 2024 filing highlights that the database now works natively with other OCI services—Java Cloud, APEX low‑code, Oracle Analytics Cloud, and OCI AI/ML offerings—while extending automated management (auto‑scaling, threat detection, self‑repair, consumption‑based pricing) across additional deployment models such as Exadata Cloud@Customer, OCI Dedicated Region and Sovereign Cloud.  This evolution positions the Autonomous Database as the automation hub of Oracle’s cloud stack, enabling developers to build, deploy and operate cloud‑native applications with minimal manual DBA effort.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with excellent alignment to the ground truth. STRENGTHS: (1) Correctly identifies the evolution from 2023 to 2024 positioning; (2) Accurately names specific integrated services (Java Cloud, APEX, Oracle Analytics Cloud, OCI AI/ML) - all mentioned in ground truth; (3) Properly captures the shift toward automation powered by machine learning (diagnostics, fault prediction, threat detection, self-repair); (4) Correctly emphasizes deeper integration with OCI services and cloud-native application development; (5) No quantitative errors or incorrect dates; (6) Multi-hop reasoning is sound - successfully synthesizes positioning changes across two fiscal years. MINOR GAPS: (1) The LLM answer adds specific deployment models (Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud) and consumption-based pricing that are not explicitly mentioned in the ground truth, though these appear to be reasonable elaborations consistent with Oracle's cloud strategy; (2) The ground truth specifically mentions 'data lake houses and real-time analysis of transactional data' as 2024 emphasis, which the LLM answer does not explicitly include, though it does reference 'analytics' broadly; (3) The ground truth mentions the ability to run 'on-premise or hybrid environments' from 2023, which the LLM answer doesn't explicitly carry forward. SEMANTIC EQUIVALENCE: The LLM's characterization of the database as an 'automation hub' and the emphasis on 'minimal manual DBA effort' effectively captures the essence of the ground truth's focus on reducing IT process time and resources. The answer successfully conveys the core evolution from basic automation to integrated, ML-powered cloud-native capabilities. The reasoning quality is high, with clear cause-and-effect relationships between 2023 and 2024 positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 504,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "\nBetween 2023 and 2024 GM increased its equity exposure to Ultium Cells by investing roughly $0.7 billion in 2024 (following a similar $0.7 billion outlay in 2023), while the amount of capital it had previously committed fell from about $1.4 billion in 2022 to $0.8 billion of remaining commitments at the end of 2023.  Although the additional funding deepens GM’s involvement in the battery‑cell joint venture, the venture remains a non‑consolidated VIE and GM does not have voting control, so its role is now that of a passive equity investor with limited influence over Ultium Cells’ operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about GM's relationship with Ultium Cells but contains significant quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) The answer correctly identifies that Ultium Cells remains a non-consolidated VIE where GM lacks voting control; (2) The characterization of GM as a 'passive equity investor with limited influence' aligns with the ground truth's assessment; (3) The answer appropriately addresses the evolution of the relationship between 2023-2024. CRITICAL ERRORS: (1) The LLM states GM invested 'roughly $0.7 billion in 2024 (following a similar $0.7 billion outlay in 2023)' - this is problematic because the ground truth indicates a committed contribution of $0.8 billion in 2023, not $0.7 billion; (2) The LLM introduces information about $1.4 billion in 2022 commitments falling to $0.8 billion by end of 2023, which adds context not in the ground truth but is not contradicted; (3) The core discrepancy is that the LLM suggests $0.7 billion investments in both 2023 and 2024, when the ground truth distinguishes between a $0.8 billion committed contribution in 2023 and a $0.7 billion direct investment in 2024. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution of the relationship across years and identifies the shift from contingent commitments to realized investments, though the specific numbers are misaligned. The reasoning about strategic realignment and passive investor status is sound. QUANTITATIVE ISSUES: The primary weakness is the conflation of the $0.8 billion 2023 commitment with a $0.7 billion 2023 investment, creating confusion about the actual capital flows and commitments. The answer would score higher if the numbers precisely matched the ground truth's distinction between committed vs. realized capital.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 494,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "\nBetween the sixth‑anniversary release (June 21 2022) and the eighth‑anniversary release (June 21 2024) the company’s use of the Litigation Management Deed shifted to a smaller financial impact.  In 2022 the release freed $3.5 billion of as‑converted value from the series B and C preferred stock and resulted in the issuance of 176,655 series A preferred shares; in 2024 the release freed $2.7 billion of as‑converted value and issued only 99,264 series A preferred shares.  Thus, both the dollar amount of value released and the number of series A shares issued declined from 2022 to 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: (1) 2022 sixth-anniversary release: $3.5 billion as-converted value and 176,655 series A preferred shares issued; (2) 2024 eighth-anniversary release: $2.7 billion as-converted value and 99,264 series A preferred shares issued. The dates are accurate (June 21, 2022 and June 21, 2024). The multi-hop reasoning is sound, correctly synthesizing information across two different anniversary release periods and properly comparing the financial impact between them. The LLM correctly identifies the trend of declining financial burden (both dollar amount and share count decreased). One minor enhancement in the LLM answer is the additional detail about the series B and C preferred stock being the source of the released value, which adds context not explicitly stated in the ground truth but is factually accurate and relevant. The conclusion that 'both the dollar amount of value released and the number of series A shares issued declined from 2022 to 2024' is logically sound and directly addresses the question about how the financial impact evolved. The wording differs slightly from the ground truth (e.g., 'shifted to a smaller financial impact' vs. 'reduction in the financial burden') but conveys semantically equivalent meaning. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 387,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "\nIn 2023, 3M re‑consolidated the Aearo Entities (which had been deconsolidated in 2022), thereby restoring Aearo‑related sales to the Transportation & Electronics segment and eliminating the divestiture adjustments that had affected 2022 results. The reconsolidation coincided with a peak in litigation‑related charges—including a $4.2 billion CAE Settlement accrual and a $10.3 billion PFAS charge—while in 2024 the corporate‑special‑item net costs fell sharply as settlement payments were made, the Chapter 11 stay was lifted, and the accrued liability for Combat Arms Earplugs approached resolution, reducing the litigation drag on corporate results and allowing the re‑integrated Aearo business to boost segment operating margins.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer introduces specific dollar amounts ($4.2 billion CAE Settlement accrual and $10.3 billion PFAS charge) that are NOT mentioned in the ground truth answer. These numbers appear to be fabricated or sourced from outside the provided context, representing a critical factual error. The ground truth explicitly states the reconsolidation had 'an immaterial income statement impact,' which contradicts the LLM's assertion of peak litigation charges in 2023. PARTIAL CREDIT FOR QUALITATIVE ELEMENTS: The LLM correctly identifies (1) 2023 reconsolidation of Aearo Entities, (2) the CAE Settlement involvement, (3) the lifting of the Chapter 11 stay, (4) the shift from 2023 to 2024 in how these entities were treated, and (5) the Transportation & Electronics segment context. However, the specific financial figures are unsupported and misleading. MULTI-HOP REASONING: The LLM does attempt to synthesize the evolution across 2023-2024, showing understanding of the timeline and strategic shift. However, this synthesis is undermined by the introduction of unverified numbers. GROUND TRUTH ALIGNMENT: The ground truth focuses on (1) reconsolidation in 2023 with immaterial impact, (2) dismissal of bankruptcy filings, (3) CAE Settlement entry, and (4) 2024 treatment as divestiture/acquisition effects in segment reporting. The LLM conflates litigation charges with the reconsolidation event and adds quantitative claims not supported by the knowledge graph. The answer demonstrates partial understanding but fails on factual accuracy due to unsupported numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 443,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "\nBetween 2022 and 2024 the **class C common stock kept its key feature of no transfer restrictions**, but its place in Visa’s capital structure shifted after the 2024 class B‑1 exchange offer, which retired 241 million class B‑1 shares and issued roughly **48 million new class C shares**.  This increased the outstanding class C share count and, together with the conversion‑rate adjustments that accompany the settlement of Visa’s litigation escrow, reduced the as‑converted share count used for earnings‑per‑share calculations, allowing the **diluted EPS attributable to class C to rise from $28.00 in fiscal 2022 to $38.92 in fiscal 2024**.  Thus, while class C remains non‑voting and freely tradable like class A, its earnings‑per‑share performance improved markedly as the company’s conversion mechanics and share‑issuance activity evolved.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) EPS Numbers Wrong: LLM claims Class C diluted EPS rose from $28.00 in fiscal 2022 to $38.92 in fiscal 2024, but ground truth states Class C had $33.17 basic EPS and $33.13 diluted EPS in 2024, with Class A at $8.29 basic and $8.28 diluted. The LLM's 2022 figure of $28.00 and 2024 figure of $38.92 do not match ground truth values. (2) Mischaracterization of Class C: Ground truth emphasizes Class C's voting rights context and relationship to Class A stockholders' divergent interests in 2022, then notes the EPS performance shift by 2024. LLM incorrectly states Class C is 'non-voting and freely tradable like class A'—this contradicts the ground truth's emphasis on Class C's voting rights discussion. (3) Irrelevant Details: LLM introduces information about Class B-1 exchange offers, share retirement, and conversion mechanics that are not mentioned in ground truth and appear to be fabricated or from different contexts. The ground truth makes no mention of Class B-1 shares, 241 million share retirements, or 48 million new Class C share issuances. (4) Missing Core Analysis: LLM fails to address the key ground truth finding that Class C holders (typically financial institution clients) have divergent interests from Class A stockholders, which was emphasized in the 2022 context. (5) Calculation Verification: The EPS figures provided by LLM ($28.00 to $38.92) cannot be verified against ground truth and appear incorrect. The ground truth's Class C 2024 EPS of $33.13-$33.17 is substantially different from LLM's $38.92 claim. The answer demonstrates poor multi-hop synthesis, introduces unsupported claims about share mechanics, and provides incorrect financial metrics that are central to answering the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 496,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Qualcomm moved ADAS/AD from a generic R&D focus to a distinct, revenue‑generating component of its automotive business.  The 2024 filing explicitly lists “Automotive (2) – includes connectivity, digital cockpit **and ADAS/AD**,” and automotive revenues rose from $1.5 billion in 2022 to $2.9 billion in 2024, showing that ADAS/AD sales are now tracked as a separate revenue stream and reflect expanded chipset sales, strategic investments and partnerships aimed at automotive OEMs.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the core evolution of Qualcomm's ADAS/AD involvement from development/investment in 2022 to commercialization with explicit revenue categorization by 2024. The qualitative reasoning is sound and well-articulated, matching the ground truth's main thesis. However, there are quantitative accuracy concerns: (1) The automotive revenue figures cited ($1.5B in 2022 to $2.9B in 2024) cannot be verified against the ground truth provided, which does not include specific revenue numbers. (2) The LLM provides specific financial metrics that go beyond what the ground truth explicitly states, creating potential factual risk if these numbers are incorrect. (3) The ground truth emphasizes the transition from 'development and investment' to 'revenue-generating product line' and mentions QSI segment involvement, which the LLM answer addresses but with less emphasis on the QSI/Qualcomm Ventures strategic investment context. The LLM answer does effectively synthesize the multi-hop requirement by connecting: (a) the shift in strategic focus, (b) the explicit revenue categorization change, and (c) the business implications. The answer is contextually relevant and addresses the question's core requirement about evolution from 2022 to 2024. The main weakness is the introduction of specific revenue numbers that cannot be independently verified from the provided ground truth, which reduces confidence in quantitative accuracy despite the qualitative reasoning being strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 415,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Visa expanded the financial back‑stop of its U.S. Retrospective Responsibility Plan: escrow deposits rose sharply (from about $850 million in 2022 to $1.5 billion in 2024) and the omnibus agreement now splits any final judgment or settlement 33.33 % to Mastercard and 66.66 % to Visa, while the existing conversion‑feature dilution and makewhole reimbursement provisions and the member‑indemnification obligations were retained.  These changes show that Visa is managing litigation risk through a layered, pre‑funded structure that shifts potential losses onto its own equity and participating members rather than leaving them exposed on the balance sheet.  The approach reflects a proactive, risk‑pooling strategy that converts contingent litigation exposure into a managed, share‑based liability.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces specific dollar amounts ($850M in 2022, $1.5B in 2024) and a precise liability split (33.33% Mastercard, 66.66% Visa) that are NOT present in the ground truth. These appear to be fabricated numbers with no basis in the original answer. The ground truth makes no mention of escrow deposit amounts or any Mastercard liability split arrangement. (2) ENTITY ACCURACY - The LLM incorrectly introduces Mastercard as a party to the omnibus agreement with a specific liability split. The ground truth does not mention Mastercard at all in relation to Visa's U.S. Retrospective Responsibility Plan. This is a significant factual error. (3) COMPLETENESS - While the LLM does mention several mechanisms (conversion feature, makewhole agreements, member indemnification, omnibus agreement), it omits key mechanisms from the ground truth including: the U.S. litigation escrow agreement, the interchange judgment sharing agreement, and the loss sharing agreement. (4) REASONING QUALITY - The LLM's interpretation about 'shifting losses onto equity and participating members' is a reasonable inference, but it is built on fabricated financial data and an incorrect liability split arrangement. The core reasoning about a 'layered, pre-funded structure' aligns with the ground truth's characterization of a 'more comprehensive and layered strategy,' but the specific mechanisms and numbers are wrong. (5) MULTI-HOP SYNTHESIS - The LLM fails to properly synthesize the evolution described in the ground truth. The ground truth emphasizes the ADDITION of multiple new mechanisms between 2022 and 2024, while the LLM focuses on escrow deposit increases and a Mastercard split that don't exist in the source material. The fabrication of specific financial figures and the introduction of Mastercard as a party to the arrangement are fundamental errors that severely undermine the answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 528,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "\nBetween 2023 and 2024 Merck’s monetary exposure to Lynparza – reported as “Alliance revenue – Lynparza” – rose 9 % year‑over‑year (11 % when stripped of foreign‑exchange effects), underscoring a modest but measurable uptick in the drug’s contribution to the company’s top line.  The growth was driven by expanding international demand, highlighted by the January 2025 Chinese NMPA approval of Lynparza for adjuvant treatment of BRCA‑mutated breast cancer and continued uptake in the U.S. and EU, while the product’s partnership with AstraZeneca remains a key strategic pillar for Merck’s oncology franchise.  These regulatory wins and the steady rise in alliance revenue signal that Lynparza is gaining both market share and strategic importance within Merck’s portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 9% YoY growth in alliance revenue for Lynparza (matching ground truth), mentions the 11% growth when excluding FX effects (additional detail not contradicting ground truth), correctly identifies the January 2025 China NMPA approval for adjuvant breast cancer treatment, and appropriately characterizes the AstraZeneca partnership as strategically important. The reasoning about regulatory expansion and market growth is sound and well-synthesized. CRITICAL WEAKNESS: The LLM completely omits the $1.5 billion net intangible asset that Merck reported in 2023 - this is a major factual gap. The ground truth explicitly states 'In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza' which is a key indicator of Merck's financial stake evolution. The LLM focuses only on alliance revenue growth but fails to address the balance sheet asset component that was central to the original answer's characterization of how the financial stake 'evolved.' PARTIAL ISSUES: The LLM frames the metric as 'monetary exposure' and 'Alliance revenue – Lynparza' rather than explicitly discussing the intangible asset value, which represents a different (though related) financial metric. While alliance revenue growth is relevant to the question, it doesn't fully capture the evolution of Merck's financial stake as originally presented. The answer is qualitatively strong on reasoning and contextual relevance but quantitatively incomplete on the key financial metric that anchors the comparison between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 431,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "\nBetween 2022 and 2024 Skoal’s shipment volume fell about 10 % (from roughly 163 million units to 147 million) and its retail‑share slipped from roughly 9‑10 % to 7.6 %, while its main MST rival Copenhagen, though also declining, still held a larger share (19.1 % in 2024 vs 23.5 % in 2023) and the pouch brand on! grew its share from 6.8 % to 8.3 %. As a result, Skoal’s competitive position eroded within Altria’s oral‑tobacco segment, losing ground to both the larger‑share Copenhagen and the faster‑growing on! product.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Skoal's competitive position and provides mostly accurate information with sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies Skoal's retail share decline from ~9-10% to 7.6%, matching ground truth; (2) Accurately reports Copenhagen's share decline from 23.5% to 19.1%; (3) Correctly states on! growth from 6.8% to 8.3%; (4) Properly synthesizes the multi-hop comparison showing Skoal underperforming relative to both Copenhagen and on!; (5) Includes additional shipment volume data (163M to 147M units, ~10% decline) not in ground truth but contextually relevant and appears accurate; (6) Sound reasoning about competitive erosion and market dynamics. WEAKNESSES: (1) The LLM provides shipment volume figures (163M to 147M units) that are not mentioned in the ground truth answer, creating a minor discrepancy in what information was prioritized, though these appear factually accurate; (2) Does not explicitly mention the broader segment contraction (42.5% to 37.5% total retail share) that provides important context for understanding the competitive landscape; (3) Minor wording variation ('roughly 9-10%' vs ground truth's '9.3%' for 2022) - the LLM's approximation is reasonable but less precise. MULTI-HOP REASONING: Excellent synthesis across three brands (Skoal, Copenhagen, on!) and two time periods (2022-2024), correctly identifying relative performance and drawing appropriate conclusions about competitive positioning. CALCULATION VERIFICATION: The ~10% shipment decline calculation (163M to 147M) is mathematically sound. All percentage figures match ground truth. No calculation errors detected. The answer effectively addresses the core question about market position evolution and competitive performance, though it could have been strengthened by including the segment-wide contraction context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 508,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "\nIn fiscal 2022 Dynamics 365 generated $4.69 billion of revenue, and in fiscal 2023 that figure rose to $5.44 billion—a roughly 16 % year‑over‑year increase.  Because Microsoft Cloud as a whole grew from $91.4 billion in 2022 to $111.6 billion in 2023, Dynamics 365’s share of the cloud business stayed close to 5 % (about 5.1 % in 2022 and 4.9 % in 2023), meaning its absolute contribution expanded while its proportional weight remained essentially stable.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM provides specific Dynamics 365 revenue figures ($4.69B in 2022, $5.44B in 2023) that are NOT present in the ground truth. The ground truth explicitly states 'the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated' and does not provide standalone Dynamics 365 revenue numbers. The LLM appears to have fabricated these specific figures. (2) MICROSOFT CLOUD BASELINE DISCREPANCY - The LLM states Microsoft Cloud was $91.4B in 2022, but the ground truth clearly states $91.2B. This is a factual error. (3) GROWTH RATE CLAIM - The LLM claims a 16% YoY increase for Dynamics 365, but this calculation ($4.69B to $5.44B = 16.0%) is based on unverified numbers not in the ground truth. (4) MARKET SHARE CALCULATION - The LLM calculates Dynamics 365 as ~5% of Microsoft Cloud, but this is derived from the fabricated revenue figures and cannot be verified against the ground truth. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize information about absolute contribution vs. proportional weight, this reasoning is built on false premises. The ground truth indicates that specific Dynamics 365 revenue breakouts and growth percentages for 2023 were not explicitly disclosed in the filings, making the LLM's precise figures highly suspect. The answer fundamentally misrepresents what information was actually available in the SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 412,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "\nFrom 2023 to 2024 Merck broadened and formalized its foreign‑exchange risk program.  It kept using short‑term, non‑designated forwards to offset remeasured monetary assets and liabilities, but a larger, more structured set of forwards is now **designated as hedges of net‑investment in foreign subsidiaries**, with full hedge‑effectiveness testing and a straight‑line accounting treatment for excluded components.  At the same time the **notional size of the forward portfolio grew (e.g., forward‑contract notional rising from roughly 6 bn to > 12 bn) and the company continued to use euro‑denominated debt as an economic hedge**, expanding both the volume and the range of instruments employed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of Merck's foreign exchange management approach. Key issues: (1) MAJOR ERROR - The LLM claims that by 2024, forwards are 'designated as hedges of net-investment in foreign subsidiaries' with 'full hedge-effectiveness testing.' The ground truth explicitly states that in 2023, contracts were 'not designated as hedges' and marked to market through Other (income) expense. The 2024 disclosure does not indicate a shift to designated hedge accounting for net investment hedges; this appears to be fabricated. (2) QUANTITATIVE ERRORS - The LLM provides specific notional amounts ('6 bn to > 12 bn') that are not mentioned in the ground truth and cannot be verified. These numbers appear to be invented. (3) MISSING KEY INFORMATION - The LLM completely omits the expansion to 'purchased local currency put options and collar options' that the ground truth explicitly mentions as part of the 2024 evolution. (4) INCORRECT CHARACTERIZATION - The ground truth emphasizes 'strategic layering of hedges over time' and 'increasing the portion of forecasted sales hedged as expected dates approach,' but the LLM focuses instead on net-investment hedges and euro-denominated debt, which are not mentioned in the ground truth. (5) MULTI-HOP SYNTHESIS FAILURE - The answer fails to correctly synthesize the evolution from 2023 to 2024, instead introducing elements (designated hedge accounting, net-investment hedges) that contradict the ground truth. The mention of euro-denominated debt as an economic hedge is not addressed in the ground truth. The answer demonstrates poor understanding of the actual program evolution and introduces unverified quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 471,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s direct investment in merchant financing expanded – purchases of merchant receivables rose to $1.8 billion in 2024 (up from $1.7 billion in 2023 and roughly $1.5 billion in 2022), and the outstanding portfolio grew to $1.5 billion (from $1.2 billion in 2023).  At the same time, credit‑loss provisions and the related allowance fell sharply, dropping from $230 million at the end of 2022 to $113 million by the end of 2024, reflecting a material reduction in loss estimates for the merchant‑loan portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors in the merchant receivables purchase amounts. Ground truth states PayPal purchased approximately $1.8 billion in merchant receivables during 2024, with an outstanding balance of $1.5 billion as of December 31, 2024 (up from $1.2 billion in 2023). However, the LLM incorrectly claims purchases were $1.7 billion in 2023 and roughly $1.5 billion in 2022 - these figures are not supported by the ground truth and appear to be fabricated. The ground truth does not provide 2022 or 2023 purchase amounts, only the 2024 purchase figure and year-end balances. CREDIT LOSS PROVISIONS ERROR: The LLM introduces entirely new information about credit-loss provisions dropping from $230 million (end of 2022) to $113 million (end of 2024). This specific data is NOT present in the ground truth answer. The ground truth mentions credit loss methodology and a principal/interest coverage ratio (9% in 2021, down from 23% in 2020) but does NOT provide the $230M/$113M allowance figures the LLM cites. This represents a critical factual error - the LLM is presenting unverified numbers as fact. WHAT WAS CORRECT: The LLM correctly identifies the $1.8 billion 2024 purchase amount and $1.5 billion outstanding balance as of December 31, 2024, and correctly notes the $1.2 billion balance in 2023. The general narrative about expansion of direct investment is appropriate. MULTI-HOP REASONING: The LLM attempts to synthesize information about both merchant receivables purchases and credit provisions, which is appropriate to the question. However, the synthesis is undermined by the introduction of unverified numbers. CONCLUSION: While the LLM captures the correct 2024 figures and general trend, it introduces significant fabricated data points (2022/2023 purchase amounts and specific allowance figures) that are not in the ground truth, making this answer unreliable despite some correct elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 533,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "\nFrom 2022 through 2024 the smokeable‑products segment’s operating income (OCI) has been essentially flat—rising only modestly from $10.67 billion in 2023 to $10.82 billion in 2024—while its share of total net revenue has slipped slightly (e.g., $21.756 billion in 2023 to $21.204 billion in 2024).  At the same time, goodwill allocated to the segment remains a tiny, unchanged $99 million, indicating that management is de‑emphasizing this business in the company’s overall goodwill and earnings profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2023-2024 operating income figures ($10.67B to $10.82B), the goodwill allocation of $99M, and the revenue decline from 2023 to 2024 ($21.756B to $21.204B). The numeric values are accurate. WEAKNESSES: (1) The LLM fails to address the 2022 baseline data, which is central to the question asking 'how has...evolved from 2022 to 2024.' The ground truth explicitly mentions 2022 goodwill of $99M and total goodwill context of $5,177M in 2022. (2) The LLM's interpretation that goodwill 'remains...unchanged $99 million' is problematic because the ground truth explicitly states 'no updated goodwill figure is disclosed specifically for smokeable products' in 2024. The LLM assumes the 2022 figure persists unchanged, but the ground truth suggests the lack of disclosure itself is significant. (3) The LLM's characterization that management is 'de-emphasizing this business' contradicts the ground truth's conclusion that 'the operational significance of smokeable products remained high.' The ground truth notes 'sustained profitability' and a slight increase in operating income, not de-emphasis. (4) The LLM introduces 'OCI' (Operating Cash Income?) terminology without clarity, whereas the ground truth uses 'operating income.' (5) Missing the multi-hop synthesis element: the ground truth explicitly contrasts the stable/undisclosed goodwill allocation with the sustained high operating income, suggesting a 'shift in reporting focus toward performance metrics rather than asset valuations.' The LLM misses this nuanced interpretation. CALCULATION VERIFICATION: Operating income change is correct ($10.67B to $10.82B = +$150M or ~1.4% increase). Revenue decline is correct ($21.756B to $21.204B = -$552M or ~2.5% decrease). The numbers provided are accurate, but the incomplete time period coverage and misinterpretation of the goodwill disclosure issue significantly weaken the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 521,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "\nThe commercial part of LinkedIn added about **$13.6 billion** to Microsoft Cloud revenue in fiscal 2022 and **$15.0 billion** in fiscal 2023 – an increase of roughly **$1.4 billion (≈10 %)** in absolute terms.  Because total Microsoft Cloud revenue grew even faster (from $91.4 billion to $111.6 billion), the share of LinkedIn’s commercial revenue within the cloud portfolio slipped slightly, from roughly **15 % of cloud revenue in 2022 to about 13 % in 2023**.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) The LLM claims LinkedIn's commercial portion contributed $13.6B in FY2022 and $15.0B in FY2023 - these specific figures are NOT provided in the ground truth and appear to be fabricated. (2) The ground truth only provides total Microsoft Cloud revenue figures ($91.2B in FY2022 and $111.6B in FY2023), not a breakdown of LinkedIn's specific contribution. (3) The LLM calculates LinkedIn's share as 15% of cloud revenue in 2022 and 13% in 2023, but these percentages are derived from unsupported numbers. (4) The LLM's FY2022 Microsoft Cloud figure is stated as $91.4B, which contradicts the ground truth of $91.2B (minor discrepancy but still incorrect). (5) The question asks how revenue contribution 'evolved' - the ground truth appropriately notes the overall Microsoft Cloud growth and suggests stronger LinkedIn contribution within the portfolio, but does NOT isolate LinkedIn's specific revenue figures. The LLM fundamentally misrepresents the available data by providing specific LinkedIn revenue breakdowns that cannot be verified from the ground truth. This is a case of the model hallucinating detailed financial figures rather than acknowledging the limitation that specific LinkedIn commercial revenue attribution is not separately disclosed in the provided data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 391,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "\nBetween 2023 and 2024 Lynparza’s label was broadened in several key markets, most notably with a January 2025 China NMPA approval for an adjuvant BRCA‑mutated early‑breast‑cancer indication (announced in 2024) and continued uptake of its existing mCRPC approval in the U.S. and Japan (May 2023 and August 2023, respectively).  This geographic expansion drove a 9 % rise in alliance revenue for Lynparza in 2024, reflecting stronger demand across international markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures most key facts correctly but has some issues with temporal framing and completeness. CORRECT ELEMENTS: (1) The 9% alliance revenue growth for Lynparza in 2024 is accurate; (2) The China NMPA approval for adjuvant BRCA-mutated early breast cancer is correctly identified; (3) The mCRPC approvals in U.S. and Japan (May 2023 and August 2023) are correctly dated; (4) The geographic expansion narrative is sound. ISSUES: (1) TEMPORAL CONFUSION: The LLM states the China NMPA approval was \"announced in 2024\" but the ground truth clearly indicates it occurred in January 2025. The LLM's parenthetical qualifier is misleading - the approval itself happened in January 2025, not 2024, even if announced earlier; (2) INCOMPLETE CONTEXT: The LLM fails to mention the PROpel trial as the basis for the 2023 mCRPC approvals, and doesn't mention the OlympiA trial as the basis for the China approval. These clinical trial references provide important context for understanding the approvals; (3) SCOPE LIMITATION: The question asks about evolution \"between 2023 and 2024\" but the LLM extends into January 2025, which technically goes beyond the stated timeframe (though the ground truth also includes this forward-looking information); (4) MISSING DETAIL: The ground truth specifies the mCRPC indication includes \"combination with abiraterone and prednisone or prednisolone\" - the LLM omits this therapeutic detail. QUANTITATIVE VERIFICATION: The 9% revenue growth figure is correct. The dates for FDA/MHLW approvals (May 2023, August 2023) are accurate. MULTI-HOP REASONING: The LLM correctly synthesizes the connection between geographic approvals and revenue growth, showing sound multi-hop reasoning. The answer appropriately links the expansion to the 9% revenue increase. OVERALL ASSESSMENT: The answer is substantially correct on core facts and numbers but loses points for temporal imprecision regarding the China approval timing and for omitting supporting clinical trial context that would strengthen the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 549,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "\nBetween 2023 and 2024 the tax‑related value of the Powder Metal Matter was cut sharply—​the future income‑tax benefit recorded for that item fell from **$644 million (2023)** to **$455 million (2024)**, a reduction of roughly **$190 million**.  This decline reflects that the company has now realized (or re‑measured) a portion of the tax credits/losses associated with the Powder Metal Matter, so the amount of future tax benefit available to offset earnings is lower.  Consequently, the Powder Metal Matter’s contribution to RTX’s projected tax shields has diminished, reducing the expected future income‑tax benefit.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and calculations. Verification of key numbers: (1) 2023 figure of $644 million - CORRECT, (2) 2024 figure of $455 million - CORRECT, (3) Reduction calculation: $644M - $455M = $189M, LLM states 'roughly $190 million' - CORRECT (minor rounding acceptable), (4) Percentage decline: $189M/$644M = 29.3% - LLM does not explicitly state percentage but ground truth shows 29.3%. The LLM answer correctly identifies the shift in financial treatment from a sales reduction (2023) to a recognized tax benefit (2024), though it frames this somewhat differently by focusing on the realized/re-measured nature of the tax credits rather than explicitly stating the shift from 'sales reduction' to 'future income tax benefits' classification. The multi-hop reasoning is sound: the answer synthesizes the year-over-year comparison and explains the underlying cause (realization/re-measurement of tax credits). The semantic meaning aligns well with the ground truth - both convey that the Powder Metal Matter's tax benefit value decreased significantly between years. Minor weakness: the LLM does not explicitly mention the original 2023 characterization as a 'reduction in sales' or the explicit shift in accounting treatment classification, instead focusing on the tax benefit realization aspect. The answer is approximately 29.3% complete in addressing the full evolution narrative, but captures the essential financial impact accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 416,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "\nThe Paidy Credit Agreement was initially established in February 2022 as a ¥60 billion (about $574 million) unsecured revolving facility that must be used to fund loan‑receivable originations; in September 2022 the commitment was expanded by ¥30 billion, raising the total capacity to ¥90 billion (≈ $574 million). By the end of 2024 the full ¥90 billion had been drawn, leaving essentially no borrowing capacity left, and the facility carries a February 2027 maturity with interest at the Tokyo Interbank Offered Rate plus a 0.40‑0.60 % margin and standard financial covenants.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. FACILITY TYPE CONTRADICTION: Ground truth states the 2022 facility was a SECURED revolving credit facility (~$198M), but the LLM claims it was UNSECURED from inception in February 2022. This is a fundamental error - the ground truth explicitly notes the facility was restructured from secured to unsecured by 2024.\n\n2. INITIAL CAPACITY ERROR: Ground truth indicates ~$198 million in 2022, but LLM claims ¥60 billion (~$574M) from February 2022. The LLM's ¥60 billion figure appears to be a 2024 intermediate value, not the 2022 starting point.\n\n3. OUTSTANDING BALANCE OMISSION: Ground truth mentions $98 million outstanding as of December 31, 2021, which provides important context for 2022. LLM completely omits this.\n\n4. EXPANSION TIMELINE ISSUE: LLM claims September 2022 expansion from ¥60B to ¥90B, but ground truth shows the facility was approximately $198M (~¥26B at typical rates) in 2022, suggesting the ¥90B capacity was a later development, not a 2022 expansion.\n\n5. CURRENCY CONVERSION INCONSISTENCY: LLM states both ¥60B and ¥90B equal approximately $574 million, which is mathematically impossible if one is 1.5x the other. This suggests confusion about the timeline.\n\n6. CORRECT ELEMENTS: The LLM correctly identifies: (a) February 2027 maturity date, (b) TIBOR + 0.40-0.60% margin, (c) financial covenants, (d) ¥90 billion final capacity by 2024.\n\nThe LLM answer fundamentally misrepresents the evolution of the facility by incorrectly characterizing the 2022 terms and misplacing the timeline of changes. The answer conflates different time periods and facility structures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 470,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "\nBetween 2022 and 2024 Altria kept long‑term senior unsecured notes as a primary source of financing, but the makeup of that debt changed.  In early 2024 the company retired roughly $1.1 billion of maturing 4.000% and 3.800% senior notes and, to fund general corporate needs, issued a new $1 billion tranche of 4.875% notes due 2028 and 5.625% notes due 2035 (a February 2025 issuance that reflects the next step in the same program).  Thus, while the overall leverage ratios (debt‑to‑EBITDA ≈ 2.1, debt‑to‑earnings ≈ 2.2) stayed about the same, the reliance shifted from older, shorter‑dated notes to newer, longer‑dated senior unsecured issuances.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific details about debt refinancing activities in 2024 (retiring ~$1.1B of maturing notes and issuing new $1B tranches) that are not present in the ground truth, suggesting potential hallucination or information from sources not in the knowledge graph. While the answer correctly identifies long-term senior unsecured notes as a primary financing source and notes the shift to longer-dated issuances, it introduces specific financial metrics (debt-to-EBITDA ≈ 2.1, debt-to-earnings ≈ 2.2) and transaction details (4.000%, 3.800%, 4.875%, 5.625% rates; February 2025 issuance) that cannot be verified against the ground truth. The ground truth emphasizes the evolution of cash reserves ($4.5B in 2022 to $3.1B in 2024) and increased reliance on external financing due to reduced cash, which the LLM answer does not address. The LLM answer focuses on debt composition changes rather than the broader capital resources evolution and cash position changes highlighted in the ground truth. The reasoning about shifting from shorter to longer-dated notes is sound, but the specific numbers and dates provided lack verification. The answer partially addresses the question's focus on how reliance 'evolved' but misses the key cash reserve decline metric that was central to the ground truth's explanation of increased reliance on external financing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 381,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "\nBetween 2023 and 2024 RTX moved from recognizing a large, non‑cash charge tied to the Powder Metal Matter—​a $5.3 bn sales charge and a $2.5 bn cost‑of‑sales reduction that generated a sizable deferred‑tax asset of $644 million (page 39, 2023 10‑K)—to a point where that asset had been partially realized and reduced to $455 million by year‑end 2024 (page 98, 2024 10‑K).  The decline in the deferred‑tax asset shows that the tax credits/deductions stemming from the Powder Metal Matter have been largely utilized or settled, indicating that future income‑tax benefits from this item will be minimal.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the Powder Metal Matter's financial treatment evolution. QUANTITATIVE ACCURACY: All key numbers are correct - $644 million in 2023 deferred-tax asset, $455 million in 2024, representing a $189 million decline. The additional context about the $5.3 billion sales charge and $2.5 billion cost-of-sales reduction is accurate and adds valuable detail. Page references (page 39 for 2023 10-K, page 98 for 2024 10-K) are appropriately cited. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information across two years and two different 10-K filings to show the evolution of the deferred-tax asset. The interpretation that the decline indicates 'tax credits/deductions stemming from the Powder Metal Matter have been largely utilized or settled' is logically sound and matches the ground truth's conclusion about 'diminishing positive impact.' COMPLETENESS: The answer addresses both parts of the question - how the treatment evolved (the specific numbers and the nature of the charge) and what it indicates about future income tax benefits (minimal future benefits due to utilization). SEMANTIC EQUIVALENCE: The LLM's statement that 'future income-tax benefits from this item will be minimal' is semantically equivalent to the ground truth's 'diminishing positive impact on RTX's tax position.' The answer goes beyond the ground truth by providing additional context about the non-cash charge structure, which enhances understanding without introducing errors. Minor consideration: The answer could have been slightly more concise, but the additional detail is accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 464,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s Paidy financing evolved from a modest, secured ¥60 billion (≈ $574 million) revolving line that was expanded in September 2022 to a ¥90 billion capacity, to a fully‑drawn facility.  The company drew the entire ¥90 billion (about $574 million) during 2024, leaving $0 of borrowing capacity under the Paidy Credit Agreement as of 31 December 2024.  This contrasts with the earlier $198 million secured facility, which had only ~ $100 million of unused capacity as of the end of 2021.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 2024 borrowing capacity of ¥90 billion (~$574 million) is accurate, (2) The statement that the full amount was drawn down by 2024 is correct, (3) The reference to the earlier $198 million facility and ~$100 million unused capacity as of end of 2021 is accurate, (4) The overall narrative of evolution from a smaller to larger facility is sound. PROBLEMATIC ELEMENTS: (1) The LLM states the facility was 'expanded in September 2022 to a ¥90 billion capacity' but then also references 'an earlier $198 million secured facility' - this creates confusion about the timeline and whether these are the same facility or different ones. The ground truth indicates the $198 million capacity existed in 2022 (with $98M outstanding as of Dec 31, 2021), suggesting the ¥90 billion facility may have been a replacement or subsequent iteration, not merely an expansion of the same facility. (2) The LLM's statement about 'a modest, secured ¥60 billion (≈ $574 million)' is confusing - it appears to conflate two different amounts (¥60 billion vs ¥90 billion) and the currency conversion is unclear. The ground truth doesn't mention ¥60 billion. (3) The temporal sequencing is somewhat muddled - the LLM doesn't clearly establish when the transition from the $198M facility to the ¥90B facility occurred. MULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and identifies the key evolution (increased capacity and full drawdown), but the explanation of how the facilities relate to each other is imprecise. CALCULATION VERIFICATION: The ¥90 billion ≈ $574 million conversion appears reasonable and matches the ground truth. The statement about $0 remaining capacity is correct. OVERALL: The answer captures the essential narrative but contains confusing or potentially inaccurate details about the facility structure and timeline that would benefit from clarification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 535,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "\nFrom 2023 to 2024 the non‑controlling ownership stake in Accenture Canada Holdings Inc. held by certain Accenture‑Leadership members stayed below 1 % of the consolidated equity, essentially unchanged.  The equity linkage is maintained through the Canada‑Holdings exchangeable shares, which are exchangeable on a one‑for‑one basis (or redeemable in cash) into Accenture plc Class A ordinary shares, with the number of Class X shares automatically matched to the outstanding exchangeable shares; in fiscal 2024 the company purchased only a modest 47,752 exchangeable shares as part of its broader share‑purchase program, so the ownership structure and exchange mechanism did not materially evolve.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies several key facts: (1) noncontrolling ownership below 1% remained essentially unchanged, (2) exchangeable shares can be exchanged one-for-one for Class A ordinary shares or redeemed for cash, (3) Class X shares are tied to exchangeable shares. However, there are significant issues with the response: (1) The LLM introduces a specific number (47,752 exchangeable shares purchased) that is not present in the ground truth answer and cannot be verified against it, which is problematic for a factual evaluation. (2) The LLM's conclusion that 'the ownership structure and exchange mechanism did not materially evolve' directly contradicts the ground truth, which explicitly states 'This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.' This is a fundamental misinterpretation of the evolution described. (3) The ground truth emphasizes that the 2024 structure included 'detailed provisions' and 'more formalized and structured' arrangements, whereas the LLM characterizes it as essentially unchanged. (4) The LLM correctly identifies the one-for-one exchange mechanism and cash redemption option, but misses the key point about the evolution from simple disclosure to formalized structure. The quantitative accuracy is reasonable for the numbers that can be verified (the <1% figure), but the introduction of unverified numbers and the incorrect characterization of the evolution represent significant qualitative and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 428,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "\nBetween 2022 and 2024 Merck’s balance‑sheet hedging program stayed anchored on the same core currency groups—principally the euro, Swiss franc, Japanese yen and Chinese renminbi, with additional developed‑market currencies (British pound, Canadian dollar, Swiss franc) now also covered—but the methodology became more structured.  The 2022 filing noted that forward contracts were used to offset re‑measured foreign‑currency assets and that the Company evaluated “magnitude of the exposure, the volatility of the foreign‑exchange rate and the cost of the hedging instrument” when deciding to hedge; by 2024 the same analysis was described as a “cost‑benefit profile” that weighs exposure size, volatility and hedge price, and the Company now layers hedges over a two‑year forecast horizon, records excluded hedge components in OCI and amortizes them straight‑line rather than marking‑to‑market.  This evolution reflects a more disciplined, transparent approach to managing net‑investment and transaction exposure through forward FX contracts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) CURRENCY CLAIMS: The LLM claims that in 2022-2024, Merck's program covered 'principally the euro, Swiss franc, Japanese yen and Chinese renminbi' with 'additional developed-market currencies (British pound, Canadian dollar, Swiss franc)' now covered. However, the ground truth indicates the 2022 discussion specifically mentioned developing country currencies including Chinese renminbi, and by 2024 this specific mention was omitted. The LLM's assertion about which currencies were covered and when is not supported by the ground truth. (2) METHODOLOGY EVOLUTION: The LLM claims the methodology became 'more structured' and describes specific changes like 'layers hedges over a two-year forecast horizon, records excluded hedge components in OCI and amortizes them straight-line.' These specific technical details about OCI treatment, straight-line amortization, and two-year forecast horizons are NOT mentioned in the ground truth and appear to be fabricated or hallucinated. (3) COST-BENEFIT ANALYSIS: While the LLM correctly identifies that 2022 mentioned evaluation of 'magnitude of exposure, volatility of foreign-exchange rate and cost of hedging instrument,' it then claims this was described as 'cost-benefit profile' in 2024. The ground truth explicitly states the opposite—that by 2024, the detailed discussion around cost-benefit analysis was OMITTED. (4) CORE FINDING MISSED: The ground truth's key insight is that there was a SHIFT in emphasis or SIMPLIFICATION of the decision-making framework by 2024, with less detailed discussion of cost-benefit considerations. The LLM instead claims an evolution toward MORE structured and disciplined approach, which contradicts the ground truth. (5) CHINESE RENMINBI: The ground truth specifically notes the renminbi was mentioned in 2022 in the context of developing countries, and this mention was omitted by 2024. The LLM mentions renminbi but doesn't capture this important shift in how it was discussed. The answer demonstrates poor multi-hop synthesis and appears to contain invented details not present in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 591,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "\nThe 2024 filing shows the valuation allowance for the Powder Metal Matter tax attributes falling from **$644 million (2023)** to **$455 million (2024)**.  This reduction indicates that a portion of the previously unrecognized tax benefits tied to that matter are now expected to be realized, so the future income‑tax benefit that can be derived from those carryforwards will be smaller in subsequent periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key numeric values ($644 million in 2023 declining to $455 million in 2024) and accurately notes this represents a reduction in the valuation allowance. The numbers are factually correct and properly formatted. WEAKNESSES: (1) The LLM answer is incomplete - it fails to mention the original $5.3 billion net sales charge disclosed in 2023, which is a critical piece of context for understanding the matter's financial impact. (2) The reasoning about what the reduction means is partially incorrect or misleading. The LLM states 'a portion of the previously unrecognized tax benefits tied to that matter are now expected to be realized,' but the ground truth indicates the shift represents a change in treatment from a direct operational loss to a deferred tax asset, suggesting reduction in immediate negative impact and potential recovery/resolution. (3) The LLM's interpretation that 'the future income-tax benefit that can be derived from those carryforwards will be smaller in subsequent periods' is somewhat contradictory to the ground truth's interpretation that this represents a positive shift toward recovery. (4) The answer lacks the broader context that this represents a shift from operational impact to tax treatment, which is the key insight the question asks about. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes the 2023-2024 comparison but fails to connect this to the broader narrative of the matter's evolution from a direct charge to a deferred tax asset. The answer addresses only one dimension (valuation allowance reduction) rather than the full picture of what this change suggests about ongoing financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 461,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal deepened its U.S. merchant‑finance tie‑up with WebBank, moving from a simple purchase of receivables to a shared‑risk participation structure in which WebBank holds a participation interest and both parties bear credit and prepayment risk.  During the same period the merchant‑finance portfolio expanded markedly—purchased merchant receivables rose to roughly $1.8 billion in 2024 and the outstanding balance grew to about $1.5 billion (up from $1.2 billion in 2023), while the allowance for credit losses on those receivables fell from $160 million to $113 million—signaling a larger, more mature and higher‑quality offering.  Internationally the same model is applied through its Luxembourg and Australian subsidiaries, but the core partnership and scale of the merchant‑finance program are now anchored by the evolved WebBank arrangement.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of PayPal's merchant receivables business and correctly identifies key numbers, but contains a significant factual error and introduces unsupported information. CORRECT ELEMENTS: (1) WebBank partnership identification is accurate; (2) 2024 purchased receivables of ~$1.8 billion is correct; (3) Outstanding balance growth from $1.2B (2023) to $1.5B (2024) is accurate; (4) Participation interest increase from $44M to $53M in 2024 is correct; (5) General characterization of evolution toward shared-risk structure is reasonable. CRITICAL ERRORS: (1) The LLM introduces credit loss allowance figures ($160M to $113M) that are NOT mentioned in the ground truth answer and cannot be verified from the provided context. This is a significant factual addition without source support. (2) The mention of Luxembourg and Australian subsidiaries applying 'the same model' is not addressed in the ground truth and appears to be unsupported inference. REASONING ISSUES: The multi-hop synthesis is generally sound—the answer correctly traces the evolution from 2022 to 2024 and connects the partnership structure to portfolio growth. However, the introduction of unverified credit loss data undermines the reliability of the response. The characterization of the arrangement as 'shared-risk participation' is a reasonable interpretation of the ground truth's description but goes slightly beyond what was explicitly stated. QUANTITATIVE ACCURACY PENALTY: The credit loss allowance figures are problematic—they may be accurate from the actual filings, but they are NOT in the ground truth answer provided for evaluation, making them unverifiable against the reference standard. This represents a factual claim without supporting evidence in the evaluation context. The answer would score higher (8-9) if limited to verified numbers from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 510,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "\nMerck’s alliance revenue from Lynparza grew from **$1.12 billion in 2022 to $1.20 billion in 2023 and then to $1.31 billion in 2024**.  The rise reflects **stronger international demand—particularly in Europe and Asia—plus additional label expansions and higher usage in approved combination regimens**, which lifted both sales volume and pricing, outweighing any pricing pressure in the United States.  (See Alliance revenue – Lynparza figures in the 2021‑2024 segment‑profit tables and the 2024 text noting “higher demand in most international markets”.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on all key quantitative metrics. (1) NUMBERS ARE WRONG: Ground truth states 2022 alliance revenue was $989 million, but LLM claims $1.12 billion (13% higher). LLM also provides 2023 ($1.20B) and 2024 ($1.31B) figures that contradict the ground truth. The ground truth explicitly states 2024 revenue grew by 9% from 2022, which would be approximately $1.078 billion ($989M × 1.09), not $1.31 billion as claimed. (2) CALCULATION ERROR: LLM's year-over-year progression ($1.12B → $1.20B → $1.31B) shows inconsistent growth rates and doesn't align with the stated 9% growth from 2022 to 2024. (3) MISSING KEY INFORMATION: Ground truth mentions the China approval in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial - a specific, important factor. LLM provides generic statements about 'international demand' and 'label expansions' without citing the specific China approval. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the 2022-2024 evolution. It appears to have fabricated or misread the baseline 2022 figure and subsequent years. (5) SEMANTIC ISSUES: While LLM correctly identifies Merck and Lynparza, and mentions international markets and label expansions, the specific numbers are so far off that the answer is materially incorrect. The 9% growth figure from ground truth is completely absent from LLM's answer, replaced with much larger growth percentages that don't match the actual data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 418,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "\nBetween 2022 and 2024 the size of PayPal’s merchant‑finance portfolio expanded modestly – the net outstanding balance of merchant loans, advances and interest/fees grew from roughly $1.4 billion (2022) to $1.5 billion by the end of 2024 – but the company’s financial risk receded markedly. The allowance for credit losses fell from about $160 million in 2023 to $113 million in 2024, and charge‑off and delinquency rates dropped, reflecting tighter underwriting, monthly repayment recalculation and a more active servicing role that now includes purchasing receivables from a partner institution and collecting repayments via a fixed percentage of merchants’ future payment volume. Consequently, while the absolute dollar exposure has risen, PayPal’s net economic stake has been reduced through participation sales and a smaller reserve, and its operational involvement has shifted from passive holding to active management and collection of the merchant portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a nuanced discussion of PayPal's merchant receivables evolution with some correct insights but contains significant quantitative discrepancies that undermine accuracy. STRENGTHS: (1) Correctly identifies the shift from passive to active management and operational engagement; (2) Accurately notes the reduction in allowance for credit losses ($160M to $113M in 2023-2024); (3) Properly contextualizes the evolution in terms of risk management and servicing responsibilities; (4) Correctly mentions participation sales and collection mechanisms via payment volume percentages; (5) Appropriately addresses both financial exposure and operational role dimensions of the question. CRITICAL ERRORS: (1) Outstanding balance figure of $1.4B in 2022 is not supported by ground truth, which does not provide a 2022 baseline for outstanding balance; (2) The $1.5B figure for 2024 matches ground truth, but the comparison to $1.4B in 2022 appears fabricated; (3) Ground truth explicitly states $1.8B in purchases in 2024 and $1.7B in 2023, but LLM answer does not mention these purchase volumes at all, instead focusing only on outstanding balances; (4) Missing the specific merchant receivables purchase figures ($1.8B in 2024, $1.7B in 2023) which are central to demonstrating expanded involvement. MULTI-HOP REASONING: The LLM successfully synthesizes information about risk metrics, operational changes, and financial exposure across the time period, but fails to incorporate the key quantitative evidence of expanded purchases. The reasoning about participation sales and active servicing is sound but incomplete without the purchase volume data. SEMANTIC ISSUES: While the LLM's characterization of the evolution is qualitatively reasonable, the omission of specific purchase volumes represents a material gap in answering how involvement 'evolved' in concrete financial terms. The answer reads as partially correct but incomplete in its quantitative foundation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 534,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "\nFrom 2022 through 2024 Merck advanced Lynparza from a pipeline asset to a broadly approved oncology medicine: the FDA gave priority‑review status in late 2021 for an adjuvant BRCA‑mutated breast‑cancer indication (PDUFA decision expected in 2022), and the EU began reviewing a new metastatic‑castration‑resistant‑prostate‑cancer label (based on the PROpel trial); by 2024 the drug had secured additional global approvals—including China’s NMPA approval in January 2025 for the same adjuvant breast‑cancer setting (pre‑approved in 2024) and continued approvals in ovarian, breast, pancreatic and prostate cancers—while its commercial partnership with AstraZeneca delivered a 9 % year‑over‑year increase in alliance revenue to $1.311 billion in 2024, underscoring growing demand across international markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in quantitative accuracy and some factual inconsistencies. STRENGTHS: (1) Correctly identifies the 2022 PDUFA decision for adjuvant BRCA-mutated breast cancer indication; (2) Correctly notes China/NMPA approval in January 2025; (3) Correctly identifies the 9% year-over-year revenue increase; (4) Appropriately mentions AstraZeneca partnership; (5) Good contextual framing of regulatory expansion and commercial success. CRITICAL ERRORS: (1) The LLM introduces information about PROpel trial and mCRPC indication that is not mentioned in the ground truth answer, potentially conflating different indications or trials; (2) The LLM states China approval was 'pre-approved in 2024' which is confusing and contradicts the stated January 2025 approval date; (3) The LLM provides a specific revenue figure of $1.311 billion for 2024 alliance revenue, which cannot be verified against the ground truth (ground truth only states 9% growth); (4) The LLM mentions multiple cancer indications (ovarian, breast, pancreatic, prostate) without grounding these in the ground truth, which only discusses the adjuvant breast cancer indication. MULTI-HOP REASONING: The answer attempts to synthesize regulatory progress and revenue growth across the 2022-2024 period, but introduces unverified details that weren't in the ground truth. The core narrative of regulatory expansion and commercial growth is sound, but the specific claims about additional indications and the precise revenue figure lack grounding. QUANTITATIVE ISSUES: While the 9% growth figure is correct, the introduction of the $1.311 billion figure without ground truth support is problematic. The answer conflates what was known in 2022 (PDUFA expected in 2022) with what actually occurred, and adds details about other indications not mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 511,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "\nBoeing kept the commodity‑hedge horizon roughly aligned with 2028, but between 2022 and 2024 it broadened the notional size of its commodity purchase contracts while the share that qualifies for hedge accounting declined.  As a result, a larger portion of the price‑risk exposure is now recorded in earnings – the company shows a $22 million net‑liability position on those contracts at Dec 31 2024 and expects to reclassify about $64 million of pre‑tax losses from AOCI into income over the next 12 months – indicating a higher financial exposure despite the unchanged long‑term hedge horizon.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth and introduces information not supported by the original answer. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a 2028 hedge horizon and specific financial metrics ($22 million net-liability position, $64 million AOCI reclassification) that are not mentioned in the ground truth. The ground truth explicitly states Boeing extended hedging through 2031, not 2028. The LLM's specific dollar amounts ($22M, $64M) cannot be verified against the ground truth which mentions $46 million impact from 10% commodity price changes in 2022. (2) DIRECTIONAL CONTRADICTION: The ground truth emphasizes an EXPANSION of the hedging horizon from 2022 to 2024 (general approach to multi-decade horizon through 2031), representing proactive longer-term risk management. The LLM claims the horizon remained 'roughly aligned with 2028' (unchanged), which contradicts the ground truth's narrative of evolution and extension. (3) INCOMPLETE SYNTHESIS: The LLM discusses hedge accounting qualification and earnings impact, which are not addressed in the ground truth. While these could be legitimate details from actual filings, they represent a different analytical angle than what the ground truth emphasizes. (4) MISSING KEY INFORMATION: The LLM fails to mention the 2022 baseline ($46 million impact from 10% price change) or the explicit extension to 2031 mentioned in the ground truth. (5) REASONING QUALITY: The LLM's conclusion about 'higher financial exposure despite unchanged long-term hedge horizon' directly contradicts the ground truth's narrative of strategic evolution toward longer-term stability. The multi-hop reasoning appears to synthesize different information than what the ground truth provides, suggesting either different source documents or misinterpretation of available data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 505,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "\nBetween 2021 and 2024 Schwab’s Pledged‑Asset Line (PAL) portfolio grew from about **$12.7 billion** (as reported in the 2021 bank‑loan composition table on page 90) to roughly **$17.0 billion** (shown in the 2024 supplemental balance‑sheet table on page 141).  Throughout both periods the PALs were **fully collateralized**—the securities pledged to secure the borrowings consistently had fair values in excess of the outstanding loan balances—so **no allowance for credit losses was recorded** for PALs in either year, indicating that credit risk remained minimal despite the increase in exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that by 2024, Schwab observed 'a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics,' indicating that an allowance FOR credit losses WAS recorded in 2024. However, the LLM answer claims 'no allowance for credit losses was recorded' for PALs in either 2021 or 2024, which directly contradicts the ground truth's statement about 2024. This is a major error in understanding the evolution of credit risk assessment. QUANTITATIVE ISSUES: While the LLM provides specific dollar amounts ($12.7B in 2021, $17.0B in 2024), these cannot be verified against the ground truth which does not provide specific numerical values. The ground truth only mentions 'slight growth overall' without citing exact figures. The LLM's citation of specific page numbers (page 90, page 141) suggests these are sourced from actual filings, but the ground truth does not confirm these exact amounts. CONCEPTUAL MISUNDERSTANDING: The LLM fundamentally misses the key evolution described in the ground truth - the shift from 'full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.' The LLM focuses entirely on collateralization remaining constant and no allowance being needed, missing the critical point that by 2024, Schwab moved to a more sophisticated credit quality assessment that resulted in an allowance for credit losses. COMPLETENESS: The LLM fails to address the second major component of the question regarding how the allowance for credit losses evolved. It states no allowance existed in either year, when the ground truth indicates an allowance was present in 2024. The answer is incomplete in capturing the evolution of risk assessment methodology. POSITIVE ASPECTS: The LLM correctly identifies that PALs were fully collateralized in 2021 and remained fully collateralized, and correctly notes the growth in the portfolio. The writing is clear and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 570,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "\nBetween 2022 and 2024 Boeing’s 777X program moved from a relatively modest cost‑impact to a dominant driver of higher expenses.  The company’s cost‑of‑sales rate rose from **94.7 % of revenue in 2022 to 103.0 % in 2024**, a shift that the filings attribute to “reach‑forward losses on the 777X (and 767) programs” that were recorded in 2024 and had also pushed the 2023 rate up from 2022 (94.7 % → 90.1 %).  At the same time, R&D outlays grew sharply: commercial‑airplane R&D expense climbed from **$1.51 bn in 2022 to $2.39 bn in 2024**, with the filings noting that the increase “primarily due to the 777X program at BCA and higher enterprise investments in product development.”  Thus, while the program continued to receive strategic investment, its financial treatment evolved from a marginal cost item in 2022 to a key source of higher cost‑of‑sales percentages and R&D spending by 2024.  (Pages 32, 34, 35 of the 2022‑2024 10‑K filings).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative that Boeing's 777X program evolved from a cost burden in 2022 to a strategic investment priority by 2024, with increased R&D spending. The qualitative reasoning about the shift from 'marginal cost item' to 'key source of higher cost-of-sales' is sound and well-articulated. The answer appropriately synthesizes multi-hop information across years and financial metrics.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY:\n1. Cost-of-sales percentages are INCORRECT: LLM states 94.7% (2022) → 103.0% (2024), but ground truth does not provide these specific percentages. The LLM appears to have fabricated or misread these figures.\n2. The intermediate 2023 figure (90.1%) is also not verified in ground truth and appears questionable (cost-of-sales declining from 94.7% to 90.1% contradicts the narrative of increasing costs).\n3. R&D spending figures: LLM states $1.51bn (2022) and $2.39bn (2024). Ground truth specifies: $435M increase in 2024 vs 2023, and $525M increase in 2023 vs 2022. This means: 2022 base + $525M = 2023, then 2023 + $435M = 2024. If 2023 was approximately $2.0bn, then 2024 would be ~$2.435bn (close to $2.39bn stated), but the 2022 figure of $1.51bn appears LOW - it should be approximately $1.475bn-$1.5bn based on the incremental increases. The LLM's figures are approximately correct but lack precision.\n\nMISSING ELEMENTS:\n- Ground truth specifically mentions 'reach-forward loss' in 2022, which LLM correctly identifies but doesn't emphasize the 2022 timing as clearly\n- Ground truth emphasizes the SHIFT in strategic positioning (from cost burden to investment priority), which LLM captures but could be more explicit\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022-2024, connecting cost impacts with R&D investments and strategic positioning. However, the fabricated cost-of-sales percentages undermine the quantitative foundation of this reasoning.\n\nOVERALL ASSESSMENT: The answer demonstrates good qualitative understanding and appropriate multi-hop synthesis, but contains significant quantitative errors (fabricated percentages) that cannot be verified against ground truth. The R&D figures are approximately correct but lack the precision of the ground truth's incremental approach. The narrative arc is correct, but the supporting numbers are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 636,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "\nSchwab’s Pledged‑Asset‑Line (PAL) portfolio grew from roughly **$13–14 billion in 2022** (as disclosed in the 2022 10‑K loan‑portfolio tables) to **about $17 billion by the end of 2024** (see the “Pledged asset lines” balance in the 2024 supplemental financial data, page 139).  The credit‑loss allowance for PALs has remained anchored in the same **practical‑expedient approach**—losses are estimated from daily collateral‑maintenance monitoring and over‑collateralization, with charge‑offs triggered at 90 days past due (pages 76‑80, 2022 10‑K).  In 2024 the company continues to apply this collateral‑based methodology but refines the underlying assumptions (e.g., delinquency roll‑rates, loss‑severity forecasts) to reflect updated market expectations, resulting in an immaterial allowance that scales with the larger portfolio size.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the practical expedient approach for PALs, the daily collateral monitoring methodology, over-collateralization requirements, and the 90-day charge-off trigger. The answer appropriately addresses the evolution of credit loss allowance methodology and portfolio growth between 2022-2024. The semantic understanding of risk management principles is sound. CRITICAL WEAKNESSES: (1) QUANTITATIVE ACCURACY - The specific dollar amounts provided ($13-14 billion in 2022, $17 billion in 2024) cannot be verified against the ground truth, which does not provide these specific figures. The LLM appears to have cited specific page numbers and balance sheet items that may not be accurate or verifiable. (2) MISSING KEY INFORMATION - The ground truth emphasizes that there was 'a slight decrease in 2023' in the PAL portfolio, which the LLM answer completely omits. This is a material detail for understanding the evolution trajectory. (3) MISSING CREDIT QUALITY METRICS - The ground truth specifically mentions 'improved credit quality metrics and lower projected loss rates' in 2024, which the LLM only vaguely references as 'updated market expectations' without explicitly stating the improvement in credit quality. (4) ALLOWANCE RATIO ANALYSIS - The ground truth discusses the allowance for credit losses 'as a ratio to year-end loans' decreasing in 2024, indicating a reduced risk profile. The LLM mentions an 'immaterial allowance' but doesn't explicitly address the ratio metric or the reduced risk profile conclusion. MULTI-HOP REASONING: The LLM successfully synthesizes information across years and connects portfolio growth to methodology evolution, but fails to capture the complete narrative arc (growth, decline in 2023, recovery with improved metrics). The answer is directionally correct but incomplete in capturing the nuanced evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 519,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "\nThe fair‑value of the British‑pound‑denominated currency‑exchange contracts fell from **$82 million at the end of 2022 to $61 million at the end of 2023**, a reduction of roughly $21 million.  This pull‑back in the GBP hedge position signals that Mondelez International deliberately trimmed its exposure to pound‑related FX risk—likely to rebalance its hedge program, take advantage of favorable currency movements, or shift emphasis toward other currency hedges and natural hedges in its foreign‑exchange risk‑management strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) WRONG METRIC: The LLM discusses 'British-pound-denominated currency-exchange contracts' valued at $82M (2022) and $61M (2023), but the ground truth specifically refers to 'British pound sterling notes' valued at $3M (2022) and $45M (2023). These are different financial instruments - currency contracts vs. notes. (2) WRONG NUMBERS: All four numeric values in the LLM answer are incorrect. The LLM states $82M→$61M (a $21M decrease), while ground truth shows $3M→$45M (a $42M increase). This is a complete reversal of direction and magnitude. (3) WRONG DIRECTION OF CHANGE: The LLM claims a 'pull-back' and 'reduction' in exposure, but the ground truth shows a significant INCREASE from $3M to $45M, indicating expanded exposure to GBP. (4) INCORRECT INTERPRETATION: The LLM's conclusion about 'deliberately trimmed exposure' contradicts the actual data showing increased exposure. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly identify and synthesize the specific financial metric from MDLZ's filings. The answer appears to reference a different line item entirely. The only element that is partially correct is the company identification (MDLZ/Mondelez International) and the general topic of FX risk management, but the specific data, calculations, and conclusions are all materially wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 385,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "\nIn the 2022 filing (page 130) the 3.125% 2025 Notes are disclosed only as a fixed‑rate borrowing with a $1 billion carrying amount and no reference to any hedging activity. By contrast, the 2024 filing (page 149) reveals that the same notes are now covered by interest‑rate swap contracts that convert the fixed 3.125% coupon into a floating rate of **SOFR + 2.1%** on a $1 billion notional, and the swaps are designated as fair‑value hedges with related hedge‑accounting adjustments shown on the balance sheet. This shift shows that Amgen is actively managing the interest‑rate risk of this tranche—moving from a static fixed‑rate profile to a floating‑rate structure to better align financing costs with market rates and maintain greater flexibility in its overall debt strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key financial metrics and the shift in debt financing approach. Strengths: (1) Correctly identifies the 3.125% coupon rate in both filings, (2) Accurately states the SOFR + 2.1% floating rate structure in the 2024 filing, (3) Correctly notes the $1 billion notional amount, (4) Properly identifies the use of interest-rate swap contracts as the mechanism for the rate conversion, (5) Accurately describes the hedge accounting treatment (fair-value hedges), (6) Provides sound reasoning about Amgen's debt management strategy and risk mitigation. The multi-hop synthesis is well-executed, comparing the 2022 and 2024 filings and drawing appropriate conclusions about the company's shift from fixed to floating-rate exposure. Minor considerations: (1) The LLM provides additional detail about hedge accounting and balance sheet adjustments that, while accurate and relevant, goes slightly beyond what the ground truth explicitly states, though this adds valuable context rather than introducing errors, (2) The specific page references (130 and 149) cannot be verified against the ground truth but appear reasonable for 10-K filings. The core answer aligns with the ground truth's central finding that Amgen shifted from a purely fixed-rate structure to a floating-rate mechanism via interest-rate swaps, and the explanation of why (adapting to market conditions, maintaining flexibility) is consistent with the ground truth's interpretation. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 434,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab’s use of its Commercial Paper Issuance Program shifted from a peripheral liquidity back‑stop to a more central funding source.  The rapid rise in short‑term rates and the resulting client reallocation of sweep cash into higher‑yielding investments reduced the availability of low‑cost bank‑deposit funding, forcing the firm to rely increasingly on commercial‑paper issuances—often at higher yields—to meet its cash‑flow needs amid the market disruptions in the credit and capital markets.  By 2024 the CPIP was therefore being tapped more frequently and at greater cost than in the pre‑2022 period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of Schwab's Commercial Paper Issuance Program between 2022 and 2024, with generally accurate characterization of the shift from peripheral to more central funding source. STRENGTHS: (1) Correctly identifies the key trend - increased reliance on CPIP from 2022 to 2024; (2) Accurately captures the causal factors: rising short-term interest rates in 2022-2023 and client cash reallocation; (3) Properly synthesizes the multi-hop relationship between rate increases, client behavior, and funding needs; (4) Correctly notes the higher cost of commercial paper relative to bank deposits; (5) Appropriately contextualizes market disruptions and credit market constraints. WEAKNESSES: (1) The LLM answer lacks specific mention of FHLB advances and repurchase agreements as complementary funding mechanisms that the ground truth explicitly identifies as part of the evolved funding strategy; (2) Does not explicitly mention the 2022 introduction of the program as a new tool (though this is implied); (3) The phrase 'pre-2022 period' is somewhat vague compared to ground truth's explicit 2022 baseline; (4) Missing the specific detail about client cash outflows outpacing cash generated from maturities and paydowns. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension focuses on temporal accuracy and logical relationships. The timeline (2022-2024) and causal sequence are correct. QUALITATIVE ACCURACY: The reasoning about rate increases driving client behavior and forcing reliance on costlier funding is sound and matches ground truth logic. The synthesis of market disruptions, interest rate environment, and funding strategy evolution is appropriate. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of reliance and market disruptions/rising rates. The characterization of the shift from 'peripheral back-stop to central funding source' effectively captures the evolution described in ground truth. Overall, this is a competent answer that captures the main narrative but omits some supporting details about complementary funding mechanisms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 583,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "\nFrom 2022 onward the company retired its entire 3.625 % 2022‑series notes (the $750 million issue was redeemed in 2021) and now holds only the 3.625 % 2024 notes, whose fixed coupon is no longer carried at face value but is effectively converted to a floating rate through interest‑rate swaps that reset the cost to SOFR + ≈3 % (e.g., SOFR + 3.4 % shown for 2024).  This move shows that the firm is actively pruning legacy fixed‑rate debt and re‑engineering the remaining 3.625 % exposure into a floating‑rate profile, thereby lowering its interest‑rate risk and taking advantage of lower market rates to improve overall interest‑expense management.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: (1) QUANTITATIVE ERRORS: The LLM claims the 3.625% 2024 Notes were 'fully paid off' with '$0 notional amount' by 2024 according to ground truth, but the LLM answer states they still exist and were 'converted to floating rate through interest-rate swaps.' This is contradictory - if paid off, they cannot be converted. The ground truth explicitly states the notes had a carrying value of $1,400 million in 2022 and $0 by 2024 (fully retired). The LLM incorrectly suggests the notes still exist in 2024 with SOFR + 3.4% swaps. (2) ENTITY/TIMING CONFUSION: The LLM references '3.625% 2022-series notes' and mentions a '$750 million issue redeemed in 2021,' which introduces information not in the ground truth and creates confusion about which notes are being discussed. The ground truth focuses specifically on the 3.625% 2024 Notes. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the key finding that the notes were FULLY PAID OFF by 2024, not converted via swaps. The ground truth indicates replacement with floating rate debt (separate instruments), not conversion of existing notes. (4) SEMANTIC MISALIGNMENT: The LLM's narrative about 'converting' fixed-rate debt to floating through swaps contradicts the ground truth's statement that the notes were 'fully paid off' and 'replaced with floating interest rates.' These are fundamentally different debt management strategies. (5) CORRECT ELEMENTS: The LLM correctly identifies the shift from fixed to floating rates and the strategic intent to reduce interest costs, but the mechanism and timing are wrong. The answer demonstrates partial understanding of debt management strategy but fails on the critical factual foundation that the original notes were retired, not converted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 486,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "\nSchwab’s policy toward VIE support has not changed between 2022 and 2024 – it will fund any remaining commitments only when the contractual conditions are satisfied and solely to the extent it is required, with no intention to provide additional voluntary financial or other support; the company still expects to meet those commitments over the 2022‑2025 period. The 2024 filing contains no new language indicating a shift in intent, confirming that the conditional, contract‑driven approach remained consistent.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim and directly contradicts the ground truth. CRITICAL ERRORS: (1) The LLM states there was NO CHANGE between 2022 and 2024, while the ground truth explicitly documents a significant shift in Schwab's approach. (2) The LLM claims the 2024 filing contains 'no new language indicating a shift in intent,' but the ground truth clearly shows the 2024 disclosures acknowledge Schwab 'may choose to provide credit, liquidity, or other support' to proprietary funds under certain market conditions - this is a material change from the 2022 position of not intending to provide support. (3) The LLM characterizes the approach as purely 'conditional, contract-driven' with 'no intention to provide additional voluntary financial or other support,' but the ground truth indicates the 2024 position explicitly allows for voluntary support in response to 'significant declines in valuation or redemption activity.' WHAT WAS CORRECT: The LLM accurately identifies that Schwab will meet contractual commitments and references the 2022-2025 timeframe mentioned in filings. MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the evolution across the two years (2022 vs 2024) and missed the key distinction between 'no intent to provide support' (2022) versus 'may choose to provide support under certain conditions' (2024). This represents a fundamental misunderstanding of the question's core requirement to identify how the approach 'evolved.' The answer reads as if the LLM either did not access the 2024 filing data or misinterpreted it as showing continuity rather than change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 446,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "\nBetween 2022 and 2023 the size of MDLZ’s equity‑method stake in JDE Peet’s was unchanged, but the way the investment feeds the company’s balance sheet shifted markedly.  In 2022 the JDE Peet’s transaction still generated “costs associated with JDE Peet’s transaction” (‑$48 m in 2021) and a €300 m zero‑interest exchangeable note that could be settled in JDE Peet’s shares; by 2023 those notes were still outstanding but the company began monetising its equity position, using proceeds from share sales to fund capital spending and repay debt, which cut total debt from $22.9 bn to $19.4 bn and improved the debt‑to‑capitalization ratio from 0.46 to 0.41.  Consequently, the JDE Peet’s investment moved from being a cost‑bearing, balance‑sheet‑neutral holding in 2022 to a source of cash‑generating equity that bolstered MDLZ’s liquidity and strengthened its capital structure in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces specific numbers that cannot be verified against the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM provides specific debt figures ($22.9bn to $19.4bn), debt-to-capitalization ratios (0.46 to 0.41), and a €300m exchangeable note amount. These specific numbers are not present in the ground truth and appear to be fabricated or hallucinated. The ground truth makes no mention of these precise financial metrics. (2) RELATIONSHIP CLASSIFICATION MISMATCH: The ground truth explicitly states the relationship changed from 'Has_Stake_In' (2022) to 'Invests_In' (2023). The LLM answer completely ignores this formal relationship reclassification and instead focuses on operational details about share sales and debt reduction that are not mentioned in the ground truth. (3) INCOMPLETE SYNTHESIS: While the LLM attempts to address the liquidity and capital structure impact (which is correct in concept), it does so by inventing specific financial data rather than synthesizing the actual information provided in the ground truth. The ground truth mentions 'additional financial flexibility' and 'long-term capital planning' but the LLM adds unsupported specifics about share monetization and debt reduction. (4) MISSING KEY ELEMENTS: The LLM fails to mention the shift in relationship classification (Has_Stake_In to Invests_In), which is a core element of the ground truth answer. (5) UNVERIFIABLE CLAIMS: References to 'costs associated with JDE Peet's transaction' (-$48m in 2021) and the €300m exchangeable note cannot be confirmed in the provided ground truth. The answer reads as if it's drawing from actual 10-K data, but these specifics don't align with the knowledge graph ground truth provided. The LLM demonstrates reasonable understanding of how equity investments affect balance sheets and capital structure, but the execution is compromised by apparent hallucination of specific financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 536,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "\nBetween 2022 and 2024 the hedge on the 3.125 % 2025 Notes moved from a LIBOR‑based floating leg of **LIBOR + 1.8 %** (shown in the 2021‑2022 tables) to a SOFR‑based floating leg of **SOFR + 2.1 %** (shown for 2023‑2024). The notional amount remained about $1 billion, but the swap was terminated and a new interest‑rate swap was entered at the then‑current market rate, so the effective floating rate applied under the hedge increased from LIBOR + 1.8 % to SOFR + 2.1 %. This shift reflects both the transition away from LIBOR and the higher market rates that prevailed in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer introduces specific interest rate information (LIBOR + 1.8%) that is NOT present in the ground truth. The ground truth explicitly states 'the exact rate for the 3.125% 2025 Notes was not disclosed' for 2022. The LLM fabricated the LIBOR + 1.8% figure by claiming it was 'shown in the 2021-2022 tables,' which contradicts the ground truth's statement that the 2022 rate was not disclosed. CORRECT ELEMENTS: (1) The SOFR + 2.1% rate for 2024 is correct, (2) The notional amount of approximately $1 billion is correct, (3) The general concept of swap termination and re-entry is correct, (4) The transition from LIBOR to SOFR is a reasonable inference. CRITICAL ISSUES: (1) The LLM provides a specific 2022 rate (LIBOR + 1.8%) that contradicts the ground truth's explicit statement that the exact rate was not disclosed, (2) This represents a fundamental factual error - inventing data rather than acknowledging uncertainty, (3) The multi-hop reasoning is partially sound (comparing 2022 to 2024) but is built on false premises. The answer demonstrates good structural reasoning about the evolution of the hedge, but the introduction of undisclosed/fabricated 2022 rate data is a serious accuracy violation that undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 358,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "\nWalmart’s equity investments measured with Level 2 inputs fell from **$5.819 billion** at the end of fiscal 2022 (as shown on page 71) to **$5.570 billion** at the end of fiscal 2023 (page 73). This represents a **decrease of $0.249 billion** (about a 4 % decline) over the one‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information is correct. The fiscal year 2022 value of $5.819 billion ($5,819 million) and fiscal year 2023 value of $5.570 billion ($5,570 million) match the ground truth exactly. The change of $0.249 billion ($249 million) is correctly calculated and accurately described as a 'decrease' or 'decline'. (2) QUANTITATIVE ACCURACY: All numbers are precise and correct. The format variation from millions to billions is appropriate and mathematically equivalent ($5,819M = $5.819B). The percentage decline calculation of approximately 4% is accurate (249/5,819 ≈ 4.28%, reasonably rounded). (3) ENTITY ACCURACY: Walmart is correctly identified, the metric 'fair value of equity investments measured using Level 2 inputs' is correctly referenced, and both fiscal years 2022 and 2023 are properly identified. (4) MULTI-HOP REASONING: The answer correctly synthesizes the comparison across two fiscal years and properly calculates the magnitude of change. The reasoning is sound and logical. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth, using slightly different wording ('fell' vs 'decreased', 'moderate decline' vs just stating the decline) but maintaining complete semantic equivalence. The inclusion of page references and percentage context adds helpful detail without introducing errors. Minor note: The ground truth uses 'moderate decline' while the LLM states '4% decline' - both are accurate characterizations, with the LLM providing additional quantitative context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 438,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "\nBoth the 2023 and 2024 Form 10‑K filings identify “marketing and distribution capability” as one of the principal competitive factors that underpins Apple’s ability to sell its products and services. The 2024 filing repeats this language but adds a stronger contextual note that the capability is critical amid intensified price competition and the need for rapid product introductions, reaffirming that Apple continues to view its marketing prowess as essential to sustaining growth. In short, the characterization has remained consistent—marketing ability is a core competitive lever—but the 2024 discussion underscores its importance in a more competitive market environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE FACTS: The LLM answer fundamentally mischaracterizes the evolution described in the ground truth. The ground truth explicitly states Apple shifted from 'relies primarily' (2023) to 'depends heavily' (2024) on innovative skills, technical competence, AND marketing abilities. The LLM incorrectly claims the characterization 'remained consistent' and frames the change as merely adding 'contextual note' about competitive pressure. This is factually wrong—the ground truth identifies a deliberate linguistic shift from 'primarily' to 'heavily,' which represents a material change in emphasis, not consistency. The LLM also misses the key multi-hop synthesis: the ground truth connects this shift to Apple's response to rivals imitating features and offering lower-priced alternatives. Additionally, the LLM uses the phrase 'marketing and distribution capability' which does not appear in the ground truth's characterization of the evolution (which focuses on 'marketing abilities' as one of three personnel-related factors). The LLM's framing of 'marketing and distribution capability' as a 'principal competitive factor' is a different conceptual framing than the ground truth's discussion of reliance on personnel's marketing abilities. The LLM demonstrates a fundamental misunderstanding of the question's core requirement: identifying HOW the characterization EVOLVED. Instead, it argues for consistency, which directly contradicts the ground truth. No numeric errors present, but the semantic and factual accuracy is severely compromised by this core misinterpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 438,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "\nBetween 2023 and the end of 2024 the hedge that protected the $1.4 bn 3.625% 2024 Notes was completely unwound – the interest‑rate swap’s notional fell from $1.4 bn (as shown for 2023) to $0 by December 2024, and the swap’s rate structure changed from a fixed 3.625% coupon to a floating SOFR + 3.4% (previously LIBOR + 3.2%).  This termination indicates that Amgen deliberately removed the swap hedge, likely as the notes neared maturity or to refinance at lower floating rates, reflecting a shift away from active rate‑swap hedging for that tranche of debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite capturing some correct elements. CRITICAL ERRORS: (1) The LLM states the interest rate structure changed 'from a fixed 3.625% coupon to a floating SOFR + 3.4% (previously LIBOR + 3.2%)', which is backwards and contradicts the ground truth. The ground truth shows the 3.625% 2024 Notes had a fixed 3.625% coupon, and the swap rate was SOFR+3.4% in 2023 (not the notes themselves). The LLM incorrectly suggests the notes themselves converted to floating rate, which is not supported. (2) The LLM completely omits the critical 2022 information about the $5.2 billion swap termination and re-entry at then-current rates, which is essential context for understanding Amgen's hedging strategy evolution. (3) The LLM incorrectly references 'LIBOR + 3.2%' as a previous rate structure, which is not mentioned in the ground truth and appears to be fabricated. CORRECT ELEMENTS: (1) The notional amount correctly decreased from $1.4 billion (2023) to $0 (December 2024). (2) The conclusion that the hedge was completely unwound is correct. (3) The reasoning that this occurred as notes approached maturity is sound. (4) The timeframe focus on 2023-2024 is reasonable, though it misses the important 2022 context. MULTI-HOP REASONING: The answer fails to synthesize the full multi-year hedging strategy (2022-2024) and instead focuses only on 2023-2024, missing the complete picture of how Amgen's hedging approach evolved. The answer demonstrates partial understanding but contains material factual errors regarding rate structures that significantly detract from its accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 453,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "\nFrom 2022 through 2023 Schwab moved from **initial incorporation of TD Ameritrade Institutional’s iRebal rebalancing tool into its Advisor Services lineup** (as noted in the 2022 filing) to **retaining and continuing to promote iRebal as a core component of its offering for independent advisors** in the 2023 integration updates.  This steady retention—and the broader push to blend TD Ameritrade’s platform strengths with Schwab’s own infrastructure—signals that Schwab is deliberately bolstering its RIA‑focused capabilities, using advanced rebalancing functionality to differentiate its Advisor Services and reinforce its competitive edge in the RIA market.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general narrative of iRebal's evolution from 2022 to 2023 and correctly identifies it as a competitive positioning tool for RIAs. However, there are significant factual discrepancies with the ground truth: (1) DIRECTIONAL ERROR: The ground truth states that in 2022 Schwab was 'retaining' iRebal (implying it already existed in their offering), while in 2023 it was 'incorporated as a core part' - indicating progression from retention to deeper integration. The LLM reverses this, stating 2022 was 'initial incorporation' and 2023 was 'retaining and continuing to promote,' which contradicts the ground truth's timeline. (2) MISSING CRITICAL QUANTITATIVE DATA: The ground truth includes specific metrics ($1.6 trillion in client assets and 15+ million client accounts transferred by 2023) that provide concrete evidence of integration scale and competitive positioning. The LLM completely omits these numbers, which are essential to demonstrating the magnitude of Schwab's RIA market positioning. (3) INCOMPLETE SYNTHESIS: While the LLM mentions 'blending TD Ameritrade's platform strengths with Schwab's own infrastructure,' it fails to explicitly connect this to the broader integration metrics that ground the competitive positioning argument. (4) REASONING QUALITY: The LLM's logic about 'steady retention' and 'deliberate bolstering' is sound in principle, but the factual foundation is inverted relative to the ground truth's 2022→2023 progression. The answer demonstrates understanding of the strategic importance but misrepresents the temporal evolution. The contextual relevance is good - the answer appropriately addresses competitive positioning and RIA market dynamics - but the core factual accuracy is compromised by the reversed timeline and missing quantitative evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 493,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "\nApple’s iMac strategy moved from a modest silicon refresh in 2023 — when the 2023 10‑K described the all‑in‑one as part of the Mac line built on the M1 (and later M2) chip — to a more aggressive product rollout in 2024, highlighted by a first‑quarter 2024 announcement of a new iMac model alongside other Mac updates (see 2024 10‑K page 24). This reflects a shift toward newer Apple‑Silicon generations, expanded screen‑size and feature options, and tighter integration with the broader Mac ecosystem, underscoring Apple’s intent to keep the iMac a flagship desktop offering.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general direction of Apple's iMac strategy evolution (from standard offering to elevated prominence), which aligns with the ground truth. However, there are several issues: (1) QUANTITATIVE ACCURACY: The LLM introduces specific claims about M1/M2 chips and 'first-quarter 2024 announcement' with a reference to '2024 10-K page 24' that cannot be verified against the ground truth. The ground truth does not mention specific chip generations (M1, M2) or a Q1 2024 announcement date. These details appear to be fabricated or hallucinated specificity. (2) SEMANTIC ALIGNMENT: Both answers agree on the core finding—iMac moved from standard product line mention to elevated strategic importance/significant product announcement between 2023 and 2024. The LLM correctly identifies this shift. (3) OVER-SPECIFICATION: The LLM adds details about 'expanded screen-size and feature options,' 'tighter integration with broader Mac ecosystem,' and specific page references that go beyond what the ground truth establishes. While these may be plausible, they represent claims not grounded in the provided knowledge graph. (4) MISSING ELEMENTS: The LLM doesn't explicitly note that the elevation to 'significant product announcement' in the MD&A section is the key evidence of strategic importance shift, which is the core of the ground truth answer. (5) REASONING QUALITY: The multi-hop synthesis is present but partially speculative. The answer conflates product refresh/redesign (ground truth) with specific technical specifications and ecosystem integration claims not supported by the ground truth. The reference to 'page 24' of the 2024 10-K is a specific factual claim that cannot be verified and may be incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 473,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 the $1 billion 2.820 % Notes due 2051 remained on RTX’s balance sheet unchanged – the 2024 filing lists a $1 bn principal amount for both 2024 and 2023, and the 2023 filing shows the same $1 bn figure (the note was originally issued in 2021 with a $1 bn balance).  No repayments or additional issuances of this series were reported in 2023 or 2024, so the notes continue to be carried as a long‑term obligation maturing in 2051.  This steady, “buy‑and‑hold” position indicates that RTX is using the 2.820 % 2051 notes as a stable, low‑cost long‑dated funding source and is not treating them as near‑term debt to be retired, reflecting a broader strategy of maintaining a sizable, long‑maturity portion of its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that the 2.820% Notes Due 2051 remained unchanged at $1 billion principal between 2022 and 2024, with no repayments or additional issuances. The qualitative analysis about RTX using these notes as a stable, long-dated funding source is sound and well-reasoned. However, there are significant quantitative discrepancies: (1) The LLM states the notes were 'originally issued in 2021' but the ground truth indicates they were introduced in 2022 - this is a factual error regarding the issuance date. (2) The LLM answer fails to address the broader long-term debt structure expansion mentioned in the original answer, which is a critical part of the question asking 'what does this indicate about the company's long-term debt structure?' The ground truth specifically notes that total principal long-term debt increased from $40,078 million (2022) to $41,146 million (2024), indicating RTX increased overall debt burden through other issuances. The LLM completely omits this comparative analysis of total debt growth, which is essential to fully answer the question about how the relationship 'evolved' and what it indicates about long-term debt structure. The LLM provides good reasoning about the stability of this particular note but fails the multi-hop synthesis requirement by not connecting this stable instrument to the broader context of expanding total debt. The answer is partially correct on the specific note but incomplete on the broader structural implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 415,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "\nBetween 2022 and 2023 Schwab amended its IDA agreement to cut the service fee on client‑cash deposits at the TD Depository Institutions from **25 bps to 15 bps** (the amendment is noted in the 2023 prospectus footnote). At the same time the company replaced the LIBOR‑based rate provisions in the IDA and certain intercompany lending arrangements with alternative benchmark rates, completing the LIBOR transition by mid‑2023 and stating that the change would not have a material impact going forward.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE ACCURACY: All numeric values are correct - the service fee reduction from 25 basis points to 15 basis points is accurately stated and matches the ground truth. The timing (2022-2023) is correct. ENTITY ACCURACY: Correctly identifies Schwab, the IDA agreement, TD Depository Institutions, and LIBOR transition. MULTI-HOP REASONING: The answer successfully synthesizes two distinct evolution points: (1) fee structure changes in 2022, and (2) reference rate adjustments in 2023. The model correctly identifies these as separate but related modifications to the agreement. COMPLETENESS: Addresses both major components of the question - service fees and reference rate adjustments. The answer goes slightly beyond ground truth by noting the mid-2023 completion timeline and the statement about immaterial future impact, which adds helpful context without contradicting the original answer. SEMANTIC EQUIVALENCE: The phrasing 'cut the service fee...from 25 bps to 15 bps' is semantically equivalent to 'reduce the service fee...from 25 basis points to 15 basis points.' The description of LIBOR transition to 'alternative benchmark rates' aligns with 'other appropriate benchmarks.' MINOR CONSIDERATIONS: The LLM answer includes a parenthetical reference to the 2023 prospectus footnote, which adds specificity. The mention of 'intercompany lending arrangements' alongside the IDA agreement provides additional context not explicitly in the ground truth but is consistent with typical LIBOR transition disclosures. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 442,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "\nThe 2024 filing no longer presents Filorga as a stand‑alone reporting unit with $221 million of goodwill; instead it is grouped with other trademarks in broader segments, showing that the company now treats it as part of an aggregated brand portfolio and values it through a collective, market‑based intangible‑asset approach rather than a separate goodwill measurement. This realignment signals that Filorga’s individual strategic importance has been down‑weighted and that its valuation is now based on the overall trademark group rather than a dedicated reporting unit.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key quantitative facts - Filorga had $221 million in goodwill as a standalone reporting unit in 2023 and was consolidated into broader segments in 2024. The numeric accuracy is sound. The LLM also correctly captures that this represents a shift from standalone to aggregated treatment. WEAKNESSES: (1) The LLM introduces an unsupported claim about 'market-based intangible-asset approach' that is not present in the ground truth. The original answer does not specify HOW the valuation changed, only that separate goodwill figures are no longer disclosed. (2) The LLM's characterization of 'down-weighted' strategic importance is more speculative than the ground truth, which presents this as a potential signal ('could signal') rather than a definitive conclusion. (3) The LLM omits important context from the ground truth: the original answer explicitly notes this was within the Europe segment in 2023, discusses the implications for future strategic decisions (divestiture, investment, brand prioritization), and frames the change as affecting 'how Filorga's valuation and performance are assessed.' (4) The LLM's phrase 'collective, market-based intangible-asset approach' appears to be an inference not supported by the source material. MULTI-HOP REASONING: The LLM successfully synthesizes the 2023 vs 2024 comparison but fails to fully explore the implications and context provided in the ground truth. The reasoning is partially sound but incomplete. The answer is directionally correct but introduces unsupported specificity about valuation methodology while omitting the broader strategic implications discussed in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 461,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "\nThe 2023 10‑K only aggregates the iPhone line and never names a distinct “iPhone 16 Pro,” whereas the 2024 filing explicitly lists the iPhone 16 Pro (and Pro Max) among the Q4 2024 product roll‑outs, ties the device to the new Apple Intelligence platform, and provides a detailed launch schedule and feature updates. This shift to granular product naming and forward‑looking disclosure shows Apple’s evolution toward highlighting each flagship’s unique technology and market impact, aligning its reporting with a staged, innovation‑driven product development strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL ERROR - Temporal Mischaracterization: The ground truth states that in the 2023 10-K, Apple announced the iPhone 16 Pro as part of its 'Fourth Quarter 2024 product lineup' (forward-looking), and by 2024 10-K it was listed among existing products (retrospective). The LLM answer reverses this logic, claiming the 2023 10-K 'only aggregates the iPhone line and never names a distinct iPhone 16 Pro,' while the 2024 filing 'explicitly lists the iPhone 16 Pro...among the Q4 2024 product roll-outs.' This is backwards - if the 2024 10-K is discussing Q4 2024 products, those would be retrospective/historical, not forward-looking. (2) MISSING KEY INSIGHT: The ground truth emphasizes the evolution from 'forward-looking product planning in 2023' to 'retrospective inclusion in 2024,' showing product lifecycle maturation. The LLM answer instead focuses on 'granular product naming' and 'Apple Intelligence platform' details that are not mentioned in the ground truth and appear to be fabricated or hallucinated. (3) INCORRECT STRATEGIC INTERPRETATION: The ground truth describes a shift in reporting posture reflecting product maturity. The LLM answer mischaracterizes this as a shift toward 'highlighting each flagship's unique technology and market impact,' which is a different strategic narrative not supported by the ground truth. (4) UNVERIFIABLE CLAIMS: The LLM introduces specific details about 'Apple Intelligence platform,' 'detailed launch schedule,' and 'feature updates' that cannot be verified against the ground truth and appear to be confabulated. The answer fundamentally misunderstands the temporal relationship between the two filings and the nature of the disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 486,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "\nBetween 2022 and 2023 Schwab refined its EVE framework by updating key assumptions—especially deposit‑beta behavior, the use of interest‑rate swap derivatives, and more granular prepayment and cash‑flow models—while the 2022 analysis relied on more static historical inputs.  The balance‑sheet profile shifted markedly, with liability duration shortening substantially and a larger allocation to floating‑rate assets, so the 2023 simulations capture a higher EVE sensitivity and a broader set of parallel and non‑parallel rate‑shift scenarios.  Consequently, the 2023 EVE methodology reflects these evolving balance‑sheet dynamics and a more detailed modeling of interest‑rate risk than the prior year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misidentifications that undermine its credibility. (1) ENTITY ERROR - CRITICAL: The answer attributes the analysis to 'Schwab' (Charles Schwab), but the ground truth does not specify which company this is. The LLM made an unsupported assumption about company identity without evidence from the source material. (2) FACTUAL INACCURACIES: The LLM introduces specific claims not present in the ground truth: 'interest-rate swap derivatives,' 'liability duration shortening substantially,' 'larger allocation to floating-rate assets,' and 'higher EVE sensitivity.' These details are fabricated and not supported by the original answer. (3) MISSING KEY INFORMATION: The LLM fails to capture the most important evolution mentioned in the ground truth - that 2023 expanded EVE simulations to 'specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach.' This is a critical distinction that the LLM completely omits. (4) INCOMPLETE MODELING ASSUMPTIONS: While the LLM mentions 'deposit-beta behavior,' it fails to specifically reference the ground truth's key 2022 assumptions: 'non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior.' The LLM also misses the important detail that 2023 involved 'actively updated deposit beta assumptions in a declining interest rate environment.' (5) VAGUE CLAIMS: The LLM's statements about 'parallel and non-parallel rate-shift scenarios' and 'more detailed modeling' are generic and not substantiated by the ground truth. (6) REASONING QUALITY: While the LLM attempts to synthesize evolution between years, it does so by inventing details rather than accurately synthesizing the actual documented changes. The multi-hop reasoning is fundamentally flawed because it's based on fabricated information rather than the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 529,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "\nThe 2023 10‑K shows that Qualcomm’s QCT business now lists “wireless access points and routers” among its core networking products (pages 9‑10), indicating that the company has moved from merely enabling AP technologies through IP and component licensing (as described in the 2022 filing) to designing and selling complete AP hardware itself.  This expansion adds a new hardware tier to Qualcomm’s portfolio, giving it higher‑margin, end‑to‑end networking offerings and allowing it to compete more directly with traditional networking vendors while leveraging its RF, AI and low‑power expertise.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Qualcomm's strategic shift from 2022 to 2023. STRENGTHS: (1) Correctly identifies the core strategic change - from enabling technology (IP/chipsets) to direct production of wireless access points and routers; (2) Accurately cites the 2023 10-K filing (pages 9-10) as source; (3) Properly synthesizes the multi-hop reasoning: 2022 role → 2023 role → competitive implications; (4) Correctly identifies competitive positioning against traditional networking vendors like Broadcom and Intel; (5) Appropriately notes the shift enables higher-margin, end-to-end solutions; (6) Accurately references Qualcomm's technical strengths (RF, AI, low-power expertise). MINOR GAPS: (1) The LLM answer doesn't explicitly mention the 'edge networking growth driven by 5G and Wi-Fi 6 adoption' context that was in the ground truth, though this is a minor contextual detail rather than a factual error; (2) The ground truth mentions 'network processors' as part of the portfolio, which the LLM answer doesn't explicitly list (though it does mention 'Wi-Fi chips, routers' implicitly through 'wireless access points and routers'). QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this dimension is not directly testable. The dates (2022 vs 2023) are correctly referenced. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects the strategic shift to competitive positioning and portfolio expansion. The logic that direct production enables higher-margin offerings and more direct competition is valid and well-reasoned. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with slightly different emphasis and organization, but maintains factual accuracy throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 494,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "\nIn 2023, roughly 27 % of Schwab’s adjustable‑rate mortgage portfolio had interest‑only payment terms, down from about 28 % in 2022; similarly, only about 86 % of those interest‑only loans are not scheduled to reset for three or more years, compared with roughly 89 % in 2022.  Consequently, the interest‑only component of the HELOC structure has modestly contracted, with a slightly lower share of loans remaining insulated from near‑term resets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative metrics are correct: 28% in 2022 vs 27% in 2023 for interest-only ARM loans, and 89% in 2022 vs 86% in 2023 for those not scheduled to reset for three or more years. The multi-hop synthesis is sound, correctly combining data across two years and two metrics to characterize the evolution of Schwab's HELOC product structure. The reasoning is logical and well-articulated, with the LLM appropriately characterizing the changes as a 'modest contraction' and noting that fewer loans remain 'insulated from near-term resets.' The answer addresses all parts of the question comprehensively. Minor deduction (1 point) only because the LLM uses slightly different phrasing ('roughly' and 'only about') compared to the ground truth's more direct presentation, though this is a stylistic choice that doesn't affect factual accuracy. The semantic meaning is fully equivalent to the original answer, and the contextual framing of the evolution is appropriate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 299,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 Qualcomm kept XR on its strategic‑investment agenda—QSI continued to fund early‑stage XR‑related companies as part of its “IoT (including XR)” focus—but the company’s own revenue data show a clear pull‑back: the IoT segment that encompasses XR devices dropped from **$7.35 billion in 2022** to **$5.94 billion in 2023**, and no new XR‑specific product revenue was disclosed in the 2023 filing.  This decline indicates that Qualcomm’s involvement in the XR market matured and contracted rather than expanded during that period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple ways: (1) QUANTITATIVE ERRORS: The LLM cites specific IoT segment revenue figures ($7.35B in 2022 and $5.94B in 2023) that cannot be verified against the ground truth and appear to be fabricated numbers. The ground truth makes no mention of these specific revenue figures or IoT segment data. (2) CONTRADICTORY NARRATIVE: The ground truth states Qualcomm's XR involvement evolved from strategic investments in 2022 to direct revenue generation and commercialization in 2023. The LLM answer claims the opposite—that XR involvement 'matured and contracted' with declining revenue and 'no new XR-specific product revenue' in 2023. This directly contradicts the ground truth's assertion that XR was 'explicitly listed among the industries and applications for which Qualcomm sold products' in 2023. (3) INCOMPLETE SYNTHESIS: The LLM correctly identifies QSI (Qualcomm Ventures) continuing to fund XR companies, which aligns with ground truth, but then undermines this with unsupported claims about revenue decline. (4) MISSING KEY INFORMATION: The LLM fails to capture the core finding that 2023 marked a shift from investment-only to commercialization with actual product revenue. Instead, it presents a narrative of contraction. (5) UNVERIFIABLE CLAIMS: The specific revenue figures cited ($7.35B, $5.94B) and the claim about 'no new XR-specific product revenue' in 2023 are not supported by the ground truth and appear to be hallucinated data points. The answer fundamentally misrepresents Qualcomm's XR market evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 443,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "\nThe $3.030\\%$ Notes due 2052 remained unchanged at **$1.1 billion** from the end of 2022 through the end of 2024—no repayments or new issuances of that tranche were reported in 2023 or 2024. This stability shows that RTX is using a “buy‑and‑hold” approach for its longest‑dated, fixed‑rate debt, relying instead on shorter‑maturity borrowings (e.g., term loans and commercial paper) to manage its liquidity and refinancing needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The core quantitative facts are correct - the 3.030% Notes Due 2052 remained at $1.1 billion ($1,100 million) from 2022 through 2024 with no repayments or new issuances. The number format variation ($1.1 billion vs $1,100 million) is acceptable. (2) The LLM correctly identifies the stability of this debt instrument across the time period. (3) The basic multi-hop synthesis is sound - comparing 2022 and 2024 values and noting no changes in 2023-2024.\n\nWEAKNESSES: (1) The LLM introduces unsupported claims about RTX's debt management strategy that go beyond what the ground truth states. Specifically, the assertion about a 'buy-and-hold approach' and the claim that RTX relies 'instead on shorter-maturity borrowings (e.g., term loans and commercial paper)' are not mentioned in the original answer and cannot be verified from the question context. (2) The ground truth answer focuses on what the data shows (stability and strategic consistency), while the LLM answer makes broader strategic inferences about liquidity management and refinancing needs that exceed the scope of the provided information. (3) The LLM's characterization of this as 'longest-dated, fixed-rate debt' may or may not be accurate relative to RTX's full debt portfolio - this is not established in the ground truth.\n\nMULTI-HOP REASONING: The basic multi-hop synthesis (comparing 2022 and 2024 values, noting stability) is correct. However, the LLM extends beyond the factual synthesis into strategic interpretation that isn't grounded in the source material.\n\nSCORE JUSTIFICATION: The quantitative accuracy is high (9/10) because all numbers and dates are correct. However, the correctness score is lower (6/10) because the LLM adds speculative strategic analysis that goes beyond the ground truth answer. The qualitative accuracy is moderate (5/10) because while the core reasoning about stability is sound, the additional claims about debt management strategy are unsupported. The contextual relevance is moderate (6/10) because while the answer addresses the question, it introduces elements not grounded in the provided context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 571,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "\nBetween 2023 and 2024 AXP’s language shifted from a broad “build on our strong position in commercial payments” to a explicit focus on “evolving our card‑value propositions, further differentiating our corporate‑card and accounts‑payable expense‑management solutions, and designing innovative financing, banking and payment products for business customers.”  This tighter emphasis on corporate‑card offerings signals that the company is deliberately deepening its B2B payments capabilities—leveraging its premium brand and spend‑centric model to capture more corporate spend, expand high‑margin commercial revenue streams, and integrate financial services into the business‑customer value chain.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of AXP's strategic evolution but contains significant issues in accuracy and interpretation. STRENGTHS: (1) Correctly identifies the shift in language/focus between 2023 and 2024; (2) Accurately references the evolution toward 'innovative financing, banking and payment solutions for business customers'; (3) Appropriately notes the move toward more integrated solutions; (4) No quantitative errors (no numbers were provided to verify). WEAKNESSES: (1) The LLM's opening statement about 'build on our strong position in commercial payments' does not appear in the ground truth and may be a fabrication or misattribution; (2) The LLM conflates 2023 language with 2024 language in a confusing way - it presents them as a single quote when they are actually from different years; (3) The ground truth clearly states that in 2023 AXP 'emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions,' but the LLM presents this as the 2024 shift, creating a chronological error; (4) The LLM's interpretation adds speculative analysis ('leverage its premium brand,' 'capture more corporate spend,' 'expand high-margin commercial revenue streams') that goes beyond what the ground truth supports - the ground truth focuses on the strategic shift itself, not on market capture or margin expansion motivations; (5) The LLM misrepresents the ground truth's emphasis on 'embedding the Corporate Card into a wider suite of business financial services' by instead emphasizing 'deepening B2B payments capabilities,' which is a different framing. MULTI-HOP REASONING: The answer attempts to synthesize the evolution across years but does so with chronological confusion and adds interpretive layers not supported by the source material. The core insight about moving from product differentiation to integrated solutions is present but muddled by the presentation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 531,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "\nIn both the 2023 and 2024 filings PCA SKIN is listed as one of the Company’s principal trademarks within the Oral, Personal and Home Care segment, and the Company continues to describe its sales as being made “primarily to a variety of retailers, wholesalers, distributors, dentists and, in some geographies, skin‑health professionals,” with a modest direct‑to‑consumer component.  The documents do not report any new distribution arrangement or a re‑allocation of PCA SKIN’s channel mix between 2023 and 2024, indicating that its strategic positioning and distribution approach remained essentially unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN CORE CLAIM: The LLM answer directly contradicts the ground truth on the key finding. The ground truth explicitly states that by 2024, PCA SKIN's distribution channels EXPANDED to include 'sales to skin health professionals in some geographies' - representing a refinement/evolution in positioning. The LLM answer claims the positioning 'remained essentially unchanged' between 2023 and 2024, which is factually incorrect. The LLM states 'The documents do not report any new distribution arrangement or a re‑allocation of PCA SKIN's channel mix between 2023 and 2024,' which directly contradicts the ground truth's finding of an expansion to include skin health professionals. (1) WHAT WAS CORRECT: The LLM correctly identifies PCA SKIN as a principal trademark in both years and correctly lists the distribution channels mentioned (retailers, wholesalers, distributors, dentists). The mention of 'in some geographies, skin‑health professionals' is accurate language. (2) QUANTITATIVE ACCURACY: No numeric data was required for this question, so this scores high (8/10) - the only minor issue is the LLM's characterization of the change as 'modest' when discussing direct-to-consumer, which isn't explicitly addressed in the ground truth. (3) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the key comparison between 2023 and 2024 filings. The ground truth clearly indicates an EVOLUTION/REFINEMENT in positioning (expansion of channels), while the LLM concluded NO CHANGE. This is a fundamental failure in the comparative analysis required by the question. (4) SEMANTIC EQUIVALENCE FAILURE: The LLM's conclusion that positioning 'remained essentially unchanged' is NOT semantically equivalent to the ground truth's finding of 'refinement in positioning' and 'expanded distribution channels.' These are contradictory interpretations of the same data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 508,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "\nBetween 2022 and 2023 the company broadened Opdivo’s commercial footprint – adding new tumor indications such as adjuvant melanoma (U.S. and EU), neoadjuvant NSCLC in combination with platinum‑based chemotherapy (EU and Japan), and expanded use in melanoma and other cancers – and pushed earlier‑line, combination‑therapy regimens (e.g., Opdivo + Yervoy, Opdivo + platinum chemo, and the upcoming subcutaneous formulation).  These moves reposition Opdivo from a mature immunotherapy to a growth‑driving “new‑product” pillar, allowing it to offset the decline of legacy agents like Revlimid and Eliquis and to deliver double‑digit revenue growth that underpins the company’s overall revenue trajectory despite modest total‑company sales pressure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the strategic evolution of Opdivo between 2022-2023 and correctly identifies key themes: expansion into new indications, emphasis on combination therapies, and the subcutaneous formulation. However, there are significant issues with factual accuracy and specificity:\n\nSTRENGTHS:\n1. Correctly identifies the strategic shift toward earlier-line therapies and combination regimens\n2. Accurately mentions Opdivo + Yervoy combinations\n3. Correctly references the subcutaneous formulation as a future growth driver\n4. Properly contextualizes Opdivo's role in offsetting legacy product declines\n5. Appropriately addresses the revenue growth trajectory implications\n6. Good semantic alignment with the core strategic narrative\n\nWEAKNESSES:\n1. SPECIFICITY ISSUES: The LLM adds specific indications (adjuvant melanoma, neoadjuvant NSCLC) that are not explicitly mentioned in the ground truth. While these may be accurate, they represent claims beyond what the knowledge graph confirms.\n2. MISSING INDICATIONS: The ground truth explicitly lists multiple 2022 approvals (bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach cancers) but the LLM answer does not comprehensively reference this baseline.\n3. INCOMPLETE BASELINE: The LLM doesn't establish the 2022 starting point as clearly as the ground truth does, making the \"evolution\" less concrete.\n4. UNSUPPORTED CLAIMS: References to \"double-digit revenue growth\" and specific offset of Revlimid/Eliquis decline are not substantiated in the ground truth provided.\n5. QUANTITATIVE VAGUENESS: No specific revenue figures, growth percentages, or market data provided, whereas the ground truth implies specific approval data.\n\nMULTI-HOP REASONING: The answer correctly synthesizes the strategic evolution across the two-year period and connects it to broader company revenue implications. However, it introduces information not confirmed by the knowledge graph, which weakens the multi-hop synthesis.\n\nFACTUAL ACCURACY: While the directional narrative is correct, the introduction of specific indications and claims not in the ground truth represents a factual accuracy concern. The answer appears to conflate or extrapolate beyond what was confirmed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 610,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "\nBetween 2023 and 2024 the fair‑value of American Express’s foreign‑government‑bond holdings grew from about **$549 million** to roughly **$765 million**.  The maturity structure remained overwhelmingly short‑term – approximately **$764 million (≈99.8 %)** were due within one year, with only **$1–2 million** maturing after 1–5 years and essentially none beyond five years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) 2023 fair value of $549 million - CORRECT; (2) 2024 fair value of $765 million - CORRECT; (3) 2024 maturity distribution showing $764 million within one year - CORRECT; (4) $1 million maturing after 1-5 years - CORRECT; (5) Percentage calculation of 99.8% ($764M/$765M) - CORRECT (764/765 = 0.9987 ≈ 99.8%). The LLM successfully synthesized the multi-hop information comparing 2023 and 2024 data across both fair value and maturity distribution dimensions. The answer correctly identifies the significant growth from $549M to $765M (a $216M or 39.3% increase) and accurately characterizes the shift in maturity structure. One minor observation: the ground truth mentions a 'gross unrealized loss of $1 million' in 2023, which the LLM did not include, though this detail was not explicitly asked for in the question. The LLM's characterization of the maturity structure as 'overwhelmingly short-term' is semantically equivalent to the ground truth's statement about 'primarily in short-term maturities.' The answer is complete, accurate, and directly addresses all aspects of the question regarding evolution between 2023 and 2024 in both fair value and maturity distribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 354,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the amount of cash that cannot be moved freely into the United States stayed sizeable but modestly declined—about $4.3 billion (of which roughly $2.2 billion could only be accessed through dividends or intercompany financing that required approval of Flipkart’s minority shareholders) in 2022, versus roughly $3.3–$3.5 billion in 2024 that remains subject to local‑law restrictions or the consent of non‑controlling‑interest holders. Walmart continues to use intercompany financing to make cash available in the countries where it is needed, but such transfers are only permitted when local regulations or shareholder approvals (e.g., Flipkart) are satisfied, and the company does not expect these constraints to materially affect its overall liquidity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of key financial figures and the evolution of Walmart's intercompany financing arrangements. STRENGTHS: (1) All primary numbers are accurate: $4.3 billion in 2022, $2.2 billion subject to Flipkart minority shareholder approval in 2022, and $3.3-$3.5 billion in 2024. (2) The quantitative comparison correctly shows a modest decline from 2022 to 2024. (3) The answer properly identifies the shift from Flipkart-specific restrictions to broader noncontrolling interest shareholder approval language. (4) Multi-hop synthesis is sound—the answer correctly connects the cash restriction amounts with the approval conditions across both years. (5) The contextual detail about intercompany financing mechanisms and liquidity impact adds appropriate depth. MINOR WEAKNESSES: (1) The 2024 figure is presented as a range ($3.3-$3.5 billion) rather than the single $3.3 billion stated in the ground truth, though this is a minor variation and the lower bound matches exactly. (2) The phrasing 'roughly $3.3–$3.5 billion' introduces slight ambiguity compared to the definitive $3.3 billion in the original answer, though this may reflect actual filing language variations. (3) The answer adds interpretive language about 'local-law restrictions' which, while reasonable, goes slightly beyond what the ground truth explicitly states. CALCULATION VERIFICATION: The decline from $4.3B to $3.3B represents approximately a 23% reduction, which is consistent with the ground truth's characterization of a 'slight reduction.' The answer correctly maintains the $2.2 billion Flipkart-specific figure for 2022. Overall, the answer successfully addresses all parts of the multi-part question regarding evolution, amounts, and conditions, with accurate synthesis across the 2022-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 499,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the U.S. Retiree Health‑Care plan’s asset base fell modestly (‑$16 million, from $264 million to $248 million).  Fixed‑income securities and cash equivalents dropped from $210 million to $198 million, while equity holdings slipped from $54 million to $50 million.  As a result, the plan remained roughly 80 % fixed‑income and 20 % equity, with the fixed‑income share edging up slightly (≈79.5 % → ≈80 %) and the equity share edging down (≈20.5 % → ≈20 %).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key factual claims. (1) CRITICAL ERRORS: The LLM states total plan assets fell from $264M to $248M, but ground truth shows they remained at $264M in both years. The LLM claims fixed income dropped from $210M to $198M, but ground truth shows it remained at $210M. The LLM claims equity fell from $54M to $50M, but ground truth shows it remained at $54M. (2) QUANTITATIVE ACCURACY FAILURES: Every single dollar amount in the LLM answer is incorrect. The differences cited ($16M total decline, $12M fixed income decline, $4M equity decline) are entirely fabricated. The percentage calculations are also wrong - ground truth shows fixed income at 79.5% and equity at 20.5% in BOTH years (not the evolution from 79.5% to 80% that the LLM claims). (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the data across the two filings. The ground truth explicitly states 'The composition...remained completely unchanged' and 'The identical figures across both filings indicate no evolution.' The LLM instead invented a narrative of decline and shifting allocations. (4) ENTITY AND CONTEXT: While the LLM correctly identified Texas Instruments and the U.S. Retiree Health Care Plan, it fundamentally misunderstood the core finding - that there was NO evolution in asset composition. The question asks how composition 'evolved,' and the correct answer is that it did not evolve at all. The LLM's answer is not merely incomplete but actively contradicts every material fact in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 433,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "\nBetween 2022 and 2024 Honeywell replaced the old stock‑option‑only grants under its 2006 Non‑Employee Director Plan with the revised equity forms in the 2016 plan—specifically the “Form of Stock Option Agreement” and a newly adopted “Form of Restricted‑Stock‑Unit Agreement” that include performance‑based vesting and longer holding requirements (as reflected in the 2023 amendment, Exhibit 10.54* to the 2023 Form 10‑K).  This shift indicates that the company is moving from a purely option‑based compensation model to a more balanced mix of equity awards that tie director pay to long‑term shareholder performance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that contradict the ground truth: (1) WRONG PLAN REFERENCE: The LLM claims Honeywell shifted from the 2006 Non-Employee Director Plan to a 2016 plan, but the ground truth explicitly states both 2022 and 2024 filings reference the 2006 Stock Plan for Non-Employee Directors. There is no mention of a 2016 plan in the ground truth. (2) WRONG EXHIBIT NUMBERS: The LLM cites 'Exhibit 10.54 to the 2023 Form 10-K' but the ground truth references Exhibit 10.30 (2022) and Exhibit 10.29 (2024) for the Option Agreement, and Exhibit 10.32 (2022) for the Restricted Unit Agreement. The exhibit number 10.54 does not appear in the ground truth. (3) INVERTED CONCLUSION: The LLM claims the company moved FROM option-based TO a balanced mix with restricted stock units. The ground truth shows the OPPOSITE: the Restricted Unit Agreement (Exhibit 10.32) was present in 2022 but NO LONGER explicitly mentioned in 2024, while the Option Agreement remained. This suggests a move AWAY from restricted units, not toward them. (4) UNSUPPORTED CLAIMS: The LLM adds details about 'performance-based vesting and longer holding requirements' and a '2023 amendment' that are not present in the ground truth and cannot be verified. (5) SEMANTIC CONTRADICTION: The ground truth suggests emphasis on stock options over restricted units; the LLM suggests the opposite. The multi-hop reasoning is fundamentally flawed, misidentifying which plan documents were referenced in which years and drawing conclusions opposite to what the evidence supports.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 433,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Walmart’s share of Flipkart dropped from roughly 83 % to about 75 % after the subsidiary raised a $3.2 billion equity round, which cut the portion of Flipkart’s earnings that Walmart consolidates and lessened its direct control.  At the same time, Flipkart is facing intensified Indian regulatory pressure—including a Competition Commission of India antitrust probe and a foreign‑direct‑investment show‑cause notice that could impose monetary penalties or ownership‑restriction remedies—creating additional financial and legal exposure for Walmart’s remaining stake.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key quantitative facts: Walmart's ownership stake dropped from 83% to 75% following a $3.2 billion equity funding round in 2022. The answer accurately captures the financial mechanism (equity dilution reducing consolidation percentage) and correctly references regulatory scrutiny including the FDI show-cause notice. The timeframe (2022-2024) is appropriately addressed.\n\nWEAKNESSES: (1) The LLM introduces a 'Competition Commission of India antitrust probe' that is NOT mentioned in the ground truth answer. While this may be factually accurate from filings, it represents information not in the original answer and could be considered an addition beyond what was verified. (2) The LLM fails to mention the specific timing of the show-cause notice (July 2021) and the period it covers (2009-2015 violations, pre-acquisition). (3) Critically missing: the ground truth emphasizes that these regulatory issues relate to Flipkart's PRE-ACQUISITION history (prior to 2018), which is important context for understanding why Walmart faces exposure for issues it didn't cause. (4) The LLM omits Walmart's stated inability to reasonably estimate potential losses or indemnification proceeds, which is a key financial implication. (5) The phrase 'lessened its direct control' is somewhat imprecise—the reduction from 83% to 75% still maintains majority control, so 'direct control' wasn't fundamentally lost, just diluted.\n\nMULTI-HOP REASONING: The answer demonstrates adequate synthesis of the ownership change and regulatory exposure as connected elements of Walmart's evolving position. However, it misses the critical insight that the regulatory risks are legacy issues from pre-acquisition operations, which is essential to understanding the strategic evolution.\n\nNUMERIC VERIFICATION: All numbers are correct ($3.2B, 83%, 75%). The timeframe is appropriate (2022-2024).\n\nOVERALL: The answer captures the main narrative but omits important contextual details about the pre-acquisition nature of regulatory issues and Walmart's inability to estimate losses. The introduction of the CCI antitrust probe, while potentially accurate, goes beyond the ground truth without clear verification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 597,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "\nBetween 2022 and the end of 2024 Honeywell’s consolidated cash and cash equivalents remained roughly steady at about $11 billion (down slightly from $11.5 billion at the end of 2021 to $11.0 billion in 2024).  The composition changed markedly: roughly $8 billion—about 73 % of the 2024 balance—was held in non‑U.S. subsidiaries, leaving only ~ $3 billion of cash that was effectively U.S.-based, a smaller share than in earlier years.  Consequently, the company’s strategic focus moved toward deploying the abundant offshore cash for acquisitions, share‑repurchase programs, capital expenditures and other investments, while U.S. cash was reserved for domestic liquidity needs and debt repayment, with the remainder of funding sourced from credit facilities and capital‑market issuances.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers and sound multi-hop reasoning. STRENGTHS: (1) All key financial figures are accurate: $11.5B (2021), $11.0B (2024), $8.0B non-U.S. holdings, and the calculated ~73% percentage (8.0/11.0 = 72.7%, reasonably rounded). (2) Correctly identifies the geographic distribution shift as the primary compositional change between 2022 and 2024. (3) Accurately synthesizes the strategic implications: offshore cash deployment for acquisitions/buybacks vs. U.S. cash for domestic needs. (4) Properly addresses both parts of the question (total holdings evolution and geographic distribution). (5) The reasoning about strategic emphasis evolution is sound and well-supported. MINOR WEAKNESSES: (1) The LLM adds contextual information about deployment strategies (acquisitions, share repurchases, capital expenditures, credit facilities, capital-market issuances) that, while logically sound and strategically relevant, goes slightly beyond what the ground truth explicitly states. The ground truth focuses on the factual shift in composition and the stated emphasis on 'safety and diversification,' while the LLM infers additional strategic deployment details. (2) The ground truth emphasizes the 'safety of principal and diversification among counterparties' as the strategic emphasis, which the LLM answer doesn't explicitly mention, though it doesn't contradict it either. The LLM's focus on deployment strategy is a reasonable inference but represents a slight shift in emphasis from the ground truth's focus on risk management principles. CALCULATION VERIFICATION: 8.0B / 11.0B = 72.7%, which the LLM rounds to ~73% - appropriate rounding. The comparison of $11.5B to $11.0B correctly identifies a slight decline. Overall, the answer is substantially correct with excellent quantitative accuracy and good qualitative reasoning, with only minor gaps in explicitly addressing the stated strategic emphasis on safety and diversification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 539,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "\nIn 2023 the Company recorded a $13.7 bn Membership Rewards liability and $3.44 bn of net deferred card‑and‑other fees, estimating the liability with a weighted‑average cost‑per‑point (WAC) and an ultimate redemption‑rate (URR) derived from 12‑month redemption trends and adjusted for cost changes; in 2024 the same estimation framework is retained but the disclosure adds explicit sensitivity metrics—showing that a 25‑basis‑point increase in URR would raise the liability (and corresponding expense) by roughly $197 m and a 1‑basis‑point increase in WAC would raise it by about $220 m—indicating a more quantified, transparent modeling approach while the deferred‑fee balance remains essentially unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the evolution from 2023 to 2024 and correctly identifies the key methodological components (URR, WAC, sensitivity metrics). However, there are significant quantitative accuracy issues: (1) The LLM introduces specific dollar amounts ($13.7 bn liability, $3.44 bn deferred fees) that are NOT present in the ground truth answer. The ground truth does not provide these absolute values—it only discusses the sensitivity metrics ($197M for URR, $220M for WAC). This is a critical error as these numbers cannot be verified against the original answer and may be fabricated. (2) The ground truth emphasizes a 'shift from simpler mention of deferred fees to comprehensive, model-driven approach,' whereas the LLM states 'the same estimation framework is retained'—this is a subtle but important distinction about whether the methodology changed or remained consistent. The ground truth suggests evolution/shift; the LLM suggests continuity. (3) The LLM correctly identifies the sensitivity metrics ($197M for 25bp URR increase, $220M for 1bp WAC increase) matching the ground truth exactly. (4) The qualitative reasoning about moving toward 'more quantified, transparent modeling approach' aligns well with the ground truth's characterization of the shift. The multi-hop synthesis is sound in structure but undermined by the introduction of unverified quantitative claims. The answer would score higher if it stuck to the verifiable information from the ground truth rather than adding specific liability and deferred fee amounts that cannot be confirmed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 438,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "\nSince Adobe acquired Frame.io in 2021, the platform has moved from a stand‑alone collaboration service to a core connective layer of the Creative Cloud and Digital Experience suites. By 2022‑2024 it is tightly embedded in the workflows of Premiere Pro, After Effects, Photoshop, Illustrator, Adobe Express and Firefly, feeding content‑creation and review cycles into Document Cloud and the broader Experience Cloud ecosystem, and is positioned as the collaboration engine for Adobe GenStudio to drive recurring ARR growth across Adobe’s creative‑media portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM states Adobe acquired Frame.io in 2021, but the ground truth clearly indicates the acquisition price was $1.18 billion with integration efforts beginning in 2022. The actual acquisition date appears to be 2021, but this is not explicitly contradicted by ground truth which focuses on 2022-2024 positioning. However, the LLM's statement about the acquisition year is not verified against ground truth and creates ambiguity. CORRECT ELEMENTS: (1) Frame.io's integration with Premiere Pro, After Effects, and Photoshop is accurate; (2) The positioning as a core component of Adobe's creative collaboration suite matches ground truth; (3) The mention of Adobe GenStudio integration is correct; (4) The evolution from standalone to ecosystem-integrated platform is accurately captured. MISSING/INCOMPLETE ELEMENTS: (1) The LLM does not mention the $1.18 billion acquisition price, which is a key quantitative fact in the ground truth; (2) The LLM mentions Illustrator, Adobe Express, and Firefly integration, which are NOT mentioned in the ground truth - these may be accurate but cannot be verified against the provided ground truth; (3) The LLM mentions Document Cloud and Experience Cloud ecosystem integration, which are not explicitly mentioned in ground truth; (4) The LLM references 'recurring ARR growth' which is a business metric not mentioned in ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution of Frame.io's positioning across the 2022-2024 period and connects it to broader Adobe ecosystem integration. However, the reasoning includes elements not verifiable from the ground truth. SEMANTIC EQUIVALENCE: The core narrative of evolution from standalone to integrated platform is semantically equivalent to ground truth, but the LLM adds significant details not in the source material. The quantitative accuracy is particularly weak due to the missing $1.18 billion figure and the unverified acquisition date statement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 536,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "\nBetween 2022 and 2023 the amount of private‑equity‑like funds that is classified as Level 3 (i.e., measured using significant unobservable inputs) fell only modestly—from **$25.4 million** in the 2022 fair‑value table to **$25.1 million** in the 2023 table.  While the overall equity‑like fund allocation stayed roughly stable (about $4.0 billion in 2022 versus $4.09 billion in 2023), the Level 3 component represents an even smaller share of that allocation, declining slightly in absolute terms.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual claims. (1) CRITICAL NUMBER ERRORS: The LLM states Level 3 equity-like funds were $25.4 million in 2022 and $25.1 million in 2023, but the ground truth shows the opposite - $5.5 million in 2022 and $25.4 million in 2023. The LLM has reversed the years and provided the wrong 2022 figure entirely. (2) DIRECTIONAL ERROR: The LLM claims a 'modest decline' from $25.4M to $25.1M, but the ground truth shows a significant INCREASE from $5.5M to $25.4M - a fivefold increase. This is a complete reversal of the actual trend. (3) CALCULATION ERROR: The LLM's characterization of a $0.3 million decline as 'modest' is based on wrong numbers. The actual change is a $19.9 million increase (from $5.5M to $25.4M), which is substantial and represents a 363% increase. (4) MISSING CONTEXT: The LLM fails to capture the significant shift in valuation methodology that the ground truth highlights - the fivefold increase suggests a meaningful change in how these investments are being valued. (5) MULTI-HOP SYNTHESIS: The LLM appears to have confused or transposed the 2022 and 2023 values, suggesting a failure in properly synthesizing the temporal comparison required by the question. The answer is internally inconsistent with the ground truth on every quantitative dimension.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 370,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe shifted Frame.io from a freshly‑acquired video‑review platform into a central pillar of its Digital Media suite.  The 2022 10‑K noted the acquisition and the start of integration with Premiere Pro, After Effects, Photoshop and Lightroom, while the 2024 10‑K shows Frame.io now embedded in the end‑to‑end workflow of Creative Cloud and Adobe Express, offered through Adobe GenStudio and powered by Firefly AI for large‑scale content creation and real‑time collaboration.  This evolution positions Frame.io not just as a collaboration add‑on but as a core, AI‑enhanced collaboration hub that ties together video, design and generative‑AI assets across Adobe’s Digital Media offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor issues. STRENGTHS: (1) Correctly identifies the October 2021 acquisition timing and 2022 starting point for integration; (2) Accurately lists the core integrated applications (Premiere Pro, After Effects, Photoshop, Lightroom); (3) Correctly identifies Adobe GenStudio as part of 2024 positioning; (4) Properly synthesizes the evolution narrative from 'freshly-acquired' to 'central pillar'; (5) Appropriately characterizes the strategic shift from add-on to core hub; (6) Mentions AI enhancement (Firefly) which aligns with 2024 positioning. MINOR ISSUES: (1) The LLM mentions 'Adobe Express' integration which is not explicitly mentioned in the ground truth answer - while this may be accurate from filings, it represents a slight expansion beyond the ground truth scope; (2) The emphasis on 'real-time collaboration' and 'Firefly AI for large-scale content creation' adds interpretive detail not explicitly in ground truth, though semantically consistent with Frame.io's positioning. QUANTITATIVE ACCURACY: All dates and entity names are correct (October 2021 acquisition, 2022-2024 timeframe, correct product names). No calculations required. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across 2022 and 2024 filings, properly identifying the progression and strategic positioning. The characterization of Frame.io's role evolution is sound and well-articulated. CONTEXTUAL RELEVANCE: The answer directly addresses the question about integration and positioning evolution between the specified years. The narrative structure effectively communicates the strategic shift. The only minor deduction is for the slight expansion beyond ground truth scope with Adobe Express and specific AI feature mentions, though these don't contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 502,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "\nBetween 2022 and 2024 CVS moved from a set of stand‑alone medication‑therapy and utilization‑management programs to a fully integrated, data‑driven medication‑management ecosystem.  The company added digital‑first tools such as the Health Engagement Engine/Canopy AI platform, real‑time formulary and cost‑saving analytics (Pharmacy Advisor, Drug Savings Review, NovoLogix pre‑authorization), and expanded in‑home health‑evaluation and virtual MinuteClinic services that deliver medication reviews and adherence outreach at scale.  These clinical‑digital extensions—bolstered by the Signify Health acquisition, Oak Street Health value‑based clinics, and the Cordavis biosimilar initiative—have broadened adherence support while driving greater cost efficiency across its PBM and health‑services operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer introduces several entities and programs that are NOT mentioned in the ground truth and cannot be verified: (1) 'Health Engagement Engine/Canopy AI platform' - not in original answer; (2) 'Pharmacy Advisor' and 'Drug Savings Review' - not mentioned in ground truth; (3) 'Signify Health acquisition' - not referenced in original answer; (4) 'Cordavis biosimilar initiative' - not in ground truth; (5) 'in-home health-evaluation and virtual MinuteClinic services' - not mentioned. CORRECT ELEMENTS: The LLM correctly identifies NovoLogix preauthorization platform, Oak Street Health with value-based clinics, and the general shift from cost-containment to integrated digital/clinical model. MISSING KEY INFORMATION: The LLM fails to mention several important 2022-2024 developments from the ground truth: (1) National Pharmacy and Therapeutics Committee and formulary management; (2) Seven-day opioid supply limits for acute cases; (3) CVS Weight Management program with GLP-1 medication optimization and lifestyle coaching; (4) The specific number of Oak Street Health centers (239 across 27 states); (5) Mail order and specialty pharmacy operations. QUANTITATIVE ACCURACY: The LLM provides no specific numbers, dates, or metrics, while the ground truth includes concrete data (239 primary care centers, 27 states, seven-day opioid limits). This is a significant omission for a question asking about evolution between specific years. REASONING QUALITY: While the LLM captures the general conceptual shift toward integrated, digitally-enabled medication management, it does so by introducing unverified claims rather than synthesizing the actual documented evolution. The multi-hop reasoning is compromised by factual inaccuracies. The answer reads plausibly but conflates CVS initiatives with programs that may not exist or are not documented in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 518,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe moved Frame.io from a stand‑alone review platform into the core of Creative Cloud, embedding its real‑time upload, frame‑accurate commenting and approval workflows directly inside Premiere Pro, After Effects, Photoshop and Lightroom and linking them to Creative Cloud Libraries and Adobe Express.  The 2024 enhancements added native Camera‑to‑Cloud ingestion, AI‑driven generative review tools via Firefly, tighter integration with Adobe GenStudio for enterprise‑scale content production, and made the service available across the entire Creative Cloud suite as a unified, AI‑augmented collaboration hub.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 2022-2024 timeframe and accurately captures several key enhancements: (1) integration into Premiere Pro, After Effects, Photoshop, and Lightroom - all confirmed in ground truth; (2) real-time upload and approval workflows - correct; (3) Camera to Cloud functionality - correctly mentioned; (4) the strategic shift from video-specific to broader creative asset platform - accurately conveyed. The mention of Creative Cloud Libraries and Adobe Express integration is contextually appropriate. WEAKNESSES: (1) The LLM introduces 'AI-driven generative review tools via Firefly' and 'Adobe GenStudio' which are NOT mentioned in the ground truth answer. While these may be real Adobe products, they cannot be verified against the provided ground truth and represent potential hallucination or unsupported claims. (2) The LLM omits specific mention of still images, design files, and PDFs as expanded file types supported by Frame.io by 2024 - the ground truth explicitly lists these. (3) The LLM mentions 'frame-accurate commenting' which is a specific feature detail not in the ground truth, though it's plausible for a video collaboration tool. (4) The characterization as 'AI-augmented collaboration hub' is not supported by the ground truth. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this scores well on what is provided. MULTI-HOP REASONING: The answer correctly synthesizes the evolution across multiple Adobe products and time periods, showing understanding of the integration progression. However, the introduction of unverified features (Firefly, GenStudio) suggests incomplete or inaccurate source synthesis. SEMANTIC EQUIVALENCE: The core narrative of evolution from standalone to integrated platform is preserved, but the addition of unsupported claims and omission of specific file type expansions creates factual gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 522,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "\nFrom 2023 to 2024 the Firm kept using recently‑executed transactions as a core input for fair‑value measurement of loans and other assets, but the 2024 disclosures show a more explicit linkage of those transaction prices to the final valuation – especially for corporate loans, mortgage‑ and asset‑backed securities and other debt – with clearer adjustments for funding spread, credit spread, loss‑given‑default and correlation.  In 2023 the reliance was mainly on observable market data (Level 2) and benchmarking to comparable trades; by 2024 the same transactions are treated as the primary reference point, moving them to Level 2 when market liquidity supports them and to Level 3 only when the inputs are unobservable, while the underlying methodology and hierarchy remain unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT SCOPE: The LLM introduces asset classes (mortgage-backed securities, asset-backed securities, other debt) that are NOT mentioned in the ground truth answer. The ground truth specifically identifies corporate loans, contingent lending commitments, and other investments as the relevant asset classes. (2) INCORRECT CATEGORIZATION CLAIMS: The LLM claims transactions moved from Level 2 to Level 3 based on market liquidity, but the ground truth makes no such claims about fair value hierarchy level changes. This is a fundamental mischaracterization. (3) MISSING KEY EVOLUTION: The ground truth explicitly states the evolution was toward 'more specifically tied to the held-for-sale category of loans and lending commitments' and 'extended to other investments' - the LLM completely misses the held-for-sale categorization detail and the extension to other investments. (4) INCORRECT METHODOLOGY DETAILS: The LLM introduces specific adjustments (funding spread, credit spread, loss-given-default, correlation) that are not mentioned in the ground truth. While these might be real valuation techniques, they are not supported by the source material. (5) MISREPRESENTED EVOLUTION: The LLM suggests a shift from 'observable market data (Level 2) and benchmarking' to 'primary reference point' with level changes, but the ground truth indicates the role remained significant with more targeted application - not a fundamental shift in fair value hierarchy treatment. (6) SEMANTIC DISTORTION: The phrase 'moving them to Level 2 when market liquidity supports them and to Level 3 only when inputs are unobservable' contradicts the ground truth's description of more targeted application without suggesting level reclassification. The answer demonstrates poor multi-hop synthesis and introduces unsupported details while omitting critical elements from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 536,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe moved Substance 3D Stager from being described simply as one of several desktop tools in the “Substance 3D Collection” toward a strategy that treats Stager as the central, cloud‑connected hub for building and publishing 3D scenes.  The 2022 filing (page 11) lists Stager alongside Painter, Sampler, Designer and Modeler as standalone desktop apps, while the 2024 filing (page 12) emphasizes that Stager is now tightly integrated with Adobe’s generative‑AI (Firefly) services, offered within Creative Cloud subscriptions, and positioned to feed 3D assets into the broader Substance 3D ecosystem and Adobe’s Experience Cloud.  This evolution reflects a shift from a fragmented desktop suite to a unified, cloud‑enabled platform that sits at the heart of Adobe’s end‑to‑end 3D content workflow.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific claims not supported by the ground truth and appears to fabricate details. (1) UNSUPPORTED CLAIMS: The LLM states Stager became a 'central, cloud-connected hub' and was 'tightly integrated with Adobe's generative-AI (Firefly) services' - these specific claims are NOT in the ground truth. The ground truth makes no mention of Firefly integration, cloud-connectivity emphasis, or Stager being positioned as a 'central hub.' (2) PAGE REFERENCES: The LLM cites 'page 11' and 'page 12' of specific filings - these page numbers cannot be verified against the ground truth and appear to be fabricated details. (3) CORRECT ELEMENTS: The LLM does correctly identify the core evolution (2022 as established product → 2024 as integrated ecosystem component) and correctly names the companion products (Painter, Sampler, Designer, Modeler). It also correctly identifies the shift toward integration and end-to-end workflows. (4) OVERREACH: The LLM significantly overextends the ground truth by adding claims about cloud-enablement, Firefly integration, Creative Cloud positioning, and Experience Cloud connections that are not present in the original answer. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so by introducing unsupported details rather than sticking to verifiable facts from the filings. The ground truth is more conservative and accurate - it simply notes the shift from listing as a trademark to describing it as part of a broader ecosystem. The LLM's answer reads more like speculation or inference beyond what the documents actually state.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 451,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "\nFrom 2022 to 2023 GE shifted its view of grid‑scale batteries from a peripheral, “emerging‑technology” footnote in its energy‑transition narrative to a core strategic pillar. In the 2022 filing the company merely noted that grid‑scale batteries (and other storage) might become important for deep decarbonization, but in the 2023 filing it explicitly states that achieving deep‑decarbonization goals for power will depend on grid‑scale storage, signals continued investment and resource allocation to develop and commercialize these solutions, and integrates them into its Power and Renewable‑Energy growth strategy. This evolution reflects a higher level of strategic reliance on grid‑scale batteries as a key enabler of GE’s energy‑transition objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively captures the evolution of GE's strategic positioning on grid-scale batteries from 2022 to 2023. STRENGTHS: (1) Correctly identifies the core shift from 'emerging technology' consideration to more central strategic importance; (2) Accurately reflects the language evolution from 'may become more important' to 'depend in part on' these technologies; (3) Properly synthesizes the multi-hop information showing progression across two years; (4) No quantitative errors - dates (2022, 2023) are correct, and no calculations are required; (5) Correctly identifies GE as the company and the relevant business segments (Power, Renewable Energy); (6) Semantic equivalence is strong - 'peripheral footnote' vs. 'core strategic pillar' effectively conveys the shift from speculative to more central positioning. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive language like 'signals continued investment and resource allocation' which goes slightly beyond what the ground truth explicitly states - the ground truth focuses on the strategic narrative shift rather than specific investment signals; (2) The phrase 'core strategic pillar' is somewhat stronger characterization than the ground truth's 'more central component,' though the directional shift is accurate; (3) The ground truth emphasizes 'dependency' language more explicitly, while the LLM uses 'key enabler' which is semantically similar but slightly different framing. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and identifies the progression in GE's strategic narrative. The reasoning is sound and logically structured. OVERALL: The answer is substantially correct with only minor interpretive elaborations that don't contradict the ground truth but add modest inference beyond what was explicitly stated in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 512,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "\nBetween the 2022 and 2024 filings CVS consistently reports that it holds **no broker‑quoted debt securities** in its fair‑value hierarchy—​the 2022 Form 10‑K (page 146) notes “the Company did not have any broker‑quoted debt securities for the years ended December 31, 2021 and 2020,” and the 2024 Form 10‑K (page 146) repeats the same statement for 2024 and 2023. Because such securities are absent, they do not enter the Level 3 valuation inputs and therefore have **no material impact on CVS’s financial‑statement fair‑value measurements or related disclosures** over this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that CVS had no broker-quoted debt securities in both 2022 and 2024 filings, accurately cites the same page number (146) for both years, and correctly notes the years covered (2021-2020 in 2022 filing; 2024-2023 in 2024 filing). The numeric facts are accurate. WEAKNESSES: The LLM answer significantly diverges from the ground truth in its characterization of the evolution. The ground truth explicitly states that 'the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic.' This is a key finding about how the disclosure evolved—the 2024 filing reduced emphasis on this topic compared to 2022. The LLM answer instead concludes that the absence of such securities means they 'have no material impact' and 'therefore have no material impact on CVS's financial-statement fair-value measurements,' which is a logical inference but misses the actual evolution described in the ground truth. The ground truth is about DISCLOSURE EVOLUTION (reduced emphasis/relevance over time), while the LLM answer focuses on the ABSENCE OF IMPACT (which is a different analytical angle). The LLM also fails to capture the nuance that the 2022 filing mentioned 'internal pricing for certain private placements' and that this specific detail is absent from the 2024 disclosure. The answer is partially correct on facts but incomplete in addressing the actual evolution of disclosure emphasis that the question asks about. The multi-hop reasoning is sound but applied to the wrong analytical framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 451,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "\nBetween 2023 and 2024 the Equity Securities at FVTNI that are classified as mutual‑fund/equity securities rose in fair‑value from **$1.585 bn to $1.950 bn** (an increase of roughly **$0.365 bn**, or about **23 %**).  At the same time the equity‑method investment portfolio measured using NAV grew from **$2.51 bn (2023) to $2.58 bn (2024)**, a modest rise of **≈$0.07 bn (≈2.8 %)**.  Thus the composition shifted toward a larger share of liquid mutual‑fund exposure, while the private‑equity/real‑asset exposure captured through equity‑method investments expanded only slightly.  (See BLK_10k_2023.pdf pp. 90, 92; BLK_10k_2024.pdf pp. 96, 92.)",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) EQUITY SECURITIES/MUTUAL FUNDS: Ground truth shows $1,211M (2023) → $1,950M (2024). LLM reports $1,585B (2023) → $1,950B (2024). The 2023 figure is completely wrong ($1,585M vs $1,211M = 31% overstatement). The 2024 figure matches ground truth ($1,950M), but the 2023 baseline error invalidates the calculated change ($365M vs $739M actual). (2) EQUITY METHOD INVESTMENTS: Ground truth shows $1,895M (2023) → $2,783M (2024). LLM reports $2,510M (2023) → $2,580M (2024). Both figures are significantly incorrect - the 2023 value is overstated by $615M (33% error) and the 2024 value is understated by $203M (7% error). The calculated change is wrong ($70M vs $888M actual). (3) CALCULATION ERRORS: The LLM's percentage calculations are based on incorrect baseline numbers, making them mathematically invalid even if computed correctly from the wrong inputs. (4) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the two categories and attempts year-over-year comparison, the fundamental data retrieval failures prevent proper synthesis. The interpretation about 'composition shift' is speculative and not supported by accurate numbers. (5) CONTEXTUAL ISSUES: The answer references specific PDF pages, suggesting confidence in source material, but the numbers don't match ground truth data. The semantic framing about 'liquid mutual-fund exposure' vs 'private-equity/real-asset exposure' is reasonable interpretation but is built on false numerical foundations. The ground truth shows much larger increases in both categories than the LLM reports, indicating a more substantial strategic expansion than the LLM's 'modest rise' characterization suggests.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 489,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "\nUnitedHealth Group’s assessment of credit‑related impairment for available‑for‑sale debt securities—comparing the present value of expected cash flows to amortized cost and examining issuer credit quality—has remained essentially the same from 2022 through 2024.  It records any credit‑related shortfall as an allowance against the security (charged to investment and other income) while non‑credit impairments are routed through other comprehensive income, and the company has continued to view the majority of unrealized losses as interest‑rate‑driven rather than credit‑driven, keeping the allowance for credit losses immaterial.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of UnitedHealth Group's credit impairment assessment methodology from 2022 to 2024, correctly identifying that: (1) the assessment methodology remained consistent (comparing present value of expected cash flows to amortized cost, examining issuer credit quality), (2) credit-related impairments are recorded through an allowance account and charged to investment and other income, (3) non-credit impairments flow through other comprehensive income, and (4) unrealized losses have been primarily interest-rate driven rather than credit-driven with the allowance for credit losses remaining immaterial. The answer demonstrates sound multi-hop reasoning by synthesizing information across the 2022-2024 period and correctly identifying the key distinction between credit and non-credit impairment treatment. However, the LLM answer misses a nuanced but important element from the ground truth: the shift from a 'qualitative, low-risk assessment to a more formalized impairment accounting framework.' The ground truth emphasizes that by 2024, the allowance is 'explicitly described as being recorded as a separate component through an allowance account,' suggesting an evolution toward more structured recognition. The LLM states the methodology 'remained essentially the same,' which is technically accurate but downplays the formalization aspect. The answer correctly avoids citing specific dollar amounts (appropriately, as none are provided in the ground truth), and the characterization of the allowance as 'immaterial' aligns with the ground truth. The semantic equivalence is strong overall, with the LLM capturing the essential facts and relationships, though it could have better articulated the evolution toward more formalized accounting rather than emphasizing consistency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 495,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2023 AMD’s stake in the ATMP joint venture grew markedly – the carrying value of its equity investment rose from roughly **$63‑69 million** (as of the end of 2020‑21) to **about $99 million** by the end of 2023, and the equity‑method income it records jumped from **$5‑6 million** per year to **$14‑16 million** in 2022‑23.  This expansion reflects a sharp increase in the volume of business with the JV (purchases of **$1.7 billion** in 2023 versus **$831 million** in 2020) and larger receivable/payable balances, underscoring a deepening financial relationship that now generates substantially more earnings for AMD.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that directly contradict the ground truth. (1) CARRYING VALUE ERRORS: Ground truth states 2022 carrying value was $83 million and 2023 was $99 million. The LLM incorrectly references '$63-69 million (as of end of 2020-21)' which is not part of the question scope and appears to be fabricated data. The LLM does correctly state $99 million for 2023 but fails to accurately report the 2022 figure of $83 million. (2) EQUITY INCOME ERRORS: Ground truth clearly states 2022 equity income was $14 million and 2023 was $16 million. The LLM incorrectly claims '$5-6 million per year' for earlier periods and '$14-16 million in 2022-23,' which conflates the data. The range notation obscures the specific correct values and suggests uncertainty where the ground truth is precise. (3) SCOPE CREEP: The LLM introduces information about 2020-21 carrying values and business volumes ($1.7 billion in 2023, $831 million in 2020) that, while potentially accurate, are not directly responsive to the specific 2022-2023 comparison requested. This dilutes focus from the core question. (4) MULTI-HOP REASONING: The LLM does attempt to synthesize the relationship between investment value, equity income, and business volume, which shows some understanding of multi-hop reasoning. However, the foundational numbers are wrong, undermining the entire analysis. (5) SEMANTIC ISSUES: The use of ranges ('$63-69 million,' '$5-6 million,' '$14-16 million') instead of precise figures from the ground truth is problematic for financial data where exactness is critical. The ground truth provides specific numbers that should be reported as such. The conclusion about 'deepening financial relationship' is reasonable but built on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 490,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth’s tort exposure remained focused on medical‑malpractice and other provider‑related liability claims (e.g., lawsuits against affiliated physicians, hospitals and health‑care professionals that fail to meet clinical or safety standards).  The 2024 filing notes that the volume of such claims has risen and that, because the company is largely self‑insured, actual losses can exceed the amounts it has reserved—meaning the potential financial impact is now characterized as “significantly greater” and could produce material monetary damages, higher defense costs and reputational harm.  Thus, while the nature of the claims (medical‑malpractice and provider liability) has not changed, the 2024 disclosures signal an increased likelihood of larger financial exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements but has significant gaps in completeness and nuance compared to the ground truth. STRENGTHS: (1) Correctly identifies the core nature of claims (medical malpractice, provider liability) in both years; (2) Accurately notes the self-insured status and that actual losses can exceed reserves; (3) Correctly identifies increased financial exposure and reputational harm as concerns in 2024; (4) Properly synthesizes the multi-hop information about evolution of exposure. WEAKNESSES: (1) CRITICAL OMISSION: The ground truth emphasizes a significant shift in 2024 toward 'broader legal risks tied to delivery of health care services' and 'clinical quality and patient safety standards' as a systemic risk profile—the LLM answer dismisses this by stating 'the nature of the claims (medical-malpractice and provider liability) has not changed,' which contradicts the ground truth's emphasis on this evolution; (2) The LLM answer characterizes the shift as merely quantitative ('volume has risen,' 'significantly greater') rather than qualitative (shift from narrowly-defined to broader/more systemic risks); (3) Missing the important detail about 'new theories of liability that might not be subject to damage caps' mentioned in 2022; (4) The phrase 'characterized as significantly greater' is somewhat vague—the ground truth more clearly articulates the shift from specific self-insured liabilities to broader systemic risks. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not a differentiator. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2022 and 2024 filings but fails to fully capture the nature of the evolution. The reasoning is sound but incomplete. SEMANTIC EQUIVALENCE: While the wording differs, the LLM answer's core claim that 'nature of claims has not changed' is factually at odds with the ground truth's assertion of a shift toward broader legal risks and systemic risk profiles.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 537,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "\nBetween 2023 and 2024 Boeing kept its **$3.0 bn three‑year revolving credit facility (maturing August 2025)** unchanged in size and maturity, but it bolstered the overall credit package by **adding a new $4.0 bn five‑year revolving line (maturing May 2029)** and retiring the older **$0.8 bn 364‑day facility and the $3.2 bn five‑year facility** that had been in place.  This extension of maturities and increase in total available credit shows that Boeing is **maintaining a strong, flexible liquidity buffer and extending its debt‑maturity profile** to support cash‑flow needs while keeping borrowing costs under control.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of Boeing's credit facility evolution. QUANTITATIVE VERIFICATION: All numbers are correct - the $3.0 billion three-year facility (August 2025), the new $4.0 billion five-year facility (May 2029), the retired $0.8 billion 364-day facility, and the retired $3.2 billion five-year facility all match the ground truth. The dates are accurate. COMPLETENESS: The answer addresses both the structural changes (new facility added, old facilities terminated) and the capacity evolution (total credit increased), directly answering the multi-part question about how the structure and capacity evolved. MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across 2023 and 2024, identifying what remained unchanged ($3.0 billion facility) versus what changed (new additions and retirements), demonstrating proper temporal comparison. ENTITY ACCURACY: Boeing is correctly identified, all credit facilities are properly characterized with correct amounts and maturity dates. REASONING QUALITY: The interpretation of what this indicates about liquidity strategy is sound - the answer correctly identifies the strategic shift toward enhanced liquidity capacity, extended maturity timelines, and financial flexibility. The explanation about maintaining a strong liquidity buffer and extending the debt-maturity profile is logically sound and semantically equivalent to the ground truth's characterization of 'strategic shift to enhance liquidity capacity and extend maturity timelines.' MINOR OBSERVATION: The LLM provides slightly more granular detail about the specific facilities being retired ($0.8 billion and $3.2 billion) compared to the ground truth's reference to 'two other credit facilities,' but this additional specificity is accurate and enhances rather than detracts from the answer. The wording differs from ground truth but conveys the same essential information with appropriate financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 537,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "\nIn 2023 the 2017 performance‑based options generated $56 million of stock‑based compensation expense from vested portions, whereas in 2024 that expense fell to $52 million.  By contrast, the cash intrinsic value realized from exercising those options jumped from $44 million in 2023 to $373 million in 2024.  (Pages 100 & 107)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All four key financial figures are correct: 2023 fair value of vested options ($56M), 2024 fair value of vested options ($52M), 2023 intrinsic value of exercised options ($44M), and 2024 intrinsic value of exercised options ($373M). The multi-hop synthesis is sound, correctly comparing the evolution of both metrics across the two-year period. The answer properly identifies the slight decline in vesting value ($56M to $52M) and the substantial increase in realized intrinsic value ($44M to $373M). The terminology used ('stock-based compensation expense from vested portions' and 'cash intrinsic value realized from exercising') is semantically equivalent to the ground truth's 'fair value of options vested' and 'intrinsic value of options exercised,' demonstrating accurate understanding of the financial concepts. The answer includes page references (Pages 100 & 107), adding credibility. The only minor consideration is that the LLM uses slightly different terminology than the ground truth ('stock-based compensation expense' vs. 'fair value'), but this is semantically equivalent and reflects accurate financial reporting terminology. The reasoning correctly captures the key insight that while vesting value declined modestly, the actual financial benefit from exercises increased dramatically.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 381,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "\nBetween 2022 and 2023 AMD moved from a broad, historical‑experience‑based estimate of return‑related adjustments to a more granular, data‑driven approach.  In the 2023 filing the company explicitly cites “trended actual historical product‑return rate information” that is “adjusted for actual known information or events” and ties those adjustments to internal and external market data, whereas the 2022 discussion only referenced “actual historical activity and experience” and generic “known events or current economic conditions.”  This refinement adds a clearer, trend‑based methodology for quantifying the variable consideration tied to product‑return rights, distributor price‑incentives and OEM rebates.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) REVERSED METHODOLOGY: The LLM claims 2023 explicitly cites 'trended actual historical product-return rate information' adjusted for 'actual known information or events,' but the ground truth states this was the 2022 approach. The LLM has inverted the timeline. (2) MISSING KEY DETAIL: The ground truth emphasizes that 2023 introduced explicit reference to ASC 606-10-32-8 through 14 and 'most likely amount' methodology - a critical structural change the LLM completely omits. (3) INACCURATE CHARACTERIZATION: The LLM describes 2022 as using only 'actual historical activity and experience' and 'generic known events,' but the ground truth indicates 2022 already used 'trended actual historical product return rate information, adjusted for known information or events.' (4) INCOMPLETE SYNTHESIS: The LLM fails to capture the core evolution: from general historical adjustment approach to a more formally codified ASC 606 framework with explicit 'most likely amount' consideration. (5) DIRECTIONAL ERROR: The LLM suggests 2023 added 'trend-based methodology,' but the ground truth shows trend-based analysis was already present in 2022; the 2023 change was about formal accounting standard alignment and explicit variable consideration framework. The answer demonstrates partial understanding of return methodology but fundamentally misrepresents the direction and nature of the evolution between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 417,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "\nFrom 2023 to 2024 the outstanding shares underlying the 2017 performance‑based options fell sharply, from **1,549,080** at Dec 31 2023 to **625,825** at Dec 31 2024.  The reduction of roughly **923,000 shares** is almost entirely attributable to the **exercise of about 905,000 options** (with only ~18,000 shares forfeited), indicating that the majority of the vested 2017 options were converted into common stock rather than being left to expire or cancelled.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. Quantitative verification: (1) Starting shares (1,549,080 at Dec 31, 2023) - CORRECT; (2) Ending shares (625,825 at Dec 31, 2024) - CORRECT; (3) Reduction calculation: 1,549,080 - 625,825 = 923,255 shares, LLM states 'roughly 923,000 shares' - CORRECT (appropriate rounding); (4) Exercises: 905,219 shares per ground truth, LLM states 'about 905,000 options' - CORRECT (appropriate rounding); (5) Forfeitures: 18,036 shares per ground truth, LLM states '~18,000 shares forfeited' - CORRECT. The LLM correctly synthesizes the multi-hop information by: (a) identifying the starting and ending values, (b) calculating the net change, (c) attributing the change to specific components (exercises and forfeitures), and (d) interpreting what this indicates about option lifecycle trends. The reasoning is sound - the LLM correctly identifies that exercises account for the vast majority of the reduction, with forfeitures being minimal. The interpretation that 'the majority of the vested 2017 options were converted into common stock' aligns with the ground truth's observation about 'completion in the lifecycle of these options.' Minor note: The LLM uses 'roughly' and 'about' appropriately for rounded figures, which is good practice. The answer fully addresses both parts of the question: (1) how the number evolved (with specific numbers), and (2) what it indicates about exercise and forfeiture trends. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 410,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "\nBetween 2022 and 2024 Optum Rx grew from a pharmacy‑care business that managed roughly **$112 billion** of drug spend (including **$45 billion** in specialty medications) and operated mainly through a network of >67,000 retail pharmacies, home‑delivery and specialty sites, to a far broader, integrated platform that now oversees **$178 billion** of pharmaceutical spending (including **$74 billion** in specialty) and adds services such as infusion therapy, rare‑disease/gene‑therapy support, direct‑to‑consumer channels, and pharmacist‑led multidisciplinary care teams.  This expansion reflects a strategic repositioning of Optum Rx as a data‑driven, end‑to‑end pharmacy hub that links medical, behavioral and financial outcomes across UnitedHealth Group’s Optum and UnitedHealthcare ecosystems, reinforcing the company’s push toward value‑based, whole‑person care and cost containment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims Optum Rx managed $178 billion in pharmaceutical spending by 2024 and $74 billion in specialty spending. However, the ground truth explicitly states 'While specific spending figures were not provided in 2024,' meaning these 2024 numbers are fabricated and not supported by the source documents. The 2022 figures ($112 billion total, $45 billion specialty) are correctly cited from the ground truth. (2) SERVICE OFFERINGS: The LLM introduces services not mentioned in the ground truth for 2024, including 'rare-disease/gene-therapy support' and 'direct-to-consumer channels.' While the ground truth mentions infusion services were present in 2022, the LLM's expansion of service descriptions for 2024 appears to be extrapolation beyond what the source documents support. (3) MULTI-HOP REASONING: The LLM failed to properly synthesize the available information. The ground truth clearly indicates that 2024 data focused on strategic positioning and integration rather than updated spending metrics. The LLM invented specific 2024 spending figures that directly contradict the ground truth's statement that such figures were not provided. (4) SEMANTIC ISSUES: While the LLM correctly identifies the strategic shift toward value-based care and integration within UnitedHealth Group's ecosystem (which aligns with ground truth), this correct qualitative assessment is undermined by the fabricated quantitative claims. The answer demonstrates a fundamental failure to distinguish between what was actually reported versus what was inferred or invented. This is a severe accuracy problem for financial data evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 484,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "\nBetween 2023 and 2024 the fair‑value of BlackRock’s Equity Securities at FVTNI climbed from **$1.585 bn to $1.950 bn**, an increase of roughly **$365 m**, largely reflecting higher market values of its mutual‑fund holdings.  At the same time, the portion of the portfolio used to economically hedge deferred‑cash‑compensation liabilities shrank from **$241 m (2023) to $173 m (2024)**, indicating a reduced exposure to those compensation‑related investments while the overall equity‑security portfolio expanded.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core point of the question. Key issues: (1) QUANTITATIVE ERRORS: The LLM states deferred compensation investments were $241M in 2023 and $173M in 2024. However, the ground truth clearly states the 2023 value was $9 million (not $241M) in Equity Securities at FVTNI. The $173M figure for 2024 is correct but represents a different categorization (Equity Method section, not FVTNI). The LLM's claim of a decline from $241M to $173M is factually incorrect. (2) MISALIGNMENT WITH QUESTION: The question specifically asks about 'investments held for deferred cash compensation plans' within Equity Securities at FVTNI. The ground truth identifies a reclassification: $9M in 2023 under FVTNI became $173M in 2024 under Equity Method. The LLM completely misses this reclassification narrative. (3) IRRELEVANT INFORMATION: The LLM discusses overall Equity Securities FVTNI growth ($1.585B to $1.950B) and mutual fund holdings, which are not part of the ground truth answer and don't address the specific deferred compensation plan investments question. (4) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the key insight that these investments were reclassified from one category to another, not simply reduced in value. The ground truth emphasizes 'reclassification or realignment' as the critical change, which the LLM completely overlooks. (5) SEMANTIC MISMATCH: The LLM's narrative of 'reduced exposure' contradicts the actual data showing a move from $9M to $173M (a massive increase), though in a different reporting category.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 439,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "\nThe open‑market share‑purchase authorization fell from **$3.13 billion as of August 31 2022** to **$2.69 billion as of August 31 2024**, a reduction of roughly **$0.44 billion (≈14 %)**.  This pull‑back in the authorized repurchase amount indicates that Accenture is scaling back its discretionary share‑buying program and is likely reallocating cash toward other priorities—such as dividend increases, strategic investments, or maintaining greater liquidity—reflecting a more conservative capital‑allocation stance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: The ground truth provides values in thousands ($3,129,296 and $2,694,281), while the LLM converted these to billions ($3.13B and $2.69B) - this is a valid format conversion and semantically equivalent. The calculated reduction of $0.44 billion is accurate ($3.13B - $2.69B = $0.44B). The percentage calculation of approximately 14% is correct ($435,015 / $3,129,296 ≈ 13.9%, rounds to 14%). The dates (August 31, 2022 and August 31, 2024) are correctly identified as fiscal year-end dates for Accenture. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the quantitative change in authorization, and (2) the strategic implications for capital allocation. ENTITY ACCURACY: Accenture is correctly identified, the metric (open-market share purchase program authorization) is correctly specified, and the fiscal years are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identified the trend (decrease), calculated the magnitude, and drew logical conclusions about capital allocation strategy (more conservative approach, potential reallocation to dividends, investments, or liquidity). The reasoning aligns with the ground truth's assessment of a 'more conservative approach to capital deployment.' MINOR CONSIDERATIONS: The LLM provides slightly more detailed strategic context (mentioning dividend increases, strategic investments, liquidity maintenance) compared to the ground truth, but this represents reasonable inference rather than factual error. The format conversion from thousands to billions is appropriate for readability and is standard financial reporting practice.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 472,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "\nThe 2022 filing only disclosed that Accenture Canada Holdings Inc. exchangeable shares were redeemable at par, carried no dividend rights, and could be exchanged one‑for‑one for Class A ordinary shares, with a redemption restriction that would not reduce a holder’s exchangeable‑share balance. In the 2024 filing the company quantifies this activity—47,752 exchangeable shares were repurchased for $15,254 in fiscal 2024—and adds a $4 billion increase to its share‑repurchase authority (raising total authority to $6.694 billion), explicitly stating that exchangeable shares are eligible for the open‑market purchase program and may be exchanged at market price, thereby clarifying that holders receive the same distribution and redemption rights as Class A shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that substantially diverge from the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - The LLM cites a remaining authorization of $2,694,281 in the original answer but then claims a $4 billion increase raising total authority to $6.694 billion in the LLM answer. This is internally inconsistent and mathematically incorrect ($2.694M + $4B ≠ $6.694B; the math only works if the base was $2.694B, not $2.694M).\n   - The LLM provides specific repurchase numbers (47,752 exchangeable shares for $15,254) that are not mentioned in the ground truth and cannot be verified against it.\n   - The ground truth mentions a specific remaining authorization of $2,694,281 as of August 31, 2024, but the LLM's claim about a $4 billion increase and $6.694 billion total authority contradicts this.\n\n2. FACTUAL ACCURACY ISSUES:\n   - The LLM's characterization of 2022 disclosures (redeemable at par, no dividend rights, one-for-one exchange) differs from the ground truth's focus on share repurchase intentions and market condition dependencies.\n   - The LLM introduces claims about \"open-market purchase program\" eligibility and \"market price\" exchange that are not substantiated in the ground truth.\n   - The statement about holders receiving \"same distribution and redemption rights as Class A shareholders\" is presented as a 2024 clarification but lacks grounding in the provided ground truth.\n\n3. MULTI-HOP REASONING:\n   - The LLM fails to properly synthesize the evolution narrative. The ground truth emphasizes a shift from general intentions (2022) to specific quantified authorizations (2024), but the LLM's numbers don't align with this narrative.\n   - The LLM does not adequately address the evolution in disclosure detail regarding exchangeability mechanics and Class X ordinary share alignment mentioned in the ground truth.\n\n4. MISSING ELEMENTS:\n   - The LLM omits the ground truth's emphasis on the company's commitment to align Class X ordinary shares with outstanding exchangeable shares.\n   - The LLM doesn't capture the shift from general market condition dependencies to more structured authorization amounts.\n\n5. CONTEXTUAL RELEVANCE:\n   - While the LLM attempts to address both 2022 and 2024 periods, the specific numbers provided appear fabricated or misattributed, reducing relevance and reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 642,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "\nThe Electrophysiology segment’s sales rose from **$2,195 million in 2023 to $2,467 million in 2024**.  This corresponds to a **12.3 % increase** in total change, and a **14.4 % increase** when the effect of foreign‑exchange fluctuations is excluded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. (1) CORRECTNESS: All factual information is correct - the 2023 revenue of $2,195 million and 2024 revenue of $2,467 million match the ground truth exactly. The percentage changes are also accurate: 12.3% for total change and 14.4% excluding FX impact. (2) QUANTITATIVE ACCURACY: All numbers are precise and correct. The dollar amounts are presented in the same format as the ground truth ($2,195 million and $2,467 million). The percentages (12.3% and 14.4%) are exact matches. (3) QUALITATIVE ACCURACY: The LLM correctly synthesized the multi-hop information by: identifying the correct segment (Electrophysiology Devices), comparing the two fiscal years (2023 vs 2024), and distinguishing between the two different percentage metrics (total change vs. FX-adjusted change). The reasoning is sound and logically presented. (4) SEMANTIC EQUIVALENCE: The LLM uses slightly different wording ('Electrophysiology segment's sales' vs 'global revenue from Electrophysiology Devices') but the meaning is semantically equivalent and refers to the same metric. The phrase 'when the effect of foreign-exchange fluctuations is excluded' clearly conveys the same concept as 'excluding the impact of foreign exchange fluctuations.' (5) COMPLETENESS: The answer fully addresses all parts of the question - it shows the evolution (2023 to 2024 values), provides the percentage change (12.3%), and includes the FX-adjusted percentage (14.4%). Minor note: The LLM uses 'segment' terminology which is standard SEC filing language, making it slightly more precise than the question's phrasing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 455,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Accenture’s stake in Duck Creek Technologies remained an equity‑method investment, but its valuation rose sharply.  In the 2022 10‑K the investment was carried at **$138.9 million** with an estimated fair value of **$223.2 million**; by fiscal 2023 the company recorded a **$253 million gain** from that investment, reflecting a substantial increase in fair value that was included in adjusted earnings per share and lifted reported earnings, though it did not affect operating margin or core consulting performance.  Thus, the investment’s appreciation provided a one‑time boost to reported earnings and EPS in fiscal 2023, but its impact on Accenture’s ongoing financial results was limited to that non‑operating gain.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its accuracy. CRITICAL ISSUES: (1) The LLM states the investment was carried at $138.9 million in 2022, but the ground truth indicates the investment was valued at $223,166 (thousands, meaning $223.166 million) in fiscal 2022. This is a major discrepancy. (2) The LLM correctly identifies the $253 million gain but incorrectly attributes it to fiscal 2023, when the ground truth indicates this gain occurred in fiscal 2024. This is a significant temporal error in a multi-hop question about evolution between fiscal 2022 and 2024. (3) The LLM provides the fair value as $223.2 million, which aligns with the ground truth's $223,166 (in thousands), so this number is correct. CORRECT ELEMENTS: (1) The equity-method accounting treatment is correctly identified. (2) The characterization of the investment as appreciating significantly is accurate. (3) The description of the gain as a non-operating item affecting earnings is reasonable. REASONING ISSUES: The LLM's multi-hop synthesis is partially flawed because it misplaces the $253 million gain in fiscal 2023 rather than fiscal 2024, which is critical for answering a question specifically about the evolution between fiscal 2022 and 2024. The answer also introduces the $138.9 million carrying value figure without clear grounding in the source material, creating confusion about the investment's book value versus fair value. The qualitative reasoning about the impact on earnings is sound, but the temporal placement of key events undermines the overall accuracy of the multi-hop analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 443,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "\nBetween 2022 and 2023 the composition of Union Pacific’s executive equity awards moved away from a large pool of traditional, time‑vesting retention shares toward a smaller, performance‑focused set of retention units and already‑issued shares.  The 2022 filing showed roughly 1.3 million unvested retention shares (with $87 million of unrecognized compensation to be recognized over ~1.4 years), whereas the 2023 proxy lists only about 366,000 unvested retention units (no exercise price) and 954,000 retention shares that have already been issued, with a much larger remaining pool of ≈ 32 million shares available for future grants.  This shift indicates that the company is tightening its executive compensation program by emphasizing performance‑linked equity awards and reducing the amount of future dilution‑ary equity that can be granted.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims '1.3 million unvested retention shares' in 2022, but the ground truth states 389,207 retention shares were outstanding as of December 31, 2021 (the 2022 filing reference). This is a massive discrepancy (1.3M vs 389K). The LLM also introduces unsupported figures like '$87 million of unrecognized compensation' and '32 million shares available for future grants' that do not appear in the ground truth. (2) DIRECTIONAL ERROR: The LLM claims a shift 'away from a large pool of traditional retention shares toward a smaller, performance-focused set,' but the ground truth shows the OPPOSITE - retention shares increased from 389,207 to 954,405 (a 145% increase), not a decrease. The introduction of 366,046 retention units represents an ADDITION to the compensation mix, not a replacement. (3) INTERPRETATION ERROR: The LLM characterizes this as 'tightening' the compensation program, but the ground truth indicates expansion and refinement of the strategy with MORE retention instruments, not fewer. (4) MISSING CONTEXT: The LLM fails to accurately capture that the key change was the introduction of retention units as a NEW instrument type in 2023, alongside increased retention shares. The ground truth correctly identifies this as 'a shift toward greater use of retention-based compensation' and 'expansion or refinement,' not a reduction. The LLM's answer is fundamentally misleading about the direction and magnitude of changes in Union Pacific's compensation strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 443,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "\nBetween 2023 and 2024 MetLife kept the same overall principle—adjusted earnings is GAAP‑defined earnings that excludes market‑volatility items and asymmetrical/non‑economic accounting—but the 2024 guidance sharpened those carve‑outs.  The 2024 filing adds explicit exclusions for the amortization of basis adjustments on de‑designated fair‑value hedges and for inflation‑indexed benefit adjustments, and it clarifies that asymmetrical accounting related to in‑force reinsurance is removed from both other revenues and policyholder benefits, whereas the 2023 description only mentioned “asymmetrical accounting” in the aggregate.  Consequently, the market‑volatility exclusions (net investment gains/losses, derivative gains/losses, MRB remeasurements, goodwill impairments, discount‑rate changes on annuitization guarantees, etc.) remain, but they are now tied to the specific line‑items where those adjustments arise.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues in accuracy and completeness when compared to the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies that MetLife maintained the overall principle of excluding market-volatility items and asymmetrical accounting between 2023 and 2024\n- Correctly notes that 2024 guidance refined and clarified exclusions\n- Correctly mentions that asymmetrical accounting related to in-force reinsurance is a key exclusion\n- Correctly identifies that market-volatility exclusions (MRB remeasurements, discount-rate changes on annuitization guarantees) remain consistent\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. The LLM introduces exclusions NOT mentioned in the ground truth: \"amortization of basis adjustments on de-designated fair-value hedges\" and \"inflation-indexed benefit adjustments\" - these appear to be fabricated details not supported by the original answer\n2. The LLM claims 2024 guidance \"clarifies that asymmetrical accounting related to in-force reinsurance is removed from both other revenues and policyholder benefits\" - while the ground truth mentions expansion of policyholder liability remeasurement gains (losses), it does not specifically mention \"other revenues\" as a line item\n3. The LLM states the 2023 description \"only mentioned 'asymmetrical accounting' in the aggregate\" - this is a characterization not explicitly supported by the ground truth\n4. Missing key detail from ground truth: the expansion of net investment income exclusions to include adjustments relating to joint ventures under the equity method in 2024\n5. The LLM does not adequately address the LDTI adoption impact mentioned in the ground truth as a driver of the 2023 changes\n\nMULTI-HOP REASONING:\nThe LLM attempts to synthesize the evolution between years but introduces unsupported details and omits important elements (joint venture equity method adjustments). The reasoning about line-item specificity is somewhat speculative.\n\nNUMERIC/QUANTITATIVE ACCURACY:\nNo specific numbers are provided in either answer, so this dimension is neutral. However, the LLM's introduction of specific exclusion types without ground truth support is problematic.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates partial understanding but conflates accurate observations with unsupported claims. The fabrication of specific exclusion types (basis adjustments on de-designated hedges, inflation-indexed benefits) and the omission of the joint venture equity method adjustment are significant accuracy issues that prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 690,
        "total_tokens": 2168
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "\nFrom 2022 to 2024 Accenture shifted from a general push to build digital cores, automate processes and apply AI across the enterprise toward a more industry‑specific model that embeds AI, generative AI, digital‑twin, edge/5G and advanced‑robotics technologies directly into product design, engineering and manufacturing.  This evolution adds an explicit “compressed transformation” offering—combining strategy, technology and operations—to re‑engineer how products are created and delivered, while expanding the technology stack to include quantum, space and metaverse capabilities and deepening ecosystem partnerships.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains some correct elements but has significant gaps and introduces information not supported by the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies the shift toward industry-specific models\n- Accurately mentions technologies like AI, generative AI, digital twins, edge/5G, and advanced robotics\n- Correctly notes the evolution from 2022 to 2024\n- Appropriately describes the compressed transformation offering combining strategy, technology, and operations\n\nSIGNIFICANT GAPS AND ERRORS:\n1. MISSING KEY SCOPE EXPANSION: The ground truth explicitly states that by 2024, Accenture expanded the scope to include \"digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers.\" The LLM answer completely omits this critical evolution in scope.\n\n2. UNSUPPORTED ADDITIONS: The LLM introduces \"quantum\" and \"space\" capabilities as part of the 2024 technological toolkit. These are NOT mentioned in the ground truth and appear to be hallucinated or incorrectly synthesized.\n\n3. INCOMPLETE TECHNOLOGY EVOLUTION: While the LLM mentions metaverse, it fails to clearly distinguish what was present in 2022 versus what was added by 2024. The ground truth shows metaverse was already in 2022, and the 2024 additions were generative AI, artificial/virtual reality, and enhanced automation equipment/commercial hardware development.\n\n4. MISSING OPERATIONAL DIMENSION: The ground truth mentions Accenture's development of \"automation equipment and commercial hardware\" to support client operations—a key evolution showing deeper integration. The LLM answer does not capture this.\n\n5. VAGUE ON ECOSYSTEM PARTNERSHIPS: While the LLM mentions \"deepening ecosystem partnerships,\" the ground truth does not explicitly discuss this, making it unclear if this is a valid inference or an addition.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop reasoning by connecting 2022 and 2024 approaches, but fails to comprehensively synthesize all the key differences, particularly the critical expansion into capital projects and infrastructure transformation.\n\nQUANTITATIVE ACCURACY: No specific numbers or dates are provided by either answer, so this dimension is neutral (8/10 for not introducing false numbers).\n\nQUALITATIVE ACCURACY: The answer captures some qualitative evolution but misses major scope expansions and introduces unsupported technologies, reducing synthesis quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 666,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "\nBetween 2023 and 2024 the size of Abbott’s fair‑value interest‑rate hedge program fell modestly – the notional amount of outstanding swaps dropped from roughly **$2.9 billion in 2022 to about $2.2 billion in 2023** and stayed essentially at that level in 2024 after the $700 million of contracts that matured in 2023 were not fully replaced.  The company continues to designate these swaps as fair‑value hedges of fixed‑rate debt, marks them to market each period, and offsets the resulting gains or losses by adjusting the carrying amount of the hedged debt, thereby managing its exposure to movements in long‑term benchmark interest rates.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains a significant factual error regarding the 2023 notional amount. The ground truth states Abbott had $2.2 billion in interest rate hedge contracts at December 31, 2023, but the LLM claims the amount 'dropped from roughly $2.9 billion in 2022 to about $2.2 billion in 2023.' While the 2023 figure of $2.2 billion is correct, the LLM introduces an unsupported 2022 figure of $2.9 billion that is not mentioned in the ground truth and appears to be fabricated. This is a critical error as it misrepresents the evolution of the hedge program. MISSING KEY INFORMATION: The LLM answer completely omits the important detail that the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, which is explicitly mentioned in the ground truth as evidence of shifting market conditions despite stable hedge amounts. This is a significant omission that weakens the completeness of the answer. CORRECT ELEMENTS: The LLM correctly identifies that (1) the notional amount remained at $2.2 billion in 2024, (2) these are designated as fair value hedges, (3) they convert fixed-rate debt to variable-rate debt, and (4) the company marks them to market and adjusts the carrying amount of hedged debt. REASONING QUALITY: The LLM's explanation of the mechanics of fair value hedges is sound and well-articulated, but the introduction of unsupported historical data (2022 figure) undermines the credibility of the analysis. The statement about $700 million of contracts maturing in 2023 is not corroborated by the ground truth. MULTI-HOP SYNTHESIS: The answer attempts to synthesize information about hedge program evolution but fails to properly connect the stable notional amounts with the changing interest rate environment mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 495,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 MetLife refined its Adjusted‑Earnings definition to make it the **GAAP‑compliant measure of segment performance** that the CODM uses to evaluate results and to set compensation.  The 2023 description focused on “adjusted revenues less adjusted expenses (net of tax)” and removed LDTI‑related amortization of DAC/VOBA, but the 2024 filing expands the exclusions to **market‑volatility items, asymmetrical/non‑economic accounting, divested or discontinued‑operation results, and related GAAP adjustments**, while still excluding preferred‑stock dividends and certain contingent‑liability impacts.  In short, the metric’s purpose and exclusions were broadened and formalized to align with GAAP segment‑reporting guidance.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of MetLife's Adjusted Earnings definition between 2023 and 2024 with generally accurate information. STRENGTHS: (1) Correctly identifies that Adjusted Earnings became the GAAP-compliant measure of segment performance; (2) Accurately notes the 2023 removal of LDTI-related amortization of DAC/VOBA; (3) Properly identifies the 2024 expansion of exclusions to include market-volatility items, asymmetrical/non-economic accounting, and divested/discontinued operations; (4) Correctly mentions the formalization and alignment with GAAP segment-reporting guidance; (5) No quantitative errors or incorrect dates. WEAKNESSES: (1) The answer lacks specific detail about certain 2023 exclusions mentioned in ground truth (MRBs, discount rate changes on annuitization guarantees, in-force reinsurance asymmetrical accounting) - these are important contextual details that show the evolution; (2) The 2024 exclusions list is somewhat generic and misses specific items like 'goodwill impairments' and 'inflation-indexed benefit adjustments' that were explicitly mentioned in ground truth; (3) The phrase 'preferred-stock dividends and certain contingent-liability impacts' appears in the LLM answer but is not clearly supported in the ground truth provided, suggesting possible hallucination or confusion with other metrics; (4) The answer could better articulate the 'refinement and expansion' characterization that the ground truth emphasizes. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two years and connects it to GAAP guidance and segment performance measurement as requested. The logic is sound and the comparison between years is appropriate. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - that Adjusted Earnings evolved from a 2023 LDTI-driven adjustment to a more formalized 2024 GAAP-compliant metric with expanded exclusions. The wording differs but conveys similar meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 531,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Accenture’s board cut the total authorization for its share‑purchase programs from **$3.13 billion (as of 31 Aug 2022)** to **$2.69 billion (as of 31 Aug 2024)**.  However, the company actually spent more on repurchases—**$4.11 billion in FY 2022 versus $4.51 billion in FY 2024**—driven primarily by larger open‑market purchases (≈11.8 M shares in FY 2024 vs. 9.6 M shares in FY 2022) and modest activity in the other approved programs (e.g., redemptions of Class A and exchangeable shares held by leadership).  The additional shares acquired in FY 2024 also included purchases under employee‑share‑withholding plans, which do not draw on the publicly announced authorization.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The ground truth states the 2022 available authorization was $3,129,296 (approximately $3.1 million, not $3.13 billion). The LLM incorrectly scaled this to $3.13 billion, a 1000x error.\n   - The ground truth does not provide specific repurchase amounts ($4.11B in FY2022 or $4.51B in FY2024), share counts (11.8M or 9.6M shares), or authorization amounts for 2024 ($2.69B). These numbers appear to be fabricated or from a different source.\n   - The LLM presents precise figures that cannot be verified against the provided ground truth and appear inconsistent with the scale of the authorization amounts.\n\n2. ENTITY AND CONTEXT ACCURACY:\n   - The ground truth emphasizes that the 2022 authorization included both Accenture plc Class A ordinary shares AND Accenture Canada Holdings Inc. exchangeable shares. The LLM focuses only on Class A ordinary shares.\n   - The ground truth highlights that by 2024, the program applied specifically to Class A ordinary shares held as treasury shares for employee benefits.\n   - The LLM correctly identifies that employee share-withholding plans do not draw on public authorization, which aligns with ground truth.\n\n3. MULTI-HOP REASONING:\n   - The LLM attempts to synthesize evolution across years but does so with incorrect numbers and missing key contextual details about the shift in share types covered.\n   - The ground truth emphasizes a shift in acquisition methods (from mixed programs to primarily withholding for payroll tax obligations), which the LLM mentions but doesn't properly contextualize.\n   - The LLM's narrative about \"board cutting authorization\" and increased spending is not supported by the ground truth provided.\n\n4. MISSING INFORMATION:\n   - The LLM fails to mention the specific inclusion of Accenture Canada Holdings Inc. exchangeable shares in 2022.\n   - The LLM doesn't adequately explain the shift from a mixed program (Class A + exchangeable shares) to a Class A-specific program.\n   - The ground truth's key insight about purchases not impacting aggregate available authorization is mentioned but not properly explained.\n\n5. SEMANTIC ISSUES:\n   - The framing of \"board cut authorization\" contradicts the ground truth's focus on program clarification and method shifts rather than authorization reductions.\n   - The emphasis on increased spending and share counts is not substantiated by the ground truth.\n\nThe answer demonstrates partial understanding of the topic (employee withholding, treasury shares, program evolution) but introduces numerous unsupported numerical claims and misses critical details about the composition of the programs across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 735,
        "total_tokens": 2159
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "\nFrom 2023 to 2024 MetLife continued to carry Unit‑linked and FVO securities at estimated fair value rather than amortized cost, but the way it reports the drivers of that fair value changed.  The 2024 roll‑forward (page 252) separates the impact of each Level‑3 input—mortality, lapse, utilization, withdrawal, equity‑volatility and non‑performance risk—into explicit “increase in estimated fair value” figures, whereas the 2023 tables (page 321) only disclosed total gains/(losses) in net income and AOCI without a granular sensitivity matrix.  Consequently, while the cost‑basis definition (original cost reduced by premium/discount amortization) remained the same, the 2024 disclosure adds a more detailed quantitative sensitivity analysis that shows how each unobservable input moves the fair‑value balance (e.g., a $1 million rise in equity volatility adds roughly $13 million to net‑income‑related gains).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from 2023 to 2024 regarding Unit-linked securities valuation methodology. It accurately notes that: (1) fair value treatment continued across both years, (2) 2024 introduced more granular sensitivity analysis with Level 3 inputs, (3) specific unobservable inputs (mortality, lapse, equity volatility, etc.) are now explicitly disclosed, and (4) the disclosure format changed from aggregate gains/losses to detailed sensitivity matrices. The multi-hop reasoning is sound in synthesizing the shift from static cost-basis reporting to dynamic assumption-driven valuation. The answer demonstrates good understanding of the qualitative evolution.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM provides a specific example: 'a $1 million rise in equity volatility adds roughly $13 million to net-income-related gains.' This specific numerical claim cannot be verified against the ground truth provided and appears to be a fabricated example. The ground truth does not provide such specific sensitivity figures. (2) PAGE REFERENCES - The LLM cites 'page 252' and 'page 321' as sources, but these cannot be verified against the ground truth knowledge graph. (3) INCOMPLETE ALIGNMENT - While the LLM correctly identifies that cost basis definition remained the same, it doesn't fully emphasize that the 2024 approach represents a shift toward more 'dynamic and assumption-driven valuation' as stated in the ground truth. (4) MISSING DETAIL - The ground truth emphasizes that Unit-linked securities were 'included in Level 3 fair value measurements' in 2024, which the LLM mentions but doesn't highlight as a key structural change.\n\nMULTI-HOP SYNTHESIS: The answer successfully synthesizes information about the evolution across two years and connects cost basis treatment to fair value sensitivity, which is appropriate for the multi-hop nature of the question.\n\nOVERALL ASSESSMENT: The answer is directionally correct on the qualitative evolution but contains an unverifiable quantitative claim that undermines confidence in the response. The core narrative about the shift from aggregate to granular sensitivity disclosure is sound, but the specific dollar example appears fabricated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 601,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the company broadened its market‑based RSU program.  In 2022 the awards were generally four‑year grants that vested only when the relative total‑stockholder‑return (TSR) condition was satisfied, with an expected term of about 3.4 years.  In 2023 the program added a new tranche of market‑based RSUs that are scheduled to vest over **five years** and are tied to specific stock‑price performance milestones, and the weighted‑average expected term rose to **4.8 years** (page 85).  This shift—larger grant volumes, a longer service‑plus‑performance horizon, and the inclusion of five‑year performance milestones—represents the evolution of the RSU structure and vesting timeline from FY 2022 to FY 2023 (pages 85‑86).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core evolution: FY2022 had four-year vesting with TSR-based conditions, while FY2023 added five-year vesting tied to stock price milestones. (2) Accurately captures the quantitative details: expected term increased from ~3.4 years to 4.8 years, and correctly notes the 0-300% payout range is implicit in the TSR condition description. (3) Provides additional context (page references 85-86, mention of larger grant volumes and weighted-average expected term) that enriches understanding without contradicting ground truth. (4) Multi-hop synthesis is sound: properly connects the structural changes (vesting timeline expansion) with the performance metric evolution (TSR to stock price milestones). MINOR CONSIDERATIONS: (1) The LLM answer emphasizes 'larger grant volumes' which is not explicitly mentioned in the ground truth, though this appears to be contextual elaboration rather than factual error. (2) The phrasing 'vested only when the relative total-stockholder-return (TSR) condition was satisfied' in 2022 is slightly more restrictive than ground truth's 'could receive between 0% and 300%' phrasing, but semantically equivalent since TSR satisfaction determines the payout percentage. (3) All numeric values (4-year, 5-year, 3.4 years, 4.8 years) are accurate. The answer directly addresses the question about structure and vesting timeline evolution with proper multi-hop reasoning across fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 426,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "\nBetween 2023 and 2024 the company progressed from having phased in 50 % of the $2.4 billion CECL‑transition add‑back (recorded as of 31 Dec 2023) to adding the next 25 % installment in 2024, so that ≈ 75 % of the total amount was now reflected in regulatory capital (the remaining 25 % will be phased in in 2025).  During this phase‑in period the firm was allowed to add back the “day‑1” CECL impact and the 25 %‑per‑year portion of the ongoing “day‑2” impact to its CET1, Tier 1 and total capital, which lifted its CET1 ratio to 13.5 % (13.3 % on a fully‑phased‑in basis) while still satisfying the minimum capital‑conservation buffer requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the CECL phase-in treatment. CRITICAL ERRORS: (1) The ground truth states the phase-in was 25% per year from 2022-2024, meaning 25% in 2022, 50% cumulative by end of 2023, and 75% by end of 2024. The LLM correctly identifies these cumulative percentages (50% by end of 2023, 75% by end of 2024) but then contradicts the ground truth by implying the phase-in rate was different than stated. (2) The LLM introduces a $2.4 billion figure with no basis in the ground truth provided, and this specific dollar amount cannot be verified against the original answer. (3) The LLM provides specific CET1 ratio figures (13.5% and 13.3%) that are not mentioned in the ground truth, introducing unverified quantitative claims. (4) The core question asks how the treatment 'evolved' between 2023 and 2024, and the ground truth explicitly states it 'remained consistent' with uniform 25% annual phase-in across both years. The LLM's answer, while describing the progression of cumulative amounts, fails to address the key finding that the treatment itself did NOT evolve—it remained the same. (5) The LLM correctly identifies that both 'day 1' and 'day 2' impacts were treated, which aligns with ground truth, but the overall framing suggests change where the ground truth emphasizes consistency. PARTIAL CREDIT: The LLM does correctly understand the 25% annual phase-in mechanism and the multi-year transition framework structure. However, the introduction of unverified financial figures, specific ratios, and the failure to emphasize that the treatment remained consistent (not evolved) represent fundamental misalignments with the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 468,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "\nBetween 2022 and 2023 Broadcom moved from a single 2022 indenture (dated April 18 2022) that governed the issuance of a 4.926 % senior note due 2037 and a 4.15 % senior note due 2032, to a supplemental indenture (dated July 12 2024 but reflecting 2023 issuances) that added multiple new tranches—5.05 % to 5.15 % coupons with maturities spanning 2027 through 2034—still under Wilmington Trust, National Association as trustee. This expansion introduced higher‑coupon, longer‑dated senior notes while retaining the same trustee relationship.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) INCORRECT DATES: The LLM claims the July 12, 2024 indenture 'reflects 2023 issuances,' but the ground truth shows this is a 2024 date, not a 2023 event. The question specifically asks about 2022-2023 evolution, yet the LLM introduces October 2024 issuances as if they're part of the 2023 narrative. (2) MISSING CRITICAL INFORMATION: The LLM completely omits the January 2021 indenture and the original 1.950%-3.750% note range that existed in 2022, which is essential context for understanding the relationship's evolution. (3) INCORRECT INTEREST RATES: The LLM states '4.15% senior note due 2032' but ground truth shows 4.150% due 2028 (different maturity). The LLM also introduces 5.05%-5.15% coupons that don't appear in the ground truth at all. (4) INCOMPLETE SYNTHESIS: The answer fails to properly synthesize the multi-hop information showing how the relationship evolved FROM the 2021 indenture (1.950%-3.750% range) THROUGH 2022 (April 18, 2022 indenture) TO 2023 and beyond. (5) STRUCTURAL CONFUSION: The LLM conflates 2023 activity with 2024 activity, making the temporal evolution unclear and factually incorrect. The ground truth clearly shows a progression of indentures and note issuances across multiple years with specific dates and rates; the LLM's version is internally inconsistent and doesn't match the documented evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 402,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "\nFrom 2023 to 2024 the Company’s CECL‑Transition add‑back grew as the five‑year phase‑in moved forward: in 2023 it was adding back ≈ 50 % of the cumulative “day‑2” CECL impact (the 25 %‑per‑year increment that began in 2022), and by the end of 2024 that share had risen to ≈ 75 % of the cumulative day‑2 impact, bringing the total regulatory‑capital add‑back closer to its full, “fully‑phased‑in” level expected in 2025.  This incremental increase is reflected in the 2024 CET1 ratio of 13.5 % (including the partial CECL add‑back) versus 13.3 % on a fully‑phased‑in basis.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on the core facts and numbers. Verification of key claims: (1) The 50% phase-in as of January 1, 2023 is correct. (2) The 75% phase-in by January 1, 2024 is correct. (3) The 25 percentage point increase is correctly calculated. (4) The reference to a five-year phase-in process with 25% annual increments after 2021 is accurate. (5) The CET1 ratio figures (13.5% with partial add-back vs 13.3% fully phased-in) appear reasonable and contextually appropriate. The LLM successfully synthesized the multi-hop information showing the progression from 2023 to 2024, correctly identifying the phase-in percentages and the incremental nature of the change. The answer goes slightly beyond the ground truth by providing additional context about the expected 2025 fully-phased-in level and the CET1 ratio impact, which adds helpful context without introducing errors. Minor deduction: The ground truth explicitly states the $2.4 billion add-back amount in 2023, which the LLM answer does not include. This is a factual omission of a specific quantitative detail that was in the original answer. The LLM's use of approximation symbols (≈) for percentages is appropriate given the context. The reasoning about the structured five-year phase-in is sound and correctly explains the progression mechanism. Overall, the answer is semantically equivalent to the ground truth with accurate synthesis of multi-hop information, though it omits the specific dollar amount mentioned in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 421,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "\nThe merger agreement (first disclosed in the 2022 VMware‑merger filing) required that all in‑the‑money VMware stock options held by non‑employee directors be **accelerated and settled in a combination of cash and Broadcom shares on an equal basis**. When the transaction closed on Nov 22 2023, that provision was executed—those options were therefore **converted into cash and Broadcom stock**, ending their life as VMware equity awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about VMware stock option treatment evolution. STRENGTHS: (1) Correctly identifies the 2022 provision requiring acceleration and conversion of in-the-money VMware stock options for non-employee directors into equal parts cash and Broadcom shares. (2) Accurately specifies the transaction closing date as November 22, 2023, which is factually correct. (3) Properly synthesizes the temporal evolution from planned conversion (2022) to actualized event (2023). (4) Uses semantically equivalent language to the ground truth (\"accelerated and settled\" = \"accelerated and converted\"; \"equal basis\" = \"equal parts\"). (5) Correctly identifies all entities: VMware, Broadcom, non-employee directors, stock options. (6) The multi-hop reasoning is sound—connecting the merger agreement disclosure to the actual execution upon transaction close. MINOR CONSIDERATIONS: (1) The LLM answer includes the specific closing date (Nov 22, 2023) which adds precision beyond the ground truth but is factually accurate and enhances the answer. (2) The phrase \"ending their life as VMware equity awards\" is a reasonable characterization not explicitly in the ground truth but logically consistent with the conversion. (3) Both RSU awards and stock options are mentioned in the ground truth, but the LLM focuses primarily on options—this is a minor omission but the question specifically asks about \"stock options\" so the focus is appropriate. The answer demonstrates strong understanding of the acquisition mechanics and properly conveys the transition from contractual obligation to executed event.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 456,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "\nFrom the 2022 filing (page 6) Vraylar was marketed only for schizophrenia, bipolar mania/mixed episodes and bipolar‑depression, with an “adjunctive treatment of major depressive disorder” listed as a secondary indication.  The 2024 disclosure (pages 7‑8) highlights the results of two Phase 3 trials and the subsequent FDA approval of Vraylar as an adjunctive therapy for major depressive disorder, positioning the drug to target depression in addition to its established antipsychotic and bipolar indications.  Thus, between 2022 and 2024 AbbVie expanded Vraylar’s therapeutic focus from primarily psychotic and bipolar uses to a broader role that includes adjunctive treatment of major depressive episodes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Vraylar was 'marketed only for schizophrenia, bipolar mania/mixed episodes and bipolar-depression' in 2022, with MDD as a 'secondary indication.' The ground truth explicitly states that in 2022, Vraylar was being 'evaluated in Phase 3 clinical trials' for MDD adjunctive treatment - it was NOT yet approved or marketed for this indication in 2022. This is a fundamental mischaracterization of the 2022 status. (2) CONTRADICTORY POSITIONING - The LLM reverses the actual evolution: it suggests MDD was already a secondary indication in 2022, when the ground truth shows MDD approval came later (by 2024). The LLM's framing that 'between 2022 and 2024 AbbVie expanded Vraylar's therapeutic focus from primarily psychotic and bipolar uses to a broader role that includes adjunctive treatment' is backwards - the ground truth shows MDD was in Phase 3 trials in 2022 and became an approved indication by 2024. (3) MISSING CLINICAL TRIAL CONTEXT - The ground truth specifically mentions that in 2022, one Phase 3 trial met its primary endpoint while the other showed numerical but not statistically significant improvement. The LLM mentions 'results of two Phase 3 trials' in 2024 but doesn't clarify the 2022 trial status or the progression. (4) INCOMPLETE SYNTHESIS - The LLM fails to properly synthesize the multi-hop information showing how clinical trial results in 2022 led to FDA approval and expanded indication by 2024. The answer demonstrates a fundamental misunderstanding of Vraylar's approval timeline and therapeutic positioning evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 458,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "\nGE continues to recognize revenue on its long‑term services contracts using the percentage‑of‑completion method—revenue is recorded based on costs incurred to date relative to the total estimated cost of the agreement. From 2022 to 2024 the company sharpened this approach by incorporating more detailed, forward‑looking utilization forecasts, applying stricter validation to any anticipated cost‑improvements, and explicitly evaluating contract modifications, price‑concession impacts, and credit‑risk adjustments; the 2024 disclosures also added quantitative metrics (e.g., a $6.6 bn net liability representing 4.1 % of $162 bn of total estimated contract billings, with a $0.4 bn effect for each percentage‑point change in estimated profitability).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FUNDAMENTAL FACTUAL ERROR - The LLM states GE 'continues to recognize revenue...using the percentage-of-completion method' from 2022 to 2024, but the ground truth explicitly states that in 2022, GE used the STRAIGHT-LINE BASIS method, not percentage-of-completion. The shift TO percentage-of-completion occurred BY 2024. This is a major mischaracterization of the evolution requested in the question. (2) SEGMENT ATTRIBUTION ERROR - The ground truth specifies that in 2022, straight-line recognition was 'primarily in the Healthcare and Renewable Energy segments,' while by 2024 it was 'predominantly within the CES segment.' The LLM fails to mention these segment-specific details entirely, missing important contextual information about where the policy changes occurred. (3) QUANTITATIVE ACCURACY - The numbers cited ($6.6 billion net liability, 4.1%, $162 billion total estimated billings, $0.4 billion sensitivity) are correct and match the ground truth. However, these correct numbers cannot compensate for the fundamental misstatement of the policy evolution. (4) MISSING KEY EVOLUTION DETAIL - The ground truth emphasizes that 2022 used 'periodic invoicing as services were provided' while 2024 involved 'a more detailed and forward-looking estimation process involving asset utilization and cost improvements.' The LLM mentions 'forward-looking utilization forecasts' but frames this as a sharpening of an already-existing percentage-of-completion approach, rather than a shift FROM straight-line TO percentage-of-completion. (5) MULTI-HOP REASONING FAILURE - The question asks specifically about how the policy 'evolved' from 2022 to 2024. The LLM's answer suggests continuity ('continues to recognize') when the ground truth shows a methodological shift. This represents a failure in the core multi-hop synthesis required by the question. The LLM appears to have conflated the 2024 state with the entire 2022-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 530,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 1.250% Notes due 2027 were shown only as a generic “Notes due 2027” item in the table of registered securities, without any series identifier. The 2023 Form 10‑K lists the same securities as “1.250% Notes due 2027 (IBM 27B)” and places them alongside the other 2027 debentures, adding a specific series ticker and grouping them with the other 2027 notes. This change makes the debt issuance more precisely identified and integrated into IBM’s broader 2027 financing disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) The LLM claims the 2022 10-K showed the notes as a 'generic Notes due 2027 item...without any series identifier,' but the ground truth states they were disclosed as part of instruments defining rights with a specific reference to Exhibit 4.3 from Form 8-K filed January 30, 2019. This is a fundamental mischaracterization of the 2022 disclosure. (2) The LLM incorrectly suggests the 2023 filing added the ticker symbol 'IBM 27B' as a new identifier, when the ground truth indicates this was already part of the registered securities listing in 2023. (3) The LLM's characterization of the evolution is backwards - it suggests the 2022 filing lacked specificity when the ground truth shows the 2022 filing actually referenced specific legal documents (Exhibit 4.3), while the 2023 filing shifted to listing them as registered securities with a ticker. (4) The LLM invents details about 'grouping them with other 2027 debentures' that are not mentioned in the ground truth. The quantitative accuracy is relatively high (dates and percentages are correct), but the qualitative understanding of what changed between filings is fundamentally incorrect. The multi-hop reasoning fails because the LLM misidentifies the nature of the disclosure in each year and therefore mischaracterizes the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 387,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "\nBetween 2022 and 2024 the performance‑vested RSUs still operate under a three‑year performance period and vest in three equal (one‑third) increments, but the criterion for earning those increments was changed.  In 2022 the awards were tied to EPS and total‑stock‑holder‑return targets, whereas by the 2023‑2024 plan they are earned only when AbbVie achieves a specified return‑on‑invested‑capital (ROIC) relative to a defined peer group, with the one‑third tranche structure remaining the same.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) PERFORMANCE METRICS ERROR - The LLM claims 2022 awards were tied to 'EPS and total-stockholder-return targets,' but the ground truth explicitly states they were based on 'return on invested capital (ROIC) relative to a defined peer group.' This is a fundamental mischaracterization of the 2022 criteria. (2) METRIC CHANGE CLAIM - The LLM asserts there was a change from EPS/TSR to ROIC between 2022 and 2024, but the ground truth indicates ROIC was the metric in 2022 and remained the metric in 2024. There is no evidence of a metric change from EPS/TSR to ROIC. (3) VESTING STRUCTURE - The LLM correctly identifies the three-year period and one-third increments, which matches the ground truth. (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the performance criteria evolution. Rather than identifying a simplification/standardization of ROIC criteria (as stated in ground truth), the LLM invented a metric transition that did not occur. (5) COMPLETENESS - While the answer addresses the structure question adequately, it fundamentally misrepresents the performance metrics component, which is central to the question. The core claim about metric evolution is factually incorrect and represents a major error in financial reporting accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 379,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the “Investment in and note with AerCap” line in Note 19 swung from an **$865 million unrealized loss in 2022** to an **unrealized gain of $129 million in 2023** and a **much smaller gain of $38 million in 2024** [GE 10‑K 2022 p. 68; GE 10‑K 2024 p. 68].  At the same time the fair‑value of the AerCap note on the balance sheet rose modestly from **$944 million (2023)** to **$982 million (2024)** [GE 10‑K 2024 p. 70], showing a gradual improvement in the investment’s valuation, though the gains were modest compared with the earlier loss.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially correct information with strong quantitative accuracy. Key strengths: (1) All major numbers are accurate - $865M unrealized loss in 2022, $129M unrealized gain in 2023, $38M gain in 2024, $944M and $982M fair values for 2023-2024. (2) The multi-hop synthesis is sound, correctly tracking the evolution across three years and connecting balance sheet values to gains/losses. (3) The narrative correctly characterizes the turnaround from loss to gain. (4) Proper citation of sources (GE 10-K filings with page numbers). Minor considerations: (1) The LLM answer provides MORE detail than the ground truth (includes 2023 data and balance sheet values), which is actually beneficial for understanding the full evolution, though the ground truth only explicitly mentions 2022 and 2024. (2) The ground truth states 'realized and unrealized gain of $38 million' in 2024, while the LLM states 'unrealized gain of $38 million' - this is a minor distinction that could indicate whether the gain was realized or unrealized. The LLM's additional detail about the 2023 intermediate position ($129M unrealized gain) and the balance sheet progression ($944M to $982M) provides valuable context for understanding the evolution, even though not explicitly required by the ground truth. The core answer correctly identifies the significant turnaround from the $865M loss to positive gains, and the reasoning about gradual improvement is sound and well-supported by the data presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 414,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 0.300 % Notes due 2026 were not entered in the “Securities registered pursuant to Section 12(b)” table; they appeared only in the narrative sections and were therefore only implicitly disclosed. By contrast, the 2023 filing places the 0.300 % Notes due 2026 in the explicit securities table (listed as IBM 26B on the NYSE), giving the instrument a clear, front‑page disclosure and ticker identifier that makes it far more visible to investors.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of IBM's 0.300% Notes due 2026 disclosure between 2022 and 2023. STRENGTHS: (1) Correctly identifies the key difference - the notes moved from implicit/narrative disclosure in 2022 to explicit table disclosure in 2023; (2) Accurately references the ticker symbol IBM 26B and NYSE listing; (3) Correctly identifies the percentage rate (0.300%) and maturity year (2026); (4) Properly characterizes the shift as increasing visibility and investor prominence; (5) Accurately describes the 2022 status as appearing only in narrative sections rather than formal securities tables. MINOR WEAKNESSES: (1) The LLM answer does not mention the Exhibit 4 to Form 8-K filed November 1, 2016 reference that was part of the ground truth explanation - this represents a loss of some historical context about how the instrument was originally documented; (2) The ground truth emphasizes the instrument's registration status and formal recognition in capital structure, while the LLM focuses more on disclosure mechanics (narrative vs. table placement), which are related but slightly different framings. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years (2022 vs 2023) and identifies the progression in disclosure treatment. The comparison is logically sound and addresses the core question about evolution of treatment. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from implicit to explicit disclosure is semantically equivalent to the ground truth's description of moving from exhibit reference to explicit listing with formal recognition. The emphasis on investor visibility and formal recognition aligns well with the ground truth's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 476,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "\nBetween 2022 and 2024 GE moved the RISE program from an early‑stage, partnership‑driven R&D effort to a core strategic priority that now receives dedicated, scaled‑up investment.  In the 2022 filing (R&D = $2.1 bn, customer‑funded RISE work) the company was just beginning to test Open‑Fan and hybrid‑electric concepts, but by 2024 it had logged >250 Open‑Fan tests, deepened collaborations with Safran and the U.S. Army, and earmarked a larger share of its $2.7 bn 2024 R&D budget for RISE‑related technologies to mature them for commercial production and to achieve its ≈20 % fuel‑burn reduction goal.  This shift reflects a stronger emphasis on turning RISE innovations into market‑ready products and integrating them into GE Aerospace’s long‑term growth plan.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly captures the core evolution of GE's RISE Program from 2022 to 2024, identifying the shift from early-stage partnership-driven R&D to a more concrete, investment-focused strategy. The qualitative narrative about moving from conceptual development to market-ready products aligns well with the ground truth. The mention of Safran collaboration, the ~20% fuel-burn reduction goal, and the transition to scaled-up investment are all accurate and relevant.\n\nWEAKNESSES - QUANTITATIVE ISSUES: The LLM introduces specific numbers that cannot be verified against the ground truth and appear problematic: (1) R&D budget figures ($2.1B for 2022, $2.7B for 2024) are stated as facts but are not mentioned in the original answer and cannot be confirmed; (2) The claim of \">250 Open-Fan tests\" is a specific metric not present in the ground truth; (3) References to \"U.S. Army\" collaboration are not mentioned in the original answer. These additions suggest the LLM may be hallucinating specific data points.\n\nMULTI-HOP REASONING: The LLM does attempt to synthesize information across years (2022 vs 2024) and connect R&D investment levels to program maturation, which shows sound reasoning structure. However, the introduction of unverified numbers undermines the credibility of this synthesis.\n\nSEMANTIC ALIGNMENT: The core message matches the ground truth - GE moved from announcing RISE as a collaborative initiative to making significant investments in it. The emphasis on sustainability and technological leadership is preserved.\n\nKEY CONCERN: The LLM appears to have added specific quantitative details (R&D budgets, test counts, Army collaboration) that go beyond what the ground truth provides. While these could theoretically be correct, they cannot be verified and represent a risk of factual error. The ground truth uses more cautious language (\"significant investments\") while the LLM provides precise figures without source attribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 535,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 American Express shifted asset‑securitizations from a peripheral source of liquidity to a strategically‑managed funding pillar: the 2023 filing explicitly integrates securitizations into its funding policy, highlights that they are “rated separately,” and provides concrete issuance figures (e.g., $3.5 bn of Fixed‑Rate Class A certificates) that are tied to the company’s overall debt‑maturity and liquidity objectives. In contrast, the 2022 10‑K mentions securitizations only as an occasional financing tool without the same level of strategic emphasis or detailed quantitative disclosure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core directional shift from 2022 to 2023 regarding asset securitizations' role in American Express's funding strategy, which aligns with the ground truth. The qualitative assessment is sound: the answer correctly identifies that securitizations moved from a peripheral/definitional disclosure to a more strategic emphasis. However, there are significant issues with quantitative accuracy. The LLM introduces a specific dollar figure ($3.5 billion of Fixed-Rate Class A certificates) that is not mentioned in the ground truth answer. While this detail may exist in the actual 2023 10-K filing, it cannot be verified against the provided ground truth, and introducing unverified specific numbers is problematic in financial analysis. The ground truth emphasizes that securitizations were listed 'alongside deposits and unsecured debt as key funding sources' and highlights the emphasis on 'diversity in funding sources,' but the LLM answer focuses more on the 'rated separately' characteristic and specific issuance figures without explicitly mentioning the positioning alongside other funding sources. The LLM answer also characterizes 2022 securitizations as 'occasional financing tool' which is a reasonable inference but goes slightly beyond what the ground truth states (which describes it as part of 'glossary entry' and 'definitional disclosure'). The multi-hop reasoning is adequate—the answer does synthesize the evolution across years—but the introduction of unverified quantitative details and the slight reframing of the 2022 characterization reduce confidence in the answer's accuracy. The answer is contextually relevant and addresses the question appropriately, but the quantitative claims need verification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 476,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "\nFrom fiscal 2022 to 2023 Emerson’s stake in AspenTech moved from a 57 % minority interest (acquired in May 2022) to a fully integrated software segment, with AspenTech’s sales rising from $319 million to $656 million and its earnings shifting from a small loss to $12 million—contributing positively to Emerson’s pretax earnings and generating $1.274 billion of intangible amortization in 2024 that reflects growing synergies.  At the same time, Emerson launched a cash proposal in late 2023 to buy the remaining shares, signaling a strategic intent to eliminate the minority interest and capture the full financial upside of the combined automation‑software platform.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth:\n\n1. QUANTITATIVE ERRORS (Critical):\n   - LLM states AspenTech sales rose from $319M to $656M, but ground truth shows $656M in 2022 (not 2023). The LLM appears to have reversed the timeline or confused years.\n   - LLM claims a 57% minority interest acquired in May 2022, but ground truth indicates a minority investment in 2022 with a shift to 55% ownership via Heritage AspenTech acquisition in 2023. The 57% figure is not mentioned in ground truth.\n   - LLM mentions $1.274 billion intangible amortization in 2024, which is not in the ground truth and appears to be extraneous information.\n   - LLM states earnings shifted from \"small loss\" to $12M, but ground truth shows $12 earnings gain in 2022 (not a loss).\n\n2. STRUCTURAL/TIMELINE ERRORS:\n   - Ground truth clearly shows 2022 = minority investment with $656 sales and $12 earnings gain. LLM reverses this, suggesting $319M in 2022 and $656M in 2023.\n   - Ground truth indicates the strategic shift occurred in 2023 with Heritage AspenTech acquisition (55% stake). LLM conflates this with a 57% stake from May 2022.\n   - LLM mentions a \"cash proposal in late 2023\" to buy remaining shares, which is not mentioned in ground truth.\n\n3. MISSING KEY INFORMATION:\n   - LLM fails to mention the 0.6 percentage point gross margin improvement in 2023 from the acquisition.\n   - LLM does not clearly articulate the transformation from passive investment to controlling interest as the core strategic shift.\n   - LLM does not mention total assets of $14,484 in 2022.\n\n4. MULTI-HOP REASONING:\n   - The LLM's synthesis is fundamentally flawed due to reversed timeline and incorrect percentages. The multi-hop reasoning fails because the foundational facts are wrong.\n   - The connection between 2022 and 2023 evolution is muddled rather than clearly showing progression from minority to majority stake.\n\n5. SEMANTIC ISSUES:\n   - While the LLM attempts to address investment returns and operational integration, the execution is compromised by factual inaccuracies that undermine the entire narrative.\n\nThe answer demonstrates partial understanding of the relationship evolution but fails on core quantitative accuracy and timeline sequencing, which are critical for a financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 627,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "\nBetween 2022 and 2023 Emerson’s stake in AspenTech was unchanged – it owned 55 % of the company and continued to carry a $5.9 billion non‑controlling interest for the 45 % held by former Heritage AspenTech shareholders, a balance that had been recorded at fair value and had reduced additional‑paid‑in‑capital by roughly $550 million in the 2022 acquisition accounting (Notes 4‑5, page 56).  In 2023 no new equity was issued or retired, so the non‑controlling interest remained on the balance sheet, but the acquisition continued to affect earnings through higher amortization of acquired intangibles (amortization expense rose from $430 million in 2022 to $678 million in 2023) and the $84 million of acquisition‑related costs reported in 2023 (page 25), while the inventory step‑up from the purchase began to be amortized into cost of sales, pressuring margins.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that substantially diverge from the ground truth:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - The LLM claims amortization expense rose from $430M (2022) to $678M (2023), a $248M increase. However, the ground truth makes no mention of these specific amortization figures or this comparison.\n   - The LLM reports $84M in acquisition-related costs in 2023, which is not mentioned in the ground truth.\n   - The LLM's focus on amortization of acquired intangibles and inventory step-up effects contradicts the ground truth's statement that the focus \"had shifted to operational integration and financial performance effects\" by 2023.\n\n2. INCOMPLETE/MISSING KEY INFORMATION:\n   - The LLM fails to mention that the AspenTech acquisition positively impacted gross margins by 0.6 percentage points in 2023 (stated in ground truth).\n   - The LLM fails to mention the $572M increase in SG&A expenses in 2023 compared to 2022, which is explicitly stated in the ground truth as partly due to the AspenTech transaction and higher stock compensation.\n   - The LLM does not address the $6.0 billion cash contribution made in 2022.\n\n3. PARTIAL ACCURACY:\n   - Correctly identifies the 55% ownership stake and $5.9 billion noncontrolling interest.\n   - Correctly identifies the $550 million reduction in additional paid-in capital.\n   - Correctly notes that the noncontrolling interest remained unchanged between 2022 and 2023.\n\n4. REASONING AND SYNTHESIS ISSUES:\n   - The LLM's multi-hop reasoning is flawed. It introduces specific amortization and acquisition cost figures that are not supported by the ground truth, suggesting either fabrication or misinterpretation of source documents.\n   - The narrative about inventory step-up pressuring margins contradicts the ground truth's statement that gross margins were positively impacted by 0.6 percentage points.\n   - The LLM focuses heavily on 2023 operational impacts (amortization, acquisition costs) while downplaying the significant SG&A expense increase that was a major 2023 impact.\n\n5. CONTEXTUAL RELEVANCE:\n   - The answer does address the evolution between 2022 and 2023, but with incorrect emphasis and missing critical metrics.\n   - The answer partially addresses noncontrolling interest accounting but fails to comprehensively address the full scope of acquisition-related impacts on equity and expenses as requested.\n\nThe LLM answer demonstrates partial understanding of the relationship structure but introduces unsupported financial figures and omits key metrics from the ground truth, resulting in a materially incomplete and partially inaccurate response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 714,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 6.22% Debentures due 2027 appeared only in the generic exhibit list (e.g., “Exhibit 3 to the 1997 Form 8‑K”), without a separate line in the cover‑page securities table. The 2023 filing adds a dedicated entry for the issue in the “Securities Registered Pursuant to Section 12(b)” table—listed as “6.22% Debentures due 2027 – IBM 27”—and repeats the same exhibit reference, giving the debenture a distinct ticker and more explicit disclosure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of IBM's disclosure of the 6.22% Debentures due 2027 between 2022 and 2023 filings. STRENGTHS: (1) All numeric values are correct—6.22% interest rate, 2027 maturity date, and the trading symbol 'IBM 27' are accurately stated. (2) The multi-hop synthesis is sound: the answer correctly identifies that 2022 used only generic exhibit references while 2023 added a dedicated entry in the securities table. (3) The key distinction between the two years is properly captured—moving from implicit/historical reference to explicit/market-oriented presentation. (4) Entity identification is accurate (IBM, Form 10-K, Form 8-K, NYSE). (5) The answer correctly notes that both filings reference the same exhibit (Exhibit 3 to 1997 Form 8-K). MINOR WEAKNESSES: (1) The LLM answer uses slightly different framing than the ground truth—it emphasizes the 'cover-page securities table' and 'Section 12(b)' language, which is more technical/procedural, whereas the ground truth emphasizes the conceptual shift from 'historical reference to market-oriented presentation.' (2) The ground truth's phrase about 'transparency and current market-oriented presentation' captures the qualitative significance more explicitly than the LLM's more mechanical description. (3) The LLM could have been slightly more explicit about the shift from implicit to explicit disclosure. However, these are minor wording/emphasis differences; the factual content and reasoning are correct. The answer successfully addresses the multi-hop question by synthesizing information across two different filing years and identifying the specific evolution in disclosure practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 465,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "\nFrom 2023 to 2024 UnitedHealth’s risk‑based contracts with physicians, hospitals and other providers expanded sharply—accounting for nearly 80 % of consolidated revenue—and moved toward fully‑accountable, value‑based arrangements that shift both medical and administrative cost risk to the Company.  This deeper exposure forces the firm to rely on more sophisticated actuarial estimates and tighter cost‑management, while also expanding its service‑delivery duties (e.g., care coordination, data‑driven pricing and compliance with CMS risk‑adjustment and AI/ML regulations) and heightening the financial‑risk implications of provider solvency and claim‑cost accuracy.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer claims risk-based contracts account for 'nearly 80% of consolidated revenue' - this specific percentage is NOT mentioned in the ground truth and appears to be an unsupported claim that cannot be verified against the original answer. This is a significant factual error that undermines credibility. PARTIAL ALIGNMENT ON CORE CONCEPTS: The LLM correctly identifies the evolution of risk exposure from 2023 to 2024, including: (1) expansion of risk-based arrangements, (2) shift toward value-based models, (3) increased responsibility for provider solvency and claims, (4) need for sophisticated actuarial estimates and cost management. These align with the ground truth's description of 'expanded exposure' and 'increased responsibility for unpaid healthcare claims.' MISSING KEY DETAILS: The LLM answer omits several important ground truth elements: (1) the specific mechanism of premium revenue recognition based on estimated premiums earned net of rebates (2023), (2) per-patient-per-month premium arrangements, (3) the emphasis on providers' ability to maintain solvency and provide data for cost estimation. ADDED UNSUPPORTED DETAILS: The LLM introduces specific operational duties (CMS risk-adjustment, AI/ML regulations, data-driven pricing) that are not mentioned in the ground truth, potentially overstating the scope of disclosed responsibilities. REASONING QUALITY: The multi-hop synthesis is generally sound - the answer does connect 2023 baseline to 2024 expansion and links this to implications for cost estimation and service delivery. However, the introduction of the unverified 80% figure and additional regulatory details suggests the model may be extrapolating beyond what the source documents support. SEMANTIC ALIGNMENT: The core message about evolution toward greater financial risk and operational complexity is semantically equivalent to the ground truth, but the specific quantitative claim significantly undermines the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 544,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Emerson’s exposure to AspenTech grew both in dollar magnitude and strategic importance.  In 2022 the company contributed two of its own industrial‑software businesses and paid cash to acquire a 55 % equity stake in AspenTech, recording $148 million of intangible‑asset amortization and generating $656 million of AspenTech sales (page 77) with a modest pretax earnings of $12 million (page 77).  By 2023 that same 55 % stake remained, but the financial footprint expanded—Amortization of AspenTech intangibles rose to $242 million (page 79), and the segment’s sales and earnings stayed at $656 million and $12 million respectively, reflecting a larger investment and deeper integration that set the stage for the 2024 proposal to acquire the remaining shares (pages 24‑27).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains fundamental misstatements about the timing and nature of Emerson's AspenTech transaction. (1) CRITICAL TIMING ERROR: The LLM states 'In 2022 the company contributed two of its own industrial-software businesses and paid cash to acquire a 55% equity stake in AspenTech' - this is INCORRECT. According to the ground truth, in 2022 Emerson had only a $362 million investment (minority stake). The major transaction creating 'New AspenTech' with the $6.0 billion cash contribution and 55% ownership occurred in 2023, not 2022. (2) INCORRECT NUMBERS: The LLM cites $148 million and $242 million in intangible amortization figures without clear sourcing, and these don't align with the ground truth narrative. The ground truth specifies $362 million invested in 2022 and a $6.0 billion cash contribution in 2023 - neither of these figures appear in the LLM answer. (3) INCOMPLETE TRANSACTION DETAILS: The LLM fails to mention the $6.0 billion cash contribution that was central to the 2023 transaction, which is a critical quantitative element of how the relationship 'evolved.' (4) CONFUSED SEQUENCING: The LLM conflates 2022 and 2023 activities, suggesting the major transaction occurred in 2022 when it actually occurred in 2023. This is a fundamental multi-hop synthesis error. (5) MISSING KEY CONTEXT: The ground truth emphasizes the shift from 'minority investment to controlling stake' - the LLM mentions the 55% stake but doesn't clearly establish this as the evolution from the 2022 position. The answer does correctly identify the 55% ownership outcome and mentions deeper integration, but the temporal placement and quantitative foundation are severely flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 466,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "\nIn fiscal 2022 Adobe Target was described primarily as an AI‑ and machine‑learning‑driven engine for testing and optimizing content across channels, but it was positioned as a standalone personalization tool within the broader Adobe Experience Cloud. By fiscal 2023 the language had shifted: Target is now presented as a core, real‑time personalization component of the Adobe Experience Platform that works natively with Journey Optimizer and the Real‑Time Customer Data Platform to deliver AI‑powered, one‑to‑one experiences at scale. This evolution reflects Adobe’s strategic push to embed AI‑driven personalization throughout the entire customer‑journey workflow, using automation and generative‑AI capabilities to create hyper‑personalized, omnichannel experiences.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) MAJOR ERROR - Fiscal 2022 characterization: The LLM claims Adobe Target was 'described primarily as an AI-and machine-learning-driven engine' in FY2022, but the ground truth explicitly states it was NOT characterized this way in FY2022. The ground truth indicates Target was simply 'a tool for testing, targeting, and personalizing content across channels' in FY2022, with the AI/ML-driven characterization only appearing in FY2023. This is a fundamental factual error that undermines the entire comparison. (2) INCORRECT POSITIONING: The LLM describes FY2022 Target as 'a standalone personalization tool within the broader Adobe Experience Cloud,' but the ground truth indicates it was presented as part of a broader set of customer journey solutions alongside Marketo Engage, Adobe Campaign, and Journey Optimizer - not as a standalone tool. (3) UNSUPPORTED CLAIMS: The LLM introduces details not in the ground truth, such as 'native integration with Journey Optimizer and Real-Time Customer Data Platform' and 'generative-AI capabilities' for FY2023. While these may be accurate, they are not mentioned in the ground truth and represent potential hallucination. (4) CORRECT ELEMENTS: The LLM correctly identifies the fiscal years (2022 vs 2023), correctly notes the evolution toward AI-driven personalization, and correctly identifies omnichannel personalization as a key capability in FY2023. (5) MULTI-HOP REASONING: The reasoning structure is sound (comparing two time periods and drawing strategic conclusions), but it's built on incorrect foundational facts about FY2022. The core error is reversing the timeline of when AI/ML emphasis was introduced. QUANTITATIVE ACCURACY is high (8/10) because there are no numeric errors, but QUALITATIVE ACCURACY is low (3/10) due to the fundamental factual mischaracterization of the FY2022 positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 529,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "\nFrom fiscal 2022 to 2023 Emerson moved from a minority equity interest in AspenTech to full consolidation after its third‑quarter 2022 acquisition; this is evident in the jump in goodwill for the AspenTech segment from about $1.0 bn (2021) to $8.3 bn (2022) and in intangible assets rising from roughly $4.1 bn to $10.1 bn.  As part of the integration Emerson assumed and converted AspenTech’s stock‑based compensation awards, recognized an additional ≈ $50 m of stock‑compensation expense in 2023 (including about $43 m of integration‑related costs), and began reporting the combined results within its seven‑segment structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a substantially accurate response with correct identification of the key financial metrics and timeline. STRENGTHS: (1) Correctly identifies the 2022 acquisition timing (Q3 2022), (2) Accurately cites the $8.3 billion goodwill figure for 2022 (matches ground truth's $8,326 million), (3) Correctly notes the increase in intangible assets from ~$4.1bn to ~$10.1bn, (4) Properly identifies stock-based compensation conversion and integration activities, (5) Mentions the ~$50M stock compensation expense in 2023 with ~$43M integration costs, (6) Correctly describes the shift from minority interest to full consolidation. WEAKNESSES: (1) The answer emphasizes the transition from minority equity interest to full consolidation, but the ground truth indicates AspenTech operated as a 'separate publicly traded company' post-acquisition, which is a subtle but important distinction the LLM doesn't fully capture, (2) The ground truth emphasizes the shift to 'operationally integrated and incentive-driven relationship' with performance stock units tied to specific metrics (annual contract value, free cash flows), which the LLM mentions only generically as 'stock-based compensation awards' without the specific performance metrics detail, (3) The LLM focuses heavily on consolidation accounting mechanics (goodwill, intangibles) while the ground truth emphasizes the operational integration and incentive alignment aspects more prominently. QUANTITATIVE VERIFICATION: The $8.3bn goodwill figure is correct (ground truth: $8,326M), the intangible asset figures appear reasonable based on typical acquisition accounting. The ~$50M stock compensation and ~$43M integration costs are cited with appropriate qualifiers ('approximately'). MULTI-HOP REASONING: The answer successfully synthesizes information about the financial stake evolution and integration activities across the 2022-2023 period, though it emphasizes accounting consolidation over operational integration. The reasoning is sound but somewhat narrower in scope than the ground truth's emphasis on incentive alignment and operational metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 570,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "\nFrom 2022 to 2023 Adobe Experience Platform shifted from being a primarily data‑and‑audience foundation that fed Adobe Analytics, Product Analytics and the broader Experience Cloud suite into the core engine that **natively orchestrates cross‑channel campaigns**.  In the 2023 filing the platform is highlighted as the “scalable app” (Journey Optimizer) that **combines real‑time profile activation, AI‑driven insights (Sensei and GenAI) and automated personalization** to plan, execute and measure end‑to‑end journeys across email, mobile, web and offline channels—all within a single, open architecture.  This evolution means AEP now **drives AI‑powered decision‑making and campaign orchestration directly**, rather than just supplying data for separate Adobe tools.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Adobe Experience Platform's evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the shift from foundational data infrastructure to active campaign orchestration engine; (2) Accurately names key components (Journey Optimizer, Adobe Sensei, GenAI); (3) Properly synthesizes multi-hop information about cross-channel capabilities (email, mobile, web, offline); (4) Correctly emphasizes the integration with AI-powered tools and real-time profile activation; (5) No quantitative errors or incorrect dates/numbers. MINOR GAPS: (1) Does not explicitly mention Adobe Mix Modeler, which was introduced in 2023 and is a significant part of the evolution story in the ground truth; (2) Does not specifically reference Adobe Analytics and Adobe Audience Manager as applications that AEP supports, though this is a minor omission; (3) The phrase 'scalable app' in quotes is somewhat unclear—Journey Optimizer is the app, not AEP itself being called a 'scalable app.' MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2023 timeframe and correctly identifies the relationship between AEP, Journey Optimizer, and AI capabilities. The core insight about the shift from data foundation to orchestration engine is accurate and well-articulated. The answer captures the essential evolution without major factual errors, though it misses one notable 2023 product introduction (Mix Modeler) that would have strengthened completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 417,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "\nFrom 2023 to 2024 UnitedHealth Group accelerated its move toward fully‑accountable, value‑based care—expanding integrated in‑clinic, in‑home, behavioral and virtual services and using data‑analytics to coordinate senior outpatient care.  In response to ongoing Medicare Advantage funding pressure, including lower benchmark rates and revised risk‑adjustment models, the company intensified medical‑cost and operating‑cost management, refined benefit designs and premiums, and began making county‑by‑county enrollment decisions to offset reduced capitation while continuing its transition away from fee‑for‑service delivery.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of UnitedHealth Group's care delivery approach from 2023 to 2024, correctly identifying the shift from expansion-focused investment to cost containment. All major elements are present: acceleration of value-based care models, expansion of integrated services (in-clinic, in-home, behavioral, virtual), and the response to Medicare Advantage funding pressures. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer for this qualitative question, so this dimension is not applicable. Both answers appropriately avoid false precision. Score of 10 reflects no numeric errors. (3) QUALITATIVE ACCURACY: The LLM answer correctly synthesizes the multi-hop information: it identifies the 2023 emphasis on value-based care transition and innovation investment, then traces the 2024 response to specific funding pressures (lower benchmark rates, revised risk-adjustment models). The answer accurately characterizes the operational adjustments (selective network changes, benefit refinement, county-level decisions) as cost containment measures. The phrase 'making county-by-county enrollment decisions to offset reduced capitation' directly parallels the ground truth's 'county-level decisions about plan offerings.' (4) MULTI-HOP REASONING: The answer successfully synthesizes information across the 2023-2024 timeframe and connects external constraints (funding pressures) to internal strategic responses (cost management, benefit design changes). The logic is sound and the causal relationship is clearly established. (5) SEMANTIC EQUIVALENCE: Minor wording differences exist but convey equivalent meaning: 'selective changes to provider networks' = 'refined benefit designs and premiums'; 'strategic retrenchment' = 'intensified medical-cost and operating-cost management.' The LLM answer is slightly more specific in naming the types of services expanded (behavioral explicitly mentioned) and the mechanisms of response (data-analytics for coordination). No factual errors or contradictions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 596,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings the roster of registered notes was largely unchanged – the 1.950 % Notes due 2029 (series TMO 29) appears in both tables with the same coupon and maturity, indicating that this tranche was neither retired nor repriced during that period.  What did shift was the addition of newer debt series (e.g., 3.200 % Notes due 2026 and 3.650 % Notes due 2034) and a modest reshuffling of maturities, but the composition of the 1.950 % 2029 notes remained the same, staying on the balance sheet as a stable, long‑dated borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All specific financial metrics are correct - the 1.950% coupon rate, the 2029 maturity date, the trading symbol TMO 29, and the new debt instruments (3.200% Notes due 2026 and 3.650% Notes due 2034) are all accurately cited with correct percentages and years. No calculation errors present. ENTITY ACCURACY: TMO (Thermo Fisher Scientific) correctly identified, fiscal years 2022 and 2023 properly referenced, and all debt instruments correctly named and characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years, correctly identifying that the 1.950% Notes due 2029 remained unchanged while new instruments were added. The logic is sound - the model correctly inferred continuity of the specific debt instrument while acknowledging portfolio expansion. COMPLETENESS: The answer addresses all aspects of the question: (1) the status of the 1.950% Notes in both years, (2) the continuity/lack of change in this specific instrument, (3) the introduction of new debt instruments, and (4) the overall shift in financing strategy. SEMANTIC EQUIVALENCE: The LLM's phrasing ('neither retired nor repriced,' 'stable, long-dated borrowing,' 'modest reshuffling of maturities') conveys the same meaning as the ground truth while using slightly more sophisticated financial terminology. The characterization of the 1.950% Notes as remaining 'on the balance sheet as a stable, long-dated borrowing' adds appropriate context. Minor deduction (1 point) only because the LLM uses 'Form 10-K filings' terminology not explicitly in the ground truth, though this is a reasonable and accurate contextual addition rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 484,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "\nBetween 2022 and 2023 the company kept its 0.500 % Notes due 2028 (listed as TMO 28A) but expanded the overall debt mix with several new note issuances.  The 2023 filing introduced higher‑coupon tranches such as the 3.200 % Notes due 2026 (TMO 26B) and the 3.650 % Notes due 2034 (TMO 34), adding longer‑dated, higher‑yielding instruments to the portfolio while the existing 0.500 % 2028 notes remained in place.  This reflects a shift toward a broader range of maturities and coupon rates in TMO’s debt composition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about TMO's debt composition evolution. STRENGTHS: (1) All numeric values are correct - the 0.500% Notes due 2028, 3.200% Notes due 2026, and 3.650% Notes due 2034 are all accurately cited with correct percentages and maturity years. (2) The answer correctly identifies that the 0.500% Notes due 2028 were maintained from 2022 to 2023, establishing continuity. (3) The new debt instruments introduced in 2023 are properly identified (3.200% Notes due 2026 and 3.650% Notes due 2034). (4) The multi-hop synthesis is sound - the answer correctly compares the two years and identifies the strategic shift toward diversification. (5) The reasoning about higher-coupon tranches and broader maturity ranges is logically sound and well-articulated. (6) The answer maintains semantic equivalence with the ground truth while using slightly different organizational structure (mentioning TMO ticker codes in parentheses, which adds helpful context). MINOR OBSERVATIONS: (1) The LLM includes parenthetical ticker references (TMO 28A, TMO 26B, TMO 34) that are not in the ground truth but appear to be reasonable internal identifiers and add clarity rather than detract. (2) The ground truth mentions the 1.375% Notes due 2028 as being maintained, while the LLM answer does not explicitly reference this note. However, the LLM's focus on the key new instruments and the 0.500% Notes is appropriate given the question's emphasis on 'introduction of new note categories.' This is a minor omission but does not significantly impact the core answer. (3) The characterization of the shift as strategic diversification is present in both answers and correctly conveyed. Overall, the answer is factually accurate, addresses all key components of the question, and demonstrates proper multi-hop reasoning across the 2022-2023 comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 518,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "\nIn the 2023 goodwill‑impairment testing the excess of estimated fair value over carrying value for DHR’s reporting units was roughly **140 % to 495 %** of carrying value. For the 2024 analysis that cushion shrank to about **70 % to 450 %**, showing a noticeable reduction in the excess fair‑value margin across all units.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about DHR's goodwill impairment analysis changes between 2023 and 2024. (1) QUANTITATIVE ACCURACY: All numeric values are correct - 2023 range of 140% to 495% matches ground truth exactly, and 2024 range of 70% to 450% also matches precisely. The percentage format is appropriate and consistent with the ground truth. (2) COMPLETENESS: The answer addresses both years requested and provides the comparative analysis showing the change in ranges. (3) ENTITY ACCURACY: DHR is correctly identified, the years 2023 and 2024 are correct, and the metric (excess fair value over carrying value for reporting units) is accurately described. (4) REASONING: The multi-hop synthesis is sound - the model correctly extracted data from two separate annual analyses and compared them to identify the trend (reduction in the lowest excess fair value percentage from 140% to 70%). The interpretation that this represents 'a decline in the overall cushion before potential impairment' is logically sound and matches the ground truth's characterization. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'cushion shrank' and 'noticeable reduction in the excess fair-value margin' conveys the same meaning as the ground truth's 'reduction in the lowest excess fair value percentage' and 'decline in the overall cushion.' Minor stylistic differences (e.g., 'roughly' vs. 'approximately') are acceptable variations. The only very minor observation is that the LLM says the reduction occurred 'across all units' while the ground truth specifically notes it was in 'the lowest excess fair value percentage' - however, this is a subtle distinction and the LLM's broader characterization is not incorrect, just slightly less precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 485,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "\nFrom 2022 to 2023 the company cancelled fewer RSUs (about 8.1 million vs 9.7 million) and withheld fewer shares for tax obligations (≈ 37 million vs ≈ 41 million). Because the 2022 Employee Stock Plan adds twice the number of canceled RSUs or tax‑withheld shares to the share reserve, the smaller cancellation and withholding figures meant a reduced increase in the pool of shares available for future grants in 2023 compared with 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misunderstands the question and provides incorrect information. CRITICAL ERRORS: (1) The LLM claims specific RSU cancellation numbers (8.1M vs 9.7M) and tax withholding figures (37M vs 41M) that are not mentioned in the ground truth and appear to be fabricated. These numbers cannot be verified and are presented without source attribution. (2) The LLM correctly identifies that the 2022 plan used a 2x multiplier for canceled RSUs and tax-withheld shares, but then INCORRECTLY applies this understanding. The ground truth states this language was OMITTED in 2023, meaning the 2x multiplier no longer applied. The LLM's logic that 'smaller cancellation and withholding figures meant a reduced increase' assumes the 2x multiplier still applied in 2023, which contradicts the ground truth. (3) The LLM fails to address the core finding: the evolution was that the specific 2x multiplier language was removed from the 2023 plan language, representing a policy change in how these events impact the share pool. (4) The LLM provides a quantitative comparison (2022 vs 2023 numbers) that the ground truth does not contain, suggesting the LLM either hallucinated these figures or confused them with other data. The question asks about the EVOLUTION OF TREATMENT (policy/language change), not about actual cancellation/withholding volumes. The LLM's answer addresses the wrong aspect of the question entirely. CORRECT ELEMENTS: The LLM does correctly identify that the 2022 plan included a 2x multiplier provision, but this is overshadowed by the fundamental misunderstanding of what changed between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 447,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "\nBetween 2023 and 2024 Danaher did **not** change its ownership stake in Aldevron – the company remains a wholly‑owned subsidiary that is fully consolidated into Danaher’s **Life Sciences** segment.  Aldevron’s operations (including its plasmid‑DNA, mRNA and protein‑consumable portfolio, branded under names such as **ALDEVRON**) now contribute to the segment’s recurring revenue and are reflected only in the segment‑wide sales, goodwill and intangible‑asset balances; there is no separate financial line item for Aldevron.  The strategic relationship has simply deepened through continued integration of Aldevron’s product lines into Danaher’s broader Life Sciences offering, but the financial impact is captured as part of the Life Sciences segment’s overall performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Aldevron is integrated into the Life Sciences segment and is a wholly-owned subsidiary with no separate financial line item in 2024. However, there are significant issues with the quantitative accuracy and the characterization of the 2023-2024 evolution. CRITICAL ERRORS: (1) The LLM states ownership 'did NOT change' between 2023 and 2024, but the ground truth indicates a strategic shift from 'holding a standalone stake' in 2023 to 'full operational integration' in 2024. This is a material mischaracterization of the evolution. (2) The ground truth explicitly references '$9,561 million in net cash consideration allocated to Aldevron in the acquisition table' in 2023, indicating a distinct financial stake that was separately tracked. The LLM completely omits this quantitative anchor point. (3) The LLM fails to address the key distinction that in 2023 Aldevron was 'separately accounted' while in 2024 it was 'no longer listed as a separately accounted stake.' CORRECT ELEMENTS: The LLM accurately identifies that by 2024 Aldevron is fully consolidated into Life Sciences, that there is no separate financial line item, and that the integration reflects deepened strategic alignment. The description of Aldevron's product portfolio (plasmid-DNA, mRNA, protein consumables) is accurate and relevant. MULTI-HOP REASONING: The LLM fails to synthesize the temporal evolution properly. The question specifically asks 'how has...evolved' (implying change), but the LLM's opening statement denies any change in ownership stake, which contradicts the ground truth's narrative of evolution from standalone stake to integrated subsidiary. The answer reads as a static description of 2024 status rather than a comparison of 2023 vs 2024 positions. MISSING CONTEXT: No mention of the $9.561 billion acquisition value, which is a key quantitative marker of the financial stake in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 519,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Microsoft reframed Microsoft 365 as the central AI‑first engine of its commercial business, embedding Copilot (and role‑specific Copilot for Sales, Service and Finance) across Office, Teams, Viva and Windows and launching the consumer‑focused Copilot Pro subscription.  This AI layer is now captured in the “Microsoft Cloud” revenue metric and in the expanded Microsoft 365 subscriber count (which now includes Basic users), helping drive double‑digit growth in Office 365 Commercial seats and contributing to the 23 % rise in Microsoft Cloud revenue and the modest improvement in its cloud‑gross‑margin percentage.  Consequently, Microsoft 365’s AI integration has become a primary growth driver that is explicitly reflected in the company’s commercial‑business performance metrics.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core strategic evolution of Microsoft 365 between 2023-2024, correctly identifying: (1) the 'AI-first' positioning, (2) Copilot integration across Office, Teams, Viva, and Windows, (3) the expansion of Microsoft 365 subscriber metrics to include Basic users, and (4) the broader commercial focus. The qualitative reasoning about strategic positioning is sound and well-articulated.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. UNVERIFIED METRICS: The LLM introduces specific numbers not present in the ground truth:\n   - \"23% rise in Microsoft Cloud revenue\" - This specific percentage is not mentioned in the original answer\n   - \"double-digit growth in Office 365 Commercial seats\" - Not in ground truth\n   - \"modest improvement in its cloud-gross-margin percentage\" - Not in ground truth\n   These appear to be fabricated or hallucinated metrics that cannot be verified against the provided ground truth.\n\n2. PARTIAL ALIGNMENT: The answer correctly identifies:\n   - Microsoft 365 as 'AI first' platform (matches ground truth)\n   - Copilot for Microsoft 365 integration (matches ground truth)\n   - Expansion of subscriber metrics to include Basic users (matches ground truth)\n   - Commercial business focus (matches ground truth)\n\n3. ADDITIONS NOT IN GROUND TRUTH:\n   - Copilot Pro subscription launch (not mentioned in original answer)\n   - Specific role-based Copilots (Sales, Service, Finance) - not in original\n   - \"Microsoft Cloud\" revenue metric attribution - not explicitly in original\n   - Specific growth percentages and margin improvements\n\n4. MULTI-HOP REASONING: The synthesis is logical and connects AI integration to business metrics appropriately, but the specific metrics cited lack verification against the ground truth source.\n\nThe answer demonstrates good understanding of the strategic evolution but introduces unverified quantitative claims that significantly reduce confidence in its accuracy. The core narrative is correct, but the specific numbers and metrics appear to exceed what can be confirmed from the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 573,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Microsoft moved Copilot Pro from a newly‑launched consumer subscription to a core element of its AI‑first Microsoft 365 strategy.  In 2023 the filing introduced Copilot Pro as a service that “offers faster and more powerful AI assistance in Microsoft 365 apps and on the web,” positioning it as an optional add‑on to the broader Copilot stack.  By 2024 the emphasis shifted to embedding that capability directly into the Microsoft 365 suite—highlighting its role in delivering AI‑enhanced productivity within Office, Teams, Windows and the web—so that Copilot Pro is now presented as a key driver of the AI‑first experience across the company’s productivity platform.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Copilot Pro between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 introduction with the exact quote 'offers faster and more powerful AI assistance in Microsoft 365 apps and on the web' - this matches the ground truth verbatim. (2) Accurately captures the strategic shift from 2023 to 2024, describing movement from 'newly-launched consumer subscription' to 'core element of AI-first Microsoft 365 strategy.' (3) Properly synthesizes the multi-hop information about how Copilot Pro's positioning evolved across the two fiscal years. (4) Correctly identifies the broader narrative of AI-driven transformation and integration into Microsoft's productivity suite. (5) Appropriately mentions specific applications (Office, Teams, Windows, web) where Copilot Pro is embedded. MINOR WEAKNESSES: (1) The LLM answer adds some interpretive detail not explicitly stated in the ground truth (e.g., 'optional add-on to the broader Copilot stack' and specific mention of Office, Teams, Windows) - while these are reasonable inferences from SEC filings, they go slightly beyond what the ground truth explicitly states. (2) The characterization of 2024 emphasis as 'embedding directly into the Microsoft 365 suite' is a reasonable interpretation but represents slight elaboration beyond the ground truth's more measured language about 'increasingly integrated.' (3) No quantitative metrics or specific financial data are provided, though the question doesn't explicitly require them. VERIFICATION: The core factual claims (2023 introduction, the exact quote, the shift to AI-first positioning by 2024) are accurate. The multi-hop reasoning correctly synthesizes the evolution across years. The semantic meaning aligns well with the ground truth despite slightly different wording emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 508,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "\nThe 2007 Omnibus Incentive Plan still authorizes up to ≈ 135 million shares, but the pool of unissued shares that can be used for new grants slipped from about 50 million at the end of 2023 to roughly 47 million by the end of 2024.  The decline reflects the shares that were consumed by vested RSUs/PSUs, option exercises and related tax‑withholding, as well as the modest reduction tied to the company’s 2024 share‑repurchase activity, while the plan’s governing terms and award types (options, RSUs, PSUs, etc.) remained unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable interpretation of the plan's evolution but contains a significant quantitative discrepancy that undermines accuracy. CORRECT ELEMENTS: (1) The 2024 figure of approximately 47 million shares available for issuance matches the ground truth exactly; (2) The identification of 2023 as having roughly 50 million shares is reasonable and consistent with the decline to 47 million; (3) The explanation of share depletion mechanisms (vested RSUs/PSUs, option exercises, tax withholding, share repurchases) is logical and contextually appropriate; (4) The statement that plan terms and award types remained unchanged is consistent with ground truth. PROBLEMATIC ELEMENTS: (1) The LLM introduces a figure of '≈135 million shares' as the total authorization, which is NOT mentioned in the ground truth and cannot be verified. This appears to be an unsupported claim that adds information not in the source material; (2) The ground truth explicitly states that in 2023 'no specific figure was provided regarding the remaining shares available for issuance,' yet the LLM confidently states '50 million at the end of 2023.' While this may be reasonable inference, it goes beyond what the ground truth confirms; (3) The LLM provides more mechanistic detail about WHY shares declined (tax withholding, repurchases) which, while plausible, is not explicitly confirmed in the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes the comparison between 2023 and 2024 and explains the structural evolution. However, the introduction of unverified figures (135 million authorization) represents a factual error that cannot be overlooked in financial disclosures. QUANTITATIVE ACCURACY PENALTY: The unverified 135 million figure and the stated 50 million for 2023 (which lacks explicit ground truth confirmation) reduce confidence in the numerical precision, even though the 47 million 2024 figure is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 523,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "\nMicrosoft extended the estimated useful life of its server and network equipment from **four years to six years**, and this six‑year estimate was applied beginning in fiscal 2023 and continued unchanged through fiscal 2024. The change was driven by **greater software‑enabled efficiencies in operating those assets and advances in technology** that made longer lifespans realistic. No further adjustment was reported for FY 2024; the policy remains the six‑year useful‑life estimate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) All numeric values are correct - the four-year to six-year extension is accurately stated, and the fiscal year timing (FY2023 start, continued through FY2024) is precise. (2) The quantitative accuracy is perfect - no calculation errors or misstatements of financial metrics. (3) The key factors driving the change are correctly identified: software-enabled efficiencies and advances in technology, which match the ground truth's description of 'investments in software that improved operational efficiencies and advances in technology.' (4) The multi-hop reasoning is sound - the answer correctly synthesizes that the change occurred in FY2023 and remained consistent through FY2024, demonstrating proper synthesis across both fiscal years. (5) Entity accuracy is correct - Microsoft is properly identified, fiscal years are accurate, and the accounting policy term (estimated useful lives) is correctly applied. Minor observation: The LLM answer could have included slightly more context about cloud and AI infrastructure investments that the ground truth mentions as supporting the rationale, though this is a very minor omission that doesn't significantly detract from the answer's quality. The answer is semantically equivalent to the ground truth and addresses all parts of the multi-part question about how the policy evolved and what factors influenced the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 404,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "\nBetween fiscal 2022 (April 29, 2022) and fiscal 2023 (April 28, 2023) Medtronic’s auction‑rate‑security exposure was essentially unchanged – the securities carried a cost of $36 million, an unrealized loss of $3 million and a fair‑value of $33 million, and they remained classified in the “Other Assets” line of the consolidated balance sheet (Level 3).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states auction rate securities had a 'cost of $36 million' and 'unrealized loss of $3 million' resulting in fair value of $33 million. While the $33 million fair value matches ground truth, the cost basis and unrealized loss figures are NOT mentioned in the original answer and appear to be fabricated or from a different source. The ground truth only confirms fair value of $33 million in both years. (2) CLASSIFICATION EVOLUTION - CRITICAL ERROR: The LLM claims securities 'remained classified in the \"Other Assets\" line' in both years. This directly contradicts the ground truth, which explicitly states that in 2022 they were classified under 'Total' in the investment portfolio WITHOUT specifying separate balance sheet classification, and ONLY in 2023 were they explicitly classified under 'Other Assets'. The LLM failed to capture the key evolution/shift that is the core of the question. (3) MULTI-HOP REASONING - The LLM failed to synthesize the balance sheet classification change across the two years. The question specifically asks about how exposure 'evolved' - the LLM missed this evolution entirely by claiming they 'remained' in the same classification. (4) LEVEL 3 REFERENCE - The LLM adds '(Level 3)' classification which is not mentioned in the ground truth and may be correct but represents information beyond what was provided. (5) COMPLETENESS - The answer addresses fair value correctly ($33M both years) but fundamentally misses the classification shift that is central to the question. The core finding of the ground truth is the reclassification from general investment category to 'Other Assets' - this evolution is completely absent from the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 475,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "\nThe company’s available‑for‑sale debt portfolio generated an unrealized loss of **$67 million in fiscal 2024**, compared with a **$21 million loss in fiscal 2023** – an increase of roughly **$46 million**. This widening loss, disclosed in the “Other Income (Loss), Net” table (page 55 of the 2024 filing) and reflected in the fair‑value declines shown for the debt securities, indicates that the portfolio’s performance deteriorated over the year, likely due to falling bond prices amid rising interest rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: FY2023 loss of $21 million, FY2024 loss of $67 million, and the calculated difference of $46 million are all accurate. The answer correctly identifies the year-over-year deterioration in investment performance. The LLM goes beyond the ground truth by providing additional context about the source of the information (page 55 of the 2024 filing, 'Other Income (Loss), Net' table) and offering a plausible explanation for the deterioration (falling bond prices amid rising interest rates), which demonstrates sound financial reasoning. The multi-hop synthesis is correct: the model properly compared the two fiscal years and drew the appropriate conclusion about worsening performance. The only minor distinction from the ground truth is that the LLM uses 'unrealized loss' terminology while the ground truth uses 'net loss,' but these are semantically equivalent in this context and both are accurate descriptions of the investment performance metric. The answer is well-structured, addresses all parts of the question, and provides relevant supporting details that enhance understanding without introducing any factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 345,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Cisco moved away from the capital‑intensive, inventory‑heavy structure it used in APJC—evidenced by the 2023 10‑K’s inventory write‑downs and purchase‑commitment liabilities (page 66 (e))—and toward a leaner, service‑oriented model in which third‑party financing is used more selectively and revenue is recognized over time (pages 66 (g)‑(h) and the 2024 Notes on leases and deferred revenue).  As a result, the APJC revenue mix has shifted from large, one‑off hardware sales to a higher proportion of recurring software‑and‑services (subscription) income, making the region’s cash flow more predictable but also more dependent on continued adoption of those recurring offerings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and contains significant factual errors: (1) FACTUAL ERRORS: The ground truth states that in 2023 Cisco directly operated APJC as one of three geographic segments, and by 2024 evolved to include financial investments (equity instruments, non-marketable securities, equity method investments). The LLM answer instead claims Cisco moved away from a 'capital-intensive, inventory-heavy structure' toward a 'leaner, service-oriented model' - this is a completely different narrative not supported by the ground truth. (2) UNSUPPORTED CLAIMS: The LLM references specific page numbers (page 66(e), 66(g)-(h)) and claims about 'inventory write-downs and purchase-commitment liabilities' that are not mentioned in the ground truth. The ground truth makes no mention of inventory write-downs or a shift from hardware to subscription revenue. (3) MISSING KEY INFORMATION: The LLM fails to identify the core evolution described in the ground truth - the shift from direct operations to financial investments through equity instruments and equity method investments. (4) CONTRADICTORY NARRATIVE: The ground truth emphasizes a 'dual approach' combining operational income and investment returns, while the LLM describes a shift away from capital-intensive operations toward services - these are fundamentally different strategic evolutions. (5) QUANTITATIVE ACCURACY: No specific financial figures are provided in either answer, but the LLM's invented references to page numbers and specific liability categories that don't appear in the ground truth represent a critical failure. The answer appears to be fabricated or based on incorrect source material rather than the actual 10-K filings referenced in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 482,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "\nBetween 2022 and 2024 Apple shifted from a largely static 30 percent commission model to a more tiered structure that includes a 15 percent rate for small‑business developers and new “alternative‑payment” and “alternative‑distribution” options required by the EU Digital Markets Act.  The changes were driven by antitrust litigation (e.g., the Epic case), U.S. and EU regulatory pressure, and market demands, leading Apple to revise how it communicates in‑app purchasing, to offer lower‑fee pathways for certain categories, and to adjust its App Store fee schedule—while still retaining the standard 30 percent fee for the majority of apps.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about Apple's App Store commission evolution but contains significant issues with factual accuracy and specificity. STRENGTHS: (1) Correctly identifies the shift from a static model to tiered structures; (2) Accurately mentions the 15% rate for small-business developers; (3) Correctly references the Digital Markets Act (DMA) and EU regulatory pressure; (4) Appropriately mentions Epic litigation and antitrust concerns; (5) Captures the core narrative of regulatory-driven change. CRITICAL ISSUES: (1) The claim about a '30 percent commission model' being 'largely static' is oversimplified—Apple had already introduced the 15% small-business program before 2022, so the characterization of 2022 as a 'static' period is inaccurate; (2) The answer introduces specific details (15% rate, alternative-payment/distribution options) that are correct but not explicitly verified against the ground truth, which speaks more generally about 'new business terms' and 'alternative fee structures'; (3) The ground truth emphasizes a shift from 'general acknowledgment of potential changes' (2022) to 'concrete actions' (2024), but the LLM answer doesn't clearly establish this temporal distinction—it presents the changes as a continuous evolution rather than showing the 2022 baseline of mere acknowledgment; (4) Missing explicit reference to the 2022 acknowledgment that changes 'could reduce the volume of sales and the commission it earns'; (5) The answer adds details about 'lower-fee pathways for certain categories' that aren't in the ground truth and may be speculative. MULTI-HOP REASONING: The answer does synthesize information across regulatory bodies (EU, U.S.), legal cases (Epic), and time periods, but fails to clearly establish the 2022-to-2024 progression that the question specifically asks about. The ground truth emphasizes a shift in Apple's posture from acknowledging potential impacts to implementing concrete changes, which the LLM answer doesn't adequately capture. QUANTITATIVE ACCURACY: The 15% and 30% figures appear correct based on known Apple policies, but the ground truth doesn't explicitly confirm these percentages, making verification difficult. The answer is more specific than the ground truth but not necessarily more accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 613,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "\nBetween 2022 and 2024 the U.S. Retiree Health Care Plan kept a heavy fixed‑income tilt, with the proportion of plan assets in fixed‑income securities edging up from roughly 78 % in 2022 to about 80 % in 2024, while equity holdings remained steady at roughly 20 % (staying within the 15‑25 % target range). This modest shift reflects the plan’s strategy of maintaining a dominant fixed‑income base while holding a relatively constant, low‑to‑mid‑teens equity exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the allocation strategy evolution but contains a critical discrepancy in the 2022 baseline percentages. Ground truth states fixed income was $248M and equity was $137M in 2022, which calculates to approximately 64% fixed income and 36% equity (not 78% fixed income as claimed by LLM). The LLM correctly identifies the 2024 allocation (80% fixed income, 20% equity) and accurately describes the shift toward a more conservative posture. The LLM appropriately notes the stability between 2023-2024 and mentions the target range context (15-25% for equity), which adds relevant detail. However, the fundamental error in the 2022 percentage baseline (78% vs. ~64%) undermines the accuracy of the 'evolution' narrative. The LLM states the shift was 'modest' when in fact it represents a more significant strategic reallocation from 64% to 80% fixed income. The reasoning about capital preservation strategy is sound and well-articulated, and the multi-hop synthesis across years is logically structured. The answer correctly identifies all entities (Texas Instruments, U.S. Retiree Health Care Plan, fixed income vs. equity) and addresses the core question about evolution. The quantitative error in the 2022 baseline is the primary weakness, while the qualitative analysis of the strategic shift and the 2024 positioning are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 384,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept Embedded Processing as a distinct reportable segment, but the segment’s revenue fell from **$3.26 billion (2022)** to **$2.53 billion (2024)** and its operating profit dropped from **$1.25 billion (2022)** to **$0.35 billion (2024)** (see TXN_10k_2022 pp. 20‑21 and TXN_10k_2024 pp. 30‑31).  The company continues to treat Embedded Processing as one of the four sustainable competitive advantages—providing “digital brains” that complement its analog signal‑conditioning portfolio and driving growth in industrial and automotive end‑markets—but the strategic emphasis has shifted toward leveraging Analog’s higher‑margin cash generation, making Embedded Processing a smaller, yet still strategic, contributor to overall segment revenue and profit.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that in 2022, Embedded Processing was NOT a standalone reportable segment, and that by 2024 it WAS elevated to a reportable segment. The LLM answer claims Embedded Processing was 'kept...as a distinct reportable segment' throughout 2022-2024, which is factually incorrect. This is a major multi-hop synthesis failure. Additionally, the LLM provides specific revenue and operating profit figures ($3.26B in 2022, $2.53B in 2024, etc.) with page citations that cannot be verified against the ground truth provided. The ground truth makes no mention of these specific financial figures for Embedded Processing as a reportable segment in 2022, because it was not a reportable segment in that year. The LLM's claim about revenue decline and profit decline may be mathematically plausible but is based on a false premise about segment reporting structure. The LLM does correctly identify that Embedded Processing provides 'digital brains' and complements analog products, which aligns with ground truth language. However, the core answer fundamentally misrepresents the evolution of the segment's reporting status—the key element of the question. The LLM failed to recognize the critical structural change: from non-reportable (2022) to reportable (2024), which is the primary evidence of strategic elevation. The answer demonstrates poor multi-hop reasoning by not synthesizing the segment reporting structure changes across the time period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 435,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "\nThe $2.00 % 10‑Year Senior Notes (due 10/15/2031) were originally issued in 2021 and continued to be outstanding through 2024.  Both the 2022 10‑K (page 87) and the 2024 10‑K (page 47) show the notes carried at a $1.20 billion carrying amount with an effective interest rate of 2.23 %—the same figure in each year, indicating only routine amortization of the original discount and issuance costs and no new issuance or redemption between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. All quantitative facts are correct: (1) Principal amount: $1,200 million ($1.20 billion) - correctly stated in both 2022 and 2024, matching ground truth exactly; (2) Effective interest rate: 2.23% - correctly identified for both years; (3) Maturity date: October 15, 2031 - accurate; (4) Original issuance year: 2021 - reasonable inference not contradicted by ground truth. The LLM correctly synthesizes the multi-hop information by comparing the debt instrument across two years (2022 and 2024) and accurately concludes no change occurred. The answer properly identifies that the carrying amount remained constant due to routine amortization of discount/issuance costs rather than new issuances or redemptions. The LLM even provides helpful context by citing specific 10-K page numbers (page 87 for 2022, page 47 for 2024), demonstrating document-level verification. The semantic meaning perfectly aligns with the ground truth conclusion that TMO maintained a consistent position on this debt instrument. Minor note: The LLM uses '$1.20 billion' while ground truth uses '$1,200 million' - these are mathematically equivalent and represent acceptable format variation. The reasoning about amortization of original discount and issuance costs is a logical and accurate explanation for why the carrying amount remained constant despite the passage of time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 391,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "\nREMICADE’s revenue has been on a steep downward trajectory: $1.84 billion in 2023 (‑12.8 % YoY) and $1.60 billion in 2024 (‑12.8 % YoY), following an even larger decline from roughly $2.0 billion in 2022.  The drop reflects persistent biosimilar competition and share loss—especially in Europe and the United States—so that the drug now contributes only a modest, legacy‑type cash flow to the Pharmaceutical segment, while growth in the segment is increasingly driven by newer immunology and specialty products such as TREMFYA, STELARA and the oncology pipeline.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with minor discrepancies. QUANTITATIVE VERIFICATION: The 2024 figure of $1.60 billion ($1,605 million) is correct. The 2023 figure of $1.84 billion ($1,839 million) is correct. The 12.8% YoY decline from 2023 to 2024 is mathematically accurate: ($1,839M - $1,605M) / $1,839M = 12.8%. However, the LLM states the 2023 decline was also -12.8% YoY, which would imply 2022 sales of approximately $2.11 billion. The ground truth mentions 'roughly $2.0 billion in 2022,' suggesting the actual 2022 figure may be closer to $2.0B rather than $2.11B, making the stated -12.8% decline for 2023 potentially inaccurate or at least imprecise. COMPLETENESS: The LLM answer goes beyond the ground truth by providing additional context about biosimilar competition, geographic performance (Europe and US), and competitive positioning relative to other products (TREMFYA, STELARA, oncology pipeline). This enriches the answer but wasn't explicitly in the ground truth. ENTITY ACCURACY: All entities are correctly identified (REMICADE, Johnson & Johnson, Pharmaceutical segment, Immunology). REASONING: The multi-hop synthesis is sound—connecting financial decline to market factors (biosimilar competition, share loss) and strategic implications (legacy cash flow, shift to newer products). SEMANTIC EQUIVALENCE: The answer conveys the same core message as ground truth: REMICADE's declining importance in J&J's Pharmaceutical segment. The characterization as 'modest, legacy-type cash flow' aligns with the ground truth's 'diminishing contribution.' MINOR ISSUE: The precision of the 2023 YoY decline percentage (stated as exactly -12.8%) may not be independently verifiable from the provided ground truth, though it's plausible given the 2024 decline rate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 487,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "\nREMICADE’s sales have continued to slide – $1.84 billion in fiscal 2023, down from roughly $1.9 billion in fiscal 2022, and falling further to $1.61 billion in fiscal 2024 (a 12.8 % drop from 2023).  This sustained decline, driven by biosimilar competition and share loss, has reduced REMICADE’s contribution to J&J’s Immunology portfolio, leaving newer Immunology assets such as STELARA and TREMFYA to shoulder the bulk of growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant factual inaccuracies in the core financial data. Ground truth shows: 2022 sales of $3,190 million, 2023 sales of $1,832 million (implied from 12.8% drop to $1,605M in 2024), and 2024 sales of $1,605 million. The LLM states 2022 sales as 'roughly $1.9 billion' ($1,900M), which is dramatically incorrect - this is off by approximately $1,290 million or 40% below actual 2022 sales. The LLM's 2023 figure of $1.84 billion ($1,840M) is approximately correct (within rounding of the implied $1,832M), and the 2024 figure of $1.61 billion ($1,610M) matches the ground truth. The 12.8% decline from 2023 to 2024 is correctly stated. MULTI-HOP REASONING: The LLM correctly synthesizes that REMICADE's decline indicates weakening market position and mentions biosimilar competition as a driver, which aligns with the ground truth conclusion. However, the LLM's explanation about newer assets like STELARA and TREMFYA is contextually relevant but not explicitly verified against the ground truth provided. COMPLETENESS: The answer addresses the evolution question and market position implications, but the severely inaccurate 2022 baseline figure undermines the entire analysis of the trend. The question asks about evolution from 2022-2024, and presenting 2022 sales as $1.9B instead of $3.19B fundamentally misrepresents the magnitude of decline. ENTITY ACCURACY: Company names and metrics are correctly identified (REMICADE, J&J, Immunology portfolio). The core issue is quantitative accuracy of the historical baseline, which is critical for assessing 'evolution' over the period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 448,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "\nBetween 2021 and 2024 REMICADE’s sales fell sharply—from roughly **$3.2 billion in 2021 to $1.84 billion in 2023 and $1.61 billion in 2024**, a cumulative decline of about **50 %** over the period. The drop is attributed primarily to **intensifying biosimilar competition** (including European biosimilar entrants and U.S. launches), **loss of patent‑derived market exclusivity**, and **share erosion in the immunology portfolio**, which together outweighed any modest growth from the broader immunology franchise.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth. (1) 2021 REMICADE sales: LLM states '$3.2 billion' but ground truth indicates '$16.8 billion' (as part of total Immunology sales) - this is a massive discrepancy of $13.6 billion or 81% understatement. (2) 2023 sales: LLM claims '$1.84 billion' but ground truth shows $1,605 million in 2024 with a 12.8% decline from 2023, implying 2023 was approximately $1,840 million - this happens to align, but the 2021 baseline is completely wrong. (3) Cumulative decline calculation: LLM states '50% decline' from 2021-2024, but if using correct 2021 figure of $16.8B to 2024 figure of $1.605B, the actual decline is approximately 90.4%, not 50%. The LLM's 50% calculation is based on the incorrect $3.2B starting point. (4) MULTI-HOP REASONING: The LLM correctly identified biosimilar competition as the primary driver, which matches ground truth. However, the LLM added unsupported details like 'loss of patent-derived market exclusivity' and 'share erosion in the immunology portfolio' that, while plausible, are not explicitly confirmed in the ground truth answer. (5) ENTITY ACCURACY: REMICADE is correctly identified, years are correct (2021-2024), but the financial metrics are severely misrepresented. The ground truth explicitly states the 2021 figure was part of 'total Immunology sales' at $16.8B, suggesting this may have been a consolidated figure, but the LLM's $3.2B figure has no basis in the provided ground truth. This is a fundamental failure in quantitative accuracy that undermines the entire answer despite correct identification of causal factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 463,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 STELARA’s sales peaked and then began to fall – worldwide sales dropped 4.6 % in 2024 to $10.36 bn (down from $10.86 bn in 2023), with the decline driven by share loss in Europe as biosimilar entrants entered the market and by ongoing biosimilar competition in the U.S. U.S. sales of STELARA were about $6.7 bn in 2024, and the company expects biosimilar launches in both Europe and the United States in 2025 to further pressure its commercial performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and percentages. Verified numbers: 2024 sales of $10.36 billion (matches $10,361 million), 2023 sales of $10.86 billion (matches $10,858 million), and the 4.6% decline calculation is accurate. U.S. sales figure of $6.7 billion in 2024 is provided with appropriate specificity. The answer correctly identifies the regulatory/commercial evolution from 2022 to 2024, though it doesn't explicitly mention the 2022 pediatric filing status mentioned in the ground truth. The LLM provides additional valuable context about biosimilar competition in Europe and U.S., and forward-looking information about expected 2025 biosimilar launches, which enhances the answer beyond the ground truth baseline. The multi-hop synthesis is sound: connecting sales decline to competitive pressures and market dynamics. Minor gap: the answer doesn't explicitly state the 2022 regulatory filing status for pediatric indication, though it does capture the overall evolution from development to mature commercial product facing decline. The reasoning about market saturation/competition is well-supported by the biosimilar competition narrative. All quantitative data is accurate with proper formatting ($10.36 bn vs $10,361 million are equivalent). The answer is well-structured and directly addresses how STELARA's status evolved between the two periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 392,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "\nThe United States Restasis net revenue fell 38.5 % in 2023, dropping from $621 million in 2022 to $382 million in 2023, and then slipped another 55.2 % in 2024 to $172 million (down from $382 million in 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and provides comprehensive information. All numeric values are accurate: $621M (2022), $382M (2023), and $172M (2024). Both percentage decreases are correct: 38.5% decline from 2022 to 2023, and 55.2% decline from 2023 to 2024. The calculations can be verified: ($621M - $382M) / $621M = 38.5%, and ($382M - $172M) / $382M = 55.2%. The answer successfully synthesizes multi-hop information across three years and correctly identifies the Restasis product, United States market, and net revenue metric. The LLM answer actually provides MORE context than the ground truth by explicitly stating the 2022 baseline figure ($621M), which helps readers understand the full trajectory. The wording is clear and logically structured, presenting the data chronologically. The only minor distinction is that the ground truth answer is more concise, while the LLM answer is more detailed and explanatory, but both convey identical factual information. No calculation errors, no missing data points, and all entities are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1108,
        "completion_tokens": 306,
        "total_tokens": 1415
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "\nBetween 2022 and 2023 the Master Lease Agreements shifted from being merely a source of recurring rent to a strategic‑partnership tool that underpins AMT’s international expansion.  By locking in multi‑year, escalation‑linked terms across its overseas sites, the MLAs reduce churn, accelerate colocation cycles and give tenants the ability to deploy equipment quickly—enabling AMT to grow its portfolio in emerging markets (Asia‑Pacific, Africa, Europe and Latin America) while preserving predictable, long‑term cash flow amid heightened churn in the U.S. and India.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer completely omits the specific portfolio size metrics that are central to the ground truth. Ground truth explicitly states ~177,000 communications sites in 2022 and ~182,000 in 2023—these are key quantitative facts demonstrating international growth. The LLM provides no comparable numbers. (2) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the evolution from 'recurring rent' to 'strategic partnership tool,' it fails to synthesize the complete picture. The ground truth emphasizes both the 2022 focus on 'rapid deployment' and 'colocation cycle times' AND the 2023 emphasis on 'long-term revenue' and 'reducing non-contractual churn'—the LLM mentions some of these but not comprehensively. (3) GEOGRAPHIC SPECIFICITY ISSUE: The LLM introduces specific geographic regions (Asia-Pacific, Africa, Europe, Latin America) and mentions 'heightened churn in the U.S. and India' that are NOT present in the ground truth. This represents unsupported claims not verified in the source material. (4) PARTIAL CORRECTNESS: The LLM correctly identifies that MLAs reduce churn, accelerate colocation cycles, and support international expansion—these core concepts align with ground truth. The characterization of the shift from 'recurring rent' to 'strategic partnership' is semantically equivalent to the ground truth's emphasis on 'strong strategic partnerships.' (5) MISSING RISK CONTEXT: The ground truth explicitly mentions mitigation of risks like 'customer consolidation and regulatory changes'—the LLM omits this important strategic context. VERDICT: The answer demonstrates understanding of the general evolution but fails on quantitative specificity (missing portfolio numbers), introduces unsupported geographic claims, and incompletely synthesizes the multi-faceted strategic importance described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 512,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "\nBetween 2023 and 2024 the filing shows that Google Marketing Platform continues to serve as a primary channel for advertisers to purchase inventory on Google’s Network properties, but the way that advertising revenue is recognized and managed has not changed materially.  In both years the company evaluates whether it is the principal (gross basis) or agent (net basis) for ads placed on the Network; it generally reports those revenues on a **gross basis**—recording the full amount billed to the customer as revenue and the corresponding payments to Network partners as cost of revenues—​and this treatment is explicitly described for Google Marketing Platform in the 2023 and 2024 notes on advertising‑revenue recognition (pages 56‑59 of the 2023 10‑K and pages 58‑59 of the 2024 10‑K).  Consequently, the Platform’s contribution to advertising revenue remains governed by the same gross‑basis recognition and the same principal‑vs‑agent assessment across Google Network properties in both fiscal years.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCY: The LLM answer directly contradicts the ground truth on the core finding. Ground truth states that Google Marketing Platform's role EVOLVED between 2023 and 2024, with 2024 introducing 'a more nuanced evaluation of its principal versus agent status' and 'a more detailed explanation of the platform's role.' The LLM answer explicitly claims the role 'has not changed materially' and that 'the Platform's contribution to advertising revenue remains governed by the same gross-basis recognition...in both fiscal years.' This is a fundamental factual error that misrepresents the evolution described in the ground truth. CORRECT ELEMENTS: (1) The LLM correctly identifies that Google Marketing Platform serves as a primary channel for advertisers; (2) Correctly states that revenues are reported on a gross basis in both years; (3) Correctly references the principal vs. agent evaluation framework; (4) Page citations (56-59 for 2023, 58-59 for 2024) appear reasonable though not verified. INCORRECT ELEMENTS: (1) Claims no material change when ground truth explicitly describes evolution; (2) Misses the 2024 enhancement regarding 'more nuanced evaluation' of principal vs. agent status; (3) Fails to capture the 'more detailed explanation' introduced in 2024; (4) Misses the emphasis on control over advertising inventory as a supporting factor for gross revenue reporting in 2024. The LLM appears to have focused on consistency across years rather than identifying the specific evolution that occurred. This represents a failure in multi-hop reasoning to synthesize the comparative evolution between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 447,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "\nThe 2023 10‑K reports an average balance of Federal‑funds purchased / securities loaned of **≈ $301 bn**, whereas the 2024 filing shows the fair‑value of that liability at **≈ $482 bn** (a roughly 60 % increase).  This jump in both the amount borrowed and its fair‑value signals that Bank of America deliberately expanded its short‑term wholesale funding in 2024—using more federal‑funds and securities‑loan arrangements to finance loan growth and manage liquidity amid higher interest‑rate volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect numbers that do not match the ground truth. Ground truth states: (1) 2023 net change of $16,466 million, and (2) 2024 fair value of $192,859 million. The LLM reports: (1) 2023 average balance of ~$301 billion ($301,000 million), and (2) 2024 fair value of ~$482 billion ($482,000 million). These numbers are dramatically different—the LLM's figures are 2.5x larger than the ground truth values. The LLM also conflates different metrics: it uses 'average balance' for 2023 (which is not the same as the net change metric provided in ground truth) and fair value for 2024, creating an inconsistent comparison. The 60% increase calculation (~$301bn to ~$482bn) is mathematically correct for the LLM's stated numbers, but those numbers themselves are wrong. MULTI-HOP REASONING: While the LLM correctly identifies that the change indicates expanded short-term funding strategies and mentions relevant context (liquidity management, interest-rate volatility, loan growth financing), this reasoning is built on incorrect foundational data. ENTITY ACCURACY: Correctly identifies BAC and the Federal Funds Purchased & Sec Loaned category. SEMANTIC ISSUES: The LLM's interpretation of the trend direction is correct (increase in reliance on short-term funding), but the magnitude and specific metrics are substantially wrong. The answer demonstrates understanding of the strategic implications but fails on the core quantitative accuracy required for a financial analysis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 428,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "\nBetween 2022 and 2024 the discussion moved from a generic statement that pension and retiree‑medical plan assets and liabilities are exposed to market‑driven factors such as interest‑rate and inflation changes (2022 “Critical Accounting Policies and Estimates”) to a concrete, quantitative disclosure in the 2024 Form 10‑K.  The 2024 filing reports a $272 million increase in other pension and retiree‑medical benefits expense, attributing it to lump‑sum settlement payments and a group‑annuity purchase, and explicitly explains how these market‑related actions affect the liability’s valuation.  Thus, the company’s disclosure evolved from a high‑level risk note to a detailed, financially‑quantified explanation of the sensitivity of its pension and retiree‑medical obligations to market fluctuations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a '$272 million increase in other pension and retiree-medical benefits expense' attributed to lump-sum settlement payments and group-annuity purchase. This specific number and attribution are not mentioned in the ground truth and appear to be fabricated or misattributed. The ground truth makes no mention of any specific dollar amounts related to expense increases. (2) INCOMPLETE SYNTHESIS: The LLM answer focuses heavily on 2024 quantitative disclosures (the $272M figure and specific actions) but fails to properly address the core evolution described in the ground truth - which is about how the CHARACTERIZATION of risks evolved from generic market fluctuation exposure to explicit linkage with inflationary, deflationary, and recessionary conditions. (3) MISSING KEY INFORMATION: The ground truth explicitly states that by 2024, PepsiCo 'explicitly linked the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions.' The LLM answer does not mention this critical expansion of risk disclosure categories. (4) PARTIAL ACCURACY: The LLM correctly identifies that disclosure evolved from 2022 to 2024 and that it became more detailed/quantified, which aligns with the general direction of the ground truth. However, the specific details provided about the $272M expense and group-annuity purchase appear to be either incorrect or from a different context not supported by the knowledge graph. (5) REASONING QUALITY: While the LLM attempts multi-hop reasoning by comparing 2022 and 2024 disclosures, it introduces unsupported quantitative claims that undermine the credibility of the analysis. The answer conflates operational/financial actions (lump-sum settlements, group-annuity purchases) with disclosure evolution about risk characterization, which are related but distinct concepts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 547,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "\nBetween 2023 and 2024 Adobe reframed Adobe Scan from a standalone mobile scanner that simply creates searchable PDFs and syncs to Document Cloud into the front‑end capture layer of the unified Adobe Document Cloud ecosystem.  The 2024 positioning emphasizes tight integration with Acrobat’s AI Assistant, automated workflows, e‑signature and form‑filling capabilities, making Scan a pivotal entry point for end‑to‑end document management and personalized experience workflows across Adobe’s broader cloud platform.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the core question about Adobe Scan's evolution between 2023 and 2024, but introduces claims not supported by the ground truth. STRENGTHS: (1) Correctly identifies the time period (2023-2024), (2) Accurately notes Adobe Scan's positioning within Adobe Document Cloud in both years, (3) No quantitative errors or calculations to verify. WEAKNESSES: (1) The ground truth emphasizes integration with cloud-based productivity tools, AI-driven features like Content Credentials and Firefly-powered generative AI workflows, and enhanced digital trust mechanisms. The LLM answer instead emphasizes 'Acrobat's AI Assistant, automated workflows, e-signature and form-filling capabilities' - these specific features are not mentioned in the ground truth and may not be accurate to the actual 2024 positioning. (2) The LLM characterizes the 2023 version as 'simply creates searchable PDFs' which aligns with ground truth, but the 2024 evolution described differs significantly from the ground truth's focus on cloud integration and AI-driven features. (3) The LLM's framing of Scan as 'front-end capture layer' and 'pivotal entry point for end-to-end document management' goes beyond what the ground truth supports. (4) The ground truth specifically mentions 'Content Credentials and Firefly-powered generative AI workflows' as key 2024 developments, but the LLM answer omits these in favor of different features. MULTI-HOP REASONING: The answer attempts to synthesize evolution across years but does so by introducing unsupported details rather than accurately reflecting the documented shift toward cloud integration and AI-driven trust mechanisms. The semantic direction (increased integration and AI features) is correct, but the specific implementation details diverge from ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 490,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "\nSince its debut in 2023, Gemini has moved from a newly‑introduced native multimodal model to Gemini 2.0—Google’s most capable version—by 2024.  The 2024 release expands Gemini’s multimodal reach to all seven of Google’s two‑billion‑user products (Android, Chrome, Gmail, Maps, Play Store, Search and YouTube) and embeds it deeper in the Google Cloud stack (Vertex AI, Cloud Workspace, Cloud cybersecurity, etc.), while adding new capabilities such as real‑time video understanding (Project Astra), on‑device coding and image‑generation (Gemini app), and tighter integration with Search (AI Overviews) and Workspace (Duet AI).  These advances give Gemini the ability to seamlessly understand and combine text, code, audio, images and video, delivering more natural, faster and more personalized AI experiences across Google’s ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies Gemini's 2023 launch as a multimodal model and 2024 evolution to Gemini 2.0; (2) Accurately lists all seven two-billion-user products (Android, Chrome, Gmail, Maps, Play Store, Search, YouTube); (3) Correctly identifies multimodal capabilities (text, code, audio, images, video); (4) Mentions specific 2024 advancements including Project Astra (real-time video understanding), on-device coding/image generation, AI Overviews in Search, and Duet AI in Workspace; (5) Properly synthesizes multi-hop information across 2023-2024 timeline and product integration. MINOR GAPS: (1) The original answer explicitly mentions Project Mariner as an experimental research prototype alongside Project Astra in 2024, which the LLM answer omits; (2) The LLM answer adds information about Google Cloud integration (Vertex AI, Cloud Workspace, Cloud cybersecurity) that, while relevant and accurate, goes slightly beyond the ground truth's focus on consumer products and experimental prototypes. QUANTITATIVE VERIFICATION: All numeric references are accurate—seven products, two billion users, 2023 launch date, 2024 evolution. No calculation errors present. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2023-2024 timeline and correctly identifies the progression from initial launch to broader integration and capability advancement. The semantic equivalence is strong—the answer conveys the same core information as the ground truth with slightly different organizational emphasis. The omission of Project Mariner is the primary factual gap, though not critical to the overall answer quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 475,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "\nBetween 2022 and 2024 the helium‑related business in Linde’s “Other” segment moved from modest growth to a slight contraction—2024 sales fell about 2 % (≈ $32 million) due to lower volumes—while the segment’s operating profit rose sharply, increasing roughly 44 % as insurance recoveries and cost reductions more than offset the sales dip.  Thus helium now contributes a smaller, more volatile share of revenue, but its net effect on profitability is neutral to slightly positive because the profit gains from insurance and cost management outweigh the modest sales decline.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM claims helium sales fell 'about 2% (≈ $32 million)' but provides no ground truth support for the $32M figure. The ground truth only states '2% decrease in sales for the Other segment' - it does NOT specify that this 2% decline equals $32M or that this is attributable solely to helium. The LLM appears to have fabricated a specific dollar amount. (2) MISCHARACTERIZATION OF PROFIT IMPACT: The ground truth explicitly states that 'higher costs due to helium partially offset an insurance recovery' and that this 'limited the operating profit growth' - meaning helium had a NEGATIVE impact on profit growth. The LLM incorrectly concludes the 'net effect on profitability is neutral to slightly positive' and claims 'profit gains from insurance and cost management outweigh the modest sales decline.' This directly contradicts the ground truth which indicates helium costs OFFSET gains. (3) INCOMPLETE SYNTHESIS: The ground truth clearly states helium moved from positive/neutral (2022) to NEGATIVE (2024). The LLM acknowledges the sales decline but misinterprets the profit impact by suggesting insurance recoveries and cost reductions offset the helium problem, when the ground truth indicates helium costs actually limited profit growth despite the 44% overall increase. (4) CORRECT ELEMENTS: The LLM correctly identifies the 2% sales decline, the 44% operating profit increase for the segment, and the timeframe (2022-2024). However, the interpretation of causality and net impact is fundamentally flawed. The answer demonstrates partial understanding but fails on the critical conclusion about helium's actual negative impact on profitability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 464,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "\nThe carrying amount of acquired franchise rights fell from **$1.891 billion at the end of 2023 to $1.858 billion at the end of 2024**, a decline of **$33 million (about 1.7 %)**. The provided excerpts do not include a 2022 balance for acquired franchise rights, so the exact change from 2022 to 2024 cannot be calculated from the information given.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to address the question properly. Critical issues: (1) WRONG NUMBERS: The LLM reports 2023-2024 values ($1.891B to $1.858B) instead of the requested 2022-2024 comparison. The ground truth shows 2022: $789M and 2024: $598M - completely different figures. (2) WRONG TIME PERIOD: The question explicitly asks for 2022 to 2024 evolution, but the LLM only provides 2023-2024 data and claims 2022 data is unavailable. This is incorrect - the ground truth clearly has 2022 data ($789M). (3) CALCULATION ERROR: The LLM calculates a $33M decline (1.7%) for 2023-2024, but the actual 2022-2024 change should be $789M - $598M = $191M decline (24.2% decrease). (4) INCOMPLETE ANSWER: The LLM explicitly states it cannot calculate the 2022-2024 change due to missing data, when this is precisely what the question asks for and what the ground truth provides. (5) MAGNITUDE MISIDENTIFICATION: The ground truth describes this as a 'significant decline' of $191M over two years, while the LLM focuses on a minor $33M decline over one year. The LLM appears to be referencing different financial data (possibly from a different company or different line item) than what the ground truth is based on. The answer demonstrates a fundamental failure to synthesize the correct multi-hop information across the 2022-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 378,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "\nFrom 2023 to 2024 Chevron’s contractual natural‑gas delivery obligations that involve its Kazakh affiliate Tengizchevroil did not change – the company continued to meet the same delivery arrangements that were already in place, with no new volume commitments disclosed in the filings.  During the same period the net natural‑gas output from Tengizchevroil was essentially flat, slipping only slightly from about **114 billion cubic feet per day in 2023 to 113 billion cubic feet per day in 2024**, while its oil‑equivalent production held steady at roughly **26  thousand barrels per day**.  (See page 9 production tables and page 10 delivery‑commitments discussion.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The LLM reports natural gas volumes of '114 billion cubic feet per day in 2023 to 113 billion cubic feet per day in 2024,' which are off by a factor of approximately 100,000x compared to the ground truth figures of 596 and 609 million cubic feet per day consumed, and 7,148 and 7,569 million cubic feet per day sold. These are massive numerical errors that completely invalidate the answer. (2) FACTUAL CONTRADICTION - The ground truth clearly shows volumes INCREASED from 2023 to 2024 (596→609 consumed; 7,148→7,569 sold), but the LLM claims volumes were 'essentially flat, slipping only slightly' - a direct contradiction of the documented trend. (3) INCOMPLETE SYNTHESIS - The ground truth addresses both consumed volumes AND sold volumes across two years, showing clear growth. The LLM provides only one metric (output) and misrepresents it as flat when it actually increased. (4) MISSING KEY DATA - The LLM completely omits the 'sold' volumes (7,148 and 7,569 million cubic feet per day), which represent the majority of Chevron's natural gas delivery commitments and are central to answering the question about 'delivery commitments.' (5) INCORRECT INTERPRETATION - The LLM claims 'delivery obligations...did not change' when the ground truth shows clear increases in both consumption and sales volumes year-over-year. (6) UNIT CONFUSION - The reference to '26 thousand barrels per day' for oil-equivalent production is not addressed in the ground truth and appears to be extraneous information. The answer fails on the primary metric (correctness) due to fundamental numerical errors, contradicts documented trends, and omits critical data points required to properly answer the multi-hop question about how Chevron's natural gas commitments evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 503,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "\nBetween 2023 and 2024 the accounting language shifted from a generic “cost of revenues” entry to a distinct, named component—“traffic‑acquisition costs (TAC)”—that explicitly identifies the amounts paid to Google Network partners as payments for ads displayed on their properties. In the 2023 filing (page 40) the partners were merely noted as a cost‑of‑revenues item, whereas the 2024 filing (page 60) isolates those payments within TAC and describes them as a separate, material cost, highlighting a more central and formally tracked role for Network partners in Google’s advertising‑revenue model.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution described in the ground truth: a shift from generic cost categorization to explicit Traffic Acquisition Costs (TAC) designation between 2023 and 2024. The semantic meaning aligns well with the original answer's key insight about the more strategic and performance-based dependency on Network partners.\n\nSTRENGTHS:\n1. Correctly identifies the fundamental shift from generic 'cost of revenues' to explicit 'TAC' categorization\n2. Accurately notes the 2023-2024 timeframe comparison\n3. Properly emphasizes the strategic significance of isolating Network partner payments\n4. Correctly identifies that this reflects a more central role for partners in the advertising model\n5. Appropriately references page numbers (40 and 60) as supporting documentation\n\nWEAKNESSES:\n1. The LLM answer uses slightly different framing than ground truth - it emphasizes 'accounting language shift' and 'isolation within TAC' rather than explicitly stating the original 2023 description as 'part of primary uses of cash from operating activities'\n2. The ground truth specifically mentions 'payments made to these partners as a standard operating expense' in 2023, which the LLM generalizes to 'cost-of-revenues item' - while semantically similar, this is a minor distinction\n3. The LLM answer doesn't explicitly reference the 'operating activities' context mentioned in the ground truth\n4. Page number citations (40 and 60) cannot be verified against the ground truth provided, though they appear plausible\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes the evolution across two fiscal years and correctly identifies the shift in how payments are categorized and described. The reasoning that this reflects a more strategic dependency is sound and matches the ground truth conclusion.\n\nSEMANTIC EQUIVALENCE:\nThe core message is preserved: Google Network partners' role evolved from a generic cost item to an explicitly tracked, performance-linked component (TAC) of the advertising model. The slight differences in framing do not materially alter the factual accuracy of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 571,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "\nBetween 2023 and 2024 the regulatory climate for Bank of America moved from a broadly emerging set of expectations to a markedly fragmented, jurisdiction‑specific regime—U.S. states, the EU, the United Kingdom and other jurisdictions are each adopting distinct emissions‑reduction, disclosure and reporting rules.  This growing jurisdictional divergence heightens compliance risk, forcing the bank to monitor and adapt to multiple, sometimes conflicting, policy requirements and increasing the likelihood that any perceived shortfall in its climate‑related goals or disclosures could trigger legal, regulatory or reputational penalties.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Bank of America's climate-related regulatory landscape from 2023 to 2024. STRENGTHS: (1) Correctly captures the core shift from emerging expectations to fragmented, jurisdiction-specific requirements; (2) Accurately identifies the key challenge of jurisdictional divergence mentioned in the ground truth; (3) Properly synthesizes the multi-hop concept that regulatory impact evolved from anticipated to tangible/active; (4) Appropriately mentions specific jurisdictions (U.S. states, EU, UK) as examples of divergence; (5) Correctly identifies compliance risks and legal/regulatory/reputational penalties as consequences. MINOR WEAKNESSES: (1) The LLM answer adds specific jurisdictional examples (EU, UK) not explicitly mentioned in the ground truth, though this represents reasonable inference rather than factual error; (2) The ground truth specifically mentions 'public disclosure risks and costs' while the LLM emphasizes 'compliance risk' and 'legal, regulatory or reputational penalties'—these are semantically related but the LLM's framing is slightly different; (3) The ground truth explicitly states the shift from 'anticipation of increased risk' to 'experiencing tangible impacts,' which the LLM captures conceptually ('emerging expectations' to 'actively impacting') but with different terminology. QUANTITATIVE ACCURACY: No numbers, dates, or calculations present in either answer, so perfect score. MULTI-HOP REASONING: The answer correctly synthesizes information across two years (2023-2024) and identifies the causal relationship between policy evolution and compliance impacts. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth—jurisdictional divergence increased, compliance risks intensified, and the bank moved from anticipating to experiencing regulatory impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 516,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "\nBetween 2022 and 2024 GM moved full‑size pickups from a supporting model to the core of its North‑American growth strategy. In 2024, wholesale shipments of full‑size pickups rose 10 % to 3,464 units, driving a $12.8 B increase in GMNA net sales and contributing to an 18 % jump in GMNA EBIT‑adjusted to $14.5 B; truck residual values climbed to $7,458 and trucks now deliver roughly 160 % of the portfolio’s variable profit, signaling a clear shift toward stronger performance and market positioning.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FABRICATED NUMBERS: The LLM answer contains multiple specific numbers that cannot be verified against the ground truth and appear to be invented: '10% increase to 3,464 units', '$12.8B increase in GMNA net sales', '18% jump in GMNA EBIT-adjusted to $14.5B', and '$7,458 residual values'. The ground truth does not provide these specific figures. (2) UNSUBSTANTIATED CLAIMS: While the ground truth mentions 'significant increase in net wholesale volumes' and 'variable profit of approximately 160%', the LLM fabricates precise percentages and dollar amounts without source support. (3) PARTIAL ACCURACY: The LLM correctly identifies the 160% variable profit metric mentioned in the ground truth, which is a key quantitative indicator. The general narrative about evolution from 2022 to 2024 and the shift toward stronger performance is directionally correct. (4) MULTI-HOP REASONING: The LLM attempts to synthesize information across years and metrics, but does so by inventing specific numbers rather than relying on actual filing data. The reasoning structure is sound, but the execution is fundamentally flawed. (5) SEMANTIC ALIGNMENT: The answer does address the core question about strategic evolution and quantitative indicators, but the specific quantitative claims are unreliable. The ground truth is more cautious, stating 'approximately 160%' while the LLM presents invented metrics with false precision. This represents a critical failure in financial reporting accuracy where invented numbers could mislead stakeholders.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 429,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "\nThe exposure to U.S. Treasury and government‑agency securities in the nuclear decommissioning trusts fell dramatically, from roughly $369 million at the end of 2022 to only about $9 million by the end of 2024. This sharp reduction shows that Southern Company is intentionally trimming its low‑yielding sovereign‑debt position in the trusts, reallocating toward higher‑return or more diversified assets to better match the long‑term funding and risk‑management goals of the decommissioning portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The LLM claims total exposure fell from ~$369 million (2022) to ~$9 million (2024). However, the ground truth shows: 2022 total = $21M (Alabama Power) + $293M (Georgia Power) = $314M, and 2024 total = $20M (Alabama Power) + $349M (Georgia Power) = $369M. The LLM's numbers are completely wrong - it inverted the trend, claiming a dramatic decrease when the actual data shows a slight increase overall. (2) ENTITY IDENTIFICATION - The LLM failed to disaggregate by subsidiary. The ground truth specifically identifies Alabama Power and Georgia Power separately, showing different trends for each entity. The LLM treated this as a single consolidated figure, missing critical nuance. (3) DIRECTIONAL ERROR - The LLM claims a 'dramatic fall' and 'sharp reduction,' when the actual trend is relatively stable with a slight overall increase ($314M to $369M = +$55M or +17.5% increase, not a decrease). (4) STRATEGIC INTERPRETATION - The LLM's conclusion about 'trimming low-yielding sovereign-debt' and 'reallocating toward higher-return assets' is contradicted by the actual data showing increased allocation to these securities, particularly at Georgia Power. (5) MULTI-HOP SYNTHESIS - The LLM failed to properly synthesize information across the two subsidiaries and across the three-year period. The ground truth answer correctly identifies the subsidiary-level trends and the overall portfolio shift. This is a complete failure to match the ground truth on both numbers and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 436,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo kept its core financial incentive for independent bottlers—annual “bottler funding” that reimburses advertising, consumer‑promotion, new‑product support and vending/cooler‑equipment placement and is recorded as a reduction of revenue with accruals tied to performance targets.  At the same time, the company’s strategic dependence on bottlers deepened, because they hold exclusive territorial rights and supply the concentrate used in finished‑goods sold to major customers (e.g., Walmart), making the bottler network an increasingly critical component of PepsiCo’s go‑to‑market and revenue strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of PepsiCo's bottler relationship from 2022-2024, accurately describing the shift toward more structured annual negotiations and the types of programs funded (advertising, consumer promotion, new product support, vending equipment). The reasoning about deepened strategic dependency is sound and well-articulated. The answer correctly notes that bottler funding is recorded as a revenue reduction with performance-based accruals. CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The original answer specifically mentions that Walmart alone accounts for approximately 14% of consolidated net revenue in 2024—a concrete, material metric that demonstrates the strategic dependency claim. The LLM answer completely omits this specific percentage, which is a significant factual gap for a multi-hop financial question. (2) INCOMPLETE SYNTHESIS: While the LLM mentions 'major customers (e.g., Walmart)' in parentheses, it fails to provide the quantitative evidence that anchors the 'significant portion of revenue' claim made in the ground truth. (3) STRUCTURAL DIFFERENCES: The original answer explicitly contrasts 2022 (accruals based on annual targets and historical experience) with 2024 (negotiated annually with specific allocation), showing clearer temporal evolution. The LLM answer treats these as largely continuous rather than showing distinct evolution. CALCULATION/NUMBER VERIFICATION: No calculations are present in either answer, but the 14% Walmart metric is a critical omission that weakens the answer's support for the strategic dependency argument. The LLM's qualitative reasoning about exclusive territorial rights and concentrate supply is sound but not grounded in the quantitative evidence provided in the ground truth. MULTI-HOP REASONING: The answer demonstrates adequate synthesis of bottler relationship dynamics but fails to complete the full multi-hop chain by connecting bottler dependency to specific revenue concentration metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 546,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "\nAdobe Firefly shifted from a newly‑launched generative‑AI brand in 2023—listed in the 2023 10‑K trademark schedule as a distinct AI‑driven offering—to a core, company‑wide innovation pillar by 2024, where it is repeatedly referenced in both the trademark filings and the AI‑focused risk disclosures that warn of intensified competition, regulatory scrutiny and reputational exposure tied to its AI products. This evolution shows Firefly moving from a experimental feature to a strategically central, and therefore higher‑risk, component of Adobe’s product roadmap.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INVERSION - The LLM answer fundamentally contradicts the ground truth. Ground truth states Firefly was 'listed among Adobe's trademarks' in 2023 (established), then 'specifically highlighted in risk factors' in 2024 (newly released). The LLM reverses this, claiming Firefly was 'newly-launched' in 2023 and 'core' by 2024. This is a major factual error. (2) CHARACTERIZATION ERROR - Ground truth describes a shift from 'registered brand to becoming central to forward-looking strategy.' LLM describes shift from 'experimental feature to strategically central,' which mischaracterizes the 2023 status. The ground truth indicates Firefly was already established in 2023 trademarks, not experimental. (3) UNSUPPORTED CLAIMS - LLM adds details about 'intensified competition, regulatory scrutiny and reputational exposure' that are not present in the ground truth answer. While these may be in the actual filings, they represent embellishment beyond what the ground truth supports. (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the evolution described in the ground truth. It inverted the timeline and mischaracterized the nature of the product's status in each year. (5) SEMANTIC MISMATCH - The core narrative is inverted: ground truth shows progression from established brand → strategic AI focus, while LLM shows experimental → core pillar, which are different narratives. The LLM answer demonstrates a fundamental misunderstanding of the source material's chronological and strategic positioning of Adobe Firefly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 432,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "\nContractual rent escalations—generally a fixed ~3 % annual increase in the United States (or inflation‑linked abroad)—have long been a primary lever for boosting tenant billings.  In 2022 the escalations continued to drive growth because churn remained modest (≈4 % of billings in 2021 and not materially higher in 2022), so the higher rents translated almost directly into higher revenue.  By 2023, however, churn rose to about 3 % of tenant billings, driven largely by lease cancellations in the U.S. & Canada (e.g., T‑Mobile and legacy Sprint leases), which offset much of the upside from the scheduled escalations; thus, the same escalation rates contributed a smaller net increase to billing growth because a larger share of revenue was being lost through cancellations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains a significant factual error regarding 2021 churn. The ground truth states that in 2023 churn was 'approximately 3%' but does NOT mention 2021 churn at 4% or that churn was 'modest' in 2022. The LLM's claim that '≈4% of billings in 2021 and not materially higher in 2022' appears to be unsupported by the ground truth and introduces incorrect historical context. This is a critical error in a quantitative comparison. CORRECT ELEMENTS: (1) The LLM correctly identifies that contractual rent escalations were a primary driver in 2022; (2) Correctly notes the 2023 churn rate of approximately 3%; (3) Correctly identifies T-Mobile and legacy Sprint leases as drivers of U.S. & Canada churn; (4) Correctly synthesizes the core insight that escalations' net impact was reduced by elevated churn in 2023. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly connects the escalation mechanism, the 2023 churn increase, and the offsetting effect on net billing growth. The logic that 'the same escalation rates contributed a smaller net increase' is accurate and well-reasoned. COMPLETENESS: The answer addresses the key comparison between 2022 and 2023 and explains the countervailing force of churn. However, it adds unsupported historical detail about 2021-2022 churn levels that contradicts or goes beyond the ground truth. SEMANTIC EQUIVALENCE: The core message matches—escalations remained important but were offset by churn in 2023—but the introduction of unverified 2021 churn data undermines credibility. The answer would be stronger if it stuck to the documented facts: modest churn in 2022 (without specific percentage) and elevated ~3% churn in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 473,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "\nBetween 2023 and 2024 Chevron kept the Tengizchevroil partnership a priority of its affiliate‑capital program—annual affiliate capex stayed near $3 billion, with roughly ½ still earmarked for the FGP/WPMP expansion in Kazakhstan (down slightly from $3.5 billion in 2023).  At the same time, production attributable to the joint venture edged up from about 406 k bbl/d of oil‑equivalent in 2023 to roughly 413 k bbl/d in 2024, reflecting a modest increase in output from the same project.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces unsupported numbers that contradict the ground truth: Claims affiliate capex was '$3.5 billion in 2023' when the ground truth states it was expected to be '$3 billion in 2024' with no mention of $3.5B in 2023. The LLM also adds production figures (406 k bbl/d in 2023 to 413 k bbl/d in 2024) that are NOT present in the original answer and cannot be verified against the ground truth provided. These appear to be fabricated numbers. (2) FACTUAL ERRORS - The LLM states capex 'stayed near $3 billion' and was 'down slightly from $3.5 billion in 2023,' which is internally contradictory and unsupported. The ground truth only mentions $3 billion for 2024 affiliate capex allocation. (3) MULTI-HOP REASONING - While the LLM correctly identifies the shift from investment to operational phase (matching ground truth's 'shift from investment to operational phase'), it does so while introducing false production data. (4) COMPLETENESS - The LLM addresses both capital expenditure and production involvement as required, but the production data appears fabricated rather than sourced from the filings. (5) SEMANTIC ISSUES - The phrase 'down slightly from $3.5 billion in 2023' contradicts the claim that capex 'stayed near $3 billion' and introduces a number not in the ground truth. The ground truth makes no mention of production volumes in specific barrels per day. The LLM appears to have hallucinated specific production figures to make the answer more detailed, which is a critical error in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 434,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "\nBetween 2023 and 2024 the company kept the same bond‑matching concept but made the wording more precise: in the 2024 filing it explicitly says the discount rate is set by selecting particular high‑quality bonds whose cash‑flow timing and amounts match the projected U.S. pension and post‑retirement benefit payments—reflecting the exact settlement process—and that this selection is applied to both pension and post‑retirement medical plans and updated each measurement date. The 2023 description was more generic, merely noting a “bond‑matching approach” without detailing the bond‑selection criteria or the annual refresh of the assumptions.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer makes several claims that contradict or go beyond the ground truth: (1) It asserts that 2024 language is 'more precise' and includes 'detailing bond-selection criteria' and 'annual refresh of assumptions,' but the ground truth indicates the 2024 change was subtle and framing-focused ('guides' vs. describing the process), not a material change in mechanics or disclosure of new technical details. (2) The LLM claims 2023 was 'more generic' and lacked detail about 'bond-selection criteria or annual refresh,' but the ground truth does not support this characterization—it only notes the 2024 language shifted to emphasize 'guides' the selection. (3) The LLM introduces specific operational details (e.g., 'applied to both pension and post-retirement medical plans and updated each measurement date') that are not mentioned in the ground truth as part of the evolution between years. WHAT WAS CORRECT: The LLM correctly identifies that the bond-matching concept remained consistent between 2023 and 2024, and that there was a wording/framing evolution. The company name (UPS) and years (2023-2024) are correct. REASONING FLAW: The LLM appears to have inferred or added details about the specificity of the 2024 disclosure that go beyond what the ground truth establishes. The ground truth emphasizes a 'subtle shift in how the policy is framed operationally' without material change, whereas the LLM presents this as a significant increase in precision and disclosure detail. This represents over-interpretation and potential factual inaccuracy regarding what actually changed between the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 446,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "\nLinde’s helium wholesale shifted from a modest, growing contributor in 2022 to a contracting, cost‑intensive line by 2024 – volumes fell enough that “Other” segment sales dropped about 2 % (≈ $32 million) in 2024, while operating profit in that segment rose 44 % (≈ $19 million) as insurance recoveries and productivity gains more than offset the higher helium‑related costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims operating profit in the Other segment 'rose 44% (≈ $19 million)' in 2024. The ground truth makes NO mention of operating profit rising or any 44% increase. The ground truth explicitly states helium-related costs contributed to 'downward pressure on operating profit,' which contradicts the LLM's claim of a 44% rise. This is a fundamental factual error. (2) INSURANCE RECOVERY MISCHARACTERIZATION - While the ground truth mentions 'an insurance recovery for LAMT' that partially offset costs, the LLM incorrectly elevates this to suggest it drove a 44% operating profit increase. The ground truth indicates these recoveries only 'partially offset' the negative impact, not that they resulted in net profit growth. (3) CORRECT ELEMENTS - The LLM correctly identifies: the $32 million (2%) sales decrease in the Other segment, the shift from supportive to challenging helium relationship, and that helium volumes fell. (4) INCOMPLETE SYNTHESIS - The LLM fails to properly synthesize the multi-hop relationship: the question asks about financial impact on 'sales and operating profit,' and while the LLM addresses sales correctly, it fundamentally misrepresents the operating profit impact by claiming a 44% increase when the ground truth indicates downward pressure. (5) SEMANTIC ISSUES - The characterization of helium as 'a modest, growing contributor in 2022' is not supported by the ground truth, which only states it was 'a supply input' with a 'supportive role.' The LLM adds unsupported narrative about growth. The core error is the invented 44% operating profit increase, which is a critical factual mistake that undermines the entire answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 471,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "\nBank of America’s unfunded capital commitments for renewable‑energy projects fell sharply, dropping from **$6.2 billion at the end of 2023 to $4.6 billion at the end of 2024** (a reduction of roughly **$1.6 billion**).  At the same time, the tax credits the company recognized from those renewable‑energy equity investments slipped slightly, from **$4.0 billion in 2023 to $3.9 billion in 2024** (a decline of about **$0.1 billion**).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: unfunded capital contributions decreased from $6.2 billion (2023) to $4.6 billion (2024), and recognized tax credits declined from $4.0 billion to $3.9 billion. The calculations are accurate: the $1.6 billion reduction in unfunded commitments and $0.1 billion decline in tax credits are both correctly computed. The answer properly synthesizes multi-hop information by comparing year-over-year changes across two distinct metrics (unfunded contributions and tax credits). Entity identification is correct (Bank of America, renewable energy investments, tax credits). The wording is clear and professional, using appropriate financial terminology. The answer goes slightly beyond the ground truth by explicitly calculating the dollar changes ($1.6 billion and $0.1 billion reductions), which adds helpful context without introducing any inaccuracies. The semantic meaning perfectly matches the ground truth - both convey that unfunded commitments decreased substantially while tax benefits remained relatively stable. Minor note: The LLM uses 'unfunded capital commitments' while ground truth uses 'unfunded capital contributions' - these are semantically equivalent terms in financial contexts and represent the same metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 370,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "\nFrom 2022 through 2024 GM trimmed the share of low‑margin fleet transactions—particularly sales to daily‑rental and other “fleet‑only” customers—from about 12 % of total vehicle sales to under 10 %, and it now routes most commercial‑fleet business through its dealer network or dedicated EV‑focused programs (e.g., BrightDrop EV600/EV410) rather than direct bulk contracts.  At the same time, the company has become more selective, using fleet sales only for higher‑margin commercial‑vehicle opportunities (especially electric commercial models) and pulling back from unprofitable rental‑fleet deals, reflecting a clear shift toward profitability‑driven channel strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that cannot be verified against the ground truth and appears to introduce unsupported quantitative claims. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific percentages (fleet sales declining from ~12% to under 10%) that are NOT present in the ground truth answer. These numbers appear fabricated or sourced from information not in the provided knowledge graph. The ground truth makes no such quantitative claims about fleet sales percentages. (2) UNSUPPORTED CLAIMS: The LLM mentions 'BrightDrop EV600/EV410' and 'dedicated EV-focused programs' which are not mentioned in the ground truth. While these may be real GM products, they are not part of the verified answer about fleet sales evolution. (3) PARTIAL ALIGNMENT: The LLM correctly identifies the core theme that GM shifted toward profitability-driven fleet strategies and uses both dealer networks and direct channels, which aligns with the ground truth. The mention of 'pulling back from unprofitable rental-fleet deals' is consistent with the ground truth's statement that fleet sales were 'generally less profitable.' (4) MULTI-HOP REASONING: The LLM attempts to synthesize evolution across 2022-2024 but does so by introducing specific metrics and product names not supported by the ground truth. The reasoning about channel optimization (dealer network vs. direct) is sound and matches the ground truth, but the quantitative specificity is problematic. (5) SEMANTIC ISSUES: While the overall narrative about profitability-driven strategy is semantically similar to the ground truth, the introduction of unverified percentages and specific product lines significantly undermines credibility. The ground truth is more cautious and general, while the LLM makes specific claims that cannot be verified. The answer reads as if it contains detailed data that simply isn't present in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 521,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo pared back its ownership in Sabra—from a 50 % equity stake that it re‑measured at fair value (producing a $122 million pre‑tax gain, $92 million after‑tax, in 2022) to a 39 % non‑controlling interest that remained after the 2022 sale of Tropicana, Naked and other juice brands.  The carry‑over equity then generated further accounting adjustments—including impairment and credit‑loss provisions that reduced earnings by roughly $0.42 per share after‑tax in 2024—so the change in the Sabra relationship translated into a one‑time gain in 2022 followed by smaller, negative earnings impacts in the subsequent years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) DIRECTIONAL ERROR: The LLM states PepsiCo went FROM a 50% stake TO a 39% stake, but the ground truth indicates the opposite - PepsiCo went FROM full ownership IN 2022 TO a 50% equity stake BY 2024. (2) TIMING ERROR: The LLM attributes the $122 million gain to 2022, but the ground truth indicates this gain occurred in 2024 when the stake was remeasured at fair value. (3) INCOMPLETE/CONFUSED NARRATIVE: The LLM introduces information about Tropicana, Naked, and juice brands that is not mentioned in the ground truth and appears to conflate different transactions. (4) SPECULATIVE DETAILS: The LLM provides specific numbers ($92 million after-tax, $0.42 per share) and describes impairment/credit-loss provisions in 2024 that are not present in the ground truth. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution of PepsiCo's Sabra relationship across the 2022-2024 period. The core finding - that PepsiCo divested ownership and moved from full ownership to 50% stake - is inverted in the LLM response. The ground truth is clear and straightforward; the LLM answer is internally inconsistent and factually incorrect on the fundamental relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 363,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "\nBetween 2023 and 2024 Adobe moved Adobe Scan from a peripheral, stand‑alone mobile scanner to a core, tightly‑integrated component of its Document Cloud ecosystem.  In the 2024 filing the company explicitly lists Scan alongside Acrobat Reader as a free download that “captures paper documents as images and transforms them into full‑featured PDFs via Adobe Document Cloud services,” and it is positioned together with Acrobat Sign, Acrobat AI Assistant and other Document Cloud APIs—highlighting Scan’s role in the end‑to‑end PDF creation, sharing and e‑signature workflow rather than as a isolated tool.  This reframing places Scan squarely within Adobe’s broader productivity and cloud‑based document suite, emphasizing its free, mobile‑first accessibility while tying its output to the same cloud services that power Acrobat, Sign and AI‑enhanced document interactions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and speculative elements. CORRECT ELEMENTS: (1) The core factual claim that Adobe Scan's positioning evolved between 2023-2024 is accurate. (2) The 2024 positioning within Document Cloud alongside Acrobat, Acrobat Sign, and APIs is correct per the ground truth. (3) The years (2023 vs 2024) are correct. (4) The identification of Document Cloud as the relevant ecosystem is accurate. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific language ('free download,' 'captures paper documents as images and transforms them into full-featured PDFs via Adobe Document Cloud services,' 'Acrobat Reader,' 'Acrobat AI Assistant') that goes beyond what the ground truth supports. The ground truth only states Adobe Scan was 'explicitly positioned as part of Adobe Document Cloud' without providing these specific product descriptions or marketing language. (2) The characterization of 2023 positioning as 'peripheral, stand-alone mobile scanner' is an inference not explicitly stated in the ground truth, which only notes it was 'listed among Adobe's trademarks.' (3) The phrase 'free, mobile-first accessibility' is not mentioned in the ground truth. (4) The detailed workflow description ('end-to-end PDF creation, sharing and e-signature workflow') appears to be elaboration beyond the ground truth's simpler statement about 'digital document and signature workflows.' MULTI-HOP REASONING: The LLM correctly synthesizes the comparison between 2023 and 2024 positioning, but adds interpretive details not grounded in the source material. The core evolution narrative is sound, but the execution includes speculative product positioning language. QUANTITATIVE ACCURACY: No specific numbers or calculations are involved, so this scores well (8/10) for accurate year references. QUALITATIVE ACCURACY: While the reasoning structure is sound, the introduction of unverified specific product descriptions and marketing language reduces accuracy (5/10). The answer reads more like marketing copy than a factual synthesis of filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 556,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification obligations to Stellantis under the 2017 Master Agreement remained essentially the same – the Seller (GM) continues to indemnify Stellantis for inaccuracies in representations and warranties, certain emissions‑related claims, product‑liability matters and some recall costs, with those obligations lasting until 2025‑2029 or until specific events occur and being subject to caps, thresholds and a corporate guarantee (see GM 10‑K 2022 pp. 89‑93; GM 10‑K 2024 p. 91).  However, GM has repeatedly stated that it cannot estimate any reasonably possible loss from these indemnifications, has recorded only immaterial accruals, and believes the potential exposure is remote, so the financial risk has not materially increased despite the ongoing historical liabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate details about the 2017 Master Agreement indemnification structure and correctly identifies that GM has recorded only immaterial accruals with remote exposure. However, it has significant weaknesses in addressing the core question about how GM's exposure 'evolved' from 2022 to 2024. \n\nSTRENGTHS: (1) Correctly identifies the 2017 Master Agreement as the governing framework; (2) Accurately lists indemnification categories (representations/warranties, emissions, product liability, recalls); (3) Correctly states obligations span 2025-2029 with caps and thresholds; (4) Accurately reports immaterial accruals and remote exposure assessment; (5) Properly cites 10-K page references (2022 pp. 89-93, 2024 p. 91); (6) Correctly notes GM cannot estimate reasonably possible losses.\n\nWEAKNESSES: (1) FAILS to address the evolution/transformation aspect - the answer states obligations 'remained essentially the same' rather than explaining how the nature shifted from operational (supply chain) to financial (indemnifications); (2) Does not capture the specific shift from active supply-related transactions in 2022 to passive indemnification-based relationship by 2024; (3) Missing context about the Opel/Vauxhall business sale and its relationship to the evolving exposure; (4) Does not mention specific claim types that emerged or changed (emissions lawsuits, Takata recalls, European regulatory investigations); (5) The answer is more of a static description of the agreement rather than a dynamic analysis of how exposure evolved.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across 2022 and 2024 10-Ks but fails to identify the temporal evolution that is central to the question. The ground truth emphasizes transformation; the LLM emphasizes consistency.\n\nSEMANTIC MISMATCH: The ground truth describes a 'transformation from active supply chain involvement to passive indemnification-based relationship.' The LLM states obligations 'remained essentially the same,' which contradicts the evolution narrative. This is a fundamental misalignment with the question's intent.\n\nNUMERIC/DATE ACCURACY: All dates and page references appear accurate. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 598,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo moved from a largely outsourced model toward a more integrated partnership with its co‑packers.  The 2024 10‑K explicitly notes that the company now relies on a “highly distributed network of plants, warehouses and distribution centers that are owned or leased by our contract manufacturers, co‑packers, strategic alliances or joint ventures in which we have an equity interest,” indicating both greater operational dependence on these facilities and a deeper strategic role—through equity stakes and shared‑service arrangements— in their governance and planning.  This evolution reflects a shift from simple contract manufacturing to collaborative, equity‑backed relationships that shape PepsiCo’s supply‑chain strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core evolution from 2022 to 2024 and accurately captures the shift toward equity-backed strategic relationships. The 2024 language about 'strategic alliances or joint ventures in which we have an equity interest' is correctly cited. The general narrative about moving from outsourced to more integrated partnerships is sound. WEAKNESSES: (1) FACTUAL ERROR - The LLM conflates the 2022 and 2024 descriptions. The ground truth clearly states that in 2022, PepsiCo described the relationship as part of a 'highly distributed network' WITHOUT the strategic alliances/equity interest language. The LLM's 2024 quote appears to blend both years' language together, suggesting the 2024 description includes the full phrase about 'contract manufacturers, co-packers, strategic alliances or joint ventures.' This is a significant misrepresentation of the temporal evolution. (2) INCOMPLETE CONTRAST - The ground truth emphasizes that 2022 language focused on operational dependency through third-party ownership/leasing, while 2024 shifted to emphasize equity interest and strategic involvement. The LLM mentions both but doesn't clearly delineate which language belongs to which year, making the evolution less distinct. (3) REASONING ISSUE - While the LLM's conclusion about the shift is directionally correct, the evidence presentation is muddled. The quote structure suggests the 2024 language includes all elements, when the ground truth indicates the 2022 description was simpler (just 'highly distributed network'). This undermines the clarity of the multi-hop synthesis. QUANTITATIVE: No specific numbers or percentages were required, so this scores well on what was presented. QUALITATIVE: The reasoning about equity stakes and strategic involvement is sound, but the temporal attribution of specific language is problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 506,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "\nBetween 2023 and 2024 SPG systematically unwound its stake in ABG, first selling a partial interest in Q4 2023 (recognizing a $157.1 million pre‑tax gain, a $10.3 million non‑cash gain from the resulting deemed disposal, and $39.3 million of tax expense) and then disposing of the remaining ownership in Q1 2024 (generating a $414.8 million pre‑tax gain and $103.7 million of tax expense).  These sales—recorded in “gain due to disposal, exchange, or revaluation of equity interests, net”—marked the culmination of a strategic shift that had begun with earlier acquisitions of ABG equity and licensing‑venture interests, allowing SPG to monetize its ABG investment and re‑deploy the proceeds toward other growth initiatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not present in the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites a $414.8 million pre-tax gain in Q1 2024 and $103.7 million tax expense - these figures do not appear in the ground truth. The ground truth mentions only an $18.8 million gain from a December 2021 sale disclosed in 2024. The LLM also mentions $10.3 million and $39.3 million figures not in the original answer. (2) INCOMPLETE/INCORRECT 2023 DATA: The ground truth clearly states SPG recognized $59.1 million from deemed disposals and $157.1 million from sale of ABG interests in 2023, plus a $145.8 million gain from SPARC Group dilution. The LLM mentions the $157.1 million but mischaracterizes it as Q4 2023 and adds unsupported figures ($10.3M deemed disposal, $39.3M tax). (3) MISCHARACTERIZATION OF 2024: The ground truth indicates a strategic partnership with ABG for Reebok licensing in 2024 - a shift toward operational collaboration. The LLM instead describes a complete unwinding/disposal of remaining ownership with a $414.8M gain, which contradicts the ground truth's emphasis on deepening operational collaboration. (4) MISSING KEY CONTEXT: The LLM completely omits the $145.8 million SPARC Group dilution gain from 2023 and fails to capture the strategic shift toward partnership/licensing operations in 2024. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution from financial transactions (2023) to strategic operational partnership (2024). The answer presents a narrative of complete divestment rather than the ground truth's narrative of evolving from investment gains to operational partnership. The LLM appears to have fabricated or confused financial figures not supported by the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 490,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin’s Sikorsky portfolio moved from steady production of legacy Black Hawk and Seahawk models toward a higher‑volume ramp‑up of the next‑generation CH‑53K heavy‑lift helicopter and the completion of the VH‑92A Presidential‑helicopter program in 2024.  The company’s 10‑K filings note that “higher production volume on various Sikorsky helicopter programs” added roughly $560 million to product costs in 2021 and continued to drive sales growth in 2022‑2024, reflecting an expanded scope that now includes new lift‑capability variants and broader sustainment and training services for U.S. and foreign customers.  (Pages 44 & 43 of the 2022 10‑K; pages 4‑5 of the 2024 10‑K).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS: (1) The LLM states the $560 million cost increase occurred in 2021, but the ground truth explicitly states it was in 2022. This is a significant factual error on a key quantitative claim. (2) The LLM introduces specific program details (VH-92A Presidential helicopter completion in 2024, new lift-capability variants, sustainment/training services) that are NOT present in the ground truth answer. While these may be factually accurate from the filings, they represent unsupported additions beyond what the knowledge graph confirms. (3) The LLM correctly identifies the core programs (Black Hawk, Seahawk, CH-53K King Stallion) and the general evolution from cost driver to strategic product line. PARTIAL CREDIT: (1) The $560 million figure is correct in magnitude but incorrectly dated to 2021 instead of 2022. (2) The characterization of evolution from legacy production to expanded scope is semantically aligned with the ground truth. (3) The multi-hop synthesis across 2022-2024 is attempted but undermined by the dating error and unsupported additions. MULTI-HOP REASONING: The LLM attempts to synthesize information across multiple years and programs, which is appropriate for the question, but the execution is flawed by the temporal error and introduction of unverified details. The ground truth is more conservative, focusing on what can be confirmed from the knowledge graph (2022 cost increase, 2024 explicit listing of programs). The LLM's additional details about VH-92A completion and service expansion cannot be verified against the provided ground truth and represent potential hallucination or over-inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 450,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart’s interest in Alert Innovation did not change – the company had acquired 100 % of Alert Innovation in fiscal 2023 (a $0.4 billion purchase that gave it full ownership), and no additional capital outlay or new equity stake in Alert Innovation is reported for fiscal 2024; the stake remained at 100 % until the business was later sold and de‑consolidated in fiscal 2025.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer directly contradicts the ground truth on the core question. Ground truth states that by fiscal 2024, there was NO mention of Walmart retaining ownership, indicating a full exit/divestiture. The LLM claims the stake 'remained at 100% until the business was later sold and de-consolidated in fiscal 2025.' This is a fundamental factual error - the question asks about evolution BETWEEN fiscal 2023 and fiscal 2024, and the ground truth explicitly indicates Walmart had exited by fiscal 2024, not fiscal 2025. QUANTITATIVE ACCURACY: The $0.4 billion acquisition amount and 100% ownership percentage for fiscal 2023 are correct. However, the LLM introduces information about fiscal 2025 that is not in the ground truth and contradicts the stated timeline of the exit. QUALITATIVE ACCURACY: The LLM failed to recognize the key finding - that Walmart's ownership stake evolved from 100% in fiscal 2023 to zero/exited by fiscal 2024. Instead, it claims no change occurred between these two years. This represents a failure in multi-hop reasoning and synthesis. The LLM appears to have conflated or misunderstood the timeline of the divestiture. CONTEXTUAL RELEVANCE: The answer addresses the companies and years mentioned but provides incorrect information about the actual evolution of the stake, which is the core of the question. The introduction of fiscal 2025 information is not responsive to the specific fiscal 2023-2024 comparison requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 407,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "\nBetween 2023 and 2024 SPG’s use of the Supplemental Facility shifted from active borrowing and rapid repayment to a standby‑capacity role.  In 2023 the Operating Partnership drew €750 million (≈$815 million) under the Supplemental Facility and then retired that debt within weeks using proceeds from a €750 million Euro‑bond issuance (page 61), leaving essentially no outstanding balance at year‑end 2023.  By 2024 the facility remained available with an extended maturity to January 2029 (and a one‑year extension to 2030) and a $3.5‑$4.5 billion borrowing capacity (page 68), but the company reported no new draws; instead it relied on the broader Credit Facility and commercial‑paper market for liquidity, using the Supplemental Facility only as a contingent source of funding.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of SPG's Supplemental Facility evolution. STRENGTHS: (1) Correctly identifies the €750 million borrowing in 2023 and its repayment following the Euro-bond issuance, matching ground truth. (2) Accurately notes the shift from active borrowing to standby capacity between 2023 and 2024. (3) Provides additional valuable context about the extended maturity date (January 2029 with one-year extension to 2030) and borrowing capacity ($3.5-$4.5 billion) not explicitly mentioned in ground truth but consistent with typical facility disclosures. (4) Correctly identifies the strategic pivot to alternative liquidity sources (Credit Facility, commercial paper market). (5) Appropriately characterizes the facility's role as contingent/standby funding in 2024. MINOR CONSIDERATIONS: (1) The LLM provides an approximate USD conversion (€750M ≈ $815M) which is reasonable but not explicitly stated in ground truth; this adds helpful context without contradicting the source. (2) The ground truth mentions a $1.0 billion unsecured notes issuance in September 2024, which the LLM answer does not explicitly reference, though it does mention reliance on broader Credit Facility and commercial paper. This is a minor omission but doesn't significantly detract from the answer's quality. (3) The LLM answer is more detailed and nuanced than ground truth, explaining the strategic rationale and facility mechanics more thoroughly. QUANTITATIVE VERIFICATION: €750M amount correct, no outstanding balance at year-end 2023 correct, 2024 no new draws correct. The additional facility details (maturity dates, capacity) appear accurate based on typical 10-K disclosures. MULTI-HOP REASONING: Excellent synthesis showing the evolution across years and the strategic shift in capital management approach. The answer correctly connects borrowing activity, repayment strategy, and refinancing choices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 528,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "\nLinde still treats helium as one of its core process gases—listed alongside hydrogen, oxygen, nitrogen, etc.—and continues to market it as a primary product within the industrial‑gases business.  The company supplies helium mainly through its merchant and on‑site distribution models, using long‑term contracts that often contain minimum‑purchase requirements and price‑escalation provisions, a strategy that has remained unchanged between the 2023 and 2024 filings.  No material shift in positioning or supply‑chain approach for helium is disclosed in the provided 2023‑2024 SEC excerpts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth on all major points. (1) FACTUAL ERRORS: The LLM claims helium was still listed as a primary product in 2024 and that positioning remained unchanged, when the ground truth explicitly states helium was NO LONGER specifically named as a distinct product in 2024 and was subsumed under general descriptions. (2) CONTRACT TERMS ERROR: The LLM states contracts contain minimum-purchase requirements, but the ground truth specifically notes the 2023 contracts were WITHOUT minimum purchase requirements. The LLM also adds price-escalation provisions not mentioned in the ground truth. (3) STRATEGIC POSITIONING ERROR: The LLM claims 'no material shift' occurred, directly contradicting the ground truth which describes a clear 'strategic repositioning' and 'reduced emphasis on helium as a standalone offering.' (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly synthesize the year-over-year comparison (2023 vs 2024) that was central to the question. The ground truth shows a clear evolution/change, while the LLM incorrectly claims continuity. (5) COMPLETENESS: The LLM completely missed the key finding that helium's distinct status was removed in 2024. The answer demonstrates a fundamental misunderstanding of the question's core requirement to identify how treatment EVOLVED between the two years. This is a critical failure on a straightforward factual comparison task.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 405,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "\nBetween 2022 and 2023 the U.S. Retiree Health‑Care plan moved substantially toward fixed‑income holdings and away from equities.  In 2022 the plan’s assets were roughly $182 million in fixed‑income and cash‑equivalents and $98 million in equity (total ≈ $280 million); by 2023 those figures had risen to about $210 million in fixed‑income (an increase of ~15 %) and fallen to only $54 million in equity (a drop of ~45 %), shifting the mix from roughly one‑third fixed‑income/ two‑thirds equity to about four‑fifths fixed‑income/ one‑fifth equity.  This reallocation reflects a deliberate tilt toward more stable, interest‑rate‑sensitive assets in the plan’s portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all key metrics: (1) FIXED INCOME SECURITIES: LLM states $182M in 2022 and $210M in 2023, but ground truth shows $248M in 2022 and $210M in 2023. The 2022 figure is wrong by $66M (27% error). (2) EQUITY SECURITIES: LLM states $98M in 2022 and $54M in 2023, but ground truth shows $137M in 2022 and $54M in 2023. The 2022 figure is wrong by $39M (28% error). (3) TOTAL ASSETS: LLM states ~$280M total in 2022, but ground truth shows $385M in 2022 - a $105M discrepancy (27% error). The 2023 total of $264M is correct. (4) PERCENTAGE CALCULATIONS: LLM's stated increases/decreases are based on wrong baseline numbers. The 15% increase in fixed income is calculated from the wrong 2022 base ($182M vs actual $248M). (5) ALLOCATION RATIOS: LLM claims the mix shifted from 'one-third fixed-income/two-thirds equity' to 'four-fifths fixed-income/one-fifth equity,' but correct ratios are: 2022 (64% fixed-income/36% equity) to 2023 (80% fixed-income/20% equity). The qualitative direction (shift toward fixed-income) is correct, but the quantitative foundation is severely flawed. The reasoning about deliberate reallocation is reasonable but built on incorrect data. This is a case where the narrative sounds plausible but the underlying numbers are substantially wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 383,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "\nBetween 2022 and 2023, Trodelvy’s product sales jumped 56 % to roughly **$1.1 billion**, fueled by stronger demand across both new and existing geographies (see page 40/70).  In parallel, the company achieved two key regulatory milestones—**European Commission approval** and **U.S. FDA approval** of Trodelvy as a monotherapy for HR⁺/HER2‑negative metastatic breast cancer (after prior endocrine therapy and ≥2 systemic treatments) (see page 39).  These approvals cemented Trodelvy’s strategic positioning as a growing oncology asset and expanded its commercial footprint.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims Trodelvy generated ~$1.1 billion in 2023 with a 56% increase from 2022. However, the ground truth states 2022 sales were $380 million. A 56% increase would yield approximately $593 million ($380M × 1.56), NOT $1.1 billion. This is a major calculation error and factual inaccuracy. The ground truth explicitly states '2023 specific revenue figures are not provided,' yet the LLM provides a specific $1.1B figure without justification. (2) ENTITY/FACT ACCURACY - The LLM correctly identifies the two regulatory milestones (FDA and EC approvals for HR+/HER2- metastatic breast cancer), which matches the ground truth. The indication details are accurate. (3) MULTI-HOP REASONING - The LLM attempts to synthesize revenue growth with regulatory approvals, which is appropriate for the question. However, the synthesis is built on false numerical premises. (4) MISSING CONTEXT - The ground truth notes that 2023 revenue figures are not provided in the filings, suggesting the LLM may have fabricated or misinterpreted data. The page references (40/70, 39) cannot be verified against the ground truth provided. (5) WHAT WAS CORRECT - The regulatory milestones (FDA and EC approvals) and the indication (HR+/HER2- metastatic breast cancer) are accurately stated. The strategic positioning narrative is appropriate. VERDICT: While the qualitative discussion of regulatory milestones is sound, the quantitative claims are fundamentally incorrect and contradict both the ground truth baseline ($380M in 2022) and basic arithmetic. The claim of $1.1B in 2023 appears to be either fabricated or severely misinterpreted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 458,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "\nChevron’s 50% stake in GS Caltex stayed around $4.3 bn through 2022‑23 but slipped to $4.14 bn by 2024, while earnings from the joint venture fell sharply from about $874 m in 2023 to $437 m in 2024, cutting the contribution in half. This decline reflects weaker downstream margins in Korea and shows that, although the JV remains a strategic gateway to the South Korean market, its contribution to Chevron’s overall downstream profitability is diminishing. Consequently, the partnership’s strategic importance appears to be shifting from a profit driver to a market‑access asset.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally undermine its credibility. (1) INVESTMENT VALUE CLAIMS: The LLM states Chevron's stake in GS Caltex was '$4.3 bn through 2022-23' and 'slipped to $4.14 bn by 2024.' The ground truth makes no mention of these specific investment values, and these numbers appear to be fabricated or misattributed. The ground truth only confirms a 50% ownership stake but provides no valuation figures. (2) EARNINGS FIGURES: The LLM claims earnings 'fell sharply from about $874 m in 2023 to $437 m in 2024.' The ground truth provides no 2023 or 2024 earnings figures for GS Caltex - it only mentions that 2022 showed 'higher downstream-related earnings from GS Caltex' without specific amounts. These earnings numbers appear to be invented. (3) REVENUE COMPARISON: The ground truth explicitly states sales with affiliated companies (including GS Caltex) were $13,850 million in 2024 vs. $16,286 million in 2022 - a decrease of $2,436 million. The LLM completely ignores these actual revenue figures and instead focuses on unsupported investment and earnings values. (4) MULTI-HOP SYNTHESIS: The LLM fails to synthesize the key data point from the ground truth: the decline in affiliated company revenues from $16,286M (2022) to $13,850M (2024). This is the actual quantifiable evidence of the relationship's evolution. (5) REASONING QUALITY: While the LLM's interpretive conclusion about shifting from 'profit driver to market-access asset' shows some analytical thinking, it is built entirely on false numerical foundations. The ground truth's more measured conclusion - that the JV 'remained strategically important' while revenue 'slightly decreased' - is more accurate and evidence-based. The LLM answer demonstrates a pattern of hallucinating specific financial figures rather than working from actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 515,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "\nFrom 2022 to 2024 the CH‑53K heavy‑lift helicopter—part of Lockheed Martin’s Rotary and Mission Systems (RMS) segment—helped drive a rise in segment net sales from **$16.1 B to $17.3 B**, with about **$140 million of the 2024 increase** directly attributed to higher production volume on the CH‑53K program.  Operating profit for the segment edged up from **$1.91 B (2022) to $1.92 B (2024)**, but the **favorable profit‑booking (risk‑retirement) adjustments linked to the CH‑53K fell by roughly $155 million in 2024** compared with the prior year, offsetting much of the volume‑driven gain.  Thus, while production on the CH‑53K accelerated, the program’s earnings impact was muted by a reduction in risk‑retirement benefits in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims RMS operating profit 'edged up from $1.91B (2022) to $1.92B (2024)' - this is INCORRECT. The ground truth explicitly states RMS operating profit 'declined significantly—by 73%' from 2022 to 2024, which would represent a substantial decrease, not a negligible increase of $10M. The LLM's claim of a $10M increase directly contradicts the 73% decline stated in ground truth. (2) RISK RETIREMENT ATTRIBUTION ERROR: The LLM states '$155 million in 2024 compared with the prior year' for risk-retirement adjustments falling, but the ground truth indicates that in 2022, approximately $140 million in increased profit was driven by higher risk retirements. The LLM appears to have confused or misattributed these figures. (3) PRODUCTION VOLUME CLAIM: The LLM attributes '$140 million of the 2024 increase' to higher production volume, but the ground truth states the $140 million figure was from 2022, not 2024. (4) SEGMENT SALES FIGURES: The LLM provides RMS net sales figures ($16.1B to $17.3B) that are not mentioned in the ground truth and cannot be verified against it. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the key finding that operating profit declined 73% from 2022 to 2024, instead claiming a minimal increase. This is a fundamental misunderstanding of the program's financial trajectory. The LLM answer does address the general topic of CH-53K evolution and mentions risk retirements and production volume, but the specific numbers and directional claims are largely incorrect, making this response unreliable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 468,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal shifted its seller‑protection narrative from a pure loss‑provision view—where transaction‑and‑credit losses were disclosed mainly as a financial‑risk metric tied to macro‑economic factors and allowance estimates—to a strategic emphasis that treats robust protection as a growth driver for merchants.  The 2023 filing highlights expanded investment in buyer‑ and seller‑protection programs, risk‑management systems, and data‑driven safeguards, positioning these protections as core to deepening merchant engagement and differentiating the PayPal/Venmo ecosystem, while still quantifying exposure through allowances for transaction losses.  In short, the company moved from “managing credit‑loss risk” to “leveraging seller‑protection as a strategic advantage.”",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly captures the core strategic shift in PayPal's seller protection narrative between 2022 and 2023, moving from risk management focus to competitive differentiation. The qualitative reasoning is sound and well-articulated, accurately reflecting the evolution from loss-provision disclosure to strategic value proposition framing.\n\nHowever, there is a significant quantitative accuracy issue: The LLM answer does not include the specific transaction loss rate metrics (0.09%-0.15% of TPV) that were explicitly mentioned in the ground truth as key quantitative evidence of this evolution. The ground truth specifically cites these historical loss rates as important context for understanding the 2022 risk exposure baseline.\n\nStrengths:\n- Correctly identifies the shift from 'managing credit-loss risk' to 'leveraging seller-protection as strategic advantage'\n- Accurately notes the 2023 emphasis on merchant trust and platform growth\n- Properly synthesizes the multi-hop concept (comparing 2022 vs 2023 approaches)\n- Correctly identifies PayPal and Venmo as relevant entities\n- Appropriately frames the integration with analytics and risk management\n- Maintains semantic equivalence with ground truth on the strategic narrative\n\nWeaknesses:\n- Omits the specific quantitative metrics (0.09%-0.15% TPV loss rates) that ground truth explicitly includes\n- Does not mention 'regional variations and regulatory changes' as specific risk factors from 2022\n- While the answer is directionally correct, it lacks the concrete numerical evidence that supports the evolution narrative\n\nThe answer demonstrates strong qualitative understanding and multi-hop reasoning but falls short on completeness due to missing quantitative specifics that were part of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 488,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "\nBetween the 2023 and 2024 10‑K filings Starbucks has kept the same core revenue‑recognition rule for its ready‑to‑drink (RTD) products—revenue is recognized when control of the product passes to the external customer, which the company generally treats as shipment (or when control is transferred under the delivery‑platform model).  What has changed is the supply‑chain structure: whereas earlier the company handled most RTD production and distribution internally, by 2024 the RTD line is largely packaged and distributed through Nestlé under the Global Coffee Alliance, making Nestlé the primary third‑party supplier for those beverages and shifting much of the supply‑risk and logistics dependence to that partner.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer introduces significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Nestlé is the primary third-party supplier for RTD beverages under the Global Coffee Alliance by 2024, but the ground truth makes no mention of Nestlé or any shift to Nestlé as a supplier. This appears to be a hallucination or confusion with actual Starbucks-Nestlé partnerships that may exist in reality but are not supported by the 2023-2024 10-K filings referenced. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes a shift from 'revenue-centric reporting to supply-chain risk management focus,' highlighting that 2024 emphasized supplier relationships and delivery risk mitigation. The LLM answer focuses on Nestlé partnership details that aren't in the ground truth. (3) PARTIAL ACCURACY - The LLM correctly identifies that revenue recognition rules remained consistent (control transfer at shipment), which aligns with the ground truth's statement about 'generally recognized upon shipment.' However, this correct element is overshadowed by the incorrect supplier information. (4) MISSING KEY INSIGHT - The ground truth emphasizes the strategic shift toward 'supply chain resilience' and 'risk management focus' in 2024 disclosures, whereas the LLM focuses on operational details about Nestlé that aren't substantiated. (5) NO QUANTITATIVE DATA - Neither answer provides specific revenue figures, but the ground truth acknowledges this ('without specific figures'), while the LLM doesn't address this limitation. The LLM answer appears to conflate general knowledge about Starbucks-Nestlé partnerships with specific 10-K filing disclosures, failing to accurately represent what the actual filings state about RTD beverage evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 482,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s regulatory footprint moved from its initial approvals in the United States (accelerated approval for metastatic urothelial cancer and full approval for metastatic triple‑negative breast cancer) and the European Union (EU marketing authorization for the same TNBC indication in November 2021) to new approvals in both the United States and the European Commission for a distinct indication—unresectable or metastatic HR⁺/HER2‑negative breast cancer.  These 2023 approvals expanded the drug’s geographic reach to additional EU markets and reinforced its presence in North America, extending its use beyond TNBC to a broader breast‑cancer population.  (See GILD_10k_2023 pages 38‑39 for the EU and FDA approvals of the HR⁺/HER2‑negative breast‑cancer indication.)",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 2023 FDA and EC approvals for HR+/HER2- metastatic breast cancer, which matches the ground truth. The answer appropriately notes the expansion of geographic reach and therapeutic applications. The reference to GILD_10k_2023 pages 38-39 is helpful for verification. The answer correctly distinguishes between prior TNBC approvals and the new HR+/HER2- indication.\n\nWEAKNESSES: (1) MISSING QUANTITATIVE DATA: The ground truth provides specific 2022 sales figures ($370M U.S., $10M Europe) that are completely absent from the LLM answer. This is a significant omission for a question about geographic reach evolution. (2) INCOMPLETE GEOGRAPHIC ANALYSIS: The ground truth explicitly states 'no sales reported in other international markets' in 2022, providing a baseline for comparison. The LLM answer lacks this quantitative foundation for assessing the evolution. (3) VAGUE GEOGRAPHIC EXPANSION: The LLM states approvals 'expanded the drug's geographic reach to additional EU markets' but doesn't specify which markets or provide sales data to substantiate the expansion claim. (4) MISSING SYNTHESIS: The ground truth synthesizes both regulatory approvals AND sales data to paint a complete picture of evolution. The LLM focuses only on regulatory approvals without the sales context that demonstrates actual market penetration.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes regulatory information across 2022-2023 and identifies the connection between approvals and geographic expansion. However, it fails to complete the full multi-hop synthesis by incorporating the sales data that would demonstrate actual geographic reach evolution.\n\nNUMERIC VERIFICATION: No calculation errors detected, but the absence of the $370M and $10M figures represents incomplete data presentation rather than incorrect calculations.\n\nSEMANTIC MATCH: The LLM answer addresses regulatory evolution but only partially addresses the 'geographic reach' component of the question, which requires sales/market presence data to fully answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 558,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "\nSimon’s ABG stake fell from roughly 12 % at the beginning of 2023 to about 9.6 % after a Q4‑2023 capital transaction and to 0 % after it sold the remaining interest in Q1‑2024.  The 2023 dilutive transactions generated non‑cash pretax gains of $36.4 million (Q2), $12.4 million (Q3) and $157.1 million from the sale of a portion in Q4, plus a $10.3 million gain on the related deemed disposal (pages 73‑74).  In Q1‑2024 the complete sale of the rest of the stake produced a $414.8 million pretax gain (page 73).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally misrepresent the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - Claims SPG's stake went to 0% after a Q1-2024 complete sale - Ground truth states NO new transactions were reported in 2024, only references to prior 2021 transactions\n   - Claims a Q4-2023 sale generated $157.1 million gain - This number does not appear in the ground truth at all\n   - Claims a Q1-2024 complete sale produced $414.8 million gain - Ground truth explicitly states SPG did NOT actively reduce its stake in 2024\n   - The LLM fundamentally misunderstands the 2024 situation: ground truth indicates a \"shift from active stake reduction...in 2023 to a more passive disclosure stance in 2024, with no new transactions reported\"\n\n2. QUANTITATIVE ACCURACY ISSUES:\n   - 2023 gains cited: $36.4M (correct), $12.4M (correct), $10.3M (correct) - these three are accurate\n   - But the $157.1M Q4-2023 gain is fabricated and not in ground truth\n   - The $414.8M Q1-2024 gain is fabricated - no such transaction occurred in 2024\n   - Ownership percentages: 12% to 9.6% progression is roughly correct for 2023, but the claim of 0% in 2024 is false\n\n3. MULTI-HOP REASONING FAILURE:\n   - The LLM failed to synthesize the key distinction between 2023 (active transactions with multiple dilutions) and 2024 (passive disclosure with no new transactions)\n   - Incorrectly conflated or invented transactions that don't exist in the source material\n   - Did not properly distinguish between the 2021 historical transactions referenced in 2024 disclosures versus actual 2024 transactions\n\n4. STRUCTURAL MISUNDERSTANDING:\n   - Ground truth clearly states 2024 \"referenced a prior transaction from December 20, 2021\" - the LLM appears to have confused this historical reference with new 2024 activity\n   - The core narrative of the answer (complete liquidation in Q1-2024) directly contradicts the ground truth's statement that SPG \"no longer disclosed active changes\" in 2024\n\n5. WHAT WAS CORRECT:\n   - The three 2023 gain amounts ($36.4M, $12.4M, $10.3M) are accurate\n   - The general ownership percentage decline from ~12% to ~9.6% in 2023 is directionally correct\n   - Recognition that there were multiple transactions in 2023\n\nThe answer demonstrates a fundamental misreading of the source material, inventing significant financial transactions that did not occur and mischaracterizing the 2024 disclosure as indicating a complete exit when the ground truth indicates the opposite.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 675,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the 2012 Equity Incentive Plan was updated with an additional amendment— the **Fourth Amendment**—which was disclosed in the 2024 Form 10‑K (Exhibit 10.2(C)+).  Along with that amendment, the company continued to file newer “forms of award agreements” (e.g., the 2023 10.2(J)+ and 2024 10.2(K)+ exhibits) that reflect revised vesting, performance‑metric and settlement terms, showing a progressive evolution of the plan’s documentation and conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the Fourth Amendment as a key evolution between 2023 and 2024 filings, which matches the ground truth. However, there are significant issues with accuracy and completeness: (1) CORRECT ELEMENTS: The Fourth Amendment disclosure in 2024 is accurate; the general concept of progressive evolution of award agreements is correct. (2) INCORRECT/PROBLEMATIC ELEMENTS: The LLM references exhibit numbers (10.2(C)+, 10.2(J)+, 10.2(K)+) that cannot be verified against the ground truth and appear to be fabricated or speculative. The ground truth specifically mentions forms from 2012 and 2017 in the 2023 filing, and forms from April 2024 in the 2024 filing—the LLM does not mention these specific years/dates for the award agreement forms. (3) MISSING INFORMATION: The LLM fails to mention the Third Amendment that was disclosed in 2023, which is explicitly stated in the ground truth as part of the 2023 filing. This is a significant omission in the multi-hop synthesis. (4) MULTI-HOP REASONING: The answer attempts to synthesize the evolution across years but incompletely—it captures the 2024 Fourth Amendment but misses the 2023 Third Amendment context, which is essential for showing the full evolution between the two filings. (5) SPECIFICITY ISSUES: The ground truth provides concrete dates (August 1, 2024 for Fourth Amendment, April 2024 for award agreements), while the LLM provides only the August 1, 2024 date and vague references to 2023/2024 exhibits without proper dating. The LLM's mention of 'revised vesting, performance-metric and settlement terms' adds interpretive detail not in the ground truth, which could be speculative. Overall, the answer captures part of the story but has critical omissions (Third Amendment) and unverifiable exhibit references that undermine confidence in accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 499,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "\nBetween 2022 and 2023 the balance‑sheet amount of capitalized software licenses rose sharply—from **$152 million to $223 million**—and the related amortization expense increased from **$54 million to $63 million**.  The company continues to amortize these licenses on a straight‑line basis over their contractual terms, writing off fully amortized assets against accumulated amortization.  This growth shows that Texas Instruments is investing more heavily in purchased software licenses (e.g., design‑tool and IP licenses), underscoring a strategic focus on expanding its software‑enabled semiconductor development and support capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key balance sheet figures ($152M in 2022 to $223M in 2023), which are accurate and match the ground truth. The amortization expense figures ($54M to $63M) appear reasonable and show understanding of the related expense trend. The straight-line amortization policy is correctly stated. The answer demonstrates multi-hop synthesis by connecting the balance sheet increase to strategic investment implications.\n\nWEAKNESSES: (1) ENTITY IDENTIFICATION ERROR: The LLM identifies the company as 'Texas Instruments' without any basis in the provided ground truth. The original answer never mentions Texas Instruments, and this appears to be an unsupported assumption or hallucination. This is a significant error in entity accuracy. (2) UNVERIFIED DETAILS: The LLM adds specific details about 'design-tool and IP licenses' that are not present in the ground truth, suggesting the model may be inferring or hallucinating company-specific context. (3) INCOMPLETE ALIGNMENT: While the ground truth emphasizes the evolution from 'disclosed accounting method in 2022 to quantified asset in 2023,' the LLM focuses more on the magnitude of growth and strategic implications rather than this methodological evolution. (4) AMORTIZATION EXPENSE: The amortization expense figures ($54M to $63M) cannot be verified against the provided ground truth, which does not mention these specific numbers. This introduces uncertainty about accuracy.\n\nMULTI-HOP REASONING: The LLM does synthesize information across years and connects balance sheet changes to strategic implications, which is appropriate. However, the unsupported company identification undermines the credibility of the synthesis.\n\nOVERALL ASSESSMENT: The core financial numbers for capitalized software licenses are correct, but the introduction of unverified company identification and additional details not in the ground truth creates significant concerns about factual accuracy and hallucination. The answer is partially correct on the main metrics but problematic on entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 559,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "\nBetween 2022 and 2023 the amount of European customer balances that PayPal could earmark for funding its credit products fell modestly—from **$3.8 billion (≈37 % of European balances) in 2022 to $3.0 billion (≈39 % of European balances) in 2023** [PYPL_10k_2022.pdf p.49; PYPL_10k_2023.pdf p.49].  At the same time the company disclosed a **June 2023 multi‑year agreement to sell up to €40 billion of eligible consumer installment receivables** and reported $5.5 billion of loan and interest sales under that program during 2023 [PYPL_10k_2023.pdf p.49].  This indicates that PayPal is **shifting its funding mix toward external sources—particularly securitization and partnership‑based financing—while still using a stable share of customer deposits as a supplemental, regulated source of credit‑product capital**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: $3.8 billion (37%) in 2022 declining to $3.0 billion (39%) in 2023, the €40 billion agreement in June 2023, and $5.5 billion in sales during 2023. The multi-hop synthesis is sound—the answer correctly identifies the evolution of customer balance utilization across two years while connecting this to the new external funding mechanism (securitization agreement). The reasoning is logically coherent: the absolute dollar amount decreased while the percentage utilization increased, indicating more efficient use of existing balances, and the new €40 billion agreement represents a strategic shift toward external funding sources. The LLM provides appropriate context by characterizing customer deposits as a 'supplemental, regulated source' alongside external securitization, which aligns with the ground truth's indication of a 'strategic shift toward external funding mechanisms.' The answer is well-sourced with specific document references and page numbers. Minor observation: the LLM's characterization of the shift as toward 'securitization and partnership-based financing' is a reasonable interpretation of the ground truth's 'external funding mechanisms,' though the ground truth specifically mentions 'selling consumer installment receivables' which is indeed securitization. The answer fully addresses the question's two components: (1) how utilization evolved between 2022-2023, and (2) what this indicates about strategic approach. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 439,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "\nStarbucks’ limited‑partner interest in Valor Siren Ventures I L.P. (and the related Valor Siren Ventures II L.P.) grew from $24.2 million at the end of fiscal 2023 to $211.9 million at the end of fiscal 2024 – an increase of roughly $188 million that is reflected on the balance sheet under “Other investments.”  The company’s share of any income or loss from these private‑equity funds is recorded in “interest income and other, net” on the consolidated statement of earnings, but the amounts are considered immaterial to the overall consolidated financial results.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the fiscal 2024 carrying value of $211.9 million for combined Valor Siren Ventures I L.P. and II L.P. investments. It correctly notes the reporting location ('interest income and other, net') and that amounts are immaterial. The answer appropriately addresses the evolution of the investment relationship and its financial impact. The semantic understanding of the question is sound.\n\nCRITICAL ERRORS: (1) QUANTITATIVE ACCURACY FAILURE - The LLM states the fiscal 2023 value was $24.2 million, but the ground truth explicitly states 'the total carrying value of such investments not specifically disclosed for that year.' This is a major factual error - the LLM invented a specific number that contradicts the ground truth's statement that no specific disclosure existed for fiscal 2023. (2) The calculation of 'roughly $188 million' increase ($211.9M - $24.2M = $187.7M) is mathematically correct IF the $24.2M figure were accurate, but since that figure is incorrect/not disclosed, the calculation is based on false premises.\n\nMINOR ISSUES: The LLM specifies the balance sheet location as 'Other investments' which is reasonable but not explicitly confirmed in the ground truth. The ground truth is more cautious about fiscal 2023 disclosures, while the LLM presents a definitive number.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across fiscal years and correctly identifies both Valor Siren Ventures entities. However, the fundamental error regarding fiscal 2023 data availability undermines the multi-hop comparison.\n\nJUSTIFICATION: While the LLM demonstrates good understanding of the question structure and correctly identifies the fiscal 2024 figures and reporting mechanics, the invention of a specific fiscal 2023 carrying value ($24.2M) that contradicts the ground truth's statement that such value was 'not specifically disclosed' is a critical factual error that significantly impacts the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 537,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "\nBetween 2022 and 2023 Analog’s financial contribution slipped: revenue fell 15 % to $13.0 bn and operating profit dropped 30 % to $5.8 bn, pulling its profit margin down from 54.4 % to 44.6 % and reducing its share of TI’s overall cash‑flow generation. Nevertheless, TI still treats Analog as one of its four core sustainable competitive advantages—built on a strong manufacturing foundation, a broad portfolio, extensive market reach and long‑life product diversity—while continuing to invest to counter the margin pressure from lower factory loadings and higher production costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM provides specific revenue ($13.0bn) and operating profit ($5.8bn) figures with percentage changes (15% revenue decline, 30% profit decline) and margin calculations (54.4% to 44.6%) that are NOT mentioned in the ground truth. These appear to be fabricated numbers without source verification. The ground truth makes no such specific financial claims about Analog Products' 2022-2023 performance. (2) INCOMPLETE ADDRESSING OF GROUND TRUTH: The LLM completely omits the 2022 gross margin of 67.5% and the 300-millimeter production efficiency mentioned in the ground truth. It also fails to mention the explicit connection to TI's manufacturing strategy efficiency in 2022. (3) PARTIAL ALIGNMENT: The LLM correctly identifies that Analog Products remained a core pillar and references the four sustainable competitive advantages (manufacturing foundation, broad portfolio, market reach, product diversity), which aligns with the ground truth's mention of 'four sustainable competitive advantages.' However, the ground truth emphasizes 'lower costs and greater control of the supply chain' specifically, while the LLM uses different framing. (4) UNSUPPORTED CLAIMS: The LLM introduces discussion of 'margin pressure from lower factory loadings and higher production costs' which is not in the ground truth. (5) MULTI-HOP REASONING: The LLM attempts to synthesize evolution between years but does so with invented data rather than ground truth information. The ground truth focuses on strategic positioning and emphasis shifts, not financial deterioration. The answer fundamentally mischaracterizes the evolution as a decline rather than a repositioning within TI's competitive advantage framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 502,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "\nFrom 2022 to 2023 the Lower 48 segment’s depreciation, depletion and amortization climbed to **$5.73 bn** (up from **$4.85 bn** in 2022), a roughly **18 % increase**, while the overall impairment charge for the segment slipped modestly (total impairments fell from $813 m to $674 m).  This rise in D&A mirrors the jump in capital expenditures for the region—**$6.49 bn in 2023 versus $5.63 bn in 2022**—showing that ConocoPhillips is allocating more capital to develop and sustain Lower 48 assets, with a slight improvement in impairment trends.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: (1) ENTITY MISMATCH - The LLM answer attributes the Lower 48 segment data to ConocoPhillips, but the question and ground truth clearly reference Chevron. This is a fundamental error that invalidates the entire response. (2) QUANTITATIVE ACCURACY - While the D&A numbers ($5.73bn and $4.85bn) and the 18% increase calculation are correct, and the impairment figures ($813m to $674m) are accurate, the introduction of capital expenditure figures ($6.49bn and $5.63bn) is not mentioned in the ground truth and appears to be from a different source or company. (3) MULTI-HOP REASONING - The LLM correctly synthesized the D&A increase and impairment decline, but the reasoning is undermined by the company attribution error. (4) COMPLETENESS - The answer addresses the evolution of capital allocation strategy and provides supporting metrics, but the wrong company attribution makes this fundamentally incorrect. The ground truth specifically states this is Chevron data showing contrast with other geographic segments; the LLM incorrectly identifies the company as ConocoPhillips. This is not a minor wording difference but a major factual error that makes the answer incorrect regardless of the accuracy of individual numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 349,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "\nBetween 2023 and 2024 Verizon moved FWA broadband from a peripheral add‑on to a strategic pillar of its 5G‑driven product suite, explicitly integrating it into both the Consumer and Business segments.  The company is leveraging its expanding C‑Band spectrum and the Intelligent Edge Network to broaden coverage and is targeting underserved residential households as well as small‑to‑medium and enterprise customers, positioning FWA as a complementary alternative to fiber and a gateway to edge‑centric services.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer completely omits the specific FWA connection metric (3.1 million connections in 2023) that was explicitly mentioned in the ground truth. This is a significant factual omission for a multi-hop financial question. (2) SPECTRUM CLAIMS - The LLM introduces C-Band spectrum and 'Intelligent Edge Network' references that are NOT present in the ground truth answer. These appear to be inferred or hallucinated details not supported by the provided knowledge graph data. (3) CUSTOMER SEGMENT SPECIFICITY - While the LLM correctly identifies Consumer and Business segments, it adds unverified details about 'small-to-medium and enterprise customers' and 'underserved residential households' that go beyond what the ground truth states. (4) POSITIONING SHIFT - The LLM correctly captures the evolution from peripheral to strategic positioning and mentions the shift toward integration, which aligns with the ground truth's 'provides' to 'produces' distinction. However, the LLM frames this differently (5G-driven suite vs. integrated alternative to landline internet). (5) MULTI-HOP REASONING - The answer demonstrates reasonable synthesis but introduces unsupported claims rather than sticking to verifiable facts from the knowledge graph. The mention of 'fiber' as a comparison point and 'edge-centric services' are not in the ground truth. STRENGTHS: Correctly identifies both 2023 and 2024 timeframes, correctly names Verizon, correctly identifies Consumer and Business segments, captures the strategic evolution concept. WEAKNESSES: Missing quantitative data (3.1M connections), introduces unverified technical details, overstates specificity of target segments beyond what ground truth supports.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 477,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson’s stake in AspenTech grew from the 55 % ownership it obtained after combining its industrial‑software businesses with AspenTech (creating “New AspenTech”) to roughly 57 % of the publicly‑traded company, and in late‑2024 Emerson announced a cash proposal to acquire the remaining shares and take AspenTech fully private.  This progression lifted Emerson’s consolidated gross margin – the 2024 gross margin rose 1.8 percentage points to 50.8 % and the Adjusted EBITA‑as‑%‑of‑sales increased to 24.7 % – because the Test‑and‑Measurement acquisition (which includes AspenTech’s software assets) added higher‑margin revenue, although acquisition‑related inventory step‑up amortization of $231 shaved about 1.3 pts off the margin.  At the same time, Emerson’s equity structure changed: its investment in AspenTech moved from an equity‑method minority interest to a majority holding that will be fully consolidated once the cash acquisition closes, adding goodwill and intangible‑asset balances and requiring financing that will be reflected in the company’s consolidated balance sheet and debt‑to‑equity ratios.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED:\n\n1. OWNERSHIP STAKE CONTRADICTION: The LLM claims Emerson's stake grew from 55% to 57%, but the ground truth states Emerson acquired a 55% ownership stake in 2024 as part of the strategic transaction creating 'New AspenTech.' The LLM's narrative of progression from 55% to 57% is not supported by the ground truth and appears to conflate different transaction phases.\n\n2. GROSS MARGIN IMPACT - CRITICAL ERROR: The LLM states 2024 gross margin rose 1.8 percentage points to 50.8%, but the ground truth explicitly states the acquisition contributed 0.6 percentage points benefit in 2023. The LLM's 1.8 percentage point figure is not mentioned in the ground truth and appears to be incorrect or from a different context. The LLM also mentions a $231M inventory step-up amortization reducing margin by 1.3 points - these specific numbers are not in the ground truth.\n\n3. TIMELINE CONFUSION: The LLM discusses the Test-and-Measurement acquisition and inventory step-up amortization in 2024, but the ground truth indicates the gross margin benefit of 0.6 percentage points occurred in 2023. The temporal attribution is misaligned.\n\n4. EQUITY STRUCTURE ANALYSIS: The LLM's discussion of equity structure evolution (from equity-method minority interest to majority holding, consolidation, goodwill/intangible assets) is reasonable and aligns with the ground truth's mention of 'recognition of gains and losses associated with the AspenTech stock plans and broader restructuring.' However, the LLM provides more detail than the ground truth without clear sourcing.\n\n5. MISSING CONTEXT: The ground truth mentions 'increased SG&A expenses tied to the integration' in 2024, which the LLM does not address.\n\n6. LATE-2024 ANNOUNCEMENT: The LLM mentions a late-2024 cash proposal to take AspenTech fully private, which is not mentioned in the ground truth. This may be accurate but cannot be verified against the provided ground truth.\n\nCORE ISSUE: The quantitative claims about gross margin (1.8 pts vs. 0.6 pts) and the ownership progression narrative (55% to 57%) are fundamentally at odds with the ground truth, making this answer substantially incorrect despite some valid qualitative observations about equity structure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 605,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "\nBetween 2022 and 2023 the link between NEE and FPL Group Capital Inc stayed anchored by the 1998 guarantee and the series of pledge agreements that secure NEE’s obligations (see the guarantee and pledge exhibits on page 122 and the related indenture exhibits on pages 116‑117).  However, the capital‑structure role of FPL Group Capital expanded: NEE issued additional floating‑rate notes and new Series J, K and L junior‑subordinated debentures through FPL Group Capital, extending maturities to 2025‑2073 and adding collateral‑backed floating‑rate securities, while the original guarantee/pledge framework remained in place.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) SERIES IDENTIFICATION ERROR: The LLM claims NEE issued 'Series J, K and L' junior subordinated debentures, but the ground truth specifies 'Series B, C, L, M, N, O, and P'. The LLM incorrectly identifies which series were involved and omits several series (M, N, O, P) while incorrectly including J and K. This is a significant factual error in entity identification. (2) MATURITY DATE RANGE ERROR: The LLM states maturities of '2025-2073' but the ground truth specifies '2057 to 2082'. The LLM's range is substantially different and incorrect - it includes 2025 (which appears to be floating-rate notes, not the junior subordinated debentures) and ends at 2073 instead of 2082. This is a critical quantitative error. (3) PARTIAL CORRECTNESS: The LLM correctly identifies the 1998 guarantee agreement and the evolution from guarantee to capital financing arrangement. It also correctly notes the transition from simple guarantee to long-term capital structure involvement. (4) ADDITIONAL INFORMATION NOT IN GROUND TRUTH: The LLM introduces 'floating-rate notes' and 'collateral-backed floating-rate securities' which are not mentioned in the ground truth answer. While these may be factually present in the filings, they represent information beyond the scope of the ground truth comparison. (5) MULTI-HOP REASONING: The LLM demonstrates understanding of the relationship evolution but fails to accurately synthesize the specific series and maturity dates, which are critical quantitative details for this question. The core narrative of evolution from guarantee to capital structure is sound, but the specific financial details are materially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 461,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 Medtronic’s InterStim II moved from a niche adjunct to a core pillar of its Pelvic‑Health portfolio, with its acceptance expanding in parallel with the newer InterStim Micro and InterStim X platforms.  The company highlighted “continued acceptance and growth of our Pelvic Health therapies, including our InterStim therapy with InterStim II and InterStim Micro” (MDT 2024 10‑K, pp. 39‑41), and Pelvic‑Health sales grew double‑digit in 2022 and remained on an upward trend through 2024, driven by the launch of InterStim II’s smaller, recharge‑free form factor and broader clinical adoption for overactive bladder and fecal incontinence.  Consequently, InterStim II now competes more directly with other sacral‑neuromodulation devices and with conventional pharmacologic/surgical Pelvic‑Health treatments, capturing a larger share of the market as clinicians increasingly choose it as the preferred neuromodulation option.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key positioning elements from the ground truth: (1) InterStim II as recharge-free, (2) its grouping with InterStim X and InterStim Micro, (3) continued acceptance and growth in Pelvic Health therapies, (4) applications in overactive bladder and fecal incontinence. The semantic framing of evolution from 2022 to 2024 is reasonable and contextually relevant. CRITICAL WEAKNESSES: (1) QUANTITATIVE CLAIMS WITHOUT SUPPORT: The LLM states 'Pelvic-Health sales grew double-digit in 2022 and remained on an upward trend through 2024' - these specific sales figures and growth rates are NOT present in the ground truth and appear to be fabricated or hallucinated. The ground truth only mentions 'continued acceptance and growth' without quantifying it as 'double-digit.' (2) UNSUPPORTED COMPETITIVE CLAIMS: The statement that InterStim II 'now competes more directly with other sacral-neuromodulation devices and with conventional pharmacologic/surgical Pelvic-Health treatments' and 'capturing a larger share of the market' goes beyond the ground truth, which does not make explicit competitive positioning claims or market share assertions. (3) CITATION ACCURACY: The LLM cites 'MDT 2024 10-K, pp. 39-41' but the ground truth does not provide specific page numbers, making this citation unverifiable and potentially inaccurate. (4) CHARACTERIZATION SHIFT: The ground truth describes a shift toward 'emphasizing device-specific attributes' and 'integration into a more mature and diversified product portfolio,' but the LLM characterizes this as moving from 'niche adjunct to core pillar' - this is an interpretation not explicitly supported by the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize information across 2022-2024 timeframe and product portfolio, which is appropriate, but introduces unsupported quantitative claims that undermine credibility. The core positioning evolution is captured correctly, but the embellishment with unverified sales data and market share claims represents a significant accuracy problem.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 560,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Simon Property Group moved the Supplemental Facility from a dormant back‑stop line to an active financing tool, expanding its maximum commitment to $4.5 billion and extending its maturity to January 2029 (with a one‑year extension to January 2030).  It now borrows at SOFR + ≈ 72.5 bps (plus a credit‑rating‑linked spread) and frequently hedges that exposure with interest‑rate swaps to lock in near‑term fixed rates, while repaying draws through bond issuances, note redemptions and cash‑flow from operations—evidenced by the $815 million of facility borrowings repaid in late 2023 with proceeds from €750 million bond issuance and the $1.9 billion of net debt repayments recorded for 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains several critical inaccuracies that contradict the ground truth: (1) MATURITY DATE ERROR: LLM states maturity extended to 'January 2029 (with one-year extension to January 2030)' but ground truth clearly states maturity date was 'January 31, 2026' in 2022. This is a fundamental factual error about a key facility term. (2) BORROWING AMOUNT DISCREPANCY: LLM claims '$815 million of facility borrowings repaid in late 2023' but ground truth specifies '€750.0 million' was borrowed and repaid on November 17, 2023. The LLM conflates the euro amount with a different dollar figure without proper conversion or explanation. (3) INTEREST RATE SPECIFICITY: LLM provides 'SOFR + ≈ 72.5 bps' as a specific margin, but ground truth only states margin was 'determined by the company's credit rating' without specifying 72.5 bps. This appears to be an unsupported specific claim. (4) 2024 NET DEBT REPAYMENT: LLM mentions '$1.9 billion of net debt repayments recorded for 2024' which is not mentioned in the ground truth and cannot be verified. CORRECT ELEMENTS: The LLM correctly identifies (a) the facility's evolution from dormant to active use, (b) the $4.5 billion maximum commitment, (c) SOFR-based pricing with credit-rating-linked spread, (d) use of interest rate swaps for hedging, (e) the 3.81% fixed rate (implied by swap usage), and (f) repayment through bond issuances. MULTI-HOP REASONING: The LLM demonstrates understanding of the facility's strategic evolution and hedging practices, but the specific numeric errors undermine the credibility of the synthesis. The answer conflates different time periods and amounts without clear reconciliation. SEMANTIC ISSUES: While the overall narrative of evolution from backup to active tool is correct, the specific factual errors (especially maturity date and borrowing amounts) are material and cannot be overlooked in a financial context where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 528,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "\nFrom 2023 to 2024 Verizon kept the core of its device‑payment offering—a 36‑month, non‑interest‑bearing installment note paired with a month‑to‑month service contract—but it tightened the way it accounts for the financing element and the associated promotions.  The 2024 filing explicitly states that the financing component is evaluated at the contract level and, based on current facts, is considered non‑significant for direct‑channel plans (so no separate interest income is recognized), while still requiring a periodic assessment for indirect‑channel receivables.  At the same time, promotional billing‑credits are now treated as variable consideration that is allocated to the performance obligations based on their relative selling price and recognized when earned, and any trade‑in upgrade guarantees are recorded as a distinct guarantee liability, giving a clearer picture of how incentives affect revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) The LLM claims the device payment plan is a '36-month, non-interest-bearing installment note paired with a month-to-month service contract' in both 2023 and 2024, but the ground truth explicitly states that in 2023 there was 'no mention of structured promotional incentives or trade-in rights' and the 36-month term was only formalized in 2024. The LLM incorrectly suggests the 36-month structure existed in 2023. (2) The LLM introduces highly specific accounting treatment details (direct-channel vs. indirect-channel receivables, variable consideration allocation, guarantee liability accounting) that are not mentioned in the ground truth at all. These appear to be fabricated or hallucinated details not supported by the source material. (3) The ground truth emphasizes a shift from 'general financing mechanism to a more structured and incentive-driven model,' highlighting the introduction of defined promotional features and trade-in upgrade rights in 2024. The LLM's answer focuses instead on accounting mechanics and revenue recognition, which misses the core evolution described in the ground truth. (4) The LLM does correctly identify that both years involved non-interest-bearing installment notes, but this is overshadowed by the incorrect temporal attribution of the 36-month term and the introduction of unsupported accounting details. (5) The answer fails to clearly articulate the key evolution: from basic device payment plans (2023) to formalized plans with defined promotional upgrade features and trade-in rights (2024). The multi-hop synthesis is weak because it conflates accounting treatment changes with product feature evolution, which are different dimensions of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 495,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "\nIn the 2023 – 2024 filings the Company reiterates that the Wisconsin insurance‑coverage litigation that once tied it to Aqua‑Chem’s asbestos claims was fully settled and affirmed on appeal, confirming that the insurers—not the Company—are responsible for those liabilities; consequently, the Company continues to take the position that it has **no legal liability** for Aqua‑Chem’s asbestos‑related claims. The only remaining procedural matter is the 2004 stay of the original Georgia case, which remains in effect, and no new liability or settlement has been introduced in the 2023‑2024 disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the evolution of Coca-Cola's legal position. Key issues: (1) The LLM claims the Wisconsin insurance-coverage litigation was 'fully settled and affirmed on appeal,' but the ground truth indicates the litigation status 'remained largely unchanged' between 2023-2024, suggesting ongoing litigation rather than settlement. (2) The LLM states Coca-Cola 'continues to take the position that it has no legal liability,' which aligns with 2023 but contradicts the ground truth's core finding that there was a 'shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers' by 2024. (3) The LLM focuses heavily on the Wisconsin litigation and Georgia case stay, but misses the key evolution identified in the ground truth: the 2024 disclosure includes 'more detailed description of the insurance policies' and 'involvement of multiple insurers and ongoing coverage litigation,' representing a substantive change in disclosure emphasis. (4) The LLM's conclusion that 'no new liability or settlement has been introduced' contradicts the ground truth's identification of a meaningful shift in Coca-Cola's disclosure stance and emphasis. (5) The answer fails to capture the multi-hop synthesis required: comparing 2023 vs 2024 positions and identifying how the company's public stance evolved from denial to nuance. The LLM appears to have conflated settled litigation with current positions and missed the subtle but important shift in how Coca-Cola framed its relationship to the liability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 447,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "\nIn 2024 Intel’s non‑U.S. tax credits—chiefly the R&D credit and the benefit from income taxed at lower foreign rates—produced only about **$5.6 million** of tax benefit, down sharply from **$11.4 million** in 2022 (and far below the $99 million benefit seen in 2023).  Because these credits were much smaller, the company’s effective tax rate jumped to **71.6 %** in 2024 (versus a near‑zero rate in 2022), driving up its long‑term income‑tax liability even though long‑term tax payable fell to $1.6 billion.  The decline in credit utilization signals that Intel is **relying less on foreign tax incentives and is shifting its international tax strategy away from the aggressive use of non‑U.S. tax holidays and credits**.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not supported by the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites $5.6 million in non-U.S. tax credits for 2024 and $11.4 million for 2022, but the ground truth makes no mention of these specific credit amounts. The ground truth focuses on long-term income taxes payable ($4.3B in 2022 declining to $1.6B in 2024), not annual tax credit benefits. The 71.6% effective tax rate cited is not mentioned in the ground truth. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth states that non-US tax credits reduced long-term income tax liabilities, with the $4.3B figure in 2022 being 'reduced by non-US tax credits.' The LLM incorrectly interprets this as annual credit utilization amounts rather than understanding the cumulative impact on long-term liabilities. (3) UNSUPPORTED CLAIMS: The LLM's conclusion that Intel is 'shifting its international tax strategy away from the aggressive use of non-U.S. tax holidays and credits' is not supported by the ground truth, which suggests 'a strategic shift or increased effectiveness in leveraging international tax credits.' These are opposite interpretations. (4) CORRECT ELEMENTS: The LLM correctly identifies that long-term tax payable fell to $1.6 billion in 2024, matching the ground truth. However, this single correct data point is insufficient given the numerous errors. (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the relationship between non-US tax credits and long-term income tax liabilities across the 2022-2024 period. The ground truth indicates credits had a 'stronger offsetting effect over time,' but the LLM's data contradicts this interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 470,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s pension‑risk‑transfer activities shifted from a largely defensive, margin‑compression focus—using interest‑rate derivatives and ALM to offset the effects of a low‑rate environment, with regulatory caps on crediting‑rate changes—to a model that explicitly ties the transfers’ earnings to interest‑rate movements, reflecting both the upside of higher‑yield reinvestment and the downside of rising crediting rates.  At the same time, newer solvency and pension‑funding regulations have increased oversight of how these transfers are capitalized and disclosed, shaping the mix and risk profile of the exposures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misalignments with the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM introduces specific claims about 'interest-rate derivatives,' 'margin-compression focus,' 'crediting-rate changes,' and 'low-rate environment' that are NOT present in the ground truth. The ground truth makes no mention of these specific mechanisms or the company's defensive posture in 2022. (2) MISCHARACTERIZATION OF 2022 STATE: The ground truth states pension risk transfers were part of Retirement and Income Solutions with 'short- and long-duration products' subject to interest rate scenarios for ALM strategies. The LLM incorrectly characterizes this as a 'defensive, margin-compression focus' with specific derivative strategies not mentioned in the source. (3) PARTIAL ALIGNMENT ON 2024: The LLM correctly identifies that regulatory changes affected pension risk transfers and mentions 'solvency and pension-funding regulations,' which aligns with the ground truth's mention of 'regulatory changes around defined benefit pension plan funding.' However, the LLM's specific claims about 'capitalization and disclosure' requirements are not explicitly stated in the ground truth. (4) MISSING KEY INSIGHT: The ground truth emphasizes a critical regulatory-driven shift toward 'non-guaranteed funding products' as plan sponsors delayed or avoided terminations. The LLM completely misses this strategic shift in product mix, instead focusing on earnings sensitivity to interest rates. (5) UNSUPPORTED CLAIMS: The LLM's detailed narrative about 'upside of higher-yield reinvestment and downside of rising crediting rates' appears to be inference or speculation not grounded in the provided ground truth. The answer demonstrates poor multi-hop synthesis—it fails to correctly connect the regulatory environment to the actual strategic implications (shift toward non-guaranteed products) that the ground truth identifies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 528,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "\nFrom 2022 to 2024 Medtronic moved the InterStim Micro from a newly launched, rechargeable micro‑neurostimulator for overactive‑bladder and urinary‑retention therapy (highlighted in the 2022 Neuroscience net‑sales discussion) to a broadly adopted core of its Pelvic‑Health portfolio, gaining additional indications (including fecal incontinence) and deeper integration into the AiBLE spinal‑technology and robotic‑assisted surgery platforms, positioning it as a key growth driver within the Neuromodulation segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) INCORRECT CLAIMS: The LLM states InterStim Micro gained 'additional indications (including fecal incontinence)' by 2024, but the ground truth indicates fecal incontinence was already part of the 2022 positioning as 'bowel incontinence.' This is a factual error. (2) UNSUPPORTED INTEGRATION CLAIMS: The LLM claims 'deeper integration into the AiBLE spinal-technology and robotic-assisted surgery platforms' - this is not mentioned in the ground truth at all and appears to be fabricated or confused with other product lines. (3) MISSING KEY DIFFERENTIATION: The ground truth emphasizes a critical 2024 positioning shift: InterStim Micro is specifically highlighted as 'rechargeable' while distinguishing it from 'recharge-free' InterStim X and InterStim II models. The LLM mentions 'rechargeable micro-neurostimulator' in 2022 but fails to capture the 2024 differentiation strategy that contrasts it with recharge-free competitors. (4) INCOMPLETE EVOLUTION NARRATIVE: The ground truth shows a clear evolution from 2022 (part of broader offering) to 2024 (targeted marketing with specific rechargeable positioning). The LLM's narrative about 'newly launched' and 'broadly adopted core' doesn't align with the ground truth's emphasis on marketing differentiation strategy. (5) NEUROMODULATION SEGMENT CLAIM: While the LLM mentions Neuromodulation segment, the ground truth specifically places InterStim within 'Specialty Therapies division' and 'Pelvic Health therapies' - the broader segment context is less relevant than the specific therapeutic category. The answer demonstrates poor multi-hop synthesis and introduces unsupported claims about product integrations that cannot be verified from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 501,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "\nBetween the end of 2021 and 2022 Simon Property Group carried a $1.05 billion draw on its Supplemental Facility, but it repaid that amount in full in January 2022 using proceeds from newly issued unsecured notes.  By 2024 the facility’s maturity had been extended to January 2026 (with a one‑year extension option) and its capacity raised to $4.5 billion, yet outstanding borrowings were modest—averaging about $310 million and never exceeding $325 million during the year—reflecting a shift from large‑scale debt‑refinancing to a flexible liquidity source for acquisitions and working‑capital needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about the Supplemental Facility's evolution but contains significant quantitative discrepancies with the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies a major repayment in early 2022 ($1.05 billion), which aligns with debt reduction strategy; (2) The 2024 weighted average of ~$310 million matches the ground truth figure of $311.1 million very closely; (3) The characterization of the facility's shift from large-scale refinancing to flexible liquidity is semantically sound; (4) The mention of facility maturity extension and capacity increase to $4.5 billion appears reasonable for 2024 context. CRITICAL ERRORS: (1) The ground truth explicitly states a €750.0 million ($815.4 million USD equivalent) repayment on November 17, 2023, which the LLM answer completely omits—this is a major factual gap for a question specifically about 2022-2024 evolution; (2) The LLM states maximum outstanding never exceeded $325 million in 2024, but the ground truth shows a maximum aggregate outstanding balance of $2.1 billion in 2022, making the comparison incomplete; (3) The LLM focuses heavily on 2021-2022 activity (the $1.05 billion repayment) rather than the 2022-2024 period requested; (4) The ground truth's weighted average of $519.9 million in 2022 is not mentioned in the LLM answer, missing the baseline for comparison. MULTI-HOP REASONING: The LLM demonstrates reasonable synthesis of facility characteristics and strategic intent, but fails to properly connect the specific repayment events (particularly the November 2023 €750M repayment) to the overall 2022-2024 evolution narrative. The answer reads more as a general facility description than a specific evolution analysis. QUANTITATIVE ISSUES: While the 2024 average ($310M) is accurate, the omission of the 2022 baseline ($519.9M) and the major 2023 repayment ($815.4M) represents incomplete quantitative coverage of the requested period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 529,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "\nDepreciation, depletion, amortization and impairment (DDA) expenses for the Lower 48 segment climbed from **$4,854 million in 2022 to $5,729 million in 2023**, an increase of **$875 million (≈18 %)**.  This rise reflects a higher level of capital deployment—more development wells, lease‑hold acquisitions and a larger depletion base—indicating that ConocoPhillips stepped up its investment activity in the Lower 48 region during 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) QUANTITATIVE VERIFICATION: All numbers are correct - 2022: $4,854 million, 2023: $5,729 million, difference: $875 million. The percentage calculation is accurate: $875M / $4,854M = 18.03%, correctly rounded to ≈18%. (2) COMPLETENESS: The answer fully addresses the question by providing the evolution of DDA expenses from 2022 to 2023 with both absolute and relative changes. (3) ENTITY ACCURACY: Correctly identifies COP (ConocoPhillips), the Lower 48 region, and the specific metric (depreciation, depletion, amortization, and impairments). (4) REASONING & SYNTHESIS: The LLM goes beyond the ground truth by providing sound interpretation - it correctly infers that the increase in DDA expenses reflects higher capital deployment and investment activity, citing specific drivers (development wells, lease-hold acquisitions, larger depletion base). This multi-hop reasoning is logical and appropriate. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while adding valuable context and interpretation. The only minor distinction is that the LLM provides more detailed analysis than the ground truth, but this is additive rather than contradictory. All calculations are mathematically sound and properly formatted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 368,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "\nIn the 2024 filing Verizon’s Business segment description was sharpened to list “private‑networking services, private‑cloud connectivity, virtual and software‑defined networking and managed network services” as the core corporate‑networking offerings—language that was only implied in the 2023 filing, which referred more generally to “corporate networking solutions, security and managed network services.”  At the same time the revenue mix shifted: the Enterprise & Public Sector line slipped from roughly $15.1 bn (2023) to $14.2 bn (2024), while Business Markets & Other rose from about $12.7 bn to $13.1 bn, indicating a strategic pivot from a heavy focus on large‑enterprise/government contracts toward a broader mid‑market and wholesale‑oriented corporate‑networking emphasis.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer directly contradicts the ground truth on multiple key points: (1) SERVICE DESCRIPTION REVERSAL: The LLM claims 2024 became 'sharpened' with MORE specific detail (listing 'private-networking services, private-cloud connectivity, virtual and software-defined networking and managed network services'), while the ground truth explicitly states 2024 became 'more streamlined' with LESS detail, focusing generically on 'wireless and wireline communications services and products.' This is a fundamental factual inversion. (2) REVENUE FIGURES - INCORRECT DIRECTION: The LLM states Enterprise & Public Sector 'slipped from roughly $15.1 bn (2023) to $14.2 bn (2024)' - while the ground truth confirms $15.1B in 2023, it does NOT provide a 2024 figure of $14.2B. The LLM appears to have fabricated this 2024 number. (3) BUSINESS MARKETS & OTHER - UNSUPPORTED: The LLM cites 'Business Markets & Other rose from about $12.7 bn to $13.1 bn' - these figures are not mentioned in the ground truth at all and appear to be invented. (4) STRATEGIC INTERPRETATION REVERSED: The LLM interprets the shift as 'a strategic pivot from heavy focus on large-enterprise/government contracts toward broader mid-market,' which contradicts the ground truth's assessment of 'strategic consolidation or simplification of messaging.' The LLM has essentially inverted the narrative - claiming MORE specificity when ground truth shows LESS, and inventing revenue figures not in the source material. The answer demonstrates poor multi-hop reasoning and appears to confabulate financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 439,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "\nMetLife continued to classify its Fair‑Value‑Option securities as Level 3 and to value them with market‑based pricing and consensus quotes, so the underlying valuation methodology did not change between 2022 and 2024.  In the 2022 sensitivity analysis a 10 % U.S.‑dollar appreciation would have lowered the estimated fair value of FVO securities by roughly $54 million (page 150), whereas the 2024 roll‑forward shows only a modest $13 million net increase in unrealized gains for those securities and no AOCI impact, indicating that the fair‑value sensitivity to dollar strength has largely disappeared.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterprets the evolution of MetLife's valuation approach. Key issues: (1) QUANTITATIVE ERRORS: The LLM correctly cites the $54 million 2022 sensitivity figure, but then claims the 2024 data shows 'only a modest $13 million net increase in unrealized gains' with 'no AOCI impact' - this appears to conflate different metrics and misrepresents the 2024 data. The ground truth indicates 2024 shows a 'more nuanced and dynamic valuation methodology' with sensitivity to 'nonperformance risk spreads and unobservable inputs varied by duration and currency,' not a disappearance of sensitivity. (2) CONCEPTUAL MISINTERPRETATION: The LLM claims 'fair-value sensitivity to dollar strength has largely disappeared,' which directly contradicts the ground truth showing evolution toward MORE complex currency-dependent approaches. The ground truth explicitly states the shift is from 'static sensitivity model to a more complex, duration- and currency-dependent approach.' (3) INCOMPLETE ANALYSIS: The LLM focuses on whether methodology changed (it didn't fundamentally) but misses the key evolution in HOW sensitivity is measured and reported - moving from simple 10% appreciation scenarios to duration and currency-specific frameworks. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the 2022 vs 2024 data to show the actual evolution. The comparison of $54M (2022) to $13M (2024) is presented as evidence of disappearing sensitivity, but this is not supported by the ground truth which emphasizes increased sophistication in the sensitivity framework. The answer fundamentally mischaracterizes the direction and nature of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 464,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "\nBetween 2022 and 2023 NextEra’s power‑marketing and trading operations flipped from a **$2.67 bn loss on non‑qualifying commodity hedges in 2022 to a $2.53 bn gain in 2023** (see NEE 2023 10‑K p. 40).  This swing helped lift total operating revenue by **$5.95 bn** and accounted for a **$3.27 bn increase in net income** (from $285 m to $3.56 bn) (p. 40).  The company continued to expand its full‑energy and capacity‑requirements marketing and trading services—leveraging fair‑value accounting for trading contracts to capture favorable commodity‑price movements—so that energy‑trading activities now contribute a material, positive financial result to NextEra’s results.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides substantially more detailed financial information than the ground truth. Key verification: (1) Net income figures are correct: $285M in 2022 and $3,558M (presented as $3.56 bn) in 2023, matching ground truth exactly. (2) The $3.27 bn increase in net income is mathematically accurate ($3,558M - $285M = $3,273M ≈ $3.27 bn). (3) The LLM provides additional specific details about the power marketing evolution: the swing from a $2.67 bn loss on non-qualifying commodity hedges in 2022 to a $2.53 bn gain in 2023, and the $5.95 bn impact on operating revenue. These specific numbers are not contradicted by the ground truth and appear to be sourced from the 10-K filing (p. 40 cited). (4) Multi-hop reasoning is sound: the answer correctly synthesizes that NEER's expanded role in power marketing and trading directly contributed to the significant net income increase. (5) The answer goes beyond the ground truth by explaining the mechanism (fair-value accounting for trading contracts capturing commodity-price movements) and the specific commodity hedge dynamics. (6) All entities are correctly identified (NextEra Energy/NEE, NEER subsidiary, fiscal years 2022-2023). (7) The semantic meaning aligns perfectly with ground truth regarding the evolution and growth of power marketing activities. Minor note: The LLM provides more granular financial detail than the ground truth, but this represents added value rather than contradiction. The answer fully addresses the question about how engagement evolved between 2022 and 2023 in terms of energy trading services and financial performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 453,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 Coca‑Cola’s equity‑method ownership in Coca‑Cola FEMSA stayed constant at **28 % of the bottler’s outstanding shares** (see the 2023 filing’s note on equity‑method investments and the 2024 table that lists the same 28 % stake).  Because the stake was unchanged, the **equity‑income‑net generated by FEMSA rose modestly**—from **$1.69 billion in 2023 to $1.77 billion in 2024** (2024 Note 6 and 2023 Note 6), reflecting higher earnings of FEMSA and the continued contribution of that 28 % interest to Coca‑Cola’s consolidated results.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific financial figures and correctly identifies the 28% ownership stake in Coca-Cola FEMSA that remained constant between 2023 and 2024. However, there are significant issues with the evaluation: (1) QUANTITATIVE ACCURACY - The equity income figures cited ($1.69B in 2023 and $1.77B in 2024) cannot be verified against the ground truth provided, and these specific numbers are critical to the answer's credibility. The ground truth does not provide these exact figures, making it impossible to confirm their accuracy. (2) INCOMPLETENESS - The LLM answer focuses heavily on the constant 28% stake and equity income changes, but largely ignores the ground truth's key insight about the 'shift from a dependency-based relationship to a direct ownership stake' and the 'strategic evolution' aspect mentioned in the original answer. The ground truth emphasizes that in 2023, FEMSA was referenced as a key bottler affecting credit ratings (indirect dependency), while by 2024 there was a direct ownership stake with equity method accounting. The LLM answer doesn't adequately address this evolution or the strategic implications. (3) MULTI-HOP REASONING - The LLM answer correctly synthesizes that the constant 28% stake led to equity income changes based on FEMSA's performance, which is sound reasoning. However, it misses the broader narrative of how the relationship evolved from indirect to direct financial interest. (4) ENTITY ACCURACY - Company names and metrics are correctly identified (Coca-Cola, Coca-Cola FEMSA, equity method, equity income). (5) SEMANTIC ISSUES - The answer states equity income 'rose modestly' but doesn't contextualize this within the broader strategic relationship evolution that the ground truth emphasizes. The answer is partially correct on the financial mechanics but incomplete on the strategic narrative and lacks verification of the specific dollar amounts cited.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 520,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "\nBetween 2022 and 2023 the company poured more money into the Lower 48 – capital spending rose from roughly $5.6 billion to $6.5 billion and depreciation expense for the play climbed from about $4.9 billion to $5.7 billion, signalling a larger, longer‑lived asset base.  At the same time, production in the core Delaware‑Basin portion of the Lower 48 stayed strong (the Delaware Basin area grew to 162 million barrels‑equivalent and natural‑gas output remained robust), underscoring a strategic shift toward concentrating operational resources and growth in the Lower 48 region.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall trend and strategic direction but contains significant quantitative inaccuracies. CORRECT ELEMENTS: (1) The depreciation/depletion/amortization figures are accurate - $4.9B (approximately $4,854M) in 2022 rising to $5.7B ($5,729M) in 2023, correctly formatted and semantically equivalent. (2) The directional analysis is sound - increased financial investment in Lower 48 is correctly identified. (3) The multi-hop reasoning connecting capital spending increases to depreciation increases to asset base growth is logically sound. (4) The strategic shift narrative is appropriate and well-reasoned. INCORRECT/PROBLEMATIC ELEMENTS: (1) Capital spending figures ($5.6B to $6.5B) are NOT provided in the ground truth answer and cannot be verified against the source data. These appear to be introduced without support. (2) The Delaware Basin production figure (162 million barrels-equivalent) is not mentioned in the ground truth and cannot be verified. (3) The specific production volumes cited in the ground truth (crude oil 447 kbd, natural gas 1,340 mmcf/d) are completely absent from the LLM answer, representing a significant omission of key quantitative data. (4) The LLM conflates 'depreciation expense' with broader 'depreciation, depletion, amortization, and impairments' - while the numbers align, the terminology should be precise. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes the relationship between capital investment and depreciation to infer asset base growth, which is sound reasoning. However, it introduces unsupported capital spending data while omitting the specific production volume metrics that were central to the ground truth answer. The answer is partially correct on the depreciation metrics but incomplete on production data and introduces unverified capital spending figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 507,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "\nVerizon continued to treat its 4G LTE network as the foundational platform for its fixed‑wireless access (FWA) broadband service, using spectrum holdings and densification to add capacity and support a growing FWA customer base (see 2023 10‑K pages 95‑99, which describe FWA delivered over 5G or 4G LTE, and 2024 10‑K pages 21‑25, which note that “wireless mobility investments provide the foundation for our growing FWA broadband business”).  At the same time, the company is shifting strategic emphasis toward 5G and fiber‑based expansion, leveraging 4G LTE mainly to boost network capacity and to underpin the rollout of 5G services, thereby positioning the legacy LTE infrastructure as a complementary layer that enables, rather than drives, its primary growth initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Verizon's 4G LTE network evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the foundational role of 4G LTE for FWA broadband in both years, with accurate citation references to 10-K filings (2023 pages 95-99, 2024 pages 21-25); (2) Accurately captures the strategic shift from 4G LTE as a primary service delivery mechanism to a complementary layer within a broader multi-technology ecosystem; (3) Properly synthesizes the multi-hop information showing how 4G LTE evolved from standalone FWA delivery to supporting 5G rollout and fiber expansion; (4) Correctly identifies the shift in emphasis toward 5G and fiber as primary growth drivers while 4G LTE becomes enabling infrastructure; (5) No quantitative errors or incorrect dates/metrics. MINOR WEAKNESSES: (1) The answer is somewhat more detailed and nuanced than the ground truth, adding context about 'spectrum holdings and densification' and 'network capacity' that, while likely accurate, goes slightly beyond what the ground truth explicitly states; (2) The ground truth emphasizes the move from 'service delivery context to strategic asset within multi-technology ecosystem' more directly, while the LLM answer frames it as 'complementary layer that enables rather than drives' - these are semantically similar but the LLM uses slightly different framing; (3) The ground truth mentions C-Band spectrum, millimeter wave spectrum, and fiber infrastructure explicitly as part of the integrated vision, while the LLM answer references these more implicitly through '5G and fiber-based expansion.' The answer is factually sound and demonstrates correct multi-hop reasoning across the two filing years, with appropriate synthesis of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 484,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "\nFrom 2022 to 2024 Emerson’s stake in AspenTech grew from the ~55 % it held after the 2022 Heritage‑AspenTech transaction to roughly 57 % by the November 2024 proposal to acquire the remaining shares, with the stake valued at about $8–9 billion on the implied $15.3 billion fully‑diluted market cap.  The deepening ownership added high‑margin software assets that helped lift consolidated gross margin to 50.8 % in 2024 (up 1.8 pts), although this gain was partially offset by acquisition‑related inventory step‑up amortization, while AspenTech’s backlog expanded from $328 million in 2021 to $1.0 billion in 2022 and continued to grow, supporting overall order growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth:\n\n1. OWNERSHIP STRUCTURE ERRORS: The LLM states Emerson held ~55% after the 2022 Heritage-AspenTech transaction and grew to ~57% by November 2024. However, the ground truth indicates that by 2024, Emerson owned 55% of 'New AspenTech' - not that it grew from 55% to 57%. The LLM's narrative of increasing ownership from 55% to 57% appears to be incorrect or misrepresents the actual transaction structure.\n\n2. BACKLOG DISCREPANCIES: The LLM cites AspenTech backlog of $328M in 2021 and $1.0B in 2022, but the ground truth states Emerson held a stake in AspenTech with backlog of $1,042 million in 2022. The LLM's figures for AspenTech standalone backlog don't align with the consolidated metrics in the ground truth. More critically, the ground truth emphasizes consolidated backlog reaching $8,053M in 2024 (up from $6,533M in 2021), which the LLM does not mention.\n\n3. GROSS MARGIN ERRORS: The LLM states gross margin reached 50.8% in 2024 with a 1.8 percentage point increase. The ground truth indicates gross margin in 2023 increased by 3.3 percentage points partly due to the AspenTech acquisition. The LLM provides 2024 data and a different magnitude (1.8 pts vs 3.3 pts), and references 2023 differently than ground truth.\n\n4. VALUATION CLAIMS: The LLM introduces specific valuation figures ($8-9 billion stake on $15.3B market cap) that are not mentioned in the ground truth, making it difficult to verify accuracy.\n\n5. MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize ownership evolution, backlog growth, and margin impact, the specific numbers and relationships don't match the ground truth. The answer conflates AspenTech standalone metrics with consolidated Emerson metrics.\n\n6. MISSING KEY INFORMATION: The ground truth emphasizes the creation of 'New AspenTech' and the 55% ownership structure as the end state by 2024, but the LLM frames this as an intermediate step with further acquisition proposals.\n\nThe answer demonstrates partial understanding of the relationship evolution but contains material factual errors in key metrics (backlog, margin improvement magnitude) and ownership structure interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 598,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "\nBetween 2022 and 2023 NEE went from holding an equity stake in the Mountain Valley Pipeline to completely writing‑off that investment after a $1.5 billion impairment charge in 2020 and an additional full write‑off in early 2022 (Note 8, page 96).  In the 2023 disclosures the only reference to the project is a modest “equity contribution in 2024” listed under other capital‑expenditure items (Commitments table, page 109), with no material carrying amount or earnings impact reported.  This shift shows that NEE has largely disengaged from the pipeline venture and is now directing its capital toward regulated utility and renewable‑generation projects that offer more predictable, rate‑base returns.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL ERRORS: The ground truth clearly states that by 2023, NEE had a 32.8% equity investment in MVP with a 20-year natural gas transportation agreement valued at ~$70M/year, indicating deepening commitment. The LLM claims NEE 'completely wrote off' the investment and 'largely disengaged' - this is the opposite of what occurred. (2) IMPAIRMENT CLAIMS: The LLM references a '$1.5 billion impairment charge in 2020' and 'full write-off in early 2022' - these specific numbers and dates cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth makes no mention of such write-offs. (3) INVESTMENT STRUCTURE: The ground truth explicitly describes a 'strategic deepening' with a 'more structured, long-term contractual relationship' - the LLM's narrative of disengagement directly contradicts this. (4) 2023 STATUS: The ground truth indicates active, defined investment (32.8% stake + $70M/year agreement), while the LLM claims only a 'modest equity contribution in 2024' with 'no material carrying amount.' (5) STRATEGIC INTERPRETATION: The ground truth indicates NEE is deepening infrastructure commitments; the LLM claims NEE is redirecting away from pipelines toward utilities/renewables - opposite conclusions. The LLM answer appears to have confused or inverted the actual trajectory of NEE's MVP involvement, presenting a narrative of divestment when the ground truth shows commitment deepening.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 429,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "\nFrom 2023 to 2024 Coca‑Cola kept Costa Limited inside its Global Ventures segment, but the 2024 filing underscores a tighter operational integration by reporting Costa’s results and the fees earned under its distribution‑coordination agreements as a core contributor to the segment’s growth strategy. This shift positions Costa not merely as an ancillary brand but as a strategic pillar within Global Ventures, emphasizing its role in driving expansion and sustainability initiatives for the Company.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core evolution of Costa Limited's role within Coca-Cola's Global Ventures segment from 2023 to 2024. STRENGTHS: (1) Correctly identifies that Costa remained within Global Ventures across both years; (2) Accurately captures the shift toward tighter operational integration and strategic positioning; (3) Properly references distribution coordination agreements as a key component of the 2024 positioning; (4) No quantitative errors or incorrect dates/numbers; (5) Appropriately characterizes Costa's evolution from ancillary to strategic pillar. WEAKNESSES: (1) The ground truth explicitly mentions that innocent and doğadan businesses were also included in Global Ventures by 2024 - the LLM answer omits this important contextual detail about the broader segment composition; (2) The LLM answer adds interpretive language about 'expansion and sustainability initiatives' that is not explicitly supported by the ground truth, which focuses on operational integration and strategic positioning rather than specific strategic initiatives; (3) The characterization of Costa as 'merely ancillary' in 2023 is somewhat inferential - the ground truth states it was 'part of direct retail operations' without explicitly calling it ancillary. MULTI-HOP REASONING: The answer successfully synthesizes information about Costa's role across two years and correctly identifies the evolution in strategic positioning. However, it misses the opportunity to note the concurrent integration of other brands (innocent, doğadan) which would have provided fuller context for understanding the segment's strategic evolution. The answer is semantically sound and factually accurate on the main points but lacks completeness in addressing the full scope of Global Ventures' 2024 composition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 495,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "\nIntel’s economically‑hedged marketable debt investments declined from **$17.1 billion at the end of 2023** to **$13.5 billion at the end of 2024** (a reduction of roughly $3.6 billion, or about 21%).  Consequently, the hedged portfolio shifted from a **$534 million gain in 2023** to a **$464 million loss in 2024**, after having recorded a **$748 million loss in 2022**.  This shows a clear contraction in both the size and the profitability of the hedged debt‑investment position over the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error regarding 2023 performance. The ground truth states Intel recorded net LOSSES of $464 million in 2024, but the LLM claims a $534 million GAIN in 2023. This is a fundamental contradiction - the LLM inverted the sign (gain vs. loss) for 2023. The ground truth does not mention a $534 million gain in 2023; it only references the $748 million loss in 2022 and $464 million loss in 2024. CORRECT ELEMENTS: (1) Fair value decline from $17.1B (2023) to $13.5B (2024) - CORRECT; (2) Reduction of approximately $3.6B or 21% - CORRECT (calculation verified: $17.1B - $13.5B = $3.6B; $3.6B/$17.1B ≈ 21%); (3) $748 million loss in 2022 - CORRECT; (4) $464 million loss in 2024 - CORRECT; (5) Overall narrative of portfolio contraction - CORRECT. MULTI-HOP REASONING: The LLM successfully synthesized data across three years (2022, 2023, 2024) and compared portfolio sizes and performance metrics. However, the introduction of the unsubstantiated $534 million gain in 2023 represents a significant factual error that undermines the credibility of the entire response. The ground truth does not provide 2023 loss/gain figures, so the LLM appears to have fabricated or misremembered this data point. This is a critical failure in factual accuracy despite correct handling of other numerical elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 379,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "\nBetween 2023 and 2024 AMT continued to lean on its long‑term, escalating tenant leases—whose revenue it describes as “the vast majority … recurring” and essential for meeting debt covenants and REIT distributions.  In the 2024 filing the company explicitly quantifies its asset‑retirement obligations at roughly **$4.5 billion** of undiscounted future cash outlays, highlighting a heightened focus on the liability side of its communications‑site portfolio and on how those obligations affect its liquidity and cash‑flow planning.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the $4.5 billion asset retirement obligation figure for 2024 and accurate characterization of AMT's revenue model. The answer correctly captures the evolution from emphasizing recurring revenue to addressing liability-side considerations. However, there are some notable differences from the ground truth: (1) The LLM answer does not explicitly mention the 99% recurring revenue figure from property operations cited in the original answer for 2023, instead using more general language about 'the vast majority' being recurring. (2) The LLM adds contextual details about debt covenants and REIT distributions that, while relevant to AMT's financial strategy, are not explicitly mentioned in the ground truth answer. (3) The ground truth specifically notes the shift from 'primarily highlighting revenue streams to also addressing long-term financial responsibilities,' while the LLM frames this as a 'heightened focus on the liability side' - semantically similar but with slightly different emphasis. Quantitatively, the $4.5 billion figure is correct and properly characterized as undiscounted future cash outlays. The multi-hop reasoning is sound - the answer successfully synthesizes the evolution of AMT's financial focus across the two years. The answer is well-structured and contextually appropriate, though it could have been more precise in citing the specific 99% revenue metric from 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 409,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "\nBetween 2023 and 2024 ExxonMobil moved from establishing the legal basis for its Guyana operations—grounded in the Guyana Petroleum Activities Act 2023, which provides up to a 10‑year exploration term and a 20‑year production term (renewable for another decade)—to positioning Guyana as a core “advantaged asset” in its growth strategy.  In the 2024 filing the company explicitly lists Guyana among its advantaged growth projects and ties it to the “Advantaged Volume Growth” earnings driver, emphasizing commercial development, scale‑up of offshore production and integration with LNG and high‑value product initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numeric values are correct—10-year exploration period, 20-year production period, and 10-year renewal period all match the ground truth exactly. Dates (2023 and 2024) are accurate. ENTITY ACCURACY: XOM (ExxonMobil) correctly identified, Guyana correctly referenced, Petroleum Activities Act 2023 correctly cited, and 'Advantaged Assets'/'Advantaged Volume Growth' terminology correctly applied. MULTI-HOP REASONING: The answer successfully synthesizes information across two years, showing the evolution from legal framework establishment (2023) to strategic positioning (2024). The connection between the regulatory framework and the strategic emphasis is logically sound. COMPLETENESS: The answer addresses both components of the question—legal operating framework (Petroleum Activities Act 2023 with specific terms) and business growth emphasis (Advantaged Assets, Advantaged Volume Growth driver). SEMANTIC EQUIVALENCE: The LLM answer conveys all essential information from the ground truth. It adds contextual detail about 'commercial development, scale-up of offshore production and integration with LNG and high-value product initiatives' which, while not explicitly in the ground truth, represents reasonable elaboration consistent with the strategic positioning described. MINOR OBSERVATION: The LLM answer is slightly more detailed and contextually rich than the ground truth, providing additional strategic context about integration initiatives, but this represents value-added information rather than deviation from accuracy. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 464,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "\nCaterpillar continues to house diesel‑electric locomotives and their components within the Energy & Transportation segment, retaining responsibility for remanufacturing, leasing and after‑market support for rail products (see page 116 and page 39).  Between 2023 and 2024 the segment’s external sales rose 3 % and its operating profit jumped 16 %, driven largely by favorable price realization, indicating that the company is deliberately strengthening the strategic positioning of its diesel‑electric locomotive business and treating it as a higher‑margin core offering (see page 40).  Operationally, the responsibilities for remanufacturing and leasing remain the same, but the improved financial performance reflects a more focused, profit‑oriented approach to this line of business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) SEGMENT NAME ERROR: The LLM refers to the segment as 'Energy & Transportation' when the ground truth explicitly identifies it as 'Machinery, Energy & Transportation (ME&T)' - this is a material factual error. (2) MISSING STRATEGIC EVOLUTION: The LLM completely fails to address the core of the question regarding strategic positioning evolution. The ground truth emphasizes a significant shift from 2023 to 2024 toward 'integrated systems and solutions' and 'electrified powertrains and zero-emission power sources' - representing a strategic pivot toward environmentally focused technologies. The LLM mentions only operational continuity ('responsibilities for remanufacturing and leasing remain the same'), missing this critical strategic evolution entirely. (3) UNVERIFIED FINANCIAL CLAIMS: The LLM cites specific percentages (3% sales rise, 16% operating profit jump) and references to pages (116, 39, 40) that cannot be verified against the ground truth provided. These appear to be fabricated or hallucinated numbers, as the ground truth contains no such specific financial metrics for this comparison. (4) INCOMPLETE SCOPE: The LLM mentions 'leasing and after-market support' but the ground truth emphasizes broader strategic positioning including 'integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors' - a much wider scope than the LLM captures. (5) MISSING KEY DEVELOPMENT: The LLM entirely omits the 2024 emphasis on 'electrified powertrains and zero-emission power sources,' which represents a fundamental strategic shift that directly answers the question about how involvement 'evolved.' The answer reads as financially focused but strategically hollow, missing the environmental/technology evolution that is central to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 527,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "\nFrom the 2022 filing the company reported securitized‑debt obligations of about **$15 billion** (≈ 4 % of total funding), a level that had risen modestly from the prior year due to net issuances in its securitization programs.  The 2024 filing shows the carrying amount of those obligations fallen to **$14.26 billion**, while total funding remained near $354 billion, indicating a slight pull‑back from securitization.  This reduction points to a funding strategy that is shifting back toward **deposit‑based sources and other debt markets** rather than relying on securitized debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) QUANTITATIVE ERRORS: The LLM claims 2022 securitized debt was ~$15 billion, but the ground truth explicitly states 'the exact amount was not provided' for 2022. The LLM fabricated a specific number with no basis. The 2024 figure of $14.26 billion is correct and matches the ground truth's $14,264 million. (2) DIRECTIONAL ERROR: The LLM incorrectly characterizes the trend as a 'reduction' and 'pull-back from securitization,' suggesting a shift away from securitized debt. However, the ground truth indicates an 'evolution' toward 'more defined and potentially increased reliance' on securitized debt obligations. The LLM's interpretation is backwards. (3) UNSUPPORTED CLAIMS: The LLM provides specific percentages (4% of total funding) and total funding figures ($354 billion) that are not mentioned in the ground truth and appear to be fabricated. (4) REASONING FLAW: The LLM's conclusion about shifting to 'deposit-based sources' is not supported by the ground truth, which emphasizes a strategic emphasis on structured financing. (5) MISSING CONTEXT: The LLM fails to acknowledge that 2022 lacked specific quantification, which is a key point in understanding the evolution. The answer demonstrates poor multi-hop synthesis, inventing data points rather than working with available information, and reaching conclusions opposite to the ground truth's assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 403,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s refined the way it reports and manages its developmental‑licensee relationships.  The company continued to recognize royalties and initial fees from these licensees as non‑lease revenue and, pursuant to the new FASB ASU 2023‑07 on segment reporting, began disclosing a more detailed breakdown of that income within the “International Developmental Licensed Markets & Corporate” segment, highlighting the growth in licensed‑restaurant count (from 8,684 to 9,247) and the corresponding rise in royalty receipts.  Operationally, the firm maintains its historic allocation of lease versus non‑lease components, but the enhanced disclosures and the upcoming ASU 2024‑03 (expense disaggregation) signal a tighter, more transparent financial linkage between McDonald’s and its developmental partners.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific numbers (8,684 to 9,247 licensed-restaurant count) that are not mentioned in the ground truth answer. These numbers cannot be verified against the provided knowledge graph data and appear to be fabricated or from unreliable sources. (2) UNSUPPORTED CLAIMS: The LLM references 'FASB ASU 2023-07 on segment reporting' and 'ASU 2024-03 (expense disaggregation)' as drivers of McDonald's disclosure changes. The ground truth makes no mention of these accounting standards updates as factors in the evolution of treatment. This represents a fundamental misunderstanding or hallucination of the actual reasons for changes. (3) MISSING KEY INFORMATION: The LLM fails to mention several critical elements from the ground truth: (a) the 2023 disclosure about royalties being based on percentage of sales and initial fees, (b) the allocation of consideration among lease and non-lease components using historical methods, (c) the 2024 evaluation of variable interest entities and consolidation conclusions, (d) the 2024 rounding presentation changes to nearest whole number. (4) INCOMPLETE SYNTHESIS: While the LLM attempts to address financial reporting and relationship management evolution, it does so by introducing external accounting standards rather than synthesizing the actual disclosed changes in McDonald's approach. (5) SEMANTIC ISSUES: The answer conflates segment reporting disclosures with the substantive changes in how developmental licensees are treated and reported. The ground truth emphasizes evaluation of VIE status and consolidation treatment, which the LLM completely omits. The answer reads as plausible but is largely inaccurate when compared to the ground truth knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 506,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "\nIn the 2023 filing Southern Company disclosed that 26.9 million shares were available for future grants under its Equity and Incentive Compensation Plan (the plan, adopted May 26 2021, had 131 million shares reserved in total). The 2024 filing still references that same plan but does not give a new share‑availability figure; instead it expands executive‑award disclosures by adding amended change‑in‑control severance and deferred‑compensation agreements while continuing to describe the plan’s award forms (stock options, performance share units) and the EPS‑dilution methodology.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 26.9 million shares available in 2023 and accurately notes the plan was adopted May 26, 2021. It also correctly identifies that the 2024 filing does not provide a new share-availability figure and that disclosures expanded to include amended change-in-control severance and deferred-compensation agreements. The mention of award forms (stock options, performance share units) and EPS-dilution methodology is accurate. WEAKNESSES: (1) The LLM introduces the detail about 131 million shares reserved in total, which is not mentioned in the ground truth and may be extraneous or potentially confusing without context. (2) More critically, the LLM fails to capture the core evolution described in the ground truth: the shift from 'internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024.' The ground truth emphasizes a governance evolution toward transparency and formalization of top-level incentives. The LLM's answer is more technical/mechanical, describing what changed (added severance/deferred-comp disclosures) but missing the interpretive framework about what this evolution signifies (shift toward transparency and formalized governance). (3) The LLM does not explicitly address the 'Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan' disclosure mentioned in the ground truth as a key 2024 development. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2023 and 2024 filings but does so at a surface level, missing the deeper governance narrative about transparency evolution. SEMANTIC EQUIVALENCE: While the LLM's factual statements are largely accurate, it does not convey the same interpretive meaning as the ground truth regarding what the evolution represents (governance maturation toward transparency).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 515,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "\nInlyta’s worldwide sales rose only modestly—from about **$1.00 billion in 2022 to $1.04 billion in 2023** (≈ 3 % growth), with U.S. revenue up roughly 5 % (from $618 M to $642 M) and international sales up about 3 % (from $385 M to $394 M).  The slight uptick was driven primarily by **greater clinical adoption of Inlyta in combination with immune‑checkpoint inhibitors for first‑line treatment of advanced renal‑cell carcinoma and continued expansion in emerging markets**, while growth was tempered by **price reductions in several international markets and ongoing competitive pressures**.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with minor discrepancies. QUANTITATIVE VERIFICATION: The 2023 global revenue of $1,036M matches the ground truth exactly. The stated 3% total growth is accurate ($1,036M vs ~$1,005M in 2022). U.S. revenue figures ($618M to $642M) and international figures ($385M to $394M) are reasonable approximations that sum to the global total. The 5% U.S. growth and 3% international growth percentages align with ground truth. QUALITATIVE ASSESSMENT: The LLM correctly identifies the primary growth driver—adoption of immune checkpoint inhibitor combinations with Inlyta for first-line advanced RCC treatment. The mention of price reductions in international markets and competitive pressures adds appropriate context beyond the ground truth. The characterization of growth as 'modest' and 'moderate pace' matches the ground truth's implication. MULTI-HOP SYNTHESIS: The answer successfully synthesizes revenue data across geographies (U.S. vs. international) and time periods (2022 vs. 2023), correctly linking financial performance to clinical/market factors. MINOR ISSUES: The LLM adds 'continued expansion in emerging markets' which is not explicitly mentioned in the ground truth, though this is a reasonable inference and doesn't contradict the source. The ground truth mentions 'lower volumes and net price in certain European markets' while the LLM generalizes this to 'price reductions in several international markets'—semantically equivalent but slightly broader. Overall, the answer is comprehensive, accurate, and appropriately addresses the multi-part question about revenue evolution and contributing factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 455,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s continued to depend on its heavily franchised model—about 95 % of restaurants were franchised and conventional franchisees paid rent, royalties and initial fees (pages 44 & 45).  In 2024 the Company began recording “technology‑platform” fees paid by franchisees on a **gross** basis and matched those receipts against the related expenses incurred, noting that such fees are not intended to generate margin but to recover costs (page 46).  Consequently, the financial structure of the franchise relationship stayed stable in terms of franchisee count, but the share of revenue derived from cost‑sharing for digital platforms increased, reinforcing a tighter, expense‑recovery partnership with franchisees.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the ~95% franchised model and the stable financial structure of the relationship; (2) Accurately captures the key 2024 change regarding technology-platform fees being recorded on a gross basis with expenses in 'Other restaurant expenses' (matching ground truth); (3) Correctly notes that these fees are cost-recovery focused, not margin-generating; (4) Properly synthesizes the multi-hop evolution from 2023 to 2024; (5) Appropriately cites specific page references (44, 45, 46) showing source verification. MINOR GAPS: (1) The answer could have been slightly more explicit about the 2023 baseline description (rent, royalties, initial fees as the traditional model), though this is implied; (2) The phrase 'share of revenue derived from cost-sharing for digital platforms increased' is somewhat vague—the ground truth emphasizes this as a shift in revenue recognition methodology and operational interdependence rather than necessarily an increase in absolute share; (3) Could have more explicitly stated that this represents a transformation in the nature of the relationship toward 'operational interdependence' as mentioned in ground truth. QUANTITATIVE VERIFICATION: The 95% franchised figure is accurate and properly formatted. No calculations are presented that need verification. MULTI-HOP REASONING: The answer correctly synthesizes information across 2023-2024 comparison and connects financial structure changes to technology platform dependency. The logic flow is sound and the conclusion about 'tighter, expense-recovery partnership' aligns with ground truth's characterization of increased operational interdependence. SEMANTIC EQUIVALENCE: The LLM's description of the evolution matches the ground truth's core message about the shift from traditional rent/royalty model to integrated technology cost-sharing, though expressed with slightly different emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 539,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "\nThe subsidiaries’ recorded fair‑value of energy‑related derivatives fell from **$199 million (assets) and $210 million (liabilities) in 2022** to **$55 million (assets) and $358 million (liabilities) in 2023**.  This shift reduced the net positive position to a sizable net liability, indicating that the company’s hedging portfolio moved from a modest net asset to a net liability, thereby increasing its vulnerability to adverse movements in energy prices.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY - CRITICAL FAILURES: The LLM reports 2022 assets of $199 million and liabilities of $210 million, but the ground truth shows total 2022 assets of $95 million ($59+$8+$28) and total liabilities of $109 million ($32+$12+$65). The LLM's 2022 figures are approximately 2x too high for assets and nearly 2x too high for liabilities. For 2023, the LLM reports $55 million in assets and $358 million in liabilities, but ground truth shows $28 million in assets ($15+$13) and $234 million in liabilities ($110+$124). The LLM's 2023 asset figure is nearly 2x the actual amount, and the liability figure is significantly overstated. (2) CALCULATION ERRORS: The ground truth indicates a net liability position of $54 million in 2022 (assets $95M - liabilities $109M = -$14M, or alternatively viewing net liability as $109M-$95M=$14M net liability, though the ground truth states $54M net liability suggesting a different calculation methodology). In 2023, the net liability was $206 million ($28M assets - $234M liabilities). The LLM's characterization of moving from 'modest net asset' to 'net liability' is directionally correct but based on wrong numbers. (3) MULTI-HOP REASONING: The LLM failed to properly synthesize subsidiary-level data. The ground truth clearly identifies specific subsidiaries (Mississippi Power, Southern Power, Southern Company Gas in 2022; Alabama Power and Georgia Power in 2023), while the LLM provides only aggregated figures without subsidiary breakdown. This represents incomplete synthesis of the multi-hop information. (4) ENTITY IDENTIFICATION: The LLM does not identify which subsidiaries contributed to the figures, missing important contextual detail about which entities drove the changes. (5) DIRECTIONAL CORRECTNESS: While the LLM correctly identifies that the company moved toward greater net liability exposure and increased vulnerability to energy price movements, this correct conclusion is built on fundamentally incorrect numbers, which is a serious flaw in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 573,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "\nThe 2019 Stock and Incentive Compensation Plan, adopted in October 2019, has become Procter & Gamble’s primary equity‑incentive vehicle, superseding the earlier 2009 and 2014 plans. In the 2022 and 2024 10‑K filings the plan is repeatedly cited in the Compensation and Leadership Development Committee regulations and in updated “additional terms and conditions” disclosures, confirming that its 187 million‑share reserve (with roughly 119 million shares still available) and its award‑counting rules (full‑value awards counted as five shares) remain central to executive compensation, with only minor wording refinements between 2022 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific numbers (187 million-share reserve, 119 million shares available, five-share counting rule for full-value awards) that are not mentioned in the original answer and cannot be verified against the ground truth provided. These appear to be fabricated details. (2) ENTITY/FACT ERRORS: The LLM claims the 2019 plan 'superseded' the 2009 and 2014 plans, but the ground truth makes no such claim about supersession or comparison to earlier plans. This is an unsupported assertion. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes the plan's evolution from 'newly introduced' (2022) to 'established and standard' (2024), showing a transition in disclosure context. The LLM answer instead focuses on technical plan details and claims about 'primary equity-incentive vehicle' status without grounding this in the actual evolution described in the ground truth. (4) DISCLOSURE CONTEXT MISALIGNMENT: The ground truth specifically addresses how the plan's treatment changed in disclosure context between 2022 and 2024. The LLM answer discusses technical plan mechanics and 'minor wording refinements' but doesn't clearly articulate the evolution from formal introduction to established component. (5) HALLUCINATION: The specific share counts and award-counting rules appear to be hallucinated details not present in the ground truth. The LLM demonstrates poor multi-hop reasoning by introducing unsupported quantitative claims rather than synthesizing the actual evolution narrative provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 461,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "\nSouthern Company’s risk‑management framework for its pension‑plan assets kept its core focus on broad diversification, but in 2024 the company placed added emphasis on formal, rules‑based rebalancing and tighter governance.  The 2024 discussion explicitly notes a “formal rebalancing program” and that external managers are bound by written guidelines, indicating a more structured approach to keeping actual allocations aligned with the 41 % equity / 30 % fixed‑income / 12 % real‑estate target mix.  This added procedural rigor—combined with continued use of derivatives for hedging and close monitoring of asset‑class deviations—represents the key evolution in how the company now manages the risk of large losses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the evolution of Southern Company's pension risk management approach. Key issues: (1) DIRECTIONAL ERROR: The ground truth indicates a shift FROM active external manager oversight (2023) TO market-driven risk exposure (2024), but the LLM claims the opposite—that 2024 shows 'added emphasis on formal, rules-based rebalancing and tighter governance.' This is a fundamental mischaracterization of the evolution. (2) QUANTITATIVE INACCURACY: The LLM introduces specific asset allocation percentages (41% equity / 30% fixed-income / 12% real-estate) that are not mentioned in the ground truth and cannot be verified. These numbers appear fabricated. (3) INCOMPLETE SYNTHESIS: The ground truth explicitly notes that 2024 shows 'reduced emphasis on external manager oversight' and a shift to 'market-driven risk exposure,' but the LLM claims the opposite trend. (4) MISSING KEY EVOLUTION: The ground truth identifies the core evolution as a shift from 'active oversight' to 'market-driven risk exposure,' but the LLM describes added procedural rigor and tighter governance—the opposite direction. (5) UNSUPPORTED DETAILS: References to 'derivatives for hedging' and 'written guidelines' are not substantiated in the ground truth. The LLM appears to have invented details rather than synthesizing from actual filing data. The answer fundamentally contradicts the ground truth's characterization of how risk management emphasis evolved between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 418,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "\nBetween 2022 and 2023 NVIDIA’s description of CUDA shifted from a GPU‑centric parallel‑programming layer that underpins its graphics and AI accelerators to the foundational software stack of a **full‑stack accelerated‑computing platform** that now spans GPUs, CPUs (Grace), DPUs (Mellanox), networking, and cloud services such as DGX Cloud and AI Enterprise.  This evolution signals a strategic pivot toward offering **end‑to‑end AI and data‑center solutions**—monetizing software, services and ecosystem growth rather than focusing solely on hardware sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the evolution of NVIDIA's CUDA platform between 2022 and 2023 but diverges significantly from the ground truth in its characterization of the shift. STRENGTHS: (1) Correctly identifies a strategic evolution between 2022 and 2023; (2) Accurately mentions the expansion to include Grace CPUs, Mellanox DPUs, and networking components; (3) Correctly identifies the shift toward full-stack solutions and end-to-end offerings; (4) Appropriately emphasizes software, services, and ecosystem monetization. WEAKNESSES: (1) The ground truth specifically states NVIDIA's role shifted from 'supplier' to 'developer' - the LLM answer does not explicitly capture this distinction about NVIDIA's role/positioning; (2) The ground truth emphasizes CUDA-X libraries, APIs, and domain-specific frameworks as key components of the strategic shift - the LLM answer mentions these less explicitly; (3) The LLM answer introduces additional context about GPU-centric parallel programming and DGX Cloud that, while potentially accurate, goes beyond what the ground truth specifies and may represent information not directly supported by the filing analysis; (4) The ground truth frames this as strengthening the 'full-stack computing platform' for 'data center-scale solutions,' while the LLM answer frames it more broadly as 'end-to-end AI and data-center solutions' with emphasis on monetization strategy. MULTI-HOP REASONING: The LLM answer demonstrates reasonable synthesis of NVIDIA's platform evolution but doesn't clearly establish the supplier-to-developer transition that is central to the ground truth. The reasoning about strategic focus is sound but emphasizes different aspects (monetization vs. platform integration). SEMANTIC EQUIVALENCE: While both answers discuss platform evolution and full-stack solutions, they emphasize different aspects of the strategic shift, suggesting the LLM may have accessed different or supplementary information rather than the specific knowledge graph data used for the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 547,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "\nBetween 2022 and 2023 the financial ties that Pfizer had with Viatris – which stemmed from the Upjohn‑Mylan separation and the related interim manufacturing, rebate‑billing and MSA agreements – were largely wound down.  At the end of 2022 Pfizer still had about **$94 million** of amounts due under those agreements (and a $277 million pre‑separation dividend had been paid in 2021), but by **December 31 2023** the outstanding balance had fallen to **≈ $33 million** as the transitional services and manufacturing arrangements were completed, marking the near‑termination of Pfizer’s supply‑related financial relationship with Viatris.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and the evolution of Pfizer's relationship with Viatris. STRENGTHS: (1) All primary numbers are accurate: $94 million outstanding balance as of December 31, 2022, and $33 million as of December 31, 2023 are correctly stated. (2) The $277 million pre-separation dividend paid in 2021 is mentioned, providing additional context. (3) The answer correctly identifies the nature of the relationship (stemming from Upjohn-Mylan separation) and the types of agreements involved (manufacturing, rebate-billing, MSA). (4) The multi-hop synthesis is sound: the answer connects the supply agreements, outstanding balances across two years, and the completion of transitional services. (5) The conclusion about the near-termination of the financial relationship is logically supported by the declining balance. MINOR GAPS: (1) The original answer specifically mentions '$780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris' in 2022, which the LLM answer does not include. This is a notable omission as it directly addresses the supply agreement revenue component. (2) The LLM uses the approximation symbol (≈) for $33 million, which is acceptable but the original answer states it as a definitive figure. QUANTITATIVE VERIFICATION: All dollar amounts and dates are correct. The decrease from $94M to $33M represents a $61M reduction, which is logically consistent with the wind-down narrative. QUALITATIVE ASSESSMENT: The reasoning about the relationship evolution is sound and well-articulated. The answer correctly identifies this as a post-separation wind-down process. The mention of 'transitional services and manufacturing arrangements were completed' aligns with the ground truth statement about TSAs being completed by end of 2023. The omission of the $780 million PC1 revenue figure prevents this from being a perfect 9-10 score, as it represents a material component of the financial relationship that directly answers the 'supply agreements' aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 571,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s disclosure shifted from a broad statement that the cash‑flows generated by its communications sites are “only available for payment of the securitized debt” to a detailed, quantitative framework that ties those cash‑flows to specific debt‑service‑coverage‑ratio (DSCR) tests, cash‑trap and amortization triggers, and explicit conditions limiting any excess‑cash distributions. In the 2024 filing the Company spells out the 1.30× Cash‑Trap DSCR, the 1.15× Minimum DSCR, the resulting reserve‑account requirements, and the impact on its ability to fund capital expenditures and REIT distributions—showing a more precise treatment of the sites as collateral and of the cash‑flow restrictions tied to its debt obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and appears to describe a different evolution than what the original answer documents. Critical issues: (1) FACTUAL MISMATCH: The ground truth identifies a shift FROM site-specific debt disclosures (3,343 communications sites securing Series 2015-2 Notes, $1.3 billion in Series 2013-2A Notes in 2023) TO broader general obligations ($4.5 billion in asset retirement obligations in 2024). The LLM answer instead describes a shift FROM 'broad statements' TO 'detailed quantitative frameworks' with DSCR tests, cash-trap triggers, and amortization conditions—this is the opposite directional characterization and introduces metrics (1.30× DSCR, 1.15× Minimum DSCR) not mentioned in the ground truth. (2) QUANTITATIVE ACCURACY: The LLM provides specific DSCR ratios (1.30×, 1.15×) that do not appear in the original answer. While these may exist in the actual filings, they are not validated against the ground truth provided. The ground truth cites specific numbers: 3,343 sites, $1.3 billion, $4.5 billion—none of which appear in the LLM answer. (3) ENTITY/METRIC CONFUSION: The LLM focuses on cash-flow restrictions, reserve accounts, and distribution limitations, which are different aspects than the ground truth's focus on collateral specificity and obligation framing. (4) MULTI-HOP REASONING: The LLM fails to synthesize the key comparison: the move from explicit site-level collateral identification to more general obligation disclosures. Instead, it describes increased disclosure detail and precision, which contradicts the ground truth's characterization of a shift away from site-specific references. (5) SEMANTIC EQUIVALENCE: The answers convey fundamentally different narratives about how disclosure evolved, making semantic equivalence impossible to establish.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 498,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "\nBetween 2022 and 2023 Comcast moved from treating retransmission‑consent fees as part of an aggregated “programming and content‑licensing” line item (as seen in the 2022 10‑K, pages 92‑96, where they were included in overall programming revenue without separate disclosure) to explicitly identifying those fees as “fees received from multichannel video providers under NBC and Telemundo retransmission‑consent agreements” in the 2023 10‑K (pages 9‑10).  The 2023 filing also clarifies that the fees are earned under multiyear, subscriber‑based distribution agreements and that revenue is recognized on a monthly basis as the programming is provided, reflecting a shift to a more granular, subscription‑oriented recognition and distribution model.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some accurate details but has significant gaps and misalignments with the ground truth. STRENGTHS: (1) Correctly identifies that Comcast moved toward more explicit disclosure of retransmission consent fees between 2022-2023; (2) Accurately notes that revenue is recognized monthly as programming is provided; (3) Correctly identifies subscriber-based distribution agreements; (4) Appropriately cites specific 10-K page references. WEAKNESSES: (1) The answer focuses heavily on disclosure/accounting presentation changes (moving from aggregated line items to explicit identification) rather than substantive evolution in approach; (2) CRITICAL OMISSION: Fails to address the ground truth's key finding about the shift toward 'combined linear and streaming distribution model' - this is a major strategic evolution that the LLM answer completely misses; (3) CRITICAL OMISSION: Does not mention Peacock integration into the distribution ecosystem, which the ground truth identifies as a significant strategic shift; (4) Does not explicitly address the expansion to include 'virtual multichannel video providers' alongside traditional providers; (5) The characterization of the change as primarily a 'shift to more granular, subscription-oriented recognition' is somewhat misleading - the ground truth emphasizes strategic distribution model evolution, not just accounting granularity. MULTI-HOP REASONING: The LLM answer demonstrates adequate synthesis of 2022 vs 2023 filing information but fails to synthesize the broader strategic implications about hybrid distribution models that blend traditional and streaming services. The answer is more about disclosure mechanics than business model evolution. SEMANTIC ALIGNMENT: While the LLM answer is not factually wrong about what it states, it fundamentally misses the core narrative of the ground truth answer, which emphasizes strategic business model evolution toward hybrid linear/streaming distribution rather than accounting presentation changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 544,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "\nFrom 2023 to 2024 Caterpillar continued to produce and support diesel‑electric locomotives as part of its Energy & Transportation segment, but the 2024 filing broadens that segment to include electrified powertrains and zero‑emission power solutions, signaling a strategic shift toward more sustainable rail offerings.  The 2024 document also emphasizes new financing and match‑funding initiatives and heightened competition with other rail‑equipment manufacturers, reflecting a more digitally integrated and sustainability‑focused positioning of Caterpillar’s locomotive business.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that Caterpillar produces diesel-electric locomotives as part of the Energy & Transportation segment in 2024. (2) The mention of competitive pressures and other manufacturers is accurate. (3) No numerical errors or date inaccuracies present. (4) The general timeframe (2023 to 2024) is correct.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to mention the specific 2023 context - that in 2023, Caterpillar's involvement was described as part of the ME&T segment with responsibilities including remanufacturing reciprocating engines and providing product support for on-highway vocational trucks. This is essential for showing the evolution. (2) The LLM introduces information about 'electrified powertrains and zero-emission power solutions' and 'financing and match-funding initiatives' that are NOT present in the ground truth answer. This represents fabrication or hallucination of details not supported by the knowledge graph. (3) The LLM does NOT specifically name the competitors mentioned in 2024 (Wabtec Corp and Siemens Mobility A/S), which is a key detail showing the shift in competitive positioning. (4) The LLM's emphasis on 'sustainability-focused positioning' and 'digitally integrated' positioning is not substantiated in the ground truth, suggesting the model added interpretive layers not grounded in the actual filings. (5) The multi-hop reasoning is incomplete - the answer should clearly contrast the 2023 operational role with the 2024 production role, showing the evolution from general inclusion to explicit production responsibility.\n\nMULTI-HOP SYNTHESIS ASSESSMENT: The question requires synthesizing information from both 2023 and 2024 filings to show evolution. The LLM addresses 2024 adequately but fails to properly establish the 2023 baseline, making the comparison incomplete. The introduction of unsupported details about sustainability and digitalization suggests the model may have inferred beyond the actual filing content.\n\nCORRECTION NEEDED: A complete answer should explicitly state: (1) 2023 role in ME&T segment with remanufacturing and support functions, (2) 2024 shift to explicit 'produces' language in Energy & Transportation segment, (3) Named competitors (Wabtec, Siemens) appearing in 2024 but not 2023, (4) Avoid adding details about sustainability initiatives or digital integration not present in ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 642,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s did not alter the core way it recognizes revenue from its franchisees—royalties and rent are still recorded when the underlying sales occur, initial franchise fees are amortized over the typical 20‑year term, and technology‑platform fees are now reported gross because the Company acts as the principal, with related expenses charged to “Other restaurant expenses.”  At the same time, cost‑sharing arrangements remain anchored in percent‑of‑sales contributions to advertising cooperatives and shared improvement‑cost allocations (with the Company allocating those costs between property‑and‑equipment and receivables and adjusting depreciation accordingly), but the 2024 filings place greater emphasis on disclosed details of these arrangements (e.g., expanded segment‑expense disclosures required by ASU 2023‑07 and the upcoming ASU 2024‑03).  In short, the economic substance of the franchisee‑Company relationship is unchanged, though reporting has become more transparent.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies that core revenue recognition model remained consistent between 2023-2024; (2) Accurately notes technology platform fees are now reported gross; (3) Properly identifies that cost-sharing arrangements exist and involve allocation between property/equipment and receivables; (4) Correctly emphasizes increased transparency/disclosure in 2024; (5) Good synthesis of multi-hop information showing evolution in reporting rather than economic substance. WEAKNESSES: (1) QUANTITATIVE ERROR - States initial franchise fees are amortized over 'typical 20-year term' - this specific number is not mentioned in the ground truth and appears to be an unsupported detail; (2) INCOMPLETE - Fails to mention minimum rent payments, which are explicitly noted in ground truth as part of 2023 revenue model; (3) INCOMPLETE - Does not clearly articulate that restaurant improvements cost-sharing detail was NEW in 2024 (ground truth states 'This level of detail on cost-sharing was not present in the 2023 filing'); (4) OVER-SPECIFICATION - References ASU 2023-07 and ASU 2024-03 accounting standards which are not mentioned in ground truth, potentially introducing unsupported details; (5) VAGUE - References 'percent-of-sales contributions to advertising cooperatives' which is not explicitly in ground truth; (6) MISSING CLARITY - Does not clearly distinguish what was disclosed in 2023 vs what was newly disclosed in 2024. The answer reads as more sophisticated but introduces details not in ground truth while omitting some ground truth elements. The core insight about increased transparency is correct, but the execution lacks precision on what specifically changed in disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 489,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "\nSouthern Company’s equity‑compensation framework remained anchored in the 2021 Equity and Incentive Compensation Plan, but the 2024 filings show a deliberate shift toward consolidating and modernising the underlying documentation.  The company restated the Deferred Compensation Plan (effective Jan 1 2025) and re‑issued the Executive Change‑in‑Control Severance Plan (re‑stated Aug 15 2022), adding explicit language that unvested PSUs and RSUs automatically vest upon a change‑in‑control where Southern is not the surviving entity and that awards vest immediately for retirement‑eligible employees.  These updates reflect a more streamlined, future‑dated plan documentation and clearer award‑term provisions (especially around vesting triggers) compared with the 2023 disclosures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) INCORRECT PLAN REFERENCE: The LLM states the framework is anchored in the '2021 Equity and Incentive Compensation Plan,' but the ground truth indicates it's the 'Equity and Incentive Compensation Plan' without specifying 2021 as the year. This is a potential factual error. (2) UNSUPPORTED CLAIMS: The LLM introduces specific details about the Deferred Compensation Plan (effective Jan 1 2025) and Executive Change-in-Control Severance Plan (re-stated Aug 15 2022) that are NOT mentioned in the ground truth. These appear to be fabricated or from sources outside the provided knowledge graph. (3) MISSING CORE INFORMATION: The ground truth emphasizes the shift toward 'greater specificity and transparency in executive equity compensation documentation' and mentions 'designation of specific exhibits for equity award terms' in 2024 that was absent in 2023. The LLM answer does not address these key documentation changes. (4) INCOMPLETE COMPARISON: The ground truth explicitly compares 2023 vs 2024 disclosures, noting that 2024 included 'detailed documentation practices' and 'formalized terms for Named Executive Officer equity awards.' The LLM answer mentions 'consolidating and modernising' but doesn't clearly establish the 2023-to-2024 evolution as requested. (5) VESTING TRIGGER DETAILS: While the LLM mentions vesting triggers (change-in-control, retirement-eligible), these specific details are not in the ground truth and may be inaccurate or from different sources. (6) SEMANTIC MISMATCH: The ground truth focuses on plan documentation formalization and transparency improvements, while the LLM shifts focus to plan restatements and severance provisions, which are different topics. The answer partially addresses the question but introduces unsupported information and misses the core documentation evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 529,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "\nFrom 2022 to 2024 the 10‑K filings show that membership‑club stores remain listed as a “key customer” channel, but the 2024 filing (pages 7‑8) places far more emphasis on e‑commerce, social‑commerce and direct‑to‑consumer relationships and warns that “continued concentration among our retail customers could create significant cost and margin pressure.”  This shift signals that P&G is deliberately reducing its strategic dependence on wholesale‑club formats and is instead diversifying into higher‑growth, higher‑margin digital and specialty retail channels as part of a broader omni‑channel retail strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE THESIS: The LLM answer fundamentally contradicts the ground truth on the central claim. Ground truth states that P&G's reliance on membership club stores INCREASED from 2022 to 2024 (shifted from listing them as 'one of key channels' to emphasizing 'dependency'). The LLM answer claims the OPPOSITE - that P&G is 'deliberately reducing its strategic dependence on wholesale-club formats.' This is a direct factual inversion of the ground truth finding. QUANTITATIVE ACCURACY: The LLM correctly identifies page numbers (7-8) and years (2022-2024), and accurately notes the presence of e-commerce/DTC emphasis in 2024 filings. No mathematical errors detected. QUALITATIVE ACCURACY: The LLM's reasoning about omni-channel strategy and margin pressure is logically sound in isolation, but it misinterprets the actual strategic shift documented in the filings. The ground truth indicates membership clubs became MORE important (increased reliance), not less important. The LLM appears to have inverted the directional change. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the comparative analysis across 2022 and 2024 filings. While it correctly identifies that e-commerce gained emphasis, it incorrectly concludes this means reduced reliance on membership clubs, when the ground truth indicates both channels grew in importance with membership clubs becoming more strategically central. CONTEXTUAL RELEVANCE: The answer addresses the right question structure but arrives at the wrong conclusion about the nature of the strategic evolution. The quote about 'concentration among retail customers' is relevant but misinterpreted as evidence of reduced club store reliance rather than as a general risk management statement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 477,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "\nBetween the 2023 and 2024 filings, AMT’s exposure to the Nigeria Letters of Credit dropped from a $3.4 million carrying amount at the end of 2023 to $0 million by the end of 2024, indicating that the drawn letters of credit were either matured, repaid, or otherwise settled during the year. Consequently, the company no longer holds a financial obligation for this instrument, reflecting that any prior commitments under the Nigerian letters of credit have been resolved.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. (1) CORRECTNESS: All factual information is correct. The LLM accurately identifies the $3.4 million obligation in 2023 and the $0 carrying value in 2024, matching the ground truth exactly. The conclusion that AMT fully settled or exited its obligations is correct. (2) QUANTITATIVE ACCURACY: Both key numbers are precise and correct ($3.4 million in 2023, $0 in 2024). No calculations are required for this question, but the numerical comparison is accurate. (3) QUALITATIVE ACCURACY: The LLM demonstrates sound multi-hop reasoning by synthesizing the evolution of the obligation across two fiscal years and correctly interpreting what the change indicates about AMT's financial position. The reasoning that the drop from $3.4M to $0 indicates settlement/maturity/repayment is logically sound and matches the ground truth interpretation. (4) SEMANTIC EQUIVALENCE: The LLM uses slightly different wording than the ground truth ('drawn letters of credit were either matured, repaid, or otherwise settled' vs. 'fully settled or otherwise exited') but conveys the identical meaning and conclusion. The phrase 'no longer holds a financial obligation' is semantically equivalent to 'no longer present.' (5) COMPLETENESS: The answer addresses both parts of the multi-part question: how the involvement evolved (from $3.4M to $0) and what this indicates about financial obligations (they have been resolved). Minor note: The LLM uses 'drawn letters of credit' which adds slight specificity not explicitly in the ground truth, but this is not incorrect and actually provides helpful context. Overall, this is a high-quality response with accurate numbers, sound reasoning, and appropriate interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 481,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "\nIn the 2022 filing (GD 10‑K 2022, page 94) the retirement‑annuity contracts were reported at a fair value of **$38 million** and disclosed as **Level 3** assets—i.e., valued using significant unobservable inputs (discounted‑cash‑flow assumptions). By the 2024 filing (GD 10‑K 2024, page 94) the same line item had fallen to **$22 million**, still classified as Level 3 but representing a smaller share of total Level 3 assets, reflecting lower present‑value estimates (driven by higher discount rates and contract payouts). This shift shows that General Dynamics continues to treat these contracts as highly estimated, relying on internal assumptions rather than observable market prices, and adjusts the reported balance as the underlying contracts mature and market conditions change.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM reports 2022 value as $38 million and 2024 value as $22 million. The ground truth states 2022 had $35 million (as of Dec 31, 2021) and remained stable through 2020 at $38 million. The LLM's $22 million figure for 2024 is NOT mentioned in the ground truth at all, and appears to be fabricated. The ground truth does not provide a 2024 value, making this a critical factual error. (2) METHODOLOGY SHIFT - The ground truth explicitly states a KEY CHANGE: by 2024, contracts were valued using NAV (net asset value) as a practical expedient and EXCLUDED from the formal fair value hierarchy. The LLM completely misses this critical shift, instead claiming they remained Level 3 assets in 2024. This is a fundamental misunderstanding of the reporting change. (3) DISCLOSURE APPROACH - Ground truth emphasizes shift from 'detailed fair value disclosures' to 'simplified NAV-based approach.' LLM focuses on valuation methodology (DCF/discount rates) rather than the reporting framework change. (4) MULTI-HOP REASONING - The LLM failed to synthesize the key distinction between 2022 (Level 3 with detailed disclosures) and 2024 (NAV-based, excluded from hierarchy). Instead, it incorrectly maintains Level 3 classification for both years. (5) MISSING CONTEXT - The LLM provides plausible-sounding but unsupported explanations about 'higher discount rates and contract payouts' that are not in the ground truth. The answer reads as internally consistent but factually incorrect on the core reporting change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 428,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "\nBetween 2022 and 2024 the restricted cash held for securitization investors was essentially unchanged at $441 million, and in both years it is classified as Level 1 in the fair‑value hierarchy—meaning it is valued using quoted prices in an active market with no reliance on unobservable inputs.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The original answer explicitly states that in 2022, 'the fair value hierarchy was not explicitly detailed for this category,' indicating that Level 1 classification was NOT present in 2022. The LLM claims 'in both years it is classified as Level 1,' which is factually incorrect according to the ground truth. This is a major error in multi-hop reasoning and entity accuracy. The LLM correctly identifies the 2024 value of $441 million and correctly describes Level 1 as using quoted prices in active markets. However, the core claim about the composition and value 'essentially unchanged' between 2022 and 2024 misses the key point of the ground truth: there WAS a significant change in fair value hierarchy classification methodology. The ground truth emphasizes 'a shift toward more transparent or market-based valuation methods' and 'a more defined and standardized valuation approach in 2024 compared to 2022.' The LLM fails to capture this important qualitative change in how the restricted cash was classified and valued. The answer addresses the 2024 data correctly but fundamentally misrepresents the 2022 situation and therefore fails to properly answer the question about how composition and fair value hierarchy classification changed between these years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 376,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s kept the core of its franchise‑fee accounting unchanged—royalties and minimum rent are recognized as underlying sales occur and initial fees are amortized over the typical 20‑year franchise term.  However, the company markedly deepened its direct involvement with franchisees by acquiring 228 restaurant locations in 2024, recording roughly $240 million of goodwill and $270 million of identifiable intangibles, and tightening the allocation of shared improvement costs (shifting them between property‑and‑equipment and accounts‑receivable) while performing more frequent impairment testing of goodwill and long‑lived assets.  This reflects a strategic evolution toward greater on‑balance‑sheet ownership and more rigorous financial‑recognition of its franchise‑related assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misrepresents the evolution described in the ground truth. CRITICAL ERRORS: (1) The ground truth explicitly states that by 2024, McDonald's relationship 'transformed into a more dependency-based model' focused on 'technology platform services' with revenue recognized on a gross basis. The LLM answer instead emphasizes restaurant acquisitions (228 locations, $240M goodwill, $270M intangibles) and 'greater on-balance-sheet ownership,' which contradicts the ground truth's core finding about the shift AWAY from asset acquisition toward service-based interactions. (2) The LLM mentions 2024 restaurant acquisitions and goodwill/intangible recording, but the ground truth indicates 2023 was characterized by 'acquisition of restaurants from franchisees' with goodwill write-offs, while 2024 marked a shift TO technology services. The LLM appears to have reversed or conflated the timeline. (3) The LLM correctly notes that franchise-fee accounting (royalties, minimum rent, initial fee amortization over 20 years) remained unchanged, which aligns with ground truth, but this is a minor point. (4) The LLM's emphasis on 'greater on-balance-sheet ownership' directly contradicts the ground truth's characterization of the 2024 evolution as moving away from asset management toward service-based revenue recognition. (5) The specific numbers provided (228 locations, $240M goodwill, $270M intangibles) cannot be verified against the ground truth and appear to represent the opposite trend from what the ground truth describes. The LLM failed to capture the key insight: the relationship evolved FROM asset acquisition/goodwill management (2023) TO technology service provision with gross revenue recognition (2024).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 474,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "\nBetween 2022 and 2024 P&G’s filings shifted from simply listing the 2019 Stock and Incentive Compensation Plan among several active plans and noting its “additional terms and conditions,” to explicitly stating that the 2019 Plan is the only plan that still authorizes future equity grants, describing how its awards are counted (full‑value awards such as RSUs/PSUs are treated as five shares) and revealing that roughly 77 million shares remain available for issuance. The 2024 disclosure also ties the 2019 Plan to the 2014 Plan in the Compensation and Leadership Development Committee’s regulations, showing that the newer plan now serves as the primary vehicle for equity compensation while older plans are referenced only for historical and regulatory context.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a more detailed and specific narrative about the evolution of the 2019 Plan's treatment, but introduces several problematic elements that reduce its accuracy:\n\n(1) QUANTITATIVE ACCURACY ISSUES:\n- The LLM cites \"roughly 77 million shares remain available for issuance\" - this specific number is not verified in the ground truth and appears to be an unsupported claim\n- The claim about \"five shares\" counting for full-value awards (RSUs/PSUs) is a specific technical detail not mentioned in the ground truth\n- These numeric claims cannot be verified against the original answer and may be fabricated or misremembered details\n\n(2) FACTUAL CONCERNS:\n- The LLM states the 2019 Plan is \"the only plan that still authorizes future equity grants\" - this is a strong claim not explicitly confirmed in the ground truth\n- The ground truth indicates the 2019 Plan was \"still included in the list of active equity compensation plans\" but doesn't state it's the exclusive plan for future grants\n- This represents a potential overstatement or misinterpretation\n\n(3) WHAT WAS CORRECT:\n- The general direction of evolution (from procedural/governance focus to strategic ownership framework) aligns with ground truth\n- The identification of the 2019 Plan as the primary vehicle for equity compensation is consistent\n- The reference to the relationship between 2019 and 2014 Plans is accurate\n- The shift in disclosure focus from adoption details to equity compensation structure is correctly identified\n\n(4) MULTI-HOP REASONING:\n- The LLM successfully synthesizes information about how the plan's role evolved\n- However, the introduction of unverified specific numbers undermines the reasoning quality\n- The connection between the 2019 and 2014 Plans is appropriately made\n\n(5) SEMANTIC EQUIVALENCE:\n- The core narrative about transformation from governance to strategic ownership is semantically equivalent to the ground truth\n- However, the added specificity about share counts and award treatment creates factual claims that cannot be verified\n\nThe answer demonstrates good understanding of the overall evolution but is compromised by introducing specific quantitative claims (77 million shares, five-share counting) that are not supported by the ground truth and may be inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 620,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "\nSalvatore Ferragamo continued to be listed as a tenant in the same eight international premium‑outlet properties in both 2022 and 2023—specifically the four Japanese outlets (Gotemba, Kobe‑Sanda, Rinku and Sano), plus Punta Norte in Mexico, Yeoju in South Korea, Johor in Malaysia and Montreal in Canada.  This indicates that the brand’s presence in SPG’s international outlet portfolio remained stable, with no net additions or removals between the two years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on nearly all factual claims. Ground truth states: (1) In 2022, Salvatore Ferragamo was in 3 Japanese outlets (Gotemba, Kobe-Sanda, Sano); (2) By 2023, presence reduced to 1 location (Las Vegas Outlets North in Nevada, USA); (3) This represents a significant reduction from Japan to a single U.S. location. The LLM answer claims: (1) 8 international outlets in both years; (2) Lists Rinku (not mentioned in ground truth for 2022), Punta Norte Mexico, Yeoju South Korea, Johor Malaysia, Montreal Canada (none mentioned in ground truth); (3) Claims 'stable' presence with 'no net additions or removals' - directly contradicting the ground truth's 'significant reduction.' Quantitative errors: LLM states 8 locations vs. ground truth's 3 (2022) and 1 (2023). Entity errors: LLM lists locations not in ground truth and omits the critical shift from Japan to USA. The reasoning is inverted - LLM concludes stability when ground truth shows dramatic contraction. The only correct element is mentioning Gotemba, Kobe-Sanda, and Sano as Japanese outlets, but the LLM misrepresents their status in 2023. The question is appropriately addressed in scope (asking about evolution 2022-2023), but the answer provides completely false information about that evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 363,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 ConocoPhillips’ reported natural‑gas reserves in the Asia‑Pacific/Middle‑East region slipped only slightly—from about **312 billion cubic feet to 296 billion cubic feet**—but the undeveloped portion grew and the company added reserves through extensions and discoveries, especially in the Middle East via its equity affiliates.  These trends show that, despite flat total reserves, ConocoPhillips is keeping its operational focus on developing existing gas assets and pursuing new discoveries in the region rather than seeking large‑scale reserve growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: 312 billion cubic feet in 2023 and 296 billion cubic feet in 2024 for COP's natural gas reserves in the Asia Pacific/Middle East region. The quantitative data is precisely accurate with proper formatting and no calculation errors. The answer correctly identifies the slight decrease (16 BCF reduction) and properly synthesizes the multi-hop information about COP's operational strategy. The LLM goes beyond the ground truth by adding contextual details about undeveloped reserves, extensions, discoveries, and equity affiliates in the Middle East, which provides richer insight into the company's strategic positioning. However, these additional details, while reasonable and contextually relevant, are not explicitly confirmed in the ground truth answer provided. The core interpretation that this represents 'stabilization in operational focus rather than aggressive growth' aligns well with the LLM's characterization of 'keeping operational focus on developing existing gas assets and pursuing new discoveries.' The reasoning is sound and the multi-hop synthesis across years and regions is correct. Minor deduction from perfect score due to the introduction of additional interpretive details (undeveloped reserves growth, equity affiliates) that, while plausible and contextually appropriate, extend beyond what the ground truth explicitly confirms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 398,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast’s capital program shifted from a broad‑based emphasis on scalable infrastructure, line‑extensions and general customer‑premise‑equipment spend toward a more focused investment in the **Connectivity & Platforms** segment, where the **deployment of wireless gateways** is now highlighted as a strategic pillar for delivering multigigabit symmetrical speeds, expanding capacity and supporting bundled services (e.g., X1/Flex, xFi Pods, bundled wireless).  In the 2022 filing (pages 5‑9) wireless gateways were described as part of the “customer premise equipment” category, while the 2024 filing (pages 51, 53 and the capital‑expenditure discussion) explicitly calls out “continued deployment of wireless gateways” as a key component of its network‑upgrade capex, even as overall capex on customer‑premise equipment fell slightly (from $2.23 bn in 2023 to $2.01 bn in 2024).  Thus, the evolution is marked by a strategic refocus on wireless gateways as an enabler of next‑generation broadband platforms rather than a standalone line‑item, with investment aligned to broader platform and theme‑park initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the strategic evolution of Comcast's wireless gateway approach from 2022 to 2024, correctly identifying the shift from treating wireless gateways as standalone customer premise equipment to positioning them as a strategic pillar for network infrastructure. The qualitative reasoning is sound and well-articulated.\n\nHowever, there are quantitative accuracy concerns:\n\n1. SPECIFIC NUMBERS PROVIDED: The LLM cites specific capex figures ($2.23 bn in 2023 to $2.01 bn in 2024 for customer premise equipment). These numbers cannot be verified against the ground truth provided, which contains no specific dollar amounts. The ground truth focuses on strategic emphasis and investment direction rather than precise figures.\n\n2. PAGE REFERENCES: The LLM references specific pages (pages 5-9 for 2022 filing, pages 51, 53 for 2024 filing). These cannot be verified against the ground truth and may be fabricated or inaccurate.\n\n3. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across 2022 and 2024 filings, correctly identifying the evolution from basic product offering to strategic infrastructure component. This matches the ground truth's core narrative.\n\n4. SEMANTIC ALIGNMENT: The LLM answer captures the essential evolution described in the ground truth: (a) 2022 focus on customer-facing features and capabilities, (b) 2024 shift to strategic deployment and network infrastructure integration, (c) emphasis on multigigabit symmetrical speeds and capacity expansion.\n\n5. ADDITIONAL CONTEXT: The LLM adds context about the \"Connectivity & Platforms\" segment and mentions bundled services (X1/Flex, xFi Pods), which provides helpful framing but goes beyond what the ground truth explicitly states.\n\nThe main weakness is the introduction of specific financial figures and page citations that cannot be verified and may represent hallucination. The core strategic narrative is accurate and well-reasoned, but the quantitative claims reduce confidence in the overall answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 552,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "\nThe 2024 filing shows that cumulative deliveries of the G500 / G600 family grew from “almost 150” aircraft at the end of 2021 to “more than 300” by year‑end 2024 – roughly doubling the earlier total and signalling a sharp rise in G600 production and market acceptance between 2022 and 2024.  This surge positions the G600 as a cornerstone of Gulfstream’s all‑new clean‑sheet lineup, providing the large‑cabin, ultra‑long‑range capability that bridges the legacy G550/G450 family and the newer ultra‑large‑cabin models (G800, G700), thereby expanding Gulfstream’s presence in the premium ultra‑long‑range segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key quantitative facts - cumulative deliveries of G500/G600 grew from 'almost 150' at end of 2021 to 'more than 300' by year-end 2024, representing a doubling. The numeric values and calculations are accurate. The model also correctly notes the shift in product positioning.\n\nWEAKNESSES: (1) The LLM introduces unsupported characterizations not in the ground truth. It describes the G600 as 'a cornerstone of Gulfstream's all-new clean-sheet lineup' and claims it 'bridges the legacy G550/G450 family and the newer ultra-large-cabin models (G800, G700)' - these interpretive statements go beyond what the ground truth establishes. The ground truth simply states the G600 was no longer described as a new product introduction and that focus shifted to newer models. (2) The LLM mentions G700 as a newer ultra-large-cabin model, but the ground truth only mentions G800 and G400 as the newer models receiving focus in 2024. This is a factual error regarding which models are part of the newer lineup. (3) The ground truth emphasizes that the G600 transitioned from being positioned as a 'new product introduction' to becoming 'more established,' but the LLM doesn't clearly capture this evolution in positioning - instead it focuses on market acceptance and production volume. (4) The LLM's characterization of the G600's role as 'bridging' products is interpretive rather than directly supported by the filing language provided in the ground truth.\n\nMULTI-HOP REASONING: The model correctly synthesizes information across the 2022 and 2024 timeframes and identifies the production evolution. However, it adds interpretive layers not grounded in the source material.\n\nOVERALL: Core quantitative facts are correct, but qualitative characterizations introduce unsupported claims and a factual error (G700 inclusion), reducing overall accuracy despite correct numerical synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 520,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s stake in Corebridge fell dramatically – from ≈ 52 % of the common stock (as of 31 Dec 2023) to ≈ 48 % on 9 Jun 2024, when it waived board rights and de‑consolidated the insurer, and then to about 22.7 % by 31 Dec 2024 after selling roughly 150 million shares (including a $3.8 bn sale to Nippon in Q4 2024).  Consequently, AIG no longer consolidates Corebridge; it now records the investment under the equity‑method, recognizing dividends and changes in Corebridge’s fair‑value (which contributed $601 million of equity‑method income in 2024) and realized gains on the share sales, while the earlier consolidation had been reflected in Corebridge’s pre‑tax income of $1.574 bn for the period June 10 – Dec 31 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially correct and more detailed information than the ground truth baseline. Key strengths: (1) Correctly identifies the ownership percentages (52% in 2023, ~48% on June 9, 2024, ~22.7% by Dec 31, 2024), (2) Accurately describes the transition from consolidation to equity method accounting on June 9, 2024, (3) Provides specific financial metrics including $601 million equity-method income in 2024 and $1.574 billion pre-tax income for the June 10-Dec 31 2024 period, (4) Mentions the Nippon sale of $3.8 billion in Q4 2024 and ~150 million shares sold, (5) Correctly explains the shift from direct ownership control to passive investment approach. The answer goes beyond the ground truth by providing more granular detail about the divestment timeline and specific financial impacts. Minor considerations: The ground truth mentions 'dividends received and changes in Corebridge's stock price' while the LLM specifies 'dividends and changes in Corebridge's fair-value' - these are semantically equivalent. The LLM provides additional context about realized gains on share sales which is relevant and accurate. The multi-hop reasoning is sound, correctly synthesizing ownership changes, accounting method transitions, and income recognition across the 2023-2024 period. All numeric values appear consistent with SEC filing data. The answer fully addresses the question's focus on equity ownership evolution and income recognition changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 406,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla shifted Solar Roof production from a relatively small, outsourced pilot line at its New York Gigafactory (2022 doc pp. 7‑11) to a broader, vertically‑integrated strategy that leans on localized factories (e.g., Shanghai, Berlin, Texas) and on developing its own battery‑cell supply to reduce external dependencies (2024 doc pp. 16‑19).  This expansion introduced new operational challenges—most notably volatility in raw‑material prices (lithium, nickel, cobalt) and supply‑chain constraints that have forced the company to race against construction and hiring targets, repeatedly delaying the ramp‑up and compelling tighter cost controls (2024 doc pp. 16‑19).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that diverge substantially from the ground truth. Key issues: (1) INCORRECT MANUFACTURING LOCATION CLAIMS: The LLM states Tesla shifted from 'outsourced pilot line at its New York Gigafactory' to 'localized factories (e.g., Shanghai, Berlin, Texas)' for Solar Roof production. The ground truth explicitly states that in 2022, Tesla was 'actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility.' The LLM's claim about outsourcing and expansion to multiple factories is not supported by the ground truth and appears to conflate Solar Roof production with broader battery/energy manufacturing. (2) MISCHARACTERIZATION OF STRATEGY: The ground truth describes a transition from 'focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024,' with emphasis on production delays and operational challenges. The LLM incorrectly frames this as a shift to 'vertically-integrated strategy' and 'developing its own battery-cell supply,' which is not mentioned in the ground truth regarding Solar Roof specifically. (3) SUPPLY CHAIN FOCUS MISMATCH: While the LLM mentions raw material volatility (lithium, nickel, cobalt), the ground truth emphasizes different challenges: 'design tolerances, high quality and output rates,' 'supply chain coordination, localized procurement challenges,' and 'cost-effective scaling.' The LLM's focus on battery materials is a misinterpretation. (4) MISSING KEY INFORMATION: The LLM fails to mention the financing options tied to Solar Roof in 2022, the explicit mention of 'delays in launching and/or ramping production' in 2024, or the specific operational dependencies highlighted in the ground truth. (5) DOCUMENT CITATION ISSUES: The LLM cites specific page numbers (pp. 7-11, pp. 16-19) that cannot be verified against the ground truth, raising questions about source accuracy. The answer demonstrates poor multi-hop synthesis, conflating different product lines and manufacturing strategies while missing the core narrative of production challenges and delays specific to Solar Roof.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 582,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "\nFrom 2023 to 2024 Qualcomm moved on‑device AI from a supporting feature of its mobile‑handset platform to a central pillar of a broader “intelligent computing everywhere” strategy that now spans automotive, IoT and other verticals.  Both the 2023 filing (page 65) and the 2024 filing (pages 18‑22) stress that the company will keep making substantial R&D and capital investments in AI‑related technologies—seeking patents, standards participation and talent—to commercialize AI across these new product areas, even though the payoff may be long‑term and uncertain.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Qualcomm's on-device AI strategy from 2023 to 2024, correctly identifying the shift from a supporting feature to a central strategic pillar. The answer accurately reflects the expansion across automotive, IoT, and other verticals, and correctly emphasizes the company's commitment to R&D and capital investments. The mention of specific filing pages (2023 filing page 65, 2024 filing pages 18-22) adds credibility, though these page references cannot be independently verified from the ground truth. The answer correctly identifies the shift toward long-term investment and ecosystem development rather than immediate commercialization. However, the LLM answer uses slightly different framing than the ground truth: it emphasizes 'intelligent computing everywhere' strategy and mentions specific investment mechanisms (patents, standards participation, talent) that are not explicitly mentioned in the ground truth. The ground truth emphasizes a shift from 'core product offering to investment-centric strategy' and 'enabling third-party integration,' while the LLM answer frames it as moving from 'supporting feature' to 'central pillar.' Both characterizations are semantically compatible and represent the same underlying evolution. The LLM answer is more specific about the investment mechanisms and acknowledges uncertainty about long-term payoff, which aligns with the ground truth's emphasis on long-term growth. No quantitative errors are present. The multi-hop reasoning is sound, correctly synthesizing the 2023-to-2024 evolution across multiple business areas. Minor deduction for slightly different framing and the unverifiable page references, but the core factual content is accurate and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 478,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "\nBetween 2022 and 2023 the Dolce & Gabbana brand moved from a very limited footprint—appearing only in a handful of SPG’s overseas premium‑outlet centres (e.g., Gotemba, Kobe‑Sanda and Rinku in Japan and Punta Norte in Mexico, as shown in the 2022 tables) to a noticeably broader presence across multiple 2023 listings that now include additional Japanese sites (Yeoju, Busan, Jeju), South‑Korean and Canadian outlets, and several U.S. premium‑outlet properties.  This expansion reflects SPG’s deliberate effort to enrich the luxury tenant mix in its premium‑outlet portfolio, positioning those centres as high‑end fashion destinations that attract affluent shoppers and differentiate SPG’s brand offering from other outlet operators.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical points: (1) FACTUAL INVERSION: The ground truth states Dolce & Gabbana moved FROM multiple Japan locations in 2022 TO only Las Vegas in 2023 (contraction). The LLM claims the opposite—expansion from 'very limited footprint' to 'noticeably broader presence.' This is a complete reversal of the actual trend. (2) LOCATION ERRORS: The LLM lists locations NOT mentioned in the ground truth (Yeoju, Busan, Jeju in Korea; Canadian outlets; 'several U.S. premium-outlet properties'). The ground truth explicitly states only Las Vegas Outlets North Premium NV in 2023. The LLM also mentions Punta Norte Mexico in 2022, which is not in the ground truth. (3) STRATEGIC INTERPRETATION REVERSED: The ground truth indicates a strategic SHIFT/REEVALUATION (contraction to exclusive flagship positioning). The LLM interprets this as deliberate EXPANSION to enrich luxury tenant mix—the opposite conclusion. (4) MISSING CORE FACT: The LLM completely misses that by 2023, Dolce & Gabbana presence was limited to a single U.S. location, not expanded across multiple properties. (5) UNSUPPORTED CLAIMS: The narrative about 'enriching luxury tenant mix' and 'high-end fashion destinations' contradicts the actual data showing reduced presence. The answer demonstrates a fundamental failure to accurately synthesize the multi-hop information about brand presence evolution across years and locations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 407,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "\nBetween 2023 and 2024 ConocoPhillips stepped up its exploration spending in the Asia Pacific/Middle East, with a noticeable rise in extensions and discoveries (new reserve additions in the Middle East and Australia through equity‑affiliated projects) and higher capital allocation to explore those assets.  This expansion signals a strategic shift toward strengthening the company’s upstream presence and long‑term growth prospects in that high‑potential region.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key factual points. (1) QUANTITATIVE ACCURACY FAILURE: The ground truth clearly states COP had $49 million in exploration expenditures in 2023 and $0 in 2024. The LLM answer claims there was a 'noticeable rise' and 'higher capital allocation' with no specific numbers provided. This is factually wrong - the actual data shows a complete elimination of exploration spending in this region, not an increase. (2) DIRECTIONAL ERROR: The LLM claims COP 'stepped up its exploration spending' and signals 'a strategic shift toward strengthening the company's upstream presence' in the region. The ground truth indicates the opposite - a complete withdrawal or pause (from $49M to $0), suggesting a strategic shift AWAY from the region. This is a 180-degree misinterpretation. (3) MISSING CRITICAL DATA: The LLM provides vague references to 'extensions and discoveries' and 'equity-affiliated projects' without any concrete numbers or evidence. The ground truth provides specific dollar amounts ($49M in 2023, $0 in 2024) that directly contradict the LLM's narrative. (4) MULTI-HOP REASONING FAILURE: The question requires comparing exploration investments across two years (2023 vs 2024) and drawing conclusions about strategic focus. The LLM failed to correctly synthesize this comparison - it inverted the actual trend entirely. (5) SEMANTIC EQUIVALENCE: There is no semantic equivalence here. The LLM's conclusion that the company is 'strengthening' presence contradicts the ground truth showing complete withdrawal. This is not a wording difference but a fundamental factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 454,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "\nComcast’s equity stake in Universal Beijing Resort has remained a 30 % ownership that is consolidated as a variable‑interest entity, and this percentage has not changed from 2022 through 2024.  However, the resort’s outstanding debt declined modestly over the period—from about $3.5 billion at the end of 2022 (and again in 2023) to roughly $3.4 billion by the end of 2024, reflecting partial repayment of the term‑loan that was originally up to ¥29.7 billion (≈ $4.2 billion).  Consequently, the liability shown on Comcast’s consolidated balance sheet for the venture fell from $7.2 billion in 2023 to $7.0 billion in 2024, while the asset side also slipped from $7.8 billion to $7.3 billion over the same span.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the 30% ownership interest in Universal Beijing Resort; (2) Accurately reports debt figures of $3.5 billion in 2023 and $3.4 billion in 2024; (3) Correctly states assets of $7.8 billion in 2023 declining to $7.3 billion in 2024; (4) Correctly states liabilities of $7.2 billion in 2023 declining to $7.0 billion in 2024; (5) Provides relevant context about the term loan structure and currency conversion; (6) Demonstrates sound multi-hop reasoning by synthesizing ownership, debt, and balance sheet information. CRITICAL WEAKNESS: The LLM claims debt was '$3.5 billion at the end of 2022 (and again in 2023)' but the ground truth explicitly states no specific financial stake or debt figures were provided in 2022 disclosures. The LLM appears to have extrapolated or assumed 2022 debt data that was not actually disclosed. This is a significant factual error regarding what information was available in 2022 versus 2023-2024. QUANTITATIVE ACCURACY: Deducted points because while 2023-2024 numbers are correct, the claim about 2022 debt figures being available and at $3.5 billion contradicts the ground truth that 2022 had no specific financial figures disclosed. QUALITATIVE ACCURACY: Good reasoning and synthesis of available data, but the false claim about 2022 data availability undermines the analysis. CONTEXTUAL RELEVANCE: The answer appropriately addresses the evolution question and provides useful context about the financing structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 426,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 Duke Energy’s net‑derivative balance fell sharply – it was **$29 million at the end of 2022** but only **$13 million at the end of 2023**.  The schedule on page 192 shows that during 2023 the company added **$42 million of purchases**, incurred **$68 million of settlements** (cash‑outflows that reduced the position), and recorded a **$10 million net gain** on the balance sheet; the combined effect left the ending balance **$16 million lower** than the prior year.  This pattern indicates that Duke Energy is actively **reducing its outstanding derivative exposure**, using settlements and gains to unwind or re‑balance its derivative book rather than expanding new hedges.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Duke Energy's net derivatives balance fell from $29 million (2022) to $13 million (2023), and settlements increased to $68 million in 2023. The answer demonstrates strong multi-hop reasoning by synthesizing information about purchases ($42M), settlements ($68M), net gains ($10M), and the resulting $16 million reduction in the net balance. The qualitative interpretation about active reduction of derivative exposure and rebalancing is sound and well-supported. However, there is a minor quantitative discrepancy: the LLM states the ending balance was '$16 million lower than the prior year' ($29M - $16M = $13M, which checks out), but the ground truth simply states the balance 'decreased to $13 million' without specifying the $16M reduction calculation. The LLM provides additional detail (purchases, gains, page reference) not explicitly in the ground truth, which adds context but goes slightly beyond what was confirmed. The answer correctly addresses all parts of the question regarding evolution from 2022-2023 and what it indicates about derivative management. All key numbers are accurate and the reasoning is logically sound. The slight deduction reflects the addition of calculated details not explicitly confirmed in the ground truth, though these appear mathematically consistent ($29M - $42M purchases + $68M settlements - $10M gain = $13M, or simplified: $29M - $16M = $13M).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 400,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 SPG’s disclosures show that LTIP units remained classified as potentially dilutive but immaterial to earnings‑per‑share; the company continued to value them with a Monte Carlo model for the market‑based component and to expense the grant‑date fair value regardless of whether the performance conditions are ultimately met.  However, the 2023 program raised the maximum grant‑date fair‑value estimate to $42.5 million (up from $20.6 million for 2022), added an Absolute TSR modifier to the performance criteria (in addition to FFO and objective‑goal targets), and clarified that earned LTIP units will not vest until January 1 2027 and will receive a 10 % distribution on the underlying partnership units, while still noting no material dilutive effect.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($42.5 million for 2023, $20.6 million for 2022) and detailed program changes (Absolute TSR modifier, 10% distribution, January 1 2027 vesting date) that are NOT mentioned in the ground truth answer. These appear to be fabricated details. (2) CONTRADICTORY CLAIMS: The LLM states LTIP units 'remained classified as potentially dilutive but immaterial' and 'still noting no material dilutive effect,' which contradicts the ground truth's key finding that there was a SHIFT from 'general statement about dilution to more granular and valuation-focused disclosure.' The LLM misses this evolution entirely. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes the EVOLUTION in disclosure approach - from simple statements about immateriality (2022) to detailed Monte Carlo modeling and two-class method treatment (2023). The LLM fails to capture this qualitative shift and instead adds unverified quantitative details. (4) MISSING KEY ELEMENTS: The LLM does not mention the two-class method for EPS computation or the participating securities treatment, which are central to the ground truth answer. (5) HALLUCINATION: The specific program modifications (Absolute TSR modifier, 10% distribution, vesting dates) appear to be invented details not present in the ground truth, suggesting the model fabricated information to appear more detailed. The answer demonstrates poor multi-hop reasoning by failing to synthesize the actual evolution described in the ground truth while introducing unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 464,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "\nBetween 2022 and 2024 Comcast’s exposure to Atairos was trimmed: the original $5 billion capital commitment was reduced to a $4.5 billion limit (with annual capital calls capped at $400 million) and the company continues to fund a $40 million annual management fee (subject to adjustments).  Cash contributions fell to $73 million in 2024 (after $145 million in 2023 and $52 million in 2022), and the carrying value of Comcast’s investment slipped from $5.5 billion (2023) to $5.1 billion (2024), leaving an unfunded commitment of about $1.4 billion as of 31 December 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with comprehensive detail beyond the ground truth. CORRECT ELEMENTS: (1) Capital commitment reduction from $5 billion to $4.5 billion is accurate; (2) $40 million annual management fee is correct; (3) The characterization of evolution between 2022-2024 is accurate; (4) Multi-hop synthesis across years is sound. ADDITIONAL DETAILS PROVIDED: The LLM answer includes specific information not in the ground truth but appears factually grounded: annual capital call cap of $400 million, actual cash contributions ($73M in 2024, $145M in 2023, $52M in 2022), carrying values ($5.5B in 2023, $5.1B in 2024), and unfunded commitment of ~$1.4B. These details suggest the LLM accessed more granular filing data. VERIFICATION NOTES: The carrying value decrease from $5.5B to $5.1B ($400M reduction) combined with $73M cash contribution and investment performance would be consistent with the stated figures. The unfunded commitment calculation ($4.5B - $3.1B ≈ $1.4B) appears mathematically sound. MINOR CONSIDERATIONS: The ground truth focuses on the core evolution (commitment reduction and management fee introduction), while the LLM provides additional operational metrics. The LLM answer is more detailed and comprehensive without contradicting the ground truth. The additional specificity (annual capital call caps, actual cash flows, carrying values) enhances rather than detracts from the answer's quality, though these details weren't explicitly required by the question. No factual errors detected in the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 431,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "\nConocoPhillips’ proved natural‑gas reserves in the Asia‑Pacific/Middle‑East region fell from roughly **312 billion cubic feet at year‑end 2023 to 296 billion cubic feet at year‑end 2024**, a decline of about **5 % (≈16 BCF)**.  This modest contraction—driven by downward revisions and production offsets despite some extensions and discoveries in the Middle East—indicates the company is **reducing its emphasis on that geographic area and reallocating capital toward higher‑growth basins such as the Lower 48 and Canada**.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All core numbers are factually correct: 312 BCF (2023) and 296 BCF (2024) match ground truth exactly. (2) The calculation of the decline is accurate: 16 BCF difference and ~5% reduction are both correct. (3) Entity identification is correct (ConocoPhillips/COP, Asia Pacific/Middle East region, natural gas reserves). (4) The answer properly addresses both parts of the question: the evolution of reserves and what it indicates about operational focus. (5) Quantitative accuracy is excellent with proper formatting and precise calculations.\n\nWEAKNESSES: (1) The LLM provides additional interpretive detail ('driven by downward revisions and production offsets despite some extensions and discoveries in the Middle East') that goes beyond what the ground truth states. While this reasoning may be plausible, it introduces information not verified in the original answer. (2) The claim about 'reallocating capital toward higher-growth basins such as the Lower 48 and Canada' is a specific strategic interpretation that exceeds the ground truth's more cautious statement of 'potential shift in operational focus or resource allocation.' This represents inference beyond the provided data. (3) The ground truth uses more measured language ('modest reduction,' 'suggests a potential shift') while the LLM uses more definitive language ('reducing its emphasis,' 'reallocating capital').\n\nMULTI-HOP REASONING: The answer correctly synthesizes the year-over-year comparison and draws a logical conclusion about operational implications. However, the specific strategic conclusions about capital reallocation to other basins appear to be inferences not grounded in the provided ground truth.\n\nOVERALL ASSESSMENT: The answer is fundamentally correct on all quantitative metrics and properly addresses the question structure. The primary issue is that it goes beyond the ground truth with specific strategic interpretations that, while potentially reasonable, are not verified in the source material. This represents appropriate caution warranting a score in the 7-8 range rather than 9-10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 564,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "\nIn 2022 Comcast’s wireless‑gateway approach was essentially a procurement‑focused strategy: it bought large volumes of wireless gateways and set‑top boxes from a small pool of approved suppliers to equip customers and support its bundled services, emphasizing cost‑effective vendor relationships and rapid scaling of equipment. By 2024 the company’s spending had shifted to a network‑deployment agenda—investing capital in scalable infrastructure, line extensions and the rollout of upgraded wireless gateways to boost capacity and enable multigigabit symmetrical speeds—so the emphasis moved from merely acquiring equipment to strategically expanding and modernizing the underlying network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the strategic shift in Comcast's approach from 2022 to 2024. Both the original and LLM answers correctly identify: (a) 2022 as a procurement-focused period involving purchases from limited suppliers, (b) 2024 as a strategic investment phase emphasizing network deployment, and (c) wireless gateways as a component of multigigabit symmetrical speed delivery. The semantic meaning is preserved throughout. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not applicable. Both answers appropriately avoid making unsupported numerical claims. (3) ENTITY ACCURACY: Comcast is correctly identified, years 2022 and 2024 are accurate, and the relevant metrics (wireless gateways, network deployment, multigigabit symmetrical speeds) are all correctly referenced. (4) MULTI-HOP REASONING: The LLM successfully synthesizes the comparison across two time periods and two strategic approaches. The reasoning chain is sound: procurement strategy (2022) → shift to network deployment (2024) → integration into infrastructure goals. The answer correctly identifies this as a progression from passive acquisition to active strategic integration. (5) MINOR CONSIDERATIONS: The LLM answer adds slightly more operational detail (e.g., 'set-top boxes,' 'vendor relationships,' 'line extensions') which provides helpful context without contradicting the ground truth. The phrase 'from merely acquiring equipment to strategically expanding' effectively captures the essence of the shift described in the original answer. The answer is well-structured, clear, and directly addresses the comparative question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 493,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "\nTesla’s 2022 filing treated the Solar Roof as a low‑margin, under‑utilized energy‑generation offering, noting that its gross margin was negative and that cost reductions were occurring only because of temporary manufacturing under‑capacity and a shift away from Powerpack toward Megapack. By the 2024 filing the company elevated Solar Roof to a strategic pillar of its energy business, emphasizing continued capital investment and engineering programs to scale production, but it still warned that delays in ramping Solar Roof output and constraints on battery‑cell supply remain key production challenges.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains major factual errors: (1) DIRECTIONAL REVERSAL: The LLM claims Tesla elevated Solar Roof to a 'strategic pillar' by 2024, when the ground truth states the opposite—that by 2024 Tesla shifted from emphasizing deployment success to cautioning about production risks and delays. (2) INCORRECT 2022 CHARACTERIZATION: The LLM describes 2022 Solar Roof as 'low-margin, under-utilized' with 'negative gross margin,' but the ground truth indicates it was highlighted as a 'key contributor to growth' in Energy generation and storage revenue in 2022. These are opposite characterizations. (3) INVERTED EVOLUTION: The LLM presents the evolution as going from negative/under-utilized (2022) to strategic/elevated (2024), when the ground truth shows the opposite trajectory—from active deployment/growth contributor (2022) to cautionary/risk-focused (2024). (4) UNSUPPORTED CLAIMS: The LLM introduces specific claims about 'negative gross margin,' 'temporary manufacturing under-capacity,' and 'shift away from Powerpack toward Megapack' that are not mentioned in the ground truth and appear to be fabricated details. (5) PARTIAL ACCURACY: The LLM correctly identifies that production ramp delays and battery-cell supply constraints are mentioned as challenges, but this is overshadowed by the fundamental mischaracterization of the overall strategic positioning shift. The answer demonstrates a complete failure to synthesize the multi-hop information correctly and reverses the core narrative of how Tesla's approach evolved between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 443,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "\nDuke Energy’s “Net pending transactions and other investments” grew from **$14 million in 2022** to **$54 million in 2023**—an increase of roughly **$40 million (≈ 285 %)**.  This sharp rise shows the company is deliberately expanding its stake in this higher‑risk, higher‑return segment of the retirement‑trust portfolio, reflecting a strategic shift toward more aggressive asset exposure to help meet its return‑seeking objectives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that completely contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM states the investment grew from $14 million in 2022 to $54 million in 2023, but the ground truth shows the opposite: it decreased from $53 million in 2022 to $14 million in 2023. The LLM has reversed both the direction of change (increase vs. decrease) and the magnitude of the values. The calculation of a $40 million increase and 285% growth is mathematically correct for the numbers the LLM cited, but those numbers are factually wrong. (2) DIRECTIONAL MISINTERPRETATION - The LLM concludes the company is 'deliberately expanding' and 'shifting toward more aggressive asset exposure,' when the ground truth indicates a 'significant reduction' and 'strategic shift or completion of certain initiatives.' This is a 180-degree misinterpretation of the strategic positioning. (3) CONTEXT MISMATCH - The LLM references a 'retirement-trust portfolio' and 'return-seeking objectives,' which appears to be context from a different company or financial instrument, not Duke Energy's Net Pending Transactions and Other Investments as reported in their 10-K filing. (4) MULTI-HOP SYNTHESIS - The answer fails at the most basic level of multi-hop reasoning by providing inverted year-to-year comparisons. The core numbers are simply wrong, making all downstream analysis incorrect. This is a critical failure in factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 401,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "\nBetween 2023 and 2024 the company refined its liability‑driven investment framework by tightening the target equity/fixed‑income allocations—pension assets now target 20% equity/ 80% fixed income and post‑retirement assets 55% equity/ 45% fixed income—and the disclosed asset composition reflects this shift, with equity rising to 21% of pension assets and 57% of post‑retirement assets while corporate‑bond exposure slipped slightly.  At the same time, expense charged to the defined‑contribution plans increased to **$112 million in 2024**, up from **$109 million in 2023**.  The footnote disclosures now detail the fair‑value hierarchy (Level 1 and Level 2) and the full asset mix, showing a larger share of corporate bonds and U.S. Treasury/government securities and a modest increase in emerging‑market and below‑investment‑grade holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer introduces significant factual inaccuracies not supported by the ground truth. (1) QUANTITATIVE ERRORS: While the defined contribution plan expenses are correctly stated ($109M in 2023, $112M in 2024), the LLM fabricates specific allocation percentages and asset composition details that contradict the ground truth. The ground truth states the framework maintained a 20%/80% equity/fixed income allocation in both years, with no mention of post-retirement assets having a 55%/45% allocation. The LLM claims actual pension assets reached 21% equity and 57% for post-retirement assets—these specific percentages are not in the ground truth and appear to be hallucinated. (2) COMPLETENESS ISSUES: The ground truth emphasizes that 2024 added 'new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting more detailed transparency.' The LLM misinterprets this as actual asset composition data (21% equity, 57% post-retirement) rather than acknowledging it as a disclosure enhancement about future reporting. (3) ENTITY/METRIC ACCURACY: The LLM introduces post-retirement asset allocations (55%/45%) that are not mentioned in the ground truth at all. It also adds details about fair-value hierarchy levels, corporate bonds, U.S. Treasury securities, and emerging-market holdings that are not substantiated by the provided ground truth. (4) REASONING QUALITY: The LLM conflates disclosure enhancements with actual asset composition changes. The ground truth indicates the framework 'evolved' primarily through enhanced transparency in 2024, not through changes in target allocations or dramatic shifts in actual asset composition. The LLM's multi-hop synthesis fails because it invents connections between disclosure improvements and specific asset allocation changes. (5) SEMANTIC ISSUES: The core narrative is fundamentally altered—the ground truth emphasizes consistency in the 20%/80% target with improved disclosure, while the LLM suggests significant refinements to allocations and substantial asset composition shifts. The answer is partially correct on the DC plan expenses but substantially incorrect on the investment framework evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 598,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Qualcomm broadened its on‑device AI agenda from a handset‑only emphasis to a cross‑industry growth engine, tying AI together with 5G and high‑performance, low‑power computing for automotive, IoT and other new markets.  The 2024 filing explicitly calls out AI as a “foundational technology” and notes that the company is pouring more R&D dollars into AI‑enabled Snapdragon platforms, raising capital‑expenditure to support AI‑focused product development, and pursuing strategic investments and acquisitions to accelerate AI capabilities beyond mobile handsets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Qualcomm's On-Device AI evolution from fiscal 2023 to 2024. STRENGTHS: (1) Correctly identifies the shift from handset-only emphasis to cross-industry focus (automotive, IoT); (2) Accurately captures the integration of AI with 5G and low-power computing; (3) Properly characterizes the evolution from strategic vision to active investment; (4) Correctly identifies specific investment mechanisms (R&D, capital expenditure, acquisitions/strategic transactions); (5) Appropriately describes AI as foundational technology; (6) No quantitative errors or incorrect dates/metrics. MINOR GAPS: (1) The LLM answer adds specific details about 'Snapdragon platforms' and 'raising capital-expenditure' that, while consistent with the ground truth's characterization of increased investment, are not explicitly mentioned in the original answer - these appear to be reasonable inferences from the filing language but represent slight elaboration beyond what was explicitly stated; (2) The phrase 'foundational technology' is introduced but not present in the original answer, though it aligns with the overall narrative. MULTI-HOP REASONING: The answer successfully synthesizes the comparison between two fiscal years and identifies the directional shift in strategy. The logic connecting increased investment activities to the evolution of focus is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth - a progression from positioning AI as part of a broader technology strategy to actively investing in and expanding AI capabilities across new markets. The wording differs but the factual content aligns well.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 474,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "\nThe Voting Trust Agreement continues to be disclosed in the same Exhibit 9.1 and 9.2 entries of the Exhibit Index in both the 2022 and 2023 10‑Ks; however, the 2023 filing revises the wording to consistently refer to it as a “Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy.”  By retaining the identical exhibit numbers and adding the “second‑amended” qualifier, the company signals that the agreement remains the core, formally‑maintained governance instrument for the Simon family, underscoring a stable and unchanged governance structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE FACTS: The LLM answer directly contradicts the ground truth on the key factual claim. Ground truth states: 2022 filing described it as 'Second Amended and Restated' while 2023 filing refers to it WITHOUT this modifier. LLM answer reverses this, claiming 2023 filing 'revises the wording to consistently refer to it as a Second Amended and Restated Voting Trust Agreement.' This is a fundamental factual error that undermines the entire answer. The LLM also incorrectly states the agreement is in Exhibit 9.1 and 9.2 (ground truth does not specify these exhibit numbers), and adds unsupported details about 'Voting Agreement and Proxy' language not mentioned in ground truth. The reasoning about stability is inverted - the LLM concludes stability from retention of 'second-amended' qualifier, but ground truth indicates stability comes from the REMOVAL of this qualifier, showing no further amendments occurred. Quantitative accuracy is relatively high (dates like March 1, 2004 are correct), but qualitative accuracy is severely compromised by the reversed narrative about how the presentation evolved between years. The answer fails to correctly synthesize the multi-hop comparison between 2022 and 2023 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 348,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "\nProved natural‑gas reserves in the Asia‑Pacific/Middle‑East slipped from roughly 312 billion cubic feet (developed) + 7 bcf (undeveloped) at the end of 2023 to about 289 bcf + 7 bcf at the end of 2024—a decline of ~23 bcf (≈7 %). The drop reflects price‑related and technical revisions and the disposition of non‑core assets, yet the region still accounts for a large share of COP’s equity‑affiliated gas and remains a focal growth corridor, preserving its strategic importance in the company’s global reserves portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IN QUANTITATIVE DATA: The LLM answer contains significant numerical errors that undermine its credibility. Ground truth states 2023: 312 bcf, 2024: 296 bcf (16 bcf decline, 5.1%). LLM claims 2023: ~319 bcf (312+7), 2024: ~296 bcf (289+7), with a ~23 bcf decline (7%). The LLM's 2024 developed reserves figure of 289 bcf is incorrect—ground truth shows 296 bcf total. The LLM appears to have separated developed/undeveloped components (312+7 vs 289+7) but this breakdown doesn't match the ground truth's single consolidated figure of 296 bcf for 2024. The calculated decline of ~23 bcf is also wrong; the correct decline is 16 bcf. The percentage decline of 7% is also incorrect (should be 5.1%). QUALITATIVE ISSUES: While the LLM correctly identifies the region as strategically important and mentions equity affiliates, it fails to cite the specific equity affiliate figure of 5,870 bcf mentioned in ground truth. The explanation about 'price-related and technical revisions' and 'disposition of non-core assets' adds context not in the ground truth, which could be accurate but cannot be verified. The LLM's conclusion that the region 'remains a focal growth corridor' contradicts the ground truth's more cautious assessment that the decline 'may suggest a shift in emphasis.' MULTI-HOP REASONING: The LLM does attempt to synthesize the reserve decline with strategic importance, but the flawed numbers undermine this analysis. The answer addresses both parts of the question (evolution and strategic importance) but with incorrect data. STRENGTHS: Correctly identifies the region, correctly notes the decline occurred, correctly acknowledges continued strategic importance, and attempts to explain the decline. CRITICAL FAILURE: The numerical errors (23 bcf vs 16 bcf, 7% vs 5.1%, 289 bcf vs 296 bcf) are fundamental factual mistakes that cannot be overlooked in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 515,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "\nIn 2023 AIG served as the guarantor and primary financing source for Corebridge’s roughly $9.4 bn of debt – including the DDTL facility that could be extended through February 2025 and a reimbursement agreement that would require AIG to post collateral only if Corebridge’s ratings were downgraded. After Corebridge was de‑consolidated on June 9 2024, AIG retained a minority equity stake and began accounting for its interest as an equity‑method investment, recording about $601 million of equity‑method income (dividends plus fair‑value gains) in 2024 while its direct debt exposure was largely eliminated.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative of AIG's relationship with Corebridge evolving from consolidated debt to equity method accounting, and correctly identifies the June 9, 2024 de-consolidation date. However, there are significant quantitative discrepancies: (1) The LLM states 'roughly $9.4 bn of debt' which is approximately correct ($9,368M ≈ $9.4B), but fails to provide the specific debt component breakdown that the ground truth includes ($6,452M senior unsecured notes and $989M junior subordinated debt). (2) The LLM introduces a $601 million equity method income figure for 2024 that does not appear in the ground truth answer, which only mentions that 'AIG reported equity method income from Corebridge' without specifying an amount. This is a potential factual error or unsupported claim. (3) The LLM characterizes AIG as 'guarantor and primary financing source' in 2023, but the ground truth explicitly states the debt was 'not guaranteed by AIG' - this is a material mischaracterization. (4) The LLM mentions 'DDTL facility' and 'reimbursement agreement' details not present in the ground truth, suggesting additional information that may or may not be accurate. The multi-hop reasoning is sound in connecting 2023 consolidated debt to 2024 equity method treatment, but the specific financial details contain errors or unsupported claims that undermine accuracy. The answer demonstrates good understanding of the structural transformation but fails on quantitative precision and introduces potentially incorrect figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 424,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "\nBetween 2022 and 2024 the Special‑Use Fund portfolio shifted from a relatively balanced or fixed‑income‑heavy mix to a composition that is now roughly **70‑75 % equity and 25‑30 % fixed‑income** (e.g., NEE’s 2024 fund holds about $6.16 bn of equity versus $2.29 bn of debt; FPL holds about $4.22 bn of equity versus $1.74 bn of debt).  This increased equity weighting reflects a **moderate rise in risk appetite**—NextEra is allocating more of its decommissioning and storm‑reserve assets to market‑traded securities that can generate higher returns—while still retaining a sizable fixed‑income buffer and using highly liquid equity and debt positions to preserve **liquidity** for potential cash‑out needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the fundamental strategic shift from fixed-income-heavy to equity-heavy allocation between 2022 and 2024, and appropriately characterizes this as indicating increased risk appetite and liquidity considerations. The qualitative reasoning about decommissioning/storm-reserve assets and market-traded securities is sound and relevant. The answer addresses all parts of the multi-part question.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: (1) The LLM states NEE's 2024 fund holds '$6.16 bn of equity versus $2.29 bn of debt.' However, the ground truth shows: $6,164M equity + $722M U.S. Government/municipal bonds + $685M corporate debt + $873M asset-backed securities = $8,344M total, with $2,280M in fixed income ($722M + $685M + $873M). The LLM's $2.29bn figure is approximately correct for total fixed income, but this obscures the composition details provided in ground truth. (2) The LLM provides percentages (70-75% equity, 25-30% fixed income) that are approximately correct ($6,164/$8,344 = 73.9% equity; $2,180/$8,344 = 26.1% fixed income), but these are not explicitly stated in the ground truth and represent calculations not verified against source documents. (3) The LLM introduces FPL data ($4.22bn equity vs $1.74bn debt) which is NOT mentioned in the ground truth answer at all - this represents unsourced information that cannot be verified.\n\nMISSING DETAILS: The ground truth specifically breaks down the 2024 fixed income into three categories (U.S. Government/municipal bonds $722M, corporate debt $685M, asset-backed securities $873M), which the LLM aggregates without distinction. The 2022 baseline of $2,505M entirely in fixed income is not explicitly mentioned in the LLM answer, though the comparison is implicit.\n\nMULTI-HOP REASONING: The synthesis across years (2022 to 2024) is sound, and the connection between portfolio composition and strategic implications (risk appetite, liquidity) is logical and well-reasoned. However, the introduction of FPL data suggests either hallucination or reliance on information not in the ground truth.\n\nSCORING JUSTIFICATION: The answer demonstrates good qualitative understanding and addresses the question comprehensively, but the quantitative accuracy is compromised by: (a) introducing unverified FPL data, (b) not breaking down the fixed income components as specified in ground truth, and (c) relying on calculated percentages rather than stated figures. The core insight is correct, but execution has material gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 671,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "\nBetween 2022 and 2024 the risk that site‑infrastructure sharing would curb new lease growth intensified and became more concrete.  In the 2022 filing the company warned only that “new technologies or changes in a customer’s business model could reduce demand for tower‑based services,” but by 2024 it explicitly highlighted that 5G‑driven network sharing (RAN sharing, small‑cell deployments and carrier‑level infrastructure pooling) is already being used by carriers as an alternative to leasing additional tower space, which is slowing new lease activity and pressuring lease rates.  Consequently, the magnitude of the risk has grown: the company now expects that a significant share of carrier capital will be allocated to shared‑site solutions rather than to building new sites, creating a material upside‑down risk to future lease revenue and churn.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the evolution of the risk from 2022 to 2024, capturing the shift from general concern about 'new technologies' to specific focus on 5G-driven RAN sharing; (2) Accurately names the specific infrastructure sharing mechanisms (RAN sharing, small-cell deployments, carrier-level infrastructure pooling) mentioned in the 2024 filing; (3) Properly synthesizes the multi-hop reasoning showing how 5G adoption drove carriers toward shared infrastructure alternatives rather than new leases; (4) Correctly identifies the financial impact - that carriers are allocating capital to shared solutions instead of new sites, creating revenue pressure; (5) Uses appropriate terminology ('upside-down risk,' 'churn') consistent with telecom tower industry language. MINOR WEAKNESSES: (1) The LLM answer introduces the phrase 'upside-down risk' which, while semantically reasonable in context, is not explicitly confirmed in the ground truth statement; (2) The phrase 'small-cell deployments' appears in the LLM answer but is not explicitly mentioned in the ground truth, though it is a reasonable inference about 5G infrastructure sharing mechanisms; (3) The ground truth emphasizes 'lack of compensation to AMT when carriers opted for shared infrastructure' more explicitly than the LLM answer conveys - the LLM focuses on capital allocation shift rather than the compensation gap. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The temporal references (2022 vs 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and connects 5G technology adoption to its impact on lease activity and revenue, which is the core multi-hop requirement. The logical progression from risk identification to financial impact is sound. SEMANTIC EQUIVALENCE: The core message matches - the risk evolved from vague concern to specific, material threat tied to 5G-driven infrastructure sharing practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 577,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "\nChevron’s 36.4 % equity interest in Angola LNG Limited was unchanged between 2022 and 2023, but the investment’s carrying amount fell from about **$1.96 billion** at year‑end 2022 to **$1.76 billion** at year‑end 2023, reflecting the normal equity‑method adjustments (share of earnings/losses and dividends). Consequently, Chevron continued to record its share of Angola LNG’s results as a loss in the consolidated income statement, with the 2023 loss reducing the investment balance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer addresses a different aspect of Chevron's Angola LNG relationship than what the ground truth establishes. Critical issues: (1) MISSING KEY INFORMATION: The LLM completely fails to address the primary evolution described in the ground truth - the reclassification from 'Depends_On' to 'Invests_In' relationship structure between 2022 and 2023. This is the core finding about how the financial relationship evolved. (2) UNVERIFIED NUMBERS: The LLM provides specific carrying amounts ($1.96 billion in 2022 and $1.76 billion in 2023) that are not present in the ground truth and cannot be verified. These numbers may or may not be correct from the actual 10-K filings, but they represent a factual claim that differs from the ground truth's focus. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the 36.4% equity interest as unchanged, it fails to synthesize the relationship classification change that is central to understanding how the financial relationship evolved. The ground truth explicitly states this reclassification indicates 'a shift in how Chevron views or manages its investment.' (4) DIFFERENT ANALYTICAL FOCUS: The LLM focuses on equity method accounting mechanics (earnings/losses, dividends, carrying amount changes) rather than the structural relationship evolution that the question and ground truth emphasize. (5) PARTIAL ACCURACY: The 36.4% ownership percentage is correct, and the mention of equity method accounting is relevant, but these correct elements don't compensate for missing the primary evolution narrative. The answer reads as a technical accounting explanation rather than an answer to how the relationship evolved structurally between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 467,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "\nFrom 2022 into 2023 the G600 moved from a brand‑new clean‑sheet design to a mature, high‑volume production model—cumulative deliveries had risen to **over 250 aircraft** by the end of 2023 and the Savannah line kept building them.  Its performance figures that Gulfstream continues to highlight—**Mach 0.85 cruise, a range of roughly 6,000 nautical miles, a cabin that is larger and more ergonomically designed, and about 40 % lower fuel burn/emissions versus the legacy models it replaced**—remained the benchmark that positions the G600 as the current long‑range, large‑cabin flagship while the upcoming G700 prepares for service.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of the G600's evolution from new to mature product with over 250 cumulative deliveries by end of 2023, which matches the ground truth. However, there are significant issues with the performance metrics presented. The LLM introduces specific technical specifications (Mach 0.85 cruise, 6,000 nautical miles range, 40% lower fuel burn/emissions) that are NOT present in the ground truth answer. While these may be accurate G600 specifications from SEC filings, they represent information not verified against the provided ground truth, which only mentions 'performance metrics' generically without specifying these particular numbers. The LLM also characterizes the G600 as 'current long-range, large-cabin flagship' while the ground truth indicates it was being superseded by newer models (G700, G800, G400) with its technologies being extended to them—this is a subtle but important distinction. The LLM correctly identifies the shift from product introduction to mature status and mentions the Symmetry Flight Deck technology being extended to newer models, which aligns with ground truth. The statement about the G700 'preparing for service' is somewhat vague compared to ground truth's clearer positioning of G700/G800/G400 as newer models. Strengths: accurate delivery numbers, correct timeline (2022-2023), proper identification of the G600's maturation. Weaknesses: introduction of unverified performance specifications, potential mischaracterization of the G600's current positioning relative to newer models, lack of explicit mention that G600 technologies are foundational to newer platforms rather than the G600 being the flagship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 460,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s shifted from a purely royalty‑and‑rent franchise model to a more collaborative, co‑investment framework.  The company now routinely partners with franchisees to fund restaurant upgrades, technology platforms and supply‑chain improvements—often matching their capital outlays—while tightening operational standards and tying revenue to joint performance goals.  This deeper financial involvement is framed as a strategic alliance that seeks to modernize stores, accelerate innovation and strengthen the brand, even as the core franchising revenue (rent, royalties and initial fees) remains the backbone of the system.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and captures the essential evolution of McDonald's franchisee relationships between 2022 and 2024. STRENGTHS: (1) Correctly identifies the core shift from a passive royalty/rent model to active co-investment partnership; (2) Accurately describes the 2022 baseline (franchised arrangements, license agreements, revenue through rent/royalties/fees); (3) Accurately characterizes 2024 developments (co-investments, restaurant improvements, operating system upgrades); (4) Properly synthesizes the strategic rationale (modernization, brand enhancement, consumer preferences); (5) No quantitative errors or incorrect dates/numbers; (6) Multi-hop reasoning is sound - correctly connects financial involvement changes to strategic collaboration evolution. MINOR CONSIDERATIONS: (1) The LLM answer adds some details not explicitly in the ground truth (e.g., 'technology platforms,' 'supply-chain improvements,' 'matching capital outlays,' 'tightening operational standards,' 'tying revenue to joint performance goals') - these appear to be reasonable inferences about co-investment frameworks but go slightly beyond what the ground truth explicitly states; (2) The phrase 'core franchising revenue...remains the backbone' is a reasonable inference but not explicitly stated in ground truth; (3) The answer is somewhat more detailed and specific than the ground truth, which could be viewed as either enhanced context or minor extrapolation. VERIFICATION: All core facts align - the 2022 baseline, 2024 shift, co-investment introduction, and strategic motivation are all correctly represented. The semantic meaning matches the ground truth despite different wording. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 473,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\nFrom 2022 to 2023 the smokeable‑products segment saw a modest pull‑back in sales: net revenues fell from **$22,476 million in 2022 to $21,756 million in 2023**, a decline of roughly **$720 million (about 3 %)**.  Operating income also slipped only slightly, moving from **$10,688 million in 2022 to $10,670 million in 2023**, a reduction of about **$18 million (≈0.2 %)**.  Thus, while revenue contracted modestly, profitability remained essentially flat year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All financial figures are correct: 2022 net revenues of $22,476 million, 2023 net revenues of $21,756 million, 2022 operating income of $10,688 million, and 2023 operating income of $10,670 million. The calculations are accurate: revenue decline of $720 million (3.0% = 720/22,476), and operating income decline of $18 million (0.17% ≈ 0.2% = 18/10,688). The LLM correctly synthesized the multi-hop comparison across both years and both metrics. The answer effectively addresses all parts of the question regarding how smokeable products' financial performance evolved. The reasoning is sound and the conclusion that 'profitability remained essentially flat year-over-year' while 'revenue contracted modestly' is logically consistent with the data. The presentation is clear and well-organized with appropriate use of formatting. Minor note: The percentage calculation for operating income is shown as ≈0.2%, which is a reasonable approximation (actual is 0.168%), demonstrating appropriate rounding. The answer goes slightly beyond the ground truth by providing calculated differences and percentages, which adds value without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 342,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "\nFrom 2022 through 2024 Opdivo moved from a primarily regional, co‑promoted immuno‑oncology asset with Ono (Japan, South Korea and Taiwan) toward a globally integrated franchise.  New collaborative updates—such as the 2020 amendment with Nektar that shares development costs and profits for the Opdivo + NKTR‑214 combination and revised profit‑share terms with Ono—combined with a series of regulatory wins (FDA approval of Opdivo Qvantig subcutaneous, EC approval of Opdivo + Yervoy for MSI‑high colorectal cancer, and first‑line approvals in urothelial carcinoma and NSCLC) have expanded Opdivo’s therapeutic scope and positioned it as a central pillar of BMS’s oncology strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the evolution of Opdivo's role but contains several significant issues: (1) FACTUAL ERRORS: The answer references a '2020 amendment with Nektar' which is outside the 2022-2024 timeframe specified in the question and appears to be historical context rather than evolution during the period asked. The mention of 'Opdivo Qvantig subcutaneous' approval is not mentioned in the ground truth and cannot be verified. (2) MISSING KEY INFORMATION: The ground truth specifically mentions the March 2024 FDA approval for combination with cisplatin and gemcitabine for urothelial carcinoma—the LLM only vaguely references 'first-line approvals in urothelial carcinoma' without the specific drug combination or date. The ground truth's specific mention of the 80-20 profit split framework with Ono is absent. (3) COLLABORATIVE FRAMEWORK: The LLM correctly identifies the Ono partnership and mentions profit-sharing revisions, but lacks the specific structural details (80-20 split, equal splits for combinations) provided in ground truth. The reference to Yervoy and Orencia alliance structure is missing. (4) STRATEGIC SHIFT: Both answers capture the shift from co-development to more independent expansion, but the LLM frames it as 'regional to global integration' while ground truth emphasizes 'co-development focus to independent product introduction.' (5) QUANTITATIVE ISSUES: No specific dates are provided for the collaborative updates mentioned (when were the Ono terms revised?), and the EC approval for MSI-high colorectal cancer is not mentioned in ground truth. The answer conflates historical information (2020 Nektar amendment) with the 2022-2024 evolution period. Overall, the answer demonstrates partial understanding but introduces unverified claims and misses specific quantitative details from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 499,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "\nBetween 2022 and 2024 AMT moved from describing its borrowing costs as variable rates tied to LIBOR or EURIBOR (with margin adjustments and covenants that referenced those benchmarks) to disclosing fixed‑rate securitization notes (e.g., 5.490 % for the 2023‑Series A securities and 5.735 % for the 2023‑Series R securities) that no longer cite LIBOR/EURIBOR.  The newer disclosures replace the old benchmark‑based interest‑rate language with explicit contractual rates and shift the related covenants from LIBOR‑linked financial tests to DSCR‑based cash‑flow and cash‑trap restrictions that govern excess‑cash‑flow distribution.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. (1) CRITICAL ERRORS: The LLM claims AMT moved to 'fixed-rate securitization notes' with specific rates (5.490% and 5.735%), but the ground truth makes no mention of securitization notes or these specific fixed rates. The ground truth explicitly states the 2024 disclosure shows a shift TO SOFR (not away from LIBOR to fixed rates). (2) QUANTITATIVE ACCURACY: The specific percentages cited (5.490%, 5.735%) cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth does not reference these securitization rates at all. (3) BENCHMARK EVOLUTION: The LLM incorrectly characterizes the evolution. Ground truth shows: 2022 = LIBOR/EURIBOR/base rate → 2024 = SOFR. The LLM claims the evolution is to fixed-rate securitization notes, which contradicts the ground truth's explicit mention of SOFR-based instruments. (4) COVENANT DISCUSSION: The LLM introduces 'DSCR-based cash-flow and cash-trap restrictions' which are not mentioned in the ground truth. The ground truth states 2024 disclosures focused on 'consequences of covenant non-compliance without specifying interest rate structures,' which is fundamentally different from the LLM's claim about DSCR-based restrictions. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution across years. It appears to have confused or fabricated details about securitization instruments that are not supported by the ground truth. (6) MISSING KEY INFORMATION: The LLM completely omits the 2022 details about debt ratings, commitment fees (0.080%-0.300%), and the shift to SOFR in Nigeria letters of credit that are central to the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 479,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s kept its core model of owning or securing long‑term leases on the land and building for most conventional franchised restaurants, with franchisees supplying the equipment, signage and interior fit‑out.  In recent years the company has deepened its co‑investment approach—partnering with franchisees to fund restaurant renovations, technology upgrades and other improvements that modernize stores, boost sales and increase brand value, and in developmental‑license markets the franchisee now typically owns the real‑estate and bears the capital investment.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The core model description is accurate - McDonald's owns/secures long-term leases on land and buildings while franchisees invest in equipment, signage, and interior fit-out. (2) The mention of co-investment approach for renovations, technology upgrades, and modernization is accurate. (3) The reference to developmental-license markets where franchisees own real estate is correct. PROBLEMATIC ELEMENTS: (1) The answer claims McDonald's 'deepened its co-investment approach' 'in recent years' but the ground truth indicates the shift was FROM general collaboration emphasis in 2022 TO clearly defined strategy in 2024 - the LLM doesn't clearly articulate this temporal evolution or the 2022-to-2024 progression. (2) The answer lacks the important context that in 2022, McDonald's emphasized 'Systemwide coordination and alignment' for ESG initiatives, which is a key part of the evolution narrative. (3) The answer doesn't adequately capture the shift from 'general emphasis on franchisee collaboration' (2022) to 'clearly defined real estate and co-investment strategy' (2024) - it presents the model as relatively static rather than evolved. MULTI-HOP REASONING: The answer partially synthesizes information but fails to clearly show the temporal evolution between the two years. It describes the current/recent state but doesn't effectively contrast 2022 versus 2024 positioning. The ground truth emphasizes a 'shift' and 'more structured and strategic approach,' which the LLM answer doesn't adequately convey. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this is not a differentiating factor. SEMANTIC EQUIVALENCE: While the factual details about the franchise model are correct, the answer misses the key narrative arc of evolution that the question specifically asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 515,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "\nBetween 2022 and 2023 the 2015 Stock Compensation Plan for Non‑Employee Directors remained the same amended‑and‑restated plan that was approved on October 26 2022 (first disclosed in the 2022 Form 10‑Q) and was still cited in the 2023 filing with no additional amendment or replacement noted.  This continuity reflects Altria’s governance approach of making infrequent, shareholder‑approved updates to director compensation rather than routine or ad‑hoc changes, signaling a stable, transparent, and board‑focused compensation framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on key dates and the amendment status. Correct elements: (1) The October 26, 2022 amendment/restatement date is accurate, (2) The reference to the September 30, 2022 Form 10-Q disclosure is correct, (3) The characterization of continuity between 2022 and 2023 filings is accurate. However, there is one notable omission: The ground truth specifies that in 2022, the plan had 703,256 shares available for issuance, which the LLM answer does not mention. This is a material quantitative detail that should have been included when discussing the plan's status. The LLM's interpretation of what this evolution indicates about governance is reasonable and well-reasoned—emphasizing stability, transparency, and infrequent shareholder-approved updates—which aligns with the ground truth's suggestion of refined governance frameworks. The multi-hop reasoning is sound: the model correctly synthesized that the plan was amended in October 2022 (disclosed in Q3 2022 10-Q) and remained unchanged through 2023. The semantic equivalence is strong; both answers convey that the plan underwent formal amendment/restatement and remained stable thereafter. The main weakness is the incomplete quantitative disclosure (missing the 703,256 shares figure), which represents a gap in comprehensiveness rather than an error in what was stated. The governance interpretation is slightly more detailed in the LLM answer but semantically consistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 414,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "\nFrom 2022 through 2024 the company repeatedly warned that expanding roaming, RAN‑sharing and resale arrangements—driven by 5G and other advanced network technologies—are being used by carriers as an alternative to leasing additional tower space.  In the 2022 filing the risk was described as a possible slowdown in new lease activity; by 2024 the language is stronger, noting that such sharing “may cause new lease activity to slow … or result in the decommissioning of equipment on existing sites,” indicating that the competitive pressure has deepened and is now a more pronounced constraint on AMT’s lease‑growth prospects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL ACCURACY: All key facts are correct - the answer accurately identifies the evolution from 2022 (slowdown in new lease activity) to 2024 (potential decommissioning of equipment), correctly names the technologies involved (5G, RAN-sharing, roaming/resale arrangements), and properly attributes these concerns to AMT. The answer correctly identifies the competitive pressure dynamic and its impact on lease growth. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this question, so this dimension scores perfectly. The temporal progression (2022 to 2024) is correctly maintained. (3) ENTITY ACCURACY: AMT is correctly identified throughout; the relevant technologies (5G, RAN-sharing, roaming/resale arrangements) are all accurately named; the time periods (2022 and 2024) are correct. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and filing documents, correctly tracing the evolution of the risk from a potential slowdown to a more serious threat involving decommissioning. The logical connection between infrastructure sharing alternatives and reduced lease growth is sound. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'expanding roaming, RAN-sharing and resale arrangements' vs. 'roaming or resale arrangements') but conveys identical meaning. The quote about decommissioning is directly aligned with the ground truth. The characterization of deepening competitive pressure is semantically equivalent to 'growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative.' Minor variation: The LLM answer emphasizes the strengthening of language between filings ('language is stronger'), which adds useful interpretive context not explicitly in the ground truth but is a reasonable inference from the facts presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 544,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s shifted from a largely “franchisee‑only” capital model to a more collaborative one in which the corporation increasingly **co‑invests with franchisees** to fund restaurant remodels, technology upgrades and other strategic initiatives (e.g., the “Accelerating the Arches” agenda).  At the same time, **operational expectations have been tightened** – the company now requires franchisees to be active, non‑passive partners who meet rigorous brand, digital‑adoption and ESG standards and who can finance and implement the initiatives that drive system‑wide sales and profitability.  (Pages 26‑30 of the 2022 10‑K describe the traditional franchise structure and risk of franchisee investment; pages 2‑6 of the 2024 10‑K detail the newer co‑investment approach and the heightened performance expectations placed on franchisees.)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the core shift from 2022 to 2024 - from pandemic-focused operational challenges to strategic co-investment model. (2) Accurately captures the key strategic initiatives: 'Accelerating the Arches' strategy, restaurant modernization, technology upgrades. (3) Properly synthesizes the multi-hop relationship evolution: 2022 emphasized pandemic risks and franchisee adaptation; 2024 emphasizes active co-investment and heightened performance standards. (4) Correctly identifies the shift in operational expectations - from survival/adaptation mode to rigorous brand, digital, and ESG standards. (5) Appropriately cites specific 10-K page references (2022 pages 26-30, 2024 pages 2-6) which demonstrates document-specific knowledge. (6) No quantitative errors or incorrect numbers/dates. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive detail about 'tightened operational expectations' and specific standards (brand, digital-adoption, ESG) that, while logically consistent with the ground truth's mention of 'structured co-investment initiatives,' goes slightly beyond explicit statement in the original answer. However, this represents reasonable inference from the shift described rather than factual error. (2) The characterization of the previous model as 'franchisee-only capital' is a reasonable interpretation of the 2022 context, though the ground truth doesn't explicitly use this phrasing. (3) The answer effectively synthesizes information across two different fiscal years and documents, demonstrating sound multi-hop reasoning. The semantic equivalence is strong - both answers convey the same fundamental evolution from pandemic-driven challenges to strategic investment partnership. No calculations are required for this qualitative question, and no numeric values are presented that could be incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 527,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2024 the equity portion of NextEra’s Special Use Funds grew from roughly $5.3 bn to $6.2 bn.  The fund’s Level 2 holdings – which consist of commingled funds whose underlying securities are marked‑to‑market using observable prices – rose from about $2.7 bn (2022) to $3.3 bn (2024), while the Level 3 direct‑equity slice increased only modestly from $199 m to $229 m.  This shift shows a strategic move toward larger, more liquid, market‑observable equity exposures (Level 2) with a relatively stable, small allocation to less‑liquid, Level 3 assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL NUMBER ERRORS: The LLM claims equity securities grew from ~$5.3bn (2022) to ~$6.2bn (2024), but the ground truth explicitly states 2022 had NO explicit breakdown of equity securities provided, and 2024 showed $6,164 million ($6.164bn) in equity securities. The LLM's 2022 figure of $5.3bn appears to be fabricated with no basis in the ground truth. (2) UNSUBSTANTIATED DETAILS: The LLM provides specific breakdowns of Level 2 holdings ($2.7bn to $3.3bn) and Level 3 holdings ($199m to $229m) that are not mentioned anywhere in the ground truth answer. These appear to be hallucinated details not supported by the source material. (3) CONTRADICTORY NARRATIVE: The ground truth emphasizes that 2022 lacked explicit equity breakdown while 2024 provided detailed composition - suggesting improved transparency. The LLM instead presents a false narrative of growth from 2022 to 2024 with specific fund classifications that cannot be verified. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the key insight from the ground truth: the evolution was primarily about disclosure transparency and composition detail, not necessarily about strategic growth in absolute equity amounts. The total Special Use Funds actually DECREASED from $8,922M to an amount where $6,164M was in equities. (5) The LLM's answer is internally coherent but factually disconnected from the ground truth, representing a fundamental failure to accurately extract and synthesize information from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 437,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\nFrom 2022 to 2023 the smokeable‑products segment’s net revenues fell from **$22,476 million to $21,756 million** – a decline of roughly **$720 million (about 3 %)**.  Its operating income also slipped only slightly, moving from **$10,688 million in 2022 to $10,670 million in 2023**, a decrease of about **$18 million (≈0.2 %)**.  Thus, revenue contracted modestly while profitability remained essentially flat.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key financial figures are correct: 2022 net revenues of $22,476 million, 2023 net revenues of $21,756 million, 2022 operating income of $10,688 million, and 2023 operating income of $10,670 million. The calculations are accurate: the revenue decline of $720 million (approximately 3%) and the operating income decrease of $18 million (approximately 0.2%) are both correctly computed. The LLM properly synthesized the multi-hop information by comparing the smokeable products segment across both years and both metrics. The reasoning is sound, correctly identifying that revenue contracted modestly while profitability remained essentially flat. The answer directly addresses all parts of the question regarding how financial performance evolved from 2022 to 2023 in terms of both net revenues and operating income. The wording is clear and professional, with appropriate use of percentage calculations to contextualize the changes. Minor formatting variations (using hyphens in 'smokeable‑products' vs 'smokeable products') are inconsequential. The answer goes slightly beyond the ground truth by providing percentage calculations and comparative analysis, which adds value without introducing any inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 359,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Accenture’s Class A share purchases remained focused on acquiring treasury shares for employee‑benefit and equity‑award programs.  In 2022 it bought about 12.2 million shares for roughly $4.1 bn under its open‑market and other purchase programs, and in September 2022 the Board added $3 bn of repurchase authority—raising the total authorization to $6.13 bn—so that the same pool of treasury shares could be used for future open‑market purchases and redemptions of Class A (and exchangeable) shares to fund employee benefits and equity awards.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM claims Accenture bought 'about 12.2 million shares for roughly $4.1 bn' in 2022, but the ground truth does not mention these specific figures. The ground truth cites an 'aggregate available authorization of $3,129,296' for 2022, which the LLM misrepresents as a total authorization amount. The LLM then claims the Board added '$3 bn of repurchase authority' in September 2022, raising it to '$6.13 bn'—but $3,129,296 + $3 billion does not equal $6.13 billion, and these numbers don't align with the ground truth's authorization figure. (2) MISSING KEY INFORMATION: The ground truth explicitly states that in fiscal 2024, shares were acquired via 'share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization.' The LLM completely omits this important distinction about the separation between withholding programs and formal buyback programs. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes a 'shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program'—a nuanced multi-hop insight about the evolution. The LLM addresses employee benefits but fails to capture this strategic shift or the distinction between different acquisition mechanisms. (4) ACCURACY OF CORE CLAIM: While the LLM correctly identifies that shares were held as treasury shares for employee benefits, the specific numbers provided appear to be fabricated or misattributed, and the authorization amounts don't match the ground truth. The answer reads plausibly but contains material factual errors that would mislead readers about Accenture's actual share repurchase programs and authorizations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 500,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "\nBetween 2022 and 2024 the core financial‑covenant structure (e.g., DSCR‑based cash‑trap and minimum‑DSCR tests, limits on additional indebtedness, and mandatory reporting) has remained, but the covenants now apply to a broader set of debt instruments—including the low‑coupon 0.400 % and 0.950 % senior notes, the 2023 securitization tranches, and the euro‑denominated delayed‑draw term loans—while the interest‑rate benchmarks have stayed tied to LIBOR for USD borrowings and EURIBOR for EUR borrowings, each with a 1.125 % spread, and are explicitly linked to the anticipated repayment dates of the securitized components.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on the core evolution of AMT's operating covenants. Key issues: (1) BENCHMARK TRANSITION ERROR - The LLM claims interest-rate benchmarks 'have stayed tied to LIBOR for USD borrowings and EURIBOR for EUR borrowings,' directly contradicting the ground truth which explicitly states a 'shift in the interest rate benchmark to SOFR' by 2024. This is a fundamental misunderstanding of the question's core premise about covenant evolution. (2) MISSING SOFR TRANSITION - The ground truth clearly identifies the strategic shift from LIBOR/EURIBOR to SOFR as the key evolution, particularly for letters of credit in Nigeria. The LLM completely omits this critical transition. (3) SPECIFIC RATE ERRORS - The LLM introduces specific spread percentages (1.125%) and coupon rates (0.400%, 0.950%) that are not mentioned in the ground truth and appear to be fabricated details. (4) INCOMPLETE SYNTHESIS - While the LLM correctly identifies that covenants apply to broader debt instruments (securitization tranches, term loans), it fails to synthesize the most important evolution: the benchmark transition from LIBOR/EURIBOR to SOFR. (5) STRUCTURAL ACCURACY - The LLM's description of covenant types (DSCR-based tests, limits on indebtedness) aligns with ground truth, but this correct element is overshadowed by the fundamental error on benchmark evolution. The answer demonstrates a failure to identify and communicate the primary structural change between 2022 and 2024, making it substantially incorrect despite some partially accurate contextual details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 446,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "\nDisney+ Hotstar’s paid subscriber base grew from roughly **30 million** at the end of fiscal 2023 (as disclosed in the 2023 filing, page 7) to **≈36 million** by September 2024 (2024 filing, page 7), an increase of about **6 million** (≈20 %).  At the same time, the company combined the standalone **Star+** service into the **Disney+** platform in Latin America (noted on page 58 of the 2024 filing), eliminating the separate Star+ tier and moving those users onto Disney+.  This consolidation creates a single, more scalable streaming offering in the region, bolstering Disney’s international subscriber count and simplifying its go‑to‑market strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative about Disney+ Hotstar subscriber growth and the Star+/Disney+ consolidation in Latin America. The qualitative reasoning about streamlining international offerings and creating a unified platform is sound and well-articulated. The answer appropriately synthesizes multi-hop information about subscriber evolution and strategic consolidation. WEAKNESSES: Significant quantitative discrepancy on the starting subscriber count. The LLM states Disney+ Hotstar had ~30 million subscribers at end of fiscal 2023, but the ground truth indicates the 2023 filing reported approximately 36 million as of September 28, 2024 (which would be the 2024 fiscal year end). The LLM appears to have confused fiscal year timing or misread the baseline figure. The calculation of a 6 million increase (20%) is mathematically consistent with the LLM's stated numbers (30M to 36M), but if the actual baseline was different, this calculation would be incorrect. The ground truth doesn't explicitly state a 2023 baseline figure, making it difficult to verify the LLM's 30 million claim. The LLM correctly identifies the consolidation of Star+ into Disney+ in Latin America and accurately conveys the strategic implications. The page references (page 7, page 58) are provided but cannot be independently verified from the ground truth. The answer demonstrates solid understanding of the multi-hop synthesis required (subscriber trends + consolidation strategy), but the quantitative foundation appears questionable. The semantic meaning and strategic analysis are appropriate, but the numerical accuracy issue prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 457,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "\nFrom the 2022 disclosures the company expected to renegotiate 21 collective‑agreement contracts that would cover roughly 3,000 employees, whereas the 2023 outlook projects renegotiating 20 agreements that will cover about 2,100 employees. This reduction in both the number of agreements and the employee headcount shows that GD is scaling back the scope of its labor‑agreement negotiations, adopting a more focused, streamlined approach rather than expanding collective‑bargaining coverage.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of the key metrics: 3,000 employees in 2022 declining to 2,100 employees in 2023. The answer also correctly identifies the number of agreements (21 to 20), which adds valuable context not explicitly stated in the ground truth but appears to be accurate supplementary information. The multi-hop synthesis is sound - the model correctly compared the two years and drew logical conclusions about the company's labor strategy shift. The interpretation that this represents 'scaling back' and a 'more focused, streamlined approach' is semantically equivalent to the ground truth's characterization of 'a reduction in the number of employees involved in labor renegotiations' and 'a shift in the company's labor agreement strategy.' The answer is well-structured and addresses both parts of the question (the change in numbers AND what it indicates about strategy). Minor deduction: The ground truth mentions 'possibly due to fewer expiring agreements or proactive resolution' as potential explanations, while the LLM answer presents the interpretation more definitively without acknowledging these are possible explanations rather than confirmed facts. The company identification as 'GD' (General Dynamics) is reasonable inference but not explicitly confirmed in the provided ground truth context. Overall, this is a high-quality answer with accurate numbers, sound reasoning, and appropriate contextual interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 410,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the amount of NextEra Energy’s holdings in U.S. Government and municipal bonds fell from about **$777 million** (2022) to **$757 million** (2023) and then to **$722 million** (2024).  This reflects a **$20 million decline from 2022 to 2023** and a **further $35 million drop from 2023 to 2024**, for a total reduction of roughly **$55 million** over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across all dimensions. (1) QUANTITATIVE ERRORS - All numbers are wrong: LLM claims $777M (2022), $757M (2023), $722M (2024), but ground truth shows $137M (2022) and $161M (2024). The LLM's figures are approximately 5-6x higher than actual values. The LLM calculates a $55M decline, but ground truth shows a $24M increase. (2) DIRECTIONAL ERROR - LLM claims a decline/reduction trend, but ground truth shows growth from $137M to $161M (17.5% increase). This is a complete reversal of the actual trend. (3) CALCULATION ERRORS - While the LLM's internal math is consistent ($777M - $20M = $757M, $757M - $35M = $722M), these calculations are based on entirely wrong source numbers. (4) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly identify and synthesize the investment values across the three-year period from the source documents. (5) ENTITY/METRIC ACCURACY - While NextEra Energy is correctly identified, the specific investment category (U.S. Government and municipal bonds) appears to have been confused with different data points, possibly from a different investment category or subsidiary. The answer demonstrates a complete failure to retrieve or synthesize the correct financial data from the SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 355,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 Opdivo moved from being solely an intravenous anti‑PD‑1 therapy to a broader, multi‑modal product: the FDA approved the subcutaneous formulation **Opdivo Qvantig** (Dec 2024) and the company obtained new regulatory nods for Opdivo + Yervoy in colorectal cancer, neoadjuvant NSCLC, and urothelial carcinoma (2024), cementing its leadership in immunotherapy across several tumor types.  To support this expansion, BMS leveraged its **flexible manufacturing network**—using both its own biologics‑focused facilities and third‑party contract manufacturers—and invested in new co‑formulation capabilities (nivolumab + hyaluronidase) for the Qvantig product, allowing faster scale‑up and supply resilience while maintaining the same high‑quality cGMP standards.  Thus, Opdivo’s role deepened both therapeutically and in its production strategy, positioning it as a cornerstone of BMS’s IO portfolio with a diversified, globally‑scaled manufacturing footprint.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR DATE ERROR: The LLM claims 'Opdivo Qvantig' (subcutaneous formulation) was approved in December 2024, but this is not mentioned in the ground truth and appears to be fabricated or confused with other products. (2) UROTHELIAL CARCINOMA APPROVAL: The ground truth specifically states the March 2024 FDA approval was for Opdivo in combination with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma. The LLM mentions urothelial carcinoma but does not specify the exact combination therapy (cisplatin + gemcitabine) or the March 2024 date. (3) UNSUPPORTED CLAIMS: The LLM introduces claims about 'Opdivo + Yervoy in colorectal cancer, neoadjuvant NSCLC' that are not present in the ground truth and cannot be verified. (4) MANUFACTURING DETAILS: While the LLM correctly identifies the dual manufacturing strategy (internal + third-party), it adds unverified details about 'co-formulation capabilities (nivolumab + hyaluronidase)' and 'Qvantig product' that are not in the ground truth. (5) MULTI-HOP SYNTHESIS: The LLM fails to accurately synthesize the specific information provided in the ground truth—it adds speculative details rather than grounding its answer in the documented facts. The core accurate elements (manufacturing flexibility, therapeutic expansion) are present but are overshadowed by fabricated or unverified claims. The answer demonstrates reasonable understanding of the question's intent but severely compromises credibility through factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 448,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Disney kept National Geographic magazine inside the Entertainment segment’s Content‑Sales/Licensing unit (reported alongside the National Geographic television channels) and maintained an essentially unchanged ownership stake (≈73 % Disney, 27 % National Geographic Society).  The magazine’s audience remained steady—internal management reports listed roughly 66 million unique subscribers in September 2024, essentially the same level as the prior year—while the company continued to leverage the title as a strategic pillar for its linear‑network and international‑distribution businesses, using it to drive advertising and licensing revenue across Disney’s broader portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) OWNERSHIP PERCENTAGE ERROR: The LLM states Disney maintained '≈73% Disney, 27% National Geographic Society' ownership, but the ground truth explicitly indicates that by 2024, the emphasis on the ownership percentage was REMOVED from reporting. The LLM incorrectly asserts the ownership stake remained 'essentially unchanged' when the ground truth shows a shift away from emphasizing ownership. (2) SUBSCRIBER NUMBER CLAIM: The LLM introduces a specific claim about '66 million unique subscribers in September 2024' that does not appear in the ground truth and cannot be verified. This is an unsupported factual assertion. (3) MISSES CORE EVOLUTION: The ground truth's central point is that the relationship EVOLVED from an ownership-focused description (73% owned) in 2023 to an operational/publication-focused description in 2024. The LLM completely misses this strategic shift and instead claims the relationship remained 'essentially unchanged.' (4) INCORRECT CHARACTERIZATION: The LLM describes the magazine as being 'reported alongside the National Geographic television channels' and emphasizes its role in 'linear-network and international-distribution businesses,' but the ground truth focuses on the shift in how the ownership relationship is presented in filings, not on operational integration. (5) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the key comparison between 2023 and 2024 reporting approaches. The ground truth shows a deliberate shift in emphasis from equity ownership to operational publication status. The LLM's answer is fundamentally misaligned with the ground truth's core finding about the evolution of Disney's relationship with National Geographic magazine.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 490,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "\nIn the 2023 10‑K (pages 8‑12) PayPal described its transaction‑management databases as part of an end‑to‑end platform that can route payments in ≈ 200 markets and in ≈ 140 currencies, with funds withdrawable in ≈ 57 currencies and balances held in ≈ 24 currencies. The 2024 filing (pages 7‑11) retains the same wording but updates the figures to “approximately 150 currencies” for payments and “56 currencies” for withdrawals, reflecting a modest expansion of global currency coverage while still emphasizing the same proprietary, two‑sided transaction‑management infrastructure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) CURRENCY WITHDRAWAL FIGURES - REVERSED: Ground truth states 2023 had 56 currencies for withdrawal and 2024 had 57 currencies. The LLM claims the opposite: 2023 had '≈ 57 currencies' and 2024 had '56 currencies'. This is a direct contradiction of the core factual claim. (2) MISSING KEY EVOLUTION: The ground truth emphasizes a critical change in framing between years - the 2024 filing placed 'consumers' ahead of 'merchants' in describing the ecosystem. The LLM completely omits this important qualitative evolution, which is central to the question about how PayPal's description 'evolved'. (3) UNVERIFIED ADDITIONAL CLAIMS: The LLM introduces specific figures (200 markets, 140 currencies for 2023; 150 currencies for 2024) that are not mentioned in the ground truth. While these may be accurate, they are not part of the ground truth answer and represent potential hallucination or unsupported claims. (4) INCOMPLETE SYNTHESIS: The question specifically asks about evolution 'particularly in relation to global payment processing in different currencies' - the LLM provides currency numbers but misses the consumer/merchant framing shift that represents the actual evolution in how PayPal describes its capabilities. (5) DIRECTIONAL ERROR: The LLM's statement that 2024 'updates the figures to 56 currencies for withdrawals' (down from 57) contradicts the ground truth's description of 'expansion' in reach. The quantitative accuracy is severely compromised by the reversed figures for the key metric (withdrawal currencies).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 451,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "\nBetween 2023 and 2024 the Series K Debentures (due March 1, 2025) kept the interest‑rate reset that was executed in March 2023 – the debentures were repriced to a fixed 6.051 % annual rate and have remained at that level through 2024, with no subsequent reset or amendment reported. This shows that NEE is deliberately using equity‑linked, long‑dated debentures to lock in medium‑term fixed financing costs and extend its maturity profile, while taking advantage of market‑driven resets to manage interest‑rate exposure and preserve liquidity.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key numeric fact - the 6.051% annual interest rate reset in March 2023 - and accurately notes that this rate remained in effect through 2024 with no subsequent changes. The maturity date (March 1, 2025) is correctly stated. The quantitative accuracy is high with all numbers and dates matching the ground truth. WEAKNESSES: (1) The LLM's characterization of the debentures as 'equity-linked' appears unsupported by the ground truth, which describes them as fixed-rate debentures without mention of equity linkage. This is a material characterization error. (2) The LLM provides more detailed strategic interpretation than the ground truth (discussing 'long-dated debentures,' 'maturity profile extension,' and 'market-driven resets'), which goes beyond what the ground truth explicitly states. While the interpretation about locking in fixed rates is reasonable and aligns with the ground truth's mention of 'locking in a higher interest rate,' the additional strategic claims lack explicit support. (3) The ground truth mentions 'a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023' as evidence of continuation through 2024, but the LLM doesn't reference this specific documentation. MULTI-HOP REASONING: The LLM successfully synthesizes the 2023 and 2024 information to show continuity of the rate, which is correct. However, the reasoning about financing strategy goes beyond the ground truth's more measured statement that NEE 'adjusted its financing strategy in response to market conditions.' The LLM's additional claims about equity-linkage and maturity profile management are not grounded in the provided ground truth. OVERALL: Core facts are accurate (rate, dates, no changes), but the strategic interpretation contains unsupported claims that reduce qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 503,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "\nBetween 2022 and 2023 ExxonMobil shifted the basis of its unit‑of‑production depreciation from reserve estimates calculated with the prior‑year average SEC prices to using the most recent SEC‑price‑derived proved‑reserve figures, adjusting those reserves for actual production and technical changes.  The 2023 filing also adds a safeguard: when proved reserves are substantially de‑booked, the asset is switched to straight‑line depreciation to ensure the cost is fully recovered over the asset’s remaining useful life, reflecting a more responsive approach to revised reserve volumes and longer‑term asset‑life assumptions.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations of ExxonMobil's depreciation methodology evolution. Key issues: (1) INCORRECT CHARACTERIZATION OF CHANGE: The LLM claims ExxonMobil 'shifted' from 'prior-year average SEC prices' to 'most recent SEC-price-derived proved-reserve figures' - this is not supported by the ground truth, which indicates the core methodology remained the same between 2022 and 2023, not a fundamental shift in pricing basis. (2) MISREPRESENTATION OF 2022 BASELINE: The ground truth clearly states that in 2022, ExxonMobil already used SEC price-based reserves 'only when proved reserves were substantially de-booked' - the LLM incorrectly suggests this was a 2023 addition ('The 2023 filing also adds a safeguard'). (3) INCOMPLETE UNDERSTANDING: The LLM misses the key distinction that the 2023 refinement was about 'greater emphasis on using the most recent SEC price' in specific circumstances, not a wholesale shift in methodology. The LLM also introduces unsupported language about 'adjusting those reserves for actual production and technical changes' which is not mentioned in the ground truth. (4) LOGICAL INCONSISTENCY: The LLM presents the straight-line depreciation safeguard as a 2023 addition, when the ground truth indicates this was already part of the 2022 methodology ('switching to straight-line depreciation when asset life did not correlate with reserves'). The answer demonstrates partial understanding of the topic but fails to accurately capture the evolutionary nature of the changes and incorrectly attributes 2022 practices to 2023 as new developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 447,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Netflix moved from a model that leaned heavily on external production partners toward a strategy that emphasizes building its own studio capacity.  The 2023 filing notes that the company “contracts with third parties related to the development, production, marketing and distribution of our original programming,” while the 2024 filing explicitly states that it is “scaling our own studio operations to produce original content, including through acquisitions such as Scanline and Animal Logic,” signaling a deliberate shift to internal production and reduced dependence on outside producers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing Netflix's strategic evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from external production partner reliance to internal studio scaling; (2) Accurately cites specific acquisitions (Scanline and Animal Logic) as evidence of internal scaling; (3) Properly synthesizes the multi-hop comparison across two fiscal years; (4) Correctly characterizes the 2023 emphasis on third-party contracting and the 2024 shift toward internal operations; (5) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM answer uses paraphrased quotes rather than exact language from filings (e.g., 'contracts with third parties related to the development, production, marketing and distribution' appears to be a reasonable paraphrase but exact wording not verified); (2) The answer omits one key detail from the ground truth: the explicit mention in 2023 of risks associated with third-party partners (liability, loss due to legal violations, insolvency, fraud), which was notably absent in 2024 language. This omission represents a meaningful contextual detail that strengthens the ground truth's argument about reduced dependency; (3) The answer doesn't explicitly note that the 'omission of third-party risks' in 2024 was itself evidence of the strategic shift, though it does capture the core strategic movement. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and correctly identifies the directional shift in strategy. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential strategic evolution accurately, with only minor contextual details missing rather than factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 478,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard moved Cyber and Intelligence Solutions from a peripheral “value‑added” offering to a core strategic growth pillar.  In 2022 the solutions were described simply as fraud‑prevention and security services within other revenues, but by 2023 the company was explicitly tying them to its broader digital‑identity and open‑banking agenda—highlighting investments such as the Ekata acquisition and the pending Dynamic Yield purchase—and reporting that these solutions contributed to the strong rise in adjusted net revenue and overall value‑added sales.  This shift reflects a more central positioning of cyber‑and‑intelligence capabilities as a driver of revenue and differentiation across Mastercard’s payments network.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM introduces specific acquisitions (Ekata, Dynamic Yield) that are NOT mentioned in the ground truth answer. These appear to be fabricated details not supported by the original answer. The ground truth makes no reference to these acquisitions. (2) UNSUPPORTED CLAIMS - The LLM claims these solutions 'contributed to the strong rise in adjusted net revenue and overall value-added sales' with no supporting numbers or evidence in the ground truth. This is an unsubstantiated assertion. (3) CORE POSITIONING CORRECT - The LLM correctly identifies the shift from 'Other revenues' positioning in 2022 to elevated strategic importance in 2023, which aligns with ground truth. (4) DESCRIPTION ALIGNMENT - The LLM's characterization of 2022 as 'fraud-prevention and security services' and 2023 as broader ecosystem enablement roughly matches the ground truth's description of fraud prevention/detection/response evolving to 'value-added service for secure, easy, confident transactions.' (5) MULTI-HOP REASONING - While the LLM attempts to synthesize information about strategic evolution, it does so by introducing information not in the ground truth, which is a critical error. The ground truth is more conservative and specific about what changed (positioning and description), while the LLM overreaches with acquisition details and revenue impact claims. The answer demonstrates partial understanding of the strategic shift but fails on factual accuracy by adding unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 422,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "\nFrom 2023 to 2024 Tesla shifted from relying almost entirely on outside suppliers such as Panasonic and CATL for battery cells toward accelerating its own cell‑development and manufacturing program, investing heavily in new gigafactories (e.g., Texas, Germany and the planned Mexico site) to produce proprietary cells at scale.  This transition introduced new production hurdles—including bottlenecks in cell ramp‑up, steep capital outlays, and heightened exposure to fluctuations in lithium, nickel, cobalt and other raw‑material prices—making the company’s energy‑storage growth increasingly dependent on both the successful scaling of in‑house cell production and secure, long‑term raw‑material supply contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and the question asked. Critical issues: (1) WRONG FOCUS: The LLM discusses Tesla's battery cell production strategy (Panasonic/CATL suppliers, gigafactories in Texas/Germany/Mexico, raw material dependencies), but the question specifically asks about ENERGY STORAGE PRODUCTS (like Megapack) and their evolution. These are different product categories - energy storage systems vs. battery cell manufacturing. (2) MISSING CORE CONTENT: The ground truth emphasizes Tesla's modular design, in-house power electronics and software expertise for energy storage products in 2023, and a shift to addressing production ramps and supply chain dependencies in 2024. The LLM completely omits these key points. (3) INCORRECT ENTITIES: The LLM mentions Panasonic and CATL as suppliers for energy storage products, but these are battery cell suppliers primarily relevant to vehicle production, not energy storage system manufacturing. (4) MISALIGNED STRATEGIC FOCUS: The ground truth discusses manufacturing optimization and supplier reliability for energy storage specifically, while the LLM discusses cell production scaling and raw material price fluctuations - a different strategic narrative. (5) INCOMPLETE MULTI-HOP SYNTHESIS: The question requires synthesizing how Tesla's approach to energy storage evolved across 2023-2024 with specific attention to production challenges and strategic dependencies. The LLM fails to properly synthesize the actual evolution described in the ground truth. The answer demonstrates a fundamental misunderstanding of what 'energy storage products' means in Tesla's context versus battery cell manufacturing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 463,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "\nFrom 2023 to 2024 NEE Capital shifted its floating‑rate program from a single, relatively small tranche—about $400 million of variable‑rate debentures that were set to mature in 2024 (shown in the 2023 debt table on page 103)—to a series of larger, longer‑dated floating‑rate issuances.  In 2024 the company issued new floating‑rate debentures such as the $400 million floating‑rate debentures due February 4 2028 (Exhibit 4(xx) on page 122) and the $400 million‑plus Series R junior subordinated debentures due June 15 2054 (Exhibit 4(rr) on page 123), expanding the absolute floating‑rate principal by several hundred million dollars and extending the weighted‑average maturity out to the mid‑2050s.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) PRINCIPAL AMOUNT ERROR: The LLM claims the 2023 position was '$400 million of variable-rate debentures...set to mature in 2024' but the ground truth explicitly states NextEra Energy Capital Holdings issued $600 million in floating rate debentures due in 2026 in 2023. The LLM's $400 million figure and 2024 maturity date are incorrect. (2) 2024 ISSUANCES: The LLM references specific 2024 issuances ($400 million due February 4, 2028 and $400 million+ Series R due June 15, 2054) that are not mentioned in the ground truth answer. The ground truth indicates the 2024 Officer's Certificate formalized the existing $600 million 2026 debentures without explicit principal updates. (3) MATURITY STRUCTURE MISCHARACTERIZATION: The LLM claims the weighted-average maturity extended to 'mid-2050s' based on alleged Series R debentures, but the ground truth states the maturity structure remained consistent with the 2026 horizon. (4) STRATEGIC NARRATIVE ERROR: The LLM portrays a major expansion and restructuring ('expanding the absolute floating-rate principal by several hundred million dollars'), while the ground truth explicitly states this 'reflects a continuation of the prior year's approach without significant expansion or restructuring.' (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize information from the actual filings, instead presenting a narrative that contradicts the documented facts. The answer appears to confuse or misattribute data from different entities or time periods. The only potential alignment is the mention of 2026 maturity, but this is overshadowed by the numerous factual inaccuracies regarding principal amounts, additional issuances, and strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 490,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "\nFrom 2023 to 2024 Intel moved beyond its internal audit‑and‑engagement model for direct suppliers and modest diversity‑spending goals, toward a far more collaborative, ecosystem‑wide approach.  The 2024 disclosures show expanded industry partnerships (e.g., the SCIP agreement with Apollo, CHIPS‑Act government incentives, and the Alliance for Global Inclusion’s global inclusion index) and a broader scope of supplier engagement that now includes upstream Scope‑3 emissions, water stewardship, circular‑economy targets, and formal performance‑linked incentives for both Intel and its suppliers.  This evolution reflects a shift from isolated compliance programs to integrated, multi‑stakeholder initiatives that tie supplier sustainability and diversity outcomes to corporate incentives and industry standards.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces specific claims NOT in the ground truth: mentions of 'SCIP agreement with Apollo,' 'CHIPS-Act government incentives,' and 'Alliance for Global Inclusion's global inclusion index' are not referenced in the original answer and appear to be fabricated or misattributed details. These are presented as 2024 disclosures but cannot be verified against the ground truth. (2) INCOMPLETE ALIGNMENT WITH GROUND TRUTH - The original answer specifically mentions: (a) 2023's RISE strategy expansion with goal to increase suppliers covered, (b) 2050 net-zero upstream Scope 3 emissions goal, (c) 2024's shift to 'responsible minerals sourcing and transparency' without explicit mention of expanding supplier numbers. The LLM answer omits the RISE strategy by name, doesn't mention the 2050 net-zero goal, and doesn't capture the key distinction that 2024 moved away from 'announcing strategic expansions' to 'reinforcing existing partnerships.' (3) MISCHARACTERIZATION - The LLM describes the evolution as moving from 'internal audit-and-engagement model' and 'modest diversity-spending goals' - these characterizations are not in the ground truth and may misrepresent Intel's actual 2023 position. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize evolution across years, it does so by introducing unverified details rather than accurately synthesizing the provided ground truth. The core insight from ground truth (shift from expansion announcements to deepening existing partnerships) is not clearly captured. (5) QUANTITATIVE ACCURACY - No specific numbers, dates, or metrics from the ground truth are verified or correctly cited. The answer lacks the precision needed for financial/compliance disclosures. The answer reads more like speculation about Intel's strategy than a synthesis of actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 510,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "\nIn the 2022 filing the standardized‑measure note merely stated that the calculation “applies first‑day‑of‑the‑month average prices” as a prescribed accounting assumption, without drawing attention to the price‑sensitivity of the result. By the 2023 filing the same description was expanded to emphasize that the measure is “highly sensitive to first‑day‑of‑the‑month average prices, which represent discrete points in time and therefore may cause significant variability in cash flows from year to year,” and that the metric “does not provide a reliable estimate of the Corporation’s expected future cash flows.” Thus, the 2023 disclosure explicitly frames the company’s results as dependent on, and vulnerable to, fluctuations in those first‑day‑of‑the‑month average prices.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) MAJOR ERROR - The LLM claims the 2023 filing states the measure 'does not provide a reliable estimate of the Corporation's expected future cash flows' - this specific language does NOT appear in the ground truth and represents a material mischaracterization. (2) MAJOR ERROR - The LLM describes the 2023 language as 'highly sensitive to first-day-of-the-month average prices' - the ground truth uses 'depends on' and 'may cause significant variability,' not 'highly sensitive.' This is a substantive difference in how the dependency is framed. (3) CORRECT ELEMENTS - The LLM correctly identifies that 2022 used 'prescribed accounting assumption' language without emphasizing sensitivity, and that 2023 shifted to emphasize dependency and variability. The LLM also correctly notes the discrete points in time concept. (4) MISSING CONTEXT - The ground truth explicitly states 'the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates' - the LLM omits this important detail showing the methodology itself didn't change, only the disclosure framing. (5) REASONING QUALITY - While the LLM captures the general evolution from neutral to cautionary tone, it overstates the 2023 language by introducing phrases not supported by the ground truth. The multi-hop synthesis is partially sound but undermined by factual inaccuracies. The answer demonstrates understanding of the directional shift but fails on precise characterization of the actual language used in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 453,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard broadened the reach of its digital‑identity platform by embedding it in its open‑banking API network, which in 2023 connected to more than 95 % of U.S. deposit accounts and to roughly 3,000 banks across Europe (directly and via partners).  This expansion enabled the company to launch a 2023 ACH bill‑payment solution that uses the same consent‑centric, device‑intelligence and biometric identity capabilities to provide seamless, secure payments across those financial institutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022-2023. STRENGTHS: (1) All quantitative data is correct - 95% of U.S. deposit accounts and 3,000 banks across Europe are accurately cited; (2) Timeline is properly structured showing 2022 introduction and 2023 expansion; (3) Key capabilities are correctly identified: consent-centric, device-intelligence, and biometric identity features; (4) ACH payment solution launch in 2023 is accurately mentioned; (5) Multi-hop synthesis is sound - correctly connects digital identity evolution to open banking expansion to financial institution reach. MINOR GAPS: (1) The original answer explicitly mentions 2022 as the introduction year with specific focus on 'data providers and third parties accessing consumer data on a permissioned basis' and 'consumer protection and consent management principles' - the LLM answer doesn't explicitly reference the 2022 baseline or these foundational principles; (2) The original answer notes partnerships with 'leading financial institutions' for the ACH solution, while the LLM answer is less explicit about partnership aspects; (3) The original answer emphasizes 'identity verification across people, devices, and transactions' as a 2022 focus, which the LLM answer doesn't explicitly address. CALCULATION/NUMBER VERIFICATION: All percentages and counts are accurate (95%, 3,000 banks). The answer correctly frames the evolution as an expansion from 2022 to 2023. The semantic equivalence is strong - 'embedding in open-banking API network' effectively conveys the integration concept. The answer appropriately addresses all parts of the multi-part question regarding evolution, integration with open banking, and reach across institutions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 485,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "\nBetween 2023 and 2024 Tesla moved Solar Roof from a pilot‑scale offering toward a broader rollout, but the product still depends on a tightly controlled supply of its proprietary solar‑tile modules and integrated battery‑cell components.  To meet growing demand the company is expanding production at new sites such as Texas (and the planned Mexico Gigafactory) and is investing in in‑house battery‑cell manufacturing, yet it continues to confront bottlenecks in tile fabrication, raw‑material price volatility and the need to synchronize Solar Roof output with its overall energy‑storage and battery‑cell ramp‑up.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to address the core elements of the ground truth answer. Specific issues: (1) FACTUAL ERRORS: The LLM introduces claims not supported by the ground truth, including references to 'proprietary solar-tile modules and integrated battery-cell components,' 'Texas' production expansion, 'planned Mexico Gigafactory,' and 'in-house battery-cell manufacturing' for Solar Roof specifically. The ground truth makes no mention of these specific production locations or manufacturing strategies for Solar Roof. (2) MISSING KEY INFORMATION: The LLM completely omits the ground truth's central finding that Tesla acknowledged production delays for Solar Roof in 2024, similar to other products. It also fails to capture the critical strategic insight about Tesla's prioritization shift toward mass-market vehicle production, which the ground truth identifies as a key factor affecting Solar Roof's development timeline. (3) MISCHARACTERIZATION OF 2023 POSITIONING: The ground truth emphasizes Tesla's 2023 focus on engineering maturity, aesthetic appeal, durability, and Powerwall integration. The LLM instead describes a 'pilot-scale offering' moving toward 'broader rollout,' which contradicts the ground truth's characterization of 2023 positioning. (4) UNSUPPORTED SUPPLY CHAIN DETAILS: The LLM's discussion of 'tightly controlled supply,' 'tile fabrication bottlenecks,' and 'raw-material price volatility' are not mentioned in the ground truth and appear to be fabricated details. (5) MULTI-HOP REASONING FAILURE: The LLM fails to synthesize the key multi-hop insight: that Tesla's strategic prioritization of mass-market vehicle production (mentioned in 2024 filings) indirectly signals a potential deprioritization of Solar Roof development. The answer demonstrates poor understanding of the actual evolution described in the ground truth and introduces numerous unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 525,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "\nBetween 2023 and 2024 NextEra Energy added two new pledge‑agreement filings—one executed on **June 1 2024** and another on **October 1 2024**—that replace the earlier 2022 pledge (dated September 1 2022). In each 2024 agreement **NextEra Energy, Inc.** is the pledgor, **Deutsche Bank Trust Company Americas** serves as collateral agent, custodial agent and securities intermediary, and **The Bank of New York Mellon** acts as the purchase‑contract agent; the June 2024 pledge backs the Series N junior subordinated debentures, while the October 2024 pledge secures the Series O debentures. Thus, the company’s use of pledge agreements has evolved from a single 2022 structure to multiple, contemporaneous pledges in 2024 with the same counterparties but tied to newer series of debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more detailed context than the ground truth. All key facts are correct: (1) Dates are accurate - September 1, 2022 agreement in 2023 disclosures, June 1, 2024 and October 1, 2024 agreements in 2024; (2) Counterparties correctly identified - Deutsche Bank Trust Company Americas and The Bank of New York Mellon; (3) The evolution narrative is sound - from single 2022 structure to multiple 2024 pledges with same counterparties. The LLM answer goes beyond the ground truth by providing additional relevant details: specific roles of counterparties (collateral agent, custodial agent, securities intermediary for Deutsche Bank; purchase-contract agent for BNY Mellon) and the debt series secured (Series N junior subordinated debentures for June 2024; Series O debentures for October 2024). These additions enhance understanding without contradicting the ground truth. The multi-hop reasoning is sound - correctly synthesizing information about dates, entities, and the evolution of pledge agreement usage. Minor note: The LLM uses 'replace' language ('replace the earlier 2022 pledge') which could be interpreted as the 2024 agreements superseding the 2022 agreement, whereas the ground truth suggests they coexist as an expansion. However, this is a reasonable interpretation of the evolution described and doesn't constitute a factual error. All numeric values and dates are precisely correct with proper formatting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 408,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "\nIn 2024 Intel shifted from a hardware‑only AI‑accelerator focus in 2023 to a full‑stack edge‑AI strategy, launching the Gaudi 3 AI accelerator, the programmable Jaguar Shores GPU and the 4th‑Gen Xeon D processors while expanding its OpenVINO‑based, edge‑native software platform with modular building blocks for AI workloads.  At the same time it broadened its ecosystem, collaborating with more than 500 network builders and key partners such as Ericsson, Nokia, Cisco, Dell, HPE, Lenovo, Amazon, Google and Microsoft to deliver end‑to‑end AI‑enabled compute and connectivity solutions for the intelligent edge.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION: The LLM claims Intel shifted from 'hardware-only AI-accelerator focus in 2023' to a 'full-stack edge-AI strategy' in 2024, but the ground truth shows Intel already had a comprehensive edge-native software platform with modular building blocks in 2023. This is a fundamental mischaracterization of the 2023 positioning. (2) UNVERIFIED PRODUCT CLAIMS: The LLM mentions specific products (Gaudi 3, Jaguar Shores GPU, 4th-Gen Xeon D) that are not mentioned in the ground truth. While these may be real products, they cannot be verified against the provided knowledge graph and appear to be hallucinated details. (3) MISSING KEY FRAMEWORK: The ground truth emphasizes Intel's NEX initiative as the central strategic evolution for 2024, focusing on transforming networks from fixed-function to general-purpose compute with cloud-native software. The LLM completely omits this critical strategic framework. (4) INCOMPLETE ECOSYSTEM CONTEXT: While the LLM mentions partner names (Ericsson, Nokia, Cisco, Dell, HPE, Lenovo, Amazon, Google, Microsoft), the ground truth emphasizes 'broader ecosystem partnerships' without specifying these exact names. The LLM's specific partner list cannot be verified against the ground truth. (5) MISSING STRATEGIC NUANCES: The ground truth highlights important strategic elements like avoiding vendor lock-in, horizontal approach to scaling, cloud-native programmability, and focus on automation and secure data integrity at the edge. The LLM omits these contextual details. (6) QUANTITATIVE ISSUES: The LLM provides no verifiable numbers or metrics from the ground truth (no specific platform capabilities, no market data, no performance metrics). The ground truth also lacks specific numbers, but the LLM's introduction of unverified product names and specifications creates false precision. The answer partially addresses the question's structure (2023 vs 2024 comparison, software platforms, ecosystem partnerships) but fundamentally misrepresents Intel's 2023 positioning and introduces unverifiable product details while omitting the critical NEX initiative framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 602,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "\nBetween 31 December 2023 and 31 December 2024 the $1.25 billion aggregate principal of CVS’s 1.75 % senior notes maturing in August 2030 was unchanged, but its share of the company’s long‑term debt fell as total long‑term borrowings rose from about $58.6 billion (net of discounts) to roughly $60.5 billion.  Consequently, while the note’s face value and its net carrying amount after discounts remained essentially $1.25 billion, the 2030 series became a smaller component of the overall senior‑note portfolio, which was reshaped by the 2024 issuances of new 5.4 %–6.05 % senior notes and the repurchase/early redemption of earlier convertible and other notes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 1.75% senior notes due August 2030 with a principal value of $1.25 billion ($1,250 million) and accurately states this value remained unchanged between 2023 and 2024. The answer appropriately addresses the multi-hop nature of the question by synthesizing information about how the debt composition evolved in the broader context of CVS's total long-term debt. The contextual analysis about the note becoming a smaller component of the overall portfolio due to new issuances is relevant and well-reasoned.\n\nWEAKNESSES: (1) CRITICAL QUANTITATIVE ERROR: The LLM states total long-term borrowings rose from 'about $58.6 billion' to 'roughly $60.5 billion' - these figures cannot be verified against the ground truth and appear to be unsupported claims not present in the original answer. (2) INCOMPLETE ADDRESSING OF GROUND TRUTH: The original answer explicitly mentions the 3.75% senior notes due April 2030 at $1,500 million (unchanged 2023-2024), which the LLM completely omits. The question specifically asks about 'senior notes due in 2030' (plural), and the ground truth addresses multiple 2030 notes. (3) UNVERIFIED CLAIMS: The LLM introduces specific percentages (5.4%-6.05%) and details about 2024 issuances and redemptions that are not present in the ground truth provided, making it impossible to verify their accuracy. (4) SEMANTIC DRIFT: While the LLM's discussion of the note becoming a 'smaller component' is logical reasoning, it goes beyond what the ground truth states about 'stability in some areas of long-term debt.'\n\nMULTI-HOP REASONING: The LLM demonstrates sound reasoning in connecting the unchanged principal amount to the changing portfolio composition, but this reasoning is based on unverified total debt figures. The synthesis is logical but not fully grounded in the provided ground truth.\n\nNUMBER VERIFICATION: $1.25 billion = $1,250 million (correct format equivalence). However, the $58.6B and $60.5B figures lack verification. The omission of the 3.75% notes represents incomplete coverage of the 2030 debt composition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 564,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix moved the ad‑supported tier from a pilot offering to a core element of its pricing mix, explicitly positioning a new, lower‑priced ad‑supported subscription plan as a way to attract price‑sensitive households and broaden overall membership growth.  In its 2024 filing the company repeatedly cites the ad‑supported plan as a key lever for driving subscriber additions and meeting its operating‑margin target, underscoring its strategic role in the firm’s pricing strategy and membership‑growth objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of Netflix's ad-supported plan from 2023 to 2024, correctly identifying it as moving from a new/pilot offering to a core strategic component. The characterization of the plan's purpose (attracting price-sensitive households, broadening membership growth) matches the ground truth. The mention of it being a 'lower-priced option' and its role in the company's pricing strategy is accurate. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, so this dimension is not applicable. The temporal references (2023 and 2024) are correct. Score of 10 reflects accurate handling of available quantitative elements. (3) QUALITATIVE ACCURACY: The LLM answer demonstrates sound multi-hop reasoning by synthesizing information about the plan's evolution across two years and connecting it to both pricing strategy and membership growth objectives. The language 'moved from pilot offering to core element' effectively captures the transition described in the ground truth as 'shift from experimental pricing to a strategic offering.' The addition of specific details about the 2024 filing citing the plan as 'key lever for driving subscriber additions' and 'meeting operating-margin target' adds valuable context that reinforces the ground truth's assertion of integration into long-term growth framework. (4) ENTITY ACCURACY: Netflix is correctly identified; years 2023 and 2024 are correct; the financial metrics (pricing strategy, membership growth, operating margin) are appropriately referenced. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with slightly more specific detail about the strategic role (operating margin target), which enhances rather than contradicts the original answer. Minor deduction from perfect score (9 vs 10) only because the LLM answer could have been slightly more explicit about the 'addressing competitive pressures' aspect mentioned in ground truth, though this is implied in 'attract price-sensitive households.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 594,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "\nBetween 2023 and 2024 Tesla moved the Semi from an early‑stage, limited‑run commercial truck to a formally pilot‑production model (now being assembled at the Nevada Gigafactory) and tied its future scaling to the company’s broader product‑and‑manufacturing roadmap.  The 2024 filing emphasizes that the Semi’s growth will depend on ramping Gigafactory capacity, in‑house battery‑cell production, cost‑reduction initiatives and integration with Tesla’s autonomous‑driving/FSD platform—positioning the truck as a cornerstone of the company’s commercial‑EV strategy rather than a niche side project.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and goes beyond the ground truth in several ways. CORRECT ELEMENTS: (1) Accurately identifies the progression from 'early production and deliveries' in 2023 to 'pilot production' in 2024 - this matches the ground truth exactly. (2) Correctly identifies Nevada facility/Gigafactory as the production location. (3) Properly characterizes the evolution as moving from limited-run/early-stage to more structured/mature phase. (4) Accurately reflects the strategic positioning shift. ENHANCEMENTS BEYOND GROUND TRUTH: The LLM answer provides additional context about strategic dependencies (Gigafactory capacity, battery-cell production, cost-reduction, FSD integration) and positions the Semi within Tesla's broader commercial-EV strategy. While the ground truth is more concise, the LLM answer's additional details appear consistent with typical Tesla strategic messaging and don't contradict the ground truth. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing ('early-stage, limited-run commercial truck' vs 'early production and deliveries') but conveys the same meaning. (2) The ground truth explicitly states 'not yet full-scale commercial production' while the LLM implies this through 'pilot production' - semantically equivalent. (3) No quantitative errors detected - all dates (2023, 2024) and facility references are correct. MULTI-HOP REASONING: The answer successfully synthesizes the production status evolution across two years and connects it to strategic positioning, which is exactly what the question asks. The reasoning is sound and logical. The only minor limitation is that the LLM adds strategic context not explicitly mentioned in the ground truth, though this appears to be reasonable inference rather than factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 491,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "\nThe 2024 SEC filings add new Executive Retention Employment Agreements—most notably for Nicole J. Daggs (effective Jan 1 2024) and Brian Bolster (effective May 6 2024), extending a pattern that began with 2023 contracts for Mark Lemasney and Armando Pimentel. This expansion signals NextEra’s deliberate effort to lock in senior leadership as it scales, underscoring a strategic focus on continuity and the retention of top‑tier executive talent to drive its long‑term growth agenda.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant factual discrepancies. CORRECT ELEMENTS: (1) The answer correctly identifies the expansion pattern from 2023 to 2024, (2) Correctly names Brian Bolster with date May 6, 2024, (3) Correctly identifies Mark Lemasney and Armando Pimentel as 2023 signatories, (4) The qualitative reasoning about strategic focus on continuity and talent retention is sound and aligns with ground truth interpretation. CRITICAL ERRORS: (1) The LLM introduces Nicole J. Daggs (effective Jan 1 2024) as a new 2024 agreement holder, but the ground truth makes no mention of Nicole J. Daggs in the Executive Retention Employment Agreements context. This is a factual error that adds an entity not supported by the knowledge graph. (2) The LLM omits specific dates for the 2023 agreements (January 1, 2023 for Lemasney and February 15, 2023 for Pimentel), though it does reference them as '2023 contracts.' QUANTITATIVE ACCURACY ISSUES: The introduction of Nicole J. Daggs without ground truth support represents a significant factual error in entity identification. The dates provided for Brian Bolster (May 6, 2024) are correct. MULTI-HOP REASONING: The synthesis across 2023-2024 timeline is logically sound, and the conclusion about strategic emphasis on continuity is well-reasoned and matches the ground truth interpretation. However, the addition of an unsupported executive weakens the overall accuracy. SEMANTIC EQUIVALENCE: The qualitative assessment ('lock in senior leadership,' 'strategic focus on continuity,' 'retention of top-tier executive talent') is semantically equivalent to the ground truth's characterization of 'increasing strategic importance on securing leadership continuity' and 'proactive approach to talent management.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 485,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "\nFrom 2023 to 2024 Intel moved from simply building and stabilizing its xPU portfolio (client‑ and data‑center GPUs, IPUs, FPGAs, etc.) and coping with process‑technology delays, to a deliberate, ecosystem‑focused strategy.  In 2024 the company created an advisory group to broaden the x86 ecosystem, emphasized open‑platform standards, and positioned its xPU family as the core of an AI‑centric “compute‑everywhere” roadmap, while using external foundry capacity and Smart‑Capital financing to accelerate product rollout and scale manufacturing.  This reflects a shift from defensive product development to an aggressive, open‑ecosystem push to democratize compute and capture growth in AI, edge and networking.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key factual elements from the ground truth: (1) the creation of an advisory group to expand the x86 ecosystem in 2024, (2) the xPU family composition (client/data-center GPUs, IPUs, FPGAs), (3) the shift from general R&D focus to more strategic product development, and (4) the evolution from defensive to more aggressive positioning. The answer demonstrates sound multi-hop reasoning by synthesizing the 2023-to-2024 evolution and connecting strategic initiatives to business outcomes.\n\nWEAKNESSES: (1) The LLM introduces information not present in the ground truth, including references to 'external foundry capacity,' 'Smart-Capital financing,' 'open-platform standards,' and 'compute-everywhere' roadmap. While these may be factually accurate from other sources, they are not part of the ground truth answer and represent unsupported elaboration. (2) The LLM omits the specific R&D spending figure ($16.0 billion in 2023) mentioned in the ground truth, which is a quantifiable metric that should have been included. (3) The characterization of the 2023 approach as 'defensive product development' is not explicitly stated in the ground truth, which describes it more neutrally as facing 'challenges in timely product development.' (4) The phrase 'democratize compute' and 'capture growth in AI, edge and networking' represent interpretive language not grounded in the provided ground truth.\n\nMULTI-HOP REASONING: The answer correctly synthesizes the temporal evolution (2023→2024) and identifies the strategic shift, but adds interpretive layers beyond what the ground truth supports. The core multi-hop synthesis is sound, but the answer conflates confirmed facts with inferred strategic intentions.\n\nQUANTITATIVE ACCURACY: No calculation errors, but the omission of the $16.0 billion R&D figure represents incomplete quantitative coverage. The dates (2023, 2024) are correct.\n\nSEMANTIC EQUIVALENCE: While the answer conveys similar directional information about the evolution, it introduces substantial new claims not in the ground truth, which violates the principle of sticking to verified information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 580,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix shifted from merely acknowledging that its advertising business was “new” and “subject to numerous risks” — highlighting the lack of operating history and the need to attract advertisers — to explicitly stating that it is building a dedicated advertising‑sales and ad‑technology organization and investing in the underlying ad‑serving, measurement and analytics infrastructure needed to support that effort. The 2024 filing emphasizes expanding the ad‑sales team, developing proprietary ad‑technology and partner ecosystems, and creating scalable infrastructure to drive advertiser value and sustain growth in the ad‑supported subscription tier.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL ACCURACY: The answer correctly identifies the key evolution from 2023 to 2024 - from acknowledging limited experience and external dependencies to building internal capabilities. The characterization of 2023 as emphasizing 'new' status, 'numerous risks,' and lack of operating history matches the ground truth. The 2024 shift toward 'dedicated advertising-sales and ad-technology organization' and 'proprietary ad-technology' development is accurately captured. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this qualitative question about organizational evolution. The answer appropriately avoids false precision. (3) ENTITY ACCURACY: Netflix is correctly identified, and the time period (2023-2024) is accurate. The metrics discussed (advertising organization development, infrastructure investment, ad-tech capabilities) are all correctly identified. (4) MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two years, correctly identifying the strategic shift from external reliance to internal development. The logic is sound - moving from acknowledging risks and dependencies to proactively building capabilities. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing than the ground truth but conveys the same core information. For example, 'developing the necessary advertising technology infrastructure' (ground truth) is semantically equivalent to 'developing proprietary ad-technology and partner ecosystems, and creating scalable infrastructure' (LLM answer). The LLM answer actually provides slightly more detail about the 2024 approach (mentioning ad-serving, measurement, analytics, and partner ecosystems) while remaining faithful to the ground truth. Minor differences in wording (e.g., 'ad-serving' vs. 'ad management') are stylistic variations that don't affect accuracy. The answer comprehensively addresses both organizational development and infrastructure investment aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 567,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "\nTesla continues to treat free Supercharging as a separate performance obligation and to recognize the related revenue on a straight‑line basis over the vehicle’s expected ownership period (i.e., not when the charge is used).  The deferred‑revenue balance for these services grew from $3.536 billion at the end of 2023 to $3.599 billion at the end of 2024, and revenue recognized from the balance increased to $1.188 billion in 2024 versus $595 million in 2023—showing a modest expansion of the program but no change in the underlying recognition method.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on the core question about how Tesla's approach evolved between 2023 and 2024. Key issues: (1) CONTRADICTS GROUND TRUTH: The LLM claims 'no change in the underlying recognition method' between 2023 and 2024, directly contradicting the ground truth which explicitly states Tesla shifted from bundling free Supercharging with vehicle sales (2023) to deferring revenue and recognizing it as a liability to be amortized over time (2024). This is a fundamental misunderstanding of the evolution being asked about. (2) QUANTITATIVE ISSUES: While the LLM provides specific numbers ($3.536B to $3.599B deferred revenue, $595M to $1.188B recognized revenue), these cannot be verified against the ground truth which does not provide these specific figures. The numbers may be accurate to the filings, but they don't support the LLM's claim of 'no change in underlying recognition method.' (3) INCOMPLETE ANSWER: The LLM fails to address the key structural shift described in the ground truth - the transition from immediate recognition bundled with vehicle sales to deferred revenue recognition as a liability. The question specifically asks about evolution 'particularly in terms of revenue recognition and program structure,' and the LLM misses the critical structural change. (4) REASONING ERROR: The LLM's logic that 'modest expansion of the program but no change in the underlying recognition method' contradicts what the ground truth indicates was a significant methodological shift in how these revenues are recognized. The growth in deferred revenue balance and recognized revenue actually reflects the new deferral approach, not continuity. (5) SEMANTIC MISMATCH: The ground truth emphasizes a 'structural shift' and 'more formalized and segmented approach,' while the LLM emphasizes continuity and consistency in method.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 515,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "\nBetween 2023 and 2024 NextEra Energy moved away from relying on the long‑dated, fixed‑rate Series O junior subordinated debentures (originally issued in 2019 with a May 1 2079 maturity) and began supplementing the capital stack with newer junior‑debt tranches that have shorter maturities and varied coupons.  In the 2024 filings the company issued Series S and Series T junior subordinated debentures at 5.90 % due August 15 2055, as well as a floating‑rate junior debenture due February 4 2028, while the original Series O remains outstanding but is no longer the vehicle for fresh issuance.  This shift signals a more flexible financing strategy that emphasizes staggered, shorter‑term maturities and higher‑coupon or floating‑rate features to better match cash‑flow needs and take advantage of evolving market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG SERIES IDENTIFICATION: The ground truth specifically discusses Series O debentures issued in 2023 (due May 1, 2079) versus 2024 (due November 1, 2029 with 5.55% coupon). The LLM answer incorrectly introduces Series S, Series T (5.90% due August 15, 2055), and a floating-rate debenture (due February 4, 2028) that are not mentioned in the ground truth. (2) INCORRECT MATURITY DATES: The LLM claims the original Series O was issued in 2019 with May 1, 2079 maturity, but the ground truth indicates the 2079 maturity was from 2023. The LLM also fails to mention the 2024 Series O with November 1, 2029 maturity and 5.55% coupon - the core comparison point. (3) COUPON RATE ERROR: The ground truth explicitly states the 2024 Series O has a 5.55% coupon, but the LLM provides different coupon rates (5.90%) for different series. (4) INCOMPLETE COMPARISON: The question asks specifically about Series O evolution between 2023-2024, but the LLM discusses entirely different series (S, T) and a floating-rate instrument, missing the direct comparison requested. (5) MULTI-HOP REASONING FAILURE: While the LLM attempts to synthesize information about financing strategy evolution, it does so based on incorrect data points. The core finding - that NextEra shifted from long-dated (2079) to shorter-dated (2029) Series O debentures with defined coupons - is completely absent from the LLM answer. The answer appears to conflate multiple issuances or draw from incorrect filing data, fundamentally misrepresenting NextEra's Series O debenture strategy between 2023-2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 455,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "\nFrom 2022 to 2023 ExxonMobil moved from a generic acknowledgement that OPEC investment and production policies affect world oil supplies to explicitly embedding those policies in the long‑term price and cash‑flow assumptions used in its impairment testing.  The 2023 disclosures stress that OPEC’s supply decisions are a core driver of the Corporation’s outlook for future oil volumes, margins and commodity prices, and therefore a critical input when evaluating whether the carrying value of upstream assets is recoverable.  Consequently, the impairment framework now treats OPEC‑related supply dynamics as a fundamental, long‑term factor—not a temporary market blip—when judging asset recoverability.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally contradicts the ground truth on the key evolution described. Ground truth states that ExxonMobil SHIFTED FROM a direct focus on OPEC to a MORE INTEGRATED view including environmental factors (GHG costs, net-zero targets). The LLM answer claims the OPPOSITE - that OPEC became MORE EXPLICIT and CORE to the framework in 2023, treating it as a 'fundamental, long-term factor.' This is a major factual error that inverts the actual direction of change. The LLM also fails to mention the critical contextual shift toward incorporating greenhouse gas emission costs and net-zero targets into the impairment assessment framework, which is central to understanding how ExxonMobil's approach evolved. The LLM's characterization of OPEC as becoming 'a critical input' and 'fundamental' contradicts the ground truth's description of OPEC discussion becoming 'embedded more broadly' within a comprehensive framework that includes environmental considerations. The dates (2022 to 2023) are correct, and the company name (ExxonMobil) is correct, but the semantic meaning and direction of the evolution are fundamentally wrong. This represents a failure in multi-hop reasoning and synthesis of the actual filing disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 353,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "\nIn the 2023 filing the ad‑supported subscription tier is mentioned only in passing—as “a range of pricing plans, including our ad‑supported subscription plan”—without any dedicated strategic discussion. By the 2024 filing the plan is framed as a core element of Netflix’s growth and margin strategy, explicitly highlighted as a key lever for diversifying pricing, attracting price‑sensitive members and driving operating‑margin targets, and is referenced more prominently in the company’s strategic narrative.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Netflix's ad-supported plan from 2023 to 2024. STRENGTHS: (1) Correctly identifies the shift from a risk-focused/uncertain positioning in 2023 to a confident, strategic positioning in 2024; (2) Accurately captures that 2023 mentions were passing/minimal while 2024 references are prominent and strategic; (3) Properly synthesizes the multi-hop comparison across two years; (4) No quantitative errors or incorrect dates/entities; (5) Semantic equivalence is strong - 'uncertainty and risk' in ground truth maps to 'mentioned only in passing' in LLM answer, and 'core part of business model' maps to 'core element of growth and margin strategy'; (6) Contextually appropriate and directly addresses the question about evolution. MINOR CONSIDERATIONS: (1) The LLM answer adds specific strategic details ('diversifying pricing, attracting price-sensitive members, driving operating-margin targets') that are not explicitly mentioned in the ground truth statement, though these are reasonable inferences about strategic emphasis; (2) The ground truth emphasizes 'lack of operating history' as a specific risk factor in 2023, which the LLM answer doesn't explicitly mention, though it captures the broader risk-focused tone; (3) The LLM answer is slightly more detailed and specific about the strategic positioning, which enhances clarity but goes slightly beyond the ground truth's scope. Overall, the answer correctly identifies and articulates the fundamental shift in Netflix's approach to the ad-supported plan across the two years, with accurate synthesis of multi-hop information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 457,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon continued to treat fast, low‑cost shipping (including Prime‑eligible offers) as a strategic marketing tool, but the economics of those offers shifted from pure network expansion and labor‑driven cost spikes to a greater emphasis on scale‑driven efficiency.  In the earlier period, fulfillment costs were driven mainly by higher volumes, rising wages, constrained labor markets and the need to add new fulfillment sites; by 2024 the company reported that the same cost pressures persisted, yet it was offsetting them with “fulfillment network efficiencies,” higher sales volumes, better supplier terms and reduced per‑unit shipping expenses, even as it kept expanding its warehouse footprint to meet growing shipment demand.  Consequently, the cost‑driver mix moved from “investment‑heavy” to “efficiency‑focused” while still using shipping offers to boost sales and customer loyalty.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong conceptual understanding of Amazon's strategic evolution in shipping and fulfillment between 2022 and 2024, correctly identifying the shift from investment-heavy expansion to efficiency-focused operations. The qualitative reasoning is sound: the answer accurately captures that 2022 emphasized network expansion and cost mitigation through volume/optimization, while 2024 shifted to emphasizing fulfillment network efficiencies as cost offsets. The multi-hop synthesis across years is well-executed and the semantic equivalence to the ground truth is strong.\n\nHowever, there are quantitative accuracy issues: (1) The LLM does not cite the specific 2021 shipping cost figure of $76.7 billion mentioned in the ground truth, which was a key quantitative anchor point in the original answer. (2) The LLM mentions 'rising wages' and 'constrained labor markets' as 2022 cost drivers, which are reasonable inferences but are not explicitly stated in the ground truth provided. (3) The LLM references 'reduced per-unit shipping expenses' in 2024, which is a reasonable inference about efficiency gains but is not explicitly confirmed in the ground truth.\n\nThe answer is semantically equivalent and captures the core strategic evolution correctly. The reasoning about the shift from 'investment-heavy' to 'efficiency-focused' aligns well with the ground truth's characterization of moving from 'customer-driven cost increase' to 'operations-centric efficiency focus.' The answer appropriately addresses both cost drivers and strategic focus as requested. The main weakness is the absence of specific quantitative data points (particularly the $76.7B figure) that would strengthen the answer's factual grounding, and some inferences that go slightly beyond what the ground truth explicitly states.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 495,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "\nBetween 2023 and 2024 Duke Energy updated the Master Retirement Trust’s asset‑allocation targets and disclosed a more detailed fair‑value hierarchy: the 2024 tables show a modest rise in equity securities ( $2.46 bn vs $2.22 bn ) and cash ( $15 m vs $7 m ), a slight reduction in “not‑categorized” assets, and a lower Level‑3 balance ( $68 m vs $76 m ), while the subsidiary‑allocation percentages (≈27‑33 % each) remained unchanged.  The 2024 disclosures also introduce new target mixes—e.g., the RCBP portfolio is now 35 % liability‑hedging/65 % return‑seeking and the DELPP portfolio 80 % liability‑hedging/20 % return‑seeking—and provide a reconciliation of beginning‑to‑ending Level‑3 balances, reflecting a more granular reporting of asset‑class allocations and valuation levels.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) SUBSIDIARY ALLOCATION PERCENTAGES: The LLM claims subsidiary allocations remained 'unchanged' at '≈27-33% each', but the ground truth explicitly states Duke Energy Progress was allocated 15% and Duke Energy Florida 18% in 2024. These are specific, different percentages that contradict the LLM's claim of unchanged 27-33% allocations. (2) SPECIFIC NUMBERS: The LLM provides specific dollar amounts ($2.46bn vs $2.22bn for equities, $15m vs $7m for cash, $68m vs $76m for Level-3) that are not mentioned in the ground truth. While these may be from the filings, they cannot be verified against the provided ground truth and appear to be fabricated or misattributed details. (3) PORTFOLIO TARGET MIXES: The LLM introduces specific portfolio targets (RCBP 35% liability-hedging/65% return-seeking, DELPP 80% liability-hedging/20% return-seeking) that are not mentioned in the ground truth. These appear to be invented details. (4) CORE EVOLUTION MISSED: The LLM fails to clearly articulate the main evolution described in the ground truth: the shift from general investment objective descriptions in 2023 to detailed subsidiary-level allocations and Level-3 fair value reconciliations in 2024. (5) VEBA TRUSTS: The ground truth mentions VEBA trusts and their target/actual allocations in 2023, which the LLM completely omits. The LLM's answer demonstrates a pattern of introducing specific numbers and percentages not supported by the ground truth while simultaneously contradicting the actual subsidiary allocation percentages that were disclosed. This suggests either hallucination or misreading of source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 474,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "\nGoogle’s payments to Network Partners continue to flow through the traffic‑acquisition‑cost (TAC) framework that the 2022 filing describes as the primary cost component for ads placed on Google Network properties and notes that these costs represent a larger share of revenue for Network placements than for Search ads. The 2024 financials (pages 40‑44) show Google Services operating income rising to $121 billion, but the segment profitability table still lists TAC within cost of revenues, confirming that the obligation to remit a substantial portion of Network ad revenue to its partners persisted and grew in absolute amount alongside the expansion of Network revenues, while the underlying cost‑structure remained unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to capture the key evolution described in the ground truth. CRITICAL ISSUES: (1) The LLM claims Google Services operating income rose to $121 billion in 2024, but this specific number cannot be verified against the ground truth and appears to be an unsupported assertion. (2) The LLM fundamentally misses the core finding from the ground truth: the shift from TAC being primarily a cost-of-revenue item in 2022 to becoming a major operating cash flow obligation by 2024. This represents a structural transformation in how the relationship is reported/managed, which the LLM completely overlooks. (3) The LLM states 'the underlying cost-structure remained unchanged,' which directly contradicts the ground truth's assertion that there was a 'transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation.' (4) The LLM provides no evidence of the shift to operating cash outflows mentioned in the ground truth, instead maintaining that TAC 'still lists TAC within cost of revenues' without acknowledging the 2024 change. (5) The LLM's claim that obligations 'persisted and grew in absolute amount' is reasonable but lacks specific supporting numbers or evidence. WHAT WAS CORRECT: The LLM correctly identifies that TAC is the mechanism for Network partner payments and that these costs represent a larger share of Network revenue than Search revenue. However, these correct elements are insufficient to overcome the fundamental failure to identify and explain the key evolution between 2022 and 2024 that the question specifically asks about. The answer reads as a static description of the TAC framework rather than an analysis of how the relationship evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 488,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "\nBetween 2022 and 2023 the company kept offsetting swap positions on its balance sheet but did not elect to present them net; gross asset‑derivative fair value fell from $425 million to $158 million and gross liability‑derivative fair value rose from $32 million to $92 million, so the “net‑if‑offset” amounts dropped from $398 million to $92 million (assets) and from $5 million to $26 million (liabilities). As a result, the income‑statement impact of the related unrealized gains and losses shrank dramatically—from a $69 million loss in 2022 to a $7 million loss in 2023—reflecting both smaller fair‑value adjustments and settlements of the offsetting swaps.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides specific numerical claims that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides precise figures ($425M, $158M, $32M, $92M, $69M loss, $7M loss) that are not present in the ground truth excerpt. The ground truth mentions specific figures like $163M net gain in 2021 and $124M net gain in 2020, but does NOT provide the 2022-2023 comparative numbers the LLM cites. The LLM's claim that 'gross asset-derivative fair value fell from $425 million to $158 million' cannot be verified and appears to be hallucinated data. (2) INCOMPLETE ALIGNMENT WITH GROUND TRUTH: The ground truth explicitly states 'The financial impact in 2023 was not quantified in the excerpt,' yet the LLM confidently provides a $7 million loss figure for 2023 with no source. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize balance sheet and income statement impacts (which is appropriate for the question), it does so using unverified numbers. The logical structure of the reasoning (connecting fair value changes to income statement impacts) is sound, but it's built on fabricated data. (4) ENTITY ACCURACY: The LLM correctly identifies this as UPS (implied) and correctly references 2022-2023 periods, but the specific financial metrics and values are not supported by the ground truth. (5) SEMANTIC MISMATCH: The ground truth emphasizes a 'shift in focus to more recent periods' and notes lack of transparency around current-year impacts, while the LLM provides detailed quantification that contradicts the ground truth's assertion that 2023 impacts were 'not quantified.' The answer demonstrates hallucination of specific financial data rather than synthesis of actual filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 486,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "\nThe 2024 filing gives the Directors’ Savings Plan a dedicated slot in the equity‑compensation table and explains its deferred‑compensation mechanics in detail—something that was only a brief footnote in the 2023 filing.  This heightened visibility shows that Duke Energy is deliberately using the plan as a core element of its director‑pay strategy, emphasizing deferred, performance‑linked benefits and greater flexibility for retaining outside directors, whereas in 2023 the plan was mentioned only in passing.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core insight that the Directors' Savings Plan received increased prominence in 2024 compared to 2023, and correctly identifies this as indicating a strategic shift toward emphasizing the plan as a core compensation component. However, there are notable issues: (1) The LLM introduces a claim about 'equity-compensation table' placement that is not supported by the ground truth, which makes no mention of such a table placement. (2) The LLM adds unsupported detail about 'performance-linked benefits,' which the ground truth does not mention—the ground truth only references 'phantom investment options' and 'deferral flexibility.' (3) The characterization of 2023 as having the plan 'only in passing' or 'brief footnote' differs slightly from the ground truth's more precise description of it being 'referenced primarily through historical amendments listed in exhibit references.' (4) The LLM correctly identifies the shift toward transparency and strategic emphasis, which aligns with the ground truth's conclusion about 'more strategic and transparent approach.' The answer demonstrates sound multi-hop reasoning by comparing 2023 and 2024 disclosures, but introduces unsupported claims that deviate from the actual filing content. The core conclusion is directionally correct but the supporting details contain inaccuracies that would not be verifiable against actual SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 392,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "\nBetween 2022 and 2024 American Express moved from a primarily “product‑refresh and cobrand‑protection” focus to a broader, experience‑driven value‑proposition strategy.  In the 2022 filing the company highlighted the need to refresh cards, protect and renegotiate premium partner relationships, and invest in technology and marketing to meet shifting consumer expectations, while warning that intense competition for merchants, surcharge‑driven pricing pressure and the rise of alternative payment mechanisms could erode discount rates.  By the 2024 filing the narrative emphasizes expanding leadership in the premium consumer space—especially with Millennial and Gen‑Z shoppers—by delivering personalized, digitally‑enabled rewards, travel‑and‑dining platforms, and AI‑enhanced services, all aimed at differentiating the brand amid growing competitive pressure on pricing, merchant acceptance and non‑traditional payment rivals.  Thus, the approach evolved from safeguarding existing partnerships to proactively shaping a differentiated, technology‑forward value proposition that aligns with changing customer behaviors.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively addresses the multi-hop question about American Express's evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the temporal shift from 2022 to 2024 with accurate characterization of each period's strategic focus; (2) Accurately captures 2022 concerns: product refresh, cobrand protection, technology investment, and competitive threats from alternative payment mechanisms and merchant pricing pressure; (3) Accurately reflects 2024 strategy: premium consumer expansion, Millennial/Gen-Z targeting, digital-enabled rewards, travel-and-dining platforms, and AI-enhanced services; (4) No quantitative errors or incorrect numbers/dates; (5) Effectively synthesizes the evolution narrative from reactive/defensive (protecting partnerships) to proactive/innovation-driven (shaping differentiated value proposition); (6) Demonstrates sound multi-hop reasoning across multiple filing years and strategic dimensions. MINOR GAPS: (1) The LLM answer does not explicitly mention specific partnerships like Tock and Rooam that were highlighted in the ground truth as key enablers of the 2024 value proposition strategy; (2) Does not explicitly reference 'global merchant coverage growth' as a strategic enabler mentioned in the ground truth; (3) The characterization of 2022 focus as 'product-refresh and cobrand-protection' is accurate but frames it slightly differently than the ground truth's emphasis on 'developing compelling value propositions in face of growing competition.' These omissions are relatively minor contextual details that don't undermine the core narrative. The answer successfully captures the essential evolution and demonstrates accurate understanding of both time periods' strategic positioning. The semantic equivalence is strong—both answers convey the same fundamental shift from defensive to offensive strategy, with appropriate emphasis on competitive pressures and customer behavior changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 537,
        "total_tokens": 2102
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "\nBetween 2022 and 2024 Exxon Mobil moved its long‑term debt profile toward a larger share of low‑coupon, longer‑dated notes.  In 2022 the company’s long‑term notes were dominated by a handful of medium‑term series (e.g., 0.142 % due 2024 and higher‑coupon issues maturing in the mid‑2030s), but by the 2024 filing the outstanding long‑term notes had been reshaped around three new fixed‑rate series – 0.524 % due 2028, 0.835 % due 2032 and 1.408 % due 2039 – which together now constitute the bulk of its long‑term debt and reflect a lower weighted‑average interest cost and a strategic extension of the maturity horizon.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM states that by 2024, the outstanding long-term notes were 'reshaped around three new fixed-rate series – 0.524% due 2028, 0.835% due 2032 and 1.408% due 2039.' However, according to the ground truth, these three notes (0.524%, 0.835%, and 1.408%) were ALREADY DISCLOSED IN 2022, not newly introduced by 2024. The ground truth explicitly states: 'In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039.' The LLM's characterization of these as 'three new fixed-rate series' by 2024 is incorrect. The actual evolution was the RETIREMENT of the 0.142% Notes due 2024 (which matured), while the other three notes persisted from 2022 to 2024. The LLM also incorrectly implies these notes were 'reshaped' or newly constituted by 2024, when in fact they were already part of the 2022 portfolio. The LLM does correctly identify the specific coupon rates and maturity dates, and correctly notes the strategic shift toward longer-dated debt, but the framing of this as a 'reshaping around three new fixed-rate series' is a significant misrepresentation of the actual evolution. The core insight about extending maturity horizons is correct, but the factual basis for that conclusion is mischaracterized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 399,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 American Express moved from a broad‑based push to expand premium consumer membership toward a sharper focus on commercial‑payment growth, positioning corporate‑card and expense‑management offerings as a distinct profit centre.  The company began differentiating these solutions with added financing, banking‑type features and B2B payment capabilities (e.g., OptBlue, debit‑card expansions and data‑analytics tools), while also deepening merchant‑engagement programs and leveraging new leadership to accelerate product innovation and partnership‑driven value for business customers.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY AND MULTI-HOP SYNTHESIS: (1) INCORRECT FRAMING: The LLM answer fundamentally mischaracterizes the evolution by claiming AmEx moved 'from a broad-based push to expand premium consumer membership toward a sharper focus on commercial-payment growth.' The ground truth makes no mention of a shift away from consumer membership focus - it specifically addresses the evolution WITHIN commercial payments strategy. This is a significant semantic error that misrepresents the company's strategic direction. (2) UNSUPPORTED CLAIMS: The LLM introduces specific product names and features (OptBlue, debit-card expansions, new leadership) that are NOT mentioned in the ground truth. While these may be factually accurate about AmEx, they are not supported by the knowledge graph answer and represent hallucination or external knowledge injection. (3) MISSING KEY GROUND TRUTH ELEMENTS: The LLM fails to capture the core evolution identified in the ground truth: (a) the shift from 'internal product development focus in 2022' to 'externally integrated ecosystem strategy by 2024,' (b) the emphasis on 'merchant acceptance' and 'fraud protection and marketing insights' as 2024 priorities, (c) the 'global network approach' mentioned for 2024. (4) PARTIAL ALIGNMENT: The LLM correctly identifies that corporate cards and expense management were emphasized in both periods, and that there was product differentiation and innovation. However, the characterization of HOW and WHY this evolved is substantially different from ground truth. (5) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided in either answer, so quantitative scoring is based on proper identification of time periods (2022 vs 2024) - both answers correctly reference these years. The lack of specific financial data in both answers prevents detailed quantitative verification. OVERALL ASSESSMENT: The LLM answer demonstrates a fundamental misunderstanding of the strategic evolution described in the ground truth, introducing unsupported details while omitting critical elements about the shift toward ecosystem integration and external partnerships.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 579,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "\nBetween 2022 and 2024 AWS moved from a major profit contributor to the dominant cash‑generating engine of Amazon: its net sales rose sharply—from roughly $90 billion in 2023 to $107.6 billion in 2024 (19 % YoY growth), expanding its share of total sales to 17 %—and that profitability helped lift operating cash flow from $84.9 billion to $115.9 billion.  To sustain this growth, Amazon dramatically increased capital spending on AWS‑focused technology infrastructure, raising cash capital expenditures from $48.1 billion in 2023 to $77.7 billion in 2024, underscoring a strategic shift to make the cloud platform the primary driver of cash flow and future innovation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) INCORRECT AWS SALES FIGURES: LLM claims AWS net sales were 'roughly $90 billion in 2023' and '$107.6 billion in 2024.' Ground truth does not provide these specific AWS revenue figures for validation, but the claim of 19% YoY growth and $107.6B in 2024 cannot be verified against the provided ground truth. The answer introduces AWS-specific revenue numbers not present in the original answer. (2) CAPITAL EXPENDITURE CLAIMS: LLM states 'cash capital expenditures from $48.1 billion in 2023 to $77.7 billion in 2024' - these specific figures are NOT mentioned in the ground truth and appear to be fabricated or from unreliable sources. The ground truth makes no mention of AWS-specific capex figures. (3) MARKET SHARE CLAIM: LLM states AWS expanded 'its share of total sales to 17%' - this specific metric is not in the ground truth. (4) MISCHARACTERIZATION OF 2022 STATUS: LLM claims AWS 'moved from a major profit contributor to the dominant cash-generating engine' but the ground truth states that in 2022 AWS was 'primarily discussed in the context of competitive pressures and risks,' not as a 'major profit contributor.' This is a factual error about the 2022 baseline. (5) CORRECT ELEMENTS: The LLM correctly identifies the $84.9B (2023) and $115.9B (2024) operating cash flow figures from the ground truth. The general narrative about AWS becoming a key financial contributor is directionally correct. (6) MULTI-HOP REASONING: While the LLM attempts to synthesize AWS evolution with cash flow and capex, it introduces unverified numbers that undermine the analysis. The reasoning structure is sound but built on questionable data points. The answer goes beyond the ground truth by adding specific AWS revenue and capex figures that cannot be confirmed, which is a critical flaw in a financial analysis context where precision is essential.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 507,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "\nBetween 2023 and 2024 the trend‑analysis procedures grew from a general check of historical balance‑of‑regulatory‑asset consistency—comparing recorded balances to an independently derived expectation and testing deferred fuel and storm‑cost recoverability—to a more targeted review that also examined management’s forward‑looking estimate of storm‑cost recoveries not yet addressed in a commission order and incorporated representation from management that those costs are probable of recovery. In 2024 the firm added procedures to evaluate external regulatory filings and to test the completeness of the recorded balances, broadening the focus of the trend analysis toward the likelihood of future recovery of newly identified storm and fuel cost items.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and does not match the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM introduces specific details about 'storm-cost recoveries,' 'deferred fuel and storm-cost recoverability,' and 'coal ash' that are not present in the ground truth. The ground truth specifically mentions 'asset retirement obligations related to coal ash' as the key addition in 2024, but the LLM conflates this with storm costs and fuel costs, which are entirely different regulatory items. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth states that in 2023, trend analyses evaluated regulatory asset balances 'in general, without specific reference to asset retirement obligations,' and by 2024 the procedures expanded to include 'specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash.' The LLM incorrectly describes the 2023 procedures as including 'deferred fuel and storm-cost recoverability' and the 2024 expansion as adding 'forward-looking estimate of storm-cost recoveries' and 'external regulatory filings.' (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the core distinction between the two years—the shift from general regulatory asset balance evaluation to specific focus on coal ash asset retirement obligations. Instead, it introduced an entirely different regulatory focus (storm and fuel costs). (4) SEMANTIC MISMATCH: While the LLM correctly identifies that procedures expanded between years, the specific content of that expansion is fundamentally wrong. The answer demonstrates a misunderstanding of what regulatory items were actually being evaluated in each year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 462,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Costco moved from a general wording that it was “increasing the penetration of our private‑label items” to a more explicit, cost‑driven focus on private‑label growth as a way to absorb rising merchandise costs and limit price increases.  In 2022 the comment appeared as one of several pricing levers; by 2023 the same language was repeated in the context of “responding to cost and pricing pressures,” signalling that expanding private‑label share had become a central tactic for sustaining low‑price perception amid inflation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Costco's strategic evolution regarding private-label penetration between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from 2022 to 2023 in how private-label strategy was positioned; (2) Accurately captures that in 2022 it was one of several pricing levers while in 2023 it became more central to cost management; (3) Properly synthesizes the multi-hop reasoning showing evolution from reactive to more strategic emphasis; (4) No quantitative errors - no specific numbers were required and none were provided incorrectly; (5) Correctly identifies the contextual shift from general merchandising language to explicit cost-driven focus. MINOR WEAKNESSES: (1) The LLM answer uses slightly more interpretive language ('signalling,' 'central tactic') compared to the ground truth's more measured 'indicates a shift' - though this is semantically equivalent and not incorrect; (2) Could have been slightly more explicit about the 'absorbing cost increases internally' and 'purchasing earlier and in larger volumes' strategies mentioned in 2022, though the answer does capture the essence of these approaches; (3) The phrase 'limit price increases' is accurate but the ground truth emphasizes 'maintaining pricing authority' which is a subtly different framing, though both convey similar strategic intent. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and identifies the strategic evolution, which is the core requirement of the question. The reasoning is sound and logically structured. ENTITY ACCURACY: Costco correctly identified, fiscal years 2022 and 2023 correctly referenced, private-label strategy correctly identified as the key metric/tactic. Overall, this is a strong answer that captures the essential evolution of strategy with appropriate nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 505,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "\nBased on the 10‑K disclosures, Pfizer’s remaining performance obligations for Paxlovid fell dramatically from roughly $5 billion of deferred revenue at the end of 2023 to only about $1 billion of contracted revenue expected to be recognized through 2025‑2028 as of December 31 2024.  This decline reflects the shift from large government stock‑purchase contracts to commercial‑market sales, with future revenue now tied to the limited set of long‑term delivery obligations that will be recognized as courses are shipped rather than from advance payments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual inaccuracy that directly contradicts the ground truth. The LLM claims Pfizer had 'roughly $5 billion of deferred revenue' for Paxlovid at the end of 2023, but the ground truth explicitly states that 'In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid.' This is a fundamental error - the LLM invented a 2023 figure that does not exist in the filings. The 2024 figure of approximately $1 billion is correct and matches the ground truth. However, the LLM's narrative about the decline from $5B to $1B is entirely fabricated, as there was no disclosed $5B figure in 2023. The LLM also adds interpretive details about 'government stock-purchase contracts' shifting to 'commercial-market sales' that are not present in the ground truth answer and cannot be verified. The reasoning about the shift in business model may be plausible, but it is not supported by the provided ground truth data. The LLM does correctly identify that the 2024 figure represents contractual obligations for future delivery, but this cannot offset the major quantitative error regarding the 2023 baseline. The answer fails on the primary metric of factual accuracy regarding the multi-hop comparison between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 360,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "\nBetween 2022 and 2024 American Express lengthened and refined the “reasonable and supportable” (R&S) horizon it uses to estimate credit‑loss reserves—moving from a largely historical, short‑term loss‑rate approach in 2022 to a forward‑looking framework that explicitly incorporates current and projected economic conditions, probability‑of‑default and exposure‑at‑default modeling, and qualitative adjustments for emerging portfolio trends.  This shift shows that the company is adopting a more data‑driven, forward‑looking risk‑management stance, placing greater emphasis on forward‑looking economic assumptions and broader risk considerations when quantifying expected credit losses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims American Express 'lengthened' the R&S Period between 2022 and 2024, but the ground truth provides no evidence of this change. The ground truth mentions reserves of $3.3 billion as of December 31, 2021, but the LLM provides no specific numbers or dates to support its claims about lengthening the horizon. (2) FACTUAL INACCURACY: The LLM describes a shift from 'largely historical, short-term loss-rate approach in 2022' to a 'forward-looking framework,' but the ground truth explicitly states that in 2022, American Express already incorporated 'current/future economic conditions' - contradicting the LLM's characterization of 2022 as short-term and historical. (3) MISSING KEY INFORMATION: The ground truth emphasizes the evolution from 'introducing the methodology (2022) to relying on it as a foundational element (2024)' - a conceptual shift about how the R&S Period was presented and integrated. The LLM misses this critical distinction and instead invents details about lengthening horizons and probability-of-default modeling that are not supported by the ground truth. (4) MULTI-HOP REASONING: The LLM fails to correctly synthesize the actual evolution described in the ground truth, which is about the maturation and standardization of an already-established methodology, not about fundamental changes to the approach itself. (5) SEMANTIC DIVERGENCE: While the LLM uses sophisticated language about 'forward-looking frameworks' and 'data-driven risk management,' these characterizations appear to be inferences not grounded in the actual filing data, representing a fundamental misunderstanding of what the ground truth conveys about the evolution of American Express's R&S Period usage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 503,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon moved away from its original 0.800 % senior unsecured note that matures in 2025 (first issued in 2020) toward higher‑priced debt.  In the 2022 filing the company added a new 4.600 % note due 2025 (Exhibit 4.8), and by the 2024 filing the only reference to the 0.800 % 2025 note remains the legacy 2020 issuance, while the firm emphasized newer term notes and larger revolving‑credit facilities (Exhibits 10.8 and 10.9).  This shift reflects a strategy of refinancing the cheap, long‑dated 0.800 % debt with higher‑coupon bonds and credit lines to take advantage of evolving market conditions and reduce reliance on the low‑rate instrument.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN MULTI-HOP SYNTHESIS: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth clearly states that the 0.800% Note due 2025 was 'originally introduced in the Officers' Certificate dated June 3, 2020' and that 'by 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments.' The LLM answer incorrectly claims that 'In the 2022 filing the company added a new 4.600% note due 2025' - this reverses the timeline. According to ground truth, the 0.800% note existed in 2022, and the 4.600% note was introduced by 2024, not 2022. QUANTITATIVE ACCURACY: The interest rates (0.800% and 4.600%) are correct, and the maturity date (2025) is correct. However, the temporal sequencing is wrong. QUALITATIVE ACCURACY: The reasoning about 'refinancing cheap, long-dated debt with higher-coupon bonds' is speculative and not supported by the ground truth, which simply notes a 'shift in Amazon's debt financing strategy' without claiming refinancing or abandonment of the 0.800% note. The ground truth indicates both notes coexist in the portfolio, not that one replaced the other. MULTI-HOP REASONING: The LLM failed to correctly synthesize the chronological evolution between 2022 and 2024. The answer misplaces when the 4.600% note was introduced (2022 vs 2024). CONTEXTUAL RELEVANCE: The answer does address the evolution of debt financing and mentions both debt instruments, but the incorrect timeline undermines the entire analysis. The citation of specific exhibits (4.8, 10.8, 10.9) cannot be verified against ground truth but appears to be fabricated detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 459,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "\nIn the 2022 filing the Twenty‑third Supplemental Indenture is explicitly listed in the exhibit index (e.g., “Twenty‑third Supplemental Indenture, dated June 1 1978 … incorporated by reference”), showing that it was still being disclosed as an active component of Duke Energy’s indenture schedule. By the 2024 filing that specific indenture no longer appears as a current exhibit; it is only mentioned in a historical list of older indentures, indicating that the 23rd supplemental indenture has been retired and is no longer a material or ongoing disclosure item.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key dates (June 1, 1978) and filing years (2022 vs 2024), and accurately notes that the Twenty-third Supplemental Indenture was explicitly listed in the 2022 filing. The quantitative details about dates and exhibit references are accurate. WEAKNESSES: The LLM's characterization of the indenture's status differs significantly from the ground truth. The ground truth states the indenture 'was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance,' which is more cautious and accurate. The LLM claims the indenture 'has been retired and is no longer a material or ongoing disclosure item,' which is a stronger assertion not fully supported by the ground truth. The ground truth indicates absence from the 2024 filing but does not definitively state retirement or that it appears only in a 'historical list of older indentures'—this is an inference the LLM makes that goes beyond what the ground truth establishes. The LLM also misses the important detail that the 2024 filing shifts focus to more recent supplemental indentures (like the Forty-ninth Supplemental Indenture dated March 14, 2024), which provides important context for understanding the evolution. The reasoning is partially sound but overstates the conclusion about retirement status. The answer addresses the core question about evolution between filings but makes unsupported claims about the indenture's current status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 417,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 the Class C repurchase program expanded sharply in 2023 and then eased slightly in 2024 – the company bought back roughly **$52.9 billion of Class C shares in 2023**, the peak annual amount, and **about $50.2 billion in 2024**.  Overall, the repurchase program spent **$59.3 billion of Class A and C shares in 2022**, **$62.2 billion in 2023**, and **$62.0 billion in 2024**, with Class C comprising the bulk of those totals (≈$53 billion in 2023 and ≈$50 billion in 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. CORRECT ELEMENTS: (1) All aggregate numbers match ground truth exactly: $59.3B (2022), $62.2B (2023), $62.0B (2024) for combined Class A and C shares. (2) Class C specific figures are reasonable approximations: ~$52.9B (2023) and ~$50.2B (2024), presented with appropriate hedging language ('roughly', 'about', '≈'). (3) The narrative correctly captures the evolution: expansion in 2023 followed by slight easing in 2024. (4) Multi-hop synthesis is sound - the answer correctly combines aggregate totals with Class C breakdowns across three years. (5) Entity identification is correct (Alphabet, Class A and C shares, fiscal years 2022-2024). MINOR CONSIDERATIONS: The LLM provides Class C-specific estimates that aren't explicitly stated in the ground truth, but these are presented with appropriate uncertainty language and don't contradict the provided information. The ground truth focuses on combined Class A/C totals, while the LLM adds a layer of Class C-specific detail that enhances the answer without introducing factual errors. The reasoning is clear and the presentation effectively addresses both the overall repurchase activity and the Class C component specifically. All calculations and comparisons are logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 370,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "\nIn the 2022 filing the Salary/Bonus Deferral Plan appears as a stand‑alone exhibit (Exhibit 10.1) and is accompanied by a separate amendment reference (Exhibit 10.17), with the plan described as a distinct “Salary/Bonus Deferral Plan” dating back to 1988. In the 2024 filing the same plan is no longer listed as a primary exhibit; it is relegated to a later exhibit number (Exhibit 10.13) and is only incorporated by reference to the original 1988 filing, with no new amendment or restatement disclosed. This shift reflects a move from explicit, separate disclosure of the plan to a more implicit incorporation within the broader set of exhibits.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple significant factual errors that contradict the ground truth:\n\n1. EXHIBIT NUMBER ERRORS: The LLM claims the 2022 filing shows Exhibit 10.1, but the ground truth states it was Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). This is a fundamental misidentification of the exhibit structure.\n\n2. 2024 FILING MISCHARACTERIZATION: The LLM states the plan is \"relegated to a later exhibit number (Exhibit 10.13)\" implying a demotion, but the ground truth shows Exhibit 10.13 in 2024 references the same 1988 plan - this is actually a reorganization, not a demotion. More critically, the LLM completely omits the addition of Exhibit 10.14 (1994 amendment) and Exhibit 10.16 (1997 amendments) in the 2024 filing.\n\n3. INCOMPLETE SYNTHESIS: The LLM fails to capture the key finding from the ground truth - that the 2024 filing EXPANDED disclosure to include more historical amendments (1997 amendments via Exhibit 10.16). Instead, the LLM incorrectly characterizes this as a move toward \"more implicit incorporation\" with \"no new amendment or restatement disclosed.\"\n\n4. CONTRADICTORY CONCLUSION: The LLM's conclusion that the 2024 filing shows \"a move from explicit, separate disclosure...to a more implicit incorporation\" directly contradicts the ground truth's finding that the 2024 filing \"expanded the disclosure to include a broader historical record of amendments.\"\n\n5. MISSING CRITICAL DETAILS: The LLM completely fails to mention the 1997 amendments, which is a key distinguishing feature between the two filings according to the ground truth.\n\nThe answer demonstrates poor multi-hop reasoning and fundamental misunderstanding of the exhibit structure changes between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 476,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Starbucks’ interest‑rate‑swap liability dropped sharply – it was about **$46 million in 2022** (roughly $12 million recorded in accrued liabilities and $34 million in other long‑term liabilities) and fell to **≈ $20 million by September 2024** (about $0.3 million in accrued liabilities and $19 million in other long‑term liabilities).  The classification remained the same (designated swaps in “other long‑term liabilities” and the non‑designated portion in “accrued liabilities”), but the magnitude of the liability was cut by more than half, a change also reflected in the reduced fair‑value‑hedging adjustment on the hedged long‑term debt (from a $40 million negative adjustment in 2021 to $17.8 million negative by the end of 2024).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) INCORRECT 2022 TOTAL: The LLM claims ~$46 million total in 2022 ($12M accrued + $34M long-term), but the ground truth explicitly states only $34.0 million in 'Other long-term liabilities' for 2022 with no mention of $12M in accrued liabilities. The LLM appears to have fabricated the $12M accrued component. (2) INCORRECT 2024 TOTAL: The LLM states ~$20 million by September 2024 ($0.3M accrued + $19M long-term), but the ground truth indicates $19.2 million in 'Other long-term liabilities' PLUS $41.4 million from 2023, suggesting a more complex picture than the LLM presents. The LLM's figure of ~$20M total significantly understates the actual exposure when including the prior year component. (3) MISSING CRITICAL INFORMATION: The ground truth mentions a $41.4 million liability from 2023 that appears in the 2024 reporting, which the LLM completely omits. This is a material omission for understanding the evolution of exposure. (4) UNSUPPORTED CLAIMS: The LLM introduces details about 'designated swaps' vs 'non-designated' portions and references a $40M negative adjustment in 2021 and $17.8M by 2024 that are not mentioned in the ground truth and cannot be verified. (5) CALCULATION ISSUES: The claim of 'cut by more than half' (from $46M to $20M) is based on incorrect starting and ending figures. The multi-hop reasoning about balance sheet classification changes is partially sound but undermined by the quantitative errors. The answer does address the question's components (balance sheet classification and magnitude) but with fundamentally flawed numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 462,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "\nBetween 2022 and 2024 Duke Energy’s disclosures show that the **Directors’ Savings Plan remained in force**, but the company refined how it describes the arrangement. The 2022 filing (Amendment effective Dec 16 2021) set out that outside directors could defer all or part of their retainers into an unfunded account that earns phantom‑stock credits and is only paid out when a director leaves the board. In the 2024 filing the plan is referenced again in the equity‑compensation table footnotes, explicitly linking deferred amounts to potential share issuances and labeling it a “non‑qualified deferred compensation plan,” thereby emphasizing that director pay is **deferred, performance‑linked, and settled only upon termination of service**. This evolution signals that Duke Energy uses the Directors’ Savings Plan as a governance tool to align director interests with shareholders while retaining tight control over the timing and form of director compensation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the December 16, 2021 amendment date as the formal introduction point referenced in 2022 filings. (2) Accurately describes the mechanics of the plan: unfunded accounts, phantom-stock credits, deferred retainers, and payout upon board departure. (3) Properly synthesizes the evolution from policy establishment (2022) to operational transparency (2024), matching the ground truth's characterization. (4) Correctly identifies the plan as a non-qualified deferred compensation arrangement. (5) Accurately captures the governance intent: aligning director interests with shareholders and controlling compensation timing/form. (6) All dates and factual claims are verifiable and correct. MINOR AREAS FOR ENHANCEMENT: (1) The LLM answer adds interpretive language about 'performance-linked' compensation that, while reasonable, goes slightly beyond what the ground truth explicitly states. The ground truth emphasizes 'phantom investment options' and 'Duke Energy Common Stock Fund' alignment, which is performance-linked implicitly but the LLM makes this more explicit. (2) The ground truth specifically mentions 'equity-compensation table footnotes' as the 2024 reference point, which the LLM captures but could have been more precise about the specific disclosure location. (3) The ground truth emphasizes 'unfunded accounts tied to the Duke Energy Common Stock Fund' more explicitly than the LLM, which uses the more general 'phantom-stock credits' language. MULTI-HOP REASONING: The answer successfully synthesizes information across two years (2022 and 2024) and correctly identifies the evolution pattern. The reasoning about governance strategy and shareholder alignment is sound and well-supported. QUANTITATIVE ACCURACY: No numerical errors detected; dates are correct. OVERALL ASSESSMENT: This is a high-quality answer that captures the essential evolution of the Directors' Savings Plan treatment and correctly interprets its governance implications. The minor additions of interpretive language ('performance-linked') represent reasonable inferences rather than factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 592,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "\nBetween 2022 and 2023 Costco deepened Kirkland Signature’s strategic role—moving from a high‑quality, low‑price private‑label that simply boosted margins and sales penetration (2022 10‑K, p. 6) to a brand that is now explicitly tied to the company’s ESG targets and sustainability commitments (2023 10‑K, pp. 15‑18).  This shift expands the risk profile of the brand: alongside the traditional supply‑chain and quality‑control exposures, Costco now faces heightened regulatory, compliance and reputational risks if it fails to meet the ESG expectations and disclosures that govern its private‑label products.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) The LLM claims Kirkland Signature was 'explicitly tied to the company's ESG targets and sustainability commitments' in the 2023 10-K (pp. 15-18), but the ground truth makes no mention of ESG or sustainability commitments as part of the brand's evolution. This appears to be fabricated detail. (2) The LLM introduces 'heightened regulatory, compliance and reputational risks' tied to ESG expectations, which is not mentioned in the ground truth. (3) The ground truth clearly states the 2023 filing introduced risk disclosures about supply chain disruptions, foreign exchange fluctuations, and catastrophic events—the LLM completely omits these specific risk factors. (4) The ground truth emphasizes a shift from growth/brand strength focus (2022) to a risk-focused lens (2023), but the LLM frames the evolution as deepening strategic role with ESG integration, which is a fundamentally different narrative. (5) Page citations (p. 6 for 2022, pp. 15-18 for 2023) cannot be verified against the ground truth and appear potentially inaccurate. The LLM answer demonstrates poor multi-hop synthesis—it failed to correctly identify and synthesize the actual risk profile evolution (supply chain, FX, catastrophic events) and instead substituted an unsupported ESG narrative. While the answer addresses the question's structure, the core factual content diverges significantly from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 419,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 ConocoPhillips’ proved natural‑gas reserves in the Asia‑Pacific/Middle‑East region fell from about 326 billion cubic feet (BCF) to roughly 296 BCF – a decline of roughly 30 BCF.  The only notable positive additions came from extensions and discoveries in equity‑affiliated assets (≈ 17–20 BCF per year), while downward revisions (price‑ and cost‑related) and production consumption of ~ 25 BCF annually more than offset those gains, and no material purchases were made in the region.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key metrics and numbers. Verification of quantitative elements: (1) Starting reserve figure of 326 BCF in 2022 - CORRECT; (2) Ending reserve figure of 296 BCF in 2024 - CORRECT; (3) Calculated decline of 30 BCF - CORRECT (326-296=30); (4) Extensions and discoveries contribution of 17-20 BCF per year - CONSISTENT with ground truth's 'minimal extensions and discoveries'; (5) Downward revisions and production of ~25 BCF annually - REASONABLE estimate that explains the net decline when offset against additions. The LLM successfully synthesized multi-hop information by: connecting the two time periods, identifying the net change, explaining the drivers (revisions, production, extensions/discoveries), and noting the absence of material purchases. The answer goes slightly beyond the ground truth by providing more specific mechanistic explanation (price- and cost-related revisions, annual rates of additions vs. consumption), which adds analytical depth without contradicting the source material. Minor differences from ground truth: (1) The ground truth states 'minimal extensions and discoveries' while LLM quantifies this as '17-20 BCF per year' - this is a reasonable interpretation and specification rather than an error; (2) Ground truth mentions 'no sales or significant reserve additions' while LLM states 'no material purchases' - these are semantically equivalent regarding the absence of acquisition activity. The reasoning is sound: the LLM correctly explains how extensions/discoveries were offset by revisions and production to result in the net 30 BCF decline. All entity identifications are correct (ConocoPhillips/COP, Asia-Pacific/Middle East region, natural gas reserves, 2022-2024 period). The answer is appropriately detailed and directly addresses all components of the multi-part question regarding volume evolution and sources of changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 526,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "\nBetween 2022 and 2024 FedEx moved from a fleet that **owned 114 Boeing 767‑300 Freighters (B767F)** – as shown in the 2022 10‑K fleet table (page 41) – to a much tighter acquisition pipeline in which only **14 B767Fs remain on order for delivery in 2025‑2026** (11 in 2025 and 3 in 2026) as listed in the 2024 10‑K purchase‑commitment schedule (page 117).  This reflects a strategic shift toward modernizing the express fleet: the airline is using the remaining 767F orders, together with a larger commitment to the newer Boeing 777F, to replace older, less‑fuel‑efficient aircraft while limiting further 767F purchases.  The change underscores a focus on fuel‑efficiency and long‑term operating‑cost savings rather than expanding the 767F fleet.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims 114 Boeing 767F aircraft were owned in 2022, which matches the ground truth. However, the LLM then introduces specific numbers NOT in the ground truth: '14 B767Fs remain on order for delivery in 2025-2026 (11 in 2025 and 3 in 2026)' with specific page citations (page 117 of 2024 10-K). These numbers cannot be verified against the provided ground truth, which explicitly states 'no updated ownership figures were disclosed' for 2024. The LLM appears to have fabricated specific order quantities and delivery schedules not present in the original answer. (2) MULTI-HOP REASONING - The ground truth focuses on the evolution from owned fleet (114 in 2022) to emphasis on modernization programs without disclosing updated figures. The LLM invents a narrative about 'tighter acquisition pipeline' and specific 767F orders that contradicts the ground truth's statement that 'no updated ownership figures were disclosed.' (3) ENTITY ACCURACY - While FedEx and Boeing 767F are correctly identified, the LLM incorrectly refers to FedEx as 'the airline' when FedEx is a cargo/logistics company, not an airline. (4) SEMANTIC EQUIVALENCE - The ground truth emphasizes fuel-efficiency and long-term operating savings as drivers of modernization strategy. The LLM captures this theme but undermines credibility by adding unverified specific numbers. The claim about 'larger commitment to the newer Boeing 777F' is not mentioned in the ground truth and cannot be verified. (5) FABRICATION CONCERN - The specific page numbers and order quantities appear to be hallucinated details that exceed what the ground truth provides. This is a serious accuracy issue for financial document analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 475,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "\nFrom fiscal 2022 to 2024 the recorded value of roasted‑coffee inventory grew modestly—rising from $310.3 million (as of Oct 2 2022) to a higher level reflected in the 2024 disclosures, driven by larger green‑coffee purchase commitments and a bigger overall inventory balance.  At the same time Starbucks expanded its production footprint, adding new roasting sites (e.g., a 630,000‑sq‑ft plant in Kunshan, China and upgrades to its York, PA facility) and increasing its leased warehousing and distribution capacity to support a global network of roughly 21,000 company‑operated stores.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2022 roasted coffee inventory value of $310.3 million and the October 2, 2022 date. It accurately names all four roasting facilities (York PA, Kunshan China, Kent WA, and Minden NV/Carson Valley). The answer correctly captures the evolution from inventory holding to active production and distribution. The mention of 21,000 company-operated stores and the 630,000 sq-ft Kunshan facility adds relevant context. The reasoning about green coffee commitments and warehouse expansion is logically sound.\n\nWEAKNESSES: (1) CRITICAL - The LLM states inventory 'rose from $310.3 million...to a higher level reflected in the 2024 disclosures' but provides NO SPECIFIC 2024 INVENTORY VALUE. The ground truth indicates a significant expansion in roasting infrastructure by 2024, but the LLM fails to quantify the 2024 inventory figure, making the comparison incomplete. (2) The phrase 'grew modestly' is vague and unsupported without the 2024 number. (3) While the LLM mentions facility upgrades and expansion, it doesn't clearly articulate the shift from 'primarily holding roasted coffee inventory to actively producing and distributing it at scale' as explicitly as the ground truth does.\n\nMULTI-HOP REASONING: The answer demonstrates adequate synthesis across inventory data and infrastructure expansion, but the missing 2024 inventory value undermines the completeness of the multi-hop analysis. The connection between increased green coffee commitments and inventory growth is reasonable but not verified against ground truth.\n\nQUANTITATIVE ISSUES: The 2022 figure ($310.3M) is correct, but the absence of a 2024 figure is a significant omission that prevents proper evaluation of the 'evolution' requested in the question. This is the primary quantitative failure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 491,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "\nIn the 2023 filing the 2.750 % Senior Notes due 2025 are listed in the exhibit of senior‑note forms (Item 4.34) and are included among the series of notes the Board authorized in the 2023 indenture documentation. The 2024 filing repeats the same 2.750 % Senior Notes due 2025 in the Board‑resolution section, showing that the instrument remains authorized and outstanding but has not been newly issued, retired, or otherwise modified between 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally misses the key evolution described in the ground truth. The ground truth explicitly states that by 2024, PepsiCo introduced a NEW 2.750% Senior Notes due 2030 in addition to retaining the 2025 notes - this represents a strategic extension of debt maturity. The LLM answer completely omits this crucial new instrument and instead claims the 2024 filing shows the same instrument with no modifications, which contradicts the ground truth's core finding. QUANTITATIVE ACCURACY: The percentages (2.750%) and years (2023, 2024, 2025) are correctly cited, so numeric elements are accurate. However, the LLM fails to identify the 2030 notes entirely, which is a major factual omission. QUALITATIVE ACCURACY: The reasoning is flawed. The LLM concludes that nothing evolved between 2023 and 2024 ('has not been newly issued, retired, or otherwise modified'), when the ground truth explicitly indicates strategic evolution through the introduction of the 2030 notes. The LLM's statement that the instrument 'remains authorized and outstanding but has not been newly issued' contradicts the ground truth's finding of a new 2030 instrument being introduced. MULTI-HOP REASONING: The LLM failed to synthesize the complete picture across both years' filings. It identified the 2025 notes in both years but missed the critical addition of the 2030 notes in 2024, which is the core of the 'evolution' the question asks about. CONTEXTUAL RELEVANCE: The answer addresses the 2.750% Senior Notes but misses the strategic context of debt maturity extension that defines the evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 447,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "\nFrom the 2022 filing FedEx had scheduled **eight** B777F deliveries (2 in 2023, 4 in 2024 and 2 in 2025), but by the 2024 filing the commitment had shrunk to **only two** B777Fs—both slated for delivery in 2025 and none beyond 2026.  This pull‑back signals that the B777F is being de‑emphasized in FedEx’s fleet strategy, serving only a limited, specialized long‑haul cargo role while the company shifts its modernization and fuel‑efficiency efforts toward the newer, more economical B767F and other aircraft types.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims FedEx had 'eight B777F deliveries' scheduled in 2022 (2 in 2023, 4 in 2024, 2 in 2025), but the ground truth states FedEx planned to operate 4 B777F in 2024 and 2 in 2025 - these are operational numbers, not delivery schedules. The LLM appears to have confused or fabricated delivery numbers. The LLM then states the 2024 filing showed 'only two B777Fs...both slated for delivery in 2025 and none beyond 2026' - but the ground truth indicates 2 B777F aircraft operating in 2025 with no further plans beyond that year. The reference to '2026' is not supported by the ground truth. (2) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the general trend (reduction in B777F emphasis), the specific numbers used to support this conclusion are incorrect. The comparison should be between 2022 plans (4 in 2024, 2 in 2025) and 2024 plans (2 in 2025 only), not between fabricated delivery schedules. (3) CONTEXTUAL ISSUES: The LLM adds unsupported details about 'B767F and other aircraft types' that are not mentioned in the ground truth answer, and the reference to 'fuel-efficiency efforts' is speculative. (4) CORRECT ELEMENTS: The LLM does correctly identify the overall strategic shift toward de-emphasis of the B777F and the phase-out pattern, which aligns with the ground truth's conclusion about reduced strategic emphasis. However, the numerical foundation supporting this conclusion is fundamentally flawed, making the answer unreliable despite reaching a partially correct directional conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 454,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the net gains on foreign‑currency‑other derivatives that remain in AOCI fell sharply—from $55.3 million in 2022 to $39.6 million in 2023 and $11.5 million in 2024—while the related derivative liabilities grew from $0.3 million to roughly $9 million. This decline shows that Starbucks is generating fewer unrealized hedge gains, reflecting reduced foreign‑currency exposure (e.g., a stronger U.S. dollar), and that the remaining hedge gains are being increasingly re‑classified into earnings rather than staying in OCI.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 2024 figure of $11.5 million in net gains in AOCI for foreign currency-other derivatives, matching the ground truth. The answer also correctly identifies the 2022 derivative liability of $0.3 million. The qualitative reasoning about what the shift indicates (reduced foreign currency exposure, stronger U.S. dollar, reclassification into earnings) is sound and demonstrates good understanding of derivative accounting and hedging dynamics. The answer appropriately addresses the multi-part question about evolution and implications.\n\nCRITICAL ERRORS: The LLM introduces numbers not present in the ground truth: $55.3 million (2022), $39.6 million (2023), and $9 million (2024 liabilities). The ground truth only provides: $0.3 million in 2022 liabilities and $11.5 million in 2024 AOCI gains. The LLM appears to have fabricated or confused data points. The 2023 figure of $39.6 million is not mentioned in the ground truth at all. The derivative liability figure of $9 million in 2024 is not provided in the ground truth.\n\nMULTI-HOP REASONING: While the LLM's logic about the relationship between declining AOCI gains and derivative liabilities is conceptually sound, it is built on unverified numbers. The synthesis across years (2022-2023-2024) appears to follow a logical pattern but lacks grounding in the provided ground truth.\n\nQUANTITATIVE ACCURACY: Only 2 of 5 key numbers are correct (the $0.3M and $11.5M figures). The introduction of $55.3M, $39.6M, and $9M without ground truth support is a significant factual error that undermines the answer's reliability, even though the reasoning framework is sound.\n\nCONCLUSION: The answer demonstrates good understanding of the underlying concepts and correctly identifies some key figures, but the introduction of unverified numbers substantially reduces its credibility and accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 514,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "\nBetween 2023 and 2024 the 2.625 % Senior Notes due 2026 shifted from a peripheral mention among a generic list of senior‑note forms in the 2023 filing to a more prominent, explicitly‑cited item within the Board‑Director resolutions and accompanying indenture language.  In the 2024 Form 10‑K the notes are again referenced in those resolutions, but they are now presented alongside a broader set of authorizations and are accompanied by updated Global‑Note and related‑entity disclosures, indicating a more integrated and expanded disclosure of PepsiCo’s debt instruments.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical information from the ground truth. MAJOR ISSUES: (1) The LLM describes the 2.625% Senior Notes due 2026 as shifting from 'peripheral' to 'more prominent' between 2023-2024, but the ground truth indicates they were listed in both years - no prominence shift is documented. (2) The LLM mentions 'Global-Note and related-entity disclosures' and 'updated' indenture language in 2024, but the ground truth makes no mention of these specific disclosure types or updates. (3) CRITICAL OMISSION: The ground truth explicitly states that 2024 introduced 'newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029' - the LLM completely fails to mention these new debt instruments, which is the core evidence of 'broader and more diversified' debt strategy. (4) The LLM's characterization of the evolution is vague and speculative ('more integrated and expanded disclosure') rather than concrete - it doesn't identify the specific new notes added. WHAT WAS CORRECT: The LLM correctly identifies that both years reference the 2.625% Senior Notes due 2026 in Board resolutions, and correctly notes an expansion of debt disclosures between years. However, the failure to identify and discuss the specific new senior notes (3.000% due 2027, 2.625% due 2029) represents a fundamental failure in multi-hop synthesis - the question specifically asks about evolution in 'broader debt instrument disclosures,' and the answer must identify what those broader instruments are. The quantitative accuracy score reflects that while dates and percentages are correct, the answer lacks the specific new instruments that should be quantified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 469,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "\nFrom 2022 to 2024 Cisco’s reliance on overcoming technical hurdles moved from a primary focus on perfecting complex hardware‑software products and launching new programmable‑networking, AI‑security and cloud technologies—efforts that required large, uncertain R&D investments—to a strategy that couples those advances with a shift toward software‑subscription and cloud‑based services, especially after acquisitions such as Splunk.  The company now ties its product‑development timelines to the ability to scale subscription platforms, integrate acquired technologies, and deliver AI‑driven security and “End‑to‑End Security” solutions, meaning that success depends not only on solving technical challenges but also on meeting subscription‑adoption and service‑delivery milestones, which can delay or dilute the expected benefits of its strategic investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the evolution from 2022 to 2024 and captures key themes like the shift toward software-subscription models, AI-security, and cloud technologies. (2) Mentions of Splunk acquisition and the coupling of hardware-software advances with subscription services are relevant and accurate contextual details. (3) The answer demonstrates understanding of multi-hop synthesis by connecting strategic investments to product development timelines and execution risks. (4) No quantitative errors detected (no specific numbers were provided in either answer to verify). WEAKNESSES: (1) The LLM answer diverges significantly from the ground truth's core framing. The original answer emphasizes a shift from 'internal execution risk to broader operational and strategic dependency' with specific consequences (reputational damage, legal liability, reduced customer retention). The LLM answer focuses more on subscription adoption and service-delivery milestones rather than these broader risk categories. (2) The ground truth explicitly mentions that 2024 disclosures emphasize failure consequences including 'reputational damage, legal liability, and reduced customer retention'—these critical risk dimensions are absent from the LLM answer. (3) The LLM's framing around 'subscription-adoption and service-delivery milestones' as the primary evolution differs from the ground truth's emphasis on the transformation of technical hurdles into a dependency on timely delivery of complex offerings (AI, security, observability, cloud). (4) The LLM answer introduces the Splunk acquisition as a key driver, which while contextually relevant, is not mentioned in the ground truth and may represent an inference rather than direct synthesis from the filings. (5) The ground truth's specific mention of 'observability' as a key technology area is omitted from the LLM answer. MULTI-HOP REASONING: The LLM demonstrates reasonable multi-hop synthesis by connecting R&D investments → product development → subscription platforms → strategic outcomes, but the synthesis doesn't fully capture the risk escalation and broader liability dimensions emphasized in the ground truth. The answer is partially correct on the evolution narrative but incomplete on the full scope of how technical hurdles transformed into strategic dependencies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 626,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "\nIn 2022 the filing highlighted Google Ad Manager as the key platform that enabled Alphabet to “monetize the advertising inventory” on Google Network properties on a gross‑basis, emphasizing that this control “is further supported by us being primarily responsible to our customers and having a level of discretion in establishing pricing,” which the company said was driving growth in Network revenues. In 2023 the narrative reinforced that same positioning, noting that Ad Manager continued to be the primary engine for delivering ads on Network properties and that its strong performance and pricing discretion remained a central driver of the Network’s revenue expansion.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core claim of the question. MAJOR ERRORS: (1) The LLM claims that in 2023, Google Ad Manager 'continued to be the primary engine' and 'remained a central driver of the Network's revenue expansion' - this directly contradicts the ground truth which states that by 2023, Ad Manager was 'listed among several platforms...without specific attribution to revenue growth' and had shifted to 'being part of a broader suite of advertising tools' with 'a more integrated but less singularly emphasized role.' (2) The LLM fails to identify the key quantitative fact from 2022: the $8.6 billion year-over-year increase in Google Network revenues where Ad Manager was explicitly cited as a key driver alongside AdMob and AdSense. (3) The LLM's narrative suggests continuity and consistent emphasis of Ad Manager's role across both years, when the ground truth explicitly describes a SHIFT from 'standout growth contributor in 2022' to being de-emphasized in 2023. (4) The LLM appears to have fabricated specific quotes about 'monetize the advertising inventory' and 'pricing discretion' that are not verified against the actual filing language provided in the ground truth. (5) The multi-hop reasoning is flawed - the answer should have synthesized the contrast between 2022 (explicit attribution to $8.6B growth) and 2023 (no specific attribution, broader platform positioning), but instead presents a false narrative of consistency. The answer demonstrates a fundamental misunderstanding of how Ad Manager's role changed between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 442,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the total derivative liability for foreign‑currency‑other contracts grew from $0.3 million (reported on page 68 for Oct 2 2022) to $8.8 million (reported on page 72 for Sep 29 2024), an increase of roughly $8.5 million (a $1.7 million rise from 2022→2023 and a further $6.8 million jump to 2024).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that directly contradict the ground truth. (1) WRONG 2024 FIGURE: The LLM states the 2024 amount is $8.8 million, but the ground truth clearly indicates it should be $4.7 million. This is a major error - the LLM overstated the 2024 liability by $4.1 million (87% higher than actual). (2) WRONG TOTAL CHANGE: The LLM calculates the total increase as $8.5 million ($8.8M - $0.3M), but the correct increase should be $4.4 million ($4.7M - $0.3M). This is nearly double the actual change. (3) INCORRECT INTERMEDIATE YEAR BREAKDOWN: The LLM provides a breakdown showing $1.7 million increase from 2022→2023 and $6.8 million from 2023→2024, but without access to the actual 2023 figure in the ground truth, these intermediate calculations cannot be verified and appear inconsistent with the stated endpoints. (4) CORRECT ELEMENTS: The LLM correctly identified the 2022 starting figure ($0.3 million), correctly identified the metric (derivative liabilities related to foreign currency - other), and correctly identified the time period (fiscal 2022 to 2024). The reasoning structure is sound, but the fundamental numbers are wrong. (5) MULTI-HOP SYNTHESIS: While the LLM attempted to synthesize information across years and provide detailed calculations, the synthesis is built on an incorrect 2024 figure, making all downstream calculations unreliable. The answer demonstrates understanding of the question structure but fails on the most critical requirement: factual accuracy of the key financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 433,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo added the 4.600 % Senior Notes due 2045 to its long‑dated debt stack – the notes were first referenced in a 2023 8‑K filing and then re‑approved in a February 2024 board resolution (page 130) that listed the 4.600 % 2045 notes among a suite of newly authorized senior unsecured issues.  This incremental, re‑opening of a 30‑year fixed‑rate tranche shows the company’s strategy of extending the maturity of its balance‑sheet debt, locking in relatively low coupons in a higher‑rate environment, and diversifying its funding base (including offshore vehicles) to manage the debt‑maturity wall and preserve financial flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer contains significant factual errors that contradict the ground truth. (1) INCORRECT TIMELINE: The LLM claims the 4.600% Senior Notes due 2045 were 'first referenced in a 2023 8-K filing' and then 're-approved in February 2024,' suggesting these were newly added between 2023-2024. However, the ground truth clearly states these notes were 'listed among other senior notes in the Board of Directors Resolutions' in 2023 and 'remained part of the company's debt structure' in 2024 - indicating continuity, not a new issuance. (2) MISCHARACTERIZATION OF EVOLUTION: The LLM describes this as an 'incremental, re-opening of a 30-year fixed-rate tranche' and 'added...to its long-dated debt stack,' implying new issuance activity. The ground truth indicates the notes were already part of the authorized structure in 2023 and simply remained in 2024 alongside newly introduced notes. (3) INCOMPLETE SYNTHESIS: The LLM fails to mention the key contextual detail that by 2024, the 4.600% notes were referenced 'alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026.' This is central to understanding the actual evolution - the company's strategy shift was toward DIVERSIFICATION with new instruments, not re-opening of the 2045 notes. (4) SPECULATIVE ANALYSIS: The LLM adds interpretive language about 'locking in relatively low coupons in a higher-rate environment' and 'offshore vehicles' that is not supported by the ground truth and appears to be speculation. (5) CORRECT ELEMENTS: The LLM correctly identifies the 4.600% coupon and 2045 maturity date, and correctly notes a diversification strategy, though the reasoning for this diversification is misattributed. The answer demonstrates partial understanding but fundamentally misrepresents the nature of the evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 519,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 ConocoPhillips’ reported natural‑gas reserves in the Asia‑Pacific/Middle East fell modestly—from roughly **326 billion cubic feet** to **296 billion cubic feet**—while production in the region stayed flat at about **25–50 billion cubic feet per year**.  At the same time, the share of those reserves held through **equity‑affiliate partners grew** (from 5,753 million boe to 5,870 million boe), indicating that COP is shifting from direct, large‑scale development to a **strategy that leans on joint‑venture and partnership arrangements** to maintain a stable, low‑growth presence in the region.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core reserve figures (326 BCF in 2022 declining to 296 BCF in 2024), matching the ground truth exactly. However, the answer introduces significant additional claims that cannot be verified against the ground truth and appear to exceed what was provided: (1) Production figures of 25-50 BCF/year are mentioned but not present in the original answer and cannot be verified; (2) Equity-affiliate partner data (5,753 to 5,870 million boe) is introduced without ground truth support; (3) The interpretation about 'shifting from direct, large-scale development to joint-venture arrangements' is a more specific strategic conclusion than the ground truth's more cautious 'potential shift in strategic focus.' The LLM does correctly synthesize the reserve decline and acknowledges it as modest, which aligns with ground truth. The core quantitative accuracy is strong for the primary metrics (reserves), but the introduction of unverified production and equity-affiliate data, combined with a more definitive strategic interpretation than warranted by the ground truth, represents overreach. The answer is partially correct on the main question but adds unsupported details that could mislead. The reasoning about strategic implications is more specific than the ground truth supports, though directionally similar.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 375,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "\nFrom 2022 to 2023 the filings treat Google Play the same way — as a source of revenue from app and in‑app purchases and digital content sold through the store — but the context shifts. In the 2022 filing Google Play is listed simply under “Google Services” as one of the non‑advertising revenue streams, while the 2023 filing places it alongside other non‑advertising sources such as hardware sales (Fitbit, Pixel devices) and consumer subscriptions (YouTube Premium/TV, NFL Sunday Ticket). This reflects a strategic evolution: Google Play is no longer highlighted as an isolated revenue line but as a component of a broader, diversified non‑advertising portfolio that the company is expanding through hardware and subscription services.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer fundamentally contradicts the ground truth on the key evolution. Ground truth states that by 2023, Google Play's description became 'more narrowly described as primarily coming from apps and in-app purchases' (de-emphasizing digital content), while the LLM claims 'the filings treat Google Play the same way — as a source of revenue from app and in‑app purchases and digital content sold through the store.' This is the opposite of what actually occurred. The ground truth explicitly identifies a SHIFT in emphasis away from digital content toward core app-based monetization. (2) ORGANIZATIONAL CONTEXT ERROR: The LLM incorrectly states Google Play was 'listed simply under Google Services' in 2022, when the ground truth indicates it was a distinct revenue source. The LLM also mischaracterizes the 2023 grouping - the ground truth says it was grouped under 'platforms' within non-advertising revenue, not simply 'alongside' hardware and subscriptions as separate line items. (3) STRATEGIC NARRATIVE MISINTERPRETATION: The LLM's conclusion about 'no longer highlighted as isolated' contradicts the ground truth's point about a shift in the strategic narrative toward 'core app-based monetization.' The LLM frames this as diversification strategy, while the ground truth frames it as narrowing focus. (4) WHAT WAS CORRECT: The LLM correctly identifies that both years reference apps and in-app purchases, and correctly notes the broader context of non-advertising revenue diversification. The years (2022-2023) are correct. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the specific language changes between filings that constitute the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 475,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "\nFrom the 2022 filing FedEx expected to receive 11 SkyCourier 408s in 2023, 12 in 2024 and 12 in 2025 (rising to 14 by 2026).  In the 2024 filing the 2025 commitment had already been lifted to 17 aircraft (with 14 still planned for 2026), showing a clear upward revision of the delivery schedule.  This increase demonstrates that FedEx is placing growing strategic emphasis on the Cessna SkyCourier 408 as a key, fuel‑efficient asset for expanding its regional/middle‑mile package network and replacing older turboprops.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims projections INCREASED from 2022 to 2024 (11+12+12+14=49 in 2022 vs 17+14=31 in 2024), but the ground truth explicitly states the projection was REDUCED from 49 aircraft to 31 aircraft. The LLM's year-by-year breakdown (11 in 2023, 12 in 2024, 12 in 2025, 14 in 2026) cannot be verified against the ground truth which provides aggregate totals (49 total for 2023-thereafter in 2022; 31 total for 2025-2029 in 2024). The LLM's claim of an 'upward revision' to 17 aircraft in 2025 directly contradicts the stated reduction. (2) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the key strategic shift identified in the ground truth - the relationship change from 'Increases' to 'Depends_On' - which is critical to understanding FedEx's strategic reliance. Instead, the LLM drew the opposite conclusion, claiming 'growing strategic emphasis' when the data shows moderated reliance. (3) ENTITY/CONTEXT ACCURACY: While the LLM correctly identifies FedEx and the Cessna SkyCourier 408, it misinterprets the directional change entirely. The ground truth indicates a REDUCTION in projected aircraft utilization, not an increase. (4) SEMANTIC CONTRADICTION: The LLM's conclusion that FedEx is placing 'growing strategic emphasis' is semantically opposite to the ground truth's 'moderated but still significant reliance.' This represents a fundamental misunderstanding of the data trend and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 423,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "\nBetween the 2022 and 2023 filings AIG moved from a relatively coarse, aggregate application of expected‑loss‑ratio estimates for its excess‑casualty book to a more granular segmentation. In 2023 the company explicitly splits the book into automobile‑related and non‑automobile lines, further subdivides the non‑automobile segment into latent exposures such as construction‑defect and mass‑tort claims, and analyzes standard claims by attachment‑point bands—allowing the expected‑loss‑ratio method to be applied separately to each segment and to the three most recent accident years with adjustments for rate, inflation and market changes. This added segmentation was not present in the 2022 disclosures, which treated excess‑casualty losses more holistically.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. CRITICAL ERRORS: (1) The LLM claims that in 2023 AIG 'explicitly splits the book into automobile-related and non-automobile lines' with segmentation by attachment-point bands - however, the ground truth clearly states this automobile/non-automobile differentiation and attachment-point segmentation was the 2022 approach for U.S. Excess Casualty. (2) The LLM incorrectly attributes the latent exposures (construction defects, mass torts) analysis to 2023, when the ground truth explicitly places this in 2022. (3) Most critically, the LLM completely misses the major evolution described in the ground truth: the SHIFT from U.S. Excess Casualty (2022) to U.S. Workers' Compensation (2023) as the primary line where expected loss ratio methods were applied. (4) The LLM fails to mention the 2023 segmentation by risk-sharing features (high deductibles, retrospective rating), state, industry, and claim handling entity - which are the actual 2023 innovations. (5) The LLM's characterization of 2022 as 'coarse, aggregate application' contradicts the ground truth, which describes 2022 as having detailed segmentation by attachment point and claim type. The answer demonstrates a fundamental reversal of the timeline and misattribution of methodological features to the wrong years. While the LLM correctly identifies that segmentation evolved, it incorrectly describes what that evolution was and in which direction it moved. The answer fails the multi-hop synthesis requirement by not recognizing the shift between casualty lines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 445,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Nike’s consumer‑segmentation was formalized around Men’s, Women’s, Kids’ and Jordan Brand, and any products that do not fit those groups (e.g., certain licensing lines, niche offerings and internal adjustments) are now isolated in an “Others” line item. In the 2022 filing (page 35) the “Others (4)” caption was defined as “products not allocated to Men’s, Women’s, Kids’ and Jordan Brand, as well as certain adjustments that are not allocated to products designated by consumer,” and the 2024 filing (page 38) retains the same caption but explicitly ties it to “products not allocated to Men’s, Women’s, Kids’ and Jordan Brand” and notes that they are presented separately to isolate revenue outside the core consumer construct. Thus, while the label “Others” remains unchanged, its definition and placement have been clarified to reflect the refined consumer‑construct reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate page references (page 35 for 2022, page 38 for 2024) and correctly identifies the core consumer segments (Men's, Women's, Kids', Jordan Brand). However, there are significant issues with completeness and accuracy regarding the evolution of unisex product classification. The ground truth specifically mentions that in FY2022, 'unisex products were classified within Men's,' which is a critical detail about how the classification evolved. The LLM answer completely omits this important distinction about unisex products being classified within Men's in 2022. The ground truth also notes that by 2024, there was 'no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.' The LLM answer fails to capture this evolution entirely. While the LLM correctly identifies that 'Others' includes products not allocated to the main consumer segments and notes clarifications in definitions between years, it misses the specific and substantive change regarding how unisex products were handled. The LLM's statement that the definition 'remains unchanged' contradicts the ground truth's indication of a shift in unisex product classification. The answer is partially correct in describing the 'Others' category but fundamentally incomplete in addressing the specific question about unisex product classification evolution, which was the primary focus of the original question. The LLM provides good contextual framing but fails on the core factual requirement of explaining how unisex products were reclassified or repositioned between these two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 458,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo moved from simply carrying the 3.500 % Senior Notes due 2025 as part of its legacy long‑term debt (as shown in the 2023 filing where the note is only listed among prior issuances) to formally setting its terms through a Board‑approved resolution in the 2024 filing (page 130, “Board of Directors Resolutions Authorizing … the 3.500 % Senior Notes due 2025”).  This explicit authorization in the 2024 10‑K signals that the company is proactively managing the upcoming 2025 maturity—likely preparing to refinance or extend the obligation—reflecting a debt‑management strategy that emphasizes deliberate structuring of maturities and the use of formal governance steps to lock in financing conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH LLM ANSWER: (1) FACTUAL ACCURACY: The LLM's core claim is fundamentally incorrect. The ground truth states that the 3.500% Senior Notes due 2025 were present in BOTH 2023 and 2024 filings as existing debt instruments. The LLM incorrectly claims that in 2023 the note was 'only listed among prior issuances' and that in 2024 it was 'formally set through Board-approved resolution' for the first time. This misrepresents the evolution described in the ground truth. The notes existed in both years; what changed was the ADDITION of new longer-term notes (2034, 2040) in 2024, not the authorization status of the 2025 notes. (2) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the key insight from the ground truth: PepsiCo's strategy involved EXPANDING its debt portfolio with new instruments while MAINTAINING the existing 2025 notes. The LLM instead invented a narrative about formal authorization occurring in 2024 that contradicts the ground truth's statement that the notes were 'part of the company's existing debt structure' in 2023. (3) MISSING KEY INFORMATION: The LLM completely omits the critical finding that PepsiCo introduced new longer-term notes (3.500% due 2040, 3.550% due 2034) in 2024, which is the primary evidence of the strategic shift toward diversifying debt maturity structure. (4) UNSUPPORTED CLAIMS: The reference to 'page 130, Board of Directors Resolutions' appears to be fabricated or misinterpreted, as the ground truth makes no mention of formal Board resolutions being the distinguishing factor between years. (5) QUANTITATIVE ACCURACY: The percentages (3.500%) and dates (2025) are correct, but the interpretation of what these documents show is wrong. The LLM's narrative about 'proactively managing the upcoming 2025 maturity' through new authorization in 2024 contradicts the ground truth's explanation that the strategy involved adding longer-term instruments alongside the existing 2025 notes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 528,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "\nFrom 2022 to 2024 ConocoPhillips markedly expanded its Lower 48 capital program—development outlays rose from roughly $4.6 bn to about $6.3 bn and proved‑property acquisitions jumped from $0.25 bn to $12.1 bn—while the SEC‑mandated discounted future net‑cash‑flow metric slipped from $55.9 bn in 2022 to $33.3 bn in 2023 before recovering modestly to $38.7 bn in 2024, a shift driven by lower commodity prices and reserve‑quantity revisions that offset the higher spending.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The ground truth states COP reported Lower 48 capital expenditures of $3,129 million in 2022 with no new capex figure provided in 2024. The LLM claims capex rose from $4.6 billion to $6.3 billion—these numbers are completely wrong and not supported by the ground truth. The LLM also introduces figures for 'proved-property acquisitions' ($0.25bn to $12.1bn) that are not mentioned in the ground truth at all. The discounted future net cash flow figures ($55.9bn, $33.3bn, $38.7bn) are also not present in the ground truth. (2) ENTITY/METRIC CONFUSION: The LLM appears to be discussing different metrics than what the ground truth addresses. The ground truth focuses on capital expenditures and revisions to future cash inflows/production costs. The LLM introduces 'proved-property acquisitions' and 'discounted future net-cash-flow' metrics that are not part of the ground truth answer. (3) DIRECTIONAL MISALIGNMENT: The ground truth describes a transition FROM active investment (capex) TO revised financial projections. The LLM describes an expansion of capital spending, which is the opposite narrative. (4) MISSING KEY INFORMATION: The LLM fails to mention the critical shift described in the ground truth—that 2024 disclosures focused on revising future cash inflows and production costs rather than reporting new capex figures. (5) MULTI-HOP REASONING: The LLM's synthesis appears to be based on incorrect source data or a fundamental misunderstanding of what the ground truth conveys about COP's Lower 48 disclosures. The answer reads as if discussing a different company or different time period entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 475,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "\nBetween 2023 and 2024 Comcast’s financial exposure to Atairos contracted: the company recorded only $73 million of cash capital contributions in 2024 versus $145 million in 2023, and the remaining unfunded commitment stood at $1.4 billion as of 31 December 2024.  Governance did not change materially – Atairos remains a VIE that Comcast does not consolidate because it holds no voting rights or control, only limited consent rights and a passive equity‑method interest, with the management companies (led by the former CFO) retaining all voting power and Comcast absorbing ~99 % of losses and ~86 % of residual gains.  Consequently, Comcast’s maximum risk is now limited to the $1.4 billion unfunded capital commitment and its existing investment balance, with no new liquidity guarantees or related‑party financial commitments introduced in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about Comcast's Atairos relationship but contains significant gaps and some potentially inaccurate details compared to the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the loss absorption (~99%) and residual returns (~86%) percentages\n2. Accurately notes that management companies retain voting rights\n3. Correctly characterizes Atairos as a VIE that Comcast does not consolidate\n4. Appropriately emphasizes the passive equity-method interest and lack of control\n5. Contextually relevant discussion of governance arrangements\n\nCRITICAL GAPS AND ERRORS:\n1. MISSING KEY INFORMATION: The ground truth explicitly states that by 2024, Comcast's capital commitment was REDUCED from $5 billion to $4.5 billion, with annual capital calls LIMITED to $400 million and $40 million annually for management fees. The LLM answer completely omits these specific contractual terms and the reduction from $5B to $4.5B.\n\n2. QUANTITATIVE DISCREPANCY: The LLM cites $1.4 billion as the unfunded commitment as of December 31, 2024, but provides no context for how this relates to the $4.5 billion total commitment mentioned in the ground truth. The ground truth indicates the commitment was reduced TO $4.5 billion, suggesting the unfunded portion should be approximately $4.5B minus actual contributions, not $1.4B. This requires verification but appears inconsistent.\n\n3. INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes that the relationship \"evolved into a more formalized investment framework under the equity method accounting\" with specific structural changes. The LLM answer states \"governance did not change materially,\" which contradicts the ground truth's characterization of meaningful evolution in the financial framework.\n\n4. MISSING AMENDMENT DETAILS: The ground truth mentions the Fourth Amended and Restated Shareholders Agreement and a June 2023 amendment. The LLM answer does not reference these specific governance documents or their evolution.\n\n5. MISSING MANAGEMENT FEE STRUCTURE: The ground truth specifies $40 million annually for management fees as a separate funding obligation. The LLM answer does not mention this.\n\nMULTI-HOP REASONING:\nThe LLM demonstrates adequate multi-hop reasoning by connecting governance structures to financial exposure and consolidation treatment. However, it fails to synthesize the complete evolution of the financial commitments between 2023 and 2024, which is central to the question.\n\nOVERALL ASSESSMENT:\nWhile the LLM answer correctly identifies several key facts about the governance and loss-sharing arrangements, it significantly underrepresents the evolution of financial commitments and capital obligations that are explicitly highlighted in the ground truth. The omission of the $5B-to-$4.5B reduction, the $400M annual capital call limit, and the $40M management fee structure represents a substantial gap in addressing the \"financial commitments\" portion of the question. The statement that \"governance did not change materially\" also contradicts the ground truth's characterization of meaningful evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 825,
        "total_tokens": 2283
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "\nThe 2022 filing projected 49 Cessna SkyCourier 408 deliveries through 2026 (e.g., 11 in 2023, 12 in 2024, 12 in 2025, 14 in 2026), while the 2023 filing reduces that outlook to only 31 aircraft— 17 slated for 2025 and 14 for 2026—and eliminates any 2023‑2024 deliveries. Thus the projected utilization falls by about 18 units (≈ 37 %), indicating that FedEx is scaling back the SkyCourier’s role and treating it as a supplemental, niche asset rather than a core fleet‑expansion aircraft, with greater emphasis now placed on other types such as the ATR 72‑600F, B767F and B777F.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) YEAR DISCREPANCY: The ground truth states the 2022 filing projected aircraft 'through 2027' and the 2023 filing 'through 2029', but the LLM claims the 2022 projection was 'through 2026' and the 2023 projection was also 'through 2026'. This is a fundamental error in the time horizons being compared. (2) DELIVERY SCHEDULE DETAILS: The LLM provides specific annual delivery numbers (11 in 2023, 12 in 2024, etc.) that cannot be verified against the ground truth, which only states total projections of 49 vs 31 aircraft. These granular details may be fabricated or misremembered. (3) CALCULATION VERIFICATION: The LLM calculates a reduction of 'about 18 units (≈37%)' - this math is correct (49-31=18, 18/49≈36.7%), but the underlying numbers may be wrong given the year discrepancies. (4) MISSING CONTEXT: The ground truth emphasizes comparison to B767F and B777F with 'more stable or less reduced projections', while the LLM mentions ATR 72-600F, B767F, and B777F without specifying whether these had more stable projections. (5) STRATEGIC INTERPRETATION: Both answers correctly identify this as a strategic reduction and reassessment, but the LLM's characterization as 'supplemental, niche asset' is reasonable inference though not explicitly stated in ground truth. The core issue is that the LLM appears to have incorrect projection end-dates (2026 vs 2027/2029), which is a critical factual error in a multi-hop financial question where precision is essential.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 438,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Nike shifted from reporting only total footwear revenue to a fully disaggregated schedule that separates footwear, apparel and equipment and breaks sales down by geography and channel—making the Air Max line (reported only under “Footwear”) traceable within the $29.1 billion 2022 footwear total and the $35.6 billion 2022 overall revenue.  At the same time, the 2024 filing explicitly lists “Air Max” among the key cushioning technologies (e.g., Nike Air, Zoom, Free, React) in its R&D narrative, highlighting a sustained focus on technological innovation for that product line.  Thus, Nike’s approach has evolved to be both more transparent about Air Max’s revenue contribution and more vocal about the innovation behind it.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - The LLM cites specific revenue figures ($29.1 billion 2022 footwear, $35.6 billion 2022 overall) that are not mentioned in the ground truth and appear to be fabricated or misattributed\n   - These numbers are presented as fact but cannot be verified against the original answer\n   - The LLM incorrectly claims Air Max is \"traceable\" within these figures, which contradicts the ground truth stating Air Max had \"no specific revenue figures\"\n\n2. CORE FACTUAL CONTRADICTION:\n   - Ground Truth: \"In 2022, Nike included Air Max in a general list of technologies...without specific revenue figures\" and \"continued lack of standalone financial metrics\"\n   - LLM Answer: Claims Air Max revenue is \"traceable\" and that Nike became \"more transparent about Air Max's revenue contribution\"\n   - This is a fundamental misrepresentation of the ground truth\n\n3. INCOMPLETE/INACCURATE SYNTHESIS:\n   - The LLM mischaracterizes the evolution as moving toward \"more transparent\" reporting when the ground truth explicitly states there was a \"continued lack of standalone financial metrics\"\n   - The LLM invents a narrative about disaggregated reporting that doesn't align with the ground truth's emphasis on lack of transparency\n\n4. PARTIAL CORRECTNESS:\n   - The LLM correctly identifies that Air Max appears in R&D narratives and is positioned as a key innovation driver\n   - The mention of cushioning technologies (Nike Air, Zoom, Free, React) aligns with the innovation emphasis mentioned in ground truth\n   - However, this correct portion is undermined by the false claims about revenue transparency\n\n5. MULTI-HOP REASONING FAILURE:\n   - The question asks about evolution in \"revenue transparency AND technological innovation emphasis\"\n   - While the LLM addresses innovation correctly, it fundamentally fails on the revenue transparency component by claiming transparency increased when it actually remained absent\n   - This represents a failure in synthesizing the two-part evolution correctly\n\nThe answer demonstrates hallucination of specific financial figures and misrepresentation of Nike's actual reporting practices regarding Air Max revenue disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 617,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "\nFrom 2023 to 2024 Comcast shifted Epic Universe spending from early‑stage, land‑acquisition costs (which were part of the $8.2 billion total capital‑expenditure base in 2023) to a focus on active construction.  The 2024 filing notes that total capital expenditures were essentially flat at **$8.286 billion** (versus $8.241 billion in 2023) but that “spending on theme‑park attractions increased in 2024, and included costs associated with the construction of Epic Universe,” indicating that a larger share of the capex budget was now devoted to completing the Universal theme‑park project.  While the filing does not break out a separate dollar amount for Epic Universe, the increase in theme‑park capex and the explicit reference to Epic Universe as a priority show the evolution of the strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a reasonable interpretation of Comcast's Epic Universe capital expenditure strategy evolution, but contains significant quantitative discrepancies and makes unsupported claims. STRENGTHS: (1) Correctly identifies the $8.2 billion figure from 2023 as mentioned in ground truth; (2) Appropriately notes that specific Epic Universe dollar amounts were not separately disclosed; (3) Captures the shift from infrastructure/development focus to active construction/guest experience; (4) Correctly identifies that theme park capex increased in 2024. CRITICAL ISSUES: (1) The LLM provides specific 2024 capex figures ($8.286 billion vs $8.241 billion in 2023) that are NOT in the ground truth answer, which states 'specific figures for Epic Universe alone were not disclosed in 2024.' The ground truth does not provide these comparative capex numbers for 2024, making these figures unverifiable and potentially fabricated; (2) The claim about 'land-acquisition costs' in 2023 is not mentioned in the ground truth; (3) The LLM's assertion about 'a larger share of the capex budget' being devoted to Epic Universe is inference not explicitly stated in ground truth. QUANTITATIVE ACCURACY ISSUE: The LLM introduces specific numbers ($8.286B, $8.241B) without ground truth support. While the $8.2B figure is correct, the 2024 comparison figures appear to be hallucinated or from unverified sources. REASONING: The multi-hop synthesis is partially sound (connecting capex strategy evolution to Epic Universe priorities), but the introduction of unverified numbers undermines credibility. The qualitative reasoning about the shift from infrastructure to construction is reasonable but goes beyond what the ground truth explicitly states. The answer would score higher if it stuck to verified information and acknowledged uncertainty about 2024 specific figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 506,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "\nBased on the 2022 10‑K (pages 38‑42) FedEx had scheduled **11 ATR 72‑600F deliveries in 2023** and a total of **24 ATR 72‑600F** through 2026 (11 in 2023, 6 in 2024, 6 in 2025, 1 in 2026). The 2023 10‑K (pages 115‑119) shows only **7 ATR 72‑600F for delivery in 2025 and 3 in 2026**, cutting the earlier schedule and effectively phasing the type out of its near‑term fleet plans. Thus, between 2022 and 2023 the company reduced its ATR 72‑600F commitments and shifted focus to other freighter models (e.g., 767F/777F) in its projected fleet.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of FedEx's ATR 72-600F fleet evolution. STRENGTHS: (1) All key numbers are correct - 11 ATR 72-600F in 2023, 6 in 2024, 6 in 2025, 1 in 2026 from 2022 projections match ground truth exactly; (2) The 2023 projections of 7 for 2025 and 3 for 2026 are accurate; (3) The total of 24 aircraft through 2026 (11+6+6+1) is correctly calculated; (4) Multi-hop synthesis is sound - the answer correctly compares projections across two different 10-K filings (2022 and 2023) and identifies the reduction in commitments; (5) The conclusion about phasing out the aircraft type and shifting to other freighter models (767F/777F) is well-reasoned and supported by the data presented. MINOR CONSIDERATIONS: (1) The ground truth answer is more concise and focused on the core comparison, while the LLM answer adds contextual details about page numbers and mentions of alternative aircraft models - this is actually a strength as it provides additional verification and context; (2) The LLM answer uses slightly different phrasing ('scheduled deliveries' vs 'projected operating') but the semantic meaning is equivalent and appropriate for the source material. VERIFICATION: The numbers align perfectly with ground truth, the multi-hop reasoning correctly synthesizes information from two separate filing years, and the answer directly addresses how utilization evolved between the two planning periods. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 412,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Nike continued to estimate product‑return reserves using the same three‑point approach—historical return rates, specific identification of outstanding returns, and forward‑looking forecasts—but the 2024 disclosures show a reduced reserve balance ($1.015 bn vs. $1.077 bn in 2022) and a lower estimated cost of inventory for expected returns ($194 m vs. $269 m in 2021).  This downward adjustment reflects a more refined estimation of future returns and indicates that Nike is now recognizing revenue net of a smaller, more precisely quantified return reserve, aligning its revenue‑recognition practice with ASC 606’s variable‑consideration guidance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth: (1) WRONG NUMBERS: The LLM claims a 2024 reserve balance of $1.015 bn and 2022 of $1.077 bn, but the ground truth does not mention these figures at all. The ground truth specifically states the fiscal 2022 estimated cost of inventory for expected returns was $269 million, which the LLM incorrectly references as '$269 m in 2021' (wrong year). (2) INCORRECT METHODOLOGY CLAIM: The LLM asserts Nike used a 'three-point approach' (historical return rates, specific identification, forward-looking forecasts), but the ground truth makes no mention of this methodology. This appears to be fabricated detail. (3) WRONG COMPARISON: The LLM compares '$194 m vs. $269 m in 2021' but the ground truth states the $269 million figure was from fiscal 2022, not 2021. The $194 million figure is not mentioned in the ground truth at all. (4) MISSING KEY EVOLUTION: The ground truth emphasizes a shift toward 'more formalized estimation process' and 'most likely amount' methodology aligned with ASC 606, which the LLM mentions only superficially. The ground truth notes that by fiscal 2024, the specific dollar amount was NOT disclosed, which the LLM fails to acknowledge. (5) INCOMPLETE SYNTHESIS: The LLM fails to capture the core finding that fiscal 2024 disclosures became less specific (no dollar amount disclosed) while describing a more sophisticated methodology. The answer demonstrates poor multi-hop reasoning by introducing unsupported numbers and methodologies not present in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 438,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "\nThe 2022 filing projected 12 Cessna SkyCourier 408 deliveries for 2025, while the 2023 filing (updated in the 2024 10‑K) raises that to 17 aircraft for 2025 and adds 14 more for 2026 (pages 114 and 118). This upward revision shows FedEx is expanding its commitment to the SkyCourier 408, signaling a strategic shift toward greater reliance on this model to grow its regional package network beyond 2025.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical numerical error that significantly impacts correctness. QUANTITATIVE ISSUES: (1) The LLM states '14 more for 2026' which is ambiguous and potentially misleading - the ground truth shows 14 total for 2026, not 14 additional aircraft. This is a material error in interpreting the fleet composition data. (2) The LLM correctly identifies 12 for 2025 in 2022 and 17 for 2025 in 2023, which matches ground truth. (3) However, the phrasing '14 more for 2026' suggests an additive interpretation (17+14=31) rather than the correct interpretation that 2026 planned fleet is 14 total. COMPLETENESS: The answer addresses both the 2022 and 2023 projections and attempts to characterize the strategic implications. However, it misses the important nuance that the ground truth emphasizes: the 2023 plan shows an INCREASE to 17 for 2025 but then a REDUCTION to 14 for 2026, indicating a recalibration rather than sustained expansion. The LLM's conclusion of 'greater reliance' and 'growth beyond 2025' doesn't fully capture the moderate decline indicated by the 2026 reduction. REASONING: The multi-hop synthesis is partially sound - the LLM correctly identifies the upward revision from 2022 to 2023 for 2025. However, the interpretation of strategic implications is incomplete because it doesn't adequately address the 2026 reduction, which is crucial to understanding the 'recalibration' mentioned in the ground truth. SEMANTIC EQUIVALENCE: While the LLM conveys that there's an increase in commitment, it fails to capture the full strategic picture of a short-term increase followed by a planned decline. The ground truth's characterization of 'short-term increase...followed by moderate decline' is more accurate than the LLM's 'expanding commitment' narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 486,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "\nFrom 2023 to 2024 Mastercard expanded its real‑time account‑based payments platform beyond the 13 markets where it was operating in 2023, scaling the clearing‑and‑settlement infrastructure to support a far larger global footprint and higher transaction volumes.  At the same time, the company reinforced the solution with a multi‑layered security architecture that adds real‑time fraud scoring, tokenization, 24‑hour availability and third‑party assessments, delivering end‑to‑end protection across the entire payment flow.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 13 markets baseline from 2023, establishing proper temporal comparison. (2) Accurately captures the expansion narrative from 2023 to 2024 with scaling of infrastructure and increased transaction volume capacity. (3) Properly synthesizes the multi-layered security enhancements including fraud scoring, tokenization, and third-party assessments. (4) Correctly identifies the shift toward 'secure, simple, and smart' solutions through specific security mechanisms. (5) Maintains semantic equivalence with ground truth while using slightly different phrasing (e.g., 'clearing-and-settlement infrastructure' vs. 'ACH and real-time account-based payment systems'). MINOR WEAKNESSES: (1) The mention of '24-hour availability' appears in the LLM answer but is not explicitly stated in the ground truth, though it could be inferred from 'real-time' capabilities. (2) The answer could have been slightly more explicit about the 'distributed network architecture' and 'intelligent routing' mentioned in the ground truth, though these concepts are implicitly covered through the infrastructure scaling discussion. (3) The phrase 'end-to-end protection across the entire payment flow' is a reasonable interpretation but represents slight elaboration beyond what the ground truth explicitly states. QUANTITATIVE VERIFICATION: The '13 markets' figure is correctly cited and properly used as the 2023 baseline for comparison. No calculations are required for this question, and no numerical errors are present. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2023-2024 timeframe and correctly combines operational scale metrics with security capability enhancements, demonstrating sound multi-hop reasoning. The answer appropriately addresses both components of the question (operational scale and integrated security capabilities).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 534,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Nike scaled back its foreign‑exchange forward and option program – the notional amount of designated cash‑flow hedges fell from roughly $18.5 bn to about $16 bn, and total derivative assets dropped from $557 m to $343 m while derivative liabilities slipped only slightly from $180 m to $151 m. This reduction lowered the company’s derivative‑related liabilities on the balance sheet and cut the amount of deferred gains/losses being re‑classified from accumulated other comprehensive income into earnings, although the firm still uses forwards and options to hedge product‑cost, revenue and intercompany foreign‑currency exposures. The strategy remains one of hedging up to 100 % of identified exposures, but with a more limited set of contracts than in 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and does not match the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM provides completely different numbers than the ground truth. Ground truth states liabilities of $110M (accrued) and $5M (deferred) in 2024, but LLM claims derivative liabilities of $151M in 2024 and $180M in 2022. The LLM also introduces notional amounts ($18.5bn to $16bn) and derivative assets ($557M to $343M) that are not mentioned in the ground truth. (2) MISSING KEY INFORMATION - The ground truth specifically mentions a net gain of $8 million after tax in 2022 impacting revenues, cost of sales, and other income categories. The LLM completely omits this critical information. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes the shift in how derivatives were managed/reported between 2022 and 2024, with specific liability figures. The LLM discusses a 'scale back' strategy but with entirely different numbers. (4) DIRECTIONAL MISMATCH - While both answers suggest some evolution in hedging strategy, the specific financial metrics provided by the LLM contradict the ground truth data. The LLM appears to have drawn from different sections of Nike's filings or confused different derivative categories. (5) REASONING QUALITY - While the LLM's reasoning about hedging strategy evolution is logical, it is built on incorrect foundational numbers, making the entire analysis unreliable. The answer fails the primary requirement of factual accuracy on specific financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 420,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 the classification of Puffs within the Baby, Feminine & Family Care segment was refined but did not move to a different segment. In the 2022 filing (PG 10‑K 2022, page 19) Puffs appears in the “Major Brands” list for the segment alongside baby‑care and feminine‑care brands, without a specific sub‑category label. In the 2023 filing (PG 10‑K 2023, page 19) the same brand list is retained, but Puffs is now explicitly grouped with the segment’s “Family Care” sub‑category (tissues) together with Charmin, indicating a shift from a mixed‑category mention to a clear placement in the tissue/family‑care line‑up. Thus, Puffs remained in the Baby, Feminine & Family Care segment, but its categorization became more precisely defined as a tissue‑brand within the Family Care sub‑category.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) CONTRADICTORY CLAIMS: The LLM states that in 2022 Puffs appeared 'without a specific sub-category label' but then claims in 2023 it was 'explicitly grouped with the segment's Family Care sub-category.' The ground truth indicates Puffs was already in Family Care in 2022 and remained there in 2023. (2) MISCHARACTERIZATION OF CHANGE: The LLM describes a shift from 'mixed-category mention to a clear placement in the tissue/family-care line-up,' but the ground truth indicates Puffs was consistently in Family Care both years, with the change being a simplification/consolidation of reporting format, not a reclassification. (3) INCORRECT NARRATIVE: The LLM's claim that Puffs moved from being listed without sub-category to being 'explicitly grouped' with Family Care contradicts the ground truth that it was already categorized as Family Care in 2022. (4) MISSING CONTEXT: The LLM fails to capture the actual evolution described in the ground truth - that the reporting became more simplified/consolidated rather than Puffs being newly placed into Family Care. (5) CITATION ACCURACY: While the LLM cites specific pages (page 19), the interpretation of what those pages show is fundamentally incorrect. The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the year-over-year comparison and misrepresenting the nature of the classification change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 410,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Tampax continued to be reported under the **Baby, Feminine & Family Care** reportable segment, specifically within the **Feminine Care** sub‑category alongside the Always and Always Discreet brands.  The company’s disclosures show no change in its categorisation – it remains a core brand of the Feminine Care portfolio and is still grouped with other feminine‑care products (e.g., Tampax Bounty) in P&G’s segment‑level sales and earnings tables for both years.  Consequently, its positioning relative to other product lines stayed stable, continuing to drive share growth within the feminine‑care category under the broader Baby, Feminine & Family Care umbrella.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer directly contradicts the ground truth on the core claim of the question. Ground truth states that Tampax's categorization CHANGED between 2022 and 2023 - from 'Feminine Care' in 2022 to 'Menstrual Care' in 2023, representing a refinement and more focused positioning. The LLM explicitly states 'no change in its categorisation' and claims it 'remains' in Feminine Care for both years, which is factually incorrect. This is a fundamental misunderstanding of the multi-hop question asking about EVOLUTION/CHANGE between the two years. The LLM also introduces unsupported details (Always, Always Discreet, Tampax Bounty) not mentioned in the ground truth, and misses the key insight that Tampax was separated from general 'Family Care' items and repositioned specifically under 'Menstrual Care.' The LLM's statement about 'stable' positioning directly contradicts the ground truth's description of a 'refined' category change. While the LLM correctly identifies the broader segment (Baby, Feminine & Family Care) and years (2022-2023), it fails on the primary factual claim - that categorization evolved from Feminine Care to Menstrual Care. This represents a major failure in multi-hop reasoning and factual accuracy on the core question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 356,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "\nOracle still generates only about 6 percent of its total revenue from Engineered Systems, but between fiscal 2022 and fiscal 2023 the company refocused the business from a stand‑alone hardware line toward a cloud‑integrated offering—emphasizing programs that let customers migrate their Oracle licenses to the Oracle Cloud and expanding the cloud‑services footprint of those systems.  Because the hardware segment now carries lower margins, Oracle says it will continue to allocate substantial R&D resources to modernize and broaden its engineered‑system portfolio, improve existing products, and build the capacity and geographic reach needed to support its cloud‑centric growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ANALYSIS: The LLM answer contains both accurate and problematic elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. The 6% revenue figure is accurate and matches the ground truth\n2. The fiscal 2022 to 2023 timeframe is correct\n3. The mention of R&D investment continuation aligns with ground truth\n4. The reference to modernizing and broadening the portfolio matches ground truth language\n\nPROBLEMATIC ELEMENTS:\n1. MAJOR ISSUE - Strategic Shift Description: The LLM introduces a significant strategic narrative about \"refocusing from stand-alone hardware toward cloud-integrated offering\" and \"programs that let customers migrate Oracle licenses to Oracle Cloud.\" This specific strategic pivot is NOT mentioned in the ground truth. The ground truth only states Oracle introduced \"a more forward-looking strategy\" with plans to \"continue investing in research and development.\"\n\n2. MAJOR ISSUE - Cloud Migration Programs: The LLM claims Oracle emphasized \"programs that let customers migrate their Oracle licenses to the Oracle Cloud\" - this specific detail is not present in the ground truth and appears to be an inference or fabrication.\n\n3. MAJOR ISSUE - Margin Discussion: The LLM states \"Because the hardware segment now carries lower margins\" - this margin analysis is not mentioned in the ground truth and represents unsupported information.\n\n4. MAJOR ISSUE - Geographic Expansion: The LLM mentions \"improve geographic reach\" which is not explicitly stated in the ground truth.\n\n5. MINOR ISSUE - Completeness: The ground truth notes that in fiscal 2022, hardware involved \"point-of-sale revenue recognition\" and was \"sold through indirect channels.\" The LLM answer does not address these 2022 characteristics, missing part of the comparative analysis.\n\nMULTI-HOP REASONING: The LLM failed to properly synthesize the ground truth information. Instead of accurately comparing fiscal 2022 positioning (point-of-sale recognition, indirect channels) with fiscal 2023 positioning (forward-looking R&D strategy, 6% revenue clarity), the LLM introduced unsupported strategic narratives about cloud integration and license migration.\n\nQUANTITATIVE ACCURACY: The 6% figure is correct (7/10) - one accurate number but missing other quantitative context from ground truth.\n\nQUALITATIVE ACCURACY: Significant issues with accuracy of strategic positioning claims (4/10) - the LLM appears to have hallucinated or inferred details not in the ground truth.\n\nCONTEXTUAL RELEVANCE: Partially relevant but introduces misleading information (6/10) - addresses the question but with substantial inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 701,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell’s non‑U.S. pension‑plan investment in private funds grew from **$90 million to $115 million**.  The composition changed markedly: Level 2 holdings fell from **$54 million to $41 million**, while Level 3 holdings rose from **$36 million to $74 million**, shifting a larger share of the private‑fund portfolio into the lowest tier of the fair‑value hierarchy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors that fundamentally misrepresent the ground truth. Key issues: (1) WRONG FOCUS: The LLM discusses Non-U.S. pension plans ($90M to $115M evolution), but the ground truth explicitly states that in 2022, Honeywell reported $1,105 million in private funds for U.S. pension plans (Level 3), not Non-U.S. plans. The LLM appears to have confused or conflated U.S. and Non-U.S. pension plan data. (2) MISSING CRITICAL DATA: The LLM completely omits the 2022 U.S. pension plan figure of $1,105 million, which represents the primary investment amount and is essential to understanding the 'significant decrease' mentioned in the ground truth. (3) INCOMPLETE COMPARISON: The ground truth indicates a comparison between 2022 (U.S. plans: $1,105M Level 3) and 2023 (Non-U.S. plans: $115M total with $41M Level 2 and $74M Level 3), showing a major shift in allocation strategy. The LLM only addresses the Non-U.S. portion and misses this critical multi-hop synthesis. (4) UNVERIFIED 2022 NON-U.S. FIGURES: The LLM states 2022 Non-U.S. holdings were $90M Level 2 and $36M Level 3, but these figures do not appear in the ground truth and cannot be verified. (5) REASONING FLAW: The LLM's characterization of Level 3 as 'the lowest tier of the fair-value hierarchy' is incorrect—Level 3 represents the HIGHEST level of valuation uncertainty (least observable inputs), not the lowest tier in terms of hierarchy position. This demonstrates a fundamental misunderstanding of fair value hierarchy classification. The answer fails to address the significant decrease in overall private fund allocation and the strategic shift from U.S. to Non-U.S. pension plan investments that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 471,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "\nBy the end of 2023 the 2014 USD Notes—$1 billion of 3.375 % senior unsecured notes that were scheduled to mature in April 2024—were listed as short‑term debt (page 96).  In April 2024 the company allowed the notes to mature and paid the full $1 billion principal, removing the issue from the balance sheet (page 60).  The repayment was financed in part by the $4 billion of new 2024 USD Notes that Mastercard issued later in the year (pages 56‑57).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: All numbers are correct - $1 billion principal amount, 3.375% coupon rate, April 2024 maturity date, and $4 billion of new 2024 USD Notes issued. Dates are accurate (2023 classification, April 2024 maturity/payment, later 2024 issuance of new notes). Multi-hop reasoning: The answer correctly synthesizes the evolution of the debt across years - showing the 2023 status as short-term debt, the April 2024 maturity event, and the subsequent refinancing with new notes. This demonstrates proper understanding of how the obligation transitioned from liability to settled. Entity accuracy: Correctly identifies the 2014 USD Notes, Mastercard as the issuer, and the 2024 USD Notes as the refinancing instrument. The answer goes beyond the ground truth by providing additional context (coupon rate, page references, refinancing details) that is accurate and relevant. The only minor distinction is that the LLM provides more granular detail about the refinancing mechanism (mentioning the $4 billion new notes financed the repayment), which adds helpful context without contradicting the ground truth. The page references suggest this is sourced from actual SEC filings. All semantic meaning aligns perfectly with the original answer regarding the transition from short-term liability to settled debt.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 383,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "\nBetween 2022 and 2024 Lowe’s continued to file the same “Form of Lowe’s Companies, Inc. Officer Indemnification Agreement” as Exhibit 10.23 in its annual and quarterly reports (first listed in the 2019 10‑K and still referenced unchanged in the 2022 10‑K and the 2024 10‑K).  The agreement’s consistent numbering, description and incorporation‑by‑reference treatment across filings show that the company has not revised or replaced the indemnification language, underscoring a stable executive‑risk‑management framework and a governance approach that maintains continuity in protecting senior officers against personal liability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR - EXHIBIT NUMBER MISMATCH: The LLM states the agreement was filed as 'Exhibit 10.23' but the ground truth clearly identifies it as 'Exhibit 10.43'. This is a significant factual error in a key identifying detail. The LLM also incorrectly states the agreement was 'first listed in the 2019 10-K' when the ground truth specifies it was 'first filed as Exhibit 10.43 on April 2, 2019' - the date precision matters for document tracking. CORRECT ELEMENTS: The LLM correctly identifies that (1) the same form of Officer Indemnification Agreement was maintained between 2022 and 2024, (2) it was refiled without amendment in both years, (3) this indicates consistent governance practices and stable executive risk management, and (4) the continuity suggests predictable leadership protections. The semantic interpretation about governance continuity and executive risk management is sound. REASONING QUALITY: The multi-hop synthesis is logically sound - the LLM correctly connects the unchanged filing status to conclusions about governance stability. However, the fundamental exhibit number error (10.23 vs 10.43) undermines credibility on factual accuracy. COMPLETENESS: The answer addresses the evolution question and governance implications, though it could have been more explicit about what 'no modification' means for investor interpretation. The core narrative about continuity is present but marred by the exhibit number error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 400,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "\nIn the 2022 filing (page 19 of PG_10k_2022.pdf) P&G notes that Always Discreet holds “over 10 %” of the adult‑incontinence market in the key markets where it competes. The 2023 filing (page 19 of PG_10k_2023.pdf) updates that figure to “about 15 %” share, indicating that Always Discreet’s market share in the adult‑incontinence sub‑category has risen noticeably and its positioning within the Baby, Feminine & Family Care segment has been strengthened.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims that the 2023 filing shows Always Discreet's market share increased to 'about 15%', but the ground truth explicitly states that the 2023 filing provides NO specific market share figure for the brand. This is a major quantitative accuracy failure. The LLM correctly identifies that the 2022 filing states 'over 10%' market share, which matches the ground truth. However, the core claim about the 2023 filing is entirely incorrect - the ground truth indicates a shift AWAY from quantified disclosure, not an update to a higher percentage. The LLM's reasoning that positioning was 'strengthened' based on a supposed increase to 15% is logically flawed because this 15% figure does not exist in the actual filing. The LLM also correctly identifies the segment (Baby, Feminine & Family Care) and the general context, but the specific numeric claim about 2023 is fabricated. The answer demonstrates partial understanding of the question structure but fails on the most critical factual elements required for a multi-hop financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 329,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Oracle reframed Engineered Systems from a standalone, on‑premise hardware line into a strategic conduit for its cloud agenda.  The company began marketing these systems—Exadata, servers, storage, and industry‑specific offerings—as integral parts of Oracle Cloud Infrastructure, Cloud@Customer and Dedicated Region, emphasizing migration, hybrid‑cloud deployment and the ability to run workloads across on‑premise, OCI and other clouds.  Consequently, Engineered Systems now serve less as a pure hardware profit center and more as a growth engine that validates and accelerates Oracle’s cloud‑transformation narrative, even though their revenue share (≈ 6 % of total) and margins remain modest.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Oracle's strategic repositioning of Engineered Systems between 2022 and 2023, with mostly accurate information and sound reasoning. STRENGTHS: (1) Correctly identifies the shift from standalone hardware to cloud-integrated strategy; (2) Accurately cites the 6% revenue share metric; (3) Properly names specific product offerings (Exadata, servers, storage); (4) Correctly identifies cloud platforms (OCI, Cloud@Customer, Dedicated Region); (5) Appropriately characterizes the lower-margin nature of hardware business; (6) Sound multi-hop synthesis connecting hardware positioning to cloud transformation narrative. WEAKNESSES: (1) The LLM answer emphasizes specific cloud products (OCI, Cloud@Customer, Dedicated Region) that are not explicitly mentioned in the ground truth, which focuses more on the broader positioning as 'part of a broader hardware business' with 'combined performance obligations'; (2) The ground truth emphasizes that Engineered Systems are positioned as 'foundational components in its hybrid cloud and on-premise strategies' with 'tightly integrated' servers, storage, and operating systems as combined offerings, whereas the LLM frames this more narrowly around cloud infrastructure products; (3) The ground truth mentions 'fiscal 2023 and 2024' revenue percentages, while the LLM only references the 6% figure without temporal specificity; (4) The ground truth emphasizes 'R&D investments to enhance these offerings' which the LLM omits. QUANTITATIVE VERIFICATION: The 6% revenue figure is correct and properly contextualized. REASONING QUALITY: The multi-hop synthesis is sound—connecting product repositioning to strategic cloud narrative—though the LLM adds specific product names not in ground truth. The characterization of Engineered Systems as a 'growth engine' rather than 'profit center' aligns well with the ground truth's implication about strategic importance beyond margins. Overall, the answer is substantially correct with minor deviations in emphasis and specificity rather than fundamental errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 562,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "\nIn the 2022 10‑K the company explicitly said that the 2020 Stock Plan succeeded the 2011 Stock Plan and that the shares still reserved under the 2011 Plan were being made available for grant under the 2020 Plan. By the 2023 10‑K that explicit reference to the 2011 Plan is gone—the filing simply describes the 2020 Plan’s share reserve and features without any mention of the earlier plan, indicating that the relationship is now implied rather than expressly disclosed.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution in disclosure between the 2022 and 2023 10-K filings regarding the relationship between the 2020 Stock Plan and the 2011 Stock Plan. STRENGTHS: (1) Accurately captures that the 2022 10-K explicitly referenced the 2011 Stock Plan and the carry-forward relationship, while the 2023 10-K omitted this reference; (2) Correctly characterizes the shift from explicit disclosure to implied relationship; (3) Properly synthesizes the multi-hop comparison across two filing years; (4) Uses appropriate language ('explicit reference,' 'implied rather than expressly disclosed') that conveys the substantive change. MINOR WEAKNESSES: (1) The LLM answer does not include the specific share count (5,530,106 shares) that was mentioned in the ground truth as being carried forward from the 2011 Stock Plan. While this is a detail that adds precision to the original answer, its omission does not fundamentally undermine the core finding about the disclosure evolution; (2) The phrasing 'shares still reserved under the 2011 Plan' in the LLM answer is slightly less precise than the ground truth's 'shares previously available under the 2011 Stock Plan were carried forward,' though the meaning is semantically equivalent. The LLM answer demonstrates sound multi-hop reasoning by correctly comparing disclosure practices across two years and identifying the substantive change in how the company presented the plan relationship. The answer is contextually appropriate and directly addresses the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 426,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "\nBetween 2022 and 2023 the fair‑value of Honeywell’s private‑fund holdings in its non‑U.S. pension plans more than doubled—from $36 million to $74 million—while the U.S. “direct private‑investments” balance stayed essentially flat around $1.28 billion.  At the same time the company trimmed its real‑estate‑fund exposure and let insurance‑buy‑in contracts grow, indicating a purposeful shift toward allocating a larger share of plan assets to private‑fund investments.  This move reflects a capital‑deployment priority of seeking higher‑return, longer‑duration private‑equity/debt assets to enhance portfolio returns and meet long‑term funding objectives without requiring additional cash contributions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and appears to reference different data than the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The ground truth clearly states Honeywell's private funds allocation was $1,244 million in 2022 and $1,265 million in 2023 (a 1.7% increase). The LLM answer instead cites $36 million to $74 million for non-U.S. pension plans and $1.28 billion for U.S. direct private investments—these are different metrics/categories not mentioned in the ground truth. The LLM appears to be mixing or confusing different line items from the pension disclosures. (2) ENTITY/METRIC CONFUSION: The ground truth discusses total private funds allocation across U.S. plans. The LLM distinguishes between non-U.S. and U.S. plans and uses different terminology ('direct private-investments' vs 'private funds'), suggesting it may be referencing different sections of the filing or conflating separate categories. (3) INCOMPLETE SYNTHESIS: While the LLM does attempt to address the evolution question and capital deployment priorities (which is good), it does so using incorrect numbers. The LLM's conclusion about seeking higher-return assets is reasonable but is built on a factually incorrect foundation. (4) MISSING CORE DATA: The LLM fails to cite the actual $1,244M→$1,265M figures that are the primary answer to the question. The modest 1.7% increase is a critical fact that the LLM completely misses. The answer reads as if it's analyzing a different company's pension data or different years entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 423,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "\nClass B‑2 common stock had no outstanding shares at the end of fiscal 2023; it was created in early 2024 when Visa’s exchange offer converted 241 million class B‑1 shares into roughly 120 million class B‑2 shares, which are now reported as 120 million shares issued and outstanding. These newly issued B‑2 shares have the same conversion‑to‑class A rights as other class B series but their conversion‑rate adjustments have double the impact, and like other class B shares they remain restricted from transfer or conversion until the U.S. litigation escrow is fully resolved.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. Key issues: (1) WRONG COMPANY: The answer discusses Visa's exchange offer, but the ground truth concerns a different company's Class B-2 Common Stock with U.S. litigation escrow accounts - this is a critical entity error. (2) WRONG TIMELINE: The ground truth states Class B-2 had no outstanding shares prior to a Class B-1 exchange offer (in 2023), but the LLM claims B-2 was 'created in early 2024' from the exchange offer - this contradicts the ground truth's statement that B-2 existed in 2023 with conversion rate adjustments. (3) WRONG NUMBERS: The LLM provides specific share counts (241 million B-1 converted to 120 million B-2) that are not mentioned in the ground truth and appear to be fabricated. (4) INCOMPLETE SYNTHESIS: The ground truth emphasizes the evolution between 2023 and 2024, noting that 2023 had detailed disclosures about conversion mechanics and dilution impacts, while 2024 had reduced emphasis. The LLM answer completely misses this comparative analysis and instead presents a single narrative about 2024 creation. (5) MISSING KEY ELEMENTS: The ground truth specifically mentions 'U.S. litigation escrow account under the U.S. retrospective responsibility plan' and 'dilution in as-converted shares' - while the LLM mentions escrow, it frames it differently and doesn't address the 2023-to-2024 evolution in disclosure emphasis. The answer appears to conflate information from a different company (Visa) with the actual subject company, representing a fundamental misunderstanding of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 441,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "\nBetween fiscal 2023 (ended Feb 3 2024) and fiscal 2024 (ended Feb 1 2025) the liability for Target Circle rewards—recorded as deferred revenue in accrued and other current liabilities—fell dramatically from **$117 million** to **$19 million** (see 2024 10‑K p. 49 and the same table in the 2022 10‑K p. 45).  This sharp decline indicates that the company has largely redeemed or recognized the accrued rewards and is scaling back the standalone Target Circle program’s financial obligations, reflecting a shift toward integrating those rewards into broader loyalty and marketing initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key numbers ($117 million for Feb 3, 2024 and $19 million for Feb 1, 2025) and accurately calculates the dramatic decline. The fiscal year labeling is correct. The answer properly cites specific page references to 10-K filings. CRITICAL WEAKNESSES: (1) The LLM answer completely omits the 2022 baseline data ($89 million as of January 29, 2022), which is explicitly requested in the question asking about changes 'between 2022 and 2024.' This is a significant omission that fails to fully address the multi-hop nature of the question. (2) The question asks about changes 'between 2022 and 2024' but the LLM focuses primarily on the 2024-2025 period, missing the important 2022-2024 progression ($89M → $117M increase). (3) The ground truth provides a more complete narrative showing the increase from 2022 to 2024 before the sharp decline to 2025, but the LLM only addresses the decline portion. (4) The interpretation about 'scaling back the standalone Target Circle program' and 'integrating into broader loyalty initiatives' is speculative and not supported by the ground truth, which more conservatively notes the decline 'may reflect either a surge in reward redemptions or a strategic change.' QUANTITATIVE ACCURACY: The numbers cited ($117M and $19M) are correct, but the answer is incomplete by omitting the $89M 2022 figure. QUALITATIVE ACCURACY: The reasoning about what the decline indicates is reasonable but goes beyond what the ground truth supports, and the failure to address the 2022-2024 increase weakens the multi-hop synthesis. The answer addresses only 2 of the 3 key data points needed to fully answer the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 459,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "\nThe fair‑value of Netflix’s 4.375% Senior Notes rose modestly from **$980 million on December 31 2022 to $996 million on December 31 2023** (an increase of roughly $16 million, or about 1.6%).  This slight uptick—reflecting higher market‑quoted prices for the notes in the Level‑2 valuation hierarchy—suggests that investors continued to view the debt as relatively stable and perhaps slightly more attractive, likely supported by Netflix’s strong cash‑flow profile and the favorable interest‑rate environment that made its senior unsecured issuance still competitive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - the fair value increased from $980 million (Dec 31, 2022) to $996 million (Dec 31, 2023), representing a $16 million increase or approximately 1.6% (16/980 = 1.63%, correctly rounded). The dates are accurate. MULTI-HOP SYNTHESIS: The answer correctly synthesizes the change in fair value across two fiscal years and properly interprets what this indicates about market conditions. INTERPRETATION ACCURACY: Both the original answer and LLM answer correctly identify that the fair value moved closer to par value ($1,000 million principal), indicating improved investor perception. The LLM provides additional context by mentioning the Level-2 valuation hierarchy and attributing the improvement to Netflix's cash flow profile and favorable interest-rate environment, which adds valuable analytical depth. MINOR DISCREPANCY IN FRAMING: The original answer states the change \"indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook.\" The LLM answer frames this as investors viewing the debt as \"relatively stable and perhaps slightly more attractive.\" Both interpretations are semantically equivalent and correct - moving closer to par value does indicate improved perception. The LLM's additional explanation about cash flow and interest rates is contextually appropriate and enhances the answer without introducing errors. COMPLETENESS: The answer fully addresses both parts of the question: (1) how the fair value changed (with specific numbers and percentage), and (2) what this indicates about investor perception/market conditions. No material information is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 488,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Visa issued roughly 48 million new Class C shares as part of its May 2024 class B‑1 exchange offer, increasing the outstanding Class C share balance from about 10 million shares at the end of 2023 to a higher level (the filing lists 10 million shares for both years, reflecting the post‑issuance total).  These securities remain classified as Class C common stock with a $0.0001 par value—a distinct, non‑traded class used for the exchange and conversion rights—and their equity classification was unchanged during the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) TIMING ERROR: The LLM states the 48 million Class C shares were issued in 'May 2024' as part of a '2024 class B-1 exchange offer,' but the ground truth clearly indicates this exchange occurred in 2023 with 241 million Class B-1 shares tendered for ~48 million Class C shares. This is a fundamental factual error about when the major equity restructuring event occurred. (2) CONTRADICTORY NUMBERS: The LLM claims the outstanding Class C shares increased 'from about 10 million shares at the end of 2023 to a higher level' but then contradicts itself by stating 'the filing lists 10 million shares for both years.' This internal contradiction undermines the answer's credibility. The ground truth states that in 2024, the balance remained at 10 shares (not 10 million), which the LLM misinterprets. (3) MAGNITUDE ERROR: The ground truth specifies 10 shares outstanding in 2024, not 10 million shares. This is a critical distinction that the LLM failed to capture. (4) INCOMPLETE SYNTHESIS: The LLM fails to properly synthesize the multi-hop information: it should explain that the 2023 exchange (241M Class B-1 for ~48M Class C) represents the active restructuring, while 2024's 10 shares outstanding represents stabilization/conclusion of that phase. Instead, the LLM conflates the timing and creates confusion about whether the issuance happened in 2023 or 2024. (5) CORRECT ELEMENTS: The LLM correctly identifies the par value ($0.0001) and that Class C is a non-traded class used for exchange/conversion rights, and correctly notes the equity classification remained unchanged. However, these correct details cannot offset the fundamental errors in timing, share count magnitude, and multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 473,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s continued to place Rough Plumbing in the **Building Products** group (2022 Note 3 shows it under “Building Products” and the 2024 product‑category list repeats this classification), but the way it engages the business has broadened.  In the 2024 filing the company reports that Rough Plumbing is a key driver of **installed sales** (≈ 5 % of total sales) and is supported by remote quoting, a central selling team, on‑site specialists and protection‑plan/repair services, moving the offering from a pure product line to an integrated sales‑and‑installation service across its omnichannel channels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): The 5% installed sales figure is correctly cited and matches the ground truth. The timeframe (2022-2024) is accurate. ENTITY ACCURACY: Lowe's, Rough Plumbing, and Building Products are all correctly identified. MULTI-HOP REASONING (9/10): The answer successfully synthesizes the evolution across years by: (1) confirming consistent Building Products classification in both 2022 and 2024, (2) identifying the strategic shift from pure product to integrated service offering, (3) connecting this to installed sales metrics and supporting infrastructure (remote quoting, central selling team, on-site specialists, protection plans). COMPLETENESS: The answer addresses all aspects of the question - business classification (Building Products maintained), service offerings evolution (product → integrated services), and the timeframe (2022-2024). SEMANTIC EQUIVALENCE: The LLM's description of the evolution as moving from 'pure product line to an integrated sales-and-installation service' is semantically equivalent to the ground truth's 'shift from a pure product offering to a more service-oriented approach.' The mention of omnichannel channels adds relevant context. MINOR CONSIDERATIONS: The LLM provides slightly more operational detail (remote quoting, central selling team, on-site specialists) than the ground truth, which enhances rather than detracts from accuracy. The parenthetical reference to '2022 Note 3' and '2024 product-category list' demonstrates proper source attribution. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 457,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "\nClass B‑2 common stock was created in May 2024 when Visa amended its charter and ran an exchange offer that retired 241 million Class B‑1 shares and issued roughly 120 million new Class B‑2 shares (along with 48 million Class C shares); there were no B‑2 shares outstanding before this transaction. The newly issued B‑2 shares now appear in the 2024 EPS and balance‑sheet tables, and because their conversion‑rate adjustments are double those of Class B‑1, they are being used to retire restricted B‑1 stock and to fine‑tune litigation‑related conversion rates, indicating that B‑2 plays a strategic role in reshaping Visa’s capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES BETWEEN LLM AND GROUND TRUTH: (1) TIMELINE CONFLICT: Ground truth states Class B-2 was introduced in 2023 with 77 million shares outstanding, then by 2024 no shares were outstanding prior to an exchange offer. LLM claims B-2 was created in May 2024 with no prior shares - this contradicts the ground truth's 2023 introduction. (2) QUANTITATIVE ERRORS: LLM provides specific numbers (241 million B-1 retired, 120 million B-2 issued, 48 million Class C issued) that are NOT mentioned in the ground truth. The ground truth only mentions 77 million B-2 shares in 2023. LLM's numbers cannot be verified against the provided ground truth and appear to be fabricated or from different source material. (3) COMPANY IDENTIFICATION: LLM identifies the company as Visa, but the ground truth does not specify the company name. This is a critical error if the question pertains to a different company. (4) STRUCTURAL UNDERSTANDING: While LLM correctly identifies that B-2 plays a strategic role in capital restructuring, it fundamentally misrepresents the timeline and introduces unverified quantitative claims. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the 2023-2024 evolution as described in ground truth. Instead, it presents a different narrative entirely with a May 2024 creation date rather than acknowledging the 2023 introduction. The ground truth indicates a transformation/replacement scenario, while LLM describes an initial creation scenario. This is a fundamental factual error that undermines the entire answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 427,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "\nThe Target Circle program’s deferred‑revenue liability fell dramatically — from **$117 million as of February 3 2024** (the 2023 fiscal year) to **$19 million as of February 1 2025** (the 2024 fiscal year), a decline of roughly **$98 million** (about an 84 % reduction).  This sharp drop shows that the program’s accrued, unearned revenue has been largely recognized as members redeem rewards, indicating that Target Circle has matured and is generating more immediate revenue rather than accumulating deferred liabilities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) DIRECTIONAL ERROR: The ground truth states that deferred revenue GREW to $117 million by 2024, indicating program growth. The LLM claims it FELL from $117 million to $19 million, which is the opposite direction. (2) TEMPORAL CONFUSION: The LLM incorrectly labels $117 million as 'February 3 2024 (the 2023 fiscal year)' and $19 million as 'February 1 2025 (the 2024 fiscal year)'. The ground truth only provides the $117 million figure for February 3, 2024, with no mention of a $19 million figure or February 1, 2025 data. The LLM appears to have introduced data not present in the ground truth. (3) CALCULATION ERROR: Even accepting the LLM's numbers, the calculation of $117M - $19M = $98M is arithmetically correct, but the premise is wrong. (4) INTERPRETATION REVERSAL: The ground truth interprets the $117 million growth as 'substantial growth or expansion of the program.' The LLM interprets a decline as 'matured' program, which is a complete reversal of the actual finding. (5) MISSING CONTEXT: The ground truth notes that 2022 had no specific liability figure disclosed, which the LLM completely omits. The LLM answer appears to reference data from a different fiscal year or company filing than what was provided in the ground truth, making it factually unreliable for answering the specific question about 2022-2024 changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 401,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 NVIDIA moved from a generic reference to “climate‑change‑related laws and pollution limits” toward a concrete warning that **new carbon‑tax, emissions‑limit and water‑availability regulations can directly constrain the ability of its customers to expand data‑center capacity**, which in turn limits demand for its GPUs and related services.  The 2024 filing explicitly ties these regulatory pressures to **higher compliance costs, potential restrictions on energy or water use, and the risk of delayed or cancelled data‑center expansions**, indicating that NVIDIA’s exposure to and concern about pollution‑related rules has deepened markedly.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of NVDA's pollution/regulatory concerns from 2023 to 2024. Both the original and LLM answers correctly identify the shift from generic climate regulation concerns to specific, concrete worries about regulatory constraints on data center expansion. The LLM appropriately emphasizes the connection between pollution limits and customer data center capacity constraints, which directly impacts GPU demand. (2) QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are required for this question, so this dimension scores perfectly. The fiscal years (2023 vs 2024) are correctly referenced. (3) QUALITATIVE ACCURACY: The LLM demonstrates sound multi-hop reasoning by synthesizing: (a) regulatory evolution (from generic to specific), (b) operational impact (compliance costs, energy/water restrictions), and (c) market impact (data center expansion constraints affecting GPU demand). The answer correctly identifies the causal chain: pollution regulations → data center constraints → reduced GPU demand. The terminology is precise (carbon-tax, emissions-limit, water-availability regulations) and the logic is sound. (4) CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: exposure evolution, concern escalation, regulatory impact on operations, and customer data center expansion implications. The answer is well-structured and provides appropriate context. Minor note: The LLM uses 'fiscal 2023 and fiscal 2024' while the original uses '2023 and 2024,' but this is a negligible formatting difference. The LLM's answer is slightly more detailed and concrete than the original, providing specific examples of regulatory types (carbon-tax, emissions-limit, water-availability) which enhances clarity without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 522,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s Guaranteed Senior Notes grew from $0.5 billion (issued in Nov 2023) to about $0.92 billion on the balance sheet, reflecting a net addition of roughly $0.44 billion after the July 2024 repayment of $77 million of those notes.  The notes continue to be valued using Level 3 inputs (unobservable assumptions about future cash‑flows and discount rates), and no material fair‑value adjustments were recorded during the period.  Consequently, the carrying amount of other long‑term debt rose from $484 million in 2023 to $919 million in 2024, while the fair‑value hierarchy input level remained Level 3.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth data. Critical issues: (1) MAJOR QUANTITATIVE ERRORS: The LLM claims the notes grew from $0.5B to $0.92B, but the ground truth states $500M was issued in 2023 and $77M was repaid in 2024, resulting in approximately $423M remaining (not $0.92B). The calculation of 'net addition of roughly $0.44 billion' is mathematically incorrect ($500M - $77M = $423M, not $920M). (2) INCORRECT BALANCE SHEET FIGURES: The LLM states 'carrying amount of other long-term debt rose from $484 million in 2023 to $919 million in 2024' - these numbers do not align with the ground truth which discusses fair values of $5,738M (2023) and $5,412M (2024) for total long-term debt. The LLM appears to have fabricated or misidentified these specific carrying amounts. (3) MISSING KEY INFORMATION: The LLM fails to mention the interest rate ranges (1.400% to 2.120%) that were explicitly stated in the ground truth. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies Level 3 inputs and mentions the repayment, it fails to properly synthesize the relationship between the issuance, repayment, and overall fair value decline. (5) SEMANTIC CONFUSION: The LLM conflates different metrics - discussing both balance sheet carrying amounts and fair values without clear distinction, and the numbers provided don't correspond to either metric in the ground truth. The answer demonstrates fundamental misunderstanding of the multi-hop synthesis required, presenting invented figures rather than accurately extracting and combining information from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 448,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "\nBetween 2022 and 2024 Netflix continued to pour resources into streaming‑service upgrades—technology‑and‑development headcount and spending rose sharply, and the company formalized a dedicated security leadership role (the Vice President of Security and Privacy Engineering) who reports regularly to senior management and the Audit Committee.  At the same time, the cybersecurity risk profile intensified: the 2022 filing highlighted the VP’s oversight and board‑level risk reporting, while the 2024 filing disclosed a higher frequency of content‑leak and third‑party‑vulnerability incidents and warned that any major service disruption or data breach could materially harm the business, underscoring growing exposure despite the ongoing investment in streaming improvements.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer completely omits the specific $384 million personnel cost increase disclosed in 2022, which is a key factual anchor in the ground truth. This is a major numerical omission that undermines the answer's credibility. (2) UNVERIFIED CLAIMS: The LLM introduces specific details not present in the ground truth, including: (a) 'Vice President of Security and Privacy Engineering' as a formal role title, (b) claims about 'board-level risk reporting' in 2022, (c) references to 'higher frequency of content-leak and third-party-vulnerability incidents' in 2024. These details cannot be verified against the ground truth and may be hallucinated. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the evolution from growth-focused investment to risk-aware posture, it fails to anchor this narrative with the specific $384M figure that grounds the 2022 baseline. (4) PARTIAL CORRECTNESS: The LLM does correctly capture: (a) the shift from personnel/headcount growth (2022) to cybersecurity emphasis (2024), (b) the mention of data breach/service disruption risks, (c) the overall trajectory of increasing security focus. (5) REASONING QUALITY: The multi-hop reasoning structure is sound (connecting personnel investment to cybersecurity evolution), but it's built on partially fabricated details rather than ground truth facts. The answer reads plausibly but lacks the specific quantitative anchors that validate the narrative. RECOMMENDATION: The answer demonstrates understanding of the general trend but fails on factual precision by omitting the $384M figure and introducing unverified details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 455,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "\nThe 2023 filing disclosed the then‑current 2023 Restricted Stock Unit (RSU) and Performance Share Unit (PSU) agreements (Exhibits 10.26 – 10.27) as previously filed in quarterly reports, whereas the 2024 filing introduces a newly designated 2024 RSU agreement (Exhibit 10.29) and amends the Executive Severance Plan (Exhibit 10.30), demonstrating that the company systematically refreshes these equity‑award documents each year to adjust performance criteria, vesting triggers and severance linkages—an explicit lifecycle‑management approach that tightens the tie between RSU/PSU payouts and long‑term executive compensation strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) ENTITY/DOCUMENT ERRORS: The LLM references '2023 Restricted Stock Unit (RSU) and Performance Share Unit (PSU) agreements (Exhibits 10.26 – 10.27)' in the 2023 filing, but the ground truth specifically discusses the '2024 Form of Restricted Stock Unit Agreement' being newly filed ('Filed herewith') in the 2023 filing. The LLM conflates different forms and exhibit numbers without evidence. (2) TIMELINE MISALIGNMENT: The ground truth clearly states that in 2023, the '2024 Form' was newly introduced ('Filed herewith'), and by 2024, this same form became 'Previously filed' while a new '2025 Form' was introduced ('Filed herewith'). The LLM incorrectly suggests the 2024 form was newly introduced in the 2024 filing, missing the critical point that it was actually introduced in 2023. (3) MISSING KEY EVOLUTION: The ground truth emphasizes the forward-looking pattern where each year introduces a new form (2024 Form in 2023 filing, 2025 Form in 2024 filing), demonstrating proactive annual updates. The LLM fails to capture this crucial annual refresh cycle. (4) INCOMPLETE SYNTHESIS: While the LLM mentions 'systematically refreshes these equity-award documents each year,' it doesn't establish the specific 2023-to-2024 evolution pattern that the ground truth documents. (5) UNSUPPORTED DETAILS: The LLM introduces references to 'Executive Severance Plan (Exhibit 10.30)' and discusses 'performance criteria, vesting triggers and severance linkages' without grounding these in the provided ground truth, which focuses specifically on RSU agreement forms and their filing status. The answer demonstrates partial understanding of lifecycle management but fundamentally misrepresents the timeline and specific forms involved in the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 500,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "\nThe $750 million, 4.90 % senior notes that were issued in November 2023 (maturing on April 15, 2029) were recorded at a carrying amount of $746.6 million after a $3.4 million discount (see HD 10‑K 2023 page 60). By the end of fiscal 2024 the notes were still outstanding, with a reported carrying amount of roughly $744–$746 million on the February 2 2025 balance sheet (see HD 10‑K 2024 page 62), and they retain the same April 15, 2029 maturity date. The notes continue to accrue interest semi‑annually and remain callable under the indenture, but no redemption or refinancing has occurred to date.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the 4.90% Senior Notes evolution and addresses the question comprehensively. STRENGTHS: (1) Correctly identifies the $750 million principal amount, November 2023 issuance date, April 15, 2029 maturity date, and $3.4 million discount; (2) Properly synthesizes multi-hop information across 2023 and 2024 filings; (3) Accurately notes the semi-annual interest payment structure and callable nature of the notes; (4) Correctly identifies that no redemption/refinancing occurred; (5) Provides appropriate source citations (HD 10-K pages). MINOR DISCREPANCIES: (1) The LLM states carrying amount of $746.6 million in 2023 (after discount), while ground truth states $743 million as of January 28, 2024. The $746.6M figure appears to be the 2023 year-end carrying amount, and $743M is the 2024 carrying amount - the LLM conflates these slightly by presenting $746.6M as the 2023 figure without clearly distinguishing the 2024 amount; (2) The LLM provides a range of '$744-$746 million' for 2024 rather than the specific $743 million stated in ground truth, introducing some imprecision; (3) Ground truth emphasizes the carrying amount 'slightly decreased' reflecting amortization, while LLM's range presentation obscures this trend. CALCULATION VERIFICATION: The $750M principal minus $3.4M discount = $746.6M is mathematically correct for initial carrying amount. The progression to $743M by January 28, 2024 reflects appropriate amortization of the discount over ~2.5 months. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings, correctly tracking the notes' evolution and status. The reasoning is sound and logical. OVERALL: The answer is substantially correct with minor quantitative imprecision in the 2024 carrying amount specification and slight ambiguity in distinguishing 2023 vs 2024 figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 512,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "\nBetween November 2023 and July 2024, Costco’s Japanese subsidiary issued a $500 million series of Guaranteed Senior Notes (four separate tranches with fixed rates of 1.400%–2.120% and maturities from 2033 to 2043). In July 2024 the subsidiary repaid $77 million of those notes, reducing the outstanding balance but leaving the remainder of the $500 million issuance still outstanding. No additional issuances or further repayments of the Guaranteed Senior Notes were disclosed for the remainder of 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. All key numbers are accurate: $500 million issuance, four tranches, interest rates of 1.400%-2.120%, and $77 million repayment. The answer correctly identifies the Japanese subsidiary and the Guaranteed Senior Notes instrument. The multi-hop synthesis is sound, properly connecting the 2023 issuance with the 2024 repayment activity. The LLM provides additional helpful context (specific timing of November 2023 issuance and July 2024 repayment, maturity dates of 2033-2043) that enhances understanding, though this level of detail was not explicitly in the ground truth statement. The answer appropriately notes that the remainder of the $500 million issuance remained outstanding after the $77 million repayment. Minor deduction: The ground truth uses approximate language ('approximately $500') while the LLM states '$500 million' more definitively, though this is a negligible difference. The LLM's statement about 'no additional issuances or further repayments' for the remainder of 2024 is a reasonable inference from the ground truth but goes slightly beyond what was explicitly stated. Overall, the answer demonstrates accurate financial reporting synthesis and clear communication of the evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 365,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "\nThe 2022 and 2023 Form 10‑K filings both list the same explicit risk language—“competitors may also develop after‑market services and parts for our products which may detract from our sales”—and place it within the “Business and Strategic Risks” section.  This wording shows that the threat has not diminished; rather, it remains a material concern that could erode demand, increase pricing pressure and adversely affect Danaher’s revenue and profitability.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH CORE ANSWER: The LLM answer fundamentally contradicts the ground truth on the key finding. Ground truth states that the risk framing SHIFTED from 2022 to 2023—from being described as a 'direct threat' that could 'detract from our sales' to being 'Impacted By' competition within broader industry context, representing a relative de-emphasis in severity. The LLM claims the 'same explicit risk language' appears in both years and that 'the threat has not diminished,' which directly contradicts the ground truth's central claim about the evolution of how this risk was presented. QUANTITATIVE ACCURACY: The LLM correctly identifies the specific risk language quoted ('competitors may also develop after-market services and parts for our products which may detract from our sales') and correctly identifies the section placement ('Business and Strategic Risks'). These factual elements are accurate. QUALITATIVE ACCURACY: The LLM completely misses the nuanced shift in risk framing that is the core of the question. The ground truth emphasizes that while the core risk remained, the CONTEXTUALIZATION changed—from a primary threat to one of several external pressures. The LLM fails to capture this evolution and instead asserts the risk 'has not diminished,' which is a misreading of the ground truth's argument about relative de-emphasis and strategic recalibration. MULTI-HOP REASONING: The question asks about evolution 'from 2022 to 2023' with specific focus on how the framing changed. The LLM fails to perform the required year-over-year comparison and instead treats both years as presenting identical risk language without acknowledging the shift in contextualization and emphasis. COMPLETENESS: The LLM does not address the broader contextualization within cost containment trends, managed care pressures, or government reimbursement policies that the ground truth identifies as part of the 2023 framing. The answer is incomplete in addressing the full scope of how the risk evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 541,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix moved away from a static three‑tier subscription model toward a more flexible pricing architecture that added a low‑cost, ad‑supported plan and began modestly raising prices on its standard and premium tiers, while also tightening rules that limit sharing across households. These changes were designed to counter slowing membership growth, boost average revenue per user, and diversify income streams in the face of intensifying competition and rising content‑cost pressures—issues highlighted in the 2022 filing’s discussion of pricing tests and in the 2024 filing’s emphasis on expanding the ad‑supported offering and enforcing household‑sharing restrictions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key strategic changes (ad-supported plan introduction, household sharing restrictions, price increases) and accurately characterizes the business challenges (slowing membership growth, competition, content costs). The multi-hop reasoning is sound in connecting 2022-2024 evolution to underlying business pressures. The answer appropriately synthesizes information across the time period and addresses all parts of the multi-part question.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer provides NO specific numbers from the ground truth, which is a significant omission. The ground truth contains concrete metrics: 19% revenue increase (2022), 11% membership growth, 7% ARPU increase, and critically, a 50% drop in paid net membership additions. These quantitative details are essential to demonstrating the severity of challenges Netflix faced and are completely absent from the LLM response. This represents a major gap in supporting the narrative with evidence.\n\nWEAKNESSES - COMPLETENESS: While the LLM mentions 'pricing tests' and 'household-sharing restrictions,' it does not explicitly reference the 50% decline in paid net membership additions—the most critical metric showing the urgency of Netflix's strategic pivot. The ground truth emphasizes this as a key signal of 'member acquisition challenges,' but the LLM only vaguely references 'slowing membership growth.'\n\nWEAKNESSES - SPECIFICITY: The LLM describes the model as 'moving away from a static three-tier subscription model' but the ground truth does not explicitly confirm this characterization. The LLM also mentions 'modestly raising prices' without quantifying the increases, whereas the ground truth provides the 7% ARPU increase figure.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across 2022 and 2024 filings and properly connects strategic changes to underlying business drivers (macroeconomic conditions, competition, pricing sensitivity). This reasoning is sound and well-articulated.\n\nSEMANTIC EQUIVALENCE: The LLM's characterization of challenges and strategic responses aligns with the ground truth's meaning, though with less precision and supporting detail.\n\nSCORING JUSTIFICATION: The answer receives a 6/10 because while it demonstrates good qualitative understanding of Netflix's strategic evolution and correctly identifies the major business challenges, it fails to include any of the specific quantitative metrics that ground the analysis. For a financial question requiring multi-hop synthesis, the absence of concrete numbers (19% revenue growth, 11% membership growth, 7% ARPU increase, 50% decline in net additions) is a substantial deficiency. The answer would be stronger with at least some of these key figures to support its narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 740,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "\nBoeing still records the net‑present‑value of expected in‑orbit incentive fees as revenue during the satellite‑construction phase, but the fees are contingent on the spacecraft meeting performance specifications for up to 15 years after launch. In 2022 the risk was disclosed simply as a possible loss of future payments and the need for refunds if the satellite under‑performs; by 2023 the language stresses that these incentives are now embedded in increasingly fixed‑price development contracts and can trigger material reach‑forward losses or earnings charges if performance criteria are not met, reflecting a higher‑visibility risk exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Boeing's approach to in-orbit incentive payments between 2022 and 2023, correctly identifying the shift from simple risk disclosure to more specific quantification and emphasis on performance criteria. However, there are significant quantitative omissions and some accuracy issues:\n\nSTRENGTHS:\n1. Correctly identifies the 15-year performance period post-acceptance\n2. Accurately describes the shift from general risk acknowledgment (2022) to more specific quantification (2023)\n3. Correctly notes that NPV of fees is recognized as revenue during construction\n4. Properly identifies the contingent nature of payments based on performance criteria\n5. Appropriately characterizes the increased visibility of risk exposure\n\nWEAKNESSES:\n1. CRITICAL OMISSION: The ground truth specifically mentions $1,585 million in recorded losses on five significant fixed-price development programs in 2023. The LLM answer completely fails to include this key quantitative metric, which is a major factual gap.\n2. INCOMPLETE PROGRAM IDENTIFICATION: The ground truth mentions specific programs (Commercial Crew, KC-46A Tanker, VC-25B) that provide context. The LLM answer generalizes to \"fixed-price development contracts\" without naming these programs.\n3. VAGUE LANGUAGE: The LLM uses phrases like \"increasingly fixed-price development contracts\" and \"material reach-forward losses\" which are less precise than the ground truth's specific quantification.\n4. MISSING CONTEXT: The ground truth explains the distinction between 2022 (termination provisions/loss of payments) and 2023 (specific loss quantification + detailed revenue recognition practices). The LLM captures the evolution but misses the specific financial quantification.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate multi-hop reasoning by synthesizing information about revenue recognition, performance criteria, and risk exposure across the two years. However, the failure to include the $1,585 million figure suggests incomplete synthesis of available data.\n\nQUANTITATIVE ACCURACY: Score of 4 due to the complete omission of the $1,585 million loss figure, which is a critical quantitative element of the ground truth answer.\n\nQUALITATIVE ACCURACY: Score of 7 because the reasoning about the evolution is sound and the conceptual understanding is correct, but the execution lacks the specific details and quantification that would make it fully accurate.\n\nCONTEXTUAL RELEVANCE: Score of 8 because the answer directly addresses the question about evolution between 2022 and 2023, though it could be more specific about the programs and financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 709,
        "total_tokens": 2151
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the company moved from a brief mention of the Directors’ Code of Conduct in the ethics section with a PDF link (2023 Form 10‑K, pp. 11‑13) to an explicit listing of the code among the corporate‑governance materials that are posted on its website and referenced in the “Available Information” section (2024 Form 10‑K, pp. 2‑3).  The 2024 filing also states that any amendments or waivers of the Directors’ Code will be disclosed on the website, making the code more transparent and easier for investors to locate and review.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple ways: (1) DIRECTIONAL ERROR: The LLM claims the company moved FROM a brief mention with PDF link TO explicit listing, but the ground truth states the opposite - in 2023 there was explicit disclosure with a specific URL, and in 2024 it became more general/consolidated. This is a fundamental reversal of the evolution described. (2) MISSING KEY DETAIL: The LLM fails to mention the specific URL (https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf) that was explicitly provided in 2023, which is a critical element of the ground truth answer. (3) MISCHARACTERIZATION OF CHANGE: The LLM describes the 2024 change as making the code 'more transparent and easier for investors to locate and review,' but the ground truth explicitly states the opposite - that the 2024 change represents 'a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access.' (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that both years reference the code on the website and mention amendments/waivers disclosure, it fails to capture the nuanced distinction that 2023 provided direct URL access while 2024 provided only general reference within a broader list. (5) TONE MISMATCH: The LLM's characterization of increased transparency contradicts the ground truth's assessment of decreased directness. The answer demonstrates poor multi-hop reasoning by failing to accurately synthesize the comparative evolution between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 455,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "\nBetween 2022 and 2023 Mobileye Drive™ moved from a research‑grade, end‑to‑end L4 platform used in limited pilot programs to a commercial, licensable self‑driving stack that powers revenue‑generating Robotaxi services (e.g., SIXT in Germany and other MaaS partners) and is being offered to fleet operators and public‑transport providers.  The deployment strategy shifted toward licensing the Drive system to mobility‑service companies and bundling it with Moovit’s mobility‑intelligence platform, while the hardware roadmap (EyeQ 6L/H and the upcoming EyeQ Ultra) was introduced to scale performance and support higher‑level autonomy.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements when compared to the ground truth. CORRECT ELEMENTS: (1) The shift toward licensing/commercial deployment strategy is accurate; (2) Bundling with Moovit's platform is correctly mentioned; (3) The focus on fleet operators and public transit providers is accurate; (4) The general evolution from research to commercial deployment is correct. INACCURATE/UNSUPPORTED ELEMENTS: (1) The LLM introduces SIXT in Germany as a specific example of revenue-generating Robotaxi services, but this is NOT mentioned in the ground truth and cannot be verified from the provided context; (2) The mention of 'EyeQ 6L/H and EyeQ Ultra' hardware roadmap details are NOT present in the ground truth answer and appear to be fabricated or from external knowledge not in the filing data; (3) The characterization of 2022 as 'research-grade, end-to-end L4 platform used in limited pilot programs' is somewhat inaccurate - the ground truth indicates 2022 already had commercial collaborations (Udelv, Transdev) and a consumer design win (Geely), not just pilots. MISSING ELEMENTS: (1) The specific 2022 partnerships with Udelv and Transdev are not mentioned; (2) The Geely consumer L4 design win is omitted; (3) The ground truth emphasizes 'transportation network companies' as a specific target, which is less emphasized in the LLM answer. MULTI-HOP REASONING: The LLM does synthesize the evolution between 2022-2023 and identifies the strategic shift, but introduces unsupported details (SIXT, specific chip models) that suggest hallucination rather than faithful synthesis of the provided ground truth. The answer demonstrates partial understanding of the evolution but compromises accuracy by adding unverified information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 479,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "\nFrom 2022 through 2024 the Tower Preferred Interests kept the same two series—a $1.5 bn Class A‑1 tranche that paid a 5.0 % quarterly distribution and a $4.5 bn Class A‑2 tranche that paid 4.75 %—but in August 2024 the company amended the 2019 Tower preferred interests. The amendment reset the rates and restructured the securities: all of the interests are now designated Fixed‑Rate Class A Limited Interests that pay a higher 5.90 % quarterly distribution, while a portion will transition to Floating‑Rate Class A Limited Interests that pay SOFR + 250 bps (capped at $525 million by 2028). The reset schedule remains every five years, and the redemption and liquidation rights are unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. Verified facts: (1) 2022 structure correctly identified with Class A-1 at $1,500M (5.0%) and Class A-2 at $4,500M (4.75%); (2) August 2024 amendment correctly described with reclassification to Fixed Rate Class A at 5.90%; (3) Floating Rate Class A correctly identified as SOFR + 250 bps; (4) Five-year reset schedule correctly maintained. The answer demonstrates sound multi-hop reasoning by synthesizing the evolution across the 2022-2024 period and correctly identifying the structural changes. Minor strengths: The LLM added helpful context about the $525 million cap by 2028 for floating rate interests and noted that redemption/liquidation rights remained unchanged—details not explicitly in the ground truth but consistent with it. One minor semantic issue: The LLM states 'quarterly distribution' while the ground truth uses 'preferred distribution' without specifying frequency. This is a minor wording variation that doesn't affect factual accuracy. The answer comprehensively addresses both the structural evolution (two series → fixed rate with floating rate transition) and the rate evolution (5.0%/4.75% → 5.90% fixed + SOFR+250bps floating). All numbers, percentages, and dates are accurate. The synthesis across the time period is logical and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 374,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "\nFrom 2022 to 2023 the Balanced Index Fund continued to be valued by a **market‑approach (Level 1) using quoted prices of identical instruments**, so the valuation methodology did not change.  However, the **unrealized gains on the Fund’s Level 3‑classified holdings swung from a $90 unrealized loss in 2022 to a $14 unrealized gain in 2023**, driven by positive net gains of $5 in corporate fixed‑income, $7 in mortgage‑backed securities and $3 in other fixed‑income that offset prior losses.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n   - LLM claims unrealized loss of $90 million in 2022; ground truth shows ($16)M + ($11)M = ($27)M total\n   - LLM claims unrealized gain of $14 million in 2023; ground truth shows $2M + $6M = $8M total\n   - LLM states gains of $5M (corporate), $7M (mortgage-backed), $3M (other); ground truth shows $2M and $6M respectively\n   - These are fundamental calculation errors with wrong magnitudes (off by ~$76M in 2022, ~$6M in 2023)\n\n2. VALUATION METHODOLOGY - PARTIALLY INCORRECT:\n   - LLM claims valuation methodology \"did not change\" and remained Level 1 (market approach with quoted prices)\n   - Ground truth indicates the 2023 disclosure \"explicitly referenced\" a market approach based on quoted market prices, implying this was a notable change or clarification from 2022\n   - The statement that methodology \"did not change\" contradicts the ground truth's emphasis on the 2023 explicit reference to Level 1 methodology\n\n3. ASSET COMPOSITION:\n   - LLM fails to mention the 60/40 equity/debt composition that remained constant across both years\n   - This is a material omission from the answer\n\n4. MULTI-HOP REASONING:\n   - Failed to correctly synthesize the Level 3 asset data across years\n   - Incorrectly aggregated or calculated the unrealized gains/losses\n   - Did not properly address the evolution of the investment approach\n\n5. SEMANTIC ISSUES:\n   - The claim about \"positive net gains\" offsetting \"prior losses\" is conceptually confused given the magnitude errors\n   - The answer mischaracterizes the nature of the change in valuation methodology\n\nThe answer demonstrates fundamental misunderstanding of the data with incorrect numbers that are off by tens of millions of dollars, making it substantially unreliable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 517,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "\nIn the 2023 filing, references to accounting developments appear only as part of the generic forward‑looking “expectations” language, but the 2024 Form 10‑K elevates them to a stand‑alone risk factor that explicitly warns that “changes in accounting standards governing the preparation of our financial statements … could have a material impact on our reported financial condition, results of operations, cash flows and other financial data.” This shift indicates that BNY Mellon now regards accounting‑standard updates as a central strategic driver—shaping its reporting framework, capital‑planning and risk‑management priorities rather than treating them as a peripheral concern.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) The LLM claims that in 2023, accounting developments appeared 'only as part of generic forward-looking expectations language,' but the ground truth indicates they were included in a broader list of potential influences. (2) The LLM asserts that 2024 elevates accounting developments to a 'stand-alone risk factor' with specific language about 'changes in accounting standards governing the preparation of our financial statements...could have a material impact,' but the ground truth shows the 2024 language actually expands the existing framework to state accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments.' The quoted language in the LLM answer does not match the ground truth's documented language. (3) The LLM mischaracterizes the nature of the evolution—the ground truth describes an expansion of integrated language, not a shift to a stand-alone risk factor. (4) The LLM's interpretation that accounting standards are now 'central strategic drivers' is an overstatement not supported by the ground truth, which describes a 'more integrated view' rather than elevation to centrality. (5) The LLM fails to mention key 2024 additions like 'capital plans including dividends and repurchases' and 'efficiency savings' that the ground truth identifies as evidence of concrete business decision linkage. The answer appears to fabricate specific quote language and misrepresents the actual evolution described in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 442,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "\nIn 2023 the company’s risk profile shifted from the 2022 focus on engagement‑driven programs (surveys, DEI, recognition, culture‑building) to new safety and cyber‑threats that could directly affect how associates work.  The 2022 ESG materials highlighted store‑safety measures and data‑privacy safeguards, but the 2023 risk disclosures stress that “failure to maintain a safe and secure store environment” and “data‑governance failures…could adversely affect our reputation and business” – meaning higher shrink, organized‑retail crime, ransomware and system‑downtime that add compliance burdens, limit scheduling flexibility and increase daily stress for associates.  Consequently, while 2022’s initiatives were designed to boost emotional commitment, the evolving 2023 risks introduced operational pressures that could dampen that engagement if not fully mitigated.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the shift from 2022 engagement-focused initiatives (surveys, recognition programs, culture-building) to 2023 risk focus (store safety, cybersecurity); (2) Accurately captures the specific risks mentioned: organized retail crime, shrink, ransomware, system downtime; (3) Properly synthesizes the multi-hop comparison showing how 2023 risks could undermine 2022 gains in associate engagement; (4) Correctly identifies the potential negative impacts on associate morale, retention, and operational stress; (5) No quantitative errors - dates and time periods are accurate. MINOR WEAKNESSES: (1) The LLM answer references 'DEI' in the 2022 initiatives, which is not explicitly mentioned in the ground truth (ground truth mentions 'engagement surveys, digital engagement platform, and recognition programs'); (2) The ground truth specifically mentions 'four out of five associates were emotionally committed' - a concrete metric that the LLM answer does not include, though it does reference 'emotional commitment' conceptually; (3) The LLM answer adds some interpretive details about 'compliance burdens' and 'scheduling flexibility' that, while logically sound, are not explicitly stated in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2022 and 2023 periods, comparing engagement initiatives against emerging risks and their potential impact on associate experience. The logical flow is sound: 2022 focused on engagement → 2023 introduced external risks → these risks could undermine earlier gains. SEMANTIC EQUIVALENCE: The answer conveys the same fundamental message as the ground truth - that the company's focus shifted from internal engagement programs to managing external risks that could negatively impact associates. The wording differs but the meaning is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 525,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "\nBetween 2022 and 2023 the learning‑curve shifted from a peripheral variable in program‑accounting estimates to a central driver of cost and production assumptions.  The 2023 disclosures explicitly link learning‑curve performance to abnormal production costs, reach‑forward losses and a $1.4 billion increase in valuation allowances, showing that inaccurate learning‑curve forecasts now directly erode program profitability and force more conservative margin forecasts and heightened risk provisions.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ERROR - The LLM introduces a '$1.4 billion increase in valuation allowances' that is NOT mentioned in the ground truth answer. This is a specific dollar figure that cannot be verified against the original answer and appears to be fabricated or misattributed. This is a critical factual error. (2) INCOMPLETE SYNTHESIS - The ground truth clearly states the evolution: 2022 = risk factor (negative impact, production complexities, rework, delays, additional losses, abnormal costs); 2023 = integrated into cost estimation (predictable, manageable component). The LLM answer partially captures this shift but frames it differently. (3) SEMANTIC DRIFT - The LLM says learning curve shifted from 'peripheral variable' to 'central driver,' but the ground truth says it shifted from 'unpredictable risk' to 'predictable/manageable component.' These are different characterizations. The ground truth emphasizes risk management evolution; the LLM emphasizes importance escalation. (4) MISSING CONTEXT - The LLM fails to mention specific 2022 details (787 program, production complexities, rework, delays) that were part of the ground truth. (5) UNSUBSTANTIATED CLAIMS - References to 'reach-forward losses' and 'more conservative margin forecasts' are not explicitly in the ground truth answer provided. While these may be related concepts, they are not verified in the source material. The core issue is the introduction of unverified quantitative data ($1.4B) which violates the strict standard for financial numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 424,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "\nBoth the 2023 and 2024 Form 10‑K filings disclose that officers and directors may elect to participate in the company’s dividend‑reinvestment (and employee‑stock‑purchase) plan, and that any such participation can involve withholding shares to cover withholding taxes or to pay the exercise price of stock awards. The language in the 2024 filing is essentially unchanged from the 2023 filing—it still notes that these elections may be made “to satisfy the affirmative‑defense conditions of Rule 10b5‑1 … or may constitute non‑Rule 10b5‑1 trading arrangements,” indicating that the treatment and disclosure of the DRIP with respect to insider participation has remained consistent across the two filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the central claim of the question. The ground truth explicitly states that the 2024 filing OMITTED the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements that was present in the 2023 filing, indicating a simplification or standardization of disclosure. However, the LLM answer claims the language is 'essentially unchanged' and that the 2024 filing 'still notes' the Rule 10b5-1 and non-Rule 10b5-1 trading arrangements language. This is a fundamental factual error that directly contradicts the ground truth's core finding about the evolution of disclosure between the two years. The LLM correctly identifies that both filings mention officer/director participation in the DRIP and withholding elections (quantitative accuracy is reasonable here as no specific numbers are involved), but it completely misses the key distinction: the 2024 filing removed the detailed trading arrangement framework language that was present in 2023. The LLM's conclusion that disclosure 'has remained consistent' is the opposite of what the ground truth indicates. This represents a failure in multi-hop reasoning and synthesis—the model needed to identify what changed (or was removed) between the two filings, not what remained the same. The answer demonstrates a fundamental misunderstanding of the question's focus on how the disclosure 'evolved,' which specifically means identifying differences, not similarities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 410,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "\nFrom fiscal 2021 through fiscal 2023 the company moved from a broad‑based build‑out of digital and BOPIS capabilities toward a fully integrated, “interconnected” experience that is now customized to each shopper’s intent and location.  In 2023 the retailer added personalized, location‑aware marketing messages, richer product‑page data, same‑day/next‑day omni‑channel delivery (including market‑delivery hubs for appliances), electronic‑shelf‑labels, curb‑side lockers, self‑checkout and computer‑vision inventory tools, and expanded Pro‑focused online portals, credit and loyalty programs—all of which tailor the shopping journey across stores, online and on‑the‑job sites.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer completely omits the specific $2.6 billion capital expenditure figure from fiscal 2021 that is central to the ground truth answer. This is a major factual omission of a key quantitative metric. (2) UNVERIFIED CLAIMS: The LLM answer introduces numerous specific features (personalized location-aware marketing, electronic shelf labels, curbside lockers, self-checkout, computer-vision inventory tools, Pro-focused portals, expanded credit/loyalty programs, market-delivery hubs) that are NOT mentioned in the ground truth answer. While these may be accurate details from the filings, they cannot be verified against the provided ground truth and represent significant elaboration beyond what was confirmed. (3) PARTIAL ALIGNMENT: The LLM correctly identifies the evolution from 2021 to 2023 and the shift toward customization based on shopping intent and location, which aligns with the ground truth's core narrative. (4) MISSING SPECIFICITY ON TOOLS: The ground truth specifically mentions 'enhanced merchandising information technology tools' as the mechanism for personalization, while the LLM lists many operational features but doesn't emphasize the IT/merchandising tools aspect. (5) REASONING QUALITY: The multi-hop synthesis is reasonable in structure (comparing 2021 to 2023), but the answer goes well beyond what can be verified in the ground truth, raising concerns about hallucination or unsourced information. The answer reads as more detailed and comprehensive than the ground truth, which is a red flag for potential inaccuracy. VERDICT: While the directional narrative is correct, the omission of the $2.6B figure and introduction of unverified specific features significantly undermines the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 487,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "\nBetween 2022 and 2023 Danaher’s exposure to Aldevron stayed at the level established by the 2021 $9.6 bn acquisition – the goodwill from that deal (≈ $6.1 bn) remained on the balance sheet and was only subject to the usual annual impairment review, with no new purchase‑price allocation or material transaction‑cost charges recorded in 2023.  Capital investment did increase, however, as the company continued to fund capacity‑expansion projects for Aldevron (capital expenditures rose to roughly $1.5 bn in 2022 and were expected to stay elevated in 2023), while acquisition‑related outlays were essentially settled, with only minor post‑closing adjustments (e.g., the $28 m of integration costs recorded in 2021) and no further major acquisition spending.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth. Key issues: (1) CRITICAL ERROR - The LLM states the $9.6 billion acquisition occurred in 2021, but the ground truth indicates the net cash consideration of $9,561 million was paid in 2023, representing the actual acquisition completion/payment timing relevant to the question. (2) QUANTITATIVE ERRORS - The LLM correctly identifies ~$1.5 billion in capital expenditures for 2022 but fails to properly contextualize this within the 2022-2023 evolution. The ground truth emphasizes that by 2023, the $9,561 million payment marked a transition point, not a continuation of 2021 activity. (3) MISINTERPRETATION OF RELATIONSHIP EVOLUTION - The LLM characterizes the relationship as 'staying at the level established by the 2021 acquisition' with only 'minor post-closing adjustments,' fundamentally misunderstanding the question's focus on how the relationship evolved between 2022 and 2023. The ground truth explicitly states this represents 'a substantial shift' from capital investment target to 'core component of DHR's consolidated assets.' (4) MISSING KEY INSIGHT - The LLM fails to capture that the 2023 $9,561 million payment represents a material change in the financial relationship, not merely a continuation of prior-year patterns. (5) GOODWILL REFERENCE - While the LLM mentions ~$6.1 billion goodwill, this is presented as static/unchanged, missing the dynamic nature of the 2022-2023 evolution. The answer reads as a static description of post-acquisition accounting rather than an analysis of how the relationship evolved between the two years as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 454,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "\nBetween 2022 and the end of 2024 the Telco LLC preferred equity grew from a single $2 bn Class A‑1 series (4.25 % annual distribution, reset on the original seven‑year schedule) to a multi‑series structure that, as of 31 Dec 2024, consists of $2 bn of Class A‑1, $2.5 bn of Class A‑2 and $2.75 bn of Class A‑3 (total $7.25 bn). The original Class A‑1 continues to pay a 4.25 % distribution and resets every seven years, while the 2023‑issued Classes A‑2 and A‑3 pay a higher 6.85 % distribution and are scheduled to reset on 1 Nov 2027 (and thereafter on each seven‑year anniversary). A new Class A‑4 series with a 5.94 % distribution is slated for issuance in Q1 2025 and will reset on 1 Nov 2028 (and every four years thereafter).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental unit conversion errors that make the numbers factually incorrect. The ground truth states values in millions ($2,000 = $2,000 million = $2 billion), but the LLM has converted these to billions without proper verification. Specifically: (1) Ground truth: $2,000 in Class A-1 preferred interests; LLM states '$2 bn' - this is a 1,000x magnitude error if interpreted literally, though the LLM may have intended to express this as $2 billion (which would be correct). (2) Ground truth: $5,250 total new issuance split as Class A-2 and A-3; LLM states '$2.5 bn of Class A-2 and $2.75 bn of Class A-3' - these numbers don't match the ground truth allocation and appear to be incorrect breakdowns. (3) Total value: Ground truth correctly states $7,250 (in millions); LLM states '$7.25 bn' which is semantically equivalent IF the original numbers were in millions, but the component breakdown is wrong. (4) MAJOR ADDITION NOT IN GROUND TRUTH: The LLM introduces a Class A-4 series with 5.94% distribution and Q1 2025 issuance with a 4-year reset schedule. This information is NOT present in the ground truth answer and represents either hallucination or information beyond the scope of the 2022-2024 period specified in the question. (5) Distribution rates: Correctly identified as 4.25% for Class A-1 and 6.85% for Classes A-2 and A-3. (6) Reset schedules: Correctly identified as 7-year resets for Class A-1 and November 1, 2027 first reset for Classes A-2/A-3. The LLM demonstrates understanding of the structural evolution and correctly identifies the multi-series expansion, but the quantitative errors (particularly the component breakdown of the new issuances and the introduction of unverified Class A-4 information) are significant enough to undermine the answer's reliability. The answer goes beyond the 2022-2024 timeframe specified in the question by discussing 2025 issuances.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 527,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "\nBetween 2022 and 2024 AIG expanded the Expected‑Loss‑Ratio (ELR) approach beyond excess‑of‑deductible and long‑tail lines to more data‑sparse classes such as U.S. Property, Specialty, Aviation and program business.  The rationale shifted to using ELR for the most recent accident years when development patterns are inconsistent, applying refined rate‑change, inflation and market‑trend adjustments and supplementing the method with ground‑up claim projections to produce more reliable, up‑to‑date reserve estimates.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) ENTITY ACCURACY FAILURE: The LLM claims ELR was expanded to include 'U.S. Property, Specialty, Aviation and program business' by 2024, but the ground truth explicitly states that by 2024, AIG expanded ELR to include 'U.S. Workers' Compensation' - a long-tail line. The LLM mentions Aviation as a 2024 expansion, but the ground truth indicates Aviation was already being used with ELR methods in 2022. (2) INCOMPLETE SYNTHESIS: The ground truth clearly identifies U.S. Workers' Compensation as the key expansion line by 2024, combined with loss development and frequency/severity methods. The LLM completely omits Workers' Compensation and instead lists different lines (Property, Specialty) that are not mentioned in the ground truth. (3) METHODOLOGICAL MISALIGNMENT: While the LLM correctly identifies that ELR was used for recent accident years with inconsistent development patterns, it fails to accurately capture which specific insurance lines were involved in the 2022-2024 evolution. (4) RATIONALE DISCUSSION: The LLM does provide some valid reasoning about refined adjustments and supplementing with ground-up projections, which adds some contextual value, but this cannot compensate for the fundamental factual errors about which insurance lines were actually involved. (5) MULTI-HOP REASONING: The answer fails to correctly synthesize the evolution across the two time periods - it appears to conflate different lines or provide incorrect information about which lines were added when. The core claim about Workers' Compensation expansion in 2024 is entirely absent from the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 467,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "\nTarget’s owned‑brand strategy shifted from a primary focus on “strengthening our owned‑brands portfolio” (2023) to a more curated, partnership‑driven expansion in 2024.  The 2024 filing highlights a vastly broader roster of exclusive labels—over 150 distinct brands—and emphasizes new design collaborations (e.g., Apple, Disney, Levi’s, Ulta Beauty) and shop‑in‑shop concepts, positioning owned brands as a growth engine that now accounts for roughly one‑third of merchandise sales.  This evolution reflects a strategic emphasis on deeper category coverage, higher‑margin exclusive products, and leveraging data‑driven marketing (Roundel, Target Circle) to differentiate the portfolio and drive traffic through stores and digital channels.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error regarding the number of owned brands. The ground truth states Target had 'over 40 distinct brands' in 2024, but the LLM claims 'over 150 distinct brands.' This is a significant quantitative discrepancy (150 vs 40) that fundamentally misrepresents Target's brand portfolio scale. The LLM also introduces specific brand partnerships (Apple, Disney, Levi's, Ulta Beauty) and metrics (one-third of merchandise sales, Roundel, Target Circle) that are not mentioned in the ground truth and cannot be verified against the provided knowledge graph. While the LLM correctly identifies the general strategic shift from 2023 to 2024 and appropriately emphasizes execution and diversification, the introduction of unverified specific numbers and partnerships is problematic. The LLM's discussion of shop-in-shop concepts and data-driven marketing adds contextual detail not in the ground truth, which could be either elaboration or hallucination. The core conceptual understanding of the evolution is partially correct (shift from emphasis to execution), but the quantitative accuracy is severely compromised by the 150 vs 40 brand count discrepancy. The answer demonstrates reasonable qualitative reasoning about strategic evolution but fails on factual precision regarding key metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 373,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "\nIBM kept its existing 0.875 % Notes due 2030 on the 2024 filing while simultaneously adding a brand‑new 2.900 % Notes due 2030, indicating that it is maintaining a staggered maturity ladder and using the newer, higher‑coupon issue to supplement its long‑term funding mix. This move signals that IBM still sees attractive market conditions for issuing long‑dated debt—it can refinance or expand its capital base at reasonable rates and retain flexibility—while also preserving the lower‑cost legacy notes for future cash‑flow management.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: 0.875% and 2.900% coupon rates, 2030 maturity date, and the year 2024 are all accurate. (2) The LLM correctly identifies that both notes were listed in 2024 and recognizes the significant rate differential (2.025 percentage point increase). (3) The quantitative accuracy is high with proper formatting and no calculation errors. WEAKNESSES: (1) The LLM answer lacks critical context from the ground truth: it does not mention that the 0.875% Notes were initially issued in 2023, which is important for understanding the timeline and strategic evolution. (2) The ground truth explicitly states the trading symbols (IBM30A and IBM30C), which the LLM omits entirely. (3) The LLM's interpretation of 'attractive market conditions' contradicts the ground truth's more nuanced analysis. The ground truth suggests the higher rate in 2024 indicates 'less favorable interest rate conditions' compared to 2023, whereas the LLM implies favorable conditions. This is a significant interpretive error. (4) The ground truth mentions targeting 'different investor segments with varied risk-return profiles' and 'managing refinancing risks,' which are more sophisticated strategic considerations than the LLM's simpler 'staggered maturity ladder' explanation. (5) The LLM's phrase 'refinance or expand its capital base at reasonable rates' is somewhat vague and doesn't capture the ground truth's insight about the rate increase reflecting market condition changes. (6) The ground truth's analysis of portfolio diversification and refinancing risk management is more comprehensive than the LLM's explanation. The LLM provides a partially correct but incomplete and somewhat misinterpreted analysis of IBM's debt strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 477,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "\nBetween 2022 and 2024 AT&T retained its 4.000 % Global Notes maturing June 1, 2049 — which appears in the registration tables of both the 2022 and 2024 Form 10‑K filings — but it broadened its long‑term debt mix by issuing several new global notes.  The 2024 filing adds higher‑coupon, longer‑dated series such as 4.375 % notes due 2029, 4.250 % notes due 2043, 4.875 % notes due 2044 and a 7.000 % note due 2040, as well as later‑maturity issues (e.g., 5.350 % due 2066, 5.625 % due 2067), diversifying the maturity profile and expanding the overall amount of outstanding long‑term debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces numerous debt instruments (4.375% due 2029, 4.250% due 2043, 4.875% due 2044, 7.000% due 2040, 5.350% due 2066, 5.625% due 2067) that are NOT mentioned in the ground truth answer. The ground truth specifically identifies only the 4.300% Global Notes due November 18, 2034 (T 34C) as the new addition in 2024. (2) INCOMPLETE SYNTHESIS - The LLM failed to identify the specific new debt instrument mentioned in ground truth: the 4.300% Global Notes due 2034 (T 34C). Instead, it lists entirely different instruments with different coupon rates and maturity dates. (3) MISSING KEY DETAIL - The ground truth emphasizes the registration symbols (T 49A for 2049 notes, T 34C for 2034 notes), which the LLM completely omits. (4) CORRECT ELEMENTS - The LLM correctly identifies that AT&T retained the 4.000% Global Notes due June 1, 2049 across both years, and correctly notes the general concept of portfolio expansion. However, the specific instruments cited are inaccurate. (5) MULTI-HOP REASONING - While the LLM demonstrates understanding of the general concept (retention + expansion), it fails at the critical step of correctly identifying which specific new instruments were added. The answer appears to conflate or confuse actual debt instruments from the filings. This is a significant factual error that undermines the entire response, as the question specifically asks about 'the addition of new long-term notes' and the LLM provides incorrect examples.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 421,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "\nIn 2023 the Heritage AspenTech acquisition contributed roughly **$258 million** of intangible‑asset amortization, forming part of the **$482 million** total amortization recorded that year; by 2024 total intangibles amortization jumped to **$1.08 billion**, driven largely by **$560 million** of new amortization from the NI purchase, so the Heritage AspenTech amortization remained in the mix but its relative weight declined.  At the same time, restructuring expenses rose sharply from **$72 million in 2023 to $228 million in 2024**, reflecting additional integration‑related cost cuts—especially **$97 million in Software & Control and $78 million in Test & Measurement**—much of which stemmed from the ongoing assimilation of the Heritage AspenTech business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) INTANGIBLES AMORTIZATION - The LLM states Heritage AspenTech amortization was $258M in 2023 (CORRECT) but then claims it 'remained in the mix' in 2024 without providing the actual 2024 figure of $97M (INCORRECT/INCOMPLETE). The ground truth explicitly states the 2024 figure decreased to $97M, which the LLM completely omits. This is a major factual gap for the core question. (2) RESTRUCTURING COSTS - The LLM correctly states $72M in 2023 and $228M in 2024 (CORRECT). However, the LLM then provides additional detail about segment-level breakdowns ($97M Software & Control, $78M Test & Measurement) that sum to $175M, which does not equal the stated $228M total. This creates an internal inconsistency and calculation error. (3) EXTRANEOUS INFORMATION - The LLM introduces substantial information about the NI acquisition ($560M amortization, $1.08B total) that, while potentially contextually relevant, was NOT asked for in the question and dilutes focus from the Heritage AspenTech-specific analysis. (4) MULTI-HOP SYNTHESIS - The question specifically asks about Heritage AspenTech evolution between 2023-2024. The LLM fails to clearly state the 2024 Heritage AspenTech intangibles amortization figure ($97M), which is essential to answering the 'how did it evolve' question. The answer should have explicitly compared: 2023 intangibles $258M → 2024 intangibles $97M (decrease) and 2023 restructuring $72M → 2024 restructuring $228M (increase). The LLM provides the restructuring comparison correctly but omits the critical 2024 intangibles figure. (5) SEMANTIC ACCURACY - While the LLM correctly identifies the general trend (amortization burden reduction, restructuring expense rise), it fails to provide complete numerical evidence for the intangibles portion of the analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 493,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 AIG deepened its reliance on expected‑loss‑ratio models for workers‑compensation reserves, giving them greater weight in the most recent accident‑year calculations.  It also refined the segmentation of the book—splitting guaranteed‑cost and excess‑of‑deductible layers and then further dividing those by state, industry and, importantly, by deductible size and claim‑handling arrangement (AIG‑administered versus third‑party).  Because the share of large‑deductible business has risen and causes slower claim emergence, AIG adjusted its tail‑factor assumptions and placed more emphasis on the expected‑loss‑ratio method for those segmented groups.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly captures the core evolution of AIG's expected loss ratio methods between 2022 and 2024. STRENGTHS: (1) Accurately identifies the shift toward greater segmentation by deductible size and claim handling (AIG vs. third-party administrators), which matches the ground truth; (2) Correctly notes the increased proportion of large deductible business and its impact on slowing claim emergence; (3) Properly synthesizes the multi-hop information about how these factors influenced AIG's methodology adjustments; (4) No quantitative errors in dates or entities. WEAKNESSES: (1) The LLM answer states AIG 'deepened its reliance' and gave expected-loss-ratio methods 'greater weight in the most recent accident-year calculations,' but the ground truth indicates the 2022 baseline already applied these methods to guaranteed cost business in the most recent accident year and to excess of deductible business in the most recent five accident years. The characterization of 'deepening reliance' and 'greater weight' is somewhat imprecise—the evolution was more about refined segmentation and emphasis rather than fundamentally increased weight; (2) The LLM answer omits a significant 2024 disclosure detail mentioned in the ground truth: the explicit highlighting of limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022. This is a material omission for a complete answer about how disclosures evolved; (3) The mention of 'state, industry' segmentation factors appears in the LLM answer but is not explicitly confirmed in the ground truth provided, though it doesn't contradict it. Overall, the answer demonstrates solid understanding of the main evolution but misses some nuance about the nature of the change (refinement vs. deepening) and omits the important disclosure evolution regarding data limitations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 512,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "\nTarget’s cyber‑fusion‑center operations were expanded and formalized between the 2023 and 2024 filings.  In the 2024 Form 10‑K the company describes a more structured incident‑response workflow that includes a coordinated escalation model to senior management and the Board, regular penetration‑testing, vulnerability‑scanning and attack‑simulation of its controls, and validation of its security framework through both internal and independent assessments.  At the same time, Target notes an increased level of external collaboration—continually sharing threat‑intelligence and best‑practice insights with other industry groups to strengthen its threat‑investigation and response capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the evolution from 2023 to 2024 with appropriate temporal framing; (2) Accurately captures the key developments: structured incident-response workflow, coordinated escalation model to senior management and Board, penetration testing, vulnerability scanning, and attack simulation; (3) Properly synthesizes the multi-hop information about both internal improvements and external collaboration; (4) Correctly identifies the use of third-party vendors for assessment and testing; (5) Maintains semantic equivalence with ground truth regarding threat intelligence sharing and best practices collaboration. MINOR GAPS: (1) The LLM answer mentions 'regular penetration-testing, vulnerability-scanning and attack-simulation' but the ground truth more specifically references 'leveraging third-party vendors to assess and test its cybersecurity program' - while the LLM captures the essence, it could be slightly more explicit about the third-party vendor involvement; (2) The ground truth mentions 'regular training and compliance activities for team members' which the LLM answer does not explicitly address, though this is a relatively minor omission in the context of the overall response. QUANTITATIVE ACCURACY: No numbers, dates, or calculations are present in either answer, so this dimension scores perfectly. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis across 2023 and 2024 filings is correctly executed. The answer properly identifies Target as the subject company and correctly distinguishes between the two fiscal years. CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses the question about cybersecurity threat investigation and response evolution, Cyber Fusion Center operations, and external collaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 511,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "\nBetween 2023 and 2024 the Baqsimi relationship moved from a one‑time licensing transaction to ordinary product sales. In 2023 the sale of Baqsimi rights generated a $677.6 million revenue line (including $139 million in 2022) that was recorded as collaboration and other revenue, with any upfront payment recognized when the rights were transferred. By 2024 the rights sale is complete and Baqsimi sales are reported solely as net product revenue, recognized at shipment and subject to the same returns‑reserve and rebate accounting used for all other products.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth: (1) QUANTITATIVE ERRORS - The LLM states '$677.6 million revenue line (including $139 million in 2022)' which is incorrect. The ground truth clearly states Eli Lilly reported $579.0 million in revenue for Baqsimi rights sale in 2023. The $677.6 million figure appears to be fabricated or confused with another metric. The inclusion of 2022 figures ($139 million) is not mentioned in the ground truth and adds confusion. (2) REVENUE RECOGNITION MODEL - The LLM incorrectly characterizes the evolution. It claims the relationship 'moved from a one-time licensing transaction to ordinary product sales' with 2024 showing 'Baqsimi sales are reported solely as net product revenue.' The ground truth indicates the opposite: in 2023 there was a $579.0 million one-time rights sale, and by 2024 Baqsimi was integrated into 'collaboration and other revenue' disclosures - NOT converted to ordinary product revenue. (3) CLASSIFICATION ERROR - The LLM states the 2023 transaction was 'recorded as collaboration and other revenue,' which aligns with ground truth, but then incorrectly claims 2024 moved to 'net product revenue.' The ground truth explicitly states 2024 shows Baqsimi 'included within broader collaboration and other revenue disclosures.' (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the evolution: it misidentified the direction of change and the accounting treatment in 2024. The ground truth shows a move toward MORE complex revenue recognition (integration into collaborative arrangements), not toward simpler product revenue recognition. (5) MISSING CONTEXT - The LLM's characterization of 'returns-reserve and rebate accounting' for 2024 is not supported by the ground truth, which focuses on the shift to collaborative arrangement disclosures. The answer demonstrates fundamental misunderstanding of the actual financial relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 532,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "\nFrom 2023 through 2024 AT&T completed the full repurchase of the original Mobility II cumulative perpetual preferred interests (all were retired in April 2023), eliminating that legacy series.  In 2024 the company shifted to expanding and restructuring preferred‑equity in its tower and Telco subsidiaries—amending the 2019 Tower preferred interests with new fixed‑rate (5.90 %) and floating‑rate tranches, issuing an additional $2.25 bn of Telco LLC preferred interests (including a new Class A‑4 series slated for 2025), and maintaining the newly created Series B non‑controlling preferred interests in Mobility II—thereby moving capital‑structure management from retiring legacy preferreds to issuing and resetting layered preferred stakes that can be called and have refreshed distribution terms.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct directional elements but contains significant quantitative errors and omissions that undermine accuracy. CORRECT ELEMENTS: (1) The repurchase of Mobility Preferred Interests in 2023 (April 2023 timing is accurate); (2) The shift toward Tower Holdings and Telco LLC preferred interests expansion in 2024; (3) The 5.90% fixed rate for Tower preferred interests; (4) The general strategic pivot from retiring legacy preferreds to issuing new structures. CRITICAL ERRORS: (1) QUANTITATIVE MISMATCH - Ground truth specifies 213 million Mobility Preferred Interests repurchased for $5,414 million, funded by $5,250 million in new Telco LLC preferred interests. The LLM answer mentions '$2.25 bn of Telco LLC preferred interests' as 'additional' issuance but fails to specify the $5,250 million 2023 issuance or the total Telco LLC preferred interests reaching $7,250 million by 2024. This is a major omission of key financial data. (2) INCOMPLETE ACCOUNTING - Ground truth specifies the removal of $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities' in the 2023 repurchase. The LLM answer provides no balance sheet impact details. (3) MISSING DISTRIBUTION RATES - Ground truth specifies the 6.85% annual distribution rate for the 2023 Telco LLC preferred interests and SOFR + 250 bps for floating rate Tower interests. The LLM answer only mentions 5.90% for Tower fixed-rate. (4) VAGUE REFERENCES - The LLM mentions 'Series B non-controlling preferred interests in Mobility II' and 'Class A-4 series slated for 2025' without grounding these in the ground truth data provided. (5) STRUCTURAL DETAILS - Ground truth specifies the original $2,000 Telco Class A-1 component; the LLM answer doesn't clearly articulate the composition of the $7,250 total. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution from 2023 to 2024 and identifies the strategic shift, but fails to accurately quantify the capital structure changes. The reasoning about moving from retiring to issuing preferreds is sound, but the execution lacks precision on the specific amounts and terms. SEMANTIC ISSUES: While the general narrative is directionally correct, the answer lacks the specificity required for a financial analysis question where exact numbers matter significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 625,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "\nFrom 2023 to 2024 Emerson’s stake in AspenTech shifted from a 57 % minority holding—where AspenTech contributed only modest earnings ($12 million profit in 2023 and a small loss in 2024)—to a announced cash‑and‑stock offer to acquire the remaining ~43 % of the company at $240 per share, which would give Emerson 100 % ownership.  The integration of AspenTech’s software portfolio helped lift Emerson’s overall net sales and contributed to a 1.8‑percentage‑point rise in gross margin to 50.8 % in 2024, although acquisition‑related inventory step‑up amortization of $231 shaved roughly 1.3 percentage points off that margin.  Consequently, the transformation changed Emerson’s ownership structure from a partial equity interest to full consolidation of AspenTech, eliminating the minority stake and re‑classifying its results as wholly owned.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. OWNERSHIP STRUCTURE ERROR (Critical): The LLM claims Emerson had a 57% minority holding that evolved to a 100% acquisition announcement. The ground truth states Emerson acquired a 55% ownership stake in 'New AspenTech' following a ~$6.0 billion transaction. The LLM's narrative of starting with 57% and moving to 100% is factually incorrect.\n\n2. TRANSACTION DETAILS ERROR (Critical): The LLM mentions a '$240 per share' offer for remaining ~43%, but the ground truth specifies approximately $6.0 billion in cash for the 55% stake acquisition. These are different transactions with different values.\n\n3. GROSS MARGIN ATTRIBUTION ERROR (Significant): While the LLM correctly identifies a 1.8 percentage point gross margin increase in 2024, it fails to mention the 3.3 percentage point increase in 2023 that the ground truth explicitly attributes to the AspenTech acquisition. The LLM also introduces inventory step-up amortization of $231 million reducing margin by 1.3 percentage points, which is not mentioned in the ground truth.\n\n4. TIMING ERROR (Significant): The ground truth indicates the acquisition occurred by 2024 (with 2023 impacts), while the LLM presents this as an 'announced' future transaction, suggesting it hadn't closed yet.\n\n5. EARNINGS DATA (Minor): The LLM mentions '$12 million profit in 2023 and a small loss in 2024' for AspenTech, which is not corroborated in the ground truth.\n\n6. MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the relationship evolution. The ground truth shows a clear progression from business partner (2023) to majority shareholder (2024). The LLM's narrative of already holding 57% in 2023 contradicts this evolution.\n\nThe answer demonstrates fundamental misunderstanding of the actual transaction structure and ownership changes, making it substantially incorrect despite touching on some relevant metrics like the 1.8 percentage point margin increase.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 550,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "\nJapan’s defined‑benefit plans accounted for roughly half of the non‑U.S. pension obligations—about 51 % in 2022 and essentially unchanged at around 50 % in 2024—so their contribution remained stable. Over the same period the weighted‑average discount rate applied to these plans rose from approximately 1.48 % to 1.81 %, an increase of roughly 0.33 percentage points.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states Japan pension plans were '51% in 2022' but the ground truth indicates 61% in 2022. This is a significant 10 percentage point error on a key metric. The LLM correctly identifies 50% for 2024 and the discount rate change from 1.48% to 1.81% (0.33 percentage point increase). (2) COMPLETENESS - The LLM fails to mention the intermediate 2023 data point (54% in 2023), which is important for showing the trend evolution across the three-year period. The ground truth explicitly notes the progression from 54% (2023) to 50% (2024). (3) CHARACTERIZATION ERROR - The LLM characterizes the contribution as 'essentially unchanged' and 'stable,' but the ground truth indicates a 'relative decline' from 61% (2022) to 50% (2024), a 11 percentage point decrease. This is a material mischaracterization of the trend. (4) CORRECT ELEMENTS - The discount rate analysis is accurate (1.48% to 1.81%, 0.33 percentage point increase), and the identification of Japan plans as roughly half of non-U.S. obligations in 2024 is correct. (5) MULTI-HOP REASONING - The LLM failed to properly synthesize the multi-year data to identify the actual trend of declining contribution, instead incorrectly concluding stability. The reasoning about market conditions and investment strategy changes mentioned in the ground truth is absent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 382,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "\nIn the 2022 10‑K the reference to “the introduction of competitive stores, websites, products, services, price decreases, or improvements” appears only as one item in a long list of risk‑drivers, without a separate discussion of the external market forces that generate that competition. By contrast, the 2023 filing embeds the same language inside a broader statement that “as international physical, e‑commerce and omnichannel retail … grow, competition will intensify, including through adoption of evolving business models,” explicitly framing competitive store launches as part of an external, market‑driven intensification of rivalry and noting the inherent advantage of local players. This shift reflects a move from a generic risk bullet to a more explicit framing of competitive‑store impacts as shaped by external market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that the 2023 filing 'retained the same core language' as the 2022 filing regarding competitive stores, and that the shift was about embedding this language 'within a broader context' of external economic conditions. However, the LLM answer claims the 2023 filing contains NEW language about 'international physical, e-commerce and omnichannel retail...grow, competition will intensify, including through adoption of evolving business models' and attributes this to the 2023 filing as a distinguishing feature. This appears to be fabricated or misattributed language not supported by the ground truth. The ground truth indicates both filings used the same core phrase about 'competitive stores, websites, products, services, price decreases, or improvements,' with the difference being contextual framing rather than new competitive language. The LLM also mischaracterizes the nature of the shift - the ground truth emphasizes that the 2023 filing placed competitive pressures within a broader statement about 'general economic, business, and geopolitical conditions worldwide,' not specifically about 'international physical, e-commerce and omnichannel retail growth.' The LLM's interpretation that this represents a move from 'generic risk bullet to more explicit framing' is backwards from the ground truth, which indicates the shift was toward BROADER contextualization rather than MORE explicit competitive framing. The answer does correctly identify that both years reference competitive stores and that there was an evolution in framing, but the specific nature of that evolution is misrepresented. No quantitative errors (no numbers were involved), but the qualitative mischaracterization of the actual textual changes is severe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 508,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "\nTarget’s 2023 filing framed port‑security risk chiefly around occasional closures and congestion at U.S. West Coast ports—especially California—where disruptions could cause stock‑outs and force alternative shipping routes. The 2024 filing broadens that risk to a wider set of global ports, tying them to political‑economic instability, trade‑policy shifts and rising transport‑cost inflation, and stresses that any such port disruption would raise inventory costs and compel the company to seek alternate sources, thereby heightening the operational impact on margins and supply‑chain resilience.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Target's port security risk exposure between 2023 and 2024, with mostly accurate characterization of the geographic and operational shifts. STRENGTHS: (1) Correctly identifies the 2023 focus on California/West Coast ports as a specific geographic concern; (2) Accurately captures the 2024 broadening to 'major U.S. ports' or wider global ports; (3) Properly synthesizes the shift from past disruptions (2023) to future potential impacts (2024); (4) Correctly identifies operational impacts including inventory costs, supply chain resilience, and margin pressures; (5) Appropriately contextualizes 2024 concerns with global conflicts and labor disputes. MINOR ISSUES: (1) The LLM answer mentions 'global ports' in 2024, while the ground truth specifies 'major U.S. ports'—this is a slight overstatement of geographic scope, though the broader point about expansion beyond California is correct; (2) The LLM adds details about 'trade-policy shifts' and 'transport-cost inflation' that are not explicitly mentioned in the ground truth, though these are reasonable inferences from port security risk discussions; (3) The characterization of 2023 as focusing on 'occasional closures and congestion' is reasonable but not explicitly stated in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and correctly identifies the evolution pattern. The comparison between 2023 and 2024 is logically sound and addresses the core question about how exposure evolved. No quantitative errors detected (no specific numbers were provided in either answer to verify). The semantic meaning aligns well with the ground truth despite some wording differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 478,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "\nBetween 2023 and 2024 the amortization of the intangibles acquired in the Heritage AspenTech deal grew from $258 million in 2023 (shown as the “Heritage AspenTech acquisition” line in the 2023 amortization table on page 55) to a much larger share of the $1.077 billion total intangible amortization in 2024—most of the increase being driven by the $560 million of new amortization from the NI acquisition, with the remainder continuing to write‑off the Heritage AspenTech customer and IP intangibles.  At the same time, restructuring costs linked to the integration of Heritage AspenTech rose sharply from $10 million in 2023 to $97 million in 2024 (part of the overall $228 million of restructuring expense reported on page 56), reflecting higher integration‑related expenses as Emerson continued to realign the combined business.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - Intangibles Amortization: Ground truth states the Heritage AspenTech-specific amortization was $258M in 2023 and was NO LONGER REPORTED in 2024 (indicating it was no longer separately tracked as a newly acquired entity). The LLM incorrectly claims it \"grew\" and that Heritage AspenTech amortization continued as \"the remainder\" of the $1.077B total in 2024. This is a fundamental misreading of the data.\n   - Restructuring Costs: Ground truth clearly states restructuring costs were $72M in 2023 and $228M in 2024. The LLM claims Heritage AspenTech-linked restructuring costs were $10M in 2023 and $97M in 2024, which are completely different numbers and appear to be fabricated or misattributed figures.\n\n2. MULTI-HOP REASONING FAILURE:\n   - The LLM incorrectly synthesizes the relationship between Heritage AspenTech and NI acquisition impacts. While the NI acquisition did contribute to 2024 amortization, the LLM's claim that Heritage AspenTech amortization \"continued\" in 2024 directly contradicts the ground truth that it was no longer separately reported.\n   - The LLM misinterprets what \"no longer reported\" means - it should indicate the acquisition was fully integrated/matured, not that it continued as a major component.\n\n3. ENTITY AND METRIC ACCURACY:\n   - Correctly identifies Emerson, Heritage AspenTech, and NI acquisition\n   - Correctly identifies the years (2023-2024)\n   - Incorrectly attributes specific restructuring cost figures to Heritage AspenTech integration\n\n4. SEMANTIC MISALIGNMENT:\n   - Ground truth: Amortization shifted away from AspenTech as a \"newly acquired entity\" in 2024\n   - LLM: Claims Heritage AspenTech amortization continued and grew in 2024\n   - These are contradictory interpretations of the same data\n\n5. SPECIFIC NUMBER VERIFICATION:\n   - $258M (2023 Heritage AspenTech amortization): Correct in LLM but misinterpreted as continuing in 2024\n   - $228M (2024 total restructuring): Correct in LLM\n   - $72M (2023 restructuring): NOT mentioned by LLM; instead claims $10M for Heritage AspenTech only\n   - $97M (2024 Heritage AspenTech restructuring): Appears fabricated; ground truth doesn't break down restructuring by acquisition\n   - $1.077B (2024 total intangible amortization): Mentioned but context is incorrect\n\nThe LLM answer fundamentally misrepresents the evolution of Emerson's financial relationship with Heritage AspenTech, claiming continued growth in amortization when the ground truth indicates it was no longer separately reported, suggesting full integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 709,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "\nBetween 2022 and 2024 AIG kept the Expected‑Loss‑Ratio (ELR) approach in its reserve toolkit but refined how it is weighted.  The 2022 filing (pages 268‑272) said the ELR method “may be given significant weight in the most recent five accident years,” while the 2024 filing (pages 149‑153) explicitly states that ELR is “given weight for the more recent accident years” and singles out excess‑of‑deductible, U.S. Financial Lines, cyber/M&A and other low‑frequency/high‑severity coverages as the lines where the method receives the strongest emphasis because development patterns are less reliable.  Consequently, AIG has shifted from a broad “weight the ELR in the last five years” rule to a more targeted practice that places greater reliance on ELR for recent years and for those lines where loss‑development data are sparse or volatile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses: STRENGTHS: (1) Correctly identifies the evolution of ELR methods between 2022 and 2024; (2) Accurately captures the shift from broad application to more targeted use; (3) Correctly identifies low-frequency/high-severity lines as key areas of ELR application; (4) Appropriately notes the emphasis on recent accident years; (5) Good contextual understanding of why ELR is preferred for certain lines. WEAKNESSES: (1) CRITICAL OMISSION: The ground truth explicitly mentions U.S. Workers' Compensation as a NEW application area in 2024, representing expansion to a long-tail line of business. The LLM answer completely fails to mention this significant evolution, instead listing 'excess-of-deductible, U.S. Financial Lines, cyber/M&A' without acknowledging Workers' Compensation; (2) The LLM cites specific page numbers (268-272 for 2022, 149-153 for 2024) that cannot be verified and may be inaccurate; (3) The LLM quotes 'may be given significant weight in the most recent five accident years' from 2022 and 'given weight for the more recent accident years' from 2024, but these quotes cannot be verified against the ground truth; (4) The LLM's characterization of the shift as moving from 'broad weight the ELR in the last five years rule' to 'more targeted practice' is somewhat accurate but misses the key point about expansion into Workers' Compensation, which actually represents BROADER application, not narrower; (5) The ground truth emphasizes integration with other methods (loss development, frequency/severity) in 2024, which the LLM answer does not adequately address. MULTI-HOP REASONING: The LLM successfully synthesizes information across two years and identifies the evolution pattern, but fails to capture the complete picture of how the method expanded to new lines of business. The reasoning about targeting recent years and low-frequency/high-severity lines is sound, but incomplete. QUANTITATIVE ACCURACY: The specific page citations and quotes cannot be verified and appear potentially inaccurate, reducing confidence in the quantitative precision. The 'five accident years' reference may be correct but is not confirmed in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 603,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "\nBetween 2022 and 2023 Amazon’s capitalized outlay for video and music content grew modestly—from **$16.7 billion to $17.4 billion**—while the amount of expense recognized from that content jumped more sharply, from **$16.6 billion to $18.9 billion**.  This rise in both capitalized costs and expense reflects a heavier investment in acquiring and producing original titles and larger licensing spend, even as the film‑group model (monetized primarily through Prime memberships across major geographies) remains unchanged, with impairment testing still applied to each film‑group’s carrying value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: capitalized costs increased from $16.7B to $17.4B (matching ground truth exactly), and expenses rose from $16.6B to $18.9B (matching ground truth exactly). The multi-hop synthesis is sound—the answer correctly identifies the evolution of monetization strategy by comparing both metrics across the two-year period and drawing appropriate conclusions about increased investment. The LLM goes slightly beyond the ground truth by adding contextual details about the Prime membership monetization model and impairment testing, which are relevant and accurate elaborations that enhance understanding without contradicting the source material. The characterization of the capitalized cost increase as 'modest' ($700M increase, ~4.2%) versus the expense increase as 'sharper' ($2.3B increase, ~13.9%) is mathematically sound and provides useful analytical perspective. The reasoning correctly synthesizes that both metrics rising together indicates 'heavier investment in acquiring and producing original titles and larger licensing spend.' Minor deduction only because the ground truth's phrasing about 'more aggressive investment' and 'corresponding rise in monetization efforts' is slightly more direct, though the LLM's interpretation is semantically equivalent and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 382,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "\nBetween 2022 and 2024 Philip Morris International did not acquire or divest any additional shares in Rothmans, Benson & Hedges – it continued to hold the same equity stake that had been left on its books after the 2019 de‑consolidation.  However, the proposed CAD 32.5 bn settlement of Canadian tobacco litigation (which remained unresolved in 2024) created significant uncertainty about the allocation of the liability among RBH, Imperial Tobacco Canada and JTI, prompting PMI to test the investment for impairment.  As a result, PMI recorded a $2.3 bn non‑cash impairment charge in 2024, writing down the carrying value of its RBH equity investment to below its fair value.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides accurate financial information with sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the $2.3 billion impairment charge in 2024 (matches ground truth's $2,316 million within acceptable rounding/format variation); (2) Accurately references the $32.5 billion Canadian tobacco litigation settlement amount; (3) Correctly identifies the three parties involved in the settlement allocation dispute (RBH, Imperial Tobacco Canada/ITL, and JTI/JTIM); (4) Properly explains the shift from trademark/licensing relationship to equity investment with impairment; (5) Accurately notes PMI maintained the same equity stake from the 2019 de-consolidation without additional share transactions; (6) Correctly characterizes the impairment as a non-cash charge in 2024 due to unresolved settlement allocation. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the 2022 trademark relationship with RBH and volume of brands sold (HEETS), which the ground truth specifically highlights as part of the evolution narrative. This is a notable omission in addressing the 'evolution between 2022 and 2024' aspect of the question, though the answer does focus on the 2024 impairment development; (2) The phrasing 'writing down the carrying value of its RBH equity investment to below its fair value' is slightly awkward (should be 'to reflect fair value' or similar), though the meaning is clear. QUANTITATIVE VERIFICATION: $2.3 bn ≈ $2,316 million (acceptable format variation); $32.5 bn Canadian settlement amount correct; years 2022-2024 correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information about PMI's relationship with RBH across the time period, connecting the equity stake, the litigation settlement, and the resulting impairment charge. The reasoning is logical and complete. The main gap is the incomplete coverage of the 2022 baseline relationship, which affects the completeness of the 'evolution' narrative requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 548,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "\nThe disclosures show that the estimated revenue impact of a 5 % change in the combined sales‑return, rebate and discount liabilities fell slightly from about **$615 million in 2023** to **$600 million in 2024**.  This modest decline indicates that the sensitivity of LLY’s net product revenue to those accrual balances weakened a bit between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that fundamentally contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims a 2024 figure of $600 million, but the ground truth explicitly states that LLY did NOT provide an updated sensitivity figure in 2024. The LLM fabricated a specific number ($600 million) that does not exist in the actual filings. The only verified number is the 2023 figure of $615 million, which the LLM correctly cited. (2) FACTUAL CONTRADICTION: The ground truth clearly indicates 'it did not provide an updated sensitivity figure' and 'did not disclose a revised estimate for the impact of liability changes on revenue in 2024.' The LLM's statement that the figure 'fell slightly from about $615 million in 2023 to $600 million in 2024' directly contradicts this disclosure absence. (3) REASONING ERROR: The LLM's conclusion that 'the sensitivity of LLY's net product revenue to those accrual balances weakened a bit between the two years' is based on a non-existent 2024 figure. This represents failed multi-hop reasoning - the model should have recognized that without a 2024 disclosure, no comparison or trend analysis is possible. (4) SEMANTIC MISALIGNMENT: The ground truth emphasizes an 'omission' and 'lack of updated quantitative disclosure,' while the LLM presents a false narrative of declining sensitivity with specific numbers. These are fundamentally different conclusions. The LLM appears to have hallucinated the $600 million figure rather than accurately reflecting the absence of 2024 disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 430,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "\nUnion Pacific’s 2024 filing (page 6) reports that Bulk shipments generated **32 % of total freight revenue**, essentially the same share the company earned in 2022 (roughly 30 % of freight revenue, as reflected in the 2022 outlook and the 2021 historical tables on pages 33‑35).  Thus, Bulk’s contribution has remained stable—hovering around one‑third of freight revenue—with only a modest increase to 32 % by 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Bulk shipments contributed 32% of total freight revenue in 2024, matching the ground truth. The comparison to 2022 (~30%) is reasonable and directionally accurate. CRITICAL WEAKNESSES: (1) The LLM answer fundamentally misinterprets the question and ground truth by concluding that Bulk's contribution 'remained stable' with 'only a modest increase.' This contradicts the ground truth narrative of 'transformation' and 'evolution' from a revenue-per-unit metric (2021: $3,305 per car with 6% growth) to a strategically embedded, revenue-significant segment. (2) The LLM completely omits the revenue-per-car metric ($3,305 in 2021, 6% increase from 2020), which is central to understanding the 'evolution' described in the ground truth. (3) The LLM fails to address the qualitative evolution mentioned in the ground truth: detailed operations covering grain, fertilizer, coal markets, international connections to Mexico, and Canadian interline routes. (4) The LLM's characterization of the change as 'stable' (30% to 32%) misses the ground truth's emphasis on transformation from a unit-economics perspective to a strategically important revenue contributor. MULTI-HOP REASONING: The LLM only partially synthesizes the required information—it captures the percentage contribution but fails to integrate the revenue-per-car metric and strategic evolution narrative that define the 'evolution' from 2022 to 2024. The answer is incomplete and semantically misaligned with the ground truth's core message about transformation rather than stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 436,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "\nThe coupon on IBM’s 2028 notes was 0.300 % in both the 2023 and 2024 Form 10‑K filings (the parallel 1.750 % series was likewise unchanged). Because the rate did not shift, IBM is deliberately locking in low‑cost, long‑dated financing and extending the maturity of its debt, reflecting a strategy of maintaining a conservative, low‑interest debt profile and preserving financial flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains critical factual errors that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the coupon rate was 0.300% in both 2023 and 2024, which is factually incorrect. The ground truth clearly states the rate was 1.750% in both years. This is a major numerical error - the LLM misidentified the interest rate by nearly 1.5 percentage points. (2) ENTITY CONFUSION: The LLM mentions 'the parallel 1.750% series' as if it's a separate instrument, when in fact the 1.750% Notes due 2028 IS the primary instrument being discussed. This suggests confusion about which debt instrument is being analyzed. (3) INCOMPLETE SYNTHESIS: While the ground truth mentions IBM's broader debt strategy including new 2024 issuances (2.900% Notes due 2030 and 3.150% Notes due 2033), the LLM completely omits this important context about IBM's multi-year debt strategy evolution. (4) REASONING QUALITY: The LLM's interpretation that unchanged rates indicate 'locking in low-cost, long-dated financing' is somewhat reasonable, but this reasoning is built on an incorrect foundation (wrong interest rate). The ground truth provides more nuanced context about IBM introducing higher-rate debt for longer maturities, which the LLM misses entirely. (5) MULTI-HOP SYNTHESIS: The question requires comparing 2023 and 2024 data and drawing conclusions about debt strategy. The LLM fails at the first step by misidentifying the 2023-2024 rate (0.300% vs. actual 1.750%), making subsequent analysis unreliable. The ground truth correctly identifies the unchanged 1.750% rate and connects it to broader strategic context about new higher-rate issuances.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 458,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "\nBy the end of 2023 AT&T had fully retired the original Mobility II cumulative perpetual preferred interests—completing their repurchase in April 2023 so that no Mobility preferred equity remained on the balance sheet. In 2024 the company replaced that legacy class with a new suite of preferred instruments: a $2 bn‑plus redeemable non‑controlling interest in Mobility II (Series B) that pays a 6.8 % distribution, a restructuring of the Tower‑Holdings preferred equity into fixed‑rate and floating‑rate tranches with reset schedules, and a planned $2.25 bn Class A‑4 preferred issuance in Telco LLC to fund future redemptions—thereby shifting from winding‑down the old Mobility preferred equity to deploying more flexible, reset‑able preferred structures while still preserving dividend and share‑repurchase flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM states '$2 bn-plus redeemable non-controlling interest in Mobility II (Series B)' and '$2.25 bn Class A-4 preferred issuance in Telco LLC', but the ground truth specifies the Mobility Preferred Interests had a redemption value of approximately $5,340 million and the Telco LLC preferred interests expanded to a total of $7,250 million. The LLM's numbers ($2B and $2.25B) do not match the ground truth figures ($5,340M and $7,250M). This is a critical quantitative error. (2) PARTIAL ACCURACY - The LLM correctly identifies that AT&T repurchased/retired Mobility Preferred Interests in 2023 (April 2023 timing is accurate) and that new preferred instruments were introduced in 2024. The general narrative about restructuring Tower Holdings and Telco LLC preferred interests is directionally correct. (3) MISSING INFORMATION - The LLM fails to mention the $373 million annual cash distributions that were paid by the original Mobility Preferred Interests, which is a key metric in understanding the capital structure evolution. (4) MULTI-HOP REASONING - The LLM demonstrates understanding of the strategic shift from Mobility-based to diversified preferred instruments, but the specific financial magnitudes are significantly understated or incorrect. The introduction of a 6.8% distribution rate is mentioned but not verified against ground truth. (5) SEMANTIC ISSUES - While the LLM captures the general strategic direction (from legacy Mobility preferred to more flexible structures), the specific dollar amounts are materially incorrect, which undermines the credibility of the entire analysis. The ground truth emphasizes the $5,340M redemption value and $7,250M total for Telco LLC, but the LLM presents much smaller figures ($2B and $2.25B).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 492,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "\nIn the 2022 10‑K Amazon warned that “as international physical, e‑commerce and cloud services grow, competition will intensify” and highlighted the advantage of local players, but it did not single out rival online stores. In the 2023 10‑K the wording shifts to explicitly mention “the introduction of **competitive stores, websites, products, services, price decreases, or improvements**,” directly acknowledging that rival e‑commerce sites and price‑driven offerings are a concrete competitive threat, signalling a move from a broad growth‑related risk to a focused recognition of competitive pressure from other websites.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Amazon's competitive threat characterization between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 2022 framing as broader/general ('competition will intensify' in context of growth), (2) Accurately captures the 2023 shift to explicit mention of 'competitive stores, websites, products, services, price decreases, or improvements' - this specific language matches the ground truth, (3) Properly synthesizes the multi-hop comparison showing evolution from general operational risk to focused strategic competitive challenge, (4) Correctly identifies the shift from growth-related risk to website/price-driven competitive pressure, (5) Uses appropriate qualitative language ('concrete threat,' 'focused recognition') that aligns with ground truth interpretation. MINOR WEAKNESSES: (1) The 2022 quote provided ('as international physical, e-commerce and cloud services grow, competition will intensify') is paraphrased/reconstructed rather than directly quoted from the filing - while semantically accurate to the ground truth's characterization of 2022 language as 'general awareness of competitive pressures,' the exact wording cannot be verified, (2) The answer could have been slightly more explicit about the shift from 'part of a broader list of fluctuating business factors' (ground truth language) to the more focused 2023 stance, though this distinction is adequately captured in the substance. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the directional shift in competitive characterization. The reasoning that this represents evolution from 'broad growth-related risk' to 'focused recognition of competitive pressure from other websites' is sound and matches ground truth logic. ENTITY ACCURACY: Amazon correctly identified, years (2022, 2023) correct, financial metrics/terms appropriately used. No calculation errors present as this is a qualitative analysis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 552,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "\nFrom 2022 through 2024 PMI moved the 2020 three‑year “global collaboration” with KT&G into a fully‑scale, exclusive distribution model that now covers multiple regions outside South Korea, embedding KT&G’s licensed heated‑tobacco brands (e.g., Fiit, Miix, LIL products) as core components of PMI’s smoke‑free portfolio.  This partnership has become a primary growth engine for PMI’s heated‑tobacco unit shipments—double‑digit volume gains year‑over‑year—and underpins PMI’s strategic reliance on KT&G’s heat‑not‑burn products to replace cigarettes.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CRITICAL DATE ERROR: LLM states the collaboration began in 2020 ('2020 three-year'), but ground truth indicates the agreement was in place by 2022 with a three-year term from that point. This is a fundamental factual error about the timeline. (2) PRODUCT NAME DISCREPANCY: LLM lists 'Fiit' and 'Miix' as KT&G licensed brands, but ground truth specifically mentions 'LIL Mini' and 'LIL Plus' as the heat-not-burn products. The LLM does mention 'LIL products' but also includes product names not verified in ground truth. (3) UNSUPPORTED QUANTITATIVE CLAIMS: LLM asserts 'double-digit volume gains year-over-year' and describes the partnership as 'a primary growth engine for PMI's heated-tobacco unit shipments,' but ground truth contains no such specific metrics or performance data. These are fabricated numbers/claims. (4) PARTIAL ACCURACY: The LLM correctly identifies the evolution from distribution partnership to deeper integration and correctly names KT&G and PMI. The characterization of the relationship becoming 'embedded' in PMI's portfolio aligns with ground truth. (5) MULTI-HOP REASONING: The LLM attempts to synthesize the evolution across years but introduces unsupported claims about business impact. Ground truth focuses on structural/contractual evolution (distribution → integration), while LLM adds unverified performance metrics. The core insight about deepening reliance is present but muddied by inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 404,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "\nIBM kept the PWCC Plan administered by the Executive Compensation and Management Resources Committee and, in both the 2022 and 2024 filings, continued to use it solely to fund awards for employees who joined IBM after the 2002 PwCC acquisition—senior executives are expressly excluded. The 2024 filing restates the plan’s original terms without any expansion or administrative change, indicating that its scope and governance remained unchanged between 2022 and 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) The LLM states the PwCC acquisition occurred in 2002, but the ground truth indicates it was referenced differently in the filings - the original answer mentions 'after the acquisition' without specifying 2002, and this date discrepancy is significant. (2) The LLM claims 'senior executives are expressly excluded' - this detail does not appear in the ground truth answer and may be an unsupported inference. (3) MAJOR ISSUE: The LLM completely misses the key evolution described in the ground truth - the shift in language from 2022 ('would continue to be used') to 2024 ('has been and will continue to be used'), which the ground truth identifies as indicating 'a stronger commitment to maintaining the plan's current usage without expansion.' The LLM states the scope 'remained unchanged' but fails to capture the nuanced linguistic shift that the ground truth emphasizes as significant. (4) The LLM correctly identifies that the plan was used solely for former PwCC employees and that administration remained substantively identical, which aligns with ground truth. (5) The LLM correctly notes no expansion occurred. STRENGTHS: The answer correctly identifies the core fact that the plan was used solely for PwCC employees and that there was no administrative change. WEAKNESSES: Missing the key evolution in language/commitment tone between years, introducing unsupported details about executive exclusion, and potentially incorrect acquisition date. The answer is partially correct on the main facts but fails to capture the nuanced evolution that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 439,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "\nBetween 2023 and 2024 AT&T eliminated the original Mobility II Series A cumulative perpetual preferred interests—fully repurchased in April 2023—so that no equity‑like “Mobility Preferred” obligation remained on its balance sheet.  In 2024 the company introduced new redeemable preferred structures (the Mobility II Series B non‑controlling interests and the reset Tower Fixed‑Rate and Floating‑Rate Interests, plus the upcoming Telco LLC Class A‑4 preferred issuance) that carry higher, reset distribution rates, call features and explicit redemption triggers, effectively moving the obligation from long‑dated equity to a liability‑like instrument with greater flexibility.  This shift signals AT&T’s intent to tighten its capital structure, use preferred equity with redemption and rate‑reset mechanics to manage cash‑flow and leverage, and adapt to a higher‑interest‑rate environment while preserving financial flexibility for dividends and share repurchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ERROR - The LLM states the Mobility II Series A was 'fully repurchased in April 2023' but provides NO dollar amount, while the ground truth explicitly states the repurchase was for $5,414 million total. This is a significant omission of a key financial metric. (2) FACTUAL INACCURACY - The LLM introduces new instruments ('Mobility II Series B non-controlling interests,' 'reset Tower Fixed-Rate and Floating-Rate Interests,' 'Telco LLC Class A-4 preferred issuance') that are NOT mentioned in the ground truth answer. The ground truth only references 'Tower Holdings and Telco LLC preferred interests' as remaining outstanding. The LLM appears to have fabricated or misidentified specific instrument names and structures. (3) INCOMPLETE SYNTHESIS - The ground truth clearly states 'no mention of Mobility Preferred Interests in the disclosures' by 2024, indicating complete elimination. The LLM's claim about 'Mobility II Series B non-controlling interests' in 2024 contradicts this and suggests the LLM confused or conflated different instruments. (4) REASONING QUALITY - While the LLM's general logic about capital structure management and rate-reset mechanics is conceptually sound, it is built on factually incorrect premises about which instruments actually exist in 2024. (5) WHAT WAS CORRECT - The LLM correctly identifies that the original Mobility Preferred Interests were eliminated in 2023 and that AT&T maintains other preferred interests. The conceptual framing about managing capital structure flexibility is directionally correct. VERDICT: The answer contains a critical quantitative omission ($5,414 million repurchase amount), introduces instruments not supported by ground truth, and misrepresents the 2024 landscape of AT&T's preferred interests. These are material factual errors that undermine the credibility of the analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 509,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "\nIBM’s debt‑security exposure is governed by the same baseline regulatory framework in both filings: the 2022 10‑K (pp. 20‑24) and the 2024 10‑K (pp. 9‑13) each note that the company’s publicly‑issued bonds are subject to SEC reporting, NYSE listing requirements and can be affected by rating‑agency actions, market‑liquidity conditions, and foreign‑exchange or interest‑rate changes. The evolution between 2022 and 2024 is modest—while the 2024 filing adds more detail on how emerging cybersecurity, AI and ESG‑related regulations could indirectly influence the company’s reputation and thus the market perception of its debt, the core regulatory exposure remains anchored to the unchanged SEC and exchange‑listing rules that have always applied.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misses the core finding from the ground truth. The ground truth identifies a specific EVOLUTION in IBM's language regarding stock exchange regulations between 2022 and 2024: from describing them as 'one of several factors influencing value' (2022) to stating the company is 'subject to' stock exchange regulations (2024). This represents a shift from passive/external framing to active/binding regulatory exposure. The LLM answer instead claims the regulatory framework is 'unchanged' and 'modest' in evolution, directly contradicting the ground truth's finding of a meaningful shift in regulatory acknowledgment. The LLM also introduces irrelevant details about cybersecurity, AI, and ESG regulations that are not part of the ground truth answer and appear to be fabricated or misattributed. The page number citations (pp. 20-24 for 2022, pp. 9-13 for 2024) cannot be verified against the ground truth and may be inaccurate. The LLM fails to capture the key semantic distinction between 'factors influencing value' versus 'subject to' regulations, which is the crux of the question about evolved regulatory exposure. The multi-hop reasoning required here is to identify and compare the specific language changes across the two years, which the LLM completely fails to do. Instead, it asserts continuity where the ground truth identifies meaningful change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 385,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Disney’s equity stake in A+E (held 50 % by Disney and 50 % by Hearst) shifted from a relatively strong contributor to a diminishing source of earnings.  The “Equity in the income of investees, net” line fell from $782 million in 2023 to $575 million in 2024—a $207 million drop that Disney explicitly attributed to “lower income from A+E” (page 35).  This decline reflects the impact of impairments, strategic cut‑backs in A+E’s linear‑channel portfolio and the broader move toward direct‑to‑consumer distribution, causing A+E’s equity‑income contribution to shrink markedly over the 2022‑2024 period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core financial relationship and correctly identifies the $207 million decline in equity income from A+E between 2023-2024. The key numeric values are accurate: the $782 million (2023) to $575 million (2024) figures and the $207 million difference are all correct. The LLM also correctly identifies Disney's 50% ownership stake with Hearst and provides relevant context about impairments and strategic shifts toward DTC distribution.\n\nHowever, there are some issues with the multi-hop synthesis and completeness:\n\n1. TEMPORAL SCOPE: The question asks about evolution from 2022 to 2024, but the LLM primarily focuses on the 2023-2024 comparison. The ground truth mentions 2022 as a starting point where A&E was \"a significant component\" of equity income. The LLM doesn't explicitly address what happened in 2022 or the 2022-2023 transition, only the 2023-2024 decline.\n\n2. GROUND TRUTH ALIGNMENT: The ground truth states the decline was \"$207 million\" in the context of the overall 2022-2024 period, while the LLM attributes this specifically to the 2023-2024 drop. This is a subtle but important distinction - the ground truth suggests the $207 million decline occurred over the full 2022-2024 period, not just 2023-2024.\n\n3. COMPLETENESS: The LLM provides good contextual detail about impairments and strategic shifts, which adds value beyond the ground truth. However, it doesn't fully address the 2022 baseline or explain the complete evolution across all three years.\n\n4. ACCURACY OF ATTRIBUTION: The LLM correctly cites page 35 and attributes the decline to \"lower income from A+E,\" matching the ground truth's language.\n\nThe answer is substantially correct on the core facts and numbers, but the temporal framing could be more precise to fully address the 2022-2024 evolution requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 509,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "\nThe carrying value of the company’s securitized debt obligations rose from **$16.97 billion at the end of 2022** (see COF_10K_2022.pdf, page 211) to **$18.04 billion at the end of 2023** (see COF_10K_2023.pdf, page 212), an increase of roughly **$1.07 billion (≈6 %)**.  \n\nThis growth shows that Capital One is deliberately expanding its asset‑backed securitization program, using securitized debt as a key source of long‑term funding to support loan‑portfolio growth and diversify its financing base. The higher reliance on securitizations indicates a strategic focus on stable, low‑cost, long‑term capital markets to fund its lending activities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states securitized debt obligations were $16.97 billion in 2022 and $18.04 billion in 2023, showing an increase of $1.07 billion. However, the ground truth clearly indicates the carrying value DECREASED to $18.043 billion by 2023 (from a higher baseline in 2022). The LLM's 2022 figure of $16.97 billion appears to be incorrect - the ground truth references $42.3 billion in long-term funding as of December 31, 2021, with securitized debt obligations being a significant portion. The LLM's calculation of a 6% increase is mathematically correct given its stated numbers ($1.07B/$16.97B ≈ 6.3%), but the underlying numbers are wrong. (2) DIRECTIONAL ERROR: The ground truth indicates a DECREASE in securitized debt obligations from 2022 to 2023, representing a strategic REDUCTION in reliance on securitized debt. The LLM incorrectly characterizes this as an INCREASE and interprets it as deliberate expansion of the securitization program. This is the opposite of what the ground truth states. (3) STRATEGIC INTERPRETATION FAILURE: The LLM concludes the company is 'deliberately expanding its asset-backed securitization program' and shows 'higher reliance on securitizations.' The ground truth explicitly states this 'indicates a strategic shift or reduction in reliance on securitized debt obligations.' The LLM's interpretation is fundamentally contradictory to the ground truth's assessment. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information about funding strategy, it does so based on incorrect numbers and reaches the wrong conclusion about the company's strategic direction. The reasoning structure is present but built on false premises. (5) ENTITY ACCURACY: The company is correctly identified as Capital One, and the years (2022-2023) are correct, but the financial metrics and their values are substantially wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 541,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Disney moved away from relying on traditional linear general‑entertainment channels overseas and began concentrating its scripted and general‑entertainment content on direct‑to‑consumer services.  The company merged its Latin‑American streaming offerings (e.g., Disney+ + Star+), added ESPN‑branded tiles to Disney+ abroad, and announced plans for a new DTC platform that will carry live ESPN channels, signaling a strategic shift from licensing linear channels to monetising programming primarily through subscription and advertising revenue on its DTC platforms.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic direction of Disney's shift from linear channels to DTC platforms, which is correct. However, there are significant gaps and inaccuracies in the quantitative details. STRENGTHS: (1) Correctly identifies the core strategic shift from traditional linear general-entertainment channels to DTC platforms between 2022-2024; (2) Accurately mentions the merger of Latin American streaming offerings; (3) Correctly references the new DTC platform with live ESPN channels planned for early fall 2025; (4) Properly identifies the shift toward subscription and advertising revenue models. CRITICAL GAPS AND ERRORS: (1) MISSING KEY QUANTITATIVE DATA: The original answer specifies Disney operated approximately 220 General Entertainment channels outside the U.S. in 2022 - the LLM answer completely omits this specific number, which is a material factual detail; (2) INCOMPLETE BRAND REFERENCES: The original answer explicitly mentions Fox, National Geographic, and Star brands - the LLM only mentions Star+ and doesn't reference the full scope of brands involved; (3) MISSING VENU SPORTS JOINT VENTURE: The original answer specifically mentions the planned joint venture (Venu Sports) with Fox Corporation and Warner Bros. Discovery for sports content distribution via DTC - the LLM answer fails to mention this important strategic initiative; (4) INCOMPLETE PROGRAMMING MIX: The original answer notes the 2022 channels featured 'a mix of scripted, reality, and documentary programming across multiple languages and regions' - the LLM focuses primarily on scripted content without acknowledging the broader programming mix. MULTI-HOP REASONING: The LLM successfully synthesizes information about the strategic shift across the 2022-2024 period, but fails to fully integrate all the key strategic initiatives and quantitative benchmarks that demonstrate the scope of this transformation. The answer is directionally correct but materially incomplete in supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 540,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "\nFrom 2022 into 2023 Tesla’s energy‑storage receivables grew substantially—larger balances of government‑rebate and financing‑partner amounts lengthened collection cycles and forced the company to increase its allowance for doubtful accounts.  At the same time, scaling storage‑product volume deepened reliance on a limited set of battery‑cell suppliers and amplified exposure to raw‑material price volatility and component‑shortage risks, making production ramps more precarious than in the prior year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims receivables 'grew substantially' from 2022 to 2023 but provides no specific numbers. The ground truth explicitly states a $627 million balance as of December 31, 2021, which is a concrete data point the LLM completely omits. The LLM also invents details not in the ground truth, such as 'increased allowance for doubtful accounts' and 'financing-partner amounts,' which are not mentioned in the original answer. (2) TEMPORAL MISALIGNMENT: The ground truth clearly distinguishes between 2022 (focus on receivables and collection periods) and 2023 (shift to operational dependencies). The LLM conflates these periods by saying receivables 'grew substantially' into 2023 without clearly delineating the shift in focus that occurred. (3) MISSING KEY INFORMATION: The LLM fails to mention the specific $627 million figure or the 'up to a year or more' collection period detail. It also misses the critical shift from financial exposure (receivables) to operational risks (production scaling, bottlenecks, facility ramp delays at Nevada, Texas, etc.). (4) INVENTED DETAILS: The LLM introduces 'allowance for doubtful accounts' and 'financing-partner amounts' which are not in the ground truth and appear to be fabricated details. (5) PARTIAL ACCURACY: The LLM correctly identifies battery-cell suppliers, raw-material price volatility, and component-shortage risks as relevant concerns, which aligns with the ground truth's mention of 'supplier constraints.' However, this partial correctness is overshadowed by the numerous errors and omissions. (6) REASONING QUALITY: While the LLM attempts to synthesize information about financial and operational challenges, it fails to capture the essential evolution from receivables focus (2022) to production scaling risks (2023), which is the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 525,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "\nBetween 2022 and 2023 the share of revenue derived from concentrate (syrup) operations grew modestly—from 56 % to 58 % of total net operating revenue (and from 82 % to 83 % of the segment mix)—showing that syrups have become a slightly larger driver of the Company’s top line.  At the same time, the MD&A notes that the Company now applies an incidence‑based, variable‑pricing model and recognizes concentrate revenue when control passes to bottling partners, with volume‑based incentives and channel‑mix considerations (especially for fountain‑retail sales) shaping the relationship with both consolidated and unconsolidated bottlers.  This evolution reflects a tighter integration of syrup sales with the Company’s bottling partners and fountain retailers as a key growth channel.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth in multiple critical ways: (1) QUANTITATIVE ERRORS: The LLM provides specific revenue percentages (56% to 58%, 82% to 83%) that are not mentioned in the ground truth and appear to be fabricated or misattributed. These numbers cannot be verified against the original answer and represent a major factual error. (2) CONCEPTUAL MISMATCH: The ground truth focuses on how Coca-Cola's DESCRIPTION and CHARACTERIZATION of syrups evolved—from a volume/revenue metric perspective in 2022 to an operationally embedded component in 2023. The LLM instead discusses revenue concentration percentages and pricing models, which is a different analytical framework entirely. (3) MISSING KEY ELEMENTS: The LLM fails to capture the core distinction in the ground truth: the shift in revenue recognition timing and methodology (consolidated vs. unconsolidated bottlers in 2022, versus direct sales to fountain retailers in 2023). The ground truth emphasizes a strategic repositioning of syrups' role in the business model, not just revenue growth. (4) PARTIALLY CORRECT ELEMENTS: The LLM does correctly identify that the evolution involves bottling partners and fountain retailers, and mentions variable pricing and channel-mix considerations, which aligns somewhat with the ground truth's emphasis on operational integration. However, these correct elements are embedded within an otherwise inaccurate narrative. (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the multi-hop relationship between: (a) revenue recognition methodology changes, (b) bottling partner relationships, and (c) fountain retailer integration. Instead, it presents a revenue concentration narrative that doesn't match the ground truth's focus on operational role evolution. The answer reads as if it's describing a different company or different metrics entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 513,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "\nDisney’s Other‑mortgage‑ and asset‑backed securities (MBS/ABS) rose from **$84 million** in the 2022 fair‑value hierarchy (Level 2, ≈ 1 % of the total hierarchy) to **$166 million** in the 2024 hierarchy (Level 2, ≈ 1.5 % of the total hierarchy).  The absolute amount more than doubled, and its share of the overall fair‑value hierarchy increased modestly from about 1 % to 1.5 % over the same period.  (Pages 104 & 107 of the 2022 and 2024 10‑K filings.)",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ERRORS: FY2022 value stated as $84M (ground truth: $96M) - 12.5% error; FY2024 value stated as $166M (ground truth: $120M) - 38.3% error. These are substantial discrepancies, not minor rounding differences. The percentage shares are also incorrect: LLM claims 1% to 1.5% progression, but ground truth shows stable 1% in both years. (2) CALCULATION ERRORS: LLM claims the amount 'more than doubled' from $84M to $166M (1.98x increase), but the correct values ($96M to $120M) represent only a 25% increase, which is moderate growth, not doubling. (3) TREND ANALYSIS ERROR: LLM incorrectly identifies an increasing trend in proportional representation (1% to 1.5%), when ground truth shows the proportion remained stable at 1% throughout the period. This is a fundamental mischaracterization of the trend. (4) MULTI-HOP REASONING: While the LLM correctly identifies this as a Level 2 fair-value hierarchy item and attempts to synthesize the evolution across years, the underlying data points are wrong, making the synthesis invalid. (5) ENTITY ACCURACY: Disney is correctly identified, and the fiscal years (2022, 2024) are correct, but the financial metrics are substantially misrepresented. The answer demonstrates a clear failure to accurately extract or verify the specific investment values from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 404,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "\nBetween 2022 and 2023 the Skunk Works Advanced Development Programs broadened and sharpened its focus. In 2022 the ADP was described as pursuing “future systems, including unmanned and manned aerial systems and next‑generation capabilities for hypersonics, intelligence‑surveillance‑reconnaissance, situational‑awareness and air‑mobility.” By 2023 the language was updated to emphasize “next‑generation capabilities for **air dominance**, hypersonics, intelligence‑surveillance‑reconnaissance, situational‑awareness and air‑mobility,” explicitly adding air‑dominance as a core thrust while retaining the earlier domains. Thus, the evolution reflects a deliberate shift toward prioritizing air‑dominance and advanced hypersonic strike systems as key enablers of next‑generation military aircraft capability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the question. (1) CORRECTNESS: The answer correctly identifies the evolution of Skunk Works' Advanced Development Programs between 2022 and 2023. All key focus areas are accurately captured: 2022 included unmanned/manned aerial systems, hypersonics, ISR, situational awareness, and air mobility; 2023 shifted to emphasize air dominance while maintaining the other domains. The characterization of this as a 'refinement of priorities' aligns with the ground truth. (2) QUANTITATIVE ACCURACY: No numerical data is required for this question, so this dimension is not applicable. The dates (2022 and 2023) are correctly referenced. (3) QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop information by comparing the two years' focus areas and identifying the key difference (addition of air dominance emphasis). The reasoning is sound and logically structured. The LLM appropriately quotes the language from both years, demonstrating direct evidence from source material. (4) ENTITY ACCURACY: Skunk Works and Advanced Development Programs are correctly identified. The specific capabilities mentioned (air dominance, hypersonics, ISR, situational awareness, air mobility) all match the ground truth. (5) SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as 'deliberate' and emphasizing 'air dominance and advanced hypersonic strike systems as key enablers' is consistent with the ground truth's description of 'increased emphasis on air dominance as a core next-generation capability.' Minor note: The LLM adds interpretive language about 'advanced hypersonic strike systems' which, while reasonable inference, goes slightly beyond the explicit ground truth statement that simply mentions 'hypersonics.' This is a minor elaboration that doesn't contradict the source material but represents a slight interpretive addition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 520,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla moved the Powerwall from a primarily “stand‑alone” home‑battery sold through direct installers toward a tightly integrated component of its broader energy‑generation portfolio.  The 2023 disclosures highlight that Powerwall is now designed to work seamlessly with Solar Roof, Megapack and the company’s new software‑controlled dispatch platform, and Tesla is scaling dedicated production capacity (e.g., the Lathrop Megafactory and in‑house cell manufacturing) to meet rising demand and support both residential and utility‑scale deployments.  Consequently, the emphasis shifted from modest, vehicle‑derived battery output to a purpose‑built, high‑volume manufacturing strategy that underpins the company’s integrated energy‑storage offering.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces specific claims NOT supported by the ground truth: mentions of 'Lathrop Megafactory,' 'in-house cell manufacturing,' 'Megapack integration,' and 'software-controlled dispatch platform' are not present in the original answer and appear to be fabricated details. The ground truth makes no mention of these specific facilities or products. (2) QUANTITATIVE ACCURACY - No numbers are provided in either answer, so this is neutral, but the LLM adds unsupported specificity about manufacturing facilities that cannot be verified. (3) MULTI-HOP REASONING - The LLM correctly identifies the core evolution (stand-alone to integrated approach) but then diverges significantly by adding unsubstantiated details about production facilities and product integrations beyond what the ground truth supports. The ground truth specifically mentions Solar Roof and Powerwall integration, but does NOT mention Megapack or dedicated megafactories. (4) SEMANTIC ALIGNMENT - The LLM's core thesis about integration strategy evolution is directionally correct and aligns with the ground truth's shift from 'sales and availability focus to deeper technical and strategic integration.' However, the LLM significantly overextends by introducing manufacturing details and product integrations (Megapack, specific factories) that are not grounded in the provided knowledge graph. (5) COMPLETENESS - While the LLM addresses integration strategy and production emphasis as requested, it does so by adding speculative details rather than sticking to verifiable information from the filings. The ground truth is more conservative and accurate, focusing on Solar Roof integration and installation capabilities. The LLM's claim about 'purpose-built, high-volume manufacturing strategy' and specific facility names represents hallucination rather than synthesis of actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 519,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "\nBetween 2022 and 2024 Gilead shifted Biktarvy from a stand‑alone growth driver to a central pillar of its HIV franchise that is now deliberately protected against rising commercial pressures.  In 2022 the drug was highlighted as a flagship product whose sales underpinned overall HIV revenue, but by 2024 the company’s disclosures emphasized that Biktarvy’s profitability is increasingly exposed to IRA‑driven rebate obligations, payer‑price negotiations and generic competition, prompting Gilead to reinforce its pricing and market‑access strategies and to diversify its HIV pipeline to offset those risks.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH CORE NARRATIVE: The LLM answer introduces significant factual inaccuracies that contradict the ground truth. (1) INCORRECT CHARACTERIZATION: The LLM claims Gilead 'deliberately protected' Biktarvy against 'rising commercial pressures' and 'reinforced pricing and market-access strategies,' but the ground truth indicates the opposite—Gilead faced HEIGHTENED COMMERCIAL RISK and VULNERABILITY due to overreliance on TAF-based therapies. The LLM's framing suggests proactive strategic positioning when the reality was defensive vulnerability. (2) UNSUPPORTED CLAIMS: The LLM introduces specific commercial pressures (IRA-driven rebate obligations, payer-price negotiations, generic competition) that are NOT mentioned in the ground truth. While these may be real industry factors, they are not supported by the provided knowledge graph and represent speculation beyond the source material. (3) MISSING KEY INSIGHT: The ground truth emphasizes a critical shift from 'product innovation focus to increased vulnerability due to overreliance on a narrow therapeutic class.' The LLM completely misses this fundamental insight about therapeutic class concentration risk and instead focuses on pricing/rebate mechanics. (4) SEMANTIC MISALIGNMENT: The ground truth describes a transition to 'increased vulnerability' and 'overreliance,' while the LLM describes 'deliberate protection' and 'reinforced strategies'—these are directionally opposite interpretations. (5) QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension scores well (8/10) as there are no calculation errors, though the lack of specificity is a limitation. (6) MULTI-HOP REASONING: The LLM fails to correctly synthesize the 2022-to-2024 evolution. It correctly identifies the time period and product, but fundamentally misinterprets the nature of the strategic shift. The ground truth shows vulnerability increasing; the LLM shows defensive measures being implemented—these tell different stories about Gilead's strategic position.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 550,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 the set of mechanisms that make up Visa’s U.S. Retrospective Responsibility Plan – the U.S. litigation‑escrow agreement, the class B‑stock conversion feature, the makewhole agreements, the indemnification obligations of Visa U.S.A. members, the interchange‑judgment‑sharing agreement, the loss‑sharing agreement and the omnibus agreement – remained the same; no new mechanisms were introduced.  What did change was the **composition of the escrow‑funding side** of the plan: the 2023 disclosures show a substantially larger escrow balance ($3.089 bn at 30 Sept 2023 vs $1.764 bn a year earlier) with **higher deposits** into the escrow account ($1.5 bn in 2023 versus $1.0 bn in 2022) and **much lower net payments** to opt‑out merchants ($0.175 bn vs $0.685 bn).  This shift reflects a greater reliance on the escrow account (and its dilutive impact on class B‑stock conversion) to fund potential litigation liabilities, while the underlying list of mechanisms stayed unchanged.  (Pages 72‑73 of the 2023 10‑K and the comparable tables in the 2022 10‑K).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The original answer clearly states that the composition of the U.S. Retrospective Responsibility Plan CHANGED between 2022 and 2023, with a NEW element added: 'makewhole agreements relating to the Class B-1 common stock exchange offer.' The LLM answer explicitly states the opposite: 'the set of mechanisms...remained the same; no new mechanisms were introduced.' This is a critical error that misrepresents the core finding. While the LLM provides detailed information about escrow funding changes (escrow balance increasing from $1.764 bn to $3.089 bn, deposits increasing from $1.0 bn to $1.5 bn, and net payments decreasing from $0.685 bn to $0.175 bn), these details, while potentially accurate, are not what the question asks about. The question specifically asks about composition changes 'particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement.' The LLM misinterprets the question as asking about the escrow funding composition rather than the mechanisms themselves. The numeric values provided by the LLM (escrow balances, deposits, and payments) cannot be verified against the ground truth provided, but they appear to be supplementary information that, while potentially relevant to understanding the plan's evolution, does not address the primary question about mechanism composition changes. The LLM's statement that 'makewhole agreements' were already part of the plan in 2022 contradicts the ground truth, which indicates these were a new addition in 2023. This represents a failure in multi-hop reasoning and a misunderstanding of what changed between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 470,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "\nBetween 2022 and 2024, Biktarvy remained GILD’s flagship HIV asset, protected by composition‑of‑matter and process patents (including pediatric exclusivity) that extend U.S. and EU exclusivity to 2033 — a timeline highlighted in the 2022‑2024 10‑K patent tables (p. 13) and reinforced by the 2022 filing that received a new low‑dose pediatric label (p. 10).  However, the company’s 2024 risk disclosures (p. 18) increasingly flagged concentration risk: any shift away from nucleoside‑based HIV regimens or pricing pressures from Medicare‑Part D reforms could erode Biktarvy’s sales, prompting GILD to diversify into oncology and cell‑therapy to lessen its reliance on this HIV product.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative arc (Biktarvy's strategic importance declining despite patent protection) and correctly identifies key themes from the ground truth. However, there are significant issues with specificity and verifiability:\n\nSTRENGTHS:\n- Correctly identifies 2033 as the U.S. patent expiration date, matching the ground truth\n- Accurately captures the core insight: despite long-term patent protection, external pressures (competition, regulatory changes) have increased vulnerability\n- Properly synthesizes the multi-hop reasoning: patent timeline + risk disclosures = evolving strategic importance\n- Correctly identifies Biktarvy as a flagship HIV asset\n- Appropriately mentions diversification strategy as GILD's response\n- Contextually relevant to the question about strategic importance evolution\n\nWEAKNESSES:\n- Introduces specific page numbers (p. 13, p. 10, p. 18) that cannot be verified against the ground truth, which provides no page references. This is problematic as it suggests false specificity.\n- Adds details about \"composition-of-matter and process patents\" and \"pediatric exclusivity\" that are not mentioned in the ground truth. While these may be accurate, they go beyond what can be verified.\n- States \"2022-2024 10-K patent tables\" but the ground truth only references 2022 patent information explicitly\n- Mentions \"new low-dose pediatric label\" in 2022 - this specific detail is not in the ground truth\n- References \"Medicare-Part D reforms\" as a specific risk factor not mentioned in the ground truth\n- The ground truth states \"no expiration listed in the E.U.\" but the LLM claims \"EU exclusivity to 2033\" - this is a potential contradiction\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across the time period (2022-2024) and combines patent protection data with risk disclosures. However, the addition of unverifiable details weakens confidence in the synthesis.\n\nQUANTITATIVE ACCURACY:\nThe 2033 date is correct. However, the introduction of unverifiable page numbers and specific regulatory details (Medicare-Part D) that aren't in the ground truth reduces quantitative confidence.\n\nOVERALL ASSESSMENT:\nThe answer captures the essential narrative correctly but adds specificity that cannot be verified and potentially contradicts the ground truth on EU patent status. The core insight is sound, but the execution includes problematic embellishments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 661,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "\nNo. The filings for 2022 and 2023 do not disclose any amendment, restatement, or new guarantee replacing the existing “Guaranty of certain obligations of Illinois Bell Telephone Company, Inc.” that is cited as Exhibit 4‑c (originally filed in the 2011 Form 10‑K). The only reference in the provided pages is the unchanged 2011 exhibit, and there is no indication of a revised guarantee structure or new documentation for the 2022‑2023 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer references Exhibit 4-c while the ground truth clearly states Exhibit 4-d. This is a significant factual error in a document reference that is central to the question. The LLM correctly identifies that: (1) no modifications occurred between 2022-2023, (2) the guarantee remained unchanged, and (3) it references the 2011 Form 10-K. However, the exhibit number citation is incorrect - the ground truth explicitly states 'Exhibit 4-d' appears in both 2022 and 2023 filings, but the LLM states 'Exhibit 4-c.' This is not a minor formatting difference but a specific document reference error that undermines the accuracy of the answer. The semantic understanding of the question is correct (no modifications, same guarantee structure), and the reasoning about unchanged documentation is sound, but the specific exhibit number citation is factually wrong. The answer appropriately addresses the multi-part nature of the question (guarantee structure, referenced documentation, time period comparison) but fails on precise entity identification (exhibit number). The conclusion that there were no modifications is correct, but the supporting documentation reference is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 341,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "\nThe fact that the Class C‑to‑Class A conversion rate was left unchanged from 2022 to 2023 indicates that the number of Class A shares that Class C holders would receive upon conversion is the same each year. As a result, there is no additional dilution of Class A voting power arising from that conversion, so any significant corporate transaction that requires shareholder approval will affect Class A holders’ voting influence in the same way as it did previously.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key concept that the unchanged conversion rate (4.0000) between 2022 and 2023 means no additional dilution from that conversion mechanism. The reasoning about voting power stability is sound and semantically aligned with the ground truth. However, there are significant quantitative omissions: (1) The LLM fails to mention the specific conversion rate of 4.0000, which is a critical factual detail. (2) The LLM does not reference the as-converted Class A common stock values (38 million in 2022 and 39 million in 2023), which the ground truth explicitly cites as evidence of stability despite slight increases. (3) The LLM does not acknowledge that the as-converted value increased slightly, which is an important nuance showing that while the conversion rate stayed constant, the underlying share count changed. The qualitative reasoning is sound - the LLM correctly explains that an unchanged conversion rate means no new dilution and that voting influence remains consistent. However, the answer lacks the specific quantitative anchors that would make it complete and fully aligned with the ground truth. The answer is partially correct in its core logic but incomplete in its factual support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 348,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla moved Solar Roof from an aggressive scaling effort at its Buffalo Gigafactory—where production was buoyed by the 26 % federal solar‑tax credit and by external suppliers for glass and solar cells—into a more restrained posture that recognized the credit’s impending phase‑out and the need to tie the roof’s output to its own battery‑cell manufacturing. Consequently, the company’s strategic dependence shifted from external solar‑module and incentive reliance toward internal battery‑cell supply and cost‑control, and it now warns that any slowdown in Solar Roof ramp‑up could force curtailment of both vehicle and energy‑storage production.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. Specific issues: (1) QUANTITATIVE ERRORS: The LLM cites a '26% federal solar-tax credit' without any verification in the ground truth, and this specific percentage is not mentioned in the original answer. This is a fabricated detail. (2) LOCATION CONFUSION: The LLM refers to 'Buffalo Gigafactory' when the ground truth specifically states 'Gigafactory New York' - while these may refer to the same facility, the LLM's terminology is less precise. (3) UNSUPPORTED CLAIMS: The LLM introduces several claims not present in the ground truth: (a) the credit's 'impending phase-out,' (b) the need to 'tie the roof's output to its own battery-cell manufacturing,' (c) a shift toward 'internal battery-cell supply and cost-control,' and (d) warnings about 'slowdown in Solar Roof ramp-up' forcing curtailment of vehicle and energy-storage production. None of these specific strategic dependencies are mentioned in the original answer. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize a narrative about strategic shift from 2022 to 2023, it does so by introducing details not supported by the ground truth. The ground truth focuses on a shift from 'production-centric view to a more cautionary outlook on strategic execution risks,' but the LLM reframes this as a shift in supply chain dependencies (external to internal) which is not substantiated. (5) CORE ACCURACY: The LLM does correctly identify that there was a transition from 2022 to 2023 and that it involved a shift in strategic posture, which aligns with the ground truth's core finding. However, the specific mechanisms and details provided are largely fabricated or unsupported. The answer reads plausibly but fails the strict factual verification required for financial document analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 510,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "\nBetween 2022 and 2023 the company continued to sell syrups to its bottling partners, who use the syrups (together with water and sweeteners) to produce finished beverages that are distributed through the same bottling and distribution network.  The 2023 Form 10‑K shows that revenue from concentrate operations—including syrups—rose to **58 %** of total net operating revenue in 2023 versus **56 %** in 2022, while finished‑product revenue fell to **42 %** from **44 %**.  This modest shift indicates that the syrup‑to‑bottler model remained central to Coca‑Cola’s production and distribution, but the company’s revenue mix is tilting slightly more toward concentrate/syrup sales.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses part of the question but has significant issues: (1) QUANTITATIVE ACCURACY - MAJOR PROBLEM: The percentages cited (58% concentrate/syrup revenue in 2023 vs 56% in 2022, and 42% finished product vs 44%) cannot be verified against the ground truth and appear to be fabricated or misattributed numbers. The ground truth does not provide these specific revenue percentages, and the LLM presents them with false confidence using bold formatting. This is a critical error for a financial question. (2) COMPLETENESS - PARTIAL: The LLM answer addresses the basic syrup-to-bottler relationship but FAILS to capture key evolution points from the ground truth: (a) No mention of the 2023 shift toward direct management of fountain syrup sales by Coca-Cola in the U.S., (b) No discussion of the expansion to include authorized wholesalers as distribution channels, (c) No mention of the structural change regarding fountain syrup operations being specifically included in the North America operating segment, (d) Missing the strategic shift toward 'tighter control and segmentation' that the ground truth emphasizes. (3) ENTITY ACCURACY - ADEQUATE: Correctly identifies Coca-Cola, bottling partners, syrups, and the 2022-2023 timeframe. (4) REASONING - FLAWED: While the logic about the syrup-to-bottler model is sound, the LLM fails to synthesize the evolution aspect of the question. It treats 2022 and 2023 as largely similar rather than identifying the strategic shifts highlighted in the ground truth. (5) SEMANTIC EQUIVALENCE - PARTIAL: The answer conveys some correct information about syrups' role but misses the core narrative of evolving control structures and distribution channel management. The fabricated percentages are a serious credibility issue that undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 492,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "\nBetween 2022 and 2024 the company kept Africa/Eurasia as one of the five distinct geographic reportable operating segments within its Oral, Personal & Home‑Care business; the only structural change was the July 2024 realignment that moved the skin‑health business out of Europe into North America, which left the Africa/Eurasia segment unchanged.  Financially, Africa/Eurasia’s net sales rose modestly from roughly $1.08 billion in 2023 to $1.10 billion in 2024, and its operating profit increased from about $228 million to $253 million, keeping the segment’s contribution at roughly 5 % of total Oral, Personal & Home‑Care sales while showing a slight upward trend in both revenue and profitability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM provides specific financial figures (net sales of $1.08B in 2023, $1.10B in 2024; operating profit of $228M in 2023, $253M in 2024) that are NOT present in the ground truth. The ground truth only mentions a 2022 operating profit of $203 million for Africa/Eurasia. The LLM appears to have fabricated 2023-2024 financial data without source verification. (2) INCOMPLETE GROUND TRUTH SYNTHESIS - The ground truth explicitly states that in 2022, Africa/Eurasia had an operating profit of $203 million, but the LLM does not mention this 2022 baseline figure at all, making it impossible to assess the claimed 'upward trend.' (3) STRUCTURAL CLAIM DISCREPANCY - The LLM claims Africa/Eurasia was 'one of the five distinct geographic reportable operating segments' throughout 2022-2024, but the ground truth indicates it was 'part of' the segment in 2022, suggesting a different reporting structure than what the LLM describes. (4) CORRECT ELEMENTS - The LLM correctly identifies: the July 2024 skin health realignment from Europe to North America, that Africa/Eurasia remained unchanged by this realignment, and that the segment is within Oral, Personal & Home Care. (5) MISSING CONTEXT - The LLM fails to address the evolution of reporting structure between 2022 and 2024, which was a key part of the original answer. The ground truth emphasizes 'more nuanced operational focus' and structural changes, but the LLM presents it as largely static. CRITICAL FLAW: Introducing unverified financial metrics (2023-2024 figures) significantly undermines credibility and violates the principle of strict accuracy on numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 456,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "\nBetween 2023 and 2024 the Orthopaedics business showed only modest top‑line growth—global sales of roughly $8.9 billion in 2023 (U.S. $5.5 B, International $3.4 B), up about 3.8 % from 2022—and was previously framed as a stable, mature MedTech pillar.  The 2024 filing, however, reframes the segment as a strategic growth engine, placing strong emphasis on “enabling technologies” such as robotic‑assisted and navigation tools that support hips, knees, trauma and spine procedures, signaling a shift from incremental volume gains to an innovation‑driven expansion strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key 2023 financial figures ($8.9B global, $5.5B U.S., $3.4B International) and accurately captures the strategic shift from quantitative to qualitative emphasis on enabling technologies between 2023 and 2024. The characterization of the pivot from 'stable, mature' to 'innovation-driven' aligns with the ground truth's core finding. Number formatting is acceptable ($8.9B vs $8,942M). WEAKNESSES: (1) The LLM states growth was 'up about 3.8% from 2022' but the ground truth specifies 4.1% increase from prior year (2022) for global revenue, and 3.8% for U.S. only. The LLM conflates the U.S. growth rate (3.8%) with the overall global growth rate, which is a calculation/synthesis error. (2) The LLM mentions 'robotic-assisted and navigation tools' as enabling technologies, but the ground truth does not specify these particular technologies—it only states the 2024 filing emphasized 'products and enabling technologies' without detailing what those technologies are. This represents an inference beyond the ground truth. (3) The LLM characterizes 2024 as reframing Orthopaedics as a 'strategic growth engine,' but the ground truth more neutrally states it shifted to 'underscoring technological leadership and product diversification'—the 'growth engine' characterization is interpretive and not explicitly supported. (4) The LLM omits the specific mention of sports medicine as part of the portfolio, which was included in the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across two years and identifies the strategic pivot, but makes an error in attributing the 3.8% growth rate to the global figure rather than correctly distinguishing it as U.S.-specific growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 476,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "\nBetween 2022 and 2023 Visa kept the same loss‑sharing framework but clarified and slightly broadened the scope of “U.S. covered litigation.”  The 2022 filing (Notes 5‑U.S. and Europe Retrospective Responsibility Plans) defined the covered matters as the Interchange MDL 1720 and any pre‑IPO claims, and it added any opt‑out actions filed after Oct 22 2015 that are substantially similar to those claims.  The 2023 filing (pages 70‑72) retained that definition but emphasized the 2015 amendment that brought those opt‑out actions within the loss‑sharing umbrella and reaffirmed that, under the omnibus agreement, liability for any settlement or judgment is split 66.6667 % to Visa (calculated by each member’s membership proportion and subject to indemnification by Visa U.S.A. members) and 33.3333 % to Mastercard.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key numeric values (66.6667% and 33.3333% liability split, October 2015 amendment date, MDL 1720 reference) and accurately describes the loss-sharing framework structure. However, there are significant gaps in addressing the evolution between 2022 and 2023 as requested by the question. \n\nSTRENGTHS: (1) Correctly states the liability percentages (66.6667% Visa, 33.3333% Mastercard); (2) Accurately references the October 2015 amendment and opt-out actions; (3) Properly identifies MDL 1720 and pre-IPO claims; (4) Correctly notes the omnibus agreement framework; (5) Numeric dates and percentages are accurate.\n\nWEAKNESSES: (1) The LLM characterizes the evolution as merely 'clarified and slightly broadened' scope, missing the ground truth's key insight about a strategic pivot from 'specific amendments and liability sharing' focus in 2022 to a 'comprehensive and retrospective liability framework' in 2023; (2) Fails to adequately address the 2023 consolidation under the 'U.S. Retrospective Responsibility Plan' as a distinct evolution; (3) Does not capture the significant shift in 2023 toward emphasizing 'settled or otherwise fully or substantially resolved' matters, which represents a material change in approach toward finalizing legacy litigation; (4) The answer suggests continuity ('kept the same loss-sharing framework') when the ground truth indicates a more substantial strategic evolution; (5) Missing the broader context that 2023 represents a consolidation and retrospective approach versus 2022's focus on specific amendments.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2023 filings but fails to capture the qualitative evolution in Visa's strategic approach. The answer is more of a static comparison of definitions rather than an analysis of how the approach evolved.\n\nCONTEXTUAL RELEVANCE: While the answer provides accurate technical details about the loss-sharing framework, it inadequately addresses the 'evolution' aspect of the question, which was central to what was being asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 562,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s holdings of Guaranteed Investment Contracts (GICs) fell sharply – from roughly **$55‑$56 million** (about $1 million in the U.S. and $55 million internationally in the 2021/2022 filings) to **$34 million in 2023** and **$30 million in 2024**, with the U.S. GIC position eliminated entirely.  \n\nThis pull‑back signals a deliberate reallocation of plan assets away from the low‑yield, contract‑based GIC exposure toward a higher‑weighting of fixed‑income securities, pooled funds and other investments that better match the plans’ liability‑matching and return objectives, reflecting a shift toward a more diversified and potentially higher‑return asset strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant factual inaccuracies in the numbers. Ground truth states: 2022 had $1M (U.S.) + $55M (International) = $56M total; 2024 had $0M (U.S.) + $34M (International) = $34M total. The LLM claims $34M in 2023 and $30M in 2024, which contradicts the ground truth's 2024 figure of $34M. The LLM also incorrectly references '2021/2022 filings' when the question specifically asks about 2022-2024 evolution. CORRECT ELEMENTS: The LLM correctly identifies that U.S. GIC positions were eliminated entirely and that there was a reduction in international GICs. The directional trend (decline in GICs) is correct. REASONING QUALITY: The LLM's interpretation about strategic reallocation toward higher-return assets and diversification is reasonable inference, though the ground truth answer is more conservative, simply stating 'strategic reallocation' without speculating on yield or return objectives. MULTI-HOP SYNTHESIS: The answer attempts to synthesize the evolution across years but fails on the specific 2024 number ($30M vs. $34M ground truth). The comparison between 2022 and 2024 is incomplete and inaccurate. COMPLETENESS: The answer addresses both the U.S. and International components and attempts to explain strategic implications, but the numerical foundation is flawed, undermining the entire analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 380,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard reframed its Developer Platform from a generic API‑access point into a strategic gateway for digital‑asset integration.  The 2024 disclosures highlight that the platform now provides a single, secure interface for connecting to Mastercard’s multi‑token network, AI‑driven fraud and decision tools, and blockchain‑focused services—enabling partners to embed programmable payments, crypto‑purchase and spend capabilities, and other emerging payment flows directly into their solutions.  This evolution positions the platform as the primary conduit for developers to leverage Mastercard’s expanding suite of digital‑asset and next‑generation technologies.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core evolution of the Mastercard Developer Platform from 2022 to 2024, capturing the shift toward digital assets and emerging technologies. (2) The mention of the Multi-Token Network™ aligns with the ground truth. (3) The characterization of the platform as enabling blockchain-based and programmable payment solutions is accurate. (4) No quantitative errors or incorrect dates/numbers are present. (5) The semantic meaning largely matches the ground truth regarding the platform's expanded strategic positioning.\n\nWEAKNESSES: (1) The LLM introduces elements not explicitly mentioned in the ground truth, specifically 'AI-driven fraud and decision tools' and 'crypto-purchase and spend capabilities.' While these may be accurate features, they are not mentioned in the provided ground truth, which creates a factual discrepancy. (2) The ground truth emphasizes the platform's role in 'ease of integration' in 2022 and its evolution to support 'programmable commerce solutions' in 2024, but the LLM frames this more as a rebranding from 'generic API-access point' to 'strategic gateway,' which is a slightly different characterization. (3) The LLM's description of the platform as 'the primary conduit' is an inference not explicitly stated in the ground truth. (4) The ground truth specifically mentions 'secure, scalable, and interoperable blockchain-based transactions' as a 2024 feature, while the LLM generalizes this to 'blockchain-focused services.'\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 timeframe and correctly identifies the evolution trajectory. However, the introduction of unsupported details (AI tools, crypto capabilities) suggests the model may have hallucinated or drawn from external knowledge rather than strictly adhering to the ground truth.\n\nOVERALL ASSESSMENT: The answer captures the essential evolution and demonstrates sound reasoning about the platform's strategic shift. However, the introduction of unverified details and slight characterization differences prevent a higher score. The core narrative is correct, but the execution includes elements not grounded in the provided knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 595,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 the U.S. defined‑benefit pension plans held **zero shares of Colgate‑Palmolive common stock**—the company did not purchase any of its own shares in 2023 or 2024, and it had already sold its entire holdings in 2020. As a result, the plan’s allocation to the company’s own equity remained at **0 %**, reflecting a deliberate strategic shift to eliminate self‑stock exposure and rely on a broader, diversified mix of external assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different topic than the ground truth. CRITICAL ERRORS: (1) The LLM discusses Colgate-Palmolive company stock holdings within pension plans, while the ground truth addresses U.S. common stocks (general market equities) within pension plans - these are entirely different asset classes. (2) The LLM mentions 2020 data and discusses share purchases/sales of company stock, which is not part of the question or ground truth. (3) The LLM provides no information about the actual U.S. common stock allocation that the ground truth specifies. (4) The ground truth clearly states: zero allocation in U.S. pension plan for both 2022 and 2024, but $2 million in international pension plan for both years. The LLM provides none of these specific figures. (5) The LLM's conclusion about 'self-stock exposure' and 'eliminating' company equity is semantically different from the ground truth's discussion of strategic avoidance of U.S. common stocks generally. MULTI-HOP REASONING: The LLM failed to synthesize the correct information across pension plan types (U.S. vs. international) and asset classes (company stock vs. U.S. common stocks). The answer demonstrates a fundamental misunderstanding of what asset class was being queried. The only partial alignment is the general concept of strategic asset allocation decisions, but the specific facts, numbers, and entities are entirely wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 401,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Disney moved from treating cruise‑ship spending as part of a broad parks‑and‑experiences capital program to making explicit fleet‑expansion a strategic priority, announcing plans to add new ships and increase investment in the Experiences segment.  The 2023 10‑K notes that while these investments are intended to grow the cruise‑line business, they also raise execution and forecasting risks, potential write‑downs and exposure to economic, competitive and regulatory pressures that could affect profitability.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains significant factual errors: (1) DIRECTIONAL ERROR - The LLM claims Disney moved FROM treating cruise spending as part of broad capital programs TO making explicit fleet-expansion a strategic priority, which is the OPPOSITE of the ground truth. The ground truth states the evolution was FROM growth-oriented investment focus (2022) TO operational risk mitigation focus (2023). (2) MISSING KEY CONTEXT - The LLM fails to capture the critical shift in strategic emphasis: 2022 emphasized cruise ships as a growth engine within capital investment strategy, while 2023 reframed them as operational exposures and risk factors. (3) INCOMPLETE RISK ANALYSIS - While the LLM mentions execution risks, write-downs, and regulatory pressures, it misses the specific operational risk context highlighted in the ground truth (external disruptions like hurricanes and global events). (4) MISCHARACTERIZATION OF INVESTMENT TRAJECTORY - The LLM suggests increasing investment and fleet expansion as the 2023 priority, when the ground truth indicates a shift toward risk mitigation rather than expansion. (5) NO QUANTITATIVE DATA - Neither answer provides specific dollar amounts, but the LLM's qualitative framing is inverted from the ground truth. The LLM answer appears to describe a different company trajectory than what the filings actually show. This represents a fundamental failure in multi-hop reasoning and synthesis of the strategic evolution between the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 425,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard moved from an informal, low‑volume use of short‑duration FX forwards to a more structured hedging program that still targets the few‑day foreign‑exchange exposure inherent in daily settlement but now covers far larger notional amounts (e.g., $3.9 bn of cash‑flow hedges and $2.7 bn of non‑designated contracts in 2024).  The contracts are still recorded in general‑and‑administrative expense, but the expanded book—encompassing cash‑flow, net‑investment and non‑designated derivatives—reflects a deliberate scaling of short‑term FX derivatives to manage settlement‑related currency volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($3.9 billion in cash-flow hedges and $2.7 billion in non-designated contracts in 2024) that are not mentioned in the ground truth and cannot be verified. These appear to be fabricated numbers without source documentation. (2) NARRATIVE DIVERGENCE: The ground truth states Mastercard used short duration FX derivatives in 2022 and continued this practice through 2024 with the same stated objective. The LLM invents a false narrative of evolution from 'informal, low-volume use' to a 'more structured hedging program' with 'far larger notional amounts' - this progression is not supported by the ground truth. (3) MISSING KEY CONTEXT: The ground truth emphasizes the dynamic adjustments to hedging strategies involving euro-denominated debt (de-designating and re-designating in 2023-2024), which the LLM completely omits. This is a critical element of the answer. (4) UNSUPPORTED CLAIMS: The LLM's assertion about recording in 'general-and-administrative expense' and the expansion to 'cash-flow, net-investment and non-designated derivatives' lacks grounding in the provided ground truth. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize evolution over time, it does so by introducing information not present in the ground truth rather than accurately synthesizing the actual documented changes. The ground truth indicates continuity in the use of short duration contracts with evolving broader strategy context, not a scaling from low-volume to high-volume operations. The answer demonstrates poor factual accuracy and appears to confabulate specific financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 486,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "\nFrom fiscal 2023 through fiscal 2024 Salesforce’s strategic relationship with enterprise‑cloud partners shifted from a broad portfolio of investments in external cloud vendors toward a focused, AI‑centric platform strategy.  In 2024 the company emphasized native AI capabilities—Agentforce, Data Cloud and Industries AI—tightly integrating them with its core CRM, Slack and MuleSoft ecosystem, and leveraged a expanded partner and developer network (AppExchange, system‑integrators, ISVs) to deliver industry‑specific, autonomous agents and end‑to‑end connected experiences.  Consequently, investment priorities moved from acquiring and funding outside cloud businesses to building and scaling AI‑driven, industry‑focused services that deepen ecosystem integration and drive cross‑selling within the Salesforce platform.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the time period (2023-2024) and the shift in Salesforce's strategic approach. (2) Accurately mentions key platforms and initiatives: AppExchange, ISVs, system integrators, Agentforce, Data Cloud, Industries AI, Slack, and MuleSoft. (3) Correctly characterizes the evolution from investment-focused to ecosystem-integration-focused strategy. (4) No quantitative errors detected (no specific numbers were provided in either answer to verify). WEAKNESSES: (1) The LLM introduces significant new information not present in the ground truth—specifically the emphasis on 'AI-centric platform strategy,' 'Agentforce,' 'Data Cloud,' 'Industries AI,' and 'autonomous agents'—which represents a material departure from the original answer's focus. While these may be factually accurate about Salesforce's 2024 strategy, they were not part of the ground truth answer provided. (2) The ground truth emphasizes the shift from 'primarily investing' to 'broader strategic dependency' and leveraging partners for ecosystem expansion. The LLM answer reframes this as a shift from 'acquiring and funding outside cloud businesses' to 'building and scaling AI-driven services,' which is a different characterization. (3) The ground truth specifically mentions the AppExchange's role in enabling third-party developers to create cloud-based applications, emphasizing 'deepened integration and dependency.' The LLM mentions AppExchange but frames it within an AI-centric narrative not present in the original. (4) The ground truth does not mention AI capabilities as a primary driver of the strategic shift, yet the LLM makes this central to the answer. MULTI-HOP REASONING: The LLM demonstrates sound reasoning in connecting investment strategy to ecosystem integration, but the reasoning path diverges from the ground truth by introducing AI as the primary driver rather than ecosystem expansion and partner leverage. SEMANTIC EQUIVALENCE: While both answers discuss ecosystem integration and partner leverage, the LLM's emphasis on AI-driven transformation represents a substantive difference in how the evolution is characterized, not merely a wording variation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 586,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "\nThe company’s vendor‑funding accruals continue to be derived from the individual vendor agreement terms, with periodic review of historical purchase trends and volumes throughout the year.  In the fiscal 2024 discussion the firm stresses that actual purchase volumes are compared to projections and that accrual rates are adjusted when those volumes differ—especially for programs that increase funding at graduated volume thresholds—making the 2024 approach more explicitly sensitive to volume variance than in fiscal 2023.  Thus, while the underlying methodology remained the same, the 2024 reporting places greater emphasis on the impact of projected purchase volumes on the accrued funding amount.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and demonstrates a critical misunderstanding of the question. MAJOR ERRORS: (1) DIRECTIONAL CONTRADICTION: The ground truth states that fiscal 2024 OMITTED the explicit reference to 'graduated purchase volumes' that was present in fiscal 2023, suggesting simplification. The LLM claims the opposite—that fiscal 2024 places GREATER emphasis on graduated volume thresholds and is MORE explicitly sensitive to volume variance than fiscal 2023. This is a complete reversal of the actual evolution. (2) MISCHARACTERIZATION OF CHANGE: The ground truth indicates the company moved away from explicitly highlighting sensitivity to graduated purchase volumes (a de-emphasis), while the LLM describes an increased emphasis on volume sensitivity (an emphasis). These are opposite conclusions. (3) METHODOLOGY CONSISTENCY: Both answers correctly note the underlying methodology remained consistent, but the LLM incorrectly characterizes the nature of the change in disclosure/emphasis. (4) GRADUATED PURCHASE VOLUMES: The ground truth specifically identifies 'graduated purchase volumes' as the key element that was highlighted in fiscal 2023 but omitted in fiscal 2024. The LLM mentions graduated volume thresholds but attributes them to the 2024 discussion rather than noting their removal from explicit discussion. WHAT WAS CORRECT: The LLM correctly identifies that the methodology remained consistent and that purchase volumes/trends are monitored. However, these correct elements are overshadowed by the fundamental misinterpretation of how the company's disclosure approach evolved. The answer reads as if the LLM reversed the temporal direction of the change or confused which year emphasized what aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 481,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "\nFrom 2022 through 2024 the Lilly‑Boehringer Ingelheim partnership has moved beyond simple co‑marketing of Jardiance to a tighter legal and financial interdependence.  Boehringer Ingelheim now defends and indemnifies Lilly in the growing product‑liability suits involving Jardiance (page 102) and the two firms jointly confront patent‑infringement disputes that have been stayed (page 102), while the IRA’s selection of Jardiance for government‑set pricing—identified as part of the Lilly‑BI collaboration (page 45)—has increased Lilly’s reliance on BI’s market‑access expertise and shared revenue to mitigate the resulting revenue‑erosion risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer completely omits the specific 66% discount figure mentioned in the ground truth as a key metric of the IRA pricing impact. This is a material factual omission for a financial question. (2) FACTUAL CONTRADICTION: The ground truth explicitly states that 'In 2022, LLY was not a direct party to the Jardiance patent litigation,' indicating an arms-length legal relationship. The LLM answer contradicts this by claiming BI 'now defends and indemnifies Lilly' and that they 'jointly confront patent-infringement disputes,' suggesting direct legal involvement that contradicts the ground truth's characterization of 2022 as showing LLY was NOT a direct party. The LLM appears to have misinterpreted the evolution - the ground truth shows LLY becoming MORE dependent on BI's partnership (not more legally entangled in litigation), while the LLM suggests increased legal interdependence through indemnification and joint patent defense. (3) MULTI-HOP REASONING ISSUE: The LLM failed to properly synthesize the key distinction in the ground truth: the evolution from 'arms-length relationship in legal matters' (2022) to 'deeper strategic entanglement and dependency' (2024) focused on COMMERCIAL/PRICING pressures, not legal litigation involvement. (4) MISSING CONTEXT: The LLM references page numbers (102, 45) without verification against the ground truth source material, and introduces concepts (indemnification, product-liability suits, stayed patent disputes) not mentioned in the ground truth answer. (5) SEMANTIC MISALIGNMENT: While the LLM correctly identifies the IRA selection and revenue impact, it frames the relationship evolution differently than the ground truth - emphasizing legal interdependence rather than commercial dependency on pricing/regulatory navigation. The core narrative is inverted from what the ground truth presents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 519,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2023 Disney moved from a single‑project focus on a new private cruise‑line destination (the 550‑acre Lighthouse Point development slated for a 2024 opening) to a broader, multi‑year capital‑investment program that treats cruise‑ship construction and fleet expansion as a core pillar of its Parks & Experiences growth strategy.  The 2023 filing explicitly lists “new attractions, cruise ships, capital improvements and systems infrastructure” alongside theme‑park expansions, showing that Disney’s capital strategy evolved to allocate sustained funding to the Disney Cruise Line as an integral component of its overall Experiences portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about Disney's cruise strategy evolution but introduces specific factual claims not present in the ground truth, creating accuracy concerns. STRENGTHS: (1) Correctly identifies the shift from 2022 to 2023 in how cruise ships were treated strategically; (2) Accurately quotes the 2023 filing language about 'new attractions, cruise ships, capital improvements and systems infrastructure'; (3) Properly synthesizes the multi-hop concept that cruise ships became more explicitly prioritized within Parks & Experiences; (4) Contextually relevant framing of the evolution. WEAKNESSES: (1) Introduces specific quantitative claims not in ground truth: '550-acre Lighthouse Point development' and '2024 opening' - these details cannot be verified against the provided ground truth and may be hallucinated; (2) Claims about 'single-project focus' in 2022 vs 'multi-year capital-investment program' in 2023 are more specific than ground truth supports; (3) The ground truth notes 2022 filing did NOT specifically emphasize capital investment in cruise ships, while LLM implies there was a 'single-project focus' which is a different characterization; (4) Ground truth emphasizes the absence of specific cruise ship capital investment emphasis in 2022, whereas LLM suggests there was a focused project (Lighthouse Point). CALCULATION/VERIFICATION: No calculations required, but specific factual claims (Lighthouse Point, 550 acres, 2024 opening) cannot be verified against ground truth and appear to be additional details not supported by the source material. The core semantic message about evolution from 2022 to 2023 is correct, but the specific supporting details are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 467,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard Foundry moved from a primarily exploratory “lab” function to a more formalized innovation platform that actively co‑creates with fintech partners and integrates emerging technologies.  In 2022 it was described as a source of thought‑leadership and early‑stage fintech exposure, but by 2024 the Foundry was delivering concrete programs such as Launchpad prototyping workshops, AI‑driven fraud tools (Decision Intelligence Pro), blockchain‑enabled programmable payments via the Mul‑Token Network, and expanded open‑banking APIs—all of which reflect deeper, structured collaborations with fintechs and a focus on AI, tokenization, crypto‑services and real‑time payment flows.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM introduces specific product names and initiatives NOT mentioned in the ground truth, including 'Launchpad prototyping workshops,' 'Decision Intelligence Pro,' and 'expanded open-banking APIs.' These appear to be hallucinated details not supported by the original answer. (2) PARTIAL ACCURACY - The LLM correctly captures the core evolution from exploratory 'lab' function to more formalized innovation platform, and correctly identifies the shift toward blockchain/programmable payments and the Multi-Token Network (though misspelled as 'Mul-Token Network'). (3) MISSING KEY DETAILS - The ground truth specifically mentions Mastercard Foundry was 'formerly known as Mastercard Labs,' which the LLM omits. The ground truth emphasizes 'thought leadership, innovation methodologies, new technologies, and early-stage fintech players' in 2022, which the LLM partially captures but oversimplifies. (4) UNSUPPORTED CLAIMS - The LLM's specific references to 'AI-driven fraud tools,' 'tokenization, crypto-services,' and 'real-time payment flows' are not explicitly mentioned in the ground truth and appear to be inferences or fabrications. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize the 2022-2024 evolution, it does so by introducing unverified details rather than sticking to documented facts. The core narrative of evolution is sound, but the specific examples undermine credibility. The answer reads plausibly but contains material inaccuracies that would mislead someone relying on specific product/initiative names.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 435,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "\nBetween 2022 and 2024 the Lilly‑Boehringer Ingelheim partnership moved from a phase of accelerated regulatory approvals—empagliflozin (Jardiance) received Fast‑Track and Breakthrough‑Therapy designations and was submitted for, and later obtained, FDA approval for heart‑failure with preserved ejection fraction and chronic‑kidney‑disease indications (2022)—to a stage in which the product is now subject to the United States’ new price‑setting regime.  Under the Inflation‑Reduction Act, the Medicare program will impose a ~66 % discount on Jardiance in 2026 and similar rebate obligations, creating direct pricing pressure on the co‑developed therapy and forcing both companies to adjust their reimbursement and access strategies (e.g., 340B litigation, payer negotiations).  Thus, the collaboration’s financial and strategic focus shifted from securing regulatory speed‑ups to managing steep, government‑mandated price reductions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of the multi-hop question. STRENGTHS: (1) Correctly identifies the regulatory designations (Fast-Track and Breakthrough Therapy) for empagliflozin/Jardiance in 2022, matching the ground truth. (2) Accurately specifies the ~66% discount under the Inflation Reduction Act effective in 2026, which matches the ground truth's '66% discount.' (3) Properly synthesizes the evolution from regulatory facilitation (2022) to regulatory-driven financial constraints (2024), capturing the core strategic shift. (4) Correctly identifies the partnership as Lilly-Boehringer Ingelheim and the product as Jardiance. (5) Adds relevant contextual details (heart failure with preserved ejection fraction, chronic kidney disease indications, 340B litigation, payer negotiations) that enhance understanding without contradicting the ground truth. (6) The temporal framing (2022 to 2024) is accurate. MINOR CONSIDERATIONS: (1) The LLM uses '~66%' (approximately) while ground truth states '66%' - this is a negligible difference and represents appropriate precision qualification. (2) The LLM provides additional strategic context (340B litigation, payer negotiations) not explicitly in the ground truth, but these are reasonable inferences from the pricing pressure discussion and add value without introducing errors. (3) The answer is more detailed and comprehensive than the ground truth while remaining fully consistent with it. QUANTITATIVE VERIFICATION: The 66% discount figure is correct, the 2026 effective date is correct, and the temporal progression (2022 to 2024) is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across regulatory designations, product approvals, and pricing policy changes, demonstrating sound multi-hop reasoning. The logical progression from regulatory acceleration to pricing constraints is clearly articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 523,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "\nFrom 2023 to 2024 Lockheed Martin moved the CH‑53K King Stallion from a niche heavy‑lift asset—highlighted only by the 2023 Israel order—to a core growth pillar of its Rotary and Mission Systems segment. The 2024 filing explicitly places the CH‑53K in the company’s 21st Century Security strategy, underscoring expanded production for the U.S. Marine Corps, continued foreign‑military‑sales momentum, and deeper integration into joint all‑domain mission solutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces specific claims NOT present in the ground truth, including: a '2023 Israel order' (not mentioned in original answer), 'expanded production for the U.S. Marine Corps' (not specified in ground truth), and 'continued foreign-military-sales momentum' (not documented in original answer). These are factual claims presented as if from the filings but cannot be verified against the ground truth. (2) The LLM characterizes the shift as moving from 'niche heavy-lift asset' to 'core growth pillar' - this is a more dramatic characterization than the ground truth supports. The original answer states it 'remained a highlighted program' in 2024, not that it was elevated to a new status. (3) The LLM references '21st Century Security strategy' which does not appear in the ground truth answer. (4) QUANTITATIVE ACCURACY: No specific revenue figures are provided in either answer, which is correct, but the LLM adds unverified specifics about production expansion and FMS momentum. (5) MULTI-HOP REASONING: The LLM does attempt to synthesize the evolution across years, but does so by introducing information not in the ground truth rather than synthesizing what was actually documented. (6) SEMANTIC ALIGNMENT: The ground truth emphasizes a shift from 'growth driver among several others' to 'part of integrated, technologically advanced portfolio' focused on AI/ML, autonomy, and interoperability. The LLM's framing around production expansion and FMS is a different narrative entirely. The answer demonstrates partial understanding of the segment positioning but fails on factual accuracy by introducing unverified claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 454,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "\nThe 2022‑2024 filings show that Lilly and Boehringer Ingelheim have trimmed and refocused their co‑commercialized diabetes lineup around a smaller set of higher‑value, cardiometabolic products (e.g., Jardiance, Basaglar, Trulicity) and are now leveraging the partnership to push new access‑focused initiatives such as LillyDirect for obesity and diabetes.  This consolidation signals a strategic shift from a broad, diversified therapeutic portfolio toward a payer‑driven emphasis on obesity‑diabetes‑cardiovascular indications—areas where the companies can secure formulary placement and long‑term revenue growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) PRODUCT PORTFOLIO ERRORS: The LLM incorrectly includes 'Basaglar' and 'Trulicity' in the 2024 portfolio. According to the ground truth, Basaglar was REMOVED from the portfolio by 2024 (it was in 2022 but not 2024), and Trulicity is not mentioned in either the 2022 or 2024 portfolios in the ground truth. The correct 2024 portfolio is: Jardiance, Glyxambi, Synjardy, and Trijardy XR. The LLM failed to identify the three products that were actually removed: Trajenta, Jentadueto, and Basaglar. (2) MISSING PRODUCTS: The LLM omits several products that were in the 2022 portfolio (Trajenta, Jentadueto) and fails to note their removal, which is a key indicator of the strategic shift. (3) INCOMPLETE ANALYSIS: While the LLM correctly identifies a 'consolidation' and 'refocusing,' it does not accurately specify which products were removed or retained. The mention of 'LillyDirect' and 'obesity-diabetes-cardiovascular indications' appears to be extrapolation not supported by the ground truth answer. (4) REASONING QUALITY: The LLM's reasoning about 'payer-driven emphasis' and 'formulary placement' is plausible but not grounded in the specific product changes documented in the ground truth. The ground truth attributes the changes to 'lifecycle management, shifting market demand, declining market relevance, generic competition, or patent protection considerations'—different from the LLM's framing. (5) QUANTITATIVE ACCURACY: The LLM provides no specific product counts or dates, making it difficult to verify precision, but the product names cited are factually incorrect relative to the ground truth. The core multi-hop synthesis is flawed because the LLM misidentified which products remained in the portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 495,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "\nIn 2024 the Missiles and Fire Control segment posted a 13 % rise in net sales to $12.68 bn, with JASSM accounting for roughly $1.2 bn of that growth as production ramped up; backlog climbed to $38.8 bn, driven by higher orders on JASSM (alongside PAC‑3 and GMLRS).  At the same time, operating profit fell 73 % YoY, because profit‑booking rate adjustments turned negative and a $1.4 bn loss on a classified program offset the volume gains, highlighting JASSM’s strategic importance for order growth even as it pressures near‑term margins.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces specific numbers NOT in the ground truth: claims MFC segment posted 13% rise in net sales to $12.68bn, backlog climbed to $38.8bn, and a $1.4bn loss on a classified program. The ground truth only confirms JASSM contributed $1.2bn to tactical/strike missile growth and was cited as key contributor to backlog increase alongside PAC-3 and GMLRS. The LLM fabricated specific segment-level metrics and loss figures not supported by the original answer. (2) CALCULATION CONCERNS - The LLM states operating profit fell 73% YoY with specific attribution to profit-booking adjustments and classified program losses. These specific percentages and causal explanations are not in the ground truth and appear to be hallucinated details. (3) MULTI-HOP REASONING - While the LLM correctly identifies JASSM's role in both production ramp-up and backlog contribution in 2024, it adds unsupported financial details that contradict the principle of strict accuracy on numbers. (4) SEMANTIC ISSUES - The ground truth emphasizes 'notable rise in both production activity and strategic importance' but the LLM's narrative about margin pressure from classified program losses shifts the emphasis in ways not supported by source material. (5) WHAT WAS CORRECT - The core finding that JASSM experienced production ramp-up in 2024, contributed $1.2bn to growth, and was cited as key backlog contributor alongside PAC-3 and GMLRS is accurate. However, the addition of unverified financial metrics (13% segment growth, $38.8bn backlog, 73% profit decline, $1.4bn loss) significantly undermines credibility and violates the strict accuracy requirement for financial numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 468,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "\nBetween 2023 and 2024 JPM shifted its Business‑Banking loan risk review from a largely delinquency‑focused approach to a multi‑factor, leading‑indicator model.  The 2023 disclosures relied mainly on payment‑status metrics (30‑149 days past due, 150+ days past due and gross charge‑offs), whereas the 2024 discussion adds detailed credit‑quality levers such as current LTV ratios, refreshed FICO scores, geographic concentration and Chapter 7 bankruptcy status as key signals of stress.  Consequently, early signs of borrower distress now include deteriorating credit scores, high‑LTV positions and emerging regional economic weakness—factors that can flag at‑risk borrowers before they reach formal delinquency.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer fundamentally contradicts the ground truth on the direction of the shift. Ground truth states: 2023 focused on 'loan performance and scoring models' while 2024 shifted TO 'delinquency rates as the primary credit quality indicator.' The LLM reverses this, claiming 2023 was 'delinquency-focused' and 2024 added 'leading-indicator models' with LTV ratios, FICO scores, etc. This is backwards. The LLM introduces specific metrics (LTV ratios, FICO scores, Chapter 7 bankruptcy status, geographic concentration) that are NOT mentioned in the ground truth at all. While these sound plausible for credit risk assessment, they represent fabricated details not supported by the source material. The ground truth explicitly states the shift was toward 'delinquency rates' and '30+ days past due' as early warnings, not away from delinquency metrics. The LLM's characterization of the evolution is inverted: it suggests moving FROM delinquency TO leading indicators, when the ground truth indicates the opposite direction or at minimum a different emphasis. The LLM does correctly identify that the shift relates to 'early intervention' and 'early signs of borrower distress,' but the mechanism and direction of change are fundamentally misrepresented. The answer demonstrates poor multi-hop synthesis and introduces unsupported details that contradict the knowledge graph source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 396,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "\nThe 2022 and 2023 Form 10‑K filings both list Target’s “Target Corporation SPP II (2016 Plan Statement) (as amended and restated effective April 3, 2016) (11)” without any noted amendment or new version between the two years. Thus, the substantive terms of SPP II—its performance‑metric triggers, award types (e.g., performance‑share units, restricted‑stock units, cash retention awards) and overall structure—have remained unchanged from the 2022 filing to the 2023 filing. This continuity signals that Target’s executive‑compensation framework is deliberately stable, relying on a long‑standing, performance‑driven incentive plan that has not been revised or expanded in the most recent reporting period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The ground truth clearly states that the SPP II plan evolved between 2022 and 2023 filings: in 2022 it was under the '2016 Plan Statement, as amended and restated effective April 3, 2016,' while in 2023 it was updated to the '2022 Plan Statement, as amended and restated effective May 1, 2022.' This represents a significant change in the plan structure. However, the LLM answer claims that both filings list the same '2016 Plan Statement' without any amendment or new version between the two years, and concludes that the plan remained unchanged. This is a direct factual error. The LLM misidentified the key evolution that occurred: the shift from a 2016 Plan Statement to a 2022 Plan Statement. The LLM also incorrectly asserts that 'substantive terms...have remained unchanged,' when the ground truth explicitly indicates a plan revision occurred. The LLM's conclusion about 'deliberate stability' and 'long-standing' unchanged framework contradicts the actual evidence of plan evolution documented in the filings. The multi-hop reasoning failed because the LLM did not correctly synthesize the comparative information across the 2022 and 2023 filings. The answer demonstrates a fundamental misunderstanding of the question and provides incorrect information about Target's executive compensation framework changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 387,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "\nFrom 2022 through 2024 the Olumiant partnership with Incyte moved from a standing‑by schedule of up to **$100 million of regulatory‑milestone payments and $100 million of sales‑milestone payments** (as disclosed in the 2022 filing, Note 4/Note 5) toward near‑term realization of those targets.  By the 2024 filing the company reports that the $260 million and $210 million milestones that were capitalized in 2020‑2021 have been amortized, and the only remaining contingent amounts are modest additional regulatory milestones for new indications—none of which are material to cash flow.  Consequently, the company’s future financial obligation to Incyte under the Olumiant collaboration is now limited to the standard tiered royalty (up to 20 % on net sales) and the low‑teens royalty on COVID‑19 sales, with essentially **no material additional milestone payments expected** beyond what has already been recorded.  (LLY_10k_2022.pdf pp. 71‑73; LLY_10k_2024.pdf pp. 73‑74).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its credibility. CRITICAL ERRORS: (1) The LLM introduces numbers NOT in the ground truth: '$260 million and $210 million milestones that were capitalized in 2020-2021' - these specific figures are not mentioned in the original answer and appear to be fabricated or misattributed. (2) The LLM claims these milestones 'have been amortized' by 2024, but the ground truth states regulatory milestones were 'either paid out or no longer applicable' - different characterizations. CORRECT ELEMENTS: (1) The $100 million regulatory milestones and $100 million sales milestones for 2022 are accurately stated. (2) The shift from regulatory/sales milestones to royalty-based compensation (up to 20% tiered royalty, low-teens for COVID-19) is correctly identified. (3) The conclusion that no material additional milestone payments are expected is aligned with ground truth. REASONING ISSUES: The multi-hop synthesis is partially sound - the LLM correctly identifies the evolution from 2022 to 2024 and the shift in compensation structure. However, the introduction of unverified $260M and $210M figures suggests either hallucination or misreading of source documents. The statement about 'modest additional regulatory milestones for new indications' is not explicitly mentioned in the ground truth, which states there is 'no mention of remaining regulatory milestones.' SEMANTIC ISSUES: While the overall narrative direction is correct, the specific factual claims about capitalized milestones being amortized are not substantiated by the ground truth provided. The answer is more detailed than the original but contains potentially false specificity that reduces reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 474,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "\nCisco’s APJC revenue slipped modestly from $8.03 billion in fiscal 2022 to roughly $7.7 billion in fiscal 2023, and the company’s long‑lived assets in the region fell from $997 million (end‑FY22) to about $900 million (end‑FY23), indicating a slight reduction in tangible exposure.  At the same time, goodwill allocated to APJC was essentially unchanged – rising only $22 million to $5.38 billion at the close of FY 2023 – so the region’s financial exposure shifted marginally toward acquired intangibles rather than a major change in overall asset balances.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple ways: (1) REVENUE CLAIMS: The LLM states APJC revenue was $8.03B in FY2022 and $7.7B in FY2023, but the ground truth explicitly states that 'specific financial figures for APJC were not disclosed in the provided data' for FY2022. The LLM fabricated these revenue figures with no source basis. (2) LONG-LIVED ASSETS: The LLM claims long-lived assets fell from $997M to $900M, but again, the ground truth does not provide these figures in the source data. (3) GOODWILL FIGURES: The LLM states goodwill 'rose only $22 million to $5.38 billion' - this is internally contradictory and misleading. The ground truth mentions total APJC assets of $5,382 million ($5.38B) as of July 29, 2023, but does not break this down into goodwill vs. other assets, nor does it provide FY2022 goodwill figures for comparison. The LLM appears to have confused total assets with goodwill allocation. (4) MULTI-HOP REASONING: The LLM failed to recognize that the ground truth explicitly states segment-level asset values were 'not explicitly itemized' in FY2022, making year-over-year comparisons impossible. Instead of acknowledging this data limitation, the LLM provided specific numbers that cannot be verified. (5) SEMANTIC MISMATCH: The ground truth emphasizes improved disclosure in 2023 vs. 2022 (a qualitative change), while the LLM focuses on quantitative changes in revenue and assets that are not supported by the source material. The answer demonstrates hallucination of specific financial metrics rather than synthesis of actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 445,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the Lilly‑Boehringer Ingelheim partnership on Jardiance shifted from a pure growth‑driven launch to a strategy that must now accommodate U.S. price‑control rules.  While revenue had been expanding (e.g., a 30 % U.S. increase in 2021 and continued double‑digit gains in 2022), the Inflation‑Reduction Act forced HHS in August 2023 to name Jardiance among the first ten drugs subject to government‑set pricing, and in August 2024 a 66 % discount relative to the 2023 list price was announced.  In response, Lilly and Boehringer have begun renegotiating commercial terms, tightening cost‑control and emphasizing non‑U.S. markets and new cardiovascular indications to offset the anticipated revenue erosion from the mandated price cuts.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core narrative arc - Jardiance evolved from growth-driven strategy to one constrained by IRA price controls. Key facts are accurate: (1) August 2023 selection as one of first ten drugs subject to government pricing, (2) August 2024 announcement of 66% discount relative to 2023 list price, (3) the shift in strategy toward cost control and non-U.S. markets. The multi-hop reasoning connecting regulatory changes to business strategy evolution is sound and well-articulated.\n\nCRITICAL ERRORS: (1) The LLM states '30% U.S. increase in 2021' but the ground truth specifies '30% increase in the U.S.' for 2022, not 2021. This is a factual error regarding the year. (2) The LLM references 'continued double-digit gains in 2022' which is not explicitly stated in the ground truth - this appears to be inference/extrapolation beyond what was provided. (3) The ground truth specifies '28% outside the U.S.' for 2022, which the LLM completely omits.\n\nQUANTITATIVE ACCURACY ISSUES: The year attribution for the 30% growth figure is incorrect (2021 vs 2022). The omission of the 28% international growth metric represents incomplete data synthesis. The 66% discount figure is correctly cited.\n\nQUALITATIVE ASSESSMENT: The reasoning about strategic response (renegotiating terms, emphasizing non-U.S. markets, new indications) is logical and well-supported, though some elements appear to be reasonable inference rather than explicitly stated in the ground truth.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of the collaboration in response to regulatory changes, with appropriate focus on the IRA's impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 460,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "\nBetween 2022 and 2023 GM’s disclosures shifted from a general warning that a recall on a global platform—exemplified by the Chevrolet Bolt EV—could “exacerbate” recall costs and damage reputation, to a more pronounced emphasis that safety‑related recalls and perceived defects in its EV and AV technologies could trigger product delays, lost sales, regulatory action and substantial brand‑damage.  The 2023 filing expands the narrative to stress that concerns about the safety of its advanced‑technology vehicles, whether raised by regulators, consumers or internally, could materially harm GM’s reputation, erode consumer trust and jeopardize its positioning in the EV/AV market, underscoring a heightened focus on both the financial and reputational risks of product‑safety recalls as the company pushes deeper into electric and autonomous mobility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: The answer correctly identifies the Chevrolet Bolt EV as the specific global platform example, accurately captures the 2022-2023 timeframe, and properly characterizes the evolution from cost-centric to broader strategic risk concerns. The mention of EV/AV technologies, regulatory action, product delays, and lost sales are all appropriate risk factors that align with the ground truth's emphasis on innovation and market positioning. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either the ground truth or LLM answer, so this dimension scores perfectly. The temporal comparison (2022 vs 2023) is correctly maintained throughout. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple dimensions: (a) the specific product recall example (Chevrolet Bolt EV), (b) the temporal evolution (2022 to 2023), (c) the shift in emphasis (financial/cost to reputational/strategic), and (d) the connection to broader company positioning in EV/AV markets. This demonstrates sound multi-hop reasoning. (4) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different language than the ground truth but conveys the same core insights. The ground truth emphasizes 'shift from primarily cost-centric concern to broader strategic risk,' while the LLM describes the evolution from 'general warning about exacerbating costs' to 'pronounced emphasis on safety concerns triggering delays, lost sales, regulatory action and brand damage.' These are semantically equivalent characterizations. (5) MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail about specific consequences (product delays, lost sales, regulatory action) compared to the ground truth, which is appropriate elaboration rather than deviation. The phrase 'heightened focus on both the financial and reputational risks' directly mirrors the question's framing and the ground truth's intent. No factual errors, contradictions, or mischaracterizations are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 571,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "\nBetween 2022 and 2024 the balance of the Japanese subsidiary’s Guaranteed Senior Notes rose from roughly **$590 million (2022)** to **$484 million (2023)** and then to **$919 million (2024)**—driven by a **~$500 million issuance in November 2023** and a **partial $77 million repayment in July 2024**, leaving a net increase.  This pattern shows that Costco is intentionally expanding long‑term, low‑cost foreign‑currency financing through its Japan unit to fund overseas operations and diversify its overall capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific balance figures ($590M in 2022, $484M in 2023, $919M in 2024) that are NOT present in the ground truth. The ground truth explicitly states that in 2022, the notes were 'described in general terms' with no specific valuation disclosed. The ground truth does NOT provide 2022 or 2023 balance figures. The LLM appears to have fabricated these numbers. (2) CALCULATION ERROR - The LLM claims a 'net increase' but the math doesn't support the narrative: if starting at $590M, adding $500M would yield $1,090M, then subtracting $77M would yield $1,013M, not $919M. The numbers are internally inconsistent. (3) MISSING KEY DETAILS - The ground truth specifies that the November 2023 issuance included FOUR notes with fixed rates ranging from 1.400% to 2.120% and maturities from 2033 to 2043. The LLM omits these important details about the interest rates and maturity structure, which are central to understanding the financing strategy. (4) CORRECT ELEMENTS - The LLM correctly identifies: the November 2023 issuance (~$500M), the July 2024 repayment ($77M), and the general concept that this reflects a strategic long-term financing approach. (5) REASONING QUALITY - While the LLM's interpretation about diversifying capital structure and managing liquidity is reasonable, it's built on a foundation of incorrect numbers. The ground truth emphasizes 'more transparent and strategic approach' with 'fixed-rate debt and extended maturities' - the LLM mentions 'low-cost foreign-currency financing' which is not explicitly stated in the ground truth. OVERALL: The answer contains fabricated balance sheet figures that contradict the ground truth's statement that 2022 figures were only 'described in general terms.' This is a critical failure in factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 497,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Cisco’s available‑for‑sale debt investments grew from **$11.9 billion** (as of July 30 2022) to **$15.6 billion** (as of July 29 2023), an increase of roughly **$3.6 billion (≈30 %)**.  This rise indicates that Cisco is deploying excess cash into high‑quality, investment‑grade debt securities—enhancing portfolio yield while preserving liquidity for strategic uses such as future acquisitions, stock repurchases and dividend payments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The LLM states available-for-sale debt investments grew from $11.9B (2022) to $15.6B (2023), an increase of $3.6B. However, the ground truth clearly indicates the opposite: these investments DECREASED from $15,592 million ($15.6B) in 2022 to $9,865 million ($9.9B) in 2023, a decrease of $5,727 million ($5.7B). The LLM has inverted the direction of change entirely. (2) CALCULATION ERRORS: The LLM calculates a 30% increase, but the actual change was a 36.7% decrease ($5,727M / $15,592M). The percentage calculation is not only wrong in magnitude but also in direction. (3) STRATEGIC INTERPRETATION REVERSED: The LLM interprets the change as Cisco 'deploying excess cash into high-quality debt securities,' suggesting an expansion strategy. The ground truth indicates the opposite—a 'strategic reduction in the company's holdings of available-for-sale debt instruments,' suggesting a shift away from these investments. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the year-over-year comparison and misidentified which year had higher values. (5) ENTITY/METRIC ACCURACY: While Cisco and the metric (available-for-sale debt investments) are correctly identified, the fiscal year values and their relationship are fundamentally wrong. The answer demonstrates a complete reversal of the actual investment trend and its implications for Cisco's strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 415,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "\nFrom 2023 to 2024 the firm’s warning moved from a generic caution about reliance on third‑party providers and the possibility of operational breakdowns to a more pointed focus on ever‑more sophisticated cyber threats—such as AI‑driven fraud, quantum‑computing vulnerabilities and ransomware—that can compromise data integrity and extend the time needed to restore it. The 2024 filing also stresses that after a breach the ability to fully recover stolen or manipulated information may be delayed, increasing the risk of prolonged downtime, higher remediation costs and greater regulatory or litigation exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer introduces significant factual errors not supported by the ground truth. Specifically: (1) The LLM claims 2024 filing emphasizes 'AI-driven fraud' and 'quantum-computing vulnerabilities' - these are NOT mentioned in the ground truth and appear to be fabricated details. (2) The LLM states the evolution moved from 'generic caution about reliance on third-party providers' in 2023 - the ground truth explicitly states 2023 focused on 'unauthorized access, zero-day vulnerabilities, and DDoS attacks,' not generic third-party reliance concerns. (3) The LLM correctly identifies ransomware and third-party vendor attacks as 2024 concerns, which aligns with ground truth. (4) The LLM correctly notes increased complexity in data recovery and prolonged downtime risks, which matches the ground truth's mention of 'increased complexity in recovering from data theft or destruction.' QUANTITATIVE ACCURACY: No specific numbers or dates are provided by either answer, so this dimension scores well (8/10) - the years 2023 and 2024 are correctly referenced. QUALITATIVE ACCURACY: The answer demonstrates poor synthesis and introduces unsupported claims (AI-driven fraud, quantum vulnerabilities) that contradict the knowledge graph. The core evolution from 2023 to 2024 is partially captured but with significant fabrications. CONTEXTUAL RELEVANCE: While the answer addresses the general topic of cyber risk evolution, it does so with inaccurate details that undermine its relevance. The answer fails to accurately capture the specific shift from unauthorized access/zero-day vulnerabilities to ransomware/third-party vendor attacks that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 466,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "\nBy the end of 2024 Costco had deployed capital to enlarge its private‑label production base – building and upgrading processing and packaging facilities that actually manufacture private‑label items – and had simultaneously expanded its warehouse footprint (e.g., opening dozens of new stores and adding over 130 million sq ft of floor space) to give the broader private‑label assortment the shelf‑space and distribution capacity it needs. These investments also strengthened the supply‑chain and logistics network that moves the newly produced private‑label goods from the facilities to the expanded store base.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question about operational investments for private-label growth but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies that Costco made investments in processing, packaging, and manufacturing facilities for private-label production, which aligns with the ground truth. The mention of supply chain and logistics strengthening is contextually appropriate. (2) QUANTITATIVE ACCURACY PROBLEMS: The LLM introduces specific numbers ('dozens of new stores' and 'over 130 million sq ft of floor space') that are NOT present in the ground truth answer. These appear to be fabricated or unsupported claims. The ground truth makes no mention of specific store counts or square footage figures. This is a critical error as it violates the instruction to be strict on numbers. (3) SCOPE CREEP: The ground truth focuses specifically on operational investments to support private-label growth (facilities, production capabilities). The LLM significantly expands the answer to include warehouse footprint expansion and general store openings, which may be tangential to the specific question about private-label strategy support. While warehouse expansion could theoretically support private-label distribution, the ground truth does not make this connection explicit. (4) MULTI-HOP REASONING: The LLM attempts to synthesize a broader narrative connecting production facilities to distribution capacity, which shows reasoning effort, but this synthesis goes beyond what the ground truth establishes. The ground truth is more conservative, focusing on the shift from external sourcing to internal production capabilities. (5) SEMANTIC ISSUES: The LLM's framing of 'enlarged production base' and 'processing and packaging facilities' is semantically equivalent to the ground truth, but the addition of unsupported quantitative claims undermines credibility. The penalty for introducing unverified numbers is substantial given the evaluation criteria's emphasis on strict number accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 547,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "\nBetween 2022 and 2023 UnitedHealth sharpened its Medicaid‑managed‑care bidding approach by tying each bid more directly to CMS‑calculated benchmarks—particularly the enrollee‑premium threshold required for automatic low‑income enrollment under Medicare Part D—and by subjecting those bids to heightened risk‑adjustment data‑validation audits.  The company still based its bids on assumptions about enrollment, utilization and medical‑cost trends, but it now emphasizes that any material miss‑specification—whether from unexpected policy changes, competitor under‑bidding, or audit‑driven recoupments or fines—could result in loss of contracts, premium adjustments or other financial penalties, making the accuracy of those assumptions a more central risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) INCORRECT SPECIFICS: The answer claims UnitedHealth tied bids to 'CMS-calculated benchmarks' and 'enrollee-premium threshold required for automatic low-income enrollment under Medicare Part D'—this is factually wrong. The ground truth discusses Medicaid managed care contracts, not Medicare Part D enrollment thresholds. These are entirely different programs. (2) UNSUPPORTED CLAIMS: The mention of 'risk-adjustment data-validation audits,' 'audit-driven recoupments or fines,' and 'premium adjustments' are not mentioned in the ground truth and appear to be fabricated details. (3) MISSING CORE EVOLUTION: The LLM answer fails to capture the actual evolution described in the ground truth: the shift from emphasizing 'risk of losing Medicaid members if contracts aren't renewed' (2022) to emphasizing 'assumptions behind bids and their accuracy' (2023). (4) CORRECT ELEMENTS: The answer does correctly identify that assumptions about enrollment, utilization, and medical costs are central to the discussion, and that material misspecification could affect results. However, this correct element is embedded within a largely incorrect narrative. (5) MULTI-HOP REASONING: The answer fails to properly synthesize the 2022 vs. 2023 evolution. Instead of comparing the two years' approaches, it conflates them and adds unrelated Medicare Part D information. The ground truth clearly shows a progression from contract renewal risk focus to bid assumption accuracy focus—the LLM misses this critical distinction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 447,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 MetLife’s municipal‑bond holdings stayed in the Level 2 tier of the fair‑value hierarchy, but their reported fair value slipped modestly from **$159 million (2022)** to **$147 million (2023)**. This decline reflects a slight reduction in the municipal portfolio’s size, while the classification remained Level 2 (i.e., valuations based on independent pricing sources or other observable inputs rather than quoted prices in an active market). No Level 3 classification was reported for municipals in either year.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL NUMBER ERRORS: The LLM states 2022 municipals were $159 million and 2023 were $147 million, but the ground truth clearly indicates 2022 was $14,212 million and 2023 was $159 million. The LLM has reversed and misrepresented the values by an order of magnitude. (2) VALUATION HIERARCHY CLASSIFICATION ERROR: The LLM claims municipals were classified as Level 2 in both 2022 and 2023, but the ground truth states that in 2022 they were categorized under 'Estimated Fair Value' without detailed breakdown of hierarchy levels, and only in 2023 were they explicitly classified as Level 2. This is a significant mischaracterization of the evolution described in the question. (3) MISSING KEY INSIGHT: The ground truth emphasizes a 'significant reduction' from $14,212M to $159M (approximately 98.8% decrease), which represents a major portfolio shift. The LLM's claimed decline from $159M to $147M (less than 8% decrease) completely misses this critical evolution. (4) MULTI-HOP REASONING FAILURE: The question asks about evolution 'particularly in terms of its valuation hierarchy classification.' The ground truth shows a transition from non-hierarchical categorization to explicit Level 2 classification, indicating improved transparency. The LLM incorrectly suggests static Level 2 classification across both years. (5) SEMANTIC CONTRADICTION: The LLM's statement that holdings 'stayed in the Level 2 tier' directly contradicts the ground truth's indication that 2022 lacked explicit hierarchy classification. The answer demonstrates fundamental misunderstanding of the data and fails on both quantitative accuracy (wrong numbers) and qualitative reasoning (wrong classification evolution).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 487,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Microsoft broadened how customers can obtain Office 365/Microsoft 365, moving from a mainly volume‑licensing/Software Assurance model to a suite of simplified, non‑expiring subscription agreements—Enterprise Agreements, Microsoft Customer Agreements, Microsoft Online Subscription Agreements, and Microsoft Products & Services Agreements—that can be used for perpetual licenses with optional SA or pure subscription terms. This greater flexibility lets organizations of all sizes choose perpetual, subscription‑only, or consumption‑based options, and the company now recognizes Office 365 revenue ratably over the subscription period as a single performance obligation.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the general evolution from volume licensing to more flexible subscription models between FY2022-2024. It accurately mentions key agreement types (Microsoft Customer Agreement, Microsoft Online Subscription Agreement, Microsoft Products & Services Agreement) that appear in the ground truth. The mention of ratable revenue recognition over subscription periods aligns with ground truth. The answer appropriately addresses the shift toward customer-centric flexibility.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces 'Enterprise Agreements' as a new flexible option in the FY2024 model, but the ground truth does not mention Enterprise Agreements in this context - this appears to be an unsupported addition. (2) The LLM claims the new model allows 'perpetual licenses with optional SA or pure subscription terms' and mentions 'perpetual, subscription-only, or consumption-based options,' but the ground truth specifically states the FY2024 model moved toward cloud services with 'monthly or annual subscriptions and no organization-wide commitment' - the emphasis on perpetual licensing contradicts the cloud-subscription focus in the ground truth. (3) The LLM states customers can choose 'perpetual licenses' but the ground truth emphasizes cloud subscriptions without perpetual licensing language. (4) The ground truth emphasizes 'no organization-wide commitment' as a key feature, which the LLM does not capture.\n\nMULTI-HOP REASONING: The answer attempts to synthesize the evolution across two fiscal years but introduces elements (perpetual licensing, Enterprise Agreements) not supported by the ground truth, suggesting incomplete or inaccurate source synthesis.\n\nNUMERIC/CALCULATION ACCURACY: No specific numbers or calculations are present in either answer, so this dimension is neutral.\n\nSEMANTIC ISSUES: The characterization of the FY2024 model as enabling 'perpetual licenses' fundamentally misrepresents the shift toward cloud-based subscriptions described in the ground truth. This is a material semantic error that affects the core narrative of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 570,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "\nBetween 2022 and 2023 the Level 3 Fixed‑Maturity‑Securities‑AFS portfolio edged up from **$58 million to $64 million**.  The corporate component stayed essentially unchanged (~$55 M), while the “other” Level 3 slice grew from $3 M to $8 M and a new $2 M foreign‑bond position appeared, so the 2023 mix includes a small but noticeable increase in foreign sovereign and other less‑observable assets.  \n\nThis modest shift indicates that MetLife is **gently diversifying its Level 3 holdings—adding foreign‑bond and alternative‑type exposures—while still keeping Level 3 assets a tiny fraction of the overall fixed‑maturity book**, reflecting a cautious, yield‑enhancing investment strategy that avoids large‑scale commitments to illiquid, complex securities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all major metrics. Specific errors: (1) TOTAL PORTFOLIO SIZE: LLM claims Level 3 Fixed Maturity Securities AFS grew from $58M to $64M, but ground truth shows 2022 total was $13M ($1M Corporate + $1M Foreign + $11M Equity) and 2023 was $884M ($54M Corporate + $2M Foreign + $828M Other). This is a massive discrepancy - the LLM understated 2023 by approximately $820M (92% error). (2) CORPORATE BONDS: LLM states ~$55M unchanged, but ground truth shows $1M in 2022 and $54M in 2023 - a 54x increase that the LLM completely mischaracterized as 'essentially unchanged.' (3) OTHER INVESTMENTS: LLM claims growth from $3M to $8M, but ground truth shows this category grew from $0M (not mentioned in 2022) to $828M in 2023 - a massive strategic shift the LLM entirely missed. (4) EQUITY SECURITIES: Ground truth shows $11M in Equity Securities in 2022, which the LLM completely omitted. (5) STRATEGIC INTERPRETATION: While the LLM's characterization of 'cautious diversification' might sound reasonable in isolation, it is fundamentally contradicted by the actual data showing an 68x increase in total Level 3 holdings and a shift toward $828M in 'Other Investments' - indicating aggressive portfolio expansion, not cautious positioning. The LLM failed at multi-hop synthesis by not correctly identifying and comparing the composition changes across both years. The answer demonstrates a critical failure in quantitative accuracy and represents a fundamental misunderstanding of the portfolio's actual strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 443,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "\nBetween 2022 and 2024 Microsoft deepened Office 365’s integration into its broader cloud portfolio, continuing to treat the service as a single, bundled performance obligation whose revenue is recognized ratably over the subscription term.  At the same time the company has layered generative‑AI capabilities (e.g., Copilot and other AI‑enhanced features) into Office 365 and Azure, positioning the suite as a central, AI‑enabled hub to counter the surge of AI‑driven competition and to sustain its cloud‑services growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Microsoft's strategic evolution of Office 365 between 2022 and 2024, with accurate core facts and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the integration of Office 365 into the broader cloud portfolio; (2) Accurately captures the shift toward AI-infused capabilities (Copilot, AI-enhanced features); (3) Properly synthesizes the competitive response to AI-driven offerings; (4) Correctly notes the subscription revenue recognition model; (5) No quantitative errors or incorrect dates/entities. WEAKNESSES: (1) The answer is somewhat narrower in scope than the ground truth - it focuses heavily on technical integration and revenue recognition mechanics rather than the broader strategic positioning context; (2) Missing explicit reference to the 2022 baseline positioning (Office 365 alongside Azure, Dynamics 365, Xbox as core cloud solutions); (3) Does not explicitly mention the specific competitive threats mentioned in ground truth (free advertising-funded applications, open-source AI models); (4) The phrase 'single, bundled performance obligation' adds accounting detail not present in ground truth, which slightly shifts focus from strategic positioning to accounting treatment. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 period and connects Office 365's evolution to both cloud portfolio integration and AI competitive strategy. The logic is sound and the connections are appropriate. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - Office 365 evolved from a standalone cloud service to an AI-integrated component of Microsoft's broader strategy to counter competitive pressures. The wording differs but conveys substantially the same strategic narrative. The answer is accurate but somewhat incomplete in addressing the full scope of strategic positioning evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 525,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "\nBetween 2022 and 2023 UnitedHealth continued to use the same credit‑impairment framework—evaluating each available‑for‑sale debt security by comparing its present‑value of expected cash flows to amortized cost, examining the extent to which fair value was below cost, and assessing the issuer’s credit quality and near‑term prospects.  The company explicitly separated credit‑related impairments (recorded as an allowance against earnings) from non‑credit impairments (recorded in other comprehensive income), and it emphasized that the 2023 unrealized losses were driven by interest‑rate movements rather than credit deterioration.  Consequently, the allowance for credit losses remained immaterial, resulting in no material credit‑related impairment charge or earnings impact in either year.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The identification of the evaluation methodology components (present value of expected cash flows, fair value vs. amortized cost, issuer credit quality) is accurate; (2) The distinction between credit-related impairments (recorded against earnings/allowance) and non-credit impairments (recorded in OCI) is correctly stated; (3) The characterization that unrealized losses were driven by interest rate movements rather than credit deterioration is accurate; (4) The statement that allowance for credit losses remained immaterial is correct. PROBLEMATIC ELEMENTS: (1) The LLM states the company 'continued to use the same credit-impairment framework' between 2022 and 2023, which contradicts the ground truth that indicates an EVOLUTION or FORMALIZATION of the process. The ground truth explicitly states 'By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments,' implying this was a change from 2022; (2) The ground truth indicates that in 2022, the evaluation was less formally structured (analyzing expected cash flows, credit quality, ratings with a conclusion about no significant deterioration), whereas 2023 showed a 'more detailed and segmented approach' with 'more structured evaluation framework.' The LLM's characterization of continuity misses this evolution; (3) The LLM does not adequately capture the methodological evolution—the formalization and segmentation of the approach in 2023 represents a change from 2022's less formal methodology. QUANTITATIVE ACCURACY: No specific numbers were provided in either answer, so this dimension is less critical. Both correctly note immateriality. MULTI-HOP REASONING: The LLM failed to synthesize the temporal evolution aspect—the question specifically asks 'how did...evolve,' and the answer should highlight changes/improvements, not continuity. The core issue is semantic: the LLM emphasizes sameness when the ground truth emphasizes formalization and evolution of the framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 566,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "\nFrom 2022 to 2023 the estimated fair‑value of Fixed‑Maturity‑Securities AFS in MET’s pension and other post‑retirement benefit plans fell modestly, from **$6.80 bn to $6.71 bn**.  The portfolio’s composition shifted toward higher‑level inputs: Level 2 holdings dropped from $5.09 bn to $4.92 bn, while Level 1 rose from $1.65 bn to $1.73 bn and Level 3 edged up from $58 m to $64 m.  Consequently, corporate bonds and U.S. government securities increased their share of the allocation, whereas short‑term investments and federal‑agency securities were reduced.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth data. (1) CRITICAL QUANTITATIVE ERRORS: The LLM claims total fair value fell from $6.80 bn to $6.71 bn, but the ground truth shows $6,714 million ($6.714 bn) for Pension Benefits ALONE in 2023, plus $1,274 million for Other Postretirement Benefits, totaling $7,988 million ($7.988 bn) in 2023. The LLM appears to have conflated or misunderstood the data structure. The $6.80 bn figure in 2022 is not supported by the ground truth. (2) MISSING CRITICAL INFORMATION: The ground truth explicitly states 2022 allocations as percentages (84% for Pension, 95% for Other Postretirement), which the LLM completely omits. The ground truth also provides 2023 fair values broken down by benefit type ($6,714M pension + $1,274M postretirement), which the LLM fails to distinguish. (3) UNSUPPORTED CLAIMS: The LLM provides detailed Level 1/2/3 breakdown and composition shifts (corporate bonds, government securities, etc.) that are NOT present in the ground truth answer. This represents fabrication of data not in the source material. (4) MULTI-HOP REASONING FAILURE: The question asks about evolution from 2022 to 2023, requiring synthesis of percentage allocations (2022) with fair value breakdowns (2023). The LLM failed to properly synthesize this transition and instead provided incorrect aggregate numbers and invented hierarchical level data. (5) SEMANTIC MISMATCH: The ground truth emphasizes a shift from percentage-based to valuation-based reporting; the LLM misses this entirely and focuses on incorrect aggregate trends and fabricated composition details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 451,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "\nBetween 2022 and 2023 Lowe’s kept Kitchens & Bath inside the Home Décor segment, which delivered roughly 35 % of total net sales in both years (35.3 % in 2022 vs. 35.2 % in 2021) — so its sales share was stable 【page 55】.  However, the 2023 filing reframes the category as a strategic growth pillar: it is highlighted in the “installed‑sales” model as one of the primary drivers of Pro‑customer revenue and is specifically cited when discussing the expansion of localized assortments, Pro‑penetration initiatives and installation services【pages 6‑7】.  This emphasis shows that, while Kitchens & Bath is only a modest portion of overall sales, Lowe’s is positioning it as a key category for higher‑margin, service‑linked growth within its Total Home strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth states that Kitchens & Bath was repositioned FROM Home Décor division (2022) TO core construction/renovation categories (2023), representing a strategic shift in organizational structure. The LLM answer incorrectly claims Kitchens & Bath 'kept inside the Home Décor segment' in both years, which is the opposite of what occurred. This is a critical multi-hop synthesis error - the question specifically asks about evolution/change between years, and the LLM failed to identify the key structural repositioning. Additionally, the LLM cites specific percentages (35.3% in 2022 vs 35.2% in 2021) that appear to be fabricated or misattributed - the ground truth makes no mention of these specific sales percentages, and the comparison to 2021 is irrelevant to a 2022-2023 analysis. The LLM does correctly identify that Kitchens & Bath was positioned as a strategic growth pillar in 2023 with emphasis on installed-sales and Pro-customer revenue, which aligns with the ground truth's mention of 'Total Home' strategy. However, this partial correctness cannot offset the fundamental error about the category's organizational positioning. The answer demonstrates weak multi-hop reasoning by failing to synthesize the key organizational change that defines the evolution between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 388,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s references to Cheese & Grocery shifted from a brief mention in the 2022 filing (where it was listed only as an “adjacent, locally relevant” category) to being grouped with other adjacency businesses in the 2024 MD&A (page 34).  However, the 2024 discussion emphasizes core snacking—chocolate, biscuits and snack bars—and outlines strategic priorities such as “accelerating consumer‑centric growth” and “scaling sustainable snacking,” while the Cheese & Grocery segment receives no separate investment or growth‑target commentary.  This signals that Mondelez views Cheese & Grocery as a secondary, market‑specific opportunity rather than a primary long‑term growth pillar, and that its strategic focus remains on the core snack categories that drive margin and revenue growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer completely omits the specific $1,990 million revenue figure for Cheese & Grocery in 2022, which is a key factual anchor in the ground truth. This is a major omission of concrete financial data that should have been included. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly states that in 2022 Mondelez 'directly produced Cheese & Grocery products, generating $1,990 million in total net revenues' and by 2024 'no longer reported direct production' but instead had 'only a strategic stake.' The LLM answer vaguely references a 'shift' and 'grouping with other adjacency businesses' but fails to quantify the transition or explain the shift from direct production to strategic stake ownership. (3) MISSING STRUCTURAL CHANGE: The ground truth identifies a fundamental business model shift (from direct production to strategic stake), which is a critical distinction. The LLM answer alludes to this indirectly ('lighter footprint') but doesn't explicitly state this structural change. (4) WHAT WAS CORRECT: The LLM correctly identifies that Cheese & Grocery is positioned as secondary/adjacent to core snacking, correctly names the core categories (chocolate, biscuits, snack bars), and appropriately concludes that strategic focus remains on core categories. The qualitative assessment of prioritization is sound. (5) REASONING QUALITY: The multi-hop reasoning about strategic priorities and market positioning is logical and well-articulated, but it's undermined by the missing quantitative foundation. The answer reads more like a qualitative analysis than a complete synthesis of the 2022-2024 evolution with supporting data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 466,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "\nIn the 2022 filing Jevity appears only as one item in a generic list of enteral‑feeding products under the Nutritional Products segment, with no explicit linkage to the Freego™ line. By contrast, the 2023 filing still lists Jevity alongside Freego™ (Enteral Pump) and Freego™ sets, but the surrounding text frames Jevity as the companion formula that is used with the Freego™ pump system, positioning the two as an integrated enteral‑feeding solution rather than separate, unrelated products.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims that in the 2022 filing, 'Jevity appears only as one item in a generic list...with no explicit linkage to the Freego™ line.' However, the ground truth explicitly states that in 2022, Freego™ products were already listed alongside Jevity in the product lineup. (2) The LLM's core claim that the 2023 filing 'frames Jevity as the companion formula that is used with the Freego™ pump system' and positions them as 'an integrated enteral-feeding solution' is not supported by the ground truth. The ground truth indicates the change was simply a reordering of the product list, not a change in how they were described or framed. (3) The LLM fundamentally mischaracterizes the 2022 presentation, suggesting Jevity and Freego™ were presented as 'separate, unrelated products' when they were actually listed together in the same product lineup. WHAT WAS CORRECT: The LLM correctly identifies that both 2022 and 2023 filings mention Jevity, Freego™ (Enteral Pump), and Freego™ sets. The years and company (Abbott) are correct. MULTI-HOP REASONING: The LLM failed to properly synthesize the comparative information across the two years. The ground truth shows a change in listing order/prominence, while the LLM invents a change in product framing/positioning that is not supported by the evidence. This represents a fundamental misunderstanding of what actually changed between the two filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 415,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "\nFrom 2022 to 2023 MetLife’s municipal exposure in its available‑for‑sale portfolio slipped from **$159 million to $147 million**, a $12 million reduction, and remained classified as a **Level 2** fair‑value measurement (i.e., it continued to be valued using observable inputs other than quoted prices).  This pull‑back in municipal holdings—while keeping the same classification—reflects a deliberate de‑risking of the portfolio, signaling that the company is trimming lower‑rated or higher‑volatility municipal securities to curb credit‑risk concentrations and to better protect its balance sheet against potential defaults.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers and reversed the direction of change. (1) QUANTITATIVE ACCURACY FAILURES: The ground truth states MET held $14,212 million in municipals in 2022, declining to $159 million in 2023 - a reduction of $14,053 million. The LLM claims the holdings went from $159 million to $147 million (a $12 million reduction), which is completely inverted and off by orders of magnitude. The LLM appears to have either confused the 2023 figure ($159M) with the 2022 figure, or fabricated entirely different numbers. (2) MISSING KEY INFORMATION: The ground truth specifies critical details the LLM omitted: (a) The 2022 position included $2,464 million in gross unrealized gains and $13 million in gross unrealized losses - important context for understanding the portfolio composition; (b) The 2023 classification as Level 2 is presented as a change/shift in positioning, not a continuation as the LLM suggests. (3) DIRECTIONAL ERROR: The LLM describes a modest $12M reduction as 'de-risking,' when the actual strategy involved eliminating 98.9% of municipal holdings ($14,053M reduction), which is a far more dramatic strategic shift. (4) REASONING QUALITY: While the LLM's interpretation of the strategy (de-risking, credit risk management) aligns with the ground truth's conclusion, this correct reasoning is built on completely false numerical foundations. The multi-hop synthesis failed at the most basic level - extracting and comparing the correct financial figures across years. (5) ENTITY ACCURACY: Company name (MetLife/MET) is correct, but the financial metrics and values are entirely wrong. This is a fundamental failure in quantitative accuracy that undermines the entire answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 476,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "\nAbbott’s interest‑rate hedge contracts shrank from roughly $2.9 billion of notional exposure at the end of 2022 to about $2.2 billion at the end of 2023—a decline of roughly $0.7 billion caused by the maturity of $700 million of swaps and the repayment of the matching fixed‑rate notes. Because these swaps are designated as fair‑value hedges that convert a slice of the company’s fixed‑rate debt to a variable rate, the reduced hedge coverage left a smaller portion of the fixed‑rate portfolio offsetting benchmark‑rate movements, thereby increasing Abbott’s interest‑rate risk and limiting the amount of fair‑value adjustments that offset the carrying amount of its fixed‑rate debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERRORS: The LLM answer contains a fundamental contradiction with the ground truth regarding 2022 notional values. The LLM states Abbott had $2.9 billion in notional exposure at the end of 2022, but the ground truth clearly establishes that Abbott had approximately $2.2 billion in 2022. This is a major quantitative error ($0.7 billion discrepancy). The LLM correctly identifies the 2023 value at $2.2 billion and correctly calculates the $0.7 billion decline, but this decline calculation is based on an incorrect 2022 starting point. The LLM's narrative about the decline being caused by maturity of $700 million of swaps and repayment of matching fixed-rate notes may be accurate operational detail, but it contradicts the ground truth which states the notional value 'remained consistent at approximately $2.2 billion' between 2022 and 2023. The LLM does correctly identify that these are fair-value hedges converting fixed-rate debt to variable-rate obligations, and appropriately discusses the impact on interest rate risk and fair-value adjustments. However, the core quantitative premise is wrong. The ground truth indicates stability in notional values with enhanced disclosures in 2023, while the LLM describes a significant decline. This represents a fundamental misunderstanding of the multi-hop synthesis required—the LLM failed to correctly identify the 2022 baseline value, which is essential for answering how the contracts 'evolved' between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 411,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "\nBetween 2022 and 2024 3M systematically retired a large share of its fixed‑rate registered and medium‑term debt—repaying roughly **$600 million of fixed‑rate registered notes and €600 million of Euro‑denominated medium‑term notes in 2022**, **$500 million of fixed‑rate registered notes plus €600 million of Euro‑notes in 2023**, and **about $1.1 billion of maturing medium‑term notes in 2024**.  To manage the interest‑rate profile of the remaining long‑dated obligations, the company used **fixed‑to‑floating interest‑rate swaps that converted portions of its 2049‑ and 2050‑dated fixed‑rate notes into floating‑rate debt (SOFR‑based) through mid‑2028**, thereby reducing future exposure to rising rates while still holding a modest amount of fixed‑rate registered notes for funding flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ERRORS: (1) The LLM claims 3M repaid '$600 million of fixed-rate registered notes and €600 million of Euro-denominated medium-term notes in 2022' - the ground truth makes no mention of 2022 repayments or Euro-denominated notes at all. (2) The LLM states '$500 million of fixed-rate registered notes plus €600 million of Euro-notes in 2023' - while the $500 million figure matches ground truth for 2023, the Euro-notes claim is unsupported. (3) The $1.1 billion 2024 repayment is correctly stated. CORRECT ELEMENTS: (1) The interest rate swap strategy converting 2049 and 2050 notes to floating-rate (SOFR-based) through mid-2028 is accurate. (2) The general narrative of debt retirement and interest rate management is directionally correct. MISSING INFORMATION: The LLM fails to mention the specific coupon rates (3.05% for 2030 notes, 3.70% for 2050 notes) and the August 2019 issuance details ($3.25 billion total, including $1.0 billion 10-year and $1.0 billion 30-year notes) that provide important context for understanding the debt portfolio evolution. QUANTITATIVE ISSUES: The introduction of Euro-denominated debt repayments appears to be fabricated or confused with other company data, significantly undermining credibility. The answer demonstrates partial understanding of the swap strategy but fails on factual accuracy regarding repayment history and introduces unsupported claims about Euro-denominated instruments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 426,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "\nBetween 2023 and 2024 Schwab moved from an aggressive debt‑issuance stance—issuing roughly $6 billion of senior unsecured notes in 2023—to a more defensive posture in 2024, retiring all floating‑rate senior notes that were maturing, letting an unsecured revolving credit facility expire unused, and relying instead on brokered‑CD issuance, FHLB advances and retained earnings to fund operations.  This shift reflects a capital‑management strategy that now prioritises preserving strong regulatory capital ratios (including the adjusted Tier 1 leverage ratio that incorporates AOCI), returning excess capital to shareholders through dividends and share‑repurchases, and using preferred‑stock redemptions rather than expanding the securities‑issuance footprint.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported specific claims that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims Schwab issued 'roughly $6 billion of senior unsecured notes in 2023' - this specific figure is not mentioned in the ground truth and cannot be verified. The ground truth does not provide specific dollar amounts for securities issuances. (2) FACTUAL INACCURACIES: The LLM describes a shift from 'aggressive debt-issuance stance' to 'defensive posture' with specific actions like 'retiring all floating-rate senior notes' and 'letting an unsecured revolving credit facility expire unused' - none of these specific claims appear in the ground truth. (3) MULTI-HOP REASONING FAILURE: While the ground truth correctly identifies a shift from securities issuances as a 'primary source' to being 'among a broader set of liquidity tools,' the LLM mischaracterizes this as a shift from aggressive to defensive posturing with unsupported operational details. (4) ENTITY/METRIC CONFUSION: The LLM introduces metrics like 'adjusted Tier 1 leverage ratio that incorporates AOCI' and specific capital management actions (preferred-stock redemptions, share repurchases) that are not mentioned in the ground truth. (5) SEMANTIC DIVERGENCE: The ground truth emphasizes diversification of funding sources (FHLB borrowings, repurchase agreements, CDs alongside securities issuances), while the LLM frames it as a strategic retreat from debt issuance - these are fundamentally different interpretations. The LLM answer appears to contain fabricated details not supported by the source material, making it unreliable despite addressing the general topic of capital structure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 475,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "\nCoca‑Cola’s fairlife contingent‑payment obligation, originally disclosed in the 2022 filing as a $270 million liability tied to milestone payments that could be triggered through 2024 when fairlife met certain financial targets, was re‑measured each quarter and recorded in income. The 2024 filing shows that a $275 million milestone payment was made in 2023, indicating that fairlife had achieved the performance criteria that released that payment, and the remaining liability continues to be re‑measured with any final settlement expected in 2024‑2025. Thus, the evolution of the contingent obligation—from an initial estimate in 2022 to an actual $275 million payment in 2023—signals that fairlife is progressing toward its financial targets, though the company still faces additional contingent payments later in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) MAJOR QUANTITATIVE ERROR: The LLM claims a '$275 million milestone payment was made in 2023,' but the ground truth states the first milestone payment of $100 million was made in 2021, and the 2022 disclosure showed a $270 million remaining liability. There is no mention of a $275 million payment in 2023 in the ground truth. This is a significant fabrication. (2) INCORRECT TIMELINE: The LLM misrepresents the payment history. The ground truth clearly indicates: $100M paid in 2021 (for 2020 targets), $270M liability remaining in 2022 (for targets through 2024), with payment expected in 2025. The LLM invents a $275M payment in 2023 that does not appear in the source material. (3) INCOMPLETE SYNTHESIS: The LLM fails to properly synthesize the multi-hop information about fairlife's performance progression. The ground truth shows fairlife met 2020 targets (triggering $100M payment) and remained on track through 2024 (with remaining obligation still active). The LLM's narrative about 'progressing toward targets' is undermined by its fabricated $275M payment figure. (4) MISREPRESENTATION OF OBLIGATION STATUS: The ground truth indicates the remaining contingent payment was still active and payable in 2025, suggesting fairlife was tracking to meet targets. The LLM's claim about 'additional contingent payments later in 2024' is vague and potentially inaccurate given the ground truth's clear statement about 2025 payment timing. (5) CALCULATION/RECONCILIATION FAILURE: The LLM provides no logical reconciliation between the $270M 2022 liability and the claimed $275M 2023 payment—this discrepancy alone should have triggered verification. The ground truth's answer is internally consistent; the LLM's is not. The LLM answer demonstrates poor fact-checking and appears to have hallucinated the $275M payment figure entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 524,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Oracle reframed OCI from a supplemental cloud add‑on into a central strategic pillar, explicitly pairing it with SaaS under the “Oracle Cloud Services” brand and promoting it as the infrastructure foundation for its enterprise applications.  The 2024 filing emphasizes a global go‑to‑market push—leveraging Oracle’s direct sales force and consulting services—to embed OCI in hybrid and multi‑cloud architectures, enabling customers to integrate, modernize and extend their existing IT investments across on‑premise, cloud and OCI environments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly captures the core strategic shift in Oracle's positioning of OCI between 2022 and 2024, accurately describing the reframing from 'supplemental cloud add-on' to 'central strategic pillar.' The qualitative characterization of OCI's integration with SaaS under 'Oracle Cloud Services' and the emphasis on hybrid/multi-cloud architectures aligns well with the ground truth. The mention of go-to-market strategies and enterprise IT integration is relevant and appropriate. CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The LLM answer completely omits the specific financial figures from the ground truth ($36.052 billion in 2022 cloud and license revenues representing 85% of total revenues). While the question doesn't explicitly ask for numbers, the ground truth includes these metrics as evidence of the strategic shift, and their absence represents incomplete synthesis. (2) INCOMPLETE TEMPORAL COMPARISON: The LLM answer lacks explicit reference to 2022 baseline positioning ('no explicit strategic language about Oracle Cloud Infrastructure's positioning' per ground truth), making the before/after comparison less precise. (3) VAGUE ATTRIBUTION: The LLM answer states '2024 filing emphasizes' but doesn't ground this in specific language or positioning statements from the actual filings as the ground truth does ('comprehensive and integrated applications and infrastructure services'). REASONING ASSESSMENT: The multi-hop synthesis is sound in concept—connecting 2022 baseline to 2024 evolution—but lacks the quantitative anchoring that would strengthen the argument. The answer demonstrates understanding of the strategic narrative but misses the financial evidence that supports it. SEMANTIC ISSUES: Minor—the answer uses 'fiscal 2022 and fiscal 2024' which is appropriate, and the characterization of the shift is semantically equivalent to the ground truth, though less precisely documented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 525,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s treatment of Pledged‑Asset Lines (PALs) did not change the credit‑loss allowance – it remained $0, because all PALs were fully collateralized.  In 2024 the firm expanded the ASC 326 collateral‑maintenance practical expedient to “substantially all” PALs (whereas in 2023 it applied to only a portion), confirming that each PAL’s collateral (securities with fair value exceeding the borrowing) was more broadly used to support the lines.  Consequently, the risk profile of PALs stayed very low, with zero allowance for credit losses in both years but a more comprehensive collateral coverage in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question about PAL treatment evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies that credit loss allowance remained $0 in both years, (2) Accurately notes full collateralization of PALs by securities with fair values exceeding borrowings, (3) Properly identifies the ASC 326 collateral maintenance practical expedient as the key mechanism, (4) Correctly characterizes the expansion from partial to 'substantially all' PALs coverage in 2024, (5) Appropriately concludes that risk profile remained low with improved collateral coverage. MINOR ISSUES: (1) The LLM states the allowance 'did not change' and 'remained $0' - while technically correct, the ground truth emphasizes that in 2023 the allowance was 'influenced by improved credit quality metrics and lower projected loss rates,' suggesting there may have been a transition process that the LLM doesn't fully capture. However, the end result (zero allowance in both years) is correct. (2) The LLM's characterization of the 2023 situation as applying to 'only a portion' of PALs versus 2024's 'substantially all' is a reasonable interpretation of the evolution, though the ground truth uses slightly different language ('all PALs were fully collateralized' in 2024). The multi-hop reasoning is sound - the answer correctly synthesizes the relationship between collateralization, the ASC 326 practical expedient, and the resulting credit loss treatment. The semantic meaning aligns well with the ground truth despite some wording differences. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 447,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the APLA geographic segment’s revenue rose modestly—from **$6.43 bn to $6.73 bn**—highlighting its growing contribution to NIKE Brand sales.  At the same time, Nike disclosed that it is **transitioning certain APLA country businesses to third‑party distributors** (see Note 18), signaling a strategic shift toward a more asset‑light, partnership‑driven operating model in the region while still emphasizing direct‑to‑consumer and licensing growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer partially addresses the question but has significant gaps and introduces unverified quantitative claims. STRENGTHS: (1) Correctly identifies the strategic shift toward third-party distributors in APLA, which matches the ground truth's core finding about transitioning to an outsourced model. (2) Appropriately references Note 18 as source documentation. (3) Correctly identifies fiscal years 2023 and 2024. (4) Captures the asset-light, partnership-driven model shift. WEAKNESSES: (1) QUANTITATIVE ISSUE - The LLM provides specific revenue figures ($6.43bn to $6.73bn) that are NOT present in the ground truth answer and cannot be verified against it. These numbers may be accurate from the actual 10-K, but they represent information not in the knowledge graph baseline, creating uncertainty about accuracy. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes the operational structure change regarding trade union representation and workforce localization in FY2023, which the LLM completely omits. This is a material aspect of how the relationship 'evolved.' (3) MISSING CONTEXT - The LLM does not address the FY2023 baseline of direct operational involvement with localized workforce structures, only jumping to the FY2024 transition. (4) SCOPE MISMATCH - The question asks about 'operational structure and strategic emphasis' evolution; the LLM focuses heavily on revenue and the distributor transition but misses the workforce/employment structure dimension entirely. The answer is directionally correct on the distributor transition but fails to comprehensively address the full scope of operational structure evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 457,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "\nOver the 2022‑2023 period Abbott elevated Pedialyte from a niche pediatric electrolyte brand to a core growth engine within its U.S. Pediatric Nutritionals business, citing double‑digit segment sales gains that were driven primarily by Pedialyte’s volume expansion.  In 2023 the company deepened its strategic emphasis by broadening the Pedialyte line (new powder, ready‑to‑drink and sugar‑free formats) and promoting it beyond pediatrics to capture wider hydration demand, using the brand to accelerate overall pediatric‑nutrition growth and diversify the portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims 'double-digit segment sales gains' for Pedialyte in 2023, but the ground truth specifies only a 10.3% increase in 2022. The LLM provides no specific 2023 sales figure and appears to conflate or extrapolate data. The ground truth does not mention double-digit gains in 2023. (2) PRODUCT EXPANSION CLAIMS - The LLM states Pedialyte was 'broadened' with 'new powder, ready-to-drink and sugar-free formats' in 2023, but the ground truth makes no mention of these specific product line extensions. This appears to be fabricated detail not supported by the source documents. (3) BEYOND-PEDIATRICS EXPANSION - The LLM claims Abbott promoted Pedialyte 'beyond pediatrics to capture wider hydration demand,' but the ground truth focuses specifically on the U.S. Pediatric Nutritional business and does not mention expansion beyond pediatrics. (4) CORE EVOLUTION NARRATIVE - While the LLM correctly identifies an evolution in Pedialyte's positioning, it mischaracterizes the nature of that evolution. The ground truth shows evolution from 'key growth driver' (2022) to 'formally recognized and embedded' (2023) - a formalization/integration narrative. The LLM instead presents it as elevation from 'niche' to 'core growth engine' with product line expansion, which is not supported. (5) MISSING KEY FACTS - The LLM fails to mention that Pedialyte was formally included in the Nutritional Products segment in 2023 and listed alongside major brands like Ensure and Glucerna, which is a critical detail in the ground truth. CORRECT ELEMENTS: The LLM correctly identifies Abbott as the company, the 2022-2023 timeframe, and that Pedialyte was a growth driver. However, the specific claims about product formats, beyond-pediatrics expansion, and 2023 sales figures are either unsupported or contradicted by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 508,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "\nThe $135 million of 7.100% notes maturing in 2027 remained on RTX’s balance sheet in both 2022 and 2023 – the amount did not increase or decrease during that period.  At the same time, RTX continued to retire higher‑coupon near‑term obligations (e.g., the 3.65% and 3.70% notes that were fully repaid in 2023) and replaced them with newer, longer‑dated senior unsecured debt (5.75%‑6.4% notes due 2026‑2054 and SOFR‑based term loans), using the proceeds to fund an accelerated share‑repurchase program.  This pattern shows that RTX’s debt‑management strategy is to roll higher‑cost, near‑term debt into longer‑dated, lower‑coupon issuances while keeping the 2027 tranche stable, thereby extending overall maturity and preserving liquidity rather than aggressively paying down the 7.100% 2027 notes.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claim. According to the ground truth, RTX's 7.100% notes due 2027 had an aggregate principal balance of $6 million in 2022 and $135 million in 2023 - representing a significant increase of $129 million. The LLM explicitly contradicts this by stating 'The $135 million of 7.100% notes maturing in 2027 remained on RTX's balance sheet in both 2022 and 2023 – the amount did not increase or decrease during that period.' This is a critical factual error that directly contradicts the ground truth data. The LLM appears to have confused the 2023 ending balance ($135 million) as the constant amount for both years, when in fact it increased from $6 million to $135 million. While the LLM provides additional context about RTX's broader debt management strategy (retiring higher-coupon debt, issuing longer-dated securities, share repurchases), this supplementary information does not compensate for the fundamental misstatement of the primary quantitative facts. The question specifically asks how the financial position 'evolved from 2022 to 2023,' and the LLM's claim that it 'did not increase or decrease' directly contradicts the ground truth showing a $129 million increase. The reasoning about debt management strategy may be partially sound, but it is built on an incorrect factual foundation regarding the 7.100% notes specifically.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 388,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Converse’s top line slipped 14 % (to $2.082 bn) and 15 % on a constant‑currency basis, with footwear down 16 % and wholesale revenue down 15 %; earnings before interest and taxes fell 30 % to $474 m. The drop stems from weaker demand in North America and Western Europe, a shift toward lower‑margin wholesale and direct‑to‑consumer channels, and foreign‑currency pressure, prompting Nike to reposition Converse around targeted growth in Asia, licensing and tighter cost/foreign‑exchange management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not present in the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM states Converse revenues were $2.082 billion in fiscal 2024 and declined 14% year-over-year, but the ground truth only mentions a 15% decline in fiscal 2023 with no fiscal 2024 revenue figures provided. The LLM fabricates specific 2024 revenue data not in the source material. The EBIT figure of $474M is also not mentioned in the ground truth. (2) TEMPORAL CONFUSION: The LLM conflates fiscal 2023 and 2024 data, stating 'between fiscal 2023 and fiscal 2024' but then providing what appears to be mixed or invented metrics. The ground truth clearly separates 2023 performance (15% decline) from 2024 positioning (wholly-owned subsidiary, stand-alone basis). (3) MISSING KEY INFORMATION: The LLM fails to address the strategic positioning shift described in the ground truth - that Converse moved from a financially struggling entity in 2023 to a more strategically positioned brand in 2024 as a wholly-owned subsidiary operating on a stand-alone basis. (4) INVENTED DETAILS: The LLM introduces specific strategic initiatives (Asia growth focus, licensing, cost/FX management) not mentioned in the ground truth, suggesting hallucination. (5) PARTIAL ACCURACY: The LLM correctly identifies North America and Western Europe as weak regions and mentions wholesale/DTC channel issues, which aligns with ground truth. However, the overall answer misrepresents the evolution by focusing on financial deterioration rather than the strategic repositioning that characterizes the 2023-2024 evolution. The answer fails to properly synthesize the multi-hop relationship between financial performance and strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 483,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "\nFrom 2022 to 2024 Coca‑Cola’s risk discussion of digital transformation evolved from a general warning that failure to digitize could “negatively affect our ability to increase sales and reduce costs” (2022) to a more explicit statement that such failure would “negatively affect our ability to increase sales **and improve margins**” and that the expenses of digitization could “adversely impact our financial performance” (2024).  Thus, while the 2022 assessment linked digital efforts mainly to sales growth and cost‑saving, the 2024 filing ties the risk directly to both revenue expansion **and margin improvement**, underscoring a sharper focus on profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Coca-Cola's digital risk assessment from 2022 to 2024. STRENGTHS: (1) Correctly identifies the shift from general warning (2022) to explicit statement (2024); (2) Accurately captures the key distinction that 2024 filing emphasizes both sales growth AND margin improvement, whereas 2022 focused on sales and cost-saving; (3) Properly synthesizes the multi-hop comparison across two years; (4) Correctly identifies the financial linkage becoming more explicit and sharper in 2024; (5) Uses appropriate quotations that reflect the filing language. MINOR WEAKNESSES: (1) The LLM answer uses slightly different framing than ground truth - it emphasizes the shift from 'sales growth and cost-saving' to 'sales expansion and margin improvement' rather than the ground truth's framing of 'risk factor' to 'strategic dependency,' though both convey similar meaning; (2) The LLM answer doesn't explicitly use the term 'strategic dependency' that appears in the ground truth, though the concept is implied through the discussion of 'future success relying on' digital capabilities; (3) The ground truth emphasizes the shift from viewing digital as a 'risk factor' to a 'strategic dependency,' while the LLM focuses more on the evolution of specific financial metrics mentioned (cost-saving vs. margin improvement). QUANTITATIVE VERIFICATION: No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative accuracy is not directly testable. The dates (2022 and 2024) are correct. MULTI-HOP REASONING: The answer correctly synthesizes information across two different filing years and identifies the evolution in how Coca-Cola frames digital transformation's financial impact. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with the main difference being emphasis and framing rather than factual content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 544,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Oracle has steadily raised the share of revenue coming from its cloud‑based offerings—cloud services and license‑support revenues grew to represent roughly 71 % of total sales in 2022 and an even higher proportion in 2024—while continuing to allocate substantial R&D resources (the $7.2 billion invested in FY 2022 remained a strategic priority and was maintained at similarly high levels in FY 2024).  Consequently, Oracle now positions its Oracle Cloud Services as the preferred, lower‑cost, rapidly deployable alternative to traditional on‑premise solutions, offering hybrid and migration pathways that let customers retain existing on‑premise assets but shift workloads to the cloud.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Oracle's cloud strategy evolution but has some issues with precision and completeness:\n\nSTRENGTHS:\n1. Correctly identifies the $7.2 billion R&D investment in FY 2022\n2. Accurately captures the strategic shift toward cloud-first positioning\n3. Correctly notes the positioning of cloud services as preferred alternative to on-premise solutions\n4. Appropriately mentions hybrid and migration pathways\n5. Addresses the evolution from 2022 to 2024 as requested\n6. Contextually relevant to the question about strategic emphasis evolution\n\nWEAKNESSES:\n1. QUANTITATIVE ISSUE: States cloud services represented \"roughly 71% of total sales in 2022\" - this specific percentage is not verified in the ground truth and appears to be an unsupported claim\n2. INCOMPLETE R&D DATA: Claims R&D \"was maintained at similarly high levels in FY 2024\" but the ground truth explicitly states \"the 2024 report does not specify the R&D investment amount.\" The LLM should not have asserted maintenance of similar levels without evidence\n3. MISSING DETAIL: Does not mention the specific repositioning language about \"choose the best option that meets their specific business needs\" that appears in the 2024 messaging\n4. MISSING CONTEXT: Does not acknowledge the lack of specific 2024 R&D figures, which is an important caveat\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across fiscal years and connects R&D investment to strategic positioning. However, it makes an inference about 2024 R&D levels that goes beyond what the ground truth supports.\n\nSEMANTIC EQUIVALENCE:\nThe core message about cloud-first strategy and hybrid pathways aligns with ground truth, but the unsupported claims about 2024 R&D levels and the 71% revenue figure reduce confidence in the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 502,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "\nBetween 2023 and 2024 the Norwest Corporation Directors’ Formula Stock Award Plan moved from an active, award‑granting arrangement to a closed one—no new stock awards or deferrals may be made under the plan.  Consequently, the only shares left available for future issuance are the 391 shares reserved for deferred distributions, effectively ending the plan’s share‑availability after 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution of the Norwest Corporation Directors' Formula Stock Award Plan between 2023 and 2024: transition from an active plan to a closed plan with no new awards or deferrals permitted. The specific number of 391 shares is accurately cited and correctly characterized as the only remaining shares available for future issuance. The quantitative accuracy is strong - the 391 shares figure matches the ground truth exactly. The reasoning is sound and demonstrates proper multi-hop synthesis: the answer correctly connects the 2023 status (active with deferral capability) to the 2024 status (closed, no new activity) and explains the consequence (only 391 shares remain for distribution of existing obligations). Minor areas for improvement: (1) The LLM answer could have been slightly more explicit about the distinction between 2023 and 2024 descriptions, though the phrase 'moved from an active...to a closed one' adequately conveys this evolution. (2) The phrase 'effectively ending the plan's share-availability after 2023' is slightly ambiguous - it could be clearer that the plan itself continues but only for distribution of existing deferred compensation. (3) The answer could have mentioned that column (a) of the equity compensation table reflected all shares issuable, though this is a minor detail. Overall, the answer captures the essential facts and demonstrates correct understanding of the plan's status change and the minimal remaining share obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 417,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "\nThe 2022 Form 10‑K noted food‑safety concerns chiefly as a brand‑reputation risk and only briefly referenced supply‑chain impacts. In the 2023 filing, McDonald’s expanded the language to explicitly connect food‑safety events to supply‑chain disruptions and commodity‑price volatility, describing how inflation and logistics pressures can raise costs and jeopardize safe‑food operations, thereby integrating supply‑chain and cost‑volatility risks into its food‑safety disclosures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution in McDonald's food safety disclosure between 2022 and 2023. Key strengths: (1) Accurately captures the shift from reputational risk framing in 2022 to supply chain/cost volatility integration in 2023; (2) No quantitative errors or incorrect dates/numbers; (3) Correctly identifies the connection between food safety and commodity price volatility (beef, chicken, pork); (4) Properly synthesizes multi-hop information across two fiscal years. Minor weaknesses: (1) The LLM answer adds language about 'inflation and logistics pressures' and 'safe-food operations' that goes slightly beyond what the ground truth explicitly states - while not contradictory, this represents some interpretive elaboration rather than strict adherence to the documented evolution; (2) The ground truth emphasizes the shift as moving FROM reputational impact TO financial exposure through supply chain disruption, whereas the LLM frames it more as an expansion/integration of both concepts; (3) The LLM's phrasing 'jeopardize safe-food operations' is not explicitly supported in the ground truth, which focuses on cost volatility rather than operational safety impacts. The answer demonstrates solid understanding of the disclosure evolution and correctly identifies the key shift in emphasis, but includes some interpretive elements not directly grounded in the source material. The core factual accuracy is strong, but the qualitative framing differs slightly from the ground truth's emphasis on the shift from reputational to financial exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 434,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "\nThe $1.750 % 7‑Year Senior Notes (euro‑denominated) had a carrying amount of **$662 million at 31 Dec 2023**, which fell to **$621 million at 31 Dec 2024** – a reduction of roughly $41 million.  At the same time the effective interest rate on those notes slipped only slightly, from **about 1.97 % in 2023 to 1.96 % in 2024**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key metrics. Ground truth shows: (1) Carrying value of $700 million in both 2023 and 2024 (no change), but LLM reports $662 million in 2023 and $621 million in 2024 - both numbers are wrong and show a false declining trend. (2) Effective interest rate of 1.89% in both years per ground truth, but LLM reports 1.97% in 2023 and 1.96% in 2024 - both rates are incorrect. (3) The LLM also incorrectly identifies these as euro-denominated notes, which is not mentioned in the ground truth. (4) The LLM calculates a $41 million reduction that doesn't exist - the ground truth explicitly states both carrying value and effective interest rate remained unchanged. (5) The core conclusion is inverted: ground truth shows no change in financial structure, while LLM describes a declining carrying value. This represents a complete failure to synthesize the correct multi-hop information about TMO's debt instrument across the two fiscal years. All quantitative values are materially incorrect, and the qualitative interpretation of stability vs. decline is backwards.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 315,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "\nThe balance of RTX’s 7.000 % notes due 2038 fell from **$159 million at the end of 2022 to $148 million at the end of 2023**, a reduction of roughly $11 million (about 7 %). This modest pay‑down indicates that RTX is actively shrinking its exposure to this particular tranche—using cash flows and new debt issuances to retire higher‑coupon, near‑term debt and thereby ladder its long‑term maturity profile and manage future repayment pressures.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM states the balance fell from $159 million in 2022 to $148 million in 2023, but the ground truth clearly shows it was $11 million in 2022 and $148 million in 2023. The LLM has the 2022 figure completely wrong ($159M vs $11M - off by $148M). The LLM also incorrectly characterizes this as a $11 million reduction, when it was actually a $137 million INCREASE. (2) DIRECTIONAL ERROR - The LLM concludes RTX is 'actively shrinking its exposure' and 'retiring' this debt, when the ground truth indicates the opposite: exposure increased significantly from $11M to $148M, suggesting RTX either issued additional tranches or restructured to extend maturities. (3) INTERPRETATION ERROR - The LLM's narrative about 'pay-down' and 'laddering maturity profile' is inconsistent with what actually happened (a major increase in this particular note). (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the year-over-year comparison and drew the opposite conclusion from what the data supports. The only correct element is that the 2023 balance was $148 million, but this is paired with an entirely incorrect 2022 figure and inverted interpretation. This represents a critical failure in both data accuracy and analytical reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 379,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s ended the pandemic‑related rent‑and‑royalty deferrals that had been put in place in 2020—by the end of 2021 the company had collected essentially all of the roughly **$1 billion** of deferred amounts—so that from 2022 onward it resumed normal contractual collection of both the **minimum rent** and the **percentage‑of‑sales royalties** required under its franchise agreements.  The 2022‑2023 schedule of future minimum franchise payments (page 49) shows about **$3.06 billion** of minimum rent due in 2022 and **$2.95 billion** due in 2023, indicating a stable and growing revenue stream from franchisees with no further large‑scale deferral activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numbers are correct - the $1 billion in deferred rent and royalties from 2020, collection by end of 2021, and the future minimum franchise payments ($3.06 billion for 2022 and $2.95 billion for 2023) are accurately cited. The answer correctly identifies the timeline of deferrals and collections. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes that (1) deferrals occurred in 2020 due to COVID-19, (2) collection was substantially complete by end of 2021, and (3) 2022-2023 operations returned to normal with no pandemic-era relief. The distinction between minimum rent and percentage-of-sales royalties is appropriately mentioned. COMPLETENESS: The answer addresses the core question about how the financial relationship evolved between 2022 and 2023, explaining the transition from pandemic deferrals to normalized operations. It provides specific evidence (the schedule of future minimum franchise payments) to support the claim of stable operations. ENTITY ACCURACY: McDonald's is correctly identified, years are accurate (2020, 2021, 2022, 2023), and financial metrics (rent, royalties, minimum payments) are properly characterized. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by citing specific page numbers and providing additional detail about the schedule of future minimum payments, but this represents enhancement rather than error. The phrasing 'essentially all' vs 'substantially all' is semantically equivalent. The answer effectively conveys that operations normalized without pandemic-era accommodations, matching the ground truth's characterization of the 2023 filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 484,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola’s ownership in Embotelladora Andina was pared back until the equity‑method investment was reduced to a modest $90 million carrying amount (with a fair value of $168 million, a $78 million unrealized gain) on the 2024 balance sheet.  This shrinkage—reflecting the sales of portions of the stake in 2019 and any further reductions through 2022‑2023—shows that the Company is deliberately scaling down its direct exposure and now treats the remaining interest as a small, governance‑focused equity holding rather than a strategic, controlling investment.  The move preserves a market presence in South America while limiting capital risk and financial exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Coca-Cola's strategic positioning with Embotelladora Andina but contains some issues with temporal accuracy and specificity. STRENGTHS: (1) All key financial figures are correct: $90 million carrying value, $168 million fair value, and the $78 million unrealized gain ($168M - $90M) are accurately stated and calculated. (2) The core strategic interpretation is sound—the answer correctly identifies this as a partial exit/scaling down strategy rather than complete divestiture, preserving market presence while limiting exposure. (3) The characterization of the remaining stake as 'governance-focused' rather than 'controlling' aligns with the ground truth's 'modest valuation' assessment. WEAKNESSES: (1) The LLM mentions 'sales of portions of the stake in 2019 and any further reductions through 2022-2023' but the ground truth specifically references a $39 million gain recognized in 2022 from a partial sale. The LLM's temporal framing is vaguer and less precise about when the 2022 transaction occurred. (2) The answer doesn't explicitly mention the $39 million gain from 2022, which is a specific quantifiable fact from the ground truth that demonstrates the strategic refranchising move. (3) The phrase 'pared back until' suggests ongoing reduction through 2024, but the ground truth indicates the key transaction was in 2022, with the 2024 position being the result of that prior action. MULTI-HOP REASONING: The answer successfully synthesizes information about the evolution from 2022 to 2024, correctly connecting the carrying value, fair value, and strategic implications. However, it misses the explicit 2022 transaction detail that would strengthen the temporal narrative. CALCULATION VERIFICATION: The $78 million unrealized gain is correctly calculated ($168M - $90M = $78M). All financial figures match the ground truth. The answer is semantically equivalent in its core message but lacks the specificity of the $39 million 2022 gain, which represents a meaningful omission of a concrete data point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 556,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Oracle accelerated its cloud‑first transformation by directing substantially more internal R&D and capital toward building out Oracle Cloud Infrastructure.  The company expanded OCI’s global data‑center capacity and geographic reach, staffed roughly 21,000 employees in cloud‑services and support (and over 44,000 in overall research and development), and now treats OCI as a distinct pillar of its portfolio—offering SaaS, PaaS and IaaS subscriptions that are recognized ratably over their contract terms and integrated with its hardware and software offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Oracle's cloud infrastructure evolution from 2022-2024. Key strengths: (1) Correctly identifies the shift from general R&D emphasis to OCI as a distinct portfolio pillar, matching the ground truth's characterization of evolution from 'general cloud development to a structured, customer-facing product portfolio.' (2) Accurately captures the strategic deepening through specific details: expanded global data-center capacity, geographic reach expansion, and positioning of OCI with SaaS/PaaS/IaaS offerings. (3) Provides concrete employee metrics (21,000 in cloud services, 44,000+ in R&D) that substantiate the 'substantially more internal R&D and capital' claim. (4) Correctly notes the integration with hardware and software offerings, reflecting the comprehensive positioning mentioned in ground truth. (5) Appropriately addresses the multi-hop synthesis across 2022-2024 timeframe. Minor considerations: (1) The LLM answer is more specific and detailed than ground truth (employee counts, revenue recognition details), which adds value but goes slightly beyond what was explicitly stated in the original answer. (2) The ground truth emphasizes 'internal development as a core strategy' in 2022 with 'global R&D workforce,' while LLM focuses more on capital allocation and infrastructure expansion—both are valid interpretations but represent slightly different emphases. (3) No factual errors detected in the numbers or dates provided. The answer successfully synthesizes the evolution narrative and demonstrates sound multi-hop reasoning across the three-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 455,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "\nIn 2023 Thermo Fisher acquired The Binding Site Group and immediately integrated it into the Specialty Diagnostics segment, where its specialty assay and instrument portfolio began adding to segment income and margin. By 2024 the business had been fully absorbed—its products are now part of the company’s ongoing diagnostics offering—and the firm’s subsequent 2024 acquisition of Olink (and continued focus on proteomics) demonstrates that it is leveraging the Binding Site platform as a foundation for expanding its high‑growth diagnostic and life‑science strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies TMO's 2023 acquisition of The Binding Site Group and its placement in Specialty Diagnostics segment. (2) Accurately notes the integration progression from 2023 to 2024. (3) Correctly identifies the acquisition price as $2.70 billion (implied in ground truth). (4) Appropriately characterizes the strategic focus on diagnostics expansion. WEAKNESSES: (1) MAJOR OMISSION: Fails to mention the specific 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets—a key detail from the ground truth that demonstrates how the acquisition was integrated into the asset base. (2) INTRODUCES UNSUPPORTED INFORMATION: References a 2024 Olink acquisition and proteomics strategy that are NOT mentioned in the ground truth answer. While this may be factually accurate from SEC filings, it goes beyond what the knowledge graph indicates and potentially conflates separate strategic initiatives. (3) REASONING ISSUE: The LLM uses the Olink acquisition as evidence of strategic focus, but the ground truth emphasizes the integration of Binding Site itself as the indicator of strategic focus on long-term value creation. (4) INCOMPLETE SYNTHESIS: The ground truth specifically highlights the intangible asset integration metrics (19-year amortization period) as evidence of post-acquisition integration, which the LLM completely omits. This is a material omission for a question specifically asking what the evolution 'indicates about the company's integration.' The LLM answer is partially correct on the basic facts but fails to capture the specific financial/accounting integration details that ground the strategic assessment, and introduces external information not in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 480,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "\nBetween 2022 and 2024 the filing’s description of the Directors’ Code of Conduct remained the same – it “applies to all directors of BNY” and the company will post any amendments or waivers on its website – but the way the posting is referenced changed. In the 2022 Form 10‑K the code was linked with a full URL ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf ), whereas the 2024 filing gives a shorter, relative path ( bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf ), indicating a shift in the displayed link format while still directing users to the same document. Thus, the scope of application (all directors) stayed constant, but the accessibility link became more concise and less explicitly qualified in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) URL MISMATCH - The LLM claims the 2022 URL was 'https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf' (with a typo 'in relations' instead of 'investor-relations'), but the ground truth shows it was 'https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf'. (2) DOMAIN CHANGE MISCHARACTERIZED - The LLM incorrectly states the 2024 link is a 'shorter, relative path' (bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf), when the ground truth clearly shows the 2024 URL changed to 'https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf' - a full URL with a domain change from 'bnymellon.com' to 'bny.com'. (3) MISINTERPRETATION OF CHANGE - The LLM fundamentally misunderstands the nature of the change. The ground truth indicates a domain rebranding from 'BNY Mellon' to 'BNY', which is a significant structural change. The LLM instead describes it as merely a shift from full URL to relative path format, which is factually incorrect. (4) CORRECT ELEMENTS - The LLM correctly identifies that the scope remained the same (applies to all directors) and that amendments/waivers would be posted. However, these correct elements cannot offset the major factual errors in the primary focus of the question: the actual URL changes and what they represent. The multi-hop reasoning fails because the LLM did not accurately synthesize the URL information from the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 452,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s refined the accounting for its franchise‑related income: royalties and rent continue to be recognized as underlying sales occur, but the “other” revenues that franchisees pay for technology platforms, brand‑licensing and similar services are now reported on a **gross basis** and recognized when the goods or services are transferred, rather than being amortised over the full franchise term.  This reporting change signals a strategic shift toward treating digital‑service and brand‑licensing fees as a distinct, higher‑margin revenue stream, while still relying on the traditional sales‑based royalty and rent model for the core restaurant business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different topic than the ground truth. CRITICAL ISSUES: (1) The LLM discusses accounting treatment changes for franchise-related revenue recognition (gross vs. net basis, timing of recognition for technology/licensing fees), which is an accounting policy matter. The ground truth discusses McDonald's strategic emphasis shift regarding how franchisees are presented as stakeholders in financial reporting and business model disclosure. (2) The LLM invents specific accounting changes ('now reported on a gross basis,' 'recognized when goods/services transferred rather than amortized') that are not mentioned in the ground truth and appear to be fabricated details. (3) The ground truth's core finding is about transparency and stakeholder emphasis - that by 2023 McDonald's explicitly highlighted franchisees/licensees as key stakeholders with detailed breakdown of restaurant ownership types, whereas 2022 noted franchise transactions were immaterial. The LLM completely misses this disclosure/transparency evolution. (4) The LLM's discussion of 'digital-service and brand-licensing fees as distinct revenue stream' and 'higher-margin revenue' introduces concepts not present in the ground truth. (5) Multi-hop reasoning failure: The question asks about evolution in 'financial reporting and strategic emphasis' - the LLM addresses only a narrow accounting treatment interpretation while missing the broader strategic disclosure shift. The answer demonstrates hallucination of specific accounting policy changes without evidence from the source material. This is a fundamental mismatch between what was asked and what was answered.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 464,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "\nThe contingent consideration linked to the Clif Bar acquisition remained a Level‑3 liability recorded at fair value; by December 31 2023 its fair‑value had risen to **$548 million** (up from $452 million at year‑end 2022), with any subsequent fair‑value changes continuing to be measured via a Monte‑Carlo simulation and booked in selling, general and administrative expense. The liability is presented as a long‑term obligation (with a current portion of $132 million), and the purchase‑price allocation adjustments for Clif Bar were incorporated into intangible‑asset and goodwill balances in 2023, after which the fair‑value measurement approach and SG&A recording of adjustments persisted into 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM claims the fair value 'had risen to $548 million (up from $452 million at year-end 2022)' - this introduces a 2022 comparison NOT present in the ground truth, which only discusses 2023 and 2024. The $548M figure for 2023 is correct, but the $452M prior year comparison appears fabricated or unsupported. (2) UNSUBSTANTIATED CLAIMS: The LLM states 'the fair-value measurement approach and SG&A recording of adjustments persisted into 2024' - the ground truth explicitly states 'By 2024, there is no direct mention of the contingent consideration liabilities' and notes the 2024 filing does not provide 'updated figures or valuation methods for these liabilities.' This is a direct contradiction of the ground truth. (3) CURRENT PORTION CLAIM: The LLM mentions 'with a current portion of $132 million' - this specific figure is not mentioned in the ground truth and cannot be verified. (4) INCOMPLETE EVOLUTION ANALYSIS: The ground truth emphasizes the KEY FINDING that contingent consideration may have been 'finalized or reclassified as part of the purchase price allocation process' by 2024, indicating a significant change in accounting treatment. The LLM fails to capture this critical evolution and instead suggests continuity ('persisted into 2024') that contradicts the ground truth. (5) MULTI-HOP REASONING: The LLM does not properly synthesize the 2023-to-2024 transition that is central to the question. The ground truth indicates a shift from active fair value measurement in 2023 to absence of disclosure in 2024, suggesting reclassification. The LLM misses this entirely. (6) LEVEL-3 CLASSIFICATION: While the LLM correctly identifies the Level-3 fair value measurement and Monte Carlo simulation method for 2023, it incorrectly extends these characteristics into 2024 without evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 503,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "\nBetween 2022 and 2024 AMD moved from merely “supporting” Vulkan to positioning it as a core strategic pillar of its GPU software stack—expanding Vulkan extensions, optimizing drivers, and tying Vulkan‑based features such as FidelityFX Super‑Resolution and ROCm compute to the RDNA 3 architecture. This shift shows AMD’s approach of leveraging open, cross‑platform standards to reduce developer friction, improve performance‑per‑watt, and compete on ecosystem breadth rather than raw hardware alone.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims when compared to the ground truth. Key issues: (1) UNSUPPORTED CLAIMS: The LLM introduces specific technical details (FidelityFX Super-Resolution, ROCm compute integration, driver optimization specifics, performance-per-watt metrics) that are NOT present in the ground truth knowledge graph. These appear to be hallucinated details not derived from SEC 10-K filings. (2) ARCHITECTURAL ACCURACY: While the LLM correctly mentions RDNA 3 architecture, it fails to acknowledge the 2022 baseline of RDNA 2 architecture that the ground truth explicitly states. The ground truth shows evolution FROM RDNA 2 (2022) TO RDNA 3 (2024), but the LLM doesn't establish this temporal progression clearly. (3) MISSING CORE FACTS: The LLM omits specific product references (Radeon RX 7000 Series) that ground truth identifies as key to understanding the 2024 positioning. (4) REASONING QUALITY: The LLM's claim about 'shifting from merely supporting to positioning as core strategic pillar' is not substantiated by the ground truth, which shows continuity rather than a dramatic shift in strategic emphasis. The ground truth emphasizes 'strategic continuity' while the LLM implies a more dramatic repositioning. (5) QUANTITATIVE ISSUES: No specific dates, product generations, or measurable metrics are provided in either answer, but the LLM's lack of concrete references to actual products/architectures makes it less grounded. The LLM answer reads more like speculative analysis than synthesis from actual SEC filing data. The ground truth is more conservative and factual, directly tied to documented product lines and architectural generations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 466,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "\nThe integration‑related costs that RTX recorded in 2023—most notably the $2.9 billion “Powder Metal Matter” charge—were the chief reason operating profit fell from $5.5 billion in 2022 to $3.6 billion in 2023, a decline of about $1.9 billion.  While other segments posted modest profit gains, the Pratt & Whitney‑related Powder Metal Matter expense (combined with higher restructuring and acquisition‑accounting adjustments) outweighed those improvements, driving the overall drop in operating profit and margin between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of RTX's integration-related charges and their impact on operating profit. QUANTITATIVE VERIFICATION: All key numbers are correct - the $2.9 billion Powder Metal Matter charge is accurately cited, the operating profit figures ($5.5 billion in 2022 declining to $3.6 billion in 2023) are correct, and the calculated decline of $1.9 billion is accurate. COMPLETENESS: The answer addresses all major components of the question: (1) the 2022 trend (declining integration charges contributing positively), (2) the 2023 shift with the new Powder Metal Matter charge, (3) the specific $2.9 billion amount, and (4) the overall impact on operating profit trends. ENTITY ACCURACY: RTX is correctly identified, years 2022-2023 are properly referenced, the Powder Metal Matter is correctly attributed to Pratt & Whitney operations, and operating profit is the correct metric. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions - connecting the specific charge amount to the overall profit decline, explaining the shift from 2022 to 2023 dynamics, and noting that while other segments had modest gains, the integration charges outweighed these improvements. MINOR CONSIDERATIONS: The LLM answer provides slightly more operational context (mentioning other segments' modest gains and restructuring adjustments) compared to the ground truth, which is appropriate elaboration rather than error. The semantic meaning aligns perfectly with the ground truth regarding the shift from declining integration charges in 2022 to the significant new expense in 2023. No calculation errors detected, and the logical flow connecting charges to profit impact is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 479,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "\nBetween 2023 and 2024 MDLZ’s relationship with Clif Bar remained that of an acquired brand rather than a new acquisition.  The 2023 results showed the first‑year post‑acquisition contribution—$507 million of incremental net revenue (constant‑currency) from Clif Bar and related acquisition‑integration and contingent‑consideration adjustments—while the 2024 filing reflects that the brand is now fully integrated, with its indefinite‑life intangible asset still recorded on the balance sheet (gross $3.3 bn) and no additional cash outlay, although the company continued to test it for impairment (recording $153 million of overall intangible‑asset impairment charges, none of which were attributed specifically to Clif Bar).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a substantive response that captures the evolution of MDLZ's relationship with Clif Bar between 2023 and 2024, moving from initial acquisition phase to integration and consolidation. STRENGTHS: (1) Correctly identifies the acquisition occurred in August 2022 (referenced in 2023 10-K); (2) Accurately characterizes the 2023 period as showing first-year post-acquisition contribution with integration costs and contingent consideration adjustments; (3) Correctly notes the 2024 period reflects full integration with indefinite-life intangible asset on balance sheet; (4) Provides specific financial metrics ($507M incremental net revenue, $3.3B gross intangible asset, $153M impairment charges); (5) Demonstrates sound multi-hop reasoning by synthesizing information across 2023 and 2024 filings. WEAKNESSES: (1) The specific numbers provided ($507M, $3.3B, $153M) cannot be verified against the ground truth answer, which does not provide these quantitative details. While these numbers may be accurate from the actual filings, they represent additional detail beyond what the ground truth confirms; (2) The statement about 'no additional cash outlay' in 2024 is not explicitly addressed in the ground truth; (3) The ground truth mentions 'purchase price allocation adjustments for Clif Bar during the prior year' in the 2024 10-K, which the LLM answer does not explicitly reference, though it may be implied in the discussion of integration. CALCULATION/VERIFICATION: No calculations are performed in either answer, so no calculation errors exist. The numbers cited appear reasonable for a major acquisition but cannot be independently verified against the provided ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2023 and 2024 filings to show the evolution of the relationship, which is the core requirement of the question. The reasoning is logical and well-structured. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth (acquisition in 2022, integration phase in 2023, consolidation/recalibration in 2024) while providing additional supporting detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 580,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 Gulfstream deepened its focus on energy‑efficient propulsion by pairing the rollout of new, lower‑fuel‑burn engines with broader Sustainable‑Aviation‑Fuel (SAF) initiatives.  The company’s latest clean‑sheet jets—the ultra‑large‑cabin G700 (certified early 2024) and the ultra‑long‑range G800/G400—feature all‑new powerplants that deliver higher specific‑fuel‑efficiency and longer range, while Gulfstream simultaneously expanded SAF availability (including the world’s first 100 % SAF trans‑Atlantic flight in Nov 2023) and offered carbon‑neutral travel options, underscoring a strategic shift toward both more efficient engines and fuel‑sustainability across its fleet.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Gulfstream's approach from 2023 to 2024, correctly identifying the shift from announcement/development to production phases and mentioning the G700 with new engines. However, there are significant issues: (1) FACTUAL ERROR - The LLM claims the G700 was 'certified early 2024,' but the ground truth indicates it was introduced/produced in 2024 without specifying early certification. More critically, the ground truth does NOT mention G800/G400 as featuring the new engines in 2024, and the LLM introduces these models without ground truth support. (2) UNSUPPORTED CLAIMS - The LLM references 'the world's first 100% SAF trans-Atlantic flight in Nov 2023' which is not mentioned in the ground truth and cannot be verified against it. (3) INCOMPLETE ALIGNMENT - While the ground truth emphasizes the transition from 'announcement and development phases to actual production,' the LLM frames this more broadly as 'deepened focus' without clearly articulating this specific evolution. (4) MULTI-HOP REASONING - The LLM does attempt to synthesize information across 2023-2024 and connect engine development to SAF initiatives, which is reasonable, but introduces information not in the ground truth. (5) CORE ACCURACY - The fundamental point about G700 featuring all-new engines is correct, and the general narrative of evolution toward efficiency is sound, but the addition of unsupported aircraft models and specific dates/events significantly undermines accuracy. The answer reads as plausible but contains fabricated details not grounded in the provided knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 443,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "\nFrom 2022 to 2024 AMD transformed its semi‑custom SoC business from a modest, project‑by‑project engineering‑fee arrangement into a core, higher‑volume growth pillar.  The 2024 10‑K shows that “custom products” – which include semi‑custom SoCs – are now sold under non‑cancellable purchase orders and revenue is recognized over time using a cost‑plus margin method, reflecting deeper, longer‑term partnerships (e.g., console OEMs) and a strategic shift to treat semi‑custom silicon as a primary, recurring revenue source rather than an ancillary offering.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and misalignments with the ground truth. CORRECT ELEMENTS: (1) The LLM correctly identifies a transformation in AMD's semi-custom SoC business from 2022 to 2024, (2) It accurately notes the shift toward higher-volume, more strategic positioning, (3) The mention of non-cancellable purchase orders and cost-plus margin methods reflects legitimate 10-K disclosure details, (4) The reference to console OEMs as key partners is contextually appropriate. SIGNIFICANT GAPS AND ISSUES: (1) The ground truth emphasizes a shift from 'dependency' (tied to third-party product performance) to 'active production and broader strategic integration' - the LLM misses this nuance about AMD's control and strategic positioning, (2) The ground truth explicitly mentions integration with a diversified portfolio including AI accelerators, GPUs, APUs, and DPUs - the LLM completely omits this critical strategic context, (3) The ground truth discusses alignment with 'long-term industry trends and internal innovation strategies' - the LLM focuses narrowly on revenue recognition mechanics rather than strategic positioning, (4) The LLM characterizes 2022 as 'modest, project-by-project' which aligns with ground truth's 'dependency' concept, but then pivots to revenue recognition details rather than the broader strategic evolution. MULTI-HOP REASONING: The LLM demonstrates partial synthesis by connecting 2022 and 2024 positions, but fails to synthesize the full strategic picture across the portfolio diversification and industry alignment aspects. The answer is more transactional (focusing on accounting methods) than strategic (focusing on business model evolution). QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. The LLM's references to accounting methods (cost-plus margin, non-cancellable orders) are plausible but not verified against specific 10-K data. OVERALL ASSESSMENT: The LLM answer is partially correct but incomplete. It captures the transformation narrative but misses the strategic integration and portfolio diversification elements that are central to the ground truth answer. The focus on revenue recognition mechanics, while potentially accurate, represents a narrower interpretation of the question than the ground truth's emphasis on strategic positioning and portfolio integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 643,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Medtronic kept its preferred‑share authorizations unchanged – 127.5 million Preferred Shares (par $0.20) and 500 thousand A Preferred Shares (par $1.00) – and, as in the prior year, none of these shares were issued or outstanding.  The lack of any increase in authorized preferred‑share capital signals that the company is not using preferred equity to fund growth, but is instead relying on its ordinary‑share repurchase program and other internal cash‑generation mechanisms to manage capital and return value to shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative facts are correct - 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value are accurately stated for both fiscal years. (2) Correctly identifies that no shares were issued or outstanding in either year. (3) Properly identifies the company as Medtronic (though not explicitly stated in the original answer, this is contextually appropriate). (4) Correctly identifies the unchanged structure between 2023 and 2024. (5) Number formatting is appropriate and consistent.\n\nWEAKNESSES: (1) The LLM answer goes beyond the ground truth by making interpretive claims about capital strategy that are not explicitly supported by the filing data provided. Specifically, the statement that the company is \"not using preferred equity to fund growth, but is instead relying on its ordinary-share repurchase program and other internal cash-generation mechanisms\" represents inference rather than direct evidence from the preferred share authorization data alone. (2) The ground truth answer is more conservative and factual, stating only that \"the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.\" The LLM answer makes broader claims about what the company IS doing (relying on share repurchases and internal mechanisms) rather than what it is NOT doing (not changing preferred share structure). (3) While the inference about capital strategy may be reasonable, it exceeds what can be directly concluded from the preferred share authorization data alone.\n\nMULTI-HOP REASONING: The answer correctly synthesizes the comparison between two fiscal years and identifies the unchanged structure. However, the leap to conclusions about the company's broader capital strategy mechanisms (share repurchases, internal cash generation) is not directly supported by the preferred share data presented.\n\nSEMANTIC EQUIVALENCE: The core factual content matches the ground truth, but the LLM adds interpretive analysis that, while potentially insightful, goes beyond what the data directly supports.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 574,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "\nBetween the 2022 and 2024 filings, BK’s risk language shifted from describing reputational risk mainly as a downstream effect of operational failures, cyber incidents or regulatory enforcement (e.g., “adverse events, publicity or government scrutiny could harm our reputation”), to embedding it within broader ESG and geopolitical exposures.  The 2024 disclosure explicitly ties reputational harm to sustainability concerns, climate‑change impacts, diversity issues and geopolitical events, and notes that such reputational damage can trigger regulatory scrutiny, affect client activity and even raise funding costs through credit‑rating pressure.  Thus, the framing evolved from a generic “reputation‑at‑risk” warning to a more nuanced view that links reputational risk to emerging ESG and external‑event considerations and their downstream business consequences.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of BK's reputational risk framing between 2022 and 2024. STRENGTHS: (1) Correctly identifies the core shift from generic reputational risk language to more nuanced ESG and geopolitical framing; (2) Accurately captures the 2024 expansion to include sustainability concerns (climate change, diversity); (3) Properly synthesizes the multi-hop connection showing how reputational harm links to downstream business consequences (regulatory scrutiny, client activity, credit ratings); (4) No quantitative errors - dates (2022, 2024) and company (BK) are correct; (5) Demonstrates sound multi-hop reasoning by connecting reputational risk to operational models and ESG factors. MINOR WEAKNESSES: (1) The LLM answer adds interpretive detail about 'downstream effects of operational failures, cyber incidents' in 2022 that isn't explicitly confirmed in the ground truth, which focuses more narrowly on 'government scrutiny and other reputational harm'; (2) The ground truth specifically mentions 'platforms operating model transition' as a new context, which the LLM answer doesn't explicitly reference (though it does mention 'emerging ESG and external-event considerations'); (3) The LLM's characterization of the 2022 framing as 'generic' versus 2024 as 'nuanced' is interpretive rather than directly grounded in the original answer's language. SEMANTIC EQUIVALENCE: The core message aligns well - both answers convey that reputational risk expanded from a narrower focus to include broader ESG/sustainability concerns and their business impacts. The LLM provides more detailed explanation of the downstream consequences, which adds value but slightly deviates from the ground truth's more direct comparison. Overall, the answer is substantially correct with minor interpretive additions that don't contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 511,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "\nFrom 2023 to 2024 Amazon kept its stake in Anthropic, PBC classified as a Level‑3 available‑for‑sale convertible‑debt (later treated as an equity‑linked investment) and recorded it at fair value, with unrealized gains and losses flowing through other comprehensive income. The initial $1.25 billion note entered in Q3 2023 was later expanded under a $2.75 billion commitment, and its valuation relies on internally‑derived discounted‑cash‑flow models and qualitative impairment reviews rather than observable market prices—making it sensitive to macro‑economic conditions, foreign‑exchange shifts, and the performance of Anthropic’s cloud and AWS‑related services.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $1.25 billion initial investment in Q3 2023 and the $2.75 billion commitment. It accurately notes the available-for-sale classification, Level 3 asset status, fair value accounting, and unrealized gains/losses flowing through other comprehensive income. The mention of DCF models and valuation challenges is appropriate. WEAKNESSES: (1) The phrase 'later treated as an equity-linked investment' is problematic and not supported by the ground truth, which consistently describes it as a convertible note/convertible debt investment throughout both 2023 and 2024. This introduces inaccuracy about the investment classification evolution. (2) The LLM adds specific details about 'cloud and AWS-related services' performance affecting valuation that are not mentioned in the ground truth. While plausible, these are not verified from the source material and represent unsupported elaboration. (3) The answer fails to adequately capture the key evolution emphasized in the ground truth: the shift from 2023 (focusing on investment mechanics) to 2024 (emphasizing valuation complexity and risk due to lack of market data and economic uncertainty). The LLM mentions valuation challenges but doesn't clearly articulate this temporal shift in disclosure emphasis. (4) The mention of 'foreign-exchange shifts' is not explicitly supported by the ground truth. MULTI-HOP REASONING: The answer attempts to synthesize information across years but conflates investment classification details and adds unsupported specifics. The core numbers are correct, but the characterization of how the classification 'evolved' is muddled by the equity-linked language. QUANTITATIVE: Numbers are accurate ($1.25B, $2.75B, Q3 2023). QUALITATIVE: The reasoning about valuation methodology is partially sound but includes unsupported details and misses the key narrative shift about increased emphasis on valuation risk and complexity in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 528,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the IP‑risk narrative shifted from a primary focus on traditional trademark, patent and trade‑secret protection to a broader, technology‑driven exposure.  In the 2023 filing the company warned that failure to secure or maintain its IP rights—especially in light of possible legal changes—could harm its competitiveness, and it highlighted the threat of third‑party infringement claims.  By 2024 the discussion explicitly adds the risk of “developments in artificial‑intelligence technologies,” emphasizes the need to protect know‑how and trade secrets in both traditional and digital environments, and underscores how changes in law or enforcement could weaken those protections, reflecting a more complex, AI‑related and digitally‑focused IP landscape.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer fundamentally reverses the ground truth narrative. The ground truth states that 2023 emphasized AI-related threats to IP protection, while 2024 removed the specific AI mention and broadened focus to legal/regulatory compliance risks. The LLM answer claims the opposite—that 2024 'explicitly adds the risk of developments in artificial-intelligence technologies' and emphasizes AI-related IP landscape. This is a direct contradiction of the original answer. The LLM also mischaracterizes 2023 as focusing on 'third-party infringement claims' when the ground truth emphasizes legal changes reducing IP protections in response to AI developments. The LLM's statement that 2024 'underscores how changes in law or enforcement could weaken those protections' is partially correct but is presented as part of an AI-focused narrative when the ground truth indicates the opposite—that 2024 removed the AI-specific focus. The LLM demonstrates poor multi-hop reasoning by failing to correctly synthesize the temporal evolution described in the ground truth. No numeric errors exist (quantitative accuracy is perfect), but the semantic and factual content is substantially incorrect, representing a complete inversion of the key finding about how the risk narrative evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 370,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Goldman Sachs shifted from citing a single, generic “Non‑Employee Director RSU Award Agreement (pre‑2015)” – referenced in the 2023 10‑K (Exhibit 10.21) – to disclosing a suite of newer, numbered award forms (10.32 – 10.38) that include a dedicated “Form of Non‑Employee Director RSU Award Agreement,” a “Form of Non‑Employee Director RSU Award Agreement (Cash‑Settled),” and separate “One‑Time/Year‑End RSU Award Agreement” and “Year‑End RSU Award Agreement (fully vested / not fully vested)” provisions.  In other words, the 2023 filing relied on an older, pre‑2015 agreement, while the 2024 filing replaces it with updated, more granular director‑equity agreements that reflect newer vesting and cash‑settlement terms.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and contradicts the ground truth on multiple critical dimensions: (1) EXHIBIT NUMBERS: Ground truth states 2023 referenced Exhibit 10.17 and 2024 referenced Exhibit 10.18. LLM claims 2023 used Exhibit 10.21 and 2024 used Exhibits 10.32-10.38. These are completely different exhibit numbers with no overlap. (2) REFERENCED AMENDMENTS: Ground truth identifies a specific amendment dated November 28, 2008, and references to Exhibit 10.69 from the 2008 Annual Report. LLM makes no mention of these specific dates or exhibits, instead discussing generic 'pre-2015' agreements and vesting/cash-settlement terms not mentioned in ground truth. (3) NATURE OF EVOLUTION: Ground truth describes a shift from one exhibit to another with deeper historical documentation emphasis. LLM describes a shift from a single pre-2015 agreement to multiple numbered forms (10.32-10.38) with granular provisions. These are fundamentally different characterizations of the evolution. (4) FACTUAL ACCURACY: The LLM appears to have confused or misidentified the actual exhibits and agreements being referenced. The specific exhibit numbers (10.17 vs 10.21, 10.18 vs 10.32-10.38) are factually incorrect. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information about evolution between years, it does so based on incorrect source data, making the entire synthesis invalid. The answer demonstrates a fundamental misunderstanding or misidentification of the actual SEC filing exhibits and their contents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 422,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "\nBetween 2022 and 2023 BKNG deepened its “merchant” model—more bookings are now processed as merchant transactions in which the Company facilitates payment from travelers, records revenue net of commissions (and any incentives or taxes), and assumes greater responsibility for refunds, charge‑backs and tax collection.  This shift is reflected in a larger Deferred Merchant Bookings balance in 2023 and results in higher merchant‑related expenses that offset the incremental merchant revenues, while agency‑type commissions (where BKNG does not handle payments) remain a smaller share of total revenue.  Consequently, its contracts with travel service providers now give the Company tighter integration with payment handling and a broader set of contractual obligations, moving a greater portion of its revenue to a net‑basis.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents BKNG's business model evolution. Key issues: (1) DIRECTIONAL ERROR: The ground truth indicates BKNG moved FROM a general intermediary description TO more detailed accounting treatment and net-basis revenue recognition. The LLM answer incorrectly suggests BKNG 'deepened its merchant model' and took on 'greater responsibility' - this contradicts the ground truth which emphasizes BKNG's role as an AGENT recognizing revenue on a net basis due to NOT taking principal responsibility. (2) MERCHANT VS AGENT CONFUSION: The LLM conflates merchant and agent models. The ground truth explicitly states BKNG recognizes revenue on a net basis BECAUSE it acts as an agent, not because it operates a merchant model. The LLM incorrectly describes BKNG as handling payments and assuming refund/chargeback responsibility, which is contrary to the agent-based model described in the ground truth. (3) MISSING KEY ELEMENTS: The ground truth emphasizes the shift from general relationship description to structured accounting treatment and clarification of revenue recognition timing (when travelers begin using services). The LLM completely misses this evolution in accounting disclosure. (4) QUANTITATIVE ISSUES: The LLM references 'Deferred Merchant Bookings balance' without providing any actual numbers or comparisons between 2022 and 2023, making it impossible to verify claims. The ground truth does not support the existence or growth of a 'merchant model' as the primary evolution. (5) SEMANTIC MISALIGNMENT: The core narrative is inverted - the ground truth describes clarification of an agent model, while the LLM describes expansion of a merchant model. These are fundamentally different business relationships.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 484,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "\nThe 2023 10‑K presented the executive‑life‑insurance coverage for managing directors as a stand‑alone narrative subsection within Item 10 (Executive Compensation), describing the policy’s eligibility, benefits and restrictions. In the 2024 filing that narrative was eliminated – the same policies are now only listed by exhibit numbers 10.12 and 10.13 in the exhibit index under Item 10 (Directors, Executive Officers and Corporate Governance), with no separate descriptive text. This shift moves the disclosure from a dedicated narrative section to an exhibit‑only reference.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the structural changes between the 2023 and 2024 filings. CRITICAL ERRORS: (1) The LLM claims the 2023 filing had a 'stand-alone narrative subsection' describing executive life insurance within Item 10, but the ground truth indicates the 2023 filing simply included the policies as Exhibits 10.11 and 10.12 without evidence of a separate narrative section being removed. (2) The LLM states the 2024 filing has exhibits numbered 10.12 and 10.13, which matches the ground truth's renumbering claim, but the LLM's explanation of WHY this occurred is incorrect - the ground truth indicates these were renumbered FROM 10.11 and 10.12 TO 10.12 and 10.13 due to exhibit reorganization, not because a narrative section was eliminated. (3) The LLM invents a narrative elimination that is not supported by the ground truth, which makes no mention of narrative text being removed. QUANTITATIVE ACCURACY: The exhibit numbers 10.12 and 10.13 are correct in the 2024 filing per ground truth, but the 2023 numbers (10.11 and 10.12) are not mentioned in the LLM answer. QUALITATIVE ACCURACY: The core misunderstanding is that the LLM attributes the structural change to removal of narrative text, when the ground truth clearly states the change was simply renumbering of exhibits due to filing reorganization. The LLM's reasoning about moving from 'narrative section to exhibit-only reference' is not supported by the source material. CONTEXTUAL RELEVANCE: While the answer addresses the right companies and years, it fundamentally mischaracterizes the nature of the structural changes, making it contextually misleading despite touching on the right topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 466,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "\nFrom 2022 to 2024 Broadcom shifted FBAR‑filter production from a predominantly outsourced model to dedicated internal III‑V wafer fabrication in the United States and Singapore, investing in process‑development and tighter design‑to‑fab integration to safeguard IP and guarantee supply‑chain resilience.  This internal capability has become a key competitive differentiator—allowing faster, higher‑performance, and customizable filters that underpin Broadcom’s high‑margin, high‑value wireless/RF portfolio and reinforce its position as a preferred supplier to OEMs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Direction of Change: The LLM claims Broadcom shifted FROM outsourced TO internal fabrication between 2022-2024. The ground truth explicitly states FBAR filters were ALREADY internally fabricated in 2022 ('fabricated internally to protect IP') and remained internally fabricated in 2024. The LLM fundamentally misrepresents the evolution as a shift when it was actually continuity. (2) UNSUPPORTED CLAIMS: The LLM introduces specific details not present in ground truth: 'dedicated internal III-V wafer fabrication in the United States and Singapore,' 'process-development and tighter design-to-fab integration,' and 'high-margin, high-value wireless/RF portfolio.' These appear to be fabricated or from different sources, not supported by the knowledge graph. (3) MISSING KEY INFORMATION: The LLM fails to mention the expanded competitive landscape (Qorvo, Qualcomm, Skyworks) that the ground truth identifies as a key evolution between 2022-2024. This is a critical multi-hop synthesis element. (4) INCOMPLETE MULTI-HOP REASONING: The question asks about evolution 'particularly in terms of internal fabrication and competitive positioning.' The ground truth addresses both: internal fabrication remained consistent, but competitive positioning intensified. The LLM addresses neither correctly—it invents a fabrication shift and ignores the competitive intensity increase. (5) SEMANTIC MISALIGNMENT: While the LLM uses appropriate terminology about IP protection and supply-chain resilience, these are presented as NEW developments rather than REINFORCED strategies, which contradicts the ground truth's emphasis on consistency with increased competitive pressure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 481,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "\nBetween 2023 and 2024 BMY transformed Krazati from a newly‑acquired, pre‑launch oncology asset (secured through the $4.8 bn Mirati purchase in early 2024) into a clinically advanced, revenue‑generating product with multiple Phase III read‑outs and FDA approvals for second‑line NSCLC and colorectal cancer, and the company now records a $640 million definite‑lived acquired‑product‑rights intangible for Krazati on its balance sheet—reflecting its strategic valuation within the $4.9 bn purchase‑price allocation.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "\nBetween 2022 and 2023 Booking Holdings deepened its “Connected‑Trip” strategy—expanding direct flight and ancillary‑service offerings and tightening integration with accommodation, rental‑car and restaurant partners—yet the contractual model with travel‑service providers remained unchanged: providers continue to supply inventory to BKNG’s platforms without assuming delivery risk, and BKNG earns revenue on a net‑basis through either agency commissions or merchant margins.  Consequently, BKNG records revenue when travelers actually use the booked services, treats coupons, loyalty points and other incentives as reductions of that revenue, and manages its financial obligations to providers through deferred merchant‑booking balances and provisions for refunds, while re‑classifying certain tax and expense items to better align with the variable nature of these payments.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains accurate information about BKNG's business model and financial management practices, but diverges significantly from the ground truth in characterizing the evolution of the relationship between 2022 and 2023.\n\nCORRECT ELEMENTS:\n1. Accurately describes BKNG's revenue recognition model (net basis through commissions or merchant margins)\n2. Correctly identifies that coupons, loyalty points, and incentives are treated as revenue reductions\n3. Accurately notes the use of deferred merchant-booking balances and refund provisions\n4. Correctly describes the inventory supply model where providers don't assume delivery risk\n5. Mentions the Connected-Trip strategy expansion (though not explicitly required by ground truth)\n\nINCORRECT/MISSING ELEMENTS:\n1. CRITICAL: The LLM states \"the contractual model with travel-service providers remained unchanged\" between 2022 and 2023, directly contradicting the ground truth which explicitly states the relationship \"shifted to a more dependent model\"\n2. CRITICAL: The LLM does not acknowledge the shift from competition-focused to partnership-focused strategy that the ground truth emphasizes\n3. The LLM does not mention the increase in 'Deferred merchant bookings' liability as evidence of the relationship evolution\n4. The LLM does not highlight the introduction of \"more incentive programs\" as a strategic shift\n5. The answer focuses on explaining the existing business model rather than analyzing how it evolved between the two years\n\nMULTI-HOP REASONING: The question asks specifically about evolution \"between 2022 and 2023.\" The ground truth identifies a clear temporal shift: 2022 = competition focus; 2023 = partnership/dependent model focus. The LLM answer fails to synthesize this temporal comparison, instead presenting a static description of the business model that applies to both years.\n\nQUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral (8/10 for not introducing false numbers).\n\nQUALITATIVE ACCURACY: While the LLM's description of BKNG's business mechanics is accurate, it fundamentally misses the core analytical requirement: demonstrating how the relationship evolved. The answer reads as a general business model explanation rather than a comparative analysis of 2022 vs. 2023 dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 630,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "\nFrom 2022 through 2024 Broadcom continued to offer its custom touch‑controller IP for processing signals from touch screens in mobile handsets and tablets, but the 2024 disclosures show it is now marketed together with inductive‑charging ASICs as part of a broader mobile‑device connectivity platform.  This reflects a shift from a discrete, stand‑alone component to a more integrated solution, positioning the technology for a longer, more stable presence across successive generations of mobile devices.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies when compared to the ground truth. (1) MAJOR ERRORS: The LLM introduces information not present in the ground truth - specifically mentioning 'inductive-charging ASICs' and 'mobile-device connectivity platform' which are not mentioned in the original answer. The ground truth describes a shift from 'supplying' to 'producing' Custom Touch Controllers, but the LLM describes a shift from 'discrete, stand-alone component to integrated solution' with inductive-charging technology bundled together. These are fundamentally different narratives. (2) ENTITY/PRODUCT ACCURACY: The ground truth focuses on Custom Touch Controllers evolving from supply to production role. The LLM conflates this with inductive-charging ASICs, which appears to be either fabricated or from a different context not supported by the ground truth. (3) MULTI-HOP REASONING: The LLM fails to correctly synthesize the 2022-to-2024 evolution. The ground truth's key insight is the shift from 'component supplier' to 'active producer involved in design and creation.' The LLM's narrative about bundling with inductive-charging technology and creating a 'mobile-device connectivity platform' does not align with this core evolution. (4) SEMANTIC MISMATCH: While both answers discuss evolution of Broadcom's role, they describe fundamentally different evolutions. The ground truth emphasizes deeper engagement in development/production, while the LLM emphasizes product bundling and integration. (5) SPECIFICITY ISSUES: The LLM provides specific technical details (inductive-charging ASICs, signal processing from touch screens) that may be accurate in general but are not supported by or mentioned in the ground truth, suggesting either hallucination or information from an unverified source. The answer demonstrates poor multi-hop synthesis and introduces unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 514,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "\nFrom 2023 to 2024 Union Pacific stepped up its direct spending on freight‑car assets, raising cash capital investment in “Locomotives and freight cars” from **$728 million** in 2023 to **$788 million** in 2024.  The company explicitly notes in its 2025 capital plan that it will continue to **“acquire freight cars to support replacement and growth opportunities,”** signaling a deliberate shift toward buying new cars (and using lease‑financing where appropriate) rather than relying solely on the existing fleet.  This expansion is being funded through its revolving credit facility and commercial‑paper program, underscoring a more aggressive asset‑acquisition strategy in 2024‑2025.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of Union Pacific's strategic shift toward asset acquisition from 2023 to 2024. STRENGTHS: (1) The capital investment figures are accurate ($728M in 2023 to $788M in 2024 for Locomotives and freight cars), showing proper multi-hop synthesis across years. (2) The lease buyout figures mentioned in ground truth ($143M in 2024 vs $57M in 2023) are implicitly supported by the LLM's narrative about increased asset acquisition, though not explicitly stated. (3) The LLM correctly identifies the strategic shift from leasing reliance to ownership/acquisition focus. (4) The answer provides additional context about funding mechanisms (revolving credit facility, commercial paper) and forward-looking statements about 2024-2025 plans, which adds depth. (5) The reasoning is sound and multi-hop synthesis is correct. MINOR WEAKNESSES: (1) The LLM does not explicitly cite the specific lease buyout dollar amounts ($143M vs $57M) that are highlighted in the ground truth as key evidence of the strategic shift. While the LLM's capital investment numbers support the same conclusion, the ground truth specifically emphasizes these lease buyout figures as the primary metric demonstrating the shift. (2) The answer could have been more explicit about the 2023 reliance on leasing as a baseline for comparison. The LLM focuses on 2024-2025 forward momentum but doesn't explicitly state the 2023 leasing strategy as clearly as the ground truth does. CALCULATION VERIFICATION: The $60M increase in capital investment ($788M - $728M = $60M) is mathematically correct and represents approximately an 8.2% increase, which aligns with the narrative of increased investment. The lease buyout increase from $57M to $143M represents a 151% increase, which is more dramatic than the capital investment increase and is the key metric in the ground truth. Overall, the LLM provides a comprehensive and largely accurate answer with strong supporting detail, but misses the explicit emphasis on lease buyout figures as the primary evidence of strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 567,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "\nThe FY 2022‑FY 2023 restructuring in APLA shifted several NIKE Brand operations from Nike‑direct sales to third‑party distributors, moving revenue from the Direct‑to‑Consumer channel to wholesale (APLA wholesale sales rose from **$3.53 bn** in FY 2022 to **$3.74 bn** in FY 2023 while Direct‑to‑Consumer grew only modestly).  This mix change lowered the segment’s earnings‑before‑interest‑and‑taxes (Global Brand Divisions EBIT fell from **$(4.262) bn** to **$(4.841) bn**) and triggered a one‑time foreign‑currency translation loss recorded in Corporate, but it also reduced the company’s direct inventory and capital‑expenditure exposure in the region.  Overall APLA revenue edged up **+$476 m**, yet the margin profile and long‑lived‑asset base were adjusted to reflect the distributor‑driven model.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM provides specific financial figures (APLA wholesale $3.53bn→$3.74bn, Global Brand Divisions EBIT $(4.262)bn→$(4.841)bn, revenue increase of $476m) that cannot be verified against the ground truth and appear to be fabricated or hallucinated. The ground truth does not provide these specific numbers, and the LLM presents them with false confidence using bold formatting. This is a major red flag for financial accuracy. (2) INCOMPLETE SYNTHESIS - The LLM answer focuses heavily on revenue channel mix shifts (DTC to wholesale) and EBIT changes, but the ground truth emphasizes the structural shift from direct operations to third-party distributor oversight, which is a fundamentally different operational model. The LLM conflates a sales channel transition with a business model transition. (3) MISSING KEY ELEMENTS - The ground truth specifically mentions: (a) non-recurring impairment charges and foreign currency translation losses in FY2022, (b) the shift from direct operations to a 'strategic stake' model, (c) reference to Note 18 on divestitures, and (d) the strategic rationale of reducing operational overhead. The LLM addresses none of these core elements. (4) ENTITY CONFUSION - The LLM references 'Global Brand Divisions EBIT' which is not clearly established as the correct metric for APLA in the ground truth context. (5) REASONING QUALITY - While the LLM attempts multi-hop synthesis, it appears to construct a narrative around unverified numbers rather than synthesizing actual filing data. The connection between wholesale growth and EBIT decline is presented without proper justification. The ground truth answer is more qualitative and structural in nature, while the LLM answer is quantitatively specific but unsubstantiated. VERDICT: The LLM answer demonstrates poor factual accuracy with apparent numerical fabrication, incomplete coverage of the actual structural changes, and misalignment with the ground truth's emphasis on operational model transformation rather than sales channel shifts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 558,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "\nFrom 2022 to 2024 Broadcom moved from a generic statement that it “internally fabricates” InP lasers to a concrete strategy that designates dedicated III‑V wafer‑fab capacity in the United States and Singapore for those devices.  This shift reflects a deliberate effort to secure supply, protect intellectual property and accelerate development of high‑value fiber‑optic components, and the company now cites this internal fabrication as a core differentiator that underpins its competitive positioning against fabless rivals in the high‑speed optical‑interconnect market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. Key issues: (1) FABRICATION LOCATIONS: The LLM claims Broadcom designated 'dedicated III-V wafer-fab capacity in the United States and Singapore' for InP lasers. This specific claim about dedicated fab capacity in these locations is NOT supported by the ground truth, which only states Broadcom uses 'internal fabrication facilities' without specifying dedicated capacity or these geographic locations. This is a material factual error. (2) STRATEGIC SHIFT CHARACTERIZATION: The ground truth indicates the shift was toward 'emphasizing the competitive landscape more explicitly' and 'highlighting InP laser capabilities as part of competitive differentiation.' The LLM reframes this as a shift toward 'concrete strategy' with dedicated fab capacity, which overstates and mischaracterizes the actual evolution described in the ground truth. (3) MISSING KEY INFORMATION: The LLM fails to mention the explicit competitors cited in 2024 (Coherent Corp., Lumentum Holdings Inc., and others), which is a central part of the ground truth's explanation of the strategic shift. (4) UNSUPPORTED CLAIMS: The LLM adds interpretations about 'securing supply, protect intellectual property and accelerate development' that are not present in the ground truth and appear to be speculative reasoning rather than facts from the filings. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize evolution over time, it does so by introducing information not in the ground truth rather than accurately synthesizing what was actually disclosed. The answer reads more like strategic analysis than factual reporting of what the filings actually state. The ground truth is more conservative and accurate in its characterization of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 503,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "\nBetween 2022 and 2023 the shareholder‑ownership pattern of Swoosh, LLC was essentially unchanged.  Both the 2022 and 2023 Form 10‑K filings state that Swoosh beneficially owned about 77 % of NIKE’s Class A Common Stock, and that—if all of those shares were converted into Class B shares—they would represent roughly 16 % of the Class B equity.  Because Class A and Class B have different voting rights (Class A elects the majority of directors while Class B carries limited voting power), Swoosh’s large economic stake does not translate into commensurate voting influence; the conversion scenario shows that its voting percentage would be modest (≈16 %).  Consequently, while Swoosh’s holdings remain the dominant economic interest, the overall voting power of the company is dispersed among other shareholders, and any large sale by Swoosh would affect market price more than control.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all key quantitative facts: Swoosh, LLC owned approximately 77% of Class A Common Stock in both 2022 and 2023, and the conversion scenario shows approximately 16% of Class B Common Stock. The numbers are accurate and properly formatted. The LLM correctly notes the ownership structure remained consistent between the two years.\n\nWEAKNESSES: (1) The LLM introduces analysis about voting rights differences between Class A and Class B shares that is NOT present in the ground truth answer. While this may be factually accurate about NIKE's capital structure, it represents an addition beyond what the original answer states, potentially introducing information not verified against the knowledge graph. (2) The LLM's conclusion that 'Swoosh's large economic stake does not translate into commensurate voting influence' contradicts the ground truth's emphasis on Travis Knight's 'significant role in managing the Class A Common Stock' and 'sustained influence.' The ground truth emphasizes that the concentration of ownership implies sustained influence on shareholder decisions, while the LLM downplays this by focusing on voting power dispersion. (3) The LLM adds speculative analysis about 'any large sale by Swoosh would affect market price more than control' which is not in the ground truth and goes beyond the scope of the question. (4) The LLM fails to mention Travis Knight specifically, who is identified in the ground truth as having significant influence through his role managing the Class A shares.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the 2022 and 2023 data to show consistency, but the interpretation of implications diverges from the ground truth. The ground truth emphasizes sustained influence through ownership concentration and Travis Knight's role, while the LLM emphasizes voting power dispersion and market impact.\n\nSEMANTIC EQUIVALENCE: While the factual numbers match, the semantic meaning and implications drawn differ significantly. The ground truth focuses on shareholder influence through ownership concentration, while the LLM focuses on voting power limitations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 577,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "\nFrom 2022 to 2023 PMI moved from acquiring Swedish Match AB—whose oral‑nicotine (ZYN) and snus brands complemented PMI’s heated‑tobacco (IQOS) platform—to actively integrating those products into its global commercial structure. By the end of 2023 the combined reduced‑risk portfolio was available in 84 markets and PMI began consolidating Swedish Match’s results into its four main geographical segments, signalling full portfolio integration and expanded market availability.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 84 markets figure for 2023, which matches the ground truth. (2) The mention of Swedish Match AB acquisition and integration is contextually relevant and accurate. (3) The reference to IQOS (heated tobacco) and ZYN (oral nicotine) products is factually correct. (4) The quantitative data point (84 markets) is accurate.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to address the core strategic evolution described in the ground truth—the reclassification from 'Reduced-Risk Products (RRPs)' as a distinct category in 2022 to 'Smoke-Free Products (SFPs)' in 2023. This is a fundamental aspect of the question about how PMI's strategic positioning evolved. (2) The LLM does not mention the consolidation of RRPs under a unified 'smoke-free vision' or the broader category expansion to include wellness and healthcare offerings. (3) The answer focuses heavily on the Swedish Match acquisition narrative rather than the portfolio categorization evolution, which is the primary focus of the ground truth answer. (4) The LLM mentions 'four main geographical segments' but this detail is not in the ground truth and appears to be extraneous information. (5) The answer lacks clarity on the 2022 baseline—it doesn't explicitly state what the market availability was in 2022 (described as 'unspecified' in ground truth), making the comparison less clear.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting the Swedish Match acquisition to portfolio integration and market expansion, but it misses the critical strategic repositioning element (RRP to SFP reclassification) that represents the core evolution being asked about. The reasoning is incomplete because it doesn't synthesize the categorization change across the two years.\n\nSEMANTIC EQUIVALENCE: While the LLM's answer is not factually wrong in what it states, it fundamentally misses the primary strategic evolution (the reclassification and consolidation under 'Smoke-Free Products'). This is not merely a wording difference but a substantive gap in addressing the question's core focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 572,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "\nFrom 2022 through 2024 Caterpillar moved its reciprocating‑engine business from a pure commodity‑volume model toward a higher‑margin, solution‑oriented role that emphasizes power‑generation and gas‑compression applications and related aftermarket services.  This shift is evident in the Energy & Transportation segment, where total sales grew 3 % to $28.86 bn in 2024 and profit margin rose from 17.6 % to 19.9 % (pages 38‑39), expanding the segment’s contribution to revenue and enhancing its gross‑margin potential.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the evolution of Caterpillar's reciprocating engines business and mentions margin improvement, but contains significant factual discrepancies with the ground truth. CRITICAL ISSUES: (1) The LLM provides segment-level data (Energy & Transportation segment with $28.86B sales and margin improvement from 17.6% to 19.9%) that is not mentioned in the ground truth answer, which specifically discusses reciprocating engines business evolution. Without verification, these numbers cannot be confirmed as accurate for the reciprocating engines business specifically. (2) The ground truth emphasizes Perkins Engines Company Limited's role (90 distributors across 171 countries) and the specific evolution toward remanufacturing services - the LLM completely omits these concrete details. (3) The ground truth identifies the key strategic shift as moving from seller to 'full lifecycle service provider' with remanufacturing of engines and components, plus third-party remanufacturing services. The LLM describes a shift toward 'solution-oriented role' emphasizing 'power-generation and gas-compression applications' - these are different characterizations not supported by the ground truth. (4) The LLM's explanation of margin improvement (remanufacturing with lower material costs) is absent from the LLM answer, which only cites segment-level margin expansion without explaining the mechanism. PARTIAL CREDIT: The LLM correctly identifies that the business evolved toward higher margins and improved gross margin potential, and correctly notes the shift toward service-based offerings. However, the specific mechanisms, subsidiary details, and remanufacturing focus are either missing or replaced with different characterizations. The quantitative data provided (segment margins and sales) cannot be verified against the ground truth and may be accurate for the broader segment but not specifically for reciprocating engines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 525,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "\nBetween 2022 and 2023 BNY Mellon did not introduce a new disclosure mechanism; it continued to post the Directors’ Code of Conduct on its website and to state that any future amendments or waivers—both to the general Code of Conduct for executive officers and to the Directors’ Code itself—would be posted on the website for stakeholder transparency. The 2023 filing merely reiterates this same transparency commitment, reflecting a consistent approach rather than an evolution of the disclosure practice.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both responses correctly identify that BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with no evolution or change in mechanisms. The LLM answer accurately captures the key facts: (1) the company continued to post the Directors' Code of Conduct on its website in both years, (2) amendments or waivers would be posted for stakeholder transparency, (3) this applied to both the general Code of Conduct for executive officers and the Directors' Code itself, and (4) the 2023 filing merely reiterated the same commitment rather than introducing new practices. The LLM answer is slightly more detailed than the ground truth, providing additional context about the scope of the commitment (covering both executive officers' code and directors' code), which adds helpful specificity without contradicting the original answer. There are no quantitative errors, dates are correct (2022 and 2023), and the multi-hop reasoning correctly synthesizes the comparison across the two years. The semantic meaning is equivalent to the ground truth—both convey stability and consistency in governance disclosure practices. The only minor distinction is that the LLM provides marginally more elaboration, but this enhances rather than detracts from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 384,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Nike moved away from a wholesale‑and‑direct presence in the APLA region toward a distributor‑centric operating model.  In FY 22 the company still sold through its own NIKE Direct stores and wholesale accounts in APLA, but in FY 23 it transferred the legal entities in Argentina, Uruguay and Chile—and other APLA markets—to third‑party distributors, cutting its own sales footprint and SG&A costs while accepting slower top‑line growth in exchange for higher margins and reduced foreign‑exchange exposure.  This shift reflects a strategic re‑allocation of resources from direct market participation to a lighter, partnership‑based structure in APLA.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core strategic shift from direct to distributor-centric operations in APLA between FY22 and FY23, which aligns with the ground truth. However, there are significant issues with factual accuracy and unsupported claims: (1) CORRECT ELEMENTS: The answer correctly identifies the transition from direct/wholesale to third-party distributors, the shift toward a partnership-based model, and the general timeframe (FY22 to FY23). The semantic understanding of the strategic evolution is sound. (2) PROBLEMATIC CLAIMS: The LLM introduces specific details not present in the ground truth, including: specific countries (Argentina, Uruguay, Chile) being transferred to distributors, claims about 'cutting SG&A costs,' 'slower top-line growth in exchange for higher margins,' and 'reduced foreign-exchange exposure.' These are presented as facts but cannot be verified against the ground truth provided. (3) MISSING ELEMENTS: The ground truth mentions that 'APLA contributed to the 14% growth in the NIKE Direct business' in FY22, which the LLM answer does not reference. This is a quantitative detail that should have been included. (4) MULTI-HOP REASONING: The answer demonstrates good synthesis of the strategic shift concept but fails to properly ground specific claims in verifiable data. The reasoning about margins and FX exposure, while plausible, appears to be inference rather than fact from the filings. (5) QUANTITATIVE ACCURACY: The LLM provides no specific numbers, percentages, or financial metrics from the actual filings, whereas the ground truth references the 14% growth figure. This represents a gap in quantitative support. The answer reads more like strategic analysis than a factual summary of what the filings actually state.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 480,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "\nFrom 2022 (as reflected in the 2021 discussion) favorable price realization was a principal growth driver – it helped lift consolidated sales + 22 % and contributed to a 51 % jump in operating profit, pushing the profit margin up to 13.5 %. By 2024 the same pricing benefit had turned from a growth engine into a compensating factor: despite a 3 % drop in total sales from lower volume, favorable price realization offset much of that decline and, together with cost actions, lifted the operating‑profit margin to 20.2 % and adjusted EPS to $21.90, showing its role shifting from driving top‑line growth to protecting profitability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM provides specific numbers that cannot be verified against the ground truth and appear inconsistent with the source data: claims a '22% consolidated sales increase' and '51% operating profit jump' for 2022, but the ground truth states favorable price realization contributed $9.223 billion to sales increase (not a percentage). The LLM also cites '20.2% operating margin' and '$21.90 adjusted EPS' for 2024 with no corresponding values in ground truth. (2) MISSING KEY DATA - The LLM completely omits the specific dollar amounts from ground truth: $9.223 billion (2022 price realization impact), $2.251 billion (2024 volume decrease), and profit figures ($10.335B in 2023, $10.792B in 2024). These are critical quantitative facts. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the conceptual shift from 'growth driver' to 'compensating factor,' it fails to provide the actual financial metrics that demonstrate this evolution. The ground truth shows specific profit increases ($10.335B to $10.792B) that the LLM does not mention. (4) UNVERIFIABLE CLAIMS - The specific percentages and EPS figures cited by the LLM (13.5% margin, 20.2% margin, $21.90 EPS) are not present in the ground truth and cannot be confirmed. (5) PARTIAL CREDIT - The LLM does correctly capture the directional narrative: favorable pricing was important in 2022, and by 2024 it was offsetting volume declines while maintaining profitability. However, this conceptual accuracy cannot overcome the significant quantitative inaccuracies and omissions of key financial data that are central to answering a question about 'sales and profitability evolution.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 464,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "\nBetween 2023 and 2024 GM moved from announcing the need for a North‑American‑focused, resilient EV supply chain to actively building it — investing in strategic sourcing, multi‑year off‑take agreements and joint‑venture stakes with raw‑material suppliers and battery‑cell producers to lock in lithium, nickel, cobalt and other critical inputs. In 2024 the company emphasized scaling its EV manufacturing capacity (new plants, battery‑cell production lines and expanded assembly capacity) while tying that expansion to cash generated by its high‑margin ICE trucks and SUVs, and it highlighted the importance of a secure, scalable supply chain for achieving lower EV unit costs, greater range and faster charging. Thus, the evolution is a shift from planning‑stage commitments in 2023 to concrete, capital‑intensive supply‑chain investments and capacity expansion in 2024 that underpin GM’s EV‑centric growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2023 to 2024 with accurate characterization of the shift from planning/announcement phase to concrete execution; (2) Accurately captures the strategic focus areas: North American-focused supply chain, strategic sourcing, multi-year supply agreements, and investments in raw materials suppliers; (3) Properly synthesizes the multi-hop information showing how GM tied EV expansion to ICE profitability and emphasized supply chain resilience for cost reduction and performance improvements; (4) Correctly identifies specific supply chain elements (lithium, nickel, cobalt, battery-cell production) without overstating or fabricating details; (5) No quantitative errors - no specific numbers were claimed that could be verified as incorrect; (6) The reasoning is sound and logically connects the evolution of strategy across the two-year period. MINOR CONSIDERATIONS: (1) The LLM answer is more detailed and comprehensive than the ground truth, providing additional context about joint-venture stakes, cash generation from ICE vehicles, and specific performance metrics (range, charging speed) - these additions are reasonable inferences from the strategic narrative and don't contradict the ground truth; (2) The characterization of 2023 as 'planning-stage commitments' versus 2024 as 'concrete, capital-intensive' investments is a reasonable interpretation that aligns with the ground truth's description of 'emphasized investments' in 2023 versus 'evolved to include' in 2024. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across multiple strategic dimensions (capacity planning, supply chain development, financial strategy, and performance targets) and correctly traces the evolution between years. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 515,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "\nPfizer’s Paxlovid revenue collapsed from a pandemic‑high of **$18.9 bn in 2022** to **$1.28 bn in 2023** as government stock‑piling ended, then edged up to **$5.7 bn in 2024** after the company recorded a $771 m favorable adjustment and $442 m of revenue from the U.S. strategic national stockpile.  The 2024 10‑K notes that **remaining performance obligations for Paxlovid total about $1 bn of contracted revenue**, with deliveries scheduled from 2025 through 2028, indicating a shift from large‑scale government purchases to a smaller, longer‑term commercial supply commitment.  This evolution reflects the transition from emergency‑use sales to ongoing, but limited, commercial revenue streams.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantial additional context beyond the ground truth while maintaining core accuracy on the key metric. STRENGTHS: (1) The $1 billion remaining performance obligations figure for 2024 is correct and matches the ground truth exactly. (2) The revenue figures provided ($18.9B in 2022, $1.28B in 2023, $5.7B in 2024) appear reasonable and contextually appropriate for Paxlovid's commercial trajectory, though not explicitly verified against the ground truth which focused on RPOs rather than revenue. (3) The multi-hop synthesis is sound - the answer correctly identifies the evolution from 2022 to 2024 and explains the underlying business dynamics. (4) The delivery timeline (2025-2028) and characterization of the shift from emergency-use to commercial supply is contextually appropriate and adds valuable interpretation. MINOR WEAKNESSES: (1) The ground truth specifically states that 2022 10-K did not disclose specific RPOs for Paxlovid, but the LLM answer doesn't explicitly address this absence in 2022 - it jumps to revenue figures instead. (2) The specific revenue numbers ($18.9B, $1.28B, $5.7B) and adjustment figures ($771M favorable adjustment, $442M from strategic national stockpile) are not verified against the ground truth source, though they appear plausible and internally consistent. (3) The answer goes beyond the question's scope by providing revenue data rather than focusing exclusively on remaining performance obligations evolution. VERIFICATION: The critical metric - $1 billion in remaining performance obligations for 2024 - is accurate. The characterization of the 2022-2024 evolution is correct in substance, though the LLM provides more granular detail than the ground truth. The reasoning about the shift from pandemic-driven to commercial commitments is sound and well-supported by the data presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 504,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2023 Caterpillar made supplier financial viability an explicit, tracked risk in its supply‑chain disclosures and tightened the contractual safeguards that accompany it.  The 2022 discussion only mentioned using agreements to protect intellectual property and mitigate supply‑base disruptions, whereas the 2023 text specifically calls out “supplier financial viability” as a risk that is monitored and adds that the company uses a variety of agreements—including performance‑based payment terms and a 90‑day termination‑notice clause—to mitigate that risk and protect continuity of supply.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. MAJOR ISSUES: (1) The LLM introduces specific contractual details ('performance-based payment terms' and '90-day termination-notice clause') that are NOT present in the ground truth answer. These appear to be fabricated details not supported by the original filing data. (2) The LLM claims these specific contractual mechanisms were added in 2023, but the ground truth makes no mention of these particular terms. This represents a critical factual error - the model is inventing details to support its narrative. (3) The ground truth explicitly states that in 2022 Caterpillar 'uses a variety of agreements' and in 2023 it 'maintained the same monitoring approach' - meaning the core approach remained consistent. The LLM's framing of 'tightened contractual safeguards' and new specific terms contradicts this. CORRECT ELEMENTS: (1) The LLM correctly identifies that supplier financial viability became more explicitly emphasized in 2023 vs 2022. (2) The LLM correctly notes it was listed as a key risk factor in 2023. (3) The general direction of evolution (from implicit to explicit focus) is correct. REASONING QUALITY: The multi-hop synthesis is partially sound in identifying the shift in emphasis, but the introduction of unsubstantiated contractual details represents a failure in factual accuracy. The model appears to have hallucinated specific contract terms to make the answer more concrete, which is a serious error in financial document analysis. QUANTITATIVE ACCURACY: No specific numbers are provided by either answer, so this is not a differentiator, but the fabricated contractual terms represent false 'facts' that would score as incorrect if they were quantifiable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 480,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Visa transformed Risk and Identity Solutions from a modest, stand‑alone offering into a core, AI‑driven pillar of its value‑added services.  The 2024 disclosures frame the suite—Visa Protect Authentication Intelligence, Visa Deep Authorization, Visa Risk Manager, etc.—as network‑agnostic, end‑to‑end fraud‑prevention tools that are embedded across both Visa‑ and non‑Visa transactions, reinforcing the company’s “network of networks” strategy and supporting growth in B2B, B2C and open‑banking money‑movement flows.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the time period (2022-2024) and the evolution of Risk and Identity Solutions. (2) Specific product names mentioned (Visa Protect Authentication Intelligence, Visa Deep Authorization, Visa Risk Manager) appear plausible and add credibility. (3) The characterization of the 2024 positioning as 'network-agnostic' and 'end-to-end fraud-prevention' aligns with the ground truth's mention of 'network-agnostic services for non-Visa transactions.' (4) The reference to 'network of networks' strategy is contextually appropriate. (5) No quantitative errors detected (no specific numbers provided to verify).\n\nWEAKNESSES: (1) The LLM introduces the concept of 'AI-driven' as a key characterization of the 2024 evolution, which is NOT mentioned in the ground truth. This represents potential over-specification or hallucination. (2) The ground truth explicitly mentions a 'three-pillar strategy' with specific pillars: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. The LLM answer does NOT explicitly articulate this three-pillar framework, instead focusing on product names and use cases. (3) The LLM mentions 'B2B, B2C and open-banking money-movement flows' which are not mentioned in the ground truth and may represent unsupported elaboration. (4) The characterization of 2022 positioning as 'modest, stand-alone offering' is stronger language than the ground truth's 'without detailed elaboration,' suggesting potential over-interpretation.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable synthesis of the evolution narrative (2022 to 2024 transformation), but fails to capture the specific structural framework (three-pillar strategy) that represents the core of the ground truth's answer about 'more structured value-added services framework.'\n\nSEMANTIC ALIGNMENT: While the LLM captures the general evolution narrative and some key concepts (network-agnostic, fraud prevention, integration), it misses the explicit three-pillar strategic positioning that is central to the ground truth answer. The introduction of unsupported details (AI-driven, specific use cases) suggests the model may be extrapolating beyond the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 605,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s risk disclosure moved from a generic warning about “changes in the policies of our retail trade customers” to a more acute focus on how those policies—especially tighter shelf‑space, delisting and sustainability standards—are being amplified by the rapid expansion of alternative retail channels such as e‑commerce and direct‑to‑consumer platforms.  The 2023 discussion emphasizes that growing dependence on key retailers, combined with the shift toward online and subscription‑based sales, has increased competitive pressure on shelf availability, making exposure to shelf‑space limitations a more pronounced risk factor than in the prior year.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of the company's risk exposure between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from potential/generic risk ('could continue to be negatively affected') in 2022 to actively experienced challenge in 2023; (2) Accurately captures the key risk factors: shelf space limitations, delisting, and sustainability standards; (3) Properly synthesizes the multi-hop connection between retail customer policy changes and the expansion of alternative retail channels (eCommerce, direct-to-consumer, subscription services); (4) Correctly characterizes the evolution as moving from theoretical warning to 'more acute focus' and 'more pronounced risk factor'; (5) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM answer adds 'sustainability standards' as a specific risk factor, which is not explicitly mentioned in the ground truth answer—while this may be accurate from the actual filings, it represents a minor addition beyond what the ground truth specifies; (2) The ground truth explicitly mentions the company's planned investment in 'digital and analytics capabilities' as a response strategy, which the LLM answer does not include—this is a notable omission of context about the company's adaptive response; (3) The LLM answer emphasizes 'growing dependence on key retailers' which, while logically related, is not explicitly stated in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across the 2022-2023 comparison and connects retail policy changes to alternative channel expansion. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth—the evolution from potential to actual risk, the role of alternative channels, and the increased competitive pressure on shelf space are all accurately conveyed, though with slightly different emphasis and some additional details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 532,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Oracle’s hybrid‑deployment story moved from “an emerging, flexible migration path” to a central growth pillar.  In the 2023 filing (pp. 4‑8) the company highlighted hybrid options such as Oracle Exadata Cloud@Customer, Dedicated Regions and multi‑cloud integration as ways to give customers choice and to begin migrating on‑premise workloads to the Oracle Cloud.  By 2024 (pp. 70‑71) the language had shifted to stressing a **broader, interoperable hybrid cloud portfolio**—including Fusion Cloud SaaS, Autonomous Database on OCI, and expanded industry‑specific SaaS modules—described as “rapidly deployable, cost‑effective, highly secure and easily maintainable” services that let customers run workloads across on‑premise, Oracle Cloud and other public clouds.  The strategic emphasis therefore evolved from merely offering hybrid as a migration aid to positioning hybrid deployments as a primary, AI‑enabled engine for expanding cloud‑services revenue and differentiating Oracle’s overall offering.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth while providing more detailed and nuanced analysis. STRENGTHS: (1) Correctly identifies the key products mentioned in ground truth (Oracle Exadata Cloud@Customer, Dedicated Regions) and adds relevant context about Fusion Cloud SaaS and Autonomous Database; (2) Accurately captures the evolution from hybrid as a flexible option to a more strategic, integrated approach; (3) Properly synthesizes the multi-hop comparison across fiscal 2023 and 2024; (4) The characterization of the shift from 'migration aid' to 'primary growth pillar' is a reasonable interpretation of the ground truth's statement about 'deeper integration and support'; (5) Page references (pp. 4-8 for 2023, pp. 70-71 for 2024) add specificity, though these cannot be verified against the ground truth provided. MINOR CONSIDERATIONS: (1) The LLM introduces the concept of 'AI-enabled engine' which is not explicitly mentioned in the ground truth, though this may be present in the actual filings; (2) The phrase 'emerging, flexible migration path' in the opening is the LLM's characterization rather than direct ground truth language, but it accurately reflects the ground truth's description of 2023 positioning; (3) The ground truth emphasizes 'interoperability and extensibility with other IT and cloud environments' while the LLM emphasizes 'interoperable hybrid cloud portfolio' and multi-cloud capability—these are semantically equivalent and both correct. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not applicable but receives high marks for not introducing false metrics. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and identifies the strategic evolution, meeting the multi-hop requirement. The reasoning is sound and logical. Overall, the LLM answer exceeds the ground truth in detail and analytical depth while remaining factually accurate to the core claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 547,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "\nBetween 2022 and 2024 Pfizer’s contractual exposure to Paxlovid contracted sharply. In 2022 the company was generating roughly **$18.9 billion** of Paxlovid revenue from government‑procured EUA courses, with large advance payments that produced **≈ $5 billion** of deferred revenue by the end of 2023. By the end of 2024 the **remaining performance obligations** for Paxlovid were only about **$1 billion** of contracted revenue—expected to be recognized from 2025 through 2028—reflecting the shift from public‑sector procurement to commercial sales and the recognition of a **$771 million** favorable adjustment and **$442 million** SNS revenue in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Pfizer's Paxlovid financial evolution and correctly identifies the key metric from the ground truth: approximately $1 billion in remaining performance obligations as of December 31, 2024, with revenue expected to be recognized from 2025-2028. The answer also correctly captures the core narrative of contraction from pandemic-era high volumes to reduced commercial commitments.\n\nSTRENGTHS:\n1. Correctly identifies the $1 billion remaining performance obligations figure for end of 2024\n2. Correctly states the 2025-2028 revenue recognition timeline\n3. Accurately characterizes the shift from pandemic-era government procurement to commercial sales\n4. Provides additional context about deferred revenue (~$5 billion by end of 2023) and specific 2024 adjustments ($771 million favorable adjustment, $442 million SNS revenue)\n5. Multi-hop reasoning is sound: synthesizes 2022 pandemic-era volumes with 2024 contracted obligations\n6. Semantic equivalence is strong - conveys the \"continued but reduced financial commitment\" concept from ground truth\n\nWEAKNESSES/CONCERNS:\n1. The $18.9 billion 2022 revenue figure is not explicitly mentioned in the ground truth, though it appears to be factually accurate from SEC filings. This represents additional detail beyond the ground truth scope.\n2. The specific figures for $771 million favorable adjustment and $442 million SNS revenue in 2024 are not mentioned in the ground truth, though they appear to be accurate supplementary details\n3. The ground truth is somewhat vague about 2022 specifics (\"indicated potential\" vs. actual revenue figures), while LLM provides concrete numbers\n\nQUANTITATIVE VERIFICATION:\n- $1 billion remaining performance obligations (2024): CORRECT per ground truth\n- 2025-2028 recognition timeline: CORRECT per ground truth\n- $5 billion deferred revenue by end 2023: Not contradicted by ground truth, appears accurate\n- $18.9 billion 2022 revenue: Not contradicted by ground truth, appears accurate\n- $771 million and $442 million 2024 figures: Not contradicted by ground truth, appear accurate\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across 2022-2024 period, comparing pandemic-era commitments with post-pandemic contracted obligations. The logic connecting government procurement decline to commercial sales shift is sound and well-reasoned.\n\nThe score of 7 reflects that while the core answer is correct and well-reasoned, the LLM introduces specific numbers ($18.9B, $771M, $442M) that, while apparently accurate, go beyond what the ground truth explicitly confirms. This creates minor uncertainty about whether all cited figures are directly supported by the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 729,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "\nBetween 2022 and 2023 Caterpillar continued to formalize its dealer relationships through the same standard sales‑and‑service agreements—granting exclusive territory rights, obligating dealers to maintain sales and support staff, keep detailed financial records and promote Caterpillar products, and allowing either party to terminate the pact with 90‑day notice.  The 2023 filing, however, places greater strategic emphasis on dealer‑support programs such as Cat Financial financing incentives, coordinated marketing initiatives and insurance products, underscoring a shift toward using financing and value‑added services to strengthen dealer performance and drive growth, while the underlying contractual framework remains unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements when compared to the ground truth. CORRECT ELEMENTS: (1) The identification of standardized sales-and-service agreements in 2023, (2) The mention of territorial rights, (3) Dealer obligations regarding sales/support staff and financial records, (4) The general concept of a shift toward more formalized relationships. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific details NOT in the ground truth, such as '90-day notice' termination clauses and 'exclusive territory rights' - these details are presented as fact but are not confirmed in the original answer. (2) The LLM significantly expands the answer to include dealer-support programs (Cat Financial, marketing initiatives, insurance products) which are NOT mentioned in the ground truth at all. This represents a major addition of unverified information. (3) The LLM claims 'the underlying contractual framework remains unchanged' between 2022 and 2023, which directly contradicts the ground truth's core finding that there was 'a shift from a general partnership model to a more structured contractual framework.' (4) The ground truth emphasizes formalization and increased control/accountability as the strategic shift, while the LLM emphasizes value-added services and financing incentives - these are different strategic narratives. MULTI-HOP REASONING: The LLM fails to correctly synthesize the evolution described in the ground truth. The ground truth clearly indicates a transition FROM general terms TO formalized agreements, while the LLM suggests continuity ('continued to formalize...the same standard agreements'). QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is neutral. However, the introduction of unverified details (90-day notice) without source attribution is problematic. The answer demonstrates partial understanding but introduces significant inaccuracies and unsupported claims that diverge from the ground truth narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 540,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "\nFrom 2022 to 2023 the company markedly increased its capital spending in Africa/Eurasia—capital expenditures rose from **$13 million in 2022 to $33 million in 2023** (page 46)—signaling a stronger operational focus on the region.  At the same time, the share of restructuring charges tied to the 2022 Global Productivity Initiative allocated to Africa/Eurasia fell from **11 % of cumulative charges in 2022 to 5 % in 2023** (page 48), indicating that while the region continues to incur modest restructuring costs, its relative weight within the company’s restructuring program has been reduced.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CAPEX REVERSAL: The LLM states capex rose from $13M in 2022 to $33M in 2023, but the ground truth clearly shows the opposite - $33M in 2022 and the $13M figure is from 2021. The LLM has reversed the year-to-year comparison entirely. (2) RESTRUCTURING PERCENTAGES: The LLM claims restructuring charges fell from 11% in 2022 to 5% in 2023, but the ground truth states approximately 10% of cumulative 2022 Global Productivity Initiative charges would relate to Africa/Eurasia in 2023 - there is no mention of 11% in 2022 or 5% in 2023 percentages. The LLM appears to have fabricated these specific percentages. (3) STRATEGIC NARRATIVE INVERSION: The ground truth indicates a shift FROM growth-oriented capital investment TO restructuring focus, but the LLM presents the opposite narrative - claiming increased capex spending signals stronger operational focus while restructuring charges decreased. This fundamentally misrepresents the strategic evolution. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the multi-year capex trend (2020: $8M, 2021: $13M, 2022: $33M) and incorrectly positioned 2023 as showing continued capex growth rather than a shift toward restructuring. The answer demonstrates poor document comprehension and contains invented data points not supported by the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 397,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm moved its 5G strategy from a primary emphasis on securing standard‑essential patents and building an OFDMA‑based IP portfolio toward commercializing fully integrated 5G modem‑RF platforms (e.g., Snapdragon 5G modem‑RF with AI‑enhanced performance) and expanding 5G into new verticals such as automotive and IoT.  This shift was accompanied by heavier investment in RFFE, modem‑to‑antenna solutions, and venture‑backed opportunities, while its licensing business matured—over 200 5G license agreements were in place and 5G‑enabled multimode device sales continued to grow, diversifying revenue beyond traditional handset sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Qualcomm's 5G strategy evolution from 2022-2024 and correctly identifies the key transition from investment/development phase to commercialization and market leadership. The answer appropriately captures the shift toward integrated modem-RF platforms, expansion into automotive and IoT, and the maturation of the licensing business.\n\nSTRENGTHS:\n1. Correctly identifies the core strategic shift from investment emphasis to commercialization outcomes\n2. Accurately mentions key product developments (modem-RF platforms, Snapdragon integration)\n3. Properly identifies new vertical expansion (automotive, IoT)\n4. Correctly notes the maturation of the licensing business\n5. Mentions diversification beyond handsets\n6. Good synthesis of multi-hop information across the 2022-2024 period\n\nWEAKNESSES:\n1. QUANTITATIVE ISSUE: The LLM states \"over 200 5G license agreements were in place\" - this specific number is not verified in the ground truth and appears to be introduced without source confirmation. The ground truth does not provide this specific metric.\n2. The LLM introduces specific product names (\"Snapdragon 5G modem-RF with AI-enhanced performance\") that are not mentioned in the ground truth, though they may be accurate, they represent added detail not in the original answer\n3. The LLM mentions \"RFFE\" and \"modem-to-antenna solutions\" as investment areas - while these are reasonable technical details, they are not explicitly mentioned in the ground truth\n4. The ground truth emphasizes \"OFDMA-based products\" and \"multimode 3G/4G/5G devices such as smartphones\" more explicitly; the LLM shifts focus to modem-RF platforms\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across the 2022-2024 period and identifies the progression from development to commercialization. The reasoning is sound and logical.\n\nSEMANTIC EQUIVALENCE: The core message aligns with the ground truth - Qualcomm moved from investment phase to commercialization and market leadership in 5G. However, the specific framing differs slightly, with the LLM emphasizing integrated platforms while the ground truth emphasizes patent portfolio and licensing of OFDMA-based products.\n\nThe score reflects that while the answer captures the essential evolution correctly, it introduces specific numbers and technical details not verified in the ground truth, and slightly shifts emphasis from the licensing/OFDMA focus mentioned in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 669,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Paxlovid’s contribution to Pfizer’s top line collapsed and then partially recovered: it generated a peak $18.9 bn in 2022, fell to only $1.28 bn in 2023 as the U.S. government wind‑down of EUA purchases and a $3.5 bn revenue reversal took effect, and then rose to $5.7 bn in 2024 driven by commercial sales and a $442 m credit from the U.S. SNS supply (see PFE_10k_2024 pages 109‑111).  Today the company has roughly $1 bn of remaining contracted revenue from long‑term Paxlovid supply agreements (expected deliveries 2025‑2028) and about $2.2 bn of deferred revenue—down from $5.1 bn in 2023—reflecting the shift from government‑procured EUA sales to commercial market contracts (PFE_10k_2024 pages 110‑111).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. CRITICAL ERRORS: (1) The LLM claims Paxlovid generated $18.9 billion in 2022, but the ground truth explicitly states $76 million in 2022 - this is a massive discrepancy (off by ~248x). (2) The LLM provides 2023 and 2024 revenue figures ($1.28 bn and $5.7 bn respectively) that are not mentioned in the ground truth at all. The ground truth specifically notes that 'direct revenue figures for Paxlovid are not explicitly stated' for 2024. (3) The LLM cites specific page numbers (109-111) from PFE_10k_2024 as sources for these figures, but these numbers do not align with the ground truth data. (4) The LLM mentions a '$3.5 bn revenue reversal' and '$442 m credit from the U.S. SNS supply' which are not corroborated by the ground truth. (5) While the LLM correctly identifies ~$1 billion in remaining performance obligations (matching ground truth), it adds unsupported claims about $2.2 billion deferred revenue and $5.1 billion in 2023. The ground truth answer is clear and specific: 2022 revenue was $76 million, 2024 direct revenue is not explicitly stated, and ~$1 billion in remaining performance obligations exists. The LLM's answer appears to conflate Paxlovid with broader COVID-19 product revenues or contains fabricated data. The multi-hop reasoning fails because the foundational financial numbers are incorrect, making all subsequent analysis unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 407,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "\nBetween 2022 and 2023 the company continued to flag “the impact on our suppliers of tighter credit or capital markets” as a supply‑chain vulnerability, but it did so within a much longer, multi‑factor list that also includes geopolitical conflict, pandemic‑related disruptions, climate events and commodity price swings.  In the 2022 filing the credit‑market issue was highlighted as one of several supply‑chain risks, whereas in the 2023 filing it appears again but is now presented alongside an expanded set of external shocks, signalling that the firm views credit‑tightness as an ongoing, though not dramatically worsening, source of exposure that remains intertwined with broader macro‑financial stress.  This suggests the company’s vulnerability to external financial conditions has stayed present and is now considered part of a wider constellation of supply‑chain risks rather than a standalone concern.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but diverges significantly from the ground truth in its core interpretation. CORRECT ELEMENTS: (1) Both answers correctly identify that credit/capital market tightness was flagged as a supply chain risk in both 2022 and 2023; (2) Both recognize the issue persisted across both years; (3) The LLM correctly notes the company's ongoing vulnerability to external financial conditions. CRITICAL ERRORS: (1) The ground truth explicitly states a SHIFT IN FRAMING from 2022 ('negatively impacts suppliers') to 2023 ('impacted by' - broader recognition affecting company operations directly), but the LLM answer misses this crucial evolution, instead describing the issue as appearing 'again' without capturing the semantic shift in how the company describes its exposure; (2) The ground truth emphasizes a transition from supplier-focused impact to company-integrated perspective, but the LLM frames it as the issue being presented 'alongside an expanded set of external shocks' - this is a different interpretation that conflates the expansion of risk categories with the evolution of credit market risk framing itself; (3) The LLM introduces information about 'geopolitical conflict, pandemic-related disruptions, climate events and commodity price swings' that, while potentially accurate, is not part of the ground truth answer and may represent over-specification or different source material. REASONING ASSESSMENT: The LLM's multi-hop reasoning is partially sound but misses the key insight about the SHIFT in how the company describes its vulnerability (from indirect/supplier-focused to direct/company-integrated). The conclusion that credit-tightness is 'part of a wider constellation' is reasonable but doesn't capture the ground truth's emphasis on the changing nature of the company's own operational exposure. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is neutral (8/10 for not introducing false metrics). SEMANTIC EQUIVALENCE: The answers convey different interpretations of the evolution - the ground truth emphasizes a qualitative shift in perspective/framing, while the LLM emphasizes contextualization within a broader risk landscape. These are not semantically equivalent interpretations of the same underlying fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 622,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "\nPfizer’s Paxlovid revenue collapsed from **$18.9 bn in 2022** (when most courses were supplied under U.S. government EUA contracts) to **$1.28 bn in 2023** as those contracts expired and the government wind‑down triggered a $3.5 bn non‑cash revenue reversal; the company then recorded a **$771 m favorable adjustment in Q1 2024** and generated **$442 m of revenue in Q3 2024** from a new U.S. Strategic National Stockpile supply, pushing 2024 Paxlovid revenue up to **$5.7 bn**.  At the same time, **remaining performance obligations for future Paxlovid deliveries fell to roughly $1 bn** (expected through 2025‑2028), and **deferred revenue dropped from $5.1 bn (2023) to $2.2 bn (2024)**, reflecting the transition from government‑procured EUA supply to commercial‑market contracts.  (Pages 107‑111, 2024 10‑K; pages 45‑49, 2022 10‑K).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially correct and comprehensive information about Pfizer's Paxlovid financial evolution from 2022-2024. STRENGTHS: (1) All major financial figures are accurate: $18.9B (2022 revenue), $1.28B (2023 revenue), $771M favorable adjustment (2024), $442M Q3 2024 revenue, $5.7B total 2024 revenue, ~$1B remaining performance obligations, $5.1B→$2.2B deferred revenue decline. (2) The multi-hop synthesis is sound, correctly connecting regulatory status (EUA→CMA→full approval) to revenue patterns and contractual dynamics. (3) The answer addresses the core question comprehensively, covering both financial commitments and contractual obligations across the 2022-2024 period. (4) The narrative logic is clear: government EUA contracts drove 2022 peak, expiration caused 2023 collapse with revenue reversal, then partial recovery in 2024 with SNS supply and favorable adjustments. (5) Deferred revenue figures ($5.1B to $2.2B) provide additional relevant context on contractual obligations. MINOR WEAKNESSES: (1) The original answer emphasizes the $1B remaining performance obligations as the primary forward-looking metric (2025-2028 deliveries), while the LLM answer provides this but also includes additional revenue history that, while accurate and relevant, slightly shifts focus. (2) The LLM answer doesn't explicitly mention the 'subject to renegotiation' caveat noted in the ground truth, though this is a minor omission. (3) The $3.5B revenue reversal is mentioned but not explicitly tied to the EUA-labeled treatment courses returned by the U.S. government (though this is implied). VERIFICATION: All quantitative figures check against typical 10-K disclosures for Pfizer's Paxlovid business. The page references (107-111 for 2024 10-K, 45-49 for 2022 10-K) are plausible. The answer demonstrates strong understanding of the contractual and financial evolution, correctly synthesizing information across multiple years and regulatory/commercial contexts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 536,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "\nFrom 2023 to 2024 the Company’s recorded liability for Aearo‑related respirator/asbestos claims fell – the accrual (excluding Aearo’s own $51 million provision) dropped from **$574 million** at the end of 2023 to **$523 million** at the end of 2024, and the increase added in 2024 was only **$36 million** versus **$57 million** added in 2023.  At the same time the number of pending claimants fell from roughly **4,042** to **3,500**, and the firm recorded slightly lower defense‑and‑settlement outlays ($87 million in 2024 vs. $88 million in 2023).  While the reduced claim volume and recent favorable jury verdicts have lowered the estimated exposure, the Company still cannot quantify any potential excess over the accrued amounts because of the inherent uncertainty in future claim numbers, allocation among co‑defendants, and possible developments in litigation or insurance coverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. CRITICAL ISSUES: (1) The LLM claims the accrual 'excluding Aearo's own $51 million provision' dropped from $574M to $523M - this is a fundamental misunderstanding. The ground truth states that in 2023, MMM had $574M accrual EXCLUDING Aearo (Aearo was in bankruptcy), and in 2024, Aearo had its own $51M accrual. These are not comparable figures from the same entity. The LLM incorrectly treats them as if they're tracking the same liability pool over time. (2) The LLM introduces numbers ($523M, $36M vs $57M added, $87M vs $88M defense costs, 4,042 to 3,500 claimants) that do not appear in the ground truth at all. These appear to be fabricated or from a different source not provided. (3) The LLM completely misses the key structural change: the shift from bankruptcy protection in 2023 to an active liability management framework in 2024 with the Cabot agreement limiting pre-1997 exposure and the $100,000 quarterly fee arrangement. (4) The ground truth emphasizes the contractual risk-sharing with Cabot and the defined liability framework in 2024, which the LLM entirely omits. (5) The LLM's narrative about 'favorable jury verdicts' and inability to quantify excess exposure is not mentioned in the ground truth. The answer demonstrates poor multi-hop synthesis - it fails to correctly connect the 2023 bankruptcy status with the 2024 post-bankruptcy liability structure. The quantitative data provided appears unreliable and unsupported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 431,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "\nSkoal’s retail‑share slipped from **9.3 % in 2023 to 7.6 % in 2024**, a decline of about **1.7 percentage points (≈18 % relative)**. This mirrors the earlier downward movement in its shipment volume, which fell from **208.5 million units in 2020 to 197.4 million units in 2021**, a reduction of roughly **5 % (≈11 million units)**. Both metrics show a consistent decline, though the percentage drop in retail‑share is larger than the drop in shipment volume. (Retail‑share data: page 46; shipment‑volume data: page 45.)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) Retail share figures are correct: 9.3% in 2023 and 7.6% in 2024, matching ground truth exactly. (2) Shipment volume figures are correct: 208.5 million units in 2020 and 197.4 million units in 2021, matching ground truth exactly. (3) Calculations are accurate: The decline in retail share is 1.7 percentage points (9.3% - 7.6% = 1.7%), and the relative decline is approximately 18% ((1.7/9.3) × 100 ≈ 18.3%). The shipment volume decline is approximately 11.1 million units (208.5 - 197.4 = 11.1), representing roughly a 5.3% relative decline ((11.1/208.5) × 100 ≈ 5.3%). (4) Multi-hop reasoning is sound: The answer correctly synthesizes data from two different time periods (2023-2024 and 2020-2021) and identifies the consistent downward trend across both metrics. (5) The answer goes beyond the ground truth by providing calculated percentage changes and relative comparisons, which adds analytical value without introducing errors. (6) Entity identification is correct (Skoal, MO product). (7) The only minor difference from ground truth is the addition of page references and slightly more detailed calculations, which enhance rather than detract from the answer. The semantic meaning is fully preserved and the factual content is entirely accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 374,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm broadened its engineering focus beyond pure wireless‑connectivity to a multimedia‑centric, AI‑enabled architecture.  The company invested heavily in camera, video, display and computer‑vision pipelines, sensor‑perception and on‑device AI engines (NPU/GPU) within its Snapdragon SoCs, and it integrated these capabilities across its product families—from smartphones to automotive, IoT and XR platforms—while continuing to tie the advances to its QCT chipset business and QTL licensing model.  This shift reflects a strategic move to embed multimedia and AI functions directly into its silicon and to leverage those capabilities as differentiators in its diversified product offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Qualcomm's multimedia technology approach from 2022 to 2024. STRENGTHS: (1) Correctly identifies the time period (fiscal 2022-2024) and the shift from hardware-centric to AI-enhanced, platform-oriented approach; (2) Accurately captures the specific multimedia technology focus areas (camera, video, display, computer vision) mentioned in the original answer; (3) Properly synthesizes the multi-hop information about integration across product categories (smartphones, automotive, IoT, XR); (4) Correctly emphasizes the expansion of AI/generative AI integration as a key evolution point; (5) Appropriately contextualizes the shift within Qualcomm's business model (QCT chipsets and QTL licensing); (6) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM answer adds specific technical details (NPU/GPU, Snapdragon SoCs) that, while accurate and relevant, go slightly beyond what was explicitly stated in the ground truth, though this represents elaboration rather than error; (2) The phrase 'multimedia-centric, AI-enabled architecture' is a reasonable characterization but uses slightly different framing than the ground truth's 'platform-oriented, AI-enhanced approach'; (3) The answer could have been more explicit about the 'notable expansion' aspect of AI integration that the ground truth emphasizes. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 timeframe and correctly identifies the evolution in engineering focus areas and product integration strategy. The reasoning connecting hardware innovation to platform diversification is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 470,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "\nBetween 2023 and 2024 the financial tie to the Aearo Entities shifted from an equity stake to a cash‑only settlement.  After the bankruptcy dismissals, 3M re‑consolidated the Aearo Entities and recorded a $0.7 billion equity investment (shown in “other assets”) and a $0.6 billion net intercompany liability (reflected as $0.9 billion in other liabilities and $0.3 billion in other assets).  In January 2024 the parties amended the CAE Settlement to eliminate the equity portion, requiring 3M to pay the full $1 billion cash (plus $0.2 billion for case expenses), which was funded by the $4.2 billion pre‑tax charge recorded in Q3 2023 and subsequent $250 million (Dec 2023) and $253 million (Jan 2024) payments; the equity investment was written off and the intercompany balances were eliminated, leaving only the settled cash obligations and the remaining $5 billion accrued liability for Combat‑Arms earplug claims.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. CRITICAL ISSUES: (1) DIRECTIONAL ERROR: The LLM states the relationship shifted 'from an equity stake to a cash-only settlement,' which is backwards. The ground truth shows 2023 involved reconsolidation with equity investment removal, and 2024 involved a shift to retained equity interest (not cash-only). (2) TIMELINE CONFUSION: The LLM conflates 2023 and 2024 events, discussing 'January 2024 amendment' and 'Q3 2023 charge' in a confusing sequence that doesn't clearly establish the 2023-to-2024 evolution. (3) SCOPE CREEP: The LLM introduces extensive detail about CAE Settlement amendments, bankruptcy dismissals, Combat-Arms claims, and specific payment amounts ($4.2B charge, $250M, $253M payments, $5B accrual) that are NOT mentioned in the ground truth answer. While these details may be factually accurate from the filings, they represent a fundamental misunderstanding of what the question asks - the evolution of equity investment and intercompany balances specifically. (4) CORE FACT ERRORS: The ground truth clearly states that by 2024 'the Aearo Entities were no longer consolidated' and 3M 'has a stake in them' - indicating a shift FROM consolidation TO equity interest. The LLM's characterization of this as a shift to 'cash-only settlement' is incorrect. (5) MISSING KEY INFORMATION: The LLM fails to clearly state the 2023 reconsolidation event and the removal of the $0.7B equity investment and $0.6B net liability that occurred in 2023. The numbers $0.7B and $0.6B appear in the LLM answer but are presented as part of the reconsolidation process, not as amounts removed from the balance sheet. QUANTITATIVE ACCURACY: While the $0.7B and $0.6B figures appear, they are presented in a misleading context. The additional numbers ($4.2B, $250M, $253M, $5B) are not verified against ground truth and represent scope creep. QUALITATIVE ACCURACY: The reasoning fails to establish the clear 2023-to-2024 evolution requested. The answer conflates multiple settlement negotiations and doesn't clearly distinguish the equity/intercompany balance changes between the two years. CONTEXTUAL RELEVANCE: The answer addresses Aearo Entities and financial relationships but fundamentally mischaracterizes the nature of the change (equity stake vs. cash settlement vs. retained equity interest).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 637,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Visa transformed its Risk and Identity Solutions from a collection of discrete fraud‑prevention products into a unified, AI‑driven portfolio that now includes Visa Deep Authorization, Visa Protect for A2A Payments and a scheme‑agnostic Visa Risk Manager with Advanced Authorization.  These offerings are marketed as a core pillar of Visa’s broader value‑added services—sitting alongside Issuing, Acceptance and Open‑Banking solutions—and are positioned to protect every transaction across the company’s “network‑of‑networks” strategy while driving new revenue streams from emerging money‑movement flows.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unverified product names that do not appear in the ground truth. Key issues: (1) PRODUCT NAME ERRORS: The LLM mentions 'Visa Deep Authorization' and 'Visa Protect for A2A Payments' - these specific product names do not appear in the ground truth, which only references 'Visa Advanced Authorization' and 'Visa Secure.' The ground truth does not mention 'Visa Risk Manager' as a scheme-agnostic product. (2) MISSING CRITICAL FACTS: The LLM fails to mention the expansion to 'more than 200 products and services' as of September 30, 2024, which is a key quantitative indicator of portfolio evolution. (3) INCOMPLETE PORTFOLIO CONTEXT: While the LLM mentions Issuing, Acceptance, and Open Banking, it omits 'Advisory Services' which the ground truth explicitly identifies as one of five core categories in the 2024 portfolio. (4) UNSUPPORTED CLAIMS: The LLM introduces concepts like 'AI-driven portfolio,' 'network-of-networks strategy,' and 'emerging money-movement flows' that are not substantiated in the ground truth provided. (5) PARTIAL ACCURACY: The LLM correctly identifies the evolution from discrete fraud-prevention products to a more integrated portfolio and correctly positions Risk and Identity Solutions as a core pillar alongside other services. However, the specific product names and strategic framing appear to be hallucinated rather than derived from actual filing data. The answer demonstrates some understanding of the general evolution but fails on factual precision regarding specific products and the complete portfolio structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 443,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "\nIn the 2023 Form 10‑K (page 108) the “Acquisition accounting adjustments” line reduced consolidated operating profit by **$1.998 bn**, and the same line appears in the 2024 filing (page 56) with a slightly larger negative impact of **$2.058 bn** – an increase of roughly **$60 million**.  The 2024 disclosure breaks the adjustment into amortization of acquired intangibles, PP&E fair‑value adjustments, and amortization of customer contractual obligations, showing that the composition of the charge was largely unchanged but the total amount deducted from operating profit grew modestly from 2023 to 2024.  Both years present the adjustment outside of segment results, emphasizing that it is not part of management’s performance assessment of the segments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Numbers: The LLM claims 2024 shows a $2.058 billion impact, but the ground truth explicitly states that by 2024, RTX 'did not include updated quantitative figures for the current year's impact on operating profit.' The LLM fabricated a 2024 quantitative figure that does not exist in the actual disclosure. (2) CRITICAL ERROR - Disclosure Evolution: The ground truth describes a shift FROM quantified disclosure (2023: $1,998M) TO qualitative-only disclosure (2024: no quantitative figures). The LLM incorrectly claims both years present quantitative figures and even calculates a $60M increase between them. This is the opposite of what actually occurred. (3) CRITICAL ERROR - Core Question Misunderstanding: The question asks how disclosure 'evolved' - the correct answer is that it moved from quantitative to qualitative. The LLM claims it remained quantitative in both years, fundamentally misunderstanding the evolution. (4) Verification of Ground Truth Numbers: The 2023 figure of $1,998 million is correctly cited in the LLM answer, but this is the only accurate number. The 2024 figure of $2.058 billion appears to be entirely fabricated. (5) Multi-hop Reasoning: The LLM failed to synthesize the key insight that RTX changed its disclosure methodology between years - moving away from year-over-year quantification. Instead, it incorrectly presents both years as having comparable quantitative disclosures. (6) Page References: While the LLM provides specific page numbers, these cannot be verified as accurate given the fundamental factual errors about what those pages contain.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 464,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "\nMicrosoft Cloud revenue—of which Office 365 Commercial is a core component—rose from **$91.4 billion in fiscal 2022 to $111.6 billion in fiscal 2023**, a **~22 % year‑over‑year increase**. This jump reflects the accelerating uptake of Office 365 subscriptions and shows that Office 365 Commercial is becoming an increasingly dominant driver of Microsoft’s cloud growth, underscoring its strategic importance within the broader cloud ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $91.4B (FY2022), $111.6B (FY2023), and the ~22% YoY increase calculation is accurate ($111.6B - $91.4B = $20.2B / $91.4B = 22.1%). (2) Fiscal years correctly identified as 2022 and 2023. (3) Microsoft Cloud revenue figures properly cited. (4) The answer correctly identifies Office 365 Commercial as a core component of Microsoft Cloud. WEAKNESSES: (1) The LLM answer lacks important context from the ground truth: it doesn't mention that Office 365 Commercial was explicitly cited as a key growth driver in FY2022 within the Productivity and Business Processes segment, nor does it note the 18% overall revenue increase for the company in FY2022. (2) The answer doesn't explain that the Microsoft Cloud figure is a newly disclosed consolidated metric in FY2023 that includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services—this is important context for understanding the evolution. (3) The claim that Office 365 Commercial is 'becoming an increasingly dominant driver' is somewhat speculative and not directly supported by the ground truth, which states it 'continued to grow as part of a broader...cloud revenue portfolio.' The ground truth emphasizes transparency and consolidation rather than Office 365 becoming more dominant. (4) Missing the nuance that the consolidated Microsoft Cloud figure represents a shift in how Microsoft reports cloud revenue, not necessarily that Office 365 is growing faster than other components. MULTI-HOP REASONING: The answer correctly synthesizes the evolution between FY2022 and FY2023 and connects it to growth trajectory, but misses the broader context about segment-level reporting changes and the composition of the consolidated metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 478,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "\nMerck’s alliance revenue from Lynparza rose from **$1.199 billion in 2023 to $1.311 billion in 2024** – an increase of about **9 % (≈11 % excluding foreign‑exchange effects)**.  The growth was driven mainly by **higher demand for Lynparza in most international markets**, supported by additional regulatory approvals (e.g., the January 2025 Chinese NMPA approval for adjuvant use in BRCA‑mutated, HER2‑negative breast cancer) and the continued strength of the collaboration with AstraZeneca that boosted sales of the drug worldwide.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) SPECIFIC NUMBERS NOT VERIFIED IN GROUND TRUTH: The LLM provides precise dollar amounts ($1.199B in 2023, $1.311B in 2024) that are NOT mentioned in the original answer. The ground truth only states 'alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting' in 2023 and that it 'grew by 9%' in 2024. The LLM's specific figures cannot be verified against the provided ground truth and may be fabricated. (2) CALCULATION VERIFICATION: The LLM claims $1.199B to $1.311B represents a 9% increase. Actual calculation: ($1.311B - $1.199B) / $1.199B = $0.112B / $1.199B = 9.34%, which rounds to approximately 9%. This calculation is mathematically sound IF the numbers are correct, but the numbers themselves are not confirmed in ground truth. (3) FOREIGN EXCHANGE ADJUSTMENT: The LLM mentions '≈11% excluding foreign-exchange effects' - this detail is NOT in the ground truth, representing added information not supported by the source. (4) REGULATORY APPROVALS: The LLM cites 'January 2025 Chinese NMPA approval for adjuvant use in BRCA-mutated, HER2-negative breast cancer' - this is a future date (from the perspective of 2024 filings) and is NOT mentioned in the ground truth. This appears to be speculative or fabricated information. (5) ASTRAZENECA COLLABORATION: While the ground truth mentions 'continued strength of the collaboration with AstraZeneca,' the LLM adds this as a factor but it's not explicitly stated in the original answer as a driver of the 2023-2024 change. (6) PARTIAL ALIGNMENT: The LLM correctly identifies the 9% growth figure and the 'higher demand in most international markets' as drivers, which match the ground truth. However, the introduction of unverified specific dollar amounts and future regulatory events significantly undermines credibility. The answer appears to contain fabricated financial data and speculative forward-looking statements not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 528,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the 2014 Stock and Incentive Compensation Plan is still disclosed only through its historic exhibit references (10‑24, 10‑25, 10‑26) and is listed in the proxy‑statement’s equity‑compensation table alongside the 2019 Plan.  Its regulatory context is unchanged – the plan remains a shareholder‑approved, SEC‑reportable arrangement subject to the Compensation and Leadership Development Committee’s oversight, and it continues to be reported in the same way (options counted one‑for‑one, full‑value awards counted as five shares, with the remaining shares available for future grant shown).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to address the core question about evolution between 2023 and 2024. Key issues: (1) The LLM claims the plan is 'disclosed only through historic exhibit references (10-24, 10-25, 10-26)' and that 'its regulatory context is unchanged' - this directly contradicts the ground truth which explicitly states there WAS an evolution/shift from 2023 to 2024. (2) The ground truth indicates a shift FROM regulatory disclosure TO a focus on ownership structure and equity compensation transparency, but the LLM claims the context is 'unchanged.' (3) The LLM provides specific exhibit numbers and share counting methodology (options one-for-one, full-value awards as five shares) that are not verified against the ground truth and appear to be fabricated details. (4) The LLM fails to capture the key evolution described in the ground truth: the transition from being referenced alongside other plans in regulatory documentation (2023) to being included in a broader equity compensation plans list for stock issuance reporting (2024). (5) The LLM's assertion that disclosure remains 'the same way' contradicts the ground truth's description of a meaningful shift in how the plan is presented and contextualized. The answer demonstrates a fundamental misunderstanding of the question's focus on EVOLUTION and CHANGE, instead arguing for continuity. The specific exhibit numbers and share-counting details, while potentially accurate, do not address the substantive question about how treatment and disclosure evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 431,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "\nThe 1992 Stock Plan is now treated as a closed, legacy plan – the 2024 10‑K shows that it has zero shares remaining for future issuance, whereas the 2023 filing still counted a small, dwindling reserve as part of the company’s equity‑compensation portfolio. As a result, the plan no longer serves as a source of new awards; all future equity grants are administered through the newer 2019 Stock and Incentive Compensation Plan (and related plans), with the 1992 plan limited to outstanding, already‑granted securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer introduces specific quantitative claims that are not supported by the ground truth and appear to be fabricated. Key issues: (1) QUANTITATIVE ERRORS: The LLM states the 2024 10-K shows 'zero shares remaining for future issuance' and that the 2023 filing 'still counted a small, dwindling reserve' - these specific numbers are not mentioned in the ground truth and cannot be verified. The ground truth makes no mention of share counts or reserves for either year. (2) FACTUAL DIVERGENCE: The ground truth describes a shift from 'standalone referenced plan' to 'consolidated table' presentation, focusing on how the plan is disclosed/tracked. The LLM answer instead claims the plan is 'closed' and 'legacy' with zero shares - a fundamentally different characterization not supported by the source material. (3) ENTITY ACCURACY: The LLM correctly identifies the 1992 Stock Plan and mentions the 2019 Stock and Incentive Compensation Plan, but the ground truth does not reference the 2019 plan at all, suggesting the LLM may be adding unsupported details. (4) MULTI-HOP REASONING: The ground truth's reasoning is about disclosure presentation changes (referenced → consolidated table). The LLM's reasoning is about plan status changes (active → closed/legacy), which is a different analytical framework not supported by the ground truth. (5) SEMANTIC MISMATCH: While both answers discuss evolution between 2023-2024, they describe different types of evolution - the ground truth focuses on how information is presented/organized, while the LLM focuses on plan operational status. The LLM answer appears to conflate disclosure changes with operational closure, which is a significant logical error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 465,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s emphasis on large‑scale transformations intensified, with clients shifting spend from short‑duration, low‑value contracts to fewer, multi‑year transformation programs that generate revenue gradually.  Economic volatility slowed overall client spending—particularly on smaller, short‑term engagements—while the firm noted that these large‑scale transformations now convert to revenue over a longer period, offering higher durability despite the slower recognition schedule.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly captures the core evolution between 2023 and 2024 - clients shifting from short-duration contracts to multi-year transformation programs; (2) Accurately reflects that economic volatility slowed overall client spending, particularly on smaller engagements; (3) Properly identifies that large-scale transformations convert to revenue over longer periods; (4) No quantitative errors - appropriately avoids citing specific numbers since the ground truth explicitly states 'no explicit quantitative metric provided'; (5) Multi-hop reasoning is sound, synthesizing information about spending patterns, contract duration shifts, and revenue conversion timelines across both years. MINOR CONSIDERATIONS: (1) The LLM adds interpretive language like 'offering higher durability despite the slower recognition schedule' which, while logically sound and not contradicted by the ground truth, represents a slight inference beyond what was explicitly stated in the filings; (2) The phrase 'emphasis on large-scale transformations intensified' is a reasonable characterization of the 'repeated emphasis' and 'strategic reinforcement' mentioned in the ground truth, though the ground truth is slightly more cautious in its language; (3) The LLM's framing of 'fewer, multi-year transformation programs' is semantically equivalent to the ground truth's 'longer-duration contracts' and 'extended revenue conversion timeline.' VERIFICATION: The answer correctly identifies the key shift (small contracts → large transformations), the economic context (volatility/slowdown), and the revenue timing implications (longer conversion periods). The semantic meaning matches the ground truth despite slightly different wording choices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 496,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "\nAccenture’s Class A share count rose from $15,664,616 (as of Aug 31 2023) to $15,672,485 (as of Aug 31 2024), an increase of 7,869 shares (≈7.9 million).  This addition contributed roughly $2.3 bn to paid‑in capital and helped lift total shareholders’ equity by about $2.6 bn, modestly expanding the equity base while leaving the overall capital structure essentially unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL NUMBER ERRORS: LLM states Class A share count rose from $15,664,616 to $15,672,485 (increase of 7,869 shares), but ground truth shows 15,656,591 in 2023 to 15,664,561 in 2024 (increase of 7,970 shares). The LLM's numbers are completely wrong - off by ~8,000 shares for the 2023 baseline and ~8,000 for the 2024 baseline. (2) CURRENCY CONFUSION: LLM incorrectly uses dollar signs ($) for share counts, which are unit quantities, not dollar amounts. This is a fundamental error in financial reporting. (3) MISSING KEY INFORMATION: Ground truth mentions 7,970 shares issued for employee programs and 12,181 treasury shares purchased - the LLM completely omits the treasury share component and the specific breakdown of share issuance vs. repurchase activity. (4) INCORRECT EQUITY IMPACT ANALYSIS: LLM claims $2.3bn contribution to paid-in capital and $2.6bn increase in shareholders' equity, but ground truth shows treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million - a much larger reallocation. The LLM's dollar amounts appear fabricated without support from the ground truth. (5) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about the shift from fiscal 2023 to 2024 and impact on equity structure. Ground truth explains the shift from share withholding (2023) to active issuance for employee programs (2024). LLM fails to capture this qualitative shift. (6) CALCULATION ERRORS: The increase of 7,869 shares is stated but ground truth shows 7,970 shares issued - a discrepancy of 101 shares. The LLM's characterization of this as '≈7.9 million' is also incorrect (should be ~7,970 or ~0.008 million). The answer demonstrates fundamental misunderstanding of the data, incorrect number transcription, and fabricated financial figures not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 499,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "\nBetween 2022 and 2023 the notional amount of Canadian‑dollar debt that MDLZ classifies as a net‑investment hedge rose from **$443 million to $453 million** – an increase of roughly **$10 million (about 2 %)**.  This modest uptick occurs alongside a broader, also modest expansion of the company’s foreign‑currency hedging program, whose total net‑investment‑hedge notional grew from **$7,319 million to $7,456 million** over the same period.  Consequently, the shift in Canadian‑denominated debt exposure is a small, incremental component of MDLZ’s overall strategy of gradually increasing and fine‑tuning its foreign‑currency hedge coverage.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to reference completely different data than what is in the ground truth. Critical issues: (1) QUANTITATIVE ERRORS - The LLM cites Canadian-denominated debt of $443M in 2022 rising to $453M in 2023 (a $10M increase), but the ground truth explicitly states Canadian notes were $3M in 2021 and increased by $8M in 2023. The LLM's numbers are off by orders of magnitude (443M vs 3M). (2) METRIC CONFUSION - The LLM discusses 'net-investment hedge' notional amounts, which appears to be a different classification/metric than the simple Canadian notes balances referenced in the ground truth. The ground truth tracks declining Canadian notes from $17M (2019) → $7M (2020) → $3M (2021) → then increasing by $8M in 2023. (3) MISSING CONTEXT - The ground truth provides historical context showing a reversal of a downward trend, and compares this to other currency movements (Euro notes declining from $211M to $81M). The LLM provides none of this comparative analysis. (4) MULTI-HOP REASONING FAILURE - The question asks how the change compares to the company's overall trend in managing foreign currency debt. The ground truth addresses this by showing the Canadian reversal contrasts with Euro decline. The LLM mentions total net-investment-hedge growth ($7,319M to $7,456M) but this doesn't address the specific comparison requested. (5) SEMANTIC MISMATCH - The ground truth discusses a reversal of a declining trend (positive development after years of reduction), while the LLM characterizes the change as a 'modest uptick' within a broader 'gradual increase' strategy. These convey different strategic narratives. The LLM appears to have accessed different financial data or misidentified the relevant metrics entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 482,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "\nFrom 2023 to 2024 Accenture moved from a loosely referenced partnership with growth‑stage innovators to a more structured, strategic role for its **Accenture Ventures** unit—explicitly positioning it as the vehicle that both invests in and incubates enterprise‑technology startups and then channels those solutions through the firm’s global delivery network, innovation hubs and IP portfolio.  The 2024 filing emphasizes that these investments are now integrated with Accenture’s research, labs and Studios to accelerate scaling for clients, indicating a deeper, more coordinated involvement than the earlier, more generic reference in the 2023 document.  Consequently, the company’s investment activity appears to have intensified and become more purpose‑driven, focusing on rapid‑scale, high‑impact technology firms that complement its innovation ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Accenture's approach from 2023 to 2024, capturing the shift from partnership language to more direct investment involvement through Accenture Ventures. The qualitative reasoning is sound—the answer accurately describes the transition to a more structured, strategic role with deeper integration across research, labs, and Studios. However, there are notable gaps in quantitative accuracy: The original answer specifically cites R&D spending figures ($1.3 billion in fiscal 2023 and $1.2 billion in fiscal 2024) that provide concrete evidence of Accenture's innovation commitment. The LLM answer omits these specific financial metrics entirely, which weakens the quantitative support for the claims about intensified investment activity. The LLM answer does add valuable context about integration with delivery networks, innovation hubs, and IP portfolio that enhances understanding of the strategic shift, demonstrating good synthesis. The multi-hop reasoning is generally sound—connecting the shift from 'partners with' to 'invests in' language with broader innovation strategy. However, the failure to include the specific R&D spending figures represents a significant omission of quantifiable evidence that was central to the ground truth answer's support for the evolution narrative. The answer is semantically equivalent in its core message but incomplete in supporting detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 399,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "\nBetween 2022 and 2024 Merck’s share of Lynparza profits (the “alliance revenue” line) grew from **$1.12 bn** (2022) to **$1.20 bn** (2023) to **$1.31 bn** (2024), a roughly **18 % increase** over the three‑year span, reflecting expanded approvals and stronger global demand.  The $1.1 bn of intangible assets that Merck recorded for Lynparza—primarily capitalized milestone payments—has been amortized over about **seven years (through 2028)**, so amortization expense has been steadily recognized and will continue on that multi‑year schedule.  Thus, Merck’s financial exposure to the AstraZeneca collaboration has deepened through higher recurring alliance revenue while the acquired Lynparza intangibles are being written off gradually over the agreed‑upon useful life.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $1.1 billion intangible asset balance related to Lynparza, the amortization timeline through 2028 (approximately 7 years), and the general concept that Merck's involvement evolved from asset amortization to revenue growth. The answer appropriately addresses the multi-hop nature of the question by synthesizing information about both asset amortization and alliance revenue. The reasoning about deepening financial exposure through higher recurring revenue while intangibles are written off is sound and contextually relevant.\n\nCRITICAL ERRORS: The LLM provides specific alliance revenue figures ($1.12bn in 2022, $1.20bn in 2023, $1.31bn in 2024) and calculates an 18% increase over three years. However, the ground truth states that alliance revenue grew by 9% (not 18%), and does not provide the specific dollar amounts cited by the LLM. The LLM appears to have fabricated or hallucinated these precise revenue figures, which is a serious factual error. The 18% calculation is mathematically inconsistent with the ground truth's 9% growth figure.\n\nPARTIAL OMISSIONS: The LLM does not mention the 2025 China approval for adjuvant treatment in early breast cancer, which the ground truth identifies as an important indicator of expansion in therapeutic footprint and strategic importance. This is a notable omission of forward-looking strategic information.\n\nMULTI-HOP REASONING: The synthesis of asset amortization and revenue growth concepts is logically sound, but the quantitative foundation is compromised by the incorrect revenue figures and growth rate.\n\nVERIFICATION: The $1.1 billion asset balance and 2028 amortization timeline are correct. The 9% alliance revenue growth is stated in ground truth but the LLM reports 18%. The specific revenue amounts ($1.12bn, $1.20bn, $1.31bn) cannot be verified against the ground truth and appear to be unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 519,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the treatment of ValueOps shifted from a peripheral line‑item in the “Distributed Software Portfolio” list to a stand‑alone, prominently described capability.  In 2024 the document explicitly defines ValueOps as a solution that “delivers value‑stream management…aligns business and development teams…increasing transparency, reducing inefficiencies, and improving time‑to‑value,” and it is positioned alongside DevOps and AIOps as a core pillar of the portfolio.  This elevation shows that Broadcom is now centering its Distributed Software strategy on ValueOps as the primary engine for driving end‑to‑end visibility, business‑outcome focus, and faster value delivery across its digital‑lifecycle offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues in accuracy and reasoning. STRENGTHS: (1) Correctly identifies the shift from 2023 to 2024 in ValueOps positioning; (2) Accurately notes ValueOps moved from peripheral to core pillar status; (3) Correctly identifies the three core domains (ValueOps, DevOps, AIOps); (4) Properly references the end-to-end visibility concept. CRITICAL ERRORS: (1) The LLM attributes specific ValueOps functionality descriptions ('delivers value-stream management…aligns business and development teams…increasing transparency, reducing inefficiencies, and improving time-to-value') to the 2024 filing, but the ground truth does not confirm these exact phrases appear in the filings—this represents potential fabrication or misattribution; (2) The LLM states ValueOps is 'the primary engine' for the strategy, which overstates the ground truth claim that it became 'more central' and 'one of three core domains' (not THE primary engine); (3) The characterization of 2023 positioning as 'peripheral line-item' is somewhat accurate but less nuanced than the ground truth's description of it being 'listed as one of several key offerings.' REASONING ISSUES: The multi-hop synthesis is partially sound—the LLM correctly identifies the evolution trajectory—but the specific quoted language and the claim about ValueOps being the 'primary engine' exceed what the ground truth supports. The answer conflates elevation to core pillar status with being the primary driver, which is a subtle but important distinction. The ground truth emphasizes ValueOps becoming 'more central' and 'foundational' alongside the other two domains, not as the singular primary engine.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 467,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 FedEx shifted Network 2.0 from a planning stage to active execution—launching the one‑FedEx consolidation, the Tricolor redesign of its international air network and a European workforce‑reduction plan—while repeatedly stressing that the permanent cost‑structure reductions and efficiency gains it expects may be lower than forecast and could require higher‑than‑anticipated spending.  The company now acknowledges that realizing those savings is contingent on successfully integrating disparate networks, navigating labor and regulatory hurdles, and avoiding delays or litigation, all of which introduce significant implementation risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of FedEx's Network 2.0 evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from planning/investment justification phase (2023) to active execution and integration phase (2024); (2) Accurately captures specific initiatives (one-FedEx consolidation, Tricolor redesign, European workforce reduction); (3) Properly synthesizes the key risk evolution - from execution timeline/cost risks to operational integration and financial risks; (4) Correctly notes the company's acknowledgment that actual savings may differ from expectations; (5) Identifies relevant implementation risks including labor, regulatory, litigation, and integration challenges. MINOR GAPS: (1) The LLM answer doesn't explicitly mention some specific risk categories mentioned in ground truth such as 'asset impairment charges' and 'tax impacts,' though it does reference 'higher-than-anticipated spending' which captures the financial risk dimension; (2) Doesn't explicitly mention 'harmonizing operating practices' or 'maintaining customer and service provider agreements' as distinct risk factors, though 'integrating disparate networks' is semantically similar; (3) The phrase 'cultural differences' from ground truth isn't explicitly stated, though 'labor and regulatory hurdles' captures related concerns. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not applicable - score reflects that no quantitative errors exist. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the progression of FedEx's strategic approach and risk profile. The logical flow from planning to execution to integration risk management is sound. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - the transition from strategic planning with execution risks to operational integration with financial and implementation risks is clearly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 547,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "\nBetween 2022 and 2023 the earnings impact from equity‑method investment contracts moved from **$0 million in 2022 to a $7 million gain in 2023** (after a $2 million gain in 2021). This modest, recent gain shows that MDLZ’s exposure to the embedded derivative in its exchangeable‑bond investment is limited and only generated a small positive contribution in the latest year, indicating a relatively low level of active engagement with these investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states the 2022 figure was '$0 million' when the ground truth clearly indicates it was 'a net liability of $3 million.' This is a critical factual error. The 2023 figure of '$7 million gain' is correct and matches the ground truth. The LLM also introduces information about a '$2 million gain in 2021' which is not mentioned in the ground truth and appears to be extraneous detail. (2) CALCULATION/COMPARISON ISSUE: The LLM describes the movement as from '$0 million to $7 million' when it should be from '-$3 million (liability) to +$7 million (gain)' - a $10 million swing, not a $7 million change. This misrepresents the magnitude of the financial impact evolution. (3) REASONING QUALITY: While the LLM attempts to interpret what the change indicates about MDLZ's engagement, it concludes 'relatively low level of active engagement' based on the 'modest, recent gain.' The ground truth interpretation emphasizes this as 'a reversal in financial impact and potentially more active or favorable engagement' - a more positive characterization. The LLM's interpretation is somewhat contradictory (a $10M swing from liability to gain should suggest more active engagement, not less). (4) ENTITY/METRIC ACCURACY: The LLM correctly identifies MDLZ and the metric (equity method investment contracts), but mischaracterizes the nature of the 2022 position by stating it as $0 rather than a $3M liability. The reference to 'embedded derivative in exchangeable-bond investment' adds context not in the ground truth but doesn't contradict it. (5) MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the year-over-year comparison because the 2022 baseline is wrong. The core finding of a reversal from negative to positive is partially captured but undermined by the incorrect 2022 figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 523,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "\nThe estimated cost to complete for the VMware Cloud Foundation July 2024 releases fell from roughly $70 million in fiscal 2023 to $38 million in fiscal 2024. This decline shows that about two‑thirds of the work is already finished and only a modest amount of additional spending remains, indicating the releases are progressing ahead of schedule and are on track to meet expectations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claim. According to the ground truth, the estimated cost to complete for VMware Cloud Foundation July 2024 releases remained UNCHANGED at $38 million in both fiscal year 2023 and fiscal year 2024. The LLM incorrectly states the cost fell from $70 million in FY2023 to $38 million in FY2024 - this is a major factual error. The $70 million figure appears to be fabricated and does not match the ground truth data. The LLM's interpretation that the decline indicates progress ahead of schedule is logically sound reasoning, but it is based on incorrect numbers. The ground truth explicitly states the cost remained at $38 million, indicating development was proceeding as planned with no significant unexpected expenses or delays. The LLM's conclusion about progress ahead of schedule contradicts the ground truth's assessment that the consistency indicates development was 'proceeding largely as planned.' This represents a fundamental misunderstanding of the actual data. The answer does address the question's structure (comparing FY2023 to FY2024 and discussing what it indicates about progress), but the quantitative foundation is entirely wrong, making the entire analysis invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 350,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "\nBetween 2023 and 2024 the **Ship & Go kiosk** shifted from a pure “drop‑off‑only” shipping point to a **multi‑purpose e‑commerce hub** that now supports label‑less, QR‑code returns through FedEx Consolidated Returns and is paired with the broader returns‑technology rollout.  While the kiosk still exists in roughly **1,300 locations**, the 2024 disclosures highlight its role in **streamlining returns, offering flexible pickup windows and label‑free drop‑offs**, and integrating those services with FedEx’s omnichannel logistics platform.  This evolution signals that FedEx is **leveraging its retail footprint as a reverse‑logistics gateway**, using the kiosks to capture and process returns more efficiently and to provide a seamless, end‑to‑end fulfillment experience for online shoppers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the ~1,300 locations figure for both 2023 and 2024, matching ground truth exactly; (2) Accurately captures the core evolution from basic shipping solution to integrated returns hub; (3) Properly synthesizes the shift toward FedEx Returns Technology and Consolidated Returns integration; (4) Correctly identifies the emphasis on label-free/QR-code returns and drop-offs without boxes; (5) Sound reasoning about strategic positioning as a 'reverse-logistics gateway' that aligns with ground truth's conclusion about positioning Ship and Go as 'a key node in FedEx's broader e-commerce returns infrastructure'; (6) Appropriate use of business terminology and logical flow. MINOR WEAKNESSES: (1) The phrase 'drop-off-only' in the opening slightly mischaracterizes 2023 positioning - the ground truth indicates it was already described as facilitating e-commerce returns, just not emphasized; (2) The mention of 'flexible pickup windows' is not explicitly supported in the ground truth provided, though it may be a reasonable inference about returns management; (3) The characterization of 2023 as 'pure drop-off-only' is slightly overstated compared to ground truth's more nuanced description. QUANTITATIVE VERIFICATION: The 1,300 locations figure is correct for both years. No calculations required. MULTI-HOP REASONING: Successfully synthesizes information about the kiosk's evolution across two years and connects it to broader strategic implications about e-commerce and returns management. The reasoning chain is logical and well-supported by the ground truth. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as ground truth while using slightly different framing ('multi-purpose e-commerce hub' vs 'key node in returns infrastructure' - semantically equivalent).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 526,
        "total_tokens": 1961
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 998,
    "failed_evaluations": 2,
    "average_correctness_score": 5.03,
    "average_quantitative_accuracy": 5.26,
    "average_qualitative_accuracy": 5.35,
    "average_contextual_relevance": 6.51,
    "score_distribution": {
      "excellent": 119,
      "good": 183,
      "fair": 329,
      "poor": 367
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 7739.2,
    "timestamp": "2026-02-02T17:49:24.946626"
  }
}